PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Buchan, J				Buchan, James			Challenges for WHO code on international recruitment	BRITISH MEDICAL JOURNAL			English	Editorial Material									Queen Margaret Univ, Edinburgh, Midlothian, Scotland	Queen Margaret University	Buchan, J (corresponding author), Queen Margaret Univ, Edinburgh, Midlothian, Scotland.	jbuchan@qmu.ac.uk						Buchan J, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-33; Buchan James, 2006, Hum Resour Health, V4, P14, DOI 10.1186/1478-4491-4-14; *COMM SECR, 2003, COMM COD PRACT INT R; DEMESQUITA J, 2006, HUMAN RIGHTS ANAL HL; Department of Health, 2004, COD PRACT INT RECR H; Directorate for Health and Social Affairs Norway, 2007, RECR HLTH WORK GLOB; GORDON M, 2008, WHO ORG EC COOP DEV; MafuBelu Daisy, 2004, INT ORG MIGR SEM HLT; McIntosh T., 2007, ETHICAL RECRUITMENT; Mills EJ, 2008, LANCET, V371, P685, DOI 10.1016/S0140-6736(08)60308-6; Organisation for Economic Co-operation and Development, 2009, HLTH GLANC; Robinson R., 2007, 49 EQ, P56; SCOTTISH EXECUTIVE, 2006, COD PRACT INT RECR H; Seccombe I., 2009, DIFFICULT TIMES DIFF; Stilwell Barbara, 2003, Hum Resour Health, V1, P8, DOI 10.1186/1478-4491-1-8; United Nations Development Program, 2009, OV BARR HUM MOB DEV; WHO, 2010, INCREASING ACCESS TO HEALTH WORKERS IN REMOTE AND RURAL AREAS THROUGH IMPROVED RETENTION: GLOBAL POLICY RECOMMENDATIONS, P1; WHO, GLOB HLTH ATL; *WHO EX BOARD, FLOW HLTH PROF POOR; *WHO EX BOARD, 2009, INT RECR HLTH PERS D; *WHO W PAC REG OFF, 2007, PAC COD PRACT RECR H; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	22	5	5	3	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 29	2010	340								c1486	10.1136/bmj.c1486	http://dx.doi.org/10.1136/bmj.c1486			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579VI	20351078				2022-12-28	WOS:000276404000003
J	Hackermuller, L; Schneider, U; Moreno-Cardoner, M; Kitagawa, T; Best, T; Will, S; Demler, E; Altman, E; Bloch, I; Paredes, B				Hackermueller, Lucia; Schneider, Ulrich; Moreno-Cardoner, Maria; Kitagawa, Takuya; Best, Thorsten; Will, Sebastian; Demler, Eugene; Altman, Ehud; Bloch, Immanuel; Paredes, Belen			Anomalous Expansion of Attractively Interacting Fermionic Atoms in an Optical Lattice	SCIENCE			English	Article							HUBBARD-MODEL; MOTT INSULATOR; PHYSICS; GASES; SUPERCONDUCTIVITY	The interplay of thermodynamics and quantum correlations can give rise to counterintuitive phenomena in many-body systems. We report on an isentropic effect in a spin mixture of attractively interacting fermionic atoms in an optical lattice. As we adiabatically increase the attraction between the atoms, we observe that the gas expands instead of contracting. This unexpected behavior demonstrates the crucial role of the lattice potential in the thermodynamics of the fermionic Hubbard model.	[Hackermueller, Lucia; Schneider, Ulrich; Moreno-Cardoner, Maria; Best, Thorsten; Will, Sebastian; Bloch, Immanuel; Paredes, Belen] Johannes Gutenberg Univ Mainz, Inst Phys, D-55099 Mainz, Germany; [Schneider, Ulrich; Moreno-Cardoner, Maria; Will, Sebastian; Bloch, Immanuel] Univ Munich, D-80799 Munich, Germany; [Kitagawa, Takuya; Demler, Eugene] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Altman, Ehud] Weizmann Inst Sci, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel; [Bloch, Immanuel] Max Planck Inst Quantum Opt, D-85748 Garching, Germany	Johannes Gutenberg University of Mainz; University of Munich; Harvard University; Weizmann Institute of Science; Max Planck Society	Paredes, B (corresponding author), Johannes Gutenberg Univ Mainz, Inst Phys, D-55099 Mainz, Germany.	paredes@uni-mainz.de	Demler, Eugene/ABG-1933-2021; Bloch, Immanuel/G-3174-2010; Moreno, Maria/I-8455-2012; Bloch, Immanuel/N-9169-2019; Schneider, Ulrich/N-4820-2015; Will, Sebastian/B-8933-2011; Altman, Ehud/C-1514-2010	Demler, Eugene/0000-0002-2499-632X; Bloch, Immanuel/0000-0002-0679-4759; Moreno, Maria/0000-0003-3583-2467; Schneider, Ulrich/0000-0003-4345-9498; Will, Sebastian/0000-0003-2672-5264; Altman, Ehud/0000-0003-4068-8287; Hackermueller, Lucia/0000-0001-9880-2914	Deutsche Forschungsgemeinschaft; European Union; EuroQUAM; Defense Advanced Research Projects Agency; Air Force Office of Scientific Research; German-Israeli Project Cooperation; U.S.-Israel Binational Science Foundation; EPSRC [EP/E036473/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E036473/1] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); EuroQUAM; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); German-Israeli Project Cooperation; U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by the Deutsche Forschungsgemeinschaft, the European Union (IP SCALA), EuroQUAM ( L. H.), the Defense Advanced Research Projects Agency ( Optical Lattice Emulator program), the Air Force Office of Scientific Research, the German-Israeli Project Cooperation (DIP) ( E. A. and I. B.), the U.S.-Israel Binational Science Foundation ( E. A. and E. D.), and MATCOR ( S. W.).	AUERBACH A, 2006, INTERACTING ELECT QU; Bartenstein M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.120401; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Chien CC, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.043612; Chin JK, 2006, NATURE, V443, P961, DOI 10.1038/nature05224; Cooper NR, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.176807; Giorgini S, 2008, REV MOD PHYS, V80, P1215, DOI 10.1103/RevModPhys.80.1215; HENDERSON JA, 1992, PHYS REV B, V46, P6328, DOI 10.1103/PhysRevB.46.6328; Ho AF, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.033620; Hofstetter W, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.220407; Jaksch D, 2005, ANN PHYS-NEW YORK, V315, P52, DOI 10.1016/j.aop.2004.09.010; Jordens R, 2008, NATURE, V455, P204, DOI 10.1038/nature07244; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Lewenstein M, 2007, ADV PHYS, V56, P243, DOI 10.1080/00018730701223200; METZNER W, 1991, PHYS REV B, V43, P8549, DOI 10.1103/PhysRevB.43.8549; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; RANDERIA M, 1992, PHYS REV LETT, V69, P2001, DOI 10.1103/PhysRevLett.69.2001; Regal CA, 2003, NATURE, V424, P47, DOI 10.1038/nature01738; Richardson RC, 1997, REV MOD PHYS, V69, P683, DOI 10.1103/RevModPhys.69.683; Rost AW, 2009, SCIENCE, V325, P1360, DOI 10.1126/science.1176627; Scarola VW, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.135302; Schneider U, 2008, SCIENCE, V322, P1520, DOI 10.1126/science.1165449; STORFERLE T, 2006, PHYS REV LETT, V96; Strohmaier N, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.220601; Toschi A, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/007; Wen X.G., 2004, QUANTUM FIELD THEORY	27	75	75	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2010	327	5973					1621	1624		10.1126/science.1184565	http://dx.doi.org/10.1126/science.1184565			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339067	Green Submitted			2022-12-28	WOS:000275970600037
J	Parks, JE				Parks, James E., II			Less Costly Catalysts for Controlling Engine Emissions	SCIENCE			English	Editorial Material							NOX-STORAGE; PT/BAO/AL2O3		Oak Ridge Natl Lab, Fuels Engines & Emiss Res Ctr, Knoxville, TN 37932 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory	Parks, JE (corresponding author), Oak Ridge Natl Lab, Fuels Engines & Emiss Res Ctr, Knoxville, TN 37932 USA.	parksjeii@ornl.gov						EICHLSEDER H, 2000, SAE TECH PAP SER; Epling WS, 2004, CATAL REV, V46, P163, DOI 10.1081/CR-200031932; Kim CH, 2010, SCIENCE, V327, P1624, DOI 10.1126/science.1184087; Muncrief RL, 2004, CATAL TODAY, V98, P393, DOI 10.1016/j.cattod.2004.08.004; Olsson L, 2002, J CATAL, V210, P340, DOI 10.1006/jcat.2002.3698; ROHR F, 2008, SAE TECH PAP SER; Schmeisser V, 2007, TOP CATAL, V42-43, P15, DOI 10.1007/s11244-007-0143-9; STROIA BJ, 2008, SAE TECH PAP SER; THEIS JR, 2007, SAE TECH PAP SER; THEIS JR, 2006, SAE TECH PAP SER	10	55	57	3	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	2010	327	5973					1584	1585		10.1126/science.1187154	http://dx.doi.org/10.1126/science.1187154			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339054				2022-12-28	WOS:000275970600022
J	Sharma, V; Agarwal, MP				Sharma, Vishal; Agarwal, Mukul P.			Picture Quiz A woman with fatigue, dyspnoea, and orthopnoea	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY HYPOTHYROIDISM; CARDIOVASCULAR-SYSTEM; PERICARDIAL-EFFUSION; CARDIAC-TAMPONADE; THYROID-HORMONE; PERICARDIOCENTESIS; MECHANISMS; DISEASE; EDEMA		[Sharma, Vishal; Agarwal, Mukul P.] Univ Delhi, Univ Coll Med Sci, Dept Med, Delhi 110095, India	University of Delhi; University College of Medical Sciences	Sharma, V (corresponding author), Univ Delhi, Univ Coll Med Sci, Dept Med, Delhi 110095, India.	docvishalsharma@gmail.com	Sharma, Vishal/B-9729-2011	Sharma, Vishal/0000-0003-2472-3409				Aggarwal A, 2008, J POSTGRAD MED, V54, P225; Biondi B, 2008, ENDOCR REV, V29, P76, DOI 10.1210/er.2006-0043; Cheitlin MD, 1997, CIRCULATION, V95, P1686; Dattilo G, 2011, INT J CARDIOL, V153, pE47, DOI 10.1016/j.ijcard.2009.03.090; Fagan SM, 1999, CHEST, V116, P275, DOI 10.1378/chest.116.2.275; Fazio S, 2004, RECENT PROG HORM RES, V59, P31, DOI 10.1210/rp.59.1.31; FREDLUND BO, 1983, ACTA MED SCAND, V213, P231; Goswami R, 1996, POSTGRAD MED J, V72, P501, DOI 10.1136/pgmj.72.850.501; GOTEHRER A, 1990, CHEST, V98, P1130, DOI 10.1378/chest.98.5.1130; Gupta A, 1996, J Assoc Physicians India, V44, P551; GUPTA A, 1996, J ASSOC PHYSICIAN I, V44, P551; HARDISTY CA, 1980, CLIN ENDOCRINOL, V13, P349, DOI 10.1111/j.1365-2265.1980.tb03395.x; Hataya Y, 2007, ENDOCR J, V54, P577, DOI 10.1507/endocrj.K06-114; KABADI UM, 1990, AM HEART J, V120, P1393, DOI 10.1016/0002-8703(90)90253-T; KHALEELI AA, 1982, POSTGRAD MED J, V58, P473, DOI 10.1136/pgmj.58.682.473; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; LeWinter M.M., 2008, BRAUNWALDS HEART DIS, V8th, P1829; Little WC, 2006, CIRCULATION, V113, P1622, DOI 10.1161/CIRCULATIONAHA.105.561514; MANCUSO L, 1986, Giornale Italiano di Cardiologia, V16, P505; PARVING HH, 1979, NEW ENGL J MED, V301, P460, DOI 10.1056/NEJM197908303010902; Rawat B, 2004, Kathmandu Univ Med J (KUMJ), V2, P182; Sagrista-Sauleda J, 2006, CIRCULATION, V114, P945, DOI 10.1161/CIRCULATIONAHA.106.634584; SAITO I, 1983, HYPERTENSION, V5, P112, DOI 10.1161/01.HYP.5.1.112; Spodick DH, 1998, CHEST, V113, P1372, DOI 10.1378/chest.113.5.1372; Spodick DH, 2003, NEW ENGL J MED, V349, P684, DOI 10.1056/NEJMra022643; STEMBACH G, 1988, J EMERGENCY MED, V6, P417; Tsang TSM, 1998, MAYO CLIN PROC, V73, P647, DOI 10.4065/73.7.647; Tsang TSM, 2002, MAYO CLIN PROC, V77, P429	28	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2010	340								c1277	10.1136/bmj.c1277	http://dx.doi.org/10.1136/bmj.c1277			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	576PP	20335641				2022-12-28	WOS:000276157700002
J	Nathan, C; Ding, AH				Nathan, Carl; Ding, Aihao			Nonresolving Inflammation	CELL			English	Review							CHRONIC GRANULOMATOUS-DISEASE; ACUTE LUNG INJURY; APOPTOTIC CELLS; IMMUNE-SYSTEM; NITRIC-OXIDE; ANTIINFLAMMATORY PROPERTIES; MEDIATED INFLAMMATION; AIRWAY INFLAMMATION; DEPENDENT CLEARANCE; PULMONARY-FIBROSIS	Nonresolving inflammation is a major driver of disease. Perpetuation of inflammation is an inherent risk because inflammation can damage tissue and necrosis can provoke inflammation. Nonetheless, multiple mechanisms normally ensure resolution. Cells like macrophages switch phenotypes, secreted molecules like reactive oxygen intermediates switch impact from pro- to anti-inflammatory, and additional mediators of resolution arise, including proteins, lipids, and gasses. Aside from persistence of initiating stimuli, nonresolution may result from deficiencies in these mechanisms when an inflammatory response begins either excessively or subnormally. This greatly complicates the development of anti-inflammatory therapies. The problem calls for conceptual, organizational, and statistical innovations.	[Nathan, Carl; Ding, Aihao] Cornell Univ, Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Nathan, Carl; Ding, Aihao] Cornell Univ, Weill Grad Sch Med Sci, Program Immunol & Microbial Pathogenesis, New York, NY 10065 USA	Cornell University; Cornell University	Nathan, C (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA.	cnathan@med.cornell.edu			William Randolph Hearst Foundation	William Randolph Hearst Foundation	We thank Kyu Rhee for critical comments. The Department of Microbiology and Immunology is supported by the William Randolph Hearst Foundation.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Akaike T, 1996, P NATL ACAD SCI USA, V93, P2448, DOI 10.1073/pnas.93.6.2448; Altznauer F, 2004, J EXP MED, V199, P1343, DOI 10.1084/jem.20032033; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Ehrchen J, 2007, BLOOD, V109, P1265, DOI 10.1182/blood-2006-02-001115; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Freeman BA, 2008, J BIOL CHEM, V283, P15515, DOI 10.1074/jbc.R800004200; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Guarda G, 2009, NATURE, V460, P269, DOI 10.1038/nature08100; Han H, 2005, J EXP MED, V202, P353, DOI 10.1084/jem.20050778; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Hedlund M, 2008, P NATL ACAD SCI USA, V105, P18936, DOI 10.1073/pnas.0803943105; Hodge-Dufour J, 1998, P NATL ACAD SCI USA, V95, P13806, DOI 10.1073/pnas.95.23.13806; HOLLINGSWORTH JW, 1967, YALE J BIOL MED, V39, P289; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI11638; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Karupiah G, 1998, J EXP MED, V188, P1541, DOI 10.1084/jem.188.8.1541; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kennedy AD, 2009, IMMUNOL RES, V43, P25, DOI 10.1007/s12026-008-8049-6; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Lo EH, 2009, NAT MED, V15, P844, DOI 10.1038/nm0809-844; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nathan C, 2003, J CLIN INVEST, V111, P769, DOI 10.1172/JCI200318174; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981; Nathan C, 2008, MOL MED, V14, P485, DOI 10.2119/2008-00038.Nathan; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Nofer JR, 2004, J CLIN INVEST, V113, P569, DOI 10.1172/JCI200418004; Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Reddy NM, 2009, J IMMUNOL, V182, P7264, DOI 10.4049/jimmunol.0804248; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; Strieter RM, 2007, J CLIN INVEST, V117, P549, DOI 10.1172/JCI30562; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; TSUNAWAKI S, 1988, NATURE, V334, P260, DOI 10.1038/334260a0; Uysal H, 2009, J EXP MED, V206, P449, DOI 10.1084/jem.20081862; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yadav UCS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006535; Zhang M, 2006, J EXP MED, V203, P141, DOI 10.1084/jem.20050390; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	80	1310	1378	7	203	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 19	2010	140	6					871	882		10.1016/j.cell.2010.02.029	http://dx.doi.org/10.1016/j.cell.2010.02.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	571IX	20303877	Bronze			2022-12-28	WOS:000275746600011
J	Tanaka, Y; Himuro, Y; Kainuma, R; Sutou, Y; Omori, T; Ishida, K				Tanaka, Y.; Himuro, Y.; Kainuma, R.; Sutou, Y.; Omori, T.; Ishida, K.			Ferrous Polycrystalline Shape-Memory Alloy Showing Huge Superelasticity	SCIENCE			English	Article							MARTENSITIC-TRANSFORMATION; SINGLE-CRYSTALS; BEHAVIOR; TEXTURE; NITI	Shape-memory alloys, such as Ni-Ti and Cu-Zn-Al, show a large reversible strain of more than several percent due to superelasticity. In particular, the Ni-Ti-based alloy, which exhibits some ductility and excellent superelastic strain, is the only superelastic material available for practical applications at present. We herein describe a ferrous polycrystalline, high-strength, shape-memory alloy exhibiting a superelastic strain of more than 13%, with a tensile strength above 1 gigapascal, which is almost twice the maximum superelastic strain obtained in the Ni-Ti alloys. Furthermore, this ferrous alloy has a very large damping capacity and exhibits a large reversible change in magnetization during loading and unloading. This ferrous shape-memory alloy has great potential as a high-damping and sensor material.	[Kainuma, R.] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808579, Japan; [Tanaka, Y.; Himuro, Y.; Sutou, Y.; Omori, T.; Ishida, K.] Tohoku Univ, Grad Sch Engn, Dept Mat Sci, Sendai, Miyagi 9808579, Japan	Tohoku University; Tohoku University	Kainuma, R (corresponding author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808579, Japan.	kainuma@tagen.tohoku.ac.jp	Omori, Toshihiro/A-4478-2017; Kainuma, Ryosuke/I-6482-2013; Sutou, Yuji/GNM-7287-2022	Omori, Toshihiro/0000-0001-9174-0239; Sutou, Yuji/0000-0002-3067-2727	Japanese Society for the Promotion of Science (JSPS); New Energy and Industrial Technology Development Organization (NEDO); Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency (JST); Tohoku University, MEXT, Japan	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Tohoku University, MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors are grateful to K. R. Ziebeck at Cambridge University for his help in critical reading. This work was supported by Grant-in-Aids from the Japanese Society for the Promotion of Science (JSPS), New Energy and Industrial Technology Development Organization (NEDO), Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), and Global COE Program, Tohoku University, MEXT, Japan.	Dadda J, 2008, METALL MATER TRANS A, V39A, P2026, DOI 10.1007/s11661-008-9543-0; DesRoches R, 2002, ENG STRUCT, V24, P325, DOI 10.1016/S0141-0296(01)00098-0; DUNNE DP, 1973, METALL TRANS, V4, P137, DOI 10.1007/BF02649612; Elnashai A. S, 2003, PROGR STRUCTURAL ENG, V5, P60; Ganzhula N, 1979, PHYS MET METALLOGR, V47, P186; HORNBOGEN E, 1967, Z METALLKD, V58, P372; HORNBOGEN E, 1967, ACTA METALL MATER, V15, P584, DOI 10.1016/0001-6160(67)90099-5; Kajiwara S, 1999, MAT SCI ENG A-STRUCT, V273, P67, DOI 10.1016/S0921-5093(99)00290-7; Kajiwara S, 2003, PROC SPIE, V5053, P250, DOI 10.1117/12.484341; KAJIWARA S, 1990, ACTA METALL MATER, V38, P847, DOI 10.1016/0956-7151(90)90038-I; KAKESHITA T, 1985, SCRIPTA METALL MATER, V19, P973, DOI 10.1016/0036-9748(85)90294-7; Kokorin VV, 1989, PHYS MET METALLOGR, V67, P202; MAKI T, 1984, SCRIPTA METALL MATER, V18, P1105, DOI 10.1016/0036-9748(84)90187-X; McCormick J, 2007, J ENG MECH, V133, P1019, DOI 10.1061/(ASCE)0733-9399(2007)133:9(1019); SATO A, 1982, ACTA METALL MATER, V30, P1177, DOI 10.1016/0001-6160(82)90011-6; Sehitoglu H, 2000, ACTA MATER, V48, P3311, DOI 10.1016/S1359-6454(00)00153-1; Shu YC, 1998, ACTA MATER, V46, P5457, DOI 10.1016/S1359-6454(98)00184-0; SOHMURA T, 1980, SCRIPTA METALL MATER, V14, P855, DOI 10.1016/0036-9748(80)90304-X; Sutou Y, 2002, METALL MATER TRANS A, V33, P2817, DOI 10.1007/s11661-002-0267-2; Takagi T, 2006, J BIOMED MATER RES B, V76B, P179, DOI 10.1002/jbm.b.30415; WATANABE T, 1989, ACTA METALL MATER, V37, P941, DOI 10.1016/0001-6160(89)90021-7; Wayman C.M., 1998, SHAPE MEMORY MAT	22	359	379	22	336	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2010	327	5972					1488	1490		10.1126/science.1183169	http://dx.doi.org/10.1126/science.1183169			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20299589				2022-12-28	WOS:000275715200041
J	Deeg, HJ; Moutou, C; Erikson, A; Csizmadia, S; Tingley, B; Barge, P; Bruntt, H; Havel, M; Aigrain, S; Almenara, JM; Alonso, R; Auvergne, M; Baglin, A; Barbieri, M; Benz, W; Bonomo, AS; Borde, P; Bouchy, F; Cabrera, J; Carone, L; Carpano, S; Ciardi, D; Deleuil, M; Dvorak, R; Ferraz-Mello, S; Fridlund, M; Gandolfi, D; Gazzano, JC; Gillon, M; Gondoin, P; Guenther, E; Guillot, T; den Hartog, R; Hatzes, A; Hidas, M; Hebrard, G; Jorda, L; Kabath, P; Lammer, H; Leger, A; Lister, T; Llebaria, A; Lovis, C; Mayor, M; Mazeh, T; Ollivier, M; Patzold, M; Pepe, F; Pont, F; Queloz, D; Rabus, M; Rauer, H; Rouan, D; Samuel, B; Schneider, J; Shporer, A; Stecklum, B; Street, R; Udry, S; Weingrill, J; Wuchterl, G				Deeg, H. J.; Moutou, C.; Erikson, A.; Csizmadia, Sz.; Tingley, B.; Barge, P.; Bruntt, H.; Havel, M.; Aigrain, S.; Almenara, J. M.; Alonso, R.; Auvergne, M.; Baglin, A.; Barbieri, M.; Benz, W.; Bonomo, A. S.; Borde, P.; Bouchy, F.; Cabrera, J.; Carone, L.; Carpano, S.; Ciardi, D.; Deleuil, M.; Dvorak, R.; Ferraz-Mello, S.; Fridlund, M.; Gandolfi, D.; Gazzano, J. -C.; Gillon, M.; Gondoin, P.; Guenther, E.; Guillot, T.; den Hartog, R.; Hatzes, A.; Hidas, M.; Hebrard, G.; Jorda, L.; Kabath, P.; Lammer, H.; Leger, A.; Lister, T.; Llebaria, A.; Lovis, C.; Mayor, M.; Mazeh, T.; Ollivier, M.; Paetzold, M.; Pepe, F.; Pont, F.; Queloz, D.; Rabus, M.; Rauer, H.; Rouan, D.; Samuel, B.; Schneider, J.; Shporer, A.; Stecklum, B.; Street, R.; Udry, S.; Weingrill, J.; Wuchterl, G.			A transiting giant planet with a temperature between 250 K and 430 K	NATURE			English	Article							ABUNDANCE ANALYSIS; EVOLUTION; STARS	Of the over 400 known(1) exoplanets, there are about 70 planets that transit their central star, a situation that permits the derivation of their basic parameters and facilitates investigations of their atmospheres. Some short-period planets(2), including the first terrestrial exoplanet(3,4) (CoRoT-7b), have been discovered using a space mission(5) designed to find smaller and more distant planets than can be seen from the ground. Here we report transit observations of CoRoT-9b, which orbits with a period of 95.274 days on a low eccentricity of 0.11 +/- 0.04 around a solar-like star. Its periastron distance of 0.36 astronomical units is by far the largest of all transiting planets, yielding a 'temperate' photospheric temperature estimated to be between 250 and 430 K. Unlike previously known transiting planets, the present size of CoRoT-9b should not have been affected by tidal heat dissipation processes. Indeed, the planet is found to be well described by standard evolution models(6) with an inferred interior composition consistent with that of Jupiter and Saturn.	[Deeg, H. J.; Tingley, B.; Almenara, J. M.; Rabus, M.] Inst Astrofis Canarias, E-38205 Tenerife, Spain; [Deeg, H. J.; Tingley, B.; Almenara, J. M.; Rabus, M.] Univ La Laguna, Dept Astrofis, E-38200 Tenerife, Spain; [Moutou, C.; Barge, P.; Barbieri, M.; Bonomo, A. S.; Deleuil, M.; Gazzano, J. -C.; Jorda, L.; Llebaria, A.] CNRS, Lab Astrophys Marseille, F-13388 Marseille 13, France; [Moutou, C.; Barge, P.; Barbieri, M.; Bonomo, A. S.; Deleuil, M.; Gazzano, J. -C.; Jorda, L.; Llebaria, A.] Univ Aix Marseille 1, F-13388 Marseille 13, France; [Erikson, A.; Csizmadia, Sz.; Kabath, P.; Rauer, H.] German Aerosp Ctr, Inst Planetary Res, D-12489 Berlin, Germany; [Bruntt, H.; Auvergne, M.; Baglin, A.; Rouan, D.] CNRS, Observ Paris, LESIA, F-92195 Meudon, France; [Havel, M.; Guillot, T.] Univ Nice Sophia Antipolis, Observ Cote Azur, CNRS, UMR 6202, F-06304 Nice 4, France; [Aigrain, S.; Pont, F.] Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England; [Aigrain, S.] Univ Oxford, Oxford OX1 3RH, England; [Alonso, R.; Lovis, C.; Mayor, M.; Pepe, F.; Queloz, D.; Udry, S.] Observ Univ Geneve, CH-1290 Sauverny, Switzerland; [Barbieri, M.] Univ Padua, Dipartimento Astron, I-35122 Padua, Italy; [Benz, W.] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Borde, P.; Leger, A.; Ollivier, M.; Samuel, B.] Univ Paris 11, Inst Astrophys Spatiale, F-91405 Orsay, France; [Bouchy, F.; Hebrard, G.] IAP, F-75014 Paris, France; [Bouchy, F.] Observ Haute Provence, CNRS, OAMP, F-04870 St Michel lObservatoire, France; [Cabrera, J.; Schneider, J.] CNRS, Observ Paris, LUTH, F-92195 Meudon, France; [Cabrera, J.; Schneider, J.] Univ Paris Diderot, F-92195 Meudon, France; [Carone, L.; Paetzold, M.] Univ Cologne, Rhein Inst Umweltforschung, D-50931 Cologne, Germany; [Carpano, S.; Fridlund, M.; Gondoin, P.; den Hartog, R.] European Space Agcy, Estec, Res & Sci Support Dept, NL-2200 AG Noordwijk, Netherlands; [Ciardi, D.] NASA, Exoplanet Sci Inst, CALTECH, Pasadena, CA 91125 USA; [Dvorak, R.] Univ Vienna, Inst Astron, A-1180 Vienna, Austria; [Ferraz-Mello, S.] Univ Sao Paulo, Inst Astron Geophys & Atmospher Sci, BR-05508 Sao Paulo, Brazil; [Gandolfi, D.; Guenther, E.; Hatzes, A.; Stecklum, B.; Wuchterl, G.] Thuringer Landessternwarte, D-07778 Tautenburg, Germany; [Gillon, M.] Univ Liege, Liege 1, Belgium; [Hidas, M.; Lister, T.; Street, R.] Las Cumbres Observ Global Telescope Network Inc, Santa Barbara, CA 93117 USA; [Hidas, M.] Univ Sydney, Sydney Inst Astron, Sch Phys, Sydney, NSW 2006, Australia; [Lammer, H.; Weingrill, J.] Austrian Acad Sci, Space Res Inst, A-8042 Graz, Austria; [Mazeh, T.; Shporer, A.] Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Rauer, H.] TU Berlin, Ctr Astron & Astrophys, D-10623 Berlin, Germany	Instituto de Astrofisica de Canarias; Universidad de la Laguna; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Helmholtz Association; German Aerospace Centre (DLR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; University of Exeter; University of Oxford; University of Geneva; University of Padua; University of Bern; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Cologne; European Space Agency; California Institute of Technology; National Aeronautics & Space Administration (NASA); University of Vienna; Universidade de Sao Paulo; University of Liege; University of Sydney; Austrian Academy of Sciences; Tel Aviv University; Technical University of Berlin	Deeg, HJ (corresponding author), Inst Astrofis Canarias, C Via Lactea S-N, E-38205 Tenerife, Spain.	hdeeg@iac.es	Ferraz-Mello, Sylvio/AAQ-6480-2020; Tingley, Brandon/E-5146-2014; Alonso, Roi/D-8799-2014; Shporer, Avi/Y-2777-2019; Ferraz-Mello, Sylvio/B-7529-2013; Jorda, Laurent/AAA-1718-2021; Deeg, Hans/AAB-1361-2019; Barbieri, Mauro/W-4602-2017	Tingley, Brandon/0000-0003-4483-2661; Alonso, Roi/0000-0001-8462-8126; Shporer, Avi/0000-0002-1836-3120; Deeg, Hans/0000-0003-0047-4241; Barbieri, Mauro/0000-0001-8362-3462; Gandolfi, Davide/0000-0001-8627-9628; Pont, Frederic/0000-0003-0076-5444; /0000-0003-2935-7196; udry, Stephane/0000-0001-7576-6236; Bouchy, Francois/0000-0002-7613-393X; Bonomo, Aldo Stefano/0000-0002-6177-198X; Lister, Tim/0000-0002-3818-7769; Cabrera, Juan/0000-0001-6653-5487; Weingrill, Jorg/0000-0002-0848-413X; Kabath, Petr/0000-0002-1623-5352; Pepe, Francesco/0000-0002-9815-773X; Guillot, Tristan/0000-0002-7188-8428; Gillon, Michael/0000-0003-1462-7739; Carone, Ludmila/0000-0001-9355-3752; Deleuil, Magali/0000-0001-6036-0225; Ciardi, David/0000-0002-5741-3047; JORDA, Laurent/0000-0001-8735-3308; Aigrain, Suzanne/0000-0003-1453-0574	Spanish Ministerio de Ciencia e Innovacion [ESP2007-65480-C02-02]; DLR [50OW0204, 50OW0603, 50QP07011]; STFC [ST/G002266/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/G002266/1] Funding Source: researchfish	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); DLR(Helmholtz AssociationGerman Aerospace Centre (DLR)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The CoRoT space mission has been developed and is operated by CNES, with the contributions of Austria, Belgium, Brazil, ESA, Germany and Spain. CoRoT data are available to the public from the CoRoT archive: http://idoc-corot.ias.u-psud.fr. The team at IAC acknowledges support by grant ESP2007-65480-C02-02 of the Spanish Ministerio de Ciencia e Innovacion. The German CoRoT Team (TLS and Univ. Cologne) acknowledges DLR grants 50OW0204, 50OW0603 and 50QP07011. Observations with the HARPS spectrograph were performed under the ESO programme ID 082. C-0120, and observations with the VLT/UVES under ID 081.C-0413(C).	Baglin A., 2009, IAU S, P71, DOI DOI 10.1017/S1743921308026252; Barbieri M, 2007, ASTRON ASTROPHYS, V476, pL13, DOI 10.1051/0004-6361:20078787; Bruntt H, 2008, ASTRON ASTROPHYS, V478, P487, DOI 10.1051/0004-6361:20078523; Bruntt H, 2004, ASTRON ASTROPHYS, V425, P683, DOI 10.1051/0004-6361:20040464; Deeg HJ, 2009, ASTRON ASTROPHYS, V506, P343, DOI 10.1051/0004-6361/200912011; Deleuil M, 2009, ASTRON J, V138, P649, DOI 10.1088/0004-6256/138/2/649; DVORAK R, 2009, P NEW TECHN PROB DIV; Fossey SJ, 2009, MON NOT R ASTRON SOC, V396, pL16, DOI 10.1111/j.1745-3933.2009.00653.x; Garcia-Melendo E, 2009, ASTROPHYS J, V698, P558, DOI 10.1088/0004-637X/698/1/558; Geem ZW, 2001, SIMULATION, V76, P60, DOI 10.1177/003754970107600201; Guillot T, 2005, ANNU REV EARTH PL SC, V33, P493, DOI 10.1146/annurev.earth.32.101802.120325; Guillot T, 2008, PHYS SCRIPTA, VT130, DOI 10.1088/0031-8949/2008/T130/014023; IBGUI L, 2009, ASTROPHYS J UNPUB; Israelian G, 2009, NATURE, V462, P189, DOI 10.1038/nature08483; Lammer H, 2009, ASTRON ASTROPHYS, V506, P399, DOI 10.1051/0004-6361/200911922; Laughlin G, 2009, NATURE, V457, P562, DOI 10.1038/nature07649; Leger A, 2009, ASTRON ASTROPHYS, V506, P287, DOI 10.1051/0004-6361/200911933; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; Mayor M., 2003, MESSENGER, V114, P20; Miller N, 2009, ASTROPHYS J, V702, P1413, DOI 10.1088/0004-637X/702/2/1413; Morel P, 2008, ASTROPHYS SPACE SCI, V316, P61, DOI 10.1007/s10509-007-9663-9; Moutou C, 2009, ASTRON ASTROPHYS, V498, pL5, DOI 10.1051/0004-6361/200911954; PERRUCHOT S, 2008, P SPIE, V7014; Queloz D, 2009, ASTRON ASTROPHYS, V506, P303, DOI 10.1051/0004-6361/200913096; SCHNEIDER J, 1999, EXTRASOLAR PLANETS E; Showman AP, 2002, ASTRON ASTROPHYS, V385, P166, DOI 10.1051/0004-6361:20020101; Siess L, 2006, ASTRON ASTROPHYS, V448, P717, DOI 10.1051/0004-6361:20053043; Sing DK, 2010, ASTRON ASTROPHYS, V510, DOI 10.1051/0004-6361/200913675; Sudarsky D, 2000, ASTROPHYS J, V538, P885, DOI 10.1086/309160; EXODAT INFORM SYSTEM	30	80	80	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					384	387		10.1038/nature08856	http://dx.doi.org/10.1038/nature08856			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20237564	Green Published			2022-12-28	WOS:000275657100040
J	Riaz, A; Miller, FH; Kulik, LM; Nikolaidis, P; Yaghmai, V; Lewandowski, RJ; Mulcahy, MF; Ryu, RK; Sato, KT; Gupta, R; Wang, E; Baker, T; Abecassis, M; Benson, AB; Nemcek, AA; Omary, R; Salem, R				Riaz, Ahsun; Miller, Frank H.; Kulik, Laura M.; Nikolaidis, Paul; Yaghmai, Vahid; Lewandowski, Robert J.; Mulcahy, Mary F.; Ryu, Robert K.; Sato, Kent T.; Gupta, Ramona; Wang, Ed; Baker, Talia; Abecassis, Michael; Benson, Al B., III; Nemcek, Albert A., Jr.; Omary, Reed; Salem, Riad			Imaging Response in the Primary Index Lesion and Clinical Outcomes Following Transarterial Locoregional Therapy for Hepatocellular Carcinoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SOLID TUMORS; Y-90 MICROSPHERES; LIVER-TRANSPLANTATION; EVALUATION CRITERIA; CHEMOEMBOLIZATION; RADIOEMBOLIZATION; SURVIVAL; ABLATION; RECIST; MODEL	Context Response Evaluation Criteria in Solid Tumors (RECIST) (unidimensional), World Health Organization (WHO) (bidimensional), and European Association for Study of the Liver (EASL) (necrosis) guidelines are commonly used to assess response following therapy for hepatocellular carcinoma (HCC). No universally accepted standard exists. Objectives To evaluate intermethod agreement between these 3 imaging guidelines and to introduce the concept of the "primary index lesion" as a biomarker for response. Design, Setting, and Participants Single-center comprehensive imaging analysis including 245 consecutive patients with HCC who were treated with chemoembolization or radioembolization between January 2000 and December 2008. Computed tomography and magnetic resonance imaging scans (N=1065) were reviewed to assess response in the "primary index lesion," defined as the largest tumor targeted during first treatment. Main Outcome Measures Intermethod agreement (kappa statistics) between RECIST, WHO, and EASL guidelines response; correlation of WHO and EASL response in the primary index lesion with time to progression and survival. Results kappa Coefficients were 0.86 (95% confidence interval [CI], 0.80-0.92) between the WHO and RECIST guidelines, 0.24 (95% CI, 0.16-0.33) between RECIST and EASL, and 0.28 (95% CI, 0.19-0.36) between WHO and EASL. Disease progressed in 96 patients; 113 died. The hazard ratio for time to progression in responders compared with nonresponders was 0.36 (95% CI, 0.23-0.57) for WHO, 0.38 (95% CI, 0.24-0.58) for RECIST, and 0.38 (95% CI, 0.22-0.64) for EASL. Hazard ratios for survival in responders compared with nonresponders in univariate and multivariate analyses were 0.46 (95% CI, 0.32-0.67) and 0.55 (95% CI, 0.35-0.84) for WHO and 0.36 (95% CI, 0.22-0.57) and 0.54 (95% CI, 0.34-0.85) for EASL. Hazard ratios for survival in responders vs nonresponders in patients with solitary and multifocal HCC were 0.39 (95% CI, 0.19-0.77) and 0.51 (95% CI, 0.32-0.82) for WHO and 0.26 (95% CI, 0.10-0.67) and 0.47 (95% CI, 0.28-0.79) for EASL. Conclusions Among a group of patients with HCC, agreement for classification of therapeutic response was high between the RECIST and WHO guidelines but low between each of these and EASL. Application of these methods to measure response in a primary index lesion resulted in statistically significant correlations with disease progression and survival. JAMA. 2010; 303(11): 1062-1069	[Riaz, Ahsun; Miller, Frank H.; Nikolaidis, Paul; Yaghmai, Vahid; Lewandowski, Robert J.; Ryu, Robert K.; Sato, Kent T.; Gupta, Ramona; Nemcek, Albert A., Jr.; Omary, Reed; Salem, Riad] NW Mem Hosp, Dept Radiol, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Kulik, Laura M.] Northwestern Univ, Dept Med, Div Hepatol, Chicago, IL 60611 USA; [Wang, Ed; Baker, Talia; Abecassis, Michael; Salem, Riad] Northwestern Univ, Dept Transplant Surg, Chicago, IL 60611 USA; [Mulcahy, Mary F.; Benson, Al B., III; Salem, Riad] Northwestern Univ, Dept Med, Div Hematol & Oncol, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern Memorial Hospital; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Salem, R (corresponding author), NW Mem Hosp, Dept Radiol, Robert H Lurie Comprehens Canc Ctr, 676 N St Clair,Ste 800, Chicago, IL 60611 USA.	r-salem@northwestern.edu	Salem, Riad/Q-3849-2017; Baker, Talia/AAD-9378-2020; Abecassis, Michael/F-7977-2011	Salem, Riad/0000-0001-9745-1825; Riaz, Ahsun/0000-0002-1544-4494	MDS Nordion; National Institutes of Health [R01 CA126809]; NATIONAL CANCER INSTITUTE [R01CA126809] Funding Source: NIH RePORTER	MDS Nordion; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial Disclosures: Dr Benson reported serving as an advisor to, and receiving grant support from, MDS Nordion. Dr Omary and Dr Salem reported being supported in part by National Institutes of Health grant R01 CA126809. Dr Salem reported serving as consultant to, and receiving grant support from, MDS Nordion. None of the other authors reported any disclosures.	Bradburn MJ, 2003, BRIT J CANCER, V89, P605, DOI 10.1038/sj.bjc.6601120; Bruix J, 1998, HEPATOLOGY, V27, P1578, DOI 10.1002/hep.510270617; Bruix J, 2004, GASTROENTEROLOGY, V127, pS179, DOI 10.1053/j.gastro.2004.09.032; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Chung JW, 2006, KOREAN J RADIOL, V7, P257, DOI 10.3348/kjr.2006.7.4.257; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; El-Serag HB, 2002, HEPATOLOGY, V36, pS74, DOI 10.1053/jhep.2002.36807; Forner A, 2009, CANCER-AM CANCER SOC, V115, P616, DOI 10.1002/cncr.24050; Hillman SL, 2009, J CLIN ONCOL, V27, P3205, DOI 10.1200/JCO.2008.18.3269; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keppke AL, 2007, AM J ROENTGENOL, V188, P768, DOI 10.2214/AJR.06.0706; Kulik LM, 2006, J SURG ONCOL, V94, P572, DOI 10.1002/jso.20609; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lewandowski RJ, 2009, AM J TRANSPLANT, V9, P1920, DOI 10.1111/j.1600-6143.2009.02695.x; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Llovet Josep M, 2004, Liver Transpl, V10, pS115, DOI 10.1002/lt.20034; Lu DSK, 2005, RADIOLOGY, V234, P954, DOI 10.1148/radiol.2343040153; Maddala YK, 2004, LIVER TRANSPLANT, V10, P449, DOI 10.1002/lt.20099; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Organization W.H, 1979, WHO HDB REP RES CANC; Park JO, 2003, JPN J CLIN ONCOL, V33, P533, DOI 10.1093/jjco/hyg093; Riaz A, 2009, HEPATOLOGY, V49, P1185, DOI 10.1002/hep.22747; Riaz A, 2010, CARDIOVASC INTER RAD, V33, P1143, DOI 10.1007/s00270-009-9766-5; Riaz A, 2009, J CLIN ONCOL, V27, P5734, DOI 10.1200/JCO.2009.23.1282; Sala M, 2004, HEPATOLOGY, V40, P1352, DOI 10.1002/hep.20465; Salem R, 2006, J VASC INTERV RADIOL, V17, P1251, DOI 10.1097/01.RVI.0000233785.75257.9A; Salem R, 2010, GASTROENTEROLOGY, V138, P52, DOI 10.1053/j.gastro.2009.09.006; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; SVANHOLM H, 1989, APMIS, V97, P689, DOI 10.1111/j.1699-0463.1989.tb00464.x; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Toso C, 2008, LIVER TRANSPLANT, V14, P1107, DOI 10.1002/lt.21484	33	148	151	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1062	1069		10.1001/jama.2010.262	http://dx.doi.org/10.1001/jama.2010.262			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569KC	20233824	Green Accepted			2022-12-28	WOS:000275594100019
J	Rothwell, PM				Rothwell, Peter M.			Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension	LANCET			English	Review							ARTERY FUNCTION EVALUATION; HIGH CARDIOVASCULAR RISK; SOCIETY-OF-HYPERTENSION; CORONARY-HEART-DISEASE; LONG-TERM RISK; EUROPEAN-SOCIETY; OLDER PATIENTS; ORGAN DAMAGE; DOUBLE-BLIND; ANTIHYPERTENSIVE TREATMENT	Although hypertension is the most prevalent treatable vascular risk factor, how it causes end-organ damage and vascular events is poorly understood. Yet, a widespread belief exists that underlying usual blood pressure can alone account for all blood-pressure-related risk of vascular events and for the benefits of antihypertensive drugs, and this notion has come to underpin all major clinical guidelines on diagnosis and treatment of hypertension. Other potentially informative measures, such as variability in clinic blood pressure or maximum blood pressure reached, have been neglected, and effects of antihypertensive drugs on such measures are largely unknown. Clinical guidelines recommend that episodic hypertension is not treated, and the potential risks of residual variability in blood pressure in treated hypertensive patients have been ignored. This Review discusses shortcomings of the usual blood-pressure hypothesis, provides background to accompanying reports on the importance of blood-pressure variability in prediction of risk of vascular events and in accounting for benefits of antihypertensive drugs, and draws attention to clinical implications and directions for future research.	John Radcliffe Hosp, Stroke Prevent Res Unit, Univ Dept Clin Neurol, Oxford OX3 9DU, England	University of Oxford	Rothwell, PM (corresponding author), John Radcliffe Hosp, Stroke Prevent Res Unit, Univ Dept Clin Neurol, Level 6,West Wing, Oxford OX3 9DU, England.	peter.rothwell@clneuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211	National Institute of Health Research (NIHR) Biomedical Research Centre, Oxford	National Institute of Health Research (NIHR) Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR))	I receive funding from the National Institute of Health Research (NIHR) Biomedical Research Centre, Oxford, and I am in receipt of an NIHR Senior Fellowship Award.	Angeli F, 2004, AM J HYPERTENS, V17, P817, DOI 10.1016/j.amjhyper.2004.06.002; [Anonymous], 1978, J Chronic Dis, V31, P651; [Anonymous], 1991, JAMA, V265, P3255; BECKETT LA, 1992, AM J EPIDEMIOL, V135, P1166, DOI 10.1093/oxfordjournals.aje.a116217; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Borzecki AM, 2003, ARCH INTERN MED, V163, P2705, DOI 10.1001/archinte.163.22.2705; Breekveldt-Postma NS, 2008, CURR MED RES OPIN, V24, P121, DOI 10.1185/030079908X253843; Brondolo E, 2009, J OCCUP HEALTH PSYCH, V14, P110, DOI 10.1037/a0014768; Brotman DJ, 2007, LANCET, V370, P1089, DOI 10.1016/S0140-6736(07)61305-1; CANONICO V, 1990, J HUM HYPERTENS, V4, P405; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Clement DL, 2003, NEW ENGL J MED, V348, P2407, DOI 10.1056/NEJMoa022273; COLANDREA MA, 1970, CIRCULATION, V41, P239, DOI 10.1161/01.CIR.41.2.239; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Cuffe RL, 2006, STROKE, V37, P2776, DOI 10.1161/01.STR.0000244761.62073.05; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; de Champlain J, 1999, Can J Cardiol, V15 Suppl A, p8A; Desjardins F, 2008, EUR HEART J, V29, P128, DOI 10.1093/eurheartj/ehm540; Duprez DA, 2009, ETHNIC DIS, V19, P243; Fedorowski A, 2010, EUR HEART J, V31, P85, DOI 10.1093/eurheartj/ehp329; Fessel J, 2006, NAT CLIN PRACT NEPHR, V2, P424, DOI 10.1038/ncpneph0228; Feugeas MCH, 2005, MAGN RESON IMAGING, V23, P929, DOI 10.1016/j.mri.2005.09.002; FISCHER U, 2009, CEREBROVASC DIS S6, V27, P60; Forette F, 1998, LANCET, V352, P1347, DOI 10.1016/S0140-6736(98)03086-4; Fournier A, 2009, EXPERT REV NEUROTHER, V9, P1413, DOI 10.1586/ERN.09.89; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Gorostidi M, 2007, J HYPERTENS, V25, P977, DOI 10.1097/HJH.0b013e32809874a2; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; GRIBBIN B, 1971, CIRC RES, V29, P424, DOI 10.1161/01.RES.29.4.424; Hansson L, 2000, LANCET, V356, P359, DOI 10.1016/S0140-6736(00)02526-5; Heuschmann PU, 2008, STROKE, V39, P2204, DOI 10.1161/STROKEAHA.107.507285; Hossain M, 2001, J CLIN EPIDEMIOL, V54, P488, DOI 10.1016/S0895-4356(00)00322-X; Howard SC, 2003, J CLIN EPIDEMIOL, V56, P1084, DOI 10.1016/S0895-4356(03)00267-1; Ichihara A, 2005, J HUM HYPERTENS, V19, P103, DOI 10.1038/sj.jhh.1001786; Ichihara A, 2007, J CARDIOVASC PHARM, V49, P161, DOI 10.1097/FJC.0b013e31803104e5; Imai Y, 1999, HYPERTENS RES-CLIN E, V22, P261, DOI 10.1291/hypres.22.261; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Kamaruzzaman S, 2010, AGE AGEING, V39, P51, DOI 10.1093/ageing/afp192; Kaplan NM, 2006, CLIN HYPERTENSION; Kario K, 2003, J CARDIOVASC PHARM, V42, pS87, DOI 10.1097/00005344-200312001-00019; Kario K, 2009, CIRC J, V73, P1002, DOI 10.1253/circj.CJ-09-0286; Keenan K, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1492; Klungel OH, 2000, J CLIN EPIDEMIOL, V53, P1158, DOI 10.1016/S0895-4356(00)00228-6; Koton S, 2004, NEUROLOGY, V63, P2006, DOI 10.1212/01.WNL.0000145842.25520.A2; Lammie GA, 2000, STROKE, V31, P1426, DOI 10.1161/01.STR.31.6.1426; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lipsitz LA, 2005, HYPERTENSION, V45, P216, DOI 10.1161/01.HYP.0000153094.09615.11; MACKENZIE ET, 1976, CIRC RES, V39, P33, DOI 10.1161/01.RES.39.1.33; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mancia G, 2006, HYPERTENSION, V47, P846, DOI 10.1161/01.HYP.0000215363.69793.bb; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Mancia G, 2009, HYPERTENSION, V54, P226, DOI 10.1161/HYPERTENSIONAHA.109.129882; Manisty C, 2009, HYPERTENSION, V54, P1009, DOI 10.1161/HYPERTENSIONAHA.109.130914; Marshall T, 2004, BMJ-BRIT MED J, V328, P933, DOI 10.1136/bmj.328.7445.933; McGuinness B, 2006, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD004034.PUB2; MEADE TW, 1992, BMJ-BRIT MED J, V304, P405; MEYER JS, 1960, NEUROLOGY, V10, P735, DOI 10.1212/WNL.10.8.735; Miao CY, 2006, J HYPERTENS, V24, P1125, DOI 10.1097/01.hjh.0000226203.57818.88; Moody DM, 1997, ANN NY ACAD SCI, V826, P103, DOI 10.1111/j.1749-6632.1997.tb48464.x; Morgan T, 2004, AM J HYPERTENS, V17, P118, DOI 10.1016/j.amjhyper.2003.09.012; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; O'Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/00004872-200305000-00001; O'Brien E, 2005, J HYPERTENS, V23, P697, DOI 10.1097/01.hjh.0000163132.84890.c4; Parati G, 2008, J HYPERTENS, V26, P1505, DOI 10.1097/HJH.0b013e328308da66; Parati G, 2007, J HYPERTENS, V25, P929, DOI 10.1097/HJH.0b013e32813a32b1; Pavek K, 2009, BLOOD PRESSURE, V18, P30, DOI 10.1080/08037050902812648; Pepine CJ, 2003, JAMA-J AM MED ASSOC, V290, P2805, DOI 10.1001/jama.290.21.2805; PERRY HM, 1992, J HYPERTENS, V10, P887; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Pickering TG, 2007, HYPERTENS RES, V30, P479, DOI 10.1291/hypres.30.479; Pickering TG, 2006, NEW ENGL J MED, V354, P2368, DOI 10.1056/NEJMra060433; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; Robinson T, 1997, CEREBROVASC DIS, V7, P214, DOI 10.1159/000108194; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Rothwell PM, 2003, STROKE, V34, P2583, DOI 10.1161/01.STR.0000094424.38761.56; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Salles GF, 2008, ARCH INTERN MED, V168, P2340, DOI 10.1001/archinte.168.21.2340; Schlaich MP, 2004, CIRCULATION, V110, P3680, DOI 10.1161/01.CIR.0000149748.79945.52; Sever PS, 2009, J HYPERTENS, V27, P947, DOI 10.1097/HJH.0b013e328326cb1a; Shan ZZ, 2001, J CARDIOVASC PHARM, V38, P427, DOI 10.1097/00005344-200109000-00011; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X; Sorond FA, 2005, J GERONTOL A-BIOL, V60, P1484, DOI 10.1093/gerona/60.11.1484; Staessen JA, 2001, LANCET, V358, P1305, DOI 10.1016/S0140-6736(01)06411-X; Staessen JA, 1997, JAMA-J AM MED ASSOC, V278, P1065, DOI 10.1001/jama.278.13.1065; Staessen JA, 1999, JAMA-J AM MED ASSOC, V282, P539, DOI 10.1001/jama.282.6.539; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Stewart R, 2009, HYPERTENSION, V54, P233, DOI 10.1161/HYPERTENSIONAHA.109.128744; STRANDGAARD S, 1973, BMJ-BRIT MED J, V1, P507, DOI 10.1136/bmj.1.5852.507; Su DF, 2006, CURR OPIN CARDIOL, V21, P486, DOI 10.1097/01.hco.0000240587.14463.58; Tatasciore A, 2008, HYPERTENS RES, V31, P2137, DOI 10.1291/hypres.31.2137; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Thom S, 2009, HYPERTENSION, V54, P405, DOI 10.1161/HYPERTENSIONAHA.109.133819; Tozawa M, 1999, NEPHROL DIAL TRANSPL, V14, P1976, DOI 10.1093/ndt/14.8.1976; Turner MJ, 2008, AM J HYPERTENS, V21, P85, DOI 10.1038/ajh.2007.25; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Verberk WJ, 2006, J HYPERTENS, V24, P1541, DOI 10.1097/01.hjh.0000239289.87141.b6; Verdecchia P, 2003, AM J HYPERTENS, V16, P87, DOI 10.1016/S0895-7061(02)03150-3; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Williams B, 2006, CIRCULATION, V113, P1213, DOI 10.1161/CIRCULATIONAHA.105.595496; Williams B, 2009, J AM COLL CARDIOL, V54, P705, DOI [10.1016/j.jacc.2009.02.088, 10.1016/j.jacc.2009.06.043]; Wiysonge CS, 2007, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD002003.PUB2; Wizner B, 2008, J HYPERTENS, V26, P1328, DOI 10.1097/HJH.0b013e3283013b59; WOODWELL DA, 2004, ADV DATA, V346, P1; Zhang R, 2007, HYPERTENSION, V49, P1149, DOI 10.1161/HYPERTENSIONAHA.106.084939	110	532	592	4	51	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	2010	375	9718					938	948		10.1016/S0140-6736(10)60309-1	http://dx.doi.org/10.1016/S0140-6736(10)60309-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	574NA	20226991				2022-12-28	WOS:000275995300033
J	Wasser, S; Poole, J; Lee, P; Lindsay, K; Dobson, A; Hart, J; Douglas-Hamilton, I; Wittemyer, G; Granli, P; Morgan, B; Gunn, J; Alberts, S; Beyers, R; Chiyo, P; Croze, H; Estes, R; Gobush, K; Joram, P; Kikoti, A; Kingdon, J; King, L; Macdonald, D; Moss, C; Mutayoba, B; Njumbi, S; Omondi, P; Nowak, K				Wasser, Samuel; Poole, Joyce; Lee, Phyllis; Lindsay, Keith; Dobson, Andrew; Hart, John; Douglas-Hamilton, Iain; Wittemyer, George; Granli, Petter; Morgan, Bethan; Gunn, Jody; Alberts, Susan; Beyers, Rene; Chiyo, Patrick; Croze, Harvey; Estes, Richard; Gobush, Kathleen; Joram, Ponjoli; Kikoti, Alfred; Kingdon, Jonathan; King, Lucy; Macdonald, David; Moss, Cynthia; Mutayoba, Benezeth; Njumbi, Steve; Omondi, Patrick; Nowak, Katarzyna			Elephants, Ivory, and Trade	SCIENCE			English	Editorial Material									[Wasser, Samuel; Gobush, Kathleen] Univ Washington, Seattle, WA 98195 USA; [Poole, Joyce; Granli, Petter] ElephantVoices, N-3236 Sandefjord, Norway; [Poole, Joyce; Lee, Phyllis; Lindsay, Keith; Croze, Harvey; Moss, Cynthia] Amboseli Trust Elephants, Nairobi 00509, Kenya; [Lee, Phyllis; Morgan, Bethan] Univ Stirling, Stirling FK9 4LA, Scotland; [Dobson, Andrew; Nowak, Katarzyna] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA; [Hart, John] Tshuapa Lomami Lualaba Project, Kinshasa, DEM REP CONGO; [Douglas-Hamilton, Iain; Wittemyer, George; King, Lucy] Save Elephants, Nairobi 00200, Kenya; [Wittemyer, George] Colorado State Univ, Ft Collins, CO 80523 USA; [Morgan, Bethan] Zool Soc San Diego, Cent Africa Program, Yaounde, Cameroon; [Gunn, Jody] Anglia Ruskin Univ, Cambridge CB1 1PT, England; [Alberts, Susan; Chiyo, Patrick] Duke Univ, Durham, NC 27708 USA; [Beyers, Rene] Univ British Columbia, Vancouver, BC V6T 1Z4, Canada; [Joram, Ponjoli] Udzungwa Mt Natl Pk, Sanje, Tanzania; [Kikoti, Alfred] Univ Massachusetts, Amherst, MA 01003 USA; [Kingdon, Jonathan; Macdonald, David; Nowak, Katarzyna] Univ Oxford, WildCRU, Oxford OX13 5QL, England; [Mutayoba, Benezeth] Sokoine Univ Agr, Morogoro, Tanzania; [Njumbi, Steve] Int Fund Anim Welf, Nairobi 00603, Kenya; [Omondi, Patrick] Kenya Wildlife Serv, Nairobi 00100, Kenya	University of Washington; University of Washington Seattle; University of Stirling; Princeton University; Colorado State University; Zoological Society of San Diego; Anglia Ruskin University; Duke University; University of British Columbia; University of Massachusetts System; University of Massachusetts Amherst; University of Oxford; Sokoine University of Agriculture	Wasser, S (corresponding author), Univ Washington, Seattle, WA 98195 USA.	wassers@u.washington.edu; knowak@princeton.edu	Wittemyer, George/AFQ-1840-2022; Wasser, Samuel K/I-5542-2015; Nowak, Katarzyna/AAT-5468-2021	Nowak, Katarzyna/0000-0002-4992-7910; Lee, Phyllis/0000-0002-4296-3513; King, Dr Lucy/0000-0002-2877-5225				[Anonymous], 1991, AFRICAN WILDLIFE RES; BEYERS R, 2008, THESIS U BRIT COLUMB; Blake S, 2009, BIOTROPICA, V41, P459, DOI 10.1111/j.1744-7429.2009.00512.x; Blanc J. J., 2007, AFRICAN ELEPHANT STA; Bulte E, 2004, SCIENCE, V306, P420, DOI 10.1126/science.1105392; *CITES, 2007, 533 COP14 CITES; *CITES, 2009, 442 COP15 CITES; *CITES, 2007, 2007022 COP14 CITES; *CITES, 2009, 363 SC58 CITES; *CITES, 2009, 4 COP15 CITES; *CITES, 2004, 293 COP13 CITES; *CITES, 2009, 5 COP15 CITES; Coppolillo P, 2004, BIOL CONSERV, V115, P419, DOI 10.1016/S0006-3207(03)00159-9; Frank B, 2006, ECOL ECON, V60, P320, DOI 10.1016/j.ecolecon.2005.12.007; KAHINDI O, AFR J ECOL; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; MILLIKEN T, 2009, 441 COP15 TRAFFIC; NIELSEN J, 2007, NPR             0102; Smith KF, 2009, SCIENCE, V324, P594, DOI 10.1126/science.1174460; Stokstad E, 2010, SCIENCE, V327, P632, DOI 10.1126/science.327.5966.632; Van Aarde RJ, 2009, ENVIRON CONSERV, V36, P8, DOI 10.1017/S0376892909005438; Wasser SK, 2008, CONSERV BIOL, V22, P1065, DOI 10.1111/j.1523-1739.2008.01012.x; Wasser SK, 2009, SCI AM, V301, P68, DOI 10.1038/scientificamerican0709-68; 2009, GMA NEWS TV     0520; 2009, THISDAY         1029	25	38	39	2	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1331	1332		10.1126/science.1187811	http://dx.doi.org/10.1126/science.1187811			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	567CA	20223971				2022-12-28	WOS:000275418700024
J	Kawai, H; Nakajima, A				Kawai, Hiromichi; Nakajima, Atsusi			Red Puffy Ears	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kawai, Hiromichi; Nakajima, Atsusi] Shiga Univ Med Sci, Otsu, Shiga 52021, Japan	Shiga University of Medical Science	Kawai, H (corresponding author), Shiga Univ Med Sci, Otsu, Shiga 52021, Japan.	hirok@belle.shiga-med.ac.jp							0	3	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10					928	928		10.1056/NEJMicm0901800	http://dx.doi.org/10.1056/NEJMicm0901800			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566JM	20220187				2022-12-28	WOS:000275365900013
J	Cushman, WC; Evans, GW; Byington, RP; Goff, DC; Grimm, RH; Cutler, JA; Simons-Morton, DG; Basile, JN; Corson, MA; Probstfield, JL; Katz, L; Peterson, KA; Friedewald, WT; Buse, JB; Bigger, JT; Gerstein, HC; Ismail-Beigi, F				Cushman, William C.; Evans, Gregory W.; Byington, Robert P.; Goff, David C., Jr.; Grimm, Richard H., Jr.; Cutler, Jeffrey A.; Simons-Morton, Denise G.; Basile, Jan N.; Corson, Marshall A.; Probstfield, Jeffrey L.; Katz, Lois; Peterson, Kevin A.; Friedewald, William T.; Buse, John B.; Bigger, J. Thomas; Gerstein, Hertzel C.; Ismail-Beigi, Faramarz			Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASE; HOT	BACKGROUND There is no evidence from randomized trials to support a strategy of lowering systolic blood pressure below 135 to 140 mm Hg in persons with type 2 diabetes mellitus. We investigated whether therapy targeting normal systolic pressure (i.e., < 120 mm Hg) reduces major cardiovascular events in participants with type 2 diabetes at high risk for cardiovascular events. METHODS A total of 4733 participants with type 2 diabetes were randomly assigned to intensive therapy, targeting a systolic pressure of less than 120 mm Hg, or standard therapy, targeting a systolic pressure of less than 140 mm Hg. The primary composite outcome was nonfatal myocardial infarction, nonfatal stroke, or death from cardiovascular causes. The mean follow-up was 4.7 years. RESULTS After 1 year, the mean systolic blood pressure was 119.3 mm Hg in the intensive-therapy group and 133.5 mm Hg in the standard-therapy group. The annual rate of the primary outcome was 1.87% in the intensive-therapy group and 2.09% in the standard-therapy group (hazard ratio with intensive therapy, 0.88; 95% confidence interval [CI], 0.73 to 1.06; P = 0.20). The annual rates of death from any cause were 1.28% and 1.19% in the two groups, respectively (hazard ratio, 1.07; 95% CI, 0.85 to 1.35; P = 0.55). The annual rates of stroke, a prespecified secondary outcome, were 0.32% and 0.53% in the two groups, respectively (hazard ratio, 0.59; 95% CI, 0.39 to 0.89; P = 0.01). Serious adverse events attributed to antihypertensive treatment occurred in 77 of the 2362 participants in the intensive-therapy group (3.3%) and 30 of the 2371 participants in the standard-therapy group (1.3%) (P<0.001). CONCLUSIONS In patients with type 2 diabetes at high risk for cardiovascular events, targeting a systolic blood pressure of less than 120 mm Hg, as compared with less than 140 mm Hg, did not reduce the rate of a composite outcome of fatal and nonfatal major cardiovascular events. (ClinicalTrials.gov number, NCT00000620.)	[Cushman, William C.] Memphis Vet Affairs VA Med Ctr, Prevent Med Sect, Memphis, TN USA; [Evans, Gregory W.; Byington, Robert P.; Goff, David C., Jr.] Wake Forest Univ, Sch Med, Div Publ Hlth Sci, Winston Salem, NC 27109 USA; [Grimm, Richard H., Jr.] Univ Minnesota, Berman Ctr Outcomes & Clin Res, Minneapolis, MN USA; [Peterson, Kevin A.] Univ Minnesota, Dept Family Practice & Community Med, Minneapolis, MN USA; [Cutler, Jeffrey A.; Simons-Morton, Denise G.] NHLBI, Bethesda, MD 20892 USA; [Basile, Jan N.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA; [Corson, Marshall A.; Probstfield, Jeffrey L.] Univ Washington, Dept Med, Seattle, WA USA; [Buse, John B.] Univ N Carolina, Sch Med, Div Endocrinol, Chapel Hill, NC USA; [Gerstein, Hertzel C.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Gerstein, Hertzel C.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Wake Forest University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; McMaster University; McMaster University; Population Health Research Institute; Case Western Reserve University; Case Western Reserve University	Cushman, WC (corresponding author), Vet Affairs Med Ctr, Cushman Prevent Med Sect 111Q, 1030 Jefferson Ave, Memphis, TN 38104 USA.	william.cushman@va.gov	Buse, John Bernard/J-9742-2019; Hug, Balthasar L./G-1568-2010; Force, Rex W/K-4094-2012; Friedewald, William T/C-8034-2011; Hramiak, Irene/G-3305-2011; Gerstein, Hertzel C/B-1235-2013; Bryan, R. Nick/P-1661-2014; Gerstein, Hertzel/ABB-8781-2020	Buse, John Bernard/0000-0002-9723-3876; Gerstein, Hertzel C/0000-0001-8072-2836; Gerstein, Hertzel/0000-0001-8072-2836; Arrey, Frida/0000-0003-4543-4219; Bryan, Robert Nick/0000-0002-2327-4579; Katz, Lois/0000-0002-6937-8170; Yusuf, Salim/0000-0003-4776-5601; Kaiser, Peter/0000-0001-5126-045X; Peterson, Kevin/0000-0002-6914-8586	National Heart, Lung, and Blood Institute [N01-HC-95178, N01-HC-95179, N01-HC-95180, N01-HC-95181, N01-HC-95182, N01-HC-95183, N01-HC-95184, IAA Y1-HC-9035, IAA Y1-HC-1010]; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute on Aging; National Eye Institute; Centers for Disease Control and Prevention; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095182, N01HC095179, N01HC095183, N01HC095178, N01HC095181, N01HC095180, N01HC095184] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL095181, R44HL095181, R01HL073030] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by contracts from the National Heart, Lung, and Blood Institute (N01-HC-95178, N01-HC-95179, N01-HC-95180, N01-HC-95181, N01-HC-95182, N01-HC-95183, N01-HC-95184, and IAA#Y1-HC-9035 and IAA#Y1-HC-1010). Other components of the National Institutes of Health, including the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Aging, and the National Eye Institute, contributed funding. The Centers for Disease Control and Prevention funded substudies within ACCORD on cost-effectiveness and health-related quality of life. General Clinical Research Centers provide support at many sites. The following companies provided study medications, equipment, or supplies: Abbott Laboratories, Amylin Pharmaceutical, AstraZeneca Pharmaceuticals, Bayer HealthCare, Closer Healthcare, GlaxoSmithKline Pharmaceuticals, King Pharmaceuticals, Merck, Novartis Pharmaceuticals, Novo Nordisk, Omron Healthcare, Sanofi-Aventis U.S., and Takeda.	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Buse JB, 2007, AM J CARDIOL, V99, p21I, DOI 10.1016/j.amjcard.2007.03.003; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cushman WC, 2007, AM J CARDIOL, V99, p44I, DOI 10.1016/j.amjcard.2007.03.005; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Levey AS, 2008, ANN INTERN MED, V149, P519, DOI 10.7326/0003-4819-149-7-200810070-00023; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Therneau TM, 2000, MODELING SURVIVAL DA; UK Prospect Diabet Study Grp, 1999, BMJ-BRIT MED J, V318, P29; Zanchetti A, 2003, J HYPERTENS, V21, P797, DOI 10.1097/00004872-200304000-00024	17	2400	2488	2	125	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2010	362	17					1575	1585		10.1056/NEJMoa1001286	http://dx.doi.org/10.1056/NEJMoa1001286			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589AX	20228401	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000277117400006
J	Koplan, JP; An, WK; Lam, RMK				Koplan, Jeffrey P.; An, Wang Ke; Lam, Ronald M. K.			Hong Kong: a model of successful tobacco control in China	LANCET			English	Editorial Material							SMOKING; CANCER		[Koplan, Jeffrey P.] Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30322 USA; [An, Wang Ke] Think Tank Res Ctr Hlth Dev, Beijing, Peoples R China; [Lam, Ronald M. K.] Dept Hlth, Control Off, Hong Kong, Hong Kong, Peoples R China	Emory University	Koplan, JP (corresponding author), Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30322 USA.	jkoplan@emory.edu						*BHAR BOOK BUR, 2010, CHIN TOB IND PROF; *CENS STAT DEP HON, 2008, THEM HOUS SURV FORM; Cheng MH, 2009, LANCET, V374, P1227, DOI 10.1016/S0140-6736(09)61769-4; FONG E, 2007, PUBLIC HLTH EPIDEMIO, V16, P1; Hedley AJ, 2006, TOXICOL SCI, V90, P539, DOI 10.1093/toxsci/kfj110; *HONG KONG COUNC S, ANN REP 2008 09; *INF SERV DEP HONG, 2009, FIX PEN SMOK OFF COM; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; TAM B, 2009, 2 CHIN HLTH ED HLTH	9	30	32	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 17	2010	375	9723					1330	1331		10.1016/S0140-6736(10)60398-4	http://dx.doi.org/10.1016/S0140-6736(10)60398-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	588GW	20347129				2022-12-28	WOS:000277057800009
J	Chernew, ME; Baicker, K; Hsu, J				Chernew, Michael E.; Baicker, Katherine; Hsu, John			The Specter of Financial Armageddon -- Health Care and Federal Debt in the United States.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chernew, Michael E.; Hsu, John] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Baicker, Katherine] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Hsu, John] Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Chernew, ME (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.							[Anonymous], 2010, COMMUNICATION   0305; CUTLER D, 2010, WALL STREET J   0309; KOGAN R, 2008, LONG TERM FISCAL OUT; Organisation for Economic Co-operation and Development (OECD), GROSS DOM PROD; ORSZAG PR, 2007, COMMUNICATION   0709	5	48	48	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2010	362	13					1166	1168		10.1056/NEJMp1002873	http://dx.doi.org/10.1056/NEJMp1002873			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	577QQ	20237338				2022-12-28	WOS:000276239500003
J	Miller, S; Tavshanjian, B; Oleksy, A; Perisic, O; Houseman, BT; Shokat, KM; Williams, RL				Miller, Simon; Tavshanjian, Brandon; Oleksy, Arkadiusz; Perisic, Olga; Houseman, Benjamin T.; Shokat, Kevan M.; Williams, Roger L.			Shaping Development of Autophagy Inhibitors with the Structure of the Lipid Kinase Vps34	SCIENCE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE COMPLEXES; PHOSPHOINOSITIDE 3-KINASE; SACCHAROMYCES-CEREVISIAE; REGULATES AUTOPHAGY; PROTEIN-KINASE; BECLIN 1; UVRAG; ACTIVATION; ENDOSOME; HVPS34	Phosphoinositide 3-kinases (PI3Ks) are lipid kinases with diverse roles in health and disease. The primordial PI3K, Vps34, is present in all eukaryotes and has essential roles in autophagy, membrane trafficking, and cell signaling. We solved the crystal structure of Vps34 at 2.9 angstrom resolution, which revealed a constricted adenine-binding pocket, suggesting the reason that specific inhibitors of this class of PI3K have proven elusive. Both the phosphoinositide-binding loop and the carboxyl-terminal helix of Vps34 mediate catalysis on membranes and suppress futile adenosine triphosphatase cycles. Vps34 appears to alternate between a closed cytosolic form and an open form on the membrane. Structures of Vps34 complexes with a series of inhibitors reveal the reason that an autophagy inhibitor preferentially inhibits Vps34 and underpin the development of new potent and specific Vps34 inhibitors.	[Miller, Simon; Oleksy, Arkadiusz; Perisic, Olga; Williams, Roger L.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Tavshanjian, Brandon; Houseman, Benjamin T.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Tavshanjian, Brandon; Houseman, Benjamin T.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	MRC Laboratory Molecular Biology; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Williams, RL (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	rlw@mrc-lmb.cam.ac.uk		Williams, Roger/0000-0001-7754-4207; Perisic, Olga/0000-0002-3842-2896	Mount Zion Health Fund; Achievement Rewards for College Scientists Fellowship at UCSF; Waxman Foundation; MRC [MC_U105184308] Funding Source: UKRI; Medical Research Council [MC_U105184308] Funding Source: researchfish	Mount Zion Health Fund; Achievement Rewards for College Scientists Fellowship at UCSF; Waxman Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank European Synchrotron Radiation Facility beamline scientists for ID14-4, ID23-1, and ID29. We are grateful to Y. Ohashi and A. Gillingham for help with yeast experiments, C. Sachse for electron microscopy, M. Allen for help with x-ray data collection, A. Berndt for advice and discussions, S. Munro for critically reading the manuscript, B. Gonz~lez for a clone of HsVps34, and G. Ducker for help in optimizing Vps34 inhibitor assays. B. T. H. is supported by the Mount Zion Health Fund, B. T. is supported by the Achievement Rewards for College Scientists Fellowship at UCSF, and K. M. S. thanks the Waxman Foundation for support. The coordinates have been deposited in the Protein Data Bank, with the following identification numbers (PDB IDs): 2X6H (apo), 2X6I (PIK-90), 2X6J (PIK-93), 2X6K (PI-103), and 2X6F (3-MA).	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Berndt A, 2010, NAT CHEM BIOL, V6, P117, DOI [10.1038/nchembio.293, 10.1038/NCHEMBIO.293]; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Budovskaya YV, 2002, J BIOL CHEM, V277, P287, DOI 10.1074/jbc.M109263200; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Murray JT, 2005, METHOD ENZYMOL, V403, P789, DOI 10.1016/S0076-6879(05)03068-5; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Obara K, 2006, MOL BIOL CELL, V17, P1527, DOI 10.1091/mbc.E05-09-0841; Panaretou C, 1997, J BIOL CHEM, V272, P2477; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Yan Y, 2009, BIOCHEM J, V417, P747, DOI 10.1042/BJ20081865	27	170	183	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2010	327	5973					1638	1642		10.1126/science.1184429	http://dx.doi.org/10.1126/science.1184429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339072	Green Accepted, Green Published			2022-12-28	WOS:000275970600042
J	Chen, DL; Shan, J; Zhu, WG; Qin, J; Gu, W				Chen, Delin; Shan, Jing; Zhu, Wei-Guo; Qin, Jun; Gu, Wei			Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses	NATURE			English	Article							TUMOR-SUPPRESSOR PATHWAY; NUCLEOPHOSMIN; PROTEIN; EXPRESSION; CANCER; POLYUBIQUITINATION; PROLIFERATION; INDUCTION; TARGETS; MUTANT	The tumour suppressor ARF is specifically required for p53 activation under oncogenic stress(1-6). Recent studies showed that p53 activation mediated by ARF, but not that induced by DNA damage, acts as a major protection against tumorigenesis in vivo under certain biological settings(7,8), suggesting that the ARF-p53 axis has more fundamental functions in tumour suppression than originally thought. Because ARF is a very stable protein in most human cell lines, it has been widely assumed that ARF induction is mediated mainly at the transcriptional level and that activation of the ARF-p53 pathway by oncogenes is a much slower and largely irreversible process by comparison with p53 activation after DNA damage. Here we report that ARF is very unstable in normal human cells but that its degradation is inhibited in cancerous cells. Through biochemical purification, we identified a specific ubiquitin ligase for ARF and named it ULF. ULF interacts with ARF both in vitro and in vivo and promotes the lysine-independent ubiquitylation and degradation of ARF. ULF knockdown stabilizes ARF in normal human cells, triggering ARF-dependent, p53-mediated growth arrest. Moreover, nucleophosmin (NPM) and c-Myc, both of which are commonly overexpressed in cancer cells, are capable of abrogating ULF-mediated ARF ubiquitylation through distinct mechanisms, and thereby promote ARF stabilization in cancer cells. These findings reveal the dynamic feature of the ARF-p53 pathway and suggest that transcription-independent mechanisms are critically involved in ARF regulation during responses to oncogenic stress.	[Chen, Delin; Shan, Jing; Gu, Wei] Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; [Chen, Delin; Shan, Jing; Gu, Wei] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Zhu, Wei-Guo] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China; [Qin, Jun] Baylor Coll Med, Dept Biochem & Cell Biol, Houston, TX 77030 USA	Columbia University; Columbia University; Peking University; Baylor College of Medicine	Gu, W (corresponding author), Columbia Univ, Coll Phys & Surg, Inst Canc Genet, 1130 St Nicholas Ave, New York, NY 10032 USA.	wg8@columbia.edu	zhu, wei-guo/E-1334-2012	Zhu, Wei-Guo/0000-0001-8385-6581	National Institutes of Health/National Cancer Institute; Leukemia and Lymphoma Society; NSFC [30628028]; NATIONAL CANCER INSTITUTE [R01CA131439, R01CA085533, R01CA129627, P01CA097403, R01CA118561, P01CA080058] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NSFC(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Baer and R. Dalla-Favera for critical comments on this study; B. Falini and J. B. Yoon for providing reagents; W. Z. Zhang for helping in mass spectrometry analysis; E. McIntush for developing the anti-ULF antibody. This study was supported by grants from National Institutes of Health/National Cancer Institute, the Leukemia and Lymphoma Society and NSFC-30628028. W. G. is an Ellison Medical Foundation Senior Scholar in aging.	ABIDE WM, 2006, CANCER RES, V68, P352; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Brady SN, 2004, MOL CELL BIOL, V24, P9327, DOI 10.1128/MCB.24.21.9327-9338.2004; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Cheng K, 2007, ONCOGENE, V26, P7391, DOI 10.1038/sj.onc.1210549; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Colombo E, 2006, CANCER RES, V66, P3044, DOI 10.1158/0008-5472.CAN-05-2378; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; den Besten W, 2005, CELL CYCLE, V4, P1593; FEUERSTEIN N, 1987, J BIOL CHEM, V262, P11389; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Matheu A, 2008, CANCER RES, V68, P6031, DOI 10.1158/0008-5472.CAN-07-6851; Moulin S, 2008, ONCOGENE, V27, P2382, DOI 10.1038/sj.onc.1210887; Nozawa Y, 1996, J PATHOL, V178, P48; PALINI B, 2005, NEW ENGL J MED, V352, P254; Quentmeier H, 2005, LEUKEMIA, V19, P1760, DOI 10.1038/sj.leu.2403899; Saporita AJ, 2007, CURR MED CHEM, V14, P1815; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	32	115	118	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					624	U193		10.1038/nature08820	http://dx.doi.org/10.1038/nature08820			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20208519	Green Accepted			2022-12-28	WOS:000275974200055
J	Dial, OE; Ashoori, RC; Pfeiffer, LN; West, KW				Dial, O. E.; Ashoori, R. C.; Pfeiffer, L. N.; West, K. W.			Anomalous structure in the single particle spectrum of the fractional quantum Hall effect	NATURE			English	Article							2-DIMENSIONAL ELECTRON-GAS; COMPOSITE FERMIONS; SKYRMIONS; ENERGY; GAPS; EXCITATIONS; CROSSOVER; INTEGER; GAAS	The two-dimensional electron system is a powerful laboratory for investigating the physics of interacting particles. Application of a large magnetic field produces massively degenerate quantum levels known as Landau levels; within a Landau level the kinetic energy of the electrons is suppressed, and electron-electron interactions set the only energy scale(1). Coulomb interactions break the degeneracy of the Landau levels and can cause the electrons to order into complex ground states. Here we observe, in the high energy single particle spectrum of this system, salient and unexpected structure that extends across a wide range of Landau level filling fractions. The structure appears only when the two-dimensional electron system is cooled to very low temperatures, indicating that it arises from delicate ground state correlations. We characterize this structure by its evolution with changing electron density and applied magnetic field, and present two possible models for understanding these observations. Some of the energies of the features agree qualitatively with what might be expected for composite fermions, which have proven effective for interpreting other experiments in this regime. At the same time, a simple model with electrons localized on ordered lattice sites also generates structure similar to that observed in the experiment. Neither of these models alone is sufficient to explain the observations across the entire range of densities measured. The discovery of this unexpected prominent structure in the single particle spectrum of an otherwise thoroughly studied system suggests that there exist core features of the two-dimensional electron system that have yet to be understood.	[Dial, O. E.; Ashoori, R. C.] MIT, Cambridge, MA 02139 USA; [Pfeiffer, L. N.; West, K. W.] Alcatel Lucent Bell Labs, Murray Hill, NJ 07974 USA	Massachusetts Institute of Technology (MIT); Alcatel-Lucent	Dial, OE (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dial@alum.mit.edu; ashoori@mit.edu		/0000-0001-5031-1673	Office of Science of the US Department of Energy	Office of Science of the US Department of Energy(United States Department of Energy (DOE))	We are grateful to A. MacDonald and Y. Meir, who independently suggested the identification of sash features with nearby localized states that formed the basis for the lattice model. We thank P. Lee, L. Levitov and B. Halperin for discussions regarding the interpretation of our results. This work was sponsored by the Office of Science of the US Department of Energy.	ANDO T, 1974, J PHYS SOC JPN, V37, P1044, DOI 10.1143/JPSJ.37.1044; ASHOORI RC, 1990, PHYS REV LETT, V64, P681, DOI 10.1103/PhysRevLett.64.681; ASHOORI RC, 1993, PHYS REV B, V48, P4616, DOI 10.1103/PhysRevB.48.4616; BARRETT SE, 1995, PHYS REV LETT, V74, P5112, DOI 10.1103/PhysRevLett.74.5112; Chan HB, 1997, PHYS REV LETT, V79, P2867, DOI 10.1103/PhysRevLett.79.2867; Dial OE, 2007, NATURE, V448, P176, DOI 10.1038/nature05982; EISENSTEIN JP, 1992, PHYS REV LETT, V69, P3804, DOI 10.1103/PhysRevLett.69.3804; Gallais Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.086806; HALPERIN BI, 1993, PHYS REV B, V47, P7312, DOI 10.1103/PhysRevB.47.7312; Hirjibehedin CF, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.186802; JAIN JK, 1989, PHYS REV LETT, V63, P199, DOI 10.1103/PhysRevLett.63.199; Jain JK, 2007, COMPOSITE FERMIONS, P1, DOI 10.1017/CBO9780511607561; Khrapai VS, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.086802; Leadley DR, 1996, PHYS REV B, V53, P2057, DOI 10.1103/PhysRevB.53.2057; Luhman DR, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2767978; MORF R, 1995, PHYS REV LETT, V74, P5116, DOI 10.1103/PhysRevLett.74.5116; Park K, 1999, J PHYS-CONDENS MAT, V11, P7283, DOI 10.1088/0953-8984/11/38/308; Peterson MR, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.046402; PIKUS FG, 1995, PHYS REV B, V51, P16871, DOI 10.1103/PhysRevB.51.16871; SCHMELLER A, 1995, PHYS REV LETT, V75, P4290, DOI 10.1103/PhysRevLett.75.4290; YANG SRE, 1993, PHYS REV LETT, V70, P4110, DOI 10.1103/PhysRevLett.70.4110	24	29	29	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					566	570		10.1038/nature08941	http://dx.doi.org/10.1038/nature08941			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20336140	Green Submitted			2022-12-28	WOS:000275974200042
J	McCormick, J; Mehta, G; Olesen, HV; Viviani, L; Macek, M; Mehta, A				McCormick, Jonathan; Mehta, Gita; Olesen, Hanne V.; Viviani, Laura; Macek, Milan, Jr.; Mehta, Anil		European Registry Working Grp	Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis	LANCET			English	Article							MORTALITY; AGE; OUTCOMES	Background Country-specific patients' registries are rarely used to make international comparisons because of protocol discrepancies in data collation. We present data from a European cystic fibrosis registry that is dedicated to collection of demographic data, and assess whether the resources available in countries with and without European Union (EU) membership affects care and survival of patients. Methods Data for demographic indicators age, age at diagnosis, sex, and genotype for patients with cystic fibrosis from 35 European countries were combined, and used to establish the differences in demographic indicators between EU and non-EU countries. EU membership status in 2003 was used to divide countries. We modelled demographic indicators of EU countries on non-EU countries to estimate the size of the cystic fibrosis population if non-EU countries had had the same resources available for patients as did EU countries. Findings Data were gathered for 29 025 patients, who had a median age of 16.3 years (IQR 8.9-24.8), with a difference of 4.9 years (95% CI 4.4-5.1; p<0.0001) between EU (median 17.0 years, IQR 9.5-25.6) and non-EU countries (12.1 years, 6.0-19.2). The proportion of patients older than 40 years was higher in EU countries (1205 [5%]) than in non-EU countries (76 [2%]), with an odds ratio of 2.4 (95% CI 1.9-3.0, p<0.0001). We estimated that the cystic fibrosis population in non-EU countries would increase by 84% if patients had a demographic profile comparable to that of patients in EU countries. Interpretation Future studies need to establish the reasons for the lower proportion of patients with cystic fibrosis in non-EU countries than in EU countries, such as underdiagnosis and premature childhood mortality.	[McCormick, Jonathan] Univ Dundee, Ninewells Hosp & Med Sch, Ctr Acad Clin Practice, Div Clin Populat Sci & Educ, Dundee DD1 9SY, Scotland; [Mehta, Gita; Mehta, Anil] Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Coll Med Dent & Nursing, Dundee DD1 9SY, Scotland; [Olesen, Hanne V.] Aarhus Univ Hosp, Cyst Fibrosis Ctr Aarhus, DK-8000 Aarhus N, Denmark; [Viviani, Laura] Univ Milan, Dipartimento Med Lavoro, Clin Lavoro Luigi Devoto, Sez Stat Med & Biometria GA Maccacaro, Milan, Italy; [Macek, Milan, Jr.] Charles Univ Prague, Dept Biol & Med Genet, Fac Med 2, Prague, Czech Republic; [Macek, Milan, Jr.] Univ Hosp Motol, Prague, Czech Republic	University of Dundee; University of Dundee; Aarhus University; University of Milan; Charles University Prague; Motol University Hospital	McCormick, J (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Ctr Acad Clin Practice, Div Clin Populat Sci & Educ, MACHS Bldg, Dundee DD1 9SY, Scotland.	jonathan.mccormick@nhs.net	Viviani, Laura/A-4787-2010; Sciuca, Svetlana/AAF-7239-2020; Kahre, Tiina/D-6198-2012	Viviani, Laura/0000-0003-2419-8472; Sciuca, Svetlana/0000-0003-1091-9419; mei-zahav, meir/0000-0002-6683-0264; Cinek, Ondrej/0000-0002-0526-8714	European Community [LSHM-CT-2005-018932]; Czech Ministry of Health [MZOFNM2005, 9448/3]	European Community(European Commission); Czech Ministry of Health(Ministry of Health, Czech Republic)	EuroCareCF was supported by the European Community's Sixth Framework Programme for Research, priority one Life Sciences, Genomics and Biotechnology for Health (contract number LSHM-CT-2005-018932) which supported GM and Margaret Fraser; we thank Margaret Fraser for expert data validation. MM was supported by grants from the Czech Ministry of Health (local grant number MZOFNM2005, and Internal Grant Agency [IGA] number 9448/3). We thank David Sheppard, Scientific Coordinator of EuroCareCF; and all the cystic fibrosis patient groups, the legal and ethics experts of EuroCareCF, and the US Cystic Fibrosis Foundation for their support.	Bellis G, 2007, J CYST FIBROS, V6, P179, DOI 10.1016/j.jcf.2006.07.001; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Corey M, 1996, AM J EPIDEMIOL, V143, P1007, DOI 10.1093/oxfordjournals.aje.a008664; Cystic Fibrosis Foundation, 2008, PAT REG ANN DAT REP; Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506; Farrell PM, 2008, J CYST FIBROS, V7, P450, DOI 10.1016/j.jcf.2008.03.007; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; Fogarty A, 2000, CHEST, V117, P1656, DOI 10.1378/chest.117.6.1656; Koch C, 1997, PEDIATR PULM, V24, P147, DOI 10.1002/(SICI)1099-0496(199708)24:2<147::AID-PPUL15>3.3.CO;2-Y; Mastella G, 2000, EUR RESPIR J, V16, P464, DOI 10.1034/j.1399-3003.2000.016003464.x; McCormick Jonathan, 2005, J Cyst Fibros, V4, P115, DOI 10.1016/j.jcf.2005.01.001; McKone EF, 2006, CHEST, V130, P1441, DOI 10.1378/chest.130.5.1441; Mehta G, 2004, J ROY SOC MED, V97, P60; O'Connor GT, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e333; OLESEN HV, EUROPEAN CYSTIC FIBR; OLESEN HV, EUROPEAN REGISTRY CY; Schechter MS, 2001, AM J RESP CRIT CARE, V163, P1331, DOI 10.1164/ajrccm.163.6.9912100; Sims EJ, 2005, J PEDIATR-US, V147, P306, DOI 10.1016/j.jpeds.2005.05.034; Sims EJ, 2007, LANCET, V369, P1187, DOI 10.1016/S0140-6736(07)60565-0; Sims EJ, 2007, PEDIATRICS, V119, P19, DOI 10.1542/peds.2006-1498; STERN M, 2009, QUALITATSSICHERUNG M; STERN M, 2007, ECFS REG DEF CONS M; *UN DEP EC SOC AFF, 2008, STAT YB, P171	23	98	100	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 20	2010	375	9719					1007	1013		10.1016/S0140-6736(09)62161-9	http://dx.doi.org/10.1016/S0140-6736(09)62161-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	575YU	20304245				2022-12-28	WOS:000276110700033
J	Shen, H; Sabaliauskas, N; Sherpa, A; Fenton, AA; Stelzer, A; Aoki, C; Smith, SS				Shen, Hui; Sabaliauskas, Nicole; Sherpa, Ang; Fenton, Andre A.; Stelzer, Armin; Aoki, Chiye; Smith, Sheryl S.			A Critical Role for alpha 4 beta delta GABA(A) Receptors in Shaping Learning Deficits at Puberty in Mice	SCIENCE			English	Article							LONG-TERM POTENTIATION; SPATIAL MEMORY; DELTA-SUBUNIT; HIPPOCAMPAL-NEURONS; WATER MAZE; STRESS; INHIBITION; ANXIETY; RAT; MATURATION	The onset of puberty defines a developmental stage when some learning processes are diminished, but the mechanism for this deficit remains unknown. We found that, at puberty, expression of inhibitory alpha 4 beta delta gamma-aminobutyric acid type A (GABA(A)) receptors (GABAR) increases perisynaptic to excitatory synapses in CA1 hippocampus. Shunting inhibition via these receptors reduced N-methyl-D-aspartate receptor activation, impairing induction of long-term potentiation (LTP). Pubertal mice also failed to learn a hippocampal, LTP-dependent spatial task that was easily acquired by delta-/- mice. However, the stress steroid THP (3 alpha OH-5 alpha[beta]-pregnan-20-one), which reduces tonic inhibition at puberty, facilitated learning. Thus, the emergence of alpha 4 beta delta GABARs at puberty impairs learning, an effect that can be reversed by a stress steroid.	[Shen, Hui; Sabaliauskas, Nicole; Sherpa, Ang; Fenton, Andre A.; Stelzer, Armin; Smith, Sheryl S.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Sabaliauskas, Nicole; Aoki, Chiye] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Sherpa, Ang; Fenton, Andre A.; Stelzer, Armin; Smith, Sheryl S.] Suny Downstate Med Ctr, Program Neural & Behav Sci, Brooklyn, NY 11203 USA; [Fenton, Andre A.; Stelzer, Armin; Smith, Sheryl S.] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; New York University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Smith, SS (corresponding author), Suny Downstate Med Ctr, Dept Physiol & Pharmacol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	sheryl.smith@downstate.edu	Aoki, Chiye/T-9405-2019	Aoki, Chiye/0000-0003-4010-9425; Smith, Sheryl/0000-0003-4308-3267; Fenton, Andre/0000-0002-5063-1156	NIH [DA09618, AA12958]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009618] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank D. Lovinger for a critical reading of the manuscript; W. Sieghart for his generous gift of the delta antibody; and A. Kuver, L. Silva, and J. Molla for technical assistance. This work was supported by NIH grants DA09618 and AA12958 to S. S. S.	Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Belelli D, 2002, NEUROPHARMACOLOGY, V43, P651, DOI 10.1016/S0028-3908(02)00172-7; Bianchi MT, 2002, NEUROPHARMACOLOGY, V43, P492, DOI 10.1016/S0028-3908(02)00163-6; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brown N, 2002, BRIT J PHARMACOL, V136, P965, DOI 10.1038/sj.bjp.0704795; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cheng VY, 2006, J NEUROSCI, V26, P3713, DOI 10.1523/JNEUROSCI.5024-05.2006; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; Collinson N, 2006, PSYCHOPHARMACOLOGY, V188, P619, DOI 10.1007/s00213-006-0361-z; Crestani F, 2002, P NATL ACAD SCI USA, V99, P8980, DOI 10.1073/pnas.142288699; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; FRIEDMAN SB, 1967, PSYCHOSOM MED, V29, P323, DOI 10.1097/00006842-196707000-00003; Girdler SS, 2001, BIOL PSYCHIAT, V49, P788, DOI 10.1016/S0006-3223(00)01044-1; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; HASSLER M, 1991, INT J NEUROSCI, V58, P183, DOI 10.3109/00207459108985434; HERRON CE, 1986, NATURE, V322, P265, DOI 10.1038/322265a0; Hodes GE, 2005, HORM BEHAV, V48, P163, DOI 10.1016/j.yhbeh.2005.02.008; IZUMI Y, 1995, SYNAPSE, V20, P19, DOI 10.1002/syn.890200104; JOHNSON JS, 1989, COGNITIVE PSYCHOL, V21, P60, DOI 10.1016/0010-0285(89)90003-0; KRASNOFF A, 1976, DEV PSYCHOBIOL, V9, P261, DOI 10.1002/dev.420090310; Luine Victoria, 1996, Physiology and Behavior, V59, P27, DOI 10.1016/0031-9384(95)02016-0; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; Matthews DB, 2002, ALCOHOL CLIN EXP RES, V26, P1747, DOI 10.1097/01.ALC.0000037219.79257.17; McGivern RF, 2002, BRAIN COGNITION, V50, P73, DOI 10.1016/S0278-2626(02)00012-X; Meredith RM, 2003, J NEUROSCI, V23, P11142, DOI 10.1523/jneurosci.23-35-11142.2003; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Peng Z, 2002, J COMP NEUROL, V446, P179, DOI 10.1002/cne.10210; PURDY RH, 1991, P NATL ACAD SCI USA, V88, P4553, DOI 10.1073/pnas.88.10.4553; Sadowski RN, 2009, BEHAV BRAIN RES, V205, P19, DOI 10.1016/j.bbr.2009.06.027; Shen H, 2007, NAT NEUROSCI, V10, P469, DOI 10.1038/nn1868; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Subrahmanyam K., 1994, J APPL DEV PSYCHOL, V15, P13, DOI DOI 10.1016/0193-3973(94)90004-3; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0	35	124	127	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	2010	327	5972					1515	1518		10.1126/science.1184245	http://dx.doi.org/10.1126/science.1184245			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20299596	Green Accepted			2022-12-28	WOS:000275715200050
J	Yang, Q; Pando, BF; Dong, GG; Golden, SS; van Oudenaarden, A				Yang, Qiong; Pando, Bernardo F.; Dong, Guogang; Golden, Susan S.; van Oudenaarden, Alexander			Circadian Gating of the Cell Cycle Revealed in Single Cyanobacterial Cells	SCIENCE			English	Article							GENE-EXPRESSION; DIVISION; CLOCK; RHYTHMS; OSCILLATIONS; ZEBRAFISH; TIMES	Although major progress has been made in uncovering the machinery that underlies individual biological clocks, much less is known about how multiple clocks coordinate their oscillations. We simultaneously tracked cell division events and circadian phases of individual cells of the cyanobacterium Synechococcus elongatus and fit the data to a model to determine when cell cycle progression slows as a function of circadian and cell cycle phases. We infer that cell cycle progression in cyanobacteria slows during a specific circadian interval but is uniform across cell cycle phases. Our model is applicable to the quantification of the coupling between biological oscillators in other organisms.	[Yang, Qiong; Pando, Bernardo F.; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Dong, Guogang; Golden, Susan S.] Univ Calif San Diego, Ctr Chronobiol, La Jolla, CA 92093 USA; [Dong, Guogang; Golden, Susan S.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT)	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019; Yang, Qiong/G-9630-2016	Yang, Qiong/0000-0002-2442-2094	NSF [PHY-0548484]; NIH [R01-GM068957, R01-GM062419]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068957, R01GM062419] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Gore, P. Luitel, C. Engert, and S. Klemm for helpful discussions and/or experimental help. Supported by NSF grant PHY-0548484 and by NIH grants R01-GM068957 and R01-GM062419.	Chabot JR, 2007, NATURE, V450, P1249, DOI 10.1038/nature06395; Charvin G, 2009, P NATL ACAD SCI USA, V106, P6632, DOI 10.1073/pnas.0809227106; Dekens MPS, 2003, CURR BIOL, V13, P2051, DOI 10.1016/j.cub.2003.10.022; Dong GG, 2010, CELL, V140, P529, DOI 10.1016/j.cell.2009.12.042; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Glass L, 2001, NATURE, V410, P277, DOI 10.1038/35065745; Glass L, 1988, CLOCKS CHAOS RHYTHMS; Goldbeter A., 1996, BIOCH OSCILLATIONS C; Goldbeter A, 2008, CURR BIOL, V18, pR751, DOI 10.1016/j.cub.2008.06.044; Hirayama J, 2005, P NATL ACAD SCI USA, V102, P10194, DOI 10.1073/pnas.0502610102; Imai K, 2004, J BIOL CHEM, V279, P36534, DOI 10.1074/jbc.M405861200; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Maroto M., 2008, CELLULAR OSCILLATORY; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Mori T, 1996, P NATL ACAD SCI USA, V93, P10183, DOI 10.1073/pnas.93.19.10183; Mori T, 2001, J BACTERIOL, V183, P2439, DOI 10.1128/JB.183.8.2439-2444.2001; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Salter MG, 2003, NATURE, V426, P680, DOI 10.1038/nature02174; Strogatz HS., 1994, NONLINEAR DYNAMICS C; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Zamborszky J, 2007, J BIOL RHYTHM, V22, P542, DOI 10.1177/0748730407307225	24	117	120	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2010	327	5972					1522	1526		10.1126/science.1181759	http://dx.doi.org/10.1126/science.1181759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20299597	Green Submitted, Green Accepted			2022-12-28	WOS:000275715200052
J	Greenberger, S; Boscolo, E; Adini, I; Mulliken, JB; Bischoff, J				Greenberger, Shoshana; Boscolo, Elisa; Adini, Irit; Mulliken, John B.; Bischoff, Joyce			Corticosteroid Suppression of VEGF-A in Infantile Hemangioma-Derived Stem Cells.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VASCULAR MALFORMATIONS; PROGENITOR CELLS; EXPRESSION; DEXAMETHASONE; APOPTOSIS; GLUCOCORTICOIDS; INHIBITION; ACTIVATION; CHILDREN	Background: Corticosteroids are commonly used to treat infantile hemangioma, but the mechanism of action of this therapy is unknown. We investigated the effect of corticosteroids in a previously described in vivo model of infantile hemangioma and in cultured hemangioma-derived cells. Methods: We tested hemangioma-derived stem cells for vasculogenic activity in vivo after implantation into immune-deficient (nude) mice. We studied dexamethasone treatment of both the cells before implantation and the mice after implantation. We also tested hemangioma-derived stem cells for expression of vascular endothelial growth factor A (VEGF-A) in vitro and studied the inhibition of VEGF-A expression, using short hairpin RNA (shRNA) in vivo and in vitro. Results: Systemic treatment with dexamethasone led to dose-dependent inhibition of tumor vasculogenesis in the murine model. Pretreatment of hemangioma-derived stem cells in vitro before implantation also inhibited vasculogenesis. Dexamethasone suppressed VEGF-A production by hemangioma-derived stem cells in vitro but not by hemangioma-derived endothelial cells or human umbilical-vein endothelial cells. Silencing VEGF-A in hemangioma-derived stem cells reduced vasculogenesis in vivo. VEGF-A was detected in hemangioma specimens in the proliferating phase but not in the involuting phase and was shown by immunostaining to reside outside of vessels. Corticosteroid treatment suppressed other proangiogenic factors in hemangioma-derived stem cells, including urokinase plasminogen activator receptor, interleukin-6, monocyte chemoattractant protein 1, and matrix metalloproteinase 1. Conclusions: In a murine model, dexamethasone inhibited the vasculogenic potential of stem cells derived from human infantile hemangioma. The corticosteroid also inhibited the expression of VEGF-A by hemangioma-derived stem cells, and silencing of VEGF-A expression in these cells inhibited vasculogenesis in vivo. N Engl J Med 2010;362:1005-13.	[Bischoff, Joyce] Harvard Univ, Vasc Biol Program, Childrens Hosp Boston, Sch Med, Boston, MA 02115 USA; [Greenberger, Shoshana; Boscolo, Elisa; Adini, Irit; Bischoff, Joyce] Childrens Hosp Boston, Dept Surg, Boston, MA 02115 USA; [Mulliken, John B.] Childrens Hosp Boston, Dept Plast Surg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Bischoff, J (corresponding author), Harvard Univ, Vasc Biol Program, Childrens Hosp Boston, Sch Med, Boston, MA 02115 USA.	joyce.bischoff@childrens.harvard.edu	Boscolo, Elisa/F-9483-2019; BISCHOFF, JOYCE/K-3354-2019	Boscolo, Elisa/0000-0002-6996-0419; BISCHOFF, JOYCE/0000-0002-6367-1974	National Institutes of Health [P01-AR48564, R01-HL096384]; Translational Research Program at Children's Hospital Boston; Harvard Skin Diseases Pilot Study Grant; Sheba Medical Center, Israel; John Butler Mulliken Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR048564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Translational Research Program at Children's Hospital Boston; Harvard Skin Diseases Pilot Study Grant; Sheba Medical Center, Israel; John Butler Mulliken Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by the National Institutes of Health (P01-AR48564 and R01-HL096384); the Translational Research Program at Children's Hospital Boston; a Harvard Skin Diseases Pilot Study Grant (to Dr. Greenberger); the Talpiot Medical Leadership Program, Sheba Medical Center, Israel (to Dr. Greenberger); and the John Butler Mulliken Foundation.	Boye E, 2001, J CLIN INVEST, V107, P745, DOI 10.1172/JCI11432; Chang J, 1999, PLAST RECONSTR SURG, V103, P1, DOI 10.1097/00006534-199901000-00001; Cifone MG, 1999, BLOOD, V93, P2282, DOI 10.1182/blood.V93.7.2282.407a23_2282_2296; Claesson-Welsh L, 2008, NAT MED, V14, P1147, DOI 10.1038/nm1108-1147; Drolet BA, 1999, NEW ENGL J MED, V341, P173, DOI 10.1056/NEJM199907153410307; Drolet BA, 2008, J PEDIATR, V153, P712, DOI 10.1016/j.jpeds.2008.05.043; EDGERTON MT, 1976, ANN SURG, V183, P517, DOI 10.1097/00000658-197605000-00009; Enjolras O, 1997, Adv Dermatol, V13, P375; GAILLARD RC, 1985, J CLIN ENDOCR METAB, V61, P1009, DOI 10.1210/jcem-61-6-1009; Hasan Q, 2003, CLIN EXP PHARMACOL P, V30, P140, DOI 10.1046/j.1440-1681.2003.03815.x; Hata Y, 2008, BRIT J OPHTHALMOL, V92, P1540, DOI 10.1136/bjo.2008.141002; Isik FF, 1996, J SURG RES, V61, P71, DOI 10.1006/jsre.1996.0083; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; Khan ZA, 2008, J CLIN INVEST, V118, P2592, DOI 10.1172/JCI33493; Khan ZA, 2006, BLOOD, V108, P915, DOI 10.1182/blood-2006-03-006478; Kleinman ME, 2007, ARTERIOSCL THROM VAS, V27, P2664, DOI 10.1161/ATVBAHA.107.150284; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; MULLIKEN JB, 1982, PLAST RECONSTR SURG, V69, P412, DOI 10.1097/00006534-198203000-00002; Mulliken JB, 2000, CURR PROB SURG, V37, P521; Nauck M, 1998, EUR J PHARMACOL, V341, P309, DOI 10.1016/S0014-2999(97)01464-7; Oh HY, 2006, CELL DEATH DIFFER, V13, P512, DOI 10.1038/sj.cdd.4401771; Ritter MR, 2002, P NATL ACAD SCI USA, V99, P7455, DOI 10.1073/pnas.102185799; Short SM, 2005, J CELL BIOL, V169, P541, DOI 10.1083/jcb.200407060042805c; Short SM, 2005, J CELL BIOL, V168, P643, DOI 10.1083/jcb.200407060; SMOLLER BR, 1993, J CUTAN PATHOL, V20, P330, DOI 10.1111/j.1600-0560.1993.tb01271.x; TAKAHASHI K, 1994, J CLIN INVEST, V93, P2357, DOI 10.1172/JCI117241; Wilson C, 2008, BRIT J CANCER, V99, P2054, DOI 10.1038/sj.bjc.6604804; Wu WS, 2006, J INVEST DERMATOL, V126, P1264, DOI 10.1038/sj.jid.5700274; Yamamoto M, 1998, HEPATOLOGY, V27, P959, DOI 10.1002/hep.510270410; Yu Y, 2004, BLOOD, V103, P1373, DOI 10.1182/blood-2003-08-2859; Yu Y, 2001, AM J PATHOL, V159, P2271, DOI 10.1016/S0002-9440(10)63077-5; ZACHARCHUK CM, 1990, J IMMUNOL, V145, P4037; Zhang L, 2005, PLAST RECONSTR SURG, V116, P200, DOI 10.1097/01.PRS.0000170804.80834.5F; Zins K, 2007, CANCER RES, V67, P1038, DOI 10.1158/0008-5472.CAN-06-2295	34	173	193	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2010	362	11					1005	1013		10.1056/NEJMoa0903036	http://dx.doi.org/10.1056/NEJMoa0903036			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570CY	20237346	Green Accepted, Bronze			2022-12-28	WOS:000275650400011
J	Hui, D; Elsayem, A; De La Cruz, M; Berger, A; Zhukovsky, DS; Palla, S; Evans, A; Fadul, N; Palmer, JL; Bruera, E				Hui, David; Elsayem, Ahmed; De La Cruz, Maxine; Berger, Ann; Zhukovsky, Donna S.; Palla, Shana; Evans, Avery; Fadul, Nada; Palmer, J. Lynn; Bruera, Eduardo			Availability and Integration of Palliative Care at US Cancer Centers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; SUPPORTIVE CARE; MEDICAL-CARE; DATA-BASE; LIFE; ONCOLOGY; QUALITY; END; HOSPITALS; SOCIETY	Context The current state of palliative care in cancer centers is not known. Objectives To determine the availability and degree of integration of palliative care services and to compare between National Cancer Institute (NCI) and non-NCI cancer centers in the United States. Design, Setting, and Participants A survey of 71 NCI-designated cancer centers and a random sample of 71 non-NCI cancer centers of both executives and palliative care clinical program leaders, where applicable, regarding their palliative care services between June and October 2009. Survey questions were generated after a comprehensive literature search, review of guidelines from the National Quality Forum, and discussions among 7 physicians with research interest in palliative oncology. Executives were also asked about their attitudes toward palliative care. Main Outcome Measure Availability of palliative care services in the cancer center, defined as the presence of at least 1 palliative care physician. Results A total of 142 and 120 surveys were sent to executives and program leaders, with response rates of 71% and 82%, respectively. National Cancer Institute cancer centers were significantly more likely to have a palliative care program (50/51 [98%] vs 39/50 [78%]; P=.002), at least 1 palliative care physician (46/50 [92%] vs 28/38 [74%]; P=.04), an inpatient palliative care consultation team (47/51 [92%] vs 28/50 [56%]; P<.001), and an outpatient palliative care clinic (30/51 [59%] vs 11/50 [22%]; P<.001). Few centers had dedicated palliative care beds (23/101 [23%]) or an institution-operated hospice (37/101 [37%]). The median (interquartile range) reported durations from referral to death were 7 (4-16), 7 (5-10), and 90 (30-120) days for inpatient consultation teams, inpatient units, and outpatient clinics, respectively. Research programs, palliative care fellowships, and mandatory rotations for oncology fellows were uncommon. Executives were supportive of stronger integration and increasing palliative care resources. Conclusion Most cancer centers reported a palliative care program, although the scope of services and the degree of integration varied widely. JAMA. 2010; 303(11): 1054-1061	[Hui, David; Elsayem, Ahmed; De La Cruz, Maxine; Zhukovsky, Donna S.; Evans, Avery; Fadul, Nada; Bruera, Eduardo] Univ Texas MD Anderson Canc Ctr, Dept Palliat Care & Rehabil Med, Houston, TX 77030 USA; [Palla, Shana; Palmer, J. Lynn] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Berger, Ann] NCI, Dept Palliat Care, Ctr Clin Canc, Bethesda, MD 20892 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Elsayem, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Palliat Care & Rehabil Med, Unit 1414,1515 Holcombe Blvd, Houston, TX 77030 USA.	aelsayem@mdanderson.org	Bruera, Eduardo/AAA-1550-2022		National Institutes of Health [RO1NR010162-01A1, RO1CA122292-01, RO1CA124481-01]; National Cancer Institute [CA16672]; Royal College of Physicians and Surgeons of Canada; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA124481, R01CA122292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010162] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL000785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Royal College of Physicians and Surgeons of Canada; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); CLINICAL CENTER	Funding/Support: This work was supported in part by grants RO1NR010162-01A1, RO1CA122292-01, and RO1CA124481-01 from the National Institutes of Health (Dr Bruera); grant CA16672 from the National Cancer Institute (Patient- Reported Outcomes, Survey and Population Research Shared Resources); and the Clinician Investigator Program, Royal College of Physicians and Surgeons of Canada (Dr Hui).	[Anonymous], 2006, NAT FRAM PREF PRACT; Baker JN, 2008, PEDIATR CLIN N AM, V55, P223, DOI 10.1016/j.pcl.2007.10.011; Bilimoria KY, 2008, ANN SURG ONCOL, V15, P683, DOI 10.1245/s10434-007-9747-3; Bilimoria KY, 2009, J CLIN ONCOL, V27, P4177, DOI 10.1200/JCO.2008.21.7018; Billings J A, 2001, J Palliat Med, V4, P309, DOI 10.1089/109662101753123913; Byock I, 2000, CA-CANCER J CLIN, V50, P123, DOI 10.3322/canjclin.50.2.123; Cheng Wen-Wu, 2005, J Palliat Med, V8, P1025, DOI 10.1089/jpm.2005.8.1025; Cherny NI, 2003, CANCER-AM CANCER SOC, V98, P2502, DOI 10.1002/cncr.11815; COLUZZI PH, 1995, J CLIN ONCOL, V13, P756, DOI 10.1200/JCO.1995.13.3.756; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; El Osta B, 2008, J PALLIAT MED, V11, P51, DOI 10.1089/jpm.2007.0103; Elsayem A, 2004, J CLIN ONCOL, V22, P2008, DOI 10.1200/JCO.2004.11.003; Ferrell B, 2008, J CLIN ONCOL, V26, P3824, DOI 10.1200/JCO.2007.15.7552; Ferris FD, 2009, J CLIN ONCOL, V27, P3052, DOI 10.1200/JCO.2008.20.1558; Goldsmith B, 2008, J PALLIAT MED, V11, P1094, DOI 10.1089/jpm.2008.0053; Higginson IJ, 2003, J PAIN SYMPTOM MANAG, V25, P150, DOI 10.1016/S0885-3924(02)00599-7; Hui D, 2010, J PALLIAT MED, V13, P49, DOI 10.1089/jpm.2009.0166; INGHAM J, 1998, PRINCIPLES PRACTICE, P749; *IOM NAT CANC POL, 2001, IMPR PALL CAR CANC; Johnson CE, 2008, PALLIATIVE MED, V22, P51, DOI 10.1177/0269216307085181; Lagman R, 2005, SEMIN ONCOL, V32, P134, DOI 10.1053/j.seminoncol.2004.11.015; LENEXA KS, 2009, STANDARD DEFINITIONS; Levy MH, 2009, J NATL COMPR CANC NE, V7, P436, DOI 10.6004/jnccn.2009.0031; Meyers FJ, 2004, J PAIN SYMPTOM MANAG, V28, P548, DOI 10.1016/j.jpainsymman.2004.03.002; Meyers FJ, 2003, J CLIN ONCOL, V21, P1412, DOI 10.1200/JCO.2003.01.104; Morita T, 2005, J CLIN ONCOL, V23, P2637, DOI 10.1200/JCO.2005.12.107; Morrison RS, 2005, J PALLIAT MED, V8, P1127, DOI 10.1089/jpm.2005.8.1127; Pan C X, 2001, J Palliat Med, V4, P315, DOI 10.1089/109662101753123922; Schnipper L, 1998, J CLIN ONCOL, V16, P1986; Temel JS, 2007, J CLIN ONCOL, V25, P2377, DOI 10.1200/JCO.2006.09.2627; World Health Organization, 2002, NAT CANC CONTR PROGR, V2nd, P83; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665	33	349	353	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1054	1061		10.1001/jama.2010.258	http://dx.doi.org/10.1001/jama.2010.258			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569KC	20233823	Green Accepted			2022-12-28	WOS:000275594100018
J	Allman, ES; Rhodes, JA				Allman, Elizabeth S.; Rhodes, John A.			Trees, Fast and Accurate	SCIENCE			English	Editorial Material									[Allman, Elizabeth S.; Rhodes, John A.] Univ Alaska, Dept Math & Stat, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks	Allman, ES (corresponding author), Univ Alaska, Dept Math & Stat, POB 756660, Fairbanks, AK 99775 USA.	e.allman@alaska.edu; j.rhodes@alaska.edu		Allman, Elizabeth/0000-0002-4866-9606; Rhodes, John/0000-0001-9921-1091				Daskalakis C, 2011, PROBAB THEORY REL, V149, P149, DOI 10.1007/s00440-009-0246-2; Erdos PL, 1999, RANDOM STRUCT ALGOR, V14, P153, DOI 10.1002/(SICI)1098-2418(199903)14:2<153::AID-RSA3>3.0.CO;2-R; Felsenstein J., 2004, INFERRING PHYLOGENIE; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Roch S, 2010, SCIENCE, V327, P1376, DOI 10.1126/science.1182300	5	5	5	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	2010	327	5971					1334	1335		10.1126/science.1187797	http://dx.doi.org/10.1126/science.1187797			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223973				2022-12-28	WOS:000275418700026
J	Bollinger, JM; Matthews, ML				Bollinger, J. Martin, Jr.; Matthews, Megan L.			Remote Enzyme Microsurgery	SCIENCE			English	Editorial Material							TRYPTOPHAN TRYPTOPHYLQUINONE COFACTOR; METHYLAMINE DEHYDROGENASE; MAUG; BIOSYNTHESIS; BIOCHEMISTRY; BIOGENESIS; MECHANISM		[Bollinger, J. Martin, Jr.; Matthews, Megan L.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bollinger, JM (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	jmb21@psu.edu	Matthews, Megan/W-2217-2017; Bollinger, Joseph/C-1425-2016	Matthews, Megan/0000-0003-1178-4616; 				Bollinger JM, 2008, SCIENCE, V320, P1730, DOI 10.1126/science.1160001; Chen LY, 1998, J MOL BIOL, V276, P131, DOI 10.1006/jmbi.1997.1511; Cotruvo JA, 2010, BIOCHEMISTRY-US, V49, P1297, DOI 10.1021/bi902106n; Jensen LMR, 2010, SCIENCE, V327, P1392, DOI 10.1126/science.1182492; Li XH, 2008, P NATL ACAD SCI USA, V105, P8597, DOI 10.1073/pnas.0801643105; MCINTIRE WS, 1991, SCIENCE, V252, P817, DOI 10.1126/science.2028257; Pearson AR, 2004, BIOCHEMISTRY-US, V43, P5494, DOI 10.1021/bi049863l; Pearson AR, 2006, J AM CHEM SOC, V128, P12416, DOI 10.1021/ja064466e; Pettigrew GW, 2006, J INORG BIOCHEM, V100, P551, DOI 10.1016/j.jinorgbio.2005.12.008; Wang YT, 2005, J AM CHEM SOC, V127, P8258, DOI 10.1021/ja051734k; Wang YT, 2003, BIOCHEMISTRY-US, V42, P7318, DOI 10.1021/bi034243q; Wilmot CM, 2009, CURR OPIN CHEM BIOL, V13, P469, DOI 10.1016/j.cbpa.2009.06.026; Xie LL, 2001, P NATL ACAD SCI USA, V98, P12863, DOI 10.1073/pnas.231485998	13	1	1	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	2010	327	5971					1337	1338		10.1126/science.1187421	http://dx.doi.org/10.1126/science.1187421			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223975				2022-12-28	WOS:000275418700028
J	Hathaway, DH; Rightmire, L				Hathaway, David H.; Rightmire, Lisa			Variations in the Sun's Meridional Flow over a Solar Cycle	SCIENCE			English	Article							MICHELSON DOPPLER IMAGER; POLAR MAGNETIC-FIELDS; CIRCULATION; NETWORK	The Sun's meridional flow is an axisymmetric flow that is generally directed from its equator toward its poles at the surface. The structure and strength of the meridional flow determine both the strength of the Sun's polar magnetic field and the intensity of sunspot cycles. We determine the meridional flow speed of magnetic features on the Sun using data from the Solar and Heliospheric Observatory. The average flow is poleward at all latitudes up to 75 degrees, which suggests that it extends to the poles. It was faster at sunspot cycle minimum than at maximum and substantially faster on the approach to the current minimum than it was at the last solar minimum. This result may help to explain why this solar activity minimum is so peculiar.	[Hathaway, David H.] NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA; [Rightmire, Lisa] Univ Memphis, Memphis, TN 38152 USA	National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; University of Memphis	Hathaway, DH (corresponding author), NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA.	david.hathaway@nasa.gov		Upton, Lisa/0000-0003-0621-4803	NASA [NAG5-10483]; Marshall Space Grant Research Internship Project	NASA(National Aeronautics & Space Administration (NASA)); Marshall Space Grant Research Internship Project	The SOHO/MDI project is supported by NASA grant NAG5-10483 to Stanford University. SOHO is a project of international cooperation between ESA and NASA. L. R. was supported as a summer intern at NASA/Marshall Space Flight Center through the Marshall Space Grant Research Internship Project.	Beck JG, 2005, ASTROPHYS J, V621, pL153, DOI 10.1086/429224; Choudhuri AR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.131103; DEVORE CR, 1987, SOL PHYS, V108, P47, DOI 10.1007/BF00152076; Dikpati M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025221; Giles PM, 1997, NATURE, V390, P52, DOI 10.1038/36294; Hathaway DH, 2004, SOL PHYS, V224, P5, DOI 10.1007/s11207-005-3996-8; Hathaway DH, 1996, ASTROPHYS J, V460, P1027, DOI 10.1086/177029; Hernandez IG, 2006, ASTROPHYS J, V638, P576, DOI 10.1086/498642; KAMBRY MA, 1991, SOL PHYS, V132, P41, DOI 10.1007/BF00159128; KOMM RW, 1993, SOL PHYS, V147, P207, DOI 10.1007/BF00690713; Lean JL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034864; *MDI, MDI CAL NOT KNOWN PR; RIBES E, 1985, NATURE, V318, P170, DOI 10.1038/318170a0; Scherrer PH, 1995, SOL PHYS, V162, P129, DOI 10.1007/BF00733429; Schou J, 1998, ASTROPHYS J, V504, pL131, DOI 10.1086/311575; Schrijver CJ, 2008, SOL PHYS, V252, P19, DOI 10.1007/s11207-008-9240-6; Schrijver CJ, 2001, ASTROPHYS J, V551, P1099, DOI 10.1086/320237; SHEELEY NR, 1969, SOL PHYS, V9, P347, DOI 10.1007/BF02391657; Svalgaard L, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021664; TOPKA K, 1982, SOL PHYS, V79, P231, DOI 10.1007/BF00146242; van Ballegooijen AA, 1998, ASTROPHYS J, V501, P866, DOI 10.1086/305823; Wang YM, 2009, ASTROPHYS J, V707, P1372, DOI 10.1088/0004-637X/707/2/1372; Wang YM, 2005, ASTROPHYS J, V625, P522, DOI 10.1086/429689	23	174	176	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	2010	327	5971					1350	1352		10.1126/science.1181990	http://dx.doi.org/10.1126/science.1181990			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223980				2022-12-28	WOS:000275418700033
J	Snippert, HJ; Haegebarth, A; Kasper, M; Jaks, V; van Es, JH; Barker, N; van de Wetering, M; van den Born, M; Begthel, H; Vries, RG; Stange, DE; Toftgard, R; Clevers, H				Snippert, Hugo J.; Haegebarth, Andrea; Kasper, Maria; Jaks, Viljar; van Es, Johan H.; Barker, Nick; van de Wetering, Marc; van den Born, Maaike; Begthel, Harry; Vries, Robert G.; Stange, Daniel E.; Toftgard, Rune; Clevers, Hans			Lgr6 Marks Stem Cells in the Hair Follicle That Generate All Cell Lineages of the Skin	SCIENCE			English	Article							LABEL-RETAINING CELLS; ADULT-MOUSE SKIN; POPULATION; EPIDERMIS; KERATINOCYTES; DISTINCT; BULGE; EXPRESSION; RENEWAL; DEFINES	Mammalian epidermis consists of three self-renewing compartments: the hair follicle, the sebaceous gland, and the interfollicular epidermis. We generated knock-in alleles of murine Lgr6, a close relative of the Lgr5 stem cell gene. Lgr6 was expressed in the earliest embryonic hair placodes. In adult hair follicles, Lgr6+ cells resided in a previously uncharacterized region directly above the follicle bulge. They expressed none of the known bulge stem cell markers. Prenatal Lgr6+ cells established the hair follicle, sebaceous gland, and interfollicular epidermis. Postnatally, Lgr6+ cells generated sebaceous gland and interfollicular epidermis, whereas contribution to hair lineages gradually diminished with age. Adult Lgr6+ cells executed long-term wound repair, including the formation of new hair follicles. We conclude that Lgr6 marks the most primitive epidermal stem cell.	[Snippert, Hugo J.; Haegebarth, Andrea; van Es, Johan H.; Barker, Nick; van de Wetering, Marc; van den Born, Maaike; Begthel, Harry; Vries, Robert G.; Stange, Daniel E.; Clevers, Hans] Royal Netherlands Acad Arts & Sci, Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Snippert, Hugo J.; Haegebarth, Andrea; van Es, Johan H.; Barker, Nick; van de Wetering, Marc; van den Born, Maaike; Begthel, Harry; Vries, Robert G.; Stange, Daniel E.; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Kasper, Maria; Jaks, Viljar; Toftgard, Rune] Karolinska Inst, Ctr Biosci, SE-14157 Huddinge, Sweden; [Kasper, Maria; Jaks, Viljar; Toftgard, Rune] Novum, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Karolinska Institutet; Karolinska Institutet	Clevers, H (corresponding author), Royal Netherlands Acad Arts & Sci, Hubrecht Inst KNAW, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	Barker, Nick/AAS-2774-2020; Barker, Nick/AAE-9833-2021; Kasper, Maria/Q-6318-2016; Barker, Nick/A-5535-2011; van+Es, Johan/ABD-5411-2021; Jaks, Viljar/H-2467-2012; Stange, Daniel E/O-1837-2015	Barker, Nick/0000-0003-3566-4475; Jaks, Viljar/0000-0002-2221-6262; Stange, Daniel E/0000-0003-4246-2230; Kasper, Maria/0000-0002-6117-2717	Koningin Wilhelmina Fonds; European Research Council; European Molecular Biology Organization; Swedish Cancer Society; Swedish Research Council	Koningin Wilhelmina Fonds; European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission)	We acknowledge M. Cozijnsen, J. Korving, A. Bergstrom, A. Dackland, and Hubrecht Imaging Centre for technical help and support. This work was supported by the Koningin Wilhelmina Fonds and a European Research Council grant to H. C., a European Molecular Biology Organization Long-Term Fellowship to A. H., and by grants from the Swedish Cancer Society and the Swedish Research Council to R. T. A patent is pending on work with Lgr5 and Lgr6 (A. H., N. B., and H. C.). GEO microarray accession number is GSE20269.	Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Iseki S, 1996, BIOCHEM BIOPH RES CO, V218, P688, DOI 10.1006/bbrc.1996.0123; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Jensen UB, 2008, J CELL SCI, V121, P609, DOI 10.1242/jcs.025502; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nijhof JGW, 2006, DEVELOPMENT, V133, P3027, DOI 10.1242/dev.02443; Pispa J, 2008, HUM MOL GENET, V17, P3380, DOI 10.1093/hmg/ddn232; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Van Loy T, 2008, GEN COMP ENDOCR, V155, P14, DOI 10.1016/j.ygcen.2007.06.022; Van Schoore G, 2005, HISTOCHEM CELL BIOL, V124, P35, DOI 10.1007/s00418-005-0002-3; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064	30	543	575	6	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1385	1389		10.1126/science.1184733	http://dx.doi.org/10.1126/science.1184733			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223988				2022-12-28	WOS:000275418700043
J	Ammirante, M; Luo, JL; Grivennikov, S; Nedospasov, S; Karin, M				Ammirante, Massimo; Luo, Jun-Li; Grivennikov, Sergei; Nedospasov, Sergei; Karin, Michael			B-cell-derived lymphotoxin promotes castration-resistant prostate cancer	NATURE			English	Article							FACTOR-KAPPA-B; IKK-ALPHA; CHRONIC INFLAMMATION; T-CELLS; ACTIVATION; INTERLEUKIN-6; PROGRESSION; METASTASIS; EXPRESSION; RELEASE	Prostate cancer (CaP) progresses from prostatic intraepithelial neoplasia through locally invasive adenocarcinoma to castration-resistant metastatic carcinoma(1). Although radical prostatectomy, radiation and androgen ablation are effective therapies for androgen-dependent CaP, metastatic castration-resistant CaP is a major complication with high mortality(2). Androgens stimulate growth and survival of prostate epithelium and early CaP. Although most patients initially respond to androgen ablation, many develop castration-resistant CaP within 12-18 months(2). Despite extensive studies, the mechanisms underlying the emergence of castration-resistant CaP remain poorly understood and their elucidation is critical for developing improved therapies. Curiously, castration-resistant CaP remains androgen-receptor dependent, and potent androgen-receptor antagonists induce tumour regression in castrated mice(3). The role of inflammation in castration-resistant CaP has not been addressed, although it was reported that intrinsic NF-kappa B activation supports its growth(4). Inflammation is a localized protective reaction to injury or infection, but it also has a pathogenic role in many diseases, including cancer(5). Whereas acute inflammation is critical for host defence, chronic inflammation contributes to tumorigenesis and metastatic progression. The inflammation-responsive I kappa B kinase (IKK)-beta and its target NF-kB have important tumour-promoting functions within malignant cells and inflammatory cells(6). The latter, including macrophages and lymphocytes, are important elements of the tumour microenvironment(7-9), but the mechanisms underlying their recruitment remain obscure, although they are thought to depend on chemokine and cytokine production(10). We found that CaP progression is associated with inflammatory infiltration and activation of IKK-alpha, which stimulates metastasis by an NF-kappa B-independent, cell autonomous mechanism(11). Here we show that androgen ablation causes infiltration of regressing androgen-dependent tumours with leukocytes, including B cells, in which IKK-beta activation results in production of cytokines that activate IKK-alpha and STAT3 in CaP cells to enhance hormone-free survival.	[Ammirante, Massimo; Grivennikov, Sergei; Karin, Michael] Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, La Jolla, CA 92093 USA; [Ammirante, Massimo; Grivennikov, Sergei; Karin, Michael] Univ Calif San Diego, Sch Med, Ctr Canc, La Jolla, CA 92093 USA; [Luo, Jun-Li] Scripps Res Inst Florida, Dept Canc Biol, Jupiter, FL 33458 USA; [Nedospasov, Sergei] VA Engelhardt Mol Biol Inst, Lab Mol Immunol, Moscow 119991, Russia	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Grivennikov, Sergei/AAE-7365-2019; Nedospasov, Sergei/J-5936-2013; Nedospasov, Sergei/L-1990-2015; Nedospasov, Sergei/C-3043-2018; Nedospasov, Sergei/Q-7319-2016	Grivennikov, Sergei/0000-0003-2987-0555; Luo, Jun-Li/0000-0002-7625-4766	Fondazione Italiana per la Ricerca sul Cancro; American-Italian Cancer Foundation; Life Science Research Fellowship; National Institutes of Health; US Army Medical Research and Material Command and Prostate Cancer Foundation; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; NATIONAL CANCER INSTITUTE [R01CA127923] Funding Source: NIH RePORTER	Fondazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); American-Italian Cancer Foundation; Life Science Research Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Army Medical Research and Material Command and Prostate Cancer Foundation; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank C. Sawyers for myc-CaP cells, L. Coussens for J<INF>H</INF><SUP>-/-</SUP> (FVB) mice, Y. X. Fu for LT beta R-Ig fusion protein, R. Rickert for help with B-cell phenotyping, H. Cheroutre for flow cytometer use and C. Ware for bone marrow. M. A. was supported by Fondazione Italiana per la Ricerca sul Cancro and American-Italian Cancer Foundation fellowships. J.-L.L. was supported by a Life Science Research Fellowship. Work in M.K.'s laboratory was supported by grants from the National Institutes of Health, the US Army Medical Research and Material Command and Prostate Cancer Foundation. M. K. is an American Cancer Society Research Professor.	Bai AL, 2008, P NATL ACAD SCI USA, V105, P13003, DOI 10.1073/pnas.0805599105; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Chen TS, 2000, CANCER RES, V60, P2132; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Eriksen KW, 2001, LEUKEMIA, V15, P787, DOI 10.1038/sj.leu.2402093; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Gulley James, 2003, Clin Adv Hematol Oncol, V1, P49; Hamel K, 2008, J IMMUNOL, V180, P4994, DOI 10.4049/jimmunol.180.7.4994; Isaacs JT, 1999, UROL CLIN N AM, V26, P263, DOI 10.1016/S0094-0143(05)70066-5; Izmailova ES, 2007, ARTHRITIS RHEUM-US, V56, P117, DOI 10.1002/art.22303; Jin RJ, 2008, CANCER RES, V68, P6762, DOI 10.1158/0008-5472.CAN-08-0107; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kortylewski M, 2007, J IMMUNOTHER, V30, P131, DOI 10.1097/01.cji.0000211327.76266.65; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee Y, 2006, IMMUNITY, V25, P499, DOI 10.1016/j.immuni.2006.06.016; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Liu X, 2006, AM J EPIDEMIOL, V164, P984, DOI 10.1093/aje/kwj294; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Smith PC, 2001, CYTOKINE GROWTH F R, V12, P33, DOI 10.1016/S1359-6101(00)00021-6; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Tumanov AV, 2003, IMMUNOL REV, V195, P106, DOI 10.1034/j.1600-065X.2003.00071.x; Watson PA, 2005, CANCER RES, V65, P11565, DOI 10.1158/0008-5472.CAN-05-3441; Wen DY, 2006, J PHARMACOL EXP THER, V317, P989, DOI 10.1124/jpet.105.097584; Worm MM, 1998, EUR J IMMUNOL, V28, P901, DOI 10.1002/(SICI)1521-4141(199803)28:03<901::AID-IMMU901>3.0.CO;2-S; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Zheng B, 2005, ARTHRITIS RHEUM-US, V52, P620, DOI 10.1002/art.20768	39	430	450	4	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					302	U187		10.1038/nature08782	http://dx.doi.org/10.1038/nature08782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20220849	Green Accepted			2022-12-28	WOS:000275366100052
J	Chosidow, O; Giraudeau, B; Cottrell, J; Izri, A; Hofmann, R; Mann, SG; Burgess, I				Chosidow, Olivier; Giraudeau, Bruno; Cottrell, Jeremy; Izri, Arezki; Hofmann, Robert; Mann, Stephen G.; Burgess, Ian			Oral Ivermectin versus Malathion Lotion for Difficult-to-Treat Head Lice	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PEDICULUS-HUMANUS-CAPITIS; PERMETHRIN RESISTANCE; MASS TREATMENT; ANOPLURA; EFFICACY; SCABIES; SUSCEPTIBILITY; DIMETICONE	BACKGROUND Head-lice infestation is prevalent worldwide, especially in children 3 to 11 years old. Topical insecticides (i.e., pyrethroids and malathion) used as a lotion, applied twice at an interval of 7 to 11 days, are typically used for treatment. Resistance of lice to insecticides, particularly pyrethroids, results in treatment failure. The efficacy of alternative agents is controversial. METHODS We conducted a multicenter, cluster-randomized, double-blind, double-dummy, controlled trial comparing oral ivermectin (at a dose of 400 mu g per kilogram of body weight) with 0.5% malathion lotion, each given on days 1 and 8, for patients with live lice not eradicated by topical insecticide used 2 to 6 weeks before enrollment. The cluster was defined as the household. Infestation was confirmed and monitored by means of fine-toothed combing. Patients were at least 2 years of age and weighed at least 15 kg; all were treated at the study sites. The primary end point was the absence of head lice on day 15. RESULTS A total of 812 patients from 376 households were randomly assigned to receive either ivermectin or malathion. In the intention-to-treat population, 95.2% of patients receiving ivermectin were lice-free on day 15, as compared with 85.0% of those receiving malathion (absolute difference, 10.2 percentage points; 95% confidence interval [CI], 4.6 to 15.7; P<0.001). In the per-protocol population, 97.1% of patients in the ivermectin group were lice-free on day 15, as compared with 89.8% of those in the malathion group (absolute difference, 7.3 percentage points; 95% CI, 2.8 to 11.8; P = 0.002). There were no significant differences in the frequencies of adverse events between the two treatment groups. CONCLUSIONS For difficult-to-treat head-lice infestation, oral ivermectin, given twice at a 7-day interval, had superior efficacy as compared with topical 0.5% malathion lotion, a finding that suggests that it could be an alternative treatment. (ClinicalTrials.gov number, NCT00819520.)	[Chosidow, Olivier] Hop Henri Mondor, Dept Dermatol, F-94010 Creteil, France; [Chosidow, Olivier] Univ Paris 06, Paris, France; [Chosidow, Olivier] AP HP, Paris, France; [Giraudeau, Bruno] INSERM, U738, Paris, France; [Giraudeau, Bruno] Univ Tours, INSERM, Ctr Invest Clin 202, Tours, France; [Giraudeau, Bruno] Ctr Hosp Reg Univ Tours, Tours, France; [Izri, Arezki] Univ Paris 13, Bobigny, France; [Izri, Arezki] Hop Avicenne, Dept Parasitol, F-93009 Bobigny, France; [Cottrell, Jeremy; Mann, Stephen G.] McNeil, High Wycombe, Bucks, England; [Burgess, Ian] Med Entomol Ctr, Cambridge, England; [Hofmann, Robert] Johnson & Johnson, Neuss, Germany	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Johnson & Johnson; Johnson & Johnson	Chosidow, O (corresponding author), Hop Henri Mondor, Dept Dermatol, 51 Ave Marechal Lattre Tassigny, F-94010 Creteil, France.	olivier.chosidow@hmn.aphp.fr	Burgess, Ian/N-2977-2013; Giraudeau, Bruno/L-9003-2015	Burgess, Ian/0000-0003-0747-3938; Giraudeau, Bruno/0000-0003-3031-8258	Johnson & Johnson-Merck Sharp Dohme-Chibret	Johnson & Johnson-Merck Sharp Dohme-Chibret	Supported by Johnson & Johnson-Merck Sharp & Dohme-Chibret.	Badiaga S, 2008, J ANTIMICROB CHEMOTH, V62, P404, DOI 10.1093/jac/dkn161; Barkwell R, 1997, LANCET, V349, P1144, DOI 10.1016/S0140-6736(05)63020-6; Bourguinat C, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000072; BURGESS IF, 1995, BRIT MED J, V311, P752, DOI 10.1136/bmj.311.7007.752; Burgess IF, 2005, BRIT MED J, V330, P1423, DOI 10.1136/bmj.38497.506481.8F; Chosidow O, 2006, NEW ENGL J MED, V354, P1718, DOI 10.1056/NEJMcp052784; CHOSIDOW O, 1994, LANCET, V344, P1724, DOI 10.1016/S0140-6736(94)92884-3; Chosidow O, 2000, LANCET, V355, P819, DOI 10.1016/S0140-6736(99)09458-1; Chosidow O, 2006, ARCH DERMATOL, V142, P1635, DOI 10.1001/archderm.142.12.1635; Currie BJ, 2004, CLIN INFECT DIS, V39, pE8, DOI 10.1086/421776; del Giudice P, 1999, ARCH DERMATOL, V135, P351, DOI 10.1001/archderm.135.3.351; DODD CS, 2007, COCHRANE DB SYST REV, V4; Elston DM, 2002, J AM ACAD DERMATOL, V46, P794, DOI 10.1067/mjd.2002.121027; Foucault C, 2006, J INFECT DIS, V193, P474, DOI 10.1086/499279; Gardon J, 1997, LANCET, V350, P18, DOI 10.1016/S0140-6736(96)11094-1; Giraudeau B, 2006, STAT MED, V25, P957, DOI 10.1002/sim.2260; GLAZIOU P, 1994, TROP MED PARASITOL, V45, P253; Heukelbach J, 2004, B WORLD HEALTH ORGAN, V82, P563; Heukelbach J, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-115; Hunter JA, 2003, PARASITOL RES, V90, P476, DOI 10.1007/s00436-003-0881-y; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Kristensen M, 2006, J MED ENTOMOL, V43, P533, DOI 10.1603/0022-2585(2006)43[533:SOPAMR]2.0.CO;2; Lee SH, 2000, PESTIC BIOCHEM PHYS, V66, P130, DOI 10.1006/pest.1999.2460; MEINKING TL, 1995, NEW ENGL J MED, V333, P26, DOI 10.1056/NEJM199507063330105; Meinking TL, 2002, ARCH DERMATOL, V138, P220, DOI 10.1001/archderm.138.2.220; Menegaux F, 2006, OCCUP ENVIRON MED, V63, P131, DOI 10.1136/oem.2005.023036; Morikawa T, 1995, J Biopharm Stat, V5, P297, DOI 10.1080/10543409508835115; Mounsey KE, 2009, ARCH DERMATOL, V145, P840, DOI 10.1001/archdermatol.2009.125; MUMCUOGLU KY, 1995, MED VET ENTOMOL, V9, P427, DOI 10.1111/j.1365-2915.1995.tb00018.x; Mumcuoglu KY, 2001, PEDIATR DERMATOL, V18, P9, DOI 10.1046/j.1525-1470.2001.018001009.x; MUMCUOGLU KY, 1990, J MED ENTOMOL, V27, P72, DOI 10.1093/jmedent/27.1.72; Ottesen EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000317; Pollack RJ, 1999, ARCH PEDIAT ADOL MED, V153, P969, DOI 10.1001/archpedi.153.9.969; Roberts RJ, 2002, NEW ENGL J MED, V346, P1645, DOI 10.1056/NEJMcp012640; Roberts RJ, 2000, LANCET, V356, P540, DOI 10.1016/S0140-6736(00)02578-2; Roulet A, 2003, EUR J PHARMACOL, V460, P85, DOI 10.1016/S0014-2999(02)02955-2; Strycharz JP, 2008, J MED ENTOMOL, V45, P75, DOI 10.1603/0022-2585(2008)45[75:ANIFTK]2.0.CO;2; VANDERSTICHELE RH, 1995, BMJ-BRIT MED J, V311, P604, DOI 10.1136/bmj.311.7005.604; Vassena CV, 2003, J MED ENTOMOL, V40, P447, DOI 10.1603/0022-2585-40.4.447; Yoon KS, 2003, ARCH DERMATOL, V139, P994, DOI 10.1001/archderm.139.8.994; 1999, MED LETT DRUGS THER, V41, P73	41	127	126	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10					896	905		10.1056/NEJMoa0905471	http://dx.doi.org/10.1056/NEJMoa0905471			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566JM	20220184				2022-12-28	WOS:000275365900010
J	Pettker, CM; Funai, EF				Pettker, Christian M.; Funai, Edmund F.			Getting It Right When Things Go Wrong	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							2ND VICTIM		[Pettker, Christian M.; Funai, Edmund F.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA	Yale University	Pettker, CM (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, POB 208063,333 Cedar St, New Haven, CT 06520 USA.	christian.pettker@yale.edu						Agency for Healthcare Research and Quality, PAT SAF PRIM SAF CUL; Kohn KT, 2000, ERR IS HUMAN BUILDIN; Marx D, 2001, PATIENT SAFETY JUST; MARX JDD, COMMUNICATION; Pettker CM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.022; Scott SD, 2009, QUAL SAF HEALTH CARE, V18, P325, DOI 10.1136/qshc.2009.032870; *US DEP VET AFF, VAS APPR PAT SAF; Wachter RM, 2009, NEW ENGL J MED, V361, P1401, DOI 10.1056/NEJMsb0903885; Wenzel M, 2008, LAW HUMAN BEHAV, V32, P375, DOI 10.1007/s10979-007-9116-6; Wu AW, 2000, BRIT MED J, V320, P726, DOI 10.1136/bmj.320.7237.726	10	10	10	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2010	303	10					977	978		10.1001/jama.2010.256	http://dx.doi.org/10.1001/jama.2010.256			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	565UC	20215611				2022-12-28	WOS:000275319300025
J	Nout, RA; Smit, VTHBM; Putter, H; Juergenliemk-Schulz, IM; Jobsen, JJ; Lutgens, LCHW; van der Steen-Banasik, EM; Mens, JWM; Slot, A; Kroese, MCS; van Bunningen, BNFM; Ansink, AC; van Putten, WLJ; Creutzberg, CL				Nout, R. A.; Smit, V. T. H. B. M.; Putter, H.; Juergenliemk-Schulz, I. M.; Jobsen, J. J.; Lutgens, L. C. H. W.; van der Steen-Banasik, E. M.; Mens, J. W. M.; Slot, A.; Kroese, M. C. Stenfert; van Bunningen, B. N. F. M.; Ansink, A. C.; van Putten, W. L. J.; Creutzberg, C. L.		PORTEC Study Grp	Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial	LANCET			English	Article							POSTOPERATIVE RADIOTHERAPY; RADIATION-THERAPY; GRADING SYSTEM; STAGE IB; CARCINOMA; IRRADIATION; PATTERNS; SURGERY; VAULT	Background After surgery for intermediate-risk endometrial carcinoma, the vagina is the most frequent site of recurrence. This study established whether vaginal brachytherapy (VBT) is as effective as pelvic external beam radiotherapy (EBRT) in prevention of vaginal recurrence, with fewer adverse effects and improved quality of life. Methods In this open-label, non-inferiority, randomised trial undertaken in 19 Dutch radiation oncology centres, 427 patients with stage I or IIA endometrial carcinoma with features of high-intermediate risk were randomly assigned by a computer-generated, biased coin minimisation procedure to pelvic EBRT (46 Gy in 23 fractions; n=214) or VBT (21 Gy high-dose rate in three fractions, or 30 Gy low-dose rate; n=213). All investigators were masked to the assignment of treatment group. The primary endpoint was vaginal recurrence. The predefined non-inferiority margin was an absolute difference of 6% in vaginal recurrence. Analysis was by intention to treat, with competing risk methods. The study is registered, number ISRCTN16228756. Findings At median follow-up of 45 months (range 18-78), three vaginal recurrences had been diagnosed after VBT and four after EBRT. Estimated 5-year rates of vaginal recurrence were 1.8% (95% CI 0.6-5.9) for VBT and 1.6% (0.5-4-9) for EBRT (hazard ratio [HR] 0.78, 95% CI 0-17-3.49; p=0.74). 5-year rates of locoregional relapse (vaginal or pelvic recurrence, or both) were 5.1% (2.8-9.6) for VBT and 2.1% (0.8-5.8) for EBRT (HR 2.08,0.71-6.09; p=0.17). 1.5% (0.5-4.5) versus 0.5% (0.1-3.4) of patients presented with isolated pelvic recurrence (HR 3.10, 0.32-29.9; p=0.30), and rates of distant metastases were similar (8.3% [5.1-13.4] vs 5.7% [3.3-9.9]; HR 1.32, 0.63-2.74; p=0.46). We recorded no differences in overall (84-8% [95% CI 79.3-90.3] vs 79.6% [71.2-88.0]; HR 1.17, 0.69-1.98; p=0.57) or disease-free survival (82.7% [76.9-88.6] vs 78.1% [69.7-86.5]; HR 1.09, 0.66-1.78; p=0.74). Rates of acute grade 1-2 gastrointestinal toxicity were significantly lower in the VBT group than in the EBRT group at completion of radiotherapy (12.6% [27/215] vs 53.8% [112/208]). Interpretation VBT is effective in ensuring vaginal control, with fewer gastrointestinal toxic effects than with EBRT. VBT should be the adjuvant treatment of choice for patients with endometrial carcinoma of high-intermediate risk.	[Nout, R. A.; Creutzberg, C. L.] Leiden Univ, Med Ctr, Dept Clin Oncol, NL-2300 RC Leiden, Netherlands; [Smit, V. T. H. B. M.] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands; [Putter, H.] Leiden Univ, Med Ctr, Dept Med Stat, NL-2300 RC Leiden, Netherlands; [Juergenliemk-Schulz, I. M.] Univ Med Ctr Utrecht, Dept Radiat Oncol, Utrecht, Netherlands; [Jobsen, J. J.] Med Spectrum Twente, Dept Radiotherapy, Enschede, Netherlands; [Lutgens, L. C. H. W.] MAASTricht Radiat Oncol Clin, Maastricht, Netherlands; [van der Steen-Banasik, E. M.] Arnhem Radiotherapy Inst, Arnhem, Netherlands; [Mens, J. W. M.] ErasmusMC, Dr Daniel Den Hoed Canc Ctr, Dept Radiat Oncol, Rotterdam, Netherlands; [van Putten, W. L. J.] ErasmusMC, Dr Daniel Den Hoed Canc Ctr, Dept Biostat, Rotterdam, Netherlands; [Ansink, A. C.] ErasmusMC, Dr Daniel Den Hoed Canc Ctr, Dept Gynecol, Rotterdam, Netherlands; [Slot, A.] Radiotherapy Inst Friesland, Leeuwarden, Netherlands; [Kroese, M. C. Stenfert] Radiotherapy Inst Stedendriehoek & Omstreken, Deventer, Netherlands; [van Bunningen, B. N. F. M.] Netherlands Canc Inst, Dept Radiotherapy, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; Medical Spectrum Twente; Maastricht University; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Netherlands Cancer Institute	Nout, RA (corresponding author), Leiden Univ, Med Ctr, Dept Clin Oncol, POB 9600, NL-2300 RC Leiden, Netherlands.	r.a.nout@lumc.nl	Leer, J.W.H./H-8067-2014; Smit, Vincent/AAD-1811-2022; Putter, Hein/C-2244-2018; Creutzberg, Carien L/E-2253-2018	Smit, Vincent/0000-0003-3730-5652; Putter, Hein/0000-0001-5395-1422; Creutzberg, Carien L/0000-0002-7008-4321; Nout, Remi/0000-0001-8011-2982	Dutch Cancer Society [CKTO 2001-04]	Dutch Cancer Society(KWF Kankerbestrijding)	The PORTEC-2 study was supported by a grant from the Dutch Cancer Society (CKTO 2001-04). Part of this research has been presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, May 30 June 3, 2008, Chicago IL, USA. We thank Philine van den Tol and Chantal te Marvelde, central data managers, for all their meticulous work and extra efforts to obtain compete follow up; the radiation oncologists, gynaecologists, and data managers at the participating centres; and the patients who greatly contributed by repeatedly filling in questionnaires throughout the study.	AALDERS J, 1980, OBSTET GYNECOL, V56, P419; Alektiar KM, 2005, INT J RADIAT ONCOL, V62, P111, DOI 10.1016/j.ijrobp.2004.09.054; Anderson JM, 2000, INT J RADIAT ONCOL, V46, P417, DOI 10.1016/S0360-3016(99)00427-7; Blake P, 2009, LANCET, V373, P137, DOI 10.1016/S0140-6736(08)61767-5; Bray F, 2005, INT J CANCER, V117, P123, DOI 10.1002/ijc.21099; Chadha M, 1999, GYNECOL ONCOL, V75, P103, DOI 10.1006/gyno.1999.5526; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; Creutzberg CL, 2001, INT J RADIAT ONCOL, V51, P1246, DOI 10.1016/S0360-3016(01)01765-5; Creutzberg CL, 2000, LANCET, V355, P1404, DOI 10.1016/S0140-6736(00)02139-5; Keys HM, 2004, GYNECOL ONCOL, V92, P744, DOI 10.1016/j.ygyno.2003.11.048; Kitchener H, 2009, LANCET, V373, P125, DOI 10.1016/S0140-6736(08)61766-3; Lax SF, 2000, AM J SURG PATHOL, V24, P1201, DOI 10.1097/00000478-200009000-00002; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; National Cancer Institute, 2006, CANC THER EV PROGR C; Nout RA, 2009, J CLIN ONCOL, V27, P3547, DOI 10.1200/JCO.2008.20.2424; Panici PB, 2008, JNCI-J NATL CANCER I, V100, P1707, DOI 10.1093/jnci/djn397; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Rittenberg PVC, 2005, GYNECOL ONCOL, V98, P434, DOI 10.1016/j.ygyno.2005.04.030; Scholten AN, 2005, INT J RADIAT ONCOL, V63, P834, DOI 10.1016/j.ijrobp.2005.03.007; Scholten AN, 2004, CANCER, V100, P764, DOI 10.1002/cncr.20040; SHEPHERD JH, 1989, BRIT J OBSTET GYNAEC, V96, P889, DOI 10.1111/j.1471-0528.1989.tb03341.x; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; Weiss E, 1998, GYNECOL ONCOL, V71, P72, DOI 10.1006/gyno.1998.5155	23	751	769	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 6	2010	375	9717					816	823		10.1016/S0140-6736(09)62163-2	http://dx.doi.org/10.1016/S0140-6736(09)62163-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570MO	20206777				2022-12-28	WOS:000275682600031
J	Han, QD; Chen, L; Evans, TG; Summerskill, W				Han, Qide; Chen, Lincoln; Evans, Tim G.; Summerskill, William			Recent scientific health developments in China	LANCET			English	Editorial Material									[Chen, Lincoln] Harvard Univ, China Med Board, Cambridge, MA 02138 USA; [Han, Qide] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Evans, Tim G.] WHO, CH-1211 Geneva, Switzerland; [Summerskill, William] The Lancet, London NW1 7BY, England	Harvard University; Peking University; World Health Organization	Chen, L (corresponding author), Harvard Univ, China Med Board, Cambridge, MA 02138 USA.	lincoln_chen@harvard.edu						CPC Central Committee. State Council, 2022, 2021 STAT B DEV HEAL, DOI 10.16619/j.cnki.rmltxsqy.2021.14.010; Guo Y, 2010, LANCET, V375, P1056, DOI 10.1016/S0140-6736(10)60397-2; Han QD, 2008, LANCET, V372, P1439, DOI 10.1016/S0140-6736(08)61350-1; *MIN HLTH GOV PEOP, 2009, SUMM AN REP NAT HLTH; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; Xu D, 2010, LANCET, V375, P1502, DOI 10.1016/S0140-6736(10)60241-3; Yip WCM, 2010, LANCET, V375, P1120, DOI 10.1016/S0140-6736(10)60063-3; Yu XR, 2010, LANCET, V375, P1420, DOI 10.1016/S0140-6736(10)60003-7; Zhang JF, 2010, LANCET, V375, P1110, DOI 10.1016/S0140-6736(10)60062-1	9	3	5	0	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2010	375	9720					1055	1056		10.1016/S0140-6736(10)60412-6	http://dx.doi.org/10.1016/S0140-6736(10)60412-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	578ZB	20346796				2022-12-28	WOS:000276334600004
J	Ginsberg, HN; Elam, MB; Lovato, LC; Crouse, JR; Leiter, LA; Linz, P; Friedewald, WT; Buse, JB; Gerstein, HC; Probstfield, J; Grimm, RH; Ismail-Beigi, F; Bigger, JT; Goff, DC; Cushman, WC; Simons-Morton, DG; Byington, RP				Ginsberg, Henry N.; Elam, Marshall B.; Lovato, Laura C.; Crouse, John R., III; Leiter, Lawrence A.; Linz, Peter; Friedewald, William T.; Buse, John B.; Gerstein, Hertzel C.; Probstfield, Jeffrey; Grimm, Richard H.; Ismail-Beigi, Faramarz; Bigger, J. Thomas; Goff, David C., Jr.; Cushman, William C.; Simons-Morton, Denise G.; Byington, Robert P.		ACCORD Study Grp	Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; RISK-FACTORS; PRIMARY-PREVENTION; LDL CHOLESTEROL; ARTERY-DISEASE; FENOFIBRATE; MEN; INTERVENTION; GEMFIBROZIL	BACKGROUND We investigated whether combination therapy with a statin plus a fibrate, as compared with statin monotherapy, would reduce the risk of cardiovascular disease in patients with type 2 diabetes mellitus who were at high risk for cardiovascular disease. METHODS We randomly assigned 5518 patients with type 2 diabetes who were being treated with open-label simvastatin to receive either masked fenofibrate or placebo. The primary outcome was the first occurrence of nonfatal myocardial infarction, nonfatal stroke, or death from cardiovascular causes. The mean follow-up was 4.7 years. RESULTS The annual rate of the primary outcome was 2.2% in the fenofibrate group and 2.4% in the placebo group (hazard ratio in the fenofibrate group, 0.92; 95% confidence interval [CI], 0.79 to 1.08; P = 0.32). There were also no significant differences between the two study groups with respect to any secondary outcome. Annual rates of death were 1.5% in the fenofibrate group and 1.6% in the placebo group (hazard ratio, 0.91; 95% CI, 0.75 to 1.10; P = 0.33). Prespecified subgroup analyses suggested heterogeneity in treatment effect according to sex, with a benefit for men and possible harm for women (P = 0.01 for interaction), and a possible interaction according to lipid subgroup, with a possible benefit for patients with both a high baseline triglyceride level and a low baseline level of high-density lipoprotein cholesterol (P = 0.057 for interaction). CONCLUSIONS The combination of fenofibrate and simvastatin did not reduce the rate of fatal cardiovascular events, nonfatal myocardial infarction, or nonfatal stroke, as compared with simvastatin alone. These results do not support the routine use of combination therapy with fenofibrate and simvastatin to reduce cardiovascular risk in the majority of high-risk patients with type 2 diabetes. (ClinicalTrials.gov number, NCT00000620.)	[Ginsberg, Henry N.] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Elam, Marshall B.; Cushman, William C.] Memphis Vet Affairs Med Ctr, Memphis, TN USA; [Lovato, Laura C.; Goff, David C., Jr.; Byington, Robert P.] Wake Forest Univ, Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27109 USA; [Crouse, John R., III] Wake Forest Univ, Sch Med, Prevent Cardiol Program, Winston Salem, NC 27109 USA; [Leiter, Lawrence A.] Univ Toronto, Toronto, ON, Canada; [Linz, Peter] USN, Med Ctr, San Diego, CA 92152 USA; [Friedewald, William T.] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Friedewald, William T.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Buse, John B.] Univ N Carolina, Sch Med, Div Endocrinol, Chapel Hill, NC USA; [Gerstein, Hertzel C.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Gerstein, Hertzel C.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Probstfield, Jeffrey] Univ Washington, Seattle, WA 98195 USA; [Grimm, Richard H.] Berman Ctr Outcomes & Clin Res, Minneapolis, MN USA; [Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Bigger, J. Thomas] Columbia Univ Coll Phys & Surg, Div Cardiol, New York, NY 10032 USA; [Simons-Morton, Denise G.] NHLBI, Bethesda, MD 20892 USA	Columbia University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Wake Forest University; Wake Forest University; University of Toronto; United States Department of Defense; United States Navy; Columbia University; Columbia University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; McMaster University; McMaster University; Population Health Research Institute; University of Washington; University of Washington Seattle; Case Western Reserve University; Case Western Reserve University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Ginsberg, HN (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, Rm PH 10-305, New York, NY 10032 USA.	hng1@columbia.edu	Bryan, R. Nick/P-1661-2014; Leiter, Lawrence/AAG-4059-2020; Januszkiewicz, Łukasz/M-4384-2018; Force, Rex W/K-4094-2012; Friedewald, William T/C-8034-2011; Buse, John Bernard/J-9742-2019; Hramiak, Irene/G-3305-2011; Gerstein, Hertzel C/B-1235-2013; Gerstein, Hertzel/ABB-8781-2020	Januszkiewicz, Łukasz/0000-0002-6286-4651; Buse, John Bernard/0000-0002-9723-3876; Gerstein, Hertzel C/0000-0001-8072-2836; Gerstein, Hertzel/0000-0001-8072-2836; Kaiser, Peter/0000-0001-5126-045X; Bryan, Robert Nick/0000-0002-2327-4579; Arrey, Frida/0000-0003-4543-4219; Yusuf, Salim/0000-0003-4776-5601	National Heart, Lung, and Blood Institute [N01-HC-95178, N01-HC-95179, N01-HC-95180, N01-HC-95181, N01-HC-95182, N01-HC-95183, N01-HC-95184, IAAY1-HC-9035, IAAY1-HC-1010]; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute on Aging; National Eye Institute; Centers for Disease Control and Prevention; General Clinical Research Centers; Merck; Merck Schering-Plough; Bristol-Myers Squibb; AstraZeneca; Abbott; Roche; Isis/Genzyme; GlaxoSmithKline; Novartis; Pfizer; Regeneron/Sanofi-Aventis; National Lipid Association; Solvay; Novo Nordisk; Amylin; Becton Dickinson; Eli Lilly; Hoffmann-La Roche; GlycoMark; Wyeth; Daiichi Sankyo; Bayhill Therapeutics; LipoScience; MannKind; Veritas; MicroIslet; Exsulin; GI Dynamics; Medtronic; Tolerex; Osiris; Halozyme; InterKrin; Sanofi-Aventis; Dexcom; Johnson Johnson; Fujisawa; Takeda; King; DaiichiSankyo; Gilead; Theravance; Pharmacopeia; Sciele; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095184, N01HC095182, N01HC095180, N01HC095178, N01HC095183, N01HC095179, N01HC095181] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL095181, R44HL095181, R01HL055638, R01HL073030] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); General Clinical Research Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Merck(Merck & Company); Merck Schering-Plough(Merck & CompanySchering Plough Corporation); Bristol-Myers Squibb(Bristol-Myers Squibb); AstraZeneca(AstraZeneca); Abbott(Abbott Laboratories); Roche(Roche Holding); Isis/Genzyme(Sanofi-AventisGenzyme Corporation); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Pfizer(Pfizer); Regeneron/Sanofi-Aventis(Sanofi-Aventis); National Lipid Association; Solvay(Solvay SA); Novo Nordisk(Novo Nordisk); Amylin; Becton Dickinson; Eli Lilly(Eli Lilly); Hoffmann-La Roche(Hoffmann-La Roche); GlycoMark; Wyeth(Wyeth); Daiichi Sankyo(Daiichi Sankyo Company Limited); Bayhill Therapeutics; LipoScience; MannKind; Veritas; MicroIslet; Exsulin; GI Dynamics; Medtronic(Medtronic); Tolerex; Osiris; Halozyme; InterKrin; Sanofi-Aventis(Sanofi-Aventis); Dexcom; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Fujisawa; Takeda(Takeda Pharmaceutical Company Ltd); King; DaiichiSankyo(Daiichi Sankyo Company Limited); Gilead(Gilead Sciences); Theravance; Pharmacopeia; Sciele; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the National Heart, Lung, and Blood Institute (contracts N01-HC-95178, N01-HC-95179, N01-HC-95180, N01-HC-95181, N01-HC-95182, N01-HC-95183, N01-HC-95184, IAAY1-HC-9035, and IAAY1-HC-1010), the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Aging, the National Eye Institute, the Centers for Disease Control and Prevention, and General Clinical Research Centers at many sites. The following companies provided study medications, equipment, or supplies: Abbott Laboratories, Amylin Pharmaceutical, AstraZeneca Pharmaceuticals, Bayer HealthCare, Closer Healthcare, GlaxoSmithKline Pharmaceuticals, King Pharmaceuticals, Merck, Novartis Pharmaceuticals, Novo Nordisk, Omron Healthcare, Sanofi-Aventis, and Takeda Pharmaceuticals.; Dr. Ginsberg reports receiving consulting fees from Merck, Merck Schering-Plough, Bristol-Myers Squibb, AstraZeneca, Abbott, Roche, Isis/Genzyme, GlaxoSmithKline, Novartis, Pfizer, and Regeneron/Sanofi-Aventis and grant support from Merck, Isis/Genzyme, Roche, and AstraZeneca; Dr. Elam, receiving consulting fees from Pfizer, Abbott, and Merck Schering-Plough; Dr. Crouse, receiving consulting fees from the National Lipid Association, AstraZeneca, Merck, and Merck Schering-Plough and grant support from AstraZeneca; Dr. Leiter, receiving consulting fees from AstraZeneca, Merck, Pfizer, Roche, and Solvay and grant support from AstraZeneca, Merck, Pfizer, and Roche; Dr. Linz, having an equity interest in Pfizer, Novartis, and AstraZeneca; Dr. Buse, receiving consulting fees from Novo Nordisk, Amylin, Becton Dickinson, Eli Lilly, Hoffmann-La Roche, GlycoMark, Wyeth, Daiichi Sankyo, Bristol-Myers Squibb, Bayhill Therapeutics, LipoScience, MannKind, Veritas, MicroIslet, GlaxoSmithKline, Abbott, Exsulin, and GI Dynamics and grant support from Amylin, Novo Nordisk, Medtronic, Eli Lilly, Novartis, Tolerex, Osiris, Halozyme, Pfizer, Hoffmann-La Roche, InterKrin, Merck, Sanofi-Aventis, Dexcom, Johnson & Johnson, BristolMyers Squibb, and Fujisawa, having an equity interest in Insulet, and providing expert testimony for Novo Nordisk; Dr. Gerstein, receiving consulting fees from Sanofi-Aventis, GlaxoSmithKline, Eli Lilly, Novo Nordisk, AstraZeneca, Bristol-Myers Squibb, Roche, Medtronic, Merck, Bayer, Bioavail, and Janssen-Ortho, grant support from Sanofi-Aventis, GlaxoSmithKline, Novo Nordisk, Merck, Pronova, and Roche, and lecture fees from Sanofi-Aventis, GlaxoSmithKline, Solvay, Boehringer Ingelheim, Servier, Bayer, Eli Lilly, Novo Nordisk, and Takeda; Dr. Probstfield, receiving grant support from Sanofi-Aventis, Boehringer Ingelheim, and Abbott; Dr. Grimm, receiving consulting and lecture fees and grant support from Pfizer, Merck, and Novartis, consulting and lecture fees from Takeda, and lecture fees from AstraZeneca, Forest Laboratories, and Schering-Plough; Dr. Bigger, receiving consulting fees from Merck and Roche; Dr. Goff, receiving consulting fees from Takeda and grant support from Merck; and Dr. Cushman, receiving consulting fees from Novartis, Takeda, Sanofi-Aventis, Bristol-Myers Squibb, King, DaiichiSankyo, Gilead, Theravance, Pharmacopeia, and Sciele and grant support from Novartis, GlaxoSmithKline, and Merck. No other potential conflict of interest relevant to this article was reported.	Almdal T, 2004, ARCH INTERN MED, V164, P1422, DOI 10.1001/archinte.164.13.1422; Bergman AJ, 2004, J CLIN PHARMACOL, V44, P1054, DOI 10.1177/0091270004268044; Buse JB, 2007, AM J CARDIOL, V99, p21I, DOI 10.1016/j.amjcard.2007.03.003; Chahil TJ, 2006, ENDOCRIN METAB CLIN, V35, P491, DOI 10.1016/j.ecl.2006.06.002; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2003, LANCET, V361, P2005; Cushman WC, 2007, AM J CARDIOL, V99, p44I, DOI 10.1016/j.amjcard.2007.03.005; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Genest J, 2004, AM J CARDIOL, V93, P848, DOI 10.1016/j.amjcard.2003.12.022; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Ginsberg HN, 2007, AM J CARDIOL, V99, p56I, DOI 10.1016/j.amjcard.2007.03.024; Goff DC, 2007, AM J CARDIOL, V99, p4I, DOI 10.1016/j.amjcard.2007.03.002; Grundy, 2004, CIRCULATION, V110, P763, DOI 10.1161/01.CIR.0000140446.06098.6B; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Jones PH, 2005, AM J CARDIOL, V95, P120, DOI 10.1016/j.amjcard.2004.08.076; Keech A, 2006, LANCET, V368, P1415, DOI 10.1016/S0140-6736(06)69594-9; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; MANNINEN V, 1992, CIRCULATION, V85, P37, DOI 10.1161/01.CIR.85.1.37; Miettinen H, 1998, DIABETES CARE, V21, P69, DOI 10.2337/diacare.21.1.69; Pasternak RC, 2002, CIRCULATION, V106, P1024, DOI 10.1161/01.CIR.0000032466.44170.44; Rubins HB, 2002, ARCH INTERN MED, V162, P2597, DOI 10.1001/archinte.162.22.2597; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21; Scott R, 2009, DIABETES CARE, V32, P493, DOI 10.2337/dc08-1543; Shepherd J, 2006, DIABETES CARE, V29, P1220, DOI 10.2337/dc05-2465; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823	29	1872	1979	0	108	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2010	362	17					1563	1574		10.1056/NEJMoa1001282	http://dx.doi.org/10.1056/NEJMoa1001282			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589AX	20228404	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000277117400005
J	Lee, MG; Park, HS; Hwang, HS				Lee, Myung Gyoon; Park, Hong Soo; Hwang, Ho Seong			Detection of a Large-Scale Structure of Intracluster Globular Clusters in the Virgo Cluster	SCIENCE			English	Article							DIGITAL SKY SURVEY; DIFFUSE LIGHT; GALAXIES; SYSTEM; M87; DISTRIBUTIONS; LUMINOSITY; KINEMATICS; HALO	Globular clusters are usually found in galaxies, and they are excellent tracers of dark matter. Long ago it was suggested that intracluster globular clusters (IGCs) may exist that are bound to a galaxy cluster rather than to any single galaxy. Here we present a map showing the large-scale distribution of globular clusters over the entire Virgo cluster. It shows that IGCs are found out to 5 million light years from the Virgo center and that they are concentrated in several substructures that are much larger than galaxies. These objects might have been mostly stripped off from low-mass dwarf galaxies.	[Lee, Myung Gyoon; Park, Hong Soo; Hwang, Ho Seong] Seoul Natl Univ, Dept Phys & Astron, Astron Program, Seoul 151742, South Korea; [Hwang, Ho Seong] CEA Saclay, Serv Astrophys, F-91191 Gif Sur Yvette, France	Seoul National University (SNU); CEA; UDICE-French Research Universities; Universite Paris Saclay	Lee, MG (corresponding author), Seoul Natl Univ, Dept Phys & Astron, Astron Program, Seoul 151742, South Korea.	mglee@astro.snu.ac.kr	HWANG, Ho Seong/AAS-6010-2020	HWANG, Ho Seong/0000-0003-3428-7612; Lee, Myung Gyoon/0000-0003-2713-6744	Korean government [R01-2007-000-20336-0]; Alfred P. Sloan Foundation; American Museum of Natural History; Astrophysical Institute Potsdam; University of Basel; University of Cambridge; Case Western Reserve University; University of Chicago; Drexel University; Fermilab; Institute for Advanced Study; Japan Participation Group; Johns Hopkins University; Joint Institute for Nuclear Astrophysics; Kavli Institute for Particle Astrophysics and Cosmology; Korean Scientist Group; Chinese Academy of Sciences; Los Alamos National Laboratory; Max Planck Institute for Astronomy; Max Planck Institute for Astrophysics; New Mexico State University; Ohio State University; University of Pittsburgh; University of Portsmouth; Princeton University; U.S. Naval Observatory; University of Washington; NSF; U. S. Department of Energy; NASA; Japanese Monbukagakusho; Max Planck Society; Higher Education Funding Council for England	Korean government(Korean Government); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); American Museum of Natural History; Astrophysical Institute Potsdam; University of Basel; University of Cambridge(University of Cambridge); Case Western Reserve University; University of Chicago(University of Chicago); Drexel University; Fermilab; Institute for Advanced Study(Institute for Advanced Study); Japan Participation Group(Sloan Digital Sky Survey (SDSS)); Johns Hopkins University(Johns Hopkins University); Joint Institute for Nuclear Astrophysics; Kavli Institute for Particle Astrophysics and Cosmology; Korean Scientist Group; Chinese Academy of Sciences(Chinese Academy of Sciences); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); Max Planck Institute for Astronomy(Max Planck Society); Max Planck Institute for Astrophysics; New Mexico State University; Ohio State University(Ohio State University); University of Pittsburgh(University of Pittsburgh); University of Portsmouth; Princeton University(Princeton University); U.S. Naval Observatory; University of Washington(University of Washington); NSF(National Science Foundation (NSF)); U. S. Department of Energy(United States Department of Energy (DOE)); NASA(National Aeronautics & Space Administration (NASA)); Japanese Monbukagakusho(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE))	We thank D. Geisler, M. Im, and N. Hwang for their careful reading of the manuscript and useful comments and the anonymous referees for their comments, which improved the original manuscript significantly. This work was supported by a National Research Foundation of Korea grant funded by the Korean government (grant no. R01-2007-000-20336-0). Funding for the SDSS and SDSS-II has been provided by the Alfred P. Sloan Foundation, the Participating Institutions, NSF, the U. S. Department of Energy, NASA, the Japanese Monbukagakusho, the Max Planck Society, and the Higher Education Funding Council for England. The SDSS Web site is www.sdss.org. The SDSS is managed by the Astrophysical Research Consortium for the Participating Institutions. The Participating Institutions are the American Museum of Natural History, Astrophysical Institute Potsdam, University of Basel, University of Cambridge, Case Western Reserve University, University of Chicago, Drexel University, Fermilab, the Institute for Advanced Study, the Japan Participation Group, Johns Hopkins University, the Joint Institute for Nuclear Astrophysics, the Kavli Institute for Particle Astrophysics and Cosmology, the Korean Scientist Group, the Chinese Academy of Sciences, Los Alamos National Laboratory, the Max Planck Institute for Astronomy, the Max Planck Institute for Astrophysics, New Mexico State University, Ohio State University, University of Pittsburgh, University of Portsmouth, Princeton University, the U.S. Naval Observatory, and the University of Washington.	Adelman-McCarthy JK, 2008, ASTROPHYS J SUPPL S, V175, P297, DOI 10.1086/524984; Bekki K, 2008, MON NOT R ASTRON SOC, V387, P1131, DOI 10.1111/j.1365-2966.2008.13318.x; Bekki K, 2006, MON NOT R ASTRON SOC, V372, P1019, DOI 10.1111/j.1365-2966.2006.10833.x; BINGGELI B, 1985, ASTRON J, V90, P1681, DOI 10.1086/113874; BOHRINGER H, 1994, NATURE, V368, P828, DOI 10.1038/368828a0; Castro-Rodriguez N, 2009, ASTRON ASTROPHYS, V507, P621, DOI 10.1051/0004-6361/200809774; Coenda V, 2009, ASTROPHYS J, V700, P1382, DOI 10.1088/0004-637X/700/2/1382; Cote P, 2001, ASTROPHYS J, V559, P828, DOI 10.1086/322347; Doherty M, 2009, ASTRON ASTROPHYS, V502, P771, DOI 10.1051/0004-6361/200811532; Durrell PR, 2002, ASTROPHYS J, V570, P119, DOI 10.1086/339735; Feldmeier JJ, 2004, ASTROPHYS J, V615, P196, DOI 10.1086/424372; Harris WE, 2009, ASTROPHYS J, V703, P939, DOI 10.1088/0004-637X/703/1/939; Jordan A, 2003, ASTRON J, V125, P1642, DOI 10.1086/368393; Juric M, 2008, ASTROPHYS J, V673, P864, DOI 10.1086/523619; Lee M. G., 2003, J KOREAN ASTRON SOC, V36, P189; Lee MG, 2008, ASTROPHYS J, V682, P135, DOI 10.1086/587469; Lee MG, 2010, ASTROPHYS J, V709, P1083, DOI 10.1088/0004-637X/709/2/1083; Marin-Franch A, 2003, ASTROPHYS J, V585, P714, DOI 10.1086/346259; McLaughlin DE, 1999, ASTROPHYS J, V512, pL9, DOI 10.1086/311860; Mihos JC, 2005, ASTROPHYS J, V631, pL41, DOI 10.1086/497030; Miller BW, 2007, ASTROPHYS J, V670, P1074, DOI 10.1086/522323; MUZZIO JC, 1987, PUBL ASTRON SOC PAC, V99, P245, DOI 10.1086/131981; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; Peng EW, 2006, ASTROPHYS J, V639, P95, DOI 10.1086/498210; Tamura N, 2006, MON NOT R ASTRON SOC, V373, P601, DOI 10.1111/j.1365-2966.2006.11059.x; VANDENBERGH S, 1956, PUBL ASTRON SOC PAC, V68, P449, DOI 10.1086/126970; WEST MJ, 1995, ASTROPHYS J, V453, pL77, DOI 10.1086/309748; WHITE RE, 1987, MON NOT R ASTRON SOC, V227, P185, DOI 10.1093/mnras/227.1.185; Williams BF, 2007, ASTROPHYS J, V654, P835, DOI 10.1086/509317; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513; Zwicky F., 1951, PASP, V63, P61, DOI [10.1086/126318, DOI 10.1086/126318]	31	55	56	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 16	2010	328	5976					334	336		10.1126/science.1186496	http://dx.doi.org/10.1126/science.1186496			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20223950	Green Submitted			2022-12-28	WOS:000276685000030
J	Nakagawa, A; Shi, Y; Kage-Nakadai, E; Mitani, S; Xue, D				Nakagawa, Akihisa; Shi, Yong; Kage-Nakadai, Eriko; Mitani, Shohei; Xue, Ding			Caspase-Dependent Conversion of Dicer Ribonuclease into a Death-Promoting Deoxyribonuclease	SCIENCE			English	Article							APOPTOTIC DNA-DEGRADATION; C-ELEGANS; RNA-INTERFERENCE; CAENORHABDITIS-ELEGANS; ENDONUCLEASE-G; CHROMATIN CONDENSATION; ACTIVATED DNASE; CELL-DEATH; GENE; DROSOPHILA	Chromosome fragmentation is a hallmark of apoptosis, conserved in diverse organisms. In mammals, caspases activate apoptotic chromosome fragmentation by cleaving and inactivating an apoptotic nuclease inhibitor. We report that inactivation of the Caenorhabditis elegans dcr-1 gene, which encodes the Dicer ribonuclease important for processing of small RNAs, compromises apoptosis and blocks apoptotic chromosome fragmentation. DCR-1 was cleaved by the CED-3 caspase to generate a C-terminal fragment with deoxyribonuclease activity, which produced 3' hydroxyl DNA breaks on chromosomes and promoted apoptosis. Thus, caspase-mediated activation of apoptotic DNA degradation is conserved. DCR-1 functions in fragmenting chromosomal DNA during apoptosis, in addition to processing of small RNAs, and undergoes a protease-mediated conversion from a ribonuclease to a deoxyribonuclease.	[Nakagawa, Akihisa; Shi, Yong; Xue, Ding] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Kage-Nakadai, Eriko; Mitani, Shohei] Japan Sci & Technol Agcy, Tokyo 1628666, Japan; [Kage-Nakadai, Eriko; Mitani, Shohei] Tokyo Womens Med Univ, Dept Physiol, Tokyo 1628666, Japan	University of Colorado System; University of Colorado Boulder; Japan Science & Technology Agency (JST); Tokyo Women's Medical University	Xue, D (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	ding.xue@colorado.edu		XUE, DING/0000-0002-8429-8136	Burroughs Wellcome Fund Award; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; NIH [R01 GM59083, R01 GM79097]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059083, R01GM079097] Funding Source: NIH RePORTER	Burroughs Wellcome Fund Award(Burroughs Wellcome Fund); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Blumenthal, N. Pace, M. Yarus, L. He, X. D. Liu, and S. Marquez for comments; Y. Kohara for dcr-1 cDNA; Q. H. Liu for purified fly Dicer-2 protein; K. Morita for the alg-1 RNAi construct; and members of the Xue lab for helpful discussions. This work was supported by a Burroughs Wellcome Fund Award (D. X.), a grant from Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (S. M.), and NIH grants R01 GM59083 and R01 GM79097 (D. X.).	Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Durrieu F, 2000, CURR BIOL, V10, P923, DOI 10.1016/S0960-9822(00)00620-5; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; ELLIS RE, 1991, GENETICS, V129, P79; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jaskiewicz L, 2008, CURR TOP MICROBIOL, V320, P77; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Kokel D, 2006, NAT CHEM BIOL, V2, P338, DOI 10.1038/nchembio791; Lamontagne B, 2004, J MOL BIOL, V338, P401, DOI 10.1016/j.jmb.2004.02.059; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; MacRae IJ, 2007, CURR OPIN STRUC BIOL, V17, P138, DOI 10.1016/j.sbi.2006.12.002; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Parrish JZ, 2006, CHROMOSOMA, V115, P89, DOI 10.1007/s00412-005-0038-0; Parrish JZ, 2003, EMBO J, V22, P3451, DOI 10.1093/emboj/cdg320; Parrish JZ, 2003, MOL CELL, V11, P987, DOI 10.1016/S1097-2765(03)00095-9; Pavelec DM, 2009, GENETICS, V183, P1283, DOI 10.1534/genetics.109.108134; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Samejima K, 2005, NAT REV MOL CELL BIO, V6, P677, DOI 10.1038/nrm1715; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Stanfield GM, 2000, MOL CELL, V5, P423, DOI 10.1016/S1097-2765(00)80437-2; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Widlak P, 2005, J CELL BIOCHEM, V94, P1078, DOI 10.1002/jcb.20409; Widlak P, 2000, J BIOL CHEM, V275, P8226, DOI 10.1074/jbc.275.11.8226; Wu YC, 2000, GENE DEV, V14, P536; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582; Zhang JH, 1998, P NATL ACAD SCI USA, V95, P12480, DOI 10.1073/pnas.95.21.12480	52	93	106	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2010	328	5976					327	334		10.1126/science.1182374	http://dx.doi.org/10.1126/science.1182374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20223951	Green Accepted			2022-12-28	WOS:000276685000029
J	Zalzman, M; Falco, G; Sharova, LV; Nishiyama, A; Thomas, M; Lee, SL; Stagg, CA; Hoang, HG; Yang, HT; Indig, FE; Wersto, RP; Ko, MSH				Zalzman, Michal; Falco, Geppino; Sharova, Lioudmila V.; Nishiyama, Akira; Thomas, Marshall; Lee, Sung-Lim; Stagg, Carole A.; Hoang, Hien G.; Yang, Hsih-Te; Indig, Fred E.; Wersto, Robert P.; Ko, Minoru S. H.			Zscan4 regulates telomere elongation and genomic stability in ES cells	NATURE			English	Article							EMBRYONIC STEM-CELLS; DOUBLE-STRAND BREAKS; DNA; EXPRESSION; LENGTH; LINES; RECOMBINATION; MAINTENANCE; MICE; IDENTIFICATION	Exceptional genomic stability is one of the hallmarks of mouse embryonic stem (ES) cells. However, the genes contributing to this stability remain obscure. We previously identified Zscan4 as a specific marker for two-cell embryo and ES cells. Here we show that Zscan4 is involved in telomere maintenance and long-term genomic stability in ES cells. Only 5% of ES cells express Zscan4 at a given time, but nearly all ES cells activate Zscan4 at least once during nine passages. The transient Zscan4-positive state is associated with rapid telomere extension by telomere recombination and upregulation of meiosis-specific homologous recombination genes, which encode proteins that are colocalized with ZSCAN4 on telomeres. Furthermore, Zscan4 knockdown shortens telomeres, increases karyotype abnormalities and spontaneous sister chromatid exchange, and slows down cell proliferation until reaching crisis by passage eight. Together, our data show a unique mode of genome maintenance in ES cells.	[Zalzman, Michal; Falco, Geppino; Sharova, Lioudmila V.; Nishiyama, Akira; Thomas, Marshall; Lee, Sung-Lim; Stagg, Carole A.; Hoang, Hien G.; Yang, Hsih-Te; Ko, Minoru S. H.] NIA, Dev Genom & Aging Sect, Genet Lab, Baltimore, MD 21224 USA; [Indig, Fred E.; Wersto, Robert P.] NIA, Res Resources Branch, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Ko, MSH (corresponding author), NIA, Dev Genom & Aging Sect, Genet Lab, Baltimore, MD 21224 USA.	kom@mail.nih.gov	Ko, Minoru S. H./B-7969-2009; Zalzman, Michal/Z-2121-2019	Ko, Minoru S. H./0000-0002-3530-3015; YANG, HSIH-TE/0000-0002-4851-1374; falco, geppino/0000-0001-6193-7233; Zalzman, Michal/0000-0002-4689-2951	National Institute on Aging, National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZICAG000615, ZIAAG000700, ZICAG000618, ZIAAG000655, ZIAAG000678, ZIAAG000662, ZIAAG000706, ZIAAG000656] Funding Source: NIH RePORTER	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank T. Hamatani, Y. Nakatake, M. Monti, L. Xin, B. Binder and A. A. Sharov for discussion; Y. Piao, C. Nguyen, D. Eckley, I. Goldberg, D. Dudekula and I. Stanghellini for technical assistance; P. Soriano for providing ROSA26-floxed LacZ cells; and H. Niwa for providing ROSA-tet-inducible system. This work was entirely supported by the Intramural Research Program of the National Institute on Aging, National Institutes of Health.	Aiba K, 2009, DNA RES, V16, P73, DOI 10.1093/dnares/dsn035; Bailey SM, 2004, NUCLEIC ACIDS RES, V32, P3743, DOI 10.1093/nar/gkh691; Bailey SM, 1996, MUTAGENESIS, V11, P139, DOI 10.1093/mutage/11.2.139; Blelloch RH, 2004, P NATL ACAD SCI USA, V101, P13985, DOI 10.1073/pnas.0405015101; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Carter MG, 2008, GENE EXPR PATTERNS, V8, P181, DOI 10.1016/j.gep.2007.10.009; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cervantes RB, 2002, P NATL ACAD SCI USA, V99, P3586, DOI 10.1073/pnas.062527199; Cesare AJ, 2008, MECH AGEING DEV, V129, P99, DOI 10.1016/j.mad.2007.11.006; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; De Boeck G, 2009, J PATHOL, V217, P327, DOI 10.1002/path.2500; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Dronkert MLG, 2000, MOL CELL BIOL, V20, P3147, DOI 10.1128/MCB.20.9.3147-3156.2000; Edelstein LC, 2005, GENE, V359, P1, DOI 10.1016/j.gene.2005.06.022; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Falco G, 2007, DEV BIOL, V307, P539, DOI 10.1016/j.ydbio.2007.05.003; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; GOODWIN E, 1993, CYTOGENET CELL GENET, V63, P126, DOI 10.1159/000133516; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Liu L, 2007, NAT CELL BIOL, V9, P1436, DOI 10.1038/ncb1664; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longo L, 1997, TRANSGENIC RES, V6, P321, DOI 10.1023/A:1018418914106; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A., 2003, MANIPULATING MOUSE E; Niida H, 2000, MOL CELL BIOL, V20, P4115, DOI 10.1128/MCB.20.11.4115-4127.2000; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Olson LE, 2003, CANCER RES, V63, P6602; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; Poon SSS, 1999, CYTOMETRY, V36, P267, DOI 10.1002/(SICI)1097-0320(19990801)36:4<267::AID-CYTO1>3.0.CO;2-O; Rebuzzini P, 2008, CYTOTECHNOLOGY, V58, P17, DOI 10.1007/s10616-008-9164-x; Reinholdt LG, 2005, CHROMOSOMA, V114, P127, DOI 10.1007/s00412-005-0346-4; Revenkova E, 2004, NAT CELL BIOL, V6, P555, DOI 10.1038/ncb1135; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Storm MP, 2009, STEM CELLS, V27, P764, DOI 10.1002/stem.3; SUDA Y, 1987, J CELL PHYSIOL, V133, P197, DOI 10.1002/jcp.1041330127; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka TS, 2009, REPROD FERT DEVELOP, V21, P67, DOI 10.1071/RD08219; Tateishi S, 2003, MOL CELL BIOL, V23, P474, DOI 10.1128/MCB.23.2.474-481.2003; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Wang YS, 2005, P NATL ACAD SCI USA, V102, P10256, DOI 10.1073/pnas.0504635102; Yoshikawa T, 2006, GENE EXPR PATTERNS, V6, P213, DOI 10.1016/j.modgep.2005.06.003	52	283	296	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					858	U66		10.1038/nature08882	http://dx.doi.org/10.1038/nature08882			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20336070	Green Accepted			2022-12-28	WOS:000276397300030
J	Hamback, PA				Hambaeck, Peter A.			A Green or a Prickly World?	SCIENCE			English	Editorial Material							SERVICES		Stockholm Univ, Dept Bot, SE-10691 Stockholm, Sweden	Stockholm University	Hamback, PA (corresponding author), Stockholm Univ, Dept Bot, SE-10691 Stockholm, Sweden.	peter.hamback@botan.su.se	Hambäck, Peter A/A-8194-2008	Hambäck, Peter A/0000-0001-6362-6199				Bukovinszky T, 2008, SCIENCE, V319, P804, DOI 10.1126/science.1148310; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Kant MR, 2009, ADV BOT RES, V51, P613, DOI 10.1016/S0065-2296(09)51014-2; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Mooney KA, 2010, SCIENCE, V327, P1642, DOI 10.1126/science.1184814; Ode PJ, 2006, ANNU REV ENTOMOL, V51, P163, DOI 10.1146/annurev.ento.51.110104.151110; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; Stenberg JA, 2007, OIKOS, V116, P482, DOI [10.1111/j.2006.0030-1299.15357.x, 10.1111/j.0030-1299.2007.15357.x]; Stenberg JA, 2006, OECOLOGIA, V148, P414, DOI 10.1007/s00442-006-0390-7	9	0	0	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	2010	327	5973					1583	1584		10.1126/science.1187724	http://dx.doi.org/10.1126/science.1187724			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339053				2022-12-28	WOS:000275970600021
J	Reid, S; Barbui, C				Reid, Steven; Barbui, Corrado			Long term treatment of depression with selective serotonin reuptake inhibitors and newer antidepressants	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RISK; METAANALYSIS; PATIENT; DISCONTINUATION; HYPONATREMIA; ASSOCIATION; MANAGEMENT; DISORDERS; SEVERITY; DURATION		[Reid, Steven] St Marys Hosp, Dept Liaison Psychiat, London W2 1PF, England; [Barbui, Corrado] Univ Verona, Sect Psychiat & Clin Psychol, Dept Med & Publ Hlth, I-37134 Verona, Italy	Imperial College London; University of Verona	Reid, S (corresponding author), St Marys Hosp, Dept Liaison Psychiat, London W2 1PF, England.	steve.reid@nhs.net	Barbui, Corrado/E-7146-2010					Alvarez W, 2003, PHARMACOTHERAPY, V23, P754, DOI 10.1592/phco.23.6.754.32185; Alwan S, 2009, CNS DRUGS, V23, P493, DOI 10.2165/00023210-200923060-00004; Anderson IM, 2008, J PSYCHOPHARMACOL, V22, P343, DOI 10.1177/0269881107088441; Barbui C, 2009, CAN MED ASSOC J, V180, P291, DOI 10.1503/cmaj.081514; Coupland NJ, 1996, J CLIN PSYCHOPHARM, V16, P356, DOI 10.1097/00004714-199610000-00003; de Abajo FJ, 1999, BRIT MED J, V319, P1106, DOI 10.1136/bmj.319.7217.1106; de Abajo FJ, 2008, ARCH GEN PSYCHIAT, V65, P795, DOI 10.1001/archpsyc.65.7.795; Deshauer D, 2008, J CLIN PSYCHOPHARM, V28, P467, DOI 10.1097/JCP.0b013e31817ea9d4; Deshauer D, 2008, CAN MED ASSOC J, V178, P1293, DOI 10.1503/cmaj.071068; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Furukawa TA, 2007, CAN J PSYCHIAT, V52, P545, DOI 10.1177/070674370705200902; Gartlehner G, 2008, DRUG SAFETY, V31, P851, DOI 10.2165/00002018-200831100-00004; Geddes JR, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3066; Geddes JR, 2003, LANCET, V361, P653, DOI 10.1016/S0140-6736(03)12599-8; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; Haddad P, 1997, J CLIN PSYCHIAT, V58, P17; Hansen R, 2008, PSYCHIAT SERV, V59, P1121, DOI 10.1176/appi.ps.59.10.1121; Hu XH, 2004, J CLIN PSYCHIAT, V65, P959; Kaymaz N, 2008, J CLIN PSYCHIAT, V69, P1423, DOI 10.4088/JCP.v69n0910; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Kupfer DJ, 1996, INTERPERSONAL FACTORS IN THE ORIGIN AND COURSE OF AFFECTIVE DISORDERS, P289; Moore M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3999; National Institute for Health and Clinical Excellence, 2009, DEPR TREATM MAN DEPR; National Institute for Health and Clinical Excellence, 2007, ANT POSTN MENT HLTH; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; Parker G, 2009, BRIT J PSYCHIAT, V194, P1, DOI 10.1192/bjp.bp.108.054767; Paykel ES, 2007, INT J NEUROPSYCHOPH, V10, P131, DOI 10.1017/S1461145706006912; Petty DR, 2006, AGE AGEING, V35, P523, DOI 10.1093/ageing/afl023; Pirraglia Paul A., 2003, Prim Care Companion J Clin Psychiatry, V5, P153; Rosenbaum JF, 1997, J CLIN PSYCHIAT, V58, P37; Serretti A, 2009, J CLIN PSYCHOPHARM, V29, P259, DOI 10.1097/JCP.0b013e3181a5233f; Sharma H, 1996, DRUG AGING, V8, P430, DOI 10.2165/00002512-199608060-00004; Spence D, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3995; Stone M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2880; Von Ruden AE, 2008, J CARDIOVASC PHARM T, V13, P32, DOI 10.1177/1074248407308467; Wright SK, 2008, J AM ACAD NURSE PRAC, V20, P47, DOI 10.1111/j.1745-7599.2007.00280.x	36	54	54	1	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2010	340								c1468	10.1136/bmj.c1468	http://dx.doi.org/10.1136/bmj.c1468			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	576PR	20348175				2022-12-28	WOS:000276157900017
J	Shuman, EK				Shuman, Emily K.			Global Climate Change and Infectious Diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Michigan, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Shuman, EK (corresponding author), Univ Michigan, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA.							*ENV PROT AG, 2009, CLIM CHANG; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; MACKENZIE WR, 1994, NEW ENGL J MED, V331, P161, DOI 10.1056/NEJM199407213310304; MACKENZIE WR, 1994, NEW ENGL J MED, V331, P1035; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; [No title captured]	6	132	140	2	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	2010	362	12					1061	1063		10.1056/NEJMp0912931	http://dx.doi.org/10.1056/NEJMp0912931			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573FU	20335580				2022-12-28	WOS:000275894600001
J	Kastner, DL; Aksentijevich, I; Goldbach-Mansky, R				Kastner, Daniel L.; Aksentijevich, Ivona; Goldbach-Mansky, Raphaela			Autoinflammatory Disease Reloaded: A Clinical Perspective	CELL			English	Article							FAMILIAL MEDITERRANEAN FEVER; NALP3 INFLAMMASOME; B30.2 DOMAIN; PYRIN; MUTATIONS; PROTEIN; INTERLEUKIN-1-BETA; CIAS1; INHIBITION; ACTIVATION	Our understanding of the etiology of autoinflammatory disease is growing rapidly. Recent advances offer new opportunities for therapeutic intervention and suggest that the definition of what constitutes an autoinflammatory disease should be reassessed.	[Kastner, Daniel L.; Aksentijevich, Ivona; Goldbach-Mansky, Raphaela] NIAMSD, Clin Invest Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Kastner, DL (corresponding author), NIAMSD, Clin Invest Lab, NIH, Bethesda, MD 20892 USA.	kastnerd@mail.nih.gov	Goldbach-Mansky, Raphaela/N-5917-2017; Aksentijevich, Ivona/AAF-1335-2019		National Institute of Arthritis and Musculoskeletal; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041176, ZIDAR041180, ZIAAR041162, Z01AR041180, ZIAAR041170, Z01AR041153, ZIEAR041176, ZIAAR041123, Z01AR041139, ZIAAR041185, ZIAAR041153, ZIAAR041138, ZIAAR041139, Z01AR041170, ZIAAR041083] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases.	Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Aksentijevich I, 1999, AM J HUM GENET, V64, P949, DOI 10.1086/302327; Aksentijevich I, 1997, CELL, V90, P797; Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Bernot A, 1997, NAT GENET, V17, P25; Booty MG, 2009, ARTHRITIS RHEUM-US, V60, P1851, DOI 10.1002/art.24569; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Chae JJ, 2006, P NATL ACAD SCI USA, V103, P9982, DOI 10.1073/pnas.0602081103; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Choi HK, 2010, CURR OPIN RHEUMATOL, V22, P144, DOI 10.1097/BOR.0b013e32833645e8; Dinarello CA, 2009, NEW ENGL J MED, V360, P2467, DOI 10.1056/NEJMe0811014; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Feder HM, 2010, ACTA PAEDIATR, V99, P178, DOI 10.1111/j.1651-2227.2009.01554.x; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Galon J, 2000, CURR OPIN IMMUNOL, V12, P479, DOI 10.1016/S0952-7915(00)00124-2; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Gul Ahmet, 2005, Current Drug Targets - Inflammation and Allergy, V4, P81, DOI 10.2174/1568010053622894; Hoffman HM, 2008, ARTHRITIS RHEUM, V58, P2443, DOI 10.1002/art.23687; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hopkins Donald R., 1983, GREATEST KILLER SMAL; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Kuijk LM, 2008, BLOOD, V112, P3563, DOI 10.1182/blood-2008-03-144667; Lachmann HJ, 2009, NEW ENGL J MED, V360, P2416, DOI 10.1056/NEJMoa0810787; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lobito AA, 2006, BLOOD, V108, P1320, DOI 10.1182/blood-2005-11-006783; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Marek-Yagel D, 2009, ARTHRITIS RHEUM-US, V60, P1862, DOI 10.1002/art.24570; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; McGonagle D, 2006, PLOS MED, V3, P1242, DOI 10.1371/journal.pmed.0030297; Ozen S, 2009, ARTHRITIS RHEUM, V60, P1575, DOI 10.1002/art.24565; Reddy S, 2009, NEW ENGL J MED, V360, P2438, DOI 10.1056/NEJMoa0809568; Shoham NG, 2003, P NATL ACAD SCI USA, V100, P13501, DOI 10.1073/pnas.2135380100; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; Suber T, 2009, ARTHRITIS RHEUM-US, V60, P2216, DOI 10.1002/art.24715; Sugiura T, 2008, MOD RHEUMATOL, V18, P57, DOI 10.1007/s10165-007-0003-2; Terkeltaub R, 2009, ANN RHEUM DIS, V68, P1613, DOI 10.1136/ard.2009.108936; Touitou I, 2007, ARTHRITIS RHEUM, V56, P1706, DOI 10.1002/art.22507; Verma D, 2008, ARTHRITIS RHEUM, V58, P888, DOI 10.1002/art.23286; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029	51	322	340	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2010	140	6					784	790		10.1016/j.cell.2010.03.002	http://dx.doi.org/10.1016/j.cell.2010.03.002			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	571IX	20303869	Green Accepted, Bronze			2022-12-28	WOS:000275746600003
J	Zitvogel, L; Kepp, O; Kroemer, G				Zitvogel, Laurence; Kepp, Oliver; Kroemer, Guido			Decoding Cell Death Signals in Inflammation and Immunity	CELL			English	Article							TUMOR-CELLS; CALRETICULIN EXPOSURE; AUTOPHAGY; CLEARANCE; INDUCTION; RECEPTOR; SYSTEM; AUTOIMMUNITY; SENESCENCE; RELEASE	Dying cells release and expose at their surface molecules that signal to the immune system. We speculate that combinations of these molecules determine the route by which dying cells are engulfed and the nature of the immune response that their death elicits.	[Zitvogel, Laurence] Inst Gustave Roussy, INSERM, U805, F-94805 Villejuif, France; [Zitvogel, Laurence; Kepp, Oliver; Kroemer, Guido] Univ Paris 11, F-94805 Villejuif, France; [Kepp, Oliver; Kroemer, Guido] Inst Gustave Roussy, INSERM, U848, F-94805 Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Zitvogel, L (corresponding author), Inst Gustave Roussy, INSERM, U805, F-94805 Villejuif, France.	zitvogel@igr.fr; kroemer@orange.fr	Kroemer, Guido/AAY-9859-2020; Kepp, Oliver/GPX-8627-2022; KROEMER, Guido/B-4263-2013; Kepp, Oliver/N-2763-2017	KROEMER, Guido/0000-0002-9334-4405; Kepp, Oliver/0000-0002-6081-9558; ZITVOGEL, laurence/0000-0003-1596-0998	Ligue Nationale contre le Cancer (equipes labellisees); Fondation pour la Recherche Medicale; European Union; Canceropole Ile-de-France; Institut National du Cancer; Agence Nationale pour la Recherche	Ligue Nationale contre le Cancer (equipes labellisees); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Union(European Commission); Canceropole Ile-de-France(Region Ile-de-France); Institut National du Cancer(Institut National du Cancer (INCA) France); Agence Nationale pour la Recherche(French National Research Agency (ANR))	G.K. and L.Z. are supported by grants from the Ligue Nationale contre le Cancer (equipes labellisees), Fondation pour la Recherche Medicale, European Union, Canceropole Ile-de-France, Institut National du Cancer, and Agence Nationale pour la Recherche.	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bartek J, 2008, NAT CELL BIOL, V10, P887, DOI 10.1038/ncb0808-887; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Bournazou I, 2009, J CLIN INVEST, V119, P20, DOI 10.1172/JCI36226; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Garg AD, 2010, BBA-REV CANCER, V1805, P53, DOI 10.1016/j.bbcan.2009.08.003; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kepp O, 2010, EUR J IMMUNOL, V40, P627, DOI 10.1002/eji.200940160; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li YH, 2008, CANCER RES, V68, P6889, DOI 10.1158/0008-5472.CAN-08-0161; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; METCHNIKOFF E, 1990, SCAND J IMMUNOL, V31, P1; Miles K, 2009, J IMMUNOL, V183, P2122, DOI 10.4049/jimmunol.0804187; Morselli E, 2009, AGING-US, V1, P961, DOI 10.18632/aging.100110; Munoz LE, 2010, AUTOIMMUN REV, V9, P425, DOI 10.1016/j.autrev.2009.11.016; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Raulet DH, 2009, NAT REV IMMUNOL, V9, P568, DOI 10.1038/nri2604; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Schulze C, 2008, AUTOIMMUN REV, V8, P5, DOI 10.1016/j.autrev.2008.07.049; Spisek R, 2007, BLOOD, V109, P4839, DOI 10.1182/blood-2006-10-054221; Thorburn J, 2009, CELL DEATH DIFFER, V16, P175, DOI 10.1038/cdd.2008.143; Uhl M, 2009, CELL DEATH DIFFER, V16, P991, DOI 10.1038/cdd.2009.8; Valle FM, 2008, AUTOIMMUN REV, V7, P359, DOI 10.1016/j.autrev.2008.02.002; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Wartha F, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.121pe25; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651	42	412	436	2	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2010	140	6					798	804		10.1016/j.cell.2010.02.015	http://dx.doi.org/10.1016/j.cell.2010.02.015			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	571IX	20303871	Bronze			2022-12-28	WOS:000275746600005
J	Fareed, J; Hull, R				Fareed, Jawed; Hull, Russell			Apixaban to prevent venous thromboembolism after knee replacement	LANCET			English	Editorial Material									[Fareed, Jawed] Loyola Univ, Med Ctr, Dept Pathol, Maywood, IL 60153 USA; [Hull, Russell] Univ Calgary, Thrombosis Res Unit, Calgary, AB, Canada	Loyola University Chicago; University of Calgary	Fareed, J (corresponding author), Loyola Univ, Med Ctr, Dept Pathol, Maywood, IL 60153 USA.	jfareed@lumc.edu						Douketis JD, 2006, ARCH INTERN MED, V166, P853, DOI 10.1001/archinte.166.8.853; Fareed J, 2008, SEMIN THROMB HEMOST, V34, P58, DOI 10.1055/s-2008-1066025; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Hull RD, 2009, CLIN APPL THROMB-HEM, V15, P377, DOI 10.1177/1076029609338712; Lassen MR, 2010, LANCET, V375, P807, DOI 10.1016/S0140-6736(09)62125-5; Lassen MR, 2009, NEW ENGL J MED, V361, P594, DOI 10.1056/NEJMoa0810773; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Straus SE, 2002, EVAL HEALTH PROF, V25, P210, DOI 10.1177/01678702025002006	8	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 6	2010	375	9717					779	780		10.1016/S0140-6736(10)60139-0	http://dx.doi.org/10.1016/S0140-6736(10)60139-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570MO	20206758				2022-12-28	WOS:000275682600004
J	Savage, DF; Afonso, B; Chen, AH; Silver, PA				Savage, David F.; Afonso, Bruno; Chen, Anna H.; Silver, Pamela A.			Spatially Ordered Dynamics of the Bacterial Carbon Fixation Machinery	SCIENCE			English	Article							CARBOXYSOMES; PROTEINS	Cyanobacterial carbon fixation is a major component of the global carbon cycle. This process requires the carboxysome, an organelle-like proteinaceous microcompartment that sequesters the enzymes of carbon fixation from the cytoplasm. Here, fluorescently tagged carboxysomes were found to be spatially ordered in a linear fashion. As a consequence, cells undergoing division evenly segregated carboxysomes in a nonrandom process. Mutation of the cytoskeletal protein ParA specifically disrupted carboxysome order, promoted random carboxysome segregation during cell division, and impaired carbon fixation after disparate partitioning. Thus, cyanobacteria use the cytoskeleton to control the spatial arrangement of carboxysomes and to optimize the metabolic process of carbon fixation.	[Savage, David F.; Afonso, Bruno; Chen, Anna H.; Silver, Pamela A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Silver, PA (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	pamela_silver@hms.harvard.edu			Fundacao para a Ciencia e a Tecnologia and Graduate Program in Areas of Basic and Applied Biology (GABBA); Army Research Office [W911NF-09-1-0226]	Fundacao para a Ciencia e a Tecnologia and Graduate Program in Areas of Basic and Applied Biology (GABBA); Army Research Office	We thank R. Milo, R. Ward, R. Losick, S. Stanley, and E. Garner for comments on the manuscript; M. Ericsson and L. Benecchi for electron microscopy; and S. Golden for reagents. D. F. S. is a U.S. Department of Energy Biosciences Fellow of the Life Sciences Research Foundation. B. A. is supported by the Fundacao para a Ciencia e a Tecnologia and Graduate Program in Areas of Basic and Applied Biology (GABBA). This work was supported by Army Research Office Award W911NF-09-1-0226.	Cannon GC, 2001, APPL ENVIRON MICROB, V67, P5351, DOI 10.1128/AEM.67.12.5351-5361.2001; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; Iancu CV, 2007, J MOL BIOL, V372, P764, DOI 10.1016/j.jmb.2007.06.059; Iancu CV, 2010, J MOL BIOL, V396, P105, DOI 10.1016/j.jmb.2009.11.019; JENSEN TE, 1976, ARCH MICROBIOL, V111, P1, DOI 10.1007/BF00446542; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Komelli A, 2007, ANNU REV BIOCHEM, V76, P351, DOI 10.1146/annurev.biochem.74.082803.133444; Ohkawa H, 1998, CAN J BOT, V76, P1035, DOI 10.1139/b98-076; Overmann J, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P32, DOI 10.1007/0-387-30742-7_3; PRICE GD, 1993, J BACTERIOL, V175, P2871, DOI 10.1128/JB.175.10.2871-2879.1993; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Schmid MF, 2006, J MOL BIOL, V364, P526, DOI 10.1016/j.jmb.2006.09.024; SHIVELY JM, 1973, J BACTERIOL, V116, P1405, DOI 10.1128/JB.116.3.1405-1411.1973; Soufo HJD, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-10; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Thanbichler M, 2008, NAT REV MICROBIOL, V6, P28, DOI 10.1038/nrmicro1795; Thompson SR, 2006, P NATL ACAD SCI USA, V103, P8209, DOI 10.1073/pnas.0600919103; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913	19	224	229	3	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2010	327	5970					1258	1261		10.1126/science.1186090	http://dx.doi.org/10.1126/science.1186090			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20203050				2022-12-28	WOS:000275162100040
J	O'Hanlon, S				O'Hanlon, Shane			Personal View My year without drug reps	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Mercy Univ Hosp, Cork, Ireland	University College Cork	O'Hanlon, S (corresponding author), Mercy Univ Hosp, Cork, Ireland.	sohanlon@gmail.com	O'Hanlon, Shane/I-5990-2019	O'Hanlon, Shane/0000-0002-9270-2768					0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2010	340								c1102	10.1136/bmj.c1102	http://dx.doi.org/10.1136/bmj.c1102			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	565FJ	20351076				2022-12-28	WOS:000275274400001
J	Boehm, A; Kaiser, M; Li, H; Spangler, C; Kasper, CA; Ackermann, M; Kaever, V; Sourjik, V; Roth, V; Jenal, U				Boehm, Alex; Kaiser, Matthias; Li, Hui; Spangler, Christian; Kasper, Christoph Alexander; Ackermann, Martin; Kaever, Volkhard; Sourjik, Victor; Roth, Volker; Jenal, Urs			Second Messenger-Mediated Adjustment of Bacterial Swimming Velocity	CELL			English	Article							C-DI-GMP; FLAGELLAR ROTARY MOTOR; ESCHERICHIA-COLI; PILZ DOMAIN; IN-VIVO; MOTILITY; CHEMOTAXIS; PROTEINS; TORQUE; PATHWAY	Bacteria swim by means of rotating flagella that are powered by ion influx through membrane-spanning motor complexes. Escherichia coli and related species harness a chemosensory and signal transduction machinery that governs the direction of flagellar rotation and allows them to navigate in chemical gradients. Here, we show that Escherichia coli can also fine-tune its swimming speed with the help of a molecular brake (YcgR) that, upon binding of the nucleotide second messenger cyclic di-GMP, interacts with the motor protein MotA to curb flagellar motor output. Swimming velocity is controlled by the synergistic action of at least five signaling proteins that adjust the cellular concentration of cyclic di-GMP. Activation of this network and the resulting deceleration coincide with nutrient depletion and might represent an adaptation to starvation. These experiments demonstrate that bacteria can modulate flagellar motor output and thus swimming velocity in response to environmental cues.	[Boehm, Alex; Kaiser, Matthias; Kasper, Christoph Alexander; Jenal, Urs] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Li, Hui; Sourjik, Victor] Univ Heidelberg, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany; [Spangler, Christian; Kaever, Volkhard] Hannover Med Sch, Inst Pharmacol, D-30625 Hannover, Germany; [Ackermann, Martin] ETH, Dept Environm Sci, CH-8092 Zurich, Switzerland; [Ackermann, Martin] EAWAG, Dept Environm Microbiol, CH-8092 Zurich, Switzerland; [Roth, Volker] Univ Basel, Dept Comp Sci, CH-4056 Basel, Switzerland	University of Basel; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Hannover Medical School; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Basel	Boehm, A (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	alexander.boehm@unibas.ch	Roth, Volker/Q-4025-2017; Ackermann, Martin/V-4554-2017; Kaever, Volkhard/G-3280-2013	Roth, Volker/0000-0003-0991-0273; Ackermann, Martin/0000-0003-0087-4819; 	Swiss National Science Foundation [3100A0-108186]; Baden-Wurttemberg; Deutsche Forschungsgemeinschaft [SO 421/7-1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Baden-Wurttemberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank F. Hamburger for help with cloning, M. Durrenberger for microscopy support, M. Podvinec for IT service, A. Vaknin for pAV1, and S. Parkinson for FliC antibody and advice. This work was supported by Swiss National Science Foundation Fellowship 3100A0-108186 to U.J. H. L. was supported by the Bioquant Graduate Program of Baden-Wurttemberg, M. A. by a grant from the Swiss National Science Foundation, and V. S. by the grant SO 421/7-1 from the Deutsche Forschungsgemeinschaft.	Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; AMSLER CD, 1993, J BACTERIOL, V175, P6238, DOI 10.1128/JB.175.19.6238-6244.1993; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BLAIR DF, 1988, SCIENCE, V242, P1678, DOI 10.1126/science.2849208; Blair KM, 2008, SCIENCE, V320, P1636, DOI 10.1126/science.1157877; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darnton NC, 2007, J BACTERIOL, V189, P1756, DOI 10.1128/JB.01501-06; Frye J, 2006, J BACTERIOL, V188, P2233, DOI 10.1128/JB.188.6.2233-2243.2006; Gabel CV, 2003, P NATL ACAD SCI USA, V100, P8748, DOI 10.1073/pnas.1533395100; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Kentner D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.77; Ko M, 2000, J MOL BIOL, V303, P371, DOI 10.1006/jmbi.2000.4147; Lemke JJ, 2009, MOL MICROBIOL, V74, P1368, DOI 10.1111/j.1365-2958.2009.06939.x; MEISTER M, 1987, CELL, V49, P643, DOI 10.1016/0092-8674(87)90540-X; Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808; Pilizota T, 2009, P NATL ACAD SCI USA, V106, P11582, DOI 10.1073/pnas.0813164106; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; Reid SW, 2006, P NATL ACAD SCI USA, V103, P8066, DOI 10.1073/pnas.0509932103; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; SLOCUM MK, 1985, J BACTERIOL, V163, P586, DOI 10.1128/JB.163.2.586-594.1985; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P12669, DOI 10.1073/pnas.192463199; Sourjik V, 2007, METHOD ENZYMOL, V423, P365, DOI 10.1016/S0076-6879(07)23017-4; Sowa Y, 2008, Q REV BIOPHYS, V41, P103, DOI 10.1017/S0033583508004691; Stephens L, 2008, CURR BIOL, V18, pR485, DOI 10.1016/j.cub.2008.04.048; van den Heuvel MGL, 2007, SCIENCE, V317, P333, DOI 10.1126/science.1139570; Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x; Wolfe AJ, 2008, J BACTERIOL, V190, P463, DOI 10.1128/JB.01418-07; Yuan JH, 2008, P NATL ACAD SCI USA, V105, P1182, DOI 10.1073/pnas.0711539105; Zhou JD, 1998, P NATL ACAD SCI USA, V95, P6436, DOI 10.1073/pnas.95.11.6436	35	326	344	3	78	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 1	2010	141	1					107	116		10.1016/j.cell.2010.01.018	http://dx.doi.org/10.1016/j.cell.2010.01.018			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20303158	Bronze			2022-12-28	WOS:000276211100016
J	Takagi, H; Hwang, HY				Takagi, Hidenori; Hwang, Harold Y.			An Emergent Change of Phase for Electronics	SCIENCE			English	Editorial Material							TRANSITION; RESISTANCE; FILMS; STATES	Correlated electrons in transition metal oxides can form a variety of electronic phases. The phase change between these various states gives rise to novel device functions, including sensing, signal conversion, and nonvolatile memory, and is now at the frontier of research on "emergent research device materials." Those oxide devices may have an advantage over conventional semiconductor devices for added functionality and future downsizing to the nanoscale. The elucidation of the microscopic physics behind their operation is a key step for further development.	[Takagi, Hidenori; Hwang, Harold Y.] Univ Tokyo, Dept Adv Mat, Kashiwa, Chiba 2778561, Japan; [Takagi, Hidenori] RIKEN, Adv Sci Inst, Wako, Saitama 3510198, Japan	University of Tokyo; RIKEN	Takagi, H (corresponding author), Univ Tokyo, Dept Adv Mat, Kashiwa, Chiba 2778561, Japan.	h-takagi@riken.jp; hyhwang@k.u-tokyo.ac.jp	Takagi, Hidenori/B-2935-2010; TAKAGI, HIDENORI/Q-1041-2019; Hwang, Harold Y/I-6943-2012	TAKAGI, HIDENORI/0000-0001-5700-3761; 				Ahn SE, 2008, ADV MATER, V20, P924, DOI 10.1002/adma.200702081; Bruck E, 2005, J PHYS D APPL PHYS, V38, pR381, DOI 10.1088/0022-3727/38/23/R01; Cen C, 2008, NAT MATER, V7, P298, DOI 10.1038/nmat2136; Cheong SW, 2007, NAT MATER, V6, P13, DOI 10.1038/nmat1804; Chu YH, 2008, NAT MATER, V7, P478, DOI 10.1038/nmat2184; Dagotto E, 2005, SCIENCE, V309, P257, DOI 10.1126/science.1107559; DEARNALEY G, 1970, REP PROG PHYS, V33, P1129, DOI 10.1088/0034-4885/33/3/306; Garcia V, 2009, NATURE, V460, P81, DOI 10.1038/nature08128; Kozuka Y, 2009, NATURE, V462, P487, DOI 10.1038/nature08566; Liu SQ, 2000, APPL PHYS LETT, V76, P2749, DOI 10.1063/1.126464; Miyano K, 1997, PHYS REV LETT, V78, P4257, DOI 10.1103/PhysRevLett.78.4257; Pan SH, 2001, NATURE, V413, P282, DOI 10.1038/35095012; Sawa A, 2008, MATER TODAY, V11, P28, DOI 10.1016/S1369-7021(08)70119-6; Seo S, 2004, APPL PHYS LETT, V85, P5655, DOI 10.1063/1.1831560; Szot K, 2006, NAT MATER, V5, P312, DOI 10.1038/nmat1614; Takenaka K, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2147726; Terasaki I, 2003, PHYSICA B, V328, P63, DOI 10.1016/S0921-4526(02)01810-0; Tian W, 2004, MATER RES BULL, V39, P1319, DOI 10.1016/j.materresbull.2004.03.024; Tokura Y, 2006, REP PROG PHYS, V69, P797, DOI 10.1088/0034-4885/69/3/R06; Tsukazaki A, 2007, SCIENCE, V315, P1388, DOI 10.1126/science.1137430; Yoshida C, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2818691; Zhou C, 1997, APPL PHYS LETT, V70, P598, DOI 10.1063/1.118285	22	227	227	5	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	2010	327	5973					1601	1602		10.1126/science.1182541	http://dx.doi.org/10.1126/science.1182541			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	574ED	20339063				2022-12-28	WOS:000275970600031
J	Theis, TN; Solomon, PM				Theis, Thomas N.; Solomon, Paul M.			It's Time to Reinvent the Transistor!	SCIENCE			English	Editorial Material								A breakthrough in materials could refresh and sustain the information technology revolution.	[Theis, Thomas N.; Solomon, Paul M.] IBM Res, TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA	International Business Machines (IBM)	Theis, TN (corresponding author), IBM Res, TJ Watson Res Ctr, POB 218, Yorktown Hts, NY 10598 USA.	ttheis@us.ibm.com						Appenzeller J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.196805; BANERJEE S, 1987, IEEE ELECTR DEVICE L, V8, P347, DOI 10.1109/EDL.1987.26655; DENNARD RH, 1974, IEEE J SOLID-ST CIRC, VSC 9, P256, DOI 10.1109/JSSC.1974.1050511; Haensch W, 2006, IBM J RES DEV, V50, P339, DOI 10.1147/rd.504.0339; Kim SH, 2009, 2009 SYMPOSIUM ON VLSI TECHNOLOGY, DIGEST OF TECHNICAL PAPERS, P178; Kopp T, 2009, J APPL PHYS, V106, DOI 10.1063/1.3197246; Li J, 2004, APPL PHYS LETT, V84, P1174, DOI 10.1063/1.1644917; Mannhart J, 2010, SCIENCE, V327, P1607, DOI 10.1126/science.1181862; MOOKERJEA S, 2009, IEDM, P949; Salahuddin S, 2008, NANO LETT, V8, P405, DOI 10.1021/nl071804g	10	179	183	1	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2010	327	5973					1600	1601		10.1126/science.1187597	http://dx.doi.org/10.1126/science.1187597			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	574ED	20339062				2022-12-28	WOS:000275970600030
J	Vaupel, JW				Vaupel, James W.			Biodemography of human ageing	NATURE			English	Review							APOLIPOPROTEIN-E GENOTYPE; LIFE-SPAN; HUMAN LONGEVITY; UNITED-STATES; COHORTS BORN; MORTALITY; HEALTH; AGE; POPULATION; DEMOGRAPHY	Human senescence has been delayed by a decade. This finding, documented in 1994 and bolstered since, is a fundamental discovery about the biology of human ageing, and one with profound implications for individuals, society and the economy. Remarkably, the rate of deterioration with age seems to be constant across individuals and over time: it seems that death is being delayed because people are reaching old age in better health. Research by demographers, epidemiologists and other biomedical researchers suggests that further progress is likely to be made in advancing the frontier of survival - and healthy survival - to even greater ages.	[Vaupel, James W.] Max Planck Inst Demog Res, D-18057 Rostock, Germany; [Vaupel, James W.] Univ So Denmark, Inst Publ Hlth, DK-5000 Odense C, Denmark; [Vaupel, James W.] Duke Univ, Sanford Sch Publ Policy, Ctr Demog Aging, Durham, NC 27708 USA	Max Planck Society; University of Southern Denmark; Duke University	Vaupel, JW (corresponding author), Max Planck Inst Demog Res, Konrad Zuse Str 1, D-18057 Rostock, Germany.	jwv@demogr.mpg.de		Vaupel, James/0000-0003-0783-3905	Max Planck Society; US National Institute on Aging (NIA) [P01-08761]; NATIONAL INSTITUTE ON AGING [P01AG008761] Funding Source: NIH RePORTER	Max Planck Society(Max Planck Society); US National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	I thank Z. Zhang, A. Baudisch, K. Christensen, G. Doblhammer, J. Haaga, B. Jeune, S. Leek, R. Rau, S. Scherneck, R. Suzman and N. Vaupel. My research is supported in part by the Max Planck Society and by the US National Institute on Aging (NIA P01-08761).	ALHO JM, 2005, STAT DEMOGRAPHY FORE; ARISTOTLE, 1984, COMPLETE WORKS ARIST, P740; Austad Steven N, 2006, Gend Med, V3, P79, DOI 10.1016/S1550-8579(06)80198-1; BACON R, 1806, CODE HLTH LONGEVITY; Barker DJP., 2008, WINDOW OPPORTUNITY P; Baudisch A, 2005, P NATL ACAD SCI USA, V102, P8263, DOI 10.1073/pnas.0502155102; Baudisch A, 2008, DEMOGR RES MONOGR, P1, DOI 10.1007/978-3-540-76656-8; Bonduriansky R, 2008, FUNCT ECOL, V22, P443, DOI 10.1111/j.1365-2435.2008.01417.x; Bongaarts J, 2009, POP STUD-J DEMOG, V63, P203, DOI 10.1080/00324720903165456; Butler RN, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a399; Canudas-Romo V, 2008, DEMOGR RES, V19, P1179, DOI 10.4054/DemRes.2008.19.30; Carey JR, 2003, LIFE SPAN: EVOLUTIONARY, ECOLOGICAL, AND DEMOGRAPHIC PERSPECTIVES, P1; CAREY JR, 1992, SCIENCE, V258, P457, DOI 10.1126/science.1411540; Carey JR, 2005, HDB POPULATION, P625; Caselli Graziella, 2006, DEMOGRAPHY ANAL SYNT, V1; Cheung SLK, 2007, POP STUD-J DEMOG, V61, P85, DOI 10.1080/00324720601103833; CHRISTENSEN K, 1995, BRIT MED J, V310, P432, DOI 10.1136/bmj.310.6977.432; Christensen K, 2008, P NATL ACAD SCI USA, V105, P13274, DOI 10.1073/pnas.0804931105; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Chu CYC, 2008, THEOR POPUL BIOL, V73, P171, DOI 10.1016/j.tpb.2007.11.005; CORNARO L, 2005, ART LIVING; CRIMMINS EM, DIVERGENT T IN PRESS; CURTSINGER JW, 1992, SCIENCE, V258, P461, DOI 10.1126/science.1411541; Cutler D., 2008, HLTH OLDER AGES CAUS; Doblhammer G, 2003, P ROY SOC B-BIOL SCI, V270, P1541, DOI 10.1098/rspb.2003.2400; Doblhammer G., 2004, LATE LIFE LEGACY VER; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Edwards RD, 2005, POPUL DEV REV, V31, P645, DOI 10.1111/j.1728-4457.2005.00092.x; Engberg H, 2008, J GERONTOL A-BIOL, V63, P1186, DOI 10.1093/gerona/63.11.1186; Ewbank DC, 2007, J GERONTOL A-BIOL, V62, P899, DOI 10.1093/gerona/62.8.899; FARRELLY C, 2008, BMJ-BRIT MED J, V337, P148; Finch CE, 1990, LONGEVITY SENESCENCE; Finkelstein M, 2006, ADV APPL PROBAB, V38, P244, DOI 10.1017/S0001867800000896; Freedman VA, 2004, DEMOGRAPHY, V41, P417, DOI 10.1353/dem.2004.0022; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; GALEN, 1951, HYGIENE SANITATE TUE, V1, pCH2; Gerdes LU, 2000, GENET EPIDEMIOL, V19, P202, DOI 10.1002/1098-2272(200010)19:3<202::AID-GEPI2>3.0.CO;2-Q; GRUENBERG EM, 1977, MILBANK FUND Q, V55, P3, DOI 10.2307/3349592; GURALNIK JM, 1988, MILBANK Q, V66, P283, DOI 10.2307/3350033; HAAGA JG, 2009, POPUL DEV REV, V323, P365; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Hayflick L, 2007, ANN NY ACAD SCI, V1100, P1, DOI 10.1196/annals.1395.001; Herskind AM, 1996, HUM GENET, V98, P467, DOI 10.1007/s004390050241; Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y; HOLMES OW, 1890, TEACUPS, P181; Jagger C, 2008, LANCET, V372, P2124, DOI 10.1016/S0140-6736(08)61594-9; Jeune B, 2002, AGING CLIN EXP RES, V14, P72; Jeune B., 1999, VALIDATION EXCEPTION; Jeune B, 2008, EUR J AGEING, V5, P279, DOI 10.1007/s10433-008-0100-x; JOHNSON TE, 1990, SCIENCE, V249, P908, DOI 10.1126/science.2392681; Kannisto V, 1997, AM J EPIDEMIOL, V145, P987, DOI 10.1093/oxfordjournals.aje.a009067; KANNISTO V, 1994, POPUL DEV REV, V20, P793, DOI 10.2307/2137662; Kannisto V., 1996, ADV FRONTIER SURVIVA; Kannisto V., 2001, POPULATION ENGLISH S, P159; Kannisto Vaino., 1994, DEV OLDEST OLD MORTA; Kirkwood T., 1999, TIME OUR LIVES SCI H; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Lee R, 2003, LIFE SPAN: EVOLUTIONARY, ECOLOGICAL, AND DEMOGRAPHIC PERSPECTIVES, P183; MAIER H, SUPERCENTEN IN PRESS; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; MANTON KG, 1991, POPUL DEV REV, V17, P603, DOI 10.2307/1973599; MCGUE M, 1993, J GERONTOL, V48, pB237, DOI 10.1093/geronj/48.6.B237; Moore SE, 1997, NATURE, V388, P434, DOI 10.1038/41245; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Oksuzyan A, 2008, AGING CLIN EXP RES, V20, P91; Olsen TS, 2009, NEUROEPIDEMIOLOGY, V32, P47, DOI 10.1159/000170906; OLSHANSKY SJ, 1990, SCIENCE, V250, P634, DOI 10.1126/science.2237414; Parker M, 2008, EUR J AGEING, V5, P299, DOI 10.1007/s10433-008-0096-2; Perls TT, 2002, P NATL ACAD SCI USA, V99, P8442, DOI 10.1073/pnas.122587599; PERLS TT, 1999, LIVING 100; Preston S, 2000, DEMOGRAPHY MEASURING; PRESTON SH, 1975, POP STUD-J DEMOG, V29, P231, DOI 10.2307/2173509; Rau R, 2008, POPUL DEV REV, V34, P747, DOI 10.1111/j.1728-4457.2008.00249.x; Riley J, 2001, RISING LIFE EXPECTAN; ROBINE JM, FRONTIERS O IN PRESS; Rogers RG., 2000, LIVING DYING US BEHA; Rose MR, 1994, EVOLUTIONARY BIOL AG; Sierra F, 2009, ANNU REV MED, V60, P457, DOI 10.1146/annurev.med.60.061607.220533; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Steinberg MK, 2006, GEOFORUM, V37, P13, DOI 10.1016/j.geoforum.2004.11.010; Steinsaltz D, 2005, ADV APPL MATH, V35, P16, DOI 10.1016/j.aam.2004.09.003; Tissenbaum H.A., 2008, MOL BIOL AG, P153; Tuljapurkar S, 2000, NATURE, V405, P789, DOI 10.1038/35015561; Vaupel J. W., 1994, STUDIES EC AGING, P79; Vaupel JW, 2006, SCIENCE, V312, P1911, DOI 10.1126/science.1127487; Vaupel JW, 1997, PHILOS T ROY SOC B, V352, P1799, DOI 10.1098/rstb.1997.0164; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; Vaupel JW, 2004, THEOR POPUL BIOL, V65, P339, DOI 10.1016/j.tpb.2003.12.003; Vaupel JW, 2003, SCIENCE, V301, P1679, DOI 10.1126/science.1090529; VAUPEL JW, 1986, AM J PUBLIC HEALTH, V76, P430, DOI 10.2105/AJPH.76.4.430; VAUPEL JW, 1985, AM STAT, V39, P176, DOI 10.2307/2683925; Vaupel JW, 1998, SCIENCE, V280, P855, DOI 10.1126/science.280.5365.855; VAUPEL JW, 1995, EXCEPTIONAL LONGEVIT, P109; Vaupel JW, 1997, POPULATION DATA GLAN; Wachter K.W, 1997, ZEUS SALMON; Wang HD, 2009, P NATL ACAD SCI USA, V106, P393, DOI 10.1073/pnas.0811809106; Wilmoth JR, 2000, SCIENCE, V289, P2366, DOI 10.1126/science.289.5488.2366; Wilmoth JR, 1998, SCIENCE, V280, P395, DOI 10.1126/science.280.5362.395	100	600	624	5	164	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					536	542		10.1038/nature08984	http://dx.doi.org/10.1038/nature08984			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	574FL	20336136	Green Accepted			2022-12-28	WOS:000275974200037
J	Cooper, A; Timmis, A; Skinner, J				Cooper, Angela; Timmis, Adam; Skinner, Jane		Guideline Dev Grp	Guidelines Assessment of recent onset chest pain or discomfort of suspected cardiac origin: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Timmis, Adam] Barts & London Queen Marys Sch Med & Dent, London E1 2AD, England; [Skinner, Jane] Royal Victoria Infirm, Dept Cardiol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	University of London; Queen Mary University London; Newcastle University - UK		angela.cooper@rcplondon.ac.uk	Jarman, Heather/AAG-1159-2021; Jarman, Heather/AFM-8834-2022	Jarman, Heather/0000-0002-4820-3291	National Institute for Health Research [RP-PG-0407-10314] Funding Source: researchfish; Department of Health [RP-PG-0407-10314] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Goodacre S, 2005, HEART, V91, P229, DOI 10.1136/hrt.2003.027599; *NAT I HLTH CLIN E, 2010, CLIN GUID NAT I HLTH, V94; National Institute for Health and Clinical Excellence, 2010, CLIN GUID NAT I HLTH; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; PRYOR DB, 1993, ANN INTERN MED, V118, P81, DOI 10.7326/0003-4819-118-2-199301150-00001; Thygesen K, 2007, EUR HEART J, V28, P2525	6	36	39	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2010	340								c1118	10.1136/bmj.c1118	http://dx.doi.org/10.1136/bmj.c1118			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	576PP	20335334				2022-12-28	WOS:000276157700004
J	Glass, CK; Saijo, K; Winner, B; Marchetto, MC; Gage, FH				Glass, Christopher K.; Saijo, Kaoru; Winner, Beate; Marchetto, Maria Carolina; Gage, Fred H.			Mechanisms Underlying Inflammation in Neurodegeneration	CELL			English	Review							AMYOTROPHIC-LATERAL-SCLEROSIS; AMYLOID-BETA-PEPTIDE; GLYCOSYLATION END-PRODUCTS; NITRATED ALPHA-SYNUCLEIN; PLURIPOTENT STEM-CELLS; TUMOR-NECROSIS-FACTOR; MOTOR-NEURON DISEASE; TOLL-LIKE RECEPTORS; NF-KAPPA-B; ALZHEIMERS-DISEASE	Inflammation is associated with many neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis. In this Review, we discuss inducers, sensors, transducers, and effectors of neuroinflammation that contribute to neuronal dysfunction and death. Although inducers of inflammation may be generated in a disease-specific manner, there is evidence for a remarkable convergence in the mechanisms responsible for the sensing, transduction, and amplification of inflammatory processes that result in the production of neurotoxic mediators. A major unanswered question is whether pharmacological inhibition of inflammation pathways will be able to safely reverse or slow the course of disease.	[Glass, Christopher K.; Saijo, Kaoru] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Winner, Beate; Marchetto, Maria Carolina; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute	Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	ckg@ucsd.edu; gage@salk.edu	Glass, Christopher/AAI-3933-2021; Winner, Beate/K-3730-2012; Winner, Beate/O-8213-2019	Glass, Christopher/0000-0003-4344-3592; Winner, Beate/0000-0002-6909-0564; Winner, Beate/0000-0002-6909-0564	NIH; CIRM; Leducq Transatlantic Network Foundation; Alexander von Humbolt Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH088485] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); Leducq Transatlantic Network Foundation; Alexander von Humbolt Foundation(Alexander von Humboldt Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Mel Simon for helpful discussions and Jamie Simon for figure preparation. K.S., F.H.G., and C.K.G. are supported by the NIH. F.H.G., B.W., and M.C.M. are supported by CIRM. C.K.G. is supported by a Leducq Transatlantic Network Foundation Grant. B.W. is a Feodor-Lynen fellow of the Alexander von Humbolt Foundation.	Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; AKIYAMA H, 1994, TOHOKU J EXP MED, V174, P295, DOI 10.1620/tjem.174.295; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Balistreri CR, 2009, J CLIN IMMUNOL, V29, P406, DOI 10.1007/s10875-009-9297-5; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Banerjee R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002740; Barbeito LH, 2004, BRAIN RES REV, V47, P263, DOI 10.1016/j.brainresrev.2004.05.003; Benner EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001376; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Block ML, 2007, BIOCHEM SOC T, V35, P1127, DOI 10.1042/BST0351127; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boissonneault V, 2009, BRAIN, V132, P1078, DOI 10.1093/brain/awn331; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2007, ACTA NEUROPATHOL, V114, P231, DOI 10.1007/s00401-007-0244-3; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Cartier L, 2005, BRAIN RES REV, V48, P16, DOI 10.1016/j.brainresrev.2004.07.021; Castano A, 1998, J NEUROCHEM, V70, P1584; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; Choi SH, 2009, TRENDS PHARMACOL SCI, V30, P174, DOI 10.1016/j.tips.2009.01.002; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Cudkowicz ME, 2006, ANN NEUROL, V60, P22, DOI 10.1002/ana.20903; Dalakas MC, 2008, NAT CLIN PRACT NEURO, V4, P557, DOI 10.1038/ncpneuro0901; DAMIER P, 1993, NEUROSCIENCE, V52, P1, DOI 10.1016/0306-4522(93)90175-F; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Di Virgilio F, 2009, TRENDS NEUROSCI, V32, P79, DOI 10.1016/j.tins.2008.11.003; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Doi Y, 2009, AM J PATHOL, V175, P2121, DOI 10.2353/ajpath.2009.090418; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Eisen A, 2009, J CLIN NEUROSCI, V16, P505, DOI 10.1016/j.jocn.2008.07.072; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Fugger L, 2009, NAT REV IMMUNOL, V9, P408, DOI 10.1038/nri2554; FUJINAMI RS, 1985, SCIENCE, V230, P1043, DOI 10.1126/science.2414848; Gao HM, 2008, J NEUROSCI, V28, P7687, DOI 10.1523/JNEUROSCI.0143-07.2008; Gasser T, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001148; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Gordon PH, 2008, AMYOTROPH LATERAL SC, V9, P212, DOI 10.1080/17482960802195632; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Gowing G, 2006, J NEUROSCI, V26, P11397, DOI 10.1523/JNEUROSCI.0602-06.2006; Granic I, 2009, J ALZHEIMERS DIS, V16, P809, DOI 10.3233/JAD-2009-0976; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Hunot S, 1996, NEUROSCIENCE, V72, P355, DOI 10.1016/0306-4522(95)00578-1; Hunter RL, 2007, J NEUROCHEM, V100, P1375, DOI 10.1111/j.1471-4159.2006.04327.x; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Husemann J, 2002, GLIA, V40, P195, DOI 10.1002/glia.10148; Jaeger S, 2008, CURR ALZHEIMER RES, V5, P15; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; Jones A, 2009, J ALZHEIMERS DIS, V16, P787, DOI 10.3233/JAD-2009-0973; Kang J, 2007, J CELL BIOL, V179, P1219, DOI 10.1083/jcb.200705046; KASTNER A, 1992, J NEUROCHEM, V59, P1080, DOI 10.1111/j.1471-4159.1992.tb08350.x; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Kitazawa M, 2004, ANN NY ACAD SCI, V1035, P85, DOI 10.1196/annals.1332.006; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; Kroner A, 2005, J NEUROIMMUNOL, V165, P161, DOI 10.1016/j.jneuroim.2005.03.012; Kuhn DM, 2006, ANN NY ACAD SCI, V1074, P31, DOI 10.1196/annals.1369.003; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Landreth GE, 2009, CURR TOP MICROBIOL, V336, P137, DOI 10.1007/978-3-642-00549-7_8; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; Lassmann H, 2001, TRENDS MOL MED, V7, P115, DOI 10.1016/S1471-4914(00)01909-2; Lee SJ, 2008, J MOL NEUROSCI, V34, P17, DOI 10.1007/s12031-007-0012-9; Letiembre M, 2009, NEUROBIOL AGING, V30, P759, DOI 10.1016/j.neurobiolaging.2007.08.018; Licastro F, 2007, NEUROBIOL AGING, V28, P1637, DOI 10.1016/j.neurobiolaging.2006.07.007; Liu Y, 2009, J BIOL CHEM, V284, P3691, DOI 10.1074/jbc.M804446200; Luchsinger JA, 2009, J ALZHEIMERS DIS, V16, P693, DOI 10.3233/JAD-2009-1022; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mantovani S, 2009, J NEUROIMMUNOL, V210, P73, DOI 10.1016/j.jneuroim.2009.02.012; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Marta M, 2009, AUTOIMMUN REV, V8, P506, DOI 10.1016/j.autrev.2009.01.006; Marzolo MP, 2009, SEMIN CELL DEV BIOL, V20, P191, DOI 10.1016/j.semcdb.2008.10.005; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Migliore L, 2009, MUTAT RES-FUND MOL M, V667, P82, DOI 10.1016/j.mrfmmm.2008.10.011; Minoretti P, 2006, NEUROSCI LETT, V391, P147, DOI 10.1016/j.neulet.2005.08.047; Nadeau S, 2000, J NEUROSCI, V20, P3456, DOI 10.1523/JNEUROSCI.20-09-03456.2000; Nagatsu T, 2005, CURR PHARM DESIGN, V11, P999, DOI 10.2174/1381612053381620; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neymotin A, 2009, EXP NEUROL, V220, P191, DOI 10.1016/j.expneurol.2009.08.028; Nguyen MD, 2004, J NEUROSCI, V24, P1340, DOI 10.1523/JNEUROSCI.4786-03.2004; Nguyen MD, 2001, ANN NEUROL, V50, P630, DOI 10.1002/ana.1256; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Park JY, 2009, J NEUROCHEM, V110, P400, DOI 10.1111/j.1471-4159.2009.06150.x; Pehar M, 2004, J NEUROCHEM, V89, P464, DOI 10.1111/j.1471-4159.2004.02357.x; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Pocivavsek A, 2009, J NEUROIMMUNOL, V214, P25, DOI 10.1016/j.jneuroim.2009.06.010; Pocivavsek A, 2009, GLIA, V57, P444, DOI 10.1002/glia.20772; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Raoul C, 2006, P NATL ACAD SCI USA, V103, P6007, DOI 10.1073/pnas.0508774103; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Reines SA, 2004, NEUROLOGY, V62, P66, DOI 10.1212/WNL.62.1.66; Reynolds AD, 2008, J NEUROIMMUNE PHARM, V3, P59, DOI 10.1007/s11481-008-9100-z; Richard KL, 2008, J NEUROSCI, V28, P5784, DOI 10.1523/JNEUROSCI.1146-08.2008; Risner ME, 2006, PHARMACOGENOMICS J, V6, P246, DOI 10.1038/sj.tpj.6500369; Rissman RA, 2007, J NEUROCHEM, V103, P1285, DOI 10.1111/j.1471-4159.2007.04832.x; Roodveldt C, 2008, J CELL MOL MED, V12, P1820, DOI 10.1111/j.1582-4934.2008.00450.x; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Sastre M, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-25; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Schmidt AM, 2009, CURR OPIN INVEST DR, V10, P672; Simi A, 2007, BIOCHEM SOC T, V35, P1122, DOI 10.1042/BST0351122; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Srikanth V, 2011, NEUROBIOL AGING, V32, P763, DOI 10.1016/j.neurobiolaging.2009.04.016; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Tahara K, 2006, BRAIN, V129, P3006, DOI 10.1093/brain/awl249; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Tikka TM, 2002, BRAIN, V125, P722, DOI 10.1093/brain/awf068; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Uranishi H, 2001, J BIOL CHEM, V276, P13395, DOI 10.1074/jbc.M011176200; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vargas MR, 2008, J NEUROSCI RES, V86, P3515, DOI 10.1002/jnr.21797; Vitek MP, 2009, NEUROBIOL AGING, V30, P1350, DOI 10.1016/j.neurobiolaging.2007.11.014; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Watson GS, 2005, AM J GERIAT PSYCHIAT, V13, P950, DOI 10.1176/appi.ajgp.13.11.950; Wilms H, 2003, FASEB J, V17, P500, DOI 10.1096/fj.02-0314fje; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yamin G, 2009, J NEUROSCI RES, V87, P1729, DOI 10.1002/jnr.21998; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Yiangou Y, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-12; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	146	2322	2434	36	842	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2010	140	6					918	934		10.1016/j.cell.2010.02.016	http://dx.doi.org/10.1016/j.cell.2010.02.016			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	571IX	20303880	Green Accepted, Bronze			2022-12-28	WOS:000275746600014
J	Henrich, J; Ensminger, J; McElreath, R; Barr, A; Barrett, C; Bolyanatz, A; Cardenas, JC; Gurven, M; Gwako, E; Henrich, N; Lesorogol, C; Marlowe, FW; Tracer, D; Ziker, J				Henrich, Joseph; Ensminger, Jean; McElreath, Richard; Barr, Abigail; Barrett, Clark; Bolyanatz, Alexander; Camilo Cardenas, Juan; Gurven, Michael; Gwako, Edwins; Henrich, Natalie; Lesorogol, Carolyn; Marlowe, Frank W.; Tracer, David; Ziker, John			Markets, Religion, Community Size, and the Evolution of Fairness and Punishment	SCIENCE			English	Article							NORMS; CONSEQUENCES; DEFECTORS	Large-scale societies in which strangers regularly engage in mutually beneficial transactions are puzzling. The evolutionary mechanisms associated with kinship and reciprocity, which underpin much of primate sociality, do not readily extend to large unrelated groups. Theory suggests that the evolution of such societies may have required norms and institutions that sustain fairness in ephemeral exchanges. If that is true, then engagement in larger-scale institutions, such as markets and world religions, should be associated with greater fairness, and larger communities should punish unfairness more. Using three behavioral experiments administered across 15 diverse populations, we show that market integration (measured as the percentage of purchased calories) positively covaries with fairness while community size positively covaries with punishment. Participation in a world religion is associated with fairness, although not across all measures. These results suggest that modern prosociality is not solely the product of an innate psychology, but also reflects norms and institutions that have emerged over the course of human history.	[Henrich, Joseph] Univ British Columbia, Dept Psychol, Vancouver, BC V6T 1Z4, Canada; [Henrich, Joseph] Univ British Columbia, Dept Econ, Vancouver, BC V6T 1Z4, Canada; [Ensminger, Jean] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [McElreath, Richard] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Barr, Abigail] Univ Oxford, Dept Econ, Ctr Study African Economies, Oxford OX1 3UQ, England; [Barrett, Clark] Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90095 USA; [Bolyanatz, Alexander] Coll DuPage, Dept Anthropol, Glen Ellyn, IL 60137 USA; [Camilo Cardenas, Juan] Univ Los Andes, Fac Econ, Bogota, Colombia; [Gurven, Michael] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA; [Gwako, Edwins] Guilford Coll, Dept Sociol & Anthropol, Greensboro, NC 27410 USA; [Henrich, Natalie] Providence Hlth Care Res Inst, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC V6Z 1Y6, Canada; [Lesorogol, Carolyn] Washington Univ, George Warren Brown Sch Social Work, St Louis, MO 63130 USA; [Marlowe, Frank W.] Florida State Univ, Dept Anthropol, Tallahassee, FL 32306 USA; [Tracer, David] Univ Colorado, Dept Anthropol, Denver, CO 80217 USA; [Ziker, John] Boise State Univ, Dept Anthropol, Boise, ID 83725 USA	University of British Columbia; University of British Columbia; California Institute of Technology; University of California System; University of California Davis; University of Oxford; University of California System; University of California Los Angeles; Universidad de los Andes (Colombia); University of California System; University of California Santa Barbara; Washington University (WUSTL); State University System of Florida; Florida State University; University of Colorado System; University of Colorado Denver; Idaho; Boise State University	Henrich, J (corresponding author), Univ British Columbia, Dept Psychol, 2136 W Mall, Vancouver, BC V6T 1Z4, Canada.	henrich@psych.ubc.ca	cardenas, juan-camilo/B-4658-2009; Barrett, H Clark/AAE-2086-2019; Marlowe, Frank/G-9752-2012; Ziker, John/H-4395-2019	cardenas, juan-camilo/0000-0003-0005-7595; Barrett, H Clark/0000-0002-4157-6511; Ziker, John/0000-0001-9059-5594; McElreath, Richard/0000-0002-0387-5377; Gurven, Michael/0000-0002-5661-527X; Lesorogol, Carolyn/0000-0001-8946-0289	National Science Foundation; MacArthur Norms and Preferences Network; Max Planck Institute for Social Anthropology; Russell Sage Foundation	National Science Foundation(National Science Foundation (NSF)); MacArthur Norms and Preferences Network; Max Planck Institute for Social Anthropology(Max Planck Society); Russell Sage Foundation	We especially thank the communities that participated in our research. We also thank the National Science Foundation, the MacArthur Norms and Preferences Network, the Max Planck Institute for Social Anthropology, and the Russell Sage Foundation for funding this project. Thanks also to the many audiences and readers who contributed to improving our efforts.	[Anonymous], 2006, THEORY MORAL SENTIME; Bowles S, 1998, J ECON LIT, V36, P75; Bowles S., 2004, ROUNDTABLE SER BEHAV; Boyd R, 2002, J THEOR BIOL, V215, P287, DOI 10.1006/jtbi.2001.2515; BURNHAM TC, 2005, ANAL KRITIK, V27, P113; Camerer C.F., 2011, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Cancho RFI, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051915; Diamond J., 2010, RUZHYA MIKROBY STALI; Dixit Avansah K, 2004, LAWLESSNESS EC ALTER; Ensminger J, 1997, CURR ANTHROPOL, V38, P1, DOI 10.1086/204579; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fehr E., 2003, GENETIC CULTURAL EVO; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Forge A., 1972, MAN SETTLEMENT URBAN, P363; Gintis H, 2001, J THEOR BIOL, V213, P103, DOI 10.1006/jtbi.2001.2406; Gurven M, 2008, AM ANTHROPOL, V110, P179, DOI 10.1111/j.1548-1433.2008.00024.x; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2001, J THEOR BIOL, V208, P79, DOI 10.1006/jtbi.2000.2202; Henrich J., 2005, FDN HUMAN SOCIALITY; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Henrich J, 2009, EVOL HUM BEHAV, V30, P244, DOI 10.1016/j.evolhumbehav.2009.03.005; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Marcus J, 2004, P NATL ACAD SCI USA, V101, P18257, DOI 10.1073/pnas.0408551102; Marlowe FW, 2008, P R SOC B, V275, P587, DOI 10.1098/rspb.2007.1517; Norenzayan A, 2008, SCIENCE, V322, P58, DOI 10.1126/science.1158757; North D.C., 1990, I I CHANGE EC PERFOR; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Panchanathan K, 2003, J THEOR BIOL, V224, P115, DOI 10.1016/S0022-5193(03)00154-1; Poppe M, 2005, J ECON PSYCHOL, V26, P431, DOI 10.1016/j.joep.2004.12.006; Richerson P. J., 2005, NOT GENES ALONE CULT; Richerson PJ, 2001, AM ANTIQUITY, V66, P387, DOI 10.2307/2694241; Richerson PJ, 1999, HUM NATURE-INT BIOS, V10, P253, DOI 10.1007/s12110-999-1004-y; Roes FL, 2003, EVOL HUM BEHAV, V24, P126, DOI 10.1016/S1090-5138(02)00134-4; Shariff AF, 2010, EVOLUTION, CULTURE, AND THE HUMAN MIND, P119; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Vohs KD, 2006, SCIENCE, V314, P1154, DOI 10.1126/science.1132491; Wright R., 2009, THE EVOLUTION OF GOD	38	679	690	6	247	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2010	327	5972					1480	1484		10.1126/science.1182238	http://dx.doi.org/10.1126/science.1182238			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	570YQ	20299588				2022-12-28	WOS:000275715200039
J	Timmerman, R; Paulus, R; Galvin, J; Michalski, J; Straube, W; Bradley, J; Fakiris, A; Bezjak, A; Videtic, G; Johnstone, D; Fowler, J; Gore, E; Choy, H				Timmerman, Robert; Paulus, Rebecca; Galvin, James; Michalski, Jeffrey; Straube, William; Bradley, Jeffrey; Fakiris, Achilles; Bezjak, Andrea; Videtic, Gregory; Johnstone, David; Fowler, Jack; Gore, Elizabeth; Choy, Hak			Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHASE-II; CLINICAL-TRIALS; RADIOTHERAPY; CARCINOMA; MANAGEMENT; ONCOLOGY; OUTCOMES; TUMORS	Context Patients with early stage but medically inoperable lung cancer have a poor rate of primary tumor control (30%-40%) and a high rate of mortality (3-year survival, 20%-35%) with current management. Objective To evaluate the toxicity and efficacy of stereotactic body radiation therapy in a high-risk population of patients with early stage but medically inoperable lung cancer. Design, Setting, and Patients Phase 2 North American multicenter study of patients aged 18 years or older with biopsy-proven peripheral T1-T2N0M0 non-small cell tumors (measuring <5 cm in diameter) and medical conditions precluding surgical treatment. The prescription dose was 18 Gy per fraction x 3 fractions (54 Gy total) with entire treatment lasting between 11/2 and 2 weeks. The study opened May 26, 2004, and closed October 13, 2006; data were analyzed through August 31, 2009. Main Outcome Measures The primary end point was 2-year actuarial primary tumor control; secondary end points were disease-free survival (ie, primary tumor, involved lobe, regional, and disseminated recurrence), treatment-related toxicity, and overall survival. Results A total of 59 patients accrued, of which 55 were evaluable (44 patients with T1 tumors and 11 patients with T2 tumors) with a median follow-up of 34.4 months (range, 4.8-49.9 months). Only 1 patient had a primary tumor failure; the estimated 3-year primary tumor control rate was 97.6% (95% confidence interval [CI], 84.3%-99.7%). Three patients had recurrence within the involved lobe; the 3-year primary tumor and involved lobe (local) control rate was 90.6% (95% CI, 76.0%-96.5%). Two patients experienced regional failure; the local-regional control rate was 87.2% (95% CI, 71.0%-94.7%). Eleven patients experienced disseminated recurrence; the 3-year rate of disseminated failure was 22.1% (95% CI, 12.3%-37.8%). The rates for disease-free survival and overall survival at 3 years were 48.3% (95% CI, 34.4%-60.8%) and 55.8% (95% CI, 41.6%-67.9%), respectively. The median overall survival was 48.1 months (95% CI, 29.6 months to not reached). Protocol-specified treatment-related grade 3 adverse events were reported in 7 patients (12.7%; 95% CI, 9.6%-15.8%); grade 4 adverse events were reported in 2 patients (3.6%; 95% CI, 2.7%-4.5%). No grade 5 adverse events were reported. Conclusion Patients with inoperable non-small cell lung cancer who received stereotactic body radiation therapy had a survival rate of 55.8% at 3 years, high rates of local tumor control, and moderate treatment-related morbidity. JAMA. 2010; 303(11): 1070-1076	[Timmerman, Robert; Choy, Hak] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Paulus, Rebecca] Radiat Therapy Oncol Grp, Philadelphia, PA USA; [Galvin, James] Thomas Jefferson Univ, Dept Radiat Oncol, Philadelphia, PA 19107 USA; [Michalski, Jeffrey; Straube, William; Bradley, Jeffrey] Washington Univ, Dept Radiat Oncol, St Louis, MO USA; [Fakiris, Achilles] Indiana Univ, Dept Radiat Oncol, Indianapolis, IN 46204 USA; [Bezjak, Andrea] Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M4X 1K9, Canada; [Videtic, Gregory] Cleveland Clin Fdn, Dept Radiat Oncol, Cleveland, OH 44195 USA; [Johnstone, David] Dartmouth Hitchcock Med Ctr, Div Thorac Surg, Lebanon, NH 03766 USA; [Fowler, Jack] Univ Wisconsin, Dept Radiat Oncol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Gore, Elizabeth] Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Radiation Therapy Oncology Group (RTOG); Jefferson University; Washington University (WUSTL); Indiana University System; Indiana University-Purdue University Indianapolis; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Cleveland Clinic Foundation; Dartmouth College; University of Wisconsin System; University of Wisconsin Madison; Medical College of Wisconsin	Timmerman, R (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, 5801 Forest Pk Rd, Dallas, TX 75390 USA.	robert.timmerman@utsouthwestern.edu	Timmerman, Robert D/C-2222-2013	Paulus, Rebecca/0000-0001-7312-1194	Varian Medical Systems (Palo Alto, California); Elekta Oncology (Stockholm, Sweden); US National Institutes of Health; Department of Defense; National Cancer Institute [RTOG U10 CA21661, CCOP U10 CA37422, Stat U10 CA32115]; Advanced Technology Consortium [U24 CA 81647]; NATIONAL CANCER INSTITUTE [U10CA032115, U10CA037422, U10CA021661, U24CA081647] Funding Source: NIH RePORTER	Varian Medical Systems (Palo Alto, California); Elekta Oncology (Stockholm, Sweden); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Advanced Technology Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial Disclosures: Dr Timmerman reported receiving a research grant for technology development from both Varian Medical Systems (Palo Alto, California) and Elekta Oncology (Stockholm, Sweden). Both of these companies manufacture equipment used in the performance of stereotactic body radiation therapy. In addition, he reported receiving grants from the US National Institutes of Health and Department of Defense to carry out separate protocols using stereotactic radiotherapy in both lung and prostate cancer. None of the other authors reported any financial disclosures. Funding/Support: This work was funded by grants RTOG U10 CA21661, CCOP U10 CA37422, and Stat U10 CA32115 from the National Cancer Institute and grant U24 CA 81647 from the Advanced Technology Consortium.	ARMSTRONG JG, 1989, CANCER TREAT REV, V16, P247, DOI 10.1016/0305-7372(89)90044-3; DOSORETZ DE, 1992, INT J RADIAT ONCOL, V24, P3, DOI 10.1016/0360-3016(92)91013-D; DOSORETZ DE, 1993, INT J RADIAT ONCOL, V27, P507, DOI 10.1016/0360-3016(93)90373-4; Dosoretz DE, 1996, SEMIN RADIAT ONCOL, V6, P98, DOI 10.1016/S1053-4296(96)80006-3; Fakiris AJ, 2009, INT J RADIAT ONCOL, V75, P677, DOI 10.1016/j.ijrobp.2008.11.042; FLEMING TR, 1982, BIOMETRICS, V38, P143, DOI 10.2307/2530297; HAFFTY BG, 1988, INT J RADIAT ONCOL, V15, P69, DOI 10.1016/0360-3016(88)90348-3; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KASKOWITZ L, 1993, INT J RADIAT ONCOL, V27, P517, DOI 10.1016/0360-3016(93)90374-5; Lagerwaard FJ, 2008, INT J RADIAT ONCOL, V70, P685, DOI 10.1016/j.ijrobp.2007.10.053; McGarry RC, 2002, CHEST, V121, P1155, DOI 10.1378/chest.121.4.1155; Nagata Y, 2005, INT J RADIAT ONCOL, V63, P1427, DOI 10.1016/j.ijrobp.2005.05.034; Potters L, 2004, INT J RADIAT ONCOL, V60, P1026, DOI 10.1016/j.ijrobp.2004.07.701; Raz DJ, 2007, CHEST, V132, P193, DOI 10.1378/chest.06-3096; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Timmerman R, 2006, J CLIN ONCOL, V24, P4833, DOI 10.1200/JCO.2006.07.5937; Timmerman R, 2006, ACTA ONCOL, V45, P779, DOI 10.1080/02841860600902213; Timmerman RD, 2007, J CLIN ONCOL, V25, P947, DOI 10.1200/JCO.2006.09.7469; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; Xiao Y, 2009, INT J RADIAT ONCOL, V73, P1235, DOI 10.1016/j.ijrobp.2008.11.019	20	1838	1894	5	93	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1070	1076		10.1001/jama.2010.261	http://dx.doi.org/10.1001/jama.2010.261			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569KC	20233825	Bronze, Green Accepted			2022-12-28	WOS:000275594100020
J	Barer, D				Barer, David			A brief psychosocial-behavioral intervention reduced depression after stroke more than usual care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Gateshead Hlth NHS Trust, Gateshead, England		Barer, D (corresponding author), Gateshead Hlth NHS Trust, Gateshead, England.							Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003689.pub3; Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003437.pub3; Mitchell Pamela H, 2008, J Stroke Cerebrovasc Dis, V17, P109, DOI 10.1016/j.jstrokecerebrovasdis.2007.12.002; TERI L, 1997, J GERONTOL B-PSYCHOL, V52, P159, DOI DOI 10.1093/GER0NB/52B.4.P159	4	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	2010	152	6							JC3-10	10.7326/0003-4819-152-6-201003160-02010	http://dx.doi.org/10.7326/0003-4819-152-6-201003160-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573IF	20231552				2022-12-28	WOS:000275905200027
J	Livne, A; Bouchbinder, E; Svetlizky, I; Fineberg, J				Livne, Ariel; Bouchbinder, Eran; Svetlizky, Ilya; Fineberg, Jay			The Near-Tip Fields of Fast Cracks	SCIENCE			English	Article							DYNAMIC FRACTURE; BRITTLE-FRACTURE; VISCOPLASTICITY; HYPERELASTICITY; SCALE; MODEL	In a stressed body, crack propagation is the main vehicle for material failure. Cracks create large stress amplification at their tips, leading to large material deformation. The material response within this highly deformed region will determine its mode of failure. Despite its great importance, we have only a limited knowledge of the structure of this region, because it is generally experimentally intractable. By using a brittle neo-Hookean material, we overcame this barrier and performed direct and precise measurements of the near-tip structure of rapid cracks. These experiments reveal a hierarchy of linear and nonlinear elastic zones through which energy is transported before being dissipated at a crack's tip. This result provides a comprehensive picture of how remotely applied forces drive material failure in the most fundamental of fracture states: straight, rapidly moving cracks.	[Livne, Ariel; Bouchbinder, Eran; Svetlizky, Ilya; Fineberg, Jay] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Fineberg, J (corresponding author), Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel.	jay@vms.huji.ac.il		Fineberg, Jay/0000-0002-8381-6675	Israel Science Foundation [57/07]; Max Born Chair for Natural Philosophy	Israel Science Foundation(Israel Science Foundation); Max Born Chair for Natural Philosophy	This research was supported by grant 57/07 of the Israel Science Foundation. J. F. acknowledges the support of the Max Born Chair for Natural Philosophy.	ABRAHAM FF, 1994, PHYS REV LETT, V73, P272, DOI 10.1103/PhysRevLett.73.272; Aranson IS, 2000, PHYS REV LETT, V85, P118, DOI 10.1103/PhysRevLett.85.118; Baumberger T, 2010, EUR PHYS J E, V31, P51, DOI 10.1140/epje/i2010-10546-x; Bouchbinder E, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.245505; Bouchbinder E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.134301; Bouchbinder E, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.164301; Bouchbinder E, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026119; Bouchbinder E, 2009, J MECH PHYS SOLIDS, V57, P1568, DOI 10.1016/j.jmps.2009.05.006; Bouchbinder E, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.264302; Buehler MJ, 2006, NATURE, V439, P307, DOI 10.1038/nature04408; Buehler MJ, 2003, NATURE, V426, P141, DOI 10.1038/nature02096; Falk ML, 2001, J PHYS IV, V11, P43, DOI 10.1051/jp4:2001506; Fineberg J, 1999, PHYS REP, V313, P1, DOI 10.1016/S0370-1573(98)00085-4; Freund LB, 1990, DYNAMIC FRACTURE MEC, DOI [10.1017/oretCBO9780511546761-en, DOI 10.1017/ORETCBO9780511546761-EN]; Gao HJ, 1996, J MECH PHYS SOLIDS, V44, P1453, DOI 10.1016/0022-5096(96)00038-5; Gumbsch P, 2000, MRS BULL, V25, P15, DOI 10.1557/mrs2000.68; Holland D, 1998, PHYS REV LETT, V80, P746, DOI 10.1103/PhysRevLett.80.746; Karma A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.045501; Knowles J. K., 1973, Journal of Elasticity, V3, P67, DOI 10.1007/BF00045816; KNOWLES JK, 1983, J ELASTICITY, V13, P257, DOI 10.1007/BF00042997; KNOWLES JK, 1986, J APPL MECH-T ASME, V53, P545, DOI 10.1115/1.3171808; Krishnan VR, 2008, LANGMUIR, V24, P14245, DOI 10.1021/la802795e; Langer JS, 2000, PHYS REV E, V62, P1351, DOI 10.1103/PhysRevE.62.1351; Livne A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.224301; Livne A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.124301; Livne A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.264301; Lobkovsky AE, 1998, PHYS REV E, V58, P1568, DOI 10.1103/PhysRevE.58.1568; Marder M, 2006, J MECH PHYS SOLIDS, V54, P491, DOI 10.1016/j.jmps.2005.10.002; Miller O, 1999, MODEL SIMUL MATER SC, V7, P573, DOI 10.1088/0965-0393/7/4/307; Pardoen T, 2000, J MECH PHYS SOLIDS, V48, P2467, DOI 10.1016/S0022-5096(00)00019-3; RaviChandar K, 1997, J MECH PHYS SOLIDS, V45, P535, DOI 10.1016/S0022-5096(96)00096-8; RIVLIN RS, 1948, PHILOS TR R SOC S-A, V240, P459, DOI 10.1098/rsta.1948.0002; Sharon E, 1999, NATURE, V397, P333, DOI 10.1038/16891; Tarantino AM, 1999, J ELASTICITY, V57, P85, DOI 10.1023/A:1007673212904; Treloar L. R. G., 1975, PHYS TODAY, DOI DOI 10.1063/1.3060678	35	117	119	2	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1359	1363		10.1126/science.1180476	http://dx.doi.org/10.1126/science.1180476			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223982				2022-12-28	WOS:000275418700036
J	Youds, JL; Mets, DG; McIlwraith, MJ; Martin, JS; Ward, JD; ONeil, NJ; Rose, AM; West, SC; Meyer, BJ; Boulton, SJ				Youds, Jillian L.; Mets, David G.; McIlwraith, Michael J.; Martin, Julie S.; Ward, Jordan D.; ONeil, Nigel J.; Rose, Ann M.; West, Stephen C.; Meyer, Barbara J.; Boulton, Simon J.			RTEL-1 Enforces Meiotic Crossover Interference and Homeostasis	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; STRAND-EXCHANGE; C-ELEGANS; RECOMBINATION; CHROMOSOME; PROTEINS; YEAST	Meiotic crossovers (COs) are tightly regulated to ensure that COs on the same chromosome are distributed far apart ( crossover interference, COI) and that at least one CO is formed per homolog pair (CO homeostasis). CO formation is controlled in part during meiotic double-strand break (DSB) creation in Caenorhabditis elegans, but a second level of control must also exist because meiotic DSBs outnumber COs. We show that the anti-recombinase RTEL-1 is required to prevent excess meiotic COs, probably by promoting meiotic synthesis-dependent strand annealing. Two distinct classes of meiotic COs are increased in rtel-1 mutants, and COI and homeostasis are compromised. We propose that RTEL-1 implements the second level of CO control by promoting noncrossovers.	[Youds, Jillian L.; Martin, Julie S.; Ward, Jordan D.; Boulton, Simon J.] Canc Res UK, London Res Inst, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England; [Mets, David G.; Meyer, Barbara J.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [McIlwraith, Michael J.; West, Stephen C.] Canc Res UK, London Res Inst, Genet Recombinat Lab, S Mimms EN6 3LD, Herts, England; [ONeil, Nigel J.; Rose, Ann M.] Univ British Columbia, Fac Med, Dept Med Genet, Vancouver, BC V6T 1Z4, Canada	Cancer Research UK; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Cancer Research UK; University of British Columbia	Boulton, SJ (corresponding author), Canc Res UK, London Res Inst, DNA Damage Response Lab, Clare Hall, S Mimms EN6 3LD, Herts, England.	simon.boulton@cancer.org.uk	Ward, Jordan/H-3444-2019; Ward, Jordan/C-1505-2008; O'Neil, Nigel/J-4012-2014	Ward, Jordan/0000-0001-9870-8936; Ward, Jordan/0000-0001-9870-8936; O'Neil, Nigel/0000-0002-1992-6976; West, Stephen/0000-0001-8848-9418; Mcilwraith, Michael/0000-0003-1559-4369; Meyer, Barbara/0000-0002-6530-4588	Cancer Research UK; Canadian Institute of Health Research; Cancer Research UK [11582] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK (S.J.B. and S. C. W.) and the Canadian Institute of Health Research ( A. M. R.). B.J.M. is an investigator of the Howard Hughes Medical Institute.	Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Bhalla N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000235; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Garcia-Muse T, 2007, CHROMOSOME RES, V15, P607, DOI 10.1007/s10577-007-1146-x; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; McMahill MS, 2007, PLOS BIOL, V5, P2589, DOI 10.1371/journal.pbio.0050299; Meneely PM, 2002, GENETICS, V162, P1169; Mets DG, 2009, CELL, V139, P73, DOI 10.1016/j.cell.2009.07.035; Tsai CJ, 2008, GENE DEV, V22, P194, DOI 10.1101/gad.1618508; Wood WB, 1988, NEMATODE CAENORHABDI; Zetka M., 2009, V5, P43, DOI 10.1159/000166618	16	126	134	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2010	327	5970					1254	1258		10.1126/science.1183112	http://dx.doi.org/10.1126/science.1183112			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20203049	Green Accepted			2022-12-28	WOS:000275162100039
J	Manier, MK; Belote, JM; Berben, KS; Novikov, D; Stuart, WT; Pitnick, S				Manier, Mollie K.; Belote, John M.; Berben, Kirstin S.; Novikov, David; Stuart, Will T.; Pitnick, Scott			Resolving Mechanisms of Competitive Fertilization Success in Drosophila melanogaster	SCIENCE			English	Article							SPERM DISPLACEMENT; MALES; EVOLUTION; STORAGE; FEMALES	Our understanding of postcopulatory sexual selection has been constrained by an inability to discriminate competing sperm of different males, coupled with challenges of directly observing live sperm inside the female reproductive tract. Real-time and spatiotemporal analyses of sperm movement, storage, and use within female Drosophila melanogaster inseminated by two transgenic males with, respectively, green and red sperm heads allowed us to unambiguously discriminate among hypothesized mechanisms underlying sperm precedence, including physical displacement and incapacitation of "resident" sperm by second males, female ejection of sperm, and biased use of competing sperm for fertilization. We find that competitive male fertilization success derives from a multivariate process involving ejaculate-female and ejaculate-ejaculate interactions, as well as complex sperm behavior in vivo.	[Manier, Mollie K.; Belote, John M.; Berben, Kirstin S.; Novikov, David; Stuart, Will T.; Pitnick, Scott] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University	Pitnick, S (corresponding author), Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA.	sspitnic@syr.edu	Manier, Mollie K./I-2069-2019	Manier, Mollie K./0000-0001-9114-8649	NSF [DEB-9806649, DEB-0814732]	NSF(National Science Foundation (NSF))	Supported by the NSF (grants DEB-9806649 and DEB-0814732). We thank S. McClear for assistance with the protamine constructs and M. Wong for technical assistance.	Adams EM, 2007, J INSECT PHYSIOL, V53, P319, DOI 10.1016/j.jinsphys.2006.12.003; Birkhead TR, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P1; Birkhead TR, 1998, SPERM COMPETITION SE; Bjork A, 2007, P ROY SOC B-BIOL SCI, V274, P1779, DOI 10.1098/rspb.2007.0293; Bjork A, 2006, NATURE, V441, P742, DOI 10.1038/nature04683; Civetta A, 1999, CURR BIOL, V9, P841, DOI 10.1016/S0960-9822(99)80370-4; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; GILCHRIST AS, 1995, J INSECT PHYSIOL, V41, P1087, DOI 10.1016/0022-1910(95)00068-6; HARSHMAN LG, 1994, EVOLUTION, V48, P758, DOI [10.2307/2410484, 10.1111/j.1558-5646.1994.tb01359.x]; Holman L, 2009, FUNCT ECOL, V23, P180, DOI 10.1111/j.1365-2435.2008.01509.x; LEFEVRE G, 1962, GENETICS, V42, P1719; Miller GT, 2002, SCIENCE, V298, P1230, DOI 10.1126/science.1076968; Parker G.A., 1984, P1; Parker G.A., 1979, SEXUAL SELECTION REP, P123, DOI DOI 10.1016/B978-0-12-108750-0.50010-0; PARKER GA, 1991, P ROY SOC B-BIOL SCI, V246, P107, DOI 10.1098/rspb.1991.0131; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Pattarini JA, 2006, EVOLUTION, V60, P2064, DOI 10.1111/j.0014-3820.2006.tb01844.x; Pitnick S, 1999, EVOLUTION, V53, P1804, DOI [10.2307/2640442, 10.1111/j.1558-5646.1999.tb04564.x]; Pizzari T, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P207, DOI 10.1016/B978-0-12-372568-4.00006-9; Price CSC, 1999, NATURE, V400, P449, DOI 10.1038/22755; Ram KR, 2007, INTEGR COMP BIOL, V47, P427, DOI 10.1093/icb/icm046; Snook RR, 2004, NATURE, V428, P939, DOI 10.1038/nature02455; Stewart AD, 2007, EVOLUTION, V61, P636, DOI 10.1111/j.1558-5646.2007.00056.x	23	234	236	2	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2010	328	5976					354	357		10.1126/science.1187096	http://dx.doi.org/10.1126/science.1187096			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20299550				2022-12-28	WOS:000276685000037
J	Iglehart, JK				Iglehart, John K.			Historic Passage -- Reform at Last.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		FARRINGTON B, WHITE HOUSE EXPERTS; STOLBERG SG, 2010, NY TIMES        0813, pA1	2	10	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	2010	362	14								10.1056/NEJMp1003376	http://dx.doi.org/10.1056/NEJMp1003376			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	579SN	20335573				2022-12-28	WOS:000276393700004
J	vonHoldt, BM; Pollinger, JP; Lohmueller, KE; Han, EJ; Parker, HG; Quignon, P; Degenhardt, JD; Boyko, AR; Earl, DA; Auton, A; Reynolds, A; Bryc, K; Brisbin, A; Knowles, JC; Mosher, DS; Spady, TC; Elkahloun, A; Geffen, E; Pilot, M; Jedrzejewski, W; Greco, C; Randi, E; Bannasch, D; Wilton, A; Shearman, J; Musiani, M; Cargill, M; Jones, PG; Qian, ZW; Huang, W; Ding, ZL; Zhang, YP; Bustamante, CD; Ostrander, EA; Novembre, J; Wayne, RK				vonHoldt, Bridgett M.; Pollinger, John P.; Lohmueller, Kirk E.; Han, Eunjung; Parker, Heidi G.; Quignon, Pascale; Degenhardt, Jeremiah D.; Boyko, Adam R.; Earl, Dent A.; Auton, Adam; Reynolds, Andy; Bryc, Kasia; Brisbin, Abra; Knowles, James C.; Mosher, Dana S.; Spady, Tyrone C.; Elkahloun, Abdel; Geffen, Eli; Pilot, Malgorzata; Jedrzejewski, Wlodzimierz; Greco, Claudia; Randi, Ettore; Bannasch, Danika; Wilton, Alan; Shearman, Jeremy; Musiani, Marco; Cargill, Michelle; Jones, Paul G.; Qian, Zuwei; Huang, Wei; Ding, Zhao-Li; Zhang, Ya-Ping; Bustamante, Carlos D.; Ostrander, Elaine A.; Novembre, John; Wayne, Robert K.			Genome-wide SNP and haplotype analyses reveal a rich history underlying dog domestication	NATURE			English	Article							LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; ANCIENT DNA; ORIGIN; WILD; SELECTION; GENOTYPE; DELETION	Advances in genome technology have facilitated a new understanding of the historical and genetic processes crucial to rapid phenotypic evolution under domestication(1,2). To understand the process of dog diversification better, we conducted an extensive genome-wide survey of more than 48,000 single nucleotide polymorphisms in dogs and their wild progenitor, the grey wolf. Here we show that dog breeds share a higher proportion of multi-locus haplotypes unique to grey wolves from the Middle East, indicating that they are a dominant source of genetic diversity for dogs rather than wolves from east Asia, as suggested by mitochondrial DNA sequence data(3). Furthermore, we find a surprising correspondence between genetic and phenotypic/functional breed groupings but there are exceptions that suggest phenotypic diversification depended in part on the repeated crossing of individuals with novel phenotypes. Our results show that Middle Eastern wolves were a critical source of genome diversity, although interbreeding with local wolf populations clearly occurred elsewhere in the early history of specific lineages. More recently, the evolution of modern dog breeds seems to have been an iterative process that drew on a limited genetic toolkit to create remarkable phenotypic diversity.	[vonHoldt, Bridgett M.; Pollinger, John P.; Knowles, James C.; Novembre, John; Wayne, Robert K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Lohmueller, Kirk E.; Degenhardt, Jeremiah D.; Boyko, Adam R.; Auton, Adam; Reynolds, Andy; Bryc, Kasia; Brisbin, Abra; Bustamante, Carlos D.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Han, Eunjung] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 14853 USA; [Parker, Heidi G.; Quignon, Pascale; Mosher, Dana S.; Spady, Tyrone C.; Elkahloun, Abdel; Ostrander, Elaine A.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Earl, Dent A.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Geffen, Eli] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Pilot, Malgorzata] Polish Acad Sci, Museum Zool, PL-00679 Warsaw, Poland; [Pilot, Malgorzata] Polish Acad Sci, Inst Zool, PL-00679 Warsaw, Poland; [Jedrzejewski, Wlodzimierz] Polish Acad Sci, Mammal Res Inst, PL-17230 Bialowieza, Poland; [Greco, Claudia; Randi, Ettore] ISPRA, I-40064 Ozzano Emilia B, Italy; [Bannasch, Danika] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Wilton, Alan; Shearman, Jeremy] Univ New S Wales, Clive & Vera Ramaciotti Ctr Gene Funct Anal, Sydney, NSW 2052, Australia; [Wilton, Alan; Shearman, Jeremy] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Musiani, Marco] Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada; [Cargill, Michelle] Affymetrix Corp, Santa Clara, CA 95051 USA; [Jones, Paul G.] WALTHAM Ctr Pet Nutr, Waltham On The Worlds LE14 4RT, Leics, England; [Qian, Zuwei; Huang, Wei] AZIA Ctr, Affymetrix Asia Pacific Sci Affairs & Collaborat, Shanghai 200120, Peoples R China; [Ding, Zhao-Li] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming 650091, Peoples R China; [Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China; [Novembre, John] Univ Calif Los Angeles, Interdepartmental Program Bioinformat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Cornell University; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California Santa Cruz; Tel Aviv University; Polish Academy of Sciences; Polish Academy of Sciences; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; Italian Institute for Environmental Protection & Research (ISPRA); University of California System; University of California Davis; University of New South Wales Sydney; University of New South Wales Sydney; University of Calgary; Affymetrix; Mars; WALTHAM Petcare Science Institute; Yunnan University; Chinese Academy of Sciences; Kunming Institute of Zoology; University of California System; University of California Los Angeles	Wayne, RK (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, 621 Charles E Young Dr S, Los Angeles, CA 90095 USA.	rwayne@ucla.edu	Wilton, Alan N/C-2430-2011; Novembre, John/G-1339-2011; Bannasch, Danika/GZL-8044-2022; Shearman, Jeremy/F-1618-2010; Musiani, Marco/ABB-9387-2021; Greco, Claudia/ABA-6030-2020; Fiumefreddo, Andrea/T-2977-2019	Musiani, Marco/0000-0002-6097-5841; Parker, Heidi G./0000-0002-9707-6380; Pilot, Malgorzata/0000-0002-6057-5768; Bannasch, Danika/0000-0002-7614-7207; Greco, Claudia/0000-0002-8678-0890; Ostrander, Elaine/0000-0001-6075-9738; Bustamante, Carlos D./0000-0002-4187-7920	NSF; NIH; Polish Ministry of Science and Higher Education; European Nature Heritage Fund EURONATUR; National Basic Research Program of China; Chinese Academy of Sciences; Searle Scholars Program; National Human Genome Research Institute; Foundation for Polish Science; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200365, T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083606] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Nature Heritage Fund EURONATUR; National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Searle Scholars Program; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Grants from NSF and NIH (R. K. W.; C. D. B. and J.N.), the Polish Ministry of Science and Higher Education (M. P. and W.J.), European Nature Heritage Fund EURONATUR (W.J.), National Basic Research Program of China (Y.-p.Z.), and Chinese Academy of Sciences (Y.-p.Z.) supported this research. J.N. was supported by the Searle Scholars Program. B.M.vH. was supported by a NIH Training Grant in Genomic Analysis and Interpretation. K. E. L. was supported by a NSF Graduate Research Fellowship. E.A.O., D. S. M., T. C. S., A. E. and H. G. P. are supported by the intramural program of the National Human Genome Research Institute. M. P. was supported by the Foundation for Polish Science. Wolf samples from central and eastern Europe and Turkey were collected as a result of a continuing project on genetic differentiation in Eurasian wolves. We thank the project participants (B. Jedrzejewska, V. E. Sidorovich, M. Shkvyrya, I. Dikiy, E. Tsingarskaya and S. Nowak) for their permission to use 72 samples for this study. We acknowledge R. Hefner and the Zoological collection at Tel Aviv University for Israeli wolf samples. We thank the American Kennel Club (AKC) for the dog images reproduced in Fig. 1. We also gratefully acknowledge the dog owners who generously provided samples, the AKC Canine Health Foundation, and Affymetrix Corporation. We thank B. Van Valkenburgh, K.-P. Koepfli, D. Stahler and D. Smith for reviewing the manuscript.	American Kennel Club, 2006, COMPL DOG BOOK, Vtwentieth; Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; [Anonymous], 2013, INS PESTS POT GLOB, DOI DOI 10.1016/B978-0-12-386895-4.00005-3; Balschun D, 1999, EMBO J, V18, P5264, DOI 10.1093/emboj/18.19.5264; Boyko AR, 2009, P NATL ACAD SCI USA, V106, P13903, DOI 10.1073/pnas.0902129106; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Cruz F, 2008, MOL BIOL EVOL, V25, P2331, DOI 10.1093/molbev/msn177; DAYAN T, 1994, J ARCHAEOL SCI, V21, P633, DOI 10.1006/jasc.1994.1062; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Germonpre M, 2009, J ARCHAEOL SCI, V36, P473, DOI 10.1016/j.jas.2008.09.033; Gray MM, 2009, GENETICS, V181, P1493, DOI 10.1534/genetics.108.098830; Innan H, 2004, P NATL ACAD SCI USA, V101, P10667, DOI 10.1073/pnas.0401720101; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Macdonald D., 1993, MAMMALS BRITAIN EURO; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Parker HG, 2007, GENOME RES, V17, P1562, DOI 10.1101/gr.6772807; Parker HG, 2009, SCIENCE, V325, P995, DOI 10.1126/science.1173275; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Pedrosa S, 2005, P ROY SOC B-BIOL SCI, V272, P2211, DOI 10.1098/rspb.2005.3204; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sablin MV, 2002, CURR ANTHROPOL, V43, P795, DOI 10.1086/344372; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Verginelli F, 2005, MOL BIOL EVOL, V22, P2541, DOI 10.1093/molbev/msi248; Vila C, 2005, TRENDS GENET, V21, P214, DOI 10.1016/j.tig.2005.02.004; Vila C, 1999, J HERED, V90, P71, DOI 10.1093/jhered/90.1.71; Vonholdt BM, 2008, MOL ECOL, V17, P252, DOI 10.1111/j.1365-294X.2007.03468.x; Wilcox B, 1995, ATLAS DOG BREEDS WOR	37	509	521	10	516	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					898	U109		10.1038/nature08837	http://dx.doi.org/10.1038/nature08837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20237475	Green Accepted			2022-12-28	WOS:000276397300039
J	Lane, J				Lane, Julia			Let's make science metrics more scientific	NATURE			English	Editorial Material									Natl Sci Fdn, Sci Sci & Innovat Policy Programme, Arlington, VA 22230 USA	National Science Foundation (NSF)	Lane, J (corresponding author), Natl Sci Fdn, Sci Sci & Innovat Policy Programme, 4201 Wilson Blvd, Arlington, VA 22230 USA.	jlane@nsf.gov		Lane, Julia/0000-0002-8139-2960				CAMPBELL P, 2008, ETHICS SCI ENV POLIT, V8, P5, DOI DOI 10.3354/ESEP00078.CURRY; Curtis B, 2008, GLOB SOC EDUC, V6, P179, DOI 10.1080/14767720802061488; Gibbons R, 1998, J ECON PERSPECT, V12, P115, DOI 10.1257/jep.12.4.115; KERR S, 1975, ACAD MANAGE J, V18, P769, DOI 10.2307/255378; THRASH TM, J PERS SOC IN PRESS	5	155	169	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 25	2010	464	7288					488	489		10.1038/464488a	http://dx.doi.org/10.1038/464488a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	574FL	20336116	Green Submitted			2022-12-28	WOS:000275974200020
J	Haentjens, P; Magaziner, J; Colon-Emeric, CS; Vanderschueren, D; Milisen, K; Velkeniers, B; Boonen, S				Haentjens, Patrick; Magaziner, Jay; Colon-Emeric, Cathleen S.; Vanderschueren, Dirk; Milisen, Koen; Velkeniers, Brigitte; Boonen, Steven			Meta-analysis: Excess Mortality After Hip Fracture Among Older Women and Men	ANNALS OF INTERNAL MEDICINE			English	Review							QUALITY-OF-LIFE; OSTEOPOROTIC FRACTURES; ELDERLY-WOMEN; INTERVENTION THRESHOLDS; OBSERVATIONAL COHORT; GENDER-DIFFERENCES; POST-FRACTURE; HEALTH-STATUS; FEMORAL-NECK; SURVIVAL	Background: Although an increased risk for death after hip fracture is well established, whether this excess mortality persists over time is unclear. Purpose: To determine the magnitude and duration of excess mortality after hip fracture in older men and women. Data Sources: Electronic search of MEDLINE and EMBASE for English and non-English articles from 1957 to May 2009 and manual search of article references. Study Selection: Prospective cohort studies were selected by 2 independent reviewers. The studies had to assess mortality in women ( 22 cohorts) or men ( 17 cohorts) aged 50 years or older with hip fracture, carry out a life-table analysis, and display the survival curves of the hip fracture group and age- and sex-matched control groups. Data Extraction: Survival curve data and items relevant to study validity and generalizability were independently extracted by 2 reviewers. Data Synthesis: Time-to-event meta-analyses showed that the relative hazard for all-cause mortality in the first 3 months after hip fracture was 5.75 (95% CI, 4.94 to 6.67) in women and 7.95 ( CI, 6.13 to 10.30) in men. Relative hazards decreased substantially over time but did not return to rates seen in age- and sex-matched control groups. Through use of life-table methods, investigators estimated that white women having a hip fracture at age 80 years have excess annual mortality compared with white women of the same age without a fracture of 8%, 11%, 18%, and 22% at 1, 2, 5, and 10 years after injury, respectively. Men with a hip fracture at age 80 years have excess annual mortality of 18%, 22%, 26%, and 20% at 1, 2, 5, and 10 years after injury, respectively. Limitations: Cohort studies varied, sometimes markedly, in size, duration of observation, selection of control populations, ascertainment of death, and adjustment for comorbid conditions. Only published data that displayed findings with survival curves were examined. Publication bias was possible. Conclusion: Older adults have a 5- to 8-fold increased risk for all-cause mortality during the first 3 months after hip fracture. Excess annual mortality persists over time for both women and men, but at any given age, excess annual mortality after hip fracture is higher in men than in women.	Univ Ziekenhuis Brussel, Jette, Belgium; Vrije Univ Brussel, Elsene, Belgium; Katholieke Univ Leuven, Louvain, Belgium; Belgian Ctr Evidence Based Med, Louvain, Belgium; Univ Maryland, Baltimore, MD 21201 USA; Duke Univ, Med Ctr, Durham, NC USA; Durham Vet Affairs Med Ctr, Durham, NC USA	University Hospital Brussels; Vrije Universiteit Brussel; KU Leuven; University System of Maryland; University of Maryland Baltimore; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Haentjens, P (corresponding author), Vrije Univ Brussel, Ctr Outcomes Res, Univ Ziekenhuis Brussel, Laarbeeklaan 101, B-1090 Brussels, Belgium.	patrick.haentjens@uzbrussel.be	Haentjens, Patrick/AAE-4764-2021	vanderschueren, dirk/0000-0003-1395-0104; Milisen, Koen/0000-0001-9230-1246	Fund for Scientific Research [G.0488.08]; Leuven University; National Institutes of Health [R01 AG06322, R01 HD0073, R37 AG09901, P60 AG12583]; Paul B. Beeson Award [K23 AG024787]; Willy Gepts Foundation, Universitair Ziekenhuis Brussel; NATIONAL INSTITUTE ON AGING [P60AG012583, K23AG024787, R01AG006322, P30AG028747, R37AG009901] Funding Source: NIH RePORTER	Fund for Scientific Research; Leuven University(KU Leuven); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul B. Beeson Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Willy Gepts Foundation, Universitair Ziekenhuis Brussel; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Fund for Scientific Research and Willy Gepts Foundation, Universitair Ziekenhuis Brussel.; By the Fund for Scientific Research (G.0488.08); Leuven University; National Institutes of Health (R01 AG06322, R01 HD0073, R37 AG09901, and P60 AG12583); the Paul B. Beeson Award (K23 AG024787); and the Willy Gepts Foundation, Universitair Ziekenhuis Brussel.	Arias E, 2004, NATL VITAL STAT REPO, V56; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Boonen S, 2004, OSTEOPOROSIS INT, V15, P87, DOI 10.1007/s00198-003-1515-z; Borenstein M, 2009, INTRO META ANAL; Browner WS, 1996, ARCH INTERN MED, V156, P1521, DOI 10.1001/archinte.156.14.1521; Cauley JA, 2000, OSTEOPOROSIS INT, V11, P556, DOI 10.1007/s001980070075; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; CLAYER MT, 1989, J TRAUMA, V29, P1673, DOI 10.1097/00005373-198912000-00016; COOPER C, 1993, AM J EPIDEMIOL, V137, P1001, DOI 10.1093/oxfordjournals.aje.a116756; Cree M, 2000, J AM GERIATR SOC, V48, P283, DOI 10.1111/j.1532-5415.2000.tb02647.x; DAHL E, 1980, ACTA ORTHOP SCAND, V51, P163, DOI 10.3109/17453678008990781; de Luise C, 2008, EUR J EPIDEMIOL, V23, P115, DOI 10.1007/s10654-007-9211-5; Deeks JJ, 2001, SYSTEMATIC REV HLTH, P285, DOI DOI 10.1002/9780470693926.CH15; DEPALMA L, 1992, ACTA ORTHOP SCAND, V63, P645; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EISKJAER S, 1992, ACTA ORTHOP SCAND, V63, P293, DOI 10.3109/17453679209154785; ELMERSON S, 1988, GERONTOLOGY, V34, P186, DOI 10.1159/000212951; Empana JP, 2004, J AM GERIATR SOC, V52, P685, DOI 10.1111/j.1532-5415.2004.52203.x; Ensrud KE, 2007, J GERONTOL A-BIOL, V62, P744, DOI 10.1093/gerona/62.7.744; Farahmand BY, 2005, OSTEOPOROSIS INT, V16, P1583, DOI 10.1007/s00198-005-2024-z; Ferrucci L, 2004, J AM GERIATR SOC, V52, P625, DOI 10.1111/j.1532-5415.2004.52174.x; Fisher E S, 1991, Epidemiology, V2, P116, DOI 10.1097/00001648-199103000-00005; Fitzpatrick P, 2001, IRISH J MED SCI, V170, P49, DOI 10.1007/BF03167722; Forsen L, 1999, OSTEOPOROSIS INT, V10, P73, DOI 10.1007/s001980050197; Giversen IM, 2007, OSTEOPOROSIS INT, V18, P721, DOI 10.1007/s00198-006-0300-1; Haentjens P, 2001, J BONE JOINT SURG AM, V83A, P493, DOI 10.2106/00004623-200104000-00003; Hamerman D, 1999, ANN INTERN MED, V130, P945, DOI 10.7326/0003-4819-130-11-199906010-00022; Handoll HH., 2002, COCHRANE DB SYST REV, V4, pCD000305, DOI [10.1002/14651858.CD000305, DOI 10.1002/14651858.CD000305]; Hawkes WG, 2006, J GERONTOL A-BIOL, V61, P495, DOI 10.1093/gerona/61.5.495; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HOLMBERG S, 1986, ACTA ORTHOP SCAND, V57, P8, DOI 10.3109/17453678608993205; JACOBSEN SJ, 1992, AM J PUBLIC HEALTH, V82, P1147, DOI 10.2105/AJPH.82.8.1147; JENSEN JS, 1979, ACTA ORTHOP SCAND, V50, P161, DOI 10.3109/17453677908989751; Jitapunkul Sutthichai, 2000, Journal of the Medical Association of Thailand, V83, P1447; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Kanis JA, 2005, BONE, V36, P22, DOI 10.1016/j.bone.2004.08.018; Kanis JA, 2000, OSTEOPOROSIS INT, V11, P120, DOI 10.1007/PL00004173; Katelaris AG, 1996, AM J PUBLIC HEALTH, V86, P557, DOI 10.2105/AJPH.86.4.557; Katz MH, 2003, ANN INTERN MED, V138, P644, DOI 10.7326/0003-4819-138-8-200304150-00012; LIPSEY MW, 2001, APPL SOC RES METHODS, V49; LUYAO GL, 1994, AM J PUBLIC HEALTH, V84, P1287, DOI 10.2105/AJPH.84.8.1287; Magaziner J, 2000, J GERONTOL A-BIOL, V55, pM498, DOI 10.1093/gerona/55.9.M498; Magaziner J, 1997, AM J PUBLIC HEALTH, V87, P1630, DOI 10.2105/AJPH.87.10.1630; MAGAZINER J, 1989, AM J PUBLIC HEALTH, V79, P274, DOI 10.2105/AJPH.79.3.274; Meyer HE, 2000, OSTEOPOROSIS INT, V11, P228, DOI 10.1007/s001980050285; MILLER CW, 1978, J BONE JOINT SURG AM, V60, P930, DOI 10.2106/00004623-197860070-00010; Miller RR, 2006, J GERONTOL A-BIOL, V61, P1053, DOI 10.1093/gerona/61.10.1053; Muraki S, 2006, J BONE MINER METAB, V24, P100, DOI 10.1007/s00774-005-0654-z; Nguyen ND, 2007, J BONE MINER RES, V22, P781, DOI 10.1359/JBMR.070315; Pande I, 2006, ANN RHEUM DIS, V65, P87, DOI 10.1136/ard.2004.034611; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Petersen MB, 2006, INJURY, V37, P705, DOI 10.1016/j.injury.2006.02.046; PITTO RP, 1994, INT ORTHOP, V18, P109, DOI 10.1007/BF02484420; Poor G, 1995, OSTEOPOROSIS INT, V5, P419, DOI 10.1007/BF01626602; POOR G, 1995, J BONE MINER RES, V10, P1900; POOR G, 1995, CLIN ORTHOP RELAT R, P260; Richmond J, 2003, J ORTHOP TRAUMA, V17, P53, DOI 10.1097/00005131-200301000-00008; Robbins JA, 2006, J AM GERIATR SOC, V54, P1885, DOI 10.1111/j.1532-5415.2006.00985.x; Roche JJW, 2005, BMJ-BRIT MED J, V331, P1374, DOI 10.1136/bmj.38643.663843.55; Ryg P, 2009, J BONE MINER RES, V24, P1299, DOI [10.1359/JBMR.090207, 10.1359/jbmr.090207]; Schlesselman JJ, 1997, HUM REPROD, V12, P1851, DOI 10.1093/humrep/12.9.1851; SCHRODER HM, 1993, J ORTHOP TRAUMA, V7, P525, DOI 10.1097/00005131-199312000-00007; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sutton AJAK, 2000, METHODS METAANALYSIS; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tjiang G C, 2003, Ned Tijdschr Geneeskd, V147, P2483; Tosteson ANA, 2007, OSTEOPOROSIS INT, V18, P1463, DOI 10.1007/s00198-007-0429-6; Tosteson ANA, 2001, OSTEOPOROSIS INT, V12, P849, DOI 10.1007/s001980170036; Trombetti A, 2002, OSTEOPOROSIS INT, V13, P731, DOI 10.1007/s001980200100; Tsuboi M, 2007, J BONE JOINT SURG BR, V89B, P461, DOI [10.1302/0301-620X.89B4.18552, 10.1302/0301-620X.89B4]; van Staa T, 1997, AM J MED, V103, P462, DOI 10.1016/S0002-9343(97)00242-8; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Wehren LE, 2003, J BONE MINER RES, V18, P2231, DOI 10.1359/jbmr.2003.18.12.2231; Williamson PR, 2002, STAT MED, V21, P2613, DOI 10.1002/sim.1044; Willig R, 2001, PUBLIC HEALTH, V115, P323, DOI 10.1038/sj.ph.1900773	78	827	850	1	48	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	2010	152	6					380	+		10.7326/0003-4819-152-6-201003160-00008	http://dx.doi.org/10.7326/0003-4819-152-6-201003160-00008			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	573IF	20231569	Green Accepted			2022-12-28	WOS:000275905200006
J	Melnikow, J				Melnikow, Joy			Review: Tamoxifen, raloxifene, and tibolone prevent primary invasive breast cancer but increase risk for adverse outcomes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calif Davis, Sacramento, CA 95817 USA	University of California System; University of California Davis	Melnikow, J (corresponding author), Univ Calif Davis, Sacramento, CA 95817 USA.							Melnikow J, 2008, MED CARE, V46, P946, DOI 10.1097/MLR.0b013e318179250f; Melnikow J, 2006, CANCER-AM CANCER SOC, V107, P950, DOI 10.1002/cncr.22075	2	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	2010	152	6							JC3-4	10.7326/0003-4819-152-6-201003160-02004	http://dx.doi.org/10.7326/0003-4819-152-6-201003160-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573IF	20231558				2022-12-28	WOS:000275905200021
J	Roth, AE; Benn, CS; Ravn, H; Rodrigues, A; Lisse, IM; Yazdanbakhsh, M; Whittle, H; Aaby, P				Roth, Adam Edvin; Benn, Christine Stabell; Ravn, Henrik; Rodrigues, Amabelia; Lisse, Ida Maria; Yazdanbakhsh, Maria; Whittle, Hilton; Aaby, Peter			Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VITAMIN-A SUPPLEMENTATION; DIPHTHERIA-TETANUS-PERTUSSIS; FEMALE-MALE MORTALITY; ROUTINE VACCINATIONS; MEASLES IMMUNIZATION; TUBERCULIN REACTION; VACCINE; SURVIVAL; SCAR; MORBIDITY	Objective To determine whether BCG revaccination at 19 months of age reduces overall child mortality. Design Randomised trial, with follow-up to age 5. Setting A health project in Bissau, Guinea-Bissau, which maintains a health and demographic surveillance system in an urban area with 90 000 inhabitants. Participants 2871 children aged 19 months to 5 years with low or no reactivity to tuberculin and who were not severely sick on the day of enrolment. Intervention BCG vaccination or no vaccination (control). Main outcome measure Hazard ratios for mortality. Results 77 children died during follow-up. Compared with controls, the BCG revaccinated children had a hazard ratio of 1.20 (95% confidence interval 0.77 to 1.89). Two hundred and fifty children were admitted to hospital for the first time between enrolment and the end of the study, with an incidence rate ratio for BCG revaccinated children versus controls of 1.04 (0.81 to 1.33). The trial was stopped prematurely because of a cluster of deaths in the BCG arm of the study. This increase in mortality occurred at a time when many children had received missing vaccinations or vitamin A or iron supplementation; the hazard ratio for BCG revaccinated children compared with controls was 2.69 (1.05 to 6.88) in the period after these campaigns. Throughout the trial, the effect of BCG revaccination on mortality was significantly different (P=0.006) in children who had received diphtheria-tetanus-pertussis (DTP) booster vaccination before enrolment (hazard ratio 0.36, 0.13 to 0.99) and children who had not received the booster before enrolment (1.78, 1.04 to 3.04). Conclusions There was no overall beneficial effect of being revaccinated with BCG. The effect of BCG revaccination on mortality might depend on other health interventions.	[Benn, Christine Stabell; Ravn, Henrik; Aaby, Peter] Statens Serum Inst, Bandim Hlth Project, Danish Epidemiol Sci Ctr, DK-2300 Copenhagen S, Denmark; [Roth, Adam Edvin; Rodrigues, Amabelia; Aaby, Peter] Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau; [Roth, Adam Edvin] Lund Univ, Dept Med Microbiol, S-20502 Malmo, Sweden; [Lisse, Ida Maria] Herlev Univ Hosp, Dept Pathol, DK-2730 Herlev, Denmark; [Yazdanbakhsh, Maria] Leiden Univ, Dept Parasitol, NL-2300 RA Leiden, Netherlands; [Whittle, Hilton] MRC Labs, Fajara, Gambia	Aarhus University; Statens Serum Institut; Lund University; University of Copenhagen; Herlev & Gentofte Hospital; Leiden University; Leiden University - Excl LUMC; MRC Laboratory Molecular Biology	Aaby, P (corresponding author), Statens Serum Inst, Bandim Hlth Project, Danish Epidemiol Sci Ctr, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	p.aaby@bandim.org	Yazdanbakhsh, Maria/AAI-3996-2020	Yazdanbakhsh, Maria/0000-0002-7666-1441; Aaby, Peter/0000-0001-8331-1389	EU [ICA4-CT-2002-10053]; Danish National Research Foundation; DANIDA; Novo Nordisk Foundation	EU(European Commission); Danish National Research Foundation(Danmarks Grundforskningsfond); DANIDA; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The study was funded by the EU (ICA4-CT-2002-10053) and the Danish National Research Foundation. The Bandim Health Project received support from DANIDA. PA holds a research professorship grant from the Novo Nordisk Foundation. The funding agencies had no role in the study design, data collection, data analysis, data interpretation, or the writing of the report.	Aaby P, 2004, INT J EPIDEMIOL, V33, P374, DOI 10.1093/ije/dyh005; AABY P, 1995, BRIT MED J, V311, P481, DOI 10.1136/bmj.311.7003.481; Aaby P, 2003, LANCET, V361, P2183, DOI 10.1016/S0140-6736(03)13771-3; Aaby P, 2002, VACCINE, V21, P15, DOI 10.1016/S0264-410X(02)00441-3; Aaby P, 2007, PEDIATR INFECT DIS J, V26, P247, DOI 10.1097/01.inf.0000256735.05098.01; Aaby P, 2006, VACCINE, V24, P4701, DOI 10.1016/j.vaccine.2006.03.038; Andersen P. K., 2012, STAT MODELS BASED CO; ARONSON JD, 1948, AM REV TUBERC PULM, V58, P255; Aydinlioglu H, 1993, Paediatr Perinat Epidemiol, V7, P334, DOI 10.1111/j.1365-3016.1993.tb00408.x; Benn CS, 2009, AM J CLIN NUTR, V90, P629, DOI 10.3945/ajcn.2009.27477; Benn CS, 2008, BMJ-BRIT MED J, V336, P1416, DOI 10.1136/bmj.39542.509444.AE; Benn CS, 2009, VACCINE, V27, P2891, DOI 10.1016/j.vaccine.2009.02.080; Benn CS, 2009, INT J EPIDEMIOL, V38, P304, DOI 10.1093/ije/dyn195; Benn CS, 2005, BMJ-BRIT MED J, V331, P1428, DOI 10.1136/bmj.38670.639340.55; Benn CS, 2003, INT J EPIDEMIOL, V32, P822, DOI 10.1093/ije/dyg208; Breiman RF, 2004, LANCET, V364, P2204, DOI 10.1016/S0140-6736(04)17593-4; da Silva ZJ, 2008, AIDS, V22, P1195, DOI 10.1097/QAD.0b013e328300a33d; Fine PEM, 1996, LANCET, V348, P17, DOI 10.1016/S0140-6736(96)02166-6; Fisker AB, 2007, AM J CLIN NUTR, V86, P1032, DOI 10.1093/ajcn/86.4.1032; FOURIE PB, 1987, S AFR MED J, V72, P323; Garly ML, 2004, PEDIATR INFECT DIS J, V23, P1086, DOI 10.1097/01.inf.0000145700.77286.94; Garly ML, 2003, VACCINE, V21, P2782, DOI 10.1016/S0264-410X(03)00181-6; Gustafson P, 2004, INT J EPIDEMIOL, V33, P163, DOI 10.1093/ije/dyh026; Gustafson P, 2001, JAMA-J AM MED ASSOC, V286, P599, DOI 10.1001/jama.286.5.599; Hesseling AC, 2006, CLIN INFECT DIS, V42, P548, DOI 10.1086/499953; Ildirim I, 1995, PEDIATR INFECT DIS J, V14, P1060, DOI 10.1097/00006454-199512000-00006; Jensen H, 2007, TROP MED INT HEALTH, V12, P5, DOI 10.1111/j.1365-3156.2006.01773.x; Knudsen KM, 1996, INT J EPIDEMIOL, V25, P665, DOI 10.1093/ije/25.3.665; Kohl KS, 2007, VACCINE, V25, P5821, DOI 10.1016/j.vaccine.2007.04.057; LEVINE MI, 1946, AM REV TUBERC PULM, V53, P517; Martins CL, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a661; *MED RES COUNC TUB, 1959, BMJ-BRIT MED J, V2, P379; Naeslund C., 1932, RESULTATS EXPERIENCE; Rahman M, 2002, PREV MED, V35, P70, DOI 10.1006/pmed.2002.1043; Rodrigues A, 2008, TROP MED INT HEALTH, V13, P410, DOI 10.1111/j.1365-3156.2008.02016.x; Rodrigues A, 2007, TROP MED INT HEALTH, V12, P224, DOI 10.1111/j.1365-3165.2006.01766.x; Rodrigues LC, 2005, LANCET, V366, P1290, DOI 10.1016/S0140-6736(05)67145-0; ROSENTHAL S, 1961, AM REV RESPIR DIS, V84, P690; Roth A, 2005, INT J EPIDEMIOL, V34, P540, DOI 10.1093/ije/dyh392; Roth A, 2006, EXPERT REV VACCINES, V5, P277, DOI 10.1586/14760584.5.2.277; Roth A, 2006, EPIDEMIOLOGY, V17, P562, DOI 10.1097/01.ede.0000231546.14749.ab; Seng R, 2002, AIDS, V16, P1059, DOI 10.1097/00002030-200205030-00013; SERGENT Ed., 1960, Arch. Inst. Pasteur d'Algerie, V38, P131; SERGENT EDMOND, 1954, ARCH INST PASTEUR ALGERIE, V32, P1; SHAABAN MA, 1990, EUR RESPIR J, V3, P187; Tala-Heikkila M, 1991, Bull Int Union Tuberc Lung Dis, V66, P57; Veirum JE, 2005, VACCINE, V23, P1197, DOI 10.1016/j.vaccine.2004.02.053	47	71	72	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2010	340								c671	10.1136/bmj.c671	http://dx.doi.org/10.1136/bmj.c671			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573RA	20231251	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000275931100010
J	Horton, R				Horton, Richard			Offline: The facts on the ground	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.								0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 13	2010	375	9718					878	878		10.1016/S0140-6736(10)60362-5	http://dx.doi.org/10.1016/S0140-6736(10)60362-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	574NA	20226973				2022-12-28	WOS:000275995300011
J	Ito, T; Ando, H; Suzuki, T; Ogura, T; Hotta, K; Imamura, Y; Yamaguchi, Y; Handa, H				Ito, Takumi; Ando, Hideki; Suzuki, Takayuki; Ogura, Toshihiko; Hotta, Kentaro; Imamura, Yoshimasa; Yamaguchi, Yuki; Handa, Hiroshi			Identification of a Primary Target of Thalidomide Teratogenicity	SCIENCE			English	Article							UBIQUITIN LIGASE; MULTIPLE-MYELOMA; LIMB DEFECTS; DNA-DAMAGE; OUTGROWTH; EXPRESSION; ZEBRAFISH; PATHWAY; ORIGIN; CELLS	Half a century ago, thalidomide was widely prescribed to pregnant women as a sedative but was found to be teratogenic, causing multiple birth defects. Today, thalidomide is still used in the treatment of leprosy and multiple myeloma, although how it causes limb malformation and other developmental defects is unknown. Here, we identified cereblon (CRBN) as a thalidomide-binding protein. CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 (DDB1) and Cul4A that is important for limb outgrowth and expression of the fibroblast growth factor Fgf8 in zebrafish and chicks. Thalidomide initiates its teratogenic effects by binding to CRBN and inhibiting the associated ubiquitin ligase activity. This study reveals a basis for thalidomide teratogenicity and may contribute to the development of new thalidomide derivatives without teratogenic activity.	[Ito, Takumi; Handa, Hiroshi] Tokyo Inst Technol, Integrated Res Inst, Yokohama, Kanagawa 2268503, Japan; [Ando, Hideki; Hotta, Kentaro; Yamaguchi, Yuki; Handa, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; [Suzuki, Takayuki; Ogura, Toshihiko] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Suzuki, Takayuki] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Imamura, Yoshimasa] Astellas Pharma Inc, Drug Discovery Res, Tsukuba 3058585, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; Tohoku University; Japan Science & Technology Agency (JST); Astellas Pharmaceuticals	Handa, H (corresponding author), Tokyo Inst Technol, Integrated Res Inst, Yokohama, Kanagawa 2268503, Japan.	handa.h.aa@m.titech.ac.jp	Yamaguchi, Yuki/B-9390-2015	Yamaguchi, Yuki/0000-0002-0197-614X; Ito, Takumi/0000-0002-9997-2664	JST; Japan Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [20370084, 21770226]; New Energy and Technology Development Organization	JST(Japan Science & Technology Agency (JST)); Japan Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Technology Development Organization	We thank T. Wada, S. Sakamoto, and S. Ishihara for discussions; P. Raychaudhuri, T. Matsunaga, S. Krauss, B. Thisse, A. Kawakami, S. Noji, J. Izpisua-Belmonte, K. Kawakami, and J. Yamauchi for valuable reagents; Y. Tsuboi for technical support; and P. Sharp and A. Berk for comments on this manuscript. This work was supported by Special Coordination Funds for Promoting Science and Technology from JST, by the Global COE (Center of Excellence) Program from the Japan Ministry of Education, Culture, Sports, Science, and Technology (MEXT), and by a grant for Research and Development Projects in Cooperation with Academic Institutions from the New Energy and Technology Development Organization (H. H. and H. A.). This work was also supported by grants-in-aid for Scientific Research (20370084 to T. O.) and for Young Scientists (21770226 to T. S.) from MEXT and by the Precursory Research for Embryonic Science and Technology program from JST (T. S.). T. I. was a Japan Society for the Promotion of Science Research Fellow. An application for a patent has been filed in the Japan Patent Office.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Cang Y, 2007, P NATL ACAD SCI USA, V104, P2733, DOI 10.1073/pnas.0611311104; Cang Y, 2006, CELL, V127, P929, DOI 10.1016/j.cell.2006.09.045; Chung F, 2004, CLIN CANCER RES, V10, P5949, DOI 10.1158/1078-0432.CCR-04-0421; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Davis MC, 2007, NATURE, V447, P473, DOI 10.1038/nature05838; Franks ME, 2004, LANCET, V363, P1802, DOI 10.1016/S0140-6736(04)16308-3; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Gupta D, 2001, LEUKEMIA, V15, P1950, DOI 10.1038/sj.leu.2402295; Hansen JM, 2002, DEV DYNAM, V225, P186, DOI 10.1002/dvdy.10150; HIGGINS JJ, 1927, NEUROLOGY, V63, P2004; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Knobloch J, 2008, CELL CYCLE, V7, P1121, DOI 10.4161/cc.7.9.5793; Knobloch J, 2007, FASEB J, V21, P1410, DOI 10.1096/fj.06-7603com; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Melchert M, 2007, INT J BIOCHEM CELL B, V39, P1489, DOI 10.1016/j.biocel.2007.01.022; Miller MT, 1999, TERATOLOGY, V60, P306, DOI 10.1002/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y; Moon AM, 2000, NAT GENET, V26, P455, DOI 10.1038/82601; MOREIRA AL, 1993, J EXP MED, V177, P1675, DOI 10.1084/jem.177.6.1675; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Pajni-Underwood S, 2007, DEVELOPMENT, V134, P2359, DOI 10.1242/dev.001677; Parman T, 1999, NAT MED, V5, P582, DOI 10.1038/8466; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Sakamoto S, 2009, CHEM REC, V9, P66, DOI 10.1002/tcr.20170; SHESKIN J, 1965, CLIN PHARMACOL THER, V6, P303; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Streit A, 2001, J ANAT, V199, P99, DOI 10.1017/S0021878201008263; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Tanaka M, 2002, NATURE, V416, P527, DOI 10.1038/416527a; Therapontos C, 2009, P NATL ACAD SCI USA, V106, P8573, DOI 10.1073/pnas.0901505106; Veldman MB, 2008, PEDIATR RES, V64, P470, DOI 10.1203/PDR.0b013e318186e609; Yabu T, 2005, BLOOD, V106, P125, DOI 10.1182/blood-2004-09-3679; Zeldis JB, 1999, CLIN THER, V21, P319, DOI 10.1016/S0149-2918(00)88289-2	36	1165	1251	21	379	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1345	1350		10.1126/science.1177319	http://dx.doi.org/10.1126/science.1177319			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223979				2022-12-28	WOS:000275418700032
J	Thomas, DJB; Skelton-Robinson, M				Thomas, D. J. B.; Skelton-Robinson, Martin			A Patient's Journey Recovering from severe brain injury	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Thomas, D. J. B.; Skelton-Robinson, Martin] Hillingdon Hosp NHS Trust, Uxbridge UB8 3NN, Middx, England		Thomas, DJB (corresponding author), Hillingdon Hosp NHS Trust, Uxbridge UB8 3NN, Middx, England.	drdthomas678@btinternet.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 11	2010	340								c839	10.1136/bmj.c839	http://dx.doi.org/10.1136/bmj.c839			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570FE	20223871				2022-12-28	WOS:000275656900014
J	Segev, DL; Muzaale, AD; Caffo, BS; Mehta, SH; Singer, AL; Taranto, SE; McBride, MA; Montgomery, RA				Segev, Dorry L.; Muzaale, Abimereki D.; Caffo, Brian S.; Mehta, Shruti H.; Singer, Andrew L.; Taranto, Sarah E.; McBride, Maureen A.; Montgomery, Robert A.			Perioperative Mortality and Long-term Survival Following Live Kidney Donation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SURGICAL MORTALITY; DONOR NEPHRECTOMY; UNITED-STATES; LIVING DONOR; RACE; CHOLECYSTECTOMY; TRANSPLANTATION; COMPLICATIONS; MORBIDITY	Context More than 6000 healthy US individuals every year undergo nephrectomy for the purposes of live donation; however, safety remains in question because longitudinal outcome studies have occurred at single centers with limited generalizability. Objectives To study national trends in live kidney donor selection and outcome, to estimate short-term operative risk in various strata of live donors, and to compare long-term death rates with a matched cohort of nondonors who are as similar to the donor cohort as possible and as free as possible from contraindications to live donation. Design, Setting, and Participants Live donors were drawn from a mandated national registry of 80 347 live kidney donors in the United States between April 1, 1994, and March 31, 2009. Median (interquartile range) follow-up was 6.3 (3.2-9.8) years. A matched cohort was drawn from 9364 participants of the third National Health and Nutrition Examination Survey (NHANES III) after excluding those with contraindications to kidney donation. Main Outcome Measures Surgical mortality and long-term survival. Results There were 25 deaths within 90 days of live kidney donation during the study period. Surgical mortality from live kidney donation was 3.1 per 10 000 donors (95% confidence interval [CI], 2.0-4.6) and did not change during the last 15 years despite differences in practice and selection. Surgical mortality was higher in men than in women (5.1 vs 1.7 per 10 000 donors; risk ratio [RR], 3.0; 95% CI, 1.3-6.9; P=.007), in black vs white and Hispanic individuals (7.6 vs 2.6 and 2.0 per 10 000 donors; RR, 3.1; 95% CI, 1.3-7.1; P=.01), and in donors with hypertension vs without hypertension (36.7 vs 1.3 per 10 000 donors; RR, 27.4; 95% CI, 5.0-149.5; P < .001). However, long-term risk of death was no higher for live donors than for age-and comorbidity-matched NHANES III participants for all patients and also stratified by age, sex, and race. Conclusion Among a cohort of live kidney donors compared with a healthy matched cohort, the mortality rate was not significantly increased after a median of 6.3 years. JAMA. 2010;303(10):959-966	[Segev, Dorry L.; Muzaale, Abimereki D.; Singer, Andrew L.; Montgomery, Robert A.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Segev, Dorry L.; Muzaale, Abimereki D.; Mehta, Shruti H.] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Caffo, Brian S.] Johns Hopkins Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Taranto, Sarah E.; McBride, Maureen A.] United Network Organ Sharing, Richmond, VA USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; United Network for Organ Sharing	Segev, DL (corresponding author), Johns Hopkins Med Inst, Dept Surg, 720 Rutland Ave,Ross 771B, Baltimore, MD 21205 USA.	dorry@jhmi.edu			Health Resources and Services Administration [234-2005-370011C]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K25EB003491] Funding Source: NIH RePORTER	Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The Organ Procurement and Transplantation Network (OPTN) is supported by Health Resources and Services Administration contract 234-2005-370011C. To ensure confidentiality of Social Security number data provided to the OPTN, the Social Security number linkages to Social Security Death Master File were performed solely by United Network for Organ Sharing staff (including Dr McBride and Ms Taranto).	Andersen B, 1968, Scand J Urol Nephrol, V2, P91, DOI 10.3109/00365596809136977; BAY WH, 1987, ANN INTERN MED, V106, P719, DOI 10.7326/0003-4819-106-5-719; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Delmonico FL, 2007, KIDNEY INT, V71, P608, DOI 10.1038/sj.ki.5002125; Delmonico FL, 2005, TRANSPLANTATION, V79, pS53; FehrmanEkholm I, 1997, TRANSPLANTATION, V64, P976, DOI 10.1097/00007890-199710150-00007; Friedman AL, 2006, ANN SURG, V243, P126, DOI 10.1097/01.sla.0000193841.43474.ec; Garg AX, 2006, KIDNEY INT, V70, P1801, DOI 10.1038/sj.ki.5001819; Goldfarb DA, 2001, J UROLOGY, V166, P2043, DOI 10.1016/S0022-5347(05)65502-4; Ibrahim HN, 2009, NEW ENGL J MED, V360, P459, DOI 10.1056/NEJMoa0804883; Johnson EM, 1997, TRANSPLANTATION, V64, P1124, DOI 10.1097/00007890-199710270-00007; Lucas FL, 2006, ANN SURG, V243, P281, DOI 10.1097/01.sla.0000197560.92456.32; Matas AJ, 2003, AM J TRANSPLANT, V3, P830, DOI 10.1034/j.1600-6143.2003.00126.x; NAJARIAN JS, 1992, LANCET, V340, P807, DOI 10.1016/0140-6736(92)92683-7; Nathan H, 2008, J AM COLL SURGEONS, V207, P312, DOI 10.1016/j.jamcollsurg.2008.04.015; Nguyen GC, 2008, CLIN GASTROENTEROL H, V6, P1146, DOI 10.1016/j.cgh.2008.05.024; Okamoto M, 2009, TRANSPLANTATION, V87, P419, DOI 10.1097/TP.0b013e318192dc95; Poggio ED, 2009, CLIN J AM SOC NEPHRO, V4, P1677, DOI 10.2215/CJN.02740409; Ratner LE, 1997, TRANSPL P, V29, P138, DOI 10.1016/S0041-1345(96)00037-1; Schulam PG, 1996, J UROLOGY, V155, P1857, DOI 10.1016/S0022-5347(01)66029-4; Sheikh K, 2007, ANN VASC SURG, V21, P496, DOI 10.1016/j.avsg.2007.03.029; STEINER CA, 1994, NEW ENGL J MED, V330, P403, DOI 10.1056/NEJM199402103300607; Turrentine FE, 2006, J AM COLL SURGEONS, V203, P865, DOI 10.1016/j.jamcollsurg.2006.08.026	23	493	504	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2010	303	10					959	966		10.1001/jama.2010.237	http://dx.doi.org/10.1001/jama.2010.237			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	565UC	20215610	Bronze			2022-12-28	WOS:000275319300023
J	Murakami, H; Tamasawa, N; Yamashita, M; Takayasu, S; Nigawara, T; Matsui, J; Suda, T				Murakami, Hiroshi; Tamasawa, Naoki; Yamashita, Maki; Takayasu, Shinobu; Nigawara, Takeshi; Matsui, Jun; Suda, Toshihiro			Altered pain perception in schizophrenia	LANCET			English	Editorial Material									[Murakami, Hiroshi; Tamasawa, Naoki; Yamashita, Maki; Takayasu, Shinobu; Nigawara, Takeshi; Matsui, Jun; Suda, Toshihiro] Hirosaki Univ, Grad Sch Med, Dept Endocrinol & Metab, Aomori 0368562, Japan	Hirosaki University	Murakami, H (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Endocrinol & Metab, 5 Zaifucho, Aomori 0368562, Japan.	hiroshi@zj8.so-net.ne.jp	Takayasu, Shinobu/ABH-9199-2020					MARCHAND WE, 1959, NEW ENGL J MED, V260, P580, DOI 10.1056/NEJM195903192601203; Potvin S, 2008, J PSYCHIATR RES, V42, P1010, DOI 10.1016/j.jpsychires.2007.11.001; Rouillon F, 2005, EUR PSYCHIAT, V20, pS345, DOI 10.1016/S0924-9338(05)80189-0; Tsai SH, 2008, AM J SURG, V196, P34, DOI 10.1016/j.amjsurg.2007.05.042; Virit O, 2008, GEN HOSP PSYCHIAT, V30, P384, DOI 10.1016/j.genhosppsych.2008.01.005	5	24	25	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 6	2010	375	9717					864	864		10.1016/S0140-6736(09)62061-4	http://dx.doi.org/10.1016/S0140-6736(09)62061-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570MO	20206779				2022-12-28	WOS:000275682600036
J	Noto, T; Kurth, HM; Kataoka, K; Aronica, L; DeSouza, LV; Siu, KWM; Pearlman, RE; Gorovsky, MA; Mochizuki, K				Noto, Tomoko; Kurth, Henriette M.; Kataoka, Kensuke; Aronica, Lucia; DeSouza, Leroi V.; Siu, K. W. Michael; Pearlman, Ronald E.; Gorovsky, Martin A.; Mochizuki, Kazufumi			The Tetrahymena Argonaute-Binding Protein Giw1p Directs a Mature Argonaute-siRNA Complex to the Nucleus	CELL			English	Article							PROGRAMMED DNA ELIMINATION; PASSENGER-STRAND CLEAVAGE; DICER-LIKE PROTEIN; SMALL RNAS; GENOME REARRANGEMENT; HISTONE H3; METHYLATION; FAMILY; SLICER; INVOLVEMENT	Emerging evidence suggests that RNA interference (RNAi)-related processes act both in the cytoplasm and in the nucleus. However, the process by which the RNAi machinery is transported into the nucleus remains poorly understood. The Tetrahymena Argonaute protein Twi1p localizes to the nucleus and is crucial for small RNA-directed programmed DNA elimination. In this study, we identify Giw1p, which binds to Twi1p and is required for its nuclear localization. Furthermore, the endoribonuclease ( Slicer) activity of Twi1p plays a vital role in the removal of one of the two strands of Twi1p-associated small interfering RNAs (siRNAs), leading to a functionally mature Twi1p-siRNA complex. Slicer activity is also shown to be required for nuclear localization of Twi1p and for its association with Giw1p. These results suggest that Giw1p senses the state of Twi1p-associated siRNAs and selectively transports the mature Twi1p-siRNA complex into the nucleus.	[Noto, Tomoko; Kurth, Henriette M.; Kataoka, Kensuke; Aronica, Lucia; Mochizuki, Kazufumi] Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; [DeSouza, Leroi V.; Siu, K. W. Michael] York Univ, Dept Chem, N York, ON M3J 1P3, Canada; [Pearlman, Ronald E.] York Univ, Dept Biol, N York, ON M3J 1P3, Canada; [DeSouza, Leroi V.; Siu, K. W. Michael; Pearlman, Ronald E.] York Univ, Ctr Res Mass Spectrometry, N York, ON M3J 1P3, Canada; [Gorovsky, Martin A.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); York University - Canada; York University - Canada; York University - Canada; University of Rochester	Mochizuki, K (corresponding author), Austrian Acad Sci, IMBA, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	kazufumi.mochizuki@imba.oeaw.ac.at	Mochizuki, Kazufumi/AAW-4382-2020; Kataoka, Kensuke/D-1877-2016; Aronica, Lucia/P-7255-2019; DeSouza, Leroi V/H-3831-2013; Mochizuki, Kazufumi/A-5686-2016	Mochizuki, Kazufumi/0000-0001-7987-9852; Kataoka, Kensuke/0000-0001-6113-289X; Aronica, Lucia/0000-0002-8991-4858; Mochizuki, Kazufumi/0000-0001-7987-9852	European Research Council (ERC) [MEST-CE-2005-019676]; Canadian Institutes for Health Research [MOP13347]; National Institutes of Health [GM21793, GM72752]; ERC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021793, R01GM072752] Funding Source: NIH RePORTER	European Research Council (ERC)(European Research Council (ERC)European Commission); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Leemor Joshua-Tor for E. coli strain expressing GST-hAgo2, Kathy Karrer for Tlr1 clones, and Tim Clausen, Javier Martinez, Thomas Marlovits, Josef Loidl, Stefan Westermann, and their laboratories for materials and technical advice. The research leading to these results received funding from the European Research Council (ERC) Marie Curie Action "Early Stage Training'' (MEST-CE-2005-019676) under the European Community's Sixth Framework Programme to H. M. K. and L. A., from the Ontario Research and Development Challenge Fund and MDS SCIEX to K.W.M.S., from a Canadian Institutes for Health Research grant (MOP13347) to R.E.P., from National Institutes of Health grants GM21793 and GM72752 to M.A.G., from an ERC Starting Grant	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; Bednenko J, 2009, MOL CELL BIOL, V29, P5020, DOI 10.1128/MCB.00076-09; Bowman GR, 2005, J EUKARYOT MICROBIOL, V52, P291, DOI 10.1111/j.1550-7408.2005.00045.x; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Chalker DL, 2001, GENE DEV, V15, P1287, DOI 10.1101/gad.884601; Couvillion MT, 2009, GENE DEV, V23, P2016, DOI 10.1101/gad.1821209; Cox DN, 2000, DEVELOPMENT, V127, P503; Coyne RS, 1999, MOL CELL, V4, P865, DOI 10.1016/S1097-2765(00)80396-2; Fillingham JS, 2004, EUKARYOT CELL, V3, P157, DOI 10.1128/EC.3.1.157-169.2004; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Kurth HM, 2009, RNA, V15, P675, DOI 10.1261/rna.1455509; Lee SR, 2006, GENE DEV, V20, P28, DOI 10.1101/gad.1377006; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Loidl J, 2004, J CELL SCI, V117, P5791, DOI 10.1242/jcs.01504; Maiti M, 2007, GENE DEV, V21, P590, DOI 10.1101/gad.1497607; Malone CD, 2005, MOL CELL BIOL, V25, P9151, DOI 10.1128/MCB.25.20.9151-9164.2005; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Mochizuki K, 2005, GENE DEV, V19, P77, DOI 10.1101/gad.1265105; Mochizuki K, 2004, GENE DEV, V18, P2068, DOI 10.1101/gad.1219904; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Sigova A, 2004, GENE DEV, V18, P2359, DOI 10.1101/gad.1218004; Steiner FA, 2009, NAT STRUCT MOL BIOL, V16, P207, DOI 10.1038/nsmb.1541; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Weinmann L, 2009, CELL, V136, P496, DOI 10.1016/j.cell.2008.12.023; Wuitschick JD, 2002, NUCLEIC ACIDS RES, V30, P2524, DOI 10.1093/nar/30.11.2524; Yao MC, 2003, SCIENCE, V300, P1581, DOI 10.1126/science.1084737; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603	44	65	66	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					692	703		10.1016/j.cell.2010.02.010	http://dx.doi.org/10.1016/j.cell.2010.02.010			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211138	Bronze, Green Accepted			2022-12-28	WOS:000275197400018
J	Kaandorp, SP; Goddijn, M; van der Post, JAM; Hutten, BA; Verhoeve, HR; Hamulyak, K; Mol, B; Folkeringa, N; Nahuis, M; Papatsonis, DNM; Buller, HR; van der Veen, F; Middeldorp, S				Kaandorp, Stef P.; Goddijn, Mariette; van der Post, Joris A. M.; Hutten, Barbara A.; Verhoeve, Harold R.; Hamulyak, Karly; Mol, Ben Willem; Folkeringa, Nienke; Nahuis, Marleen; Papatsonis, Dimitri N. M.; Buller, Harry R.; van der Veen, Fulco; Middeldorp, Saskia			Aspirin plus Heparin or Aspirin Alone in Women with Recurrent Miscarriage	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREGNANCY COMPLICATIONS; CONTROLLED-TRIAL; THROMBOPHILIA; ANTIBODIES; RISK	BACKGROUND Aspirin and low-molecular-weight heparin are prescribed for women with unexplained recurrent miscarriage, with the goal of improving the rate of live births, but limited data from randomized, controlled trials are available to support the use of these drugs. METHODS In this randomized trial, we enrolled 364 women between the ages of 18 and 42 years who had a history of unexplained recurrent miscarriage and were attempting to conceive or were less than 6 weeks pregnant. We then randomly assigned them to receive daily 80 mg of aspirin plus open-label subcutaneous nadroparin (at a dose of 2850 IU, starting as soon as a viable pregnancy was demonstrated), 80 mg of aspirin alone, or placebo. The primary outcome measure was the live-birth rate. Secondary outcomes included rates of miscarriage, obstetrical complications, and maternal and fetal adverse events. RESULTS Live-birth rates did not differ significantly among the three study groups. The proportions of women who gave birth to a live infant were 54.5% in the group receiving aspirin plus nadroparin (combination-therapy group), 50.8% in the aspirin-only group, and 57.0% in the placebo group (absolute difference in live-birth rate: combination therapy vs. placebo, -2.6 percentage points; 95% confidence interval [CI], -15.0 to 9.9; aspirin only vs. placebo, -6.2 percentage points; 95% CI, -18.8 to 6.4). Among 299 women who became pregnant, the live-birth rates were 69.1% in the combination-therapy group, 61.6% in the aspirin-only group, and 67.0% in the placebo group (absolute difference in live-birth rate: combination therapy vs. placebo, 2.1 percentage points; 95% CI, -10.8 to 15.0; aspirin alone vs. placebo -5.4 percentage points; 95% CI, -18.6 to 7.8). An increased tendency to bruise and swelling or itching at the injection site occurred significantly more frequently in the combination-therapy group than in the other two study groups. CONCLUSIONS Neither aspirin combined with nadroparin nor aspirin alone improved the live-birth rate, as compared with placebo, among women with unexplained recurrent miscarriage. (Current Controlled Trials number, ISRCTN58496168.)	[Goddijn, Mariette; van der Veen, Fulco] Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, NL-1100 DE Amsterdam, Netherlands; [Kaandorp, Stef P.; van der Post, Joris A. M.] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynecol, NL-1100 DE Amsterdam, Netherlands; [Hutten, Barbara A.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1100 DE Amsterdam, Netherlands; [Buller, Harry R.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1100 DE Amsterdam, Netherlands; [Hamulyak, Karly] Maastricht Univ, Univ Hosp Maastricht, Maastricht, Netherlands; [Verhoeve, Harold R.] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands; [Mol, Ben Willem] Maxima Med Ctr, Veldhoven, Netherlands; [Folkeringa, Nienke] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Nahuis, Marleen] Med Spectrum Twente Hosp Grp, Enschede, Netherlands; [Papatsonis, Dimitri N. M.] Amphia Hosp, Breda, Netherlands; [Middeldorp, Saskia] Leiden Univ, Med Ctr, Leiden, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Maastricht University Medical Centre (MUMC); Onze Lieve Vrouwe Gasthuis Hospital; Maxima Medical Center; University of Groningen; Medical Spectrum Twente; Amphia Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Goddijn, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, H4-205,POB 22700, NL-1100 DE Amsterdam, Netherlands.	m.goddijn@amc.uva.nl	Mol, Ben/I-4526-2012; Goddijn, Mariette/L-7849-2013; Middeldorp, Saskia/ABI-8197-2020; van der Post, Joris A M/A-8991-2008	Middeldorp, Saskia/0000-0002-1006-6420; van der Post, Joris/0000-0003-3311-2116; Goddijn, Mariette/0000-0001-9928-9673	Netherlands Organization for Health Research and Development [945-27-003]; GlaxoSmithKline; Meda Pharma	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); GlaxoSmithKline(GlaxoSmithKline); Meda Pharma	Supported by a grant (945-27-003) from the Netherlands Organization for Health Research and Development and a grant from GlaxoSmithKline. Study drugs (aspirin and placebo) were packaged and donated by Meda Pharma.	Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; [Anonymous], 2002, INT J GYNECOL OBSTET, V78, P179; Badawy AM, 2008, J OBSTET GYNAECOL, V28, P280, DOI 10.1080/01443610802042688; Bose P, 2005, AM J OBSTET GYNECOL, V192, P23, DOI 10.1016/j.ajog.2004.09.029; Brenner B, 2003, J THROMB HAEMOST, V1, P2070, DOI 10.1046/j.1538-7836.2003.00504.x; Brigham SA, 1999, HUM REPROD, V14, P2868, DOI 10.1093/humrep/14.11.2868; Carp H, 2004, FERTIL STERIL, V81, P1296, DOI 10.1016/j.fertnstert.2003.09.059; Christiansen OB, 2005, FERTIL STERIL, V83, P821, DOI 10.1016/j.fertnstert.2004.12.018; Collins J, 2008, HUM REPROD UPDATE, V14, P293, DOI 10.1093/humupd/dmn009; Dolitzky M, 2006, FERTIL STERIL, V86, P362, DOI 10.1016/j.fertnstert.2005.12.068; Empson M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002859.pub2; Farquharson RG, 2002, OBSTET GYNECOL, V100, P408, DOI 10.1016/S0029-7844(02)02165-8; Fawzy M, 2008, ARCH GYNECOL OBSTET, V278, P33, DOI 10.1007/s00404-007-0527-x; Freundl G, 2003, HUM REPROD, V18, P2628, DOI 10.1093/humrep/deg488; GILCHRIST DM, 1991, J REPROD MED, V36, P184; Gnoth C, 2003, HUM REPROD, V18, P1959, DOI 10.1093/humrep/deg366; INFANTERIVARD C, 1991, NEW ENGL J MED, V325, P1063, DOI 10.1056/NEJM199110103251503; Isermann B, 2003, NAT MED, V9, P331, DOI 10.1038/nm825; Jauniaux E, 2006, HUM REPROD, V21, P2216, DOI 10.1093/humrep/del150; Kaandorp S, 2009, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858; KNUDSEN UB, 1991, EUR J OBSTET GYN R B, V39, P31, DOI 10.1016/0028-2243(91)90138-B; Laude I, 2001, THROMB HAEMOSTASIS, V85, P18, DOI 10.1055/s-0037-1612657; Lockshin MD, 1999, THROMB HAEMOSTASIS, V82, P641; Middeldorp S, 2007, J THROMB HAEMOST, V5, P276, DOI 10.1111/j.1538-7836.2007.02501.x; Middeldorp S, 2007, SEMIN THROMB HEMOST, V33, P563, DOI 10.1055/s-2007-985752; Quenby S, 2005, HUM REPROD, V20, P1729, DOI 10.1093/humrep/deh844; Rai R, 2002, HUM REPROD, V17, P442, DOI 10.1093/humrep/17.2.442; Rai R, 1997, BRIT MED J, V314, P253, DOI 10.1136/bmj.314.7076.253; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Regan L, 2000, BEST PRACT RES CL OB, V14, P839, DOI 10.1053/beog.2000.0123; REGAN L, 1989, BRIT MED J, V299, P541, DOI 10.1136/bmj.299.6698.541; Rodger MA, 2008, OBSTET GYNECOL, V112, P320, DOI 10.1097/AOG.0b013e31817e8acc; *ROYAL COLL OBST G, 2003, GUID ROYAL COLL OBST, V17; Tulppala M, 1997, HUM REPROD, V12, P1567, DOI 10.1093/humrep/12.7.1567	35	302	317	4	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2010	362	17					1586	1596		10.1056/NEJMoa1000641	http://dx.doi.org/10.1056/NEJMoa1000641			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589AX	20335572				2022-12-28	WOS:000277117400007
J	Ergin, T; Stenger, N; Brenner, P; Pendry, JB; Wegener, M				Ergin, Tolga; Stenger, Nicolas; Brenner, Patrice; Pendry, John B.; Wegener, Martin			Three-Dimensional Invisibility Cloak at Optical Wavelengths	SCIENCE			English	Article							FREQUENCIES	We have designed and realized a three-dimensional invisibility-cloaking structure operating at optical wavelengths based on transformation optics. Our blueprint uses a woodpile photonic crystal with a tailored polymer filling fraction to hide a bump in a gold reflector. We fabricated structures and controls by direct laser writing and characterized them by simultaneous high-numerical-aperture, far-field optical microscopy and spectroscopy. A cloaking operation with a large bandwidth of unpolarized light from 1.4 to 2.7 micrometers in wavelength is demonstrated for viewing angles up to 60 degrees.	[Ergin, Tolga; Stenger, Nicolas; Wegener, Martin] Karlsruhe Inst Technol, Inst Angew Phys, D-76128 Karlsruhe, Germany; [Ergin, Tolga; Stenger, Nicolas; Brenner, Patrice; Wegener, Martin] Karlsruhe Inst Technol, DFG Ctr Funct Nanostruct, D-76128 Karlsruhe, Germany; [Pendry, John B.] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2AZ, England; [Wegener, Martin] Karlsruhe Inst Technol, Inst Nanotechnol, D-76021 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology; German Research Foundation (DFG); Helmholtz Association; Karlsruhe Institute of Technology; Imperial College London; Helmholtz Association; Karlsruhe Institute of Technology	Ergin, T (corresponding author), Karlsruhe Inst Technol, Inst Angew Phys, D-76128 Karlsruhe, Germany.	tolga.ergin@kit.edu	Wegener, Martin/S-5456-2016; Wegener, Martin/ABD-5353-2021; Stenger, Nicolas/B-2960-2012	Wegener, Martin/0000-0002-9770-2441; Wegener, Martin/0000-0002-9770-2441; Stenger, Nicolas/0000-0002-6808-9211; Pendry, John/0000-0001-5145-5441	Deutsche Forschungsgemeinschaft (DFG); State of Baden-Wurttemberg through the DFG-Center for Functional Nanostructures [A1.4, A1.5]; European Commission [213390]; Bundesministerium fur Bildung und Forschung; KSOP	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); State of Baden-Wurttemberg through the DFG-Center for Functional Nanostructures; European Commission(European CommissionEuropean Commission Joint Research Centre); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); KSOP	We thank K. Busch, G. von Freymann, S. Linden, and M. Thiel for discussions and help regarding sample fabrication and photonic band-structure calculations. We acknowledge support from the Deutsche Forschungsgemeinschaft (DFG) and the State of Baden-Wurttemberg through the DFG-Center for Functional Nanostructures within subprojects A1.4 and A1.5. We also thank the Future and Emerging Technologies (FET) program within the Seventh Framework Programme for Research of the European Commission (FET open grant number 213390) for financial support of the project PHOME. The project METAMAT is supported by the Bundesministerium fur Bildung und Forschung. The Ph.D. education of T. E. is embedded in the Karlsruhe School of Optics and Photonics (KSOP); N.S. is supported as a mentor in the KSOP.	Alu A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016623; Cai WS, 2007, NAT PHOTONICS, V1, P224, DOI 10.1038/nphoton.2007.28; Deubel M, 2004, NAT MATER, V3, P444, DOI 10.1038/nmat1155; Gabrielli LH, 2009, NAT PHOTONICS, V3, P461, DOI 10.1038/NPHOTON.2009.117; Halimeh JC, 2009, OPT EXPRESS, V17, P19328, DOI 10.1364/OE.17.019328; HO KM, 1994, SOLID STATE COMMUN, V89, P413, DOI 10.1016/0038-1098(94)90202-X; Johnson SG, 2001, OPT EXPRESS, V8, P173, DOI 10.1364/OE.8.000173; Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130; Lee JH, 2009, OPT EXPRESS, V17, P12922, DOI 10.1364/OE.17.012922; Leonhardt U, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/10/247; Leonhardt U, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/7/118; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Leonhardt U, 2009, SCIENCE, V323, P110, DOI 10.1126/science.1166332; Li JS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.203901; Liu R, 2009, SCIENCE, V323, P366, DOI 10.1126/science.1166949; Milton GW, 2006, P R SOC A, V462, P3027, DOI 10.1098/rspa.2006.1715; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; Shalaev VM, 2008, SCIENCE, V322, P384, DOI 10.1126/science.1166079; Smolyaninov II, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.213901; Valentine J, 2009, NAT MATER, V8, P568, DOI [10.1038/nmat2461, 10.1038/NMAT2461]	21	973	1009	18	592	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 16	2010	328	5976					337	339		10.1126/science.1186351	http://dx.doi.org/10.1126/science.1186351			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20299551				2022-12-28	WOS:000276685000031
J	Yin, QS; Tan, JM; Besson, C; Geletii, YV; Musaev, DG; Kuznetsov, AE; Luo, Z; Hardcastle, KI; Hill, CL				Yin, Qiushi; Tan, Jeffrey Miles; Besson, Claire; Geletii, Yurii V.; Musaev, Djamaladdin G.; Kuznetsov, Aleksey E.; Luo, Zhen; Hardcastle, Ken I.; Hill, Craig L.			A Fast Soluble Carbon-Free Molecular Water Oxidation Catalyst Based on Abundant Metals	SCIENCE			English	Article							OXYGEN-EVOLVING CATALYST; SOLAR-ENERGY; LIGHT; COMPLEXES; EVOLUTION; DIOXYGEN; LIGANDS; CLUSTER; BOND	Traditional homogeneous water oxidation catalysts are plagued by instability under the reaction conditions. We report that the complex [Co-4(H2O)(2)(PW9O34)(2)](10-), comprising a Co4O4 core stabilized by oxidatively resistant polytungstate ligands, is a hydrolytically and oxidatively stable homogeneous water oxidation catalyst that self-assembles in water from salts of earth-abundant elements (Co, W, and P). With [Ru(bpy)(3)](3+) (bpy is 2,2'-bipyridine) as the oxidant, we observe catalytic turnover frequencies for O-2 production >= 5 s(-1) at pH = 8. The rate's pH sensitivity reflects the pH dependence of the four-electron O-2-H2O couple. Extensive spectroscopic, electrochemical, and inhibition studies firmly indicate that [Co-4(H2O)(2)(PW9O34)(2)](10-) is stable under catalytic turnover conditions: Neither hydrated cobalt ions nor cobalt hydroxide/oxide particles form in situ.	[Yin, Qiushi; Tan, Jeffrey Miles; Besson, Claire; Geletii, Yurii V.; Musaev, Djamaladdin G.; Kuznetsov, Aleksey E.; Luo, Zhen; Hardcastle, Ken I.; Hill, Craig L.] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Besson, Claire] Univ Paris 06, CNRS, UMR 7201, Inst Parisien Chim Mol, F-75005 Paris, France	Emory University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Hill, CL (corresponding author), Emory Univ, Dept Chem, 1515 Pierce Dr, Atlanta, GA 30322 USA.	chill@emory.edu	Geletii, Yurii/B-3930-2014; Luo, Zhen/F-6819-2011; Kuznetsov, Aleksey E/F-1345-2010	Geletii, Yurii/0000-0002-2287-330X; Kuznetsov, Aleksey/0000-0001-8857-3118; Besson, Claire/0000-0002-0502-3610	U.S. Department of Energy [DE-FG02-03ER-15461]; French Ministere de l'Education Nationale, de la Recherche, et de la Technologie	U.S. Department of Energy(United States Department of Energy (DOE)); French Ministere de l'Education Nationale, de la Recherche, et de la Technologie	We thank the U.S. Department of Energy through grant DE-FG02-03ER-15461 for support of this work. C. B. thanks the French Ministere de l'Education Nationale, de la Recherche, et de la Technologie for a research fellowship. Additional details on the crystal structure investigations may be obtained from the Fachinformationszent Wrum Karlsruhe, 76344 Eggenstein-Leopoldshafen, Germany, on quoting registry number CSD-421465.	Baes J., 1976, HYDROLYSIS CATIONS; Balzani V, 2008, CHEMSUSCHEM, V1, P26, DOI 10.1002/cssc.200700087; Brimblecombe R, 2008, ANGEW CHEM INT EDIT, V47, P7335, DOI 10.1002/anie.200801132; BURSTALL FH, 1952, J CHEM SOC, P3570, DOI 10.1039/jr9520003570; Chow J, 2003, SCIENCE, V302, P1528, DOI 10.1126/science.1091939; Eisenberg R, 2008, INORG CHEM, V47, P1697, DOI 10.1021/ic800155g; Elizarova GL, 2000, CATAL TODAY, V58, P71, DOI 10.1016/S0920-5861(00)00243-1; Geletii YV, 2008, ANGEW CHEM INT EDIT, V47, P3896, DOI 10.1002/anie.200705652; Geletii YV, 2009, J AM CHEM SOC, V131, P7522, DOI 10.1021/ja901373m; GERSTEN SW, 1982, J AM CHEM SOC, V104, P4029, DOI 10.1021/ja00378a053; GHOSH PK, 1984, J AM CHEM SOC, V106, P4772, DOI 10.1021/ja00329a022; HARRIMAN A, 1988, J CHEM SOC FARAD T 1, V84, P2795, DOI 10.1039/f19888402795; Hull JF, 2009, J AM CHEM SOC, V131, P8730, DOI 10.1021/ja901270f; Hurst JK, 2005, COORDIN CHEM REV, V249, P313, DOI 10.1016/j.ccr.2004.06.017; Jiao F, 2009, ANGEW CHEM INT EDIT, V48, P1841, DOI 10.1002/anie.200805534; Kanan MW, 2008, SCIENCE, V321, P1072, DOI 10.1126/science.1162018; Kohl SW, 2009, SCIENCE, V324, P74, DOI 10.1126/science.1168600; Kunkely H, 2009, ANGEW CHEM INT EDIT, V48, P1685, DOI 10.1002/anie.200804712; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Limburg J, 2001, J AM CHEM SOC, V123, P423, DOI 10.1021/ja001090a; Muckerman JT, 2008, INORG CHEM, V47, P1787, DOI 10.1021/ic701892v; Romain S, 2009, J AM CHEM SOC, V131, P2768, DOI 10.1021/ja808166d; Ruhlmann L, 2002, EUR J INORG CHEM, P975; Sartorel A, 2008, J AM CHEM SOC, V130, P5006, DOI 10.1021/ja077837f; SHAFIROVICH VY, 1980, NOUV J CHIM, V4, P81; Wada T, 2000, ANGEW CHEM INT EDIT, V39, P1479, DOI 10.1002/(SICI)1521-3773(20000417)39:8<1479::AID-ANIE1479>3.0.CO;2-4; WEAKLEY TJR, 1973, J CHEM SOC CHEM COMM, P139, DOI 10.1039/c39730000139; Weinstock IA, 2001, NATURE, V414, P191, DOI 10.1038/35102545; Youngblood WJ, 2009, J AM CHEM SOC, V131, P926, DOI 10.1021/ja809108y; Zong R, 2005, J AM CHEM SOC, V127, P12802, DOI 10.1021/ja054791m	30	1188	1206	15	813	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2010	328	5976					342	345		10.1126/science.1185372	http://dx.doi.org/10.1126/science.1185372			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20223949				2022-12-28	WOS:000276685000033
J	McDaniell, R; Lee, BK; Song, L; Liu, Z; Boyle, AP; Erdos, MR; Scott, LJ; Morken, MA; Kucera, KS; Battenhouse, A; Keefe, D; Collins, FS; Willard, HF; Lieb, JD; Furey, TS; Crawford, GE; Iyer, VR; Birney, E				McDaniell, Ryan; Lee, Bum-Kyu; Song, Lingyun; Liu, Zheng; Boyle, Alan P.; Erdos, Michael R.; Scott, Laura J.; Morken, Mario A.; Kucera, Katerina S.; Battenhouse, Anna; Keefe, Damian; Collins, Francis S.; Willard, Huntington F.; Lieb, Jason D.; Furey, Terrence S.; Crawford, Gregory E.; Iyer, Vishwanath R.; Birney, Ewan			Heritable Individual-Specific and Allele-Specific Chromatin Signatures in Humans	SCIENCE			English	Article							GENE-EXPRESSION; SITES	The extent to which variation in chromatin structure and transcription factor binding may influence gene expression, and thus underlie or contribute to variation in phenotype, is unknown. To address this question, we cataloged both individual-to-individual variation and differences between homologous chromosomes within the same individual (allele-specific variation) in chromatin structure and transcription factor binding in lymphoblastoid cells derived from individuals of geographically diverse ancestry. Ten percent of active chromatin sites were individual-specific; a similar proportion were allele-specific. Both individual-specific and allele-specific sites were commonly transmitted from parent to child, which suggests that they are heritable features of the human genome. Our study shows that heritable chromatin status and transcription factor binding differ as a result of genetic variation and may underlie phenotypic variation in humans.	[Song, Lingyun; Boyle, Alan P.; Kucera, Katerina S.; Willard, Huntington F.; Furey, Terrence S.; Crawford, Gregory E.] Duke Univ, IGSP, Durham, NC 27708 USA; [McDaniell, Ryan; Lee, Bum-Kyu; Liu, Zheng; Battenhouse, Anna; Iyer, Vishwanath R.] Univ Texas Austin, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Song, Lingyun; Crawford, Gregory E.] Duke Univ, Dept Pediat, Div Med Genet, Durham, NC 27708 USA; [Erdos, Michael R.; Scott, Laura J.; Morken, Mario A.; Collins, Francis S.] NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; [Scott, Laura J.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Keefe, Damian; Birney, Ewan] European Bioinformat Inst, Cambridge CB10 1RQ, England; [Lieb, Jason D.] Univ N Carolina, Dept Biol, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Lieb, Jason D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Duke University; University of Texas System; University of Texas Austin; Duke University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Michigan System; University of Michigan; European Molecular Biology Laboratory (EMBL); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Crawford, GE (corresponding author), Duke Univ, IGSP, Durham, NC 27708 USA.	greg.crawford@duke.edu; vishy@mail.utexas.edu; birney@ebi.ac.uk	Boyle, Alan/I-1848-2014; Liu, Zheng/G-2612-2011	Boyle, Alan/0000-0002-2081-1105; Kucera, Katerina/0000-0003-4148-6599; Lee, Bum Kyu/0000-0001-7835-419X; Battenhouse, Anna/0000-0002-7455-9064; Furey, Terry/0000-0001-5546-9672; Birney, Ewan/0000-0001-8314-8497	National Human Genome Research Institute (NHGRI) ENCODE Consortium [U54 HG004563-03]; NHGRI [HG000024]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000024, ZIAHG000024, U54HG004563] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI) ENCODE Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank T. Severson, F. Ye, and L. Bukovnik at the Duke IGSP Sequencing Core Facility and K. Moon and S. Luo at Illumina for sequencing; S. Tenenbaum and S. Chittur at the State University of New York, Albany, for expression data; J. Lucas and Z. Zhang at Duke for gene expression analysis; the Texas Advanced Computing Center for computational infrastructure; and the 1000 Genomes Project for genotypes. E. B. has been a paid consultant to EagleGenomics, UK. Supported by National Human Genome Research Institute (NHGRI) ENCODE Consortium grant U54 HG004563-03 and NHGRI grant Z01 HG000024. Raw data from this paper are available at Gene Expression Omnibus (GSE15805 and GSE19622) and at the University of California, Santa Cruz (UCSC) Genome Browser.	Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; Filippova GN, 2008, CURR TOP DEV BIOL, V80, P337, DOI 10.1016/S0070-2153(07)80009-3; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Hachwell E, 2007, TRENDS GENET, V23, P588, DOI 10.1016/j.tig.2007.08.010; Kadota M, 2007, PLOS GENET, V3, P768, DOI 10.1371/journal.pgen.0030081; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Lewis A, 2006, CYTOGENET GENOME RES, V113, P81, DOI 10.1159/000090818; Lewis A, 2004, CURR BIOL, V14, pR284, DOI 10.1016/j.cub.2004.03.026; Mohlke KL, 2002, P NATL ACAD SCI USA, V99, P16928, DOI 10.1073/pnas.262661399; Montgomery SB, 2009, HUM MOL GENET, V18, pR211, DOI 10.1093/hmg/ddp400; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Plagnol V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002966; WU C, 1979, CELL, V16, P797, DOI 10.1016/0092-8674(79)90095-3; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357	16	238	248	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2010	328	5975					235	239		10.1126/science.1184655	http://dx.doi.org/10.1126/science.1184655			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580OU	20299549	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000276459600044
J	Gradinaru, V; Zhang, F; Ramakrishnan, C; Mattis, J; Prakash, R; Diester, I; Goshen, I; Thompson, KR; Deisseroth, K				Gradinaru, Viviana; Zhang, Feng; Ramakrishnan, Charu; Mattis, Joanna; Prakash, Rohit; Diester, Ilka; Goshen, Inbal; Thompson, Kimberly R.; Deisseroth, Karl			Molecular and Cellular Approaches for Diversifying and Extending Optogenetics	CELL			English	Article							EXCITATORY CORTICAL-NEURONS; IN-VIVO CONTROL; OPTICAL CONTROL; MILLISECOND-TIMESCALE; ADENOASSOCIATED VIRUS; EXPRESSION; ACTIVATION; RHODOPSIN; PROTEINS; HALORHODOPSIN	Optogenetic technologies employ light to control biological processes within targeted cells in vivo with high temporal precision. Here, we show that application of molecular trafficking principles can expand the optogenetic repertoire along several long-sought dimensions. Subcellular and transcellular trafficking strategies now permit (1) optical regulation at the far-red/infrared border and extension of optogenetic control across the entire visible spectrum, (2) increased potency of optical inhibition without increased light power requirement (nanoampere-scale chloride-mediated photocurrents that maintain the light sensitivity and reversible, step-like kinetic stability of earlier tools), and (3) generalizable strategies for targeting cells based not only on genetic identity, but also on morphology and tissue topology, to allow versatile targeting when promoters are not known or in genetically intractable organisms. Together, these results illustrate use of cell-biological principles to enable expansion of the versatile fast optogenetic technologies suitable for intact-systems biology and behavior.	[Gradinaru, Viviana; Zhang, Feng; Ramakrishnan, Charu; Mattis, Joanna; Prakash, Rohit; Diester, Ilka; Goshen, Inbal; Thompson, Kimberly R.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Gradinaru, Viviana; Mattis, Joanna; Prakash, Rohit] Stanford Univ, Program Neurosci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Ritter, Stefanie L/D-9312-2012; Macrae, Rhiannon/AAX-1536-2020; Diester, Ilka/D-4473-2011; Goshen, Inbal/GQI-2230-2022	Goshen, Inbal/0000-0001-7578-2615; Mattis, Joanna/0000-0003-0341-1270; Ramakrishnan, Charu/0000-0002-3474-6332	National Institutes of Health (NIH); Harvard Society; Stanford Medical Scientist Training Program; German Academic Exchange Service; Human Frontier Science Program; Machiah Foundation; Weizmann Institute; National Alliance for Research on Schizophrenia and Depression; Woo, Keck, Snyder, McKnight, Yu, and Coulter Foundations; California Institute of Regenerative Medicine; National Science Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Society; Stanford Medical Scientist Training Program; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Human Frontier Science Program(Human Frontier Science Program); Machiah Foundation; Weizmann Institute; National Alliance for Research on Schizophrenia and Depression(NARSAD); Woo, Keck, Snyder, McKnight, Yu, and Coulter Foundations; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Science Foundation(National Science Foundation (NSF))	V. G. is supported by the Stanford Interdisciplinary Graduate Fellowship, F. Z. by the National Institutes of Health (NIH) and Harvard Society of Fellows, J. M. by the Stanford Medical Scientist Training Program, R. P. by the NIH, I. D. by the German Academic Exchange Service and the Human Frontier Science Program, I. G. by the Machiah Foundation and the Weizmann Institute, K. T. by the National Alliance for Research on Schizophrenia and Depression, and K. D. by the Woo, Keck, Snyder, McKnight, Yu, and Coulter Foundations, as well as by the California Institute of Regenerative Medicine, the National Science Foundation, and the NIH. We thank the entire Deisseroth lab for their support.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Arrenberg AB, 2009, P NATL ACAD SCI USA, V106, P17968, DOI 10.1073/pnas.0906252106; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Colechio EM, 2009, BRAIN STRUCT FUNCT, V213, P423, DOI 10.1007/s00429-009-0215-7; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Fleischmann A, 2008, NEURON, V60, P1068, DOI 10.1016/j.neuron.2008.10.046; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hagglund M, 2010, NAT NEUROSCI, V13, P246, DOI 10.1038/nn.2482; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Han X, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.012.2009; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Hofherr A, 2005, J CELL SCI, V118, P1935, DOI 10.1242/jcs.02322; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Kalaidzidis IV, 1998, FEBS LETT, V427, P59, DOI 10.1016/S0014-5793(98)00394-9; Kissa K, 2002, MOL CELL NEUROSCI, V20, P627, DOI 10.1006/mcne.2002.1141; LANYI JK, 1982, J BIOL CHEM, V257, P2674; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Lewis TL, 2009, NAT NEUROSCI, V12, P568, DOI 10.1038/nn.2318; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; LOZIER RH, 1975, BIOPHYS J, V15, P955, DOI 10.1016/S0006-3495(75)85875-9; MARTI T, 1991, J BIOL CHEM, V266, P6919; Maskos U, 2002, P NATL ACAD SCI USA, V99, P10120, DOI 10.1073/pnas.152266799; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nathanson JL, 2009, NEUROSCIENCE, V161, P441, DOI 10.1016/j.neuroscience.2009.03.032; Passini MA, 2005, MOL THER, V11, P754, DOI 10.1016/j.ymthe.2005.01.011; Paterna JC, 2004, J VIROL, V78, P6808, DOI 10.1128/JVI.78.13.6808-6817.2004; Perreault MC, 2006, NEUROSCIENCE, V141, P803, DOI 10.1016/j.neuroscience.2006.04.008; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Ratzliff ADH, 2004, J NEUROSCI, V24, P2259, DOI 10.1523/JNEUROSCI.5191-03.2004; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Sano H, 2007, GENESIS, V45, P123, DOI 10.1002/dvg.20273; Sato M, 2005, BIOCHEMISTRY-US, V44, P4775, DOI 10.1021/bi047500f; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Silberberg G, 2004, J PHYSIOL-LONDON, V556, P19, DOI 10.1113/jphysiol.2004.060962; Simon S M, 1993, Subcell Biochem, V21, P1; Sineshchekov OA, 2005, BIOPHYS J, V89, P4310, DOI 10.1529/biophysj.105.070920; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; STOECKENIUS W, 1982, ANNU REV BIOCHEM, V51, P587, DOI 10.1146/annurev.bi.51.070182.003103; Sugita M, 2005, SCIENCE, V309, P781, DOI 10.1126/science.1110787; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Tengholm A, 2009, MOL CELL ENDOCRINOL, V297, P58, DOI 10.1016/j.mce.2008.07.009; Tonnesen J, 2009, P NATL ACAD SCI USA, V106, P12162, DOI 10.1073/pnas.0901915106; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tsunoda SP, 2006, BIOPHYS J, V91, P1471, DOI 10.1529/biophysj.106.086421; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988; Zhao SL, 2008, BRAIN CELL BIOL, V36, P141, DOI 10.1007/s11068-008-9034-7	77	662	731	5	253	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2010	141	1					154	165		10.1016/j.cell.2010.02.037	http://dx.doi.org/10.1016/j.cell.2010.02.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20303157	Green Accepted, Bronze			2022-12-28	WOS:000276211100020
J	Ackland, G				Ackland, Graeme			Controlling Radiation Damage	SCIENCE			English	Editorial Material									Univ Edinburgh, Sch Phys, Edinburgh EH9 3JZ, Midlothian, Scotland	University of Edinburgh	Ackland, G (corresponding author), Univ Edinburgh, Sch Phys, James Clerk Maxwell Bldg,Kings Bldg, Edinburgh EH9 3JZ, Midlothian, Scotland.	gjackland@ed.ac.uk	Ackland, Graeme J/H-2215-2015	Ackland, Graeme J/0000-0002-1205-7675	Engineering and Physical Sciences Research Council [981109] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Bai XM, 2010, SCIENCE, V327, P1631, DOI 10.1126/science.1183723; Misra A, 2007, JOM-US, V59, P62, DOI 10.1007/s11837-007-0120-6; Sorensen MR, 2000, J CHEM PHYS, V112, P9599, DOI 10.1063/1.481576; Sutton A., 2006, INTERFACES CRYSTALLI; Ukai S, 2002, J NUCL MATER, V307, P749, DOI 10.1016/S0022-3115(02)01043-7; GENERATION 4 TRANSMU	6	267	274	7	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	2010	327	5973					1587	1588		10.1126/science.1188088	http://dx.doi.org/10.1126/science.1188088			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339056				2022-12-28	WOS:000275970600024
J	Bezzu, CG; Helliwell, M; Warren, JE; Allan, DR; McKeown, NB				Bezzu, C. Grazia; Helliwell, Madeleine; Warren, John E.; Allan, David R.; McKeown, Neil B.			Heme-Like Coordination Chemistry Within Nanoporous Molecular Crystals	SCIENCE			English	Article							PORPHYRIN FRAMEWORK; ZINC PORPHYRIN; CUBIC SYMMETRY; NETWORK; SOLIDS; DINITROGEN; CLATHRATE; OXIDATION; POLYMERS; VOIDS	Crystal engineering of nanoporous structures has not yet exploited the heme motif so widely found in proteins. Here, we report that a derivative of iron phthalocyanine, a close analog of heme, forms millimeter-scale molecular crystals that contain large interconnected voids (8 cubic nanometers), defined by a cubic assembly of six phthalocyanines. Rapid ligand exchange is achieved within these phthalocyanine nanoporous crystals by single-crystal-to-single-crystal (SCSC) transformations. Differentiation of the binding sites, similar to that which occurs in hemoproteins, is achieved so that monodentate ligands add preferentially to the axial binding site within the cubic assembly, whereas bidentate ligands selectively bind to the opposite axial site to link the cubic assemblies. These bidentate ligands act as molecular wall ties to prevent the collapse of the molecular crystal during the removal of solvent. The resulting crystals possess high surface areas (850 to 1000 square meters per gram) and bind N-2 at the equivalent of the heme distal site through a SCSC process characterized by x-ray crystallography.	[Bezzu, C. Grazia; McKeown, Neil B.] Cardiff Univ, Sch Chem, Cardiff CF10 3AT, S Glam, Wales; [Helliwell, Madeleine] Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England; [Warren, John E.] SRS, Daresbury Lab, Warrington WA4 4AD, Cheshire, England; [Allan, David R.] Diamond Light Source, Didcot OX11 0DE, Oxon, England	Cardiff University; University of Manchester; STFC Daresbury Laboratory; Diamond Light Source	McKeown, NB (corresponding author), Cardiff Univ, Sch Chem, Cardiff CF10 3AT, S Glam, Wales.	mckeownnb@cardiff.ac.uk	Warren, John E/H-6071-2019; Bezzu, C. Grazia/C-3594-2013; Warren, John/B-5219-2008; McKeown, Neil B/A-2451-2011; McKeown, Neil/U-8963-2019	Warren, John E/0000-0002-8755-7981; Bezzu, C. Grazia/0000-0001-6918-8281; Warren, John/0000-0002-8755-7981; McKeown, Neil B/0000-0002-6027-261X; McKeown, Neil/0000-0002-6027-261X	Engineering and Physical Sciences Research Council [GR/F019114]; EPSRC [EP/F019114/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F019114/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Engineering and Physical Sciences Research Council grant no. GR/F019114. We thank F. Tuna (University of Manchester) for help with the synthesis of PNC[Co-cPy], H. Nowell (Diamond) and B. Kariuki ( Cardiff University) for technical support during crystallographic data collection, and K. D. M. Harris and G. J. Hutchings for valuable discussions. Crystallographic parameters for the PNCs and PUNCs are available free of charge from	ABRAHAMS BF, 1994, NATURE, V369, P727, DOI 10.1038/369727a0; CAMENZIND MJ, 1988, INORG CHEM, V27, P3054, DOI 10.1021/ic00290a031; Choi EY, 2008, CRYSTENGCOMM, V10, P824, DOI 10.1039/b720035h; Choi EY, 2009, CRYSTENGCOMM, V11, P553, DOI 10.1039/b819707p; Collman JP, 2004, CHEM REV, V104, P561, DOI 10.1021/cr0206059; COLLMAN JP, 1988, J AM CHEM SOC, V110, P3486, DOI 10.1021/ja00219a024; Deiters E, 2005, CHEM COMMUN, P3906, DOI 10.1039/b508135c; Ferey G, 2008, CHEM SOC REV, V37, P191, DOI 10.1039/b618320b; Ghosh A, 2008, SMALLEST BIOMOLECULES: DIATOMICS AND THEIR INTERACTIONS WITH HEME PROTEINS, P1; Goldberg I, 2005, CHEM COMMUN, P1243, DOI 10.1039/b416425c; Kawamichi T, 2009, NATURE, V461, P633, DOI 10.1038/nature08326; Kempe R, 2005, Z ANORG ALLG CHEM, V631, P1038, DOI 10.1002/zaac.200400483; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; Kosal ME, 2002, NAT MATER, V1, P118, DOI 10.1038/nmat730; Lord EA, 2003, CURR SCI INDIA, V85, P346; Makhseed S, 2008, CHEM-EUR J, V14, P4810, DOI 10.1002/chem.200701980; MARTINSEN J, 1980, INORG CHEM, V19, P2162, DOI 10.1021/ic50209a065; McKeown N. B., 1998, PHTHALOCYANINE MAT S; McKeown NB, 2005, ANGEW CHEM INT EDIT, V44, P7546, DOI 10.1002/anie.200502668; MEUNIER B, 1992, CHEM REV, V92, P1411, DOI 10.1021/cr00014a008; Msayib KJ, 2009, ANGEW CHEM INT EDIT, V48, P3273, DOI 10.1002/anie.200900234; Ohmura T, 2006, INORG CHEM, V45, P7988, DOI 10.1021/ic060358h; Shultz AM, 2009, J AM CHEM SOC, V131, P4204, DOI 10.1021/ja900203f; Smithenry DW, 2003, INORG CHEM, V42, P7719, DOI 10.1021/ic034873g; Sorokin AB, 2008, CHEM COMMUN, P2562, DOI 10.1039/b804405h; Suslick KS, 2005, ACCOUNTS CHEM RES, V38, P283, DOI 10.1021/ar040173j; Tozawa T, 2009, NAT MATER, V8, P973, DOI [10.1038/nmat2545, 10.1038/NMAT2545]; Wright PA, 2008, RSC MATER MONOGR, P1; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650	29	157	157	3	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2010	327	5973					1627	1630		10.1126/science.1184228	http://dx.doi.org/10.1126/science.1184228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	574ED	20339069				2022-12-28	WOS:000275970600039
J	Sfeir, A; Kabir, S; van Overbeek, M; Celli, GB; de Lange, T				Sfeir, Agnel; Kabir, Shaheen; van Overbeek, Megan; Celli, Giulia B.; de Lange, Titia			Loss of Rap1 Induces Telomere Recombination in the Absence of NHEJ or a DNA Damage Signal	SCIENCE			English	Article							HOMOLOGOUS RECOMBINATION; DYSFUNCTIONAL TELOMERES; CHROMOSOME ENDS; PROTECTION; POT1; COMPLEX; TRF2; TPP1; ATM	Shelterin is an essential telomeric protein complex that prevents DNA damage signaling and DNA repair at mammalian chromosome ends. Here we report on the role of the TRF2-interacting factor Rap1, a conserved shelterin subunit of unknown function. We removed Rap1 from mouse telomeres either through gene deletion or by replacing TRF2 with a mutant that does not bind Rap1. Rap1 was dispensable for the essential functions of TRF2-repression of ATM kinase signaling and nonhomologous end joining (NHEJ)-and mice lacking telomeric Rap1 were viable and fertile. However, Rap1 was critical for the repression of homology-directed repair (HDR), which can alter telomere length. The data reveal that HDR at telomeres can take place in the absence of DNA damage foci and underscore the functional compartmentalization within shelterin.	[Sfeir, Agnel; Kabir, Shaheen; van Overbeek, Megan; Celli, Giulia B.; de Lange, Titia] Rockefeller Univ, New York, NY 10065 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X	Women in Science Fellowship Program; The Leukemia & Lymphoma Society; NIH [AG016642, GM049046]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049046, R37GM049046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016642] Funding Source: NIH RePORTER	Women in Science Fellowship Program; The Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	D. White, H. Takai, and the Rockefeller University Transgenics Facility are thanked for help in generating genetically modified mice. We thank L. Jovine for identifying the conserved helix in TRF2. A. S. is supported by Susan G. Komen for the Cure. G.B.C. was supported by the Women in Science Fellowship Program and The Leukemia & Lymphoma Society. Supported by NIH grants AG016642 and GM049046.	Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; Cesare AJ, 2008, MOL CELL BIOL, V28, P20, DOI 10.1128/MCB.01122-07; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Hanaoka S, 2001, J MOL BIOL, V312, P167, DOI 10.1006/jmbi.2001.4924; Kibe T, 2010, MOL CELL BIOL, V30, P1059, DOI 10.1128/MCB.01498-09; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Li BB, 2003, MOL BIOL CELL, V14, P5060, DOI 10.1091/mbc.e03-06-0403; Marcand S, 2008, GENE DEV, V22, P1153, DOI 10.1101/gad.455108; Miller KM, 2005, EMBO J, V24, P3128, DOI 10.1038/sj.emboj.7600779; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; Palm W, 2009, MOL CELL BIOL, V29, P471, DOI 10.1128/MCB.01352-08; Pardo B, 2005, EMBO J, V24, P3117, DOI 10.1038/sj.emboj.7600778; Sarthy J, 2009, EMBO J, V28, P3390, DOI 10.1038/emboj.2009.275; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tsai YL, 2002, MOL CELL BIOL, V22, P5679, DOI 10.1128/MCB.22.16.5679-5687.2002; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037	20	187	193	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2010	327	5973					1657	1661		10.1126/science.1185100	http://dx.doi.org/10.1126/science.1185100			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339076	Green Accepted			2022-12-28	WOS:000275970600048
J	Althorpe, SC				Althorpe, Stuart C.			Setting the Trap for Reactive Resonances	SCIENCE			English	Editorial Material							TRANSITION-STATE		Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Althorpe, SC (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	sca10@cam.ac.uk						Althorpe SC, 2002, NATURE, V416, P67, DOI 10.1038/416067a; Dai DX, 2003, SCIENCE, V300, P1730, DOI 10.1126/science.1084041; Dong WR, 2010, SCIENCE, V327, P1501, DOI 10.1126/science.1185694; Fu B, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2955729; Koszinowski K, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2217742; Liu K, 2002, PHYSCHEMCOMM, V5, P27, DOI 10.1039/b110570a; MANOLOPOULOS DE, 1993, SCIENCE, V262, P1852, DOI 10.1126/science.262.5141.1852; MILLER WH, 1991, J PHYS CHEM-US, V95, P12, DOI 10.1021/j100154a007; NEUMARK DM, 1985, J CHEM PHYS, V82, P3045, DOI 10.1063/1.448254; Newton R. G., 1982, THEOR MATH PHYS+; Qiu MH, 2006, SCIENCE, V311, P1440, DOI 10.1126/science.1123452; Ren ZF, 2008, P NATL ACAD SCI USA, V105, P12662, DOI 10.1073/pnas.0709974105; Skodje RT, 2000, PHYS REV LETT, V85, P1206, DOI 10.1103/PhysRevLett.85.1206; Stark K, 1996, J CHEM PHYS, V104, P6515, DOI 10.1063/1.471372; WALLER IM, 1990, J PHYS CHEM-US, V94, P2240, DOI 10.1021/j100369a009	15	5	5	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2010	327	5972					1460	1461		10.1126/science.1187822	http://dx.doi.org/10.1126/science.1187822			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20299579				2022-12-28	WOS:000275715200030
J	Locksley, RM				Locksley, Richard M.			Asthma and Allergic Inflammation	CELL			English	Article							LUNG DENDRITIC CELLS; CLASS-II EXPRESSION; IMMUNE-RESPONSES; T-CELLS; IN-VIVO; AIRWAY; INNATE; IL-4; BASOPHILS; RECEPTOR	Studies of the initiation and maintenance of asthma and allergic inflammation implicate dysregulated interactions between mucosal epithelia and innate immune cells as the underlying cause of these disorders. The similarities of these responses with mucosal responses to parasitic intestinal worms may reveal pathways relevant to the perplexing rise of these chronic inflammatory disorders.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu			Howard Hughes Medical Institute; National Institutes of Health; UCSF Strategic Asthma Basic Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439, R37AI026918, R01AI030663] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Strategic Asthma Basic Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	I gratefully acknowledge helpful discussions with faculty and members of my laboratory at UCSF and support from the Howard Hughes Medical Institute, the National Institutes of Health, and the UCSF Strategic Asthma Basic Research Center.	Allenspach EJ, 2008, IMMUNITY, V29, P795, DOI 10.1016/j.immuni.2008.08.013; Aspock H, 1996, PARASITOL TODAY, V12, P255, DOI 10.1016/0169-4758(96)30008-2; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Ballantyne SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1324, DOI 10.1016/j.jaci.2007.07.051; Barrett NA, 2009, IMMUNITY, V31, P425, DOI 10.1016/j.immuni.2009.08.014; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Cortez-Retamozo V, 2008, J CLIN INVEST, V118, P4058, DOI 10.1172/JCI36335; de Lange EE, 2009, RADIOLOGY, V250, P567, DOI 10.1148/radiol.2502080188; Delmotte P, 2006, AM J RESP CELL MOL, V35, P110, DOI 10.1165/rcmb.2005-0417OC; Demehri S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000067; Eller LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003919; Fallon PG, 2009, NAT GENET, V41, P602, DOI 10.1038/ng.358; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Grayson MH, 2007, J EXP MED, V204, P2759, DOI 10.1084/jem.20070360; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Kambayashi T, 2009, J IMMUNOL, V182, P4686, DOI 10.4049/jimmunol.0803180; Kepley CL, 2001, AM J RESP CRIT CARE, V164, P1053, DOI 10.1164/ajrccm.164.6.2102025; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; Moorman Jeanne E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Muller S, 2009, PEDIAT ALLERG IMM-UK, V20, P358, DOI 10.1111/j.1399-3038.2008.00808.x; Niu N, 2009, J IMMUNOL, V183, P1523, DOI 10.4049/jimmunol.0901349; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Parkinson J, 2004, NAT GENET, V36, P1259, DOI 10.1038/ng1472; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Porter P, 2009, MUCOSAL IMMUNOL, V2, P504, DOI 10.1038/mi.2009.102; Pushparaj PN, 2009, P NATL ACAD SCI USA, V106, P9773, DOI 10.1073/pnas.0901206106; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Rogers AJ, 2009, AM J RESP CRIT CARE, V179, P1084, DOI 10.1164/rccm.200812-1860OC; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Seibold MA, 2009, J BIOL CHEM, V284, P19650, DOI 10.1074/jbc.M109.012443; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Thomas WR, 2002, INT ARCH ALLERGY IMM, V129, P1, DOI 10.1159/000065179; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Tzeng YS, 2009, J APPL PHYSIOL, V106, P813, DOI 10.1152/japplphysiol.01133.2007; van Panhuys N, 2008, P NATL ACAD SCI USA, V105, P12423, DOI 10.1073/pnas.0806372105; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Wang HB, 2007, J IMMUNOL, V179, P7585, DOI 10.4049/jimmunol.179.11.7585; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737	51	274	288	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2010	140	6					777	783		10.1016/j.cell.2010.03.004	http://dx.doi.org/10.1016/j.cell.2010.03.004			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	571IX	20303868	Green Accepted, Bronze			2022-12-28	WOS:000275746600002
J	Cristofanilli, M; Braun, S				Cristofanilli, Massimo; Braun, Stephan			Circulating Tumor Cells Revisited	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							METASTATIC BREAST-CANCER; SURVIVAL; PROGRESSION		[Cristofanilli, Massimo] Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA; [Braun, Stephan] Med Univ Innsbruck, Dept Gynecol, Innsbruck, Austria	Fox Chase Cancer Center; Medical University of Innsbruck	Cristofanilli, M (corresponding author), Fox Chase Canc Ctr, Dept Med Oncol, 333 Cottman Ave, Philadelphia, PA 19111 USA.	massimo.cristofanilli@fccc.edu						Alix-Panabieres C, 2005, J IMMUNOL METHODS, V299, P177, DOI 10.1016/j.jim.2005.02.007; Ashworth T. R, 1869, AUST MED J, V14, P146, DOI DOI 10.1038/SJ.BJC.6604218; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; De Giorgi U, 2009, J CLIN ONCOL, V27, P3303, DOI 10.1200/JCO.2008.19.4423; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44	10	36	47	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1092	1093		10.1001/jama.2010.292	http://dx.doi.org/10.1001/jama.2010.292			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569KC	20233831				2022-12-28	WOS:000275594100026
J	Haase, AT				Haase, Ashley T.			Targeting early infection to prevent HIV-1 mucosal transmission	NATURE			English	Review							SIMIAN IMMUNODEFICIENCY VIRUS; T-CELL DEPLETION; RHESUS MACAQUES; GENITAL-TRACT; INTRAVAGINAL INOCULATION; VAGINAL TRANSMISSION; MALE CIRCUMCISION; EPITHELIAL-CELLS; LYMPHOID-TISSUE; CERVICOVAGINAL MUCOSA	Measures to prevent sexual mucosal transmission of human immunodeficiency virus (HIV)-1 are urgently needed to curb the growth of the acquired immunodeficiency syndrome (AIDS) pandemic and ultimately bring it to an end. Studies in animal models and acute HIV-1 infection reviewed here reveal potential viral vulnerabilities at the mucosal portal of entry in the earliest stages of infection that might be most effectively targeted by vaccines and microbicides, thereby preventing acquisition and averting systemic infection, CD4 T-cell depletion and pathologies that otherwise rapidly ensue.	Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Haase, AT (corresponding author), Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA.	haase001@umn.edu			National Institutes of Health [AI 38565, AI 48484, AI 71976]; International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI071976, R33AI071976, R01AI048484, R01AI038565, R01AI138565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	I thank J. V. Carlis, R. P. Johnson, Q. Li, J. D. Lifson, D. Masopust, S. Pambuccian, P. J. Southern, J. Estes, D. Douek, H. W. Virgin and B. D. Walker for discussions. Errors of commission are mine as are errors of omission, with apologies to the authors of work that I could not cite because of space limitations and exclusive focus on tissue analyses. I thank C. O'Neill and T. Leonard for help with the manuscript and figures. Work from my laboratory cited in the review was supported by grants from the National Institutes of Health (AI 38565, AI 48484, AI 71976) and the International AIDS Vaccine Initiative.	Abel K, 2005, J VIROL, V79, P12164, DOI 10.1128/JVI.79.19.12164-12172.2005; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Belyakov IM, 2006, BLOOD, V107, P3258, DOI 10.1182/blood-2005-11-4374; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Berlier W, 2006, HUM REPROD, V21, P1135, DOI 10.1093/humrep/dei496; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; CHECK E, 2007, NATURE, V446, P12; CHRISTOPHER DP, 2004, J INFECT DIS, V189, P1785; Clayton F, 1997, CLIN EXP IMMUNOL, V107, P288, DOI 10.1111/j.1365-2249.1997.236-ce1111.x; Cohen J, 2008, SCIENCE, V321, P902, DOI 10.1126/science.321.5891.902; Cranage M, 2008, PLOS MED, V5, P1238, DOI 10.1371/journal.pmed.0050157; Cremel M, 2005, J LEUKOCYTE BIOL, V78, P158, DOI 10.1189/jlb.0305147; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Dieu-Nosjean MC, 2000, J EXP MED, V192, P705, DOI 10.1084/jem.192.5.705; EDWARDS JNT, 1985, BRIT J OBSTET GYNAEC, V92, P974, DOI 10.1111/j.1471-0528.1985.tb03080.x; Estes JD, 2008, SEMIN IMMUNOL, V20, P181, DOI 10.1016/j.smim.2008.04.002; Estes JD, 2007, J INFECT DIS, V195, P551, DOI 10.1086/510852; Estes JD, 2006, J INFECT DIS, V193, P703, DOI 10.1086/500368; Fahey JV, 2008, MUCOSAL IMMUNOL, V1, P317, DOI 10.1038/mi.2008.20; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Fauci AS, 2008, NATURE, V453, P289, DOI 10.1038/453289a; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Genesca M, 2008, MUCOSAL IMMUNOL, V1, P219, DOI 10.1038/mi.2008.6; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Haase A T, 1975, Curr Top Microbiol Immunol, V72, P101; Haase AT, 1999, ANNU REV IMMUNOL, V17, P625, DOI 10.1146/annurev.immunol.17.1.625; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; HEISE C, 1994, J INFECT DIS, V169, P1116, DOI 10.1093/infdis/169.5.1116; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; Kader M, 2009, MUCOSAL IMMUNOL, V2, P439, DOI 10.1038/mi.2009.90; KARIM SA, 2009, 16 C RETR OPP INF; Kaul R, 2008, J REPROD IMMUNOL, V77, P32, DOI 10.1016/j.jri.2007.02.002; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; KELL PD, 1992, J ROY SOC MED, V85, P706; KOTLER DP, 1984, ANN INTERN MED, V101, P421, DOI 10.7326/0003-4819-101-4-421; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Li QS, 2008, J INFECT DIS, V197, P420, DOI 10.1086/525046; Li QS, 2009, J IMMUNOL, V183, P1975, DOI 10.4049/jimmunol.0803222; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Li QS, 2009, SCIENCE, V323, P1726, DOI 10.1126/science.1168676; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Lifson JD, 2000, J VIROL, V74, P2584, DOI 10.1128/JVI.74.6.2584-2593.2000; Ma ZM, 2004, J VIROL, V78, P14048, DOI 10.1128/JVI.78.24.14048-14052.2004; Ma ZM, 2001, CLIN IMMUNOL, V100, P240, DOI 10.1006/clim.2001.5058; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; McChesney MB, 1998, J VIROL, V72, P10029, DOI 10.1128/JVI.72.12.10029-10035.1998; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Miller CJ, 2003, MICROBES INFECT, V5, P59, DOI 10.1016/S1286-4579(02)00056-4; MILLER CJ, 1992, J MED PRIMATOL, V21, P64; MILLER CJ, 1989, J VIROL, V63, P4277, DOI 10.1128/JVI.63.10.4277-4284.1989; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; MILUSH JM, 2004, AIDS, V18, P1; Miyake A, 2006, J GEN VIROL, V87, P1311, DOI 10.1099/vir.0.81307-0; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Myer L, 2006, SEX TRANSM DIS, V33, P683, DOI 10.1097/01.olq.0000216026.67352.f9; NORVELL MK, 1984, J REPROD MED, V29, P269; O'Connor DM, 2008, OBSTET GYN CLIN N AM, V35, P565, DOI 10.1016/j.ogc.2008.09.009; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Pudney J, 2005, BIOL REPROD, V73, P1253, DOI 10.1095/biolreprod.105.043133; Quinn TC, 2005, SCIENCE, V308, P1582, DOI 10.1126/science.1112489; Reinhart TA, 1997, J INFECT DIS, V176, P1198, DOI 10.1086/514113; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Reynolds MR, 2005, J VIROL, V79, P9228, DOI 10.1128/JVI.79.14.9228-9235.2005; Robertson SA, 2005, CELL TISSUE RES, V322, P43, DOI 10.1007/s00441-005-1127-3; Robertson SA, 2002, J REPROD IMMUNOL, V57, P109, DOI 10.1016/S0165-0378(02)00015-3; Rudnicka D, 2009, J VIROL, V83, P6234, DOI 10.1128/JVI.00282-09; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Schacker T, 2001, J INFECT DIS, V183, P555, DOI 10.1086/318524; Sodora DL, 1998, AIDS RES HUM RETROV, V14, pS119; Stahl-Hennig C, 1999, SCIENCE, V285, P1261, DOI 10.1126/science.285.5431.1261; Trivedi P, 1996, J VIROL, V70, P6876, DOI 10.1128/JVI.70.10.6876-6883.1996; *UNAIDS, 2008, 2008 REP GLOB AIDS E; Veazey RS, 2005, NATURE, V438, P99, DOI 10.1038/nature04055; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Vendrame D, 2009, J VIROL, V83, P10527, DOI 10.1128/JVI.01235-09; VIRGIN HW, NATURE IN PRESS; Wang YC, 2005, J VIROL, V79, P14355, DOI 10.1128/JVI.79.22.14355-14370.2005; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Weiler AM, 2008, J VIROL, V82, P4154, DOI 10.1128/JVI.01947-07; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Wira CR, 2005, AM J REPROD IMMUNOL, V53, P65, DOI 10.1111/j.1600-0897.2004.00248.x; WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006; Zhu TF, 2003, J VIROL, V77, P6108, DOI 10.1128/JVI.77.11.6108-6116.2003; Zhu TF, 1996, J VIROL, V70, P3098, DOI 10.1128/JVI.70.5.3098-3107.1996	98	456	468	0	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					217	223		10.1038/nature08757	http://dx.doi.org/10.1038/nature08757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20220840				2022-12-28	WOS:000275366100035
J	Hannaford, PC; Iversen, L; Macfarlane, TV; Elliott, AM; Angus, V; Lee, AJ				Hannaford, Philip C.; Iversen, Lisa; Macfarlane, Tatiana V.; Elliott, Alison M.; Angus, Valerie; Lee, Amanda J.			Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study	BRITISH MEDICAL JOURNAL			English	Article							FOLLOW-UP; SMOKING; WOMEN; RISK	Objective To see if the mortality risk among women who have used oral contraceptives differs from that of never users. Design Prospective cohort study started in 1968 with mortality data supplied by participating general practitioners, National Health Service central registries, or both. Setting 1400 general practices throughout the United Kingdom. Participants 46 112 women observed for up to 39 years, resulting in 378 006 woman years of observation among never users of oral contraception and 819 175 among ever users. Main outcome measures Directly standardised adjusted relative risks between never and ever users for all cause and cause specific mortality. Results 1747 deaths occurred in never users of oral contraception and 2864 in ever users. Compared with never users, ever users of oral contraception had a significantly lower rate of death from any cause ( adjusted relative risk 0.88, 95% confidence interval 0.82 to 0.93). They also had significantly lower rates of death from all cancers; large bowel/rectum, uterine body, and ovarian cancer; main gynaecological cancers combined; all circulatory disease; ischaemic heart disease; and all other diseases. They had higher rates of violent deaths. No association between overall mortality and duration of oral contraceptive use was observed, although some disease specific relations were apparent. An increased relative risk of death from any cause between ever users and never users was observed in women aged under 45 years who had stopped using oral contraceptives 5-9 years previously but not in those with more distant use. The estimated absolute reduction in all cause mortality among ever users of oral contraception was 52 per 100 000 woman years. Conclusion Oral contraception was not associated with an increased long term risk of death in this large UK cohort; indeed, a net benefit was apparent. The balance of risks and benefits, however, may vary globally, depending on patterns of oral contraception usage and background risk of disease.	[Hannaford, Philip C.] Univ Aberdeen, Ctr Acad Primary Care, Foresterhill Hlth Ctr, Aberdeen AB25 2AY, Scotland; [Angus, Valerie] Coll Life Sci & Med, Aberdeen AB25 2ZD, Scotland; [Lee, Amanda J.] Univ Aberdeen, Sect Populat Hlth, Med Stat Team, Aberdeen AB25 2ZD, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen	Hannaford, PC (corresponding author), Univ Aberdeen, Ctr Acad Primary Care, Foresterhill Hlth Ctr, Aberdeen AB25 2AY, Scotland.	p.hannaford@abdn.ac.uk	Potter, Joseph E/A-3122-2008; Angus, Valerie/A-5324-2008; Hannaford, Philip C/B-7867-2012	Iversen, Lisa/0000-0002-2524-5229; Macfarlane, Tatiana/0000-0002-9392-0812	Royal College of General Practitioners; Medical Research Council; Imperial Cancer Research Fund; British Heart Foundation; Cruden Foundation; Schering AG; Schering Health Care; Wyeth Ayerst International; Ortho Cilag; Searle	Royal College of General Practitioners; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Imperial Cancer Research Fund; British Heart Foundation(British Heart Foundation); Cruden Foundation; Schering AG; Schering Health Care; Wyeth Ayerst International; Ortho Cilag; Searle	The study received funding from the Royal College of General Practitioners, Medical Research Council, Imperial Cancer Research Fund, British Heart Foundation, Cruden Foundation, Schering AG, Schering Health Care, Wyeth Ayerst International, Ortho Cilag, and Searle. None of the funders had a role in the data collection, analysis, or interpretation or in the writing of this paper.	Beral V, 1999, BRIT MED J, V318, P96, DOI 10.1136/bmj.318.7176.96; Beral V, 1996, EVIDENCE GUIDED PRES, P327; COLDITZ GA, 1994, ANN INTERN MED, V120, P821, DOI 10.7326/0003-4819-120-10-199405150-00002; Hannaford PC, 2007, BRIT MED J, V335, P651, DOI 10.1136/bmj.39289.649410.55; KAY CR, 1981, LANCET, V1, P541; Owen-Smith V, 1998, J EPIDEMIOL COMMUN H, V52, P420, DOI 10.1136/jech.52.7.420; Prentice RL, 2005, AM J EPIDEMIOL, V162, P404, DOI 10.1093/aje/kwi223; Rosner B., 2000, FUNDAMENTALS BIOSTAT; *ROYAL COLL GEN PR, 1977, LANCET, V2, P727; Royal College of General Practitioners, 1974, OR CONTR HLTH; Vessey M, 2003, LANCET, V362, P185, DOI 10.1016/S0140-6736(03)13907-4; WINGRAVE SJ, 1981, J EPIDEMIOL COMMUN H, V35, P51, DOI 10.1136/jech.35.1.51	12	123	128	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 11	2010	340								c927	10.1136/bmj.c927	http://dx.doi.org/10.1136/bmj.c927			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570FE	20223876	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000275656900016
J	Schlereth, A; Moller, B; Liu, WL; Kientz, M; Flipse, J; Rademacher, EH; Schmid, M; Jurgens, G; Weijers, D				Schlereth, Alexandra; Moller, Barbara; Liu, Weilin; Kientz, Marika; Flipse, Jacky; Rademacher, Eike H.; Schmid, Markus; Juergens, Gerd; Weijers, Dolf			MONOPTEROS controls embryonic root initiation by regulating a mobile transcription factor	NATURE			English	Article							AUXIN-RESPONSE FACTORS; LOOP-HELIX PROTEINS; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; FAMILY; EMBRYOGENESIS; ACTIVATION; MUTATION; RECEPTOR; ENCODES	Acquisition of cell identity in plants relies strongly on positional information(1), hence cell-cell communication and inductive signalling are instrumental for developmental patterning. During Arabidopsis embryogenesis, an extra-embryonic cell is specified to become the founder cell of the primary root meristem, hypophysis, in response to signals from adjacent embryonic cells(2). The auxin-dependent transcription factor MONOPTEROS (MP) drives hypophysis specification by promoting transport of the hormone auxin from the embryo to the hypophysis precursor. However, auxin accumulation is not sufficient for hypophysis specification, indicating that additional MP-dependent signals are required(3). Here we describe the microarray-based isolation of MP target genes that mediate signalling from embryo to hypophysis. Of three direct transcriptional target genes, TARGET OF MP5 (TMO5) and TMO7 encode basic helix-loop-helix (bHLH) transcription factors that are expressed in the hypophysis-adjacent embryo cells, and are required and partially sufficient for MP-dependent root initiation. Importantly, the small TMO7 transcription factor moves from its site of synthesis in the embryo to the hypophysis precursor, thus representing a novel MP-dependent intercellular signal in embryonic root specification.	[Schlereth, Alexandra; Kientz, Marika; Juergens, Gerd; Weijers, Dolf] Univ Tubingen, ZMBP, D-72076 Tubingen, Germany; [Moller, Barbara; Liu, Weilin; Flipse, Jacky; Rademacher, Eike H.; Weijers, Dolf] Wageningen Univ, Biochem Lab, NL-6703 HA Wageningen, Netherlands; [Schmid, Markus] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Wageningen University & Research; Max Planck Society	Jurgens, G (corresponding author), Univ Tubingen, ZMBP, Morgenstelle 3, D-72076 Tubingen, Germany.	gerd.juergens@zmbp.uni-tuebingen.de; dolf.weijers@wur.nl	Weijers, Dolf/ABI-1332-2020; Weijers, Dolf/A-2076-2010; Schmid, Markus/I-4384-2015; Rademacher, Eike/K-2302-2012	Weijers, Dolf/0000-0003-4378-141X; Weijers, Dolf/0000-0003-4378-141X; Schmid, Markus/0000-0002-0068-2967; Flipse, Jacky/0000-0002-2195-5282; Moller, Barbara/0000-0001-6521-4200	Netherlands Organization for Scientific Research (NWO) [VIDI 864.06.012]; Deutsche Forschungsgemeinschaft (DFG) [SFB446]; Netherlands Proteomics Centre (NPC)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Netherlands Proteomics Centre (NPC)	We acknowledge P. van Oorschot, A. van Haperen and S. Heilbronner for technical assistance, C. Arsene for plant care, S. de Folter and O. Mathieu for advice on ChIP, M. Wunderlich and G. Bijl for help with qPCR, G. Hooiveld for help with statistical analysis of the microarray data and the Nottingham Arabidopsis Stock Centre for mutant and transgenic seeds. We thank P. Maier, S. de Vries, A. Koltunow, A. Lokerse, S. Saiga, V. Willemsen and M. Tsiantis for discussions and comments on the manuscript. This work was supported by grants from the Netherlands Organization for Scientific Research (NWO; VIDI 864.06.012 to D.W.), from the Deutsche Forschungsgemeinschaft (DFG; SFB446 to G.J.) and the Netherlands Proteomics Centre (NPC; D. W., grant awarded to S. de Vries).	Aker J, 2006, J STRUCT BIOL, V156, P62, DOI 10.1016/j.jsb.2006.03.004; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cole M, 2009, DEVELOPMENT, V136, P1643, DOI 10.1242/dev.032177; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Donner TJ, 2009, DEVELOPMENT, V136, P3235, DOI 10.1242/dev.037028; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Hamann T, 1999, DEVELOPMENT, V126, P1387; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; Lee S, 2006, PLANT CELL PHYSIOL, V47, P591, DOI 10.1093/pcp/pcj026; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Rashotte AM, 2006, P NATL ACAD SCI USA, V103, P11081, DOI 10.1073/pnas.0602038103; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Scheres B, 2001, PLANT PHYSIOL, V125, P112, DOI 10.1104/pp.125.1.112; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Takada S, 2007, DEVELOPMENT, V134, P1141, DOI 10.1242/dev.02803; Tian Q, 2002, PLANT CELL, V14, P301, DOI 10.1105/tpc.010283; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; van den Bosch HM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-267; Wang H, 2009, PLANT CELL, V21, P3781, DOI 10.1105/tpc.109.072504; Weigel D, 2002, NATURE, V415, P751, DOI 10.1038/415751a; Weijers D, 2006, DEV CELL, V10, P265, DOI 10.1016/j.devcel.2005.12.001; Weijers D, 2005, EMBO J, V24, P1874, DOI 10.1038/sj.emboj.7600659; Weijers D, 2001, DEVELOPMENT, V128, P4289; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683	36	396	422	7	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					913	U128		10.1038/nature08836	http://dx.doi.org/10.1038/nature08836			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20220754				2022-12-28	WOS:000276397300042
J	Kim, CH; Qi, GS; Dahlberg, K; Li, W				Kim, Chang Hwan; Qi, Gongshin; Dahlberg, Kevin; Li, Wei			Strontium-Doped Perovskites Rival Platinum Catalysts for Treating NOx in Simulated Diesel Exhaust	SCIENCE			English	Article							METHANE COMBUSTION; NITROGEN MONOXIDE; AUTO EXHAUST; REDUCTION; OXIDATION; OXIDES; METAL; LAMNO3; PERFORMANCE; PALLADIUM	The high cost and poor thermal durability of current lean nitrogen oxides (NOx) aftertreatment catalysts are two of the major barriers to widespread adoption of highly fuel-efficient diesel engines. We demonstrated the use of strontium-doped perovskite oxides as efficient platinum substitutes in diesel oxidation (DOC) and lean NOx trap (LNT) catalysts. The lanthanum-based perovskite catalysts coated on monolith substrates showed excellent activities for the NO oxidation reaction, a critical step that demands heavy usage of platinum in a current diesel aftertreatment system. Under realistic conditions, La1-xSrxCoO3 catalysts achieved higher NO-to-NO2 conversions than a commercial platinum-based DOC catalyst. Similarly, a La0.9Sr0.1MnO3-based LNT catalyst achieved NOx reduction performance comparable to that of a commercial platinum-based counterpart. The results show promise for a considerably lower-cost diesel exhaust treatment system.	[Kim, Chang Hwan; Qi, Gongshin; Dahlberg, Kevin; Li, Wei] Gen Motors Global Res & Dev, Chem Sci & Mat Syst Lab, Warren, MI 48090 USA	General Motors	Li, W (corresponding author), Gen Motors Global Res & Dev, Chem Sci & Mat Syst Lab, 30500 Mound Rd, Warren, MI 48090 USA.	wei.1.li@gm.com	Kim, Chang/E-7752-2010	Kim, Chang/0000-0001-5729-0967; qi, gongshin/0000-0003-2508-1946				Alifanti M, 2003, APPL CATAL B-ENVIRON, V41, P71, DOI 10.1016/S0926-3373(02)00194-7; Arendt E, 2008, APPL CATAL A-GEN, V339, P1, DOI 10.1016/j.apcata.2008.01.016; Bialobok B, 2007, APPL CATAL B-ENVIRON, V72, P395, DOI 10.1016/j.apcatb.2006.12.006; Bourges P, 1998, STUD SURF SCI CATAL, V116, P213; Despres J, 2004, APPL CATAL B-ENVIRON, V50, P73, DOI 10.1016/j.apcatb.2003.12.020; Engelmann-Pirez M, 2005, CATAL TODAY, V107-08, P315, DOI 10.1016/j.cattod.2005.07.087; FARRAUTO RJ, 1992, APPL CATAL A-GEN, V81, P227, DOI 10.1016/0926-860X(92)80095-T; FIERRO JLG, 1984, J CATAL, V89, P209, DOI 10.1016/0021-9517(84)90298-7; Irfan MF, 2008, APPL CATAL B-ENVIRON, V78, P267, DOI 10.1016/j.apcatb.2007.09.029; Koebel M, 2000, CATAL TODAY, V59, P335, DOI 10.1016/S0920-5861(00)00299-6; Koebel M, 2002, CATAL TODAY, V73, P239, DOI 10.1016/S0920-5861(02)00006-8; Koponen MJ, 2006, J MOL CATAL A-CHEM, V258, P246, DOI 10.1016/j.molcata.2006.05.045; Li N, 2008, SOLID STATE IONICS, V179, P1396, DOI 10.1016/j.ssi.2008.01.060; LIBBY WF, 1971, SCIENCE, V171, P499, DOI 10.1126/science.171.3970.499; Pena MA, 2001, CHEM REV, V101, P1981, DOI 10.1021/cr980129f; Ponce S, 2000, APPL CATAL B-ENVIRON, V24, P193, DOI 10.1016/S0926-3373(99)00111-3; Salasc S, 2002, APPL CATAL B-ENVIRON, V36, P145, DOI 10.1016/S0926-3373(01)00300-9; Satterfield C.N., 1980, HETEROGENEOUS CATALY; SCHLATTE.JC, 1973, SCIENCE, V179, P798, DOI 10.1126/science.179.4075.798; SEIYAMA T, 1985, IND ENG CHEM PROD RD, V24, P19, DOI 10.1021/i300017a005; Spinicci R, 2003, J MOL CATAL A-CHEM, V197, P147, DOI 10.1016/S1381-1169(02)00621-0; Takahashi N, 1996, CATAL TODAY, V27, P63, DOI 10.1016/0920-5861(95)00173-5; Tanaka H, 2001, CURR OPIN SOLID ST M, V5, P381, DOI 10.1016/S1359-0286(01)00035-3; Tanigawa H, 2007, J NUCL MATER, V367, P42, DOI 10.1016/j.jnucmat.2007.03.167; VOORHOEV.RJ, 1972, SCIENCE, V177, P353, DOI 10.1126/science.177.4046.353; VOORHOEVE RJH, 1977, SCIENCE, V195, P827, DOI 10.1126/science.195.4281.827; Wen Y, 2007, CATAL TODAY, V126, P400, DOI 10.1016/j.cattod.2007.06.032; Yung MM, 2007, J CATAL, V247, P356, DOI 10.1016/j.jcat.2007.02.020	28	474	502	19	514	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	2010	327	5973					1624	1627		10.1126/science.1184087	http://dx.doi.org/10.1126/science.1184087			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339068				2022-12-28	WOS:000275970600038
J	Pless, ML; Chen, YB; Copen, WA; Frosch, MP				Pless, Misha L.; Chen, Yi-Bin; Copen, William A.; Frosch, Matthew P.			A Woman with Paresthesias and Ataxia Intravascular large-B-cell lymphoma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; ANTHRACYCLINE-BASED CHEMOTHERAPY; HIGH-DOSE CHEMOTHERAPY; PRIMARY CNS LYMPHOMA; MATRIX METALLOPROTEINASES; ADHESION MOLECULES; MULTIPLE-SCLEROSIS; 1ST-LINE TREATMENT; TRANSPLANTATION; RADIOTHERAPY		[Pless, Misha L.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Chen, Yi-Bin] Massachusetts Gen Hosp, Div Hematol & Oncol, Boston, MA 02114 USA; [Copen, William A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Frosch, Matthew P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Pless, Misha L.] Harvard Univ, Sch Med, Dept Neurol, Cambridge, MA 02138 USA; [Chen, Yi-Bin] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Copen, William A.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Frosch, Matthew P.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University	Pless, ML (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.		Frosch, Matthew P/ABD-7456-2021	Frosch, Matthew P/0000-0002-3940-9861	Bayer; EMD Serono; Pfizer; Teva Neuroscience; Novartis; Elsevier	Bayer(Bayer AG); EMD Serono; Pfizer(Pfizer); Teva Neuroscience(Teva Pharmaceutical Industries); Novartis(Novartis); Elsevier	Dr. Pless reports receiving consulting fees from Bayer, EMD Serono, Pfizer, and Teva Neuroscience; honoraria from Bayer, EMD Serono, Novartis, Pfizer, and Teva Neuroscience; and grant support from EMD Serono; and Dr. Frosch, receiving honoraria from Elsevier. No other potential conflict of interest relevant to this article was reported.	Batchelor TT, 2005, NEW ENGL J MED, V352, P185, DOI 10.1056/NEJMcpc049033; Bazhenova L, 2006, LEUKEMIA LYMPHOMA, V47, P337, DOI 10.1080/10428190500300837; Brevet M, 2005, EUR J HAEMATOL, V75, P288, DOI 10.1111/j.1600-0609.2005.00508.x; Carroll MB, 2007, JCR-J CLIN RHEUMATOL, V13, P334, DOI 10.1097/RHU.0b013e31815c2516; Cheng G, 2003, BONE MARROW TRANSPL, V31, P679, DOI 10.1038/sj.bmt.1703917; DeAngelis LM, 2002, J CLIN ONCOL, V20, P4643, DOI 10.1200/JCO.2002.11.013; Delalande S, 2004, MEDICINE, V83, P280, DOI 10.1097/01.md.0000141099.53742.16; Ferreira S, 2005, RHEUMATOLOGY, V44, P434, DOI 10.1093/rheumatology/keh532; Ferreri AJM, 2004, ANN ONCOL, V15, P1215, DOI 10.1093/annonc/mdh274; Ferreri AJM, 2008, BRIT J HAEMATOL, V143, P253, DOI 10.1111/j.1365-2141.2008.07338.x; Ferreri AJM, 2007, HAEMATOLOGICA, V92, P486, DOI 10.3324/haematol.10829; FERRY JA, 1988, MODERN PATHOL, V1, P444; Illerhaus G, 2007, HAEMATOLOGICA, V93, P147, DOI 10.3324/haematol.11771; Illerhaus G, 2006, J CLIN ONCOL, V24, P3865, DOI 10.1200/JCO.2006.06.2117; Imai H, 2004, PATHOL INT, V54, P231, DOI 10.1111/j.1440-1827.2004.01613.x; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Kinoshita M, 2008, BRAIN TUMOR PATHOL, V25, P73, DOI 10.1007/s10014-008-0232-x; Molloy ES, 2008, CURR OPIN RHEUMATOL, V20, P29, DOI 10.1097/BOR.0b013e3282f1dcf2; Nakamura S., 2008, WHO CLASSIFICATION T, P252; Ponzoni M, 2000, HUM PATHOL, V31, P220, DOI 10.1016/S0046-8177(00)80223-3; Ponzoni M, 2007, J CLIN ONCOL, V25, P3168, DOI 10.1200/JCO.2006.08.2313; Rehman HU, 2000, J ROY SOC MED, V93, P586, DOI 10.1177/014107680009301108; Rhiannon JJ, 2008, CLIN REV ALLERG IMMU, V34, P356, DOI 10.1007/s12016-007-8052-z; Rolak LA, 2007, NEUROLOGIST, V13, P57, DOI 10.1097/01.nrl.0000254705.39956.34; Schmidley JW, 2008, NEUROLOGIST, V14, P138, DOI 10.1097/NRL.0b013e31815bdc2b; Shimada K, 2008, J CLIN ONCOL, V26, P3189, DOI 10.1200/JCO.2007.15.4278; Stefanidakis M, 2006, BLOOD, V108, P1441, DOI 10.1182/blood-2006-02-005363; Treadwell SD, 2007, POSTGRAD MED J, V83, P389, DOI 10.1136/pgmj.2006.055970; 2009, N ENGL J MED, V360, P1656; 2007, N ENGL J MED, V357, P807	30	5	5	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	2010	362	12					1129	1138		10.1056/NEJMcpc0910092	http://dx.doi.org/10.1056/NEJMcpc0910092			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573FU	20335590				2022-12-28	WOS:000275894600012
J	Yang, WY; Lu, JM; Weng, JP; Jia, WP; Ji, LN; Xiao, JZ; Shan, ZY; Liu, J; Tian, HM; Ji, QH; Zhu, DL; Ge, JP; Lin, LX; Chen, L; Guo, XH; Zhao, ZG; Li, Q; Zhou, ZG; Shan, GL; He, J				Yang, Wenying; Lu, Juming; Weng, Jianping; Jia, Weiping; Ji, Linong; Xiao, Jianzhong; Shan, Zhongyan; Liu, Jie; Tian, Haoming; Ji, Qiuhe; Zhu, Dalong; Ge, Jiapu; Lin, Lixiang; Chen, Li; Guo, Xiaohui; Zhao, Zhigang; Li, Qiang; Zhou, Zhiguang; Shan, Guangliang; He, Jiang		China Natl Diabet Metab Disorders	Prevalence of Diabetes among Men and Women in China	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPAIRED FASTING GLUCOSE; RISK-FACTORS; CARDIOVASCULAR-DISEASE; ADULT-POPULATION; EDUCATION; MELLITUS; OBESITY	BACKGROUND Because of the rapid change in lifestyle in China, there is concern that diabetes may become epidemic. We conducted a national study from June 2007 through May 2008 to estimate the prevalence of diabetes among Chinese adults. METHODS A nationally representative sample of 46,239 adults, 20 years of age or older, from 14 provinces and municipalities participated in the study. After an overnight fast, participants underwent an oral glucose-tolerance test, and fasting and 2-hour glucose levels were measured to identify undiagnosed diabetes and prediabetes (i.e., impaired fasting glucose or impaired glucose tolerance). Previously diagnosed diabetes was determined on the basis of self-report. RESULTS The age-standardized prevalences of total diabetes ( which included both previously diagnosed diabetes and previously undiagnosed diabetes) and prediabetes were 9.7% (10.6% among men and 8.8% among women) and 15.5% (16.1% among men and 14.9% among women), respectively, accounting for 92.4 million adults with diabetes (50.2 million men and 42.2 million women) and 148.2 million adults with prediabetes (76.1 million men and 72.1 million women). The prevalence of diabetes increased with increasing age (3.2%, 11.5%, and 20.4% among persons who were 20 to 39, 40 to 59, and >= 60 years of age, respectively) and with increasing weight (4.5%, 7.6%, 12.8%, and 18.5% among persons with a body-mass index [ the weight in kilograms divided by the square of the height in meters] of <18.5, 18.5 to 24.9, 25.0 to 29.9, and >= 30.0, respectively). The prevalence of diabetes was higher among urban residents than among rural residents (11.4% vs. 8.2%). The prevalence of isolated impaired glucose tolerance was higher than that of isolated impaired fasting glucose (11.0% vs. 3.2% among men and 10.9% vs. 2.2% among women). CONCLUSIONS These results indicate that diabetes has become a major public health problem in China and that strategies aimed at the prevention and treatment of diabetes are needed.	[Yang, Wenying] China Japan Friendship Hosp, Dept Endocrinol, Beijing 100029, Peoples R China; [Lu, Juming] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China; [Weng, Jianping] Sun Yat Sen Univ, Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Ji, Linong] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China; [Shan, Zhongyan] Chinese Med Univ, Affiliated Hosp 1, Liaoling, Peoples R China; [Liu, Jie] Shanxi Prov Peoples Hosp, Taiyuan, Shanxi, Peoples R China; [Tian, Haoming] Sichuan Univ, W China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Ji, Qiuhe] Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Zhu, Dalong] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Ge, Jiapu] Xinjiang Uygur Autonomous Reg Hosp, Urumqi, Xinjiang, Peoples R China; [Lin, Lixiang] Fujian Prov Hosp, Fuzhou, Fujiang, Peoples R China; [Chen, Li] Shandong Univ, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Guo, Xiaohui] Peking Univ, Hosp 1, Beijing 100871, Peoples R China; [Zhao, Zhigang] Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China; [Li, Qiang] Harbin Med Univ, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China; [Zhou, Zhiguang] Xiangya Second Hosp, Changsha, Hunan, Peoples R China; [Shan, Guangliang] Peking Union Med Coll, Beijing 100021, Peoples R China; [He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA	China-Japan Friendship Hospital; Chinese People's Liberation Army General Hospital; Sun Yat Sen University; Shanghai Jiao Tong University; Peking University; China Medical University; Shanxi People's Hospital; Sichuan University; Air Force Military Medical University; Nanjing University; Fujian Provincial Hospital; Shandong University; Peking University; Zhengzhou University; Harbin Medical University; Central South University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tulane University	Yang, WY (corresponding author), China Japan Friendship Hosp, Dept Endocrinol, Beijing 100029, Peoples R China.	ywy_1010@yahoo.com.cn	Shi, Zumin/A-1093-2009; Li, Hongliang/AAV-1697-2020; He, Jiang/AAF-5303-2020; Linong, Ji/AAB-6543-2020	Shi, Zumin/0000-0002-3099-3299; He, Jiang/0000-0002-8286-9652; Yang, Wenying/0000-0002-7997-9404; Zhou, Zhiguang/0000-0002-0374-1838; Weng, Jianping/0000-0002-7889-1697	Chinese Medical Association Foundation; Chinese Diabetes Society	Chinese Medical Association Foundation; Chinese Diabetes Society	Supported by grants from the Chinese Medical Association Foundation and Chinese Diabetes Society.	[Anonymous], 1981, Zhonghua Nei Ke Za Zhi, V20, P678; Borrell LN, 2006, AM J PUBLIC HEALTH, V96, P1637, DOI 10.2105/AJPH.2005.072884; Brancati FL, 1997, JAMA-J AM MED ASSOC, V278, P2069, DOI 10.1001/jama.278.23.2069; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; *DEP NONC DIS SURV, 1999, DEF DIAGN CLASS DIAB; Diabetes Prevention Program Research Group, 2002, NEW ENGL J MED, V346, P393, DOI [10.1056/NEJMoa012512, DOI 10.1056/NEJMOA012512]; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; *INT DIAB FED, 2008, DIAB ATL; Jia WP, 2007, DIABETOLOGIA, V50, P286, DOI 10.1007/s00125-006-0503-1; Ko GTC, 2001, EUR J EPIDEMIOL, V17, P289, DOI 10.1023/A:1017935707807; Leeder S, 2004, RACE TIME CHALLENGE; Levitzky YS, 2008, J AM COLL CARDIOL, V51, P264, DOI 10.1016/j.jacc.2007.09.038; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Li GW, 1996, CHINESE MED J-PEKING, V109, P599; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Luepker R. V., 2004, Cardiovascular survey methods; Muntner P, 2005, AM J PUBLIC HEALTH, V95, P1631, DOI 10.2105/AJPH.2004.044743; *NAT BUR STAT CHIN, 2006, CHIN STAT YB 2006; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; *PLAN OP 3 NAT HLT, 1994, VITAL HLTH STAT, V32, P1; Qiao Q, 2000, DIABETOLOGIA, V43, P1470, DOI 10.1007/s001250051557; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Schramm TK, 2008, CIRCULATION, V117, P1945, DOI 10.1161/CIRCULATIONAHA.107.720847; Seeman T, 2008, SOC SCI MED, V66, P72, DOI 10.1016/j.socscimed.2007.08.027; Singh RB, 1998, INT J CARDIOL, V66, P65, DOI 10.1016/S0167-5273(98)00141-7; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yan LJL, 2006, JAMA-J AM MED ASSOC, V295, P1793, DOI 10.1001/jama.295.15.1793; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5	33	2349	3758	26	782	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	2010	362	12					1090	1101		10.1056/NEJMoa0908292	http://dx.doi.org/10.1056/NEJMoa0908292			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573FU	20335585	Bronze			2022-12-28	WOS:000275894600006
J	Detering, KM; Hancock, AD; Reade, MC; Silvester, W				Detering, Karen M.; Hancock, Andrew D.; Reade, Michael C.; Silvester, William			The impact of advance care planning on end of life care in elderly patients: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DECISION-MAKING; FAMILY-MEMBERS; MEDICAL-CARE; EVENT SCALE; DISCUSSIONS; DIRECTIVES; DEATH; DEPRESSION; SYMPTOMS; AUTONOMY	Objective To investigate the impact of advance care planning on end of life care in elderly patients. Design Prospective randomised controlled trial. Setting Single centre study in a university hospital in Melbourne, Australia. Participants 309 legally competent medical inpatients aged 80 or more and followed for six months or until death. Interventions Participants were randomised to receive usual care or usual care plus facilitated advance care planning. Advance care planning aimed to assist patients to reflect on their goals, values, and beliefs; to consider future medical treatment preferences; to appoint a surrogate; and to document their wishes. Main outcome measures The primary outcome was whether a patient's end of life wishes were known and respected. Other outcomes included patient and family satisfaction with hospital stay and levels of stress, anxiety, and depression in relatives of patients who died. Results 154 of the 309 patients were randomised to advance care planning, 125 (81%) received advance care planning, and 108 (84%) expressed wishes or appointed a surrogate, or both. Of the 56 patients who died by six months, end of life wishes were much more likely to be known and followed in the intervention group (25/29, 86%) compared with the control group (8/27, 30%; P<0.001). In the intervention group, family members of patients who died had significantly less stress (intervention 5, control 15; P<0.001), anxiety (intervention 0, control 3; P=0.02), and depression (intervention 0, control 5; P=0.002) than those of the control patients. Patient and family satisfaction was higher in the intervention group. Conclusions Advance care planning improves end of life care and patient and family satisfaction and reduces stress, anxiety, and depression in surviving relatives. Trial registration Australian New Zealand clinical trials registry ACTRN12608000539336.	[Detering, Karen M.; Hancock, Andrew D.; Silvester, William] Austin Hlth, Respecting Patient Choices Program, Heidelberg, Vic 3084, Australia; [Reade, Michael C.] Austin Hlth, Intens Care Unit, Heidelberg, Vic 3084, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Detering, KM (corresponding author), Austin Hlth, Respecting Patient Choices Program, POB 555, Heidelberg, Vic 3084, Australia.	Karen.detering@austin.org.au	Reade, Michael/G-7035-2012	Reade, Michael/0000-0003-1570-0707	Australian Commonwealth; Victorian state governments	Australian Commonwealth; Victorian state governments	Funding: This study was carried out using staff employed in the Respecting Patient Choices programme, which receives public funding from the Australian Commonwealth and the Victorian state governments. No external funding was utilised.	Adams DH, 2006, J AM OSTEOPATH ASSOC, V106, P402; *AUSTR MED ASS, 1998, OP 2 225 OPT US ORD; *AUSTR MED ASS, 2006, AMA BACKS ADV CAR PL; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Briggs LA, 2004, J PROF NURS, V20, P47, DOI 10.1016/j.profnurs.2003.12.001; Briggs Linda, 2004, J Palliat Med, V7, P341, DOI 10.1089/109662104773709503; *BRIT MED ASS, 2007, END OF LIF DEC; Cartwright Colleen M, 2004, Aust Fam Physician, V33, P815; Drazen JM, 2009, NEW ENGL J MED, V360, P444, DOI 10.1056/NEJMp0809496; EMANUEL LL, 1991, NEW ENGL J MED, V324, P889, DOI 10.1056/NEJM199103283241305; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Gillick MR, 2004, NEW ENGL J MED, V350, P7, DOI 10.1056/NEJMp038202; Grimaldo DA, 2001, ANESTHESIOLOGY, V95, P43, DOI 10.1097/00000542-200107000-00012; Hammes BJ, 1998, ARCH INTERN MED, V158, P383, DOI 10.1001/archinte.158.4.383; HAMMES BJ, 1999, LESSONS RESPECTING Y; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Keay Timothy J, 2003, J Palliat Med, V6, P205, DOI 10.1089/109662103764978452; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; Levinsky NG, 1996, NEW ENGL J MED, V335, P741, DOI 10.1056/NEJM199609053351012; Medical Research Council, 2008, DEV EV COMPL INT NEW; MORRISON RS, 1994, ARCH INTERN MED, V154, P2311, DOI 10.1001/archinte.154.20.2311; Pearlman RA, 2005, ARCH INTERN MED, V165, P667, DOI 10.1001/archinte.165.6.667; Perkins HS, 2007, ANN INTERN MED, V147, P51, DOI 10.7326/0003-4819-147-1-200707030-00008; Pochard F, 2001, CRIT CARE MED, V29, P1893, DOI 10.1097/00003246-200110000-00007; Prendergast TJ, 2001, CRIT CARE MED, V29, pN34, DOI 10.1097/00003246-200102001-00007; Ramsaroop SD, 2007, J AM GERIATR SOC, V55, P277, DOI 10.1111/j.1532-5415.2007.01065.x; Romer Anna L, 2004, J Palliat Med, V7, P335, DOI 10.1089/109662104773709495; Schwartz Carolyn, 2003, J Palliat Med, V6, P593, DOI 10.1089/109662103768253704; Schwartz CE, 2002, ARCH INTERN MED, V162, P1611, DOI 10.1001/archinte.162.14.1611; Singer PA, 1998, ARCH INTERN MED, V158, P879, DOI 10.1001/archinte.158.8.879; Singer PA, 1996, CAN MED ASSOC J, V155, P1689; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Skene L., 2008, LAW MED PRACTICE RIG, V3rd, P346; Song MK, 2005, MED CARE, V43, P1049, DOI 10.1097/01.mlr.0000178192.10283.b4; Song MK, 2004, NURS OUTLOOK, V52, P118, DOI 10.1016/j.outlook.2003.10.014; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; Sundin EC, 2003, PSYCHOSOM MED, V65, P870, DOI 10.1097/01.PSY.0000084835.46074.F0; *SUPPORT PRINC INV, 1996, JAMA-J AM MED ASSOC, V275, P1232, DOI DOI 10.1001/JAMA.1995.03530200027032; Tierney WM, 2001, J GEN INTERN MED, V16, P32, DOI 10.1111/j.1525-1497.2001.00215.x; Tilden VP, 2001, NURS RES, V50, P105, DOI 10.1097/00006199-200103000-00006; Tolle SW, 1998, J AM GERIATR SOC, V46, P1097, DOI 10.1111/j.1532-5415.1998.tb06647.x; Tulsky JA, 2005, JAMA-J AM MED ASSOC, V294, P359, DOI 10.1001/jama.294.3.359; Volandes AE, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2159; Winzelberg GS, 2005, J AM GERIATR SOC, V53, P1046, DOI 10.1111/j.1532-5415.2005.53317.x; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	46	1408	1427	3	62	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2010	340								c1345	10.1136/bmj.c1345	http://dx.doi.org/10.1136/bmj.c1345			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	576PO	20332506	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000276157600005
J	Neely, RDG; Bassendine, MF				Neely, R. Dermot G.; Bassendine, Margaret F.			Antisense technology to lower LDL cholesterol	LANCET			English	Editorial Material							NONALCOHOLIC FATTY LIVER; FAMILIAL HYPOBETALIPOPROTEINEMIA; APOLIPOPROTEIN-B; HYPERCHOLESTEROLEMIA		[Neely, R. Dermot G.] Royal Victoria Infirm, Dept Clin Biochem, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Bassendine, Margaret F.] Univ Newcastle, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Neely, RDG (corresponding author), Royal Victoria Infirm, Dept Clin Biochem, Queen Victoria Rd, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	Dermot.Neely@nuth.nhs.uk			Medical Research Council [G0502028] Funding Source: Medline; MRC [G0502028] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bonnefont-Rousselot D, 2009, EUR J GASTROEN HEPAT, V21, P104, DOI 10.1097/MEG.0b013e3282ffd9f8; Burnett JR, 2006, CURR OPIN MOL THER, V8, P461; Funatsu T, 2002, EUR J PHARMACOL, V455, P161, DOI 10.1016/S0014-2999(02)02611-0; Lin X, 2002, ARTERIOSCL THROM VAS, V22, P476, DOI 10.1161/hq0302.105271; Olofsson SO, 1999, CURR OPIN LIPIDOL, V10, P341, DOI 10.1097/00041433-199908000-00008; Raal FJ, 2010, LANCET, V375, P998, DOI 10.1016/S0140-6736(10)60284-X; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Sankatsing RR, 2005, ARTERIOSCL THROM VAS, V25, P1979, DOI 10.1161/01.ATV.0000176191.64314.07; Schonfeld G, 2003, J LIPID RES, V44, P878, DOI 10.1194/jlr.R300002-JLR200; Tanoli T, 2004, J LIPID RES, V45, P941, DOI 10.1194/jlr.M300508-JLR200; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Visser ME, 2010, J LIPID RES, V51, P1057, DOI 10.1194/jlr.M002915	13	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 20	2010	375	9719					959	961		10.1016/S0140-6736(10)60364-9	http://dx.doi.org/10.1016/S0140-6736(10)60364-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	575YU	20227757				2022-12-28	WOS:000276110700005
J	Kitamura, T; Iwami, T; Kawamura, T; Nagao, K; Tanaka, H; Hiraide, A				Kitamura, Tetsuhisa; Iwami, Taku; Kawamura, Takashi; Nagao, Ken; Tanaka, Hideharu; Hiraide, Atsushi		All-Japan Utstein Registry Fire	Nationwide Public-Access Defibrillation in Japan.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMERICAN-HEART-ASSOCIATION; HOSPITAL CARDIAC-ARREST; AUTOMATED EXTERNAL DEFIBRILLATOR; EUROPEAN-RESUSCITATION-COUNCIL; CARDIOPULMONARY-RESUSCITATION; STROKE-FOUNDATION; TASK-FORCE; STATEMENT; SURVIVAL; CARE	Background: It is unclear whether dissemination of automated external defibrillators (AEDs) in public places can improve the rate of survival among patients who have had an out-of-hospital cardiac arrest. Methods: From January 1, 2005, through December 31, 2007, we conducted a prospective, population-based, observational study involving consecutive patients across Japan who had an out-of-hospital cardiac arrest and in whom resuscitation was attempted by emergency responders. We evaluated the effect of nationwide dissemination of public-access AEDs on the rate of survival after an out-of-hospital cardiac arrest. The primary outcome measure was the 1-month rate of survival with minimal neurologic impairment. A multivariate logistic-regression analysis was performed to assess factors associated with a good neurologic outcome. Results: A total of 312,319 adults who had an out-of-hospital cardiac arrest were included in the study; 12,631 of these patients had ventricular fibrillation and had an arrest that was of cardiac origin and that was witnessed by bystanders. In 462 of these patients (3.7%), shocks were administered by laypersons with the use of public-access AEDs, and the proportion increased, from 1.2% to 6.2%, as the number of public-access AEDs increased (P<0.001 for trend). Among all patients who had a bystander-witnessed arrest of cardiac origin and who had ventricular fibrillation, 14.4% were alive at 1 month with minimal neurologic impairment; among patients who received shocks from public-access AEDs, 31.6% were alive at 1 month with minimal neurologic impairment. Early defibrillation, regardless of the type of provider (bystander or emergency-medical-services personnel), was associated with a good neurologic outcome after a cardiac arrest with ventricular fibrillation (adjusted odds ratio per 1-minute increase in the time to administration of shock, 0.91; 95% confidence interval, 0.89 to 0.92; P<0.001). The mean time to shock was reduced from 3.7 to 2.2 minutes, and the annual number of patients per 10 million population who survived with minimal neurologic impairment increased from 2.4 to 8.9 as the number of public-access AEDs increased from fewer than 1 per square kilometer of inhabited area to 4 or more. Conclusions: Nationwide dissemination of public-access AEDs in Japan resulted in earlier administration of shocks by laypersons and in an increase in the 1-month rate of survival with minimal neurologic impairment after an out-of-hospital cardiac arrest. N Engl J Med 2010;362:994-1004.	[Iwami, Taku] Kyoto Univ, Hlth Serv, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan; [Hiraide, Atsushi] Kyoto Univ, Grad Sch Med, Ctr Med Educ, Kyoto 6068501, Japan; [Nagao, Ken] Surugadai Nihon Univ Hosp, Dept Cardiol Cardiopulm Resuscitat & Emergency Ca, Tokyo, Japan; [Tanaka, Hideharu] Kokushikan Univ, Grad Sch Sport Syst, Tokyo, Japan	Kyoto University; Kyoto University; Nihon University	Iwami, T (corresponding author), Kyoto Univ, Hlth Serv, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.	iwamit@e-mail.jp	Kitamura, Tetsuhisa/AAA-2555-2020; IWAMI, Taku/HCH-0599-2022	Kitamura, Tetsuhisa/0000-0003-0107-0580; IWAMI, Taku/0000-0002-4150-7065	Fire and Disaster Management Agency; Ministry of Education, Culture, Sports, Science and Technology [19390458]	Fire and Disaster Management Agency; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported by grants from the Fire and Disaster Management Agency (to Dr. Hiraide, on behalf of the study group concerning strategy for applying the results of Utstein report for improvement of emergency service) and the Ministry of Education, Culture, Sports, Science and Technology (19390458).	[Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; [Anonymous], 2007, JAP GUID EM CAR CARD; Bardy GH, 2008, NEW ENGL J MED, V358, P1793, DOI 10.1056/NEJMoa0801651; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Caffrey SL, 2002, NEW ENGL J MED, V347, P1242, DOI 10.1056/NEJMoa020932; Capucci A, 2002, CIRCULATION, V106, P1065, DOI 10.1161/01.CIR.0000028148.62305.69; Cobb LA, 1999, JAMA-J AM MED ASSOC, V281, P1182, DOI 10.1001/jama.281.13.1182; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Hallstrom AP, 2004, NEW ENGL J MED, V351, P637; Hazinski MF, 2005, CIRCULATION, V111, P3336, DOI 10.1161/CIRCULATIONAHA.105.165674; *HLTH WELF STAT AS, 2007, VIT STAT JAP 2005; Holzer M, 2002, NEW ENGL J MED, V346, P549; Iwami T, 2009, CIRCULATION, V119, P728, DOI 10.1161/CIRCULATIONAHA.108.802058; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; *JAP STAT ASS, 2005, SOC IND PREF 2005; *JAP STAT ASS, 2006, 2005 POP CENS JAP; Kuramoto N, 2008, RESUSCITATION, V79, P475, DOI 10.1016/j.resuscitation.2008.07.005; LARSEN MP, 1993, ANN EMERG MED, V22, P1652, DOI 10.1016/S0196-0644(05)81302-2; MacDonald RD, 2001, ANN EMERG MED, V38, P262, DOI 10.1067/mem.2001.117953; *MIN INT AFF COMM, AMB SERV PLANN OFF F; Mitamura H, 2008, NAT CLIN PRACT CARD, V5, P690, DOI 10.1038/ncpcardio1330; Nichol G, 2009, ANN EMERG MED, V54, P226, DOI 10.1016/j.annemergmed.2009.01.021; Nishiyama C, 2008, RESUSCITATION, V79, P90, DOI 10.1016/j.resuscitation.2008.05.009; Page RL, 2000, NEW ENGL J MED, V343, P1210, DOI 10.1056/NEJM200010263431702; Rea TD, 2003, CIRCULATION, V107, P2780, DOI 10.1161/01.CIR.0000070950.17208.2A; Rea TD, 2006, CIRCULATION, V114, P2760, DOI 10.1161/CIRCULATIONAHA.106.654715; Sayre MR, 2008, CIRCULATION, V117, P2162, DOI 10.1161/CIRCULATIONAHA.107.189380; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; van Alem AP, 2003, BMJ-BRIT MED J, V327, P1312, DOI 10.1136/bmj.327.7427.1312; White RD, 2005, RESUSCITATION, V65, P279, DOI 10.1016/j.resuscitation.2004.10.018; REPORT STUDY SOCIAL; JAPAN FDN EMERGENCY	32	402	407	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2010	362	11					994	1004		10.1056/NEJMoa0906644	http://dx.doi.org/10.1056/NEJMoa0906644			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570CY	20237345	Bronze, Green Published			2022-12-28	WOS:000275650400010
J	Seppelt, I; Sullivan, E; Bellomo, R; Ellwood, D; Finfer, S; Howe, B; Knight, M; McArthur, C; McDonnell, N; McLintock, C; Morgan, TJ; Morrison, S; Nguyen, N; Peek, MJ; Pollock, W; Vaughan, G; Wang, YA; Web, SAR; Pettila, V; Bailey, M; Cooper, DJ; Cretikos, M; Davies, AR; Finfer, S; Harrigan, PWJ; Hart, GK; Howe, B; Iredell, J; McArthur, C; Mitchell, I; Morrison, S; Nichol, A; Paterson, DL; Peake, S; Richards, B; Stephens, D; Turner, A; Yung, M; Homer, C; Pulver, LJ; Knight, M; Peek, MJ; Elliot, E; Ho, T; McDonnell, N; McLintock, C; Thompson, J; Zurynski, Y; Callaway, L; Welsh, A; Oats, J; Gupta, B; Hague, W; Pollock, W; Vaughan, G; Wang, YA; Mckee, A; McGuinness, S; Parke, R; Whitley, A; Newby, L; Simmonds, C; Eastwood, G; Peck, L; Fletcher, J; Boschert, C; Smith, J; Bennett, G; Ong, L; Nand, K; Reece, G; Sara, T; Ernest, D; Eliott, S; Sidhu, J; Carroll, A; Richmond, S; Wenck, D; Bishop, G; Ashley, R; Crowfoot, E; Henderson, S; Mehrtens, J; Cretikos, M; Fizzell, J; Faithfull, S; Baynes, T; Bersten, A; Ryan, E; Scroggs, S; Blythe, D; Palermo, A; Bortz, P; Lodding, K; Mott, M; Vagg, S; Frengley, R; Haslam, A; La Pine, M; Bingham, T; Cavill, D; Jennings, B; Parr, M; Micallef, S; Chaplin, J; Gregory, K; Morgan, T; Presneill, J; Sutton, J; Horsley, C; Tai, J; Tilsley, A; Crozier, T; Galt, P; Reilly, M; Rockell, J; Hoyling, L; Nguyen, N; Weisbrodt, L; Bell, J; Flanagan, A; Laing, J; Duke, G; Parkes, M; Carr, J; Lambert, J; Boots, R; Callaway, L; Lassig-Smith, M; McLaine, J; Thomas, J; Winter, S; Barge, D; Caf, T; Harley, N; MacIsaac, C; Bird, S; Raper, R; Chamberlain, J; Gould, A; McEntaggart, G; Gattas, D; Rajbhandari, D; Rees, C; Baker, S; Bicknell, A; Roberts, B; Nair, P; Reynolds, C; Evans, J; Gordon, G; Jones, L; Radtke, S; Andrews, L; Elder, R; Hicks, P; Mackle, D; Boyd, R; Mudaliar, Y; Nayyar, V; Skelly, C; Stachowski, E; Sterba, M; Johnson, B; Hague, W; Robinson, J				Seppelt, I.; Sullivan, Elizabeth; Bellomo, Rinaldo; Ellwood, David; Finfer, Simon; Howe, Belinda; Knight, Marian; McArthur, Colin; McDonnell, Nolan; McLintock, Clare; Morgan, Thomas John; Morrison, Siouxzy; Nguyen, Nhi; Peek, Michael John; Pollock, Wendy; Vaughan, Geraldine; Wang, Yueping Alex; Web, Steven A. R.; Pettila, V.; Bailey, M.; Cooper, D. J.; Cretikos, M.; Davies, A. R.; Finfer, S.; Harrigan, P. W. J.; Hart, G. K.; Howe, B.; Iredell, J.; McArthur, C.; Mitchell, I.; Morrison, S.; Nichol, A.; Paterson, D. L.; Peake, S.; Richards, B.; Stephens, D.; Turner, A.; Yung, M.; Homer, C.; Pulver, L. J.; Knight, M.; Peek, M. J.; Elliot, E.; Ho, T.; McDonnell, N.; McLintock, C.; Thompson, J.; Zurynski, Y.; Callaway, L.; Welsh, A.; Oats, J.; Gupta, B.; Hague, W.; Pollock, W.; Vaughan, G.; Wang, Y. A.; McKee, A.; McGuinness, S.; Parke, R.; Whitley, A.; Newby, L.; Simmonds, C.; Eastwood, G.; Peck, L.; Fletcher, J.; Boschert, C.; Smith, J.; Bennett, G.; Ong, L.; Nand, K.; Reece, G.; Sara, T.; Ernest, D.; Eliott, S.; Sidhu, J.; Carroll, A.; Richmond, S.; Wenck, D.; Bishop, G.; Ashley, R.; Crowfoot, E.; Henderson, S.; Mehrtens, J.; Cretikos, M.; Fizzell, J.; Faithfull, S.; Baynes, T.; Bersten, A.; Ryan, E.; Scroggs, S.; Blythe, D.; Palermo, A.; Bortz, P.; Lodding, K.; Mott, M.; Vagg, S.; Frengley, R.; Haslam, A.; La Pine, M.; Bingham, T.; Cavill, D.; Jennings, B.; Parr, M.; Micallef, S.; Chaplin, J.; Gregory, K.; Morgan, T. J.; Presneill, J.; Sutton, J.; Horsley, C.; Tai, J.; Tilsley, A.; Crozier, T.; Galt, P.; Reilly, M.; Rockell, J.; Hoyling, L.; Nguyen, N.; Weisbrodt, L.; Bell, J.; Flanagan, A.; Laing, J.; Duke, G.; Parkes, M.; Carr, J.; Lambert, J.; Boots, R.; Callaway, L.; Lassig-Smith, M.; McLaine, J.; Thomas, J.; Winter, S.; Barge, D.; Caf, T.; Harley, N.; MacIsaac, C.; Bird, S.; Raper, R.; Chamberlain, J.; Gould, A.; McEntaggart, G.; Gattas, D.; Rajbhandari, D.; Rees, C.; Baker, S.; Bicknell, A.; Roberts, B.; Nair, P.; Reynolds, C.; Evans, J.; Gordon, G.; Jones, L.; Radtke, S.; Andrews, L.; Elder, R.; Hicks, P.; Mackle, D.; Boyd, R.; Mudaliar, Y.; Nayyar, V.; Skelly, C.; Stachowski, E.; Sterba, M.; Johnson, B.; Hague, W.; Robinson, J.		ANZIC Influenza Investigators; Australasian Maternity Outcomes Su; ANZICS CTG; ANZIC RC; ASID CTG; PSG; ANZICS CORE; AMOSS	Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To describe the epidemiology of 2009 A/H1N1 influenza in critically ill pregnant women. Design Population based cohort study. Setting All intensive care units in Australia and New Zealand. Participants All women with 2009 H1N1 influenza who were pregnant or recently post partum and admitted to an intensive care unit in Australia or New Zealand between 1 June and 31 August 2009. Main outcome measures Maternal and neonatal mortality and morbidity. Results 64 pregnant or postpartum women admitted to an intensive care unit had confirmed 2009 H1N1 influenza. Compared with non-pregnant women of childbearing age, pregnant or postpartum women with 2009 H1N1 influenza were at increased risk of admission to an intensive care unit (relative risk 7.4, 95% confidence interval 5.5 to 10.0). This risk was 13-fold greater (13.2, 9.6 to 18.3) for women at 20 or more weeks' gestation. At the time of admission to an intensive care unit, 22 women (34%) were post partum and two had miscarried. 14 women (22%) gave birth during their stay in intensive care and 26 (41%) were discharged from an intensive care unit with ongoing pregnancy. All subsequently delivered. 44 women (69%) were mechanically ventilated. Of these, nine (14%) were treated with extracorporeal membrane oxygenation. Seven women (11%) died. Of 60 births after 20 weeks' gestation, four were stillbirths and three were infant deaths. 22 (39%) of the liveborn babies were preterm and 32 (57%) were admitted to a neonatal intensive care unit. Of 20 babies tested, two were positive for the 2009 H1N1 virus. Conclusions Pregnancy is a risk factor for critical illness related to 2009 H1N1 influenza, which causes maternal and neonatal morbidity and mortality.	[Seppelt, I.] Nepean Hosp, Dept Intens Care Med, POB 63 Penrith, Sydney, NSW 2751, Australia; [Seppelt, I.; Nguyen, Nhi; Peek, Michael John] Sydney Med Sch, Sydney, NSW, Australia; [Sullivan, Elizabeth; Pollock, Wendy; Vaughan, Geraldine; Wang, Yueping Alex] Univ New S Wales, Perinatal & Reprod Epidemiol Res Unit, Sch Womens & Childrens Hlth, Kensington, NSW 2033, Australia; [Bellomo, Rinaldo] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic, Australia; [Ellwood, David] Australian Natl Univ, Canberra, ACT, Australia; [Ellwood, David] Canberra Hosp, Dept Obstet & Gynaecol, Canberra, ACT, Australia; [Finfer, Simon] Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia; [Howe, Belinda; Morrison, Siouxzy] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Clayton, Vic 3168, Australia; [Knight, Marian] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX1 2JD, England; [McArthur, Colin] Auckland City Hosp, Dept Crit Care Med, Auckland, New Zealand; [McDonnell, Nolan] King Edward Mem Hosp Women, Dept Anaesthesia & Pain Med, Perth, WA, Australia; [McDonnell, Nolan] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA, Australia; [McLintock, Clare] Auckland City Hosp, Dept Womens Hlth, Auckland, New Zealand; [Morgan, Thomas John] Mater Hlth Serv, Adult Intens Care Unit, Brisbane, Qld, Australia; [Morgan, Thomas John] Univ Queensland, Sch Med Anaesthesiol & Critical Care, Brisbane, Qld, Australia; [Pollock, Wendy] Univ Melbourne, Dept Nursing, Parkville, Vic 3052, Australia; [Web, Steven A. R.] Royal Perth Hosp, Dept Intens Care Med, Perth, WA, Australia; [Web, Steven A. R.] Univ Western Australia, Sch Populat Hlth, Perth, WA, Australia; [Web, Steven A. R.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA, Australia; [Pettila, V.; Howe, B.; Morrison, S.] ANZIC Res Ctr, Melbourne, Vic, Australia; [McKee, A.; McGuinness, S.; Parke, R.; Whitley, A.] Auckland City Hosp Cardiovasc Intens Care Unit, Auckland, New Zealand; [McArthur, C.; Newby, L.; Simmonds, C.] Auckland City Hosp, Dept Crit Care Med, Auckland, New Zealand; [Bellomo, Rinaldo; Eastwood, G.; Peck, L.] Austin & Repatriat Med Ctr, Melbourne, Vic, Australia; [Fletcher, J.; Boschert, C.; Smith, J.] Bendigo Hosp, Bendigo, Vic, Australia; [Bennett, G.; Ong, L.] Bankstown Hosp, Sydney, NSW, Australia; [Nand, K.; Reece, G.; Sara, T.] Blacktown Hosp, Sydney, NSW, Australia; [Ernest, D.; Eliott, S.; Sidhu, J.] Box Hill Hosp, Melbourne, Vic, Australia; [Carroll, A.; Richmond, S.; Wenck, D.] Cairns Base Hosp, Cairns, Qld, Australia; [Bishop, G.] Campbelltown Hosp, Sydney, NSW, Australia; [Mitchell, I.; Ashley, R.; Crowfoot, E.] Canberra Hosp, Canberra, ACT, Australia; [Henderson, S.; Mehrtens, J.] Christchurch Hosp, Christchurch, New Zealand; [Cretikos, M.; Fizzell, J.; Faithfull, S.] Dept Hlth, Sydney, NSW, Australia; [Baynes, T.; Bersten, A.; Ryan, E.; Scroggs, S.] Flinders Med Ctr, Bedford Pk, SA, Australia; [Blythe, D.; Palermo, A.] Fremantle Hosp, Fremantle, WA, Australia; [Bortz, P.; Lodding, K.; Mott, M.; Vagg, S.] Griffith Base Hosp, Griffith, NSW, Australia; [Frengley, R.; Haslam, A.; La Pine, M.] Hlth Waikato, Waikato, New Zealand; [McDonnell, N.; Bingham, T.; Cavill, D.; Jennings, B.] King Edward Mem Hosp Women, Subiaco, WA, Australia; [Parr, M.; Micallef, S.] Liverpool Hosp, Liverpool, Merseyside, England; [Chaplin, J.; Gregory, K.; Morgan, T. J.; Presneill, J.; Sutton, J.] Mater Adult Hosp, Brisbane, Qld, Australia; [Horsley, C.; Tai, J.; Tilsley, A.] Middlemore Hosp, Auckland, New Zealand; [Crozier, T.; Galt, P.; Reilly, M.] Monash Med Ctr, Melbourne, Vic, Australia; [Rockell, J.] Mt Isa Base Hosp, Mt Isa, Qld, Australia; [Seppelt, I.; Hoyling, L.; Nguyen, N.; Weisbrodt, L.] Nepean Hosp, Penrith, NSW, Australia; [Bell, J.; Flanagan, A.; Laing, J.] N Shore Hosp, Auckland, New Zealand; [Duke, G.; Parkes, M.] Northern Hosp, Melbourne, Vic, Australia; [Carr, J.; Lambert, J.] Orange Base Hosp, Orange, NSW, Australia; [Callaway, L.; Boots, R.; Lassig-Smith, M.] Royal Brisbane Hosp, Brisbane, Qld, Australia; [Stephens, D.; McLaine, J.; Thomas, J.; Winter, S.] Royal Darwin Hosp, Darwin, NT, Australia; [Barge, D.; Caf, T.; Harley, N.; MacIsaac, C.] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Finfer, S.; Bird, S.; Raper, R.] Royal N Shore Hosp, Sydney, NSW, Australia; [Web, Steven A. R.; Chamberlain, J.; Gould, A.; McEntaggart, G.] Royal Perth Hosp, Perth, WA, Australia; [Gattas, D.; Rajbhandari, D.; Rees, C.] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Baker, S.; Bicknell, A.; Roberts, B.] Sir Charles Gairdner Hosp, Nedlands, WA, Australia; [Nair, P.; Reynolds, C.] St Vincents Hosp, Sydney, NSW, Australia; [Evans, J.] Toowoomba Base Hosp, Toowoomba, Qld, Australia; [Gordon, G.; Jones, L.; Radtke, S.] Townsville Hosp, Townsville, Qld, Australia; [Andrews, L.; Elder, R.; Hicks, P.; Mackle, D.] Wellington Hosp, Wellington, New Zealand; [Boyd, R.; Mudaliar, Y.; Nayyar, V.; Skelly, C.; Stachowski, E.] Westmead Hosp, Sydney, NSW, Australia; [Sterba, M.; Johnson, B.] Wollongong Hosp, Wollongong, NSW, Australia; [Hague, W.; Robinson, J.] Women & Childrens Hosp, Adelaide, SA, Australia	Nepean Hospital; University of Sydney; University of Sydney; University of New South Wales Sydney; Monash University; Australian National University; Australian National University; Canberra Hospital; University of Sydney; Monash University; University of Oxford; Auckland City Hospital; King Edward Memorial Hospital; University of Western Australia; University of Western Australia; Auckland City Hospital; Mater Health Services; University of Queensland; University of Melbourne; Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia; Auckland City Hospital; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Blacktown & Mount Druitt Hospital; Box Hill Hospital; Australian National University; Canberra Hospital; Christchurch Hospital New Zealand; Flinders Medical Centre; University of Western Australia; King Edward Memorial Hospital; University of Western Australia; Monash University; Nepean Hospital; University of Sydney; Royal Brisbane & Women's Hospital; Royal Melbourne Hospital; Royal North Shore Hospital; University of Sydney; Royal Perth Hospital; University of Western Australia; University of Sydney; University of Western Australia; St Vincents Hospital Sydney; University of Sydney; Wollongong Hospital	Seppelt, I (corresponding author), Nepean Hosp, Dept Intens Care Med, POB 63 Penrith, Sydney, NSW 2751, Australia.	seppelt@med.usyd.edu.au	Chaplin, John/AAI-8584-2020; Vaughan, Geraldine/G-8127-2015; Knight, Marian/B-6225-2009; Peek, Michael/D-5991-2016; Gattas, David/AAN-9668-2020; Cooper, D. James/G-7961-2013; Parke, Rachael/AAX-4004-2021; Pollock, Wendy E/ABI-8269-2020	Chaplin, John/0000-0001-8128-4225; Vaughan, Geraldine/0000-0002-0132-9946; Knight, Marian/0000-0002-1984-4575; Peek, Michael/0000-0001-6055-5129; Gattas, David/0000-0002-9282-7093; Cooper, D. James/0000-0002-5872-9051; Parke, Rachael/0000-0003-4209-0334; Pollock, Wendy E/0000-0002-1091-3757; Bellomo, Rinaldo/0000-0002-1650-8939; Micallef, Sharon/0000-0002-8496-2324; Finfer, Simon/0000-0002-2785-5864	Department of Health and Ageing, Commonwealth Government of Australia; New South Wales Health, Government of New South Wales; Department of Health, Government of Victoria; Australian and New Zealand Intensive Care Research Centre; Australian and New Zealand Intensive Care Society; CSL, Melbourne, Victoria; National Health and Medical Research Council (Australia) [510298]	Department of Health and Ageing, Commonwealth Government of Australia(Australian Government); New South Wales Health, Government of New South Wales; Department of Health, Government of Victoria; Australian and New Zealand Intensive Care Research Centre; Australian and New Zealand Intensive Care Society; CSL, Melbourne, Victoria; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	The ANZIC Influenza Investigators registry is supported by the Department of Health and Ageing, Commonwealth Government of Australia; New South Wales Health, Government of New South Wales; Department of Health, Government of Victoria; the Australian and New Zealand Intensive Care Research Centre; the Australian and New Zealand Intensive Care Society; and an unrestricted grant from CSL, Melbourne, Victoria. The Australasian Maternity Outcomes Surveillance System is supported by National Health and Medical Research Council (Australia) project grant, No 510298. None of the funders had any role in the study design and the collection, analysis, and interpretation of data, or in the writing of the article and the decision to submit it for publication. The researchers confirm their independence from funders and sponsors. All researchers had access to all the data.	Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; *AUSTR BUR STAT, 2007, 3304 0 PER DEATHS; *AUSTR BUR STAT, 2008, 3235 0 POP AG SEX RE; *AUSTR BUR STAT, 2008, 33010 BIRTHS; *AUSTR BUR STAT, 2009, TABL 9 AB TORR STRAI; *AUSTR GOV, 2008, AUSTR IMM HDB; Bersten AD, 2002, AM J RESP CRIT CARE, V165, P443, DOI 10.1164/ajrccm.165.4.2101124; Chan A, 2005, MED J AUSTRALIA, V182, P447, DOI 10.5694/j.1326-5377.2005.tb06783.x; CHAN A, 2008, PREGNANCY OUTCOME S; CHENG A, 2009, MED J AUSTRALIA, V191, P1; Clifton VL, 2009, AUST NZ J OBSTET GYN, V49, P619, DOI 10.1111/j.1479-828X.2009.01077.x; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Knight M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b542; LAWS PI, 2008, PER STAT SER, V22; LEWIS G, 2001, CONFIDENTIAL ENQUIRI; Lewis G., 2007, SAVING MOTHERS LIVES; LEWIS G, 2005, CONFIDENTIAL ENQUIRI; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; *NZ MIN HLTH, 2009, MAT SNAPSH; Rasmussen SA, 2008, EMERG INFECT DIS, V14, P95, DOI 10.3201/eid1401.070667; SLAYTOR EK, 1999, MATERNAL DEATHS AUST; *STAT NZ, NAT OP EST JUN 2009; SULLIVAN EA, 2006, MATERNAL DEATH SERIE, V3; SULLIVAN EA, 2000, MATERNAL DEATHS SERI, V2; Tomlinson MW, 1998, OBSTET GYNECOL, V91, P108, DOI 10.1016/S0029-7844(97)00585-1; *UK OBST SURV SYST, 2009, 1 UK OBST SURV SYST; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Webb SAR, 2009, CRIT CARE RESUSC, V11, P170; 2009, STAT NZ ABORTION STA; AUSTR NATL VACCINE P; 2009, STAT NZ BIRTHS DEATH	36	114	116	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2010	340								c1279	10.1136/bmj.c1279	http://dx.doi.org/10.1136/bmj.c1279			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573RI	20299694	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000275931900003
J	Hawkes, N				Hawkes, Nigel			Medicine and the Media Prostate screening: is the tide turning against the test?	BRITISH MEDICAL JOURNAL			English	Editorial Material							CANCER					nigel.hawkes1@btinternet.com						ABLIN R, 2010, NY TIMES        0309; Roehr B, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1293; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084	3	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 17	2010	340								c1497	10.1136/bmj.c1497	http://dx.doi.org/10.1136/bmj.c1497			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	573RG	20236997				2022-12-28	WOS:000275931700006
J	Rothwell, PM; Howard, SC; Dolan, E; O'Brien, E; Dobson, JE; Dahlof, B; Sever, PS; Poulter, NR				Rothwell, Peter M.; Howard, Sally C.; Dolan, Eamon; O'Brien, Eoin; Dobson, Joanna E.; Dahlof, Bjorn; Sever, Peter S.; Poulter, Neil R.			Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension	LANCET			English	Article							TRANSIENT ISCHEMIC ATTACK; SOCIETY-OF-HYPERTENSION; CARDIOVASCULAR EVENTS; ANTIHYPERTENSIVE TREATMENT; REGRESSION DILUTION; RISK-FACTOR; STROKE; TRIAL; PREDICTOR; MORTALITY	Background The mechanisms by which hypertension causes vascular events are unclear. Guidelines for diagnosis and treatment focus only on underlying mean blood pressure. We aimed to reliably establish the prognostic significance of visit-to-visit variability in blood pressure, maximum blood pressure reached, untreated episodic hypertension, and residual variability in treated patients. Methods We determined the risk of stroke in relation to visit-to-visit variability in blood pressure (expressed as standard deviation [SDI and parameters independent of mean blood pressure) and maximum blood pressure in patients with previous transient ischaemic attack (TIA; UK-TIA trial and three validation cohorts) and in patients with treated hypertension (Anglo-Scandinavian Cardiac Outcomes Trial Blood Pressure Lowering Arm [ASCOT-BPLA]). In ASCOT-BPLA, 24-h ambulatory blood-pressure monitoring (ABPM) was also studied. Findings In each TIA cohort, visit-to-visit variability in systolic blood pressure (SBP) was a strong predictor of subsequent stroke (eg, top-decile hazard ratio [HR] for SD SBP over seven visits in UK-TIA trial: 6.22, 95% CI 4.16-9.29, p<0.0001), independent of mean S BP, but dependent on precision of measurement (top-decile HR over ten visits: 12.08, 7.40-19.72, p<0.0001). Maximum SBP reached was also a strong predictor of stroke (HR for top-decile over seven visits: 15.01, 6.56-34.38, p<0.0001, after adjustment for mean SBP). In ASCOT-BPLA, residual visit-to-visit variability in SBP on treatment was also a strong predictor of stroke and coronary events (eg, top-decile HR for stroke: 3.25, 2.32-4.54, p<0.0001), independent of mean S BP in clinic or on ABPM. Variability on ABPM was a weaker predictor, but all measures of variability were most predictive in younger patients and at lower (<median) values of mean SBP in every cohort. Interpretation Visit-to-visit variability in SBP and maximum SBP are strong predictors of stroke, independent of mean SBP. Increased residual variability in SBP in patients with treated hypertension is associated with a high risk of vascular events.	[Rothwell, Peter M.; Howard, Sally C.] John Radcliffe Hosp, Stroke Prevent Res Unit, Univ Dept Clin Neurol, Oxford OX3 9DU, England; [Dolan, Eamon] Connolly Hosp, Stroke & Hypertens Unit, Dublin, Ireland; [O'Brien, Eoin] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [Dobson, Joanna E.; Sever, Peter S.; Poulter, Neil R.] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London, England; [Dahlof, Bjorn] Univ Gothenburg, Dept Med, Gothenburg, Sweden	University of Oxford; University College Dublin; Imperial College London; University of Gothenburg	Rothwell, PM (corresponding author), John Radcliffe Hosp, Stroke Prevent Res Unit, Univ Dept Clin Neurol, Level 6,West Wing, Oxford OX3 9DU, England.	peter.rothwell@clneuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211	UK Medical Research Council; National Institute for Health Research (NIHR) Biomedical Research Centre, Oxford, UK; Biomedical Research Centre Award; British Heart Foundation Centre for Excellence Award; Pfizer; Servier Research Group, Paris, France; Medical Research Council [G0500987] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10116] Funding Source: researchfish; MRC [G0500987] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Biomedical Research Centre, Oxford, UK(National Institute for Health Research (NIHR)); Biomedical Research Centre Award; British Heart Foundation Centre for Excellence Award; Pfizer(Pfizer); Servier Research Group, Paris, France; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the investigators of the UK-TIA aspirin trial, the European Stroke Prevention Study (ESPS-1), the Dutch TIA aspirin trial, and the ASCOT-BPLA study. We acknowledge the collaboration of the other ASCOT-BPLA ABPM substudy researchers: Alice V Stanton, Simon Thom, Mark Caulfield, Gordon McInnes, and David Collier. SCH was funded by the UK Medical Research Council and by the National Institute for Health Research (NIHR) Biomedical Research Centre, Oxford, UK. NRP and PSS were supported by a Biomedical Research Centre Award to Imperial College NHS Health Care Trust, are in receipt of a British Heart Foundation Centre for Excellence Award, and along with PMR are recipients of NIHR Senior Investigator Awards. Pfizer was the major funding source of the main ASCOT trial with additional support provided by Servier Research Group, Paris, France.	[Anonymous], 1978, J Chronic Dis, V31, P651; [Anonymous], 1987, LANCET, V2, P1351; ARMITAGE P, 1966, CLIN SCI, V30, P337; Chalmers J, 1996, J HYPERTENS, V14, pS41; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COLANDREA MA, 1970, CIRCULATION, V41, P239, DOI 10.1161/01.CIR.41.2.239; CUFFE RL, 2005, CEREBROVASC DIS, V19, P51; Cuffe RL, 2006, STROKE, V37, P2776, DOI 10.1161/01.STR.0000244761.62073.05; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Dolan E, 2009, J HYPERTENS, V27, P876, DOI 10.1097/HJH.0b013e328322cd62; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Hata Y, 2002, J HUM HYPERTENS, V16, P141, DOI 10.1038/sj.jhh.1001301; Hata Y, 2000, HYPERTENS RES, V23, P553, DOI 10.1291/hypres.23.553; Havlik RJ, 2002, STROKE, V33, P26, DOI 10.1161/hs0102.101890; Howard SC, 2009, CEREBROVASC DIS, V28, P331, DOI 10.1159/000229551; Howard SC, 2003, J CLIN EPIDEMIOL, V56, P1084, DOI 10.1016/S0895-4356(03)00267-1; JANSEN PAF, 1986, AGE AGEING, V15, P129, DOI 10.1093/ageing/15.3.129; Keenan K, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1492; Kikuya M, 2008, HYPERTENSION, V52, P1045, DOI 10.1161/HYPERTENSIONAHA.107.104620; Klungel OH, 2000, J CLIN EPIDEMIOL, V53, P1158, DOI 10.1016/S0895-4356(00)00228-6; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Leenen FHH, 2004, CAN J CARDIOL, V20, p77B; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Marshall T, 2004, BMJ-BRIT MED J, V328, P933, DOI 10.1136/bmj.328.7445.933; O'Brien E, 2005, J HYPERTENS, V23, P697, DOI 10.1097/01.hjh.0000163132.84890.c4; O'Brien E, 2001, J HUM HYPERTENS, V15, pS47, DOI 10.1038/sj.jhh.1001076; OBRIEN E, 1994, J HYPERTENS, V12, P1089; OBRIEN E, 1991, J HYPERTENS, V9, P573, DOI 10.1097/00004872-199106000-00016; Parati G, 2008, J HYPERTENS, V26, P1505, DOI 10.1097/HJH.0b013e328308da66; Pickering TG, 2007, HYPERTENS RES, V30, P479, DOI 10.1291/hypres.30.479; Poulter NR, 2005, LANCET, V366, P907, DOI 10.1016/S0140-6736(05)67186-3; Pringle E, 2003, J HYPERTENS, V21, P2251, DOI 10.1097/00004872-200312000-00012; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; Robinson T, 1997, CEREBROVASC DIS, V7, P214, DOI 10.1159/000108194; Rodgers A, 1996, BRIT MED J, V313, P147, DOI 10.1136/bmj.313.7050.147; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Toschke AM, 2009, CEREBROVASC DIS, V28, P105, DOI 10.1159/000223434; Tozawa M, 1999, NEPHROL DIAL TRANSPL, V14, P1976, DOI 10.1093/ndt/14.8.1976; Turnbull F, 2008, BMJ-BRIT MED J, V336, P1121, DOI 10.1136/bmj.39548.738368.BE; Turner MJ, 2008, AM J HYPERTENS, V21, P85, DOI 10.1038/ajh.2007.25; VANGIJN J, 1991, NEW ENGL J MED, V325, P1261, DOI 10.1056/NEJM199110313251801; Verdecchia P, 2003, AM J HYPERTENS, V16, P87, DOI 10.1016/S0895-7061(02)03150-3; Warlow C, 2003, LANCET, V362, P1211, DOI 10.1016/S0140-6736(03)14544-8; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Whelton P K, 1989, Clin Geriatr Med, V5, P639; Williams B, 2008, LANCET, V371, P2219, DOI 10.1016/S0140-6736(08)60804-1; Zhang ZH, 2000, BRAIN RES, V863, P25, DOI 10.1016/S0006-8993(00)02068-0	51	1203	1363	3	97	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	2010	375	9718					895	905		10.1016/S0140-6736(10)60308-X	http://dx.doi.org/10.1016/S0140-6736(10)60308-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	574NA	20226988				2022-12-28	WOS:000275995300029
J	Mazin, II				Mazin, Igor I.			Superconductivity gets an iron boost	NATURE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTIVITY; PAIRING STATE; PNICTIDES; SYMMETRY	Superconductivity, the resistance-free flow of electrical charges, is one of the most exotic phenomena in solid-state physics. Even though it was discovered almost a century ago, many questions remain unanswered, in particular those concerning the physics of high-temperature superconductivity. The recent discovery of iron-based superconductors was arguably the most important breakthrough in this field for more than two decades and may provide new avenues for understanding this high-temperature phenomenon. Here I present my view of the recent developments in this field that have led to the current understanding of this important new class of superconductor.	USN, Res Lab, Washington, DC 20375 USA	United States Department of Defense; United States Navy; Naval Research Laboratory	Mazin, II (corresponding author), USN, Res Lab, Code 6390,4555 Overlook Ave SW, Washington, DC 20375 USA.	mazin@dave.nrl.navy.mil	Mazin, Igor I/B-6576-2008; Mazin, Igor/L-4294-2019	Mazin, Igor/0000-0001-9456-7099				Anisimov VI, 2009, PHYSICA C, V469, P442, DOI 10.1016/j.physc.2009.03.040; Chu PCW, 2009, PHYSICA C, V469, P313, DOI 10.1016/j.physc.2009.03.052; Hosono H, 2009, BUTSURI, V64, P807; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Kuroki K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.087004; Lee CH, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.083704; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Mazin II, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057003; Mazin II, 2009, PHYSICA C, V469, P614, DOI 10.1016/j.physc.2009.03.019; Mazin II, 2008, PHYSICA C, V468, P105, DOI 10.1016/j.physc.2007.08.015; Mazin II, 2003, PHYSICA C, V385, P49, DOI 10.1016/S0921-4534(02)02299-2; Pickett WE, 2001, PHYSICA B, V296, P112, DOI 10.1016/S0921-4526(00)00787-0; Scalapino DJ, 1999, J LOW TEMP PHYS, V117, P179, DOI 10.1023/A:1022559920049; VANHARLINGEN DJ, 1995, REV MOD PHYS, V67, P515, DOI 10.1103/RevModPhys.67.515; Yang WL, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.014508	15	354	358	5	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 11	2010	464	7286					183	186		10.1038/nature08914	http://dx.doi.org/10.1038/nature08914			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20220835				2022-12-28	WOS:000275366100030
J	Stern, A				Stern, Ady			Non-Abelian states of matter	NATURE			English	Review							PAIRED HALL STATE; QUANTUM HALL; ELECTRON-GAS; INTERFERENCE; STATISTICS; ANYONS; ENERGY; CHARGE; ORDER	Quantum mechanics classifies all elementary particles as either fermions or bosons, and this classification is crucial to the understanding of a variety of physical systems, such as lasers, metals and superconductors. In certain two-dimensional systems, interactions between electrons or atoms lead to the formation of quasiparticles that break the fermion-boson dichotomy. A particularly interesting alternative is offered by 'non-Abelian' states of matter, in which the presence of quasiparticles makes the ground state degenerate, and interchanges of identical quasiparticles shift the system between different ground states. Present experimental studies attempt to identify non-Abelian states in systems that manifest the fractional quantum Hall effect. If such states can be identified, they may become useful for quantum computation.	Weizmann Inst Sci, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Stern, A (corresponding author), Weizmann Inst Sci, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel.	adiel.stern@weizmann.ac.il		Stern, Ady/0000-0002-9493-268X	US-Israel Binational Science Foundation; Minerva foundation; Microsoft's Station Q	US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Minerva foundation; Microsoft's Station Q	This work was supported by the US-Israel Binational Science Foundation, the Minerva foundation and Microsoft's Station Q.	Bishara W, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.155304; Bishara W, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.155303; Bonderson P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.016803; Bonderson P, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.016401; Boyarsky A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.233302; Camino FE, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.155305; Chamon CDC, 1997, PHYS REV B, V55, P2331, DOI 10.1103/PhysRevB.55.2331; Collins GP, 2006, SCI AM, V294, P56, DOI 10.1038/scientificamerican0406-56; Cooper NR, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.176807; Cooper NR, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.120405; Das Sarma S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.166802; Das Sarma S, 2006, PHYS TODAY, V59, P32; Day C, 2005, PHYS TODAY, V58, P23, DOI 10.1063/1.2012448; Dean CR, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.186806; Dolev M, 2008, NATURE, V452, P829, DOI [10.1038/nature06855, 10.1038/natureO6855]; Eisenstein JP, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.076801; Feiguin AE, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.166803; Feiguin AE, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.115322; Feldman DE, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.085333; Feldman DE, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.186803; Feldman DE, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.161304; Fendley P, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.045317; Fiete GA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.176801; Fradkin E, 1998, NUCL PHYS B, V516, P704, DOI 10.1016/S0550-3213(98)00111-4; Freedman MH, 2003, B AM MATH SOC, V40, P31; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; Fu L, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.216403; Goldman VJ, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.045334; GREITER M, 1991, PHYS REV LETT, V66, P3205, DOI 10.1103/PhysRevLett.66.3205; Gurarie V, 2007, ANN PHYS-NEW YORK, V322, P2, DOI 10.1016/j.aop.2006.10.009; Heinonen O., 1998, COMPOSITE FERMIONS; Ilan R, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.245305; Ivanov DA, 2001, PHYS REV LETT, V86, P268, DOI 10.1103/PhysRevLett.86.268; Jain JK, 2007, COMPOSITE FERMIONS, P1, DOI 10.1017/CBO9780511607561; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; Levin MA, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.045110; Milovanovic M, 1996, PHYS REV B, V53, P13559, DOI 10.1103/PhysRevB.53.13559; MOORE G, 1991, NUCL PHYS B, V360, P362, DOI 10.1016/0550-3213(91)90407-O; Morf RH, 1998, PHYS REV LETT, V80, P1505, DOI 10.1103/PhysRevLett.80.1505; Nayak C, 1996, NUCL PHYS B, V479, P529, DOI 10.1016/0550-3213(96)00430-0; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Neder I, 2007, NATURE, V448, P333, DOI 10.1038/nature05955; Nilsson J, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.120403; OFEK N, 2009, ROLE INTERACTIONS EL; Overbosch BJ, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.062107; OVERBOSCH BJ, 2007, DYNAMICAL SCALING PR; Read N, 2000, PHYS REV B, V61, P10267, DOI 10.1103/PhysRevB.61.10267; Read N, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.045308; Read N, 1999, PHYS REV B, V59, P8084, DOI 10.1103/PhysRevB.59.8084; Rezayi EH, 2000, PHYS REV LETT, V84, P4685, DOI 10.1103/PhysRevLett.84.4685; Rosenow B, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.226803; Rosenow B, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106801; Rosenow B, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.155305; Roulleau P, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.126802; Saarikoski H, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195321; SAU JD, 2009, GENERIC NEW PLATFORM; Stern A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.205338; Stern A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.016802; Stern A, 2008, ANN PHYS-NEW YORK, V323, P204, DOI 10.1016/j.aop.2007.10.008; STORNI M, 2008, FRACTIONAL QUANTUM H; Toke C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.036806; WEN XG, 1993, PHYS REV LETT, V70, P355, DOI 10.1103/PhysRevLett.70.355; Wiegers SAJ, 1997, PHYS REV LETT, V79, P3238, DOI 10.1103/PhysRevLett.79.3238; Wilczek F, 2009, NAT PHYS, V5, P614, DOI 10.1038/nphys1380; WILLETT R, 1987, PHYS REV LETT, V59, P1776, DOI 10.1103/PhysRevLett.59.1776; Willett RL, 2009, P NATL ACAD SCI USA, V106, P8853, DOI 10.1073/pnas.0812599106; WILLETT RL, 2009, ALTERNATING E 4 E 2; Wojs A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.235319; Xia JS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.176809; Yang K, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.115317; Zhang YM, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.241304	73	243	246	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					187	193		10.1038/nature08915	http://dx.doi.org/10.1038/nature08915			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20220836				2022-12-28	WOS:000275366100031
J	Wolfe, D; Fairchild, AL				Wolfe, Daniel; Fairchild, Amy L.			The Need for Improved Surveillance of Occupational Disease and Injury	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Fairchild, Amy L.] Columbia Univ, Dept Sociomed Sci, Mailman Sch Publ Hlth, Ctr Hist & Eth Publ Hlth, New York, NY 10032 USA; [Wolfe, Daniel] Open Soc Inst, New York, NY USA	Columbia University	Fairchild, AL (corresponding author), Columbia Univ, Dept Sociomed Sci, Mailman Sch Publ Hlth, Ctr Hist & Eth Publ Hlth, 722 W 168th St, New York, NY 10032 USA.	alf4@columbia.edu	Fairchild, Amy/F-1811-2018	Fairchild, Amy/0000-0002-1292-7212				*AM ASS LAB LEG, 1911, P 4 ANN M AM ASS LAB, P73; *COUNC STAT TERR E, 2004 NAT ASS EP CAP; DEMEHL CO, 1972, AMA OCC HLTH C CHIC; ELLIOTT K, BIRTH DEFECTS DEV DI; Government Accountability Office, 2009, WORKPL SAF HLTH ENH; Hayhurst ER, 1925, AM J PUBLIC HEALTH, V15, P681, DOI 10.2105/AJPH.15.8.681; SARNOFF D, 1965, PUBLIC HLTH REP, V80, P778; SELBY CD, 1919, STUDIES MED SURG CAR; *US HR, 1986, OCC HLTH HAZ SURV 72; *US HR, 1984, 981144 US HOUS REPR	10	7	8	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2010	303	10					981	982		10.1001/jama.2010.248	http://dx.doi.org/10.1001/jama.2010.248			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	565UC	20215613				2022-12-28	WOS:000275319300027
J	Ansah, EK; Narh-Bana, S; Epokor, M; Akanpigbiam, S; Quartey, AA; Gyapong, J; Whitty, CJM				Ansah, Evelyn K.; Narh-Bana, Solomon; Epokor, Michael; Akanpigbiam, Samson; Quartey, Alberta Amu; Gyapong, John; Whitty, Christopher J. M.			Rapid testing for malaria in settings where microscopy is available and peripheral clinics where only presumptive treatment is available: a randomised controlled trial in Ghana	BRITISH MEDICAL JOURNAL			English	Article							DIAGNOSTIC-TESTS; ARTEMETHER-LUMEFANTRINE; UNCOMPLICATED MALARIA; FEBRILE ILLNESS; TANZANIA; MANAGEMENT; CHILDREN; UGANDA; KENYA; MISDIAGNOSIS	Objective To test in West Africa the impact of rapid diagnostic tests on the prescription of antimalarials and antibiotics both where microscopy is used for the diagnosis of malaria and in clinical (peripheral) settings that rely on clinical diagnosis. Design Randomised, controlled, open label clinical trial. Setting Four clinics in the rural Dangme West district of southern Ghana, one in which microscopy is used for diagnosis of malaria ("microscopy setting") and three where microscopy is not available and diagnosis of malaria is made on the basis of clinical symptoms ("clinical setting"). Participants Patients with suspected malaria. Interventions Patients were randomly assigned to either a rapid diagnostic test or the current diagnostic method at the clinic (microscopy or clinical diagnosis). A blood sample for a research microscopy slide was taken for all patients. Main outcome measures The primary outcome was the prescription of antimalarials to patients of any age whose double read research slide was negative for malaria. The major secondary outcomes were the correct prescription of antimalarials, the impact of test results on antibiotic prescription, and the correct prescription of antimalarials in children under 5 years. Results Of the 9236 patients screened, 3452 were randomised in the clinical setting and 3811 in the microscopy setting. Follow-up to 28 days was 97.6% (7088/7263). In the microscopy setting, 722 (51.6%) of the 1400 patients with negative research slides in the rapid diagnostic test arm were treated for malaria compared with 764 (55.0%) of the 1389 patients in the microscopy arm (adjusted odds ratio 0.87, 95% CI 0.71 to 1.1; P=0.16). In the clinical setting, 578 (53.9%) of the 1072 patients in the rapid diagnostic test arm with negative research slides were treated for malaria compared with 982 (90.1%) of the 1090 patients with negative slides in the clinical diagnosis arm (odds ratio 0.12, 95% CI 0.04 to 0.38; P=0.001). The use of rapid diagnostic tests led to better targeting of antimalarials and antibiotics in the clinical but not the microscopy setting, in both children and adults. There were no deaths in children under 5 years at 28 days follow-up in either arm. Conclusion Where microscopy already exists, introducing rapid diagnostic tests had limited impact on prescriber behaviour. In settings where microscopy was not available, however, using rapid diagnostic tests led to a significant reduction in the overprescription of antimalarials, without any evidence of clinical harm, and to better targeting of antibiotics.	[Ansah, Evelyn K.] Dangme W Dist Hlth Directorate, Hlth Serv, Dodowa, Ghana; [Epokor, Michael; Akanpigbiam, Samson] Dodowa Hlth Res Ctr, Dodowa, Ghana; [Gyapong, John] Ghana Hlth Serv, Div Res & Dev, Accra, Ghana; [Whitty, Christopher J. M.] London Sch Hyg & Trop Med, London, England	Ghana Health Service; University of London; London School of Hygiene & Tropical Medicine	Ansah, EK (corresponding author), Dangme W Dist Hlth Directorate, Hlth Serv, Dodowa, Ghana.	ansahekdr@yahoo.co.uk	Whitty, Christopher/C-7740-2012	Ansah, Evelyn/0000-0003-0401-8606; Whitty, Christopher/0000-0002-6076-5027; Narh-Bana, Solomon A./0000-0001-8010-2637; Gyapong, John/0000-0002-8415-1468	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This study was supported by the Gates Malaria Partnership and the ACT Consortium, with funds from the Bill & Melinda Gates Foundation. The sponsor and funder had no part in the design, conduct, analysis, or interpretation of the trial.	Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; [Anonymous], 2009, MAL RAP DIAGN TEST P; Ansah EK, 2009, PLOS MED, V6, P48, DOI 10.1371/journal.pmed.1000007; Berkley JA, 2005, BMJ-BRIT MED J, V330, P995, DOI 10.1136/bmj.38408.471991.8F; Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Chandler CIR, 2008, TROP MED INT HEALTH, V13, P1131, DOI 10.1111/j.1365-3156.2008.02118.x; Chandler CIR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-53; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; English M, 2009, PLOS MED, V6, P7, DOI 10.1371/journal.pmed.1000015; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Hopkins H, 2007, AM J TROP MED HYG, V76, P1092, DOI 10.4269/ajtmh.2007.76.1092; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Msellem MI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000070; Mundy CJF, 2003, T ROY SOC TROP MED H, V97, P403, DOI 10.1016/S0035-9203(03)90070-8; Nankabirwa J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-66; Nomhwange TI, 2009, TROP DOCT, V39, P90, DOI 10.1258/td.2008.080200; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Rowe AK, 2009, AM J PUBLIC HEALTH, V99, P837, DOI 10.2105/AJPH.2008.134411; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; Skarbinski J, 2009, AM J TROP MED HYG, V80, P919; Ssekabira U, 2008, AM J TROP MED HYG, V79, P826, DOI 10.4269/ajtmh.2008.79.826; Valea I, 2009, TROP MED INT HEALTH, V14, P338, DOI 10.1111/j.1365-3156.2009.02228.x; Wiseman V, 2006, PLOS MED, V3, P1844, DOI 10.1371/journal.pmed.0030373; Zurovac D, 2005, BRIT MED J, V331, P734, DOI 10.1136/bmj.331.7519.734; Zurovac D, 2004, INT J EPIDEMIOL, V33, P1080, DOI 10.1093/ije/dyh253; [No title captured]; [No title captured]	30	106	106	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 5	2010	340								c930	10.1136/bmj.c930	http://dx.doi.org/10.1136/bmj.c930			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	565FL	20207689	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000275274600019
J	Tai, HC; Schuman, EM				Tai, Hwan-Ching; Schuman, Erin M.			Angelman Syndrome: Finding the Lost Arc	CELL			English	Editorial Material							UBIQUITIN LIGASE		[Tai, Hwan-Ching; Schuman, Erin M.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Schuman, Erin M.] Max Planck Inst Brain Res, D-60438 Frankfurt, Germany	California Institute of Technology; Max Planck Society	Schuman, EM (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	schumane@brain.mpg.de	Schuman, Erin M/D-6204-2011; Tai, Hwan-Ching/AAF-7237-2019; Tai, Hwan-Ching/HGC-1501-2022	Tai, Hwan-Ching/0000-0003-0668-9163; 				Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Cooper EM, 2004, J BIOL CHEM, V279, P41208, DOI 10.1074/jbc.M401302200; Dan B, 2009, EPILEPSIA, V50, P2331, DOI 10.1111/j.1528-1167.2009.02311.x; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Takiyama Y, 2007, CEREBELLUM, V6, P353, DOI 10.1080/14734220701230466; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327	9	4	5	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					608	610		10.1016/j.cell.2010.02.019	http://dx.doi.org/10.1016/j.cell.2010.02.019			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211128	Bronze			2022-12-28	WOS:000275197400008
J	Anglaret, X; Eholie, S				Anglaret, Xavier; Eholie, Serge			Co-trimoxazole, cART, and non-AIDS infectious diseases	LANCET			English	Editorial Material							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; COTE-DIVOIRE; TRIMETHOPRIM-SULFAMETHOXAZOLE; HIV-1-INFECTED ADULTS; RURAL UGANDA; PROPHYLAXIS; MORTALITY; MORBIDITY; ABIDJAN		[Anglaret, Xavier] Univ Bordeaux 2, INSERM, U897, F-33076 Bordeaux, France; [Eholie, Serge] CHU Treichville, Serv Malad Infect & Trop, Abidjan, Cote Ivoire	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Anglaret, X (corresponding author), Univ Bordeaux 2, INSERM, U897, F-33076 Bordeaux, France.	Xavier.Anglaret@isped.u-bordeaux2.fr	Anglaret, Xavier/T-2757-2019; Eholie, Serge/T-6008-2019; Franzeck, Fabian C/B-5055-2011; Anglaret, Xavier/F-7333-2013	Anglaret, Xavier/0000-0003-3319-8423	NIAID NIH HHS [R01 AI058736] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058736] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Anglaret X, 2003, AIDS, V17, P575, DOI 10.1097/00002030-200303070-00013; Corbett EL, 2002, CLIN INFECT DIS, V34, P1251, DOI 10.1086/339540; Gilks CF, 1996, LANCET, V347, P718, DOI 10.1016/S0140-6736(96)90076-8; HIRSCHTICK RE, 1995, NEW ENGL J MED, V333, P845, DOI 10.1056/NEJM199509283331305; Losina E, 2007, ANTIVIR THER, V12, P543; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Walker AS, 2010, LANCET, V375, P1278, DOI 10.1016/S0140-6736(10)60057-8; Weverling GJ, 1999, LANCET, V353, P1293, DOI 10.1016/S0140-6736(99)03287-0; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; World Health Organization, GUID COTR PROPH HIV	13	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 10	2010	375	9722					1231	1233		10.1016/S0140-6736(10)60200-0	http://dx.doi.org/10.1016/S0140-6736(10)60200-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585VN	20347482				2022-12-28	WOS:000276858400007
J	Ruilope, LM; Dukat, A; Bohm, M; Lacourciere, Y; Gong, JJ; Lefkowitz, MP				Miguel Ruilope, Luis; Dukat, Andrej; Boehm, Michael; Lacourciere, Yves; Gong, Jianjian; Lefkowitz, Martin P.			Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study	LANCET			English	Article							PULSE PRESSURE; ESSENTIAL-HYPERTENSION; SYSTOLIC HYPERTENSION; NATRIURETIC PEPTIDES; HEART-FAILURE; RISK; HEMODYNAMICS; OMAPATRILAT; CANDOXATRIL; ANGIOEDEMA	Background LCZ696 is a first-in-class inhibitor of the angiotensin II receptor and neprilysin. We aimed to establish whether the dual actions of LCZ696 lead to further lowering of blood pressure, compared with the angiotensin-receptor blocker valsartan. Methods 1328 patients aged 18-75 years with mild-to-moderate hypertension were randomly assigned (double-blind) to 8 weeks' treatment in one of eight groups: 100 mg (n=156 patients), 200 mg (n=169), or 400 mg (n=172) LCZ696; 80 mg (n=163), 160 mg (n=166), or 320 mg (n=164) valsartan; 200 mg AHU377 (n=165); or placebo (n=173). The primary endpoint was the mean difference across the three single-dose pairwise comparisons of LCZ696 versus valsartan (100 mg vs 80 mg, 200 mg vs 160 mg, and 400 mg vs 320 mg) in mean sitting diastolic blood pressure during the 8-week treatment period. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00549770. Findings 1215 patients completed the 8-week treatment period. The average reduction in mean sitting diastolic blood pressure across the doses of LCZ696 versus the appropriate comparator dose of valsartan showed significantly greater reductions with LCZ696 (mean reduction: -2.17 mm Hg, 95% CI -3.28 to 1.06; p<0.0001). The reduction in mean sitting diastolic blood pressure was significantly different for 200 mg LCZ696 versus 160 mg valsartan (-2.97 mm Hg, 95% CI -4.88 to 1.07, p=0.0023) and for 400 mg LCZ696 versus 320 mg valsartan (-2.70 mm Hg, -4.61 to -0.80, p=0.0055). LCZ696 was well tolerated and no cases of angio-oedema were reported; only three serious adverse events occurred during the 8-week treatment period, of which none was judged to be related to the study drug, and no patients died. Interpretation Compared with valsartan, dual-acting LCZ696 provides complementary and fully additive reduction of blood pressure, which suggests that the drug holds promise for treatment of hypertension and cardiovascular disease.	[Miguel Ruilope, Luis] Hosp 12 Octubre, Div Hypertens, E-28041 Madrid, Spain; [Dukat, Andrej] Comenius Univ, Dept Internal Med, Bratislava, Slovakia; [Boehm, Michael] Univ Saarland, Dept Internal Med Cardiol Angiol & Intens Care 3, Homburg, Germany; [Lacourciere, Yves] CHU Laval, Hypertens Res Unit, Laval, PQ, Canada; [Gong, Jianjian; Lefkowitz, Martin P.] Novartis Pharmaceut, E Hanover, NJ USA	Hospital Universitario 12 de Octubre; Comenius University Bratislava; Saarland University; Laval University; Novartis	Ruilope, LM (corresponding author), Hosp 12 Octubre, Div Hypertens, E-28041 Madrid, Spain.	ruilope@ad-hocbox.com	Böhm, Michael/C-3638-2011	Ruilope, Luis M/0000-0001-6278-7951	Novartis, East Hanover, NJ, USA	Novartis, East Hanover, NJ, USA	Funding Novartis.; Funding for this study was provided by Novartis, East Hanover, NJ, USA. We thank Fran Karo for editorial support in the development of this report.	Andersen K, 2009, J RENIN-ANGIO-ALDO S, V10, P157, DOI 10.1177/1470320309342407; ANDO S, 1995, HYPERTENSION, V26, P1160, DOI 10.1161/01.HYP.26.6.1160; BEVAN EG, 1992, J HYPERTENS, V10, P607; Bretz F, 2005, BIOMETRICS, V61, P738, DOI 10.1111/j.1541-0420.2005.00344.x; Burnett J C Jr, 1999, J Hypertens Suppl, V17, pS37; Campbell DJ, 2003, HYPERTENSION, V41, P383, DOI 10.1161/01.HYP.0000054215.71691.16; Cicardi M, 2004, ARCH INTERN MED, V164, P910, DOI 10.1001/archinte.164.8.910; Domanski MJ, 1999, HYPERTENSION, V34, P375, DOI 10.1161/01.HYP.34.3.375; Ferro CJ, 1998, CIRCULATION, V97, P2323, DOI 10.1161/01.CIR.97.23.2323; Fryer RM, 2008, BRIT J PHARMACOL, V153, P947, DOI 10.1038/sj.bjp.0707641; Gardner DG, 2007, HYPERTENSION, V49, P419, DOI 10.1161/01.HYP.0000258532.07418.fa; Gu J, 2010, J CLIN PHARMACOL, V50, P401, DOI 10.1177/0091270009343932; Haider AW, 2003, ANN INTERN MED, V138, P10, DOI 10.7326/0003-4819-138-1-200301070-00006; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Kostis OB, 2004, AM J HYPERTENS, V17, P103, DOI 10.1016/j.amjhyper.2003.09.014; Levin ER, 1998, NEW ENGL J MED, V339, P321; MADHAVAN S, 1994, HYPERTENSION, V23, P395, DOI 10.1161/01.HYP.23.3.395; Mitchell GF, 2002, CIRCULATION, V105, P2955, DOI 10.1161/01.CIR.0000020500.77568.3C; Nawarskas J J, 2000, Heart Dis, V2, P266; Pandey KN, 2005, PEPTIDES, V26, P901, DOI 10.1016/j.peptides.2004.09.024; RICHARDS AM, 1993, J HYPERTENS, V11, P407, DOI 10.1097/00004872-199304000-00011; Safar ME, 2001, CURR OPIN NEPHROL HY, V10, P257, DOI 10.1097/00041552-200103000-00015; Sheth T, 2002, AM J CARDIOL, V90, P496, DOI 10.1016/S0002-9149(02)02521-3; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683	24	405	448	1	42	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 10	2010	375	9722					1255	1266		10.1016/S0140-6736(09)61966-8	http://dx.doi.org/10.1016/S0140-6736(09)61966-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585VN	20236700				2022-12-28	WOS:000276858400028
J	Cuzzi, JN; Burns, JA; Charnoz, S; Clark, RN; Colwell, JE; Dones, L; Esposito, LW; Filacchione, G; French, RG; Hedman, MM; Kempf, S; Marouf, EA; Murray, CD; Nicholson, PD; Porco, CC; Schmidt, J; Showalter, MR; Spilker, LJ; Spitale, JN; Srama, R; Sremcevic, M; Tiscareno, MS; Weiss, J				Cuzzi, J. N.; Burns, J. A.; Charnoz, S.; Clark, R. N.; Colwell, J. E.; Dones, L.; Esposito, L. W.; Filacchione, G.; French, R. G.; Hedman, M. M.; Kempf, S.; Marouf, E. A.; Murray, C. D.; Nicholson, P. D.; Porco, C. C.; Schmidt, J.; Showalter, M. R.; Spilker, L. J.; Spitale, J. N.; Srama, R.; Sremcevic, M.; Tiscareno, M. S.; Weiss, J.			An Evolving View of Saturn's Dynamic Rings	SCIENCE			English	Review							SELF-GRAVITY WAKES; F-RING; VISCOUS OVERSTABILITY; RADIAL STRUCTURE; B-RING; MOONLETS; PROMETHEUS; ACCRETION; EVOLUTION; WAVES	We review our understanding of Saturn's rings after nearly 6 years of observations by the Cassini spacecraft. Saturn's rings are composed mostly of water ice but also contain an undetermined reddish contaminant. The rings exhibit a range of structure across many spatial scales; some of this involves the interplay of the fluid nature and the self-gravity of innumerable orbiting centimeter- to meter-sized particles, and the effects of several peripheral and embedded moonlets, but much remains unexplained. A few aspects of ring structure change on time scales as short as days. It remains unclear whether the vigorous evolutionary processes to which the rings are subject imply a much younger age than that of the solar system. Processes on view at Saturn have parallels in circumstellar disks.	[Cuzzi, J. N.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Burns, J. A.; Hedman, M. M.; Nicholson, P. D.; Tiscareno, M. S.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Charnoz, S.] Univ Paris Diderot, CEA, CNRS, Lab Astrophys Instrumentat Modelisat, F-91191 Gif Sur Yvette, France; [Clark, R. N.] US Geol Survey, Denver, CO 80225 USA; [Colwell, J. E.] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA; [Dones, L.] SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA; [Esposito, L. W.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; [Filacchione, G.] Ist Astrofis Spaziale & Fis Cosm, I-00133 Rome, Italy; [French, R. G.] Wellesley Coll, Dept Astron, Wellesley, MA 02481 USA; [Kempf, S.; Srama, R.] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Marouf, E. A.] San Jose State Univ, Dept Elect Engn, San Jose, CA 95192 USA; [Murray, C. D.] Queen Mary Univ London, Astron Unit, London E1 4NS, England; [Porco, C. C.; Spitale, J. N.; Weiss, J.] Space Sci Inst, Cassini Imaging Cent Lab Operat CICLOPS, Boulder, CO 80301 USA; [Schmidt, J.] Univ Potsdam, Inst Phys & Astron, Potsdam, Germany; [Showalter, M. R.] SETI Inst, Mountain View, CA 94043 USA; [Spilker, L. J.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Weiss, J.] Carleton Coll, Northfield, MN 55057 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Cornell University; UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; United States Department of the Interior; United States Geological Survey; State University System of Florida; University of Central Florida; University of Colorado System; University of Colorado Boulder; Istituto Nazionale Astrofisica (INAF); Wellesley College; Max Planck Society; California State University System; San Jose State University; University of London; Queen Mary University London; University of Potsdam; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Carleton College	Cuzzi, JN (corresponding author), NASA, Ames Res Ctr, Mail Stop 245-3, Moffett Field, CA 94035 USA.	jeffrey.cuzzi@nasa.gov	ESPOSITO, LARRY W/AAB-3673-2021; Colwell, Joshua/AAP-2692-2020; Tiscareno, Matthew/D-6963-2011; Filacchione, Gianrico/S-2320-2017	ESPOSITO, LARRY W/0000-0003-3381-2016; Colwell, Joshua/0000-0001-8269-6408; Filacchione, Gianrico/0000-0001-9567-0055; Hedman, Matthew/0000-0002-8592-0812; KEMPF, SASCHA/0000-0001-5236-3004	NASA; Italian Space Agency (ASI), Deutsches Zentrum fur Luft und Raumfahrt (DLR); Newton Institute, Universite Paris Diderot and CEA-Saclay; U.K. Science and Technology Facilities Council; Science and Technology Facilities Council [PP/C50209X/1, ST/F002696/1] Funding Source: researchfish; STFC [ST/F002696/1, PP/C50209X/1] Funding Source: UKRI	NASA(National Aeronautics & Space Administration (NASA)); Italian Space Agency (ASI), Deutsches Zentrum fur Luft und Raumfahrt (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)Agenzia Spaziale Italiana (ASI)); Newton Institute, Universite Paris Diderot and CEA-Saclay; U.K. Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We applaud with gratitude the Cassini spacecraft engineering and operations teams. We thank the other members of the Cassini Rings Discipline Working group for their many contributions, not all of which could be described here. We thank our Ring Science Planning Team leaders at JPL-B. Wallis, K. Perry, C. Roumeliotis, R. Lange, and S. Brooks-and the observation planning and design specialists on all the teams represented here for their essential contributions to the mission's success. We acknowledge M. Lewis, H. Salo, and G. Stewart for the simulations and visualizations described in the SOM and for helpful comments. We also thank three anonymous reviewers, R. E. Johnson, R. Pappalardo, P. Kalas, and C. Niebur for helpful suggestions on presentation. The U.S. authors were supported by NASA through the Cassini Project and Cassini Data Analysis Program. Other support was provided by the Italian Space Agency (ASI), Deutsches Zentrum fur Luft und Raumfahrt (DLR), the Newton Institute, Universite Paris Diderot and CEA-Saclay, and the U.K. Science and Technology Facilities Council.	ALBERS N, 2008, B AM ASTRON SOC, V40, P430; Barbara JM, 2002, ICARUS, V160, P161, DOI 10.1006/icar.2002.6962; Bosh AS, 2002, ICARUS, V157, P57, DOI 10.1006/icar.2002.6791; Burns JA, 2006, SCIENCE, V312, P1753, DOI 10.1126/science.1114856; Burns JA, 2001, ASTR AST LI, P641; CANUP RM, 1995, ICARUS, V113, P331, DOI 10.1006/icar.1995.1026; Carpenter JM, 2009, ASTROPHYS J SUPPL S, V181, P197, DOI 10.1088/0067-0049/181/1/197; Chambers JE, 2009, ANNU REV EARTH PL SC, V37, P321, DOI 10.1146/annurev.earth.031208.100122; Charnoz S, 2005, SCIENCE, V310, P1300, DOI 10.1126/science.1119387; Charnoz S, 2009, SATURN FROM CASSINI-HUYGENS, P537, DOI 10.1007/978-1-4020-9217-6_17; Charnoz S, 2009, ICARUS, V201, P191, DOI 10.1016/j.icarus.2008.12.036; CHIANG E, 2010, ANN REV EARTH PLANET; Colwell JE, 2007, ICARUS, V190, P127, DOI 10.1016/j.icarus.2007.03.018; Colwell JE, 2009, SATURN FROM CASSINI-HUYGENS, P375, DOI 10.1007/978-1-4020-9217-6_13; Colwell JE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025163; Cuzzi J, 2009, SATURN FROM CASSINI-HUYGENS, P459, DOI 10.1007/978-1-4020-9217-6_15; Cuzzi JN, 1998, ICARUS, V132, P1, DOI 10.1006/icar.1997.5863; CUZZI JN, 1988, ICARUS, V74, P284, DOI 10.1016/0019-1035(88)90043-7; Daisaka H, 2001, ICARUS, V154, P296, DOI 10.1006/icar.2001.6716; DAVIS DR, 1984, SCIENCE, V224, P744, DOI 10.1126/science.224.4650.744; DONES L, 1991, ICARUS, V92, P194, DOI 10.1016/0019-1035(91)90045-U; Esposito LW, 2008, ICARUS, V194, P278, DOI 10.1016/j.icarus.2007.10.001; French RG, 2003, ICARUS, V162, P143, DOI 10.1016/S0019-1035(02)00050-7; Goldreich P, 2003, ICARUS, V166, P320, DOI 10.1016/j.icarus.2003.09.002; GOLDREICH P, 1982, ANNU REV ASTRON ASTR, V20, P249, DOI 10.1146/annurev.aa.20.090182.001341; Hedman MM, 2010, ASTRON J, V139, P228, DOI 10.1088/0004-6256/139/1/228; Hedman MM, 2007, SCIENCE, V317, P653, DOI 10.1126/science.1143964; Hedman MM, 2007, ICARUS, V188, P89, DOI 10.1016/j.icarus.2006.11.017; Hedman MM, 2007, ASTRON J, V133, P2624, DOI 10.1086/516828; HEDMAN MM, 2009, B AM ASTRON SOC, V41, P1042; Horanyi M, 2009, SATURN FROM CASSINI-HUYGENS, P511, DOI 10.1007/978-1-4020-9217-6_16; Karjalainen R, 2004, ICARUS, V172, P328, DOI 10.1016/j.icarus.2004.05.022; Lewis MC, 2005, ICARUS, V178, P124, DOI 10.1016/j.icarus.2005.04.009; LISSAUER JJ, 1988, J GEOPHYS RES-SOLID, V93, P13776, DOI 10.1029/JB093iB11p13776; LONGARETTI PY, 1989, ICARUS, V81, P51, DOI 10.1016/0019-1035(89)90125-5; LOVETT L, 2006, SATURN NEW VIEW; McGhee CA, 2001, ICARUS, V152, P282, DOI 10.1006/icar.2001.6635; Murray CD, 2008, NATURE, V453, P739, DOI 10.1038/nature06999; Murray CD, 2005, NATURE, V437, P1326, DOI 10.1038/nature04212; NICHOLSON PD, ICARUS IN PRESS, DOI DOI 10.1016/J.ICARUS.2009.07.028; Nicholson PD, 2008, ICARUS, V193, P182, DOI 10.1016/j.icarus.2007.08.036; Porco CC, 2007, SCIENCE, V318, P1602, DOI 10.1126/science.1143977; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Porco CC, 2005, SCIENCE, V307, P1226, DOI 10.1126/science.1108056; PORCO CC, 2009, 9023 IAU; PORCO CC, 2009, 9091 IAU; Postberg F, 2009, NATURE, V459, P1098, DOI 10.1038/nature08046; Poulet F, 2003, ASTRON ASTROPHYS, V412, P305, DOI 10.1051/0004-6361:20031123; Poulet F, 2001, MON NOT R ASTRON SOC, V322, P343, DOI 10.1046/j.1365-8711.2001.04128.x; ROBBINS SJ, ICARUS IN PRESS, DOI DOI 10.1016/J.ICARUS.2009.09.012; Salo H, 2001, ICARUS, V153, P295, DOI 10.1006/icar.2001.6680; Schmidt J, 2001, ICARUS, V153, P316, DOI 10.1006/icar.2001.6679; Schmidt J, 2009, SATURN FROM CASSINI-HUYGENS, P413, DOI 10.1007/978-1-4020-9217-6_14; SCHMIT U, 1995, ICARUS, V115, P304, DOI 10.1006/icar.1995.1099; Showalter MR, 2004, ICARUS, V171, P356, DOI 10.1016/j.icarus.2004.05.006; SHU FH, 1983, ICARUS, V53, P185, DOI 10.1016/0019-1035(83)90141-0; Spahn F, 2000, ASTRON ASTROPHYS, V358, P368; Sremcevic M, 2007, NATURE, V449, P1019, DOI 10.1038/nature06224; Thomson FS, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL032526; Tiscareno M.S., 2005, B AM ASTRON SOC, V37, P767; Tiscareno MS, 2008, ASTRON J, V135, P1083, DOI 10.1088/0004-6256/135/3/1083; Tiscareno MS, 2007, ICARUS, V189, P14, DOI 10.1016/j.icarus.2006.12.025; Tiscareno MS, 2010, ASTRON J, V139, P492, DOI 10.1088/0004-6256/139/2/492; Tiscareno MS, 2006, NATURE, V440, P648, DOI 10.1038/nature04581; TISCARENO MS, 2009, BAAS, V41, P559; Verbiscer AJ, 2009, NATURE, V461, P1098, DOI 10.1038/nature08515; Weiss JW, 2009, ASTRON J, V138, P272, DOI 10.1088/0004-6256/138/1/272; Winter OC, 2007, MON NOT R ASTRON SOC, V380, pL54, DOI 10.1111/j.1745-3933.2007.00347.x; [No title captured]	69	72	74	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2010	327	5972					1470	1475		10.1126/science.1179118	http://dx.doi.org/10.1126/science.1179118			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20299586	Green Submitted			2022-12-28	WOS:000275715200037
J	Gapstur, SM; Thun, MJ				Gapstur, Susan M.; Thun, Michael J.			Progress in the War on Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gapstur, Susan M.] Amer Canc Soc, Natl Home Off, Atlanta, GA 30303 USA	American Cancer Society	Gapstur, SM (corresponding author), Amer Canc Soc, Natl Home Off, 250 Williams St NW, Atlanta, GA 30303 USA.	susan.gapstur@cancer.org						American Cancer Society, 2009, CANC FACTS FIG 2009; American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Bailar JC, 1997, NEW ENGL J MED, V336, P1569, DOI 10.1056/NEJM199705293362206; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; LEAF C, WHY WERE LOSING WAR; *NAT CANC I, SEER CANC STAT 1975; *US BUR CENS, POP EST PROGR; *WHO, WORLD HLTH STAT 2007	8	14	15	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1084	1085		10.1001/jama.2010.284	http://dx.doi.org/10.1001/jama.2010.284			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569KC	20233827				2022-12-28	WOS:000275594100022
J	Codispoti, LA				Codispoti, Louis A.			Interesting Times for Marine N2O	SCIENCE			English	Editorial Material							ACIDIFICATION; ZONES		Univ Maryland, Ctr Environm Sci, Horn Point Lab, Cambridge, MD 21613 USA	University System of Maryland; University of Maryland Center for Environmental Science	Codispoti, LA (corresponding author), Univ Maryland, Ctr Environm Sci, Horn Point Lab, Cambridge, MD 21613 USA.	codispot@umces.edu						Bange HW, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P51, DOI 10.1016/B978-0-12-372522-6.00002-5; Beman JM, 2005, NATURE, V434, P211, DOI 10.1038/nature03370; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Codispoti LA, 2005, RESPIRATION IN AQUATIC ECOSYSTEMS, P225, DOI 10.1093/acprof:oso/9780198527084.003.0012; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Hofmann M, 2009, P NATL ACAD SCI USA, V106, P3017, DOI 10.1073/pnas.0813384106; Kump LR, 2009, OCEANOGRAPHY, V22, P94, DOI 10.5670/oceanog.2009.100; McGregor HV, 2007, SCIENCE, V315, P637, DOI 10.1126/science.1134839; Naqvi S.W.A., 2009, BIOGEOSCI DISCUSS, V6, P9455, DOI DOI 10.5194/BGD-6-9455-2009; Oschlies A, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003147; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Suntharalingam P, 2000, GLOBAL BIOGEOCHEM CY, V14, P1353, DOI 10.1029/1999GB900100; Vecchi G. A., 2008, EOS T AM GEOPHYS UN, V89, P81, DOI DOI 10.1029/2008EO090002; Wuebbles DJ, 2009, SCIENCE, V326, P56, DOI 10.1126/science.1179571; YOSHINARI T, 1976, Marine Chemistry, V4, P189, DOI 10.1016/0304-4203(76)90007-4	15	132	140	14	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1339	1340		10.1126/science.1184945	http://dx.doi.org/10.1126/science.1184945			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223977				2022-12-28	WOS:000275418700030
J	Iess, L; Rappaport, NJ; Jacobson, RA; Racioppa, P; Stevenson, DJ; Tortora, P; Armstrong, JW; Asmar, SW				Iess, Luciano; Rappaport, Nicole J.; Jacobson, Robert A.; Racioppa, Paolo; Stevenson, David J.; Tortora, Paolo; Armstrong, John W.; Asmar, Sami W.			Gravity Field, Shape, and Moment of Inertia of Titan	SCIENCE			English	Article							AMMONIUM-SULFATE; SATELLITES	Precise radio tracking of the spacecraft Cassini has provided a determination of Titan's mass and gravity harmonics to degree 3. The quadrupole field is consistent with a hydrostatically relaxed body shaped by tidal and rotational effects. The inferred moment of inertia factor is about 0.34, implying incomplete differentiation, either in the sense of imperfect separation of rock from ice or a core in which a large amount of water remains chemically bound in silicates. The equilibrium figure is a triaxial ellipsoid whose semi-axes a, b, and c differ by 410 meters (a - c) and 103 meters (b - c). The nonhydrostatic geoid height variations (up to 19 meters) are small compared to the observed topographic anomalies of hundreds of meters, suggesting a high degree of compensation appropriate to a body that has warm ice at depth.	[Iess, Luciano; Racioppa, Paolo] Univ Roma La Sapienza, Dipartimento Ingn Aerospaziale & Astronaut, I-00184 Rome, Italy; [Rappaport, Nicole J.; Jacobson, Robert A.; Armstrong, John W.; Asmar, Sami W.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Stevenson, David J.] CALTECH, Pasadena, CA 91125 USA; [Tortora, Paolo] Univ Bologna, DIEM II Fac Ingn, I-47100 Forli, Italy	Sapienza University Rome; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); California Institute of Technology; University of Bologna	Iess, L (corresponding author), Univ Roma La Sapienza, Dipartimento Ingn Aerospaziale & Astronaut, Via Eudossiana 18, I-00184 Rome, Italy.	luciano.iess@uniroma1.it	Tortora, Paolo/J-6191-2012; IESS, Luciano/F-4902-2011	Tortora, Paolo/0000-0001-9259-7673; IESS, Luciano/0000-0002-6230-5825	Italian Space Agency; NASA	Italian Space Agency(Agenzia Spaziale Italiana (ASI)); NASA(National Aeronautics & Space Administration (NASA))	The work of L. I., P. R., and P. T. was funded in part by the Italian Space Agency. The work of N. J. R., R. A. J., J. W. A., and S. W. A. was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. D. J. S. acknowledges support from NASA's planetary geology and geophysics program.	Barr AC, 2008, ICARUS, V198, P163, DOI 10.1016/j.icarus.2008.07.004; Fortes AD, 2007, ICARUS, V188, P139, DOI 10.1016/j.icarus.2006.11.002; Grindrod PM, 2008, ICARUS, V197, P137, DOI 10.1016/j.icarus.2008.04.006; Heiskanen W., 1979, PHYS GEODESY; Jacobson RA, 2006, ASTRON J, V132, P2520, DOI 10.1086/508812; Kaula W.M., 1966, THEORY SATELLITE GEO; Lunine JI, 2009, ANNU REV EARTH PL SC, V37, P299, DOI 10.1146/annurev.earth.031208.100142; Murray C. D., 1999, SOLAR SYSTEM DYNAMIC; Rappaport N, 1997, ICARUS, V126, P313, DOI 10.1006/icar.1996.5661; Showman AP, 1999, SCIENCE, V286, P77, DOI 10.1126/science.286.5437.77; Sotin C, 2009, TITAN FROM CASSINI-HUYGENS, P61, DOI 10.1007/978-1-4020-9215-2_4; Zebker HA, 2009, SCIENCE, V324, P921, DOI 10.1126/science.1168905	12	149	149	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	2010	327	5971					1367	1369		10.1126/science.1182583	http://dx.doi.org/10.1126/science.1182583			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223984				2022-12-28	WOS:000275418700038
J	Levinson, W; King, TE; Goldman, L; Goroll, AH; Kessler, B				Levinson, Wendy; King, Talmadge E., Jr.; Goldman, Lee; Goroll, Allan H.; Kessler, Bruce			American Board of Internal Medicine Maintenance of Certification Program	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; QUALITY IMPROVEMENT; SELF-ASSESSMENT; UNITED-STATES; HEALTH-CARE; PHYSICIANS; EXPERIENCE; RECERTIFICATION; EDUCATION; ADULTS		[Levinson, Wendy] Univ Toronto, Dept Med, Toronto, ON, Canada; [King, Talmadge E., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Goldman, Lee] Columbia Univ, Med Ctr, New York, NY USA; [Goroll, Allan H.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Goroll, Allan H.] Harvard Univ, Sch Med, Boston, MA USA; [Kessler, Bruce] Eureka Internal Med, Eureka, CA USA	University of Toronto; University of California System; University of California San Francisco; Columbia University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Levinson, W (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.							Audet AMJ, 2005, HEALTH AFFAIR, V24, P843, DOI 10.1377/hlthaff.24.3.843; Brennan TA, 2005, NEW ENGL J MED, V353, P1989, DOI 10.1056/NEJMp058223; Chen J, 2006, J GEN INTERN MED, V21, P238, DOI 10.1111/j.1525-1497.2006.00326.x; Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008; Davis DA, 2006, JAMA-J AM MED ASSOC, V296, P1094, DOI 10.1001/jama.296.9.1094; Davis David A., 1995, JAMA (Journal of the American Medical Association), V274, P700, DOI 10.1001/jama.274.9.700; HAAS JS, 1995, AM J PUBLIC HEALTH, V85, P1087, DOI 10.2105/AJPH.85.8_Pt_1.1087; Holmboe ES, 2008, ARCH INTERN MED, V168, P1396, DOI 10.1001/archinte.168.13.1396; Holmboe ES, 2006, J CONTIN EDUC HEALTH, V26, P109, DOI 10.1002/chp.59; Lipner RS, 2006, ANN INTERN MED, V144, P29, DOI 10.7326/0003-4819-144-1-200601030-00007; Mazmanian PE, 2002, JAMA-J AM MED ASSOC, V288, P1057, DOI 10.1001/jama.288.9.1057; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Norcini JJ, 2000, ACAD MED, V75, P1193, DOI 10.1097/00001888-200012000-00016; Pham HH, 2005, JAMA-J AM MED ASSOC, V294, P473, DOI 10.1001/jama.294.4.473; Shaw K, 2009, JAMA-J AM MED ASSOC, V302, P2008, DOI 10.1001/jama.2009.1620; Turchin A, 2008, CIRCULATION, V117, P623, DOI 10.1161/CIRCULATIONAHA.107.733949; PROSPECT RES ONLINE	17	58	58	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10					948	952						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566JM	20220192				2022-12-28	WOS:000275365900019
J	Smith, S				Smith, Stephen			Will a market deliver quality and efficiency in health care better than central planning ever could? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, Fac Med, London SW7 2AZ, England	Imperial College London	Smith, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, London SW7 2AZ, England.	s.k.smith@imperial.ac.uk						Smith Adam, 1987, INQUIRY NATURE CAUSE	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2010	340								c1299	10.1136/bmj.c1299	http://dx.doi.org/10.1136/bmj.c1299			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570FD	20219813				2022-12-28	WOS:000275656800005
J	Nagata, S; Hanayama, R; Kawane, K				Nagata, Shigekazu; Hanayama, Rikinari; Kawane, Kohki			Autoimmunity and the Clearance of Dead Cells	CELL			English	Review							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CASPASE-ACTIVATED DNASE; TUMOR-NECROSIS-FACTOR; INNATE IMMUNE-RESPONSE; GLOBULE EGF FACTOR-8; RED-BLOOD-CELLS; APOPTOTIC CELLS; PHOSPHATIDYLSERINE RECEPTOR; CAENORHABDITIS-ELEGANS; MACROPHAGE CHEMOTAXIS		[Nagata, Shigekazu; Hanayama, Rikinari; Kawane, Kohki] Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan; [Nagata, Shigekazu; Hanayama, Rikinari; Kawane, Kohki] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Nagata, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.	snagata@mfour.med.kyoto-u.ac.jp	Hanayama, Rikinari/D-2940-2011; Hanayama, Rikinari/AAO-4959-2021; Nagata, Shigekazu/AAG-3203-2019	Hanayama, Rikinari/0000-0003-2102-3386; Nagata, Shigekazu/0000-0001-9758-8426; Kawane, Kohki/0000-0003-1125-9483	Ministry of Education, Science, and Culture of Japan; Kyoto University	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kyoto University	We are grateful to all the members of our laboratory at the Graduate School of Medicine, Kyoto University. We thank L. Migletta and G. Gray of Clarity Editing for careful editing of the manuscript. The work in our laboratory was supported in part by grants-in-aid from the Ministry of Education, Science, and Culture of Japan and by the Kyoto University Global COE Program (Center for Frontier Medicine).	Angelillo-Scherrer A, 2005, J CLIN INVEST, V115, P237, DOI 10.1172/JCI200522079; Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Asano K, 2004, J EXP MED, V200, P459, DOI 10.1084/jem.20040342; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Bassnett S, 2002, EXP EYE RES, V74, P1, DOI 10.1006/exer.2001.1111; Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; Botto M, 2002, IMMUNOBIOLOGY, V205, P395, DOI 10.1078/0171-2985-00141; Bournazou I, 2009, J CLIN INVEST, V119, P20, DOI 10.1172/JCI36226; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chasis JA, 2008, BLOOD, V112, P470, DOI 10.1182/blood-2008-03-077883; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; D'Cruz DP, 2007, LANCET, V369, P587, DOI 10.1016/S0140-6736(07)60279-7; Darland-Ransom M, 2008, SCIENCE, V320, P528, DOI 10.1126/science.1155847; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fadok VA, 2001, J IMMUNOL, V166, P6847, DOI 10.4049/jimmunol.166.11.6847; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Florey O, 2009, J IMMUNOL, V183, P2330, DOI 10.4049/jimmunol.0901019; Gaipl US, 2006, CURR DIRECT AUTOIMMU, V9, P173; Gude DR, 2008, FASEB J, V22, P2629, DOI 10.1096/fj.08-107169; Hamon Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000120; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2005, P NATL ACAD SCI USA, V102, P16886, DOI 10.1073/pnas.0508599102; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Harris EN, 2008, J BIOL CHEM, V283, P17341, DOI 10.1074/jbc.M710360200; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Herlands RA, 2008, IMMUNITY, V29, P249, DOI 10.1016/j.immuni.2008.06.009; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Ichimura T, 2008, J CLIN INVEST, V118, P1657, DOI 10.1172/JCI34487; Ikehara S, 2002, DRUGS TODAY, V38, P103, DOI 10.1358/dot.2002.38.2.820106; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim SJ, 2002, J EXP MED, V196, P655, DOI 10.1084/jem.20020542; Kitano M, 2008, NATURE, V453, P241, DOI 10.1038/nature06857; Krahling S, 1999, CELL DEATH DIFFER, V6, P183, DOI 10.1038/sj.cdd.4400473; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kranich J, 2008, J EXP MED, V205, P1293, DOI 10.1084/jem.20071019; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; Kunisaki Y, 2004, BLOOD, V103, P3362, DOI 10.1182/blood-2003-09-3245; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Lecut C, 2009, J IMMUNOL, V183, P2801, DOI 10.4049/jimmunol.0804007; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Lian XM, 2004, AM J PHYSIOL-LUNG C, V286, pL801, DOI 10.1152/ajplung.00335.2003; Lippens S, 2005, CELL DEATH DIFFER, V12, P1497, DOI 10.1038/sj.cdd.4401722; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Lockshin RA, 2001, NAT REV MOL CELL BIO, V2, P545, DOI 10.1038/35080097; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Martin SJ, 1996, J BIOL CHEM, V271, P28753, DOI 10.1074/jbc.271.46.28753; Migita K, 2001, CLIN EXP IMMUNOL, V126, P334, DOI 10.1046/j.1365-2249.2001.01677.x; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Miyasaka K, 2004, EUR J IMMUNOL, V34, P1414, DOI 10.1002/eji.200424930; Mori K, 2002, NEUROSCI RES, V43, P69, DOI 10.1016/S0168-0102(02)00018-4; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nakano T, 1997, J BIOL CHEM, V272, P29411, DOI 10.1074/jbc.272.47.29411; Nakaya M, 2006, J BIOL CHEM, V281, P8836, DOI 10.1074/jbc.M510972200; Nakaya M, 2008, P NATL ACAD SCI USA, V105, P9198, DOI 10.1073/pnas.0803677105; Nakayama M, 2009, BLOOD, V113, P3821, DOI 10.1182/blood-2008-10-185884; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; Nonaka H, 2007, DEV DYNAM, V236, P2258, DOI 10.1002/dvdy.21227; Oberst A, 2008, CELL DEATH DIFFER, V15, P1139, DOI 10.1038/cdd.2008.65; Ogden CA, 2005, AUTOIMMUNITY, V38, P259, DOI 10.1080/08916930500124452; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park D, 2009, CURR BIOL, V19, P346, DOI 10.1016/j.cub.2009.01.042; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Peter C, 2008, J BIOL CHEM, V283, P5296, DOI 10.1074/jbc.M706586200; Potter PK, 2003, J IMMUNOL, V170, P3223, DOI 10.4049/jimmunol.170.6.3223; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; RUMORE PM, 1990, J CLIN INVEST, V86, P69, DOI 10.1172/JCI114716; Sahu SK, 2007, ARCH BIOCHEM BIOPHYS, V462, P103, DOI 10.1016/j.abb.2007.04.002; Sakahira H, 2000, J BIOL CHEM, V275, P8091, DOI 10.1074/jbc.275.11.8091; Sakahira H, 2001, ARCH BIOCHEM BIOPHYS, V388, P91, DOI 10.1006/abbi.2000.2266; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Samejima K, 2001, J BIOL CHEM, V276, P45427, DOI 10.1074/jbc.M108844200; SCHLEGEL RA, 2007, SCI STKE, pPE57; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Shakhov AN, 2004, EUR J IMMUNOL, V34, P494, DOI 10.1002/eji.200324590; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Suzuki M, 2007, J NEUROSCI, V27, P1879, DOI 10.1523/JNEUROSCI.5282-06.2007; Taberner M, 2005, INFLAMM RES, V54, P10, DOI 10.1007/s00011-004-1315-8; Tada K, 2003, J IMMUNOL, V171, P5718, DOI 10.4049/jimmunol.171.11.5718; TANAKA Y, 1983, J BIOL CHEM, V258, P1335; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Trouw LA, 2008, MOL IMMUNOL, V45, P1199, DOI 10.1016/j.molimm.2007.09.008; Truman LA, 2004, IMMUNOBIOLOGY, V209, P21, DOI 10.1016/j.imbio.2004.02.001; Truman LA, 2008, BLOOD, V112, P5026, DOI 10.1182/blood-2008-06-162404; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Umetsu SE, 2005, NAT IMMUNOL, V6, P447, DOI 10.1038/ni1186; van den Eijnde SM, 1998, APOPTOSIS, V3, P9, DOI 10.1023/A:1009650917818; Venegas V, 2007, MOL BIOL CELL, V18, P3180, DOI 10.1091/mbc.E07-02-0138; Wang XC, 2003, SCIENCE, V302, P1563, DOI 10.1126/science.1087641; Ward PP, 2003, MOL CELL BIOL, V23, P178, DOI 10.1128/MCB.23.1.178-185.2003; Woo EJ, 2004, MOL CELL, V14, P531, DOI 10.1016/S1097-2765(04)00258-8; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Xiong W, 2008, REPRODUCTION, V135, P77, DOI 10.1530/REP-07-0287; Yamaguchi H, 2008, J LEUKOCYTE BIOL, V83, P1300, DOI 10.1189/jlb.1107730; Yokota S, 2008, LANCET, V371, P998, DOI 10.1016/S0140-6736(08)60454-7; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; Zhang HG, 2004, ARTHRITIS RHEUM-US, V50, P420, DOI 10.1002/art.20037; Zullig S, 2007, CURR BIOL, V17, P994, DOI 10.1016/j.cub.2007.05.024	125	599	618	2	74	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 5	2010	140	5					619	630		10.1016/j.cell.2010.02.014	http://dx.doi.org/10.1016/j.cell.2010.02.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211132	Bronze			2022-12-28	WOS:000275197400012
J	Sharma, A; Dogra, S; Mahajan, R; Wanchu, A; Singh, S				Sharma, Aman; Dogra, Sunil; Mahajan, Rajiv; Wanchu, Ajay; Singh, Surjit			An unusual cause of joint swelling	LANCET			English	Editorial Material									[Sharma, Aman] Postgrad Inst Med Educ & Res, Dept Internal Med, Sector 12, Chandigarh 160012, India; [Dogra, Sunil] Postgrad Inst Med Educ & Res, Dept Dermatol, Chandigarh 160012, India; [Mahajan, Rajiv] Postgrad Inst Med Educ & Res, Dept Cardiol, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Sharma, A (corresponding author), Postgrad Inst Med Educ & Res, Dept Internal Med, Sector 12, Chandigarh 160012, India.	amansharma74@yahoo.com	Mahajan, Rajiv/Q-3033-2019; Mahajan, Rajiv/G-6714-2013; Dogra, Sunil/ABB-5314-2020	Mahajan, Rajiv/0000-0003-3375-5568; Mahajan, Rajiv/0000-0003-3375-5568; Dogra, Sunil/0000-0001-9912-0085					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2010	375	9720					1109	1109		10.1016/S0140-6736(09)60298-1	http://dx.doi.org/10.1016/S0140-6736(09)60298-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578ZB	20346816				2022-12-28	WOS:000276334600034
J	Schulz, KF; Altman, DG; Moher, D				Schulz, Kenneth F.; Altman, Douglas G.; Moher, David		CONSORT Grp	CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials	ANNALS OF INTERNAL MEDICINE			English	Article							EMPIRICAL-EVIDENCE; REVISED RECOMMENDATIONS; SYSTEMATIC REVIEWS; QUALITY; EXTENSION; EXPLANATION; TREAT; BIAS	The CONSORT (Consolidated Standards of Reporting Trials) statement is used worldwide to improve the reporting of randomized, controlled trials. Schulz and colleagues describe the latest version, CONSORT 2010, which updates the reporting guideline based on new methodological evidence and accumulating experience.	[Schulz, Kenneth F.] Family Hlth Int, Res Triangle Pk, NC 27709 USA; Univ Oxford Wolfson Coll, Ctr Stat Med, Oxford OX2 6UD, England; Univ Ottawa, Ottawa Hosp Res Inst, Ottawa Methods Ctr, Clin Epidemiol Program, Ottawa, ON K1H 8L6, Canada	University of Oxford; University of Ottawa; Ottawa Hospital Research Institute	Schulz, KF (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.		Altman, Douglas G/A-9714-2012; Trajman, Anete/C-7679-2016; Groves, Trish/A-9119-2009	Trajman, Anete/0000-0002-4000-4984; Groves, Trish/0000-0001-7915-6419; Boutron, Isabelle/0000-0002-5263-6241; Moher, David/0000-0003-2434-4206; Hopewell, Sally/0000-0002-6881-6984	United Kingdom National Institute for Health Research and the Medical Research Council; Canadian Institutes of Health Research; Presidents Fund, Canadian Institutes of Health Research; Johnson Johnson; BMJ; American Society for Clinical Oncology; Cancer Research UK; University of Ottawa; Family Health International	United Kingdom National Institute for Health Research and the Medical Research Council; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Presidents Fund, Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); BMJ; American Society for Clinical Oncology; Cancer Research UK(Cancer Research UK); University of Ottawa; Family Health International	Grant Support: From United Kingdom National Institute for Health Research and the Medical Research Council; Canadian Institutes of Health Research; Presidents Fund, Canadian Institutes of Health Research; Johnson & Johnson; BMJ; and American Society for Clinical Oncology. Dr. Altman is supported by Cancer Research UK, Dr. Moher by a University of Ottawa Research Chair, and Dr. Schulz by Family Health International. None of the sponsors had any involvement in the planning, execution, or writing of the CONSORT documents. In addition, no funder played a role in drafting the manuscript.	ANDREW E, 1994, JAMA-J AM MED ASSOC, V272, P1926, DOI 10.1001/jama.1994.03520240054041; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Gagnier JJ, 2006, ANN INTERN MED, V144, P364, DOI 10.7326/0003-4819-144-5-200603070-00013; Glasziou P, 2008, BMJ-BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Hopewell Sally, 2010, BMJ, V340, pc723, DOI 10.1136/bmj.c723; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Nuovo J, 2002, JAMA-J AM MED ASSOC, V287, P2813, DOI 10.1001/jama.287.21.2813; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; RENNIE D, 1995, JAMA-J AM MED ASSOC, V273, P1054, DOI 10.1001/jama.273.13.1054; Sackett DL, 2007, INT J EPIDEMIOL, V36, P664, DOI 10.1093/ije/dym088; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Schulz KF, 2002, LANCET, V359, P696, DOI 10.1016/S0140-6736(02)07816-9; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	33	1906	1955	6	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 1	2010	152	11					726	W293		10.7326/0003-4819-152-11-201006010-00232	http://dx.doi.org/10.7326/0003-4819-152-11-201006010-00232			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608CT	20335313	Green Submitted			2022-12-28	WOS:000278560000006
J	Shields, JD; Kourtis, IC; Tomei, AA; Roberts, JM; Swartz, MA				Shields, Jacqueline D.; Kourtis, Iraklis C.; Tomei, Alice A.; Roberts, Joanna M.; Swartz, Melody A.			Induction of Lymphoidlike Stroma and Immune Escape by Tumors That Express the Chemokine CCL21	SCIENCE			English	Article							ROR-GAMMA-T; LYMPH-NODES; CCR7; CANCER; HOMEOSTASIS; MODULATION; ONTOGENY; DISPLAY	Tumor manipulation of host immunity is important for tumor survival and invasion. Many cancers secrete CCL21, a chemoattractant for various leukocytes and lymphoid tissue inducer cells, which drive lymphoid neogenesis. CCL21 expression by melanoma tumors in mice was associated with an immunotolerant microenvironment, which included the induction of lymphoid-like reticular stromal networks, an altered cytokine milieu, and the recruitment of regulatory leukocyte populations. In contrast, CCL21-deficient tumors induced antigen-specific immunity. CCL21-mediated immune tolerance was dependent on host rather than tumor expression of the CCL21 receptor, CCR7, and could protect distant, coimplanted CCL21-deficient tumors and even nonsyngeneic allografts from rejection. We suggest that by altering the tumor microenvironment, CCL21-secreting tumors shift the host immune response from immunogenic to tolerogenic, which facilitates tumor progression.	[Shields, Jacqueline D.; Kourtis, Iraklis C.; Tomei, Alice A.; Roberts, Joanna M.; Swartz, Melody A.] Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Swartz, MA (corresponding author), Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland.	melody.swartz@epfl.ch	Swartz, Melody A./F-9563-2011; Swartz, Melody/B-7633-2009	Roberts, Joanna/0000-0003-0679-8976; Tomei, Alice/0000-0002-5059-6303	Swiss Cancer League; Swiss National Science Foundation; European Research Council; U.S. Department of Defense Breast Cancer Research	Swiss Cancer League; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); U.S. Department of Defense Breast Cancer Research(United States Department of Defense)	We thank G. Eberl for Rorc(gamma t)+/GFP and Rorc(gamma t)<SUP>GFP/GFP</SUP> mice, S. Luther for CCR7<SUP>-/-</SUP> mice, D. Hanahan for beta tumor cells, and D. Trono for lentiviral vector plasmids; S. Pradervand, A. Paillusson, D. Foretay, M. Pasquier, V. Borel, B. Dixon, and A. Jimenez for technical assistance; and J. Hubbell and G. Eberl for critical reading of the manuscript. Funding was provided by the Swiss Cancer League, the Swiss National Science Foundation, the European Research Council, and the U.S. Department of Defense Breast Cancer Research Program to M. A. S. The authors (except J. M. R.) have filed a patent application	Ben-Baruch A, 2006, CANCER METAST REV, V25, P357, DOI 10.1007/s10555-006-9003-5; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Britschgi MR, 2008, J IMMUNOL, V181, P7681, DOI 10.4049/jimmunol.181.11.7681; Davalos-Misslitz ACM, 2007, EUR J IMMUNOL, V37, P613, DOI 10.1002/eji.200636656; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2003, IMMUNOL REV, V195, P81, DOI 10.1034/j.1600-065X.2003.00074.x; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Joyce JA, 2003, CANCER CELL, V4, P393, DOI 10.1016/S1535-6108(03)00271-X; Kawase A, 2008, INT J CANCER, V123, P1053, DOI 10.1002/ijc.23611; Krautwald S, 2004, IMMUNOLOGY, V112, P301, DOI 10.1111/j.1365-2567.2004.01859.x; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Menning A, 2007, EUR J IMMUNOL, V37, P1575, DOI 10.1002/eji.200737201; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Ochando JC, 2005, J IMMUNOL, V174, P6993, DOI 10.4049/jimmunol.174.11.6993; Peduto L, 2009, J IMMUNOL, V182, P5789, DOI 10.4049/jimmunol.0803974; Prendergast GC, 2008, ONCOGENE, V27, P3889, DOI 10.1038/onc.2008.35; Randall TD, 2008, ANNU REV IMMUNOL, V26, P627, DOI 10.1146/annurev.immunol.26.021607.090257; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Varela JC, 2008, CANCER RES, V68, P6734, DOI 10.1158/0008-5472.CAN-08-0502; Weninger W, 2003, J IMMUNOL, V170, P4638, DOI 10.4049/jimmunol.170.9.4638; Ziegler E, 2006, J AM SOC NEPHROL, V17, P2521, DOI 10.1681/ASN.2005070782; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	27	347	361	3	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2010	328	5979					749	752		10.1126/science.1185837	http://dx.doi.org/10.1126/science.1185837			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20339029	Green Published			2022-12-28	WOS:000277357100039
J	Davis, ME; Zuckerman, JE; Choi, CHJ; Seligson, D; Tolcher, A; Alabi, CA; Yen, Y; Heidel, JD; Ribas, A				Davis, Mark E.; Zuckerman, Jonathan E.; Choi, Chung Hang J.; Seligson, David; Tolcher, Anthony; Alabi, Christopher A.; Yen, Yun; Heidel, Jeremy D.; Ribas, Antoni			Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles	NATURE			English	Article							RIBONUCLEOTIDE REDUCTASE; GENE-EXPRESSION; IN-VIVO; INTERFERENCE; POTENT; MICE; CELL; PHARMACOKINETICS; THERAPEUTICS; INHIBITION	Therapeutics that are designed to engage RNA interference (RNAi) pathways have the potential to provide new, major ways of imparting therapy to patients(1,2). Long, double-stranded RNAs were first shown to mediate RNAi in Caenorhabditis elegans(3), and the potential use of RNAi for human therapy has been demonstrated by the finding that small interfering RNAs (siRNAs; approximately 21-base-pair double-stranded RNA) can elicit RNAi in mammalian cells without producing an interferon response(4). We are at present conducting the first in-human phase I clinical trial involving the systemic administration of siRNA to patients with solid cancers using a targeted, nanoparticle delivery system. Here we provide evidence of inducing an RNAi mechanism of action in a human from the delivered siRNA. Tumour biopsies from melanoma patients obtained after treatment show the presence of intracellularly localized nanoparticles in amounts that correlate with dose levels of the nanoparticles administered (this is, to our knowledge, a first for systemically delivered nanoparticles of any kind). Furthermore, a reduction was found in both the specific messenger RNA (M2 subunit of ribonucleotide reductase (RRM2)) and the protein (RRM2) levels when compared to pre-dosing tissue. Most notably, we detect the presence of an mRNA fragment that demonstrates that siRNA-mediated mRNA cleavage occurs specifically at the site predicted for an RNAi mechanism from a patient who received the highest dose of the nanoparticles. Together, these data demonstrate that siRNA administered systemically to a human can produce a specific gene inhibition (reduction in mRNA and protein) by an RNAi mechanism of action.	[Davis, Mark E.; Zuckerman, Jonathan E.; Choi, Chung Hang J.; Alabi, Christopher A.] CALTECH, Pasadena, CA 91125 USA; [Seligson, David; Ribas, Antoni] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Seligson, David] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; [Ribas, Antoni] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Tolcher, Anthony] START LLC, San Antonio, TX 78229 USA; [Yen, Yun] City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA; [Heidel, Jeremy D.] Calando Pharmaceut, Pasadena, CA 91101 USA	California Institute of Technology; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; City of Hope	Davis, ME (corresponding author), CALTECH, Pasadena, CA 91125 USA.	mdavis@cheme.caltech.edu		Choi, Chung Hang Jonathan/0000-0003-2935-7217	National Cancer Institute [CA U54 119347]; Daljit S. & Elaine Sarkaria Biomarker Laboratory Fund; NATIONAL CANCER INSTITUTE [U54CA119347] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Daljit S. & Elaine Sarkaria Biomarker Laboratory Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank H. Sazegar, E. Seja, A. Villanueva and the G-CRC nursing staff at University of California, Los Angeles (UCLA), and L. Kalinoski, J. Peterkin, S. Rele, Y. Liang and J. Y. C. Liu for their assistance in conducting the clinical trial. We thank J. S. Economou for performing the tumour biopsies, and B. Chmielowski and Z. Wainberg for patient referrals. Histotechnology support at the UCLA Biomarker Innovations Laboratory was provided by C. Savina and J. Reiss. We also thank J. Rossi for discussions on RACE analyses. This work was supported in part by the National Cancer Institute Grant CA U54 119347 and the Daljit S. & Elaine Sarkaria Biomarker Laboratory Fund.	Alvarez R, 2009, ANTIMICROB AGENTS CH, V53, P3952, DOI 10.1128/AAC.00014-09; Bartlett DW, 2008, BIOTECHNOL BIOENG, V99, P975, DOI 10.1002/bit.21668; Bartlett DW, 2007, P NATL ACAD SCI USA, V104, P15549, DOI 10.1073/pnas.0707461104; Bartlett DW, 2006, NUCLEIC ACIDS RES, V34, P322, DOI 10.1093/nar/gkj439; Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Cerqueira NMFSA, 2005, CURR MED CHEM, V12, P1283, DOI 10.2174/0929867054020981; Davis ME, 2009, MOL PHARMACEUT, V6, P659, DOI 10.1021/mp900015y; DeVincenzo J, 2008, ANTIVIR RES, V77, P225, DOI 10.1016/j.antiviral.2007.11.009; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GATTER KC, 1983, J CLIN PATHOL, V36, P539, DOI 10.1136/jcp.36.5.539; Heidel JD, 2007, P NATL ACAD SCI USA, V104, P5715, DOI 10.1073/pnas.0701458104; Heidel JD, 2007, CLIN CANCER RES, V13, P2207, DOI 10.1158/1078-0432.CCR-06-2218; Juhasz A, 2006, ONCOL REP, V15, P1299; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Koldehoff M, 2007, CLIN EXP MED, V7, P47, DOI 10.1007/s10238-007-0125-z; Leachman SA, 2010, MOL THER, V18, P442, DOI 10.1038/mt.2009.273; Lewis DL, 2002, NAT GENET, V32, P107, DOI 10.1038/ng944; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; MCCLARTY GA, 1987, BIOCHEMISTRY-US, V26, P8004, DOI 10.1021/bi00398a068; RIEHL R, 1984, J CANCER RES CLIN, V107, P21, DOI 10.1007/BF00395486; Schluep T, 2009, P NATL ACAD SCI USA, V106, P11394, DOI 10.1073/pnas.0905487106; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121	25	1934	2068	16	942	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 15	2010	464	7291					1067	U140		10.1038/nature08956	http://dx.doi.org/10.1038/nature08956			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20305636	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000276635000044
J	Swinbank, AM; Smail, I; Longmore, S; Harris, AI; Baker, AJ; De Breuck, C; Richard, J; Edge, AC; Ivison, RJ; Blundell, R; Coppin, KEK; Cox, P; Gurwell, M; Hainline, LJ; Krips, M; Lundgren, A; Neri, R; Siana, B; Siringo, G; Stark, DP; Wilner, D; Younger, JD				Swinbank, A. M.; Smail, I.; Longmore, S.; Harris, A. I.; Baker, A. J.; De Breuck, C.; Richard, J.; Edge, A. C.; Ivison, R. J.; Blundell, R.; Coppin, K. E. K.; Cox, P.; Gurwell, M.; Hainline, L. J.; Krips, M.; Lundgren, A.; Neri, R.; Siana, B.; Siringo, G.; Stark, D. P.; Wilner, D.; Younger, J. D.			Intense star formation within resolved compact regions in a galaxy at z=2.3	NATURE			English	Article							SUBMILLIMETER GALAXIES; HIGH-REDSHIFT; MOLECULAR CLOUDS; BIG-BANG; RESOLUTION; POPULATION; LUMINOSITY; CONTINUUM; STARBURST; EMISSION	Massive galaxies in the early Universe have been shown to be forming stars at surprisingly high rates(1-3). Prominent examples are dust-obscured galaxies which are luminous when observed at sub-millimetre wavelengths and which may be forming stars at a rate of 1,000 solar masses (M(circle dot)) per year(4-7). These intense bursts of star formation are believed to be driven by mergers between gas-rich galaxies(8-9). Probing the properties of individual star-forming regions within these galaxies, however, is beyond the spatial resolution and sensitivity of even the largest telescopes at present. Here we report observations of the sub-millimetre galaxy SMMJ2135-0102 at redshift z = 2.3259, which has been gravitationally magnified by a factor of 32 by a massive foreground galaxy cluster lens. This magnification, when combined with high-resolution sub-millimetre imaging, resolves the star-forming regions at a linear scale of only 100 parsecs. We find that the luminosity densities of these star-forming regions are comparable to the dense cores of giant molecular clouds in the local Universe, but they are about a hundred times larger and 10(7) times more luminous. Although vigorously star-forming, the underlying physics of the star-formation processes at z approximate to 2 appears to be similar to that seen in local galaxies, although the energetics are unlike anything found in the present-day Universe.	[Swinbank, A. M.; Smail, I.; Richard, J.; Edge, A. C.; Coppin, K. E. K.] Univ Durham, Inst Computat Cosmol, Durham DH1 3LE, England; [Longmore, S.; Blundell, R.; Gurwell, M.; Wilner, D.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Harris, A. I.; Hainline, L. J.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Baker, A. J.] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; [De Breuck, C.] European So Observ, D-85748 Garching, Germany; [Ivison, R. J.] Royal Observ, Sci & Technol Facil Council, UK Astron Technol Ctr, Edinburgh EH9 3HJ, Midlothian, Scotland; [Ivison, R. J.] Royal Observ Edinburgh, Inst Astron, Edinburgh EH9 3HJ, Midlothian, Scotland; [Cox, P.; Krips, M.; Neri, R.] Inst Radio Astron Millimetr, F-38406 St Martin Dheres, France; [Lundgren, A.; Siringo, G.] European So Observ, Santiago 19, Chile; [Siana, B.] CALTECH, Pasadena, CA 91125 USA; [Stark, D. P.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Younger, J. D.] Inst Adv Study, Princeton, NJ 08540 USA	Durham University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University System of Maryland; University of Maryland College Park; Rutgers State University New Brunswick; European Southern Observatory; University of Edinburgh; University of Edinburgh; European Southern Observatory; California Institute of Technology; University of Cambridge; Institute for Advanced Study - USA	Swinbank, AM (corresponding author), Univ Durham, Inst Computat Cosmol, South Rd, Durham DH1 3LE, England.	a.m.swinbank@dur.ac.uk	Ivison, R. J./G-4450-2011; Smail, Ian/AAL-9018-2020; Baker, Andrew/HHM-6373-2022; Smail, Ian/M-5161-2013	Ivison, R. J./0000-0001-5118-1313; Smail, Ian/0000-0003-3037-257X; Smail, Ian/0000-0003-3037-257X; De Breuck, Carlos/0000-0002-6637-3315; Richard, Johan/0000-0001-5492-1049; /0000-0002-0729-2988; Lundgren, Andreas/0000-0001-6795-5301; Baker, Andrew/0000-0002-7892-396X; swinbank, mark/0000-0003-1192-5837; Gurwell, Mark/0000-0003-0685-3621; Harris, Andrew/0000-0001-6159-9174; Edge, Alastair/0000-0002-3398-6916; Wilner, David/0000-0003-1526-7587	Royal Astronomical Society Sir Norman Lockyer Fellowship; Marie Curie fellowship; Science Technology and Facilities Council fellowship; NASA through a Hubble Fellowship; Smithsonian Institution; Academia Sinica; INSU/CNRS (France); Max Planck Gesellschaft (MPG; Germany); Instituto Geografico Nacional (IGN; Spain); Science and Technology Facilities Council [ST/F002289/1, ST/F002300/1, ST/H001913/1, ST/F002963/1, ST/H005234/1, ST/F008694/1, ST/H008519/1, PP/E001181/1] Funding Source: researchfish; STFC [ST/F008694/1, ST/H005234/1, ST/F002289/1, ST/F002963/1, ST/H008519/1, ST/H001913/1, ST/F002300/1] Funding Source: UKRI	Royal Astronomical Society Sir Norman Lockyer Fellowship; Marie Curie fellowship(European Commission); Science Technology and Facilities Council fellowship; NASA through a Hubble Fellowship; Smithsonian Institution(Smithsonian Institution); Academia Sinica(Academia Sinica - Taiwan); INSU/CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); Max Planck Gesellschaft (MPG; Germany)(Max Planck Society); Instituto Geografico Nacional (IGN; Spain); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank the staff at Green Bank Telescope for scheduling the Zpectrometer observations at short notice, and the ESO director for granting director's discretionary time observations with SABOCA. A. M. S. gratefully acknowledges a Royal Astronomical Society Sir Norman Lockyer Fellowship, and J. R. and D. P. S. acknowledge a Marie Curie fellowship and a Science Technology and Facilities Council fellowship respectively. J. D. Y. acknowledges support from NASA through a Hubble Fellowship. The Zpectrometer observations were carried out on the Robert C. Byrd Green Bank Telescope, which is operated by the National Radio Astronomy Observatory, a facility of the National Science Foundation operated under cooperative agreement by Associated Universities, Inc. The APEX observations were carried out with ESO Telescopes. The 870 mm interferometric observations were carried out with the Sub-Millimeter Array, which is a joint project between the Smithsonian Astrophysical Observatory and the Academia Sinica Institute of Astronomy and Astrophysics and is funded by the Smithsonian Institution and the Academia Sinica. The CO(3-2) observations were carried out with the Plateau de Bure Interferometer, which is supported by INSU/CNRS (France), Max Planck Gesellschaft (MPG; Germany), and Instituto Geografico Nacional (IGN; Spain). J. D. Y. is a Hubble Fellow.	Blain AW, 2002, PHYS REP, V369, P111, DOI 10.1016/S0370-1573(02)00134-5; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Caldwell DA, 1996, ASTROPHYS J, V472, P611, DOI 10.1086/178092; Carilli CL, 2002, ASTRON J, V123, P1838, DOI 10.1086/339306; Chapman SC, 2005, ASTROPHYS J, V622, P772, DOI 10.1086/428082; Chapman SC, 2003, NATURE, V422, P695, DOI 10.1038/nature01540; Coppin K, 2008, MON NOT R ASTRON SOC, V384, P1597, DOI 10.1111/j.1365-2966.2007.12808.x; DOWNES D, 1995, ASTROPHYS J, V453, pL65, DOI 10.1086/309754; Elmegreen BG, 1999, ASTROPHYS J, V517, P103, DOI 10.1086/307200; Gao Y, 2004, ASTROPHYS J SUPPL S, V152, P63, DOI 10.1086/383003; Genzel R, 2006, NATURE, V442, P786, DOI 10.1038/nature05052; Greve TR, 2005, MON NOT R ASTRON SOC, V359, P1165, DOI 10.1111/j.1365-2966.2005.08979.x; Harris AI, 2007, ASTR SOC P, V375, P82; Hill T, 2005, MON NOT R ASTRON SOC, V363, P405, DOI 10.1111/j.1365-2966.2005.09347.x; Hughes DH, 1998, NATURE, V394, P241, DOI 10.1038/28328; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Lilly SJ, 1999, ASTROPHYS J, V518, P641, DOI 10.1086/307310; LINTOTT C, 2002, MON NOT R ASTRON SOC, V360, P1527; Livanou E, 2006, ASTRON ASTROPHYS, V451, P431, DOI 10.1051/0004-6361:20040330; Sakamoto K, 2008, ASTROPHYS J, V684, P957, DOI 10.1086/590484; SCOVILLE NZ, 1989, ASTROPHYS J, V339, P149, DOI 10.1086/167283; SMAIL I, 1997, APJL, V490, P5; Snell RL, 2002, ASTROPHYS J, V578, P229, DOI 10.1086/342424; Solomon PM, 2005, ANNU REV ASTRON ASTR, V43, P677, DOI 10.1146/annurev.astro.43.051804.102221; Swinbank AM, 2006, MON NOT R ASTRON SOC, V371, P465, DOI 10.1111/j.1365-2966.2006.10673.x; Tacconi LJ, 2008, ASTROPHYS J, V680, P246, DOI 10.1086/587168; Walter F, 2009, NATURE, V457, P699, DOI 10.1038/nature07681; Yun MS, 2008, MON NOT R ASTRON SOC, V389, P333, DOI 10.1111/j.1365-2966.2008.13565.x	28	283	285	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 1	2010	464	7289					733	736		10.1038/nature08880	http://dx.doi.org/10.1038/nature08880			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20305639	Green Submitted			2022-12-28	WOS:000276205000039
J	Mancia, G; Parati, G; Revera, M; Bilo, G; Giuliano, A; Veglia, F; Crepaldi, G; Zanchetti, A				Mancia, Giuseppe; Parati, Gianfranco; Revera, Miriam; Bilo, Grzegorz; Giuliano, Andrea; Veglia, Fabrizio; Crepaldi, Gaetano; Zanchetti, Alberto			Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COA REDUCTASE INHIBITORS; EUROPEAN-SOCIETY; CARDIOVASCULAR-DISEASE; HYPERTENSIVE PATIENTS; MEASURING DEVICES; ATORVASTATIN; PRAVASTATIN; SIMVASTATIN; CORONARY; THERAPY	Objective To investigate the possibility that statins reduce blood pressure as well as cholesterol concentrations through clinic and 24 hour ambulatory blood pressure monitoring. Design Randomised placebo controlled double blind trial. Setting 13 hospitals in Italy Participants 508 patients with mild hypertension and hypercholesterolaemia, aged 45 to 70 years. Intervention Participants were randomised to antihypertensive treatment (hydrochlorothiazide 25 mg once daily or fosinopril 20 mg once daily) with or without the addition of a statin (pravastatin 40 mg once daily). Main outcome measures Clinic and ambulatory blood pressure measured every year throughout an average 2. 6 year treatment period. Results Both the group receiving antihypertensive treatment without pravastatin (n=254) (with little change in total cholesterol) and the group receiving antihypertensive treatment with pravastatin (n=253) (with marked and sustained reduction in total cholesterol and low density lipoprotein cholesterol) had a clear cut sustained reduction in clinic measured systolic and diastolic blood pressure as well as in 24 hour, and day and night, systolic and diastolic blood pressure. Pravastatin performed slightly worse than placebo, and between group differences did not exceed 1.9 (95% confidence interval -0.6 to 4.3, P=0.13) mm Hg throughout the treatment period. This was also the case when participants who remained on monotherapy with hydrochlorothiazide or fosinopril throughout the study were considered separately. Conclusions Administration of a statin in hypertensive patients in whom blood pressure is effectively reduced by concomitant antihypertensive treatment does not have an additional blood pressure lowering effect.	[Mancia, Giuseppe; Parati, Gianfranco; Revera, Miriam; Bilo, Grzegorz] Univ Milano Bicocca, Dept Clin Med & Prevent, Milan, Italy; [Mancia, Giuseppe] Osped San Gerardo, Med Clin, I-20052 Monza, Italy; [Parati, Gianfranco; Revera, Miriam; Bilo, Grzegorz; Giuliano, Andrea] IRCCS, Ist Auxol Italiano, Dept Cardiol, I-20149 Milan, Italy; [Veglia, Fabrizio] IRCCS, Ctr Cardiol Monzino, Biostat Unit, I-20138 Milan, Italy; [Crepaldi, Gaetano] Univ Padua, Med Clin 1, I-35128 Padua, Italy; [Zanchetti, Alberto] Univ Milan, Ctr Clin Physiol & Hypertens, Milan, Italy; [Zanchetti, Alberto] IRCCS, Ist Auxol Italiano, I-20145 Milan, Italy	University of Milano-Bicocca; San Gerardo Hospital; IRCCS Istituto Auxologico Italiano; IRCCS Centro Cardiologico Monzino; University of Padua; University of Milan; IRCCS Istituto Auxologico Italiano	Mancia, G (corresponding author), Univ Milano Bicocca, Dept Clin Med & Prevent, Milan, Italy.	giuseppe.mancia@unimib.it	Parati, Gianfranco/K-7151-2016; Bilo, Grzegorz/J-8694-2016; Veglia, Fabrizio/K-1958-2016	Parati, Gianfranco/0000-0001-9402-7439; Bilo, Grzegorz/0000-0002-5104-9176; Veglia, Fabrizio/0000-0002-9378-8874; Revera, Miriam/0000-0002-3388-1858; zanchetti, alberto/0000-0003-4796-7959	Bristol-Myers Squibb Italy, Rome; Menarini, Florence	Bristol-Myers Squibb Italy, Rome(Bristol-Myers Squibb); Menarini, Florence(Menarini Group)	Funding: PHYLLIS was an investigator generated trial sponsored by Bristol-Myers Squibb Italy, Rome, and Menarini, Florence. All authors carried out this research project in full independence from funders.	Bautista LE, 2009, J HYPERTENS, V27, P1478, DOI 10.1097/HJH.0b013e32832b1e78; Borghi C, 2004, AM HEART J, V148, P285, DOI 10.1016/j.ahj.2004.02.003; Borghi C, 2000, J CARDIOVASC PHARM, V35, P549, DOI 10.1097/00005344-200004000-00006; Chan PS, 2007, CIRCULATION, V115, P2398, DOI 10.1161/CIRCULATIONAHA.106.667683; Dorval JF, 2005, AM J CARDIOL, V95, P249, DOI 10.1016/j.amjcard.2004.09.012; Ferrier KE, 2002, J AM COLL CARDIOL, V39, P1020, DOI 10.1016/S0735-1097(02)01717-5; Glorioso N, 1999, HYPERTENSION, V34, P1281, DOI 10.1161/01.HYP.34.6.1281; Golomb BA, 2008, ARCH INTERN MED, V168, P721, DOI 10.1001/archinte.168.7.721; Ichihara A, 2005, J HUM HYPERTENS, V19, P103, DOI 10.1038/sj.jhh.1001786; Kanbay M, 2005, RENAL FAILURE, V27, P297, DOI 10.1081/JDI-200056610; Koh KK, 2004, CIRCULATION, V110, P3687, DOI 10.1161/01.CIR.0000143085.86697.13; Krauss RM, 2000, CIRCULATION, V102, P2284; Laufs U, 2001, AM J CARDIOL, V88, P1306, DOI 10.1016/S0002-9149(01)02095-1; Leibovitz E, 2001, AM J HYPERTENS, V14, P1096, DOI 10.1016/S0895-7061(01)02210-5; MANCIA G, 1983, CIRC RES, V53, P96, DOI 10.1161/01.RES.53.1.96; Mancia G, 2007, HYPERTENSION, V49, P1265, DOI 10.1161/HYPERTENSIONAHA.107.088708; Mancia G, 2006, CURR HYPERTENS REP, V8, P330, DOI 10.1007/s11906-006-0073-0; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; O'Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/00004872-200305000-00001; O'Brien E, 2002, BLOOD PRESS MONIT, V7, P3, DOI 10.1097/00126097-200202000-00002; O'Brien E, 2001, BMJ-BRIT MED J, V322, P531, DOI 10.1136/bmj.322.7285.531; PARATI G, 1987, J HYPERTENS, V5, P93, DOI 10.1097/00004872-198702000-00013; PARATI G, 2005, HYPERTENSION COMPANI; Patterson D, 2002, HEART, V88, P415, DOI 10.1136/heart.88.4.415; Prasad GVR, 2003, KIDNEY INT, V63, P360, DOI 10.1046/j.1523-1755.2003.00742.x; Ray Kausik K, 2007, Curr Treat Options Cardiovasc Med, V9, P46, DOI 10.1007/s11936-007-0050-1; Riche DM, 2007, AM J HEALTH-SYST PH, V64, P1603, DOI 10.2146/ajhp060397; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Simons LA, 1998, ATHEROSCLEROSIS, V137, P197, DOI 10.1016/S0021-9150(97)00252-9; Staessen JA, 1999, JAMA-J AM MED ASSOC, V282, P539, DOI 10.1001/jama.282.6.539; STRAZNICKY NE, 1995, AM J CARDIOL, V75, P582, DOI 10.1016/S0002-9149(99)80621-3; Strazzullo P, 2007, HYPERTENSION, V49, P792, DOI 10.1161/01.HYP.0000259737.43916.42; Tonelli M, 2006, J HUM HYPERTENS, V20, P560, DOI 10.1038/sj.jhh.1002036; Williams B, 2009, CIRCULATION, V119, P53, DOI 10.1161/CIRCULATIONAHA.108.785915; Zanchetti A, 2004, STROKE, V35, P2807, DOI 10.1161/01.STR.0000147041.00840.59; Zhou Z, 2006, AM HEART J, V151, P273, DOI 10.1016/j.ahj.2005.04.003	36	37	42	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2010	340								c1197	10.1136/bmj.c1197	http://dx.doi.org/10.1136/bmj.c1197			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	576PQ	20339154	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000276157800001
J	Sablier, F; Slaouti, T; Dreze, PA; El Fouly, PE; Allemeersch, D; Van Melderen, L; Smeesters, PR				Sablier, Frederique; Slaouti, Tayeb; Dreze, Pierre-Alexandre; El Fouly, Pierre Emmanuel; Allemeersch, Daniel; Van Melderen, Laurence; Smeesters, Pierre R.			Nosocomial transmission of necrotising fasciitis	LANCET			English	Editorial Material									[Dreze, Pierre-Alexandre; Van Melderen, Laurence; Smeesters, Pierre R.] Univ Libre Bruxelles, Lab Bacterial Genet & Physiol, IBMM, Fac Sci, B-6041 Gosselies, Belgium; [Smeesters, Pierre R.] Univ Libre Bruxelles, Hop Univ Enfants Reine Fabiola, Dept Infect Dis, Brussels, Belgium; [Sablier, Frederique; Allemeersch, Daniel] Clin Europe, Dept Bacteriol, Brussels, Belgium; [Slaouti, Tayeb] Clin Europe, Dept Pediat, Brussels, Belgium; [El Fouly, Pierre Emmanuel] Clin Europe, Dept Plast Surg, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Smeesters, PR (corresponding author), Univ Libre Bruxelles, Lab Bacterial Genet & Physiol, IBMM, Fac Sci, 12 Rue Prof Jeener & Brachet, B-6041 Gosselies, Belgium.	psmeeste@ulb.ac.be	Smeesters, Pierre/I-7723-2012	Smeesters, Pierre/0000-0002-2642-9919; Van Melderen, Laurence/0000-0002-7778-1736				Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; BREIMAN RF, 1993, JAMA-J AM MED ASSOC, V269, P390, DOI 10.1001/jama.1993.03500030088038; Hassell M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-60; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612	5	12	12	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 20	2010	375	9719					1052	1052		10.1016/S0140-6736(10)60052-9	http://dx.doi.org/10.1016/S0140-6736(10)60052-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	575YU	20304249				2022-12-28	WOS:000276110700038
J	den Boer, SPA; Baer, B; Boomsma, JJ				den Boer, Susanne P. A.; Baer, Boris; Boomsma, Jacobus J.			Seminal Fluid Mediates Ejaculate Competition in Social Insects	SCIENCE			English	Article							SPERM VIABILITY; EVOLUTION; FEMALES; SELECTION; MONOGAMY; PROTEOME; STORAGE; QUEENS; COST	Queens of ants and bees normally obtain a lifetime supply of sperm on a single day of sexual activity, and sperm competition is expected to occur in lineages where queens receive sperm from multiple males. We compared singly mated (monandrous) and multiply mated (polyandrous) sister groups of ants and bees and show that seminal fluid of polyandrous species has a more positive effect on the survival of a male's own sperm than on other males' sperm. This difference was not observed in the monandrous species, suggesting that incapacitation of competing sperm may have independently evolved in both bees and ants. In Atta leafcutter ants, the negative effect of the seminal fluid of other males was negated by secretion from the queen sperm-storage organ, suggesting that queens may control ejaculate competition after sperm storage.	[den Boer, Susanne P. A.; Boomsma, Jacobus J.] Univ Copenhagen, Dept Biol, Ctr Social Evolut, DK-2100 Copenhagen, Denmark; [Baer, Boris] Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, Crawley 6009, Australia; [Baer, Boris] Univ Western Australia, Sch Anim Biol MO92, Ctr Evolutionary Biol, Crawley 6009, Australia	University of Copenhagen; University of Western Australia; University of Western Australia	Boomsma, JJ (corresponding author), Univ Copenhagen, Dept Biol, Ctr Social Evolut, Univ Pk 15, DK-2100 Copenhagen, Denmark.	jjboomsma@bio.ku.dk	den Boer, Susanne/F-5821-2011; Boomsma, Jacobus J/M-2785-2014; Baer, Boris/F-5301-2011	den Boer, Susanne/0000-0001-9149-527X; Boomsma, Jacobus J/0000-0002-3598-1609; Baer, Boris/0000-0002-1136-5967	Danish National Research Foundation; Australian Research Council [DP 0878107]; Queen Elizabeth II Fellowship [DP 0770050]	Danish National Research Foundation(Danmarks Grundforskningsfond); Australian Research Council(Australian Research Council); Queen Elizabeth II Fellowship	We thank G. Nachman and D. R. Nash for statistical help, L. Holman and D. R. Nash for discussion and comments, M. Sturup for collecting ants in the field, M. King for collecting part of the sperm viability data for honeybees, the honeybee keepers of Western Australia (Better Bees of WA) for providing the necessary bee material, the Smithsonian Tropical Research Institute in Panama for facilities and logistic support during fieldwork, and the Autoridad Nacional de Ambiente (ANAM) for issuing collecting and export permits for fungus-growing ants. Supported by a grant from the Danish National Research Foundation (to J.J.B.) and an Australian Research Council Discovery Project (DP 0878107) and Queen Elizabeth II Fellowship (DP 0770050) (to B. B.).	Aanen DK, 2009, SCIENCE, V326, P1103, DOI 10.1126/science.1173462; Baer B, 2005, APIDOLOGIE, V36, P187, DOI 10.1051/apido:2005013; Baer B, 2006, NATURE, V441, P872, DOI 10.1038/nature04698; Baer B, 2006, J MORPHOL, V267, P1165, DOI 10.1002/jmor.10467; Baer B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r67; Baer B, 2009, PROTEOMICS, V9, P2085, DOI 10.1002/pmic.200800708; Boomsma Jacobus J., 2009, P3; Boomsma JJ, 2009, PHILOS T R SOC B, V364, P3191, DOI 10.1098/rstb.2009.0101; Boomsma JJ, 2005, ANNU REV ENTOMOL, V50, P395, DOI 10.1146/annurev.ento.50.071803.130416; Boomsma JJ, 1996, PHILOS T R SOC B, V351, P947, DOI 10.1098/rstb.1996.0087; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; COLE BJ, 1983, BEHAV ECOL SOCIOBIOL, V12, P191, DOI 10.1007/BF00290771; Crozier RH, 2001, ANN ZOOL FENN, V38, P267; den Boer SPA, 2008, BEHAV ECOL SOCIOBIOL, V62, P1843, DOI 10.1007/s00265-008-0613-5; den Boer SPA, 2009, P ROY SOC B-BIOL SCI, V276, P3945, DOI 10.1098/rspb.2009.1184; den Boer SPA, 2009, J INSECT PHYSIOL, V55, P538, DOI 10.1016/j.jinsphys.2009.01.012; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; HOLLDOBLER B, 1985, EXPT BEHAV ECOLOGY S, P237; Holman L, 2009, BEHAV ECOL SOCIOBIOL, V63, P1679, DOI 10.1007/s00265-009-0816-4; Hughes WOH, 2008, SCIENCE, V320, P1213, DOI 10.1126/science.1156108; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; KOENIGER N, 1989, APIDOLOGIE, V20, P413, DOI 10.1051/apido:19890506; Leigh EG, 2010, J EVOLUTION BIOL, V23, P6, DOI 10.1111/j.1420-9101.2009.01876.x; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Reichardt AK, 1996, BEHAV ECOL SOCIOBIOL, V38, P219, DOI 10.1007/s002650050235; Simmons L. W., 2001, MG BEH ECOL; Strassmann J, 2001, INSECT SOC, V48, P1, DOI 10.1007/PL00001737; Villesen P, 2002, P ROY SOC B-BIOL SCI, V269, P1541, DOI 10.1098/rspb.2002.2044	29	136	136	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2010	327	5972					1506	1509		10.1126/science.1184709	http://dx.doi.org/10.1126/science.1184709			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20299595	Green Submitted			2022-12-28	WOS:000275715200047
J	Garrett, WS; Gordon, JI; Glimcher, LH				Garrett, Wendy S.; Gordon, Jeffrey I.; Glimcher, Laurie H.			Homeostasis and Inflammation in the Intestine	CELL			English	Review							EPITHELIAL TIGHT JUNCTIONS; GENOME-WIDE ASSOCIATION; T-BET DEFICIENCY; DENDRITIC CELLS; CROHNS-DISEASE; STROMAL CELLS; ENTEROENDOCRINE CELLS; GERM-FREE; ADAPTIVE IMMUNITY; INNATE IMMUNITY	The gut is home to our largest collection of microbes. The ability of the immune system to coevolve with the microbiota during postnatal life allows the host and microbiota to coexist in a mutually beneficial relationship. Failure to achieve or maintain equilibrium between a host and its microbiota has negative consequences for both intestinal and systemic health. In this Review, we consider the many cellular and molecular methods by which inflammatory responses are regulated to maintain intestinal homeostasis and the disease states that can ensue when this balance is lost.	[Garrett, Wendy S.; Glimcher, Laurie H.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Garrett, Wendy S.; Glimcher, Laurie H.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci, St Louis, MO 63108 USA; [Glimcher, Laurie H.] Massachusetts Gen Hosp East, Ragon Inst MGH Harvard MIT, Boston, MA 02129 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Washington University (WUSTL); Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Garrett, WS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	wgarrett@hsph.harvard.edu; lglimche@hsph.harvard.edu	Longo, Kenneth A/A-5631-2010	Garrett, Wendy/0000-0002-5092-0150	National Institutes of Health [AI32412, CA112663]; Burroughs Wellcome Fund; Crohn's and Colitis Foundation of America; NATIONAL CANCER INSTITUTE [R01CA112663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Crohn's and Colitis Foundation of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank the members of the Glimcher and Gordon labs for helpful discussions. This work was supported by National Institutes of Health grants AI32412 and CA112663 (L.H.G.), the Burroughs Wellcome Fund, and the Crohn's and Colitis Foundation of America. L. H. G. is a member of the Board of Directors of and holds equity in the Bristol Myers Squibb Corporation.	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Antar AAR, 2009, CELL HOST MICROBE, V5, P59, DOI 10.1016/j.chom.2008.12.001; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Barnes MJ, 2009, NAT IMMUNOL, V10, P563, DOI 10.1038/ni0609-563; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Bergelson JM, 2009, CELL HOST MICROBE, V5, P517, DOI 10.1016/j.chom.2009.05.009; Bogunovic M, 2007, AM J PHYSIOL-GASTR L, V292, pG1770, DOI 10.1152/ajpgi.00249.2006; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bowey E, 2003, FOOD CHEM TOXICOL, V41, P631, DOI 10.1016/S0278-6915(02)00324-1; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Brown SL, 2007, J CLIN INVEST, V117, P258, DOI 10.1172/JCI29159; Burger-van Paassen N, 2009, BIOCHEM J, V420, P211, DOI 10.1042/BJ20082222; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Camp JG, 2009, GASTROENTEROLOGY, V136, P1989, DOI 10.1053/j.gastro.2009.02.075; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Corr SC, 2008, FEMS IMMUNOL MED MIC, V52, P2, DOI 10.1111/j.1574-695X.2007.00359.x; Coulombe F, 2009, LANCET, V374, P769, DOI 10.1016/S0140-6736(09)61576-2; El-Salhy M, 1997, J INTERN MED, V242, P413, DOI 10.1046/j.1365-2796.1997.00237.x; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Fujiwara D, 2008, J IMMUNOL, V180, P5843, DOI 10.4049/jimmunol.180.9.5843; Gardner JM, 2009, CURR OPIN IMMUNOL, V21, P582, DOI 10.1016/j.coi.2009.08.007; Garlanda C, 2007, CANCER RES, V67, P6017, DOI 10.1158/0008-5472.CAN-07-0560; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Garrett WS, 2009, CANCER CELL, V16, P208, DOI 10.1016/j.ccr.2009.07.015; Gersemann M, 2009, DIFFERENTIATION, V77, P84, DOI 10.1016/j.diff.2008.09.008; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hanada T, 2006, J EXP MED, V203, P1391, DOI 10.1084/jem.20060436; Haverson K, 2007, VET IMMUNOL IMMUNOP, V119, P243, DOI 10.1016/j.vetimm.2007.05.022; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; HOFSTAD T, 1993, CLIN INFECT DIS, V16, pS200, DOI 10.1093/clinids/16.Supplement_4.S200; Hooper LV, 2009, NAT REV MICROBIOL, V7, P367, DOI 10.1038/nrmicro2114; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kanther M, 2010, CURR OPIN IMMUNOL, V22, P10, DOI 10.1016/j.coi.2010.01.006; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2009, SEMIN IMMUNOL, V21, P156, DOI 10.1016/j.smim.2009.01.001; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Kukkonen K, 2007, J ALLERGY CLIN IMMUN, V119, P192, DOI 10.1016/j.jaci.2006.09.009; Kyd JM, 2008, VACCINE, V26, P6221, DOI 10.1016/j.vaccine.2008.09.061; Laukoetter MG, 2007, J EXP MED, V204, P3067, DOI 10.1084/jem.20071416; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Linden DR, 2005, NEUROGASTROENT MOTIL, V17, P565, DOI 10.1111/j.1365-2982.2005.00673.x; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Magnusson FC, 2008, GASTROENTEROLOGY, V134, P1028, DOI 10.1053/j.gastro.2008.01.070; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Meresse B, 2009, SEMIN IMMUNOL, V21, P121, DOI 10.1016/j.smim.2009.01.002; Muller AJ, 2009, CELL HOST MICROBE, V6, P125, DOI 10.1016/j.chom.2009.07.007; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Mukherjee S, 2009, J BIOL CHEM, V284, P4881, DOI 10.1074/jbc.M808077200; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Newberry RD, 2001, J IMMUNOL, V166, P4465, DOI 10.4049/jimmunol.166.7.4465; Newberry RD, 1999, NAT MED, V5, P900, DOI 10.1038/11341; Nichols LA, 2007, J IMMUNOL, V179, P993, DOI 10.4049/jimmunol.179.2.993; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; O'Hara JR, 2008, FRONT BIOSCI-LANDMRK, V13, P7008, DOI 10.2741/3206; O'Hara JR, 2006, CELL MICROBIOL, V8, P646, DOI 10.1111/j.1462-5822.2005.00657.x; Olson TS, 2006, J EXP MED, V203, P541, DOI 10.1084/jem.20050407; Palazzo M, 2007, J IMMUNOL, V178, P4296, DOI 10.4049/jimmunol.178.7.4296; Platt AM, 2008, IMMUNOL LETT, V119, P22, DOI 10.1016/j.imlet.2008.05.009; Rakoff-Nahoum S, 2008, MUCOSAL IMMUNOL, V1, pS10, DOI 10.1038/mi.2008.49; Ramasundara M, 2009, J GASTROEN HEPATOL, V24, P202, DOI 10.1111/j.1440-1746.2008.05772.x; Raschperger E, 2006, EXP CELL RES, V312, P1566, DOI 10.1016/j.yexcr.2006.01.025; Rawls JF, 2007, P NATL ACAD SCI USA, V104, P7622, DOI 10.1073/pnas.0702386104; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rescigno M, 2009, J CLIN INVEST, V119, P2441, DOI 10.1172/JCI39134; Reynoso ED, 2009, ADV EXP MED BIOL, V633, P113, DOI 10.1007/978-0-387-79311-5_10; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rubin DC, 2000, MICROSC RES TECHNIQ, V51, P112, DOI 10.1002/1097-0029(20001015)51:2<112::AID-JEMT2>3.0.CO;2-D; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Sansonetti PJ, 2009, CELL, V138, P416, DOI 10.1016/j.cell.2009.07.024; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; Skindersoe ME, 2009, FEMS IMMUNOL MED MIC, V55, P335, DOI 10.1111/j.1574-695X.2008.00533.x; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Stappenbeck TS, 2009, SCIENCE, V324, P1666, DOI 10.1126/science.1172687; Steinman RM, 2007, NAT MED, V13, P1155, DOI 10.1038/nm1643; Strober W, 2009, IMMUNITY, V31, P377, DOI 10.1016/j.immuni.2009.09.001; Su LP, 2009, GASTROENTEROLOGY, V136, P551, DOI 10.1053/j.gastro.2008.10.081; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; van Wijk F, 2009, SEMIN IMMUNOL, V21, P130, DOI 10.1016/j.smim.2009.03.003; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Wang J, 2009, MICROBES INFECT, V11, P321, DOI 10.1016/j.micinf.2008.12.011; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JC133145, 10.1172/JCI33145]; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2007, J IMMUNOL, V179, P3109, DOI 10.4049/jimmunol.179.5.3109; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009; Wilson NS, 2008, IMMUNOL CELL BIOL, V86, P200, DOI 10.1038/sj.icb.7100125; Yoshida M, 2004, IMMUNITY, V20, P769, DOI 10.1016/j.immuni.2004.05.007	121	512	530	3	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2010	140	6					859	870		10.1016/j.cell.2010.01.023	http://dx.doi.org/10.1016/j.cell.2010.01.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	571IX	20303876	Bronze, Green Accepted			2022-12-28	WOS:000275746600010
J	Zipkes, C; Palzer, S; Sias, C; Kohl, M				Zipkes, Christoph; Palzer, Stefan; Sias, Carlo; Koehl, Michael			A trapped single ion inside a Bose-Einstein condensate	NATURE			English	Article							SUPERCONDUCTIVITY; IMPURITIES; CAVITY	Improved control of the motional and internal quantum states of ultracold neutral atoms and ions has opened intriguing possibilities for quantum simulation and quantum computation. Many-body effects have been explored with hundreds of thousands of quantum-degenerate neutral atoms(1), and coherent light-matter interfaces have been built(2,3). Systems of single or a few trapped ions have been used to demonstrate universal quantum computing algorithms(4) and to search for variations of fundamental constants in precision atomic clocks(5). Until now, atomic quantum gases and single trapped ions have been treated separately in experiments. Here we investigate whether they can be advantageously combined into one hybrid system, by exploring the immersion of a single trapped ion into a Bose-Einstein condensate of neutral atoms. We demonstrate independent control over the two components of the hybrid system, study the fundamental interaction processes and observe sympathetic cooling of the single ion by the condensate. Our experiment calls for further research into the possibility of using this technique for the continuous cooling of quantum computers(6). We also anticipate that it will lead to explorations of entanglement in hybrid quantum systems and to fundamental studies of the decoherence of a single, locally controlled impurity particle coupled to a quantum environment(7,8).	[Zipkes, Christoph; Palzer, Stefan; Sias, Carlo; Koehl, Michael] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	University of Cambridge	Kohl, M (corresponding author), Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.	mk540@cam.ac.uk	Palzer, Stefan/A-8167-2013; Sias, Carlo/D-1317-2014; Kohl, Michael/C-6114-2009	Palzer, Stefan/0000-0003-2109-1936; Sias, Carlo/0000-0002-5390-8288; Kohl, Michael/0000-0003-4055-713X	Engineering and Physical Sciences Research Council; European Research Council [240335]; Herchel Smith Fund; EPSRC [EP/F016379/1, EP/H005676/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H005676/1, EP/F016379/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); Herchel Smith Fund; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We are grateful to N. Cooper, C. Kollath, D. Lucas, D. Moehring, E. Peik and C. Wunderlich for discussions. We acknowledge support from the Engineering and Physical Sciences Research Council, the European Research Council (grant number 240335) and the Herchel Smith Fund (C.S.).	ABRIKOSOV AA, 1961, SOV PHYS JETP-USSR, V12, P1243; Balzer C, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.041407; Berkeland DJ, 1998, J APPL PHYS, V83, P5025, DOI 10.1063/1.367318; Blatt R, 2008, NATURE, V453, P1008, DOI 10.1038/nature07125; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Brennecke F, 2007, NATURE, V450, P268, DOI 10.1038/nature06120; Colombe Y, 2007, NATURE, V450, P272, DOI 10.1038/nature06331; Cote R, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.012709; Cote R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.093001; Daley AJ, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.022306; DeVoe RG, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.063001; Epstein RJ, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.033411; GOOLD J, 2009, ION INDUCED DENSITY; Grier AT, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.223201; Idziaszek Z, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.033409; Idziaszek Z, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.010702; Kollath C, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.063602; LARSON DJ, 1986, PHYS REV LETT, V57, P70, DOI 10.1103/PhysRevLett.57.70; LEGGETT AJ, 1987, REV MOD PHYS, V59, P1, DOI 10.1103/RevModPhys.59.1; MAJOR FG, 1968, PHYS REV, V170, P91, DOI 10.1103/PhysRev.170.91; Makarov OP, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.042705; Massignan P, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.023606; Palzer S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.150601; Pan SH, 2000, NATURE, V403, P746, DOI 10.1038/35001534; Recati A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.040404; Rosenband T, 2008, SCIENCE, V319, P1808, DOI 10.1126/science.1154622; Sherkunov Y, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.023604; Soldan P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.163202; SUN J, 2004, ORTHOGONALITY CATAST; Treutlein P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.140403; Wesenberg JH, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.053416; YARMCHUK EJ, 1979, PHYS REV LETT, V43, P214, DOI 10.1103/PhysRevLett.43.214; Yazdani A, 1997, SCIENCE, V275, P1767, DOI 10.1126/science.275.5307.1767	33	304	304	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					388	U79		10.1038/nature08865	http://dx.doi.org/10.1038/nature08865			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20237565	Green Submitted			2022-12-28	WOS:000275657100041
J	Niederhuber, JE				Niederhuber, John E.			Translating Discovery to Patient Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TUMOR MICROENVIRONMENT; CANCER		NCI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Niederhuber, JE (corresponding author), NCI, 31 Ctr Dr,Room 11A48, Bethesda, MD 20892 USA.	niederj@mail.nih.gov						Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Caussinus Emmanuel, 2007, Prog Mol Subcell Biol, V45, P205; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Danish M, 2008, CANCER BIOL THER, V7, P331, DOI 10.4161/cbt.7.3.5761; Ischehko I, 2009, SURGERY, V146, P430, DOI 10.1016/j.surg.2009.05.003; Khalil I, 2010, GYNECOL ONCOL, V116, P282, DOI 10.1016/j.ygyno.2009.10.085; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Ross JS, 2004, AM J CLIN PATHOL, V122, P598, DOI 10.1309/5CWPU41AFR1VYM3F; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271	9	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1088	1089		10.1001/jama.2010.281	http://dx.doi.org/10.1001/jama.2010.281			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569KC	20233829				2022-12-28	WOS:000275594100024
J	Graham, N				Graham, Neil			Medicine and the Media The hard sell in cosmetic surgery advertising	BRITISH MEDICAL JOURNAL			English	Editorial Material									UCL, London WC1E 6BT, England	University of London; University College London	Graham, N (corresponding author), UCL, Mortimer St, London WC1E 6BT, England.	n.graham@ucl.ac.uk	Graham, Neil/AAN-2754-2021	Graham, Neil/0000-0002-0183-3368				*ADV STAND AUTH, 2008, ASA ADJ HARL MED GRO; *ADV STAND AUTH, 2009, ASA ADJ TRANSF MED G; *BBC WORLD SERV, SPAIN TACKL CULT BOD; FOGIL A, 2009, CLIN RISK, V15, P224; *IND HEALTHC ADV S, 2006, IHAS COD PRACT GOOD; Marmor T. R., 2009, BLUE GUID ADV PROM M; Mercer N., 2009, CLIN RISK, V15, P215; *NONBR COMM, 2003, BRIT COD ADV SAL PRO	8	2	2	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 16	2010	340								c1223	10.1136/bmj.c1223	http://dx.doi.org/10.1136/bmj.c1223			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	573RD	20233770				2022-12-28	WOS:000275931400004
J	Shan, XN; Patel, U; Wang, SP; Iglesias, R; Tao, NJ				Shan, Xiaonan; Patel, Urmez; Wang, Shaopeng; Iglesias, Rodrigo; Tao, Nongjian			Imaging Local Electrochemical Current via Surface Plasmon Resonance	SCIENCE			English	Article							ULTRATHIN ORGANIC FILMS; MICROSCOPY	We demonstrated an electrochemical microscopy technique based on the detection of variations in local electrochemical current from optical signals arising from surface plasmon resonance. It enables local electrochemical measurements (such as voltammetry and amperometry) with high spatial resolution and sensitivity, because the signal varies with current density rather than current. The imaging technique is noninvasive, scanning-free, and fast, and it constitutes a powerful tool for studying heterogeneous surface reactions and for analyzing trace chemicals.	[Shan, Xiaonan; Patel, Urmez; Wang, Shaopeng; Iglesias, Rodrigo; Tao, Nongjian] Arizona State Univ, Biodesign Inst, Ctr Bioelect & Biosensors, Tempe, AZ 85287 USA; [Shan, Xiaonan; Tao, Nongjian] Arizona State Univ, Dept Elect Engn, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Tao, NJ (corresponding author), Arizona State Univ, Biodesign Inst, Ctr Bioelect & Biosensors, Tempe, AZ 85287 USA.	njtao@asu.edu	Wang, Shaopeng/A-4283-2012; Shan, Xiaonan/F-9318-2011	Wang, Shaopeng/0000-0002-2680-0503; 	NSF [CHM-0554786]	NSF(National Science Foundation (NSF))	We thank H. H. White, E. Forzani, and A. Cagan for discussions and L. Zhang for help in the lab. Supported by NSF grant CHM-0554786.	ABBOTT NL, 1992, SCIENCE, V257, P1380, DOI 10.1126/science.257.5075.1380; Amemiya S, 2008, ANNU REV ANAL CHEM, V1, P95, DOI 10.1146/annurev.anchem.1.031207.112938; Andersson O, 2008, SENSOR ACTUAT B-CHEM, V134, P545, DOI 10.1016/j.snb.2008.05.042; Bard A. J., 1980, ELECTROCHEMICAL METH; BARD AJ, 1991, SCIENCE, V254, P68, DOI 10.1126/science.254.5028.68; Brockman JM, 2000, ANNU REV PHYS CHEM, V51, P41, DOI 10.1146/annurev.physchem.51.1.41; FLATGEN G, 1995, SCIENCE, V269, P668, DOI 10.1126/science.269.5224.668; Foley KJ, 2008, ANAL CHEM, V80, P5146, DOI 10.1021/ac800361p; Hanken DG, 1998, ELECTROANAL CHEM, V20, P141; Huang B, 2007, ANAL CHEM, V79, P2979, DOI 10.1021/ac062284x; LI QG, 1995, ANAL CHEM, V67, P561, DOI 10.1021/ac00099a013; Pinnaduwage LA, 2003, NATURE, V425, P474, DOI 10.1038/425474a; ROTHENHAUSLER B, 1988, NATURE, V332, P615, DOI 10.1038/332615a0; Wang J, 2007, ELECTROANAL, V19, P415, DOI 10.1002/elan.200603748; ZHANG HX, 1967, ANAL CHEM, V78, P2006; Zhang M, 2009, ANALYST, V134, P25, DOI 10.1039/b815336a	16	244	258	16	359	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1363	1366		10.1126/science.1186476	http://dx.doi.org/10.1126/science.1186476			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223983	Green Published			2022-12-28	WOS:000275418700037
J	Shannon-Lowe, J; Matheson, NJ; Cooke, FJ; Aliyu, SH				Shannon-Lowe, J.; Matheson, N. J.; Cooke, F. J.; Aliyu, S. H.			Prevention and medical management of Clostridium difficile infection	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ORAL VANCOMYCIN; DIARRHEA; METRONIDAZOLE; COLITIS; DISEASE; RISK		[Matheson, N. J.; Aliyu, S. H.] Addenbrookes Hosp, Cambridge Univ Hosp NHS Fdn Trust, Dept Infect Dis, Cambridge, England; [Shannon-Lowe, J.; Cooke, F. J.; Aliyu, S. H.] Addenbrookes Hosp, Hlth Protect Agcy, Clin Microbiol & Publ Hlth Lab, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Health Protection Agency; University of Cambridge	Matheson, NJ (corresponding author), Addenbrookes Hosp, Cambridge Univ Hosp NHS Fdn Trust, Dept Infect Dis, Cambridge, England.	nicholas.matheson@addenbrookes.nhs.uk		Matheson, Nicholas/0000-0002-3318-1851				Al-Nassir WN, 2008, ANTIMICROB AGENTS CH, V52, P2403, DOI 10.1128/AAC.00090-08; Apisarnthanarak A, 2002, CLIN INFECT DIS, V35, P690, DOI 10.1086/342334; Aslam S, 2005, LANCET INFECT DIS, V5, P549, DOI 10.1016/S1473-3099(05)70215-2; Bignardi GE, 1998, J HOSP INFECT, V40, P1, DOI 10.1016/S0195-6701(98)90019-6; BOLTON RP, 1986, GUT, V27, P1169, DOI 10.1136/gut.27.10.1169; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1201; Climo MW, 1998, ANN INTERN MED, V128, P989, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00005; Commission for Healthcare Audit and Inspection, 2006, INV OUTBR CLOSTR DIF; Commission for Healthcare Audit and Inspection, 2007, INV OUTBR CLOSTR DIF; Cooke FJ, 2007, INT J ANTIMICROB AG, V30, P25, DOI 10.1016/j.ijantimicag.2007.03.003; Cooper B S, 2003, Health Technol Assess, V7, P1; Davey P, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003543.pub4, 10.1002/14651858.CD003543.pub2, 10.1002/14651858.CD003543.pub3]; Department of Health and Health Protection Agency, 2008, CLOSTR DIFF INF DEAL; Dial S, 2008, CAN MED ASSOC J, V179, P767, DOI 10.1503/cmaj.071812; Fawley WN, 2008, J CLIN MICROBIOL, V46, P954, DOI 10.1128/JCM.01764-07; FEKETY R, 1989, AM J MED, V86, P15, DOI 10.1016/0002-9343(89)90223-4; Gerding DN, 2008, CLIN INFECT DIS, V46, pS32, DOI 10.1086/521860; Gerding DN, 2008, CLIN INFECT DIS, V46, pS43, DOI 10.1086/521861; Hickson M, 2007, BMJ-BRIT MED J, V335, P80, DOI 10.1136/bmj.39231.599815.55; Jernigan JA, 1998, INFECT CONT HOSP EP, V19, P494; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Khan R, 2003, J HOSP INFECT, V54, P104, DOI 10.1016/S0195-6701(03)00115-4; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Louie TJ, 2007, 47 INT C ANT AG CHEM; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; *NHS PURCH SUPPL A, 2009, EV REP CLOSTR DIFF T; Nobleft SE, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1563; Oughton MT, 2009, INFECT CONT HOSP EP, V30, P939, DOI 10.1086/605322; Pepin J, 2006, CLIN INFECT DIS, V42, P758, DOI 10.1086/501126; Wenisch C, 1996, CLIN INFECT DIS, V22, P813, DOI 10.1093/clinids/22.5.813; Wilcox MH, 2007, BRIT MED J, V335, P171, DOI 10.1136/bmj.39283.396285.1F; Wilcox MH, 2004, J ANTIMICROB CHEMOTH, V53, P882, DOI 10.1093/jac/dkh176; Wilcox MH, 2006, NEW ENGL J MED, V354, P1201; Wilcox MH, 1996, J HOSP INFECT, V34, P23, DOI 10.1016/S0195-6701(96)90122-X; Zar FA, 2007, CLIN INFECT DIS, V45, P302, DOI 10.1086/519265	35	20	24	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2010	340								c1296	10.1136/bmj.c1296	http://dx.doi.org/10.1136/bmj.c1296			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570FF	20228142				2022-12-28	WOS:000275657000002
J	Ladenson, PW; Kristensen, JD; Ridgway, EC; Olsson, AG; Carlsson, B; Klein, I; Baxter, JD; Angelin, B				Ladenson, Paul W.; Kristensen, Jens D.; Ridgway, E. Chester; Olsson, Anders G.; Carlsson, Bo; Klein, Irwin; Baxter, John D.; Angelin, Bo			Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							3,5-DIIODOTHYROPROPIONIC ACID; GENE-EXPRESSION; MESSENGER-RNA; RECEPTOR-BETA; SERUM-LIPIDS; CHOLESTEROL; HYPOTHYROIDISM; LIPOPROTEIN; METABOLISM; RISK	BACKGROUND Dyslipidemia increases the risk of atherosclerotic cardiovascular disease and is incompletely reversed by statin therapy alone in many patients. Thyroid hormone lowers levels of serum low-density lipoprotein (LDL) cholesterol and has other potentially favorable actions on lipoprotein metabolism. Consequently, thyromimetic drugs hold promise as lipid-lowering agents if adverse effects can be avoided. METHODS We performed a randomized, placebo-controlled, double-blind, multicenter trial to assess the safety and efficacy of the thyromimetic compound eprotirome (KB2115) in lowering the level of serum LDL cholesterol in patients with hypercholesterolemia who were already receiving simvastatin or atorvastatin. In addition to statin treatment, patients received either eprotirome (at a dose of 25, 50, or 100 mu g per day) or placebo. Secondary outcomes were changes in levels of serum apolipoprotein B, triglycerides, and Lp(a) lipoprotein. Patients were monitored for potential adverse thyromimetic effects on the heart, bone, and pituitary. RESULTS The addition of placebo or eprotirome at a dose of 25, 50, or 100 mu g daily to statin treatment for 12 weeks reduced the mean level of serum LDL cholesterol from 141 mg per deciliter (3.6 mmol per liter) to 127, 113, 99, and 94 mg per deciliter (3.3, 2.9, 2.6, and 2.4 mmol per liter), respectively, (mean reduction from baseline, 7%, 22%, 28%, and 32%). Similar reductions were seen in levels of serum apolipoprotein B, triglycerides, and Lp(a) lipoprotein. Eprotirome therapy was not associated with adverse effects on the heart or bone. No change in levels of serum thyrotropin or triiodothyronine was detected, although the thyroxine level decreased in patients receiving eprotirome. CONCLUSIONS In this 12-week trial, the thyroid hormone analogue eprotirome was associated with decreases in levels of atherogenic lipoproteins in patients receiving treatment with statins. (ClinicalTrials.gov number, NCT00593047.)	[Angelin, Bo] Karolinska Univ Hosp, Dept Endocrinol Metab & Diabet, Karolinska Inst, S-14186 Stockholm, Sweden; [Angelin, Bo] Karolinska Univ Hosp, Dept Med, Karolinska Inst, Ctr Biosci, S-14186 Stockholm, Sweden; [Ladenson, Paul W.] Johns Hopkins Univ, Sch Med, Dept Med, Div Endocrinol & Metab, Baltimore, MD 21205 USA; [Kristensen, Jens D.; Carlsson, Bo] Karo Bio, Huddinge, Sweden; [Olsson, Anders G.] Linkoping Univ, Fac Hlth Sci, Stockholm, Sweden; [Olsson, Anders G.] Stockholm Heart Ctr, Stockholm, Sweden; [Ridgway, E. Chester] Univ Colorado, Sch Med, Div Endocrinol Metab & Diabet, Aurora, CO USA; [Klein, Irwin] N Shore Univ Hosp, Dept Med, Manhasset, NY USA; [Klein, Irwin] Feinstein Inst Med Res, Manhasset, NY USA; [Baxter, John D.] Methodist Hosp, Res Inst, Ctr Diabet Res, Houston, TX 77030 USA	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Johns Hopkins University; Linkoping University; University of Colorado System; University of Colorado Anschutz Medical Campus; Northwell Health; North Shore University Hospital; Northwell Health; The Methodist Hospital System; The Methodist Hospital - Houston	Angelin, B (corresponding author), Karolinska Univ Hosp, Dept Endocrinol Metab & Diabet, Karolinska Inst, S-14186 Stockholm, Sweden.	bo.angelin@ki.se			Swedish Research Council; Swedish Heart-Lung Foundation, Karolinska Institutet; Stockholm City Council; AstraZeneca	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation, Karolinska Institutet(Swedish Heart-Lung Foundation); Stockholm City Council; AstraZeneca(AstraZeneca)	Supported by Karo Bio and by grants from the Swedish Research Council, the Swedish Heart-Lung Foundation, Karolinska Institutet, and the Stockholm City Council (all to Dr. Angelin).; Dr. Ladenson reports receiving consulting fees from Karo Bio and consulting and lecture fees from Genzyme; Dr. Kristensen, being an employee of and a shareholder in Karo Bio; Dr. Ridgway, receiving consulting fees from Karo Bio and lecture fees from Genzyme; Dr. Olsson, receiving consulting fees from AstraZeneca, Karo Bio, Merck, Pfizer, and Roche and lecture fees from AstraZeneca, Pfizer, and Roche; Mr. Carlsson, being an employee of Karo Bio and a shareholder in Karo Bio, Sectra, and Clinical Laserthermia Systems; Dr. Klein, receiving consulting fees from Karo Bio and Sanofi-Aventis; Dr. Baxter, receiving consulting fees from and being a shareholder in Karo Bio, and being listed as an inventor on a patent owned by the University of California for a compound with actions similar to those of eprotirome; Dr. Angelin, receiving consulting fees from Karo Bio, Resverlogix, and AstraZeneca, being a shareholder in Karo Bio, being a board member of and shareholder in AstraZeneca, and receiving research support from AstraZeneca. No other potential conflict of interest relevant to this article was reported.	Baigent C, 2008, LANCET, V371, P2084; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bennet A, 2008, ARCH INTERN MED, V168, P598, DOI 10.1001/archinte.168.6.598; Berkenstam A, 2008, P NATL ACAD SCI USA, V105, P663, DOI 10.1073/pnas.0705286104; BERRY MJ, 1990, MOL ENDOCRINOL, V4, P743, DOI 10.1210/mend-4-5-743; Brudi P, 2009, CARDIOLOGY, V113, P89, DOI 10.1159/000172795; Brunzell JD, 2007, NEW ENGL J MED, V357, P1009, DOI 10.1056/NEJMcp070061; CARON P, 1989, CLIN ENDOCRINOL, V31, P219, DOI 10.1111/j.1365-2265.1989.tb01245.x; DAY R, 1989, ENDOCRINOLOGY, V125, P459, DOI 10.1210/endo-125-1-459; Galman C, 2008, GASTROENTEROLOGY, V134, P1127, DOI 10.1053/j.gastro.2008.01.032; Gloss B, 2001, ENDOCRINOLOGY, V142, P544, DOI 10.1210/en.142.2.544; Goldman S, 2009, CIRCULATION, V119, P3093, DOI 10.1161/CIRCULATIONAHA.108.834424; Grover GJ, 2003, P NATL ACAD SCI USA, V100, P10067, DOI 10.1073/pnas.1633737100; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gullberg H, 2002, MOL ENDOCRINOL, V16, P1767, DOI 10.1210/me.2002-0009; Hashimoto K, 2006, ENDOCRINOLOGY, V147, P4292, DOI 10.1210/en.2006-0116; HILL SR, 1960, J CLIN INVEST, V39, P523, DOI 10.1172/JCI104066; Johansson L, 2005, P NATL ACAD SCI USA, V102, P10297, DOI 10.1073/pnas.0504379102; JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.1093/biomet/41.1-2.133; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Ladenson PW, 2010, J CLIN ENDOCR METAB, V95, P1349, DOI 10.1210/jc.2009-1209; Mason RL, 1930, NEW ENGL J MED, V203, P1273, DOI 10.1056/NEJM193012252032601; Morkin E, 2002, CARDIOLOGY, V97, P218, DOI 10.1159/000063110; Mostaza JM, 2001, CLIN CHIM ACTA, V308, P133, DOI 10.1016/S0009-8981(01)00476-4; NESS GC, 1990, BIOCHEM BIOPH RES CO, V172, P1150, DOI 10.1016/0006-291X(90)91568-D; NIKKILA EA, 1972, J CLIN INVEST, V51, P2103, DOI 10.1172/JCI107017; Pasternak RC, 2002, CIRCULATION, V106, P1024, DOI 10.1161/01.CIR.0000032466.44170.44; Pearson TA, 2000, ARCH INTERN MED, V160, P459, DOI 10.1001/archinte.160.4.459; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; Sherman SI, 1997, J CLIN ENDOCR METAB, V82, P2153, DOI 10.1210/jc.82.7.2153; Stamler J, 1977, Adv Exp Med Biol, V82, P52; STRISOWER EH, 1964, J CLIN ENDOCR METAB, V24, P139, DOI 10.1210/jcem-24-2-139; STROBL W, 1990, J CLIN INVEST, V85, P659, DOI 10.1172/JCI114489; Taylor AJ, 2009, NEW ENGL J MED, V361, P2113, DOI 10.1056/NEJMoa0907569; THOMPSON GR, 1981, P NATL ACAD SCI-BIOL, V78, P2591, DOI 10.1073/pnas.78.4.2591; UNDERWOOD AH, 1986, NATURE, V324, P425, DOI 10.1038/324425a0; WALTON KW, 1965, CLIN SCI, V29, P217	38	240	249	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10					906	916		10.1056/NEJMoa0905633	http://dx.doi.org/10.1056/NEJMoa0905633			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566JM	20220185				2022-12-28	WOS:000275365900011
J	Moore, W				Moore, Wendy			Past Caring Royal insights on smoking	BRITISH MEDICAL JOURNAL			English	Editorial Material												wendymoore@ntlworld.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 11	2010	340								c1408	10.1136/bmj.c1408	http://dx.doi.org/10.1136/bmj.c1408			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570FE	20223866				2022-12-28	WOS:000275656900008
J	Kirsch, TD; Moon, MR				Kirsch, Thomas D.; Moon, Margaret R.			The Line	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												tkirsch1@jhmi.edu						Kilner T, 2002, EMERG MED J, V19, P348, DOI 10.1136/emj.19.4.348	1	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2010	303	10					921	922		10.1001/jama.2010.239	http://dx.doi.org/10.1001/jama.2010.239			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	565UC	20215598				2022-12-28	WOS:000275319300001
J	Gracheva, EO; Ingolia, NT; Kelly, YM; Cordero-Morales, JF; Hollopeter, G; Chesler, AT; Sanchez, EE; Perez, JC; Weissman, JS; Julius, D				Gracheva, Elena O.; Ingolia, Nicholas T.; Kelly, Yvonne M.; Cordero-Morales, Julio F.; Hollopeter, Gunther; Chesler, Alexander T.; Sanchez, Elda E.; Perez, John C.; Weissman, Jonathan S.; Julius, David			Molecular basis of infrared detection by snakes	NATURE			English	Article							TRIGEMINAL SYSTEM; ION CHANNELS; TRPA1; NEURONS; PIT; CROTALINE; PROJECTIONS; RECEPTORS; NUCLEUS; THERMOSENSATION	Snakes possess a unique sensory system for detecting infrared radiation, enabling them to generate a 'thermal image' of predators or prey. Infrared signals are initially received by the pit organ, a highly specialized facial structure that is innervated by nerve fibres of the somatosensory system. How this organ detects and transduces infrared signals into nerve impulses is not known. Here we use an unbiased transcriptional profiling approach to identify TRPA1 channels as infrared receptors on sensory nerve fibres that innervate the pit organ. TRPA1 orthologues from pit-bearing snakes (vipers, pythons and boas) are the most heat-sensitive vertebrate ion channels thus far identified, consistent with their role as primary transducers of infrared stimuli. Thus, snakes detect infrared signals through a mechanism involving radiant heating of the pit organ, rather than photochemical transduction. These findings illustrate the broad evolutionary tuning of transient receptor potential (TRP) channels as thermosensors in the vertebrate nervous system.	[Gracheva, Elena O.; Kelly, Yvonne M.; Cordero-Morales, Julio F.; Hollopeter, Gunther; Chesler, Alexander T.; Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Ingolia, Nicholas T.; Weissman, Jonathan S.; Julius, David] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Ingolia, Nicholas T.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Ingolia, Nicholas T.; Weissman, Jonathan S.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Sanchez, Elda E.; Perez, John C.] Texas A&M Univ, Nat Toxins Res Ctr, Kingsville, TX 78363 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Texas A&M University System; Texas A&M University Kingsville	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.	julius@cmp.ucsf.edu	Kelly, Yvonne/AAR-3856-2020; Chesler, Alexander/V-2748-2019	Kelly, Yvonne/0000-0002-1494-0429; Chesler, Alexander/0000-0002-3131-0728; Cordero Morales, Julio/0000-0002-6505-5403; Weissman, Jonathan/0000-0003-2445-670X; Gracheva, Elena O/0000-0002-0846-3427; Sanchez, Elda E./0000-0001-5222-8873	Ruth L. Kirschstein National Research Service Award [GM080853]; NIH; Howard Hughes Medical Institute; National Institutes of Health, including NCRR [P40 RR018300-06, P01 AG010770, NS047723, NS055299]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR018300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055299, R37NS047723, R01NS047723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010770] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health, including NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Priel for advice and assistance with calcium imaging and electrophysiology, C. Chu for help with sequencing, J. Poblete for technical assistance, and the staff of the Natural Toxins Research Center serpentarium for animal husbandry. We thank P. Garrity for providing the dTrpA1 cDNA. This work was supported by a Ruth L. Kirschstein National Research Service Award (GM080853) (N.T.I.), a NIH Institutional Research Service Award in Molecular and Cellular Basis of Cardiovascular Disease (A. T. C.), the Howard Hughes Medical Institute (J. S. W.), and grants from the National Institutes of Health, including NCRR Viper grant P40 RR018300-06 (E. E. S. and J. C. P.), P01 AG010770 (J. S. W.) and NS047723 and NS055299 (D. J.).	Amemiya F, 1996, ANAT RECORD, V246, P135; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Barrett R., 1970, BIOL REPTILIA, P227; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; BLEICHMAR H, 1962, Z ZELLFORSCH MIK ANA, V56, P748, DOI 10.1007/BF00336332; BULLOCK TH, 1952, SCIENCE, V115, P541, DOI 10.1126/science.115.2994.541-a; BUNING TD, 1981, CELL MOL NEUROBIOL, V1, P271, DOI 10.1007/BF00710682; Campbell AL, 2002, MICRON, V33, P211, DOI 10.1016/S0968-4328(01)00010-5; Caspani O, 2009, J GEN PHYSIOL, V133, P245, DOI 10.1085/jgp.200810136; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; DeCoursey TE, 1998, J GEN PHYSIOL, V112, P503, DOI 10.1085/jgp.112.4.503; Dong S, 2005, J MOL EVOL, V61, P12, DOI 10.1007/s00239-004-0190-9; Ebert J, 2007, THESIS RHEINISCHE F; Ebert Jill, 2006, P215; Eng SR, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-3; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; HARTLINE PH, 1978, SCIENCE, V199, P1225, DOI 10.1126/science.628839; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; KISHIDA R, 1983, BRAIN RES, V263, P132, DOI 10.1016/0006-8993(83)91209-X; KISHIDA R, 1980, BRAIN RES, V195, P271, DOI 10.1016/0006-8993(80)90064-5; KISHIDA R, 1984, BRAIN RES, V322, P351, DOI 10.1016/0006-8993(84)90132-X; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Krochmal AR, 2004, J EXP BIOL, V207, P4231, DOI 10.1242/jeb.01278; Liman ER, 2006, PFLUG ARCH EUR J PHY, V453, P125, DOI 10.1007/s00424-006-0120-3; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Matsuura H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-228; MOLENAAR GJ, 1978, J COMP NEUROL, V179, P137, DOI 10.1002/cne.901790109; MOLENAAR GJ, 1974, BRAIN RES, V78, P340, DOI 10.1016/0006-8993(74)90560-5; Myers BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005741; NEWMAN EA, 1981, SCIENCE, V213, P789, DOI 10.1126/science.7256281; NOBLE G. K., 1937, PROC AMER PHIL SOC, V77, P263; Pappas TC, 2004, AM J PHYSIOL-CELL PH, V287, pC1219, DOI 10.1152/ajpcell.00040.2004; Prober DA, 2008, J NEUROSCI, V28, P10102, DOI 10.1523/JNEUROSCI.2740-08.2008; Ramot D, 2008, NAT NEUROSCI, V11, P908, DOI 10.1038/nn.2157; Safer AB, 2004, BEHAV BRAIN RES, V154, P55, DOI 10.1016/j.bbr.2004.01.020; SCHROEDER DM, 1976, J COMP NEUROL, V169, P1, DOI 10.1002/cne.901690102; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; TERASHIMA S, 1991, J NEUROPHYSIOL, V66, P623, DOI 10.1152/jn.1991.66.2.623; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Wang GR, 2009, EUR J NEUROSCI, V30, P967, DOI 10.1111/j.1460-9568.2009.06901.x; WARREN JW, 1968, SCIENCE, V159, P439, DOI 10.1126/science.159.3813.439; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016	48	261	267	10	250	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1006	U66		10.1038/nature08943	http://dx.doi.org/10.1038/nature08943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20228791	Green Accepted, Green Submitted			2022-12-28	WOS:000276635000031
J	Suh, JH				Suh, John H.			Stereotactic Radiosurgery for the Management of Brain Metastases	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RADIATION-THERAPY; NEUROCOGNITIVE FUNCTION; MOTEXAFIN GADOLINIUM; RESECTION CAVITY; RADIOTHERAPY; EXPERIENCE; SURVIVAL	A 50-year-old man with a history of locally advanced non-small-cell lung cancer presents with moderately severe headaches and mild numbness of the right arm. He is functionally independent and has no coexisting medical conditions. His neurologic examination is normal except for some diminished sensation in the right arm. Magnetic resonance imaging (MRI) of the brain reveals a single lesion, 2.5 cm in diameter, in the left parietal region, with a moderate amount of edema. Additional testing shows no evidence of extracranial disease. He is treated with dexamethasone, with rapid improvement of his symptoms. His physicians recommend whole-brain radiation therapy followed by stereotactic radiosurgery.	Cleveland Clin, Taussig Canc Inst, Dept Radiat Oncol, Brain Tumor & Neurooncol Ctr, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Suh, JH (corresponding author), Cleveland Clin, Taussig Canc Inst, Dept Radiat Oncol, Brain Tumor & Neurooncol Ctr, 9500 Euclid Ave, Cleveland, OH 44195 USA.	suhj@ccf.org			Schering-Plough and Medtronic; Siemens	Schering-Plough and Medtronic; Siemens(Siemens AG)	Dr. Suh reports receiving speaker's fees from Schering-Plough and Medtronic and travel reimbursement from Siemens. No other potential conflict of interest relevant to this article was reported. Disclosure forms provided by the author are available with the full text of this article at NEJM.org.	Adler JR, 1997, STEREOT FUNCT NEUROS, V69, P124, DOI 10.1159/000099863; Andrews DW, 2004, LANCET, V363, P1665, DOI 10.1016/S0140-6736(04)16250-8; Aoyama H, 2007, INT J RADIAT ONCOL, V68, P1388, DOI 10.1016/j.ijrobp.2007.03.048; Aoyama H, 2006, JAMA-J AM MED ASSOC, V295, P2483, DOI 10.1001/jama.295.21.2483; Barnett GH, 2007, J NEUROSURG, V106, P1, DOI 10.3171/jns.2007.106.1.1; Baschnagel A, 2008, RADIAT ONCOL, V3, DOI 10.1186/1748-717X-3-26; Brem Steven S, 2008, J Natl Compr Canc Netw, V6, P456; Breneman JC, 2009, INT J RADIAT ONCOL, V74, P702, DOI 10.1016/j.ijrobp.2008.11.015; Brown PD, 2008, INT J RADIAT ONCOL, V70, P1305, DOI 10.1016/j.ijrobp.2007.11.047; Brown PD, 2009, INT J RADIAT ONCOL, V75, P316, DOI 10.1016/j.ijrobp.2009.04.079; Brown PD, 2002, NEUROSURGERY, V51, P656, DOI 10.1227/01.NEU.0000023713.44940.20; Chang EL, 2005, NEUROSURGERY, V56, P936, DOI 10.1227/01.NEU.0000158324.20757.AC; Chang EL, 2007, NEUROSURGERY, V60, P277, DOI 10.1227/01.NEU.0000249272.64439.B1; Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; DELATTRE JY, 1988, ARCH NEUROL-CHICAGO, V45, P741, DOI 10.1001/archneur.1988.00520310047016; FLICKINGER JC, 1994, INT J RADIAT ONCOL, V28, P797, DOI 10.1016/0360-3016(94)90098-1; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Gaspar L, 1997, INT J RADIAT ONCOL, V37, P745, DOI 10.1016/S0360-3016(96)00619-0; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; Hwang TL, 1996, CANCER, V77, P1551; Kamath R, 2005, INT J RADIAT ONCOL, V61, P1467, DOI 10.1016/j.ijrobp.2004.08.021; Kim PK, 2006, J NEUROSURG, V105, P75, DOI 10.3171/sup.2006.105.7.75; Kondziolka D, 1999, INT J RADIAT ONCOL, V45, P427, DOI 10.1016/S0360-3016(99)00198-4; Lee S, 2009, BREAST CANCER RES TR, V114, P589, DOI 10.1007/s10549-008-0035-0; Li J, 2007, J CLIN ONCOL, V25, P1260, DOI 10.1200/JCO.2006.09.2536; Lutterbach J, 2003, NEUROSURGERY, V52, P1066, DOI 10.1227/01.NEU.0000057695.64198.FE; Mehta MP, 2003, J CLIN ONCOL, V21, P2529, DOI 10.1200/JCO.2003.12.122; Meyers CA, 2004, J CLIN ONCOL, V22, P157, DOI 10.1200/JCO.2004.05.128; O'Neill BP, 2003, INT J RADIAT ONCOL, V55, P1169, DOI 10.1016/S0360-3016(02)04379-1; Patchell RA, 2003, CANCER TREAT REV, V29, P533, DOI 10.1016/S0305-7372(03)00105-1; Patchell RA, 1998, JAMA-J AM MED ASSOC, V280, P1485, DOI 10.1001/jama.280.17.1485; Rades D, 2009, EUR J CANCER, V45, P400, DOI 10.1016/j.ejca.2008.10.033; Regine WF, 2002, INT J RADIAT ONCOL, V53, P259; Schoggl A, 2000, ACTA NEUROCHIR, V142, P621, DOI 10.1007/s007010070104; Smedby KE, 2009, BRIT J CANCER, V101, P1919, DOI 10.1038/sj.bjc.6605373; Sneed PK, 1999, INT J RADIAT ONCOL, V43, P549, DOI 10.1016/S0360-3016(98)00447-7; Sneed PK, 2002, INT J RADIAT ONCOL, V53, P519, DOI 10.1016/S0360-3016(02)02770-0; Soltys SG, 2008, INT J RADIAT ONCOL, V70, P187, DOI 10.1016/j.ijrobp.2007.06.068; Sperduto PW, 2008, INT J RADIAT ONCOL, V70, P510, DOI 10.1016/j.ijrobp.2007.06.074; SZEIFERT GT, 2005, CANCER CELL, V8, P89; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306	41	164	167	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	2010	362	12					1119	1127		10.1056/NEJMct0806951	http://dx.doi.org/10.1056/NEJMct0806951			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573FU	20335588				2022-12-28	WOS:000275894600009
J	Schulz, KF; Altman, DG; Moher, D; Grp, C				Schulz, Kenneth F.; Altman, Douglas G.; Moher, David; Grp, C. O. N. S. O. R. T.			CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials	BMC MEDICINE			English	Article							EMPIRICAL-EVIDENCE; REVISED RECOMMENDATIONS; QUALITY; EXPLANATION; EXTENSION; EPIDEMIOLOGY; TREAT; BIAS		[Schulz, Kenneth F.] Family Hlth Int, Res Triangle Pk, NC 27709 USA; [Altman, Douglas G.] Univ Oxford Wolfson Coll, Ctr Stat Med, Oxford OX2 6UD, England; [Moher, David] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa Methods Ctr, Clin Epidemiol Program,Ottawa Hosp,Res Inst, Ottawa, ON, Canada	University of Oxford; University of Ottawa; Ottawa Hospital Research Institute	Schulz, KF (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.	kschulz@fhi.org	Moher, David/I-3408-2019; Altman, Douglas G/A-9714-2012; Groves, Trish/A-9119-2009	Moher, David/0000-0003-2434-4206; Hopewell, Sally/0000-0002-6881-6984; Boutron, Isabelle/0000-0002-5263-6241; Groves, Trish/0000-0001-7915-6419	United Kingdom National Institute for Health Research; Medical Research Council; Canadian Institutes of Health Research; Johnson Johnson; BMJ; American Society for Clinical Oncology; Cancer Research UK	United Kingdom National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); BMJ; American Society for Clinical Oncology; Cancer Research UK(Cancer Research UK)	The CONSORT Group contributors to CONSORT 2010: DG Altman, Centre for Statistics in Medicine, University of Oxford; Virginia Barbour, PLoS Medicine; Jesse A Berlin, Johnson & Johnson Pharmaceutical Research and Development, USA; Isabelle Boutron, University Paris 7 Denis Diderot, Assistance Publique des Hopitaux de Paris, INSERM, France; PJ Devereaux, McMaster University, Canada; Kay Dickersin, Johns Hopkins Bloomberg School of Public Health, USA; Diana Elbourne, London School of Hygiene & Tropical Medicine; Susan Ellenberg, University of Pennsylvania School of Medicine, USA; Val Gebski, University of Sydney, Australia; Steven Goodman, Journal of the Society for Clinical Trials, USA; Peter C Gotzsche, Nordic Cochrane Centre, Denmark; Trish Groves, BMJ; Steven Grunberg, American Society of Clinical Oncology, USA; Brian Haynes, McMaster University, Canada; Sally Hopewell, Centre for Statistics in Medicine, University of Oxford; Astrid James, Lancet; Peter Juhn, Johnson & Johnson, USA; Philippa Middleton, University of Adelaide, Australia; Don Minckler, University of California Irvine, USA; D Moher, Ottawa Methods Centre, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Canada; Victor M Montori, Knowledge and Encounter Research Unit, Mayo Clinic College of Medicine, USA; Cynthia Mulrow, Annals of Internal Medicine, USA; Stuart Pocock, London School of Hygiene & Tropical Medicine; Drummond Rennie, JAMA, USA; David L Schriger, Annals of Emergency Medicine, USA; KF Schulz, Family Health International, USA; Iveta Simera, EQUATOR Network; Elizabeth Wager, Sideview. Contributors to CONSORT 2010 who did not attend the Montebello meeting: Mike Clarke, UK Cochrane Centre; Gordon Guyatt, McMaster University, Canada. Funding: We received financial support from United Kingdom National Institute for Health Research and the Medical Research Council; Canadian Institutes of Health Research; Presidents Fund, Canadian Institutes of Health Research; Johnson & Johnson; BMJ; and the American Society for Clinical Oncology. DGA is supported by Cancer Research UK, DM by a University of Ottawa Research Chair, and KFS by Family Health International. None of the sponsors had any involvement in the planning, execution, or writing of the CONSORT documents. Additionally, no funder played a role in drafting the manuscript. In order to encourage dissemination of the CONSORT 2010 Statement, this article is freely accessible on bmj.com and will also be published in the Lancet, Obstetrics and Gynecology, PLoS Medicine, Annals of Internal Medicine, Open Medicine, Journal of Clinical Epidemiology, BMC Medicine, and Trials. The authors jointly hold the copyright of this article. For details on further use, see the CONSORT website http://www.consort-statement.org.	ANDREW E, 1994, JAMA-J AM MED ASSOC, V272, P1926, DOI 10.1001/jama.1994.03520240054041; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; De Angelis C, 2004, LANCET, V364, P911, DOI 10.1016/S0140-6736(04)17034-7; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Gagnier JJ, 2006, ANN INTERN MED, V144, P364, DOI 10.7326/0003-4819-144-5-200603070-00013; Glasziou P, 2008, BMJ-BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Hopewell Sally, 2010, BMJ, V340, pc723, DOI 10.1136/bmj.c723; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Nuovo J, 2002, JAMA-J AM MED ASSOC, V287, P2813, DOI 10.1001/jama.287.21.2813; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; RENNIE D, 1995, JAMA-J AM MED ASSOC, V273, P1054, DOI 10.1001/jama.273.13.1054; Sackett DL, 2007, INT J EPIDEMIOL, V36, P664, DOI 10.1093/ije/dym088; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Schulz KF, 2002, LANCET, V359, P696, DOI 10.1016/S0140-6736(02)07816-9; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	33	3438	3484	2	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1741-7015			BMC MED	BMC Med.	MAR 24	2010	8								18	10.1186/1741-7015-8-18	http://dx.doi.org/10.1186/1741-7015-8-18			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588LZ	20332509	gold, Green Published, Green Submitted			2022-12-28	WOS:000277073000001
J	Horton, R				Horton, Richard			Offline: Life in the senior common room	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 20	2010	375	9719					968	968		10.1016/S0140-6736(10)60361-3	http://dx.doi.org/10.1016/S0140-6736(10)60361-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	575YU	20304230				2022-12-28	WOS:000276110700011
J	Dinarello, CA				Dinarello, Charles A.			Anti-inflammatory Agents: Present and Future	CELL			English	Review							HISTONE DEACETYLASE INHIBITOR; INTERLEUKIN-1 RECEPTOR ANTAGONIST; TUMOR-NECROSIS-FACTOR; SUBEROYLANILIDE HYDROXAMIC ACID; COLD AUTOINFLAMMATORY SYNDROME; PROINFLAMMATORY CYTOKINE PRODUCTION; JUVENILE IDIOPATHIC ARTHRITIS; ACTIVATED PROTEIN-KINASE; VALPROIC ACID; INFLAMMASOME ACTIVATION	Inflammation involving the innate and adaptive immune systems is a normal response to infection. However, when allowed to continue unchecked, inflammation may result in autoimmune or autoinflammatory disorders, neurodegenerative disease, or cancer. A variety of safe and effective anti-inflammatory agents are available, including aspirin and other nonsteroidal anti-inflammatories, with many more drugs under development. In particular, the new era of anti-inflammatory agents includes "biologicals" such as anticytokine therapies and small molecules that block the activity of kinases. Other anti-inflammatories currently in use or under development include statins, histone deacetylase inhibitors, PPAR agonists, and small RNAs. This Review discusses the current status of anti-inflammatory drug research and the development of new anti-inflammatory therapeutics.	[Dinarello, Charles A.] Univ Colorado, Dept Med, Aurora, CO 80045 USA; [Dinarello, Charles A.] Radboud Univ Nijmegen, Dept Med, Med Ctr, NL-6500 HC Nijmegen, Netherlands	University of Colorado System; University of Colorado Anschutz Medical Campus; Radboud University Nijmegen	Dinarello, CA (corresponding author), Univ Colorado, Dept Med, Aurora, CO 80045 USA.	cdinarello@mac.com	Dinarello, Charles/C-8524-2013		NIH [AI 15614, CA 6934]; JDRF [26-2008-893]; Royal Netherlands Academy of Arts and Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015614, R37AI015614] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); Royal Netherlands Academy of Arts and Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The author is supported by Grants AI 15614 (NIH), CA 6934 (NIH), and 26-2008-893 (JDRF) and the Royal Netherlands Academy of Arts and Sciences. The author thanks A. Abbate, M. Donath, M. Nold, L. Joosten, S.-H. Kim, T. Mandrup-Poulsen, P. Mascagni, M. Netea, A. Solinger, F. van de Veerdonk, and J. van der Meer for helpful comments.	Abbate A, 2008, CIRCULATION, V117, P2670, DOI 10.1161/CIRCULATIONAHA.107.740233; Abbate A, 2010, AM J CARDIOL, V105, P1371, DOI 10.1016/j.amjcard.2009.12.059; Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Archin NM, 2008, AIDS, V22, P1131, DOI 10.1097/QAD.0b013e3282fd6df4; Becker CE, 2009, J BIOL CHEM, V284, P34531, DOI 10.1074/jbc.M109.046102; Bocker U, 2001, IMMUNOL CELL BIOL, V79, P444, DOI 10.1046/j.1440-1711.2001.01031.x; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Charles P, 1999, J IMMUNOL, V163, P1521; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; Dasu MR, 2009, ENDOCRINOLOGY, V150, P3457, DOI 10.1210/en.2008-1757; Dinarello CA, 2005, J RHEUMATOL, V32, P40; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DINARELLO CA, 1986, J EXP MED, V163, P1433, DOI 10.1084/jem.163.6.1433; DINARELLO CA, 1987, J IMMUNOL, V139, P1902; Dinarello CA, 2009, NEW ENGL J MED, V360, P2467, DOI 10.1056/NEJMe0811014; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Donath MY, 2009, DIABETES, V58, pA30; Drenth JPH, 1999, NAT GENET, V22, P178, DOI 10.1038/9696; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1197, DOI 10.1164/rccm.200204-302OC; Emsley HCA, 2005, J NEUROL NEUROSUR PS, V76, P1366, DOI 10.1136/jnnp.2004.054882; ENDRES S, 1989, NEW ENGL J MED, V320, P265, DOI 10.1056/NEJM198902023200501; Esmon CT, 2006, SEMIN THROMB HEMOST, V32, P49, DOI 10.1055/s-2006-939554; Falco P, 2008, EXPERT REV ANTICANC, V8, P865, DOI 10.1586/14737140.8.6.865; Fantuzzi G, 1997, J IMMUNOL, V158, P1818; FERRETTI M, 1994, J CLIN INVEST, V94, P449, DOI 10.1172/JCI117345; Fitzgerald AA, 2005, ARTHRITIS RHEUM-US, V52, P1794, DOI 10.1002/art.21061; FONG YM, 1989, J EXP MED, V170, P1627, DOI 10.1084/jem.170.5.1627; Garcia-Manero G, 2008, BLOOD, V111, P1060, DOI 10.1182/blood-2007-06-098061; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Gerstner T, 2008, EXPERT OPIN PHARMACO, V9, P285, DOI 10.1517/14656566.9.2.285 ; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Graziano F, 2009, PHARMACOGENOMICS J, V9, P78, DOI 10.1038/tpj.2008.16; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Guerini V, 2008, LEUKEMIA, V22, P740, DOI 10.1038/sj.leu.2405049; Guma M, 2009, ARTHRITIS RHEUM-US, V60, P3642, DOI 10.1002/art.24959; Hilgendorff A, 2003, INT J CLIN PHARM TH, V41, P397; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hoffman HM, 2008, ARTHRITIS RHEUM, V58, P2443, DOI 10.1002/art.23687; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Huang YX, 2008, J IMMUNOL, V181, P8068, DOI 10.4049/jimmunol.181.11.8068; Jin YP, 2009, INVEST OPHTH VIS SCI, V50, P4743, DOI 10.1167/iovs.08-2462; Joosten LAB, 2009, ARTHRITIS RHEUM, V60, P3651, DOI 10.1002/art.25006; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kozikowski AP, 2009, CHEMMEDCHEM, V4, P1095, DOI 10.1002/cmdc.200900045; Krelin Y, 2007, CANCER RES, V67, P1062, DOI 10.1158/0008-5472.CAN-06-2956; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Kuijk LM, 2008, BLOOD, V112, P3563, DOI 10.1182/blood-2008-03-144667; KUMAR S, 1995, MOL MED, V1, P325, DOI 10.1007/BF03401557; Lachmann HJ, 2009, NEW ENGL J MED, V360, P2416, DOI 10.1056/NEJMoa0810787; Laliberte RE, 1999, J BIOL CHEM, V274, P36944, DOI 10.1074/jbc.274.52.36944; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533; Larsen L, 2007, DIABETOLOGIA, V50, P779, DOI 10.1007/s00125-006-0562-3; Leoni F, 2005, MOL MED, V11, P1, DOI 10.2119/2006-00005.Dinarello; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; Lewis EC, 2008, P NATL ACAD SCI USA, V105, P16236, DOI 10.1073/pnas.0807627105; Li Q, 2009, AM J PATHOL, V175, P661, DOI 10.2353/ajpath.2009.081093; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Major EO, 2010, ANNU REV MED, V61, P35, DOI 10.1146/annurev.med.080708.082655; MANDRUPPOULSEN T, 1986, DIABETOLOGIA, V29, P63, DOI 10.1007/BF02427283; Marin V, 2001, BLOOD, V98, P667, DOI 10.1182/blood.V98.3.667; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Munch J, 2007, CELL, V129, P263, DOI 10.1016/j.cell.2007.02.042; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Nicklin MJH, 2000, J EXP MED, V191, P303, DOI 10.1084/jem.191.2.303; Nold MF, 2007, THROMB HAEMOSTASIS, V98, P1118, DOI 10.1160/TH07-01-0052; O'Connor OA, 2006, J CLIN ONCOL, V24, P166, DOI 10.1200/JCO.2005.01.9679; Oldoni T, 2009, CYTOKINE, V48, P120, DOI 10.1016/j.cyto.2009.07.506; Paniagua RT, 2006, J CLIN INVEST, V116, P2633, DOI 10.1172/JCI28546; Pascual V, 2005, J EXP MED, V201, P1479, DOI 10.1084/jem.20050473; Paul F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001928; Perregaux DG, 2000, J IMMUNOL, V165, P4615, DOI 10.4049/jimmunol.165.8.4615; Pott GB, 2009, J LEUKOCYTE BIOL, V85, P886, DOI 10.1189/jlb.0208145; Proudfoot AEI, 2010, EXPERT OPIN INV DRUG, V19, P345, DOI 10.1517/13543780903535867; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Rafiq S, 2007, GENES IMMUN, V8, P344, DOI 10.1038/sj.gene.6364393; Reddy S, 2009, NEW ENGL J MED, V360, P2438, DOI 10.1056/NEJMoa0809568; Ren M, 2004, J NEUROCHEM, V89, P1358, DOI 10.1111/j.1471-4159.2004.02406.x; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; SAMPAIO EP, 1991, J EXP MED, V173, P699, DOI 10.1084/jem.173.3.699; Santini V, 2007, CURR DRUG METAB, V8, P383, DOI 10.2174/138920007780655397; Serhan CN, 2008, BRIT J PHARMACOL, V153, pS200, DOI 10.1038/sj.bjp.0707489; Shapiro L, 1995, P NATL ACAD SCI USA, V92, P12230, DOI 10.1073/pnas.92.26.12230; Shapiro L, 2001, FASEB J, V15, P115, DOI 10.1096/fj.00-0311com; Shein NA, 2009, FASEB J, V23, P4266, DOI 10.1096/fj.09-134700; Stack JH, 2005, J IMMUNOL, V175, P2630, DOI 10.4049/jimmunol.175.4.2630; Stafylas PC, 2009, INT J CARDIOL, V131, P298, DOI 10.1016/j.ijcard.2008.06.005; Stienstra R, 2009, CYTOKINE, V48, P134, DOI 10.1016/j.cyto.2009.07.567; SUSICK L, 2007, J CELL MOL MED, V5, P5; Testa L, 2008, J THORAC CARDIOV SUR, V136, P884, DOI 10.1016/j.jtcvs.2007.12.062; Thiele A, 2002, EUR J PHARMACOL, V453, P325, DOI 10.1016/S0014-2999(02)02423-8; van de Veerdonk FL, 2009, CYTOKINE, V48, P98, DOI 10.1016/j.cyto.2009.07.412; van de Veerdonk FL, 2009, J INFECT DIS, V199, P1087, DOI 10.1086/597274; Vojinovic J, 2008, ARTHRITIS RHEUM-US, V58, pS943; Weinblatt ME, 2008, ARTHRITIS RHEUM-US, V58, P3309, DOI 10.1002/art.23992; Wolf AM, 2005, P NATL ACAD SCI USA, V102, P13622, DOI 10.1073/pnas.0501758102; Zhao WP, 2009, J IMMUNOL, V183, P2729, DOI 10.4049/jimmunol.0804341; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zhou WS, 2007, J IMMUNOL, V178, P702, DOI 10.4049/jimmunol.178.2.702	106	616	654	6	127	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2010	140	6					935	950		10.1016/j.cell.2010.02.043	http://dx.doi.org/10.1016/j.cell.2010.02.043			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	571IX	20303881	Bronze, Green Accepted			2022-12-28	WOS:000275746600015
J	Ma, J; Karaman, I				Ma, Ji; Karaman, Ibrahim			Expanding the Repertoire of Shape Memory Alloys	SCIENCE			English	Editorial Material									[Ma, Ji] Texas A&M Univ, Mat Sci & Engn Interdisciplinary Program, College Stn, TX 77843 USA; Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Ma, J (corresponding author), Texas A&M Univ, Mat Sci & Engn Interdisciplinary Program, College Stn, TX 77843 USA.	jm@neo.tamu.edu; ikaraman@tamu.edu	Karaman, Ibrahim/E-7450-2010	Karaman, Ibrahim/0000-0001-6461-4958				Ashby M. F., 2005, MAT SELECTION MECH D; Chmielus M, 2009, NAT MATER, V8, P863, DOI [10.1038/nmat2527, 10.1038/NMAT2527]; Christodoulou L, 2003, JOM-J MIN MET MAT S, V55, P39, DOI 10.1007/s11837-003-0008-z; Desroches R, 2004, J EARTHQ ENG, V8, P415, DOI 10.1142/S1363246904001298; Fosdick R, 1998, INT J SOLIDS STRUCT, V35, P403, DOI 10.1016/S0020-7683(97)00033-4; Kainuma R, 2006, NATURE, V439, P957, DOI 10.1038/nature04493; Karaman I, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2721143; Liu YO, 1997, ACTA MATER, V45, P4431, DOI 10.1016/S1359-6454(97)00144-4; Otsuka K, 2005, PROG MATER SCI, V50, P511, DOI 10.1016/j.pmatsci.2004.10.001; Sarawate NN, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2969799; Takeuchi I, 2003, NAT MATER, V2, P180, DOI 10.1038/nmat829; Tanaka Y, 2010, SCIENCE, V327, P1488, DOI 10.1126/science.1183169	12	57	58	3	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	2010	327	5972					1468	1469		10.1126/science.1186766	http://dx.doi.org/10.1126/science.1186766			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20299585				2022-12-28	WOS:000275715200036
J	Zenewicz, LA; Abraham, C; Flavell, RA; Cho, JH				Zenewicz, Lauren A.; Abraham, Clara; Flavell, Richard A.; Cho, Judy H.			Unraveling the Genetics of Autoimmunity	CELL			English	Article							GENOME-WIDE ASSOCIATION; LYMPHOID TYROSINE PHOSPHATASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; RISK LOCUS; SUSCEPTIBILITY LOCI; VARIANTS; DISEASE; REGION	The chronic autoimmune diseases include multiple complex genetic disorders. Recently, genome-wide association studies (GWAS) have identified a large number of major loci, with many associations shared between various autoimmune diseases. These associations highlight key roles for lymphocyte activation and prioritize specific cytokine pathways and mechanisms of host-microbe recognition. Despite success in identifying loci, comprehensive models of disease pathogenesis are currently lacking. Future efforts comparing association patterns between autoimmune diseases may be particularly illustrative. New genomic technologies applied to classic genetic studies involving twins, early onset cases, and phenotypic extremes may provide key insights into developmental and gene-environment interactions in autoimmunity.	[Abraham, Clara; Cho, Judy H.] Yale Univ, Dept Med, New Haven, CT 06520 USA; [Zenewicz, Lauren A.; Flavell, Richard A.] Yale Univ, Dept Immunobiol, New Haven, CT 06520 USA; [Cho, Judy H.] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Cho, JH (corresponding author), Yale Univ, Dept Med, New Haven, CT 06520 USA.	judy.cho@yale.edu		Zenewicz, Lauren/0000-0002-8787-5955	National Institutes of Health [DK P30-34989, U19AI082713, R01DK077905, R01DK077903, U01 DK62429, U01 DK062422, UL1 RR024139, RCDK086800]; Bohmfalk Funds for Medical Research; Crohn's and Colitis Foundation of America; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077903, P30DK034989, R01DK077905, U01DK062422, RC1DK086800, U01DK062429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bohmfalk Funds for Medical Research; Crohn's and Colitis Foundation of America; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health: DK P30-34989 (J.H.C. and C.A.), U19AI082713 (J.H.C. and C.A.), R01DK077905 (C.A.), R01DK077903, U01 DK62429, U01 DK062422, UL1 RR024139, RCDK086800 (J.H.C.); the Bohmfalk Funds for Medical Research (J.H.C.); and the Crohn's and Colitis Foundation of America (J.H.C. and C.A.).	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Broadley SA, 2000, BRAIN, V123, P1102, DOI 10.1093/brain/123.6.1102; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Clayton DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000540; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Festen EAM, 2009, GUT, V58, P799, DOI 10.1136/gut.2008.166918; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Lin JP, 1998, HUM GENET, V103, P475, DOI 10.1007/s004390050853; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pascual V, 2006, CURR OPIN IMMUNOL, V18, P676, DOI 10.1016/j.coi.2006.09.014; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; ROSENTHAL M, 2009, NAT IMMUNOL, V10, P1000; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zenewicz LA, 2008, EUR J IMMUNOL, V38, P3265, DOI 10.1002/eji.200838655; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhernakova A, 2007, AM J HUM GENET, V81, P1284, DOI 10.1086/522037	59	97	101	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2010	140	6					791	797		10.1016/j.cell.2010.03.003	http://dx.doi.org/10.1016/j.cell.2010.03.003			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	571IX	20303870	Green Accepted, Bronze			2022-12-28	WOS:000275746600004
J	Fuchs, VR				Fuchs, Victor R.			How to Think about Future Health Care Spending.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Stanford Univ, Stanford, CA 94305 USA	Stanford University	Fuchs, VR (corresponding author), Stanford Univ, Stanford, CA 94305 USA.								0	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2010	362	11					965	967		10.1056/NEJMp1000200	http://dx.doi.org/10.1056/NEJMp1000200			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570CY	20220179				2022-12-28	WOS:000275650400001
J	Manning, KD				Manning, Kimberly D.			Do Something	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												kdmanni@emory.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1018	1018		10.1001/jama.2010.82	http://dx.doi.org/10.1001/jama.2010.82			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569KC	20233812				2022-12-28	WOS:000275594100001
J	Crowther, M				Crowther, Mark			Risk for postoperative venous thromboembolism in women was increased for >= 12 weeks and varied by type of surgery	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									McMaster Univ, Hamilton, ON, Canada	McMaster University	Crowther, M (corresponding author), McMaster Univ, Hamilton, ON, Canada.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	2010	152	6							JC3-11	10.7326/0003-4819-152-6-201003160-02011	http://dx.doi.org/10.7326/0003-4819-152-6-201003160-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573IF	20231553				2022-12-28	WOS:000275905200028
J	Krause, J; Fu, QM; Good, JM; Viola, B; Shunkov, MV; Derevianko, AP; Paabo, S				Krause, Johannes; Fu, Qiaomei; Good, Jeffrey M.; Viola, Bence; Shunkov, Michael V.; Derevianko, Anatoli P.; Paeaebo, Svante			The complete mitochondrial DNA genome of an unknown hominin from southern Siberia	NATURE			English	Article							SEQUENCE; ORIGIN; FLORES; AGE	With the exception of Neanderthals, from which DNA sequences of numerous individuals have now been determined(1), the number and genetic relationships of other hominin lineages are largely unknown. Here we report a complete mitochondrial (mt) DNA sequence retrieved from a bone excavated in 2008 in Denisova Cave in the Altai Mountains in southern Siberia. It represents a hitherto unknown type of hominin mtDNA that shares a common ancestor with anatomically modern human and Neanderthal mtDNAs about 1.0 million years ago. This indicates that it derives from a hominin migration out of Africa distinct from that of the ancestors of Neanderthals and of modern humans. The stratigraphy of the cave where the bone was found suggests that the Denisova hominin lived close in time and space with Neanderthals as well as with modern humans(2-4).	[Krause, Johannes; Fu, Qiaomei; Viola, Bence; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Good, Jeffrey M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Viola, Bence] Univ Vienna, Dept Anthropol, A-1090 Vienna, Austria; [Shunkov, Michael V.; Derevianko, Anatoli P.] Russian Acad Sci, Siberian Branch, Inst Archaeol & Ethnog, Paleolith Dept, RU-630090 Novosibirsk 17, Russia	Max Planck Society; University of Montana System; University of Montana; University of Vienna; Russian Academy of Sciences	Krause, J (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany.	krause@eva.mpg.de	Krause, Johannes/E-6640-2015; Krause, Johannes/AFP-2642-2022; Viola, Bence/B-7390-2011; Derevianko, Anatoly P./Q-5975-2016; Shunkov, Mikhail V./Q-6576-2016	Krause, Johannes/0000-0001-5475-4690; Krause, Johannes/0000-0001-9144-3920; Derevianko, Anatoly P./0000-0003-1156-8331; Shunkov, Mikhail V./0000-0003-1388-2308; Viola, Bence/0000-0001-8052-707X	Max Planck Society; NSF [OISE-0754461]	Max Planck Society(Max Planck SocietyFoundation CELLEX); NSF(National Science Foundation (NSF))	We thank A. W. Briggs, K. Finstermeier, R. E. Green, J.-J. Hublin, M. Kircher, A. I. Krivoshapkin, T. Maricic, M. Stoneking, A. Tsybonkov, L. Vigilant and V. Wiebe for comments, M. Meyer, the MPI-EVA sequencing group and M. Kircher for technical support, and the Presidential Innovation Fund of the Max Planck Society for financial support. J.M.G. was supported during this research by an NSF international postdoctoral fellowship (OISE-0754461).	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bermudez De Castro J. M., 1997, Science (Washington D C), V276, P1392, DOI 10.1126/science.276.5317.1392; Bolikhovskaya NS, 2006, PALEONTOL J+, V40, pS558, DOI 10.1134/S0031030106110025; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Caramelli D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002700; Derevianko AP, 2008, ARCHAEOL ETHNOL ANTH, V34, P13, DOI 10.1016/j.aeae.2008.07.002; Derevianko A.P., 1998, PALAEOLITHIC SIBERIA; Derevianko AP, 2000, ARCHAEOLOGY ETHNOLOG, V2, P33; Gabunia L, 2000, J HUM EVOL, V38, P785, DOI 10.1006/jhev.1999.0383; GOEBEL T, 1993, CURR ANTHROPOL, V34, P452, DOI 10.1086/204192; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Krause J, 2007, NATURE, V449, P902, DOI 10.1038/nature06193; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Schoetensack O., 1908, UNTERKIEFER HOMOHEID; Smith CI, 2003, J HUM EVOL, V45, P203, DOI 10.1016/S0047-2484(03)00106-4; STRINGER C, 1997, R SOC ARTS J, V145, P111; Stringer CB, 1999, J HUM EVOL, V37, P873, DOI 10.1006/jhev.1999.0367; Swisher CC, 1996, SCIENCE, V274, P1870, DOI 10.1126/science.274.5294.1870; Tattersall I, 2009, P NATL ACAD SCI USA, V106, P16018, DOI 10.1073/pnas.0903207106; Viola TB, 2008, AM J PHYS ANTHROPOL, P214	29	457	495	14	214	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					894	897		10.1038/nature08976	http://dx.doi.org/10.1038/nature08976			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20336068	hybrid			2022-12-28	WOS:000276397300038
J	Lupski, JR; Reid, JG; Gonzaga-Jauregui, C; Deiros, DR; Chen, DCY; Nazareth, L; Bainbridge, M; Dinh, H; Jing, C; Wheeler, DA; McGuire, AL; Zhang, F; Stankiewicz, P; Halperin, JJ; Yang, CY; Gehman, C; Guo, DW; Irikat, RK; Tom, W; Fantin, NJ; Muzny, DM; Gibbs, RA				Lupski, James R.; Reid, Jeffrey G.; Gonzaga-Jauregui, Claudia; Deiros, David Rio; Chen, David C. Y.; Nazareth, Lynne; Bainbridge, Matthew; Dinh, Huyen; Jing, Chyn; Wheeler, David A.; McGuire, Amy L.; Zhang, Feng; Stankiewicz, Pawel; Halperin, John J.; Yang, Chengyong; Gehman, Curtis; Guo, Danwei; Irikat, Rola K.; Tom, Warren; Fantin, Nick J.; Muzny, Donna M.; Gibbs, Richard A.			Whole-Genome Sequencing in a Patient with Charcot-Marie-Tooth Neuropathy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEREDITARY NEUROPATHY; STRUCTURAL VARIATION; MISSENSE MUTATIONS; POINT MUTATION; DISEASE; GENE; PROTEIN; SH3TC2; IDENTIFICATION; ASSOCIATION	Background: Whole-genome sequencing may revolutionize medical diagnostics through rapid identification of alleles that cause disease. However, even in cases with simple patterns of inheritance and unambiguous diagnoses, the relationship between disease phenotypes and their corresponding genetic changes can be complicated. Comprehensive diagnostic assays must therefore identify all possible DNA changes in each haplotype and determine which are responsible for the underlying disorder. The high number of rare, heterogeneous mutations present in all humans and the paucity of known functional variants in more than 90% of annotated genes make this challenge particularly difficult. Thus, the identification of the molecular basis of a genetic disease by means of whole-genome sequencing has remained elusive. We therefore aimed to assess the usefulness of human whole-genome sequencing for genetic diagnosis in a patient with Charcot-Marie-Tooth disease. Methods: We identified a family with a recessive form of Charcot-Marie-Tooth disease for which the genetic basis had not been identified. We sequenced the whole genome of the proband, identified all potential functional variants in genes likely to be related to the disease, and genotyped these variants in the affected family members. Results: We identified and validated compound, heterozygous, causative alleles in SH3TC2 (the SH3 domain and tetratricopeptide repeats 2 gene), involving two mutations, in the proband and in family members affected by Charcot-Marie-Tooth disease. Separate subclinical phenotypes segregated independently with each of the two mutations; heterozygous mutations confer susceptibility to neuropathy, including the carpal tunnel syndrome. Conclusions: As shown in this study of a family with Charcot-Marie-Tooth disease, whole-genome sequencing can identify clinically relevant variants and provide diagnostic information to inform the care of patients. N Engl J Med 2010;362:1181-91.	[Lupski, James R.; Reid, Jeffrey G.; Gonzaga-Jauregui, Claudia; Bainbridge, Matthew; Zhang, Feng; Stankiewicz, Pawel; Muzny, Donna M.; Gibbs, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Reid, Jeffrey G.; Deiros, David Rio; Chen, David C. Y.; Nazareth, Lynne; Bainbridge, Matthew; Dinh, Huyen; Jing, Chyn; Wheeler, David A.; Muzny, Donna M.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [McGuire, Amy L.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA; [Halperin, John J.] Atlantic Neurosci Inst, Summit, NJ USA; [Halperin, John J.] Mt Sinai Sch Med, New York, NY USA; [Yang, Chengyong; Gehman, Curtis; Guo, Danwei; Irikat, Rola K.; Tom, Warren; Fantin, Nick J.] Life Technol, Carlsbad, CA USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Icahn School of Medicine at Mount Sinai; Thermo Fisher Scientific	Gibbs, RA (corresponding author), 1 Baylor Plaza,Mail Stop BCM226, Houston, TX 77030 USA.	agibbs@bcm.edu	Wheeler, David A/M-9740-2018; halperin, john/X-6433-2019; Stankiewicz, Paweł/AAP-7906-2021; Zhang, Feng/C-7735-2009; Gonzaga-Jauregui, Claudia/H-4752-2019	Wheeler, David A/0000-0002-9056-6299; halperin, john/0000-0003-1170-1710; Stankiewicz, Paweł/0000-0002-6456-7490; Zhang, Feng/0000-0003-4556-8276; Gonzaga-Jauregui, Claudia/0000-0002-4667-3679	National Human Genome Research Institute [5 U54 HG003273]; National Institute of Neurological Disorders and Stroke [R01 NS058529]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported in part by grants from the National Human Genome Research Institute (5 U54 HG003273, to Dr. Gibbs) and the National Institute of Neurological Disorders and Stroke (R01 NS058529, to Dr. Lupski).	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Allan W, 1939, ARCH INTERN MED, V63, P1123, DOI 10.1001/archinte.1939.00180230108008; Arnaud E, 2009, P NATL ACAD SCI USA, V106, P17528, DOI 10.1073/pnas.0905523106; Auer-Grumbach M, 2008, NEUROPEDIATRICS, V39, P33, DOI 10.1055/s-2008-1077085; Azzedine H, 2006, NEUROLOGY, V67, P602, DOI 10.1212/01.wnl.0000230225.19797.93; Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Chung KW, 2005, NEUROGENETICS, V6, P159, DOI 10.1007/s10048-005-0217-4; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Del Colle R, 2003, NEUROL SCI, V24, P57, DOI 10.1007/s100720300073; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; Dvorakova L, 2001, HUM MUTAT, V18, P52, DOI 10.1002/humu.1149; England JD, 2009, NEUROLOGY, V72, P185, DOI 10.1212/01.wnl.0000336370.51010.a1; Gooding R, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.034132; Haldane JBS, 1941, J GENET, V41, P149, DOI 10.1007/BF02983018; Hodapp JA, 2006, ARCH NEUROL-CHICAGO, V63, P112, DOI 10.1001/archneur.63.1.112; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Lupo V, 2009, HUM MOL GENET, V18, P4603, DOI 10.1093/hmg/ddp427; Lupski JR, 2007, NEW ENGL J MED, V356, P1169, DOI 10.1056/NEJMcibr067658; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; Roberts RC, 2010, HUM MOL GENET, V19, P1009, DOI 10.1093/hmg/ddp565; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Senderek J, 2003, AM J HUM GENET, V73, P1106, DOI 10.1086/379525; Shy ME, 2006, ANN NEUROL, V59, P358, DOI 10.1002/ana.20777; Verny C, 2004, NEUROLOGY, V63, P1527; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	36	539	568	2	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 1	2010	362	13					1181	1191		10.1056/NEJMoa0908094	http://dx.doi.org/10.1056/NEJMoa0908094			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	577QQ	20220177	Green Accepted			2022-12-28	WOS:000276239500008
J	O'Connell, AD; Hofheinz, M; Ansmann, M; Bialczak, RC; Lenander, M; Lucero, E; Neeley, M; Sank, D; Wang, H; Weides, M; Wenner, J; Martinis, JM; Cleland, AN				O'Connell, A. D.; Hofheinz, M.; Ansmann, M.; Bialczak, Radoslaw C.; Lenander, M.; Lucero, Erik; Neeley, M.; Sank, D.; Wang, H.; Weides, M.; Wenner, J.; Martinis, John M.; Cleland, A. N.			Quantum ground state and single-phonon control of a mechanical resonator	NATURE			English	Article							RESOLVED-SIDE-BAND; CAVITY; INTERFEROMETRY; OSCILLATOR	Quantum mechanics provides a highly accurate description of a wide variety of physical systems. However, a demonstration that quantum mechanics applies equally to macroscopic mechanical systems has been a long-standing challenge, hindered by the difficulty of cooling a mechanical mode to its quantum ground state. The temperatures required are typically far below those attainable with standard cryogenic methods, so significant effort has been devoted to developing alternative cooling techniques. Once in the ground state, quantum-limited measurements must then be demonstrated. Here, using conventional cryogenic refrigeration, we show that we can cool a mechanical mode to its quantum ground state by using a microwave-frequency mechanical oscillator-a 'quantum drum'-coupled to a quantum bit, which is used to measure the quantum state of the resonator. We further show that we can controllably create single quantum excitations (phonons) in the resonator, thus taking the first steps to complete quantum control of a mechanical system.	[O'Connell, A. D.; Hofheinz, M.; Ansmann, M.; Bialczak, Radoslaw C.; Lenander, M.; Lucero, Erik; Neeley, M.; Sank, D.; Wang, H.; Weides, M.; Wenner, J.; Martinis, John M.; Cleland, A. N.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Cleland, AN (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	anc@physics.ucsb.edu	Hofheinz, Max/F-3288-2010; Wang, Haohua/G-8875-2011; Cleland, Andrew/AAG-7581-2019; Weides, Martin/C-1470-2009; Wenner, James/G-3777-2014	Wang, Haohua/0000-0001-5380-4297; Weides, Martin/0000-0002-2718-6795; Wenner, James/0000-0001-7107-4734	US National Science Foundation (NSF) [DMR-0605818]; Intelligence Advanced Research Projects [W911NF-04-1-0204]	US National Science Foundation (NSF)(National Science Foundation (NSF)); Intelligence Advanced Research Projects	We would like to thank M. Geller for numerous conversations and A. Berube for assistance with resonator fabrication and measurements. This work was supported by the US National Science Foundation (NSF) under grant DMR-0605818 and by the Intelligence Advanced Research Projects Activity under grant W911NF-04-1-0204. Devices were made at the University of California, Santa Barbara, Nanofabrication Facility, which is part of the NSF-funded US National Nanotechnology Infrastructure Network.	Ambacher O, 1998, J PHYS D APPL PHYS, V31, P2653, DOI 10.1088/0022-3727/31/20/001; Ansmann M, 2009, NATURE, V461, P504, DOI 10.1038/nature08363; Arcizet O, 2006, NATURE, V444, P71, DOI 10.1038/nature05244; Armour AD, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.148301; Blencowe M, 2004, PHYS REP, V395, P159, DOI 10.1016/j.physrep.2003.12.005; Blencowe MP, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.014511; Braginsky V. B., 1992, QUANTUM MEASUREMENT; CLARKE J, 1988, SCIENCE, V239, P992, DOI 10.1126/science.239.4843.992; Cleland AN, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.070501; Courty JM, 2001, EUR PHYS J D, V17, P399, DOI 10.1007/s100530170014; Gigan S, 2006, NATURE, V444, P67, DOI 10.1038/nature05273; Groblacher S, 2009, NATURE, V460, P724, DOI 10.1038/nature08171; Groblacher S, 2009, NAT PHYS, V5, P485, DOI 10.1038/NPHYS1301; Haroche S., 2006, EXPLORING QUANTUM; Hofheinz M, 2008, NATURE, V454, P310, DOI 10.1038/nature07136; Hofheinz M, 2009, NATURE, V459, P546, DOI 10.1038/nature08005; Kleckner D, 2006, NATURE, V444, P75, DOI 10.1038/nature05231; Knobel RG, 2003, NATURE, V424, P291, DOI 10.1038/nature01773; LaHaye MD, 2009, NATURE, V459, P960, DOI 10.1038/nature08093; LaHaye MD, 2004, SCIENCE, V304, P74, DOI 10.1126/science.1094419; Larson JD, 2000, ULTRASON, P863, DOI 10.1109/ULTSYM.2000.922679; Marquardt F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.093902; Martin I, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.125339; Martinis JM, 2009, QUANTUM INF PROCESS, V8, P81, DOI 10.1007/s11128-009-0105-1; Nam K, 2005, J KOREAN PHYS SOC, V47, pS309, DOI 10.3938/jkps.47.309; O'Connell AD, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2898887; Oliver WD, 2005, SCIENCE, V310, P1653, DOI 10.1126/science.1119678; Park YS, 2009, NAT PHYS, V5, P489, DOI 10.1038/NPHYS1303; Regal CA, 2008, NAT PHYS, V4, P555, DOI 10.1038/nphys974; Rocheleau T, 2010, NATURE, V463, P72, DOI 10.1038/nature08681; Ruby RC, 2001, ULTRASON, P813, DOI 10.1109/ULTSYM.2001.991846; Schliesser A, 2008, NAT PHYS, V4, P415, DOI 10.1038/nphys939; Schliesser A, 2009, NAT PHYS, V5, P509, DOI 10.1038/NPHYS1304; Schuster I, 2008, NAT PHYS, V4, P382, DOI 10.1038/nphys940; Shytov AV, 2003, EUR PHYS J B, V36, P263, DOI 10.1140/epjb/e2003-00343-8; Steffen M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.050502; Thompson JD, 2008, NATURE, V452, P72, DOI 10.1038/nature06715; Wilson-Rae I, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.093901	38	1441	1454	12	363	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2010	464	7289					697	703		10.1038/nature08967	http://dx.doi.org/10.1038/nature08967			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20237473				2022-12-28	WOS:000276205000034
J	Rubin, CJ; Zody, MC; Eriksson, J; Meadows, JRS; Sherwood, E; Webster, MT; Jiang, L; Ingman, M; Sharpe, T; Ka, S; Hallbook, F; Besnier, F; Carlborg, O; Bed'hom, B; Tixier-Boichard, M; Jensen, P; Siegel, P; Lindblad-Toh, K; Andersson, L				Rubin, Carl-Johan; Zody, Michael C.; Eriksson, Jonas; Meadows, Jennifer R. S.; Sherwood, Ellen; Webster, Matthew T.; Jiang, Lin; Ingman, Max; Sharpe, Ted; Ka, Sojeong; Hallbook, Finn; Besnier, Francois; Carlborg, Orjan; Bed'hom, Bertrand; Tixier-Boichard, Michele; Jensen, Per; Siegel, Paul; Lindblad-Toh, Kerstin; Andersson, Leif			Whole-genome resequencing reveals loci under selection during chicken domestication	NATURE			English	Article							QUANTITATIVE TRAIT LOCI; BODY-WEIGHT; GENETIC DISSECTION; GROWTH; HORMONE; DIFFERENCE; CONVERSION; EPISTASIS; MUTATION; STRAIN	Domestic animals are excellent models for genetic studies of phenotypic evolution(1-3). They have evolved genetic adaptations to a new environment, the farm, and have been subjected to strong human-driven selection leading to remarkable phenotypic changes in morphology, physiology and behaviour. Identifying the genetic changes underlying these developments provides new insight into general mechanisms by which genetic variation shapes phenotypic diversity. Here we describe the use of massively parallel sequencing to identify selective sweeps of favourable alleles and candidate mutations that have had a prominent role in the domestication of chickens (Gallus gallus domesticus) and their subsequent specialization into broiler (meat-producing) and layer (egg-producing) chickens. We have generated 44.5-fold coverage of the chicken genome using pools of genomic DNA representing eight different populations of domestic chickens as well as red jungle fowl (Gallus gallus), the major wild ancestor(4). We report more than 7,000,000 single nucleotide polymorphisms, almost 1,300 deletions and a number of putative selective sweeps. One of the most striking selective sweeps found in all domestic chickens occurred at the locus for thyroid stimulating hormone receptor (TSHR), which has a pivotal role in metabolic regulation and photoperiod control of reproduction in vertebrates. Several of the selective sweeps detected in broilers overlapped genes associated with growth, appetite and metabolic regulation. We found little evidence that selection for loss-of-function mutations had a prominent role in chicken domestication, but we detected two deletions in coding sequences that we suggest are functionally important. This study has direct application to animal breeding and enhances the importance of the domestic chicken as a model organism for biomedical research.	[Rubin, Carl-Johan; Zody, Michael C.; Eriksson, Jonas; Meadows, Jennifer R. S.; Webster, Matthew T.; Jiang, Lin; Lindblad-Toh, Kerstin; Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Zody, Michael C.; Sharpe, Ted; Lindblad-Toh, Kerstin] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; [Zody, Michael C.; Sharpe, Ted; Lindblad-Toh, Kerstin] MIT, Cambridge, MA 02142 USA; [Sherwood, Ellen] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Ingman, Max] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden; [Ka, Sojeong; Hallbook, Finn] Uppsala Univ, Dept Neurosci, SE-75124 Uppsala, Sweden; [Besnier, Francois; Carlborg, Orjan; Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, SE-75124 Uppsala, Sweden; [Bed'hom, Bertrand; Tixier-Boichard, Michele] INRA, Anim Genet & Integrat Biol UMR1313, F-78350 Jouy En Josas, France; [Jensen, Per] Linkoping Univ, IFM Biol, SE-58183 Linkoping, Sweden; [Siegel, Paul] Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA	Uppsala University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Karolinska Institutet; Uppsala University; Uppsala University; Swedish University of Agricultural Sciences; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Linkoping University; Virginia Polytechnic Institute & State University	Andersson, L (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Box 582, SE-75123 Uppsala, Sweden.	leif.andersson@imbim.uu.se	Bed'Hom, Bertrand/G-7313-2011	Bed'Hom, Bertrand/0000-0002-0825-0886; Meadows, Jennifer/0000-0002-0850-230X; Jiang, Lin/0000-0001-9123-5988; Carlborg, Orjan/0000-0002-2722-5264; Rubin, Carl-Johan/0000-0001-8238-5052; Webster, Matthew/0000-0003-1141-2863; Hallbook, Finn/0000-0001-7552-187X	Swedish Foundation for Strategic Research; Knut and Alice Wallenberg Foundation; Swedish National Infrastructure for Computing; The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; European Young Investigator awards	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish National Infrastructure for Computing; The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); European Young Investigator awards	Thanks are due to J. Altimiras, J. Dodgson, F. Imsland and S. Kerje for providing genomic DNA samples. We would also like to thank E. Sonnhammar for help with the bioinformatic analysis of the TSHR sequence, the Uppsala Genome Center for SOLiD sequencing and the Uppsala Multidisciplinary Center for Advanced Computational Science for help with data storage and analysis. This work was supported by grants from the Swedish Foundation for Strategic Research, the Knut and Alice Wallenberg Foundation, the Swedish National Infrastructure for Computing and The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning. K.L.-T. and O.C. are supported by European Young Investigator awards.	AGARWAL SK, 1994, J ENDOCRINOL, V142, P427, DOI 10.1677/joe.0.1420427; Alvarez-Castro JM, 2007, GENETICS, V176, P1151, DOI 10.1534/genetics.106.067348; Ambo M, 2009, ANIM GENET, V40, P200, DOI 10.1111/j.1365-2052.2008.01824.x; Andersson L, 2001, NAT REV GENET, V2, P130, DOI 10.1038/35052563; Carlborg O, 2006, NAT GENET, V38, P418, DOI 10.1038/ng1761; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; COLE RK, 1966, GENETICS, V53, P1021; Crawford R.D, 1990, POULTRY BREEDING GEN; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; Darwin C., 1859, ORIGINS SPECIES MEAN; Darwin CR., 1868, VARIATION ANIMALS PL, DOI DOI 10.1371/journal.pbio.0040088; Dobney K, 2006, J ZOOL, V269, P261, DOI 10.1111/j.1469-7998.2006.00042.x; Dunnington EA, 1996, POULTRY SCI, V75, P1168, DOI 10.3382/ps.0751168; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; FELSENSTEIN J, 1989, CLADISTICS, V5, P166; Hanon EA, 2008, CURR BIOL, V18, P1147, DOI 10.1016/j.cub.2008.06.076; Havenstein GB, 2003, POULTRY SCI, V82, P1500, DOI 10.1093/ps/82.10.1500; Hillel J, 2003, GENET SEL EVOL, V35, P533, DOI [10.1051/gse:2003038, 10.1186/1297-9686-35-6-533]; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Jacobsson L, 2005, GENET RES, V86, P115, DOI 10.1017/S0016672305007767; Ka S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-68; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kerje S, 2003, ANIM GENET, V34, P264, DOI 10.1046/j.1365-2052.2003.01000.x; Le Rouzic A, 2008, EVOL BIOINFORM, V4, P225, DOI 10.4137/EBO.S756; LILJEDAHL LE, 1979, ACTA AGR SCAND, V29, P273, DOI 10.1080/00015127909435238; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2006, TRENDS GENET, V22, P126, DOI 10.1016/j.tig.2006.01.004; Messina DN, 2009, BIOINFORMATICS, V25, P1333, DOI 10.1093/bioinformatics/btp153; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Peck GR, 2009, J BIOL CHEM, V284, P30016, DOI 10.1074/jbc.M109.035568; Price E.O., 2002, ANIMAL DOMESTICATION; Ronnegard L, 2008, GENETICS, V178, P2315, DOI 10.1534/genetics.107.083162; Rozen S, 2000, Methods Mol Biol, V132, P365; Sewalem A, 2002, POULTRY SCI, V81, P1775, DOI 10.1093/ps/81.12.1775; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Stone S, 2006, HUM MOL GENET, V15, P2709, DOI 10.1093/hmg/ddl204; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Yoshimura T, 2003, NATURE, V426, P178, DOI 10.1038/nature02117; Zhou H, 2006, POULTRY SCI, V85, P1700, DOI 10.1093/ps/85.10.1700	41	686	734	5	315	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					587	U145		10.1038/nature08832	http://dx.doi.org/10.1038/nature08832			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20220755	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000275974200047
J	Lee, IM; Djousse, L; Sesso, HD; Wang, L; Buring, JE				Lee, I-Min; Djousse, Luc; Sesso, Howard D.; Wang, Lu; Buring, Julie E.			Physical Activity and Weight Gain Prevention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; LOW-DOSE ASPIRIN; WOMENS HEALTH; CARDIOVASCULAR-DISEASE; LOSS MAINTENANCE; EXERCISE; OBESITY; CANCER; ADULTS; FAT	Context The amount of physical activity needed to prevent long-term weight gain is unclear. In 2008, federal guidelines recommended at least 150 minutes per week (7.5 metabolic equivalent [MET] hours per week) of moderate-intensity activity for "substantial health benefits." Objective To examine the association of different amounts of physical activity with long-term weight changes among women consuming a usual diet. Design, Setting, and Participants A prospective cohort study involving 34 079 healthy US women (mean age, 54.2 years) from 1992-2007. At baseline and months 36, 72, 96, 120, 144, and 156, women reported their physical activity and body weight. Women were classified as expending less than 7.5, 7.5 to less than 21, and 21 or more MET hours per week of activity at each time. Repeated-measures regression prospectively examined physical activity and weight change over intervals averaging 3 years. Main Outcome Measure Change in weight. Results Women gained a mean of 2.6 kg throughout the study. A multivariate analysis comparing women expending 21 or more MET hours per week with those expending from 7.5 to less than 21 MET hours per week showed that the latter group gained a mean (SD) 0.11 kg (0.04 kg; P=.003) over a mean interval of 3 years, and those expending less than 7.5 MET hours per week gained 0.12 kg (0.04; P=.002). There was a significant interaction with body mass index (BMI), such that there was an inverse dose-response relation between activity levels and weight gain among women with a BMI of less than 25 (P for trend <.001) but no relation among women with a BMI from 25 to 29.9 (P for trend=.56) or with a BMI of 30.0 or higher (P for trend=.50). A total of 4540 women (13.3%) with a BMI lower than 25 at study start successfully maintained their weight by gaining less than 2.3 kg throughout. Their mean activity level over the study was 21.5 MET hours per week (approximate to 60 minutes a day of moderate-intensity activity). Conclusions Among women consuming a usual diet, physical activity was associated with less weight gain only among women whose BMI was lower than 25. Women successful in maintaining normal weight and gaining fewer than 2.3 kg over 13 years averaged approximately 60 minutes a day of moderate-intensity activity throughout the study. JAMA. 2010; 303(12): 1173-1179	[Lee, I-Min; Sesso, Howard D.; Wang, Lu; Buring, Julie E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med,Dept Med, Boston, MA 02215 USA; [Lee, I-Min; Buring, Julie E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA; [Buring, Julie E.] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; [Djousse, Luc] Boston Vet Affairs Healthcare Syst, Massachusetts Vet Epidemiol & Res Informat Ctr, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Lee, IM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med,Dept Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.	ilee@rics.bwh.harvard.edu	Djousse, Luc/F-5033-2017; Lee, I-Min/ABD-5409-2021	Djousse, Luc/0000-0002-9902-3047; 	National Institutes of Health [CA047988, HL043851, HL080467, DK081141]; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851, R01HL080467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK081141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding/Support: This work was supported by grants CA047988, HL043851, HL080467, and DK081141 from the National Institutes of Health.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Blair SN, 2004, AM J CLIN NUTR, V79, P913; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Fogelholm M, 2000, Obes Rev, V1, P95, DOI 10.1046/j.1467-789x.2000.00016.x; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; He XXZ, 2004, AM J PREV MED, V27, P8, DOI 10.1016/j.amepre.2004.03.016; Institute of Medicine Food and Nutrition Board, 2002, DIET REF INT EN CARB; Irwin ML, 2003, JAMA-J AM MED ASSOC, V289, P323, DOI 10.1001/jama.289.3.323; Jakicic JM, 2008, ARCH INTERN MED, V168, P1550, DOI 10.1001/archinte.168.14.1550; Jeffery RW, 2000, HEALTH PSYCHOL, V19, P5, DOI 10.1037/0278-6133.19.Suppl1.5; Katan MB, 2009, NEW ENGL J MED, V360, P923, DOI 10.1056/NEJMe0810291; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; Lee I-M, 2009, EPIDEMIOLOGIC METHOD, P100; Lee IM, 2001, CANCER CAUSE CONTROL, V12, P137, DOI 10.1023/A:1008948125076; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Lewis CE, 2000, AM J EPIDEMIOL, V151, P1172, DOI 10.1093/oxfordjournals.aje.a010167; McTiernan A, 2007, OBESITY, V15, P1496, DOI 10.1038/oby.2007.178; Mora S, 2006, JAMA-J AM MED ASSOC, V295, P1412, DOI 10.1001/jama.295.12.1412; Physical Activity Guidelines Committee, 2008, PHYS ACT GUID ADV CO; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Saris W H M, 2003, Obes Rev, V4, P101, DOI 10.1046/j.1467-789X.2003.00101.x; Shaw K, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003817.pub3; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Slentz CA, 2005, J APPL PHYSIOL, V99, P1613, DOI 10.1152/japplphysiol.00124.2005; StJeor ST, 1997, J AM DIET ASSOC, V97, P481, DOI 10.1016/S0002-8223(97)00126-0; Svetkey LP, 2008, JAMA-J AM MED ASSOC, V299, P1139, DOI 10.1001/jama.299.10.1139; Tataranni PA, 2003, INT J OBESITY, V27, P1578, DOI 10.1038/sj.ijo.0802469; US Department of Health and Human Services, 2008, PHYS ACT GUID AM; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Wareham NJ, 2005, P NUTR SOC, V64, P229, DOI 10.1079/PNS2005423; Weinstein AR, 2004, JAMA-J AM MED ASSOC, V292, P1188, DOI 10.1001/jama.292.10.1188; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	35	207	209	1	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2010	303	12					1173	1179		10.1001/jama.2010.312	http://dx.doi.org/10.1001/jama.2010.312			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573AC	20332403	Green Accepted, Bronze			2022-12-28	WOS:000275879600022
J	Hotamisligil, GS				Hotamisligil, Goekhan S.			Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease	CELL			English	Review							UNFOLDED-PROTEIN RESPONSE; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; PANCREATIC BETA-CELLS; LINKED INSULIN-RESISTANCE; DIET-INDUCED OBESITY; ER STRESS; ADIPOSE-TISSUE; TRANSLATION INITIATION; GLUCOSE-HOMEOSTASIS	The endoplasmic reticulum (ER) is the major site in the cell for protein folding and trafficking and is central to many cellular functions. Failure of the ER's adaptive capacity results in activation of the unfolded protein response (UPR), which intersects with many different inflammatory and stress signaling pathways. These pathways are also critical in chronic metabolic diseases such as obesity, insulin resistance, and type 2 diabetes. The ER and related signaling networks are emerging as a potential site for the intersection of inflammation and metabolic disease.	[Hotamisligil, Goekhan S.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Hotamisligil, Goekhan S.] Harvard Univ, Sch Publ Hlth, Broad Inst, Harvard & MIT, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Broad Institute	Hotamisligil, GS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Dept Genet & Complex Dis, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu	Longo, Kenneth A/A-5631-2010		NIH; American Diabetes Association; Juvenile Diabetes Research Foundation; Syndexa Pharmaceuticals; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK064360, R01DK052539, P30DK040561, R01DK064360] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Syndexa Pharmaceuticals; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	G.S.H. is supported by the NIH, American Diabetes Association, and the Juvenile Diabetes Research Foundation. I am grateful to the students and fellows who contributed to the studies in my group. I thank Margaret Gregor Gustafson and Ling Yang for helpful discussions and thoughtful comments. G.S.H. is on the Scientific Advisory Board, is a shareholder, and receives research support from Syndexa Pharmaceuticals.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Alexaki VI, 2009, J IMMUNOL, V183, P5948, DOI 10.4049/jimmunol.0901186; Alvim FC, 2001, PLANT PHYSIOL, V126, P1042, DOI 10.1104/pp.126.3.1042; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Bailey D, 2007, ANTIOXID REDOX SIGN, V9, P2305, DOI 10.1089/ars.2007.1796; Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bobrovnikova-Marjon E, 2008, P NATL ACAD SCI USA, V105, P16314, DOI 10.1073/pnas.0808517105; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Cullinan SB, 2006, INT J BIOCHEM CELL B, V38, P317, DOI 10.1016/j.biocel.2005.09.018; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; DuRose JB, 2009, MOL CELL BIOL, V29, P4295, DOI 10.1128/MCB.00260-09; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fonseca SG, 2005, J BIOL CHEM, V280, P39609, DOI 10.1074/jbc.M507426200; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gotoh T, 2006, ARTERIOSCL THROM VAS, V26, P1439, DOI 10.1161/01.ATV.0000223900.67024.15; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Hosoi T, 2008, MOL PHARMACOL, V74, P1610, DOI 10.1124/mol.108.050070; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Huang CJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1656, DOI 10.1152/ajpendo.00318.2007; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kaneko M, 2003, BIOL PHARM BULL, V26, P931, DOI 10.1248/bpb.26.931; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kokame K, 2001, J BIOL CHEM, V276, P9199, DOI 10.1074/jbc.M010486200; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kovacs P, 2002, DIABETES, V51, P1618, DOI 10.2337/diabetes.51.5.1618; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Ladiges WC, 2005, DIABETES, V54, P1074, DOI 10.2337/diabetes.54.4.1074; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Maurin AC, 2005, CELL METAB, V1, P273, DOI 10.1016/j.cmet.2005.03.004; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Nadanaka S, 2007, MOL CELL BIOL, V27, P1027, DOI 10.1128/MCB.00408-06; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Oikawa D, 2007, J CELL SCI, V120, P1681, DOI 10.1242/jcs.002808; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Ozawa K, 2005, DIABETES, V54, P657, DOI 10.2337/diabetes.54.3.657; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Palakurthi SS, 2001, CANCER RES, V61, P6213; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Pirot P, 2007, DIABETOLOGIA, V50, P1006, DOI 10.1007/s00125-007-0609-0; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Powers T, 2008, MOL CELL, V31, P775, DOI 10.1016/j.molcel.2008.09.006; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; RICCA GA, 1978, J CELL PHYSIOL, V97, P137, DOI 10.1002/jcp.1040970202; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Sharma NK, 2008, J CLIN ENDOCR METAB, V93, P4532, DOI 10.1210/jc.2008-1001; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Silva AM, 2007, J BIOL CHEM, V282, P10164, DOI 10.1074/jbc.M609996200; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Tabas I, 2009, ANN NY ACAD SCI, V1173, pE40, DOI 10.1111/j.1749-6632.2009.04957.x; Thameem F, 2006, DIABETES, V55, P839, DOI 10.2337/diabetes.55.03.06.db05-1002; Tsang CK, 2007, DRUG DISCOV TODAY, V12, P112, DOI 10.1016/j.drudis.2006.12.008; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vallerie SN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003151; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; WEST DB, 1987, AM J PHYSIOL, V253, pR228, DOI 10.1152/ajpregu.1987.253.2.R228; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yamazaki H, 2009, J IMMUNOL, V183, P1480, DOI 10.4049/jimmunol.0900017; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang HH, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006189, 10.1371/journal.pone.0007826]; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	151	1994	2109	6	330	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2010	140	6					900	917		10.1016/j.cell.2010.02.034	http://dx.doi.org/10.1016/j.cell.2010.02.034			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	571IX	20303879	Green Accepted, Bronze			2022-12-28	WOS:000275746600013
J	Schroder, K; Tschopp, J				Schroder, Kate; Tschopp, Jurg			The Inflammasomes	CELL			English	Review							NF-KAPPA-B; COLD AUTOINFLAMMATORY SYNDROME; RILONACEPT INTERLEUKIN-1 TRAP; ANTHRAX LETHAL TOXIN; NALP3 INFLAMMASOME; CASPASE-1 ACTIVATION; CELL-DEATH; NLRP3 INFLAMMASOME; PATTERN-RECOGNITION; OXIDATIVE STRESS	Inflammasomes are molecular platforms activated upon cellular infection or stress that trigger the maturation of proinflammatory cytokines such as interleukin-1 beta to engage innate immune defenses. Strong associations between dysregulated inflammasome activity and human heritable and acquired inflammatory diseases highlight the importance this pathway in tailoring immune responses. Here, we comprehensively review mechanisms directing normal inflammasome function and its dysregulation in disease. Agonists and activation mechanisms of the NLRP1, NLRP3, IPAF, and AIM2 inflammasomes are discussed. Regulatory mechanisms that potentiate or limit inflammasome activation are examined, as well as emerging links between the inflammasome and pyroptosis and autophagy.	[Schroder, Kate; Tschopp, Jurg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Schroder, Kate] Monash Univ, Monash Inst Med Res, Melbourne, Vic 3800, Australia	University of Lausanne; Monash University	Tschopp, J (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	jurg.tschopp@unil.ch	Schroder, Kate/C-6132-2008	Schroder, Kate/0000-0001-9261-3805	Australian National Health and Medical Research Council [ID 490993]; Swiss National Science Foundation; EU; Institute of Arthritis Research, Lausanne	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU(European Commission); Institute of Arthritis Research, Lausanne	K. S. is supported by a C.J. Martin Fellowship from the Australian National Health and Medical Research Council (ID 490993). J.T. is supported by grants of the Swiss National Science Foundation, EU grants Mugen, Hermione, Apo-Sys, and Apo-Train, and by the Institute of Arthritis Research, Lausanne.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Aksentijevich I, 1997, CELL, V90, P797; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Arnoult D, 2009, J CELL SCI, V122, P3161, DOI 10.1242/jcs.051193; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bensaad K, 2009, EMBO J, V28, P3015, DOI 10.1038/emboj.2009.242; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bolwell GP, 1999, CURR OPIN PLANT BIOL, V2, P287, DOI 10.1016/S1369-5266(99)80051-X; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Case CL, 2009, INFECT IMMUN, V77, P1981, DOI 10.1128/IAI.01382-08; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; DeYoung KL, 1997, ONCOGENE, V15, P453, DOI 10.1038/sj.onc.1201206; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Dupont N, 2009, CELL HOST MICROBE, V6, P137, DOI 10.1016/j.chom.2009.07.005; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Faustin B, 2009, P NATL ACAD SCI USA, V106, P3935, DOI 10.1073/pnas.0809414106; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Goldbach-Mansky R, 2008, ARTHRITIS RHEUM-US, V58, P2432, DOI 10.1002/art.23620; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Guarda G, 2009, NATURE, V460, P269, DOI 10.1038/nature08100; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Harris J, 2009, TRANSBOUND EMERG DIS, V56, P248, DOI 10.1111/j.1865-1682.2009.01069.x; Hawkins PN, 2004, ARTHRITIS RHEUM-US, V50, P607, DOI 10.1002/art.20033; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Hoffman HM, 2008, ARTHRITIS RHEUM, V58, P2443, DOI 10.1002/art.23687; Hoffman HM, 2009, EXPERT OPIN BIOL TH, V9, P519, DOI [10.1517/14712590902875518, 10.1517/14712590902875518 ]; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Jeru I, 2008, P NATL ACAD SCI USA, V105, P1614, DOI 10.1073/pnas.0708616105; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kalliolias GD, 2008, EXPERT OPIN INV DRUG, V17, P349, DOI [10.1517/13543784.17.3.349, 10.1517/13543784.17.3.349 ]; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kufer TA, 2006, ANN NY ACAD SCI, V1072, P19, DOI 10.1196/annals.1326.020; Lachmann HJ, 2009, NEW ENGL J MED, V360, P2416, DOI 10.1056/NEJMoa0810787; Lachmann HJ, 2009, J EXP MED, V206, P1029, DOI 10.1084/jem.20082481; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Maedler K, 2009, EXPERT OPIN BIOL TH, V9, P1177, DOI 10.1517/14712590903136688; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; McGonagle D, 2007, ANN RHEUM DIS, V66, P1683, DOI 10.1136/ard.2007.073759; McGonagle D, 2008, ARTHRITIS RHEUM-US, V58, P631, DOI 10.1002/art.23119; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; Meyer E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000423; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Miao EA, 2007, SEMIN IMMUNOPATHOL, V29, P275, DOI 10.1007/s00281-007-0078-z; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Newman ZL, 2009, INFECT IMMUN, V77, P4327, DOI 10.1128/IAI.00730-09; Nickerson K, 2001, J BIOL CHEM, V276, P19089, DOI 10.1074/jbc.M101295200; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Oka S, 2009, ENDOCRINOLOGY, V150, P1225, DOI 10.1210/en.2008-0646; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Rouschop KMA, 2009, RADIOTHER ONCOL, V92, P411, DOI 10.1016/j.radonc.2009.06.029; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Shalev A, 2008, BIOCHEM SOC T, V36, P963, DOI 10.1042/BST0360963; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Shio MT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000559; Shoham NG, 2003, P NATL ACAD SCI USA, V100, P13501, DOI 10.1073/pnas.2135380100; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Stack JH, 2005, J IMMUNOL, V175, P2630, DOI 10.4049/jimmunol.175.4.2630; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; Sun YH, 2007, J BIOL CHEM, V282, P33897, DOI 10.1074/jbc.C700181200; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Suzuki T, 2008, AUTOPHAGY, V4, P73, DOI 10.4161/auto.5101; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Talbott JH, 1940, J CLIN INVEST, V19, P645, DOI 10.1172/JCI101167; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Terkeltaub R, 2009, ANN RHEUM DIS, V68, P1613, DOI 10.1136/ard.2009.108936; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819; Wickliffe KE, 2008, CELL MICROBIOL, V10, P332, DOI 10.1111/j.1462-5822.2007.01044.x; Wise CA, 2002, HUM MOL GENET, V11, P961, DOI 10.1093/hmg/11.8.961; Xue YL, 2006, AM J HUM GENET, V78, P659, DOI 10.1086/503116; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	128	3891	4156	45	1105	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2010	140	6					821	832		10.1016/j.cell.2010.01.040	http://dx.doi.org/10.1016/j.cell.2010.01.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	571IX	20303873	Bronze			2022-12-28	WOS:000275746600007
J	Kahn, KL; Adams, JL; Weeks, JC; Chrischilles, EA; Schrag, D; Ayanian, JZ; Kiefe, CI; Ganz, PA; Bhoopalam, N; Potosky, AL; Harrington, DP; Fletcher, RH				Kahn, Katherine L.; Adams, John L.; Weeks, Jane C.; Chrischilles, Elizabeth A.; Schrag, Deborah; Ayanian, John Z.; Kiefe, Catarina I.; Ganz, Patricia A.; Bhoopalam, Nirmala; Potosky, Arnold L.; Harrington, David P.; Fletcher, Robert H.			Adjuvant Chemotherapy Use and Adverse Events Among Older Patients With Stage III Colon Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MARGINAL STRUCTURAL MODELS; CARE OUTCOMES RESEARCH; COLORECTAL-CANCER; ELDERLY-PATIENTS; CLINICAL-TRIALS; RANDOMIZED-TRIAL; POOLED ANALYSIS; OF-LIFE; FLUOROURACIL; LEUCOVORIN	Context Randomized trials suggest adjuvant chemotherapy is effective for older patients with stage III colon cancer. However, older patients are less likely to receive this therapy than younger patients, perhaps because of concern about adverse effects. Objective To evaluate adjuvant chemotherapy use and outcomes for older patients with stage III colon cancer from well-defined population-based settings and health care systems. Design Observational study of adjuvant chemotherapy use and outcomes by age using Poisson regression to estimate the number of adverse events adjusted for demographic and clinical factors, including comorbid illness and specific elements of chemotherapy regimens documented with clinically detailed medical record reviews and patient and surrogate surveys. Setting Five geographically defined regions (Alabama, Iowa, Los Angeles County, northern California, and North Carolina), 5 integrated health care delivery systems, and 15 Veterans Affairs hospitals. Patients Six hundred seventy-five patients diagnosed with stage III colon cancer from 2003 through 2005 who underwent surgical resection and were followed up for as long as 15 months postdiagnosis. Main Outcome Measures Chemotherapy regimen, dose, duration, and annualized mean number of adverse events stratified by age. Results Of 202 patients aged 75 years and older, 101 (50%) received adjuvant chemotherapy compared with 87% of 473 younger patients (difference, 37%; 95% confidence interval [CI], 30%-45%). Among patients who received adjuvant chemotherapy, 14 patients (14%) aged 75 years and older and 178 younger patients (44%) received a regimen containing oxaliplatin (difference, 30%; 95% CI, 21%-38%). Older patients were less likely to continue treatment, such that by 150 days, 99 patients (40%) aged 65 years and older and 68 younger patients (25%) had discontinued chemotherapy (difference, 15%; 95% CI, 7%-23%). Overall, 162 patients (24%) had at least 1 adverse clinical event, with more events among patients treated with vs without adjuvant chemotherapy (mean, 0.39 vs 0.16; difference, 0.23; 95% CI, 0.11-0.36; P<.001). Among patients receiving adjuvant chemotherapy, adjusted rates of late clinical adverse events were lower for patients 75 years and older (mean, 0.28) vs for younger patients (0.35 for ages 18-54 years, 0.52 for ages 55-64 years, and 0.45 for ages 65-74 years; P=.008 for any age effect). Conclusion Among patients with stage III colon cancer who underwent surgical resection and received adjuvant chemotherapy, older patients in the community received less-toxic and shorter chemotherapy regimens, and those treated had fewer adverse events than younger patients. JAMA. 2010; 303(11): 1037-1045	[Kahn, Katherine L.; Adams, John L.] RAND Corp, Santa Monica, CA 90401 USA; [Kahn, Katherine L.] Univ Calif Los Angeles, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA USA; [Ganz, Patricia A.] Univ Calif Los Angeles, Div Hematol & Med Oncol, Los Angeles, CA USA; [Kahn, Katherine L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Ganz, Patricia A.] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90095 USA; [Weeks, Jane C.] Div Populat Sci, Boston, MA USA; [Harrington, David P.] Dept Biostat & Computat Biol, Boston, MA USA; [Schrag, Deborah] Dana Farber Canc Inst, Boston, MA 02115 USA; [Chrischilles, Elizabeth A.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA; [Ayanian, John Z.] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA; [Ayanian, John Z.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Fletcher, Robert H.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02115 USA; [Kiefe, Catarina I.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Bhoopalam, Nirmala] US Dept Vet Affairs, Vet Affairs Edward Hines Jr Hosp, Hines, IL 60141 USA; [Potosky, Arnold L.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Canc Control Program, Washington, DC 20007 USA; [Fletcher, Robert H.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Fletcher, Robert H.] Univ N Carolina, Dept Social Med, Chapel Hill, NC USA	RAND Corporation; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Harvard University; Dana-Farber Cancer Institute; University of Iowa; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Georgetown University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Kahn, KL (corresponding author), RAND Corp, 1776 Main St, Santa Monica, CA 90401 USA.	kahn@rand.org	Kahn, Katherine/AAE-2857-2020; Adams, John/ABE-6170-2021	Kahn, Katherine/0000-0002-6605-1455; 	National Cancer Institute (NCI) [U01 CA093344, U01 CA093348]; Harvard Medical School and Northern California Cancer Center [U01 CA093324]; Dana-Farber Cancer Institute and Cancer Research Network [U01 CA093332]; University of Alabama at Birmingham [U01 CA093329]; University of Iowa [U01 CA01013]; University of North Carolina [U01 CA093326]; Department of Veterans Affairs [U01 CDA093344 [MOU], HARQ 03-438MO-03]; NATIONAL CANCER INSTITUTE [U01CA093324, U01CA093348, U01CA093344, U01CA093332, U01CA093326, U01CA093329] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Harvard Medical School and Northern California Cancer Center; Dana-Farber Cancer Institute and Cancer Research Network; University of Alabama at Birmingham; University of Iowa; University of North Carolina; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding/Support: The Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium was supported by grants from the National Cancer Institute (NCI) to the statistical coordinating center at the Dana-Farber Cancer Institute (U01 CA093344) and the primary data collection and research centers at RAND Corporation and University of California, Los Angeles (U01 CA093348); Harvard Medical School and Northern California Cancer Center (U01 CA093324); Dana-Farber Cancer Institute and Cancer Research Network (U01 CA093332); University of Alabama at Birmingham (U01 CA093329); University of Iowa (U01 CA01013); and University of North Carolina (U01 CA093326) and by a Department of Veterans Affairs grant to the Durham VA Medical Center (U01 CDA093344 [MOU] and HARQ 03-438MO-03).	American Joint Committee on Cancer, 2006, AJCC CANC STAG ATL; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; [Anonymous], DEC MAK TOOLS HLTH C; Arias Elizabeth, 2007, Natl Vital Stat Rep, V56, P1; Ayanian JZ, 2004, J CLIN ONCOL, V22, P2992, DOI 10.1200/JCO.2004.06.020; Ayanian JZ, 2003, J CLIN ONCOL, V21, P1293, DOI 10.1200/JCO.2003.06.178; Dencausse Y, 2002, ONKOLOGIE, V25, P426, DOI 10.1159/000067436; Folprecht G, 2004, ANN ONCOL, V15, P1330, DOI 10.1093/annonc/mdh344; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Haller DG, 2005, J CLIN ONCOL, V23, P8671, DOI 10.1200/JCO.2004.00.5686; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Jessup JM, 2005, JAMA-J AM MED ASSOC, V294, P2703, DOI 10.1001/jama.294.21.2703; Kahn KL, 2008, J CLIN ONCOL, V26, P523, DOI 10.1200/JCO.2007.13.1870; Keating NL, 2008, J CLIN ONCOL, V26, P2532, DOI 10.1200/JCO.2007.15.9434; Keating NL, 2010, CANCER-AM CANCER SOC, V116, P998, DOI 10.1002/cncr.24761; Kohne CH, 2008, ONCOLOGIST, V13, P390, DOI 10.1634/theoncologist.2007-0043; Kuebler JP, 2007, J CLIN ONCOL, V25, P2198, DOI 10.1200/JCO.2006.08.2974; LAURIE JA, 1989, J CLIN ONCOL, V7, P1447, DOI 10.1200/JCO.1989.7.10.1447; Malin JL, 2006, SUPPORT CARE CANCER, V14, P837, DOI 10.1007/s00520-005-0902-8; Minino AM, 2007, NATL VITAL STAT REP, V55, P1; MOERTEL CG, 1990, NEW ENGL J MED, V322, P352, DOI 10.1056/NEJM199002083220602; National Cancer Institute, CANC THER EV PROGR C; Neugut AI, 2006, J CLIN ONCOL, V24, P2368, DOI 10.1200/JCO.2005.04.5005; O'Connell MJ, 1998, J CLIN ONCOL, V16, P295, DOI 10.1200/JCO.1998.16.1.295; Piccirillo AF, 2003, J REGISTRY MANAG, V30, P117; Piccirillo JF, 2004, ORL J OTO-RHINO-LARY, V66, P180, DOI 10.1159/000079875; Potosky AL, 2002, J CLIN ONCOL, V20, P1192, DOI 10.1200/JCO.20.5.1192; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sargent D, 2009, J CLIN ONCOL, V27, P872, DOI 10.1200/JCO.2008.19.5362; Sargent DJ, 2001, NEW ENGL J MED, V345, P1091, DOI 10.1056/NEJMoa010957; Schrag D, 2001, J NATL CANCER I, V93, P850, DOI 10.1093/jnci/93.11.850; StataCorp, 2005, STAT STAT SOFTW REL; Sundararajan V, 2002, ANN INTERN MED, V136, P349, DOI 10.7326/0003-4819-136-5-200203050-00007; Townsley CA, 2005, J CLIN ONCOL, V23, P3112, DOI 10.1200/JCO.2005.00.141; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Zaniboni A, 1998, CANCER, V82, P2135, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2135::AID-CNCR7>3.0.CO;2-U	38	114	119	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1037	1045		10.1001/jama.2010.272	http://dx.doi.org/10.1001/jama.2010.272			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569KC	20233821	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000275594100016
J	[Anonymous]				[Anonymous]			Expression of concern-Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial	LANCET			English	Editorial Material																		Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; *INSP GEZ CENTR CO, 2009, OND NAAR PROPATRIA S	2	15	15	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 13	2010	375	9718					875	876						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	574NA	20226971				2022-12-28	WOS:000275995300009
J	Hinde, CA; Johnstone, RA; Kilner, RM				Hinde, Camilla A.; Johnstone, Rufus A.; Kilner, Rebecca M.			Parent-Offspring Conflict and Coadaptation	SCIENCE			English	Article							MATERNAL TESTOSTERONE; HORMONES; GROWTH; EGGS; ECOLOGY; SIGNALS; BIRDS; YOLK	The evolution of family life has traditionally been studied in parallel by behavioral ecologists and quantitative geneticists. The former focus on parent-offspring conflict and whether parents or offspring control provisioning, whereas the latter concentrate on the coadaptation of parental supply and offspring demand. Here we show how prenatal effects on offspring begging can link the two different approaches. Using theoretical and experimental analyses, we show that when offspring control provisioning, prenatal effects primarily serve the parent's interests: Selection on parents drives coadaptation of parent and offspring traits. In contrast, when parents control provisioning, prenatal effects primarily serve the offspring's interests: Selection on the offspring drives coadaptation of parent and offspring traits. Parent-offspring conflict may thus be responsible for the selective forces that generate parent-offspring coadaptation.	[Hinde, Camilla A.; Johnstone, Rufus A.; Kilner, Rebecca M.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Hinde, CA (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.		Hinde, Camilla/G-4023-2012; Kilner, Rebecca/B-2867-2012; Hinde, Camilla/AAF-1597-2019	Hinde, Camilla/0000-0001-9376-4023; Kilner, Rebecca/0000-0003-1159-0758; Hinde, Camilla/0000-0001-9376-4023	Natural Environment Research Council (NERC); Magdalene College Cambridge; Wolfson Foundation; Royal Society; NERC [GR9/02650, GR9/04621, NER/A/S/2002/00776]; Isaac Newton Trust, Cambridge; Newnham College, Cambridge; Natural Environment Research Council [NER/A/S/2002/00776] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Magdalene College Cambridge; Wolfson Foundation; Royal Society(Royal Society of London); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Isaac Newton Trust, Cambridge; Newnham College, Cambridge; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	R. M. K. was supported by a Natural Environment Research Council (NERC) studentship, then a Junior Research Fellowship at Magdalene College Cambridge, a Royal Society Dorothy Hodgkin Research Fellowship (sponsored by the Wolfson Foundation), and finally a Royal Society University Research Fellowship. The experiments were funded by three NERC grants (GR9/02650, GR9/04621, and NER/A/S/2002/00776), which also supported C. A. H., and a Royal Society Equipment Grant. Additional funding for C. A. H. was provided by the Isaac Newton Trust, Cambridge, and a Junior Research Fellowship at Newnham College, Cambridge. We thank L. Barden, N. Bates, C. Donovan, P. Heavens, P. Hynes, I. Millar, J. Nightingale, and S. Shelton for their help in maintaining the birds and constructing equipment; T. Roberts, M. Wade, and J. Theaker for supplying the birds; and N. Davies, M. Clinchy, L. Zanette, and especially M. Klliker for comments on early drafts of the manuscript. R. M. K. conceived and designed the experiments, collected data, and wrote the paper. C. A. H. analyzed data and co- wrote the paper. R. A. J. contributed the theoretical analysis and co- wrote the paper.	Buchanan KL, 2007, HORM BEHAV, V52, P664, DOI 10.1016/j.yhbeh.2007.08.009; Drummond H, 2008, J AVIAN BIOL, V39, P139, DOI 10.1111/j.0908-8857.2008.04365.x; Falconer DS, 1996, INTRO QUANTITATIVE G; Gebhardt-Henrich S., 1998, AVIAN GROWTH DEV, P324; Gil D, 2008, ADV STUD BEHAV, V38, P337, DOI 10.1016/S0065-3454(08)00007-7; GODFRAY HCJ, 1995, NATURE, V376, P133, DOI 10.1038/376133a0; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Hinde CA, 2009, P ROY SOC B-BIOL SCI, V276, P2787, DOI 10.1098/rspb.2009.0375; KILNER R, 1995, P ROY SOC B-BIOL SCI, V260, P343, DOI 10.1098/rspb.1995.0102; Kilner RM, 2008, ADV STUD BEHAV, V38, P283, DOI 10.1016/S0065-3454(08)00006-5; Kilner RM, 2001, P NATL ACAD SCI USA, V98, P11394, DOI 10.1073/pnas.191221798; Kilner RM, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P87, DOI 10.1007/0-306-47660-6_5; Kolliker M, 2005, AM NAT, V166, P506, DOI 10.1086/491687; Lock JE, 2004, AM NAT, V164, P13, DOI 10.1086/421444; Lock JE, 2007, AM NAT, V170, P709, DOI 10.1086/521963; Mock D. W., 1997, EVOLUTION SIBLING RI; Muller W, 2007, AM NAT, V169, pE84, DOI 10.1086/511962; Price T, 2007, SPECIATION BIRDS; Royle NJ, 2002, TRENDS ECOL EVOL, V17, P434, DOI 10.1016/S0169-5347(02)02565-X; Schwabl H, 1997, NATURE, V386, P231, DOI 10.1038/386231a0; Schwabl H, 1996, J EXP ZOOL, V276, P157, DOI 10.1002/(SICI)1097-010X(19961001)276:2<157::AID-JEZ9>3.3.CO;2-Y; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Schwabl H, 1996, COMP BIOCHEM PHYS A, V114, P271, DOI 10.1016/0300-9629(96)00009-6; Smiseth PT, 2008, P ROY SOC B-BIOL SCI, V275, P1823, DOI 10.1098/rspb.2008.0199; TRIVERS RL, 1974, AM ZOOL, V14, P249; Wolf JB, 1998, EVOLUTION, V52, P299, DOI [10.1111/j.1558-5646.1998.tb01632.x, 10.2307/2411068]	26	109	109	1	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	2010	327	5971					1373	1376		10.1126/science.1186056	http://dx.doi.org/10.1126/science.1186056			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223985				2022-12-28	WOS:000275418700040
J	Deshpande, VV; Bockrath, M; Glazman, LI; Yacoby, A				Deshpande, Vikram V.; Bockrath, Marc; Glazman, Leonid I.; Yacoby, Amir			Electron liquids and solids in one dimension	NATURE			English	Review							SPIN-CHARGE SEPARATION; COULOMB-BLOCKADE; CARBON NANOTUBES; WIGNER CRYSTAL; TRANSPORT	Even though bulk metallic systems contain a very large number of strongly interacting electrons, their properties are well described within Landau's Fermi liquid theory of non-interacting quasiparticles. Although many higher-dimensional systems can be successfully understood on the basis of such non-interacting theories, this is not possible for one-dimensional systems. When confined to narrow channels, electron interaction gives rise to such exotic phenomena as spin-charge separation and the emergence of correlated-electron insulators. Such strongly correlated electronic behaviour has recently been seen in experiments on one-dimensional carbon nanotubes and nanowires, and this behaviour challenges the theoretical description of such systems.	[Bockrath, Marc] Univ Calif Riverside, Dept Phys & Astron, Riverside, CA 92521 USA; [Deshpande, Vikram V.] Columbia Univ, Dept Phys, New York, NY 10027 USA; [Glazman, Leonid I.] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Glazman, Leonid I.] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; [Yacoby, Amir] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	University of California System; University of California Riverside; Columbia University; Yale University; Yale University; Harvard University	Bockrath, M (corresponding author), Univ Calif Riverside, Dept Phys & Astron, Riverside, CA 92521 USA.	marc.bockrath@ucr.edu			US National Science Foundation (NSF) Division of Materials Research [DMR-0906498]; Nanosciences Foundation at Grenoble, France; US Office of Naval Research; NSF [DMR-0707484]	US National Science Foundation (NSF) Division of Materials Research(National Science Foundation (NSF)); Nanosciences Foundation at Grenoble, France; US Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF))	A. Y. and L. I. G. acknowledge a discussion with B. I. Halperin of the difference between charge fractionalization and quantization. L. I. G. acknowledges support from the US National Science Foundation (NSF) Division of Materials Research (grant no. DMR-0906498) and the Nanosciences Foundation at Grenoble, France. M. B. acknowledges the US Office of Naval Research. A. Y. is supported by the NSF under contract DMR-0707484.	ANDERSON PW, 1967, PHYS REV LETT, V18, P1049, DOI 10.1103/PhysRevLett.18.1049; Auslaender OM, 2005, SCIENCE, V308, P88, DOI 10.1126/science.1107821; Auslaender OM, 2000, PHYS REV LETT, V84, P1764, DOI 10.1103/PhysRevLett.84.1764; Auslaender OM, 2002, SCIENCE, V295, P825, DOI 10.1126/science.1066266; AVERIN DV, 1993, PHYS REV B, V47, P9944, DOI 10.1103/PhysRevB.47.9944; Bachtold A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.166801; Balents L, 2000, PHYS REV B, V61, P4429, DOI 10.1103/PhysRevB.61.4429; Basko DM, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.052203; Berg E, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.236402; Bockrath M, 1999, NATURE, V397, P598, DOI 10.1038/17569; Cao J, 2005, NAT MATER, V4, P745, DOI 10.1038/nmat1478; Carpentier D, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.153304; Charlier JC, 2007, REV MOD PHYS, V79, P677, DOI 10.1103/RevModPhys.79.677; Chen W, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.246802; Chen YF, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.036804; Clement D, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.155301; Cobden DH, 1998, PHYS REV LETT, V81, P681, DOI 10.1103/PhysRevLett.81.681; Dagotto E, 1996, SCIENCE, V271, P618, DOI 10.1126/science.271.5249.618; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; Deshpande VV, 2008, NAT PHYS, V4, P314, DOI 10.1038/nphys895; Deshpande VV, 2009, SCIENCE, V323, P106, DOI 10.1126/science.1165799; DEVORET MH, 1990, PHYS REV LETT, V64, P1824, DOI 10.1103/PhysRevLett.64.1824; Egger R, 1997, PHYS REV LETT, V79, P5082, DOI 10.1103/PhysRevLett.79.5082; Garst M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.035128; GIAMARCHI T, 2004, QUANTUM PHYS ONE DIM, P81; GIRVIN SM, 1990, PHYS REV LETT, V64, P3183, DOI 10.1103/PhysRevLett.64.3183; GLAZMAN LI, 1992, PHYS REV B, V45, P8454, DOI 10.1103/PhysRevB.45.8454; Gutman DB, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.045106; Hew WK, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.056804; Ilani S, 2006, NAT PHYS, V2, P687, DOI 10.1038/nphys412; Imambekov A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.126405; Imambekov A, 2009, SCIENCE, V323, P228, DOI 10.1126/science.1165403; Kane C, 1997, PHYS REV LETT, V79, P5086, DOI 10.1103/PhysRevLett.79.5086; KANE CL, 1992, PHYS REV LETT, V68, P1220, DOI 10.1103/PhysRevLett.68.1220; Kim BJ, 2006, NAT PHYS, V2, P397, DOI 10.1038/nphys316; Kinoshita T, 2006, NATURE, V440, P900, DOI 10.1038/nature04693; Kinoshita T, 2004, SCIENCE, V305, P1125, DOI 10.1126/science.1100700; Krotov YA, 1997, PHYS REV LETT, V78, P4245, DOI 10.1103/PhysRevLett.78.4245; Landau L. D., 1980, COURSE THEORETICAL P, V9, P1; Lefebvre J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.167406; Levitov LS, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.016401; Matveev KA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.106801; MATVEEV KA, 1993, PHYS REV LETT, V70, P990, DOI 10.1103/PhysRevLett.70.990; Maultzsch J, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.241402; Meyer JS, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/2/023203; Minot ED, 2004, NATURE, V428, P536, DOI 10.1038/nature02425; MOTT NF, 1968, REV MOD PHYS, V40, P677, DOI 10.1103/RevModPhys.40.677; NAZAROV YV, 1989, JETP LETT+, V49, P126; Nersesyan AA, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.235419; Novikov DS, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.235428; Odintsov AA, 1999, PHYS REV B, V59, P10457, DOI 10.1103/PhysRevB.59.R10457; Paredes B, 2004, NATURE, V429, P277, DOI 10.1038/nature02530; PEREIRA RG, 2009, COULOMB DRAG SPIN CH; Pereira RG, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.165113; Postma HWC, 2001, SCIENCE, V293, P76, DOI 10.1126/science.1061797; Postma HWC, 2000, PHYS REV B, V62, P10653, DOI 10.1103/PhysRevB.62.R10653; Pustilnik M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.196405; Pustilnik M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.036404; SCHMIDT TL, 2009, FATE 1D SPIN CHARGE; SCHULZ HJ, 1993, PHYS REV LETT, V71, P1864, DOI 10.1103/PhysRevLett.71.1864; Steinberg H, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.113307; Steinberg H, 2008, NAT PHYS, V4, P116, DOI 10.1038/nphys810; Tans SJ, 1998, NATURE, V394, P761, DOI 10.1038/29494; Venkataraman L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.076601; VOIT J, 1995, REP PROG PHYS, V58, P977, DOI 10.1088/0034-4885/58/9/002; Wang F, 2005, SCIENCE, V308, P838, DOI 10.1126/science.1110265; Yang L, 1999, PHYS REV B, V60, P13874, DOI 10.1103/PhysRevB.60.13874; Yao Z, 1999, NATURE, V402, P273, DOI 10.1038/46241; Zhong ZH, 2008, NAT NANOTECHNOL, V3, P201, DOI 10.1038/nnano.2008.60; [No title captured]	76	182	183	1	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					209	216		10.1038/nature08918	http://dx.doi.org/10.1038/nature08918			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20220839				2022-12-28	WOS:000275366100034
J	Frebel, A; Kirby, EN; Simon, JD				Frebel, Anna; Kirby, Evan N.; Simon, Joshua D.			Linking dwarf galaxies to halo building blocks with the most metal-poor star in Sculptor	NATURE			English	Article							SPHEROIDAL GALAXY; MILKY-WAY; CHEMICAL-COMPOSITION; GALACTIC HALO; DARK-MATTER; ABUNDANCES; SPECTROSCOPY; SATELLITES; SIGNATURES; GIANT	Current cosmological models(1,2) indicate that the Milky Way's stellar halo was assembled from many smaller systems. On the basis of the apparent absence of the most metal-poor stars in present-day dwarf galaxies, recent studies(3) claimed that the true Galactic building blocks must have been vastly different from the surviving dwarfs. The discovery of an extremely iron-poor star (S1020549) in the Sculptor dwarf galaxy based on a medium-resolution spectrum(4) cast some doubt on this conclusion. Verification of the iron-deficiency, however, and measurements of additional elements, such as the a-element Mg, are necessary to demonstrate that the same type of stars produced the metals found in dwarf galaxies and the Galactic halo. Only then can dwarf galaxy stars be conclusively linked to early stellar halo assembly. Here we report high-resolution spectroscopic abundances for 11 elements in S1020549, confirming its iron abundance of less than 1/4,000th that of the Sun, and showing that the overall abundance pattern follows that seen in low-metallicity halo stars, including the a-elements. Such chemical similarity indicates that the systems destroyed to form the halo billions of years ago were not fundamentally different from the progenitors of present-day dwarfs, and suggests that the early chemical enrichment of all galaxies may be nearly identical.	[Frebel, Anna] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Kirby, Evan N.] CALTECH, Pasadena, CA 91125 USA; [Simon, Joshua D.] Observ Carnegie Inst Washington, Pasadena, CA 91101 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; California Institute of Technology; Carnegie Institution for Science	Frebel, A (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	afrebel@cfa.harvard.edu	Simon, Joshua D/AAX-7117-2021	Kirby, Evan/0000-0001-6196-5162	NASA; Space Telescope Science Institute; Carnegie Institution of Washington	NASA(National Aeronautics & Space Administration (NASA)); Space Telescope Science Institute(Space Telescope Science Institute); Carnegie Institution of Washington	Our data was gathered using the 6.5-m Magellan telescopes located at Las Campanas Observatory, Chile. We thank L. Hernquist for discussions on galaxy formation. A. F. acknowledges support through a Clay Fellowship administered by the Smithsonian Astrophysical Observatory. Support for this work was provided by NASA through a Hubble fellowship grant awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., for NASA (to E.N.K., who is a Hubble Fellow). J.D.S. acknowledges the support of a Vera Rubin Fellowship provided by the Carnegie Institution of Washington.	Aoki W, 2009, ASTRON ASTROPHYS, V502, P569, DOI 10.1051/0004-6361/200911959; Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Barklem PS, 2005, ASTRON ASTROPHYS, V439, P129, DOI 10.1051/0004-6361:20052967; Battaglia G, 2008, ASTROPHYS J LETT, V681, pL13, DOI 10.1086/590179; Bernstein RA, 2003, P SOC PHOTO-OPT INS, V4841, P1694, DOI 10.1117/12.461502; Bullock JS, 2005, ASTROPHYS J, V635, P931, DOI 10.1086/497422; Carollo D, 2007, NATURE, V450, P1020, DOI 10.1038/nature06460; Cayrel R, 2004, ASTRON ASTROPHYS, V416, P1117, DOI 10.1051/0004-6361:20034074; Cohen JG, 2009, ASTROPHYS J, V701, P1053, DOI 10.1088/0004-637X/701/2/1053; Font AS, 2006, ASTROPHYS J, V646, P886, DOI 10.1086/505131; Frebel A, 2005, NATURE, V434, P871, DOI 10.1038/nature03455; Frebel A, 2007, ASTROPHYS J, V658, P534, DOI 10.1086/511517; Frebel A, 2010, ASTROPHYS J, V708, P560, DOI 10.1088/0004-637X/708/1/560; Fulbright JP, 2004, ASTROPHYS J, V612, P447, DOI 10.1086/421712; Geha M, 2009, ASTROPHYS J, V692, P1464, DOI 10.1088/0004-637X/692/2/1464; Geisler D, 2005, ASTRON J, V129, P1428, DOI 10.1086/427540; Helmi A, 2006, ASTROPHYS J, V651, pL121, DOI 10.1086/509784; Kirby EN, 2008, ASTROPHYS J, V682, P1217, DOI 10.1086/589627; Kirby EN, 2009, ASTROPHYS J, V705, P328, DOI 10.1088/0004-637X/705/1/328; Kirby EN, 2008, ASTROPHYS J LETT, V685, pL43, DOI 10.1086/592432; Koch A, 2008, ASTROPHYS J LETT, V688, pL13, DOI 10.1086/595001; Lai DK, 2008, ASTROPHYS J, V681, P1524, DOI 10.1086/588811; Moore B, 1999, ASTROPHYS J, V524, pL19, DOI 10.1086/312287; Pietrzynski G, 2008, ASTRON J, V135, P1993, DOI 10.1088/0004-6256/135/6/1993; Robertson B, 2005, ASTROPHYS J, V632, P872, DOI 10.1086/452619; Schorck T, 2009, ASTRON ASTROPHYS, V507, P817, DOI 10.1051/0004-6361/200810925; SEARLE L, 1978, ASTROPHYS J, V225, P357, DOI 10.1086/156499; Shetrone M, 2003, ASTRON J, V125, P684, DOI 10.1086/345966; Venn KA, 2004, ASTRON J, V128, P1177, DOI 10.1086/422734	30	133	133	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 4	2010	464	7285					72	75		10.1038/nature08772	http://dx.doi.org/10.1038/nature08772			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20203604	Green Submitted			2022-12-28	WOS:000275117500035
J	Pons, AJ; Karma, A				Pons, Antonio J.; Karma, Alain			Helical crack-front instability in mixed-mode fracture	NATURE			English	Article							PATTERN-FORMATION; GROWTH	Planar crack propagation under pure tension loading (mode I) is generally stable. However, it becomes universally unstable with the superposition of a shear stress parallel to the crack front (mode III). Under this mixed-mode (I + III) loading configuration, an initially flat parent crack segments into an array of daughter cracks that rotate towards a direction of maximum tensile stress(1). This segmentation produces stepped fracture surfaces with characteristic 'lance-shaped' markings observed in a wide range of engineering(2-7) and geological materials(1,8). The origin of this instability remains poorly understood and a theory with which to predict the surface roughness scale is lacking. Here we perform large-scale simulations of mixed-mode I + III brittle fracture using a continuum phase-field method(9-11) that describes the complete three-dimensional crack-front evolution. The simulations reveal that planar crack propagation is linearly unstable against helical deformations of the crack front, which evolve nonlinearly into a segmented array of finger-shaped daughter cracks. Furthermore, during their evolution, facets gradually coarsen owing to the growth competition of daughter cracks in striking analogy with the coarsening of finger patterns observed in nonequilibrium growth phenomena(12-14). We show that the dynamically preferred unstable wavelength is governed by the balance of the destabilizing effect of far-field stresses and the stabilizing effect of cohesive forces on the process zone scale, and we derive a theoretical estimate for this scale using a new propagation law for curved cracks in three dimensions. The rotation angles of coarsened facets are also compared to theoretical predictions and available experimental data.	[Pons, Antonio J.; Karma, Alain] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Pons, Antonio J.; Karma, Alain] Northeastern Univ, Ctr Interdisciplinary Res Complex Syst, Boston, MA 02115 USA	Northeastern University; Northeastern University	Karma, A (corresponding author), Northeastern Univ, Dept Phys, Boston, MA 02115 USA.	a.karma@neu.edu	Karma, Alain/AAL-7090-2020; Pons, Antonio J/E-7467-2011	Karma, Alain/0000-0001-7032-9862; Pons, Antonio J/0000-0002-1481-8159	US DOE [DE-FG02-07ER46400]; Spanish Ministry of Science and Innovation;  [EX2005-0085];  [FIS2009-13360-C03-02]	US DOE(United States Department of Energy (DOE)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ; 	We thank V. Hakim, J.-B. Leblond and V. Lazarus for discussions and references to the literature. This work was supported by US DOE grant number DE-FG02-07ER46400. A.J.P. also acknowledges support of grant numbers EX2005-0085 and FIS2009-13360-C03-02 and the Juan de la Cierva Program of the Spanish Ministry of Science and Innovation.	BENJACOB E, 1990, NATURE, V343, P523, DOI 10.1038/343523a0; Bouchbinder E, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.264302; Buehler MJ, 2006, NATURE, V439, P307, DOI 10.1038/nature04408; Cooke ML, 1996, J GEOPHYS RES-SOL EA, V101, P3387, DOI 10.1029/95JB02507; DEGRAFF JM, 1987, GEOL SOC AM BULL, V99, P605, DOI 10.1130/0016-7606(1987)99<605:SMOCJA>2.0.CO;2; ESHELBY JD, 1975, J ELASTICITY, V5, P321, DOI 10.1007/BF00126994; Fineberg J, 1999, PHYS REP, V313, P1, DOI 10.1016/S0370-1573(98)00085-4; FINEBERG J, 1991, PHYS REV LETT, V67, P457, DOI 10.1103/PhysRevLett.67.457; Freund L.B., 1998, DYNAMIC FRACTURE MEC; GAO H, 1986, J APPL MECH-T ASME, V53, P774, DOI 10.1115/1.3171857; GOLDSTEIN RV, 1974, INT J FRACTURE, V10, P507, DOI 10.1007/BF00155254; Hakim V, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.235501; Hakim V, 2009, J MECH PHYS SOLIDS, V57, P342, DOI 10.1016/j.jmps.2008.10.012; Karma A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.045501; KARMA A, 2005, HDB MAT MODELING, P2087; LANGER JS, 1989, SCIENCE, V243, P1150, DOI 10.1126/science.243.4895.1150; Lazarus V, 2008, INT J FRACTURE, V153, P141, DOI 10.1007/s10704-008-9307-2; Lazarus V, 2001, J MECH PHYS SOLIDS, V49, P1421, DOI 10.1016/S0022-5096(01)00008-4; MARDER M, 1995, J MECH PHYS SOLIDS, V43, P1, DOI 10.1016/0022-5096(94)00060-I; Mealdn P, 1998, FRACTALS SCALING GRO; Momber AW, 2003, J MATER SCI LETT, V22, P1477, DOI 10.1023/A:1026218211477; POLLARD DD, 1982, GEOL SOC AM BULL, V93, P1291, DOI 10.1130/0016-7606(1982)93<1291:FAIODE>2.0.CO;2; Sharon E, 2001, NATURE, V410, P68, DOI 10.1038/35065051; SMEKAL A, 1953, OSTERR ING ARCH, V7, P49; Sommer E., 1969, ENG FRACT MECH, V1, P539, DOI [10.1016/0013-7944(69)90010-1, DOI 10.1016/0013-7944(69)90010-1]; Trivedi R, 2002, NAT MATER, V1, P157, DOI 10.1038/nmat749; XU G, 1994, INT J SOLIDS STRUCT, V31, P2167, DOI 10.1016/0020-7683(94)90205-4; YATES JR, 1989, FATIGUE FRACT ENG M, V12, P259, DOI 10.1111/j.1460-2695.1989.tb00532.x; YUSE A, 1993, NATURE, V362, P329, DOI 10.1038/362329a0	29	127	129	2	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2010	464	7285					85	89		10.1038/nature08862	http://dx.doi.org/10.1038/nature08862			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20203607				2022-12-28	WOS:000275117500038
J	Holmes, MV; Desai, M; Dosekun, O; Holmes, P; Lucas, SB; Kulasegaram, R				Holmes, Michael V.; Desai, Mitesh; Dosekun, Olamide; Holmes, Paul; Lucas, Sebastian B.; Kulasegaram, Ranjababu			Is the diagnosis at hand?	LANCET			English	Editorial Material									[Holmes, Michael V.; Desai, Mitesh; Dosekun, Olamide; Kulasegaram, Ranjababu] Guys & St Thomas NHS Fdn Trust, Dept GU HIV Med, London SE1 7EH, England; [Holmes, Paul] Guys & St Thomas NHS Fdn Trust, Dept Neurol, London SE1 7EH, England; [Lucas, Sebastian B.] Guys & St Thomas NHS Fdn Trust, Dept Histopathol, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	Holmes, MV (corresponding author), Guys & St Thomas NHS Fdn Trust, Dept GU HIV Med, Westminster Bridge Rd, London SE1 7EH, England.	m.holmes@uclmail.net			MRC [G0802432] Funding Source: UKRI; Medical Research Council [G0802432] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		HAMILTONDUTOIT SJ, 1993, BLOOD, V82, P619; HEATON R, 2009, P 16 C RETR OPP INF; Miller RF, 2004, ACTA NEUROPATHOL, V108, P17, DOI 10.1007/s00401-004-0852-0; Robertson J, 2006, CLIN INFECT DIS, V42, P1639, DOI 10.1086/503903	4	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2010	375	9720					1134	1134		10.1016/S0140-6736(09)62101-2	http://dx.doi.org/10.1016/S0140-6736(09)62101-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	578ZB	20346819				2022-12-28	WOS:000276334600038
J	Goldenberg, RL; McClure, EM; Saleem, S; Reddy, UM				Goldenberg, Robert L.; McClure, Elizabeth M.; Saleem, Sarah; Reddy, Uma M.			Infection-related stillbirths	LANCET			English	Review							PARVOVIRUS B19 INFECTION; INTRAUTERINE FETAL-DEATH; BORNE RELAPSING FEVER; CONGENITAL-SYPHILIS; HISTOLOGIC CHORIOAMNIONITIS; ANTIRETROVIRAL THERAPY; DEVELOPING-COUNTRIES; AMNIOTIC-FLUID; PREGNANT-WOMEN; PRETERM LABOR	Infection is an important cause of stillbirths worldwide: in low-income and middle-income countries, 50% of stillbirths or more are probably caused by infection. By contrast, in high-income countries only 10-25% of stillbirths are caused by infection. Syphilis, where prevalent, causes most infectious stillbirths, and is the infection most amenable to screening and treatment. Ascending bacterial infection is a common cause of stillbirths, but prevention has proven elusive. Many viral infections cause stillbirths but aside from vaccination for common childhood diseases, we do not have a clear prevention strategy. Malaria, because of its high prevalence and extensive placental damage, accounts for large numbers of stillbirths. Intermittent malarial prophylaxis and insecticide-treated bednets should decrease stillbirths. Many infections borne by animals and vectors cause stillbirths, and these types of infections occur frequently in low-income countries. Research that better defines the relation between these infections and stillbirths, and develops strategies to reduce associated adverse outcomes, should play an important part in reduction of stillbirths in low-income countries.	[Goldenberg, Robert L.] Drexel Univ, Coll Med, Dept Obstet & Gynecol, Philadelphia, PA 19102 USA; [McClure, Elizabeth M.] Univ N Carolina, Chapel Hill, NC USA; [McClure, Elizabeth M.] Res Triangle Inst, Durham, NC USA; [Saleem, Sarah] Aga Khan Univ, Karachi, Pakistan; [Reddy, Uma M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA	Drexel University; University of North Carolina; University of North Carolina Chapel Hill; Research Triangle Institute; Aga Khan University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Goldenberg, RL (corresponding author), Drexel Univ, Coll Med, Dept Obstet & Gynecol, 245 N 15th St,17th Floor,Room 17113, Philadelphia, PA 19102 USA.	rgoldenb@drexelmed.edu			National Institute of Child Health and Human Development Global Network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD040636, U01HD040607] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development Global Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	RLG, EMM, and SS are funded by grants from the National Institute of Child Health and Human Development Global Network.	AABY P, 1988, LANCET, V1, P516; ACOG Committee on Obstetric Practice, 2004, Obstet Gynecol, V104, P1125; Ahmed RE, 2008, J MED VIROL, V80, P1747, DOI 10.1002/jmv.21284; AXEMO P, 1993, GYNECOL OBSTET INVES, V35, P108, DOI 10.1159/000292676; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Blackwell S, 2003, J Matern Fetal Neonatal Med, V14, P151, DOI 10.1080/jmf.14.3.151.157; BLANC WA, 1961, J PEDIATR-US, V59, P473, DOI 10.1016/S0022-3476(61)80232-1; Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x; Buekens P, 2008, MATERN CHILD HLTH J, V12, P283, DOI 10.1007/s10995-007-0246-8; Chi BH, 2007, OBSTET GYNECOL, V110, P989, DOI 10.1097/01.AOG.0000281667.35113.a5; Cnattingius S, 2002, SEMIN PERINATOL, V26, P25, DOI 10.1053/sper.2002.29841; Colbourn T, 2007, HEALTH TECHNOL ASSES, V11, pIX; Coll O, 2008, J PERINAT MED, V36, P15, DOI 10.1515/JPM.2008.002; COOPER LZ, 2006, INFECT DIS FETUS NEW, P893; COPPER RL, 1994, OBSTET GYNECOL, V84, P490; Cotter AM, 2006, J INFECT DIS, V193, P1195, DOI 10.1086/503045; Cutts FT, 1997, B WORLD HEALTH ORGAN, V75, P55; Dayan GH, 2003, J INFECT DIS, V187, pS235, DOI 10.1086/368037; de Silva NR, 1999, LANCET, V353, P1145, DOI 10.1016/S0140-6736(98)06308-9; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Di Mario S, 2007, SEX TRANSM DIS, V34, pS11, DOI 10.1097/01.olq.0000258130.07476.e3; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Dorman EK, 2002, ULTRASOUND OBST GYN, V19, P165, DOI 10.1046/j.0960-7692.2001.00545.x; Dupont HT, 1997, CLIN INFECT DIS, V25, P139, DOI 10.1086/514496; Enders M, 2004, PRENATAL DIAG, V24, P513, DOI 10.1002/pd.940; Folgosa E, 1996, GENITOURIN MED, V72, P339; Folgosa E, 1997, APMIS, V105, P329, DOI 10.1111/j.1699-0463.1997.tb00578.x; Fretts RC, 2005, AM J OBSTET GYNECOL, V193, P1923, DOI 10.1016/j.ajog.2005.03.074; FRISK G, 1992, J INFECTION, V24, P141, DOI 10.1016/0163-4453(92)92798-N; Genc M, 2000, SEX TRANSM INFECT, V76, P73, DOI 10.1136/sti.76.2.73; GERSHON AA, 2006, INFECT DIS FETUS NEW, P693; Gibbs RS, 2007, NEW ENGL J MED, V357, P918, DOI 10.1056/NEJMcpc079021; Gibbs RS, 2002, SEMIN PERINATOL, V26, P75, DOI 10.1053/sper.2002.29839; Goldenberg RL, 2003, AM J OBSTET GYNECOL, V189, P861, DOI 10.1067/S0002-9378(03)00470-8; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2006, AM J OBSTET GYNECOL, V195, P1065, DOI 10.1016/j.ajog.2006.05.046; Gregg NM, 1941, T OPHTHALMOL SOC AUS, V3, P35; HALL SM, 1990, BMJ-BRIT MED J, V300, P1166; HARDY JM, 1961, AM J PUBLIC HEALTH N, V51, P1182, DOI 10.2105/AJPH.51.8.1182; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; HORN P, 1955, OBSTET GYNECOL, V6, P121; Hossain M, 2007, SEX TRANSM DIS, V34, pS22, DOI 10.1097/01.olq.0000261049.84824.40; Howard J, 2009, J CLIN VIROL, V44, P215, DOI 10.1016/j.jcv.2008.12.013; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; JANA N, 1994, INT J GYNECOL OBSTET, V44, P119, DOI 10.1016/0020-7292(94)90064-7; Jones JL, 2001, OBSTET GYNECOL SURV, V56, P296, DOI 10.1097/00006254-200105000-00025; Jongen VHWM, 1997, ACTA OBSTET GYN SCAN, V76, P834, DOI 10.3109/00016349709024361; Kenyon S, 2013, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001058; KINNEY JS, 1988, J INFECT DIS, V157, P663, DOI 10.1093/infdis/157.4.663; Korteweg FJ, 2008, PLACENTA, V29, P71, DOI 10.1016/j.placenta.2007.07.003; Kumar A, 2007, AM J TROP MED HYG, V77, P69, DOI 10.4269/ajtmh.2007.77.69; Lahra MM, 2007, AM J OBSTET GYNECOL, V196, P229, DOI 10.1016/j.ajog.2006.10.900; Lamont RF, 2003, BJOG-INT J OBSTET GY, V110, P71, DOI 10.1016/S1470-0328(03)00034-X; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; LINGAM S, 1985, DEV MED CHILD NEUROL, V27, P670, DOI 10.1111/j.1469-8749.1985.tb14141.x; Lumbiganon P, 2002, INT J STD AIDS, V13, P486, DOI 10.1258/09564620260079653; MACDONALD AB, 1987, NEW YORK STATE J MED, V87, P615; MADAN E, 1988, ANN CLIN LAB SCI, V18, P39; Martin C, 2004, J CLIN MICROBIOL, V42, P4396, DOI 10.1128/JCM.42.9.4396-4398.2004; Maruyama Y, 2007, J OBSTET GYNAECOL RE, V33, P619, DOI 10.1111/j.1447-0756.2007.00621.x; McClure EM, 2006, INT J GYNECOL OBSTET, V94, P82, DOI 10.1016/j.ijgo.2006.03.023; McConnell J, 2003, LANCET INFECT DIS, V3, P604, DOI 10.1016/S1473-3099(03)00787-4; MCGREGOR IA, 1983, T ROY SOC TROP MED H, V77, P232, DOI 10.1016/0035-9203(83)90081-0; MELKERT PWJ, 1988, BRIT J OBSTET GYNAEC, V95, P1070, DOI 10.1111/j.1471-0528.1988.tb06516.x; Mhalu FS, 1996, E AFR MED J, V73, P583; Miller E, 1998, BRIT J OBSTET GYNAEC, V105, P174, DOI 10.1111/j.1471-0528.1998.tb10048.x; Moyo SR, 1996, INT J GYNECOL OBSTET, V54, P115, DOI 10.1016/0020-7292(96)02705-1; Moyo SR, 1995, INT J GYNECOL OBSTET, V51, P211, DOI 10.1016/0020-7292(95)02526-X; NAEYE RL, 1977, J PEDIATR-US, V90, P965, DOI 10.1016/S0022-3476(77)80573-8; Newman RD, 2003, J INFECT DIS, V187, P1765, DOI 10.1086/374878; Ng WF, 2006, PATHOLOGY, V38, P210, DOI 10.1080/00313020600696280; Niklasson B, 2007, BIRTH DEFECTS RES A, V79, P488, DOI 10.1002/bdra.20359; Nimri L, 2004, AM J TROP MED HYG, V71, P831, DOI 10.4269/ajtmh.2004.71.831; Nuovo GJ, 2005, DIAGN MOL PATHOL, V14, P152, DOI 10.1097/01.pas.0000176769.18423.37; Okie S, 2008, NEW ENGL J MED, V358, P2425, DOI 10.1056/NEJMp0803483; Okun N, 2005, OBSTET GYNECOL, V105, P857, DOI 10.1097/01.AOG.0000157108.32059.8f; Oladapo OT, 2007, AUST NZ J OBSTET GYN, V47, P383, DOI 10.1111/j.1479-828X.2007.00761.x; OLAGBUJI BN, 2009, ARCH GYNECOL OBSTET, DOI DOI 10.1007/S0040-009-1186-X; Onadeko M O, 1996, Afr J Med Med Sci, V25, P331; Ornoy A, 2006, REPROD TOXICOL, V21, P446, DOI 10.1016/j.reprotox.2005.12.007; Pillay T, 2004, INT J TUBERC LUNG D, V8, P59; Potter D, 2006, SEX TRANSM DIS, V33, P604, DOI 10.1097/01.olq.0000216029.00424.ae; Rawlinson WD, 2008, PATHOLOGY, V40, P149, DOI 10.1080/00313020701813792; Riipinen A, 2008, CLIN INFECT DIS, V47, P1519, DOI 10.1086/593190; Romero R, 1998, AM J OBSTET GYNECOL, V179, P186, DOI 10.1016/S0002-9378(98)70271-6; Rydzak CE, 2008, SEX TRANSM DIS, V35, P775, DOI 10.1097/OLQ.0b013e318176196d; Salakhov E, 2004, SEX TRANSM DIS, V31, P127, DOI 10.1097/01.OLQ.0000109516.47951.B8; Schmahmann B, 2007, TEXTILE, V5, P10, DOI 10.2752/147597507780338925; Schmid G, 2004, B WORLD HEALTH ORGAN, V82, P402; Schwarz NG, 2008, CLIN INFECT DIS, V47, P1017, DOI 10.1086/591968; Sethi S, 2007, SEX TRANSM INFECT, V83, P592, DOI 10.1136/sti.2007.025551; Sheffield JS, 2002, OBSTET GYNECOL, V100, P126, DOI 10.1016/S0029-7844(02)02010-0; SKEKETEE RW, 2001, AM J TROP MED, V64, P28; Smith B, 2009, SCAND J INFECT DIS, V41, P21, DOI 10.1080/00365540802468094; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; Stanwell-Smith R, 1994, Commun Dis Rep CDR Rev, V4, pR28; STROBINO BA, 1993, AM J OBSTET GYNECOL, V169, P367, DOI 10.1016/0002-9378(93)90088-Z; Syridou G, 2008, J MED VIROL, V80, P1776, DOI 10.1002/jmv.21293; Tolfvenstam T, 2001, LANCET, V357, P1494, DOI 10.1016/S0140-6736(00)04647-X; Tolockiene E, 2001, ACTA OBSTET GYN SCAN, V80, P511, DOI 10.1034/j.1600-0412.2001.080006511.x; Tongsong T, 2008, FETAL DIAGN THER, V23, P169, DOI 10.1159/000116737; Tuomala RE, 2002, NEW ENGL J MED, V346, P1863, DOI 10.1056/NEJMoa991159; Van Geertruyden JP, 2004, AM J TROP MED HYG, V71, P35, DOI 10.4269/ajtmh.2004.71.35; Vasquez-Manzanilla O, 2007, J TROP PEDIATRICS, V53, P274, DOI 10.1093/tropej/fmm025; Watson-Jones D, 2002, J INFECT DIS, V186, P940, DOI 10.1086/342952; Watson-Jones D, 2007, B WORLD HEALTH ORGAN, V85, P9, DOI 10.2471/BLT.06.033258; Wright C, 1996, BRIT J OBSTET GYNAEC, V103, P133, DOI 10.1111/j.1471-0528.1996.tb09664.x; 2001, MMWR MORB MORTAL WKL, V50, P573	108	136	142	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2010	375	9724					1482	1490		10.1016/S0140-6736(09)61712-8	http://dx.doi.org/10.1016/S0140-6736(09)61712-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	590FL	20223514	Green Published, Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000277210000034
J	Park, SJ; Park, DW; Kim, YH; Kang, SJ; Lee, SW; Lee, CW; Han, KH; Park, SW; Yun, SC; Lee, SG; Rha, SW; Seong, IW; Jeong, MH; Hur, SH; Lee, NH; Yoon, J; Yang, JY; Lee, BK; Choi, YJ; Chung, WS; Lim, DS; Cheong, SS; Kim, KS; Chae, JK; Nah, DY; Jeon, DS; Seung, KB; Jang, JS; Park, HS; Lee, K				Park, Seung-Jung; Park, Duk-Woo; Kim, Young-Hak; Kang, Soo-Jin; Lee, Seung-Whan; Lee, Cheol Whan; Han, Ki-Hoon; Park, Seong-Wook; Yun, Sung-Cheol; Lee, Sang-Gon; Rha, Seung-Woon; Seong, In-Whan; Jeong, Myung-Ho; Hur, Seung-Ho; Lee, Nae-Hee; Yoon, Junghan; Yang, Joo-Young; Lee, Bong-Ki; Choi, Young-Jin; Chung, Wook-Sung; Lim, Do-Sun; Cheong, Sang-Sig; Kim, Kee-Sik; Chae, Jei Keon; Nah, Deuk-Young; Jeon, Doo-Soo; Seung, Ki Bae; Jang, Jae-Sik; Park, Hun Sik; Lee, Keun			Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; LONG-TERM OUTCOMES; BARE-METAL STENTS; MYOCARDIAL-INFARCTION; THROMBOSIS; CLOPIDOGREL; DISCONTINUATION; METAANALYSIS; PREDICTORS; TRIALS	Background: The potential benefits and risks of the use of dual antiplatelet therapy beyond a 12-month period in patients receiving drug-eluting stents have not been clearly established. Methods: In two trials, we randomly assigned a total of 2701 patients who had received drug-eluting stents and had been free of major adverse cardiac or cerebrovascular events and major bleeding for a period of at least 12 months to receive clopidogrel plus aspirin or aspirin alone. The primary end point was a composite of myocardial infarction or death from cardiac causes. Data from the two trials were merged for analysis. Results: The median duration of follow-up was 19.2 months. The cumulative risk of the primary outcome at 2 years was 1.8% with dual antiplatelet therapy, as compared with 1.2% with aspirin monotherapy (hazard ratio, 1.65; 95% confidence interval [CI], 0.80 to 3.36; P=0.17). The individual risks of myocardial infarction, stroke, stent thrombosis, need for repeat revascularization, major bleeding, and death from any cause did not differ significantly between the two groups. However, in the dual-therapy group as compared with the aspirin-alone group, there was a nonsignificant increase in the composite risk of myocardial infarction, stroke, or death from any cause (hazard ratio, 1.73; 95% CI, 0.99 to 3.00; P=0.051) and in the composite risk of myocardial infarction, stroke, or death from cardiac causes (hazard ratio, 1.84; 95% CI, 0.99 to 3.45; P=0.06). Conclusions: The use of dual antiplatelet therapy for a period longer than 12 months in patients who had received drug-eluting stents was not significantly more effective than aspirin monotherapy in reducing the rate of myocardial infarction or death from cardiac causes. These findings should be confirmed or refuted through larger, randomized clinical trials with longer-term follow-up. (ClinicalTrials.gov numbers, NCT00484926 and NCT00590174.) N Engl J Med 2010;362:1374-82.	[Park, Seung-Jung] Univ Ulsan, Coll Med, Cardiac Ctr, Dept Cardiol,Asan Med Ctr, Seoul 138736, South Korea; [Yun, Sung-Cheol] Univ Ulsan, Coll Med, Div Biostat, Ctr Med Res & Informat,Asan Med Ctr, Seoul 138736, South Korea; [Rha, Seung-Woon] Korea Univ, Guro Hosp, Seoul, South Korea; [Lim, Do-Sun] Korea Univ, Coll Med, Seoul 136705, South Korea; [Lee, Keun] Seoul Vet Hosp, Seoul, South Korea; [Lee, Sang-Gon] Ulsan Univ Hosp, Ulsan, South Korea; [Seong, In-Whan] Chungnam Natl Univ Hosp, Taejon, South Korea; [Jeong, Myung-Ho] Chonnam Natl Univ Hosp, Kwangju, South Korea; [Hur, Seung-Ho] Keimyung Univ, Dongsan Med Ctr, Daugu, South Korea; [Kim, Kee-Sik] Daegu Catholic Univ, Med Ctr, Daugu, South Korea; [Park, Hun Sik] Kyung Pook Natl Univ Hosp, Daugu, South Korea; [Lee, Nae-Hee] Soonchunhyang Univ, Bucheon Hosp, Puchon, South Korea; [Yoon, Junghan] Yonsei Univ, Wonju Christian Hosp, Wonju, South Korea; [Yang, Joo-Young] Ilsan Hosp, Natl Hlth Insurance Corp, Ilsan, South Korea; [Lee, Bong-Ki] Kangwon Natl Univ Hosp, Chunchon, South Korea; [Choi, Young-Jin] Hallym Univ, Sacred Heart Hosp, Anyang, South Korea; [Chung, Wook-Sung] Catholic Univ Korea, St Marys Hosp, Yeoido, South Korea; [Cheong, Sang-Sig] GangNeung Asan Med Ctr, Kangnung, South Korea; [Chae, Jei Keon] Chonbuk Natl Univ Hosp, Jeonju, South Korea; [Nah, Deuk-Young] Donguk Univ, Gyeongju Hosp, Gyeongju, South Korea; [Jang, Jae-Sik] Inje Univ, Coll Med, Busan Paik Hosp, Pusan, South Korea	University of Ulsan; University of Ulsan; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Seoul Veterans Hospital; University of Ulsan; Ulsan University Hospital; Chungnam National University; Chungnam National University Hospital; Chonnam National University; Chonnam National University Hospital; Keimyung University; Catholic University of Daegu; Soonchunhyang University; Yonsei University; NHIS Ilsan Hospital; Kangwon National University; Kangwon National University Hospital; Hallym University; Catholic University of Korea; Catholic University Korea Hospital; Jeonbuk National University; Jeonbuk National University Hospital; Inje University	Park, SJ (corresponding author), Univ Ulsan, Coll Med, Cardiac Ctr, Dept Cardiol,Asan Med Ctr, 388-1 Poongnap Dong, Seoul 138736, South Korea.	sjpark@amc.seoul.kr	Rha, Seung-Woon/AGE-5810-2022; Hug, Balthasar L./G-1568-2010; Jang, Jae-Sik/B-4379-2015	Rha, Seung-Woon/0000-0001-9456-9852; Seong, In-Whan/0000-0003-4628-0258; Jeong, Jin-Ok/0000-0003-0763-4754; Jang, Jae-Sik/0000-0001-7865-124X; Lee, Bong-Ki/0000-0002-4289-2284; Hur, Seung-Ho/0000-0002-3895-1915	Cardiovascular Research Foundation of South Korea; Ministry of Health and Welfare [0412-CR02-0704-0001]	Cardiovascular Research Foundation of South Korea; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	Supported by grants from the Cardiovascular Research Foundation of South Korea and the Korea Health 21 Research and Development Project, Ministry of Health and Welfare (0412-CR02-0704-0001).	Airoldi F, 2007, CIRCULATION, V116, P745, DOI 10.1161/CIRCULATIONAHA.106.686048; Bavry AA, 2006, AM J MED, V119, P1056, DOI 10.1016/j.amjmed.2006.01.023; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Brar SS, 2008, J AM COLL CARDIOL, V51, P2220, DOI 10.1016/j.jacc.2008.01.063; CAIN KC, 1984, BIOMETRICS, V40, P493, DOI 10.2307/2531402; COX DR, 1972, J R STAT SOC B, V187, P220; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; *FOOD DRUG ADM, 2010, DUAL ANT THER STUD C; Harjai KJ, 2009, HEART, V95, P1579, DOI 10.1136/hrt.2009.169896; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Kimura T, 2009, CIRCULATION, V119, P987, DOI 10.1161/CIRCULATIONAHA.108.808311; King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Laskey WK, 2007, CIRCULATION, V115, P2352, DOI 10.1161/CIRCULATIONAHA.107.688416; Nakazawa G, 2008, CIRCULATION, V118, P1138, DOI 10.1161/CIRCULATIONAHA.107.762047; Park DW, 2008, CIRCULATION, V117, P2079, DOI 10.1161/CIRCULATIONAHA.107.750109; Park DW, 2006, AM J CARDIOL, V98, P352, DOI 10.1016/j.amjcard.2006.02.039; Park DW, 2009, CIRCULATION, V120, P1987, DOI 10.1161/CIRCULATIONAHA.109.876763; Park DW, 2008, JACC-CARDIOVASC INTE, V1, P494, DOI 10.1016/j.jcin.2008.06.011; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Schulz S, 2009, EUR HEART J, V30, P2714, DOI 10.1093/eurheartj/ehp275; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Stone GW, 2008, AM J CARDIOL, V102, P1017, DOI 10.1016/j.amjcard.2008.05.050; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Williams DO, 2006, CIRCULATION, V114, P2154, DOI 10.1161/CIRCULATIONAHA.106.667915; Wiviott SD, 2006, AM HEART J, V152, P627, DOI 10.1016/j.ahj.2006.04.012	26	393	415	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 15	2010	362	15					1374	1382		10.1056/NEJMoa1001266	http://dx.doi.org/10.1056/NEJMoa1001266			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582XY	20231231				2022-12-28	WOS:000276635300006
J	Kalemkerian, GP				Kalemkerian, Gregory P.			Adjuvant therapy for non-small-cell lung cancer	LANCET			English	Editorial Material							VINORELBINE PLUS CISPLATIN; CHEMOTHERAPY		Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Kalemkerian, GP (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	kalemker@umich.edu						ALBERTI W, 1995, BRIT MED J, V311, P899; Custodio AB, 2009, J THORAC ONCOL, V4, P891, DOI 10.1097/JTO.0b013e3181a4b8fb; Butts CA, 2010, J CLIN ONCOL, V28, P29, DOI 10.1200/JCO.2009.24.0333; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; Ettinger David S, 2008, J Natl Compr Canc Netw, V6, P228; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; *NSCLC MET COLL GR, 2010, LANCET; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Pisters KMW, 2007, J CLIN ONCOL, V25, P5506, DOI 10.1200/JCO.2007.14.1226; Strauss GM, 2008, J CLIN ONCOL, V26, P5043, DOI 10.1200/JCO.2008.16.4855; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb	12	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 10	2010	375	9722					1230	1231		10.1016/S0140-6736(10)60454-0	http://dx.doi.org/10.1016/S0140-6736(10)60454-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585VN	20338628				2022-12-28	WOS:000276858400006
J	Firth, PG				Firth, Paul G.			Disaster-Relief Anesthesia - Notes on Coming Home	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Boston, MA USA	Harvard University; Massachusetts General Hospital				Firth, Paul/0000-0003-1909-5225					0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	2010	362	14								10.1056/NEJMpv1003218	http://dx.doi.org/10.1056/NEJMpv1003218			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579SN	20335576				2022-12-28	WOS:000276393700035
J	Mills, AE; Tereskerz, PM				Mills, Ann E.; Tereskerz, Patricia M.			A Step in the Direction of Health Insurance Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Virginia, Ctr Bioeth Human, Charlottesville, VA USA	University of Virginia									0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2010	362	13								10.1056/NEJMpv1002647	http://dx.doi.org/10.1056/NEJMpv1002647			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	577QQ	20237341				2022-12-28	WOS:000276239500038
J	Ravi, M; Chan, SWL				Ravi, Maruthachalam; Chan, Simon W. L.			Haploid plants produced by centromere-mediated genome elimination	NATURE			English	Article							CHROMOSOME ELIMINATION; MAIZE; MUTATION; WHEAT; GENE; INHERITANCE; ANTHERS; CULTURE	Production of haploid plants that inherit chromosomes from only one parent can greatly accelerate plant breeding(1-3). Haploids generated from a heterozygous individual and converted to diploid create instant homozygous lines, bypassing generations of inbreeding. Two methods are generally used to produce haploids. First, cultured gametophyte cells may be regenerated into haploid plants(4), but many species and genotypes are recalcitrant to this process(2,5). Second, haploids can be induced from rare interspecific crosses, in which one parental genome is eliminated after fertilization(6-11). The molecular basis for genome elimination is not understood, but one theory posits that centromeres from the two parent species interact unequally with the mitotic spindle, causing selective chromosome loss(12-14). Here we show that haploid Arabidopsis thaliana plants can be easily generated through seeds by manipulating a single centromere protein, the centromere-specific histone CENH3 (called CENP-A in human). When cenh3 null mutants expressing altered CENH3 proteins are crossed to wild type, chromosomes from the mutant are eliminated, producing haploid progeny. Haploids are spontaneously converted into fertile diploids through meiotic non-reduction, allowing their genotype to be perpetuated. Maternal and paternal haploids can be generated through reciprocal crosses. We have also exploited centromere-mediated genome elimination to convert a natural tetraploid Arabidopsis into a diploid, reducing its ploidy to simplify breeding. As CENH3 is universal in eukaryotes, our method may be extended to produce haploids in any plant species.	[Ravi, Maruthachalam; Chan, Simon W. L.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Chan, SWL (corresponding author), Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA.	srchan@ucdavis.edu		Maruthachalam, Ravi/0000-0003-0036-3330	Hellman Family Foundation; University of California, Davis	Hellman Family Foundation; University of California, Davis(University of California System)	We thank L. Comai, D. Melters, J. Maloof and J. Ramahi for comments on the manuscript; and R. McNeilage, R. Clarke, P. Kwong and J. Stewart for technical assistance. This work was supported by a grant from the Hellman Family Foundation to S. W. L. C., and by the University of California, Davis.	AVETISOV VA, 1976, GENETIKA+, V12, P17; BAINS GS, 1950, NATURE, V166, P795, DOI 10.1038/166795a0; BARCLAY IR, 1975, NATURE, V256, P410, DOI 10.1038/256410a0; BENNETT MD, 1976, CHROMOSOMA, V54, P175, DOI 10.1007/BF00292839; BURK LG, 1979, SCIENCE, V206, P585, DOI 10.1126/science.206.4418.585; Bushell C, 2003, PLANT CELL, V15, P1430, DOI 10.1105/tpc.010496; CHASE SS, 1969, BOT REV, V35, P117, DOI 10.1007/BF02858912; Clausen RE, 1924, P NATL ACAD SCI USA, V10, P121, DOI 10.1073/pnas.10.4.121; COE EH, 1959, AM NAT, V93, P381, DOI 10.1086/282098; Comai L, 2006, PLANT J, V45, P684, DOI 10.1111/j.1365-313X.2006.02670.x; DUNWELL JM, PLANT BIOTE IN PRESS; Evans MMS, 2007, PLANT CELL, V19, P46, DOI 10.1105/tpc.106.047506; FINCH RA, 1983, CHROMOSOMA, V88, P386, DOI 10.1007/BF00285861; Forster BP, 2007, TRENDS PLANT SCI, V12, P368, DOI 10.1016/j.tplants.2007.06.007; Francis KE, 2006, PLANT PHYSIOL, V142, P1004, DOI 10.1104/pp.106.085274; FROSTER BP, 2005, PLANT BREEDING REV, P57; GUHA S, 1964, NATURE, V204, P497, DOI 10.1038/204497a0; HAGBERG A, 1980, HEREDITAS, V93, P341; Henikoff S, 2005, CURR OPIN GENET DEV, V15, P177, DOI 10.1016/j.gde.2005.01.004; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Henry IM, 2005, GENETICS, V170, P1979, DOI 10.1534/genetics.104.037788; HEPPICH S, 1982, THEOR APPL GENET, V61, P101, DOI 10.1007/BF00273874; HOUGAS RW, 1957, NATURE, V180, P1209, DOI 10.1038/1801209a0; Jauhar PP, 2000, CROP SCI, V40, P1742, DOI 10.2135/cropsci2000.4061742x; Jin WW, 2004, PLANT CELL, V16, P571, DOI 10.1105/tpc.018937; Josefsson C, 2006, CURR BIOL, V16, P1322, DOI 10.1016/j.cub.2006.05.045; Kasha K J, 1970, Nature, V225, P874, DOI 10.1038/225874a0; KERMICLE JL, 1969, SCIENCE, V166, P1422, DOI 10.1126/science.166.3911.1422; LAURIE DA, 1989, GENOME, V32, P953, DOI 10.1139/g89-537; Ori N, 2000, DEVELOPMENT, V127, P5523; PAUL W, 1992, PLANT MOL BIOL, V19, P611, DOI 10.1007/BF00026787; Ross KJ, 1996, CHROMOSOME RES, V4, P507, DOI 10.1007/BF02261778; SCHOLL RL, 1980, Z PFLANZENPHYSIOL, V96, P407, DOI 10.1016/S0044-328X(80)80084-5; Talbert PB, 2002, PLANT CELL, V14, P1053, DOI 10.1105/tpc.010425; Udall JA, 2006, CROP SCI, V46, pS3, DOI 10.2135/cropsci2006.07.0489tpg; Wedzony M, 2009, ADVANCES IN HAPLOID PRODUCTION IN HIGHER PLANTS, P1, DOI 10.1007/978-1-4020-8854-4_1	36	326	381	9	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					615	U180		10.1038/nature08842	http://dx.doi.org/10.1038/nature08842			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20336146				2022-12-28	WOS:000275974200053
J	Ross, JS; Normand, SLT; Wang, Y; Ko, DT; Chen, J; Drye, EE; Keenan, PS; Lichtman, JH; Bueno, H; Schreiner, GC; Krumholz, HM				Ross, Joseph S.; Normand, Sharon-Lise T.; Wang, Yun; Ko, Dennis T.; Chen, Jersey; Drye, Elizabeth E.; Keenan, Patricia S.; Lichtman, Judith H.; Bueno, Hector; Schreiner, Geoffrey C.; Krumholz, Harlan M.			Hospital Volume and 30-Day Mortality for Three Common Medical Conditions	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEALTH-CARE; QUALITY; RATES	BACKGROUND The association between hospital volume and the death rate for patients who are hospitalized for acute myocardial infarction, heart failure, or pneumonia remains unclear. It is also not known whether a volume threshold for such an association exists. METHODS We conducted cross-sectional analyses of data from Medicare administrative claims for all fee-for-service beneficiaries who were hospitalized between 2004 and 2006 in acute care hospitals in the United States for acute myocardial infarction, heart failure, or pneumonia. Using hierarchical logistic-regression models for each condition, we estimated the change in the odds of death within 30 days associated with an increase of 100 patients in the annual hospital volume. Analyses were adjusted for patients' risk factors and hospital characteristics. Bootstrapping procedures were used to estimate 95% confidence intervals to identify the condition-specific volume thresholds above which an increased volume was not associated with reduced mortality. RESULTS There were 734,972 hospitalizations for acute myocardial infarction in 4128 hospitals, 1,324,287 for heart failure in 4679 hospitals, and 1,418,252 for pneumonia in 4673 hospitals. An increased hospital volume was associated with reduced 30-day mortality for all conditions (P<0.001 for all comparisons). For each condition, the association between volume and outcome was attenuated as the hospital's volume increased. For acute myocardial infarction, once the annual volume reached 610 patients ( 95% confidence interval [CI], 539 to 679), an increase in the hospital volume by 100 patients was no longer significantly associated with reduced odds of death. The volume threshold was 500 patients ( 95% CI, 433 to 566) for heart failure and 210 patients ( 95% CI, 142 to 284) for pneumonia. CONCLUSIONS Admission to higher-volume hospitals was associated with a reduction in mortality for acute myocardial infarction, heart failure, and pneumonia, although there was a volume threshold above which an increased condition-specific hospital volume was no longer significantly associated with reduced mortality.	[Ross, Joseph S.] Mt Sinai Sch Med, New York, NY 10029 USA; [Ross, Joseph S.] James J Peters Vet Affairs Med Ctr, Bronx, NY USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Med, Boston, MA USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Wang, Yun; Chen, Jersey; Drye, Elizabeth E.; Schreiner, Geoffrey C.; Krumholz, Harlan M.] Yale New Haven Med Ctr, New Haven, CT 06504 USA; [Wang, Yun; Chen, Jersey; Lichtman, Judith H.; Krumholz, Harlan M.] Yale Univ, Sch Med, New Haven, CT USA; [Ko, Dennis T.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Ko, Dennis T.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Bueno, Hector] Hosp Gen Univ Gregorio Maranon, Madrid, Spain	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Yale University; Yale University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; General University Gregorio Maranon Hospital	Ross, JS (corresponding author), Mt Sinai Sch Med, 1 Gustave L Levy Pl,Box 1070, New York, NY 10029 USA.	joseph.ross@mssm.edu	Bueno, Hector/I-3910-2015; , Harlan/AAI-2875-2020	Bueno, Hector/0000-0003-0277-7596; Ko, Dennis/0000-0001-6840-8051; Ross, Joseph/0000-0002-9218-3320; Normand, Sharon-Lise/0000-0001-7027-4769	CMS [HHSM-500-2005-CO001C]; National Institute on Aging [K08 AG032886]; American Federation for Aging Research; Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Madrid [BA08/90010]; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	CMS; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research; Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Madrid(Instituto de Salud Carlos III); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by a contract (HHSM-500-2005-CO001C) with the CMS, by a grant (K08 AG032886, to Dr. Ross) from the National Institute on Aging, by the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program, and by a grant (BA08/90010, to Dr. Bueno) from the Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Madrid.	*AM HOSP ASS, 2004, ANN SURV HOSP DAT DO; Auerbach AD, 2009, ANN INTERN MED, V150, P696, DOI 10.7326/0003-4819-150-10-200905190-00007; Bradley EH, 2006, NEW ENGL J MED, V355, P2308, DOI 10.1056/NEJMsa063117; Casale PN, 1998, J AM COLL CARDIOL, V32, P885, DOI 10.1016/S0735-1097(98)00325-8; FARLEY DE, 1992, MED CARE, V30, P77, DOI 10.1097/00005650-199201000-00009; Glance LG, 2007, INT J QUAL HEALTH C, V19, P195, DOI 10.1093/intqhc/mzm020; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Homboe ES, 2006, MED CARE, V44, P1073, DOI 10.1097/01.mlr.0000233685.22497.cf; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kohn KT, 2000, ERR IS HUMAN BUILDIN; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; KRUMHOLZ HM, 2006, RISK ADJUSTMENT ME S, V1; KRUMHOLZ HM, 2005, RISK ADJUSTMENT MODE; Lindenauer PK, 2006, ANN INTERN MED, V144, P262, DOI 10.7326/0003-4819-144-4-200602210-00008; MERRILL CT, 2005, AHRQ PUBLICATION; *NAT QUAL FOR, 2007, NAT VOL CONS STAND H; *NAT QUAL FOR, 2006, NAT VOL CONS STAND H; Normand SLT, 2007, HEALTH SERV OUTCOME, V7, P79, DOI 10.1007/s10742-006-0018-8; Normand SLT, 2002, STAT MED, V21, P331, DOI 10.1002/sim.1020; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106	22	237	241	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	2010	362	12					1110	1118		10.1056/NEJMsa0907130	http://dx.doi.org/10.1056/NEJMsa0907130			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573FU	20335587	Green Accepted			2022-12-28	WOS:000275894600008
J	Cooper, NAM; Khan, KS; Clark, TJ				Cooper, Natalie A. M.; Khan, Khalid S.; Clark, T. Justin			Local anaesthesia for pain control during outpatient hysteroscopy: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; PARACERVICAL ANESTHESIA; ENDOMETRIAL BIOPSY; POSTMENOPAUSAL WOMEN; RANDOMIZED-TRIAL; DIAGNOSTIC HYSTEROSCOPY; TOPICAL ANESTHESIA; FEASIBILITY; LIGNOCAINE	Objective To compare the effects of different types of local anaesthetic for pain control during outpatient hysteroscopy. Design Systematic review and meta-analysis of randomised controlled trials. Setting Outpatient hysteroscopy clinics. Participants Women undergoing diagnostic or operative hysteroscopy as outpatients-that is, without general anaesthesia. Study selection criteria Medline, Embase, CINAHL, the Cochrane library, and reference lists of relevant studies. Two reviewers independently selected trials. Data were abstracted on quality, characteristics, and results. Results There were 20 trials (2851 participants). Data from 15 of these were meta-analysed in subgroups defined by type of intervention and study quality. Intracervical (standardised mean difference -0.36, 95% confidence interval -0.61 to -0.10, I-2=0%) and paracervical (-1.28, -2.22 to -0.35, I-2=97%) injections of local anaesthetic significantly reduced the pain in women undergoing hysteroscopy as outpatients, whereas transcervical (-0.11, -0.31 to 0.10, I-2=27%) and topical application (-0.32, -0.97 to 0.33, I-2=90%) did not. Meta-regression showed that paracervical injection was superior to the other anaesthetic methods (P=0.04), a finding that was supported by the high quality subgroup of studies. Use of local anaesthetic did not have a significant effect on the incidence of vasovagal episodes (P=0.09). Conclusions Paracervical local anaesthetic injection is the best method of pain control for women undergoing hysteroscopy as outpatients.	[Khan, Khalid S.; Clark, T. Justin] Univ Birmingham, Birmingham Womens Hosp, Birmingham B15 2TG, W Midlands, England	Birmingham Women's Hospital; University of Birmingham	Clark, TJ (corresponding author), Univ Birmingham, Birmingham Womens Hosp, Birmingham B15 2TG, W Midlands, England.	justin.clark@bwhct.nhs.uk	Khan, Khalid S/AAT-8824-2020	Khan, Khalid S/0000-0001-5084-7312				Al-Sunaidi M, 2007, J MINIM INVAS GYN, V14, P153, DOI 10.1016/j.jmig.2006.09.007; Altman D.G., 1991, PRACTICAL STAT MED R; Bellati U, 1998, GIORN IT OST GIN, V20, P469; BERGER V, 1996, PROBABILITY PROBLEM; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; BROADBENT JAM, 1992, BRIT J OBSTET GYNAEC, V99, P777, DOI 10.1111/j.1471-0528.1992.tb13886.x; Cicinelli E, 1997, BRIT J OBSTET GYNAEC, V104, P316, DOI 10.1111/j.1471-0528.1997.tb11460.x; Cicinelli E, 1998, J REPROD MED, V43, P1014; Clark TJ, 2002, JAMA-J AM MED ASSOC, V288, P1610, DOI 10.1001/jama.288.13.1610; Clark TJ, 2002, EUR J OBSTET GYN R B, V100, P237, DOI 10.1016/S0301-2115(01)00485-7; Clark TJ, 2005, HDB OUTPATIENT HYSTE; *COCHR COLL, 2008, COCHR COLL HDB; Costello MF, 1998, GYNAECOL ENDOSC, V7, P121, DOI 10.1046/j.1365-2508.1998.00176.x; Davies A, 1997, FERTIL STERIL, V67, P1019, DOI 10.1016/S0015-0282(97)81433-1; Esteve M, 2002, GYNAECOL ENDOSC, V11, P33, DOI 10.1046/j.0962-1091.2002.00488.x; FINIKIOTIS G, 1992, AUST NZ J OBSTET GYN, V32, P373, DOI 10.1111/j.1479-828X.1992.tb02856.x; FINIKIOTIS G, 1993, AUST NZ J OBSTET GYN, V33, P61, DOI 10.1111/j.1479-828X.1993.tb02056.x; Giorda G, 2000, ACTA OBSTET GYN SCAN, V79, P593, DOI 10.1034/j.1600-0412.2000.079007593.x; Guida M, 2003, HUM REPROD, V18, P840, DOI 10.1093/humrep/deg075; HONG JY, 2006, AMBUL SURG, V12, P181; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kabli N, 2008, J MINIM INVAS GYN, V15, P308, DOI 10.1016/j.jmig.2008.01.013; Khan KS, 1996, ARCH INTERN MED, V156, P661, DOI 10.1001/archinte.156.6.661; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lau WC, 2000, BRIT J OBSTET GYNAEC, V107, P610, DOI 10.1111/j.1471-0528.2000.tb13301.x; Lau WC, 1999, BRIT J OBSTET GYNAEC, V106, P356, DOI 10.1111/j.1471-0528.1999.tb08274.x; Makris N, 2001, J GYNECOLOGIC SURG, V17, P7, DOI DOI 10.1089/; MOHER D, 1995, CONTROL CLIN TRIALS, V16, P62, DOI 10.1016/0197-2456(94)00031-W; *NORD COCHR CTR, 2008, REVMAN 5 COMP PROGR; Royal College of Obstetricians and Gynaecologists, 2008, STAND GYN REP WORK P; Sagiv R, 2006, OBSTET GYNECOL, V108, P387, DOI 10.1097/01.AOG.0000227750.93984.06; Shankar M, 2004, BJOG-INT J OBSTET GY, V111, P57, DOI 10.1046/j.1471-0528.2003.00004.x; Sinha D, 2007, BJOG-INT J OBSTET GY, V114, P676, DOI 10.1111/j.1471-0528.2007.01351.x; Soriano D, 2000, OBSTET GYNECOL, V96, P661, DOI 10.1016/S0029-7844(00)00984-4; *STATACORP LP, 2004, STAT STAT SOFTW COMP; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184; Tangsiriwatthana T, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005056.pub2; University of York Centre for Reviews and Dissemination, 2009, SYST REV CRDS GUID U; VERCELLINI P, 1994, FERTIL STERIL, V62, P1083; Wong AYK, 2000, FERTIL STERIL, V73, P1234, DOI 10.1016/S0015-0282(00)00498-2; Yang J, 2002, OBSTET GYNECOL SURV, V57, P693, DOI 10.1097/00006254-200210000-00023; ZUPI E, 1995, FERTIL STERIL, V63, P414; 2009, STANDARD DEVIATION C	43	74	78	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2010	340								c1130	10.1136/bmj.c1130	http://dx.doi.org/10.1136/bmj.c1130			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	576PO	20332307	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000276157600003
J	Rothwell, PM				Rothwell, Peter M.			Carotid stenting: more risky than endarterectomy and often no better than medical treatment alone	LANCET			English	Editorial Material							ARTERY STENOSIS; SUBGROUPS		John Radcliffe Hosp, Univ Dept Clin Neurol, Oxford OX3 9DU, England	University of Oxford	Rothwell, PM (corresponding author), John Radcliffe Hosp, Univ Dept Clin Neurol, Oxford OX3 9DU, England.	peter.rothwell@clneuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211				Abbott AL, 2009, STROKE, V40, pE573, DOI 10.1161/STROKEAHA.109.556068; Bonati LH, 2010, LANCET NEUROL, V9, P353, DOI 10.1016/S1474-4422(10)70057-0; Coward LJ, 2005, STROKE, V36, P905, DOI 10.1161/01.STR.0000158921.51037.64; Ederle J, 2010, LANCET, V375, P985, DOI 10.1016/S0140-6736(10)60239-5; Goessens BMB, 2007, STROKE, V38, P1470, DOI 10.1161/STROKEAHA.106.477091; Halliday A, 2004, LANCET, V363, P1491; Hobson RW, 2002, J AM COLL SURGEONS, V194, pS9, DOI 10.1016/S1072-7515(01)01078-X; Marquardt L, 2010, STROKE, V41, pE11, DOI 10.1161/STROKEAHA.109.561837; Mas J, 2006, NEW ENGL J MED, V355, P1660, DOI 10.1056/NEJMoa061752; Ringleb PA, 2006, LANCET, V368, P1239, DOI 10.1016/S0140-6736(06)69122-8; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Rothwell PM, 2004, LANCET, V364, P1122, DOI 10.1016/S0140-6736(04)17090-6; Spence JD, 2010, ARCH NEUROL-CHICAGO, V67, P180, DOI 10.1001/archneurol.2009.289; Touze E, 2009, STROKE, V40, pE683, DOI 10.1161/STROKEAHA.109.562041; Usman AA, 2009, J AM COLL SURGEONS, V208, P1124, DOI 10.1016/j.jamcollsurg.2009.02.043; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035	17	24	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 20	2010	375	9719					957	959		10.1016/S0140-6736(10)60404-7	http://dx.doi.org/10.1016/S0140-6736(10)60404-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	575YU	20304225				2022-12-28	WOS:000276110700004
J	Yong, Y; Yi, H; Gang, J				Yong, Yang; Yi, Huan; Gang, Ji			A retrocaval ureter	LANCET			English	Editorial Material									[Yong, Yang; Yi, Huan; Gang, Ji] Fourth Mil Med Univ, Xijing Hosp, Dept Radiol, Xian 710032, Peoples R China	Air Force Military Medical University	Yong, Y (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Radiol, Xian 710032, Peoples R China.	yunhuiyang888888@126.com							0	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 20	2010	375	9719					1029	1029		10.1016/S0140-6736(09)60301-9	http://dx.doi.org/10.1016/S0140-6736(09)60301-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	575YU	20304246				2022-12-28	WOS:000276110700035
J	Dong, WR; Xiao, CL; Wang, T; Dai, DX; Yang, XM; Zhang, DH				Dong, Wenrui; Xiao, Chunlei; Wang, Tao; Dai, Dongxu; Yang, Xueming; Zhang, Dong H.			Transition-State Spectroscopy of Partial Wave Resonances in the F plus HD Reaction	SCIENCE			English	Article								Partial wave resonances, quasi-bound resonance states with well-defined rotation in the transition state region of a chemical reaction, play a governing role in reaction dynamics but have eluded direct experimental characterization. Here, we report the observation of individual partial wave resolved resonances in the F + HD -> HF + D reaction by measuring the collision energy-dependent, angle-and state-resolved differential cross section with extremely high resolution, providing a spectroscopic probe to the transition state of F + HD -> HF + D. The agreement of the data with the high-level theoretical calculations confirms the sensitivity of this probe to the subtle quantum mechanical factors guiding this benchmark reaction.	[Dong, Wenrui; Xiao, Chunlei; Wang, Tao; Dai, Dongxu; Yang, Xueming; Zhang, Dong H.] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Dalian 116023, Liaoning, Peoples R China	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS	Yang, XM (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Dalian 116023, Liaoning, Peoples R China.	xmyang@dicp.ac.cn; zhangdh@dicp.ac.cn	Dong, Wenrui/C-8266-2013; xiao, chunlei/D-1019-2014; Yang, Xueming/C-8764-2013	xiao, chunlei/0000-0002-1549-5945; 	Chinese Academy of Sciences; National Natural Science Foundation of China; Ministry of Science and Technology of China	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	We acknowledge the support of this work by the Chinese Academy of Sciences, the National Natural Science Foundation of China, and the Ministry of Science and Technology of China.	Fernandez-Alonso F, 2002, ANNU REV PHYS CHEM, V53, P67, DOI 10.1146/annurev.physchem.53.091001.094554; MANOLOPOULOS DE, 1993, SCIENCE, V262, P1852, DOI 10.1126/science.262.5141.1852; Neumark DN, 1996, SCIENCE, V272, P1446, DOI 10.1126/science.272.5267.1446; POLANYI JC, 1995, ACCOUNTS CHEM RES, V28, P119, DOI 10.1021/ar00051a005; Qiu MH, 2006, SCIENCE, V311, P1440, DOI 10.1126/science.1123452; Ren ZF, 2008, P NATL ACAD SCI USA, V105, P12662, DOI 10.1073/pnas.0709974105; Ren ZF, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2140338; Schatz GC, 2000, SCIENCE, V288, P1599, DOI 10.1126/science.288.5471.1599; Skodje RT, 2000, J CHEM PHYS, V112, P4536, DOI 10.1063/1.481041; Skodje RT, 2000, PHYS REV LETT, V85, P1206, DOI 10.1103/PhysRevLett.85.1206	10	107	110	4	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2010	327	5972					1501	1502		10.1126/science.1185694	http://dx.doi.org/10.1126/science.1185694			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20299593				2022-12-28	WOS:000275715200045
J	Smith, TO; Sexton, D; Mann, C; Donell, S				Smith, Toby O.; Sexton, Debbie; Mann, Charles; Donell, Simon			Sutures versus staples for skin closure in orthopaedic surgery: meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; WOUND CLOSURE; SUBCUTICULAR SUTURE; NYLON SUTURES; INFECTION; HIP; REPLACEMENT; SUSCEPTIBILITY; ARTHROPLASTY; RELIABILITY	Objective To compare the clinical outcomes of staples versus sutures in wound closure after orthopaedic surgery. Design Meta-analysis. Data sources Medline, CINAHL, AMED, Embase, Scopus, and the Cochrane Library databases were searched, in addition to the grey literature, in all languages from 1950 to September 2009. Additional studies were identified from cited references. Selection criteria Two authors independently assessed papers for eligibility. Included studies were randomised and non-randomised controlled trials that compared the use of staples with suture material for wound closure after orthopaedic surgery procedures. All studies were included, and publications were not excluded because of poor methodological quality. Review methods Two authors independently reviewed studies for methodological quality and extracted data from each paper. Final data for analysis were collated through consensus. The primary outcome measure was the assessment of superficial wound infection after wound closure with staples compared with sutures. Relative risk and mean difference with 95% confidence intervals were calculated and pooled with a random effects model. Heterogeneity was assessed with I-2 and X-2 statistical test. Results Six papers, which included 683 wounds, were identified; 332 patients underwent suture closure and 351 staple closure. The risk of developing a superficial wound infection after orthopaedic procedures was over three times greater after staple closure than suture closure (relative risk 3.83, 95% confidence interval 1.38 to 10.68; P=0.01). On subgroup analysis of hip surgery alone, the risk of developing a wound infection was four times greater after staple closure than suture closure (4.79, 1.24 to 18.47; P=0.02). There was no significant difference between sutures and staples in the development of inflammation, discharge, dehiscence, necrosis, and allergic reaction. The included studies had several major methodological limitations, including the recruitment of small, underpowered cohorts, poorly randomising patients, and not blinding assessors to the allocated methods of wound closure. Only one study had acceptable methodological quality. Conclusions After orthopaedic surgery, there is a significantly higher risk of developing a wound infection when the wound is closed with staples rather than sutures. This risk is specifically greater in patients who undergo hip surgery. The use of staples for closing hip or knee surgery wounds after orthopaedic procedures cannot be recommended, though the evidence comes from studies with substantial methodological limitations. Though we advise orthopaedic surgeons to reconsider their use of staples for wound closure, definitive randomised trials are still needed to assess this research question.	[Smith, Toby O.; Sexton, Debbie; Mann, Charles; Donell, Simon] Norfolk & Norwich Univ Hosp, Norwich NR2 7UY, Norfolk, England	Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital	Smith, TO (corresponding author), Norfolk & Norwich Univ Hosp, Norwich NR2 7UY, Norfolk, England.	toby.smith@uea.ac.uk		Smith, Toby/0000-0003-1673-2954; Donell, Simon/0000-0001-6664-7470				Alderdice F, 2003, COCHRANE DB SYST REV, V2; ANGELINI GD, 1984, THORAX, V39, P942, DOI 10.1136/thx.39.12.942; BLANDM A, 2006, INTRO MED STAT; Brown JJ, 2008, EXP DERMATOL, V17, P610, DOI 10.1111/j.1600-0625.2007.00654.x; Carcoforo P, 1997, Minerva Chir, V52, P1009; CLAYER M, 1991, AUST NZ J SURG, V61, P363, DOI 10.1111/j.1445-2197.1991.tb00235.x; Clughtai T, 2000, CAN J CARDIOL, V16, P1403; Dennis DA, 1997, ORTHOPEDICS, V20, P837; Edwards C, 2008, J BONE JOINT SURG BR, V90B, P770, DOI 10.1302/0301-620X.90B6.20194; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Foley NC, 2006, PHYS THER, V86, P817, DOI 10.1093/ptj/86.6.817; Frishman GN, 1997, J REPROD MED, V42, P627; GATT D, 1985, ANN ROY COLL SURG, V67, P318; Graham DA, 2000, KNEE, V7, P239, DOI 10.1016/S0968-0160(00)00055-7; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOLLANDER JE, 1995, ANN EMERG MED, V25, P675, DOI 10.1016/S0196-0644(95)70183-4; JOHNSON A, 1981, ANN EMERG MED, V10, P631, DOI 10.1016/S0196-0644(81)80086-8; JONSSON K, 1991, ANN SURG, V214, P605, DOI 10.1097/00000658-199111000-00011; Judkins DR, 2007, STAT MED, V26, P1022, DOI 10.1002/sim.2591; Kanegaye JT, 1997, J PEDIATR-US, V130, P808, DOI 10.1016/S0022-3476(97)80025-X; KETTLE C, 2009, COCHRANE DB SYST REV; Khan ANGA, 2002, PEDIATR EMERG CARE, V18, P171, DOI 10.1097/00006565-200206000-00005; Khan RJK, 2006, J BONE JOINT SURG BR, V88B, P238, DOI 10.1302/0301-620X.88B2.16923; Kindberg S, 2008, BJOG-INT J OBSTET GY, V115, P472, DOI 10.1111/j.1471-0528.2007.01637.x; Livesey C, 2009, J BONE JOINT SURG BR, V91B, P725, DOI 10.1302/0301-620X.91B6.21831; LUBOWSKI D, 1985, AUST NZ J SURG, V55, P405, DOI 10.1111/j.1445-2197.1985.tb00910.x; Maher CG, 2003, PHYS THER, V83, P713, DOI 10.1093/ptj/83.8.713; MANTEL N, 1959, J NATL CANCER I, V22, P719; MEIRING L, 1982, S AFR MED J, V62, P371; Murphy M, 2004, EUR J ORTHOP SURG TR, V14, P16, DOI DOI 10.1007/S00590-003-0121-2; MURPHY PG, 1995, ANN VASC SURG, V9, P480, DOI 10.1007/BF02143863; PICKFORD IR, 1983, BRIT J SURG, V70, P226, DOI 10.1002/bjs.1800700414; RANABOLDO CJ, 1992, BRIT J SURG, V79, P1172, DOI 10.1002/bjs.1800791122; Reed MR, 1997, BRIT J SURG, V84, P118, DOI 10.1002/bjs.1800840142; RITCHIE AJ, 1989, INJURY, V20, P217, DOI 10.1016/0020-1383(89)90116-2; Saleh K, 2002, J ORTHOP RES, V20, P506, DOI 10.1016/S0736-0266(01)00153-X; Selvadurai D, 1997, ANN ROY COLL SURG, V79, P303; Shetty A A, 2004, J Orthop Surg (Hong Kong), V12, P191; Singh Bijayendra, 2006, Eur J Orthop Surg Traumatol, V16, P124, DOI 10.1007/s00590-005-0043-2; Singhal A, 2006, JK PRACTITIONER, V13, P142; STILLMAN RM, 1980, ARCH SURG-CHICAGO, V115, P674; STOCKLEY I, 1987, ANN ROY COLL SURG, V69, P76; Valenzuela P, 2009, BJOG-INT J OBSTET GY, V116, P436, DOI 10.1111/j.1471-0528.2008.02056.x	43	118	122	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2010	340								c1199	10.1136/bmj.c1199	http://dx.doi.org/10.1136/bmj.c1199			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573RD	20234041	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000275931400003
J	Soth, M				Soth, Mark			On-demand ordering of chest radiographs reduced the number of chest radiographs in mechanically ventilated adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									McMaster Univ, Hamilton, ON, Canada	McMaster University	Soth, M (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Clec'h C, 2008, INTENS CARE MED, V34, P264, DOI 10.1007/s00134-007-0919-1; Graat ME, 2006, CRIT CARE, V10, DOI 10.1186/cc3955	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	2010	152	6							JC3-7	10.7326/0003-4819-152-6-201003160-02007	http://dx.doi.org/10.7326/0003-4819-152-6-201003160-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573IF	20231561				2022-12-28	WOS:000275905200024
J	Zhao, D; McBride, D; Nandi, S; McQueen, HA; McGrew, MJ; Hocking, PM; Lewis, PD; Sang, HM; Clinton, M				Zhao, D.; McBride, D.; Nandi, S.; McQueen, H. A.; McGrew, M. J.; Hocking, P. M.; Lewis, P. D.; Sang, H. M.; Clinton, M.			Somatic sex identity is cell autonomous in the chicken	NATURE			English	Article							DOSAGE COMPENSATION; DETERMINING GENE; DIFFERENTIATION; EXPRESSION; EMBRYOS; BIRDS; RNAS; SRY	In the mammalian model of sex determination, embryos are considered to be sexually indifferent until the transient action of a sex-determining gene initiates gonadal differentiation. Although this model is thought to apply to all vertebrates, this has yet to be established. Here we have examined three lateral gynandromorph chickens (a rare, naturally occurring phenomenon in which one side of the animal appears male and the other female) to investigate the sex-determining mechanism in birds. These studies demonstrated that gynandromorph birds are genuine male: female chimaeras, and indicated that male and female avian somatic cells may have an inherent sex identity. To test this hypothesis, we transplanted presumptive mesoderm between embryos of reciprocal sexes to generate embryos containing male: female chimaeric gonads. In contrast to the outcome for mammalian mixed-sex chimaeras, in chicken mixed-sex chimaeras the donor cells were excluded from the functional structures of the host gonad. In an example where female tissue was transplanted into a male host, donor cells contributing to the developing testis retained a female identity and expressed a marker of female function. Our study demonstrates that avian somatic cells possess an inherent sex identity and that, in birds, sexual differentiation is substantively cell autonomous.	[Zhao, D.; McBride, D.; Nandi, S.; McGrew, M. J.; Sang, H. M.; Clinton, M.] Univ Edinburgh, Roslin Inst, Div Dev Biol, Roslin EH25 9PS, Midlothian, Scotland; [Hocking, P. M.] Univ Edinburgh, Roslin Inst, Div Genet & Genom, Roslin EH25 9PS, Midlothian, Scotland; [Hocking, P. M.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9PS, Midlothian, Scotland; [McQueen, H. A.] Univ Edinburgh, Inst Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Lewis, P. D.] Univ KwaZulu Natal, Dept Anim & Poultry Sci, Pietermaritzburg, South Africa	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Kwazulu Natal	Clinton, M (corresponding author), Univ Edinburgh, Roslin Inst, Div Dev Biol, Roslin EH25 9PS, Midlothian, Scotland.	Michael.clinton@roslin.ed.ac.uk	McQueen, Heather/AAS-3294-2020	McQueen, Heather/0000-0002-4228-6081	DEFRA; BBSRC [BB/E015425/1]; Biotechnology and Biological Sciences Research Council [BBS/E/R/00001603, BB/E015425/2, BB/E011276/2, BB/H012486/1, BB/E015425/1] Funding Source: researchfish; BBSRC [BB/H012486/1, BB/E015425/2, BB/E011276/2, BBS/E/R/00001603] Funding Source: UKRI	DEFRA(Department for Environment, Food & Rural Affairs (DEFRA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by DEFRA and BBSRC (BB/E015425/1). We thank G. Miele, G. Robertson, S. Wilson, A. Sherman, M. Hutchison, F. Thomson and R. Mitchell for technical support and for provision of fertilized eggs and embryos. We also thank T. Cannon for donation of gynandromorph bird G1, and R. Field and N. Russell for photography.	Agate RJ, 2003, P NATL ACAD SCI USA, V100, P4873, DOI 10.1073/pnas.0636925100; Arnold AP, 1997, J NEUROBIOL, V33, P572, DOI 10.1002/(SICI)1097-4695(19971105)33:5<572::AID-NEU6>3.3.CO;2-6; Birkhead T., 2008, WISDOM BIRDS ILLUSTR; BURGOYNE PS, 1988, DEVELOPMENT, V104, P683; Clinton M, 1998, J EXP ZOOL, V281, P457, DOI 10.1002/(SICI)1097-010X(19980801)281:5&lt;457::AID-JEZ10&gt;3.0.CO;2-6; Clinton M, 2001, BRIT POULTRY SCI, V42, P134, DOI 10.1080/713655025; CLINTON M, 2006, DIFFERENTIAL DISPLAY, P157; COCK A. G., 1955, JOUR GENETICS, V53, P49, DOI 10.1007/BF02981508; Dewing P, 2003, MOL BRAIN RES, V118, P82, DOI 10.1016/S0169-328X(03)00339-5; Ellegren H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-40; Glickman SE, 2005, HORM BEHAV, V48, P403, DOI 10.1016/j.yhbeh.2005.07.013; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HARRY JL, 1995, NAT GENET, V11, P347, DOI 10.1038/ng1195-347; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; HOLLANDER WF, 1975, J HERED, V66, P197, DOI 10.1093/oxfordjournals.jhered.a108612; Hori T, 2000, MOL BIOL CELL, V11, P3645, DOI 10.1091/mbc.11.10.3645; Hutt F.B., 1949, GENETICS OF THE FOWL; JOST A, 1970, PHILOS T ROY SOC B, V259, P119, DOI 10.1098/rstb.1970.0052; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lillie FR, 1917, P NATL ACAD SCI USA, V3, P464, DOI 10.1073/pnas.3.7.464; Matsuda M, 2007, P NATL ACAD SCI USA, V104, P3865, DOI 10.1073/pnas.0611707104; McGrew MJ, 2008, DEVELOPMENT, V135, P2289, DOI 10.1242/dev.022020; McQueen HA, 1996, NAT GENET, V12, P321, DOI 10.1038/ng0396-321; McQueen HA, 2001, CURR BIOL, V11, P253, DOI 10.1016/S0960-9822(01)00070-7; McQueen HA, 2009, CHROMOSOME RES, V17, P687, DOI 10.1007/s10577-009-9056-8; Melamed E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r202; Nishikimi H, 2000, MOL REPROD DEV, V55, P20, DOI 10.1002/(SICI)1098-2795(200001)55:1&lt;20::AID-MRD4&gt;3.0.CO;2-E; Nomura O, 1999, J STEROID BIOCHEM, V71, P103, DOI 10.1016/S0960-0760(99)00127-2; OWENS IPF, 1995, TRENDS ECOL EVOL, V10, P44, DOI 10.1016/S0169-5347(00)88967-3; PATEK CE, 1991, DEVELOPMENT, V113, P311; RENFREE MB, 1988, PHILOS T ROY SOC B, V322, P41, DOI 10.1098/rstb.1988.0112; Sambrook J., 2001, MOL CLONING LAB MANU; Scholz B, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-12; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Smith CA, 2001, J EXP ZOOL, V290, P691, DOI 10.1002/jez.1119; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Smith CA, 2009, INT J DEV BIOL, V53, P59, DOI 10.1387/ijdb.082742cs; Stern C. D., 1993, ESSENTIAL DEV BIOL P, P193; Volff JN, 2003, TRENDS GENET, V19, P196, DOI 10.1016/S0168-9525(03)00051-9; Wade J, 1996, P NATL ACAD SCI USA, V93, P5264, DOI 10.1073/pnas.93.11.5264; Wade J, 2004, ANN NY ACAD SCI, V1016, P540, DOI 10.1196/annals.1298.015; WS O, 1988, NATURE, V331, P716, DOI DOI 10.1038/331716A0	43	140	150	2	74	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					237	U115		10.1038/nature08852	http://dx.doi.org/10.1038/nature08852			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20220842	Green Accepted			2022-12-28	WOS:000275366100038
J	Kumar, D; Nath, L; Kamal, MA; Varshney, A; Jain, A; Singh, S; Rao, KVS				Kumar, Dhiraj; Nath, Lekha; Kamal, Md. Azhar; Varshney, Ankur; Jain, Avinash; Singh, Sarman; Rao, Kanury V. S.			Genome-wide Analysis of the Host Intracellular Network that Regulates Survival of Mycobacterium tuberculosis	CELL			English	Article							AUTOPHAGY; MACROPHAGES; PATHOGEN; BIOLOGY; ACTIVATION; PHAGOSOME; VIRULENCE; INTERPLAY; GROWTH; LIPIDS	We performed a genome-wide siRNA screen to identify host factors that regulated pathogen load in human macrophages infected with a virulent strain of Mycobacterium tuberculosis. Iterative rounds of confirmation, followed by validation, identified 275 such molecules that were all found to functionally associate with each other through a dense network of interactions. This network then yielded to a molecular description of the host cell functional modules that were both engaged and perturbed by the pathogen. Importantly, a subscreen against a panel of field isolates revealed that the molecular composition of the host interface varied with both genotype and the phenotypic properties of the pathogen. An analysis of these differences, however, permitted identification of those host factors that were invariantly involved, regardless of the diversification in adaptive mechanisms employed by the pathogen. Interestingly, these factors were found to predominantly function through the regulation of autophagy.	[Kumar, Dhiraj; Nath, Lekha; Kamal, Md. Azhar; Varshney, Ankur; Jain, Avinash; Rao, Kanury V. S.] Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi 110067, India; [Singh, Sarman] All India Inst Med Sci, Dept Lab Med, Div Clin Microbiol, New Delhi 110029, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Rao, KVS (corresponding author), Ctr Genet Engn & Biotechnol, Immunol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	kanury@icgeb.res.in	Singh, Sarman/AAR-8914-2020; Kamal, Mohammad Azhar/H-9624-2012	Singh, Sarman/0000-0002-0749-9647; Kamal, Mohammad Azhar/0000-0002-0180-3441	Department of Biotechnology, Government of India; Institute of Life Sciences, Hyderabad	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Institute of Life Sciences, Hyderabad	This study was funded in part by the Department of Biotechnology, Government of India, and in part by the Institute of Life Sciences, Hyderabad. We are grateful to V. Biswas, M. Jain, N. Karwal, R. Kashikar, S. Kumari, A. Kumar, K. Midha, M. K. Midha, S. Seth, S. Sharma, M. Sharma, Z. Sidiqui, A. Srivastava, and S. Tirpattiwar for technical assistance during the various stages of the RNA interference screen. We also thank S. Kulkarni (BARC) for spoligotyping analysis of the field isolates used in this study.	Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; DECHASTELIER C, 2009, IMMUNOBIOLO IN PRESS; Flynn JL, 1999, TRENDS MICROBIOL, V7, P477, DOI 10.1016/S0966-842X(99)01611-X; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gertow K, 2004, DIABETOLOGIA, V47, P1118, DOI 10.1007/s00125-004-1417-4; Ginsberg AM, 2007, NAT MED, V13, P290, DOI 10.1038/nm0307-290; Gutierrez MG, 2009, CELL MICROBIOL, V11, P406, DOI 10.1111/j.1462-5822.2008.01263.x; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Jain M, 2007, P NATL ACAD SCI USA, V104, P5133, DOI 10.1073/pnas.0610634104; Kaufmann SHE, 2005, J EXP MED, V201, P1693, DOI 10.1084/jem.20050842; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Park JS, 2006, J LEUKOCYTE BIOL, V79, P80, DOI 10.1189/jlb.0505250; Schaible UE, 2005, TRENDS MICROBIOL, V13, P373, DOI 10.1016/j.tim.2005.06.009; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Theus SA, 2006, INFECT IMMUN, V74, P6865, DOI 10.1128/IAI.00561-06; Ting LM, 1999, J IMMUNOL, V163, P3898; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Van Limbergen J, 2009, MUCOSAL IMMUNOL, V2, P315, DOI 10.1038/mi.2009.20; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Warner DF, 2007, NAT MED, V13, P282, DOI 10.1038/nm0307-282; Young D, 2008, NAT REV MICROBIOL, V6, P520, DOI 10.1038/nrmicro1919	33	278	287	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					731	743		10.1016/j.cell.2010.02.012	http://dx.doi.org/10.1016/j.cell.2010.02.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211141	Bronze			2022-12-28	WOS:000275197400021
J	Assefa, S; Xia, FNA; Vlasov, YA				Assefa, Solomon; Xia, Fengnian; Vlasov, Yurii A.			Reinventing germanium avalanche photodetector for nanophotonic on-chip optical interconnects	NATURE			English	Article							INSULATOR; GAIN; GE; PHOTODIODES; NOISE	Integration of optical communication circuits directly into high-performance microprocessor chips can enable extremely powerful computer systems(1). A germanium photodetector that can be monolithically integrated with silicon transistor technology(2-8) is viewed as a key element in connecting chip components with infrared optical signals. Such a device should have the capability to detect very-low-power optical signals at very high speed. Although germanium avalanche photodetectors(9,10) (APD) using charge amplification close to avalanche breakdown can achieve high gain and thus detect low-power optical signals, they are universally considered to suffer from an intolerably high amplification noise characteristic of germanium(11). High gain with low excess noise has been demonstrated using a germanium layer only for detection of light signals, with amplification taking place in a separate silicon layer(12). However, the relatively thick semiconductor layers that are required in such structures limit APD speeds to about 10GHz, and require excessively high bias voltages of around 25V (ref. 12). Here we show how nanophotonic and nanoelectronic engineering aimed at shaping optical and electrical fields on the nanometre scale within a germanium amplification layer can overcome the otherwise intrinsically poor noise characteristics, achieving a dramatic reduction of amplification noise by over 70 per cent. By generating strongly non-uniform electric fields, the region of impact ionization in germanium is reduced to just 30nm, allowing the device to benefit from the noise reduction effects(13-15) that arise at these small distances. Furthermore, the smallness of the APDs means that a bias voltage of only 1.5V is required to achieve an avalanche gain of over 10dB with operational speeds exceeding 30GHz. Monolithic integration of such a device into computer chips might enable applications beyond computer optical interconnects(1)-in telecommunications(16), secure quantum key distribution(17), and subthreshold ultralow-power transistors(18).	[Assefa, Solomon; Xia, Fengnian; Vlasov, Yurii A.] IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	International Business Machines (IBM)	Assefa, S (corresponding author), IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA.	sassefa@us.ibm.com	Vlasov, Yurii A/E-8209-2011; Xia, Fengnian/O-2637-2015; Xia, Fengnian/D-1003-2012	Vlasov, Yurii A/0000-0002-5864-3346; Xia, Fengnian/0000-0001-5176-368X; 				AGRAWAL GP, 2001, FIBER OPTIC COMMUNIC, pCH4; Ahn D, 2007, OPT EXPRESS, V15, P3916, DOI 10.1364/OE.15.003916; ANDO H, 1978, IEEE J QUANTUM ELECT, V14, P804, DOI 10.1109/JQE.1978.1069698; ASSEFA S, 2008, Patent No. 12191687; ASSEFA S, OPT EXPRESS IN PRESS; ASSEFA S, 2009, Patent No. 12533521; ASSEFA S, 2009, OPT FIB COMM C; ASSEFA S, 2007, Patent No. 11925170; Campbell JC, 2007, J LIGHTWAVE TECHNOL, V25, P109, DOI 10.1109/JLT.2006.888481; Carrano JC, 1998, J APPL PHYS, V83, P6148, DOI 10.1063/1.367484; Chen L, 2009, OPT EXPRESS, V17, P7901, DOI 10.1364/OE.17.007901; *DARPA IPTO, 2008, EX COMP STUD REP; DEHLINGER G, 2006, Patent No. 7515793; Gopalakrishnan K, 2005, IEEE T ELECTRON DEV, V52, P69, DOI 10.1109/TED.2004.841344; Hayat MA, 2002, IEEE T ELECTRON DEV, V49, P2114, DOI 10.1109/TED.2002.805573; HAYAT MM, 1992, IEEE T ELECTRON DEV, V39, P546, DOI 10.1109/16.123476; Kang YM, 2009, NAT PHOTONICS, V3, P59, DOI 10.1038/NPHOTON.2008.247; Kardynal BE, 2008, NAT PHOTONICS, V2, P425, DOI 10.1038/nphoton.2008.101; Kobayashi M, 2009, J APPL PHYS, V105, DOI 10.1063/1.3065990; Liu YC, 2004, APPL PHYS LETT, V84, P2563, DOI 10.1063/1.1691175; Masini Gianlorenzo, 2008, Advances in Optical Technologies, V2008, DOI 10.1155/2008/196572; MCLNTYRE RJ, 1966, T ELECT DEVICES, V13, P164; MELCHIOR H, 1966, IEEE T ELECTRON DEV, VED13, P829, DOI 10.1109/T-ED.1966.15856; Mun SCLT, 2008, J APPL PHYS, V104, DOI 10.1063/1.2952003; PEARSALL TP, 1986, IEEE ELECTR DEVICE L, V7, P330, DOI 10.1109/EDL.1986.26390; REGGIANI L, 1977, PHYS REV B, V16, P2781, DOI 10.1103/PhysRevB.16.2781; Tang L, 2008, NAT PHOTONICS, V2, P226, DOI 10.1038/nphoton.2008.30; Vivien L, 2009, OPT EXPRESS, V17, P6252, DOI 10.1364/OE.17.006252; Vlasov Y, 2008, NAT PHOTONICS, V2, P242, DOI 10.1038/nphoton.2008.31; Yin T, 2007, OPT EXPRESS, V15, P13965, DOI 10.1364/OE.15.013965	30	432	445	21	330	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2010	464	7285					80	U91		10.1038/nature08813	http://dx.doi.org/10.1038/nature08813			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20203606				2022-12-28	WOS:000275117500037
J	Hirschey, MD; Shimazu, T; Goetzman, E; Jing, E; Schwer, B; Lombard, DB; Grueter, CA; Harris, C; Biddinger, S; Ilkayeva, OR; Stevens, RD; Li, Y; Saha, AK; Ruderman, NB; Bain, JR; Newgard, CB; Farese, RV; Alt, F; Kahn, CR; Verdin, E				Hirschey, Matthew D.; Shimazu, Tadahiro; Goetzman, Eric; Jing, Enxuan; Schwer, Bjoern; Lombard, David B.; Grueter, Carrie A.; Harris, Charles; Biddinger, Sudha; Ilkayeva, Olga R.; Stevens, Robert D.; Li, Yu; Saha, Asish K.; Ruderman, Neil B.; Bain, James R.; Newgard, Christopher B.; Farese, Robert V., Jr.; Alt, FrederickW.; Kahn, C. Ronald; Verdin, Eric			SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation	NATURE			English	Article							COA DEHYDROGENASE-DEFICIENCY; GENE-EXPRESSION PROFILES; HEPATIC STEATOSIS; LIVER-DISEASE; ACETYLATION; RISK; SIRTUINS; ROLES; MICE	Sirtuins are NAD(+)-dependent protein deacetylases. They mediate adaptive responses to a variety of stresses, including calorie restriction and metabolic stress. Sirtuin 3 (SIRT3) is localized in the mitochondrial matrix, where it regulates the acetylation levels of metabolic enzymes, including acetyl coenzyme A synthetase 2 (refs 1, 2). Mice lacking both Sirt3 alleles appear phenotypically normal under basal conditions, but show marked hyperacetylation of several mitochondrial proteins(3). Here we report that SIRT3 expression is upregulated during fasting in liver and brown adipose tissues. During fasting, livers from mice lacking SIRT3 had higher levels of fatty-acid oxidation intermediate products and triglycerides, associated with decreased levels of fatty-acid oxidation, compared to livers from wild-type mice. Mass spectrometry of mitochondrial proteins shows that long-chain acyl coenzyme A dehydrogenase (LCAD) is hyperacetylated at lysine 42 in the absence of SIRT3. LCAD is deacetylated in wild-type mice under fasted conditions and by SIRT3 in vitro and in vivo; and hyperacetylation of LCAD reduces its enzymatic activity. Mice lacking SIRT3 exhibit hallmarks of fatty-acid oxidation disorders during fasting, including reduced ATP levels and intolerance to cold exposure. These findings identify acetylation as a novel regulatory mechanism for mitochondrial fatty-acid oxidation and demonstrate that SIRT3 modulates mitochondrial intermediary metabolism and fatty-acid use during fasting.	[Hirschey, Matthew D.; Shimazu, Tadahiro; Schwer, Bjoern; Verdin, Eric] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Hirschey, Matthew D.; Shimazu, Tadahiro; Schwer, Bjoern; Verdin, Eric] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Goetzman, Eric] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15201 USA; [Jing, Enxuan; Biddinger, Sudha; Kahn, C. Ronald] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; [Schwer, Bjoern; Lombard, David B.; Alt, FrederickW.] Harvard Univ, Sch Med, Childrens Hosp,Immune Dis Inst,Dept Genet, Howard Hughes Med Inst,Program Cellular & Mol Med, Boston, MA 02115 USA; [Grueter, Carrie A.; Harris, Charles; Farese, Robert V., Jr.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Ilkayeva, Olga R.; Stevens, Robert D.; Bain, James R.; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA; [Li, Yu] Cell Signaling Technol, Danvers, MA 01923 USA; [Saha, Asish K.; Ruderman, Neil B.] Boston Univ, Med Ctr, Diabet Unit, Boston, MA 02118 USA; [Saha, Asish K.; Ruderman, Neil B.] Boston Univ, Med Ctr, Dept Physiol & Med Biophys, Boston, MA 02118 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California San Francisco; The J David Gladstone Institutes; Duke University; Boston University; Boston University	Verdin, E (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA.	everdin@gladstone.ucsf.edu	SHIMAZU, Tadahiro/ABC-3950-2020; Verdin, Eric/AAB-7999-2019; Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228; Saha, Asish/0000-0003-1001-5110; Verdin, Eric/0000-0003-3703-3183; Hirschey, Matthew/0000-0003-4541-5376; Ruderman, Neil/0000-0002-6589-6587; Lombard, David/0000-0002-4292-0185; Bain, James R./0000-0002-8917-9187; Grueter, Carrie/0000-0002-1913-2527	Elison Medical Foundation; National Institute on Aging; National Institutes of Health (NIH) [PO1 HL068758-06A1, DK019514-29, R01 DK067509-04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK059637, P30DK026743, K01DK076573, U24DK059637, R01DK019514, R01DK067509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG022325] Funding Source: NIH RePORTER	Elison Medical Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank T. Canavan and J. J. Maher for primary hepatocyte preparation (P30 DK026743); C. Harris, L. Swift and the Mouse Metabolic Phenotyping Center (DK59637) for analysis of plasma and tissue lipid analysis; J. Wong for electron microscopy studies, S. Mihalik and D. Cuebas for synthesis of the 2,6-dimethylheptanoyl-CoA; A.-W. Mohsen for purification of recombinant pig ETF; Y.-C. Si for assistance with adenoviral studies; A. Wilson and J. Carroll for preparation of figures; and G. Howard and S. Ordway for editorial review. This work was supported in part by a Senior Scholarship in Aging from the Elison Medical Foundation to E. V. and by institutional support from the J. David Gladstone Institutes. F. W. A. is an Investigator of the Howard Hughes Medical Institute and recipient of an Ellison Medical Foundation Senior Scholar Award. D. B. L. is supported by a K08 award from the National Institute on Aging and the National Institutes of Health. B. S. is supported by an Ellison Medical Foundation/AFAR Senior Postdoctoral Research Grant. N.B.R. and A. K. S. are supported by National Institutes of Health (NIH) grants PO1 HL068758-06A1, DK019514-29 and R01 DK067509-04.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Bennett MJ, 2007, METHOD CELL BIOL, V80, P179, DOI 10.1016/S0091-679X(06)80009-9; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cox KB, 2001, HUM MOL GENET, V10, P2069, DOI 10.1093/hmg/10.19.2069; Eaton S, 1996, BIOCHEM J, V320, P345, DOI 10.1042/bj3200345; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRERMAN FE, 1985, BIOCHEM MED METAB B, V33, P38, DOI 10.1016/0006-2944(85)90124-3; GRAHAM JM, 1999, CURR PROTOCOLS CEL S, V4; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Herrema H, 2008, HEPATOLOGY, V47, P1894, DOI 10.1002/hep.22284; Hirschey MD, 2009, METHOD ENZYMOL, V457, P137, DOI 10.1016/S0076-6879(09)05008-3; Hsiao PJ, 2007, J GASTROEN HEPATOL, V22, P2118, DOI 10.1111/j.1440-1746.2006.04698.x; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, pE1039, DOI 10.1152/ajpendo.2000.279.5.E1039; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kurtz DM, 1998, P NATL ACAD SCI USA, V95, P15592, DOI 10.1073/pnas.95.26.15592; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; MORRISON WR, 1964, J LIPID RES, V5, P600; OLIVER H, 1972, FLEXIBLE SYSTEM ENZY; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Saha AK, 2004, BIOCHEM BIOPH RES CO, V314, P580, DOI 10.1016/j.bbrc.2003.12.120; Schuler A Michele, 2002, ILAR J, V43, P57; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Shibata M, 2007, DIABETES CARE, V30, P2940, DOI 10.2337/dc07-0792; Son CG, 2005, GENOME RES, V15, P443, DOI 10.1101/gr.3124505; Spiekerkoetter U, 2006, HORM METAB RES, V38, P625, DOI 10.1055/s-2006-954581; STREMMEL W, 1986, P NATL ACAD SCI USA, V83, P3086, DOI 10.1073/pnas.83.10.3086; Taniguchi CM, 2005, J CLIN INVEST, V115, P718, DOI 10.1172/JCI200523187; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; Tolwani RJ, 2005, PLOS GENET, V1, P205, DOI 10.1371/journal.pgen.0010023; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Wu JY, 2004, J CLIN INVEST, V113, P434, DOI 10.1172/JCI200419574; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yechoor VK, 2004, P NATL ACAD SCI USA, V101, P16525, DOI 10.1073/pnas.0407574101; Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104; Zhang W, 2008, LIFE SCI, V83, P35, DOI 10.1016/j.lfs.2008.04.021	43	1146	1187	8	262	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2010	464	7285					121	U137		10.1038/nature08778	http://dx.doi.org/10.1038/nature08778			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20203611	Green Submitted, Green Accepted			2022-12-28	WOS:000275117500046
J	Rudan, I; Chan, KY; Zhang, JSF; Theodoratou, E; Feng, XL; Salomon, JA; Lawn, JE; Cousens, S; Black, RE; Guo, Y; Campbell, H				Rudan, Igor; Chan, Kit Yee; Zhang, Jian S. F.; Theodoratou, Evropi; Feng, Xing Lin; Salomon, Joshua A.; Lawn, Joy E.; Cousens, Simon; Black, Robert E.; Guo, Yan; Campbell, Harry		WHO UNICEF's CHERG	Causes of deaths in children younger than 5 years in China in 2008	LANCET			English	Article							COVERAGE; POLICY	Background Previous estimates of the global burden of disease for children have not included much information from China, leading to a large gap in data. We identified the main causes of deaths in neonates (<1 month), postneonatal infants (1-11 months), and children (<5 years) in China using information that was available to the public. Methods The Child Health Epidemiology Reference Group in collaboration with colleagues from Peking University systematically searched Chinese databases that were available to the public. Information was obtained from the Chinese Ministry of Health and Bureau of Statistics websites, Chinese National Knowledge Infrastructure database, and Chinese Health Statistics yearbooks for 1990-2008. We also obtained information from 206 high-quality community-based longitudinal studies of different causes of deaths in children (<5 years) that were written in the Chinese language. A statistical model was developed to estimate the total number of deaths in children according to provinces, age groups, and main causes. Findings During 1990-2008, the mortality rates in neonates, postneonatal infants, and children were reduced by 70% (from 34.0 to 10.2 per 1000 livebirths), 72% (from 53.5 to 14.9 per 1000 livebirths), and 71% (from 64.6 to 18.5 per 1000 livebirths), respectively, meeting the targets set in the Millennium Development Goal 4. The leading causes of deaths in 2008 were pneumonia, birth asphyxia, and preterm birth complications, each accounting for 15-17% of all deaths. Congenital abnormalities and accidents increased in importance during this period, contributing to 11% and 10% of child deaths, respectively. Sudden infant death syndrome contributed to 5% of deaths in children. Interpretation Publically available Chinese databases contain much important information that has been underused in the estimation of global and regional burden of disease. On the basis of trends, preterm birth complications are expected to become the leading cause of child mortality in China, whereas deaths from congenital abnormalities, accidents, and sudden infant death syndrome are predicted to continue increasing in importance in the long term.	[Rudan, Igor; Theodoratou, Evropi; Campbell, Harry] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia; [Chan, Kit Yee; Zhang, Jian S. F.] Univ Melbourne, Nossal Inst Global Hlth, Melbourne, Vic, Australia; [Chan, Kit Yee; Feng, Xing Lin] Peking Univ, Sch Publ Hlth, Beijing 100871, Peoples R China; [Salomon, Joshua A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Lawn, Joy E.] Saving Newborn Lives Save Children, Cape Town, South Africa; [Cousens, Simon] London Sch Hyg & Trop Med, London WC1, England; [Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	University of Edinburgh; University of Split; University of Melbourne; Peking University; Harvard University; Harvard T.H. Chan School of Public Health; Save the Children; University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Campbell, H (corresponding author), Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland.	guoyan@bjmu.edu.cn; Harry.Campbell@ed.ac.uk	Theodoratou, Evropi/C-3430-2014; Rudan, Igor/I-1467-2012; Lawn, Joy/ABE-6382-2020; Salomon, Joshua A/D-3898-2009; Feng, Xing Lin/D-8734-2011; Salomon, Joshua/S-1929-2019; Campbell, Harry/E-2959-2010	Theodoratou, Evropi/0000-0001-5887-9132; Rudan, Igor/0000-0001-6993-6884; Lawn, Joy/0000-0002-4573-1443; Salomon, Joshua A/0000-0003-3929-5515; Feng, Xing Lin/0000-0003-3588-1859; Salomon, Joshua/0000-0003-3929-5515; Campbell, Harry/0000-0002-6169-6262; Black, Robert/0000-0001-9926-7984; Chan, Kit Yee/0000-0002-3465-8383	Bill & Melinda Gates Foundation [50140, 51285]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by grants from the Bill & Melinda Gates Foundation to the US Fund for UNICEF (number 50140, strengthening the evidence for maternal and child health, REB principal investigator), and to the University of Edinburgh (number 51285, modelling the impact of emerging interventions against pneumonia. IR and HC principal investigators). We sincerely thank Bickhar Yeung (Ballieu Library, University of Melbourne) whose help was invaluable to our understanding of the Chinese databases.	Ameratunga SN, 2009, INJURY, V40, P469, DOI 10.1016/j.injury.2008.11.015; China Ministry of Agriculture, 2008, CHIN HUM DEV REP 200, P1; Fung ICH, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-21; Fung ICH, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-20; Goodkind DM, 2004, POP STUD-J DEMOG, V58, P281, DOI 10.1080/0032472042000272348; Hesketh T, 1997, BRIT MED J, V314, P1685, DOI 10.1136/bmj.314.7095.1685; Lanata CF, 2004, INT J EPIDEMIOL, V33, P1362, DOI 10.1093/ije/dyh229; Liu DT, 2008, INT J CONTROL AUTOM, V6, P35; Miller BD, 2001, AM ANTHROPOL, V103, P1083, DOI 10.1525/aa.2001.103.4.1083; Ministry of Health of the People's Republic of China,, 2009, CHIN ANN HLTH STAT R, V19, P1612; Mulholland K, 2007, LANCET, V370, P285, DOI 10.1016/S0140-6736(07)61130-1; Rudan I, 2005, LANCET, V365, P2031, DOI 10.1016/S0140-6736(05)66697-4; Shang Q, 1999, Wei Sheng Yan Jiu, V28, P339; United Nations, 2009, MILL DEV GOALS REP 2; Xia J, 2008, HEALTH INFO LIBR J, V25, P55, DOI 10.1111/j.1471-1842.2007.00734.x; ZHANG DQ, 2003, GROUND WATER, V25, P71; W PU DATABASE; 2008, LANCET, V371, P1247	18	153	196	2	41	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2010	375	9720					1083	1089		10.1016/S0140-6736(10)60060-8	http://dx.doi.org/10.1016/S0140-6736(10)60060-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578ZB	20346815				2022-12-28	WOS:000276334600031
J	Holman, RR; Haffner, SM; McMurray, JJ; Bethel, MA; Holzhauer, B; Hua, TA; Belenkov, Y; Boolell, M; Buse, JB; Buckley, BM; Chacra, AR; Chiang, FT; Charbonnel, B; Chow, CC; Davies, MJ; Deedwania, P; Diem, P; Einhorn, D; Fonseca, V; Fulcher, GR; Gaciong, Z; Gaztambide, S; Giles, T; Horton, E; Ilkova, H; Jenssen, T; Kahn, SE; Krum, H; Laakso, M; Leiter, LA; Levitt, NS; Mareev, V; Martinez, F; Masson, C; Mazzone, T; Meaney, E; Nesto, R; Pan, CY; Prager, R; Raptis, SA; Rutten, GEHM; Sandstroem, H; Schaper, F; Scheen, A; Schmitz, O; Sinay, I; Soska, V; Stender, S; Tamas, G; Tognoni, G; Tuomilehto, J; Villamil, AS; Vozar, J; Califf, RM				Holman, Rury R.; Haffner, Steven M.; McMurray, John J.; Bethel, M. Angelyn; Holzhauer, Bjoern; Hua, Tsushung A.; Belenkov, Yuri; Boolell, Mitradev; Buse, John B.; Buckley, Brendan M.; Chacra, Antonio R.; Chiang, Fu-Tien; Charbonnel, Bernard; Chow, Chun-Chung; Davies, Melanie J.; Deedwania, Prakash; Diem, Peter; Einhorn, Daniel; Fonseca, Vivian; Fulcher, Gregory R.; Gaciong, Zbigniew; Gaztambide, Sonia; Giles, Thomas; Horton, Edward; Ilkova, Hasan; Jenssen, Trond; Kahn, Steven E.; Krum, Henry; Laakso, Markku; Leiter, Lawrence A.; Levitt, Naomi S.; Mareev, Viacheslav; Martinez, Felipe; Masson, Chantal; Mazzone, Theodore; Meaney, Eduardo; Nesto, Richard; Pan, Changyu; Prager, Rudolf; Raptis, Sotirios A.; Rutten, Guy E. H. M.; Sandstroem, Herbert; Schaper, Frank; Scheen, Andre; Schmitz, Ole; Sinay, Isaac; Soska, Vladimir; Stender, Steen; Tamas, Gyula; Tognoni, Gianni; Tuomilehto, Jaako; Villamil, Alberto S.; Vozar, Juraj; Califf, Robert M.		NAVIGATOR Study Grp	Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; INSULIN-SECRETION; LIFE-STYLE; PREVENTION; MELLITUS; NIDDM; ACARBOSE; DISEASE; TRIAL; DIET	BACKGROUND The ability of short-acting insulin secretagogues to reduce the risk of diabetes or cardiovascular events in people with impaired glucose tolerance is unknown. METHODS In a double-blind, randomized clinical trial, we assigned 9306 participants with impaired glucose tolerance and either cardiovascular disease or cardiovascular risk factors to receive nateglinide (up to 60 mg three times daily) or placebo, in a 2-by-2 factorial design with valsartan or placebo, in addition to participation in a lifestyle modification program. We followed the participants for a median of 5.0 years for incident diabetes (and a median of 6.5 years for vital status). We evaluated the effect of nateglinide on the occurrence of three coprimary outcomes: the development of diabetes; a core cardiovascular outcome that was a composite of death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure; and an extended cardiovascular outcome that was a composite of the individual components of the core composite cardiovascular outcome, hospitalization for unstable angina, or arterial revascularization. RESULTS After adjustment for multiple testing, nateglinide, as compared with placebo, did not significantly reduce the cumulative incidence of diabetes (36% and 34%, respectively; hazard ratio, 1.07; 95% confidence interval [CI], 1.00 to 1.15; P = 0.05), the core composite cardiovascular outcome (7.9% and 8.3%, respectively; hazard ratio, 0.94, 95% CI, 0.82 to 1.09; P = 0.43), or the extended composite cardiovascular outcome (14.2% and 15.2%, respectively; hazard ratio, 0.93, 95% CI, 0.83 to 1.03; P = 0.16). Nateglinide did, however, increase the risk of hypoglycemia. CONCLUSIONS Among persons with impaired glucose tolerance and established cardiovascular disease or cardiovascular risk factors, assignment to nateglinide for 5 years did not reduce the incidence of diabetes or the coprimary composite cardiovascular outcomes. (ClinicalTrials.gov number, NCT00097786.)	[Holman, Rury R.; Bethel, M. Angelyn] Univ Oxford, Diabet Trials Unit, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [McMurray, John J.] Univ Glasgow, British Heart Fdn, Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Davies, Melanie J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Haffner, Steven M.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Bethel, M. Angelyn] Duke Univ, Duke Clin Res Inst, Durham, NC 27706 USA; [Califf, Robert M.] Duke Univ, Duke Translat Med Inst, Durham, NC 27706 USA; [Buse, John B.] Univ N Carolina, Sch Med, Div Gen Med, Chapel Hill, NC USA; [Buse, John B.] Univ N Carolina, Sch Med, Clin Epidemiol & Diabet Care Ctr, Chapel Hill, NC USA; [Holzhauer, Bjoern; Boolell, Mitradev; Masson, Chantal] Novartis Pharmaceut, Basel, Switzerland; [Diem, Peter] Univ Hosp Bern, Inselspital, Div Endocrinol Diabet & Clin Nutr, CH-3010 Bern, Switzerland; [Diem, Peter] Univ Bern, Bern, Switzerland; [Hua, Tsushung A.] Novartis Pharmaceut, E Hanover, NJ USA; [Belenkov, Yuri; Mareev, Viacheslav] Moscow MV Lomonosov State Univ, Moscow 117234, Russia; [Buckley, Brendan M.] Natl Univ Ireland Univ Coll Cork, Cork, Ireland; [Chacra, Antonio R.] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Chiang, Fu-Tien] Natl Taiwan Univ Hosp, Dept Cardiol, Taipei, Taiwan; [Charbonnel, Bernard] Univ Hosp, Dept Endocrinol, Nantes, France; [Chow, Chun-Chung] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Pan, Changyu] 301 Hosp, Dept Endocrinol, Beijing, Peoples R China; [Deedwania, Prakash] Calif State Univ Fresno, San Francisco Program Fresno, Div Cardiol, Fresno, CA 93740 USA; [Deedwania, Prakash] VA Cent Calif Hlth Care Syst, Fresno, CA USA; [Einhorn, Daniel] Univ Calif San Diego, La Jolla, CA 92093 USA; [Einhorn, Daniel] Scripps Whittier Diabet Inst, La Jolla, CA USA; [Fonseca, Vivian] Tulane Univ, Sch Med, Dept Endocrinol, New Orleans, LA 70112 USA; [Giles, Thomas] Tulane Univ, Sch Med, Inst Heart & Vasc, New Orleans, LA 70112 USA; [Fulcher, Gregory R.] Univ Sydney, Royal N Shore Hosp, Sydney, NSW 2006, Australia; [Krum, Henry] Monash Univ, Alfred Hosp, Clin Pharmacol Unit, Dept Epidemiol & Prevent Med, Prahran, Vic, Australia; [Gaciong, Zbigniew] Warsaw Med Univ, Dept Internal Med Hypertens & Vasc Dis, Warsaw, Poland; [Gaztambide, Sonia] Hosp Univ Cruces, Dept Endocrinol, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Baracaldo, Spain; [Horton, Edward] Joslin Diabet Ctr, Boston, MA 02215 USA; [Ilkova, Hasan] Istanbul Univ, Dept Diabet Endocrinol & Metab, Istanbul, Turkey; [Jenssen, Trond] Oslo Univ Hosp, Rikshosp, Oslo Inst Clin Med, Tromso, Norway; [Jenssen, Trond] Univ Tromso, Tromso, Norway; [Kahn, Steven E.] VA Puget Sound Hlth Care Syst, Seattle, WA USA; [Kahn, Steven E.] Univ Washington, Seattle, WA 98195 USA; [Laakso, Markku] Univ Kuopio, FIN-70211 Kuopio, Finland; [Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Tuomilehto, Jaako] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Tuomilehto, Jaako] S Ostrobothnia Cent Hosp, Seinajoki, Finland; [Leiter, Lawrence A.] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Levitt, Naomi S.] Univ Cape Town, Dept Med, Endocrine Unit, Groote Schuur Hosp, ZA-7925 Cape Town, South Africa; [Martinez, Felipe] Natl Univ Cordoba, Cordoba, Spain; [Sinay, Isaac] Univ Buenos Aires, Inst Cardiovasc Buenos Aires, Buenos Aires, DF, Argentina; [Villamil, Alberto S.] Univ Buenos Aires, Hypertens Unit, Div Cardiol, Argerich Hosp, Buenos Aires, DF, Argentina; [Mazzone, Theodore] Univ Illinois, Dept Diabet & Metab, Chicago, IL USA; [Meaney, Eduardo] Hosp 10 Octubre, Inst Seguridad & Serv Sociales Trabajadores Estad, Mexico City, DF, Mexico; [Nesto, Richard] Lahey Clin Fdn, Burlington, MA USA; [Prager, Rudolf] Krankenhaus Hietzing Neurolog, Zentrum Rosenhugel, Hietzig Hosp, Vienna, Austria; [Raptis, Sotirios A.] Attikon Univ Hosp, Hellen Natl Diabet Ctr, Dept Internal Med Endocrinol & Diabetol 2, Athens, Greece; [Rutten, Guy E. H. M.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Sandstroem, Herbert] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Schaper, Frank] Tech Univ Dresden, Ctr Clin Studies Metab & Endocrinol Knowledge & T, D-8027 Dresden, Germany; [Scheen, Andre] Univ Liege, Div Diabet, Liege, Belgium; [Scheen, Andre] Univ Liege, Clin Pharmacol Unit, Ctr Hosp Univ Liege, Liege, Belgium; [Schmitz, Ole] Aarhus Univ, Med Dept Endocrinol & Diabet M, Arhus Univ Hosp, Aarhus, Denmark; [Schmitz, Ole] Aarhus Univ, Dept Clin Pharmacol, Aarhus, Denmark; [Stender, Steen] Univ Copenhagen, Gentofte Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Soska, Vladimir] Fac Hosp St Anna, Clin Internal Med 2, Brno, Czech Republic; [Soska, Vladimir] Fac Hosp St Anna, Dept Clin Biochem, Brno, Czech Republic; [Tamas, Gyula] Semmelweis Univ, Diabet Unit, Dept Med 1, H-1085 Budapest, Hungary; [Tognoni, Gianni] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, I-66030 Santa Maria Imbaro, Italy; [Vozar, Juraj] Diabetol Outpatient Clin, Jesenius Samaria, Samorin, Slovakia	University of Oxford; University of Glasgow; University of Leicester; University of Texas System; University of Texas Health San Antonio; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Novartis; University of Bern; University Hospital of Bern; University of Bern; Novartis; Lomonosov Moscow State University; University College Cork; Universidade Federal de Sao Paulo (UNIFESP); National Taiwan University; National Taiwan University Hospital; Nantes Universite; CHU de Nantes; Chinese University of Hong Kong; Prince of Wales Hospital; California State University System; California State University Fresno; University of California System; University of California San Diego; Tulane University; Tulane University; Royal North Shore Hospital; University of Sydney; Florey Institute of Neuroscience & Mental Health; Monash University; Medical University of Warsaw; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Hospital Universitario Cruces; Harvard University; Joslin Diabetes Center, Inc.; Istanbul University; University of Oslo; National Hospital Norway; UiT The Arctic University of Tromso; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Helsinki; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Cape Town; Instituto Cardiovascular de Buenos Aires (ICBA); University of Buenos Aires; University of Buenos Aires; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Lahey Hospital & Medical Center; Hietzing Hospital; University Hospital Attikon; Utrecht University; Utrecht University Medical Center; Umea University; Technische Universitat Dresden; University of Liege; University of Liege; Aarhus University; Aarhus University; University of Copenhagen; Herlev & Gentofte Hospital; St Anne's University Hospital Brno (FNUSA-ICRC); St Anne's University Hospital Brno (FNUSA-ICRC); Semmelweis University; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Holman, RR (corresponding author), Churchill Hosp, Diabet Trials Unit, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England.	rury.holman@dtu.ox.ac.uk	mcmurray, John/B-2467-2013; Leiter, Lawrence/AAG-4059-2020; Diem, Peter/A-7650-2008; Belenkov, Yury N/B-4159-2018; ALMEIDA, FERNANDO/S-1880-2019; Buse, John Bernard/J-9742-2019; Holzhauer, Bjoern/AAR-2582-2020; Gaztambide, Sonia/E-1760-2012; Mareev, Viacheslav Yurivich/Q-1375-2017	mcmurray, John/0000-0002-6317-3975; Diem, Peter/0000-0002-1190-9880; ALMEIDA, FERNANDO/0000-0002-9404-9707; Buse, John Bernard/0000-0002-9723-3876; Holzhauer, Bjoern/0000-0002-9209-757X; Mareev, Viacheslav Yurivich/0000-0002-7285-2048; GAZTAMBIDE, SONIA/0000-0003-3569-2265; CHIANG, FU-TIEN/0000-0003-4936-8968	Novartis Pharma	Novartis Pharma	Supported by Novartis Pharma.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], 2008, GUID IND DIAB MELL E; Bethel MA, 2008, AM HEART J, V156, P633, DOI 10.1016/j.ahj.2008.05.018; Borch-Johnsen K, 1999, LANCET, V354, P617; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Califf RM, 2008, AM HEART J, V156, P623, DOI 10.1016/j.ahj.2008.05.017; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Chiasson JL, 2003, JAMA-J AM MED ASSOC, V290, P486, DOI 10.1001/jama.290.4.486; COX DR, 1972, J R STAT SOC B, V187, P220; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; GERSTEIN HC, 2006, LANCET, V368, P1770; HOLMAN RR, 2007, DIAB VASC DIS RES S1, V4, pS40; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P5824, DOI 10.1210/jc.86.12.5824; Karunakaran S, 1997, METABOLISM, V46, P56, DOI 10.1016/S0026-0495(97)90319-X; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; McMurray JJ, 2010, NEW ENGL J MED, V362, P1477, DOI 10.1056/NEJMoa1001121; Murthy K, 2005, KIDNEY INT, V68, P1884, DOI 10.1111/j.1523-1755.2005.00608.x; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Saloranta C, 2002, DIABETES CARE, V25, P2141, DOI 10.2337/diacare.25.12.2141; SARTOR G, 1980, DIABETES, V29, P41, DOI 10.2337/diabetes.29.1.41; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Uto Y, 2002, METABOLISM, V51, P20, DOI 10.1053/meta.2002.29008	28	327	341	1	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 22	2010	362	16					1463	1476		10.1056/NEJMoa1001122	http://dx.doi.org/10.1056/NEJMoa1001122			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586GP	20228402	Green Published			2022-12-28	WOS:000276894700006
J	McMurray, JJ; Holman, RR; Haffner, SM; Bethel, MA; Holzhauer, B; Hua, TA; Belenkov, Y; Boolell, M; Buse, JB; Buckley, BM; Chacra, AR; Chiang, FT; Charbonnel, B; Chow, CC; Davies, MJ; Deedwania, P; Diem, P; Einhorn, D; Fonseca, V; Fulcher, GR; Gaciong, Z; Gaztambide, S; Giles, T; Horton, E; Ilkova, H; Jenssen, T; Kahn, SE; Krum, H; Laakso, M; Leiter, LA; Levitt, NS; Mareev, V; Martinez, F; Masson, C; Mazzone, T; Meaney, E; Nesto, R; Pan, CY; Prager, R; Raptis, SA; Rutten, GEHM; Sandstroem, H; Schaper, F; Scheen, A; Schmitz, O; Sinay, I; Soska, V; Stender, S; Tamas, G; Tognoni, G; Tuomilehto, J; Villamil, AS; Vozar, J; Califf, RM				McMurray, John J.; Holman, Rury R.; Haffner, Steven M.; Bethel, M. Angelyn; Holzhauer, Bjoern; Hua, Tsushung A.; Belenkov, Yuri; Boolell, Mitradev; Buse, John B.; Buckley, Brendan M.; Chacra, Antonio R.; Chiang, Fu-Tien; Charbonnel, Bernard; Chow, Chun-Chung; Davies, Melanie J.; Deedwania, Prakash; Diem, Peter; Einhorn, Daniel; Fonseca, Vivian; Fulcher, Gregory R.; Gaciong, Zbigniew; Gaztambide, Sonia; Giles, Thomas; Horton, Edward; Ilkova, Hasan; Jenssen, Trond; Kahn, Steven E.; Krum, Henry; Laakso, Markku; Leiter, Lawrence A.; Levitt, Naomi S.; Mareev, Viacheslav; Martinez, Felipe; Masson, Chantal; Mazzone, Theodore; Meaney, Eduardo; Nesto, Richard; Pan, Changyu; Prager, Rudolf; Raptis, Sotirios A.; Rutten, Guy E. H. M.; Sandstroem, Herbert; Schaper, Frank; Scheen, Andre; Schmitz, Ole; Sinay, Isaac; Soska, Vladimir; Stender, Steen; Tamas, Gyula; Tognoni, Gianni; Tuomilehto, Jaako; Villamil, Alberto S.; Vozar, Juraj; Califf, Robert M.		NAVIGATOR Study Grp	Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; CONVERTING-ENZYME-INHIBITORS; LIFE-STYLE INTERVENTIONS; FASTING GLUCOSE; MELLITUS; PREVENTION; TRIAL; COMPONENTS; DIAGNOSIS; DISEASE	BACKGROUND It is not known whether drugs that block the renin-angiotensin system reduce the risk of diabetes and cardiovascular events in patients with impaired glucose tolerance. METHODS In this double-blind, randomized clinical trial with a 2-by-2 factorial design, we assigned 9306 patients with impaired glucose tolerance and established cardiovascular disease or cardiovascular risk factors to receive valsartan (up to 160 mg daily) or placebo (and nateglinide or placebo) in addition to lifestyle modification. We then followed the patients for a median of 5.0 years for the development of diabetes (6.5 years for vital status). We studied the effects of valsartan on the occurrence of three coprimary outcomes: the development of diabetes; an extended composite outcome of death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, hospitalization for heart failure, arterial revascularization, or hospitalization for unstable angina; and a core composite outcome that excluded unstable angina and revascularization. RESULTS The cumulative incidence of diabetes was 33.1% in the valsartan group, as compared with 36.8% in the placebo group (hazard ratio in the valsartan group, 0.86; 95% confidence interval [CI], 0.80 to 0.92; P<0.001). Valsartan, as compared with placebo, did not significantly reduce the incidence of either the extended cardiovascular outcome (14.5% vs. 14.8%; hazard ratio, 0.96; 95% CI, 0.86 to 1.07; P = 0.43) or the core cardiovascular outcome (8.1% vs. 8.1%; hazard ratio, 0.99; 95% CI, 0.86 to 1.14; P = 0.85). CONCLUSIONS Among patients with impaired glucose tolerance and cardiovascular disease or risk factors, the use of valsartan for 5 years, along with lifestyle modification, led to a relative reduction of 14% in the incidence of diabetes but did not reduce the rate of cardiovascular events. (ClinicalTrials.gov number, NCT00097786.)	[McMurray, John J.] Univ Glasgow, British Heart Fdn, Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Holman, Rury R.; Bethel, M. Angelyn] Univ Oxford, Diabet Trials Unit, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Haffner, Steven M.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Bethel, M. Angelyn] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Holzhauer, Bjoern; Boolell, Mitradev; Masson, Chantal] Novartis Pharmaceut, Basel, Switzerland; [Hua, Tsushung A.] Novartis Pharmaceut, E Hanover, NJ USA; [Belenkov, Yuri; Fonseca, Vivian] Moscow MV Lomonosov State Univ, Moscow 117234, Russia; [Buse, John B.] Univ N Carolina, Sch Med, Div Gen Med & Clin Epidemiol, Diabet Care Ctr, Chapel Hill, NC USA; [Buckley, Brendan M.] Natl Univ Ireland Univ Coll Cork, Cork, Ireland; [Chacra, Antonio R.] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Chiang, Fu-Tien] Natl Taiwan Univ Hosp, Dept Cardiol, Taipei, Taiwan; [Charbonnel, Bernard] Univ Hosp, Dept Endocrinol, Nantes, France; [Chow, Chun-Chung] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Davies, Melanie J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Deedwania, Prakash] Calif State Univ Fresno, San Francisco Program Fresno, Div Cardiol, Fresno, CA 93740 USA; [Deedwania, Prakash] VA Cent Calif Hlth Care Syst, Fresno, CA USA; [Diem, Peter] Univ Hosp Bern, Inselspital, Div Endocrinol Diabet & Clin Nutr, CH-3010 Bern, Switzerland; [Diem, Peter] Univ Bern, Bern, Switzerland; [Einhorn, Daniel] Univ Calif San Diego, La Jolla, CA 92093 USA; [Einhorn, Daniel] Scripps Whittier Diabet Inst, La Jolla, CA USA; [Fonseca, Vivian] Tulane Univ, Dept Endocrinol, New Orleans, LA 70118 USA; [Fulcher, Gregory R.] Univ Sydney, Royal N Shore Hosp, Sydney, NSW 2006, Australia; [Gaciong, Zbigniew] Warsaw Med Univ, Dept Internal Med Hypertens & Vasc Dis, Warsaw, Poland; [Gaztambide, Sonia] Hosp Univ Cruces, CIBERDEM, Dept Endocrinol, Baracaldo, Spain; [Giles, Thomas] Tulane Univ, Sch Med, Inst Heart & Vasc, New Orleans, LA 70112 USA; [Horton, Edward] Joslin Diabet Ctr, Boston, MA 02215 USA; [Ilkova, Hasan] Istanbul Univ, Dept Diabet Endocrinol & Metab, Istanbul, Turkey; [Jenssen, Trond] Oslo Univ Hosp, Rikshosp, Oslo, Norway; [Jenssen, Trond] Univ Tromso, Inst Clin Med, Tromso, Norway; [Kahn, Steven E.] VA Puget Sound Hlth Care Syst, Seattle, WA USA; [Kahn, Steven E.] Univ Washington, Seattle, WA 98195 USA; [Krum, Henry] Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Clin Pharmacol Unit, Prahran, Vic, Australia; [Laakso, Markku] Univ Kuopio, FIN-70211 Kuopio, Finland; [Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Leiter, Lawrence A.] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Levitt, Naomi S.] Univ Cape Town, Dept Med, Groote Schuur Hosp, ZA-7925 Cape Town, South Africa; [Martinez, Felipe] Natl Univ Cordoba, Cordoba, Argentina; [Mazzone, Theodore] Univ Illinois, Dept Diabet & Metab, Chicago, IL USA; [Meaney, Eduardo] Hosp Primero Octubre, Mexico City, DF, Mexico; [Nesto, Richard] Lahey Clin Fdn, Burlington, MA USA; [Pan, Changyu] 301 Hosp, Dept Endocrinol, Beijing, Peoples R China; [Prager, Rudolf] Krankenhaus Hietzing Neurol, Zentrum Rosenhugel, Hietzig Hosp, Vienna, Austria; [Raptis, Sotirios A.] Attikon Univ Hosp, Hellen Natl Diabet Ctr, Dept Internal Med Endocrinol & Diabetol 2, Athens, Greece; [Rutten, Guy E. H. M.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Sandstroem, Herbert] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Schaper, Frank] Tech Univ Dresden, Ctr Clin Studies Metab & Endocrinol Knowledge & T, D-8027 Dresden, Germany; [Scheen, Andre] Univ Liege, Div Diabet, Liege, Belgium; [Scheen, Andre] Univ Liege, Clin Pharmacol Unit, Ctr Hosp Univ Liege, Liege, Belgium; [Schmitz, Ole] Aarhus Univ, Med Dept Endocrinol & Diabet M, Aarhus, Denmark; [Schmitz, Ole] Aarhus Univ, Dept Clin Pharmacol, Aarhus, Denmark; [Sinay, Isaac] Inst Cardiovasc Buenos Aires, Buenos Aires, DF, Argentina; [Soska, Vladimir] Fac Hosp St Anna, Dept Clin Biochem, Brno, Czech Republic; [Soska, Vladimir] Fac Hosp St Anna, Clin Internal Med 2, Brno, Czech Republic; [Stender, Steen] Univ Copenhagen, Gentofte Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Tamas, Gyula] Semmelweis Univ, Diabet Unit, Dept Med 1, H-1085 Budapest, Hungary; [Tognoni, Gianni] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, I-66030 Santa Maria Imbaro, Italy; [Tuomilehto, Jaako] Univ Helsinki, Hjelt Inst, Helsinki, Finland; [Tuomilehto, Jaako] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Tuomilehto, Jaako] S Ostrobothnia Cent Hosp, Seinajoki, Finland; [Villamil, Alberto S.] Univ Buenos Aires, Div Cardiol, Hypertens Unit, Argerich Hosp, Buenos Aires, DF, Argentina; [Vozar, Juraj] Diabetol Outpatient Clin, Jesenius Samaria, Samorin, Slovakia; [Califf, Robert M.] Duke Univ, Duke Translat Med Inst, Durham, NC USA	University of Glasgow; University of Oxford; University of Texas System; University of Texas Health San Antonio; Duke University; Novartis; Novartis; Lomonosov Moscow State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University College Cork; Universidade Federal de Sao Paulo (UNIFESP); National Taiwan University; National Taiwan University Hospital; Nantes Universite; CHU de Nantes; Chinese University of Hong Kong; Prince of Wales Hospital; University of Leicester; California State University System; California State University Fresno; University of Bern; University Hospital of Bern; University of Bern; University of California System; University of California San Diego; Tulane University; Royal North Shore Hospital; University of Sydney; Medical University of Warsaw; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Hospital Universitario Cruces; Tulane University; Harvard University; Joslin Diabetes Center, Inc.; Istanbul University; University of Oslo; National Hospital Norway; UiT The Arctic University of Tromso; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; Florey Institute of Neuroscience & Mental Health; Monash University; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Cape Town; National University of Cordoba; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Lahey Hospital & Medical Center; Hietzing Hospital; University Hospital Attikon; Utrecht University; Utrecht University Medical Center; Umea University; Technische Universitat Dresden; University of Liege; University of Liege; Aarhus University; Aarhus University; Instituto Cardiovascular de Buenos Aires (ICBA); St Anne's University Hospital Brno (FNUSA-ICRC); St Anne's University Hospital Brno (FNUSA-ICRC); University of Copenhagen; Herlev & Gentofte Hospital; Semmelweis University; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Helsinki; University of Helsinki; University of Buenos Aires; Duke University	Califf, RM (corresponding author), Duke Translat Med Inst, POB 17969, Durham, NC 27715 USA.	calif001@mc.duke.edu	Gaztambide, Sonia/E-1760-2012; Mareev, Viacheslav Yurivich/Q-1375-2017; Buse, John Bernard/J-9742-2019; Belenkov, Yury N/B-4159-2018; ALMEIDA, FERNANDO/S-1880-2019; Holzhauer, Bjoern/AAR-2582-2020; mcmurray, John/B-2467-2013; Diem, Peter/A-7650-2008; Leiter, Lawrence/AAG-4059-2020	Mareev, Viacheslav Yurivich/0000-0002-7285-2048; Buse, John Bernard/0000-0002-9723-3876; ALMEIDA, FERNANDO/0000-0002-9404-9707; Holzhauer, Bjoern/0000-0002-9209-757X; mcmurray, John/0000-0002-6317-3975; Diem, Peter/0000-0002-1190-9880; GAZTAMBIDE, SONIA/0000-0003-3569-2265; CHIANG, FU-TIEN/0000-0003-4936-8968; Davies, Melanie/0000-0002-9987-9371; Kahn, Steven/0000-0001-7307-9002; stender, steen/0000-0003-1037-1158	Novartis Pharma	Novartis Pharma	Supported by Novartis Pharma.	Abuissa H, 2005, J AM COLL CARDIOL, V46, P821, DOI 10.1016/j.jacc.2005.05.051; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Barzilay JI, 2006, ARCH INTERN MED, V166, P2191, DOI 10.1001/archinte.166.20.2191; Bethel MA, 2008, AM HEART J, V156, P633, DOI 10.1016/j.ahj.2008.05.018; Bethel MA, 2007, AM J CARDIOL, V99, P726, DOI 10.1016/j.amjcard.2006.09.122; Borch-Johnsen K, 1999, LANCET, V354, P617; Bosch J, 2006, NEW ENGL J MED, V355, P1551; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Califf RM, 2008, AM HEART J, V156, P623, DOI 10.1016/j.ahj.2008.05.017; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; Elliott WJ, 2007, LANCET, V369, P1518; Fox KM, 2003, LANCET, V362, P782; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; GERSTEIN HC, 2006, LANCET, V368, P1770; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Gress TW, 2000, NEW ENGL J MED, V342, P905, DOI 10.1056/NEJM200003303421301; Holman RR, 2010, NEW ENGL J MED, V362, P1463, DOI 10.1056/NEJMoa1001122; Ilanne-Parikka P, 2008, DIABETES CARE, V31, P805, DOI 10.2337/dc07-1117; Ingelfinger JR, 2006, NEW ENGL J MED, V355, P1608, DOI 10.1056/NEJMe068213; Jandeleit-Dahm KAM, 2005, J HYPERTENS, V23, P463, DOI 10.1097/01.hjh.0000160198.05416.72; Kjeldsen SE, 2006, J HYPERTENS, V24, P1405, DOI 10.1097/01.hjh.0000234122.55895.5b; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Murthy K, 2005, KIDNEY INT, V68, P1884, DOI 10.1111/j.1523-1755.2005.00608.x; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Razak F, 2005, CIRCULATION, V111, pE254; Scheen AJ, 2004, DIABETES METAB, V30, P498, DOI 10.1016/S1262-3636(07)70147-7; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Yusuf S, 2008, LANCET, V372, P1384; Yusuf S, 2008, LANCET, V372, P1174, DOI 10.1016/S0140-6736(08)61242-8; Yusuf S, 2005, CIRCULATION, V112, P48, DOI 10.1161/CIRCULATIONAHA.104.528166; Yusuf S, 2001, JAMA-J AM MED ASSOC, V286, P1882, DOI 10.1001/jama.286.15.1882; Yusuf S, 2000, NEW ENGL J MED, V342, P145	40	483	499	0	62	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 22	2010	362	16					1477	1490		10.1056/NEJMoa1001121	http://dx.doi.org/10.1056/NEJMoa1001121			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586GP	20228403	Green Published, Bronze			2022-12-28	WOS:000276894700007
J	Waeber, B; Feihl, F				Waeber, Bernard; Feihl, Francois			Blood-pressure reduction with LCZ696	LANCET			English	Editorial Material							HYPERTENSION		[Waeber, Bernard] CHU Vaudois, Div Pathophysiol, CH-1011 Lausanne, Switzerland; Univ Lausanne, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Waeber, B (corresponding author), CHU Vaudois, Div Pathophysiol, CH-1011 Lausanne, Switzerland.	Bernard.Waeber@chuv.ch						Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Falaschetti E, 2009, HYPERTENSION, V53, P480, DOI 10.1161/HYPERTENSIONAHA.108.125617; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Levin ER, 1998, NEW ENGL J MED, V339, P321; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Messerli FH, 2000, LANCET, V356, P608, DOI 10.1016/S0140-6736(00)02596-4; Ruilope LM, 2010, LANCET, V375, P1255, DOI 10.1016/S0140-6736(09)61966-8; Struijker-Boudier HAJ, 2007, INT J CLIN PRACT, V61, P1592, DOI 10.1111/j.1742-1241.2007.01302.x; Wang YR, 2007, ARCH INTERN MED, V167, P141, DOI 10.1001/archinte.167.2.141; Weber MA, 2001, LANCET, V358, P1525, DOI 10.1016/S0140-6736(01)06584-9	10	4	8	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 10	2010	375	9722					1228	1229		10.1016/S0140-6736(10)60363-7	http://dx.doi.org/10.1016/S0140-6736(10)60363-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585VN	20236699				2022-12-28	WOS:000276858400005
J	Kinchen, JM; Ravichandran, KS				Kinchen, Jason M.; Ravichandran, Kodi S.			Identification of two evolutionarily conserved genes regulating processing of engulfed apoptotic cells	NATURE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; PHAGOSOME MATURATION; DEATH; DEGRADATION; RECEPTOR; ENDOCYTOSIS; MECHANISMS; PROTEINS; PATHWAY	Engulfment of apoptotic cells occurs throughout life in multicellular organisms. Impaired apoptotic cell clearance (due to defective recognition, internalization or degradation) results in autoimmune disease(1,2). One fundamental challenge in understanding how defects in corpse removal translate into diseased states is the identification of critical components orchestrating the different stages of engulfment. Here we use genetic, cell biological and molecular studies in Caenorhabditis elegans and mammalian cells to identify SAND-1 and its partner CCZ-1 as new factors in corpse removal. In worms deficient in either sand-1 or ccz-1, apoptotic cells are internalized and the phagosomes recruit the small GTPase RAB-5 but fail to progress to the subsequent RAB-7(+) stage. The mammalian orthologues of SAND-1, namely Mon1a and Mon1b, were similarly required for phagosome maturation. Mechanistically, Mon1 interacts with GTP-bound Rab5, identifying Mon1 as a previously unrecognized Rab5 effector. Moreover, a Mon1-Ccz1 complex (but not either protein alone) could bind Rab7 and could also influence Rab7 activation, suggesting Mon1-Ccz1 as an important link in progression from the Rab5-positive stage to the Rab7-positive stage of phagosome maturation. Taken together, these data identify SAND-1 (Mon1) and CCZ-1 (Ccz1) as critical and evolutionarily conserved components regulating the processing of ingested apoptotic cell corpses.	[Kinchen, Jason M.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Ravichandran, Kodi S.] Univ Virginia, Beirne Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Kinchen, Jason M.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA.	kinchen@virginia.edu; ravi@virginia.edu	Kinchen, Jason/ABC-5663-2021	Kinchen, Jason/0000-0001-8430-2265; Ravichandran, Kodi/0000-0001-9049-1410	NIH; American Heart Association; NIGMS/NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069998, R01GM064709] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIGMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Casanova, C. Grimsley and members of the Ravichandran laboratory for helpful conversations; the Caenorhabditis Genetics Consortium (CGC) for nematode strains; A. Wandinger-Ness for Rab7 expression constructs; and J. Redick and S. Guillot of the Advanced Microscopy Facility for the preparation of specimens for electron microscopy. This work was supported by a post-doctoral fellowship via an NIH T32 Immunology Training Grant and American Heart Association Award (to J. M. K.), and grants from the NIGMS/NIH (to K. S. R.). K. S. R. is a William Benter Senior Fellow of the American Asthma Foundation.	Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308; BRENNER S, 1974, GENETICS, V77, P71; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Gengyo-Ando K, 2007, EMBO REP, V8, P152, DOI 10.1038/sj.embor.7400882; Grimsley CM, 2006, J BIOL CHEM, V281, P5928, DOI 10.1074/jbc.M510647200; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hackam DJ, 1997, J BIOL CHEM, V272, P29810, DOI 10.1074/jbc.272.47.29810; Hoeppner DJ, 2004, DEV BIOL, V274, P125, DOI 10.1016/j.ydbio.2004.06.022; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; KARNATH RS, 2003, NATURE, V421, P231; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Kinchen JM, 2008, NAT CELL BIOL, V10, P556, DOI 10.1038/ncb1718; Kinchen JM, 2005, CURR TOP DEV BIOL, V65, P1; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Lettre G, 2004, CELL DEATH DIFFER, V11, P1198, DOI 10.1038/sj.cdd.4401488; Li WD, 2009, DEVELOPMENT, V136, P2445, DOI 10.1242/dev.035949; Lu Q, 2008, DEVELOPMENT, V135, P1069, DOI 10.1242/dev.016063; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Poteryaev D, 2007, EMBO J, V26, P301, DOI 10.1038/sj.emboj.7601498; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Sun J, 2007, J LEUKOCYTE BIOL, V82, P1437, DOI 10.1189/jlb.0507289; Tosello-Trampont AC, 2007, CELL DEATH DIFFER, V14, P963, DOI 10.1038/sj.cdd.4402094; Tosello-Trampont AC, 2001, J BIOL CHEM, V276, P13797, DOI 10.1074/jbc.M011238200; Wang CW, 2003, J CELL BIOL, V163, P973, DOI 10.1083/jcb.200308071; Yu XM, 2008, PLOS BIOL, V6, P581, DOI 10.1371/journal.pbio.0060061; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	35	166	177	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2010	464	7289					778	U157		10.1038/nature08853	http://dx.doi.org/10.1038/nature08853			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20305638	Green Accepted			2022-12-28	WOS:000276205000049
J	Benson, RBJ; Barrett, PM; Rich, TH; Vickers-Rich, P				Benson, Roger B. J.; Barrett, Paul M.; Rich, Tom H.; Vickers-Rich, Pat			A Southern Tyrant Reptile	SCIENCE			English	Article							DINOSAUR		[Benson, Roger B. J.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Barrett, Paul M.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Rich, Tom H.; Vickers-Rich, Pat] Museum Victoria, Dept Paleontol, Melbourne, Vic 3000, Australia; [Rich, Tom H.; Vickers-Rich, Pat] Monash Univ, Sch Geosci, Clayton, Vic 3800, Australia	University of Cambridge; Natural History Museum London; Museum Victoria; Monash University	Benson, RBJ (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	rbb27@cam.ac.uk	Barrett, Paul M/A-2648-2010; Benson, Roger/A-1252-2011	Barrett, Paul M/0000-0003-0412-3000; Benson, Roger/0000-0001-8244-6177				Norell Mark A., 1997, American Museum Novitates, V3215, P1; Rauhut OWM, 2010, ZOOL J LINN SOC-LOND, V158, P155, DOI 10.1111/j.1096-3642.2009.00591.x; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Sereno PC, 2009, SCIENCE, V326, P418, DOI 10.1126/science.1177428; WAGSTAFF BE, 1989, NATL GEOGR RES, V5, P54; Xu X, 2006, NATURE, V439, P715, DOI 10.1038/nature04511	6	39	44	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2010	327	5973					1613	1613		10.1126/science.1187456	http://dx.doi.org/10.1126/science.1187456			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339066				2022-12-28	WOS:000275970600034
J	Stenestrand, U; Wijkman, M; Fredrikson, M; Nystrom, FH				Stenestrand, Ulf; Wijkman, Magnus; Fredrikson, Mats; Nystrom, Fredrik H.			Association Between Admission Supine Systolic Blood Pressure and 1-Year Mortality in Patients Admitted to the Intensive Care Unit for Acute Chest Pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYOCARDIAL-INFARCTION; HEART-FAILURE; RISK-FACTORS; HYPERTENSION; DISEASE; POPULATION; OUTCOMES	Context High resting blood pressure (BP) is among the best studied and established risk factors for cardiovascular disease. However, little is known about the relationship between BP under acute stress, such as in acute chest pain, and subsequent mortality. Objective To study long-term mortality related to supine BP in patients admitted to the medical intensive care unit (ICU) for acute chest pain. Design, Setting, and Participants Data from the RIKS-HIA (Registry of Information and Knowledge About Swedish Heart Intensive Care Admissions) was used to analyze the mortality in relation to supine admission systolic BP in 119 151 participants who were treated at the ICU for the symptom of chest pain from 1997 through 2007. Results from this prospective cohort study were presented according to systolic BP quartiles: Q1, less than 128 mm Hg; Q2, from 128 to 144 mm Hg; Q3, from 145 to 162 mm Hg; and Q4, at or above 163 mm Hg. Main Outcome Measure Total mortality. Results Mean (SD) follow-up time was 2.47 (1.5) years (range, 1-10 years). One-year mortality rate by Cox proportional hazard model (adjusted for age, sex, smoking, diastolic BP, use of antihypertensive medication at admission and discharge, and use of lipid-lowering and antiplatelet medication at discharge) showed that participants in Q4 had the best prognosis (hazard ratio [HR], 0.76; 95% confidence interval [CI], 0.72-0.80, Q4 compared with Q2; corresponding risks for Q1 were HR, 1.46; 95% CI, 1.39-1.52, and for Q3, HR, 0.83; 95% CI, 0.79-0.87). Patients in Q4 had a 21.7% lower absolute risk compared with Q2, patients in Q3 had a 15.2% lower risk than in Q2, and patients in Q1 had a 40.3% higher risk for mortality than in Q2. The worse prognosis in Q2 compared with Q4 was independent of body mass index and previous diagnoses and similar when analysis was restricted to patients with a final diagnosis of angina or myocardial infarction (HR, 0.75; 95% CI, 0.71-0.80, Q4 compared with Q2). Conclusion Among patients admitted to the ICU for chest pain, there is an inverse association between admission supine systolic BP and 1-year mortality rate. JAMA. 2010; 303(12): 1167-1172	[Stenestrand, Ulf; Wijkman, Magnus; Nystrom, Fredrik H.] Linkoping Univ, Dept Med & Hlth Sci, Fac Hlth Sci, SE-58185 Linkoping, Sweden; [Wijkman, Magnus; Nystrom, Fredrik H.] Linkoping Univ, Diabet Res Ctr, Fac Hlth Sci, SE-58185 Linkoping, Sweden; [Fredrikson, Mats] Linkoping Univ, Dept Clin & Expt Med, Fac Hlth Sci, SE-58185 Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University	Nystrom, FH (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Fac Hlth Sci, SE-58185 Linkoping, Sweden.	fredrik.nystrom@lio.se		Nystrom, Fredrik/0000-0002-1680-1000				Amar J, 2002, HEART, V88, P587, DOI 10.1136/heart.88.6.587; Boggia J, 2007, LANCET, V370, P1219, DOI 10.1016/S0140-6736(07)61538-4; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; FOLKOW B, 1982, PHYSIOL REV, V62, P347, DOI 10.1152/physrev.1982.62.2.347; Franklin SS, 2001, CIRCULATION, V103, P1245; Franklin SS, 1997, CIRCULATION, V96, P308; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005; Mundal R, 1996, HYPERTENSION, V27, P324, DOI 10.1161/01.HYP.27.3.324; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Staessen JA, 2003, LANCET, V361, P1629, DOI 10.1016/S0140-6736(03)13302-8; Stenestrand U, 2006, JAMA-J AM MED ASSOC, V296, P1749, DOI 10.1001/jama.296.14.1749; Tabrizi F, 2007, EUR HEART J, V28, P2449, DOI 10.1093/eurheartj/ehm262; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	16	28	31	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2010	303	12					1167	1172		10.1001/jama.2010.314	http://dx.doi.org/10.1001/jama.2010.314			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573AC	20332402				2022-12-28	WOS:000275879600021
J	Bawa, KS; Koh, LP; Lee, TM; Liu, JG; Ramakrishnan, PS; Yu, DW; Zhang, YP; Raven, PH				Bawa, Kamaljit S.; Koh, Lian Pin; Lee, Tien Ming; Liu, Jianguo; Ramakrishnan, P. S.; Yu, Douglas W.; Zhang, Ya-ping; Raven, Peter H.			China, India, and the Environment	SCIENCE			English	Editorial Material							BIODIVERSITY; CLIMATE; WATER		[Raven, Peter H.] Missouri Bot Garden, St Louis, MO 63166 USA; [Bawa, Kamaljit S.] Univ Massachusetts, Boston, MA 02125 USA; [Bawa, Kamaljit S.] Harvard Univ, Sustainabil Sci Program, Cambridge, MA 02138 USA; [Bawa, Kamaljit S.] Ashoka Trust Res Ecol & Environm, Bangalore 560024, Karnataka, India; [Lee, Tien Ming] Univ Calif San Diego, La Jolla, CA 92093 USA; [Lee, Tien Ming] Yale Univ, New Haven, CT 06520 USA; [Liu, Jianguo] Michigan State Univ, E Lansing, MI 48824 USA; [Ramakrishnan, P. S.] Jawaharlal Nehru Univ, New Delhi 110067, India; [Yu, Douglas W.; Zhang, Ya-ping] Kunming Inst Zool, Yunnan 650223, Peoples R China; [Yu, Douglas W.] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England; [Koh, Lian Pin] ETH, Inst Terr Ecosyst, CH-8092 Zurich, Switzerland	Missouri Botanical Gardens; University of Massachusetts System; University of Massachusetts Boston; Harvard University; University of California System; University of California San Diego; Yale University; Michigan State University; Jawaharlal Nehru University, New Delhi; Chinese Academy of Sciences; Kunming Institute of Zoology; University of East Anglia; Swiss Federal Institutes of Technology Domain; ETH Zurich	Raven, PH (corresponding author), Missouri Bot Garden, St Louis, MO 63166 USA.	peter.raven@mobot.org	Liu, Jianguo/G-5211-2015; Koh, Lian Pin/A-5794-2010; Yu, Douglas W./D-2536-2009	Liu, Jianguo/0000-0001-6344-0087; Koh, Lian Pin/0000-0001-8152-3871; Yu, Douglas W./0000-0001-8551-5609; Bawa, Kamal/0000-0001-6174-9777				Ali S. H, 2007, PEACE PARKS CONSERVA; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Bawa KS, 2007, AGR ECOSYST ENVIRON, V121, P287, DOI 10.1016/j.agee.2006.12.023; Briscoe J., 2006, INDIAS WATER EC BRAC; HAND E, 2010, NATURE, V463, P282; Johnson Todd M., 1997, CLEAR WATER BLUE SKI; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; MOORE M, 2008, TELEGRAPH       1014; Pomeranz K, 2009, NEW LEFT REV, P5; VANGELDER JW, 2008, NEW TRENDS FINANCING; World Bank, 2010, GLOB EC PROSP 2010 C; Xu JC, 2009, CONSERV BIOL, V23, P520, DOI 10.1111/j.1523-1739.2009.01237.x; 2009, EC TIMES        1021; 2003, NATL NATURAL SCI FDN; CONFUCIUS I	16	72	75	6	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2010	327	5972					1457	1459		10.1126/science.1185164	http://dx.doi.org/10.1126/science.1185164			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	570YQ	20299578				2022-12-28	WOS:000275715200029
J	Grivennikov, SI; Greten, FR; Karin, M				Grivennikov, Sergei I.; Greten, Florian R.; Karin, Michael			Immunity, Inflammation, and Cancer	CELL			English	Review							NF-KAPPA-B; PROMOTE TUMOR-GROWTH; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; EPITHELIAL-MESENCHYMAL TRANSITION; CHRONIC LYMPHOCYTIC-LEUKEMIA; COLITIS-ASSOCIATED CANCER; NECROSIS-FACTOR-ALPHA; T-CELL RESPONSES; MYELOID CELLS; TGF-BETA	Inflammatory responses play decisive roles at different stages of tumor development, including initiation, promotion, malignant conversion, invasion, and metastasis. Inflammation also affects immune surveillance and responses to therapy. Immune cells that infiltrate tumors engage in an extensive and dynamic crosstalk with cancer cells, and some of the molecular events that mediate this dialog have been revealed. This review outlines the principal mechanisms that govern the effects of inflammation and immunity on tumor development and discusses attractive new targets for cancer therapy and prevention.	[Grivennikov, Sergei I.; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; [Grivennikov, Sergei I.; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pathol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; [Greten, Florian R.] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, D-81675 Munich, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; Technical University of Munich	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Greten, Florian R/AAF-5196-2020; Grivennikov, Sergei/AAE-7365-2019	Greten, Florian R/0000-0002-3928-6080; Grivennikov, Sergei/0000-0003-2987-0555	Crohn's and Colitis Foundation of America (CCFA) [1762]; Deutsche Forschungsgemeinschaft; Deutsche Krebshilfe; Association for International Cancer Research; National Institutes of Health; American Association for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA127923, R01CA118165, R01CA132586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America (CCFA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Association for International Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Koltsova for help with figure preparation. This work was supported by a Research Fellowship Award from the Crohn's and Colitis Foundation of America (CCFA #1762) to S. G; by grants from the Deutsche Forschungsgemeinschaft, Deutsche Krebshilfe, and the Association for International Cancer Research to F. R. G.; and by the National Institutes of Health and the American Association for Cancer Research to M. K., who is an American Cancer Society Research Professor.	Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Apetoh L, 2007, IMMUNOL REV, V220, P47, DOI 10.1111/j.1600-065X.2007.00573.x; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Aspord C, 2007, J EXP MED, V204, P1037, DOI 10.1084/jem.20061120; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Bonecchi R, 2009, FRONT BIOSCI-LANDMRK, V14, P540, DOI 10.2741/3261; Buckowitz A, 2005, BRIT J CANCER, V92, P1746, DOI 10.1038/sj.bjc.6602534; Bui JD, 2007, CURR OPIN IMMUNOL, V19, P203, DOI 10.1016/j.coi.2007.02.001; Calle EE, 2007, BRIT MED J, V335, P1107, DOI 10.1136/bmj.39384.472072.80; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cooper CS, 2009, BRIT J CANCER, V100, P240, DOI 10.1038/sj.bjc.6604771; Crowe NY, 2005, J EXP MED, V202, P1279, DOI 10.1084/jem.20050953; de Martel C, 2009, CRIT REV ONCOL HEMAT, V70, P183, DOI 10.1016/j.critrevonc.2008.07.021; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Enzler T, 2003, J EXP MED, V197, P1213, DOI 10.1084/jem.20021258; Enzler T, 2009, BLOOD, V114, P4469, DOI 10.1182/blood-2009-06-230169; Erdman SE, 2005, CANCER RES, V65, P3998, DOI 10.1158/0008-5472.CAN-04-3104; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; Ferreri AJM, 2009, J INTERN MED, V265, P421, DOI 10.1111/j.1365-2796.2009.02083.x; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gallimore AM, 2008, ONCOGENE, V27, P5886, DOI 10.1038/onc.2008.269; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gierach GL, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2089; Granziero L, 2001, BLOOD, V97, P2777, DOI 10.1182/blood.V97.9.2777; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Guidoboni M, 2001, AM J PATHOL, V159, P297, DOI 10.1016/S0002-9440(10)61695-1; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Hahn MA, 2008, CANCER RES, V68, P10280, DOI 10.1158/0008-5472.CAN-08-1957; Hanada T, 2006, J EXP MED, V203, P1391, DOI 10.1084/jem.20060436; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haybaeck J, 2009, CANCER CELL, V16, P295, DOI 10.1016/j.ccr.2009.08.021; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Hurst LC, 2009, NEW ENGL J MED, V361, P968, DOI 10.1056/NEJMoa0810866; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kastritis E, 2009, SEMIN HEMATOL, V46, P143, DOI 10.1053/j.seminhematol.2009.01.004; Khasawneh J, 2009, P NATL ACAD SCI USA, V106, P3354, DOI 10.1073/pnas.0802864106; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kitamura T, 2007, NAT GENET, V39, P467, DOI 10.1038/ng1997; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kohrt HE, 2005, PLOS MED, V2, P904, DOI 10.1371/journal.pmed.0020284; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Kraus S, 2009, CURR OPIN PHARMACOL, V9, P405, DOI 10.1016/j.coph.2009.06.006; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Laghi L, 2009, LANCET ONCOL, V10, P877, DOI 10.1016/S1470-2045(09)70186-X; Langowski JL, 2007, TRENDS IMMUNOL, V28, P207, DOI 10.1016/j.it.2007.03.006; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Lin L, 2009, ONCOGENE, V28, P961, DOI 10.1038/onc.2008.448; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Liu X, 2006, AM J EPIDEMIOL, V164, P984, DOI 10.1093/aje/kwj294; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Lust JA, 2009, MAYO CLIN PROC, V84, P114, DOI 10.4065/84.2.114; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; McDonald B, 2009, INT J CANCER, V125, P1298, DOI 10.1002/ijc.24409; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Musteanu M, 2010, GASTROENTEROLOGY, V138, P1003, DOI 10.1053/j.gastro.2009.11.049; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nickoloff BJ, 2005, J INVEST DERMATOL, V124, pX, DOI 10.1111/j.0022-202X.2005.23724.x; Oguma K, 2008, EMBO J, V27, P1671, DOI 10.1038/emboj.2008.105; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; Okazaki Il-mi, 2007, Adv Immunol, V94, P245, DOI 10.1016/S0065-2776(06)94008-5; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Palucka AK, 2007, IMMUNOL REV, V220, P129, DOI 10.1111/j.1600-065X.2007.00575.x; Palumbo JS, 2007, BLOOD, V110, P133, DOI 10.1182/blood-2007-01-065995; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Pedersen IM, 2002, BLOOD, V100, P1795, DOI 10.1182/blood.V100.5.1795.h81702001795_1795_1801; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Punturieri A, 2009, JNCI-J NATL CANCER I, V101, P554, DOI 10.1093/jnci/djp023; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Roberts SJ, 2007, P NATL ACAD SCI USA, V104, P6770, DOI 10.1073/pnas.0604982104; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Ruzankina Y, 2009, NAT GENET, V41, P1144, DOI 10.1038/ng.441; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shibata W, 2010, GASTROENTEROLOGY, V138, P1022, DOI 10.1053/j.gastro.2009.11.054; Shime H, 2008, J IMMUNOL, V180, P7175, DOI 10.4049/jimmunol.180.11.7175; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; SIEWEKE MH, 1990, SCIENCE, V248, P1656, DOI 10.1126/science.2163544; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Smyth MJ, 2003, IMMUNITY, V18, P1, DOI 10.1016/S1074-7613(02)00502-2; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Swann JB, 2008, P NATL ACAD SCI USA, V105, P652, DOI 10.1073/pnas.0708594105; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Swann JB, 2009, BLOOD, V113, P6382, DOI 10.1182/blood-2009-01-198564; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Takai A, 2009, ONCOGENE, V28, P469, DOI 10.1038/onc.2008.415; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Umar S, 2009, J BIOL CHEM, V284, P22274, DOI 10.1074/jbc.M109.020941; Vakkila J, 2004, NAT REV IMMUNOL, V4, P641, DOI 10.1038/nri1415; Waldner MJ, 2009, SEMIN IMMUNOPATHOL, V31, P249, DOI 10.1007/s00281-009-0161-8; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Wong VWS, 2009, INT J CANCER, V124, P2766, DOI 10.1002/ijc.24281; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang B, 2007, J EXP MED, V204, P49, DOI 10.1084/jem.20062056; Zhang JY, 2004, GENE DEV, V18, P17, DOI 10.1101/gad.1160904; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	155	7013	7327	70	1774	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2010	140	6					883	899		10.1016/j.cell.2010.01.025	http://dx.doi.org/10.1016/j.cell.2010.01.025			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	571IX	20303878	Green Accepted, Bronze			2022-12-28	WOS:000275746600012
J	McGeer, A				McGeer, Allison			Review: Extended-duration chemoprophylaxis with neuraminidase inhibitors prevents symptomatic influenza	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	McGeer, A (corresponding author), Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada.		mcgeer, allison/H-7747-2014; McGeer, Allison/AAB-6885-2020	mcgeer, allison/0000-0001-5647-6137; McGeer, Allison/0000-0001-5647-6137				Cooper NJ, 2003, BRIT MED J, V326, P1235, DOI 10.1136/bmj.326.7401.1235; Jefferson TO, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001265.pub2; Monto AS, 2009, NEW ENGL J MED, V361, P1260, DOI 10.1056/NEJMoa0808652; Praditsuwan Rungnirand, 2005, Journal of the Medical Association of Thailand, V88, P256	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	2010	152	6							JC3-3	10.7326/0003-4819-152-6-201003160-02003	http://dx.doi.org/10.7326/0003-4819-152-6-201003160-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573IF	20231557				2022-12-28	WOS:000275905200020
J	Jensen, LMR; Sanishvili, R; Davidson, VL; Wilmot, CM				Jensen, Lyndal M. R.; Sanishvili, Ruslan; Davidson, Victor L.; Wilmot, Carrie M.			In Crystallo Posttranslational Modification Within a MauG/Pre-Methylamine Dehydrogenase Complex	SCIENCE			English	Article							TRYPTOPHAN TRYPTOPHYLQUINONE; OXYGEN ACTIVATION; COFACTOR; MECHANISM	MauG is a diheme enzyme responsible for the posttranslational modification of two tryptophan residues to form the tryptophan tryptophylquinone (TTQ) cofactor of methylamine dehydrogenase (MADH). MauG converts preMADH, containing monohydroxylated beta Trp(57), to fully functional MADH by catalyzing the insertion of a second oxygen atom into the indole ring and covalently linking beta Trp(57) to beta Trp(108). We have solved the x-ray crystal structure of MauG complexed with preMADH to 2.1 angstroms. The c-type heme irons and the nascent TTQ site are separated by long distances over which electron transfer must occur to achieve catalysis. In addition, one of the hemes has an atypical His-Tyr axial ligation. The crystalline protein complex is catalytically competent; upon addition of hydrogen peroxide, MauG-dependent TTQ synthesis occurs.	[Jensen, Lyndal M. R.; Wilmot, Carrie M.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Sanishvili, Ruslan] Argonne Natl Lab, Biosci Div, Collaborat Access Team, Gen Med Inst, Argonne, IL 60439 USA; [Sanishvili, Ruslan] Argonne Natl Lab, Biosci Div, Collaborat Access Team, Inst Canc, Argonne, IL 60439 USA; [Davidson, Victor L.] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	University of Minnesota System; University of Minnesota Twin Cities; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Mississippi; University of Mississippi Medical Center	Wilmot, CM (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	wilmo004@umn.edu		Davidson, Victor/0000-0002-1966-7302; Wilmot, Carrie/0000-0002-8706-0000	NIH [GM66569, GM41574]; Minnesota Partnership for Biotechnology and Medical Genomics [SPAP-05-0013-P-FY06]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066569, R01GM041574, R37GM041574] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Partnership for Biotechnology and Medical Genomics; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grants GM66569 (C. M. W.) and GM41574 (V. L. D.) and Minnesota Partnership for Biotechnology and Medical Genomics grant SPAP-05-0013-P-FY06. Computer resources were provided by the Basic Sciences Computing Laboratory of the University of Minnesota Supercomputing Institute, and we thank C. Ergenekan for his support. X-ray data were collected at the Kahlert Structural Biology Laboratory (KSBL) at the University of Minnesota and GM/CA-CAT at the Advanced Photon Source (APS), Argonne National Laboratory, Argonne, IL. GM/CA-CAT is funded by National Cancer Institute grant Y1-CO-1020 and National Institute of General Medical Sciences grant Y1-GM-1104. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract DE-AC02-06CH11357. We thank E. Hoeffner for KSBL support and the staff at Sector 23, APS, for their support, especially M. Becker, S. Corcoran, V. Nagarajan, and D. Yoder. We thank S. Shin for performing the experiment shown in fig. S4. Coordinates and structure factors have been deposited in the Protein Data Bank with acquisition codes 3L4M (MauG-preMADH complex) and 3L4O (MauG-preMADH complex treated with H<INF>2</INF>O<INF>2</INF>).	Chen LY, 1998, J MOL BIOL, V276, P131, DOI 10.1006/jmbi.1997.1511; Davidson VL, 2007, BIOCHEMISTRY-US, V46, P5283, DOI 10.1021/bi700468t; Davidson VL, 2001, ADV PROTEIN CHEM, V58, P95; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Fulop V, 2001, ADV INORG CHEM, V51, P163; Hersleth HP, 2006, J INORG BIOCHEM, V100, P460, DOI 10.1016/j.jinorgbio.2006.01.018; Kovaleva EG, 2007, ACCOUNTS CHEM RES, V40, P475, DOI 10.1021/ar700052v; Lee SY, 2009, BIOCHEMISTRY-US, V48, P2442, DOI 10.1021/bi802166c; Li XH, 2006, BIOCHEMISTRY-US, V45, P821, DOI 10.1021/bi052000n; Li XH, 2008, P NATL ACAD SCI USA, V105, P8597, DOI 10.1073/pnas.0801643105; Li XH, 2006, BIOCHEMISTRY-US, V45, P13276, DOI 10.1021/bi061497d; Makris TM, 2002, DRUG METAB REV, V34, P691, DOI 10.1081/DMR-120015691; MCINTIRE WS, 1991, SCIENCE, V252, P817, DOI 10.1126/science.2028257; Pearson AR, 2004, BIOCHEMISTRY-US, V43, P5494, DOI 10.1021/bi049863l; Pearson AR, 2006, J AM CHEM SOC, V128, P12416, DOI 10.1021/ja064466e; Pettigrew GW, 2006, J INORG BIOCHEM, V100, P551, DOI 10.1016/j.jinorgbio.2005.12.008; RAAG R, 1991, BIOCHEMISTRY-US, V30, P2674, DOI 10.1021/bi00224a016; Wang YT, 2005, J AM CHEM SOC, V127, P8258, DOI 10.1021/ja051734k; Wang YT, 2003, BIOCHEMISTRY-US, V42, P7318, DOI 10.1021/bi034243q	19	100	101	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1392	1394		10.1126/science.1182492	http://dx.doi.org/10.1126/science.1182492			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223990	Green Accepted			2022-12-28	WOS:000275418700045
J	Lawson, N				Lawson, Neal			Will a market deliver quality and efficiency in health care better than central planning ever could? No	BRITISH MEDICAL JOURNAL			English	Editorial Material									Compass, London SE1 7SJ, England		Lawson, N (corresponding author), Compass, London SE1 7SJ, England.	neal.lawson@btinternet.com							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2010	340								c1300	10.1136/bmj.c1300	http://dx.doi.org/10.1136/bmj.c1300			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570FD	20219814				2022-12-28	WOS:000275656800006
J	Agulhon, C; Fiacco, TA; McCarthy, KD				Agulhon, Cendra; Fiacco, Todd A.; McCarthy, Ken D.			Hippocampal Short- and Long-Term Plasticity Are Not Modulated by Astrocyte Ca2+ Signaling	SCIENCE			English	Article							IN-SITU; INWARD CURRENTS; GLUTAMATE; CALCIUM; STIMULATION; DEPOTENTIATION; POTENTIATION; ACTIVATION; FREQUENCY; RELEASE	The concept that astrocytes release neuroactive molecules (gliotransmitters) to affect synaptic transmission has been a paradigm shift in neuroscience research over the past decade. This concept suggests that astrocytes, together with pre- and postsynaptic neuronal elements, make up a functional synapse. Astrocyte release of gliotransmitters (for example, glutamate and adenosine triphosphate) is generally accepted to be a Ca2+-dependent process. We used two mouse lines to either selectively increase or obliterate astrocytic G(q) G protein-coupled receptor Ca2+ signaling to further test the hypothesis that astrocytes release gliotransmitters in a Ca2+-dependent manner to affect synaptic transmission. Neither increasing nor obliterating astrocytic Ca2+ fluxes affects spontaneous and evoked excitatory synaptic transmission or synaptic plasticity. Our findings suggest that, at least in the hippocampus, the mechanisms of gliotransmission need to be reconsidered.	[Agulhon, Cendra; McCarthy, Ken D.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Fiacco, Todd A.] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA	University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Riverside	Agulhon, C (corresponding author), Univ N Carolina, Dept Pharmacol, Genet Med Bldg,CB 7365, Chapel Hill, NC 27599 USA.	cendra_agulhon@med.unc.edu		Agulhon, Cendra/0000-0001-7508-6978	NIH [NS033938, NS020212]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020212, R01NS033938] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Casper for making MrgA1<SUP>+</SUP> mice; J. Chen for providing IP<INF>3</INF>R2 KO mice; and B. Djukic, B. Philpot, A. Roberts, and J. de Marchena for valuable help and discussions. This work was supported by NIH grants NS033938 and NS020212.	Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Andersson M, 2007, J PHYSIOL-LONDON, V585, P843, DOI 10.1113/jphysiol.2007.142737; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Chung HJ, 2009, P NATL ACAD SCI USA, V106, P635, DOI 10.1073/pnas.0811685106; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Fiacco TA, 2009, ANNU REV PHARMACOL, V49, P151, DOI 10.1146/annurev.pharmtox.011008.145602; Huang CC, 2001, J BIOL CHEM, V276, P48108, DOI 10.1074/jbc.M106388200; Izumi Y, 2008, J NEUROSCI, V28, P9557, DOI 10.1523/JNEUROSCI.3346-08.2008; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Li R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-55; Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c; Mannaioni G, 2001, J NEUROSCI, V21, P5925, DOI 10.1523/JNEUROSCI.21-16-05925.2001; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pasti L, 1997, J NEUROSCI, V17, P7817; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Porter JT, 1996, J NEUROSCI, V16, P5073; Rae MG, 2004, NEUROPHARMACOLOGY, V46, P1057, DOI 10.1016/j.neuropharm.2004.02.002; Sasaki Y, 1997, J NEUROCHEM, V68, P2194; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; Shigetomi E, 2008, J NEUROSCI, V28, P6659, DOI 10.1523/JNEUROSCI.1717-08.2008; Tritsch NX, 2007, NEURON, V54, P497, DOI 10.1016/j.neuron.2007.05.008; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Zho WM, 2002, J NEUROSCI, V22, P8838; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	29	314	321	0	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2010	327	5970					1250	1254		10.1126/science.1184821	http://dx.doi.org/10.1126/science.1184821			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20203048				2022-12-28	WOS:000275162100038
J	Guo, CX; Tang, TS; Friedberg, EC				Guo, Caixia; Tang, Tie-Shan; Friedberg, Errol C.			SnapShot: Nucleotide Excision Repair	CELL			English	Editorial Material									[Guo, Caixia] Chinese Acad Sci, Beijing Inst Genom, Beijing 100101, Peoples R China; [Tang, Tie-Shan] Chinese Acad Sci, Inst Zool, SKLBMB, Beijing 100101, Peoples R China; [Guo, Caixia; Friedberg, Errol C.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Texas System; University of Texas Southwestern Medical Center Dallas	Guo, CX (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Beijing 100101, Peoples R China.				NIEHS NIH HHS [ES11344] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011344] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Coin F, 2008, MOL CELL, V31, P9, DOI 10.1016/j.molcel.2008.04.024; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7	9	8	10	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					754	U169	754.e1	10.1016/j.cell.2010.02.033	http://dx.doi.org/10.1016/j.cell.2010.02.033			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211143	Bronze			2022-12-28	WOS:000275197400024
J	Zhang, Q; Raoof, M; Chen, Y; Sumi, Y; Sursal, T; Junger, W; Brohi, K; Itagaki, K; Hauser, CJ				Zhang, Qin; Raoof, Mustafa; Chen, Yu; Sumi, Yuka; Sursal, Tolga; Junger, Wolfgang; Brohi, Karim; Itagaki, Kiyoshi; Hauser, Carl J.			Circulating mitochondrial DAMPs cause inflammatory responses to injury	NATURE			English	Article							OPERATED CALCIUM INFLUX; HUMAN NEUTROPHILS; TRAUMA; SHOCK; MOBILIZATION; CHEMOTAXIS; RECEPTORS; PEPTIDES; MODELS; SIRS	Injury causes a systemic inflammatory response syndrome (SIRS) that is clinically much like sepsis(1). Microbial pathogen-associated molecular patterns (PAMPs) activate innate immunocytes through pattern recognition receptors(2). Similarly, cellular injury can release endogenous 'damage'-associated molecular patterns (DAMPs) that activate innate immunity(3). Mitochondria are evolutionary endosymbionts that were derived from bacteria(4) and so might bear bacterial molecular motifs. Here we show that injury releases mitochondrial DAMPs (MTDs) into the circulation with functionally important immune consequences. MTDs include formyl peptides and mitochondrial DNA. These activate human polymorphonuclear neutrophils (PMNs) through formyl peptide receptor-1 and Toll-like receptor (TLR) 9, respectively. MTDs promote PMN Ca2+ flux and phosphorylation of mitogen-activated protein (MAP) kinases, thus leading to PMN migration and degranulation in vitro and in vivo. Circulating MTDs can elicit neutrophil-mediated organ injury. Cellular disruption by trauma releases mitochondrial DAMPs with evolutionarily conserved similarities to bacterial PAMPs into the circulation. These signal through innate immune pathways identical to those activated in sepsis to create a sepsis-like state. The release of such mitochondrial 'enemies within' by cellular injury is a key link between trauma, inflammation and SIRS.	[Zhang, Qin; Raoof, Mustafa; Chen, Yu; Sumi, Yuka; Sursal, Tolga; Junger, Wolfgang; Itagaki, Kiyoshi; Hauser, Carl J.] Beth Israel Deaconess Med Ctr, Dept Surg, Div Trauma, Boston, MA 02215 USA; [Zhang, Qin; Raoof, Mustafa; Chen, Yu; Sumi, Yuka; Sursal, Tolga; Junger, Wolfgang; Itagaki, Kiyoshi; Hauser, Carl J.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Brohi, Karim] Univ London, Barts & London Sch Med & Dent, Trauma Clin Acad Unit, London E1 1BB, England	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of London; Queen Mary University London	Hauser, CJ (corresponding author), Beth Israel Deaconess Med Ctr, Dept Surg, Div Trauma, 330 Brookline Ave, Boston, MA 02215 USA.	cjhauser@bidmc.harvard.edu	Sursal, Tolga/AAN-8585-2021; Hauser, Carl J./Y-1189-2019; Junger, Wolfgang G/I-1932-2013; Raoof, Mustafa/D-1664-2012; Itagaki, Kiyoshi/M-5501-2015	Junger, Wolfgang G/0000-0003-3350-8452; Itagaki, Kiyoshi/0000-0002-6033-1122; Hauser, Carl/0000-0003-3167-1846	National Institute of General Medical Sciences; Department of Defense; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059179, R01GM051477] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by a National Institute of General Medical Sciences grant and a Department of Defense CDMRP/DRMRP hypothesis development award (to C.J.H.).	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BONE RC, 1992, JAMA-J AM MED ASSOC, V268, P3452, DOI 10.1001/jama.268.24.3452; CARDON LR, 1994, P NATL ACAD SCI USA, V91, P3799, DOI 10.1073/pnas.91.9.3799; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Collins LV, 2004, J LEUKOCYTE BIOL, V75, P995, DOI 10.1189/jlb.0703328; Deitch EA, 2006, FRONT BIOSCI-LANDMRK, V11, P520, DOI 10.2741/1816; Fekete Z, 2001, SHOCK, V16, P15, DOI 10.1097/00024382-200116010-00003; FINE J, 1959, NEW ENGL J MED, V260, P214, DOI 10.1056/NEJM195901292600505; Hauser CJ, 2005, SHOCK, V24, P24, DOI 10.1097/01.shk.0000191387.18818.43; Hauser CJ, 2000, J TRAUMA, V48, P592, DOI 10.1097/00005373-200004000-00003; Hauser CJ, 2001, J LEUKOCYTE BIOL, V69, P63; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Lee SH, 2007, BIOCHEM BIOPH RES CO, V364, P996, DOI 10.1016/j.bbrc.2007.10.111; MARCKER K, 1964, J MOL BIOL, V8, P835, DOI 10.1016/S0022-2836(64)80164-9; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; MOORE FA, 1991, J TRAUMA, V31, P629, DOI 10.1097/00005373-199105000-00006; MOORE FA, 1991, J TRAUMA, V31, P636, DOI DOI 10.1097/00005373-199105000-00006]; Rabiet MJ, 2005, EUR J IMMUNOL, V35, P2486, DOI 10.1002/eji.200526338; Sagan L, 1967, J Theor Biol, V14, P255; Sasser Scott M., 2009, Morbidity and Mortality Weekly Report, V58, P1; SCHIFFMANN E, 1975, P NATL ACAD SCI USA, V72, P1059, DOI 10.1073/pnas.72.3.1059; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Simms HH, 2000, J TRAUMA, V48, P597; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tarlowe MH, 2003, J IMMUNOL, V171, P2066, DOI 10.4049/jimmunol.171.4.2066; UCHIDA K, 1993, P NATL ACAD SCI USA, V90, P8742, DOI 10.1073/pnas.90.18.8742; Van Lint P, 2006, CYTOKINE GROWTH F R, V17, P217, DOI 10.1016/j.cytogfr.2006.04.001; WENZELSEIFERT K, 1993, J IMMUNOL, V150, P4591; West MA, 2007, J TRAUMA, V62, P805, DOI 10.1097/01.ta.0000259267.74789.9b; Zhang Q, 2005, LIFE SCI, V77, P3068, DOI 10.1016/j.lfs.2005.02.034	32	2319	2425	20	354	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2010	464	7285					104	U115		10.1038/nature08780	http://dx.doi.org/10.1038/nature08780			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20203610	Green Accepted			2022-12-28	WOS:000275117500042
J	Iezzoni, LI; Ronan, LJ				Iezzoni, Lisa I.; Ronan, Laurence J.			Disability Legacy of the Haitian Earthquake	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							AMPUTATION		[Iezzoni, Lisa I.] Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Iezzoni, LI (corresponding author), Massachusetts Gen Hosp, Mongan Inst Hlth Policy, 50 Staniford St,Room 901B, Boston, MA 02114 USA.	liezzoni@partners.org						Bigelow J, 2004, DISABIL REHABIL, V26, P246, DOI 10.1080/09638280310001644915; Collins Diane M., 2006, Critical Reviews in Biomedical Engineering, V34, P379, DOI 10.1615/CritRevBiomedEng.v34.i5.20; Cummings D, 1996, PROSTHET ORTHOT INT, V20, P51; Cummings Donald R, 2006, Phys Med Rehabil Clin N Am, V17, P15, DOI 10.1016/j.pmr.2005.10.002; Esquenazi A, 2004, DISABIL REHABIL, V26, P831, DOI 10.1080/09638280410001708850; Iezzoni LI, 2008, JAMA-J AM MED ASSOC, V299, P332, DOI 10.1001/jama.299.3.332; Kirschner KL, 2007, JAMA-J AM MED ASSOC, V297, P1121, DOI 10.1001/jama.297.10.1121; Sontag Deborah, 2010, NY TIMES, pA1; Sullivan SR, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp1000976; *UN OFF COORD HUM, 2010, 25 UN OFF COORD HUM; United Nations Office for the Coordination of Humanitarian Affairs, 2010, 24 UN OFF COORD HUM; Ustun TB, 2003, HEALTH CARE FINANC R, V24, P77; *WHO, 2010, REV UN HUM AFF GLOB; WHO, 2001, WHO INT CLASS FUNCT	14	27	27	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	2010	152	12					812	814		10.7326/0003-4819-152-12-201006150-00234	http://dx.doi.org/10.7326/0003-4819-152-12-201006150-00234			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611OP	20231547				2022-12-28	WOS:000278827700008
J	Van Gelder, IC; Groenveld, HF; Crijns, HJGM; Tuininga, YS; Tijssen, JGP; Alings, AM; Hillege, HL; Bergsma-Kadijk, JA; Cornel, JH; Kamp, O; Tukkie, R; Bosker, HA; Van Veldhuisen, DJ; Van den Berg, MP				Van Gelder, Isabelle C.; Groenveld, Hessel F.; Crijns, Harry J. G. M.; Tuininga, Ype S.; Tijssen, Jan G. P.; Alings, A. Marco; Hillege, Hans L.; Bergsma-Kadijk, Johanna A.; Cornel, Jan H.; Kamp, Otto; Tukkie, Raymond; Bosker, Hans A.; Van Veldhuisen, Dirk J.; Van den Berg, Maarten P.		RACE II Investigators	Lenient versus Strict Rate Control in Patients with Atrial Fibrillation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC HEART-FAILURE; RHYTHM CONTROL; DRONEDARONE; EFFICACY; OUTCOMES; REGISTRY; EVENTS; DESIGN; DEATH; RACE	Background: Rate control is often the therapy of choice for atrial fibrillation. Guidelines recommend strict rate control, but this is not based on clinical evidence. We hypothesized that lenient rate control is not inferior to strict rate control for preventing cardiovascular morbidity and mortality in patients with permanent atrial fibrillation. Methods: We randomly assigned 614 patients with permanent atrial fibrillation to undergo a lenient rate-control strategy (resting heart rate <110 beats per minute) or a strict rate-control strategy (resting heart rate <80 beats per minute and heart rate during moderate exercise <110 beats per minute). The primary outcome was a composite of death from cardiovascular causes, hospitalization for heart failure, and stroke, systemic embolism, bleeding, and life-threatening arrhythmic events. The duration of follow-up was at least 2 years, with a maximum of 3 years. Results: The estimated cumulative incidence of the primary outcome at 3 years was 12.9% in the lenient-control group and 14.9% in the strict-control group, with an absolute difference with respect to the lenient-control group of -2.0 percentage points (90% confidence interval, -7.6 to 3.5; P<0.001 for the prespecified noninferiority margin). The frequencies of the components of the primary outcome were similar in the two groups. More patients in the lenient-control group met the heart-rate target or targets (304 [97.7%], vs. 203 [67.0%] in the strict-control group; P<0.001) with fewer total visits (75 [median, 0], vs. 684 [median, 2]; P<0.001). The frequencies of symptoms and adverse events were similar in the two groups. Conclusions: In patients with permanent atrial fibrillation, lenient rate control is as effective as strict rate control and is easier to achieve. (ClinicalTrials.gov number, NCT00392613.) N Engl J Med 2010;362:1363-73.	[Van Gelder, Isabelle C.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Thoraxctr, NL-9700 RB Groningen, Netherlands; [Hillege, Hans L.; Bergsma-Kadijk, Johanna A.] Univ Groningen, Univ Med Ctr Groningen, Trial Coordinat Ctr, Dept Epidemiol, NL-9700 RB Groningen, Netherlands; [Van Gelder, Isabelle C.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Crijns, Harry J. G. M.] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Tuininga, Ype S.] Deventer Hosp, Deventer, Netherlands; [Tijssen, Jan G. P.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Kamp, Otto] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Alings, A. Marco] Amphia Hosp, Breda, Netherlands; [Cornel, Jan H.] Med Ctr, Alkmaar, Netherlands; [Tukkie, Raymond] Kennemer Hosp, Haarlem, Netherlands; [Bosker, Hans A.] Rijnstate Hosp, Arnhem, Netherlands	University of Groningen; University of Groningen; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Maastricht University; Deventer Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Amphia Hospital; Spaarne Hospital; Rijnstate Hospital	Van Gelder, IC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Thoraxctr, POB 30-001, NL-9700 RB Groningen, Netherlands.	i.c.van.gelder@thorax.umcg.nl	cornel, jan hein/Y-7065-2019; van Veldhuisen, Dirk Jan/E-8967-2014	cornel, jan hein/0000-0002-1006-2112; tuininga, ype/0000-0002-7861-8623; kamp, otto/0000-0003-2707-2090; van den Berg, Maarten/0000-0002-1493-2998				Anter E, 2009, CIRCULATION, V119, P2516, DOI 10.1161/CIRCULATIONAHA.108.821306; Cooper HA, 2004, AM J CARDIOL, V93, P1247, DOI 10.1016/j.amjcard.2004.01.069; DiMarco JP, 2005, AM HEART J, V149, P650, DOI 10.1016/j.ahj.2004.11.015; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Hohnloser SH, 2008, J CARDIOVASC ELECTR, V19, P69, DOI 10.1111/j.1540-8167.2007.01016.x; Hohnloser SH, 2009, NEW ENGL J MED, V360, P668, DOI 10.1056/NEJMoa0803778; LAZZARI JO, 1997, HEART, P77; Lechat P, 2001, CIRCULATION, V103, P1428, DOI 10.1161/01.CIR.103.10.1428; Nerheim P, 2004, CIRCULATION, V110, P247, DOI 10.1161/01.CIR.0000135472.28234.CC; Reynolds MR, 2006, AM HEART J, V152, P1097, DOI 10.1016/j.ahj.2006.08.011; Rienstra M, 2006, INT J CARDIOL, V109, P95, DOI 10.1016/j.ijcard.2005.05.054; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; Van Gelder IC, 2006, EUROPACE, V8, P935, DOI 10.1093/europace/eul106; Van Gelder IC, 2006, AM HEART J, V152, P420, DOI 10.1016/j.ahj.2006.02.033; van Veldhuisen DJ, 2006, EUR J HEART FAIL, V8, P539, DOI 10.1016/j.ejheart.2006.01.015; VANGELDER IC, 1993, AM J CARDIOL, V72, P560, DOI 10.1016/0002-9149(93)90352-D; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	18	593	617	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 15	2010	362	15					1363	1373		10.1056/NEJMoa1001337	http://dx.doi.org/10.1056/NEJMoa1001337			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582XY	20231232				2022-12-28	WOS:000276635300005
J	Sun, X; Briel, M; Walter, SD; Guyatt, GH				Sun, Xin; Briel, Matthias; Walter, Stephen D.; Guyatt, Gordon H.			Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY PREVENTION; CLINICAL-TRIALS; METAANALYSIS; MEDICINE; THERAPY; ASPIRIN; CANCER; END		[Sun, Xin; Briel, Matthias; Walter, Stephen D.; Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Sun, Xin] Sichuan Univ, W China Hosp, Ctr Clin Epidemiol & Evidence Based Med, Chengdu 610064, Peoples R China; [Briel, Matthias] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Guyatt, Gordon H.] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University; Sichuan University; University of Basel; McMaster University	Guyatt, GH (corresponding author), 1200 Main St W,Rm 2C12, Hamilton, ON L8N 3Z5, Canada.	guyatt@mcmaster.ca	Walter, Stephen/AAB-5548-2022; Briel, Matthias/AAT-9284-2021	Walter, Stephen/0000-0003-4157-8928; Briel, Matthias/0000-0002-2070-5230	National Natural Science Foundation of China [70703025]; Santesuisse; Gottfried and Julia Bangerter-Rhyner Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Santesuisse; Gottfried and Julia Bangerter-Rhyner Foundation	Funding: XS is supported by a grant from the National Natural Science Foundation of China (grant No. 70703025). MB is supported by Santesuisse and the Gottfried and Julia Bangerter-Rhyner Foundation.	Akl EA, 2008, ARCH INTERN MED, V168, P1261, DOI 10.1001/archinte.168.12.1261; Altman DG, 1998, J CLIN EPIDEMIOL, V51, P301, DOI 10.1016/S0895-4356(98)00005-5; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Bhandari M, 2006, CLIN ORTHOP RELAT R, P247, DOI 10.1097/01.blo.0000218736.23506.fe; Bhandari M, 2008, J BONE JOINT SURG AM, V90A, P2567, DOI 10.2106/JBJS.G.01694; Billingham LJ, 2001, ANN ONCOL, V12, P1671, DOI 10.1023/A:1013582618920; Bundy DG, 2004, ARCH PEDIAT ADOL MED, V158, P469, DOI 10.1001/archpedi.158.5.469; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; DANS AL, 2008, USERS GUIDES MED LIT, P273; Feinstein AR, 1998, J CLIN EPIDEMIOL, V51, P297, DOI 10.1016/S0895-4356(98)00004-3; Freemantle N, 2001, BRIT MED J, V322, P989, DOI 10.1136/bmj.322.7292.989; Guyatt G, 2002, ENDOCR REV, V23, P496, DOI 10.1021/er.2001-1002; Guyatt G, 2008, USERS GUIDES MED LIT; Hatala R, 2005, CAN MED ASSOC J, V172, P661, DOI 10.1503/cmaj.1031920; Heckman GA, 2007, CAN MED ASSOC J, V176, P644, DOI 10.1503/cmaj.061309; Horwitz RI, 1996, J CLIN EPIDEMIOL, V49, P395, DOI 10.1016/0895-4356(95)00058-5; Horwitz RI, 1998, J CLIN EPIDEMIOL, V51, P305, DOI 10.1016/S0895-4356(98)00006-7; Horwitz RI, 1997, J CLIN EPIDEMIOL, V50, P753; Jaeschke R, 2008, AM J RESP CRIT CARE, V178, P1009, DOI 10.1164/rccm.200804-494OC; Kirpalani H, 2007, PEDIATRICS, V120, P1126, DOI 10.1542/peds.2006-2776; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; Ridker PM, 2006, JAMA-J AM MED ASSOC, V296, P391, DOI 10.1001/jama.296.4.391-a; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Senn S, 1997, J CLIN EPIDEMIOL, V50, P749; Smith GD, 1998, J CLIN EPIDEMIOL, V51, P289, DOI 10.1016/S0895-4356(97)00293-X; Szczurko O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000919; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Thavendiranathan P, 2006, ARCH INTERN MED, V166, P2307, DOI 10.1001/archinte.166.21.2307; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	33	419	423	4	46	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2010	340								c117	10.1136/bmj.c117	http://dx.doi.org/10.1136/bmj.c117			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579VJ	20354011				2022-12-28	WOS:000276404100003
J	Chapman, JA; Kirkness, EF; Simakov, O; Hampson, SE; Mitros, T; Weinmaier, T; Rattei, T; Balasubramanian, PG; Borman, J; Busam, D; Disbennett, K; Pfannkoch, C; Sumin, N; Sutton, GG; Viswanathan, LD; Walenz, B; Goodstein, DM; Hellsten, U; Kawashima, T; Prochnik, SE; Putnam, NH; Shu, SQ; Blumberg, B; Dana, CE; Gee, L; Kibler, DF; Law, L; Lindgens, D; Martinez, DE; Peng, JS; Wigge, PA; Bertulat, B; Guder, C; Nakamura, Y; Ozbek, S; Watanabe, H; Khalturin, K; Hemmrich, G; Franke, A; Augustin, R; Fraune, S; Hayakawa, E; Hayakawa, S; Hirose, M; Hwang, JS; Ikeo, K; Nishimiya-Fujisawa, C; Ogura, A; Takahashi, T; Steinmetz, PRH; Zhang, XM; Aufschnaiter, R; Eder, MK; Gorny, AK; Salvenmoser, W; Heimberg, AM; Wheeler, BM; Peterson, KJ; Boettger, A; Tischler, P; Wolf, A; Gojobori, T; Remington, KA; Strausberg, RL; Venter, JC; Technau, U; Hobmayer, B; Bosch, TCG; Holstein, TW; Fujisawa, T; Bode, HR; David, CN; Rokhsar, DS; Steele, RE				Chapman, Jarrod A.; Kirkness, Ewen F.; Simakov, Oleg; Hampson, Steven E.; Mitros, Therese; Weinmaier, Thomas; Rattei, Thomas; Balasubramanian, Prakash G.; Borman, Jon; Busam, Dana; Disbennett, Kathryn; Pfannkoch, Cynthia; Sumin, Nadezhda; Sutton, Granger G.; Viswanathan, Lakshmi Devi; Walenz, Brian; Goodstein, David M.; Hellsten, Uffe; Kawashima, Takeshi; Prochnik, Simon E.; Putnam, Nicholas H.; Shu, Shengquiang; Blumberg, Bruce; Dana, Catherine E.; Gee, Lydia; Kibler, Dennis F.; Law, Lee; Lindgens, Dirk; Martinez, Daniel E.; Peng, Jisong; Wigge, Philip A.; Bertulat, Bianca; Guder, Corina; Nakamura, Yukio; Ozbek, Suat; Watanabe, Hiroshi; Khalturin, Konstantin; Hemmrich, Georg; Franke, Andre; Augustin, Rene; Fraune, Sebastian; Hayakawa, Eisuke; Hayakawa, Shiho; Hirose, Mamiko; Hwang, Jung Shan; Ikeo, Kazuho; Nishimiya-Fujisawa, Chiemi; Ogura, Atshushi; Takahashi, Toshio; Steinmetz, Patrick R. H.; Zhang, Xiaoming; Aufschnaiter, Roland; Eder, Marie-Kristin; Gorny, Anne-Kathrin; Salvenmoser, Willi; Heimberg, Alysha M.; Wheeler, Benjamin M.; Peterson, Kevin J.; Boettger, Angelika; Tischler, Patrick; Wolf, Alexander; Gojobori, Takashi; Remington, Karin A.; Strausberg, Robert L.; Venter, J. Craig; Technau, Ulrich; Hobmayer, Bert; Bosch, Thomas C. G.; Holstein, Thomas W.; Fujisawa, Toshitaka; Bode, Hans R.; David, Charles N.; Rokhsar, Daniel S.; Steele, Robert E.			The dynamic genome of Hydra	NATURE			English	Article							TYROSINE KINASE; SEA-ANEMONE; STEM-CELLS; GENE; MOLECULES; MAINTENANCE; EXPRESSION; EVOLUTION; ORIGINS; CLUSTER	The freshwater cnidarian Hydra was first described in 1702(1) and has been the object of study for 300 years. Experimental studies of Hydra between 1736 and 1744 culminated in the discovery of asexual reproduction of an animal by budding, the first description of regeneration in an animal, and successful transplantation of tissue between animals(2). Today, Hydra is an important model for studies of axial patterning(3), stem cell biology(4) and regeneration(5). Here we report the genome of Hydra magnipapillata and compare it to the genomes of the anthozoan Nematostella vectensis(6) and other animals. The Hydra genome has been shaped by bursts of transposable element expansion, horizontal gene transfer, trans-splicing, and simplification of gene structure and gene content that parallel simplification of the Hydra life cycle. We also report the sequence of the genome of a novel bacterium stably associated with H. magnipapillata. Comparisons of the Hydra genome to the genomes of other animals shed light on the evolution of epithelia, contractile tissues, developmentally regulated transcription factors, the Spemann-Mangold organizer, pluripotency genes and the neuromuscular junction.	[Blumberg, Bruce; Dana, Catherine E.; Gee, Lydia; Law, Lee; Lindgens, Dirk; Peng, Jisong; Bode, Hans R.; Steele, Robert E.] Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92717 USA; [Chapman, Jarrod A.; Goodstein, David M.; Hellsten, Uffe; Prochnik, Simon E.; Putnam, Nicholas H.; Shu, Shengquiang] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Kirkness, Ewen F.; Borman, Jon; Busam, Dana; Disbennett, Kathryn; Pfannkoch, Cynthia; Sumin, Nadezhda; Sutton, Granger G.; Viswanathan, Lakshmi Devi; Walenz, Brian; Remington, Karin A.; Strausberg, Robert L.; Venter, J. Craig] J Craig Venter Inst, Rockville, MD 20850 USA; [Simakov, Oleg; Balasubramanian, Prakash G.; Bertulat, Bianca; Guder, Corina; Nakamura, Yukio; Ozbek, Suat; Watanabe, Hiroshi; Holstein, Thomas W.] Heidelberg Univ, Dept Mol Evolut & Genom, Inst Zool, D-69120 Heidelberg, Germany; [Simakov, Oleg; Mitros, Therese; Kawashima, Takeshi; Putnam, Nicholas H.; Rokhsar, Daniel S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Hampson, Steven E.; Kibler, Dennis F.] Univ Calif Irvine, Dept Comp Sci, Irvine, CA 92697 USA; [Weinmaier, Thomas; Rattei, Thomas; Tischler, Patrick] Tech Univ Munich, Dept Genome Oriented Bioinformat, D-85354 Freising Weihenstephan, Germany; [Blumberg, Bruce; Gee, Lydia; Law, Lee; Lindgens, Dirk; Peng, Jisong; Bode, Hans R.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Dana, Catherine E.; Steele, Robert E.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Martinez, Daniel E.] Pomona Coll, Dept Biol, Claremont, CA 91711 USA; [Wigge, Philip A.] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Khalturin, Konstantin; Hemmrich, Georg; Franke, Andre; Augustin, Rene; Fraune, Sebastian; Bosch, Thomas C. G.] Univ Kiel, Inst Zool, D-24098 Kiel, Germany; [Hayakawa, Eisuke; Hayakawa, Shiho; Hirose, Mamiko; Hwang, Jung Shan; Ikeo, Kazuho; Nishimiya-Fujisawa, Chiemi; Ogura, Atshushi; Gojobori, Takashi; Fujisawa, Toshitaka] Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Takahashi, Toshio] Suntory Inst Bioorgan Res, Osaka 6188503, Japan; [Steinmetz, Patrick R. H.; Technau, Ulrich] Univ Vienna, Dept Mol Evolut & Dev, A-1090 Vienna, Austria; [Zhang, Xiaoming] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA; [Aufschnaiter, Roland; Eder, Marie-Kristin; Gorny, Anne-Kathrin; Salvenmoser, Willi; Hobmayer, Bert] Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria; [Aufschnaiter, Roland; Eder, Marie-Kristin; Gorny, Anne-Kathrin; Salvenmoser, Willi; Hobmayer, Bert] Univ Innsbruck, Ctr Mol Biosci, A-6020 Innsbruck, Austria; [Heimberg, Alysha M.; Peterson, Kevin J.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Wheeler, Benjamin M.] N Carolina State Univ, Dept Comp Sci, Raleigh, NC 27695 USA; [Boettger, Angelika; Wolf, Alexander; David, Charles N.] Univ Munich, Dept Biol 2, D-82152 Planegg Martinsried, Germany	University of California System; University of California Irvine; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; J. Craig Venter Institute; Ruprecht Karls University Heidelberg; University of California System; University of California Berkeley; University of California System; University of California Irvine; Technical University of Munich; University of California System; University of California Irvine; University of California System; University of California Irvine; Claremont Colleges; Pomona College; Salk Institute; University of Kiel; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Suntory Holdings Ltd; University of Vienna; University of Kansas; University of Kansas Medical Center; University of Innsbruck; University of Innsbruck; Dartmouth College; University of North Carolina; North Carolina State University; University of Munich	Steele, RE (corresponding author), Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92717 USA.	dsrokhsar@gmail.com; resteele@uci.edu	Putnam, Nicholas/B-9968-2008; Fraune, Sebastian/B-7970-2010; Guder, Corina/L-8413-2014; Bosch, Thomas C. G./D-5218-2011; Weinmaier, Thomas/K-5780-2013; Wigge, Philip Anthony/ABD-5113-2021; Rattei, Thomas/F-1366-2011; Bertulat, Bianca/F-5330-2012; Kawashima, Takeshi/M-4510-2015; Wolf, Alexander/K-2178-2013; Özbek, Suat/D-3701-2014; Hwang, Jung Shan/AAJ-3014-2020; Franke, Andre/B-2151-2010; Simakov, Oleg/AAV-2494-2020; Wigge, Philip/B-3333-2010; Peterson, Kevin J/A-2188-2009; Simakov, Oleg/G-4572-2015; Hemmrich-Stanisak, Georg/D-4319-2012; Watanabe, Hiroshi/GOP-0177-2022	Putnam, Nicholas/0000-0002-1315-782X; Fraune, Sebastian/0000-0002-6940-9571; Guder, Corina/0000-0002-8438-5168; Weinmaier, Thomas/0000-0002-9552-3220; Wigge, Philip Anthony/0000-0003-4822-361X; Rattei, Thomas/0000-0002-0592-7791; Hwang, Jung Shan/0000-0002-0908-2036; Franke, Andre/0000-0003-1530-5811; Simakov, Oleg/0000-0002-3585-4511; Simakov, Oleg/0000-0002-3585-4511; Hemmrich-Stanisak, Georg/0000-0002-2896-4691; Watanabe, Hiroshi/0000-0001-8887-5407; Technau, Ulrich/0000-0003-4472-8258; Dana, Catherine/0000-0003-3788-7955; Rokhsar, Daniel/0000-0002-8704-2224; Ozbek, Suat/0000-0003-2569-3942; Goodstein, David/0000-0001-6287-2697; Wolf, Alexander/0000-0003-0649-3363; Shu, Shengqiang/0000-0002-4336-8994; Steinmetz, Patrick/0000-0002-3705-2774; Bottger, Angelika/0000-0003-3273-9558; Hayakawa, Eisuke/0000-0003-1054-4266; Holstein, Thomas/0000-0003-0480-4674	National Science Foundation [IBN-0120591]; NSF [DEB-0716960]; Austrian Science Fund; Norwegian Research Council; Austrian Science Fund [FWF P16685, FWF P20734]; R. Melmon and the Gordon and Betty Moore Foundation; Office of Science of the US Department of Energy [DE-AC02-05CH11231]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Deutsche Forschungsgemeinschaft [SFB617-A1, SFB488-A12]; TOYOBO Biotechnology Foundation; Alexander von Humboldt Foundation; Austrian Science Fund (FWF) [P 20734, P 21108] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR015088] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Austrian Science Fund(Austrian Science Fund (FWF)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Austrian Science Fund(Austrian Science Fund (FWF)); R. Melmon and the Gordon and Betty Moore Foundation; Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); TOYOBO Biotechnology Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We are grateful to S. Clifton, R. Wilson and the EST sequencing group at the Genome Sequencing Center at the Washington University School of Medicine for their efforts in generating the Hydra ESTs and to the National Science Foundation for its support of the Hydra EST project (grant number IBN-0120591). Funding for the sequencing of the Hydra genome was provided by the National Human Genome Research Institute. We thank J. Gerhart who, as co-chair of the National Human Genome Research Institute Working Group on Comparative Genome Evolution, advocated sequencing of the Hydra genome. The septate junction electron micrograph in Fig. 3 was provided by G. Rieger. K. J. P. thanks N. Margulis for technical assistance and the NSF for support ( grant number DEB-0716960). U. T. was supported by the Austrian Science Fund and the Norwegian Research Council. B. H. was supported by Austrian Science Fund grants FWF P16685 and FWF P20734. D. S. R. was supported by R. Melmon and the Gordon and Betty Moore Foundation. Work at the US Department of Energy Joint Genome Institute was supported by the Office of Science of the US Department of Energy under Contract No. DE-AC02-05CH11231. T. F. and T. G. were supported by Grants-In-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. T. C. G. B. was supported by grants from the Deutsche Forschungsgemeinschaft ( DFG SFB617-A1) and from the DFG Cluster of Excellence programs 'The Future Ocean' and 'Inflammation at Interfaces'. T. W. H. was supported by grants from the Deutsche Forschungsgemeinschaft including SFB488-A12 and the DFG Cluster of Excellence program 'CellNetworks'. Support for H. W. was provided by the TOYOBO Biotechnology Foundation and the Alexander von Humboldt Foundation. Support for A. B., B. B., C. G., C. N. D., H. W., P. G. B., S. O., T. F. (Mercator Professor) and Y. N. was provided by the Deutsche Forschungsgemeinschaft.	Alexopoulos H, 2004, CURR BIOL, V14, pR879, DOI 10.1016/j.cub.2004.09.067; Bode HR, 1984, PATTERN FORMATION PR, V1, P213; Bridge DM, 2000, DEV BIOL, V220, P253, DOI 10.1006/dbio.2000.9653; Broun M, 2005, DEVELOPMENT, V132, P2907, DOI 10.1242/dev.01848; Browne EN, 1909, J EXP ZOOL, V7, P1, DOI 10.1002/jez.1400070102; Butts T, 2008, TRENDS GENET, V24, P259, DOI 10.1016/j.tig.2007.09.006; Chourrout D, 2006, NATURE, V442, P684, DOI 10.1038/nature04863; DAVID CN, 1977, DEV BIOL, V58, P372, DOI 10.1016/0012-1606(77)90098-7; Ding LX, 2004, INT J SYST EVOL MICR, V54, P2223, DOI 10.1099/ijs.0.02975-0; Douris V, 2010, MOL BIOL EVOL, V27, P684, DOI 10.1093/molbev/msp286; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; Holstein TW, 2003, DEV DYNAM, V226, P257, DOI 10.1002/dvdy.10227; Jager M, 2006, MOL PHYLOGENET EVOL, V39, P468, DOI 10.1016/j.ympev.2005.12.005; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Mokady O, 1998, P NATL ACAD SCI USA, V95, P3673, DOI 10.1073/pnas.95.7.3673; Pace JK, 2008, P NATL ACAD SCI USA, V105, P17023, DOI 10.1073/pnas.0806548105; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Reidling JC, 2000, J BIOL CHEM, V275, P10323, DOI 10.1074/jbc.275.14.10323; Ryan JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000153; Takahashi T, 1997, P NATL ACAD SCI USA, V94, P1241, DOI 10.1073/pnas.94.4.1241; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Trembley A., 1744, MEMOIRES SERVIR HIST; van Leeuwenhoek A., 1702, COLLECTED LETT A VAN, VXIV, P169; WESTFALL JA, 1971, J CELL BIOL, V51, P318, DOI 10.1083/jcb.51.1.318; Wittlieb J, 2006, P NATL ACAD SCI USA, V103, P6208, DOI 10.1073/pnas.0510163103; Yen MR, 2007, PROG BIOPHYS MOL BIO, V94, P5, DOI 10.1016/j.pbiomolbio.2007.03.006; Zacharias H, 2004, ZOOLOGY, V107, P219, DOI 10.1016/j.zool.2004.04.005	30	563	588	6	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					592	596		10.1038/nature08830	http://dx.doi.org/10.1038/nature08830			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20228792	hybrid, Green Accepted			2022-12-28	WOS:000275974200048
J	Raal, FJ; Santos, RD; Blom, DJ; Marais, AD; Charng, MJ; Cromwell, WC; Lachmann, RH; Gaudet, D; Tan, JL; Chasan-Taber, S; Tribble, DL; Flaim, JD; Crooke, ST				Raal, Frederick J.; Santos, Raul D.; Blom, Dirk J.; Marais, A. David; Charng, Min-Ji; Cromwell, William C.; Lachmann, Robin H.; Gaudet, Daniel; Tan, Ju L.; Chasan-Taber, Scott; Tribble, Diane L.; Flaim, JoAnn D.; Crooke, Stanley T.			Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; TRIGLYCERIDE TRANSFER PROTEIN; ANTISENSE; EZETIMIBE	Background Homozygous familial hypercholesterolaemia is a rare genetic disorder in which both LDL-receptor alleles are defective, resulting in very high concentrations of LDL cholesterol in plasma and premature coronary artery disease. This study investigated whether an antisense inhibitor of apolipoprotein B synthesis, mipomersen, is effective and safe as an adjunctive agent to lower LDL cholesterol concentrations in patients with this disease. Methods This randomised, double-blind, placebo-controlled, phase 3 study was undertaken in nine lipid clinics in seven countries. Patients aged 12 years and older with clinical diagnosis or genetic confirmation of homozygous familial hypercholesterolaemia, who were already receiving the maximum tolerated dose of a lipid-lowering drug, were randomly assigned to mipomersen 200 mg subcutaneously every week or placebo for 26 weeks. Randomisation was computer generated and stratified by weight (<50 kg vs >= 50 kg) in a centralised blocked randomisation, implemented with a computerised interactive voice response system. All clinical, medical, and pharmacy personnel, and patients were masked to treatment allocation. The primary endpoint was percentage change in LDL cholesterol concentration from baseline. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00607373. Findings 34 patients were assigned to mipomersen and 17 to placebo; data for all patients were analysed. 45 patients completed the 26-week treatment period (28 mipomersen, 17 placebo). Mean concentrations of LDL cholesterol at baseline were 11.4 mmol/L (SD 3.6) in the mipomersen group and 10.4 mmol/L (3.7) in the placebo group. The mean percentage change in LDL cholesterol concentration was significantly greater with mipomersen (-24.7%, 95% CI 31.6 to 17.7) than with placebo (-3.3%, 12.1 to 5.5; p=0.0003). The most common adverse events were injection-site reactions (26 [76%] patients in mipomersen group vs four [24%] in placebo group). Four (12%) patients in the mipomersen group but none in the placebo group had increases in concentrations of alanine aminotransferase of three times or more the upper limit of normal. Interpretation Inhibition of apolipoprotein B synthesis by mipomersen represents a novel, effective therapy to reduce LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia who are already receiving lipid-lowering drugs, including high-dose statins.	[Raal, Frederick J.] Univ Witwatersrand, Dept Med, ZA-2193 Johannesburg, South Africa; [Santos, Raul D.] Univ Sao Paulo, Sch Med, Lipid Clin, Heart Inst InCor, Sao Paulo, Brazil; [Blom, Dirk J.] Univ Cape Town, Dept Med, Div Lipidol, ZA-7925 Cape Town, South Africa; [Charng, Min-Ji] Taipei Vet Gen Hosp, Dept Cardiol, Taipei, Taiwan; [Charng, Min-Ji] Natl Yang Ming Univ, Taipei 112, Taiwan; [Cromwell, William C.] Presbyterian Ctr Preventat Cardiol, Div Atherosclerosis & Lipoprot Disorders, Charlotte, NC USA; [Lachmann, Robin H.] Univ Coll London Hosp, Charles Dent Metab Unit, London, England; [Gaudet, Daniel] Univ Montreal, ECOGENE 21, Clin Res Ctr & Lipid Clin, Chicoutimi, PQ, Canada; [Tan, Ju L.] Natl Heart Ctr, Dept Cardiol, Singapore, Singapore; [Chasan-Taber, Scott] Genzyme Corp, Biomed Data Sci & Informat, Cambridge, MA USA; [Tribble, Diane L.; Flaim, JoAnn D.; Crooke, Stanley T.] ISIS Pharmaceut, Carlsbad, CA 92008 USA	University of Witwatersrand; Universidade de Sao Paulo; University of Cape Town; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; University College London Hospitals NHS Foundation Trust; University of London; University College London; Universite de Montreal; National Heart Centre Singapore; Sanofi-Aventis; Genzyme Corporation; Isis Pharmaceuticals Inc	Raal, FJ (corresponding author), Univ Witwatersrand, Dept Med, ZA-2193 Johannesburg, South Africa.	frederick.raal@wits.ac.za	Raal, FJ/ABD-5111-2021; Santos, Raul/A-1170-2010	Raal, FJ/0000-0002-9170-7938; Santos, Raul/0000-0002-9860-6582; Lachmann, Robin/0000-0002-2618-2581; Blom, Dirk/0000-0003-3965-5912; Cromwell, William/0000-0001-7610-4920	ISIS Pharmaceuticals; Genzyme Corporation	ISIS Pharmaceuticals; Genzyme Corporation(Sanofi-AventisGenzyme Corporation)	The authors wish to acknowledge the contributions of all co-principal investigators and site coordinators for their efforts related to conduct of the trial; and Karen M Anderson (Genzyme Corporation), for assistance with preparation of the report. This study was sponsored by ISIS Pharmaceuticals and Genzyme Corporation.	ABBOTT RD, 1988, ARTERIOSCLEROSIS, V8, P207, DOI 10.1161/01.ATV.8.3.207; AKDIM F, AM J CARDIO IN PRESS; AKDIM F, J AM COLL C IN PRESS; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bjornsson E, 2005, HEPATOLOGY, V42, P481, DOI 10.1002/hep.20800; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; CROOKE R, 2007, ANTISENSE DRUG TECHN, P601; Crooke RM, 2005, J LIPID RES, V46, P872, DOI 10.1194/jlr.M400492-JLR200; Cuchel M, 2007, NEW ENGL J MED, V356, P148, DOI 10.1056/NEJMoa061189; Davis RA, 1999, BBA-MOL CELL BIOL L, V1440, P1, DOI 10.1016/S1388-1981(99)00083-9; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Fishbein M, 2005, J CLIN GASTROENTEROL, V39, P619, DOI 10.1097/00004836-200508000-00012; Gagne C, 2002, CIRCULATION, V105, P2469, DOI 10.1161/01.CIR.0000018744.58460.62; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; Kastelein JJP, 2006, CIRCULATION, V114, P1729, DOI 10.1161/CIRCULATIONAHA.105.606442; Lopez-Santamaria M, 2000, J PEDIATR SURG, V35, P630, DOI 10.1053/jpsu.2000.0350630; Maron DJ, 2000, CIRCULATION, V101, P207, DOI 10.1161/01.CIR.101.2.207; Moghadasian MH, 2001, J INVEST SURG, V14, P71, DOI 10.1080/08941930152024183; PEDERSEN TR, 1994, LANCET, V344, P1383; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; Rayburn ER, 2008, DRUG DISCOV TODAY, V13, P513, DOI 10.1016/j.drudis.2008.03.014; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Sachais BS, 2005, J CLIN APHERESIS, V20, P252, DOI 10.1002/jca.20036; Samaha FF, 2008, NAT CLIN PRACT CARD, V5, P497, DOI 10.1038/ncpcardio1250; Stein EA, 2009, ENDOCRIN METAB CLIN, V38, P99, DOI 10.1016/j.ecl.2008.11.011; Thompson GR, 2008, ATHEROSCLEROSIS, V198, P247, DOI 10.1016/j.atherosclerosis.2008.02.009; Visser ME, 2010, J LIPID RES, V51, P1057, DOI 10.1194/jlr.M002915; Yokoo T, 2009, RADIOLOGY, V251, P67, DOI 10.1148/radiol.2511080666; Yu RZ, 2009, BIOCHEM PHARMACOL, V77, P910, DOI 10.1016/j.bcp.2008.11.005	31	680	702	2	109	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 20	2010	375	9719					998	1006		10.1016/S0140-6736(10)60284-X	http://dx.doi.org/10.1016/S0140-6736(10)60284-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	575YU	20227758				2022-12-28	WOS:000276110700032
J	Jiang, LH; Fan, XH; Brandt, WN; Carilli, CL; Egami, E; Hines, DC; Kurk, JD; Richards, GT; Shen, Y; Strauss, MA; Vestergaard, M; Walter, F				Jiang, Linhua; Fan, Xiaohui; Brandt, W. N.; Carilli, Chris L.; Egami, Eiichi; Hines, Dean C.; Kurk, Jaron D.; Richards, Gordon T.; Shen, Yue; Strauss, Michael A.; Vestergaard, Marianne; Walter, Fabian			Dust-free quasars in the early Universe	NATURE			English	Article							BLACK-HOLE MASSES; NEAR-INFRARED SPECTROSCOPY; Z-SIMILAR-TO-6 QUASARS; ENERGY-DISTRIBUTIONS; EVOLUTION; GALAXIES; EMISSION; SAMPLE	The most distant quasars known, at redshifts z approximate to 6, generally have properties indistinguishable from those of lower-redshift quasars in the rest-frame ultraviolet/optical and X-ray bands(1-3). This puzzling result suggests that these distant quasars are evolved objects even though the Universe was only seven per cent of its current age at these redshifts. Recently one z approximate to 6 quasar was shown not to have any detectable emission from hot dust(4), but it was unclear whether that indicated different hot-dust properties at high redshift or if it is simply an outlier. Here we report the discovery of a second quasar without hot-dust emission in a sample of 21 z approximate to 6 quasars. Such apparently hot-dust-free quasars have no counterparts at low redshift. Moreover, we demonstrate that the hot-dust abundance in the 21 quasars builds up in tandem with the growth of the central black hole, whereas at low redshift it is almost independent of the black hole mass. Thus z approximate to 6 quasars are indeed at an early evolutionary stage, with rapid mass accretion and dust formation. The two hot-dust-free quasars are likely to be first-generation quasars born in dust-free environments and are too young to have formed a detectable amount of hot dust around them.	[Jiang, Linhua; Fan, Xiaohui; Egami, Eiichi; Vestergaard, Marianne] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Fan, Xiaohui; Kurk, Jaron D.; Walter, Fabian] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Brandt, W. N.] Penn State Univ, Dept Astron & Astrophys, Davey Lab 525, University Pk, PA 16802 USA; [Carilli, Chris L.] Natl Radio Astron Observ, Socorro, NM 87801 USA; [Hines, Dean C.] Space Sci Inst, Boulder, CO 80301 USA; [Kurk, Jaron D.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Richards, Gordon T.] Drexel Univ, Dept Phys, Philadelphia, PA 19104 USA; [Shen, Yue] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Strauss, Michael A.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Vestergaard, Marianne] Niels Bohr Inst, Dark Cosmol Ctr, DK-2100 Copenhagen O, Denmark	University of Arizona; Max Planck Society; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Radio Astronomy Observatory (NRAO); Max Planck Society; Drexel University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Princeton University; University of Copenhagen; Niels Bohr Institute	Jiang, LH (corresponding author), Univ Arizona, Steward Observ, 933 N Cherry Ave, Tucson, AZ 85721 USA.	ljiang@email.arizona.edu	Vestergaard, Marianne/M-5247-2014; Jiang, Linhua/H-5485-2016; Brandt, William N/N-2844-2015	Vestergaard, Marianne/0000-0001-9191-9837; Jiang, Linhua/0000-0003-4176-6486; Brandt, William N/0000-0002-0167-2453; Shen, Yue/0000-0003-1659-7035; Walter, Fabian/0000-0003-4793-7880	NASA; JPL/Caltech; NSF AST; Packard Fellowship; John Simon Guggenheim Memorial Fellowship; NASA ADP; Max-Planck-Gesellschaft; Humboldt-Stiftung; DFG; Danish National Research Foundation.	NASA(National Aeronautics & Space Administration (NASA)); JPL/Caltech; NSF AST(National Science Foundation (NSF)); Packard Fellowship(The David & Lucile Packard Foundation); John Simon Guggenheim Memorial Fellowship; NASA ADP(National Aeronautics & Space Administration (NASA)); Max-Planck-Gesellschaft(Max Planck Society); Humboldt-Stiftung(Alexander von Humboldt Foundation); DFG(German Research Foundation (DFG)); Danish National Research Foundation.(Danmarks Grundforskningsfond)	This work is based on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. Support for this work was provided by NASA through an award issued by JPL/Caltech. X. F. acknowledges support by NSF AST, a Packard Fellowship for Science and Engineering, and a John Simon Guggenheim Memorial Fellowship. W.N.B. was supported by the NASA ADP program. C. L. C. thanks the Max-Planck-Gesellschaft and the Humboldt-Stiftung for support through the Max-Planck-Forschungspreis. J.D.K. thanks the DFG for support via German-Israeli Project Cooperation. The Dark Cosmology Centre is funded by the Danish National Research Foundation.	ANTONUCCI R, 1993, ANNU REV ASTRON ASTR, V31, P473, DOI 10.1146/annurev.aa.31.090193.002353; Barth AJ, 2003, ASTROPHYS J, V594, pL95, DOI 10.1086/378735; Elitzur M, 2008, NEW ASTRON REV, V52, P274, DOI 10.1016/j.newar.2008.06.010; ELVIS M, 2002, APJ, V567, P107; Fan XH, 2004, ASTRON J, V128, P515, DOI 10.1086/422434; Fan XH, 2006, ASTRON J, V132, P117, DOI 10.1086/504836; Glikman E, 2006, ASTROPHYS J, V640, P579, DOI 10.1086/500098; Haas M, 2000, ASTRON ASTROPHYS, V354, P453; Haas M, 2003, ASTRON ASTROPHYS, V402, P87, DOI 10.1051/0004-6361:20030110; Hernan-Caballero A, 2009, MON NOT R ASTRON SOC, V395, P1695, DOI 10.1111/j.1365-2966.2009.14660.x; Hines DC, 2006, ASTROPHYS J, V641, pL85, DOI 10.1086/504109; HYLAND AR, 1982, MON NOT R ASTRON SOC, V199, P943, DOI 10.1093/mnras/199.4.943; Jiang LH, 2007, ASTRON J, V134, P1150, DOI 10.1086/520811; Jiang LH, 2006, ASTRON J, V132, P2127, DOI 10.1086/508209; Kurk JD, 2009, ASTROPHYS J, V702, P833, DOI 10.1088/0004-637X/702/2/833; Kurk JD, 2007, ASTROPHYS J, V669, P32, DOI 10.1086/521596; Maiolino R, 2004, NATURE, V431, P533, DOI 10.1038/nature02930; NEUGEBAUER G, 1987, ASTROPHYS J SUPPL S, V63, P615, DOI 10.1086/191175; Richards GT, 2006, ASTROPHYS J SUPPL S, V166, P470, DOI 10.1086/506525; RIEKE GH, 1978, ASTROPHYS J, V226, P550, DOI 10.1086/156639; Ryan CJ, 2007, ASTROPHYS J, V654, P799, DOI 10.1086/509313; Shemmer O, 2006, ASTROPHYS J, V644, P86, DOI 10.1086/503543; Shen Y, 2008, ASTROPHYS J, V680, P169, DOI 10.1086/587475; Stratta G, 2007, ASTROPHYS J, V661, pL9, DOI 10.1086/518502; Vestergaard M, 2006, ASTROPHYS J, V641, P689, DOI 10.1086/500572; Vestergaard M, 2009, ASTROPHYS J, V699, P800, DOI 10.1088/0004-637X/699/1/800; Wang R, 2008, ASTROPHYS J, V687, P848, DOI 10.1086/591076; Wang R, 2007, ASTRON J, V134, P617, DOI 10.1086/518867; Willott CJ, 2007, ASTRON J, V134, P2435, DOI 10.1086/522962	30	81	83	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					380	383		10.1038/nature08877	http://dx.doi.org/10.1038/nature08877			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20237563	Green Submitted			2022-12-28	WOS:000275657100039
J	Paszek, M; Weaver, V				Paszek, Matthew; Weaver, Valerie			Enforcing Order on Signaling	SCIENCE			English	Editorial Material									[Paszek, Matthew; Weaver, Valerie] Univ Calif San Francisco, Dept Surg, Ctr Bioengn & Tissue Regenerat, San Francisco, CA 94143 USA; [Weaver, Valerie] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Weaver, Valerie] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Weaver, Valerie] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Weaver, Valerie] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Pennsylvania	Paszek, M (corresponding author), Univ Calif San Francisco, Dept Surg, Ctr Bioengn & Tissue Regenerat, San Francisco, CA 94143 USA.	valerie.weaver@ucsfmedctr.org		Weaver, Valerie marie/0000-0003-4786-6752	NATIONAL CANCER INSTITUTE [R01CA138818, R01CA192914, R01CA174929, U54CA143836] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA138818, R01 CA174929, R01 CA192914, U54 CA143836] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333; Janmey PA, 2004, TRENDS BIOCHEM SCI, V29, P364, DOI 10.1016/j.tibs.2004.05.003; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pennarun B, 2010, BBA-REV CANCER, V1805, P123, DOI 10.1016/j.bbcan.2009.11.004; Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606	11	8	9	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	2010	327	5971					1335	1336		10.1126/science.1187865	http://dx.doi.org/10.1126/science.1187865			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223974				2022-12-28	WOS:000275418700027
J	Csontos, D				Csontos, Dan			EXOTIC MATTER	NATURE			English	Editorial Material																			0	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 11	2010	464	7286					175	175		10.1038/464175a	http://dx.doi.org/10.1038/464175a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20220833	Bronze			2022-12-28	WOS:000275366100028
J	Loeb, M; Russell, ML; Moss, L; Fonseca, K; Fox, J; Earn, DJD; Aoki, F; Horsman, G; Van Caeseele, P; Chokani, K; Vooght, M; Babiuk, L; Webby, R; Walter, SD				Loeb, Mark; Russell, Margaret L.; Moss, Lorraine; Fonseca, Kevin; Fox, Julie; Earn, David J. D.; Aoki, Fred; Horsman, Gregory; Van Caeseele, Paul; Chokani, Khami; Vooght, Mark; Babiuk, Lorne; Webby, Richard; Walter, Stephen D.			Effect of Influenza Vaccination of Children on Infection Rates in Hutterite Communities A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREVENTION; VACCINES; VIRUS; TIME; SCHOOLCHILDREN; HOUSEHOLD; MORBIDITY; MORTALITY; TECUMSEH; BENEFITS	Context Children and adolescents appear to play an important role in the transmission of influenza. Selectively vaccinating youngsters against influenza may interrupt virus transmission and protect those not immunized. Objective To assess whether vaccinating children and adolescents with inactivated influenza vaccine could prevent influenza in other community members. Design, Setting, and Participants A cluster randomized trial involving 947 Canadian children and adolescents aged 36 months to 15 years who received study vaccine and 2326 community members who did not receive the study vaccine in 49 Hutterite colonies in Alberta, Saskatchewan, and Manitoba. Follow-up began December 28, 2008, and ended June 23, 2009. Intervention Children were randomly assigned according to community and in a blinded manner to receive standard dosing of either inactivated trivalent influenza vaccine or hepatitis A vaccine, which was used as a control. Main Outcome Measures Confirmed influenza A and B infection using a real-time reverse transcriptase polymerase chain reaction (RT-PCR) assay and by measuring serum hemagglutination inhibition titers. Results The mean rate of study vaccine coverage among eligible participants was 83% (range, 53%-100%) for the influenza vaccine colonies and 79% (range, 50%-100%) for the hepatitis A vaccine colonies. Among nonrecipients, 39 of 1271 (3.1%) in the influenza vaccine colonies and 80 of 1055 (7.6%) in the hepatitis A vaccine colonies had influenza illness confirmed by RT-PCR, for a protective effectiveness of 61% (95% confidence interval [CI], 8%-83%; P=.03). Among all study participants (those who were and those who were not vaccinated), 80 of 1773 (4.5%) in the influenza vaccine colonies and 159 of 1500 (10.6%) in the hepatitis A vaccine colonies had influenza illness confirmed by RT-PCR for an overall protective effectiveness of 59% (95% CI, 5%-82%; P=.04). No serious vaccine adverse events were observed. Conclusion Immunizing children and adolescents with inactivated influenza vaccine significantly protected unimmunized residents of rural communities against influenza.	[Loeb, Mark; Moss, Lorraine] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada; [Loeb, Mark] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Loeb, Mark; Earn, David J. D.; Walter, Stephen D.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; [Loeb, Mark; Earn, David J. D.] McMaster Univ, Michael G De Groote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada; [Earn, David J. D.] McMaster Univ, Dept Math & Stat, Hamilton, ON L8N 3Z5, Canada; [Russell, Margaret L.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Fonseca, Kevin; Fox, Julie] Univ Calgary, Prov Lab Publ Hlth, Calgary, AB, Canada; [Fonseca, Kevin; Fox, Julie] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada; [Aoki, Fred] Univ Manitoba, Dept Med, Winnipeg, MB, Canada; [Aoki, Fred] Univ Manitoba, Dept Med Microbiol & Pharmacol, Winnipeg, MB, Canada; [Aoki, Fred] Univ Manitoba, Dept Therapeut, Winnipeg, MB, Canada; [Horsman, Gregory] Saskatchewan Dis Control Lab, Regina, SK, Canada; [Van Caeseele, Paul] Cadham Prov Lab, Winnipeg, MB, Canada; [Chokani, Khami] Saskatchewan Hlth, Cypress Hlth Reg, Swift Current, SK, Canada; [Vooght, Mark] Saskatchewan Hlth, Five Hills, SK, Canada; [Babiuk, Lorne] Univ Alberta, Edmonton, AB, Canada; [Webby, Richard] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Webby, Richard] WHO Collaborating Ctr, Memphis, TN USA	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; University of Calgary; University of Calgary; University of Calgary; University of Manitoba; University of Manitoba; University of Manitoba; University of Alberta; St Jude Children's Research Hospital; World Health Organization	Loeb, M (corresponding author), McMaster Univ, Dept Pathol & Mol Med, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	loebm@mcmaster.ca	Webby, Richard J/N-5657-2018; Walter, Stephen/AAB-5548-2022	Walter, Stephen/0000-0003-4157-8928; Earn, David/0000-0002-7562-1341	Canadian Institutes for Health Research; National Institute for Allergy and Infectious Diseases	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Canadian Institutes for Health Research and the National Institute for Allergy and Infectious Diseases. Sanofi Pasteur donated vaccines used for the study but provided no funding for the study.	Brownstein JS, 2005, AM J EPIDEMIOL, V162, P686, DOI 10.1093/aje/kwi257; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Cox, 2009, MMWR RECOMM REP, V58, P896; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Dushoff J, 2007, PLOS MED, V4, P921, DOI 10.1371/journal.pmed.0040174; Esposito S, 2003, VACCINE, V21, P3162, DOI 10.1016/S0264-410X(03)00253-6; FOX JP, 1982, AM J EPIDEMIOL, V116, P212, DOI 10.1093/oxfordjournals.aje.a113407; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Halloran ME, 2002, VACCINE, V20, P3254; Hurwitz ES, 2000, JAMA-J AM MED ASSOC, V284, P1677, DOI 10.1001/jama.284.13.1677; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jeffersom T, 2007, LANCET, V370, P1199, DOI 10.1016/S0140-6736(07)61389-0; Jefferson TO, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub3; Jordan R, 2006, VACCINE, V24, P1047, DOI 10.1016/j.vaccine.2005.09.017; Kermode-Scott B, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2746; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; Langley JM, 2004, CAN MED ASSOC J, V171, P1213, DOI 10.1503/cmaj.1031737; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; LONGINI IM, 1978, MATH BIOSCI, V38, P141, DOI 10.1016/0025-5564(78)90023-8; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Piedra PA, 2005, VACCINE, V23, P1540, DOI 10.1016/j.vaccine.2004.09.025; *PUBL HLTH AG CAN, FLU WATCH MAY 31 200; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; RUDENKO LG, 1993, J INFECT DIS, V168, P881, DOI 10.1093/infdis/168.4.881; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Weycker D, 2005, VACCINE, V23, P1284, DOI 10.1016/j.vaccine.2004.08.044; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	34	266	270	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2010	303	10					943	950		10.1001/jama.2010.250	http://dx.doi.org/10.1001/jama.2010.250			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	565UC	20215608	Bronze			2022-12-28	WOS:000275319300021
J	Horton, R				Horton, Richard			Offline: Those who think freely think well	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.								0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 6	2010	375	9717					790	790		10.1016/S0140-6736(10)60315-7	http://dx.doi.org/10.1016/S0140-6736(10)60315-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570MO	20206762				2022-12-28	WOS:000275682600011
J	Greer, PL; Hanayama, R; Bloodgood, BL; Mardinly, AR; Lipton, DM; Flavell, SW; Kim, TK; Griffith, EC; Waldon, Z; Maehr, R; Ploegh, HL; Chowdhury, S; Worley, PF; Steen, J; Greenberg, ME				Greer, Paul L.; Hanayama, Rikinari; Bloodgood, Brenda L.; Mardinly, Alan R.; Lipton, David M.; Flavell, Steven W.; Kim, Tae-Kyung; Griffith, Eric C.; Waldon, Zachary; Maehr, Rene; Ploegh, Hidde L.; Chowdhury, Shoaib; Worley, Paul F.; Steen, Judith; Greenberg, Michael E.			The Angelman Syndrome Protein Ube3A Regulates Synapse Development by Ubiquitinating Arc	CELL			English	Article							FRAGILE-X-SYNDROME; ACTIVITY-DEPENDENT REGULATION; MENTAL-RETARDATION; E6-ASSOCIATED PROTEIN; RECEPTOR TRAFFICKING; BDNF TRANSCRIPTION; AMPA RECEPTORS; MOUSE MODEL; GENE; PHOSPHORYLATION	Angelman Syndrome is a debilitating neurological disorder caused by mutation of the E3 ubiquitin ligase Ube3A, a gene whose mutation has also recently been associated with autism spectrum disorders (ASDs). The function of Ube3A during nervous system development and how Ube3A mutations give rise to cognitive impairment in individuals with Angleman Syndrome and ASDs are not clear. We report here that experience-driven neuronal activity induces Ube3A transcription and that Ube3A then regulates excitatory synapse development by controlling the degradation of Arc, a synaptic protein that promotes the internalization of the AMPA subtype of glutamate receptors. We find that disruption of Ube3A function in neurons leads to an increase in Arc expression and a concomitant decrease in the number of AMPA receptors at excitatory synapses. We propose that this deregulation of AMPA receptor expression at synapses may contribute to the cognitive dysfunction that occurs in Angelman Syndrome and possibly other ASDs.	[Greer, Paul L.; Hanayama, Rikinari; Bloodgood, Brenda L.; Mardinly, Alan R.; Lipton, David M.; Flavell, Steven W.; Kim, Tae-Kyung; Griffith, Eric C.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Greer, Paul L.] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Chowdhury, Shoaib; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Maehr, Rene; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Waldon, Zachary; Steen, Judith] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Waldon, Zachary; Steen, Judith] Childrens Hosp, Dept Neurol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Johns Hopkins University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	meg@hms.harvard.edu	Hanayama, Rikinari/AAO-4959-2021; Hanayama, Rikinari/D-2940-2011; Kim, Tae-Kyung/AAX-4230-2020	Hanayama, Rikinari/0000-0003-2102-3386; Kim, Tae-Kyung/0000-0001-5161-9864; Mardinly, Alan/0000-0001-9891-6719; Bloodgood, Brenda/0000-0002-4797-9119; Flavell, Steven/0000-0001-9464-1877; Griffith, Eric/0000-0003-0428-3215	National Science Foundation; Human Frontier Science Program Fellowship; National Institute of Mental Health [MH53608]; AS Foundation; National Institutes of Health [NS28829]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH053608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028829, R37NS028829] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Human Frontier Science Program Fellowship(Human Frontier Science Program); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); AS Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Margolis for sharing unpublished results and C. Chen, J. Zieg, and S. Cohen for helpful discussions; J. Zieg for assistance with figure making; K. Condon and M. Ehlers for their generous advice on culturing Ube3A knockout neurons; R. Greenberg for assistance with enriched environment experiments; and E. Bennechi for sectioning array tomography ribbons. This research was supported by a National Science Foundation predoctoral fellowship (P.L.G), a Human Frontier Science Program Fellowship (R.H.), a grant from the National Institute of Mental Health (MH53608 to P.F.W), an AS Foundation grant during the initial stages of this work, and a National Institutes of Health grant (NS28829) (M.E.G).	Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Clayton-Smith J, 2003, J MED GENET, V40, P87, DOI 10.1136/jmg.40.2.87; Cook EH, 1997, AM J HUM GENET, V60, P928; Cooper EM, 2004, J BIOL CHEM, V279, P41208, DOI 10.1074/jbc.M401302200; Dolen G, 2008, J PHYSIOL-LONDON, V586, P1503, DOI 10.1113/jphysiol.2008.150722; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kamionka M, 2004, PROTEIN SCI, V13, P2370, DOI 10.1110/ps.04824304; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kumar S, 1999, J BIOL CHEM, V274, P18785, DOI 10.1074/jbc.274.26.18785; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Miura K, 2002, NEUROBIOL DIS, V9, P149, DOI 10.1006/nbdi.2001.0463; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nakamoto M, 2007, P NATL ACAD SCI USA, V104, P15537, DOI 10.1073/pnas.0707484104; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Rose J, 2009, NEURON, V61, P351, DOI 10.1016/j.neuron.2008.12.030; Ryu KY, 2007, EMBO J, V26, P2693, DOI 10.1038/sj.emboj.7601722; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sharfe N, 2003, J IMMUNOL, V170, P6024, DOI 10.4049/jimmunol.170.12.6024; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Sutcliffe JS, 2003, J AM ACAD CHILD PSY, V42, P253, DOI 10.1097/00004583-200302000-00021; van Woerden GM, 2007, NAT NEUROSCI, V10, P280, DOI 10.1038/nn1845; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Williams CA, 2006, AM J MED GENET A, V140A, P413, DOI 10.1002/ajmg.a.31074; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	41	429	448	2	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					704	716		10.1016/j.cell.2010.01.026	http://dx.doi.org/10.1016/j.cell.2010.01.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211139	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000275197400019
J	Guo, Y; Shibuya, K; Cheng, G; Rao, KQ; Lee, L; Tang, SL				Guo, Yan; Shibuya, Kenji; Cheng, Gang; Rao, Keqin; Lee, Liming; Tang, Shenglan			Tracking China's health reform	LANCET			English	Editorial Material									[Tang, Shenglan] TDR WHO, CH-1211 Geneva 27, Switzerland; [Guo, Yan; Cheng, Gang; Lee, Liming] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Beijing 100871, Peoples R China; [Shibuya, Kenji] Univ Tokyo, Tokyo, Japan; [Rao, Keqin] Minist Hlth, Beijing, Peoples R China; [Tang, Shenglan] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	World Health Organization; Peking University; University of Tokyo; Liverpool School of Tropical Medicine; University of Liverpool	Tang, SL (corresponding author), TDR WHO, CH-1211 Geneva 27, Switzerland.	tangs@who.int	Tang, Shenglan/AAO-7403-2020	Shibuya, Kenji/0000-0003-2528-7530				CPC Central Committee. State Council, 2022, 2021 STAT B DEV HEAL, DOI 10.16619/j.cnki.rmltxsqy.2021.14.010; *MIN HLTH, 2007, NAT HLTH STAT SURV S; Murray CJL, 2008, LANCET, V371, P1191, DOI 10.1016/S0140-6736(08)60526-7; State Council Research and Development Center People's Republic of China, 2005, CHINA DEV COMMENTS S, VA01, P1; WANG J, 2005, CHINA YOUTH DAI 0729; XU L, 2009, SEIN LEV SEM NAT HLT	6	41	43	2	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2010	375	9720					1056	1058		10.1016/S0140-6736(10)60397-2	http://dx.doi.org/10.1016/S0140-6736(10)60397-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	578ZB	20346797				2022-12-28	WOS:000276334600005
J	Montgomery, SB; Sammeth, M; Gutierrez-Arcelus, M; Lach, RP; Ingle, C; Nisbett, J; Guigo, R; Dermitzakis, ET				Montgomery, Stephen B.; Sammeth, Micha; Gutierrez-Arcelus, Maria; Lach, Radoslaw P.; Ingle, Catherine; Nisbett, James; Guigo, Roderic; Dermitzakis, Emmanouil T.			Transcriptome genetics using second generation sequencing in a Caucasian population	NATURE			English	Article							RNA-SEQ; REGULATORY VARIATION; EXPRESSION; GENOME; NUCLEOTIDE; RESOLUTION	Gene expression is an important phenotype that informs about genetic and environmental effects on cellular state. Many studies have previously identified genetic variants for gene expression phenotypes using custom and commercially available microarrays(1-5). Second generation sequencing technologies are now providing unprecedented access to the fine structure of the transcriptome(6-14). We have sequenced the mRNA fraction of the transcriptome in 60 extended HapMap individuals of European descent and have combined these data with genetic variants from the HapMap3 project(15). We have quantified exon abundance based on read depth and have also developed methods to quantify whole transcript abundance. We have found that approximately 10 million reads of sequencing can provide access to the same dynamic range as arrays with better quantification of alternative and highly abundant transcripts. Correlation with SNPs (small nucleotide polymorphisms) leads to a larger discovery of eQTLs (expression quantitative trait loci) than with arrays. We also detect a substantial number of variants that influence the structure of mature transcripts indicating variants responsible for alternative splicing. Finally, measures of allele-specific expression allowed the identification of rare eQTLs and allelic differences in transcript structure. This analysis shows that high throughput sequencing technologies reveal new properties of genetic effects on the transcriptome and allow the exploration of genetic effects in cellular processes.	[Montgomery, Stephen B.; Gutierrez-Arcelus, Maria; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Montgomery, Stephen B.; Lach, Radoslaw P.; Ingle, Catherine; Nisbett, James; Dermitzakis, Emmanouil T.] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Sammeth, Micha; Guigo, Roderic] Univ Pompeu Fabra, Ctr Genom Regulat, Barcelona 08003, Catalonia, Spain	University of Geneva; Wellcome Trust Sanger Institute; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Dermitzakis, ET (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	stephen.montgomery@unige.ch; emmanouil.dermitzakis@unige.ch	Guigo, Roderic/D-1303-2010; Mustafa, Zafirah/W-9358-2018; Dermitzakis, Emmanouil/B-7687-2013; Sammeth, Michael/C-1157-2014	Guigo, Roderic/0000-0002-5738-4477; Sammeth, Michael/0000-0002-6528-9883; Montgomery, Stephen/0000-0002-5200-3903	Wellcome Trust; Louis-Jeantet foundation; Swiss National Science Foundation NCCR; Spanish Ministry of Science and Consolider Ingenio	Wellcome Trust(Wellcome TrustEuropean Commission); Louis-Jeantet foundation; Swiss National Science Foundation NCCR(Swiss National Science Foundation (SNSF)); Spanish Ministry of Science and Consolider Ingenio	The authors would like to acknowledge H. Li, S. White, J. O'Brien, S. Searle, M. Quail, S. V. V. Deevi and the Sequencing Core facility at the Wellcome Trust Sanger Institute. We would also like to thank C. Beazley, A. Nica, L. Jostins, K. Morley, J. Barrett and V. Anttila. Funding was provided by the Wellcome Trust, the Louis-Jeantet foundation and the Swiss National Science Foundation NCCR ('Frontiers in Genetics') to E. T. D. and Spanish Ministry of Science and Consolider Ingenio 2010 to R. G.	Ahuja R. K., 1993, NETWORK FLOWS THEORY; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; CORMEN TH, 2001, INTRO ALGORITHMS, P770; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; HILLER D, 2009, BIOINFORMATICS, P93901; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oshlack A, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-14; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; PICKRELL JK, 2010, NATURE, V30, P93901; Sabatti C, 2002, GENETICS, V160, P1707; Sammeth M, 2009, J COMPUT BIOL, V16, P1117, DOI 10.1089/cmb.2009.0108; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Verlaan DJ, 2009, GENOME RES, V19, P118, DOI 10.1101/gr.084798.108; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357; Zheng SK, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp282	34	623	642	2	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2010	464	7289					773	U151		10.1038/nature08903	http://dx.doi.org/10.1038/nature08903			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20220756	Green Accepted			2022-12-28	WOS:000276205000048
J	Weatherall, DJ				Weatherall, D. J.			Is modern genetics a blind alley? No	BRITISH MEDICAL JOURNAL			English	Editorial Material							GENOMICS		Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England	University of Oxford	Weatherall, DJ (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	liz.rose@imm.ox.ac.uk						Brenner S, 2010, PHILOS T R SOC B, V365, P207, DOI 10.1098/rstb.2009.0221; Futreal PA, 2001, NATURE, V409, P850, DOI 10.1038/35057046; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; Hayden EC, 2009, NATURE, V461, P458, DOI 10.1038/461458a; HORGAN J, 2007, END SCI; WHO, 2002, GEN WORLD HLTH; [No title captured]	7	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 30	2010	340								c1088	10.1136/bmj.c1088	http://dx.doi.org/10.1136/bmj.c1088			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579VJ	20354020				2022-12-28	WOS:000276404100001
J	Hartzband, P; Groopman, J				Hartzband, Pamela; Groopman, Jerome			Untangling the Web - Patients, Doctors, and the Internet	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hartzband, Pamela; Groopman, Jerome] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Hartzband, Pamela; Groopman, Jerome] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Hartzband, P (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.							SUNSTEIN CR, 2009, RUMOR FALSEHOODS SPR; Tang HW, 2006, BRIT MED J, V333, P1143, DOI 10.1136/bmj.39003.640567.AE	2	80	81	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	2010	362	12					1063	1066		10.1056/NEJMp0911938	http://dx.doi.org/10.1056/NEJMp0911938			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	573FU	20335581				2022-12-28	WOS:000275894600002
J	Kaeberlein, M				Kaeberlein, Matt			Lessons on longevity from budding yeast	NATURE			English	Review							LIFE-SPAN EXTENSION; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; DIETARY RESTRICTION; SCHIZOSACCHAROMYCES-POMBE; DAUGHTER CELLS; RESVERATROL; SIR2; AGE; TOR	The past decade has seen fundamental advances in our understanding of the ageing process and raised optimism that interventions to slow ageing may be on the horizon. Studies of budding yeast have made immense contributions to this progress. Yeast longevity factors have now been shown to modulate ageing in invertebrate and mammalian models, and studies of yeast have resulted in some of the best candidates for anti-ageing drugs currently in development. The first interventions to slow human ageing may spring from the humble yeast.	[Kaeberlein, Matt] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Kaeberlein, Matt] Guangdong Med Coll, Inst Aging Res, Dongguan 523808, Peoples R China	University of Washington; University of Washington Seattle; Guangdong Medical University	Kaeberlein, M (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	kaeber@u.washington.edu		Kaeberlein, Matt/0000-0002-1311-3421	US National Institutes of Health (NIH) [R21AG031965]; University of Washington Nathan Shock Center of Excellence in the Basic Biology of Aging (NIH) [P30AG013280]; Ellison Medical Foundation; NATIONAL INSTITUTE ON AGING [P30AG013280, R21AG031965] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Nathan Shock Center of Excellence in the Basic Biology of Aging (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Studies related to this topic in the Kaeberlein laboratory have been supported by US National Institutes of Health (NIH) grant R21AG031965, a Pilot Project grant from the University of Washington Nathan Shock Center of Excellence in the Basic Biology of Aging (NIH grant P30AG013280) and a New Scholar in Aging Award from the Ellison Medical Foundation.	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Alvers AL, 2009, AUTOPHAGY, V5, P847, DOI 10.4161/auto.8824; Alvers AL, 2009, AGING CELL, V8, P353, DOI 10.1111/j.1474-9726.2009.00469.x; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Ashrafi K, 1999, P NATL ACAD SCI USA, V96, P9100, DOI 10.1073/pnas.96.16.9100; Austriaco NR, 1997, P NATL ACAD SCI USA, V94, P9768, DOI 10.1073/pnas.94.18.9768; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Barker MG, 1999, YEAST, V15, P1511, DOI 10.1002/(SICI)1097-0061(199910)15:14<1511::AID-YEA482>3.3.CO;2-P; Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Burhans WC, 2009, CELL CYCLE, V8, P2300, DOI 10.4161/cc.8.14.8852; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Chiocchetti A, 2007, EXP GERONTOL, V42, P275, DOI 10.1016/j.exger.2006.11.002; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; EGILMEZ NK, 1989, J BACTERIOL, V171, P37, DOI 10.1128/jb.171.1.37-42.1989; EISENBERG T, 2009, NATURE CELL, V11, P1277; Erjavec N, 2008, P NATL ACAD SCI USA, V105, P18764, DOI 10.1073/pnas.0804550105; Erjavec N, 2007, P NATL ACAD SCI USA, V104, P10877, DOI 10.1073/pnas.0701634104; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fabrizio P, 2008, BBA-MOL CELL RES, V1783, P1280, DOI 10.1016/j.bbamcr.2008.03.017; Fabrizio Paola, 2007, Methods Mol Biol, V371, P89; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Ganley ARD, 2009, MOL CELL, V35, P683, DOI 10.1016/j.molcel.2009.07.012; Guarente L, 2005, MECH AGEING DEV, V126, P923, DOI 10.1016/j.mad.2005.03.013; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jiang JC, 2000, FASEB J, V14, P2135; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kaeberlein M, 2005, PLOS GENET, V1, P614, DOI 10.1371/journal.pgen.0010069; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2007, AGEING RES REV, V6, P128, DOI 10.1016/j.arr.2007.04.001; Kaeberlein M, 2006, SCIENCE, V312, DOI 10.1126/science.1124608; Kaeberlein M, 2010, BIOESSAYS, V32, P96, DOI 10.1002/bies.200900171; Kaeberlein M, 2009, NAT CELL BIOL, V11, P1277, DOI 10.1038/ncb1109-1277; Kaeberlein M, 2009, SCIENCE, V326, P55, DOI 10.1126/science.1181034; Kennedy BK, 2007, CELL MOL LIFE SCI, V64, P1323, DOI 10.1007/s00018-007-6470-y; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; KENNEDY BK, 1994, J CELL BIOL, V127, P1985, DOI 10.1083/jcb.127.6.1985; Kennedy BK, 2009, AGING CELL, V8, P617, DOI 10.1111/j.1474-9726.2009.00522.x; Kirchman PA, 1999, GENETICS, V152, P179; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lai CY, 2002, GENETICS, V162, P73; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lindstrom DL, 2009, GENETICS, V183, P413, DOI 10.1534/genetics.109.106229; Lorenz DR, 2009, P NATL ACAD SCI USA, V106, P1145, DOI 10.1073/pnas.0812551106; Lu SP, 2010, BBA-PROTEINS PROTEOM, V1804, P1567, DOI 10.1016/j.bbapap.2009.09.030; Managbanag JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003802; McMurray MA, 2003, SCIENCE, V301, P1908, DOI 10.1126/science.1087706; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Murakami CJ, 2008, J GERONTOL A-BIOL, V63, P113, DOI 10.1093/gerona/63.2.113; Oliveira GA, 2008, J BIOENERG BIOMEMBR, V40, P381, DOI 10.1007/s10863-008-9159-5; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Qin H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002670; Riesen M, 2009, AGING CELL, V8, P624, DOI 10.1111/j.1474-9726.2009.00514.x; Rockenfeller P, 2008, EXP GERONTOL, V43, P876, DOI 10.1016/j.exger.2008.08.044; Roux AE, 2006, AGING CELL, V5, P345, DOI 10.1111/j.1474-9726.2006.00225.x; Roux AE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000408; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Shawi M, 2008, MECH AGEING DEV, V129, P3, DOI 10.1016/j.mad.2007.11.007; Shcheprova Z, 2008, NATURE, V454, P728, DOI 10.1038/nature07212; Smith DL, 2007, AGING CELL, V6, P649, DOI 10.1111/j.1474-9726.2007.00326.x; Smith DL, 2009, AGING CELL, V8, P633, DOI 10.1111/j.1474-9726.2009.00516.x; Smith ED, 2008, GENOME RES, V18, P564, DOI 10.1101/gr.074724.107; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; Tsuchiya M, 2006, AGING CELL, V5, P505, DOI 10.1111/j.1474-9726.2006.00240.x; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Wang XW, 2008, NAT CELL BIOL, V10, P1090, DOI 10.1038/ncb1769; Wei M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000467; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	86	303	310	4	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					513	519		10.1038/nature08981	http://dx.doi.org/10.1038/nature08981			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20336133	Green Accepted			2022-12-28	WOS:000275974200034
J	Kang, K; Pulver, SR; Panzano, VC; Chang, EC; Griffith, LC; Theobald, DL; Garrity, PA				Kang, Kyeongjin; Pulver, Stefan R.; Panzano, Vincent C.; Chang, Elaine C.; Griffith, Leslie C.; Theobald, Douglas L.; Garrity, Paul A.			Analysis of Drosophila TRPA1 reveals an ancient origin for human chemical nociception	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; COVALENT MODIFICATION; MAXIMUM-LIKELIHOOD; CHANNEL TRPA1; ION CHANNELS; PAINLESS; CHEMOSENSATION; ACTIVATION; EXPRESSION; RECEPTORS	Chemical nociception, the detection of tissue-damaging chemicals, is important for animal survival and causes human pain and inflammation, but its evolutionary origins are largely unknown. Reactive electrophiles are a class of noxious compounds humans find pungent and irritating, such as allyl isothiocyanate (in wasabi) and acrolein ( in cigarette smoke)(1-3). Diverse animals, from insects to humans, find reactive electrophiles aversive(1-3), but whether this reflects conservation of an ancient sensory modality has been unclear. Here we identify the molecular basis of reactive electrophile detection in flies. We demonstrate that Drosophila TRPA1 (Transient receptor potential A1), the Drosophila melanogaster orthologue of the human irritant sensor, acts in gustatory chemosensors to inhibit reactive electrophile ingestion. We show that fly and mosquito TRPA1 orthologues are molecular sensors of electrophiles, using a mechanism conserved with vertebrate TRPA1s. Phylogenetic analyses indicate that invertebrate and vertebrate TRPA1s share a common ancestor that possessed critical characteristics required for electrophile detection. These findings support emergence of TRPA1-based electrophile detection in a common bilaterian ancestor, with widespread conservation throughout vertebrate and invertebrate evolution. Such conservation contrasts with the evolutionary divergence of canonical olfactory and gustatory receptors and may relate to electrophile toxicity. We propose that human pain perception relies on an ancient chemical sensor conserved across similar to 500 million years of animal evolution.	[Kang, Kyeongjin; Pulver, Stefan R.; Panzano, Vincent C.; Chang, Elaine C.; Griffith, Leslie C.; Garrity, Paul A.] Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA; [Kang, Kyeongjin; Pulver, Stefan R.; Panzano, Vincent C.; Chang, Elaine C.; Griffith, Leslie C.; Garrity, Paul A.] Brandeis Univ, Volen Ctr Complex Syst, Dept Biol, Waltham, MA 02454 USA; [Theobald, Douglas L.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA	Brandeis University; Brandeis University; Brandeis University	Garrity, PA (corresponding author), Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA.	pgarrity@brandeis.edu	Theobald, Douglas L/F-3514-2013; babakinejad, babak/G-2674-2012	Theobald, Douglas L/0000-0002-2695-8343; Kang, KyeongJin/0000-0003-0446-469X; Pulver, Stefan/0000-0001-5170-7522; Garrity, Paul/0000-0002-8274-6564; Griffith, Leslie/0000-0003-3164-9876	NIMH [R21 MH080206, RO1 MH067284]; NINDS [PO1 NS044232]; Royal Society; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH080206, R01MH067284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044232] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Royal Society(Royal Society of London); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Amrein, G. Boekh, K. Scott, D. Tracey and Bloomington Stock center for flies, C. Miller-Patterson and D. Zeiger for assistance, and members of the Garrity laboratory, J. P. Garrity, L. Huang, E. Marder, S. Nelson, G. Turrigiano and M. Rosbash for comments. This work was supported by grants from the NIMH (R21 MH080206, P. A. G.; RO1 MH067284, L. C. G.), NINDS (PO1 NS044232), and the Royal Society (Newton International Fellowship, S. R. P.).	Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Eisner T., 1970, CHEM ECOL, P157; Gendre N, 2004, DEVELOPMENT, V131, P83, DOI 10.1242/dev.00879; GOMES R, 2002, 43 WHO; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Joiner MLA, 1997, J NEUROSCI, V17, P9384; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kindt KS, 2007, NAT NEUROSCI, V10, P568, DOI 10.1038/nn1886; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Rosenzweig M, 2008, P NATL ACAD SCI USA, V105, P14668, DOI 10.1073/pnas.0805041105; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sokabe T, 2008, J NEUROSCI, V28, P9929, DOI 10.1523/JNEUROSCI.2757-08.2008; Swofford D.L., 2003, PAUP VERSION 40 B10; Talavera K, 2009, NAT NEUROSCI, V12, P1293, DOI 10.1038/nn.2379; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	38	225	229	3	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					597	U155		10.1038/nature08848	http://dx.doi.org/10.1038/nature08848			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20237474	Green Accepted			2022-12-28	WOS:000275974200049
J	Li, JF; Huang, YF; Ding, Y; Yang, ZL; Li, SB; Zhou, XS; Fan, FR; Zhang, W; Zhou, ZY; Wu, DY; Ren, B; Wang, ZL; Tian, ZQ				Li, Jian Feng; Huang, Yi Fan; Ding, Yong; Yang, Zhi Lin; Li, Song Bo; Zhou, Xiao Shun; Fan, Feng Ru; Zhang, Wei; Zhou, Zhi You; Wu, De Yin; Ren, Bin; Wang, Zhong Lin; Tian, Zhong Qun			Shell-isolated nanoparticle-enhanced Raman spectroscopy	NATURE			English	Article							SINGLE MOLECULES; SCATTERING; NANOSTRUCTURES; SERS; DNA	Surface-enhanced Raman scattering (SERS) is a powerful spectroscopy technique that can provide non-destructive and ultrasensitive characterization down to single molecular level, comparable to single-molecule fluorescence spectroscopy(1-15). However, generally substrates based on metals such as Ag, Au and Cu, either with roughened surfaces or in the form of nanoparticles, are required to realise a substantial SERS effect, and this has severely limited the breadth of practical applications of SERS. A number of approaches have extended the technique to non-traditional substrates(14,16,17), most notably tip-enhanced Raman spectroscopy (TERS)(18-20) where the probed substance (molecule or material surface) can be on a generic substrate and where a nanoscale gold tip above the substrate acts as the Raman signal amplifier. The drawback is that the total Raman scattering signal from the tip area is rather weak, thus limiting TERS studies to molecules with large Raman cross-sections. Here, we report an approach, which we name shell-isolated nanoparticle-enhanced Raman spectroscopy, in which the Raman signal amplification is provided by gold nanoparticles with an ultrathin silica or alumina shell. A monolayer of such nanoparticles is spread as 'smart dust' over the surface that is to be probed. The ultrathin coating keeps the nanoparticles from agglomerating, separates them from direct contact with the probed material and allows the nanoparticles to conform to different contours of substrates. High-quality Raman spectra were obtained on various molecules adsorbed at Pt and Au single-crystal surfaces and from Si surfaces with hydrogen monolayers. These measurements and our studies on yeast cells and citrus fruits with pesticide residues illustrate that our method significantly expands the flexibility of SERS for useful applications in the materials and life sciences, as well as for the inspection of food safety, drugs, explosives and environment pollutants.	[Li, Jian Feng; Huang, Yi Fan; Yang, Zhi Lin; Li, Song Bo; Zhou, Xiao Shun; Fan, Feng Ru; Zhang, Wei; Zhou, Zhi You; Wu, De Yin; Ren, Bin; Tian, Zhong Qun] Xiamen Univ, State Key Lab Phys Chem Solid Surfaces, Xiamen 361005, Peoples R China; [Li, Jian Feng; Huang, Yi Fan; Yang, Zhi Lin; Li, Song Bo; Zhou, Xiao Shun; Fan, Feng Ru; Zhang, Wei; Zhou, Zhi You; Wu, De Yin; Ren, Bin; Tian, Zhong Qun] Xiamen Univ, Coll Chem & Chem Engn, Xiamen 361005, Peoples R China; [Ding, Yong; Fan, Feng Ru; Wang, Zhong Lin] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA	Xiamen University; Xiamen University; University System of Georgia; Georgia Institute of Technology	Tian, ZQ (corresponding author), Xiamen Univ, State Key Lab Phys Chem Solid Surfaces, Xiamen 361005, Peoples R China.	zhong.wang@mse.gatech.edu; zqtian@xmu.edu.cn	Wang, Zhong Lin/E-2176-2011; Fan, Fengru/D-1422-2011; Tian, ZQ/G-3411-2010; Zhou, Xiao-Shun/C-3847-2008; , De Yin Wu/G-4678-2010; Yang, ZL/G-3971-2010; Li, Jian-Feng/J-5843-2015; wang, jie/GRS-0942-2022; ZHOU, ZHIYOU/G-4690-2010; Ding, Yong/F-3705-2017; Ren, Bin/G-4641-2010; Im, Hwon/B-5659-2012	Wang, Zhong Lin/0000-0002-5530-0380; Fan, Fengru/0000-0001-6474-471X; Tian, ZQ/0000-0002-9775-8189; Zhou, Xiao-Shun/0000-0003-1673-8125; Li, Jian-Feng/0000-0003-1598-6856; ZHOU, ZHIYOU/0000-0001-5181-0642; Ding, Yong/0000-0001-5805-347X; Ren, Bin/0000-0002-9821-5864; 	MOST, China [2009CB930703, 2007DFC40440, 2007CB935603]; NSF of China [20620130427, 20533040]; BES DOE [DE-FG02-07ER46394]; US NSF [DMS 0706436, CMMI 0403671]	MOST, China(Ministry of Science and Technology, China); NSF of China(National Natural Science Foundation of China (NSFC)); BES DOE(United States Department of Energy (DOE)); US NSF(National Science Foundation (NSF))	We thank P. Bartlett for suggestions and editing of the English while writing the paper. We thank R. Zare, N. Zheng, B. Mao, U. K. Sur and L. Yang for discussions. We also thank Y. Yu, Y. Wu, M. Zhuang, X. Wang and A. Wang for assistance in experiments. This work was supported by MOST, China (2009CB930703, 2007DFC40440 and 2007CB935603), the NSF of China (20620130427 and 20533040), the BES DOE (DE-FG02-07ER46394) and the US NSF (DMS 0706436, CMMI 0403671).	Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162; Baumberg JJ, 2005, NANO LETT, V5, P2262, DOI 10.1021/nl051618f; Camden JP, 2008, ACCOUNTS CHEM RES, V41, P1653, DOI 10.1021/ar800041s; Cao YWC, 2002, SCIENCE, V297, P1536, DOI 10.1126/science.297.5586.1536; Chen Z, 2008, NAT BIOTECHNOL, V26, P1285, DOI 10.1038/nbt.1501; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; Graham D, 2008, NAT NANOTECHNOL, V3, P548, DOI 10.1038/nnano.2008.189; Jackson JB, 2004, P NATL ACAD SCI USA, V101, P17930, DOI 10.1073/pnas.0408319102; Jain PK, 2008, ACCOUNTS CHEM RES, V41, P1578, DOI 10.1021/ar7002804; Kneipp K, 1997, PHYS REV LETT, V78, P1667, DOI 10.1103/PhysRevLett.78.1667; Kneipp K., 2006, SURFACE ENHANCED RAM; Lee D, 2006, APPL SPECTROSC, V60, P373, DOI 10.1366/000370206776593762; Liz-Marzan LM, 1996, LANGMUIR, V12, P4329, DOI 10.1021/la9601871; Lu Y, 2002, NANO LETT, V2, P785, DOI 10.1021/nl025598i; MOSKOVITS M, 1985, REV MOD PHYS, V57, P783, DOI 10.1103/RevModPhys.57.783; Mulvaney SP, 2003, LANGMUIR, V19, P4784, DOI 10.1021/la026706j; Nie SM, 1997, ANNU REV BIOPH BIOM, V26, P567, DOI 10.1146/annurev.biophys.26.1.567; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Park S, 2002, J AM CHEM SOC, V124, P2428, DOI 10.1021/ja017406b; Pettinger B, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.096101; Qian XM, 2008, NAT BIOTECHNOL, V26, P83, DOI 10.1038/nbt1377; Ren B, 1998, APPL PHYS LETT, V72, P933, DOI 10.1063/1.120877; Schulte F, 2009, ANAL CHEM, V81, P8426, DOI 10.1021/ac901389p; Sherry LJ, 2005, NANO LETT, V5, P2034, DOI 10.1021/nl0515753; Smith WE, 2008, CHEM SOC REV, V37, P955, DOI 10.1039/b708841h; Stockle RM, 2000, CHEM PHYS LETT, V318, P131, DOI 10.1016/S0009-2614(99)01451-7; Sujith A, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2891086; Tian ZQ, 2007, CHEM COMMUN, P3514, DOI 10.1039/b616986d; Tian ZQ, 2004, ANNU REV PHYS CHEM, V55, P197, DOI 10.1146/annurev.physchem.54.011002.103833; Wu DY, 2008, CHEM SOC REV, V37, P1025, DOI 10.1039/b707872m	30	2669	2778	160	4978	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					392	395		10.1038/nature08907	http://dx.doi.org/10.1038/nature08907			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20237566				2022-12-28	WOS:000275657100042
J	Lin, HK; Chen, ZB; Wang, GC; Nardella, C; Lee, SW; Chan, CH; Yang, WL; Wang, J; Egia, A; Nakayama, KI; Cordon-Cardo, C; Teruya-Feldstein, J; Pandolfi, PP				Lin, Hui-Kuan; Chen, Zhenbang; Wang, Guocan; Nardella, Caterina; Lee, Szu-Wei; Chan, Chan-Hsin; Yang, Wei-Lei; Wang, Jing; Egia, Ainara; Nakayama, Keiichi I.; Cordon-Cardo, Carlos; Teruya-Feldstein, Julie; Pandolfi, Pier Paolo			Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence	NATURE			English	Article							ONCOGENE-INDUCED SENESCENCE; BOX PROTEIN SKP2; TUMOR SUPPRESSION; P53; PTEN; EXPRESSION; ACCUMULATION; RESTORATION; INHIBITOR; COMPLEX	Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19(Arf)-p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19(Arf)-p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19(Arf)-p53 response is impaired, whereas a Skp2-SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy.	[Lin, Hui-Kuan; Chen, Zhenbang; Wang, Guocan; Nardella, Caterina; Pandolfi, Pier Paolo] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA; [Lin, Hui-Kuan; Chen, Zhenbang; Wang, Guocan; Nardella, Caterina; Cordon-Cardo, Carlos; Teruya-Feldstein, Julie; Pandolfi, Pier Paolo] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA; [Lin, Hui-Kuan; Lee, Szu-Wei; Chan, Chan-Hsin; Yang, Wei-Lei; Wang, Jing] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Chen, Zhenbang; Wang, Guocan; Nardella, Caterina; Egia, Ainara] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Chen, Zhenbang; Wang, Guocan; Nardella, Caterina; Egia, Ainara] Beth Israel Deaconess Canc Ctr, Canc Genet Program, Boston, MA 02215 USA; [Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 8128582, Japan	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Kyushu University	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	ppandolf@bidmc.harvard.edu	Chan, Chia-Hsin/AAT-7782-2020; Chan, Chia-Hsin/F-2272-2011; Yang, Wei-Lei/E-2598-2012; Wang, Guocan/F-1530-2011	Nardella, Caterina/0000-0002-1901-7916; Chan, Chia-Hsin/0000-0001-8506-7500	NIH; Anderson Trust Scholar Award; DOD Prostate Cancer New Investigator Award; NATIONAL CANCER INSTITUTE [R01CA082328] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD004038] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anderson Trust Scholar Award; DOD Prostate Cancer New Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We are grateful to C. J. Sherr, S. W. Lowe and M. Oren for mice and reagents. We would also like to thank B. Carver, L. DiSantis, J. Clossey and S. Megan for editing and critical reading of the manuscript, J. A. Koutcher, C. Le, C. Matei and M. Lupa for MRI analysis, as well all the members of the Pandolfi laboratory for comments and discussion. We extend our thanks to M. Rolfe, P. G. Smith, and Millennium Pharmaceuticals for discussion and for providing the MLN4924 compound. This work was supported by NIH grants to P. P. P. and M. D. Anderson Trust Scholar Award and DOD Prostate Cancer New Investigator Award to H. K.	Agarwal A, 2008, BLOOD, V112, P1960, DOI 10.1182/blood-2007-09-113860; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chen ZB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000053; Chiarle R, 2002, AM J PATHOL, V160, P1457, DOI 10.1016/S0002-9440(10)62571-0; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; GOTTLIEB E, 1994, EMBO J, V13, P1368, DOI 10.1002/j.1460-2075.1994.tb06390.x; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kuo YL, 2006, EMBO J, V25, P1741, DOI 10.1038/sj.emboj.7601054; Latres E, 2001, P NATL ACAD SCI USA, V98, P2515, DOI 10.1073/pnas.041475098; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharpless NE, 2005, NATURE, V436, P636, DOI 10.1038/436636a; Shim EH, 2003, CANCER RES, V63, P1583; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yaswen P, 2007, CELL, V128, P233, DOI 10.1016/j.cell.2007.01.005; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324	41	311	336	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					374	U66		10.1038/nature08815	http://dx.doi.org/10.1038/nature08815			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20237562	Green Accepted			2022-12-28	WOS:000275657100038
J	Ray, WA; Murray, KT; Md, MRG; Chung, CP; Smalley, WE; Hall, K; Daugherty, JR; Kaltenbach, LA; Stein, CM				Ray, Wayne A.; Murray, Katherine T.; Md, Marie R. Griffin; Chung, Cecilia P.; Smalley, Walter E.; Hall, Kathi; Daugherty, James R.; Kaltenbach, Lisa A.; Stein, C. Michael			Outcomes With Concurrent Use of Clopidogrel and Proton-Pump Inhibitors A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CORONARY HEART-DISEASE; RISK; OMEPRAZOLE; PHARMACOEPIDEMIOLOGY; PHARMACOKINETICS; RESPONSIVENESS; LANSOPRAZOLE; PANTOPRAZOLE; POLYMORPHISM	Background: Proton-pump inhibitors (PPIs) and clopidogrel are frequently coprescribed, although the benefits and harms of their concurrent use are unclear. Objective: To examine the association between concurrent use of PPIs and clopidogrel and the risks for hospitalizations for gastroduodenal bleeding and serious cardiovascular disease. Design: Retrospective cohort study using automated data to identify patients who received clopidogrel between 1999 through 2005 after hospitalization for coronary heart disease. Setting: Tennessee Medicaid program. Patients: 20 596 patients (including 7593 concurrent users of clopidogrel and PPIs) hospitalized for myocardial infarction, coronary artery revascularization, or unstable angina pectoris. Measurements: Baseline and follow-up drug use was assessed from automated records of dispensed prescriptions. Primary outcomes were hospitalizations for gastroduodenal bleeding and serious cardiovascular disease ( fatal or nonfatal myocardial infarction or sudden cardiac death, stroke, or other cardiovascular death). Results: Pantoprazole and omeprazole accounted for 62% and 9% of concurrent PPI use, respectively. Adjusted incidence of hospitalization for gastroduodenal bleeding in concurrent PPI users was 50% lower than that in nonusers (hazard ratio, 0.50 [95% CI, 0.39 to 0.65]). For patients at highest risk for bleeding, PPI use was associated with an absolute reduction of 28.5 (CI, 11.7 to 36.9) hospitalizations for gastroduodenal bleeding per 1000 person-years. The hazard ratio associated with concurrent PPI use for risk for serious cardiovascular disease was 0.99 (CI, 0.82 to 1.19) for the entire cohort and 1.01 (CI, 0.76 to 1.34) for the subgroup of patients who had percutaneous coronary interventions with stenting during the qualifying hospitalization. Limitations: Unmeasured confounding and misclassification of exposure (no information on adherence or over-the-counter use of drugs) and end points (not confirmed by medical record review) were possible. Because many patients entered the cohort from hospitals with relatively few cohort members, the analysis relied on the assumption that after adjustment for observed covariates, PPI users from one such hospital could be compared with nonusers from a different hospital. Conclusion: In patients with serious coronary heart disease treated with clopidogrel, concurrent PPI use was associated with reduced incidence of hospitalizations for gastroduodenal bleeding. The corresponding point estimate for serious cardiovascular disease was not increased; however, the 95% CI included a clinically important increased risk.	Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Ray, WA (corresponding author), Dept Prevent Med, 1500 21st Ave S,Suite 2600, Nashville, TN 37212 USA.	Wayne.Ray@vanderbilt.edu	Chung, Cecilia P/ABE-2177-2021	Chung, Cecilia P/0000-0001-5908-9423	Agency for Healthcare Research and Quality [HS1-16974]; National Heart, Lung, and Blood Institute [HL081707]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081707, R01HL096844] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Agency for Healthcare Research and Quality and National Heart, Lung, and Blood Institute.; By the Agency for Healthcare Research and Quality Centers for Education and Research on Therapeutics cooperative agreement (HS1-16974) and the National Heart, Lung, and Blood Institute (HL081707).	Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; Arnason T, 2006, THROMB RES, V118, P253, DOI 10.1016/j.thromres.2005.06.015; Bhatt DL, 2008, CIRCULATION, V118, P1894, DOI 10.1161/CIRCULATIONAHA.108.191087; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; CHAE YK, 2009, JAMA-J AM MED ASSOC, V302, P31; Chae YK, 2009, JAMA-J AM MED ASSOC, V302, P29, DOI 10.1001/jama.2009.896; Chin MWS, 2007, AM J GASTROENTEROL, V102, P2411, DOI 10.1111/j.1572-0241.2007.01460.x; Choma NN, 2009, PHARMACOEPIDEM DR S, V18, P1064, DOI 10.1002/pds.1821; Cryer B, 2005, NEW ENGL J MED, V352, P287, DOI 10.1056/NEJMe048330; Eshaghian S, 2007, ANN INTERN MED, V146, P434, DOI 10.7326/0003-4819-146-6-200703200-00008; Freedman JE, 2009, NEW ENGL J MED, V360, P411, DOI 10.1056/NEJMe0810513; Gerson LB, 2001, EUR J GASTROEN HEPAT, V13, P611, DOI 10.1097/00042737-200105000-00025; Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Gugler R, 1996, BRIT J CLIN PHARMACO, V42, P249, DOI 10.1046/j.1365-2125.1996.40619.x; Gurbel PA, 2008, J AM COLL CARDIOL, V51, P261, DOI 10.1016/j.jacc.2007.07.090; Hernandez-Diaz Sonia, 2001, American Journal of Medicine, V110, p20S; Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; JOHNSON RE, 1991, J AM GERIATR SOC, V39, P1079, DOI 10.1111/j.1532-5415.1991.tb02872.x; JUURLINK DN, 2009, CAN MED ASSOC J, V180, P1; Kahrilas PJ, 2008, NEW ENGL J MED, V359, P1700, DOI 10.1056/NEJMcp0804684; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Lanas A, 2007, AM J GASTROENTEROL, V102, P507, DOI 10.1111/j.1572-0241.2006.01062.x; LANDRY JA, 1988, GERONTOLOGIST, V28, P672, DOI 10.1093/geront/28.5.672; Li XQ, 2004, DRUG METAB DISPOS, V32, P821, DOI 10.1124/dmd.32.8.821; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; O'Donoghue ML, 2009, LANCET, V374, P989, DOI 10.1016/S0140-6736(09)61525-7; Ray WA, 2002, LANCET, V360, P1071, DOI 10.1016/S0140-6736(02)11131-7; Ray WA, 2003, NEW ENGL J MED, V349, P1592, DOI 10.1056/NEJMp038145; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; Ray WA, 2002, LANCET, V359, P118, DOI 10.1016/S0140-6736(02)07370-1; Ray WA, 2007, GASTROENTEROLOGY, V133, P790, DOI 10.1053/j.gastro.2007.06.058; Ray WA, 2009, NEW ENGL J MED, V360, P225, DOI 10.1056/NEJMoa0806994; Rournie CL, 2008, PHARMACOEPIDEM DR S, V17, P20, DOI 10.1002/pds.1518; Schneider-Lindner V, 2009, JAMA-J AM MED ASSOC, V302, P29, DOI 10.1001/jama.2009.897; SCHNEIDERLINDNE.V, 2009, JAMA-J AM MED ASSOC, V302, P31, DOI DOI 10.1001/JAMA.2009.897; Shahi CN, 2001, AM HEART J, V142, P263, DOI 10.1067/mhj.2001.116477; Siller-Matula JM, 2009, AM HEART J, V157, P148, DOI 10.1016/j.ahj.2008.09.017; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Small DS, 2008, J CLIN PHARMACOL, V48, P475, DOI 10.1177/0091270008315310; WEST SL, 1995, AM J EPIDEMIOL, V142, P1103, DOI 10.1093/oxfordjournals.aje.a117563; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yu KS, 2001, CLIN PHARMACOL THER, V69, P266, DOI 10.1067/mcp.2001.114231	44	183	200	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	2010	152	6					337	+		10.7326/0003-4819-152-6-201003160-00003	http://dx.doi.org/10.7326/0003-4819-152-6-201003160-00003			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573IF	20231564	Green Accepted			2022-12-28	WOS:000275905200001
J	Balents, L				Balents, Leon			Spin liquids in frustrated magnets	NATURE			English	Review							GEOMETRICAL FRUSTRATION; ORBITAL LIQUID; MOTT INSULATOR; ICE; STATE; LATTICE; PHYSICS; MONOPOLES; ORDER; ANTIFERROMAGNET	Frustrated magnets are materials in which localized magnetic moments, or spins, interact through competing exchange interactions that cannot be simultaneously satisfied, giving rise to a large degeneracy of the system ground state. Under certain conditions, this can lead to the formation of fluid-like states of matter, so-called spin liquids, in which the constituent spins are highly correlated but still fluctuate strongly down to a temperature of absolute zero. The fluctuations of the spins in a spin liquid can be classical or quantum and show remarkable collective phenomena such as emergent gauge fields and fractional particle excitations. This exotic behaviour is now being uncovered in the laboratory, providing insight into the properties of spin liquids and challenges to the theoretical description of these materials.	Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Balents, L (corresponding author), Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA.	balents@kitp.ucsb.edu			US National Science Foundation; US Department of Energy; David and Lucile Packard Foundation; US Army Research Office; Direct For Mathematical & Physical Scien [0804564] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); US Army Research Office; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	I am grateful to countless friends and collaborators, especially O. Starykh and M. Fisher for many stimulating interactions. I would also like to thank R. Coldea, H. Takagi, A. Loidl and P. Mendels for sharing their insights into experiments on frustrated magnets. My research is supported by the US National Science Foundation, the US Department of Energy, the David and Lucile Packard Foundation and the US Army Research Office.	Alet F, 2006, PHYSICA A, V369, P122, DOI 10.1016/j.physa.2006.04.003; ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; AZUMA M, 1994, PHYS REV LETT, V73, P3463, DOI 10.1103/PhysRevLett.73.3463; Balents L, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.224412; Bergman DL, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.134402; Bergman D, 2007, NAT PHYS, V3, P487, DOI 10.1038/nphys622; Bocquet M, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.094425; Bramwell ST, 2009, NATURE, V461, P956, DOI 10.1038/nature08500; Bramwell ST, 2001, SCIENCE, V294, P1495, DOI 10.1126/science.1064761; Buttgen N, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.132409; Castelnovo C, 2008, NATURE, V451, P42, DOI 10.1038/nature06433; Cepas O, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.140405; Chen G, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.096406; Chen G, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.094403; Coldea R, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.134424; Coldea R, 2001, PHYS REV LETT, V86, P1335, DOI 10.1103/PhysRevLett.86.1335; den Hertog BC, 2000, PHYS REV LETT, V84, P3430, DOI 10.1103/PhysRevLett.84.3430; Feiner LF, 1997, PHYS REV LETT, V78, P2799, DOI 10.1103/PhysRevLett.78.2799; FENNELL T, 2009, EXPT PROOF MAGNETIC; Fortune NA, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.257201; Fritsch V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.116401; Gardner JS, 1999, PHYS REV LETT, V82, P1012, DOI 10.1103/PhysRevLett.82.1012; Harris MJ, 1997, PHYS REV LETT, V79, P2554, DOI 10.1103/PhysRevLett.79.2554; Helton JS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.107204; Henley CL, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.014424; Hermele M, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.064404; Hiroi Z, 2001, J PHYS SOC JPN, V70, P3377, DOI 10.1143/JPSJ.70.3377; Isakov SV, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.167204; Isakov SV, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.217201; Ishihara S, 1997, PHYS REV B, V56, P686, DOI 10.1103/PhysRevB.56.686; Itou T, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/14/145247; Itou T, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.104413; Iwase H, 1996, J PHYS SOC JPN, V65, P2397, DOI 10.1143/JPSJ.65.2397; Jaubert LDC, 2009, NAT PHYS, V5, P258, DOI 10.1038/NPHYS1227; Kadowaki H, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.103706; Kageyama H, 1999, PHYS REV LETT, V82, P3168, DOI 10.1103/PhysRevLett.82.3168; Kezsmarki I, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.201101; Khaliullin G, 2000, PHYS REV LETT, V85, P3950, DOI 10.1103/PhysRevLett.85.3950; Khomskii DI, 2005, PHYS SCRIPTA, V72, pCC8, DOI 10.1238/Physica.Regular.072a00CC8; Kitaev A, 2006, ANN PHYS-NEW YORK, V321, P2, DOI 10.1016/j.aop.2005.10.005; Kleman M., 2003, SOFT MATTER PHYS INT; Kohno M, 2007, NAT PHYS, V3, P790, DOI 10.1038/nphys749; Koretsune T, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.074719; Krimmel A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.237402; Kurosaki Y, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.177001; Kyung B, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.046402; Lake B, 2005, NAT MATER, V4, P329, DOI 10.1038/nmat1327; Lawler MJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.197202; Lecheminant P, 1997, PHYS REV B, V56, P2521, DOI 10.1103/PhysRevB.56.2521; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Lee PA, 2008, SCIENCE, V321, P1306, DOI 10.1126/science.1163196; Lee SH, 2002, NATURE, V418, P856, DOI 10.1038/nature00964; Lee SS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.036403; Levin MA, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.045110; LIANG S, 1988, PHYS REV LETT, V61, P365, DOI 10.1103/PhysRevLett.61.365; MARSTON JB, 1991, J APPL PHYS, V69, P5962, DOI 10.1063/1.347830; McClarty PA, 2009, J PHYS CONF SER, V145, DOI 10.1088/1742-6596/145/1/012032; Mendels P, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.077204; Moessner R, 2001, PHYS REV LETT, V86, P1881, DOI 10.1103/PhysRevLett.86.1881; Morita H, 2002, J PHYS SOC JPN, V71, P2109, DOI 10.1143/JPSJ.71.2109; Morris DJP, 2009, SCIENCE, V326, P411, DOI 10.1126/science.1178868; Motrunich OI, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.045105; Motrunich OI, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.277004; Nakatsuji S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.087204; Nikuni T, 2000, PHYS REV LETT, V84, P5868, DOI 10.1103/PhysRevLett.84.5868; Norman MR, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.067204; Okamoto Y, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.033701; Okamoto Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.137207; Olariu A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.087202; Onsager L, 1934, J CHEM PHYS, V2, DOI 10.1063/1.1749541; Pauling L, 1935, J AM CHEM SOC, V57, P2680, DOI 10.1021/ja01315a102; PESIN DA, 2009, MOTT PHYS BAND TOPOL; Podolsky D, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.186401; Powell S, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.024422; Ramirez AP, 1999, NATURE, V399, P333, DOI 10.1038/20619; RAMIREZ AP, 1994, ANNU REV MATER SCI, V24, P453, DOI 10.1146/annurev.ms.24.080194.002321; Ramirez AP, 2000, PHYSICA B, V280, P290, DOI 10.1016/S0921-4526(99)01695-6; Ramirez AP, 2008, NAT PHYS, V4, P442, DOI 10.1038/nphys978; Ran Y, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.117205; Rantner W, 2001, PHYS REV LETT, V86, P3871, DOI 10.1103/PhysRevLett.86.3871; READ N, 1991, PHYS REV LETT, V66, P1773, DOI 10.1103/PhysRevLett.66.1773; Saunders TE, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.214438; Senthil T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.045109; Senthil T, 2001, PHYS REV LETT, V86, P292, DOI 10.1103/PhysRevLett.86.292; Shimizu Y, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.107001; Shimizu Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.256403; Singh RRP, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.180407; Smith DF, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.024512; Starykh OA, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.077205; Tokura Y, 2000, SCIENCE, V288, P462, DOI 10.1126/science.288.5465.462; Tristan N, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.174404; WANNIER GH, 1950, PHYS REV, V79, P357, DOI 10.1103/PhysRev.79.357; Wawrzynska E, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.157204; Wen XG, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.165113; Wynn JC, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.197002; Yamashita S, 2008, NAT PHYS, V4, P459, DOI 10.1038/nphys942; Yoshida H, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.043704; Yoshida M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.077207; YOUNGBLOOD R, 1980, PHYS REV B, V21, P5212, DOI 10.1103/PhysRevB.21.5212	101	2655	2669	46	875	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					199	208		10.1038/nature08917	http://dx.doi.org/10.1038/nature08917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20220838				2022-12-28	WOS:000275366100033
J	Xie, T				Xie, Tao			Tunable polymer multi-shape memory effect	NATURE			English	Article							BIOMEDICAL APPLICATIONS; NANOCOMPOSITES; NETWORKS; DEGRADATION; RECOVERY; IONOMERS	Shape memory polymers are materials that can memorize temporary shapes and revert to their permanent shape upon exposure to an external stimulus such as heat(1), light(2,3), moisture(4) or magnetic field(5). Such properties have enabled a variety of applications including deployable space structures(6), biomedical devices(7,8), adaptive optical devices(9), smart dry adhesives(10) and fasteners(11). The ultimate potential for a shape memory polymer, however, is limited by the number of temporary shapes it can memorize in each shape memory cycle and the ability to tune the shape memory transition temperature(s) for the targeted applications. Currently known shape memory polymers are capable of memorizing one or two temporary shapes, corresponding to dual-and triple-shape memory effects (also counting the permanent shape), respectively(11-13). At the molecular level, the maximum number of temporary shapes a shape memory polymer can memorize correlates directly to the number of discrete reversible phase transitions (shape memory transitions) in the polymer(11-13). Intuitively, one might deduce that multi-shape memory effects are achievable simply by introducing additional reversible phase transitions. The task of synthesizing a polymer with more than two distinctive and strongly bonded(13) reversible phases, however, is extremely challenging. Tuning shape memory effects, on the other hand, is often achieved through tailoring the shape memory transition temperatures, which requires alteration in the material composition(14-16). Here I show that the perfluoro sulphonic acid ionomer (PFSA), which has only one broad reversible phase transition, exhibits dual-, triple-, and at least quadruple-shape memory effects, all highly tunable without any change to the material composition.	Gen Motors Res & Dev Ctr, Chem Sci & Mat Syst Lab, Warren, MI 48090 USA	General Motors	Xie, T (corresponding author), Gen Motors Res & Dev Ctr, Chem Sci & Mat Syst Lab, Mail Code 480-106-710,30500 Mound Rd, Warren, MI 48090 USA.	tao.xie@gm.com	Xie, Tao/B-2323-2009; Xie, Tao/H-8633-2013	Xie, Tao/0000-0003-0222-9717				Behl M, 2009, ADV FUNCT MATER, V19, P102, DOI 10.1002/adfm.200800850; Bellin I, 2006, P NATL ACAD SCI USA, V103, P18043, DOI 10.1073/pnas.0608586103; Deng Q, 1998, POLYMER, V39, P5961, DOI 10.1016/S0032-3861(98)00055-X; Gall K, 2005, J BIOMED MATER RES A, V73A, P339, DOI 10.1002/jbm.a.30296; Gall K, 2004, APPL PHYS LETT, V85, P290, DOI 10.1063/1.1769087; Huang WM, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1880448; Koerner H, 2004, NAT MATER, V3, P115, DOI 10.1038/nmat1059; Kunzelman J, 2008, J MATER CHEM, V18, P1082, DOI 10.1039/b718445j; Kushner AM, 2009, J AM CHEM SOC, V131, P8766, DOI 10.1021/ja9009666; Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102; Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496; Li JH, 2007, ADV MATER, V19, P2851, DOI 10.1002/adma.200602260; Liu C, 2007, J MATER CHEM, V17, P1543, DOI 10.1039/b615954k; Liu C, 2002, J APPL MED POLYM, V6, P47; Liu CD, 2002, MACROMOLECULES, V35, P9868, DOI 10.1021/ma021141j; Mauritz KA, 2004, CHEM REV, V104, P4535, DOI 10.1021/cr0207123; Miaudet P, 2007, SCIENCE, V318, P1294, DOI 10.1126/science.1145593; Mohr R, 2006, P NATL ACAD SCI USA, V103, P3540, DOI 10.1073/pnas.0600079103; Page KA, 2005, MACROMOLECULES, V38, P6472, DOI 10.1021/ma0503559; Ping P, 2005, BIOMACROMOLECULES, V6, P587, DOI 10.1021/bm049477j; RODRIGUEZ E, 2008, MAT RES SOC FALL M S; Weiss RA, 2008, MACROMOLECULES, V41, P2978, DOI 10.1021/ma8001774; Xie T, 2008, CHEM MATER, V20, P2866, DOI 10.1021/cm800173c; Xie T, 2007, POLYMER, V48, P5497, DOI 10.1016/j.polymer.2007.07.043; Xie T, 2009, MACROMOL RAPID COMM, V30, P1823, DOI 10.1002/marc.200900409; Xie T, 2009, POLYMER, V50, P1852, DOI 10.1016/j.polymer.2009.02.035; Yakacki CM, 2008, ADV FUNCT MATER, V18, P2428, DOI 10.1002/adfm.200701049; Yakacki CM, 2007, BIOMATERIALS, V28, P2255, DOI 10.1016/j.biomaterials.2007.01.030	28	1034	1073	50	1166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 11	2010	464	7286					267	270		10.1038/nature08863	http://dx.doi.org/10.1038/nature08863			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20220846				2022-12-28	WOS:000275366100044
J	Ravasi, T; Suzuki, H; Cannistraci, CV; Katayama, S; Bajic, VB; Tan, K; Akalin, A; Schmeier, S; Kanamori-Katayama, M; Bertin, N; Carninci, P; Daub, CO; Forrest, ARR; Gough, J; Grimmond, S; Han, JH; Hashimoto, T; Hide, W; Hofmann, O; Kawaji, H; Kubosaki, A; Lassmann, T; van Nimwegen, E; Ogawa, C; Teasdale, RD; Tegner, J; Lenhard, B; Teichmann, SA; Arakawa, T; Ninomiya, N; Murakami, K; Tagami, M; Fukuda, S; Imamura, K; Kai, C; Ishihara, R; Kitazume, Y; Kawai, J; Hume, DA; Ideker, T; Hayashizaki, Y				Ravasi, Timothy; Suzuki, Harukazu; Cannistraci, Carlo Vittorio; Katayama, Shintaro; Bajic, Vladimir B.; Tan, Kai; Akalin, Altuna; Schmeier, Sebastian; Kanamori-Katayama, Mutsumi; Bertin, Nicolas; Carninci, Piero; Daub, Carsten O.; Forrest, Alistair R. R.; Gough, Julian; Grimmond, Sean; Han, Jung-Hoon; Hashimoto, Takehiro; Hide, Winston; Hofmann, Oliver; Kawaji, Hideya; Kubosaki, Atsutaka; Lassmann, Timo; van Nimwegen, Erik; Ogawa, Chihiro; Teasdale, Rohan D.; Tegner, Jesper; Lenhard, Boris; Teichmann, Sarah A.; Arakawa, Takahiro; Ninomiya, Noriko; Murakami, Kayoko; Tagami, Michihira; Fukuda, Shiro; Imamura, Kengo; Kai, Chikatoshi; Ishihara, Ryoko; Kitazume, Yayoi; Kawai, Jun; Hume, David A.; Ideker, Trey; Hayashizaki, Yoshihide			An Atlas of Combinatorial Transcriptional Regulation in Mouse and Man	CELL			English	Article							EMBRYONIC STEM-CELLS; PROTEIN INTERACTIONS; GENE-EXPRESSION; NETWORKS; DNA; BINDING; FAMILY; YEAST; LIPOPOLYSACCHARIDE; DIFFERENTIATION	Combinatorial interactions among transcription factors are critical to directing tissue-specific gene expression. To build a global atlas of these combinations, we have screened for physical interactions among the majority of human and mouse DNA-binding transcription factors (TFs). The complete networks contain 762 human and 877 mouse interactions. Analysis of the networks reveals that highly connected TFs are broadly expressed across tissues, and that roughly half of the measured interactions are conserved between mouse and human. The data highlight the importance of TF combinations for determining cell fate, and they lead to the identification of a SMAD3/FLI1 complex expressed during development of immunity. The availability of large TF combinatorial networks in both human and mouse will provide many opportunities to study gene regulation, tissue differentiation, and mammalian evolution.	[Ravasi, Timothy; Suzuki, Harukazu; Cannistraci, Carlo Vittorio; Katayama, Shintaro; Bajic, Vladimir B.; Tan, Kai; Akalin, Altuna; Schmeier, Sebastian; Kanamori-Katayama, Mutsumi; Bertin, Nicolas; Carninci, Piero; Daub, Carsten O.; Forrest, Alistair R. R.; Gough, Julian; Grimmond, Sean; Han, Jung-Hoon; Hashimoto, Takehiro; Hide, Winston; Hofmann, Oliver; Kawaji, Hideya; Kubosaki, Atsutaka; Lassmann, Timo; van Nimwegen, Erik; Ogawa, Chihiro; Teasdale, Rohan D.; Tegner, Jesper; Lenhard, Boris; Teichmann, Sarah A.; Arakawa, Takahiro; Ninomiya, Noriko; Murakami, Kayoko; Tagami, Michihira; Fukuda, Shiro; Imamura, Kengo; Kai, Chikatoshi; Ishihara, Ryoko; Kitazume, Yayoi; Kawai, Jun; Hume, David A.; Ideker, Trey; Hayashizaki, Yoshihide] Univ Calif San Diego, FANTOM Consortium, La Jolla, CA 92093 USA; [Suzuki, Harukazu; Katayama, Shintaro; Kanamori-Katayama, Mutsumi; Bertin, Nicolas; Carninci, Piero; Daub, Carsten O.; Forrest, Alistair R. R.; Hashimoto, Takehiro; Kawaji, Hideya; Kubosaki, Atsutaka; Lassmann, Timo; Ogawa, Chihiro; Arakawa, Takahiro; Ninomiya, Noriko; Murakami, Kayoko; Tagami, Michihira; Fukuda, Shiro; Imamura, Kengo; Kai, Chikatoshi; Ishihara, Ryoko; Kitazume, Yayoi; Kawai, Jun; Hayashizaki, Yoshihide] Univ Calif San Diego, RIKEN Om Sci Ctr, La Jolla, CA 92093 USA; [Ravasi, Timothy; Cannistraci, Carlo Vittorio; Tan, Kai; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ravasi, Timothy; Cannistraci, Carlo Vittorio; Tan, Kai; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Ravasi, Timothy; Cannistraci, Carlo Vittorio; Bajic, Vladimir B.; Han, Jung-Hoon] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Div Chem & Life Sci & Engn, Red Sea Integrat Syst Biol Lab, Jeddah, Saudi Arabia; [Suzuki, Harukazu; Katayama, Shintaro; Kanamori-Katayama, Mutsumi; Bertin, Nicolas; Carninci, Piero; Daub, Carsten O.; Forrest, Alistair R. R.; Hashimoto, Takehiro; Kawaji, Hideya; Kubosaki, Atsutaka; Lassmann, Timo; Ogawa, Chihiro; Arakawa, Takahiro; Ninomiya, Noriko; Murakami, Kayoko; Tagami, Michihira; Fukuda, Shiro; Imamura, Kengo; Kai, Chikatoshi; Ishihara, Ryoko; Kitazume, Yayoi; Kawai, Jun; Hayashizaki, Yoshihide] RIKEN Yokohama Inst, RIKEN Om Sci Ctr, Tsurumi Ku, Kanagawa 2300045, Japan; [Cannistraci, Carlo Vittorio] Politecn Torino, Dept Mech, I-10129 Turin, Italy; [Cannistraci, Carlo Vittorio] Ist Sci San Raffaele, I-20132 Milan, Italy; [Cannistraci, Carlo Vittorio] Politecn Torino, CMP Grp Microsoft Res, I-10129 Turin, Italy; [Bajic, Vladimir B.; Schmeier, Sebastian; Hide, Winston; Hofmann, Oliver] Univ Western Cape, S African Natl Bioinformat Inst, ZA-7535 Bellville, South Africa; [Akalin, Altuna; Lenhard, Boris] Bergen Ctr Computat Sci, N-5008 Bergen, Norway; [Forrest, Alistair R. R.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Griffith, Qld 4111, Australia; [Gough, Julian] Univ Bristol, Dept Comp Sci, Bristol BS8 1UB, Avon, England; [Grimmond, Sean; Teasdale, Rohan D.] Univ Queensland, Inst Mol Biosci, Australian Res Council, Special Res Ctr Funct & Appl Genom, St Lucia, Qld 4072, Australia; [Han, Jung-Hoon; Teichmann, Sarah A.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Hide, Winston] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [van Nimwegen, Erik] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [van Nimwegen, Erik] Swiss Inst Bioinformat, CH-4056 Basel, Switzerland; [Tegner, Jesper] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Med, Atherosclerosis Res Unit,Ctr Mol Med,Computat Med, SE-17176 Stockholm, Sweden; [Tegner, Jesper] Linkoping Univ, Dept Phys Chem & Biol, SE-58183 Linkoping, Sweden; [Hume, David A.] Univ Edinburgh, Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; [Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9PS, Midlothian, Scotland; [Ideker, Trey] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; King Abdullah University of Science & Technology; RIKEN; Polytechnic University of Turin; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Polytechnic University of Turin; South African National Biodiversity Institute; University of the Western Cape; Griffith University; University of Bristol; University of Queensland; MRC Laboratory Molecular Biology; Harvard University; Harvard T.H. Chan School of Public Health; University of Basel; Swiss Institute of Bioinformatics; Karolinska Institutet; Karolinska University Hospital; Linkoping University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of California System; University of California San Diego	Ideker, T (corresponding author), Univ Calif San Diego, FANTOM Consortium, 9500 Gilman Dr, La Jolla, CA 92093 USA.	tideker@ucsd.edu; yosihide@gsc.riken.jp	Lassmann, Timo/HCH-4313-2022; Hayashizaki, Yoshihide/N-6590-2015; Tomic, Nevena/AAA-2135-2021; van Nimwegen, Erik/ABF-1085-2021; Ravasi, Timothy/B-8777-2008; Katayama, Shintaro/F-2958-2010; Radovanovic, Aleksandar/D-1313-2012; Hide, Winston Hide/C-7217-2009; Grimmond, Sean M/J-5304-2016; Hofmann, Oliver M/F-1800-2013; Teasdale, Rohan/AAD-6698-2019; Hide, Winston/R-3815-2019; Kawaji, Hideya/N-5116-2015; Lassmann, Timo/A-8271-2008; Bertin, Nicolas/O-9602-2019; Suzuki, Harukazu/N-9553-2015; tegner, jesper N/R-5095-2017; Radovanovic, Aleksandar/M-3687-2019; Cannistraci, Carlo Vittorio/G-1710-2014; Schmeier, Sebastian/D-4731-2011; Teasdale, Rohan D/B-2538-2009; Hide, Winston A/V-2727-2017; Kawai, Jun/A-6451-2016; Grimmond, Sean/K-3246-2019; Daub, Carsten O/A-7436-2010; Forrest, Alistair/A-6597-2008; Califano, Andrea/F-7239-2012; Hume, David A/C-7695-2013; Carninci, Piero/K-1568-2014; AKALIN, ALTUNA/A-4424-2012; Kaur, Mandeep/N-4550-2015; Bertin, Nicolas/C-3025-2008; Bajic, Vladimir/D-2810-2009	Lassmann, Timo/0000-0002-0138-2691; van Nimwegen, Erik/0000-0001-6338-1312; Katayama, Shintaro/0000-0001-7581-5157; Radovanovic, Aleksandar/0000-0002-8749-7608; Hide, Winston Hide/0000-0002-8621-3271; Grimmond, Sean M/0000-0002-8102-7998; Hofmann, Oliver M/0000-0002-7738-1513; Teasdale, Rohan/0000-0001-7455-5269; Hide, Winston/0000-0002-8621-3271; Kawaji, Hideya/0000-0002-0575-0308; Lassmann, Timo/0000-0002-0138-2691; Suzuki, Harukazu/0000-0002-8087-0836; tegner, jesper N/0000-0002-9568-5588; Radovanovic, Aleksandar/0000-0002-8749-7608; Cannistraci, Carlo Vittorio/0000-0003-0100-8410; Schmeier, Sebastian/0000-0002-3947-8226; Teasdale, Rohan D/0000-0001-7455-5269; Hide, Winston A/0000-0002-8621-3271; Grimmond, Sean/0000-0002-8102-7998; Daub, Carsten O/0000-0002-3295-8729; Forrest, Alistair/0000-0003-4543-1675; Carninci, Piero/0000-0001-7202-7243; AKALIN, ALTUNA/0000-0002-0468-0117; Kaur, Mandeep/0000-0002-9757-4048; Fukuda, Shiro/0000-0002-0065-662X; Ravasi, Timothy/0000-0002-9950-465X; Bertin, Nicolas/0000-0002-9835-9606; MacPherson, Cameron/0000-0002-8945-9736; Lenhard, Boris/0000-0002-1114-1509; Tan, Kai/0000-0002-9104-5567; Ideker, Trey/0000-0002-1708-8454; Hume, David/0000-0002-2615-1478; Teichmann, Sarah/0000-0002-6294-6366; Kamburov, Atanas/0000-0002-0580-0619; Bajic, Vladimir/0000-0001-5435-4750	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); US National Institute of Mental Health [MH062261]; King Abdullah University of Science and Technology; Max Planck Society for the Advancement of Science; SA National Bioinformatics Network; Claude Leon Foundation; Australian NHMRC; Scuola Interpolitecnica di Dottorato; BBSRC [BB/G022771/1] Funding Source: UKRI; MRC [MC_U105161047] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G022771/1] Funding Source: researchfish; Medical Research Council [MC_U105161047, G9900991B] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Max Planck Society for the Advancement of Science(Max Planck SocietyEuropean Commission); SA National Bioinformatics Network; Claude Leon Foundation; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Scuola Interpolitecnica di Dottorato; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work for the RIKEN Omics Science Center was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) through the Genome Network Project and for the RIKEN Omics Science Center (YH, Principal Investigator). Members of the FANTOM Consortium were supported by grant MH062261 from the US National Institute of Mental Health (TR, KT, TI), the King Abdullah University of Science and Technology (TR, VBB), the Max Planck Society for the Advancement of Science (AK), the SA National Bioinformatics Network (SS, AR, VBB, WAH), the Claude Leon Foundation (MK), a CJ Martin Fellowship from the Australian NHMRC (ARRF), and the Scuola Interpolitecnica di Dottorato (CVC). The authors gratefully acknowledge S. Choi for critical feedback on the manuscript.	Ameyar M, 2003, BIOCHIMIE, V85, P747, DOI 10.1016/j.biochi.2003.09.006; Ban J, 2008, CANCER RES, V68, P7100, DOI 10.1158/0008-5472.CAN-07-6145; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Duverger O, 2008, J CELL PHYSIOL, V216, P337, DOI 10.1002/jcp.21491; Fedorova E, 2008, BBA-MOL CELL RES, V1783, P2174, DOI 10.1016/j.bbamcr.2008.07.018; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Jaenisch R, 2009, J THROMB HAEMOST, V7, P21, DOI 10.1111/j.1538-7836.2009.03418.x; Jin GX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001207; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kalaev M, 2008, BIOINFORMATICS, V24, P594, DOI 10.1093/bioinformatics/btm630; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mathur D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r126; Meran S, 2008, J BIOL CHEM, V283, P6530, DOI 10.1074/jbc.M704819200; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Naef F, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni104; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Park DU, 2005, BIOINFORMATICS, V21, P3234, DOI 10.1093/bioinformatics/bti512; Roach JC, 2007, P NATL ACAD SCI USA, V104, P16245, DOI 10.1073/pnas.0707757104; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Schreiber J, 2006, P NATL ACAD SCI USA, V103, P5899, DOI 10.1073/pnas.0510996103; Shachaf CM, 2008, CANCER RES, V68, P5132, DOI 10.1158/0008-5472.CAN-07-6192; Suzuki H, 2001, GENOME RES, V11, P1758, DOI 10.1101/gr.180101; Suzuki H, 2004, BIOTECHNIQUES, V37, P918, DOI 10.2144/04376BM06; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Tan K, 2008, P NATL ACAD SCI USA, V105, P2934, DOI 10.1073/pnas.0708670105; Tan K, 2008, GENOMICS, V91, P219, DOI 10.1016/j.ygeno.2007.11.005; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Tuch BB, 2008, SCIENCE, V319, P1797, DOI 10.1126/science.1152398; Usui K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r98; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Walhout AJM, 2006, GENOME RES, V16, P1445, DOI 10.1101/gr.5321506; Wen XL, 1998, P NATL ACAD SCI USA, V95, P334, DOI 10.1073/pnas.95.1.334; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P4925, DOI 10.1093/nar/gkl595; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16; Zhou LQ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-54	41	519	533	2	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					744	752		10.1016/j.cell.2010.01.044	http://dx.doi.org/10.1016/j.cell.2010.01.044			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211142	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000275197400022
J	Xu, R; Ekiert, DC; Krause, JC; Hai, R; Crowe, JE; Wilson, IA				Xu, Rui; Ekiert, Damian C.; Krause, Jens C.; Hai, Rong; Crowe, James E., Jr.; Wilson, Ian A.			Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus	SCIENCE			English	Article							RECEPTOR-BINDING; HEMAGGLUTININ; ORIGIN; EMERGENCE	The 2009 H1N1 swine flu is the first influenza pandemic in decades. The crystal structure of the hemagglutinin from the A/California/04/2009 H1N1 virus shows that its antigenic structure, particularly within the Sa antigenic site, is extremely similar to those of human H1N1 viruses circulating early in the 20th century. The cocrystal structure of the 1918 hemagglutinin with 2D1, an antibody from a survivor of the 1918 Spanish flu that neutralizes both 1918 and 2009 H1N1 viruses, reveals an epitope that is conserved in both pandemic viruses. Thus, antigenic similarity between the 2009 and 1918-like viruses provides an explanation for the age-related immunity to the current influenza pandemic.	[Xu, Rui; Ekiert, Damian C.; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Krause, Jens C.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Krause, Jens C.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Hai, Rong] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Vanderbilt University; Vanderbilt University; Icahn School of Medicine at Mount Sinai; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu	Xu, Rui/I-8098-2012; Crowe, James/B-5549-2009	Crowe, James/0000-0002-0049-1079; Ekiert, Damian/0000-0002-2570-0404	NIH [AI058113, AI057157, GM080209]; Achievement Rewards for College Scientists Foundation; Skaggs Institute for Chemical Biology; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; Pediatric Infectious Diseases Society Fellowship; MedImmune; AstraZeneca; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157, P01AI058113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080209] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Achievement Rewards for College Scientists Foundation(General Electric); Skaggs Institute for Chemical Biology; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); Pediatric Infectious Diseases Society Fellowship; MedImmune(AstraZenecaMedimmune); AstraZeneca(AstraZeneca); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported in part by NIH grants AI058113 (I. A. W., J.E.C., and P. Palese) and AI057157 (J.E.C.), predoctoral fellowships from the Achievement Rewards for College Scientists Foundation and the NIH Molecular Evolution Training Program GM080209 (D. C. E.), and the Skaggs Institute for Chemical Biology. X-ray diffraction data sets were collected at the Stanford Synchrotron Radiation Lightsource beamline 9-2 and at the Advanced Photon Source beamline 23ID-B (GM/CA-CAT). The GM/CA CAT 23-ID-B beamline has been funded in whole or in part with federal funds from National Cancer Institute (Y1-CO-1020) and National Institute of General Medical Sciences (Y1-GM-1104). Use of the Advanced Photon Source (APS) was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. We thank P. Palese (Mount Sinai School of Medicine) for providing the CA04 clone and helpful comments, X. Dai and M. A. Elsliger (Scripps Research Institute) and C.J. Huffman (Vanderbilt University) for expert technical assistance, H. Tien and D. Marciano of the Robotics Core at the Joint Center for Structural Genomics for automated crystal screening, and M. Becker and the staff of the APS GM/CA CAT 23-ID-B for beamline support. This is publication 20395 from the Scripps Research Institute. Coordinates and structure factors are deposited in the PDB [3LZG for CA04 HA (two trimers) and 3LZF for 1918 HA/2D1 complex]. Vanderbilt University has applied for a provisional patent covering the diagnostic and therapeutic use of antibodies described in this paper. J.E.C. Jr. is a founder of the vaccine company Corbeau Biotech LLC and has consulted for MedImmune, Novartis, Sanofi, and Immunobiosciences. J.C.K. is funded by a Pediatric Infectious Diseases Society Fellowship funded by MedImmune and AstraZeneca.	Brownlee GG, 2001, PHILOS T ROY SOC B, V356, P1871, DOI 10.1098/rstb.2001.1001; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; FISMAN DN, 2000, NEW ENGL J MED, V361, P2009; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gaydos JC, 2006, EMERG INFECT DIS, V12, P23, DOI 10.3201/eid1201.050965; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; HANCOCK K, 1945, NEW ENGL J MED, V361, P2009; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Krause JC, 2010, J VIROL, V84, P3127, DOI 10.1128/JVI.02184-09; Lin TW, 2009, VIROLOGY, V392, P73, DOI 10.1016/j.virol.2009.06.028; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Schulze Irene T., 1997, Journal of Infectious Diseases, V176, pS24, DOI 10.1086/514170; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; WEBB SA, 1925, NEW ENGL J MED, V361, P2009; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Xing Z, 2009, EMERG INFECT DIS, V15, P1847, DOI 10.3201/eid1511.090685; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231; Zimmer SM, 2009, NEW ENGL J MED, V361, P279, DOI 10.1056/NEJMra0904322	27	456	485	1	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2010	328	5976					357	360		10.1126/science.1186430	http://dx.doi.org/10.1126/science.1186430			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20339031	Green Accepted, Green Submitted			2022-12-28	WOS:000276685000038
J	Kasowski, M; Grubert, F; Heffelfinger, C; Hariharan, M; Asabere, A; Waszak, SM; Habegger, L; Rozowsky, J; Shi, MY; Urban, AE; Hong, MY; Karczewski, KJ; Huber, W; Weissman, SM; Gerstein, MB; Korbel, JO; Snyder, M				Kasowski, Maya; Grubert, Fabian; Heffelfinger, Christopher; Hariharan, Manoj; Asabere, Akwasi; Waszak, Sebastian M.; Habegger, Lukas; Rozowsky, Joel; Shi, Minyi; Urban, Alexander E.; Hong, Mi-Young; Karczewski, Konrad J.; Huber, Wolfgang; Weissman, Sherman M.; Gerstein, Mark B.; Korbel, Jan O.; Snyder, Michael			Variation in Transcription Factor Binding Among Humans	SCIENCE			English	Article							STRUCTURAL VARIATION	Differences in gene expression may play a major role in speciation and phenotypic diversity. We examined genome-wide differences in transcription factor (TF) binding in several humans and a single chimpanzee by using chromatin immunoprecipitation followed by sequencing. The binding sites of RNA polymerase II (PolII) and a key regulator of immune responses, nuclear factor kappa B (p65), were mapped in 10 lymphoblastoid cell lines, and 25 and 7.5% of the respective binding regions were found to differ between individuals. Binding differences were frequently associated with single-nucleotide polymorphisms and genomic structural variants, and these differences were often correlated with differences in gene expression, suggesting functional consequences of binding variation. Furthermore, comparing PolII binding between humans and chimpanzee suggests extensive divergence in TF binding. Our results indicate that many differences in individuals and species occur at the level of TF binding, and they provide insight into the genetic events responsible for these differences.	[Waszak, Sebastian M.; Huber, Wolfgang; Korbel, Jan O.] European Mol Biol Lab, Genome Biol Res Unit, Heidelberg, Germany; [Kasowski, Maya; Grubert, Fabian; Heffelfinger, Christopher; Hariharan, Manoj; Asabere, Akwasi; Shi, Minyi; Urban, Alexander E.; Hong, Mi-Young; Snyder, Michael] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Grubert, Fabian; Hariharan, Manoj; Shi, Minyi; Karczewski, Konrad J.; Snyder, Michael] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Waszak, Sebastian M.] Weihenstephan Triesdorf Univ Appl Sci, Dept Biotechnol & Bioinformat, D-85350 Freising Weihenstephan, Germany; [Habegger, Lukas; Gerstein, Mark B.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Rozowsky, Joel; Gerstein, Mark B.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Urban, Alexander E.; Weissman, Sherman M.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Gerstein, Mark B.] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Korbel, Jan O.] European Mol Biol Lab European Bioinformat Inst, Hinxton CB10 1SD, England	European Molecular Biology Laboratory (EMBL); Yale University; Stanford University; Yale University; Yale University; Yale University; Yale University; European Molecular Biology Laboratory (EMBL)	Korbel, JO (corresponding author), European Mol Biol Lab, Genome Biol Res Unit, Heidelberg, Germany.	jan.korbel@embl.de; mpsnyder@stanford.edu	Hariharan, Manoj/N-2855-2015; Pillay, Nischalan/F-9536-2012; Korbel, Jan O/G-6470-2012; Waszak, Sebastian M./D-7828-2015	Hariharan, Manoj/0000-0002-1006-5372; Korbel, Jan O/0000-0002-2798-3794; Waszak, Sebastian M./0000-0003-3042-9521; Huber, Wolfgang/0000-0002-0474-2218; Snyder, Michael/0000-0003-0784-7987; Rozowsky, Joel/0000-0002-3565-0762; Karczewski, Konrad/0000-0003-2878-4671	NIH [TG T32GM07205]; European Molecular Biology Laboratory; March of Dimes Foundation; NATIONAL CANCER INSTITUTE [R01CA077808] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Laboratory; March of Dimes Foundation(March of Dimes); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the 1000 Genomes project for early data access. This research was funded by grants from NIH (M. S., S. W., and M. G.), and by funding from the European Molecular Biology Laboratory (J.K.), a March of Dimes Foundation Grant (A. U.), and the NIH Medical Scientist Training Program grant TG T32GM07205 (M. K.). M. K. was a Howard Hughes Medical Institute Medical Research Training Fellow. Data sets are available at the Gene Expression Omnibus (GEO) database with accession number GSE19486. M. S. is on the Scientific Advisory Board and a founder for both Affymetrix and Metagenomix.	Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Creely H, 2006, PROG BRAIN RES, V158, P295, DOI 10.1016/S0079-6123(06)58014-8; Faniello MC, 1999, J BIOL CHEM, V274, P7623, DOI 10.1074/jbc.274.12.7623; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Kramer OH, 2006, GENE DEV, V20, P473, DOI 10.1101/gad.364306; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Skelly DA, 2009, ANNU REV GENOM HUM G, V10, P313, DOI 10.1146/annurev-genom-082908-150121; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Watanabe H, 2004, NATURE, V429, P382, DOI 10.1038/nature02564	16	408	426	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2010	328	5975					232	235		10.1126/science.1183621	http://dx.doi.org/10.1126/science.1183621			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580OU	20299548	Green Accepted, Green Submitted			2022-12-28	WOS:000276459600043
J	Aaron, HJ; Reischauer, RD				Aaron, Henry J.; Reischauer, Robert D.			The War Isn't Over.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Aaron, Henry J.] Brookings Inst, Washington, DC 20036 USA; [Reischauer, Robert D.] Urban Inst, Washington, DC 20037 USA	Brookings Institution; Urban Institute	Aaron, HJ (corresponding author), Brookings Inst, Washington, DC 20036 USA.								0	12	12	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	2010	362	14					1259	1261		10.1056/NEJMp1003394	http://dx.doi.org/10.1056/NEJMp1003394			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	579SN	20335570				2022-12-28	WOS:000276393700003
J	Raaijmakers, MHGP; Mukherjee, S; Guo, SQ; Zhang, SY; Kobayashi, T; Schoonmaker, JA; Ebert, BL; Al-Shahrour, F; Hasserjian, RP; Scadden, EO; Aung, Z; Matza, M; Merkenschlager, M; Lin, C; Rommens, JM; Scadden, DT				Raaijmakers, Marc H. G. P.; Mukherjee, Siddhartha; Guo, Shangqin; Zhang, Siyi; Kobayashi, Tatsuya; Schoonmaker, Jesse A.; Ebert, Benjamin L.; Al-Shahrour, Fatima; Hasserjian, Robert P.; Scadden, Edward O.; Aung, Zinmar; Matza, Marc; Merkenschlager, Matthias; Lin, Charles; Rommens, Johanna M.; Scadden, David. T.			Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia	NATURE			English	Article							STEM-CELL NICHE; HEMATOPOIETIC PROGENITORS; DIFFERENTIATION; MICROENVIRONMENT; IDENTIFICATION; EXPRESSION; HEDGEHOG; SBDS	Mesenchymal cells contribute to the 'stroma' of most normal and malignant tissues, with specific mesenchymal cells participating in the regulatory niches of stem cells. By examining how mesenchymal osteolineage cells modulate haematopoiesis, here we show that deletion of Dicer1 specifically in mouse osteoprogenitors, but not in mature osteoblasts, disrupts the integrity of haematopoiesis. Myelodysplasia resulted and acute myelogenous leukaemia emerged that had acquired several genetic abnormalities while having intact Dicer1. Examining gene expression altered in osteoprogenitors as a result of Dicer1 deletion showed reduced expression of Sbds, the gene mutated in Schwachman-Bodian-Diamond syndrome-a human bone marrow failure and leukaemia pre-disposition condition. Deletion of Sbds in mouse osteoprogenitors induced bone marrow dysfunction with myelodysplasia. Therefore, perturbation of specific mesenchymal subsets of stromal cells can disorder differentiation, proliferation and apoptosis of heterologous cells, and disrupt tissue homeostasis. Furthermore, primary stromal dysfunction can result in secondary neoplastic disease, supporting the concept of niche-induced oncogenesis.	[Raaijmakers, Marc H. G. P.; Mukherjee, Siddhartha; Guo, Shangqin; Zhang, Siyi; Schoonmaker, Jesse A.; Scadden, Edward O.; Aung, Zinmar; Matza, Marc; Scadden, David. T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Raaijmakers, Marc H. G. P.; Mukherjee, Siddhartha; Guo, Shangqin; Zhang, Siyi; Schoonmaker, Jesse A.; Scadden, Edward O.; Aung, Zinmar; Matza, Marc; Scadden, David. T.] Harvard Univ, Sch Med, CPZN, Boston, MA 02114 USA; [Mukherjee, Siddhartha; Scadden, David. T.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Kobayashi, Tatsuya] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Hasserjian, Robert P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Lin, Charles] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Raaijmakers, Marc H. G. P.; Mukherjee, Siddhartha; Guo, Shangqin; Zhang, Siyi; Schoonmaker, Jesse A.; Scadden, Edward O.; Aung, Zinmar; Matza, Marc; Scadden, David. T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Raaijmakers, Marc H. G. P.; Mukherjee, Siddhartha; Guo, Shangqin; Zhang, Siyi; Schoonmaker, Jesse A.; Scadden, Edward O.; Aung, Zinmar; Matza, Marc; Scadden, David. T.] Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA; [Ebert, Benjamin L.; Al-Shahrour, Fatima] Broad Inst, Cambridge, MA 02138 USA; [Ebert, Benjamin L.; Al-Shahrour, Fatima] Massachusetts Gen Hosp, Div Hematol, Boston, MA 02115 USA; [Merkenschlager, Matthias] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, Lymphocyte Dev Grp, London W12 0NN, England; [Rommens, Johanna M.] Univ Toronto, Program Genet & Genome Biol, Hosp Sick Children, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Imperial College London; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Raaijmakers, MHGP (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Room 4265A,185 Cambridge St, Boston, MA 02114 USA.	hraaijmakers@partners.org; dscadden@mgh.harvard.edu	Guo, Shangqin/AAL-7580-2020; Guo, Shangqin/Q-4088-2019; Rommens, Johanna/AAT-7465-2021	Guo, Shangqin/0000-0003-1157-0423; Kobayashi, Tatsuya/0000-0003-4264-5117; Merkenschlager, Matthias/0000-0003-2889-3288	Dutch Cancer Society; Leukemia & Lymphoma Society; National Institutes of Health; Harvard Stem Cell Institute; Ellison Medical Foundation; Medical Research Council [MC_U120027516] Funding Source: researchfish; MRC [MC_U120027516] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097794, U54HL081030, R01HL044851, U01HL100402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050234] Funding Source: NIH RePORTER	Dutch Cancer Society(KWF Kankerbestrijding); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Ellison Medical Foundation(Lawrence Ellison Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank E. Schipani, E. Attar and H. Kronenberg for advice and discussion, A. McMahon for providing the Osx-Cre mice, J. Fujisaki, D. Wilpitz, M. Ohishi, S. Vallet, M. Churchill and G. Frankl for technical assistance, the Histocore (Endocrine Unit), Flow Core at the Center for Regenerative Medicine, Massachusetts General Hospital (L. Pickett and K. Folz-Donahue), and F. Preffer and D. Dombrowski for assistance with histology and flow-cytometry. We thank D. Machon for help preparing the manuscript and the Cytogenetics Core at Brigham Women/Dana Farber (Y. Xiao and C. Lee) for performing CGH analyses. This work was supported by a Fellowship Award of the Dutch Cancer Society (KWF) and a Special Fellowship Award of The Leukemia & Lymphoma Society to M. H. G. P. R. and grants of the National Institutes of Health, the Harvard Stem Cell Institute and the Ellison Medical Foundation to D. T. S.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Boocock GRB, 2003, NAT GENET, V33, P97, DOI 10.1038/ng1062; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Dror Y, 1999, BLOOD, V94, P3048, DOI 10.1182/blood.V94.9.3048.421k24_3048_3054; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heaney ML, 1999, NEW ENGL J MED, V340, P1649, DOI 10.1056/NEJM199905273402107; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Korkolopoulou P, 2001, LEUKEMIA, V15, P1369, DOI 10.1038/sj.leu.2402220; Krol J, 2007, MOL CELL, V25, P575, DOI 10.1016/j.molcel.2007.01.031; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Li LH, 2006, CANCER RES, V66, P4553, DOI 10.1158/0008-5472.CAN-05-3986; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; Mellibovsky L, 1996, BONE, V19, P401, DOI 10.1016/S8756-3282(96)00210-4; Montaner D, 2006, NUCLEIC ACIDS RES, V34, pW486, DOI 10.1093/nar/gkl197; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Raaijmakers MHGP, 2002, EXP HEMATOL, V30, P481, DOI 10.1016/S0301-472X(02)00787-7; Rawls AS, 2007, BLOOD, V110, P2414, DOI 10.1182/blood-2006-03-007112; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Schilling T, 2008, J CELL BIOCHEM, V103, P413, DOI 10.1002/jcb.21415; Sneddon JB, 2007, CELL STEM CELL, V1, P607, DOI 10.1016/j.stem.2007.11.009; Sternberg A, 2005, BLOOD, V106, P2982, DOI 10.1182/blood-2005-04-1543; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; van de Loosdrecht AA, 2008, BLOOD, V111, P1067, DOI 10.1182/blood-2007-07-098764; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Yang FC, 2008, CELL, V135, P437, DOI 10.1016/j.cell.2008.08.041; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	39	761	799	7	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					852	U58		10.1038/nature08851	http://dx.doi.org/10.1038/nature08851			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20305640	Green Accepted, Green Submitted			2022-12-28	WOS:000276397300029
J	Schulz, KF; Altman, DG; Moher, D; Fergusson, D				Schulz, Kenneth F.; Altman, Douglas G.; Moher, David; Fergusson, Dean			CONSORT 2010 changes and testing blindness in RCTs	LANCET			English	Editorial Material							EMPIRICAL-EVIDENCE; SUCCESS; TRIALS; BIAS; EYE		[Schulz, Kenneth F.] Family Hlth Int, Res Triangle Pk, NC 27709 USA; [Altman, Douglas G.] Univ Oxford Wolfson Coll, Ctr Stat Med, Oxford OX2 6UD, England; [Moher, David; Fergusson, Dean] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa Methods Ctr, Ottawa, ON, Canada; [Moher, David; Fergusson, Dean] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada	University of Oxford; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Schulz, KF (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.	KSchulz@FHI.org	Altman, Douglas G/A-9714-2012; Moher, David/I-3408-2019	Moher, David/0000-0003-2434-4206; Fergusson, Dean/0000-0002-3389-2485				Altman DG, 2004, BMJ-BRIT MED J, V328, P1135, DOI 10.1136/bmj.328.7448.1135-a; Day SJ, 2000, BRIT MED J, V321, P504, DOI 10.1136/bmj.321.7259.504; Fergusson D, 2004, BRIT MED J, V328, P432, DOI 10.1136/bmj.37952.631667.EE; Kolahi J, 2009, COMMUNITY DENT ORAL, V37, P477, DOI 10.1111/j.1600-0528.2009.00494.x; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Quitkin FM, 2000, AM J PSYCHIAT, V157, P327, DOI 10.1176/appi.ajp.157.3.327; Sackett DL, 2007, INT J EPIDEMIOL, V36, P664, DOI 10.1093/ije/dym088; Sackett DL, 2004, BRIT MED J, V328, P1136, DOI 10.1136/bmj.328.7448.1136-a; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Schulz KF, 2002, ANN INTERN MED, V136, P254, DOI 10.7326/0003-4819-136-3-200202050-00022; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Schulz KF, 2002, LANCET, V359, P696, DOI 10.1016/S0140-6736(02)07816-9; Schulz KF, 2006, LANCET HDB ESSENTIAL; Senn SJ, 2004, BMJ-BRIT MED J, V328, P1135, DOI 10.1136/bmj.328.7448.1135-b; Vitiello B, 2005, J CLIN PSYCHOPHARM, V25, P565, DOI 10.1097/01.jcp.0000185426.08268.92; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	16	104	107	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 3	2010	375	9721					1144	1146		10.1016/S0140-6736(10)60413-8	http://dx.doi.org/10.1016/S0140-6736(10)60413-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	585VL	20338625				2022-12-28	WOS:000276858200008
J	Himmelstein, DU; Woolhandler, S				Himmelstein, David U.; Woolhandler, Steffie			US Health Reform Obama's reform: no cure for what ails us	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Himmelstein, David U.; Woolhandler, Steffie] Harvard Univ, Cambridge, MA 02138 USA; [Himmelstein, David U.; Woolhandler, Steffie] Cambridge Hosp, Cambridge, MA USA	Harvard University; Harvard University; Cambridge Health Alliance; Cambridge Hospital	Himmelstein, DU (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	david_himmelstein@hms.harvard.edu						[Anonymous], 2010, EX HLTH CAR COST TRE; CUTLER D, 2010, WALL STREET J   0309; Himmelstein DU, 2010, AM J MED, V123, P40, DOI 10.1016/j.amjmed.2009.09.004; JOHNSON C, 2007, WASHINGTON POST 0719; *KAIS FAM FDN, 2000, ANN CHANG PREM EMPL; KOWLACZYK L, 2010, BOSTON GLOBE    0317; Long SK, 2009, HEALTH AFFAIR, V28, pW578, DOI 10.1377/hlthaff.28.4.w578; Morgan RO, 1997, NEW ENGL J MED, V337, P169, DOI 10.1056/NEJM199707173370306; Russell LB, 2009, HEALTH AFFAIR, V28, P42, DOI 10.1377/hlthaff.28.1.42; Woolhandler S, 2003, NEW ENGL J MED, V349, P768, DOI 10.1056/NEJMsa022033	10	6	6	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 30	2010	340								c1778	10.1136/bmj.c1778	http://dx.doi.org/10.1136/bmj.c1778			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	579VJ	20354017				2022-12-28	WOS:000276404100015
J	Zhang, JT; Tang, Y; Lee, K; Min, OY				Zhang, Jiatao; Tang, Yun; Lee, Kwan; Min Ouyang			Nonepitaxial Growth of Hybrid Core-Shell Nanostructures with Large Lattice Mismatches	SCIENCE			English	Article							SEMICONDUCTOR NANOCRYSTALS; COLLOIDAL NANOCRYSTALS; QUANTUM DOTS; STRAIN; BASES; SCALE; ACIDS; RODS	We report a synthetic route to achieving nanoscale heterostructures consisting of a metal core and monocrystalline semiconductor shell with substantial lattice mismatches between them, which cannot be obtained by conventional epitaxial techniques. By controlling soft acid-base coordination reactions between molecular complexes and colloidal nanostructures, we show that chemical thermodynamics can drive nanoscale monocrystalline growth of the semiconductor shell with a lattice structure incommensurate with that of the core. More complex hybrid core-shell structures with azimuthal and radial nanotailoring of structures and compositions of the monocrystalline semiconductor shell are also demonstrated.	[Min Ouyang] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; Univ Maryland, Ctr Nanophys & Adv Mat, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Min, OY (corresponding author), Univ Maryland, Dept Phys, College Pk, MD 20742 USA.	mouyang@umd.edu	TANG, Yun/C-7602-2016	TANG, Yun/0000-0002-2999-9626; LEE, KWAN/0000-0002-8269-6579	Office of Naval Research YIP [N000140710787]; NSF CAREER [DMR-0547194]; Beckman YIP [0609259093]; NSF	Office of Naval Research YIP(Office of Naval Research); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); Beckman YIP; NSF(National Science Foundation (NSF))	This work was supported by Office of Naval Research YIP award (N000140710787), NSF CAREER award (DMR-0547194), and Beckman YIP grant ( 0609259093). Facility support was from Maryland Nanocenter and its Nanoscale Imaging Spectroscopy and Properties Laboratory (supported in part by the NSF as a Materials Research Science and Engineering Center shared experiment facility). We also thank G. Jenkins, T. Einstein, and J. R. Anderson for reading and polishing the manuscript.	Anson CE, 2008, ANGEW CHEM INT EDIT, V47, P1326, DOI 10.1002/anie.200704249; Ayers J.E., 2007, HETEROEPITAXY SEMICO, V1st ed.; Battaglia D, 2003, ANGEW CHEM INT EDIT, V42, P5035, DOI 10.1002/anie.200352120; Bording JK, 2000, PHYS REV B, V62, P8098, DOI 10.1103/PhysRevB.62.8098; Caruge JM, 2008, NAT PHOTONICS, V2, P247, DOI 10.1038/nphoton.2008.34; Chen XB, 2003, NANO LETT, V3, P799, DOI 10.1021/nl034243b; HOFFMAN JD, 1958, J CHEM PHYS, V29, P1192, DOI 10.1063/1.1744688; Jeong UY, 2005, CHEM PHYS LETT, V416, P246, DOI 10.1016/j.cplett.2005.09.106; Jin YD, 2009, NAT NANOTECHNOL, V4, P571, DOI [10.1038/nnano.2009.193, 10.1038/NNANO.2009.193]; Kim H, 2005, J AM CHEM SOC, V127, P544, DOI 10.1021/ja047107x; Kim S, 2003, J AM CHEM SOC, V125, P11466, DOI 10.1021/ja0361749; Klimov VI, 2007, NATURE, V447, P441, DOI 10.1038/nature05839; Lee JS, 2008, J AM CHEM SOC, V130, P9673, DOI 10.1021/ja802890f; McBride J, 2006, NANO LETT, V6, P1496, DOI 10.1021/nl060993k; MISONO M, 1967, J INORG NUCL CHEM, V29, P2685, DOI 10.1016/0022-1902(67)80006-X; Mokari T, 2005, NAT MATER, V4, P855, DOI 10.1038/nmat1505; Mokari T, 2004, SCIENCE, V304, P1787, DOI 10.1126/science.1097830; PALMSTROM CJ, 1995, ANNU REV MATER SCI, V25, P389, DOI 10.1146/annurev.ms.25.080195.002133; Pan AL, 2006, J PHYS CHEM B, V110, P22313, DOI 10.1021/jp064664s; PEARSON RG, 1963, J AM CHEM SOC, V85, P3533, DOI 10.1021/ja00905a001; Peng XG, 1997, J AM CHEM SOC, V119, P7019, DOI 10.1021/ja970754m; Pompa PP, 2006, NAT NANOTECHNOL, V1, P126, DOI 10.1038/nnano.2006.93; Ryzhii M, 2008, PHYS MODELING TERA N; Sargent EH, 2009, NAT PHOTONICS, V3, P325, DOI 10.1038/NPHOTON.2009.89; Shimizu KT, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.117401; Smith AM, 2010, ACCOUNTS CHEM RES, V43, P190, DOI 10.1021/ar9001069; Smith AM, 2009, NAT NANOTECHNOL, V4, P56, DOI 10.1038/NNANO.2008.360; Son DH, 2004, SCIENCE, V306, P1009, DOI 10.1126/science.1103755; TURNBULL D, 1950, J APPL PHYS, V21, P1022, DOI 10.1063/1.1699435; Wang C, 2009, ADV MATER, V21, P3045, DOI 10.1002/adma.200900320; Wang ZL, 2000, J PHYS CHEM B, V104, P1153, DOI 10.1021/jp993593c; Zhang JT, 2009, NANO LETT, V9, P4061, DOI 10.1021/nl902263h	32	455	467	21	658	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2010	327	5973					1634	1638		10.1126/science.1184769	http://dx.doi.org/10.1126/science.1184769			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339071				2022-12-28	WOS:000275970600041
J	Olmedo-Monfil, V; Duran-Figueroa, N; Arteaga-Vazquez, M; Demesa-Arevalo, E; Autran, D; Grimanelli, D; Slotkin, RK; Martienssen, RA; Vielle-Calzada, JP				Olmedo-Monfil, Vianey; Duran-Figueroa, Noe; Arteaga-Vazquez, Mario; Demesa-Arevalo, Edgar; Autran, Daphne; Grimanelli, Daniel; Slotkin, R. Keith; Martienssen, Robert A.; Vielle-Calzada, Jean-Philippe			Control of female gamete formation by a small RNA pathway in Arabidopsis	NATURE			English	Article							TRANS-ACTING SIRNAS; GENE; BIOGENESIS; EXPRESSION; GENOME	In the ovules of most sexual flowering plants female gametogenesis is initiated from a single surviving gametic cell, the functional megaspore, formed after meiosis of the somatically derived megaspore mother cell (MMC)(1,2). Because some mutants and certain sexual species exhibit more than one MMC2-4, and many others are able to form gametes without meiosis (by apomixis)(5), it has been suggested that somatic cells in the ovule are competent to respond to a local signal likely to have an important function in determination(6). Here we show that the Arabidopsis protein ARGONAUTE 9 (AGO9) controls female gamete formation by restricting the specification of gameto-phyte precursors in a dosage-dependent, non-cell-autonomous manner. Mutations in AGO9 lead to the differentiation of multiple gametic cells that are able to initiate gametogenesis. The AGO9 protein is not expressed in the gamete lineage; instead, it is expressed in cytoplasmic foci of somatic companion cells. Mutations in SUPPRESSOR OF GENE SILENCING 3 and RNA-DEPENDENT RNA POLYMERASE 6 exhibit an identical defect to ago9 mutants, indicating that the movement of small RNA (sRNAs) silencing out of somatic companion cells is necessary for controlling the specification of gametic cells. AGO9 preferentially interacts with 24-nucleotide sRNAs derived from transposable elements (TEs), and its activity is necessary to silence TEs in female gametes and their accessory cells. Our results show that AGO9-dependent sRNA silencing is crucial to specify cell fate in the Arabidopsis ovule, and that epigenetic reprogramming in companion cells is necessary for sRNA-dependent silencing in plant gametes.	[Olmedo-Monfil, Vianey; Duran-Figueroa, Noe; Arteaga-Vazquez, Mario; Demesa-Arevalo, Edgar; Vielle-Calzada, Jean-Philippe] Cinvestav Irapuato, Lab Nacl Genom Biodiversidad, Grp Desarrollo Reprod & Apomixis, Guanajuato 36500, Mexico; [Olmedo-Monfil, Vianey; Duran-Figueroa, Noe; Arteaga-Vazquez, Mario; Demesa-Arevalo, Edgar; Vielle-Calzada, Jean-Philippe] Cinvestav Irapuato, Dept Ingn Genet Plantas, Guanajuato 36500, Mexico; [Autran, Daphne; Grimanelli, Daniel] Inst Rech Dev, UMR 5096, F-34394 Montpellier, France; [Slotkin, R. Keith; Martienssen, Robert A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Perpignan Via Domitia; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Cold Spring Harbor Laboratory	Vielle-Calzada, JP (corresponding author), Cinvestav Irapuato, Lab Nacl Genom Biodiversidad, Grp Desarrollo Reprod & Apomixis, Guanajuato 36500, Mexico.	vielle@ira.cinvestav.mx	Demesa-Arevalo, Edgar/AAX-8477-2020; Slotkin, R. Keith/H-6965-2013; Vielle-Calzada, Jean-Philippe/AAG-4036-2019; Grimanelli, Daniel/ABE-4777-2020; Autran, Daphné/D-4846-2009; Duran, Francisco/A-5373-2011; Arteaga-Vazquez, Mario Alberto/AAB-7979-2022; Autran, Daphné/AAV-4792-2021; Arteaga-Vazquez, Mario/M-1545-2019	Demesa-Arevalo, Edgar/0000-0002-2793-5928; Slotkin, R. Keith/0000-0001-9582-3533; Autran, Daphné/0000-0002-5227-8966; Arteaga-Vazquez, Mario Alberto/0000-0002-9435-0049; Autran, Daphné/0000-0002-5227-8966; Grimanelli, Daniel/0000-0001-5424-114X; DURAN-FIGUEROA, NOE/0000-0002-2830-7325	IRD-France; ANR; NIH; NSF; Consejo Nacional de Ciencia y Tecnologia; Consejo Estatal de Ciencia y Tecnologia de Guanajuato; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067014] Funding Source: NIH RePORTER	IRD-France; ANR(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Estatal de Ciencia y Tecnologia de Guanajuato; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Sanchez for sharing the pFM2 marker, E. Demunck for technical assistance during cloning and sequencing, S. Poethig, J. Carrington, T. Lagrange and the Arabidopsis Stock Center for providing mutants, J. Mendiola and C. Alvarez for help with genetic and bioinformatic analysis, and R. Jorgensen for critically reading the manuscript. This work was supported by IRD-France and ANR ( D. A. and D. G.), NIH and NSF (R. K. S. and R. A. M), Consejo Nacional de Ciencia y Tecnologia ( V.O.-M., N.D.-F., M.A.-V., E.D.-A. and J.-P. V.-C.), Consejo Estatal de Ciencia y Tecnologia de Guanajuato (J.-P.V.-C.), and the Howard Hughes Medical Institute (J.-P.V.-C.).	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bass HW, 2000, J CELL SCI, V113, P1033; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bicknell RA, 2004, PLANT CELL, V16, pS228, DOI 10.1105/tpc.017921; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chitwood DH, 2009, GENE DEV, V23, P549, DOI 10.1101/gad.1770009; Garcia-Aguilar M, 2005, PLANT MOL BIOL REP, V23, P279, DOI 10.1007/BF02772758; Grossniklaus U, 1998, SEMIN CELL DEV BIOL, V9, P227, DOI 10.1006/scdb.1997.0214; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Huanca-Mamani W, 2005, P NATL ACAD SCI USA, V102, P17231, DOI 10.1073/pnas.0508186102; Kasahara RD, 2005, PLANT CELL, V17, P2981, DOI 10.1105/tpc.105.034603; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Maheswari P., 1950, INTRO EMBRYOLOGY ANG; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Nonomura KI, 2003, PLANT CELL, V15, P1728, DOI 10.1105/tpc.012401; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Schwab R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005980; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sheridan WF, 1996, GENETICS, V142, P1009; Siddiqi I, 2000, DEVELOPMENT, V127, P197; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Vielle-Calzada JP, 2000, NATURE, V404, P91, DOI 10.1038/35003595; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; Voinnet O, 2005, FEBS LETT, V579, P5858, DOI 10.1016/j.febslet.2005.09.039; Walbot V, 2003, NAT REV GENET, V4, P369, DOI 10.1038/nrg1064; WEBB MC, 1990, SEX PLANT REPROD, V3, P244, DOI 10.1007/BF00202882; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605	33	390	408	3	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					628	U200		10.1038/nature08828	http://dx.doi.org/10.1038/nature08828			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20208518	Green Accepted, Green Published			2022-12-28	WOS:000275974200056
J	Smeitink, J				Smeitink, Jan			Metabolism, Gliomas, and IDH1	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Radboud Univ Nijmegen, Dept Pediat, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Smeitink, J (corresponding author), Radboud Univ Nijmegen, Dept Pediat, Med Ctr, NL-6525 ED Nijmegen, Netherlands.		Smeitink, Jan/C-1351-2013					Chalmers R A, 1980, J Inherit Metab Dis, V3, P11, DOI 10.1007/BF02312516; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Duran M, 1980, J Inherit Metab Dis, V3, P109, DOI 10.1007/BF02312543; KNAAP MS, 1999, J INHERIT METAB DIS, V22, P404; Van Schaftingen E, 2009, J INHERIT METAB DIS, V32, P135, DOI 10.1007/s10545-008-1042-3	5	14	16	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	2010	362	12					1144	1145		10.1056/NEJMcibr0912922	http://dx.doi.org/10.1056/NEJMcibr0912922			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573FU	20335593	Green Published			2022-12-28	WOS:000275894600015
J	Adams, JL; Mehrotra, A; Thomas, JW; McGlynn, EA				Adams, John L.; Mehrotra, Ateev; Thomas, J. William; McGlynn, Elizabeth A.			Physician Cost Profiling -- Reliability and Risk of Misclassification.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRIMARY-CARE PHYSICIANS	Background: Insurance products with incentives for patients to choose physicians classified as offering lower-cost care on the basis of cost-profiling tools are increasingly common. However, no rigorous evaluation has been undertaken to determine whether these tools can accurately distinguish higher-cost physicians from lower-cost physicians. Methods: We aggregated claims data for the years 2004 and 2005 from four health plans in Massachusetts. We used commercial software to construct clinically homogeneous episodes of care (e.g., treatment of diabetes, heart attack, or urinary tract infection), assigned each episode to a physician, and created a summary profile of resource use (i.e., cost) for each physician on the basis of all assigned episodes. We estimated the reliability (signal-to-noise ratio) of each physician's cost-profile score on a scale of 0 to 1, with 0 indicating that all differences in physicians' cost profiles are due to a lack of precision in the measure (noise) and 1 indicating that all differences are due to real variation in costs of services (signal). We used the reliability results to estimate the proportion of physicians in each specialty whose cost performance would be classified inaccurately in a two-tiered insurance product in which the physicians with cost profiles in the lowest quartile were labeled as ``lower cost.'' Results: Median reliabilities ranged from 0.05 for vascular surgery to 0.79 for gastroenterology and otolaryngology. Overall, 59% of physicians had cost-profile scores with reliabilities of less than 0.70, a commonly used marker of suboptimal reliability. Using our reliability results, we estimated that 22% of physicians would be misclassified in a two-tiered system. Conclusions: Current methods for profiling physicians with respect to costs of services may produce misleading results. N Engl J Med 2010;362:1014-21.	[Adams, John L.; Mehrotra, Ateev; McGlynn, Elizabeth A.] RAND Corp, Santa Monica, CA USA; [Adams, John L.; Mehrotra, Ateev; McGlynn, Elizabeth A.] RAND Corp, Pittsburgh, PA 15213 USA; [Mehrotra, Ateev] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Thomas, J. William] Univ So Maine, Portland, ME 04103 USA	RAND Corporation; RAND Corporation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Maine System; University of Southern Maine	Mehrotra, A (corresponding author), RAND Corp, 4570 5th Ave,Suite 600, Pittsburgh, PA 15213 USA.	mehrotra@rand.org	Mehrotra, Ateev/AAO-8454-2021; Adams, John/ABE-6170-2021	Mehrotra, Ateev/0000-0003-2223-1582; 	Department of Labor [J-9-P-2-0033]; National Center for Research Resources at the National Institutes of Health [05 KL2 RR024154-04]; Robert Wood Johnson Foundation; American Medical Association; Massachusetts Medical Society; Physicians Advocacy Institute; Commonwealth Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000146] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024154] Funding Source: NIH RePORTER	Department of Labor; National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); American Medical Association; Massachusetts Medical Society; Physicians Advocacy Institute; Commonwealth Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by a contract from the Department of Labor (J-9-P-2-0033), a career development award from the National Center for Research Resources at the National Institutes of Health (05 KL2 RR024154-04, to Dr. Mehrotra), and a grant from the Robert Wood Johnson Foundation (to Dr. Thomas).; Dr. Thomas reports receiving consulting fees from the Integrated Healthcare Association, the American Medical Association, the American Board of Medical Specialties, and the Arkansas Medical Society; Dr. McGlynn, serving as a paid member of the American Board of Internal Medicine Foundation; and Drs. Adams, Mehrotra, and McGlynn, grant support from the American Medical Association, the Massachusetts Medical Society, the Physicians Advocacy Institute, and the Commonwealth Fund. Ingenix provided a free research license for the use of its commercial programs. No other potential conflict of interest relevant to this article was reported.	Brennan TA, 2008, HEALTH AFFAIR, V27, P1160, DOI 10.1377/hlthaff.27.4.1160; *CTR MED MED SERV, MED RES US MEAS PLAN; Fleiss JL., 2003, STAT METHODS RATES P; Friedberg MW, 2007, J GEN INTERN MED, V22, P1385, DOI 10.1007/s11606-007-0234-0; Hays RD., 2005, ASSESSING QUALITY LI, V2, P25; Hayward RA, 2001, JAMA-J AM MED ASSOC, V286, P415, DOI 10.1001/jama.286.4.415; Hofer TP, 1999, JAMA-J AM MED ASSOC, V281, P2098, DOI 10.1001/jama.281.22.2098; Hofer TP, 2000, MED CARE, V38, P152, DOI 10.1097/00005650-200002000-00005; Institute of Medicine, 2006, PERF MEAS ACC IMPR; LAKE T, 2007, HLTH PLANS USE PHYSI; *LEAPFR GROUP, 2004, BRIDG EXC MEAS PROV; McDowell I., 1996, MEASURING HLTH GUIDE; MEHROTRA A, ANN INTERN IN PRESS; Milstein A, 2007, NEW ENGL J MED, V357, P2649, DOI 10.1056/NEJMp0706521; *NAT COMM QUAL ASS, 2008, STAND GUID CERT PHYS; National Quality Forum, 2009, MEAS FRAM EV EFF PAT; RAUDENBUCH SW, 2002, HIERARCHICAL LINEAR; Safran DG, 2006, J GEN INTERN MED, V21, P13, DOI 10.1111/j.1525-1497.2005.00311.x; Sandy LG, 2008, J GEN INTERN MED, V23, P1521, DOI 10.1007/s11606-008-0684-z; Scholle SH, 2008, AM J MANAG CARE, V14, P829; Sirovich B, 2008, HEALTH AFFAIR, V27, P813, DOI 10.1377/hlthaff.27.3.813; Sorbero M, 2006, ASSESSMENT PAY FOR P; Thomas JW, 2006, INQUIRY-J HEALTH CAR, V43, P271, DOI 10.5034/inquiryjrnl_43.3.271; TUKEY JW, 1962, ANN MATH STAT, V33, P1, DOI 10.1214/aoms/1177704711; 2008, ENHANCING PHYS QUALI	25	121	121	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2010	362	11					1014	1021		10.1056/NEJMsa0906323	http://dx.doi.org/10.1056/NEJMsa0906323			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570CY	20237347	Bronze, Green Accepted			2022-12-28	WOS:000275650400012
J	Elkin, EB; Bach, PB				Elkin, Elena B.; Bach, Peter B.			Cancer's Next Frontier Addressing High and Increasing Costs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							REIMBURSEMENT; MEDICARE		[Elkin, Elena B.; Bach, Peter B.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Hlth Outcomes Res Grp, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Hlth Outcomes Res Grp, 1275 York Ave,Box 44, New York, NY 10065 USA.	bachp@mskcc.org			NCI NIH HHS [K07 CA118189-04, K07 CA118189] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K07CA118189] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brown ML, 2001, ANNU REV PUBL HEALTH, V22, P91, DOI 10.1146/annurev.publhealth.22.1.91; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; Goldman DP, 2006, HEALTH AFFAIR, V25, P1319, DOI 10.1377/hlthaff.25.5.1319; Jacobson M, 2006, HEALTH AFFAIR, V25, P437, DOI 10.1377/hlthaff.25.2.437; National Heart Lung and Blood Institute, 2008, NHLBI FACT BOOK FISC; Neumann PJ, 2010, HEALTH AFFAIR, V29, P196, DOI 10.1377/hlthaff.2009.0077; The Kaiser Family Foundation, 2009, US TOD KAIS FAM FDN; Warren JL, 2008, J NATL CANCER I, V100, P888, DOI 10.1093/jnci/djn175; Weight CJ, 2008, CANCER-AM CANCER SOC, V112, P2195, DOI 10.1002/cncr.23421	9	110	114	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1086	1087		10.1001/jama.2010.283	http://dx.doi.org/10.1001/jama.2010.283			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	569KC	20233828	Green Accepted			2022-12-28	WOS:000275594100023
J	Radonovich, LJ; Bender, BS				Radonovich, Lewis J.; Bender, Bradley S.			Surgical masks were noninferior to N95 respirators for preventing influenza in health care providers	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Radonovich, Lewis J.; Bender, Bradley S.] Malcom Randall VA Med Ctr, Gainesville, FL USA		Radonovich, LJ (corresponding author), Malcom Randall VA Med Ctr, Gainesville, FL USA.							[Anonymous], INTERIM GUIDANCE INF; Lange S, 2005, BIOMETRICAL J, V47, P12, DOI 10.1002/bimj.200410085; Shine KI, 2009, NEW ENGL J MED, V361, P1823, DOI 10.1056/NEJMp0908437	3	1	1	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	2010	152	6							JC3-2	10.7326/0003-4819-152-6-201003160-02002	http://dx.doi.org/10.7326/0003-4819-152-6-201003160-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573IF	20231556				2022-12-28	WOS:000275905200019
J	Kajiwara, Y; Harii, K; Takahashi, S; Ohe, J; Uchida, K; Mizuguchi, M; Umezawa, H; Kawai, H; Ando, K; Takanashi, K; Maekawa, S; Saitoh, E				Kajiwara, Y.; Harii, K.; Takahashi, S.; Ohe, J.; Uchida, K.; Mizuguchi, M.; Umezawa, H.; Kawai, H.; Ando, K.; Takanashi, K.; Maekawa, S.; Saitoh, E.			Transmission of electrical signals by spin-wave interconversion in a magnetic insulator	NATURE			English	Article							SEMICONDUCTORS; FILMS	The energy bandgap of an insulator is large enough to prevent electron excitation and electrical conduction(1). But in addition to charge, an electron also has spin(2), and the collective motion of spin can propagate-and so transfer a signal-in some insulators(3). This motion is called a spin wave and is usually excited using magnetic fields. Here we show that a spin wave in an insulator can be generated and detected using spin-Hall effects, which enable the direct conversion of an electric signal into a spin wave, and its subsequent transmission through (and recovery from) an insulator over macroscopic distances. First, we show evidence for the transfer of spin angular momentum between an insulator magnet Y3Fe5O12 and a platinum film. This transfer allows direct conversion of an electric current in the platinum film to a spin wave in the Y3Fe5O12 via spin-Hall effects(4-11). Second, making use of the transfer in a Pt/Y3Fe5O12/Pt system, we demonstrate that an electric current in one metal film induces voltage in the other, far distant, metal film. Specifically, the applied electric current is converted into spin angular momentum owing to the spin-Hall effect(7,8,10,11) in the first platinum film; the angular momentum is then carried by a spin wave in the insulating Y3Fe5O12 layer; at the distant platinum film, the spin angular momentum of the spin wave is converted back to an electric voltage. This effect can be switched on and off using a magnetic field. Weak spin damping(3) in Y3Fe5O12 is responsible for its transparency for the transmission of spin angular momentum. This hybrid electrical transmission method potentially offers a means of innovative signal delivery in electrical circuits and devices.	[Kajiwara, Y.; Harii, K.; Takahashi, S.; Ohe, J.; Uchida, K.; Mizuguchi, M.; Ando, K.; Takanashi, K.; Maekawa, S.; Saitoh, E.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Kajiwara, Y.; Ando, K.; Saitoh, E.] Keio Univ, Dept Appl Phys & Physicoinformat, Yokohama, Kanagawa 2238522, Japan; [Harii, K.; Takahashi, S.; Maekawa, S.] Japan Sci & Technol Agcy, CREST, Tokyo 1020075, Japan; [Saitoh, E.] Japan Sci & Technol Agcy, PRESTO, Tokyo 1020075, Japan; [Umezawa, H.; Kawai, H.] FDK Corp, Shizuoka 4310495, Japan	Tohoku University; Keio University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Saitoh, E (corresponding author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.	saitoheiji@imr.tohoku.ac.jp	Mizuguchi, Masaki/K-3301-2013; Maekawa, Sadamichi/J-6194-2018; Takanashi, Koki/A-9488-2011; Ando, Kazuya/A-8521-2011; Saitoh, Eiji/C-1004-2011; Takahashi, Saburo/A-8472-2011; Uchida, Ken-ichi/H-3098-2011	Mizuguchi, Masaki/0000-0003-1090-0179; Maekawa, Sadamichi/0000-0002-4237-7741; Takanashi, Koki/0000-0003-4813-4641; Saitoh, Eiji/0000-0003-2675-0718; Uchida, Ken-ichi/0000-0001-7680-3051	MEXT, Japan [19048028, C12]; NEDO, Japan; TRF, Japan	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NEDO, Japan(New Energy and Industrial Technology Development Organization (NEDO)); TRF, Japan(Thailand Research Fund (TRF))	We thank K. Sato, Y. Suzuki, Y. Tserkovnyak, G. Tatara, T. Ishibashi and K. M. Itoh for discussions. This work was supported by a Grant-in-Aid for Scientific Research in Priority Area 'Creation and control of spin current' (19048028) from MEXT, Japan, a Grant-in-Aid for Scientific Research (A) from MEXT, Japan, the global COE for the 'Materials integration international centre of education and research' and 'High-level global cooperation for leading-edge platform on access spaces (C12)' from MEXT, Japan, a Grant for Industrial Technology Research from NEDO, Japan, and Fundamental Research Grant from TRF, Japan.	Ando K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.036601; Ashcroft N. W., 1976, SOLID STATE PHYS; Brataas A, 2006, PHYS REP, V427, P157, DOI 10.1016/j.physrep.2006.01.001; BROWN WF, 1963, PHYS REV, V130, P1677, DOI 10.1103/PhysRev.130.1677; Chikazumi S., 1997, PHYS FERROMAGNETISM; Demokritov SO, 2001, PHYS REP, V348, P441, DOI 10.1016/S0370-1573(00)00116-2; Donahue M. J., 2004, OOMMF V1 2A3 OBJECT; DYAKONOV MI, 1971, PHYS LETT A, VA 35, P459, DOI 10.1016/0375-9601(71)90196-4; Hirsch JE, 1999, PHYS REV LETT, V83, P1834, DOI 10.1103/PhysRevLett.83.1834; Ji Y, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.106601; Kato YK, 2004, SCIENCE, V306, P1910, DOI 10.1126/science.1105514; Kimura T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.156601; Kiselev SI, 2003, NATURE, V425, P380, DOI 10.1038/nature01967; Kittel C, 2005, INTRO SOLID STATE PH; Krivorotov IN, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.024418; LAULICHT I, 1991, J APPL PHYS, V70, P2251, DOI 10.1063/1.349417; Maekawa S., 2006, CONCEPTS SPIN ELECT; Mizukami S, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.104413; Saitoh E, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2199473; Schneider T, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2834714; SILSBEE RH, 1979, PHYS REV B, V19, P4382, DOI 10.1103/PhysRevB.19.4382; Stiles MD, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.054408; Takahashi S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.116601; Takahashi S, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.031009; Tserkovnyak Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.117601; Valenzuela SO, 2006, NATURE, V442, P176, DOI 10.1038/nature04937; VALET T, 1993, PHYS REV B, V48, P7099, DOI 10.1103/PhysRevB.48.7099; WIGEN PE, 1988, J APPL PHYS, V63, P4157, DOI 10.1063/1.340525; Wunderlich J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047204	31	1198	1213	8	354	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					262	U141		10.1038/nature08876	http://dx.doi.org/10.1038/nature08876			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20220845				2022-12-28	WOS:000275366100043
J	Ropper, AH; Raje, NS; Lawrimore, TM; Camelo-Piragua, S; Sohani, AR				Ropper, Allan H.; Raje, Noopur S.; Lawrimore, Tara M.; Camelo-Piragua, Sandra; Sohani, Aliyah R.			A Man with Peripheral Neuropathy and Ascites The POEMS syndrome, with demyelinating neuropathy and solitary plasmacytoma of bone	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; STEM-CELL TRANSPLANTATION; CROW-FUKASE-SYNDROME; OF-THE-LITERATURE; BEVACIZUMAB THERAPY; POLYNEUROPATHY; DYSCRASIA; VEGF		[Ropper, Allan H.] Brigham & Womens Hosp, Dept Neurol, Boston, MA USA; [Raje, Noopur S.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Lawrimore, Tara M.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Camelo-Piragua, Sandra; Sohani, Aliyah R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Ropper, Allan H.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Raje, Noopur S.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Lawrimore, Tara M.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Camelo-Piragua, Sandra; Sohani, Aliyah R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Ropper, AH (corresponding author), Brigham & Womens Hosp, Dept Neurol, Boston, MA USA.			Camelopiragua, Sandra/0000-0002-9606-9402				Abe D, 2008, BLOOD, V112, P836, DOI 10.1182/blood-2007-12-126979; Badros A, 2005, BLOOD, V106, P1135, DOI 10.1182/blood-2005-03-0910; BARDWICK PA, 1980, MEDICINE, V59, P311, DOI 10.1097/00005792-198007000-00006; Belec L, 1999, BLOOD, V93, P3643, DOI 10.1182/blood.V93.11.3643.411k38_3643_3653; CROW RS, 1956, BRIT MED J, V2, P802, DOI 10.1136/bmj.2.4996.802; Dietrich PY, 2008, ANN ONCOL, V19, P595, DOI 10.1093/annonc/mdm602; Dispenzieri A, 2004, BLOOD, V103, P3960, DOI 10.1182/blood-2003-12-4192; Dispenzieri A, 2004, BLOOD, V104, P3400, DOI 10.1182/blood-2004-05-2046; Dispenzieri A, 2003, BLOOD, V101, P2496, DOI 10.1182/blood-2002-07-2299; Dispenzieri A, 2007, BLOOD REV, V21, P285, DOI 10.1016/j.blre.2007.07.004; Dispenzieri A, 2007, BLOOD, V110, P1075, DOI 10.1182/blood-2007-03-082354; Feinberg L, 1999, CRIT REV ONCOGENESIS, V10, P293; Fukase M, 1969, CLIN NEUROL TOKYO, V9, P657; Hashiguchi T, 2000, MUSCLE NERVE, V23, P1051, DOI 10.1002/1097-4598(200007)23:7<1051::AID-MUS7>3.0.CO;2-V; Higuchi Makoto, 2003, Clin Exp Nephrol, V7, P301, DOI 10.1007/s10157-003-0247-x; Kuwabara S, 2008, J NEUROL NEUROSUR PS, V79, P1255, DOI 10.1136/jnnp.2008.150177; LOEB JM, 1989, GASTROENTEROLOGY, V96, P247, DOI 10.1016/0016-5085(89)90789-0; MIRALLES GD, 1992, NEW ENGL J MED, V327, P1919, DOI 10.1056/NEJM199212313272705; NAKANISHI T, 1984, NEUROLOGY, V34, P712, DOI 10.1212/WNL.34.6.712; Ropper AH, 2009, ANN NEUROL, V65, P386, DOI 10.1002/ana.21675; Soubrier M, 2004, HAEMATOLOGICA, V89, pe4; Watanabe O, 1998, MUSCLE NERVE, V21, P1390, DOI 10.1002/(SICI)1097-4598(199811)21:11<1390::AID-MUS5>3.0.CO;2-4; Watanabe O, 1996, LANCET, V347, P702, DOI 10.1016/S0140-6736(96)91261-1	23	8	10	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10					929	940		10.1056/NEJMcpc0907805	http://dx.doi.org/10.1056/NEJMcpc0907805			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566JM	20220188				2022-12-28	WOS:000275365900015
J	Hochman, M; McCormick, D				Hochman, Michael; McCormick, Danny			Characteristics of Published Comparative Effectiveness Studies of Medications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLACEBO-CONTROLLED TRIALS; RANDOMIZED-TRIALS; CLINICAL-TRIALS; SYSTEMATIC REVIEWS; NONINFERIORITY; SAFETY; EQUIVALENCE; ASSOCIATION; DRUG; CONCLUSIONS	Context Policy makers and physician organizations have recently called for more comparative effectiveness (CE) research, yet little is known about existing CE studies. Objective To describe the characteristics of recently published CE studies evaluating medications. Design, Setting, and Participants Analysis of all randomized trials, observational studies, and meta-analyses involving medications published in the 6 general medicine and internal medicine journals with the highest impact factor between June 1, 2008, and September 30, 2009. Main Outcome Measures The prevalence and characteristics of CE studies (those comparing existing, active treatments) and non-CE studies (those involving novel therapies or those using an inactive control). Results We identified 328 studies evaluating medications, 104 of which were CE studies. Among the CE studies, 45 (43%; 95% confidence interval [CI], 34%-53%) compared different medications, 11 (11%; 95% CI, 5%-18%) compared medications with nonpharmacologic interventions, 32 (31%; 95% CI, 22%-41%) compared different pharmacologic strategies, and 16 (15%; 95% CI, 9%-24%) compared different medication dosing schedules. Twenty (19%; 95% CI, 12%-28%) CE studies focused on safety and 2 (2%; 95% CI, 0%-7%) included cost-effectiveness analyses. Comparative effectiveness studies were less likely than non-CE studies to have been exclusively commercially funded: 13% (95% CI, 8%-22%) vs 45% (95% CI, 38%-52%), respectively (P < .001). In total, 90 (87%; 95% CI, 78%-92%) of the CE studies received noncommercial funding, including 66 that received government funding (63%; 95% CI, 53%-73%). Of 212 randomized trials, 97 (46%; 95% CI, 39%-63%) used an active comparator; the rest used an inactive control. Active-comparator trials were less likely than trials with inactive controls to report positive results: 44% (95% CI, 33%-55%) vs 66% (95% CI, 57%-75%), respectively (P=.002). Conclusions In these high-impact general medicine journals, approximately one-third of studies evaluating medications were CE studies. Of these studies, only a minority compared pharmacologic and nonpharmacologic therapies, few focused on safety or cost, and most were funded by noncommercial funding sources. JAMA. 2010;303(10):951-958	Cambridge Hlth Alliance, Dept Med, Cambridge, MA USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Cambridge Health Alliance; Harvard University; Harvard Medical School	Hochman, M (corresponding author), Univ So Calif, Dept Med, Keck Sch Med, 1975 Zonal Ave,KAM 500, Los Angeles, CA 90089 USA.	mhochman@usc.edu						Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; *AM COLL PHYS, 2008, IMPR AV COMP EFF INF; BACIU A, 2006, FUTURE DRUG SAFETY P; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bhandari M, 2004, CAN MED ASSOC J, V170, P477; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Clement FM, 2009, JAMA-J AM MED ASSOC, V302, P1437, DOI 10.1001/jama.2009.1409; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; Emanuel EJ, 2001, NEW ENGL J MED, V345, P915, DOI 10.1056/NEJM200109203451211; Ernst E, 2001, BRIT MED J, V323, P546, DOI 10.1136/bmj.323.7312.546; Ernst E, 2001, ARCH INTERN MED, V161, P125, DOI 10.1001/archinte.161.1.125-a; Fontanarosa PB, 2004, JAMA-J AM MED ASSOC, V292, P2647, DOI 10.1001/jama.292.21.2647; Gomberg-Maitland M, 2003, AM HEART J, V146, P398, DOI 10.1016/S0002-8703(03)00324-7; Goodman DC, 2005, PEDIATRICS, V116, P493, DOI 10.1542/peds.2005-1231; Greene CJ, 2008, J TRAUMA STRESS, V21, P433, DOI 10.1002/jts.20367; *I MED, KNOW WHAT WORKS HEAL; *I MED ROUNDT EV B, 2007, LEARN WHAT WORKS BES; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Ioannidis John P A, 2008, Philos Ethics Humanit Med, V3, P14, DOI 10.1186/1747-5341-3-14; JACOBSON GA, 2007, CRS REPORT C COMP CL; Katz KA, 2006, J AM ACAD DERMATOL, V55, P814, DOI 10.1016/j.jaad.2006.07.005; Kirschner N, 2008, ANN INTERN MED, V148, P956, DOI 10.7326/0003-4819-148-12-200806170-00222; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; LEWIS TR, 2007, CASE PUBLIC FUNDING, V4; Misbin RI, 2001, DIABETES CARE, V24, P773, DOI 10.2337/diacare.24.4.773; Papanikolaou PN, 2004, AM J PSYCHIAT, V161, P1692, DOI 10.1176/appi.ajp.161.9.1692; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Pitrou I, 2009, ARCH INTERN MED, V169, P1756, DOI 10.1001/archinternmed.2009.306; Ridker PM, 2006, JAMA-J AM MED ASSOC, V295, P2270, DOI 10.1001/jama.295.19.2270; Sox HC, 2009, ANN INTERN MED, V151, P203, DOI 10.7326/0003-4819-151-3-200908040-00125; Stafford RS, 2009, NEW ENGL J MED, V361, P1230, DOI 10.1056/NEJMp0906490; StataCorp, 2009, STAT STAT SOFTW REL; *THOMS REUT, SCI J CIT REP ISI SU; Tuma RS, 2007, J NATL CANCER I, V99, P1746, DOI 10.1093/jnci/djm258; *US C BUDG OFF, 2007, RES COMP EFF MED TRE; *US DEP HHS, COMP EFF RES FUND FE; *US FDA, 2001, REG INF CHOIC CONTR; VANDENBROUKE JP, 2008, JAMA-J AM MED ASSOC, V3, P2417; Vitiello B, 2004, BIOL PSYCHIAT, V56, P3, DOI 10.1016/j.biopsych.2004.03.011; Vlahakes GJ, 2006, NEW ENGL J MED, V354, P413, DOI 10.1056/NEJMe058272; Vlopp KG, 2009, NEW ENGL J MED, V361, P331, DOI 10.1056/NEJMp0903496	41	62	64	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2010	303	10					951	958		10.1001/jama.2010.240	http://dx.doi.org/10.1001/jama.2010.240			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	565UC	20215609	Bronze			2022-12-28	WOS:000275319300022
J	Lindau, ST; Gavrilova, N				Lindau, Stacy Tessler; Gavrilova, Natalia			Sex, health, and years of sexually active life gained due to good health: evidence from two US population based cross sectional surveys of ageing	BRITISH MEDICAL JOURNAL			English	Article							SELF-RATED HEALTH; UNITED-STATES; OLDER WOMEN; EXPECTANCY; MEN; DYSFUNCTION; SATISFACTION; PREVALENCE; PREDICTORS; DISABILITY	Objectives To examine the relation between health and several dimensions of sexuality and to estimate years of sexually active life across sex and health groups in middle aged and older adults. Design Cross sectional study. Setting Two samples representative of the US population: MIDUS (the national survey of midlife development in the United States, 1995-6) and NSHAP (the national social life, health and ageing project, 2005-6). Participants 3032 adults aged 25 to 74 (1561 women, 1471 men) from the midlife cohort (MIDUS) and 3005 adults aged 57 to 85 (1550 women, 1455 men) from the later life cohort (NSHAP). Main outcome measures Sexual activity, quality of sexual life, interest in sex, and average remaining years of sexually active life, referred to as sexually active life expectancy. Results Overall, men were more likely than women to be sexually active, report a good quality sex life, and be interested in sex. These gender differences increased with age and were greatest among the 75 to 85 year old group: 38.9% of men compared with 16.8% of women were sexually active, 70.8% versus 50.9% of those who were sexually active had a good quality sex life, and 41.2% versus 11.4% were interested in sex. Men and women reporting very good or excellent health were more likely to be sexually active compared with their peers in poor or fair health: age adjusted odds ratio 2.2 (P<0.01) for men and 1.6 (P<0.05) for women in the midlife study and 4.6 (P<0.001) for men and 2.8 (P<0.001) for women in the later life study. Among sexually active people, good health was also significantly associated with frequent sex (once or more weekly) in men (adjusted odds ratio 1.6 to 2.1), with a good quality sex life among men and women in the midlife cohort (adjusted odds ratio 1.7), and with interest in sex. People in very good or excellent health were 1.5 to 1.8 times more likely to report an interest in sex than those in poorer health. At age 30, sexually active life expectancy was 34.7 years for men and 30.7 years for women compared with 14.9 to 15.3 years for men and 10. 6 years for women at age 55. This gender disparity attenuated for people with a spouse or other intimate partner. At age 55, men in very good or excellent health on average gained 5-7 years of sexually active life compared with their peers in poor or fair health. Women in very good or excellent health gained 3-6 years compared with women in poor or fair health. Conclusion Sexual activity, good quality sexual life, and interest in sex were higher for men than for women and this gender gap widened with age. Sexual activity, quality of sexual life, and interest in sex were positively associated with health in middle age and later life. Sexually active life expectancy was longer for men, but men lost more years of sexually active life as a result of poor health than women.	[Lindau, Stacy Tessler; Gavrilova, Natalia] Univ Chicago, Dept Obstet & Gynaecol, Chicago, IL 60637 USA; [Lindau, Stacy Tessler; Gavrilova, Natalia] Univ Chicago, Ctr Demog & Econ Aging, Chicago, IL 60637 USA; [Lindau, Stacy Tessler] Univ Chicago, Sect Geriatr, Dept Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Lindau, ST (corresponding author), Univ Chicago, Dept Obstet & Gynaecol, 5841 S Maryland Ave,MC2050, Chicago, IL 60637 USA.	slindau@uchicago.edu	Gavrilova, Natalia/AAH-2917-2020		National Institute on Aging/Rutgers University; University of Chicago Population Research Centre (NIH/NICHD) [R24 HD051152-01]; University of Chicago Centre on Demography and Economics of Aging pilot grant (NIH/NIA) [5P30 AG 012857]; National Institute of Child Health and Human Development [R24 HD051152-04]; National Institutes of Health, National Institute on Aging University of Chicago-NORC Centre on Demography and Economics of Aging Core on Biomarkers in Population-Based Health and Aging Research [5 P30 AG 012857];  [1K23AG032870-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD051152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG032870, P30AG012857] Funding Source: NIH RePORTER	National Institute on Aging/Rutgers University(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Chicago Population Research Centre (NIH/NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Chicago Centre on Demography and Economics of Aging pilot grant (NIH/NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health, National Institute on Aging University of Chicago-NORC Centre on Demography and Economics of Aging Core on Biomarkers in Population-Based Health and Aging Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was partially supported by the National Institute on Aging/Rutgers University pilot award, the University of Chicago Population Research Centre pilot grant (NIH/NICHD R24 HD051152-01), the University of Chicago Centre on Demography and Economics of Aging pilot grant (NIH/NIA 5P30 AG 012857), and Population Research Centre grant from the National Institute of Child Health and Human Development (R24 HD051152-04). NG was supported by, and STL partially supported by, the National Institutes of Health, National Institute on Aging University of Chicago-NORC Centre on Demography and Economics of Aging Core on Biomarkers in Population-Based Health and Aging Research (5 P30 AG 012857). STL was also supported by 1K23AG032870-01A1. The funders had no role in the study design. The authors retained full independence in the collection (NSHAP), analysis, and interpretation of the data ( NSHAP and MIDUS), the writing of this report, and in the decision to submit this article for publication. The authors were not involved in the collection of the MIDUS data.	Avis NE, 2009, MENOPAUSE, V16, P442, DOI 10.1097/gme.0b013e3181948dd0; Beckman N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a279; BINDER DA, 1983, INT STAT REV, V51, P279, DOI 10.2307/1402588; Brim O. G., 2004, MIDUS NATL SURVEY OV; Burke JP, 2007, J UROLOGY, V177, P1438, DOI 10.1016/j.juro.2006.11.059; Cambois E, 2001, DEMOGRAPHY, V38, P513, DOI 10.1353/dem.2001.0033; CANTANIA JA, 1990, PSYCHOL BULL, V108, P339; Carpenter LM, 2009, ARCH SEX BEHAV, V38, P87, DOI 10.1007/s10508-007-9215-y; Carpenter LM, 2006, J AGING STUD, V20, P93, DOI 10.1016/j.jaging.2005.06.003; Crimmins EM, 2001, SOC SCI MED, V52, P1629, DOI 10.1016/S0277-9536(00)00273-2; Decker FH, 2005, NURSING HOMES 1977 1; DIOKNO AC, 1990, ARCH INTERN MED, V150, P197, DOI 10.1001/archinte.150.1.197; *EUR MED AG, 2009, EPAR AUTH MED PROD H; Fenton KA, 2001, SEX TRANSM INFECT, V77, P84, DOI 10.1136/sti.77.2.84; Fisher WA, 2005, J MENS HLTH GEND, V2, P64; Ford J, 2008, AGE AGEING, V37, P194, DOI 10.1093/ageing/afm171; GRAY A, 1991, J CLIN ENDOCR METAB, V73, P1016, DOI 10.1210/jcem-73-5-1016; Grimm RH, 1997, HYPERTENSION, V29, P8, DOI 10.1161/01.HYP.29.1.8; GURALNIK JM, 1993, NEW ENGL J MED, V329, P110, DOI 10.1056/NEJM199307083290208; Hartmann U, 2004, MENOPAUSE, V11, P726, DOI 10.1097/01.GME.0000143705.42486.33; Hayward MD, 1999, DEMOGRAPHY, V36, P77, DOI 10.2307/2648135; Heiman JR, 2002, J SEX RES, V39, P73, DOI 10.1080/00224490209552124; HOSMER DW, 1989, APPL LOGISTIC REGRES; JAGGER C, 1999, NIHON U POPULATION R, V68; Laumann EO, 2005, INT J IMPOT RES, V17, P39, DOI 10.1038/sj.ijir.3901250; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; LINDAU ST, 2007, NEW ENGL J MED, V357, P22; Mathers CD, 1997, J EPIDEMIOL COMMUN H, V51, P578; Matthias RE, 1997, GERONTOLOGIST, V37, P6, DOI 10.1093/geront/37.1.6; Michael RT., 2000, SEX LOVE HLTH AM PRI; MOSSEY JM, 1982, AM J PUBLIC HEALTH, V72, P800, DOI 10.2105/AJPH.72.8.800; Nusselder WJ, 2005, AM J PUBLIC HEALTH, V95, P2035, DOI 10.2105/AJPH.2004.054700; Onder G, 2003, J CLIN PSYCHIAT, V64, P1177, DOI 10.4088/JCP.v64n1006; PALLONI A, 2001, DEMOGRAPHY MEASURING; PALMORE EB, 1982, GERONTOLOGIST, V22, P513, DOI 10.1093/geront/22.6.513; Satcher D., 2001, SURG GEN CALL ACTION; Schoenfeld DE, 1994, J GERONTOL, V49, P109, DOI [10.1093/geronj/49.3.M109, DOI 10.1093/GERONJ/49.3.M109]; Smith GD, 1997, BMJ-BRIT MED J, V315, P1641, DOI 10.1136/bmj.315.7123.1641; Smith S., 2009, J GERONTOL B-PSYCHOL, V64B, P20, DOI [10.1093/geronb/, DOI 10.1093/GERONB]; Solomon H, 2003, HEART, V89, P251, DOI 10.1136/heart.89.3.251; SULLIVAN DF, 1971, HSMHA HEALTH REP, V86, P347, DOI 10.2307/4594169; United Nations, 2007, WORLD POP AG 2007; *US BUR CENS, 2000, CENS 2000 PHC T 26 P; *US FDA, 2009, DRUG DET VIAGR; Westlake C, 1999, J HEART LUNG TRANSPL, V18, P1133, DOI 10.1016/S1053-2498(99)00084-4; WILKINS R, 1983, AM J PUBLIC HEALTH, V73, P1073, DOI 10.2105/AJPH.73.9.1073; Wolfe J, 2000, JAMA-J AM MED ASSOC, V284, P2469, DOI 10.1001/jama.284.19.2469; World Health Organization (WHO), 2002, DEF SEX HLTH REP TEC; 2008, HUMAN MORTALITY DATA	49	256	259	2	25	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 9	2010	340								c810	10.1136/bmj.c810	http://dx.doi.org/10.1136/bmj.c810			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570FC	20215365	Green Published, hybrid			2022-12-28	WOS:000275656700008
J	Bishop, NA; Lu, T; Yankner, BA				Bishop, Nicholas A.; Lu, Tao; Yankner, Bruce A.			Neural mechanisms of ageing and cognitive decline	NATURE			English	Review							LIFE-SPAN EXTENSION; CENTRAL-NERVOUS-SYSTEM; GENE-EXPRESSION; CALORIE RESTRICTION; ALZHEIMERS-DISEASE; MITOCHONDRIAL-DNA; STRESS RESISTANCE; ENTORHINAL CORTEX; APOLIPOPROTEIN-D; BRAIN	During the past century, treatments for the diseases of youth and middle age have helped raise life expectancy significantly. However, cognitive decline has emerged as one of the greatest health threats of old age, with nearly 50% of adults over the age of 85 afflicted with Alzheimer's disease. Developing therapeutic interventions for such conditions demands a greater understanding of the processes underlying normal and pathological brain ageing. Recent advances in the biology of ageing in model organisms, together with molecular and systems-level studies of the brain, are beginning to shed light on these mechanisms and their potential roles in cognitive decline.	[Bishop, Nicholas A.; Lu, Tao; Yankner, Bruce A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Yankner, BA (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	bruce_yankner@hms.harvard.edu	Bibi, Raquel/K-5835-2012		National Institute on Aging of the US National Institutes of Health; Ellison Medical Foundation; Glenn Foundation for Medical Research; NATIONAL INSTITUTE ON AGING [P01AG027916, R01AG027040, RC1AG036106, R01AG026651, DP1AG044161] Funding Source: NIH RePORTER	National Institute on Aging of the US National Institutes of Health; Ellison Medical Foundation(Lawrence Ellison Foundation); Glenn Foundation for Medical Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We apologize for the many studies and references that could not be included owing to space limitations. Our work is supported by the National Institute on Aging of the US National Institutes of Health, the Ellison Medical Foundation and the Glenn Foundation for Medical Research.	Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Bao AM, 2008, BRAIN RES REV, V57, P531, DOI 10.1016/j.brainresrev.2007.04.005; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Blalock EM, 2003, J NEUROSCI, V23, P3807; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Branicky R, 2000, BIOESSAYS, V22, P48, DOI 10.1002/(SICI)1521-1878(200001)22:1&lt;48::AID-BIES9&gt;3.0.CO;2-F; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Conrad CD, 2008, REV NEUROSCIENCE, V19, P395; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016; Cristina D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000450; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Erraji-Benchekroun L, 2005, BIOL PSYCHIAT, V57, P549, DOI 10.1016/j.biopsych.2004.10.034; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fischer DF, 2009, NEUROBIOL AGING, V30, P847, DOI 10.1016/j.neurobiolaging.2008.06.009; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Fraser HB, 2005, PLOS BIOL, V3, P1653, DOI 10.1371/journal.pbio.0030274; Freude S, 2009, FASEB J, V23, P3315, DOI 10.1096/fj.09-132043; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Guarente L, 2000, GENE DEV, V14, P1021; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Halagappa VKM, 2007, NEUROBIOL DIS, V26, P212, DOI 10.1016/j.nbd.2006.12.019; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; INGRAM DK, 1987, J GERONTOL, V42, P78, DOI 10.1093/geronj/42.1.78; Iser WB, 2007, DEV BIOL, V303, P434, DOI 10.1016/j.ydbio.2006.04.467; Jankord R, 2008, ANN NY ACAD SCI, V1148, P64, DOI 10.1196/annals.1410.012; Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kalman J, 2000, NEUROL RES, V22, P330; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299; Liu XX, 2005, GENE DEV, V19, P2424, DOI 10.1101/gad.1352905; Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Park SK, 2009, AGING CELL, V8, P484, DOI 10.1111/j.1474-9726.2009.00496.x; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Rodrigue KM, 2004, J NEUROSCI, V24, P956, DOI 10.1523/JNEUROSCI.4166-03.2004; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sanchez D, 2006, CURR BIOL, V16, P680, DOI 10.1016/j.cub.2006.03.024; Sanchez-Blanco A, 2006, GENETICS, V172, P1699, DOI 10.1534/genetics.105.053389; Schieke SM, 2006, BIOL CHEM, V387, P1357, DOI 10.1515/BC.2006.170; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Sedensky MM, 2006, EXP GERONTOL, V41, P237, DOI 10.1016/j.exger.2006.01.004; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Small SA, 2002, ANN NEUROL, V51, P290, DOI 10.1002/ana.10105; STEWART J, 1989, NEUROBIOL AGING, V10, P669, DOI 10.1016/0197-4580(89)90003-1; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Walker DW, 2006, CURR BIOL, V16, P674, DOI 10.1016/j.cub.2006.01.057; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Witte AV, 2009, P NATL ACAD SCI USA, V106, P1255, DOI 10.1073/pnas.0808587106; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115	100	830	873	8	285	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					529	535		10.1038/nature08983	http://dx.doi.org/10.1038/nature08983			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20336135	Green Accepted			2022-12-28	WOS:000275974200036
J	Livesley, B				Livesley, Brian			Personal View Assisted suicide: a substitute for a caring doctor?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Livesley, B (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	brian.livesley@doctors.org.uk						Gale J, 1974, Age Ageing, V3, P49, DOI 10.1093/ageing/3.1.49; KAMISAR Y, 1958, MINN LAW REV, V42, P969; The Crown Prosecution Service, POL PROS RESP CAS EN	3	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 23	2010	340								c1590	10.1136/bmj.c1590	http://dx.doi.org/10.1136/bmj.c1590			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	576PO	20332309				2022-12-28	WOS:000276157600001
J	Nylenna, M; Eiring, O; Strand, G; Rottingen, JA				Nylenna, Magne; Eiring, Oystein; Strand, Grete; Rottingen, John-Arne			Wiring a nation: putting knowledge into action	LANCET			English	Editorial Material							INFORMATION-SEEKING BEHAVIOR; QUESTIONS; DOCTORS; CARE; NEED		[Nylenna, Magne; Eiring, Oystein; Strand, Grete; Rottingen, John-Arne] Norwegian Knowledge Ctr, Norwegian Elect Hlth Lib, Hlth Serv, N-0130 Oslo, Norway; [Nylenna, Magne] Univ Oslo, Inst Hlth & Soc, Oslo, Norway; [Nylenna, Magne] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway	Norwegian Knowledge Centre for Health Services; University of Oslo; Norwegian University of Science & Technology (NTNU)	Nylenna, M (corresponding author), Norwegian Knowledge Ctr, Norwegian Elect Hlth Lib, Hlth Serv, POB 7004 St Olavsplass, N-0130 Oslo, Norway.	magne.nylenna@nokc.no						Best A, 2008, PATIENT EDUC COUNS, V71, P319, DOI 10.1016/j.pec.2008.02.013; Coumou HCH, 2006, J MED LIBR ASSOC, V94, P55; Davies K, 2007, HEALTH INFO LIBR J, V24, P78, DOI 10.1111/j.1471-1842.2007.00713.x; Dawes M, 2003, INT J MED INFORM, V71, P9, DOI 10.1016/S1386-5056(03)00023-6; DiCenso A, 2009, ANN INTERN MED, V151, DOI 10.7326/0003-4819-151-6-200909150-02002; *EBMEDS, CONT SENS GUID POINT; FOSSENG HP, FAGLIGE OPPSLAGSVERK; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Glenton C, 2006, J CLIN EPIDEMIOL, V59, P770, DOI 10.1016/j.jclinepi.2005.12.011; Gray JAM, 2006, CAN MED ASSOC J, V175, P129; Masters K, 2008, INT J MED INFORM, V77, P4, DOI 10.1016/j.ijmedinf.2006.10.002; McCord G, 2007, ACAD MED, V82, P298, DOI 10.1097/ACM.0b013e3180307fed; OXMAN AD, 1988, CAN MED ASSOC J, V138, P697; Prensky M., DIGITAL NATIVES DIGI; Prensky Marc, DIGITAL NATIVES DI 2; Skyrme D., 2001, CAPITALIZING KNOWLED; Straus S, 2009, CAN MED ASSOC J, V180, P942, DOI 10.1503/cmaj.081697	17	10	11	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 20	2010	375	9719					1048	1051		10.1016/S0140-6736(09)61832-8	http://dx.doi.org/10.1016/S0140-6736(09)61832-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	575YU	20304248				2022-12-28	WOS:000276110700037
J	Grech, R				Grech, Reuben			Aspergilloma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Mater Dei Hosp, Msida, Malta		Grech, R (corresponding author), Mater Dei Hosp, Msida, Malta.	reubengrech@yahoo.com		Grech, Reuben/0000-0002-3518-5880					0	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2010	362	11					1030	1030		10.1056/NEJMicm0802981	http://dx.doi.org/10.1056/NEJMicm0802981			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570CY	20237349				2022-12-28	WOS:000275650400014
J	Young, RH; Goodman, A; Penson, RT; Russell, AH; Uppot, RN; Tambouret, RH				Young, Robert H.; Goodman, Annekathryn; Penson, Richard T.; Russell, Anthony H.; Uppot, Raul N.; Tambouret, Rosemary H.			Case 8-2010: A 22-Year-Old Woman with Hypercalcemia and a Pelvic Mass - Ovarian small-cell carcinoma, hypercalcemic type	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SERTOLI-LEYDIG CELL; CLINICOPATHOLOGICAL ANALYSIS; TUMORS; SURGERY; CANCER; CHEMOTHERAPY; PREGNANCY; ETOPOSIDE; WOMEN		[Young, Robert H.; Tambouret, Rosemary H.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Goodman, Annekathryn] Massachusetts Gen Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02114 USA; [Penson, Richard T.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Russell, Anthony H.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Uppot, Raul N.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Young, Robert H.; Tambouret, Rosemary H.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA; [Goodman, Annekathryn] Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Cambridge, MA 02138 USA; [Penson, Richard T.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Russell, Anthony H.] Harvard Univ, Sch Med, Dept Radiat Oncol, Cambridge, MA 02138 USA; [Uppot, Raul N.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University; Harvard University	Young, RH (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.		Uppot, Raul/AAF-1859-2019					CLEMENT PB, 1980, AM J SURG PATHOL, V4, P431, DOI 10.1097/00000478-198010000-00003; Dykgraaf RHM, 2009, INT J GYNECOL CANCER, V19, P348, DOI 10.1111/IGC.0b013e3181a1a116; FEIN DA, 1994, INT J RADIAT ONCOL, V29, P169, DOI 10.1016/0360-3016(94)90240-2; FLEISCHHACKER DS, 1994, GYNECOL ONCOL, V52, P87, DOI 10.1006/gyno.1994.1016; Gershenson DM, 2007, J CLIN ONCOL, V25, P2792, DOI 10.1200/JCO.2006.08.4590; Harrison ML, 2006, GYNECOL ONCOL, V100, P233, DOI 10.1016/j.ygyno.2005.10.024; Kiyokawa T, 2006, AM J SURG PATHOL, V30, P277; LACK EE, 1992, PATHOL ANNU, V27, P281; Mittendorf EA, 2009, ANN SURG ONCOL, V16, P1768, DOI 10.1245/s10434-009-0462-0; Muzii L, 2009, FERTIL STERIL, V91, P2632, DOI 10.1016/j.fertnstert.2008.03.058; Park JY, 2008, GYNECOL ONCOL, V110, P345, DOI 10.1016/j.ygyno.2008.04.040; Reck M, 2006, LUNG CANCER, V53, P67, DOI 10.1016/j.lungcan.2006.04.001; Rouge TD, 2008, ANN ONCOL, V19, P1435, DOI 10.1093/annonc/mdn162; SCULLY RE, 1957, PROGR GYNECOLOGY, P20; SCULLY REY, 1998, ATLAS TUMOR PATHOL, V23, P51; Walter AJ, 1999, GYNECOL ONCOL, V74, P128, DOI 10.1006/gyno.1999.5370; YOUNG RH, 1994, AM J SURG PATHOL, V18, P1102, DOI 10.1097/00000478-199411000-00004; YOUNG RH, 1993, INT J GYNECOL PATHOL, V12, P8, DOI 10.1097/00004347-199301000-00002; YOUNG RH, 1983, AM J SURG PATHOL, V7, P755, DOI 10.1097/00000478-198307080-00005; YOUNG RH, 1984, GYNECOL ONCOL, V18, P181, DOI 10.1016/0090-8258(84)90026-X; Zanetta G, 1997, BRIT J OBSTET GYNAEC, V104, P1030, DOI 10.1111/j.1471-0528.1997.tb12062.x	21	16	16	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2010	362	11					1031	1040		10.1056/NEJMcpc1000272	http://dx.doi.org/10.1056/NEJMcpc1000272			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570CY	20237350	Green Published			2022-12-28	WOS:000275650400016
J	Talcott, JA; Rossi, C; Shipley, WU; Clark, JA; Slater, JD; Niemierko, A; Zietman, AL				Talcott, James A.; Rossi, Carl; Shipley, William U.; Clark, Jack A.; Slater, Jerry D.; Niemierko, Andrzej; Zietman, Anthony L.			Patient-Reported Long-term Outcomes After Conventional and High-Dose Combined Proton and Photon Radiation for Early Prostate Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; OF-LIFE OUTCOMES; CONFORMAL RADIOTHERAPY; PATIENTS PERCEPTIONS; THERAPY; ADENOCARCINOMA; IRRADIATION; CARCINOMA; SEQUELAE; ESCALATION	Context Increased radiation doses improve prostate cancer control but also increase toxicity to adjacent normal tissue. Proton radiation may attenuate adverse effects. Objective To determine long-term, patient-reported, dose-related toxicity. Design, Setting, and Patients We performed a post hoc cross-sectional survey of surviving participants in the Proton Radiation Oncology Group (PROG) 9509-a randomized trial comparing 70.2 Gy vs 79.2 Gy of combined photon and proton radiation for 393 men with clinically localized prostate cancer (stage T1b-T2b, prostate-specific antigen <15 ng/mL, and no radiographic evidence of metastasis). The estimated 10-year biochemical progression rate for patients receiving standard dose was 32% (95% confidence interval, 26%-39%) compared with 17% (95% confidence interval, 11%-23%) for patients receiving high dose (P<.001). We surveyed 280 of the surviving 337 patients (83%) from April 2007 to September 2008. Main Outcome Measures Prostate Cancer Symptom Indices, a validated measure of urinary incontinence, urinary obstruction and irritation, bowel problems, and sexual dysfunction, and related quality-of-life instruments. Results At a median of 9.4 years after treatment (range, 7.4-12.1 years), participants' demographic and clinical characteristics were similar. Patient-reported outcomes were reported as mean (SD) scale score for standard dose vs high dose: urinary obstruction/irritation (23.3 [13.7] vs 24.6 [14.0]; P=.36), urinary incontinence (10.6 [17.7] vs 9.7 [15.8]; P=.99), bowel problems (7.7 [7.8] vs 7.9 [9.1]; P=.70), sexual dysfunction (68.2 [34.6] vs 65.9 [34.7]; P=.65), and most other outcomes were also similar, although patients receiving standard dose whose cancers had more often progressed expressed less confidence that their cancers were under control (mean [SD] scale score for standard dose, 76.0 [25.4] vs high dose, 86.2 [17.9]; P<.001). Many patients characterized their urinary and bowel function as normal despite reporting symptoms that, for other prostate cancer patients before and early after cancer treatment, caused substantial distress. Conclusion Among men with clinically localized prostate cancer, treatment with higher-dose radiation compared with standard dose was not associated with an increase in patient-reported prostate cancer symptoms after a median of 9.4 years. JAMA. 2010; 303(11): 1046-1053	[Talcott, James A.] Massachusetts Gen Hosp, MGH Canc Ctr, Ctr Outcomes Res, Boston, MA 02114 USA; [Rossi, Carl; Slater, Jerry D.] Loma Linda Univ, Med Ctr, Loma Linda, CA USA; [Shipley, William U.; Niemierko, Andrzej; Zietman, Anthony L.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Clark, Jack A.] Edith Nourse Rogers Mem Vet Adm Hosp, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA 01730 USA; [Clark, Jack A.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Talcott, James A.; Shipley, William U.; Niemierko, Andrzej; Zietman, Anthony L.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Loma Linda University; Harvard University; Massachusetts General Hospital; Boston University; Harvard University; Harvard Medical School	Talcott, JA (corresponding author), Ctr Outcomes Res, Charlestown Navy Yard,Bldg 120,6th St,2nd Floor, Charlestown, MA 02129 USA.	jtalcott@partners.org	Niemierko, Andrzej/GSV-8546-2022; Niemierko, Andrzej/AAJ-2313-2020; Talcott, James/CAG-8759-2022	Niemierko, Andrzej/0000-0002-8895-5500; Clark, Jack/0000-0002-7424-1670	Massachusetts General Hospital, Boston, MA	Massachusetts General Hospital, Boston, MA	Funding/Support: This research was supported by the Bertucci Genitourinary Cancer Research Fund, Massachusetts General Hospital, Boston, MA.	BENK VA, 1993, INT J RADIAT ONCOL, V26, P551, DOI 10.1016/0360-3016(93)90978-5; Chen RC, 2009, J CLIN ONCOL, V27, P3916, DOI 10.1200/JCO.2008.18.6486; Clark JA, 2003, MED CARE, V41, P923, DOI 10.1097/00005650-200308000-00006; Clark JA, 2001, MED CARE, V39, P1118, DOI 10.1097/00005650-200110000-00009; Clark JA, 2006, J CLIN ONCOL, V24, P4457, DOI 10.1200/JCO.2006.06.2893; Dearnaley DP, 1999, LANCET, V353, P267, DOI 10.1016/S0140-6736(98)05180-0; Do YK, 2010, CANCER CAUSE CONTROL, V21, P31, DOI 10.1007/s10552-009-9431-y; Gardner BG, 2002, J UROLOGY, V167, P123, DOI 10.1016/S0022-5347(05)65395-5; Garg AK, 2006, INT J RADIAT ONCOL, V66, P1294, DOI 10.1016/j.ijrobp.2006.07.1386; Hanks GE, 1998, INT J RADIAT ONCOL, V41, P501, DOI 10.1016/S0360-3016(98)00089-3; Jacob R, 2004, CANCER-AM CANCER SOC, V100, P538, DOI 10.1002/cncr.11927; Jayadevappa R, 2007, CANCER-AM CANCER SOC, V109, P2229, DOI 10.1002/cncr.22675; Korfage IJ, 2006, SOC SCI MED, V63, P911, DOI 10.1016/j.socscimed.2006.01.027; LAWTON CA, 1991, INT J RADIAT ONCOL, V21, P935, DOI 10.1016/0360-3016(91)90732-J; Little DJ, 2003, UROLOGY, V62, P707, DOI 10.1016/S0090-4295(03)00504-1; LITWIN MS, 1995, JAMA-J AM MED ASSOC, V273, P129, DOI 10.1001/jama.273.2.129; Loeffler JS, 1997, SEMIN ONCOL, V24, P686; Mangar SA, 2006, RADIOTHER ONCOL, V80, P355, DOI 10.1016/j.radonc.2006.07.037; Papoulis A., 1991, PROBABILITY RANDOM V; Schulz-Ertner D, 2007, J CLIN ONCOL, V25, P953, DOI 10.1200/JCO.2006.09.7816; SHIPLEY WU, 1995, INT J RADIAT ONCOL, V32, P3, DOI 10.1016/0360-3016(95)00063-5; STEWART A, 1992, MEASURING FUNCTION S; Talcott JA, 2003, J CLIN ONCOL, V21, P3979, DOI 10.1200/JCO.2003.01.199; Talcott JA, 2006, J UROLOGY, V176, P1558, DOI 10.1016/j.juro.2006.06.067; Wachter S, 2001, RADIOTHER ONCOL, V59, P65, DOI 10.1016/S0167-8140(01)00281-X; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Yeoh EE, 2006, INT J RADIAT ONCOL, V66, P1072, DOI 10.1016/j.ijrobp.2006.06.005; Yonemoto LT, 1997, INT J RADIAT ONCOL, V37, P21, DOI 10.1016/S0360-3016(96)00311-2; YU CL, 2003, QUAL LIFE RES, V12, P41; Zietman AL, 2005, JAMA-J AM MED ASSOC, V294, P1233, DOI 10.1001/jama.294.10.1233; Zietman AL, 2010, J CLIN ONCOL, V28, P1106, DOI 10.1200/JCO.2009.25.8475	31	75	76	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1046	1053		10.1001/jama.2010.287	http://dx.doi.org/10.1001/jama.2010.287			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569KC	20233822	Bronze			2022-12-28	WOS:000275594100017
J	Sapienza, L; Thyrrestrup, H; Stobbe, S; Garcia, PD; Smolka, S; Lodahl, P				Sapienza, Luca; Thyrrestrup, Henri; Stobbe, Soren; Garcia, Pedro David; Smolka, Stephan; Lodahl, Peter			Cavity Quantum Electrodynamics with Anderson-Localized Modes	SCIENCE			English	Article							SPONTANEOUS EMISSION; SINGLE-PHOTON; DOT	A major challenge in quantum optics and quantum information technology is to enhance the interaction between single photons and single quantum emitters. This requires highly engineered optical cavities that are inherently sensitive to fabrication imperfections. We have demonstrated a fundamentally different approach in which disorder is used as a resource rather than a nuisance. We generated strongly confined Anderson-localized cavity modes by deliberately adding disorder to photonic crystal waveguides. The emission rate of a semiconductor quantum dot embedded in the waveguide was enhanced by a factor of 15 on resonance with the Anderson-localized mode, and 94% of the emitted single photons coupled to the mode. Disordered photonic media thus provide an efficient platform for quantum electrodynamics, offering an approach to inherently disorder-robust quantum information devices.	[Sapienza, Luca; Thyrrestrup, Henri; Stobbe, Soren; Garcia, Pedro David; Smolka, Stephan; Lodahl, Peter] Tech Univ Denmark, Dept Photon Engn, DTU Foton, DK-2800 Lyngby, Denmark	Technical University of Denmark	Sapienza, L (corresponding author), Tech Univ Denmark, Dept Photon Engn, DTU Foton, Orsteds Plads 343, DK-2800 Lyngby, Denmark.	lucs@fotonik.dtu.dk; pelo@fotonik.dtu.dk	Thyrrestrup, Henri/E-7520-2010; García, Pedro David/D-3775-2014; Lodahl, Peter/P-6297-2014; Stobbe, Søren/F-6782-2010	Thyrrestrup, Henri/0000-0001-8922-4462; García, Pedro David/0000-0002-3422-178X; Lodahl, Peter/0000-0002-9348-9591; Stobbe, Søren/0000-0002-0991-041X; Sapienza, Luca/0000-0002-0978-3430	Council for Independent Research (Technology and Production Sciences and Natural Sciences); Villum Kann Rasmussen Foundation	Council for Independent Research (Technology and Production Sciences and Natural Sciences); Villum Kann Rasmussen Foundation(Villum Fonden)	We gratefully acknowledge T. Schlereth and S. Hofling for quantum dot growth, J. M. Hvam for discussions, and the Council for Independent Research (Technology and Production Sciences and Natural Sciences) and the Villum Kann Rasmussen Foundation for financial support.	Akahane Y, 2003, NATURE, V425, P944, DOI 10.1038/nature02063; ANDERSON PW, 1958, PHYS REV, V109, P1492, DOI 10.1103/PhysRev.109.1492; Bertolotti J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.113903; Billy J, 2008, NATURE, V453, P891, DOI 10.1038/nature07000; Chabanov AA, 2000, NATURE, V404, P850, DOI 10.1038/35009055; Fushman I, 2008, SCIENCE, V320, P769, DOI 10.1126/science.1154643; Gerard JM, 1998, PHYS REV LETT, V81, P1110, DOI 10.1103/PhysRevLett.81.1110; Haffner H, 2008, PHYS REP, V469, P155, DOI 10.1016/j.physrep.2008.09.003; Hennessy K, 2007, NATURE, V445, P896, DOI 10.1038/nature05586; Hu HF, 2008, NAT PHYS, V4, P945, DOI 10.1038/nphys1101; JOHN S, 1987, PHYS REV LETT, V58, P2486, DOI 10.1103/PhysRevLett.58.2486; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Koenderink AF, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.153102; Lodahl P, 2004, NATURE, V430, P654, DOI 10.1038/nature02772; Mazoyer S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.063903; PENDRY JB, 1987, J PHYS C SOLID STATE, V20, P733, DOI 10.1088/0022-3719/20/5/009; Raimond JM, 2001, REV MOD PHYS, V73, P565, DOI 10.1103/RevModPhys.73.565; Shapiro B, 1999, PHYS REV LETT, V83, P4733, DOI 10.1103/PhysRevLett.83.4733; Somers RC, 2007, CHEM SOC REV, V36, P579, DOI 10.1039/b517613c; Topolancik J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.253901; Topolancik J, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2809614; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Wiersma DS, 1997, NATURE, V390, P671, DOI 10.1038/37757; Wilk T, 2007, SCIENCE, V317, P488, DOI 10.1126/science.1143835	29	265	266	1	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1352	1355		10.1126/science.1185080	http://dx.doi.org/10.1126/science.1185080			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223981	Green Submitted			2022-12-28	WOS:000275418700034
J	Degroote, P; Aerts, C; Baglin, A; Miglio, A; Briquet, M; Noels, A; Niemczura, E; Montalban, J; Bloemen, S; Oreiro, R; Vuckovic, M; Smolders, K; Auvergne, M; Baudin, F; Catala, C; Michel, E				Degroote, Pieter; Aerts, Conny; Baglin, Annie; Miglio, Andrea; Briquet, Maryline; Noels, Arlette; Niemczura, Ewa; Montalban, Josefina; Bloemen, Steven; Oreiro, Raquel; Vuckovic, Maja; Smolders, Kristof; Auvergne, Michel; Baudin, Frederic; Catala, Claude; Michel, Eric			Deviations from a uniform period spacing of gravity modes in a massive star	NATURE			English	Article							WHOLE EARTH TELESCOPE; STELLAR; ASTEROSEISMOLOGY; OSCILLATIONS; PULSATIONS; SUN	The life of a star is dominantly determined by the physical processes in the stellar interior. Unfortunately, we still have a poor understanding of how the stellar gas mixes near the stellar core, preventing precise predictions of stellar evolution(1). The unknown nature of the mixing processes as well as the extent of the central mixed region is particularly problematic for massive stars(2). Oscillations in stars with masses a few times that of the Sun offer a unique opportunity to disentangle the nature of various mixing processes, through the distinct signature they leave on period spacings in the gravity mode spectrum(3). Here we report the detection of numerous gravity modes in a young star with a mass of about seven solar masses. The mean period spacing allows us to estimate the extent of the convective core, and the clear periodic deviation from the mean constrains the location of the chemical transition zone to be at about 10 per cent of the radius and rules out a clearcut profile.	[Degroote, Pieter; Aerts, Conny; Briquet, Maryline; Bloemen, Steven; Oreiro, Raquel; Vuckovic, Maja; Smolders, Kristof] Katholieke Univ Leuven, Inst Sterrenkunde, B-3001 Louvain, Belgium; [Aerts, Conny] Radboud Univ Nijmegen, Dept Astrophys, IMAPP, NL-6500 GL Nijmegen, Netherlands; [Baglin, Annie; Auvergne, Michel; Catala, Claude; Michel, Eric] Univ Paris 07, Univ Paris 06, Observ Paris, LESIA,UMR8109, F-92195 Meudon, France; [Miglio, Andrea; Noels, Arlette; Montalban, Josefina] Univ Liege, Inst Astrophys & Geophys, B-4000 Liege, Belgium; [Niemczura, Ewa] Univ Wroclaw, Astron Inst, PL-51622 Wroclaw, Poland; [Baudin, Frederic] Inst Astrophys Spatiale, F-91405 Orsay, France	KU Leuven; Radboud University Nijmegen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; University of Liege; University of Wroclaw; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay	Degroote, P (corresponding author), Katholieke Univ Leuven, Inst Sterrenkunde, Celestijnenlaan 200D, B-3001 Louvain, Belgium.	pieter.degroote@ster.kuleuven.ac.be	Niemczura, Ewa/L-4689-2019; miglio, andrea/O-9594-2019; Niemczura, Ewa/X-9089-2019; Vuckovic, Maja/F-7012-2018; Miglio, Andrea/M-5789-2018	miglio, andrea/0000-0001-5998-8533; Vuckovic, Maja/0000-0001-8339-6423; Miglio, Andrea/0000-0001-5998-8533; Baudin, Frederic/0000-0001-6213-6382; Oreiro Rey, Raquel/0000-0002-4899-6199; Niemczura, Ewa/0000-0001-7290-5800; Aerts, Conny/0000-0003-1822-7126	European Research Council under the European Community; Research Council of KU Leuven; Belgian Federal Science Policy	European Research Council under the European Community(European Research Council (ERC)); Research Council of KU Leuven(KU Leuven); Belgian Federal Science Policy(Belgian Federal Science Policy Office)	The research leading to these results received funding from the European Research Council under the European Community's Seventh Framework Programme (PROSPERITY), from the Research Council of KU Leuven and from the Belgian Federal Science Policy. The CoRoT space mission has been developed, and is operated by, CNES, with contributions from Austria, Belgium, Brazil, ESA, Germany and Spain.	Aerts C, 2003, SCIENCE, V300, P1926, DOI 10.1126/science.1084993; Aerts C, 2003, SPACE SCI REV, V105, P453, DOI 10.1023/A:1023983704925; AERTS C, 2009, ASTEROSEISMOLOGY; AERTS C, 2008, P IAU, V250, P237; ANDERSEN J, 1990, ASTROPHYS J, V363, pL33, DOI 10.1086/185858; Auvergne M, 2009, ASTRON ASTROPHYS, V506, P411, DOI 10.1051/0004-6361/200810860; BARANNE A, 1996, A AS, V119, P390; Bedding TR, 2003, PUBL ASTRON SOC AUST, V20, P203, DOI 10.1071/AS03025; BRASSARD P, 1992, ASTROPHYS J SUPPL S, V80, P369, DOI 10.1086/191668; Chaplin WJ, 2008, SOL PHYS, V251, P53, DOI 10.1007/s11207-008-9136-5; Christensen-Dalsgaard J, 2002, REV MOD PHYS, V74, P1073, DOI 10.1103/RevModPhys.74.1073; De Ridder J, 2009, NATURE, V459, P398, DOI 10.1038/nature08022; Degroote P, 2009, ASTRON ASTROPHYS, V506, P471, DOI 10.1051/0004-6361/200911884; DEUBNER FL, 1975, ASTRON ASTROPHYS, V44, P371; Dupret MA, 2001, ASTRON ASTROPHYS, V366, P166, DOI 10.1051/0004-6361:20000219; KRISCIUNAS K, 1993, B AM ASTRON SOC, V25, P1442; LEIBACHER J, 1971, ASTROPHYS LETT COMM, V7, P191; LEIGHTON RB, 1962, ASTROPHYS J, V135, P474, DOI 10.1086/147285; Maeder A, 2009, ASTRON ASTROPHYS LIB, P3, DOI 10.1007/978-3-540-76949-1_1; Michel E, 2008, SCIENCE, V322, P558, DOI 10.1126/science.1163004; Miglio A, 2008, MON NOT R ASTRON SOC, V386, P1487, DOI 10.1111/j.1365-2966.2008.13112.x; NOELS A, 2009, ASTROPHYS SPACE SCI, V326, P233; RASKIN G, 2008, P SOC PHOTO-OPT INS, V7014, P178; SCHALLER G, 1992, A AS, V269, P331; Scuflaire R, 2008, ASTROPHYS SPACE SCI, V316, P83, DOI 10.1007/s10509-007-9650-1; TASSOUL M, 1980, ASTROPHYS J SUPPL S, V43, P469, DOI 10.1086/190678; ULRICH RK, 1970, ASTROPHYS J, V162, P993, DOI 10.1086/150731; WAELKENS C, 1991, ASTRON ASTROPHYS, V246, P453; WINGET DE, 1991, ASTROPHYS J, V378, P326, DOI 10.1086/170434; WINGET DE, 1994, ASTROPHYS J, V430, P839, DOI 10.1086/174455	30	116	116	0	211	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					259	261		10.1038/nature08864	http://dx.doi.org/10.1038/nature08864			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20220844	Green Published			2022-12-28	WOS:000275366100042
J	Liu, B; Balkwill, A; Reeves, G; Beral, V				Liu, Bette; Balkwill, Angela; Reeves, Gillian; Beral, Valerie		Million Women Study Collaborators	Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ALCOHOL; DISEASE; SMOKING	Objective To determine the relation between body mass index (BMI) and liver cirrhosis and the contribution that BMI and alcohol consumption make to the incidence of liver cirrhosis in middle aged women in the UK. Design Prospective cohort study ( Million Women Study). Setting Women recruited from 1996 to 2001 in NHS breast screening centres and followed by record linkage to routinely collected information on hospital admissions and deaths. Participants 1 230 662 women ( mean age 56 years at recruitment) followed for an average of 6.2 years. Main outcome measures Relative risk and absolute risk of first hospital admission with or death from liver cirrhosis adjusted for age, recruitment region, alcohol consumption, smoking, socioeconomic status, and physical activity. Results 1811 women had a first hospital admission with or died from liver cirrhosis during follow-up. Among women with a BMI of 22.5 or above, increasing BMI was associated with an increased incidence of liver cirrhosis: the adjusted relative risk of cirrhosis increased by 28% ( relative risk 1.28, 95% confidence interval 1.19 to 1.38; P<0.001) for every 5 unit increase in BMI. Although the relative increase in the risk of liver cirrhosis per 5 unit increase in BMI did not differ significantly according to the amount of alcohol consumed, the absolute risk did. Among women who reported drinking less than 70 g alcohol per week, the absolute risk of liver cirrhosis per 1000 women over five years was 0.8 (0.7 to 0.9) for those with a BMI between 22.5 and 25 and 1.0 ( 0.9 to 1.2) for those with a BMI of 30 or more. Among women who reported drinking 150 g alcohol or more per week, the corresponding figures were 2.7 (2.1 to 3.4) and 5.0 (3.8 to 6.6). Conclusions Excess body weight increases the incidence of liver cirrhosis. In middle aged women in the UK, an estimated 17% of incident or fatal liver cirrhosis is attributable to excess body weight. This compares with an estimated 42% attributable to alcohol.	[Balkwill, Angela; Reeves, Gillian; Beral, Valerie; Million Women Study Collaborators] Univ Oxford, Canc Epidemiol Unit, Oxford OX3 7LF, England	University of Oxford		Bette.Liu@ceu.ox.ac.uk		Liu, Bette/0000-0002-0787-5825; Balkwill, Angela/0000-0002-6327-6245	Cancer Research UK; NHS; Medical Research Council; Medical Research Council [G9900923, G0700474] Funding Source: researchfish; MRC [G9900923, G0700474] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); NHS; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by Cancer Research UK, the NHS Breast Screening Programme, and the Medical Research Council. The funders did not participate in the study design and conduct or in the collection, management, analysis, and interpretation of the data, nor did they have any input into the preparation, review, or approval of this manuscript. Competing interests: None declared.	Ali F, 2007, GUT, V56, P1, DOI 10.1136/gut.2006.117598; Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Ioannou GN, 2005, CLIN GASTROENTEROL H, V3, P67, DOI 10.1016/S1542-3565(04)00442-2; Kendall R.A., 1993, CONTEMP MUSIC REV, V9, P51, DOI DOI 10.1080/07494469300640341; KLATSKY AL, 1992, AM J EPIDEMIOL, V136, P1248, DOI 10.1093/oxfordjournals.aje.a116433; Leon DA, 2006, LANCET, V367, P52, DOI 10.1016/S0140-6736(06)67924-5; Liu B, 2009, AM J EPIDEMIOL, V169, P153, DOI 10.1093/aje/kwn280; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; National Centre for Social Research, 2004, HLTH SURV ENGL 2003; *OFF NAT STAT, 2003, NAT DIET NUTR SURV A, V2; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Townsend PP., 1988, HLTH DEPRIVATION INE; Westhoff CL, 1996, CONTRACEPTION, V54, P1, DOI 10.1016/0010-7824(96)00111-4; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; 2006, HOSP EPISODE STAT HO	19	127	128	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2010	340								c912	10.1136/bmj.c912	http://dx.doi.org/10.1136/bmj.c912			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570FE	20223875	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000275656900015
J	Smith, R				Smith, Richard			Libel laws and scientific debate An old battle: England's libel laws versus scientific debate	BRITISH MEDICAL JOURNAL			English	Editorial Material												richardswsmith@yahoo.co.uk						*BMJ, R WILL AP; DYER C, 1989, BRIT MED J, V299, P1418; DYER C, 1996, BRIT MED J, V313, pA897; SMITH R, 1989, BRIT MED J, V298, P1125, DOI 10.1136/bmj.298.6681.1125; Smith R., 2006, TROUBLE MED J; Wilmshurst P, 2002, BRIT MED J, V325, P1232, DOI 10.1136/bmj.325.7374.1232; WISE CC, 1969, BRIT MED J, V2, P540, DOI 10.1136/bmj.2.5656.540; 1972, BMJ, V3, P245; 1972, BMJ, V3, P122; 1972, BMJ, V4, P372; 1972, BMJ, V4, P308; 1972, BMJ, V3, P300; 1972, BMJ, V4, P313; 1972, BMJ, V3, P360; 1969, BMJ, V2, P525; 1972, BMJ, V3, P184; 1972, BMJ, V3, P423; 1970, BMJ, V1, P509; 1972, BMJ, V4, P373; 1972, BMJ, V3, P60; 1972, BMJ, V2, P774; 1972, BMJ, V4, P246	22	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2010	340								c1227	10.1136/bmj.c1227	http://dx.doi.org/10.1136/bmj.c1227			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570FD	20219790				2022-12-28	WOS:000275656800003
J	Fritz-Laylin, LK; Prochnik, SE; Ginger, ML; Dacks, JB; Carpenter, ML; Field, MC; Kuo, A; Paredez, A; Chapman, J; Pham, J; Shu, SQ; Neupane, R; Cipriano, M; Mancuso, J; Tu, H; Salamov, A; Lindquist, E; Shapiro, H; Lucas, S; Grigoriev, IV; Cande, WZ; Fulton, C; Rokhsar, DS; Dawson, SC				Fritz-Laylin, Lillian K.; Prochnik, Simon E.; Ginger, Michael L.; Dacks, Joel B.; Carpenter, Meredith L.; Field, Mark C.; Kuo, Alan; Paredez, Alex; Chapman, Jarrod; Pham, Jonathan; Shu, Shengqiang; Neupane, Rochak; Cipriano, Michael; Mancuso, Joel; Tu, Hank; Salamov, Asaf; Lindquist, Erika; Shapiro, Harris; Lucas, Susan; Grigoriev, Igor V.; Cande, W. Zacheus; Fulton, Chandler; Rokhsar, Daniel S.; Dawson, Scott C.			The Genome of Naegleria gruberi Illuminates Early Eukaryotic Versatility	CELL			English	Article							FATTY-ACID SYNTHESIS; GENE-EXPRESSION; CELL; HYDROGENASE; TRICHOMONAS; EVOLUTION; GIARDIA; ORIGIN; PROTEINS; REVEALS	Genome sequences of diverse free-living protists are essential for understanding eukaryotic evolution and molecular and cell biology. The free-living amoebo-flagellate Naegleria gruberi belongs to a varied and ubiquitous protist clade (Heterolobosea) that diverged from other eukaryotic lineages over a billion years ago. Analysis of the 15,727 protein-coding genes encoded by Naegleria's 41 Mb nuclear genome indicates a capacity for both aerobic respiration and anaerobic metabolism with concomitant hydrogen production, with fundamental implications for the evolution of organelle metabolism. The Naegleria genome facilitates substantially broader phylogenomic comparisons of free-living eukaryotes than previously possible, allowing us to identify thousands of genes likely present in the pan-eukaryotic ancestor, with 40% likely eukaryotic inventions. Moreover, we construct a comprehensive catalog of amoeboid-motility genes. The Naegleria genome, analyzed in the context of other protists, reveals a remarkably complex ancestral eukaryote with a rich repertoire of cytoskeletal, sexual, signaling, and metabolic modules.	[Fritz-Laylin, Lillian K.; Carpenter, Meredith L.; Paredez, Alex; Cande, W. Zacheus; Rokhsar, Daniel S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Neupane, Rochak] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Prochnik, Simon E.; Kuo, Alan; Chapman, Jarrod; Shu, Shengqiang; Tu, Hank; Salamov, Asaf; Lindquist, Erika; Shapiro, Harris; Lucas, Susan; Grigoriev, Igor V.; Rokhsar, Daniel S.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Ginger, Michael L.] Univ Lancaster, Div Biomed & Life Sci, Sch Hlth & Med, Lancaster LA1 4YQ, England; [Dacks, Joel B.] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada; [Dacks, Joel B.; Field, Mark C.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QT, England; [Pham, Jonathan; Cipriano, Michael; Dawson, Scott C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Mancuso, Joel] Gatan Inc, Pleasanton, CA 94588 USA; [Fulton, Chandler] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Lancaster University; University of Alberta; University of Cambridge; University of California System; University of California Davis; Brandeis University	Rokhsar, DS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 545 Life Sci Addit, Berkeley, CA 94720 USA.	dsrokhsar@gmail.com; scdawson@ucdavis.edu	Dacks, Joel/AAE-3308-2021; Field, Mark/AAD-6455-2021; Carpenter, Meredith/B-4290-2011; Paredez, Alexander R/B-9799-2009; Paredez, Alexander/E-7171-2014	Dacks, Joel/0000-0003-4520-5694; Paredez, Alexander R/0000-0002-9298-3264; Paredez, Alexander/0000-0002-9298-3264; Cipriano, Michael/0000-0001-8163-8812; Ginger, Michael/0000-0002-9643-8482; Rokhsar, Daniel/0000-0002-8704-2224; Fritz-Laylin, Lillian/0000-0002-9237-9403; Carpenter, Meredith/0000-0002-9798-9374; Field, Mark/0000-0002-4866-2885; Dawson, Scott/0000-0002-0843-1759; Grigoriev, Igor/0000-0002-3136-8903; Shu, Shengqiang/0000-0002-4336-8994	University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Los Alamos National Laboratory [DE-AC02-06NA25396]; Royal Society University; Wellcome Trust; U. of Alberta	University of California, Lawrence Berkeley National Laboratory(University of California System); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); Royal Society University(Royal Society of London); Wellcome Trust(Wellcome Trust); U. of Alberta	We thank Woodrow Fischer, Matt Welch, Dyche Mullins, David Drubin, and Anosha Siripala for discussions; Jeremy Thorner, Nicole King, Jason Stajich, Elaine Lai, and Stephen Remillard for comments on the manuscript; Zoe Assaf for manuscript editing. This work was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program and by the University of California, Lawrence Berkeley National Laboratory under contract No. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under Contract No. DE-AC52-07NA27344, and Los Alamos National Laboratory under contract No. DE-AC02-06NA25396. Additional support was provided by a Royal Society University Research Fellowship to M.L.G., a Tien Scholars Fellowship in Environmental Sciences and Biodiversity to L.K.F.-L., a Wellcome Trust and Parke-Davis Fellowship, as well as start-up funding from the U. of Alberta, to J.B.D., and funding by Wellcome Trust for M.C.F.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Archibald JM, 2002, MOL BIOL EVOL, V19, P422, DOI 10.1093/oxfordjournals.molbev.a004097; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Atteia A, 2006, J BIOL CHEM, V281, P9909, DOI 10.1074/jbc.M507862200; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Boxma B, 2005, NATURE, V434, P74, DOI 10.1038/nature03343; Boxma B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-230; Brinkmann H, 2007, ADV EXP MED BIOL, V607, P20; Burki F, 2008, BIOL LETTERS, V4, P366, DOI 10.1098/rsbl.2008.0224; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; CLARK CG, 1987, MOL CELL BIOL, V7, P3027, DOI 10.1128/MCB.7.9.3027; Dacks JB, 2003, P ROY SOC B-BIOL SCI, V270, pS168, DOI 10.1098/rsbl.2003.0058; Dacks JB, 2007, J CELL SCI, V120, P2977, DOI 10.1242/jcs.013250; De Jonckheere JF, 2002, ACTA PROTOZOOL, V41, P309; DINGLE AD, 1966, J CELL BIOL, V31, P43, DOI 10.1083/jcb.31.1.43; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Embley TM, 2006, PHILOS T R SOC B, V361, P1055, DOI 10.1098/rstb.2006.1844; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; FRANKE J, 1977, P NATL ACAD SCI USA, V74, P2157, DOI 10.1073/pnas.74.5.2157; FULTON C, 1993, J EUKARYOT MICROBIOL, V40, P520, DOI 10.1111/j.1550-7408.1993.tb04945.x; Fulton C., 1970, Methods Cell Physiol., V4, P341; FULTON C, 1974, EXP CELL RES, V88, P365, DOI 10.1016/0014-4827(74)90253-5; FULTON C, 1984, P NATL ACAD SCI-BIOL, V81, P2406, DOI 10.1073/pnas.81.8.2406; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; Hartman H, 2002, P NATL ACAD SCI USA, V99, P1420, DOI 10.1073/pnas.032658599; Hug LA, 2010, MOL BIOL EVOL, V27, P311, DOI 10.1093/molbev/msp237; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Iyer LM, 2008, INT J PARASITOL, V38, P1, DOI 10.1016/j.ijpara.2007.07.018; JANDAK J, 1990, BIOCHIM BIOPHYS ACTA, V1029, P117, DOI 10.1016/0005-2736(90)90444-S; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kurland CG, 2006, SCIENCE, V312, P1011, DOI 10.1126/science.1121674; Lee SH, 2007, NAT REV MICROBIOL, V5, P287, DOI 10.1038/nrmicro1617; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Linardopoulou EV, 2007, PLOS GENET, V3, P2477, DOI 10.1371/journal.pgen.0030237; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; MARALIKOVA B, 2009, CELL MICROBIOL; Maruyama S, 2007, J EUKARYOT MICROBIOL, V54, P333, DOI 10.1111/j.1550-7408.2007.00273.x; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Mus F, 2007, J BIOL CHEM, V282, P25475, DOI 10.1074/jbc.M701415200; NORDBORG M, 2003, HDB STAT GENETICS; Ntefidou M, 2003, PLANT PHYSIOL, V133, P1517, DOI 10.1104/pp.103.034223; Peitsch WK, 2006, EXP CELL RES, V312, P2605, DOI 10.1016/j.yexcr.2006.04.017; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Putz S, 2006, EUKARYOT CELL, V5, P579, DOI 10.1128/EC.5.3.579-586.2006; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; ROBINSON BS, 1992, J PROTOZOOL, V39, P702, DOI 10.1111/j.1550-7408.1992.tb04452.x; Rodriguez-Ezpeleta N, 2007, CURR BIOL, V17, P1420, DOI 10.1016/j.cub.2007.07.036; Sanchez LB, 2000, J BIOL CHEM, V275, P5794, DOI 10.1074/jbc.275.8.5794; Shu CJ, 2003, TRENDS BIOCHEM SCI, V28, P121, DOI 10.1016/S0968-0004(03)00032-X; SIMPSON GG, 1949, MEANING EVOLUTION ST; Slamovits CH, 2006, EUKARYOT CELL, V5, P148, DOI 10.1128/EC.5.1.148-154.2006; Slamovits CH, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-34; Song M, 2008, NEUROSCIENCE, V152, P670, DOI 10.1016/j.neuroscience.2007.10.068; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; Stechmann A, 2008, CURR BIOL, V18, P580, DOI 10.1016/j.cub.2008.03.037; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; TIBAYRENC M, 1990, P NATL ACAD SCI USA, V87, P2414, DOI 10.1073/pnas.87.7.2414; Toret CP, 2006, J CELL SCI, V119, P4585, DOI 10.1242/jcs.03251; van Grinsven KWA, 2008, J BIOL CHEM, V283, P1411, DOI 10.1074/jbc.M702528200; Visvesvara GS, 2007, FEMS IMMUNOL MED MIC, V50, P1, DOI 10.1111/j.1574-695X.2007.00232.x; Yoon HS, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-14	74	323	331	1	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					631	642		10.1016/j.cell.2010.01.032	http://dx.doi.org/10.1016/j.cell.2010.01.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211133	Green Submitted, Bronze			2022-12-28	WOS:000275197400013
J	Tobin, DM; Vary, JC; Ray, JP; Walsh, GS; Dunstan, SJ; Bang, ND; Hagge, DA; Khadge, S; King, MC; Hawn, TR; Moens, CB; Ramakrishnan, L				Tobin, David M.; Vary, Jay C., Jr.; Ray, John P.; Walsh, Gregory S.; Dunstan, Sarah J.; Bang, Nguyen D.; Hagge, Deanna A.; Khadge, Saraswoti; King, Mary-Claire; Hawn, Thomas R.; Moens, Cecilia B.; Ramakrishnan, Lalita			The lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and Humans	CELL			English	Article							NECROSIS-FACTOR-ALPHA; TUBERCULOUS MENINGITIS; MARINUM INFECTION; MACROPHAGE DEATH; LIPID MEDIATORS; INNATE IMMUNITY; IN-VIVO; LEUKOTRIENE; INDUCTION; GRANULOMA	Exposure to Mycobacterium tuberculosis produces varied early outcomes, ranging from resistance to infection to progressive disease. Here we report results from a forward genetic screen in zebrafish larvae that identify multiple mutant classes with distinct patterns of innate susceptibility to Mycobacterium marinum. A hypersusceptible mutant maps to the lta4h locus encoding leukotriene A(4) hydrolase, which catalyzes the final step in the synthesis of leukotriene B-4 (LTB4), a potent chemoattractant and proinflammatory eicosanoid. lta4h mutations confer hypersusceptibility independent of LTB4 reduction, by redirecting eicosanoid substrates to anti-inflammatory lipoxins. The resultant anti-inflammatory state permits increased mycobacterial proliferation by limiting production of tumor necrosis factor. In humans, we find that protection from both tuberculosis and multibacillary leprosy is associated with heterozygosity for LTA4H polymorphisms that have previously been correlated with differential LTB4 production. Our results suggest conserved roles for balanced eicosanoid production in vertebrate resistance to mycobacterial infection.	[Tobin, David M.; Ray, John P.; Ramakrishnan, Lalita] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Vary, Jay C., Jr.; King, Mary-Claire; Hawn, Thomas R.; Ramakrishnan, Lalita] Univ Washington, Dept Med, Seattle, WA 98195 USA; [King, Mary-Claire] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Walsh, Gregory S.; Moens, Cecilia B.] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA; [Walsh, Gregory S.; Moens, Cecilia B.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Dunstan, Sarah J.] Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam; [Dunstan, Sarah J.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 7LJ, England; [Bang, Nguyen D.] Pham Ngoc Thach Hosp TB & Lung Dis, Ho Chi Minh City, Vietnam; [Hagge, Deanna A.; Khadge, Saraswoti] Anandaban Hosp, Mycobacterial Res Lab, Kathmandu, Nepal	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; Fred Hutchinson Cancer Center; University of Oxford; University of Oxford	Ramakrishnan, L (corresponding author), Univ Washington, Dept Microbiol, Box 357242, Seattle, WA 98195 USA.	lalitar@uw.edu	Ray, John/F-3187-2015; Moens, Cecilia/AAN-1536-2020; Dunstan, Sarah/AAO-9597-2020	Ray, John/0000-0001-7294-4260; King, Mary-Claire/0000-0001-9426-1743; Vary, James/0000-0001-5390-5426; Dunstan, Sarah/0000-0001-7873-933X; Hagge, Deanna A./0000-0002-3792-2266; Tobin, David/0000-0003-3465-5518; Ramakrishnan, Lalita/0000-0003-0692-5533; Moens, Cecilia/0000-0002-1099-0728	Burroughs Wellcome Fund; Akibene Foundation; Keck Foundation; National Institutes of Health; American Cancer Society Postdoctoral Fellowship; National Institutes of Health Bacterial Pathogenesis Training; Odland Endowment of the University of Washington; American Skin Association; Human Frontiers Science Program; Dana Foundation; Heiser Program for Research in Tuberculosis and Leprosy; Wellcome Trust of Great Britain; Leprosy Mission International; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054503] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Akibene Foundation; Keck Foundation(W.M. Keck Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Postdoctoral Fellowship(American Cancer Society); National Institutes of Health Bacterial Pathogenesis Training; Odland Endowment of the University of Washington; American Skin Association; Human Frontiers Science Program(Human Frontier Science Program); Dana Foundation; Heiser Program for Research in Tuberculosis and Leprosy; Wellcome Trust of Great Britain(Wellcome Trust); Leprosy Mission International; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Payan for suggesting the zebrafish; J. Bennett and C.B. Wilson for encouragement and help in obtaining zebrafish facilities; C.N. Serhan for advice on eicosanoids; K. Winglee for developing FPC analysis; A. Carmany- Rampey, P. Grant, and C. Miller for setting up early pressure screens; R. Kim and D. Beery for assistance with microinjections; J. Cameron and L. Swaim for fish husbandry; H. Clay for the tnf/fms image; and A. Huttenlocher for the mpo antibody. For the human studies, we gratefully acknowledge all participants and the clinical staff of the Hospital of Tropical Diseases (particularly T.T.H. Chau and G. Thwaites), Pham Ngoc Thach Hospital for Tuberculosis and Lung Disease (particularly N.H. Dung, N.T.B. Yen and N.T.N. Lan), and Hung Vuong Obstetric Hospital (N.T. Hieu) for facilitating the patient sample collection, M. Janer and S. Li for DNA genotyping, and M. K. Lee for statistical advice. This work was supported by the Burroughs Wellcome Fund (L.R. and T.R.H.), the Akibene Foundation and the Keck Foundation (L.R.), the National Institutes of Health (L.R. and M.C.K.), an American Cancer Society Postdoctoral Fellowship and National Institutes of Health Bacterial Pathogenesis Training Grant (D.M.T.), the Odland Endowment of the University of Washington, Dermatology Foundation Dermatologist Investigator Research Fellowship, National Institutes of Health National Research Service Award, and the American Skin Association (J.C.V.), the Human Frontiers Science Program (G.S.W.), the Dana Foundation (T.R.H. and S.J.D.), the Heiser Program for Research in Tuberculosis and Leprosy (T.R.H.), the Wellcome Trust of Great Britain (S.J.D.) and the Leprosy Mission International (D.A.H.). C.B.M. is an investigator with the Howard Hughes Medical Institute. M.C.K. is an American Cancer Society Professor.	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Alter A, 2008, HUM GENET, V123, P227, DOI 10.1007/s00439-008-0474-z; Bafica A, 2005, J CLIN INVEST, V115, P1601, DOI 10.1172/JCI23949; Bahary N, 2004, METHOD CELL BIOL, V77, P305; Beattie CE, 1999, METHODS CELL BIOL, V60, P71; Bekker LG, 2000, INFECT IMMUN, V68, P6954, DOI 10.1128/IAI.68.12.6954-6961.2000; Blackmore TK, 2008, CLIN INFECT DIS, V47, pE83, DOI 10.1086/592695; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Cobat A, 2009, J EXP MED, V206, P2583, DOI 10.1084/jem.20090892; Cosma C. L., 2006, CURRENT PROTOCOLS MI, DOI 10.1002/; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; ElAhmady O, 1997, ANN CLIN BIOCHEM, V34, P160, DOI 10.1177/000456329703400205; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Fortin A, 2007, ANNU REV GENOM HUM G, V8, P163, DOI 10.1146/annurev.genom.8.080706.092315; GOLDMAN G, 1993, SURGERY, V113, P297; Haeggstrom JZ, 2004, J BIOL CHEM, V279, P50639, DOI 10.1074/jbc.R400027200; Hardwick C, 2006, SEX TRANSM INFECT, V82, P513, DOI 10.1136/sti.2005.017863; Hawn TR, 2006, J INFECT DIS, V194, P1127, DOI 10.1086/507907; Helgadottir A, 2006, NAT GENET, V38, P68, DOI 10.1038/ng1692; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; JOHNSON SL, 1995, GENETICS, V139, P1727; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; KOCH R, 1882, AETIOLOGY TUBERCULOS; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; MIDDLEBROOK G, 1947, J EXP MED, V86, P175, DOI 10.1084/jem.86.2.175; Misch EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000231; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; ORNING L, 1991, J BIOL CHEM, V266, P1375; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Paul-Clark MJ, 2004, J EXP MED, V200, P69, DOI 10.1084/jem.20040566; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; PETTITT TR, 1991, J BIOL CHEM, V266, P8720; Rao NL, 2007, J PHARMACOL EXP THER, V321, P1154, DOI 10.1124/jpet.106.115436; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Scollard DM, 2006, CLIN MICROBIOL REV, V19, P338, DOI 10.1128/CMR.19.2.338-381.2006; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Steyn AJC, 2002, P NATL ACAD SCI USA, V99, P3147, DOI 10.1073/pnas.052705399; Swaim LE, 2006, INFECT IMMUN, V74, P6108, DOI 10.1128/IAI.00887-06; Thwaites G, 2000, J NEUROL NEUROSUR PS, V68, P289, DOI 10.1136/jnnp.68.3.289; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509	50	375	383	3	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					717	730		10.1016/j.cell.2010.02.013	http://dx.doi.org/10.1016/j.cell.2010.02.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211140	Green Accepted, Bronze			2022-12-28	WOS:000275197400020
J	Slakey, F; Cohen, LR				Slakey, Francis; Cohen, Linda R.			Stop laser uranium enrichment	NATURE			English	Editorial Material									[Slakey, Francis] Georgetown Univ, Washington, DC 20057 USA; [Cohen, Linda R.] Univ Calif Irvine, Irvine, CA 92697 USA	Georgetown University; University of California System; University of California Irvine	Slakey, F (corresponding author), Georgetown Univ, Washington, DC 20057 USA.	slakeyf@georgetown.edu							0	6	6	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 4	2010	464	7285					32	33		10.1038/464032a	http://dx.doi.org/10.1038/464032a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20203589				2022-12-28	WOS:000275117500020
J	Webster, MWI; Ormiston, JA				Webster, Mark W. I.; Ormiston, John A.			Sorting out drug-eluting stents	LANCET			English	Editorial Material							CORONARY LESIONS; TRIAL		[Webster, Mark W. I.; Ormiston, John A.] Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland 1030, New Zealand	Auckland City Hospital	Webster, MWI (corresponding author), Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland 1030, New Zealand.	mwebster@adhb.govt.nz						Camenzind E, 2009, AM HEART J, V158, P902, DOI 10.1016/j.ahj.2009.10.002; Cook S, 2007, CIRCULATION, V115, P2426, DOI 10.1161/CIRCULATIONAHA.106.658237; Cook S, 2009, CIRCULATION, V120, P391, DOI 10.1161/CIRCULATIONAHA.109.854398; Galloe AM, 2008, JAMA-J AM MED ASSOC, V299, P409, DOI 10.1001/jama.299.4.409; Kandzari DE, 2006, J AM COLL CARDIOL, V48, P2440, DOI 10.1016/j.jacc.2006.08.035; Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9; Lee SW, 2008, J AM COLL CARDIOL, V52, P727, DOI 10.1016/j.jacc.2008.04.056; Leon MB, 2009, JACC-CARDIOVASC INTE, V2, P1208, DOI 10.1016/j.jcin.2009.10.008; Leon MB, 2010, J AM COLL CARDIOL, V55, P543, DOI 10.1016/j.jacc.2009.08.067; Meredith IT, 2009, JACC-CARDIOVASC INTE, V2, P977, DOI 10.1016/j.jcin.2009.07.007; Morice MC, 2006, JAMA-J AM MED ASSOC, V295, P895, DOI 10.1001/jama.295.8.895; PARK SJ, 2009, C AM COLL CARD ORL F; Rasmussen K, 2010, LANCET, V375, P1090, DOI 10.1016/S0140-6736(10)60208-5; Schomig A, 2007, J AM COLL CARDIOL, V50, P1373, DOI 10.1016/j.jacc.2007.06.047	14	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2010	375	9720					1060	1062		10.1016/S0140-6736(10)60402-3	http://dx.doi.org/10.1016/S0140-6736(10)60402-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578ZB	20231035				2022-12-28	WOS:000276334600007
J	Wollert, T; Hurley, JH				Wollert, Thomas; Hurley, James H.			Molecular mechanism of multivesicular body biogenesis by ESCRT complexes	NATURE			English	Article							UBIQUITIN-BINDING DOMAINS; ENDOSOME-ASSOCIATED COMPLEX; III COMPLEX; IN-VITRO; MACHINERY; PROTEINS; ALIX; COMPARTMENT; CLATHRIN; BODIES	When internalized receptors and other cargo are destined for lysosomal degradation, they are ubiquitinated and sorted by the endosomal sorting complex required for transport (ESCRT) complexes 0, I, II and III into multivesicular bodies. Multivesicular bodies are formed when cargo-rich patches of the limiting membrane of endosomes bud inwards by an unknown mechanism and are then cleaved to yield cargo-bearing intralumenal vesicles. The biogenesis of multivesicular bodies was reconstituted and visualized using giant unilamellar vesicles, fluorescent ESCRT-0, -I, -II and -III complexes, and a membrane-tethered fluorescent ubiquitin fusion as a model cargo. Here we show that ESCRT-0 forms domains of clustered cargo but does not deform membranes. ESCRT-I and ESCRT-II in combination deform the membrane into buds, in which cargo is confined. ESCRT-I and ESCRT-II localize to the bud necks, and recruit ESCRT-0-ubiquitin domains to the buds. ESCRT-III subunits localize to the bud neck and efficiently cleave the buds to form intralumenal vesicles. Intralumenal vesicles produced in this reaction contain the model cargo but are devoid of ESCRTs. The observations explain how the ESCRTs direct membrane budding and scission from the cytoplasmic side of the bud without being consumed in the reaction.	[Wollert, Thomas; Hurley, James H.] NIDDK, Mol Biol Lab, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hurley, JH (corresponding author), NIDDK, Mol Biol Lab, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	hurley@helix.nih.gov		Wollert, Thomas/0000-0001-9732-4789	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; Intramural AIDS Targeted Antiviral Program; EMBO; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036126, ZIADK036123, ZIADK036125] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural AIDS Targeted Antiviral Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank E. Boura for producing the CFP-Ub and GFP-Ub, J. Lippincott-Schwartz for microscope access, B. Wendland for a yeast strain and advice, and W. Prinz for comments on the manuscript. This work was funded by the Intramural Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases and Intramural AIDS Targeted Antiviral Program to J. H. H. and an EMBO long-term fellowship to T. W.	Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Bilodeau PS, 2003, J CELL BIOL, V163, P237, DOI 10.1083/jcb.200305007; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Doyotte A, 2005, J CELL SCI, V118, P3003, DOI 10.1242/jcs.02421; Falguieres T, 2008, MOL BIOL CELL, V19, P4942, DOI 10.1091/mbc.E08-03-0239; Fujii K, 2007, NAT REV MICROBIOL, V5, P912, DOI 10.1038/nrmicro1790; Gill DJ, 2007, EMBO J, V26, P600, DOI 10.1038/sj.emboj.7601501; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; HAIGLER HT, 1979, J CELL BIOL, V81, P382, DOI 10.1083/jcb.81.2.382; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hanson PI, 2009, CURR OPIN CELL BIOL, V21, P568, DOI 10.1016/j.ceb.2009.06.002; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Im YJ, 2009, DEV CELL, V17, P234, DOI 10.1016/j.devcel.2009.07.008; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Kostelansky MS, 2007, CELL, V129, P485, DOI 10.1016/j.cell.2007.03.016; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Lenz M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.038101; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Murk JLAN, 2003, P NATL ACAD SCI USA, V100, P13332, DOI 10.1073/pnas.2232379100; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Pires R, 2009, STRUCTURE, V17, P843, DOI 10.1016/j.str.2009.04.007; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Ren XF, 2010, EMBO J, V29, P1045, DOI 10.1038/emboj.2010.6; Rieder SE, 1996, MOL BIOL CELL, V7, P985, DOI 10.1091/mbc.7.6.985; Sachse M, 2002, MOL BIOL CELL, V13, P1313, DOI 10.1091/mbc.01-10-0525; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Samson RY, 2009, TRENDS MICROBIOL, V17, P507, DOI 10.1016/j.tim.2009.08.003; Shields SB, 2009, J CELL BIOL, V185, P213, DOI 10.1083/jcb.200811130; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Tran JH, 2009, P NATL ACAD SCI USA, V106, P17395, DOI 10.1073/pnas.0909473106; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836	52	496	510	2	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					864	U73		10.1038/nature08849	http://dx.doi.org/10.1038/nature08849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20305637	Green Accepted			2022-12-28	WOS:000276397300031
J	Dalrymple, T				Dalrymple, Theodore			Between the Lines An author spurned	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 29	2010	340								c1759	10.1136/bmj.c1759	http://dx.doi.org/10.1136/bmj.c1759			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	579VI	20351081				2022-12-28	WOS:000276404000006
J	Asherson, P; Adamou, M; Bolea, B; Muller, U; Morua, SD; Pitts, M; Thome, J; Young, S				Asherson, Philip; Adamou, Marios; Bolea, Blanca; Muller, Ulrich; Morua, Susan Dunn; Pitts, Mark; Thome, Johannes; Young, Susan			Is ADHD a valid diagnosis in adults? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DEFICIT HYPERACTIVITY DISORDER; GENETIC INFLUENCES; METAANALYSIS; TWIN; METHYLPHENIDATE; COMORBIDITY; ASSOCIATION; BEHAVIORS; CHILD		[Asherson, Philip] Kings Coll London, Inst Psychiat, MRC Social Genet & Dev Psychiat, London SE5 8AF, England; [Bolea, Blanca] Univ Bristol, Bristol Adult ADHD Clin, Avon & Wiltshire Partnership Mental Hlth Trust, Bristol BS2 8HW, Avon, England; [Muller, Ulrich] Univ Cambridge, Addenbrookes Hosp, Cambridgeshire & Peterborough NHS Fdn Trust, Adult ADHD Res Clin,Dept Psychiat, Cambridge CB2 2QQ, England; [Morua, Susan Dunn] Adult Attent Deficit Disorder UK AADD UK, London SW15 6NP, England; [Morua, Susan Dunn] Adult Attent Deficit Disorder UK AADD UK, Bristol BS40 7RT, Avon, England; [Pitts, Mark] Maudsley Hosp & Inst Psychiat, S London & Maudsley NHS Fdn Trust, Adult ADHD Serv, London SE5 8AZ, England; [Thome, Johannes] Univ Coll Swansea, Swansea Med Sch, Swansea SA2 0GH, W Glam, Wales; [Young, Susan] Kings Coll London, Inst Psychiat, Dept Forens Mental Hlth Sci, London SE5 8AF, England	University of London; King's College London; University of Bristol; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; South London & Maudsley NHS Trust; University of London; King's College London; Swansea University; University of London; King's College London	Asherson, P (corresponding author), Kings Coll London, Inst Psychiat, MRC Social Genet & Dev Psychiat, London SE5 8AF, England.	philip.asherson@kcl.ac.uk		Asherson, Philip/0000-0003-2667-2254; Young, Susan/0000-0002-8494-6949	Medical Research Council [G0400061] Funding Source: Medline; Department of Health [RP-PG-0606-1045] Funding Source: Medline; MRC [G0400061] Funding Source: UKRI; National Institute for Health Research [RP-PG-0606-1045] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Chen W, 2008, AM J MED GENET B, V147B, P1450, DOI 10.1002/ajmg.b.30672; CUBILLO A, J PSYCHIAT IN PRESS; Das Banerjee T, 2007, ACTA PAEDIATR, V96, P1269, DOI 10.1111/j.1651-2227.2007.00430.x; Faraone SV, 2006, PSYCHOL MED, V36, P159, DOI 10.1017/S003329170500471X; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; FEIGHNER JP, 1972, ARCH GEN PSYCHIAT, V26, P57, DOI 10.1001/archpsyc.1972.01750190059011; Ford T, 2003, J AM ACAD CHILD PSY, V42, P1203, DOI 10.1097/00004583-200310000-00011; Koesters M, 2009, J PSYCHOPHARMACOL, V23, P733, DOI 10.1177/0269881108092338; Kuntsi J, 2005, BIOL PSYCHIAT, V57, P647, DOI 10.1016/j.biopsych.2004.12.032; Larriviere D, 2009, NEUROLOGY, V73, P1406, DOI 10.1212/WNL.0b013e3181beecfe; Larsson H, 2006, J AM ACAD CHILD PSY, V45, P973, DOI 10.1097/01.chi.0000222787.57100.d8; Li DW, 2006, HUM MOL GENET, V15, P2276, DOI 10.1093/hmg/ddl152; Meszaros A, 2009, INT J NEUROPSYCHOPH, V12, P1137, DOI 10.1017/S1461145709990198; National Institute for Health and Clinical Excellence, 2008, ATT DEF HYP DIS DIAG; Paloyelis Yannis, 2007, Expert Rev Neurother, V7, P1337, DOI 10.1586/14737175.7.10.1337; Rosler M, 2009, EUR ARCH PSY CLIN N, V259, P120, DOI 10.1007/s00406-008-0845-4; Ronald A, 2008, J CHILD PSYCHOL PSYC, V49, P535, DOI 10.1111/j.1469-7610.2007.01857.x; Rubia K, 2005, AM J PSYCHIAT, V162, P1067, DOI 10.1176/appi.ajp.162.6.1067; Seidman LJ, 2005, BIOL PSYCHIAT, V57, P1263, DOI 10.1016/j.biopsych.2004.11.019; Stevens SE, 2008, J ABNORM CHILD PSYCH, V36, P385, DOI 10.1007/s10802-007-9185-5; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; Thapar A, 2001, BRIT J PSYCHIAT, V179, P224, DOI 10.1192/bjp.179.3.224; Thapar A, 2007, BRIT J PSYCHIAT, V190, P1, DOI 10.1192/bjp.bp.106.027003; Volkow ND, 2009, JAMA-J AM MED ASSOC, V302, P1084, DOI 10.1001/jama.2009.1308; Willcutt EG, 2007, AM J MED GENET B, V144B, P709, DOI 10.1002/ajmg.b.30310; YOUNG S, J CHILD PSY IN PRESS	26	31	32	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2010	340								c549	10.1136/bmj.c549	http://dx.doi.org/10.1136/bmj.c549			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	576PR	20348184				2022-12-28	WOS:000276157900013
J	Mannhart, J; Schlom, DG				Mannhart, J.; Schlom, D. G.			Oxide Interfaces-An Opportunity for Electronics	SCIENCE			English	Review							SUPERCONDUCTIVITY; GAS	Extraordinary electron systems can be generated at well-defined interfaces between complex oxides. In recent years, progress has been achieved in exploring and making use of the fundamental properties of such interfaces, and it has become clear that these electron systems offer the potential for possible future devices. We trace the state of the art of this emerging field of electronics and discuss some of the challenges and pitfalls that may lie ahead.	[Mannhart, J.] Univ Augsburg, Ctr Elect Correlat & Magnetism, D-86135 Augsburg, Germany; [Schlom, D. G.] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA	University of Augsburg; Cornell University	Mannhart, J (corresponding author), Univ Augsburg, Ctr Elect Correlat & Magnetism, D-86135 Augsburg, Germany.	jochen.mannhart@physik.uni-augsburg.de; schlom@cornell.edu	Schlom, Darrell G/J-2412-2013	Schlom, Darrell G/0000-0003-2493-6113; Mannhart, Jochen/0000-0001-6331-2640	Deutsche Forschungsgemeinschaft [SFB 484, TRR 80]; European Community; Army Research Office [W911NF-09-1-0415]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Community(European Commission); Army Research Office	We acknowledge helpful discussions and interactions with T. Kopp, C. Bernhard, M. Breitschaft, V. Eyert, D. Grundler, G. Hammerl, A. Herrnberger, M. Kawasaki, L. Fitting Kourkoutis, R. Jany, D. A. Muller, S. Paetel, C. J. Palmstrom, C. Richter, G. Sawatzky, A. Schmehl, C. W. Schneider, A. Tsukazaki, and K. Wiedenmann. Supported by Deutsche Forschungsgemeinschaft grants SFB 484 and TRR 80, European Community [OxIDes ( Engineering Exotic Phenomena at Oxide Interfaces)], and Army Research Office grant W911NF-09-1-0415.	Basletic M, 2008, NAT MATER, V7, P621, DOI 10.1038/nmat2223; Blamire MG, 2003, APPL PHYS LETT, V82, P2670, DOI 10.1063/1.1569430; Caviglia AD, 2008, NATURE, V456, P624, DOI 10.1038/nature07576; Cen C, 2009, SCIENCE, V323, P1026, DOI 10.1126/science.1168294; Chakhalian J, 2006, NAT PHYS, V2, P244, DOI 10.1038/nphys272; Chaloupka J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.016404; DIJKKAMP D, 1987, APPL PHYS LETT, V51, P619, DOI 10.1063/1.98366; Fix T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.166802; Freericks J. K., 2006, TRANSPORT MULTILAYER; Goniakowski J, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/1/016501; Gozar A, 2008, NATURE, V455, P782, DOI 10.1038/nature07293; Herranz G, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.216803; Hesper R, 2000, PHYS REV B, V62, P16046, DOI 10.1103/PhysRevB.62.16046; HIRSCH JE, 1985, PHYS REV B, V32, P5639, DOI 10.1103/PhysRevB.32.5639; Hotta Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.236805; Huijben M, 2006, NAT MATER, V5, P556, DOI 10.1038/nmat1675; Hwang HY, 1996, PHYS REV LETT, V77, P2041, DOI 10.1103/PhysRevLett.77.2041; Kalabukhov AS, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.146101; KAWASAKI M, 1994, SCIENCE, V266, P1540, DOI 10.1126/science.266.5190.1540; Koerting V, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.104510; Koida T, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.144418; Kopp T, 2009, J APPL PHYS, V106, DOI 10.1063/1.3197246; Kroemer H, 2001, REV MOD PHYS, V73, P783, DOI 10.1103/RevModPhys.73.783; Liebsch A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.096401; Logvenov G, 2009, SCIENCE, V326, P699, DOI 10.1126/science.1178863; Mannhart J, 1997, SUPERCOND SCI TECH, V10, P880, DOI 10.1088/0953-2048/10/12/004; Mannhart J., 2005, MULTIFUNCT THIN FILM, P251; Millis A., 2005, MULTIFUNCT THIN FILM, P279; Nakagawa N, 2006, NAT MATER, V5, P204, DOI 10.1038/nmat1569; Ohta H, 2007, NAT MATER, V6, P129, DOI 10.1038/nmat1821; Ohtomo A, 2002, NATURE, V419, P378, DOI 10.1038/nature00977; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Okamoto S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.056802; Pardo V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.166803; Pentcheva R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.107602; Popovic ZS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.176805; Reyren N, 2007, SCIENCE, V317, P1196, DOI 10.1126/science.1146006; Rijnders GJHM, 1997, APPL PHYS LETT, V70, P1888, DOI 10.1063/1.118687; Ruegg A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.245118; Salluzzo M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.166804; SAWATZKY G, 2009, 16 WORKSH OX EL TARR; Schlom DG, 2008, MRS BULL, V33, P1017, DOI 10.1557/mrs2008.221; SCHLOM DG, 1988, APPL PHYS LETT, V53, P1660, DOI 10.1063/1.100443; Schneider CW, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2354422; Sing M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.176805; Thiel S, 2006, SCIENCE, V313, P1942, DOI 10.1126/science.1131091; Tsukazaki A, 2007, SCIENCE, V315, P1388, DOI 10.1126/science.1137430; Wang Y, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.165130; Wang Y, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.212408; Willmott PR, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.155502	50	1076	1086	6	651	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2010	327	5973					1607	1611		10.1126/science.1181862	http://dx.doi.org/10.1126/science.1181862			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339065				2022-12-28	WOS:000275970600033
J	Mooney, KA; Halitschke, R; Kessler, A; Agrawal, AA				Mooney, Kailen A.; Halitschke, Rayko; Kessler, Andre; Agrawal, Anurag A.			Evolutionary Trade-Offs in Plants Mediate the Strength of Trophic Cascades	SCIENCE			English	Article							HERBIVORES; METAANALYSIS; DEFENSE; PREY; PRODUCTIVITY; TERRESTRIAL; STRATEGIES; PREDATION; GROWTH	Predators determine herbivore and plant biomass via so-called trophic cascades, and the strength of such effects is influenced by ecosystem productivity. To determine whether evolutionary trade-offs among plant traits influence patterns of trophic control, we manipulated predators and soil fertility and measured impacts of a major herbivore ( the aphid Aphis nerii) on 16 milkweed species (Asclepias spp.) in a phylogenetic field experiment. Herbivore density was determined by variation in predation and trade-offs between herbivore resistance and plant growth strategy. Neither herbivore density nor predator effects on herbivores predicted the cascading effects of predators on plant biomass. Instead, cascade strength was strongly and positively associated with milkweed response to soil fertility. Accordingly, contemporary patterns of trophic control are driven by evolutionary convergent trade-offs faced by plants.	[Mooney, Kailen A.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; [Halitschke, Rayko; Kessler, Andre; Agrawal, Anurag A.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Agrawal, Anurag A.] Cornell Ctr Sustainable Future, Ithaca, NY 14853 USA	University of California System; University of California Irvine; Cornell University	Mooney, KA (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA.	mooneyk@uci.edu	Kessler, Andre/C-7810-2014; Halitschke, Rayko/AAY-2365-2020; Agrawal, Anurag A/Y-2497-2019	Halitschke, Rayko/0000-0002-1109-8782; Agrawal, Anurag A/0000-0003-0095-1220; Kessler, Andre/0000-0002-1797-7518	NSF; Cornell Center for a Sustainable Future; University of California Irvine School of Biological Sciences	NSF(National Science Foundation (NSF)); Cornell Center for a Sustainable Future; University of California Irvine School of Biological Sciences	We thank R. A. Smith and J. Goldstein for field assistance; S. Rasmann for contributing cardenolide data; M. Fishbein for providing phylogenetic information; and the University of California Berkeley Botanical Garden, S. Malcolm, A. Rapini, and M. Fishbein for providing plant material. The manuscript was improved by comments from A. Flecker, S. Rasmann, D. Raboski, and D. Gruner and supported by NSF, the Cornell Center for a Sustainable Future, and the University of California Irvine School of Biological Sciences.	Agrawal AA, 2004, AM NAT, V164, P113, DOI 10.1086/420980; Agrawal AA, 2008, P NATL ACAD SCI USA, V105, P10057, DOI 10.1073/pnas.0802368105; Borer ET, 2006, ECOLOGY, V87, P2813, DOI 10.1890/0012-9658(2006)87[2813:AICREO]2.0.CO;2; Brett MT, 1996, P NATL ACAD SCI USA, V93, P7723, DOI 10.1073/pnas.93.15.7723; CLANCY KM, 1987, ECOLOGY, V68, P733, DOI 10.2307/1938479; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Craine JM., 2009, RESOURCE STRATEGIES; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; Forkner RE, 2000, ECOLOGY, V81, P1588, DOI 10.1890/0012-9658(2000)081[1588:WGUMCD]2.0.CO;2; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Gruner DS, 2008, ECOL LETT, V11, P740, DOI 10.1111/j.1461-0248.2008.01192.x; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.1890/0012-9658(1999)080[1150:TMAORR]2.0.CO;2; Helms SE, 2004, ECOL ENTOMOL, V29, P44, DOI 10.1111/j.0307-6946.2004.00566.x; Lill JT, 2002, NATURE, V417, P170, DOI 10.1038/417170a; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Ode PJ, 2006, ANNU REV ENTOMOL, V51, P163, DOI 10.1146/annurev.ento.51.110104.151110; OKSANEN L, 1981, AM NAT, V118, P240, DOI 10.1086/283817; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; Sipura M, 1999, OECOLOGIA, V121, P537, DOI 10.1007/s004420050960; van der Stap I, 2007, ECOLOGY, V88, P2474, DOI 10.1890/07-1731.1; Vance-Chalcraft HD, 2007, ECOLOGY, V88, P2689, DOI 10.1890/06-1869.1	27	96	125	6	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	2010	327	5973					1642	1644		10.1126/science.1184814	http://dx.doi.org/10.1126/science.1184814			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339073				2022-12-28	WOS:000275970600043
J	Wang, YZ; Krivtsov, AV; Sinha, AU; North, TE; Goessling, W; Feng, ZH; Zon, LI; Armstrong, SA				Wang, Yingzi; Krivtsov, Andrei V.; Sinha, Amit U.; North, Trista E.; Goessling, Wolfram; Feng, Zhaohui; Zon, Leonard I.; Armstrong, Scott A.			The Wnt/beta-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML	SCIENCE			English	Article							ACUTE MYELOID-LEUKEMIA; BETA-CATENIN; COLON-CANCER; HEMATOPOIETIC-CELLS; SIGNALING PATHWAY; IN-VIVO; PROGENITORS; EXPRESSION; EXPANSION; RENEWAL	Leukemia stem cells (LSCs) are capable of limitless self-renewal and are responsible for the maintenance of leukemia. Because selective eradication of LSCs could offer substantial therapeutic benefit, there is interest in identifying the signaling pathways that control their development. We studied LSCs in mouse models of acute myelogenous leukemia (AML) induced either by coexpression of the Hoxa9 and Meis1a oncogenes or by the fusion oncoprotein MLL-AF9. We show that the Wnt/beta-catenin signaling pathway is required for self-renewal of LSCs that are derived from either hematopoietic stem cells (HSC) or more differentiated granulocyte-macrophage progenitors (GMP). Because the Wnt/beta-catenin pathway is normally active in HSCs but not in GMP, these results suggest that reactivation of beta-catenin signaling is required for the transformation of progenitor cells by certain oncogenes. beta-catenin is not absolutely required for self-renewal of adult HSCs; thus, targeting the Wnt/beta-catenin pathway may represent a new therapeutic opportunity in AML.	[Wang, Yingzi; Krivtsov, Andrei V.; Sinha, Amit U.; Feng, Zhaohui; Zon, Leonard I.; Armstrong, Scott A.] Harvard Univ, Childrens Hosp, Sch Med, Div Hematol Oncol, Boston, MA 02115 USA; [Sinha, Amit U.; Feng, Zhaohui; Armstrong, Scott A.] Harvard Univ, Sch Med, Dept Pediat Oncol, Boston, MA 02115 USA; [North, Trista E.] Harvard Univ, Sch Med, Beth Israel Deaconess Hosp, Dept Pathol, Boston, MA 02115 USA; [North, Trista E.; Goessling, Wolfram; Zon, Leonard I.; Armstrong, Scott A.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Goessling, Wolfram] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Goessling, Wolfram] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Zon, Leonard I.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Armstrong, SA (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Hematol Oncol, Boston, MA 02115 USA.	scott.armstrong@childrens.harvard.edu	Wang, Jenny Y./ABD-2091-2020; North, Trista/ABG-4789-2020; Krivtsov, Andrei/AAJ-9966-2021	North, Trista/0000-0003-1249-563X; Goessling, Wolfram/0000-0001-9972-1569	NIH [5P01CA66996, 5R01HL048801]; American Cancer Society [RSG-09-068-01]; Harvard Stem Cell Institute; NATIONAL CANCER INSTITUTE [P01CA066996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048801] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Harvard Stem Cell Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank D. Fisher, X. He, and H. Widlund for plasmid pcDNA3.1-beta cat-*-Flag; D. Williams for helpful discussion and advice; and M. Smith for administrative assistance. This work was supported by the NIH grants 5P01CA66996 ( to S. A. A.) and 5R01HL048801 ( to L.I.Z.), the American Cancer Society (RSG-09-068-01), and the Harvard Stem Cell Institute. S. A. A. is a Leukemia and Lymphoma Society Scholar. Microarray data was submitted to the National Center for Biotechnology Information Gene Expression Omnibus (GEO) GSE20377. L.I.Z. is a founding member of and stockholder in Fate Therapeutics, a biotechnology company that is developing stem cell therapeutics and that has acquired a patent covering the use of prostaglandin E2 in hematopoietic stem cell modulation and tissue regeneration. W. G. and T.E.N. are paid consultants for Fate Therapeutics.	Abramovich C, 2005, ANN NY ACAD SCI, V1044, P109, DOI 10.1196/annals.1349.014; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brault V, 2001, DEVELOPMENT, V128, P1253; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Eisinger AL, 2007, PROSTAG OTH LIPID M, V82, P147, DOI 10.1016/j.prostaglandins.2006.05.026; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P2890, DOI 10.1128/MCB.24.7.2890-2904.2004; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Orido T, 2008, J PHARMACOL SCI, V108, P389, DOI 10.1254/jphs.08167SC; Park CY, 2009, MOL THER, V17, P219, DOI 10.1038/mt.2008.254; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Ysebaert L, 2006, LEUKEMIA, V20, P1211, DOI 10.1038/sj.leu.2404239; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	25	551	585	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2010	327	5973					1650	1653		10.1126/science.1186624	http://dx.doi.org/10.1126/science.1186624			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339075	Green Accepted			2022-12-28	WOS:000275970600046
J	Wong, WCW; Fairley, CK				Wong, William C. W.; Fairley, Christopher K.			10-Minute Consultation Sexual health consultation for men who have sex with men	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Wong, William C. W.] Dept Gen Practice, Carlton, Vic 3053, Australia; [Fairley, Christopher K.] Alfred Hosp, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Fairley, Christopher K.] Univ Melbourne, Melbourne Sch Populat Hlth, Melbourne, Vic 3010, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne	Wong, WCW (corresponding author), Dept Gen Practice, Carlton, Vic 3053, Australia.	w.wong@unimelb.edu.au	Wong, William Chi Wai/B-3417-2011	Christopher, Fairley/0000-0001-9081-1664					0	4	4	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 22	2010	340								c958	10.1136/bmj.c958	http://dx.doi.org/10.1136/bmj.c958			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	576PN	20308182				2022-12-28	WOS:000276157500009
J	Carnall, JMA; Waudby, CA; Belenguer, AM; Stuart, MCA; Peyralans, JJP; Otto, S				Carnall, Jacqui M. A.; Waudby, Christopher A.; Belenguer, Ana M.; Stuart, Marc C. A.; Peyralans, Jerome J. -P.; Otto, Sijbren			Mechanosensitive Self-Replication Driven by Self-Organization	SCIENCE			English	Article							MECHANICAL FORCE; CONGO RED; PEPTIDE; HEXADEOXYNUCLEOTIDE; CONFORMATION; EMERGENCE; CHEMISTRY; BINDING; SYSTEM; GROWTH	Self-replicating molecules are likely to have played an important role in the origin of life, and a small number of fully synthetic self-replicators have already been described. Yet it remains an open question which factors most effectively bias the replication toward the far-from-equilibrium distributions characterizing even simple organisms. We report here two self-replicating peptide-derived macrocycles that emerge from a small dynamic combinatorial library and compete for a common feedstock. Replication is driven by nanostructure formation, resulting from the assembly of the peptides into fibers held together by beta sheets. Which of the two replicators becomes dominant is influenced by whether the sample is shaken or stirred. These results establish that mechanical forces can act as a selection pressure in the competition between replicators and can determine the outcome of a covalent synthesis.	[Stuart, Marc C. A.; Peyralans, Jerome J. -P.; Otto, Sijbren] Univ Groningen, Stratingh Inst, Ctr Syst Chem, NL-9747 AG Groningen, Netherlands; [Carnall, Jacqui M. A.; Waudby, Christopher A.; Belenguer, Ana M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Waudby, Christopher A.] UCL, Dept Struct & Mol Biol, London WC1E 6BT, England; [Stuart, Marc C. A.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Cambridge; University of London; University College London; University of Groningen	Otto, S (corresponding author), Univ Groningen, Stratingh Inst, Ctr Syst Chem, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	s.otto@rug.nl	Otto, Sijbren/E-9568-2014; Waudby, Christopher/AAT-1736-2021; Stuart, Marc/B-6274-2008	Waudby, Christopher/0000-0001-7810-3753; Stuart, Marc/0000-0003-0667-6338; Otto, Sijbren/0000-0003-0259-5637	Engineering and Physical Sciences Research Council; Royal Society; Dynamic Combinatorial Chemistry Marie-Curie Research Training Network; Cooperation in Science and Technology (COST) [CM0703]; Engineering and Physical Sciences Research Council [EP/F035888/1] Funding Source: researchfish; EPSRC [EP/F035888/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); Dynamic Combinatorial Chemistry Marie-Curie Research Training Network; Cooperation in Science and Technology (COST)(European Cooperation in Science and Technology (COST)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank J. K. M. Sanders and J. B. F. N. Engberts for critical reading of the manuscript and C. M. Dobson for useful discussions. This research has been supported by the Engineering and Physical Sciences Research Council, the Royal Society, the Dynamic Combinatorial Chemistry Marie-Curie Research Training Network, and Cooperation in Science and Technology (COST) CM0703.	Brunsveld L, 2001, CHEM REV, V101, P4071, DOI 10.1021/cr990125q; Corbett PT, 2006, CHEM REV, V106, P3652, DOI 10.1021/cr020452p; Davis DA, 2009, NATURE, V459, P68, DOI 10.1038/nature07970; DEGRADO WF, 1985, J AM CHEM SOC, V107, P7684, DOI 10.1021/ja00311a076; Dwyer-Joyce RS, 2003, P ROY SOC A-MATH PHY, V459, P957, DOI 10.1098/rspa.2002.1018; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hickenboth CR, 2007, NATURE, V446, P423, DOI 10.1038/nature05681; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x; Krishnan-Ghosh Y, 2003, ANGEW CHEM INT EDIT, V42, P2171, DOI 10.1002/anie.200250551; Lee DH, 1996, NATURE, V382, P525, DOI 10.1038/382525a0; Lee DH, 1997, NATURE, V390, P591, DOI 10.1038/37569; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Nguyen R, 2009, ANGEW CHEM INT EDIT, V48, P1093, DOI 10.1002/anie.200804602; ORGEL LE, 1992, NATURE, V358, P203, DOI 10.1038/358203a0; ORGEL LE, 1995, ACCOUNTS CHEM RES, V28, P109, DOI 10.1021/ar00051a004; Otto S, 2000, J AM CHEM SOC, V122, P12063, DOI 10.1021/ja005507o; Paul N, 2002, P NATL ACAD SCI USA, V99, P12733, DOI 10.1073/pnas.202471099; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Piermattei A, 2009, NAT CHEM, V1, P133, DOI [10.1038/NCHEM.167, 10.1038/nchem.167]; PIETERS RJ, 1994, ANGEW CHEM INT EDIT, V33, P1579, DOI 10.1002/anie.199415791; Pross A, 2003, J THEOR BIOL, V220, P393, DOI 10.1006/jtbi.2003.3178; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; ROTELLO V, 1991, J AM CHEM SOC, V113, P9422, DOI 10.1021/ja00024a089; Sadownik JW, 2008, ANGEW CHEM INT EDIT, V47, P9965, DOI 10.1002/anie.200804223; Szathmary E, 1997, J THEOR BIOL, V187, P555, DOI 10.1006/jtbi.1996.0389; TJIVIKUA T, 1990, J AM CHEM SOC, V112, P1249, DOI 10.1021/ja00159a057; Vidonne A., 2009, EUR J ORG CHEM, V2009, P593; VONKIEDROWSKI G, 1991, ANGEW CHEM INT EDIT, V30, P423, DOI 10.1002/anie.199104231; VONKIEDROWSKI G, 1986, ANGEW CHEM INT EDIT, V25, P932, DOI 10.1002/anie.198609322; Wang B, 1997, CHEM COMMUN, P1495, DOI 10.1039/a701573i; Williams RJ, 2009, NAT NANOTECHNOL, V4, P19, DOI [10.1038/nnano.2008.378, 10.1038/NNANO.2008.378]; Xu S, 2008, J AM CHEM SOC, V130, P1826, DOI 10.1021/ja710248q; Yao S, 1997, J AM CHEM SOC, V119, P10559, DOI 10.1021/ja9710619	34	374	379	9	297	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2010	327	5972					1502	1506		10.1126/science.1182767	http://dx.doi.org/10.1126/science.1182767			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20299594				2022-12-28	WOS:000275715200046
J	Takeuchi, O; Akira, S				Takeuchi, Osamu; Akira, Shizuo			Pattern Recognition Receptors and Inflammation	CELL			English	Review							INNATE IMMUNE-RESPONSE; TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; INDEPENDENT ANTIVIRAL RESPONSE; AICARDI-GOUTIERES-SYNDROME; APOPTOTIC DNA-DEGRADATION; GENE INDUCTION-PROGRAM; ZINC-FINGER PROTEIN; RIG-I HELICASE; DENDRITIC CELLS	Infection of cells by microorganisms activates the inflammatory response. The initial sensing of infection is mediated by innate pattern recognition receptors (PRRs), which include Toll-like receptors, RIG-I-like receptors, NOD-like receptors, and C-type lectin receptors. The intracellular signaling cascades triggered by these PRRs lead to transcriptional expression of inflammatory mediators that coordinate the elimination of pathogens and infected cells. However, aberrant activation of this system leads to immunodeficiency, septic shock, or induction of autoimmunity. In this Review, we discuss the role of PRRs, their signaling pathways, and how they control inflammatory responses.	[Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, Host Def Lab, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Akira, S (corresponding author), Osaka Univ, Host Def Lab, WPI Immunol Frontier Res Ctr, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Takeuchi, Osamu/D-6007-2011; Takeuchi, Osamu/AAG-9359-2019; Akira, Shizuo/C-3134-2009	Takeuchi, Osamu/0000-0002-1260-6232; 	Japanese Ministry of Education, Culture, Sports, Science and Technology; 21st Century Center of Excellence Program of Japan; NIH [P01 AI070167]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167] Funding Source: NIH RePORTER	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 21st Century Center of Excellence Program of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. M. Standley for critical reading of this manuscript and E. Kamada for secretarial assistance. This work was supported by the Special Coordination Funds of the Japanese Ministry of Education, Culture, Sports, Science and Technology, the 21st Century Center of Excellence Program of Japan, and the NIH (P01 AI070167).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Arnoult D, 2009, J CELL SCI, V122, P3161, DOI 10.1242/jcs.051193; Arumugam TV, 2009, SHOCK, V32, P4, DOI 10.1097/SHK.0b013e318193e333; Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Choi MK, 2009, P NATL ACAD SCI USA, V106, P17870, DOI 10.1073/pnas.0909545106; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Coban C, 2010, CELL HOST MICROBE, V7, P50, DOI 10.1016/j.chom.2009.12.003; Croker BA, 2008, P NATL ACAD SCI USA, V105, P15028, DOI 10.1073/pnas.0806619105; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Ermolaeva MA, 2008, NAT IMMUNOL, V9, P1037, DOI 10.1038/ni.1638; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; HSU MT, 1987, P NATL ACAD SCI USA, V84, P8140, DOI 10.1073/pnas.84.22.8140; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Matsumoto F, 2008, BIOCHEM BIOPH RES CO, V367, P693, DOI 10.1016/j.bbrc.2007.12.130; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Negishi H, 2006, P NATL ACAD SCI USA, V103, P15136, DOI 10.1073/pnas.0607181103; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Palsson-McDermott EM, 2009, NAT IMMUNOL, V10, P579, DOI 10.1038/ni.1727; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; PATTNAIK AK, 1995, VIROLOGY, V206, P760, DOI 10.1016/S0042-6822(95)80005-0; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Pobezinskaya YL, 2008, NAT IMMUNOL, V9, P1047, DOI 10.1038/ni.1639; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Roelofs MF, 2006, J IMMUNOL, V176, P7021, DOI 10.4049/jimmunol.176.11.7021; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Ryzhakov G, 2007, EMBO J, V26, P3180, DOI 10.1038/sj.emboj.7601743; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sasai M, 2006, J IMMUNOL, V177, P8676, DOI 10.4049/jimmunol.177.12.8676; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Schmitz F, 2007, EUR J IMMUNOL, V37, P315, DOI 10.1002/eji.200636767; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Takahasi K, 2009, J BIOL CHEM, V284, P17465, DOI 10.1074/jbc.M109.007179; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; Warger T, 2006, J BIOL CHEM, V281, P22545, DOI 10.1074/jbc.M502900200; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	141	5338	5641	44	940	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2010	140	6					805	820		10.1016/j.cell.2010.01.022	http://dx.doi.org/10.1016/j.cell.2010.01.022			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	571IX	20303872	Bronze			2022-12-28	WOS:000275746600006
J	Lambeek, LC; van Mechelen, W; Knol, DL; Loisel, P; Anema, JR				Lambeek, Ludeke C.; van Mechelen, Willem; Knol, Dirk L.; Loisel, Patrick; Anema, Johannes R.			Randomised controlled trial of integrated care to reduce disability from chronic low back pain in working and private life	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OCCUPATIONAL-HEALTH-CARE; RETURN-TO-WORK; GRADED ACTIVITY; MULTIDISCIPLINARY REHABILITATION; PARTICIPATORY ERGONOMICS; MUSCULOSKELETAL PAIN; COST-EFFECTIVENESS; SICKNESS ABSENCE; INTERVENTION; DESIGN	Objective To evaluate the effectiveness of an integrated care programme, combining a patient directed and a workplace directed intervention, for patients with chronic low back pain. Design Population based randomised controlled trial. Setting Primary care (10 physiotherapy practices, one occupational health service, one occupational therapy practice) and secondary care (five hospitals). Participants 134 adults aged 18-65 sick listed for at least 12 weeks owing to low back pain. Intervention Patients were randomly assigned to usual care (n=68) or integrated care (n=66). Integrated care consisted of a workplace intervention based on participatory ergonomics, involving a supervisor, and a graded activity programme based on cognitive behavioural principles. Main outcome measures The primary outcome was the duration of time off work (work disability) due to low back pain until full sustainable return to work. Secondary outcome measures were intensity of pain and functional status. Results The median duration until sustainable return to work was 88 days in the integrated care group compared with 208 days in the usual care group (P=0.003). Integrated care was effective on return to work (hazard ratio 1.9, 95% confidence interval 1.2 to 2.8, P=0.004). After 12 months, patients in the integrated care group improved significantly more on functional status compared with patients in the usual care group (P=0.01). Improvement of pain between the groups did not differ significantly. Conclusion The integrated care programme substantially reduced disability due to chronic low back pain in private and working life.	[Lambeek, Ludeke C.; van Mechelen, Willem; Anema, Johannes R.] Vrije Univ Amsterdam Med Ctr, Dept Publ & Occupat Hlth, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Loisel, Patrick] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Toronto	Anema, JR (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Publ & Occupat Hlth, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.	h.anema@vumc.nl	van Mechelen, Willem/C-8463-2013	van Mechelen, Willem/0000-0001-7136-6382	VU University Medical Center; TNO Work Employment; Dutch Health Insurance Executive Council; Stichting Instituut GAK; Netherlands Organisation for Health Research and Development; Work Disability Prevention Canadian Institutes of Health Research [FRN: 53909]	VU University Medical Center; TNO Work Employment; Dutch Health Insurance Executive Council; Stichting Instituut GAK; Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Work Disability Prevention Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by VU University Medical Center, TNO Work & Employment, Dutch Health Insurance Executive Council, Stichting Instituut GAK, and the Netherlands Organisation for Health Research and Development. This research was carried out within the framework of the Work Disability Prevention Canadian Institutes of Health Research strategic training programme, which supported LCL ( grant FRN: 53909). The authors were independent of the funders and the funders had no role in the project.	Anema JR, 2007, SPINE, V32, P291, DOI 10.1097/01.brs.0000253604.90039.ad; Anema JR, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1174; Anema JR, 2004, OCCUP ENVIRON MED, V61, P289, DOI 10.1136/oem.2002.006460; Anema JR, 2003, AM J IND MED, V44, P273, DOI 10.1002/ajim.10259; CARLSSON AM, 1983, PAIN, V16, P87, DOI 10.1016/0304-3959(83)90088-X; CATSBARIL WL, 1991, ADULT SPINE PRINCIPL; Collet D., 1994, MODELLING SURVIVAL D; Crombez G, 1999, PAIN, V80, P329, DOI 10.1016/S0304-3959(98)00229-2; de Jong AM, 2002, APPL ERGON, V33, P439, DOI 10.1016/S0003-6870(02)00033-9; de Zwart B C, 1997, Int J Occup Med Environ Health, V10, P283; Engers AJ, 2005, SPINE, V30, P595; FLOR H, 1985, J CONSULT CLIN PSYCH, V53, P354, DOI 10.1037/0022-006X.53.3.354; Guzman J, 2001, BMJ-BRIT MED J, V322, P1511, DOI 10.1136/bmj.322.7301.1511; Henderson M, 2005, BMJ-BRIT MED J, V330, P802, DOI 10.1136/bmj.330.7495.802; Heymans MW, 2004, J MANIP PHYSIOL THER, V27, P457, DOI 10.1016/j.jmpt.2004.06.004; Hildebrandt VH, 2001, ERGONOMICS, V44, P1038, DOI 10.1080/00140130110087437; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Lambeek LC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-254; LINDSTROM I, 1995, SCAND J REHABIL MED, V27, P153; LINDSTROM I, 1992, PHYS THER, V72, P279, DOI 10.1093/ptj/72.4.279; Loisel P, 1997, SPINE, V22, P2911, DOI 10.1097/00007632-199712150-00014; Main CJ, 2002, BMJ-BRIT MED J, V325, P534, DOI 10.1136/bmj.325.7363.534; National Institute for Health and Clinical Excellence, 2009, LOW BACK PAIN EARL M; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Staal JB, 2004, ANN INTERN MED, V140, P77, DOI 10.7326/0003-4819-140-2-200401200-00007; Steenstra IA, 2006, OCCUP ENVIRON MED, V63, P718, DOI 10.1136/oem.2005.021675; van Oostrom SH, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006955.pub2; VANTULDER MW, 1995, PAIN, V62, P233, DOI 10.1016/0304-3959(94)00272-G; VERBEEK JH, 2006, NVAB RICHTLIJN HANDE; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Waddell G., 2008, AMA GUIDES NEWSLETTE, P1; WHO, 2001, WHO INT CLASS FUNCT	32	177	180	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2010	340								c1035	10.1136/bmj.c1035	http://dx.doi.org/10.1136/bmj.c1035			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	573RD	20234040	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000275931400001
J	Patel, TV				Patel, Tejas V.			Darbepoetin decreased transfusions and fatigue but increased adverse effects in patients with chronic kidney disease, diabetes, and anemia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Patel, TV (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.							Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; DRUEKE TB, N ENGL J MED; LAUPACIS A, 1990, BMJ-BRIT MED J, V300, P573; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	2010	152	6							JC3-9	10.7326/0003-4819-152-6-201003160-02009	http://dx.doi.org/10.7326/0003-4819-152-6-201003160-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573IF	20231563				2022-12-28	WOS:000275905200026
J	Wijeysundera, HC; Nallamothu, BK; Krumholz, HM; Tu, JV; Ko, DT				Wijeysundera, Harindra C.; Nallamothu, Brahmajee K.; Krumholz, Harlan M.; Tu, Jack V.; Ko, Dennis T.			Meta-analysis: Effects of Percutaneous Coronary Intervention Versus Medical Therapy on Angina Relief	ANNALS OF INTERNAL MEDICINE			English	Review							ACUTE MYOCARDIAL-INFARCTION; 5-YEAR FOLLOW-UP; CONTROLLED CLINICAL-TRIAL; ARTERY-DISEASE; BALLOON ANGIOPLASTY; STABLE SURVIVORS; RANDOMIZED-TRIAL; BYPASS-SURGERY; MASS-II; ISCHEMIA	Background: Several meta-analyses have evaluated the efficacy of percutaneous coronary intervention (PCI) compared with medical therapy, but none has focused on angina relief. Purpose: To summarize the evidence on the degree of angina relief from PCI compared with medical therapy in patients with stable coronary artery disease. Data Sources: The Cochrane Library (1993 to June 2009), EMBASE (1980 to June 2009), and MEDLINE (1950 to June 2009), with no language restrictions. Study Selection: Two independent reviewers screened citations to identify randomized, controlled trials of PCI versus medical therapy in patients with stable coronary artery disease. Data Extraction: Two independent reviewers abstracted data on patient characteristics, study conduct, and outcomes. A random-effects model was used to combine data on freedom from angina and to perform stratified analyses based on duration of follow-up, inclusion of patients with recent myocardial infarction, coronary stent utilization, recruitment period, and utilization of evidence-based medications. Data Synthesis: A total of 14 trials, enrolling 7818 patients, met the inclusion criteria. Although PCI was associated with an overall benefit on angina relief (odds ratio, 1.69 [95% CI, 1.24 to 2.30]), important heterogeneity across trials was observed. The incremental benefit of PCI observed in older trials (odds ratio, 3.38 [CI, 1.89 to 6.04]) was substantially less and possibly absent in recent trials (odds ratio, 1.13 [CI, 0.76 to 1.68]). An inverse relationship between use of evidence-based therapies and the incremental benefit of PCI was observed. Limitations: Information about the long-term use of medication was incomplete in most trials. Few trials used drug-eluting stents. Meta-regression analyses used aggregated study-level data from few trials. Conclusion: Percutaneous coronary intervention was associated with greater freedom from angina compared with medical therapy, but this benefit was largely attenuated in contemporary studies. This observation may be related to greater use of evidence-based medications in contemporary trials.	[Ko, Dennis T.] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI USA; Yale Univ, Sch Med, New Haven, CT USA	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Yale University	Ko, DT (corresponding author), Inst Clin Evaluat Sci, Room G1-06,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	dennis.ko@ices.on.ca	, Harlan/AAI-2875-2020; Wijeysundera, Harindra/AAA-6058-2020	Wijeysundera, Harindra/0000-0001-8464-1080; Ko, Dennis/0000-0001-6840-8051; Tu, Jack/0000-0003-0111-722X	Canadian Institutes of Health Research [MOP 82747]; University of Toronto Department of Medicine Clinician Scientist Training Program; Heart and Stroke Foundation of Ontario; Canada Research Chair in Health Services Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Toronto Department of Medicine Clinician Scientist Training Program; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canada Research Chair in Health Services Research(Canada Research Chairs)	Canadian Institutes of Health Research.; By the University of Toronto Department of Medicine Clinician Scientist Training Program and a research fellowship award from the Canadian Institutes of Health Research (Dr. Wijeysundera); a Heart and Stroke Foundation of Ontario Clinician Scientist Award and a Canadian Institutes of Health Research New Investigator Award (Dr. Ko); and a Canada Research Chair in Health Services Research and a Career Investigator Award from the Heart and Stroke Foundation of Ontario (Dr. Tu). This analysis of the study was funded in part by operating grants by a Canadian Institutes of Health Research (MOP 82747) and a Canadian Institutes of Health Research Team Grant in Cardiovascular Outcomes Research.	American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; Bech GJW, 2001, CIRCULATION, V103, P2928, DOI 10.1161/01.CIR.103.24.2928; BERKEY CS, 1995, STAT MED, V14, P395, DOI 10.1002/sim.4780140406; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Chamberlain DA, 1997, LANCET, V350, P461; Dakik HA, 1998, CIRCULATION, V98, P2017, DOI 10.1161/01.CIR.98.19.2017; Davies RF, 1997, CIRCULATION, V95, P2037, DOI 10.1161/01.CIR.95.8.2037; DZAVIK V, 1994, AM J CARDIOL, V73, P856, DOI 10.1016/0002-9149(94)90809-5; ELLIS SG, 1992, CIRCULATION, V86, P1400, DOI 10.1161/01.CIR.86.5.1400; Erne P, 2007, JAMA-J AM MED ASSOC, V297, P1985, DOI 10.1001/jama.297.18.1985; Folland ED, 1997, J AM COLL CARDIOL, V29, P1505, DOI 10.1016/S0735-1097(97)00097-1; Frye RL, 2009, NEW ENGL J MED, V360, P2503, DOI [DOI 10.1056/NEJMOA0805796, 10.1056/NEJMoa0805796]; Hambrecht R, 2004, CIRCULATION, V109, P1371, DOI 10.1161/01.CIR.0000121360.31954.1F; Hartigan PM, 1998, AM J CARDIOL, V82, P1445, DOI 10.1016/S0002-9149(98)00685-7; Henderson RA, 2003, J AM COLL CARDIOL, V42, P1161, DOI 10.1016/S0735-1097(03)00951-3; Hochman JS, 2006, NEW ENGL J MED, V355, P2395, DOI 10.1056/NEJMoa066139; Horie H, 1998, CIRCULATION, V98, P2377, DOI 10.1161/01.CIR.98.22.2377; Hueb W, 2004, J AM COLL CARDIOL, V43, P1743, DOI 10.1016/j.jacc.2003.08.065; HUEB WA, 1995, J AM COLL CARDIOL, V26, P1600, DOI 10.1016/0735-1097(95)00384-3; Hueb WA, 1999, CIRCULATION, V100, P107; Hueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jeremias A, 2009, AM J MED, V122, P152, DOI 10.1016/j.amjmed.2008.07.027; Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864; King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208; Madsen JK, 2007, CARDIOLOGY, V108, P243, DOI 10.1159/000096951; Mahmarian JJ, 2006, J AM COLL CARDIOL, V48, P2458, DOI 10.1016/j.jacc.2006.07.068; MORTON SC, 2004, AHRQ PUBLICATION; Patel MR, 2009, CIRCULATION, V119, P1330, DOI 10.1161/CIRCULATIONAHA.108.191768; Pfisterer M, 2001, LANCET, V358, P951; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Pitt B, 1999, NEW ENGL J MED, V341, P70, DOI 10.1056/NEJM199907083410202; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Schomig A, 2008, J AM COLL CARDIOL, V52, P894, DOI 10.1016/j.jacc.2008.05.051; Steg PG, 2004, EUR HEART J, V25, P2187, DOI 10.1016/j.ehj.2004.10.019; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Wijeysundera HC, 2009, CIRC-CARDIOVASC QUAL, V2, P123, DOI 10.1161/CIRCOUTCOMES.108.834853; Yousef ZR, 2002, J AM COLL CARDIOL, V40, P869, DOI 10.1016/S0735-1097(02)02058-2; Zeymer U, 2003, CIRCULATION, V108, P1324, DOI 10.1161/01.CIR.0000087605.09362.0E	42	92	97	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	2010	152	6					370	+		10.7326/0003-4819-152-6-201003160-00007	http://dx.doi.org/10.7326/0003-4819-152-6-201003160-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573IF	20231568				2022-12-28	WOS:000275905200005
J	Maron, BJ; Estes, NAM				Maron, Barry J.; Estes, N. A. Mark, III			MEDICAL PROGRESS Commotio Cordis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SUDDEN CARDIAC DEATH; ST-SEGMENT ELEVATION; CHEST-WALL BLOWS; LONG-QT SYNDROME; VENTRICULAR-FIBRILLATION; PRECORDIAL THUMP; EXPERIMENTAL-MODEL; MYOCARDIAL-ISCHEMIA; MECHANOELECTRIC FEEDBACK; EXTERNAL DEFIBRILLATION		[Maron, Barry J.] Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, Minneapolis, MN 55407 USA; [Estes, N. A. Mark, III] Tufts Univ, New England Cardiac Arrhythmia Ctr, Div Cardiol, Sch Med, Boston, MA 02111 USA	Minneapolis Heart Institute Foundation; Tufts University	Maron, BJ (corresponding author), Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, 920 E 28th St,Suite 620, Minneapolis, MN 55407 USA.	hcm.maron@mhif.org			Hearst Foundations; Louis J. Acompora Memorial Foundation; National Operating Committee on Standards for Athletic Equipment; Medtronic; St. Jude Medical; Boston Scientific	Hearst Foundations; Louis J. Acompora Memorial Foundation; National Operating Committee on Standards for Athletic Equipment; Medtronic(Medtronic); St. Jude Medical(St. Jude Medical); Boston Scientific(Boston Scientific)	Supported in part by grants from the Hearst Foundations, the Louis J. Acompora Memorial Foundation, and the National Operating Committee on Standards for Athletic Equipment.; Dr. Maron reports receiving consulting fees from GeneDx (a subsidiary of Bio-Reference Laboratories) and lecture fees and grant support from Medtronic. Dr. Estes reports that his institution has received fellowship funding from St. Jude Medical, Boston Scientific, and Medtronic and that he has received lecture fees and travel support from Boston Scientific.	ABRUNZO TJ, 1991, AM J DIS CHILD, V145, P1279, DOI 10.1001/archpedi.1991.02160110071023; Amir O, 2007, PACE, V30, P153, DOI 10.1111/j.1540-8159.2007.00643.x; Antzelevitch C, 2006, J INTERN MED, V259, P48, DOI 10.1111/j.1365-2796.2005.01587.x; Baker AM, 2003, CHILD ABUSE NEGLECT, V27, P125, DOI 10.1016/S0145-2134(02)00511-2; BEKHEIT SS, 1990, AM HEART J, V119, P1025, DOI 10.1016/S0002-8703(05)80231-5; Bir CA, 1999, J TRAUMA, V47, P468, DOI 10.1097/00005373-199909000-00006; Bode F, 2006, J CARDIOVASC ELECTR, V17, P1011, DOI 10.1111/j.1540-8167.2006.00547.x; Boden BP, 2004, AM J SPORT MED, V32, P1189, DOI 10.1177/0363546503262161; Boglioli LR, 1998, PEDIATR CARDIOL, V19, P436, DOI 10.1007/s002469900347; Casper J., 1857, PRAKTISCHES HDB GERI; COOPER GJ, 1982, J TRAUMA, V22, P994, DOI 10.1097/00005373-198212000-00004; Crown LA, 1997, AM FAM PHYSICIAN, V55, P2467; Deady B, 1999, J EMERG MED, V17, P459, DOI 10.1016/S0736-4679(99)00006-2; Denton JS, 2000, J FORENSIC SCI, V45, P734; Dickman Gerald L, 1978, Phys Sportsmed, V6, P85, DOI 10.1080/00913847.1978.11948393; Doerer JJ, 2007, AM J CARDIOL, V99, P857, DOI 10.1016/j.amjcard.2006.10.053; Drewniak EI, 2007, J APPL BIOMECH, V23, P282, DOI 10.1123/jab.23.4.282; EDLICH R F JR, 1987, Journal of Emergency Medicine, V5, P181, DOI 10.1016/0736-4679(87)90176-4; Efimov IR, 2006, HEART RHYTHM, V3, P187, DOI 10.1016/j.hrthm.2005.11.022; FRAZER M, 1984, AM J FOREN MED PATH, V5, P249, DOI 10.1097/00000433-198409000-00015; FROEDE RC, 1979, J FORENSIC SCI, V24, P752; Garan AR, 2005, J CARDIOVASC ELECTR, V16, P433, DOI 10.1046/j.1540-8167.2005.40664.x; GREEN ED, 1980, ANN EMERG MED, V9, P155, DOI 10.1016/S0196-0644(80)80272-1; Gussak I, 1999, J AM COLL CARDIOL, V33, P5, DOI 10.1016/S0735-1097(98)00528-2; Haissaguerre M, 2003, CIRCULATION, V108, P925, DOI 10.1161/01.CIR.0000088781.99943.95; Haman L, 2009, RESUSCITATION, V80, P14, DOI 10.1016/j.resuscitation.2008.07.022; Hamilton SJ, 2005, INT J LEGAL MED, V119, P88, DOI 10.1007/s00414-004-0511-y; Janda DH., 1992, CLIN J SPORT MED, V2, P172; KANTOR PF, 1990, CIRC RES, V66, P478, DOI 10.1161/01.RES.66.2.478; KAPLAN JA, 1993, J TRAUMA, V34, P151, DOI 10.1097/00005373-199301000-00030; Kelly M., 2001, DEATH TOUCH SCI LEGE; Kohl P, 2001, CARDIOVASC RES, V50, P280, DOI 10.1016/S0008-6363(01)00194-8; Kondo T, 1996, CARDIOVASC RES, V31, P683, DOI 10.1016/S0008-6363(96)00016-8; KUBOTA I, 1993, CIRCULATION, V88, P1845, DOI 10.1161/01.CIR.88.4.1845; Lee CC, 2005, RESUSCITATION, V64, P241, DOI 10.1016/j.resuscitation.2004.07.015; LIEDTKE AJ, 1974, AM J PHYSIOL, V226, P377, DOI 10.1152/ajplegacy.1974.226.2.377; LIEDTKE AJ, 1980, J TRAUMA, V20, P777, DOI 10.1097/00005373-198009000-00012; Link MS, 2008, PEDIATRICS, V122, P437, DOI 10.1542/peds.2007-2054; Link MS, 2003, J CARDIOVASC ELECTR, V14, P83, DOI 10.1046/j.1540-8167.2003.02017.x; Link MS, 2002, PEDIATRICS, V109, P873, DOI 10.1542/peds.109.5.873; Link MS, 1999, CIRCULATION, V100, P413, DOI 10.1161/01.CIR.100.4.413; Link MS, 2003, J AM COLL CARDIOL, V41, P99, DOI 10.1016/S0735-1097(02)02669-4; Link MS, 1998, NEW ENGL J MED, V338, P1805, DOI 10.1056/NEJM199806183382504; Link MS, 1998, CHEST, V114, P326, DOI 10.1378/chest.114.1.326; Link MS, 2001, J AM COLL CARDIOL, V37, P649, DOI 10.1016/S0735-1097(00)01142-6; Lucena JS, 2008, FORENSIC SCI INT, V177, pE1, DOI 10.1016/j.forsciint.2007.09.008; Madias C, 2009, HEART RHYTHM, V6, P1495, DOI 10.1016/j.hrthm.2009.06.029; Madias C, 2008, J CARDIOVASC ELECTR, V19, P1304, DOI 10.1111/j.1540-8167.2008.01267.x; Maron BJ, 2006, HEART RHYTHM, V3, P605, DOI 10.1016/j.hrthm.2005.12.011; Maron BJ, 2006, CIRCULATION, V114, P1633, DOI 10.1161/CIRCULATIONAHA.106.613562; Maron BJ, 2009, PEDIATRICS, V124, P966, DOI 10.1542/peds.2009-0167; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Maron BJ, 1997, AM J CARDIOL, V79, P840, DOI 10.1016/S0002-9149(96)00887-9; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1142, DOI 10.1001/jama.287.9.1142; Maron BJ, 2005, HEART RHYTHM, V2, P991, DOI 10.1016/j.hrthm.2005.06.016; MARON BJ, 1995, NEW ENGL J MED, V333, P337, DOI 10.1056/NEJM199508103330602; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Maron BJ, 2002, AM J CARDIOL, V89, P210, DOI 10.1016/S0002-9149(01)02202-0; Meola F, 1879, GIORNALE INT SCI MED, V1, P923; Miller JM, 2007, PACE, V30, P151, DOI 10.1111/j.1540-8159.2007.00642.x; Myerburg RJ, 2005, J AM COLL CARDIOL, V45, P1369, DOI 10.1016/j.jacc.2005.02.017; Nesbitt AD, 2001, LANCET, V357, P1195, DOI 10.1016/S0140-6736(00)04338-5; Pearce P Z, 2005, Curr Sports Med Rep, V4, P157; Pellis T, 2009, RESUSCITATION, V80, P17, DOI 10.1016/j.resuscitation.2008.10.018; RUTHERFORD GW, 1984, BASEBALL SOFTBALL RE; Salib EA, 2005, J PEDIATR-US, V147, P863, DOI 10.1016/j.jpeds.2005.07.041; Schlomka G., 1934, ERG INN MED KINDERHK, V47, P1, DOI 10.1007/ 978-3-642-90672-5_1.; SCHLOMKA G, 1932, Z GES EXP MED, V31, P43; Shimizu W, 1998, CIRCULATION, V98, P2314, DOI 10.1161/01.CIR.98.21.2314; Stout CW, 2007, MED SCI MONITOR, V13, pBR11; Strasburger JF, 2002, NEW ENGL J MED, V347, P1248, DOI 10.1056/NEJMicm020053; Thakore S, 2000, J ACCID EMERG MED, V17, P421; Tibballs J, 2008, RESUSCITATION, V77, P139, DOI 10.1016/j.resuscitation.2007.10.013; TURITTO G, 1989, AM J CARDIOL, V63, P1520, DOI 10.1016/0002-9149(89)90020-9; VANWAGONER DR, 1993, CIRC RES, V72, P973, DOI 10.1161/01.RES.72.5.973; Viano DC, 2000, J TRAUMA, V49, P1023, DOI 10.1097/00005373-200012000-00008; Viano DC, 1992, CLIN J SPORT MED, V2, P166; Viswanathan PC, 2000, CIRCULATION, V101, P1192, DOI 10.1161/01.CIR.101.10.1192; Wang JN, 2000, CARDIOLOGY, V93, P124, DOI 10.1159/000007013; Weinstock J, 2006, PEDIATRICS, V117, pE656, DOI 10.1542/peds.2005-1270; Yan GX, 1999, CIRCULATION, V100, P1660, DOI 10.1161/01.CIR.100.15.1660; Zangwill SD, 2004, PEDIATR CLIN N AM, V51, P1347, DOI 10.1016/j.pcl.2004.04.001	82	139	142	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10					917	927		10.1056/NEJMra0910111	http://dx.doi.org/10.1056/NEJMra0910111			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566JM	20220186				2022-12-28	WOS:000275365900012
J	Moore, JE				Moore, Joel E.			The birth of topological insulators	NATURE			English	Article							SINGLE DIRAC CONE; REALIZATION	Certain insulators have exotic metallic states on their surfaces. These states are formed by topological effects that also render the electrons travelling on such surfaces insensitive to scattering by impurities. Such topological insulators may provide new routes to generating novel phases and particles, possibly finding uses in technological applications in spintronics and quantum computing.	[Moore, Joel E.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Moore, Joel E.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Moore, JE (corresponding author), Univ Calif Berkeley, Dept Phys, 366 Le Conte 7300, Berkeley, CA 94720 USA.	jemoore@berkeley.edu	Moore, Joel/O-4959-2016	Moore, Joel/0000-0002-4294-5761	US National Science Foundation	US National Science Foundation(National Science Foundation (NSF))	I have benefited from conversations about topological insulators with L. Balents, B. A. Bernevig, A. Essin, M. Franz, D. Haldane, Z. Hasan, C. Kane, D.-H. Lee, A. Ludwig, L. Molenkamp, S. Ryu, D. Vanderbilt, A. Vishwanath, X.-G. Wen, C. Xu and S.-C. Zhang. My work on topological insulators is supported by the US National Science Foundation.	ALPICHSHEV Z, 2009, STM IMAGING ELECT WA, P41304; ANDERSON PW, 1958, PHYS REV, V109, P1492, DOI 10.1103/PhysRev.109.1492; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Chen YL, 2009, SCIENCE, V325, P178, DOI 10.1126/science.1173034; Collins GP, 2006, SCI AM, V294, P56, DOI 10.1038/scientificamerican0406-56; Essin AM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.146805; Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; GARATE I, 2009, INVERSE SPIN GALVANI, P41304; Groth CW, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.196805; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Hsieh D, 2009, NATURE, V460, P1101, DOI 10.1038/nature08234; Hsieh D, 2009, SCIENCE, V323, P919, DOI 10.1126/science.1167733; JACKIW R, 1981, NUCL PHYS B, V190, P681, DOI 10.1016/0550-3213(81)90044-4; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; Kitaev A, 2009, PERIODIC TABLE TOPOL; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Li J, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.136806; Moore JE, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121306; Moore JE, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.186805; Murakami S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.156804; Nilsson J, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.120403; Nomura K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.146806; PENG H, 2009, AHARONOVBOHM INTERFE, P41304; Qi XL, 2009, SCIENCE, V323, P1184, DOI 10.1126/science.1167747; Qi XL, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195424; Ramesh R, 2007, NAT MATER, V6, P21, DOI 10.1038/nmat1805; Ran Y, 2009, NAT PHYS, V5, P298, DOI 10.1038/NPHYS1220; Roushan P, 2009, NATURE, V460, P1106, DOI 10.1038/nature08308; Roy R, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.195322; Schnyder AP, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195125; Seradjeh B, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.066402; Teo JCY, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.046401; WILCZEK F, 1987, PHYS REV LETT, V58, P1799, DOI 10.1103/PhysRevLett.58.1799; Wilczek F, 2009, NAT PHYS, V5, P614, DOI 10.1038/nphys1380; Xia Y, 2009, NAT PHYS, V5, P398, DOI 10.1038/NPHYS1274; Zhang HJ, 2009, NAT PHYS, V5, P438, DOI 10.1038/NPHYS1270; ZHANG T, 2009, EXPT DEMONSTRATION T, P41304; ZHANG Y, 2009, CROSSOVER 3 DIMENSIO, P41304	41	2246	2278	17	886	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					194	198		10.1038/nature08916	http://dx.doi.org/10.1038/nature08916			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20220837				2022-12-28	WOS:000275366100032
J	Tomlinson, J				Tomlinson, Jonathon			Will a market deliver quality and efficiency in health care better than central planning ever could? No	BRITISH MEDICAL JOURNAL			English	Editorial Material									Lawson Practice, London, England			echothx@gmail.com						Committee on Medical Aspects of Radiation, 2007, 12 COMM MED ASP RAD; Fugelli P, 2001, BRIT J GEN PRACT, V51, P575; Gawande A., 2009, NEW YORKER; Hilton S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-42; Rodwin MA, 2004, BRIT MED J, V328, P1328, DOI 10.1136/bmj.328.7452.1328; Smith R, 2006, J ROY SOC MED, V99, P292, DOI 10.1258/jrsm.99.6.292	6	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAR 10	2010	340								c1302	10.1136/bmj.c1302	http://dx.doi.org/10.1136/bmj.c1302			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570FD	20219815				2022-12-28	WOS:000275656800007
J	Winkleby, M; Ned, J				Winkleby, Marilyn; Ned, Judith			Promoting Science Education	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Winkleby, Marilyn] Stanford Univ, Off Community Hlth, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; Stanford Med Youth Sci Program, Stanford, CA USA	Stanford University; Stanford University	Winkleby, M (corresponding author), Stanford Univ, Off Community Hlth, Sch Med, Stanford Prevent Res Ctr, 251 Campus Dr,MC 5411,Room 318, Stanford, CA 94305 USA.	winkleby@stanford.edu			Howard Hughes Medical Institute [51006099] Funding Source: Medline; NCRR NIH HHS [R25 RR026011-01, R25RR026011, UL1 RR025744, R25 RR026011] Funding Source: Medline; NIH HHS [R25 OD011139] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R25RR026011, UL1RR025744] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R25OD011139] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		[Anonymous], 2007, RIS GATH STORM EN EM; *DEP HLTH HUM SERV, STAT PROF OLD AM 200; Dorph R., 2007, STATUS SCI ED BAY AR; FRIEDMAN LN, 2006, ED WEEK, V25, P48; FRIEDMAN LN, 2006, ED WEEK, V25, P45; FRIEDMAN LN, 2006, ED WEEK, V25, P49; ICAR, 2008, SUCC STOR TRACT OP S; Institute of Medicine, 2008, RET AG AM BUILD HLTH; *US BUR CENS, CENS 2000 SUMM FIL 4; *US DEP ED, REP AC COMP COUNC; White House, ED INN; Winkleby MA, 2009, J SCI EDUC TECHNOL, V18, P535, DOI 10.1007/s10956-009-9168-0	12	5	5	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2010	303	10					983	984		10.1001/jama.2010.249	http://dx.doi.org/10.1001/jama.2010.249			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	565UC	20215614	Green Accepted			2022-12-28	WOS:000275319300028
J	Bayne, EH; White, SA; Kagansky, A; Bijos, DA; Sanchez-Pulido, L; Hoe, KL; Kim, DU; Park, HO; Ponting, CP; Rappsilber, J; Allshire, RC				Bayne, Elizabeth H.; White, Sharon A.; Kagansky, Alexander; Bijos, Dominika A.; Sanchez-Pulido, Luis; Hoe, Kwang-Lae; Kim, Dong-Uk; Park, Han-Oh; Ponting, Chris P.; Rappsilber, Juri; Allshire, Robin C.			Stc1: A Critical Link between RNAi and Chromatin Modification Required for Heterochromatin Integrity	CELL			English	Article							H3 LYSINE-9 METHYLATION; BINDING-PROTEIN TAZ1; HIDDEN MARKOV-MODELS; FISSION YEAST; HISTONE H3; SCHIZOSACCHAROMYCES-POMBE; CHROMOSOME SEGREGATION; COMPREHENSIVE ANALYSIS; CHROMODOMAIN PROTEIN; CENTROMERE FUNCTION	In fission yeast, RNAi directs heterochromatin formation at centromeres, telomeres, and the mating type locus. Noncoding RNAs transcribed from repeat elements generate siRNAs that are incorporated into the Argonaute-containing RITS complex and direct it to nascent homologous transcripts. This leads to recruitment of the CLRC complex, including the histone methyltransferase Clr4, promoting H3K9 methylation and heterochromatin formation. A key question is what mediates the recruitment of Clr4/CLRC to transcript-bound RITS. We have identified a LIM domain protein, Stc1, that is required for centromeric heterochromatin integrity. Our analyses show that Stc1 is specifically required to establish H3K9 methylation via RNAi, and interacts both with the RNAi effector Ago1, and with the chromatin-modifying CLRC complex. Moreover, tethering Stc1 to a euchromatic locus is sufficient to induce silencing and heterochromatin formation independently of RNAi. We conclude that Stc1 associates with RITS on centromeric transcripts and recruits CLRC, thereby coupling RNAi to chromatin modification.	[Bayne, Elizabeth H.; White, Sharon A.; Kagansky, Alexander; Bijos, Dominika A.; Rappsilber, Juri; Allshire, Robin C.] Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Bayne, Elizabeth H.; White, Sharon A.; Kagansky, Alexander; Bijos, Dominika A.; Rappsilber, Juri; Allshire, Robin C.] Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Sanchez-Pulido, Luis; Ponting, Chris P.] Univ Oxford, MRC Funct Genom Unit, Oxford OX1 3QX, England; [Hoe, Kwang-Lae; Kim, Dong-Uk] Korea Res Inst Biosci & Biotechnol, Integrat Om Res Ctr, Taejon 305806, South Korea; [Park, Han-Oh] Bioneer Corp, Taejon 306220, South Korea	University of Edinburgh; University of Edinburgh; University of Oxford; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Allshire, RC (corresponding author), Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland.	robin.allshire@ed.ac.uk	Rappsilber, Juri/ABF-3328-2020; Ponting, Chris/AAV-2621-2021; Rappsilber, Juri/B-7265-2015; Kagansky, Alexander/B-3137-2011; Bayne, Elizabeth H/G-5411-2010	Rappsilber, Juri/0000-0001-5999-1310; Kagansky, Alexander/0000-0002-6219-6892; Bayne, Elizabeth H/0000-0001-8775-999X; Sanchez Pulido, Luis/0000-0002-2300-8502; Hoe, Kwang Lae/0000-0002-3943-4549; Allshire, Robin/0000-0002-8005-3625; Ponting, Chris/0000-0003-0202-7816	Epigenome Network of Excellence [(EC-FP6/Contract/LSHG-CT-2004-503433]; EC Marie-Curie Excellence [MEXT-CT-014171]; EMBO-LTF [ALT325-2008]; MRC [G0301153]; MRC-FGU; Wellcome Trust [084229/Z/07/Z]; Medical Research Council [MC_U137761446, G0301153] Funding Source: researchfish; MRC [MC_U137761446] Funding Source: UKRI	Epigenome Network of Excellence; EC Marie-Curie Excellence(European Commission); EMBO-LTF(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC-FGU(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Allshire Lab members for advice, F. Alves for mass spectrometry support, and J. Hayles for deriving the haploid deletion collection. We are grateful to T. Urano for provision of anti-H3K9me2 and Z. Cande, D. Moazed, and J. Partridge for strains. This research was supported by the Epigenome Network of Excellence (EC-FP6/Contract/LSHG-CT-2004-503433 to R.C.A.), an EC Marie-Curie Excellence grant (MEXT-CT-014171 to J.R.); EMBO-LTF (ALT325-2008 to L.S.P.), an MRC Strategic grant (G0301153 to R.C.A.), MRC-FGU Core Support (to C.P.P.), Wellcome Trust Senior Research fellowship (084229/Z/07/Z to J. R.); Wellcome Trust Programme grant (065061/Z to R.C.A.). R.C.A. is a Wellcome Trust Principal Research Fellow.	ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bayne EH, 2008, SCIENCE, V322, P602, DOI 10.1126/science.1164029; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Ekwall K, 1996, J CELL SCI, V109, P2637; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grewal SIS, 1998, GENETICS, V150, P563; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hansen KR, 2006, NUCLEIC ACIDS RES, V34, P78, DOI 10.1093/nar/gkj415; Hong Eun-Jin Erica, 2005, RNA Biol, V2, P106, DOI 10.4161/rna.2.3.2131; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kagansky A, 2009, SCIENCE, V324, P1716, DOI 10.1126/science.1172026; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; Kim HS, 2004, J BIOL CHEM, V279, P42850, DOI 10.1074/jbc.M407259200; Klenov MS, 2007, NUCLEIC ACIDS RES, V35, P5430, DOI 10.1093/nar/gkm576; Kloc A, 2008, TRENDS GENET, V24, P511, DOI 10.1016/j.tig.2008.08.002; Kniola B, 2001, MOL BIOL CELL, V12, P2767, DOI 10.1091/mbc.12.9.2767; Li F, 2005, CURR BIOL, V15, P1448, DOI 10.1016/j.cub.2005.07.021; Matsuyama A, 2004, YEAST, V21, P1289, DOI 10.1002/yea.1181; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nakagawachi T, 2003, ONCOGENE, V22, P8835, DOI 10.1038/sj.onc.1207183; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Neuwald AF, 2000, NUCLEIC ACIDS RES, V28, P3570, DOI 10.1093/nar/28.18.3570; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Pidoux A, 2004, METHODS, V33, P252, DOI 10.1016/j.ymeth.2003.11.021; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Shankaranarayana GD, 2003, CURR BIOL, V13, P1240, DOI 10.1016/S0960-9822(03)00489-5; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Thon G, 2005, GENETICS, V171, P1583, DOI 10.1534/genetics.105.048298; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wiren M, 2005, EMBO J, V24, P2906, DOI 10.1038/sj.emboj.7600758; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406	55	153	154	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					666	677		10.1016/j.cell.2010.01.038	http://dx.doi.org/10.1016/j.cell.2010.01.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211136	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000275197400016
J	Nesbitt, SJ; Sidor, CA; Irmis, RB; Angielczyk, KD; Smith, RMH; Tsuji, LA				Nesbitt, Sterling J.; Sidor, Christian A.; Irmis, Randall B.; Angielczyk, Kenneth D.; Smith, Roger M. H.; Tsuji, Linda A.			Ecologically distinct dinosaurian sister group shows early diversification of Ornithodira	NATURE			English	Article							NEW-MEXICO; ARCHOSAUR; KAROO; EVOLUTION	The early evolutionary history of Ornithodira (avian-line archosaurs) has hitherto been documented by incomplete (Lagerpeton(1)) or unusually specialized forms (pterosaurs and Silesaurus(2)). Recently, a variety of Silesaurus-like taxa have been reported from the Triassic period of both Gondwana and Laurasia, but their relationships to each other and to dinosaurs remain a subject of debate(3-5). Here we report on a new avian-line archosaur from the early Middle Triassic (Anisian) of Tanzania. Phylogenetic analysis places Asilisaurus kongwe gen. et sp. nov. as an avian-line archosaur and a member of the Silesauridae, which is here considered the sister taxon to Dinosauria. Silesaurids were diverse and had a wide distribution by the Late Triassic, with a novel ornithodiran bauplan including leaf-shaped teeth, a beak-like lower jaw, long, gracile limbs, and a quadrupedal stance. Our analysis suggests that the dentition and diet of silesaurids, ornithischians and sauropodomorphs evolved independently from a plesiomorphic carnivorous form. As the oldest avian-line archosaur, Asilisaurus demonstrates the antiquity of both Ornithodira and the dinosaurian lineage. The initial diversification of Archosauria, previously documented by crocodilian-line archosaurs in the Anisian(6), can now be shown to include a contemporaneous avian-line radiation. The unparalleled taxonomic diversity of the Manda archosaur assemblage indicates that archosaur diversification was well underway by the Middle Triassic or earlier.	[Nesbitt, Sterling J.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Nesbitt, Sterling J.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Sidor, Christian A.] Univ Washington, Burke Museum, Seattle, WA 98195 USA; [Sidor, Christian A.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Irmis, Randall B.] Utah Museum Nat Hist, Salt Lake City, UT 84112 USA; [Irmis, Randall B.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; [Angielczyk, Kenneth D.] Field Museum, Dept Geol, Chicago, IL 60605 USA; [Smith, Roger M. H.] Iziko S African Museum, ZA-8000 Cape Town, South Africa; [Tsuji, Linda A.] Humboldt Univ, Museum Nat Kunde, D-10115 Berlin, Germany	Columbia University; American Museum of Natural History (AMNH); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah; Field Museum of Natural History (Chicago); Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung	Nesbitt, SJ (corresponding author), Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA.	nesbitt@jsg.utexas.edu	Smith, Roger/AAF-7947-2019	Nesbitt, Sterling/0000-0002-7017-1652	National Geographic Society Research and Exploration [7587-05]; Evolving Earth Foundation; Grainger Foundation; NSF [DBI-0306158]	National Geographic Society Research and Exploration(National Geographic Society); Evolving Earth Foundation; Grainger Foundation; NSF(National Science Foundation (NSF))	We thank L. Herzog for preparation of the material and P. Barrett, P. Makovicky, A. Turner and N. Smith for discussions. We acknowledge A. Tibaijuka and C. Saanane for their help with permits and fieldwork logistics. Funding was provided by a National Geographic Society Research and Exploration grant (7587-05 to C. A. S.), the Evolving Earth Foundation (to S.J.N.), The Grainger Foundation (to K. D. A.), an NSF Postdoctoral Research Fellowship (DBI-0306158 to K. D. A.), and NSF Graduate Research Fellowships (to S.J.N. and R. B. I.).	ARCUCCI A, 1987, Ameghiniana, V24, P89; Barrett Paul M., 2000, P42, DOI 10.1017/CBO9780511549717.004; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Butler RJ, 2009, J VERTEBR PALEONTOL, V29, P1022, DOI 10.1671/039.029.0404; Catuneanu O, 2005, J AFR EARTH SCI, V43, P211, DOI 10.1016/j.jafrearsci.2005.07.007; CHARIG AJ, 1957, DISS U CAMBR 1955 56, P28; CROMPTON A. W., 1955, PROC ZOOL SOC LONDON, V125, P617; Dzik J, 2003, J VERTEBR PALEONTOL, V23, P556, DOI 10.1671/A1097; DZIK J, 2007, PALEONT POL, V64, P1; Ezcurra MD, 2006, GEODIVERSITAS, V28, P649; Ferigolo J., 2006, HIST BIOL, V19, P1, DOI DOI 10.1080/08912960600845767; Gay SA, 1999, J AFR EARTH SCI, V29, P195, DOI 10.1016/S0899-5362(99)00089-5; Haughton S. H., 1932, Quarterly Journal of the Geological Society of London, V88, P634; HUENE FRIEDRICH V., 1939, NEUES JAHRB MINERAL GEOL U PALAONT ABT B BEILAGE BD, V81, P61; Irmis RB, 2007, SCIENCE, V317, P358, DOI 10.1126/science.1143325; Langer MC, 2006, J SYST PALAEONTOL, V4, P309, DOI 10.1017/S1477201906001970; Martinez RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004397; Nesbitt SJ, 2003, P ROY SOC B-BIOL SCI, V270, pS234, DOI 10.1098/rsbl.2003.0066; Nesbitt SJ, 2007, J SYST PALAEONTOL, V5, P209, DOI 10.1017/S1477201907002040; Nesbitt SJ, 2009, J VERTEBR PALEONTOL, V29, P498, DOI 10.1671/039.029.0218; NOVAS FE, 1989, J PALEONTOL, V63, P677, DOI 10.1017/S0022336000041317; Novas FE, 1996, J VERTEBR PALEONTOL, V16, P723, DOI 10.1080/02724634.1996.10011361; Romer A. S., 1971, Breviora, VNo. 378, P1; Romer A.S., 1972, Breviora, VNo. 394, P1; Rubidge BS, 2005, S AFR J GEOL, V108, P135, DOI 10.2113/108.1.135; Sidor C, 2008, J VERTEBR PALEONTOL, V28, p142A; VONHUENE F, 1938, NOVA ACTA LEOPOLDINA, V6, P7; WALKER AD, 1970, PHILOS T ROY SOC B, V257, P323, DOI 10.1098/rstb.1970.0028; Wopfner H, 2002, J AFR EARTH SCI, V34, P167, DOI 10.1016/S0899-5362(02)00016-7; Zanno LE, 2009, P ROY SOC B-BIOL SCI, V276, P3505, DOI 10.1098/rspb.2009.1029	30	201	211	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2010	464	7285					95	98		10.1038/nature08718	http://dx.doi.org/10.1038/nature08718			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20203608				2022-12-28	WOS:000275117500040
J	Sarewitz, D				Sarewitz, Daniel			Curing climate backlash	NATURE			English	Editorial Material									Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA	Arizona State University	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA.	dsarewitz@gmail.com							0	23	23	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 4	2010	464	7285					28	28		10.1038/464028a	http://dx.doi.org/10.1038/464028a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	563GZ	20203581	Bronze			2022-12-28	WOS:000275117500012
J	Black, DM; Kelly, MP; Genant, HK; Palermo, L; Eastell, R; Bucci-Rechtweg, C; Cauley, J; Leung, PC; Boonen, S; Santora, A; de Papp, A; Bauer, DC				Black, Dennis M.; Kelly, Michael P.; Genant, Harry K.; Palermo, Lisa; Eastell, Richard; Bucci-Rechtweg, Christina; Cauley, Jane; Leung, Ping Chung; Boonen, Steven; Santora, Arthur; de Papp, Anne; Bauer, Douglas C.		Fracture Intervention Trial Comm; HORIZON Pivotal Fracture Trial Ste	Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUPPRESSED BONE TURNOVER; FEMORAL-SHAFT FRACTURES; LONG-TERM ALENDRONATE; INTERVENTION TRIAL; VERTEBRAL FRACTURES; RANDOMIZED-TRIAL; THERAPY; WOMEN; OSTEOPOROSIS; RISK	BACKGROUND A number of recent case reports and series have identified a subgroup of atypical fractures of the femoral shaft associated with bisphosphonate use. A population-based study did not support this association. Such a relationship has not been examined in randomized trials. METHODS We performed secondary analyses using the results of three large, randomized bisphosphonate trials: the Fracture Intervention Trial (FIT), the FIT Long-Term Extension (FLEX) trial, and the Health Outcomes and Reduced Incidence with Zoledronic Acid Once Yearly (HORIZON) Pivotal Fracture Trial (PFT). We reviewed fracture records and radiographs (when available) from all hip and femur fractures to identify those below the lesser trochanter and above the distal metaphyseal flare (subtrochanteric and diaphyseal femur fractures) and to assess atypical features. We calculated the relative hazards for subtrochanteric and diaphyseal fractures for each study. RESULTS We reviewed 284 records for hip or femur fractures among 14,195 women in these trials. A total of 12 fractures in 10 patients were classified as occurring in the subtrochanteric or diaphyseal femur, a combined rate of 2.3 per 10,000 patient-years. As compared with placebo, the relative hazard was 1.03 (95% confidence interval [CI], 0.06 to 16.46) for alendronate use in the FIT trial, 1.50 (95% CI, 0.25 to 9.00) for zoledronic acid use in the HORIZON-PFT trial, and 1.33 (95% CI, 0.12 to 14.67) for continued alendronate use in the FLEX trial. Although increases in risk were not significant, confidence intervals were wide. CONCLUSIONS The occurrence of fracture of the subtrochanteric or diaphyseal femur was very rare, even among women who had been treated with bisphosphonates for as long as 10 years. There was no significant increase in risk associated with bisphosphonate use, but the study was underpowered for definitive conclusions.	[Black, Dennis M.; Kelly, Michael P.; Genant, Harry K.; Palermo, Lisa; Bauer, Douglas C.] Univ Calif San Francisco, San Francisco, CA 94107 USA; [Eastell, Richard] Univ Sheffield, Sheffield, S Yorkshire, England; [Bucci-Rechtweg, Christina] Novartis Pharmaceut, E Hanover, NJ USA; [Cauley, Jane] Univ Pittsburgh, Pittsburgh, PA USA; [Leung, Ping Chung] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Boonen, Steven] Katholieke Univ Leuven, Leuven, Belgium; [Santora, Arthur; de Papp, Anne] Merck Res Labs, Rahway, NJ USA	University of California System; University of California San Francisco; University of Sheffield; Novartis; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese University of Hong Kong; KU Leuven; Merck & Company	Black, DM (corresponding author), Univ Calif San Francisco, 185 Berry St,Suite 5700, San Francisco, CA 94107 USA.	dblack@psg.ucsf.edu	Kelly, Michael P/CAE-8607-2022; Eastell, Richard/G-5851-2011	Kelly, Michael P/0000-0001-6221-7406; Eastell, Richard/0000-0002-0323-3366; Cauley, Jane A/0000-0003-0752-4408	Merck; Novartis; Amgen; Roche; AstraZeneca; GlaxoSmithKline; Medtronics; Nastech; Nestle; Fonterra Brands; Ono Pharma; Osteologix; Pfizer; Lilly; Sanofi-Aventis; Tethys; Unilever; Unipath; Inverness Medical; Ortho Clinical Diagnostics; OSI Prosidion; Takeda; National Osteoporosis Foundation; Procter Gamble	Merck(Merck & Company); Novartis(Novartis); Amgen(Amgen); Roche(Roche Holding); AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); Medtronics; Nastech; Nestle(Nestle SA); Fonterra Brands(Fonterra); Ono Pharma; Osteologix; Pfizer(Pfizer); Lilly(Eli Lilly); Sanofi-Aventis(Sanofi-Aventis); Tethys; Unilever(Unilever); Unipath; Inverness Medical; Ortho Clinical Diagnostics; OSI Prosidion; Takeda(Takeda Pharmaceutical Company Ltd); National Osteoporosis Foundation; Procter Gamble(Procter & Gamble)	Supported by Merck and Novartis.; Dr. Black reports receiving grants (to UCSF) from Merck, Novartis, Amgen, and Roche and travel reimbursements from Merck and Novartis; Dr. Genant, receiving consulting and lecture fees and grant support from Merck and Novartis; Ms. Palermo, receiving support from Nycomed for data analysis; Dr. Eastell, serving on advisory boards for Procter & Gamble and the Medical Research Council and receiving consulting fees from Amgen, AstraZeneca, GlaxoSmithKline, Medtronics, Nastech, Nestle, Fonterra Brands, Novartis, Ono Pharma, Osteologix, Pfizer, Lilly, Sanofi-Aventis, Tethys, Unilever, Unipath, Inverness Medical, Ortho Clinical Diagnostics, OSI Prosidion, and Roche, lecture fees from Takeda, Lilly, Amgen, National Osteoporosis Foundation, Procter & Gamble, and GlaxoSmithKline Nutrition, and travel expenses from Novartis; Dr. Bucci-Rechwig, being a full-time employee of and having an equity interest in Novartis; Dr. Cauley, receiving consulting fees from Novartis; Drs. Santora and de Papp, being full-time employees of and having equity interests in Merck; and Dr. Bauer, receiving consulting fees from Amgen and lecture fees from Merck. No other potential conflict of interest relevant to this article was reported. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.	Abrahamsen B, 2009, J BONE MINER RES, V24, P1095, DOI [10.1359/JBMR.081247, 10.1359/jbmr.081247]; Armamento-Villareal R, 2006, NEW ENGL J MED, V355, P2048, DOI 10.1056/NEJMc062268; Armamento-Villareal R, 2009, CALCIFIED TISSUE INT, V85, P37, DOI 10.1007/s00223-009-9263-5; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; BLACK DM, 1993, OSTEOPOROSIS INT, V3, pS29; Black DM, 2000, J CLIN ENDOCR METAB, V85, P4118, DOI 10.1210/jc.85.11.4118; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Capeci CM, 2009, J BONE JOINT SURG AM, V91A, P2556, DOI 10.2106/JBJS.H.01774; Cheung Ralph K. H., 2007, Hong Kong Medical Journal, V13, P485; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Glover SJ, 2009, J BONE MINER RES, V24, P389, DOI [10.1359/jbmr.080703, 10.1359/JBMR.080703]; Goh SK, 2007, J BONE JOINT SURG BR, V89B, P349, DOI 10.1302/0301-620X.89B3.18146; Ing-Lorenzini K, 2009, DRUG SAFETY, V32, P775, DOI 10.2165/00002018-200932090-00002; Kwek EBK, 2008, INJURY, V39, P224, DOI 10.1016/j.injury.2007.08.036; Lenart BA, 2009, OSTEOPOROSIS INT, V20, P1353, DOI 10.1007/s00198-008-0805-x; Lenart BA, 2008, NEW ENGL J MED, V358, P1304, DOI 10.1056/NEJMc0707493; Neviaser AS, 2008, J ORTHOP TRAUMA, V22, P346, DOI 10.1097/BOT.0b013e318172841c; Nieves JW, 2010, OSTEOPOROSIS INT, V21, P399, DOI 10.1007/s00198-009-0962-6; Odvina C, 2009, CLIN ENDOCRINOL 0319; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; Salminen S, 1997, J TRAUMA, V43, P117, DOI 10.1097/00005373-199707000-00027; Somford MP, 2009, J BONE MINER RES, V24, P1736, DOI [10.1359/JBMR.090408, 10.1359/jbmr.090408]; Visekruna M, 2008, J CLIN ENDOCR METAB, V93, P2948, DOI 10.1210/jc.2007-2803; Walker AM, 1996, EPIDEMIOLOGY, V7, P335	25	351	366	1	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2010	362	19					1761	1771		10.1056/NEJMoa1001086	http://dx.doi.org/10.1056/NEJMoa1001086			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594RQ	20335571				2022-12-28	WOS:000277555500003
J	Rutkow, L; Vernick, JS; Teret, SP				Rutkow, Lainie; Vernick, Jon S.; Teret, Stephen P.			The Potential Health Effects of Citizens United.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rutkow, Lainie; Vernick, Jon S.; Teret, Stephen P.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Rutkow, L (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.			Rutkow, Helaine/0000-0001-6423-7291				Rutkow L, 2007, J LAW MED ETHICS, V35, P599, DOI 10.1111/j.1748-720X.2007.00183.x; VADA B, 2010, NATL J          0130; *WHIT HOUS, 2010, STAT PRES TOD SUPR C	3	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 15	2010	362	15					1356	1358		10.1056/NEJMp1001653	http://dx.doi.org/10.1056/NEJMp1001653			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	582XY	20237342				2022-12-28	WOS:000276635300002
J	Hagberg, CE; Falkevall, A; Wang, X; Larsson, E; Huusko, J; Nilsson, I; van Meeteren, LA; Samen, E; Lu, L; Vanwildemeersch, M; Klar, J; Genove, G; Pietras, K; Stone-Elander, S; Claesson-Welsh, L; Yla-Herttuala, S; Lindahl, P; Eriksson, U				Hagberg, Carolina E.; Falkevall, Annelie; Wang, Xun; Larsson, Erik; Huusko, Jenni; Nilsson, Ingrid; van Meeteren, Laurens A.; Samen, Erik; Lu, Li; Vanwildemeersch, Maarten; Klar, Joakim; Genove, Guillem; Pietras, Kristian; Stone-Elander, Sharon; Claesson-Welsh, Lena; Yla-Herttuala, Seppo; Lindahl, Per; Eriksson, Ulf			Vascular endothelial growth factor B controls endothelial fatty acid uptake	NATURE			English	Article							VEGF-B; LIPID-METABOLISM; TRANSPORT; ANGIOGENESIS; MOUSE; LACKING; FLT-1; PERMEABILITY; RECEPTOR-1; LETHALITY	The vascular endothelial growth factors (VEGFs) are major angiogenic regulators and are involved in several aspects of endothelial cell physiology(1). However, the detailed role of VEGF-B in blood vessel function has remained unclear(2,3). Here we show that VEGF-B has an unexpected role in endothelial targeting of lipids to peripheral tissues. Dietary lipids present in circulation have to be transported through the vascular endothelium to be metabolized by tissue cells, a mechanism that is poorly understood(4). Bioinformatic analysis showed that Vegfb was tightly co-expressed with nuclear-encoded mitochondrial genes across a large variety of physiological conditions in mice, pointing to a role for VEGF-B in metabolism. VEGF-B specifically controlled endothelial uptake of fatty acids via transcriptional regulation of vascular fatty acid transport proteins. As a consequence, Vegfb(-/-) mice showed less uptake and accumulation of lipids in muscle, heart and brown adipose tissue, and instead shunted lipids to white adipose tissue. This regulation was mediated by VEGF receptor 1 and neuropilin 1 expressed by the endothelium. The co-expression of VEGF-B and mitochondrial proteins introduces a novel regulatory mechanism, whereby endothelial lipid uptake and mitochondrial lipid use are tightly coordinated. The involvement of VEGF-B in lipid uptake may open up the possibility for novel strategies to modulate pathological lipid accumulation in diabetes, obesity and cardiovascular diseases.	[Hagberg, Carolina E.; Falkevall, Annelie; Wang, Xun; Nilsson, Ingrid; Vanwildemeersch, Maarten; Pietras, Kristian; Eriksson, Ulf] Karolinska Inst, Tissue Biol Grp, Div Matrix Biol, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Hagberg, Carolina E.; Falkevall, Annelie; Wang, Xun; Vanwildemeersch, Maarten; Klar, Joakim; Pietras, Kristian; Eriksson, Ulf] Ludwig Inst Canc Res Ltd, Stockholm Branch, Karolinska Inst, SE-17177 Stockholm, Sweden; [Larsson, Erik; Lindahl, Per] Univ Gothenburg, Inst Biomed, SE-40530 Gothenburg, Sweden; [Huusko, Jenni; Yla-Herttuala, Seppo] Univ Kuopio, AI Virtanen Inst, Dept Biotechnol & Mol Med, FIN-70211 Kuopio, Finland; [van Meeteren, Laurens A.; Klar, Joakim; Claesson-Welsh, Lena] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden; [Samen, Erik; Stone-Elander, Sharon] Karolinska Pharm, Karolinska Univ Hosp, SE-17176 Stockholm, Sweden; [Samen, Erik; Lu, Li; Stone-Elander, Sharon] Karolinska Inst, SE-17176 Stockholm, Sweden; [Genove, Guillem] Karolinska Inst, Lab Vasc Biol, Div Matrix Biol, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Lindahl, Per] Sahlgrens Univ Hosp, Wallenberg Lab Cardiovasc Res, SE-41345 Gothenburg, Sweden	Karolinska Institutet; Karolinska Institutet; Ludwig Institute for Cancer Research; University of Gothenburg; University of Eastern Finland; Uppsala University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Sahlgrenska University Hospital	Eriksson, U (corresponding author), Karolinska Inst, Tissue Biol Grp, Div Matrix Biol, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden.	ulf.pe.eriksson@ki.se	Pietras, Kristian/ABG-2097-2021; Larsson Lekholm, Erik/AHE-0932-2022; Larsson Lekholm, Erik/HDM-8032-2022; van Meeteren, Laurens/A-9890-2008; Van Meeteren, Laurens A./AGQ-6139-2022; Klar, Joakim/H-2900-2019; Pietras, Kristian/ABE-8727-2020; Genove, Guillem/F-1158-2011	Pietras, Kristian/0000-0001-6738-4705; Larsson Lekholm, Erik/0000-0003-1400-0119; Larsson Lekholm, Erik/0000-0003-1400-0119; van Meeteren, Laurens/0000-0001-9885-0668; Klar, Joakim/0000-0003-4185-7409; Genove, Guillem/0000-0002-8558-3107; Yla-Herttuala, Seppo/0000-0001-7593-2708; Hagberg, Carolina/0000-0002-5497-2855	Wilhelm och Else Stockmanns Stiftelse; Frans Wilhelm och Waldemar von Frenckells fond; European Commission [LSHG-CT-2004-503573]; Dutch Cancer Society; Novo Nordisk Foundation; Swedish Cancer Foundation; Swedish Research Council; Dr. Peter Wallenbergs Foundation for Economics and Technology; LeDucq Foundation; Swedish Brain Foundation and Hallstens Forskningsstiftelse; Karolinska Institutet	Wilhelm och Else Stockmanns Stiftelse; Frans Wilhelm och Waldemar von Frenckells fond; European Commission(European CommissionEuropean Commission Joint Research Centre); Dutch Cancer Society(KWF Kankerbestrijding); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Dr. Peter Wallenbergs Foundation for Economics and Technology; LeDucq Foundation(Leducq Foundation); Swedish Brain Foundation and Hallstens Forskningsstiftelse; Karolinska Institutet(Karolinska Institutet)	We thank S. Rezian for technical assistance; W. C. Claycomb for the gift of the HL-1 cardiomyocytes; M. McMahon for the TIME cells; A. Nash for the 2H10 anti-VEGF-B monoclonal antibody; K. Plate and M. Shibuya for Flt1-TK<SUP>-/-</SUP> mouse organs; and D. Cheresh for the EC-SCL-Cre-ER<SUP>T</SUP> Nrp1<SUP>fl/fl</SUP> mice. C. E. H. was supported by Wilhelm och Else Stockmanns Stiftelse, and by Frans Wilhelm och Waldemar von Frenckells fond. E. L. was supported by Lymphangiogenomics, an Integrated Project funded by the European Commission within its FP6 Programme, under the thematic area 'Life sciences, genomics and biotechnology for health', contract number LSHG-CT-2004-503573. L. A. v. M. was supported by The Dutch Cancer Society. This study was supported by The Novo Nordisk Foundation, The Swedish Cancer Foundation, The Swedish Research Council, Dr. Peter Wallenbergs Foundation for Economics and Technology, The LeDucq Foundation, The Swedish Brain Foundation and Hallstens Forskningsstiftelse, and the Karolinska Institutet.	Aase K, 2001, CIRCULATION, V104, P358, DOI 10.1161/01.CIR.104.3.358; Acevedo LM, 2008, BLOOD, V111, P2674, DOI 10.1182/blood-2007-08-110205; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bellomo D, 2000, CIRC RES, V86, pE29, DOI 10.1161/01.RES.86.2.e29; BREIER G, 1995, DEV DYNAM, V204, P228, DOI 10.1002/aja.1002040303; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629; Faldt J, 2004, ENDOCRINOLOGY, V145, P2680, DOI 10.1210/en.2003-1319; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Garcia MC, 2006, DIABETES, V55, P1205, DOI 10.2337/db05-1304; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Jia ZZ, 2007, J MOL NEUROSCI, V33, P25, DOI 10.1007/s12031-007-0038-z; Karpanen T, 2008, CIRC RES, V103, P1018, DOI 10.1161/CIRCRESAHA.108.178459; Lahteenvuo JE, 2009, CIRCULATION, V119, P845, DOI 10.1161/CIRCULATIONAHA.108.816454; Leppanen P, 2005, CIRCULATION, V112, P1347, DOI 10.1161/CIRCULATIONAHA.105.534107; Li X, 2008, ARTERIOSCL THROM VAS, V28, P1614, DOI 10.1161/ATVBAHA.107.158725; Makinen T, 1999, J BIOL CHEM, V274, P21217, DOI 10.1074/jbc.274.30.21217; Migdal M, 1998, J BIOL CHEM, V273, P22272, DOI 10.1074/jbc.273.35.22272; Muoio D. M., 2007, NOVART FDN SYMP, V286, P196; Muoio Deborah M, 2007, Novartis Found Symp, V286, P24; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Nauli AM, 2006, GASTROENTEROLOGY, V131, P1197, DOI 10.1053/j.gastro.2006.08.012; Olofsson B, 1996, J BIOL CHEM, V271, P19310, DOI 10.1074/jbc.271.32.19310; Olofsson B, 1998, P NATL ACAD SCI USA, V95, P11709, DOI 10.1073/pnas.95.20.11709; Petersen KF, 2002, J ROY SOC MED, V95, P8; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Rohrer L, 2006, BBA-MOL CELL BIOL L, V1761, P186, DOI 10.1016/j.bbalip.2006.01.009; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Scotney PD, 2002, CLIN EXP PHARMACOL P, V29, P1024, DOI 10.1046/j.1440-1681.2002.03769.x; Springer ML, 2005, AM J PHYSIOL-HEART C, V289, pH1307, DOI 10.1152/ajpheart.00164.2005; Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; van der Vusse GJ, 2000, CARDIOVASC RES, V45, P279, DOI 10.1016/S0008-6363(99)00263-1; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005	38	333	355	4	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					917	U136		10.1038/nature08945	http://dx.doi.org/10.1038/nature08945			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20228789				2022-12-28	WOS:000276397300043
J	Chung, I; Akita, R; Vandlen, R; Toomre, D; Schlessinger, J; Mellman, I				Chung, Inhee; Akita, Robert; Vandlen, Richard; Toomre, Derek; Schlessinger, Joseph; Mellman, Ira			Spatial control of EGF receptor activation by reversible dimerization on living cells	NATURE			English	Article							LIVE CELLS; DOMAIN; SURFACE; MECHANISM; FAMILY	Epidermal growth factor receptor (EGFR) is a type I receptor tyrosine kinase, the deregulation of which has been implicated in a variety of human carcinomas(1-4). EGFR signalling is preceded by receptor dimerization, typically thought to result from a ligand-induced conformational change in the ectodomain that exposes a loop (dimerization arm) required for receptor association. Ligand binding may also trigger allosteric changes in the cytoplasmic domain of the receptor that is crucial for signalling(5-7). Despite these insights, ensemble-averaging approaches have not determined the precise mechanism of receptor activation in situ. Using quantum-dot-based optical tracking of single molecules(8-11) combined with a novel time-dependent diffusivity analysis, here we present the dimerization dynamics of individual EGFRs on living cells. Before ligand addition, EGFRs spontaneously formed finite-lifetime dimers kinetically stabilized by their dimerization arms(12-14). The dimers were primed both for ligand binding and for signalling, such that after EGF addition they rapidly showed a very slow diffusivity state that correlated with activation. Although the kinetic stability of unliganded dimers was in principle sufficient for EGF-independent activation, ligand binding was still required for signalling. Interestingly, dimers were enriched in the cell periphery in an actin-and receptor-expression-dependent fashion, resulting in a peripheral enhancement of EGF-induced signalling that may enable polarized responses to growth factors.	[Chung, Inhee; Akita, Robert; Vandlen, Richard; Mellman, Ira] Genentech Inc, San Francisco, CA 94080 USA; [Toomre, Derek] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Schlessinger, Joseph] Yale Univ, Sch Med, Deparment Pharmacol, New Haven, CT 06510 USA	Roche Holding; Genentech; Yale University; Yale University	Mellman, I (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	mellman.ira@gene.com	Mellman, Ira/ABG-5896-2020	Chung, Inhee/0000-0002-2312-6357	Research Foundation-Flanders; Agency for Innovation by Science and Technology in Flanders ('Generisch Basisonderzoek aan de Universiteiten'); Ghent University; National Institutes of Health; Spanish Ministerio de Ciencia y Tecnologia; Comunidad de Madrid; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR054086, R01AR051448, R01AR051886] Funding Source: NIH RePORTER	Research Foundation-Flanders(FWO); Agency for Innovation by Science and Technology in Flanders ('Generisch Basisonderzoek aan de Universiteiten'); Ghent University(Ghent University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank F. Lammertyn and all colleagues of the Functional Proteomics group at VIB and Ecophysiology-Biochemistry-Toxicology, Centre for Proteome Analysis and Mass Spectrometry (EBT-CEPROMA) at Antwerp University for technical assistance; M. I. Puga and J. Paz-Ares for providing the prey cDNA library for Y2H screens; V. Storme for help with statistical analysis; J. Van Leene and M. Karimi for discussions; and M. De Cock for help in preparing the manuscript. This work was supported by the Research Foundation-Flanders (predoctoral fellowship to L. P.), the Agency for Innovation by Science and Technology in Flanders ('Generisch Basisonderzoek aan de Universiteiten', and predoctoral fellowships to S. T. and J. G.), the Special Research Fund of Ghent University (postdoctoral fellowship to W. G.), the National Institutes of Health (to J. L.) and the Spanish Ministerio de Ciencia y Tecnologia and the Comunidad de Madrid (to R. S.).	ALMEIDA PFF, 1995, LATERAL DIFFUSION ME; Bridges AJ, 1996, CURR MED CHEM, V3, P167; Chung IH, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.165304; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Gambin Y, 2006, P NATL ACAD SCI USA, V103, P2098, DOI 10.1073/pnas.0511026103; Hynes NE, 2001, ENDOCR-RELAT CANCER, V8, P151, DOI 10.1677/erc.0.0080151; JACOBSON K, 1994, FASEB J, V8, P152; Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt767; Johannessen LE, 2006, MOL CELL BIOL, V26, P389, DOI 10.1128/MCB.26.2.389-401.2006; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Klein P, 2004, P NATL ACAD SCI USA, V101, P929, DOI 10.1073/pnas.0307285101; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lidke DS, 2005, J CELL BIOL, V170, P619, DOI 10.1083/jcb.200503140; Macdonald-Obermann JL, 2009, J BIOL CHEM, V284, P13570, DOI 10.1074/jbc.M109.001487; Mattoon D, 2004, P NATL ACAD SCI USA, V101, P923, DOI 10.1073/pnas.0307286101; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Naji A, 2007, BIOPHYS J, V93, pL49, DOI 10.1529/biophysj.l07.119222; Ozcan F, 2006, P NATL ACAD SCI USA, V103, P5735, DOI 10.1073/pnas.0601469103; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SORKIN A, 1993, SCIENCE, V261, P612, DOI 10.1126/science.8342026; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	30	378	386	4	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2010	464	7289					783	U163		10.1038/nature08827	http://dx.doi.org/10.1038/nature08827			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20208517				2022-12-28	WOS:000276205000050
J	Bond-Lamberty, B; Thomson, A				Bond-Lamberty, Ben; Thomson, Allison			Temperature-associated increases in the global soil respiration record	NATURE			English	Article							INTERANNUAL VARIABILITY; TERRESTRIAL ECOSYSTEMS; CARBON; CLIMATE; SENSITIVITY; BOREAL; CO2; DECOMPOSITION; CONSTRAINTS; VEGETATION	Soil respiration, R-S, the flux of microbially and plant-respired carbon dioxide (CO2) from the soil surface to the atmosphere, is the second-largest terrestrial carbon flux(1-3). However, the dynamics of R-S are not well understood and the global flux remains poorly constrained(4,5). Ecosystem warming experiments(6,7), modelling analyses(8,9) and fundamental biokinetics(10) all suggest that R-S should change with climate. This has been difficult to confirm observationally because of the high spatial variability of R-S, inaccessibility of the soil medium and the inability of remote-sensing instruments to measure R-S on large scales. Despite these constraints, it may be possible to discern climate-driven changes in regional or global R-S values in the extant four-decade record of R-S chamber measurements. Here we construct a database of worldwide R-S observations matched with high-resolution historical climate data and find a previously unknown temporal trend in the R-S record after accounting for mean annual climate, leaf area, nitrogen deposition and changes in CO2 measurement technique. We find that the air temperature anomaly (the deviation from the 1961-1990 mean) is significantly and positively correlated with changes in R-S. We estimate that the global R-S in 2008 (that is, the flux integrated over the Earth's land surface over 2008) was 98 +/- 12 Pg C and that it increased by 0.1 Pg C yr(-1) between 1989 and 2008, implying a global R-S response to air temperature (Q(10)) of 1.5. An increasing global R-S value does not necessarily constitute a positive feedback to the atmosphere, as it could be driven by higher carbon inputs to soil rather than by mobilization of stored older carbon. The available data are, however, consistent with an acceleration of the terrestrial carbon cycle in response to global climate change.	[Bond-Lamberty, Ben; Thomson, Allison] Univ Maryland, Pacific NW Natl Lab, Joint Global Change Res Inst, College Pk, MD 20740 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; University System of Maryland; University of Maryland College Park	Bond-Lamberty, B (corresponding author), Univ Maryland, Pacific NW Natl Lab, Joint Global Change Res Inst, 5825 Univ Res Court,Suite 3500, College Pk, MD 20740 USA.	bondlamberty@pnl.gov	Bond-Lamberty, Benjamin/C-6058-2008; Thomson, Allison/GRO-3207-2022; Thomson, Allison M/B-1254-2010	Bond-Lamberty, Benjamin/0000-0001-9525-4633; Thomson, Allison M/0000-0001-5326-1755	US Department of Energy Office of Science; Pacific Northwest National Laboratory	US Department of Energy Office of Science(United States Department of Energy (DOE)); Pacific Northwest National Laboratory(United States Department of Energy (DOE))	This research was supported by the US Department of Energy Office of Science and the Laboratory Directed Research and Development program of the Pacific Northwest National Laboratory. It would not have been possible without the thousands of researchers who measured and published the data collected here. We thank B. Melchior for his assistance.	Bond-Lamberty B, 2004, GLOBAL CHANGE BIOL, V10, P1756, DOI 10.1111/j.1365-2486.2004.00816.x; Bradford MA, 2008, ECOL LETT, V11, P1316, DOI 10.1111/j.1461-0248.2008.01251.x; Bronson DR, 2008, GLOBAL CHANGE BIOL, V14, P856, DOI 10.1111/j.1365-2486.2007.01508.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Dorrepaal E, 2009, NATURE, V460, P616, DOI 10.1038/nature08216; Goetz SJ, 2005, P NATL ACAD SCI USA, V102, P13521, DOI 10.1073/pnas.0506179102; Goldewijk KK, 2007, J LAND USE SCI, V2, P167, DOI 10.1080/17474230701622940; Janssens IA, 2000, TREE PHYSIOL, V20, P23; Jarvis P, 2000, NATURE, V405, P904, DOI 10.1038/35016154; Jones CD, 2003, TELLUS B, V55, P642, DOI 10.1034/j.1600-0889.2003.01440.x; Jones CD, 2001, ATMOS SCI LETT, V2, P166, DOI 10.1006/asle.2001.0041; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; Magnani F, 2007, NATURE, V447, P848, DOI 10.1038/nature05847; Masson V, 2003, J CLIMATE, V16, P1261, DOI 10.1175/1520-0442-16.9.1261; McGuire AD, 1995, J BIOGEOGR, V22, P785, DOI 10.2307/2845980; Potter CS, 1998, GLOBAL BIOGEOCHEM CY, V12, P621, DOI 10.1029/98GB02425; R Core Team, 2020, R LANG ENV STAT COMP; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Raich JW, 2002, GLOBAL CHANGE BIOL, V8, P800, DOI 10.1046/j.1365-2486.2002.00511.x; Reichstein M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002035; Reichstein M, 2008, J PLANT NUTR SOIL SC, V171, P344, DOI 10.1002/jpln.200700075; SCHLESINGER WH, 1977, ANNU REV ECOL SYST, V8, P51, DOI 10.1146/annurev.es.08.110177.000411; Trumbore S, 2006, GLOBAL CHANGE BIOL, V12, P141, DOI 10.1111/j.1365-2486.2006.01067.x; Wutzler T, 2008, BIOGEOSCIENCES, V5, P749, DOI 10.5194/bg-5-749-2008; [No title captured]	30	949	1123	46	912	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					579	U132		10.1038/nature08930	http://dx.doi.org/10.1038/nature08930			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20336143				2022-12-28	WOS:000275974200045
J	Schiff, GD; Bates, DW				Schiff, Gordon D.; Bates, David W.			Can Electronic Clinical Documentation Help Prevent Diagnostic Errors?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Schiff, Gordon D.; Bates, David W.] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Bates, David W.] Partners HealthCare Informat Syst, Boston, MA USA; [Schiff, Gordon D.; Bates, David W.] Harvard Univ, Sch Med, Boston, MA USA; [Bates, David W.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Partners Healthcare System; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Schiff, GD (corresponding author), Brigham & Womens Hosp, Div Gen Internal Med, 75 Francis St, Boston, MA 02115 USA.		Bates, David/AAE-7283-2019					*CRICO HARV RISK M, DIAGN 64 CLAIMS THES; Hartzband P, 2008, NEW ENGL J MED, V358, P1656, DOI 10.1056/NEJMp0802221; Schiff GD, 2008, AM J MED, V121, P38, DOI 10.1016/j.amjmed.2008.02.004; Stead WW, 2009, COMPUTATIONAL TECHNO	4	161	161	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	2010	362	12					1066	1069		10.1056/NEJMp0911734	http://dx.doi.org/10.1056/NEJMp0911734			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573FU	20335582				2022-12-28	WOS:000275894600003
J	Wills, CP; River, G				Wills, Charlotte Page; River, Gerin			Herpes Zoster	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wills, Charlotte Page] Highland Hosp, Alameda Cty Med Ctr, Oakland, CA USA; [River, Gerin] Univ Calif San Francisco, Sch Med, San Francisco, CA USA	University of California System; University of California San Francisco	Wills, CP (corresponding author), Highland Hosp, Alameda Cty Med Ctr, Oakland, CA USA.	cwills@acmedctr.org							0	0	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	2010	362	12					1128	1128		10.1056/NEJMicm0803343	http://dx.doi.org/10.1056/NEJMicm0803343			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573FU	20335589				2022-12-28	WOS:000275894600010
J	Gostin, LO; Connors, EE				Gostin, Lawrence O.; Connors, Elenora E.			Health Care Reform in Transition Incremental Insurance Reform Without an Individual Mandate	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.; Connors, Elenora E.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				[Anonymous], 2010, INCOME POVERTY HLTH; CLAXTON G, 2008, PRIVATE HLTH COVERAG; Glied SA, 2008, NEW ENGL J MED, V358, P1540, DOI 10.1056/NEJMp0802027; JOST TS, 2010, HLTH AFFAIRS BL 0202; JOST TS, HLTH INSURANCE EXCHA; Pear Robert, 2010, N Y TIMES; SCHWARTZ TK, 2010, KAISER COMMISSION ME	7	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2010	303	12					1188	1189		10.1001/jama/2010.375	http://dx.doi.org/10.1001/jama/2010.375			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573AC	20332405				2022-12-28	WOS:000275879600024
J	Gombosi, TI; Ingersoll, AP				Gombosi, Tamas I.; Ingersoll, Andrew P.			Saturn: Atmosphere, Ionosphere, and Magnetosphere	SCIENCE			English	Review							ENCELADUS; FIELD; ROTATION; JUPITERS; PLASMA	The Cassini spacecraft has been in orbit around Saturn since 30 June 2004, yielding a wealth of data about the Saturn system. This review focuses on the atmosphere and magnetosphere and briefly outlines the state of our knowledge after the Cassini prime mission. The mission has addressed a host of fundamental questions: What processes control the physics, chemistry, and dynamics of the atmosphere? Where does the magnetospheric plasma come from? What are the physical processes coupling the ionosphere and magnetosphere? And, what are the rotation rates of Saturn's atmosphere and magnetosphere?	[Gombosi, Tamas I.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Ingersoll, Andrew P.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	University of Michigan System; University of Michigan; California Institute of Technology	Gombosi, TI (corresponding author), Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA.	tamas@umich.edu	Gombosi, Tamas I/G-4238-2011	Gombosi, Tamas I/0000-0001-9360-4951	Cassini mission [JPL 1358124, JPL 1228972]	Cassini mission	This work was supported by the Cassini mission under contracts JPL 1358124 (to T. I. G.) and JPL 1228972 (to A. P. I.).	Anderson JD, 2007, SCIENCE, V317, P1384, DOI 10.1126/science.1144835; Andrews DJ, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012937; Badman SV, 2007, ANN GEOPHYS-GERMANY, V25, P941, DOI 10.5194/angeo-25-941-2007; Baines KH, 2009, PLANET SPACE SCI, V57, P1650, DOI 10.1016/j.pss.2009.06.025; Del Genio AD, 2007, ICARUS, V189, P479, DOI 10.1016/j.icarus.2007.02.013; Dougherty MK, 2005, SCIENCE, V307, P1266, DOI 10.1126/science.1106098; DUNGEY JW, 1961, PHYS REV LETT, V6, P47, DOI 10.1103/PhysRevLett.6.47; Dyudina UA, 2007, ICARUS, V190, P545, DOI 10.1016/j.icarus.2007.03.035; Dyudina UA, 2009, ICARUS, V202, P240, DOI 10.1016/j.icarus.2009.02.014; Fischer G, 2007, ICARUS, V190, P528, DOI 10.1016/j.icarus.2007.04.002; Fletcher LN, 2008, SCIENCE, V319, P79, DOI 10.1126/science.1149514; Fouchet T, 2008, NATURE, V453, P200, DOI 10.1038/nature06912; GEBALLE TR, 1993, ASTROPHYS J, V408, pL109, DOI 10.1086/186843; Gerard JC, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2006JA011965; Glocer A, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA011755; Gombosi TI, 2009, SATURN FROM CASSINI-HUYGENS, P203, DOI 10.1007/978-1-4020-9217-6_9; Gurnett DA, 2005, SCIENCE, V307, P1255, DOI 10.1126/science.1105356; GURNETT DA, 2009, GEOPHYS RES LETT, V36, P4; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; Jackman CM, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013592; Johnson RE, 2006, ASTROPHYS J, V644, pL137, DOI 10.1086/505750; Kliore AJ, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013900; Krimigis SM, 2007, NATURE, V450, P1050, DOI 10.1038/nature06425; Mauk BH, 2009, SATURN FROM CASSINI-HUYGENS, P281, DOI 10.1007/978-1-4020-9217-6_11; Mitchell DG, 2009, SATURN FROM CASSINI-HUYGENS, P257, DOI 10.1007/978-1-4020-9217-6_10; Nagy AF, 2009, SATURN FROM CASSINI-HUYGENS, P181, DOI 10.1007/978-1-4020-9217-6_8; Orton GS, 2008, NATURE, V453, P196, DOI 10.1038/nature06897; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Porco CC, 2005, SCIENCE, V307, P1243, DOI 10.1126/science.1107691; Read PL, 2009, NATURE, V460, P608, DOI 10.1038/nature08194; Salyk C, 2006, ICARUS, V185, P430, DOI 10.1016/j.icarus.2006.08.007; Sanchez-Lavega A, 2007, ICARUS, V187, P510, DOI 10.1016/j.icarus.2006.10.022; Smith HT, 2007, ICARUS, V188, P356, DOI 10.1016/j.icarus.2006.12.007; Vasavada AR, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002563; Vasyliunas V.M., 1983, PHYS JOVIAN MAGNETOS, P395, DOI [10.1017/CBO9780511564574.013, DOI 10.1017/CBO9780511564574.013, 10.1017/cbo9780511564574.013]; Waite JH, 2005, SCIENCE, V307, P1260, DOI 10.1126/science.1105734; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290; Young DT, 2005, SCIENCE, V307, P1262, DOI 10.1126/science.1106151	38	16	17	4	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2010	327	5972					1476	1479		10.1126/science.1179119	http://dx.doi.org/10.1126/science.1179119			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20299587				2022-12-28	WOS:000275715200038
J	Relton, C; Torgerson, D; O'Cathain, A; Nicholl, J				Relton, Clare; Torgerson, David; O'Cathain, Alicia; Nicholl, Jon			Rethinking pragmatic randomised controlled trials: introducing the "cohort multiple randomised controlled trial" design	BMJ-BRITISH MEDICAL JOURNAL			English	Article									[Relton, Clare; O'Cathain, Alicia; Nicholl, Jon] Univ Sheffield, Sch Hlth & Related Res, Sheffield, England; [Torgerson, David] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [Relton, Clare] Univ Leeds, Sch Healthcare, Leeds, W Yorkshire, England	University of Sheffield; University of York - UK; University of Leeds	Relton, C (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Sheffield, England.	c.relton@sheffield.ac.uk	Torgerson, David/L-4566-2019	Torgerson, David/0000-0002-1667-4275				Adamson J, 2006, CONTEMP CLIN TRIALS, V27, P305, DOI 10.1016/j.cct.2005.11.003; Adamson SJ, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1864; Bartlett C, 2005, HEALTH TECHNOL ASSES, V9, P1; BREWIN CR, 1989, BRIT MED J, V299, P313, DOI 10.1136/bmj.299.6694.313; Britton A, 1998, HEALTH TECHNOL ASSES, V2, P13; Campbell Rona, 2005, J Health Serv Res Policy, V10, P220, DOI 10.1258/135581905774414150; FIRTH J, 2007, BRIT MED J, V334, P826; FRANCIS T JR, 1954, AM J PUBLIC HLTH, V45, P1; Hewitt CE, 2006, CAN MED ASSOC J, V175, P347, DOI 10.1503/cmaj.051625; Mason S, 2003, BRIT MED J, V326, P1244, DOI 10.1136/bmj.326.7401.1244; McDonald AM, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-9; OLSCHEWSKI M, 1985, METHOD INFORM MED, V24, P131; Rawlins MD, 2008, HARVEIAN ORATION; RELTON C, 2009, THESIS U SHEFFIELD; Ross S, 1999, J CLIN EPIDEMIOL, V52, P1143, DOI 10.1016/S0895-4356(99)00141-9; Schellings R, 2006, CONTEMP CLIN TRIALS, V27, P320, DOI 10.1016/j.cct.2005.11.009; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; Thorpe KE, 2009, J CLIN EPIDEMIOL, V62, P464, DOI [10.1503/cmaj.090523, 10.1016/j.jclinepi.2008.12.011]; Torgerson DJ, 2008, DESIGNING RANDOMISED TRIALS IN HEALTH, EDUCATION AND THE SOCIAL SCIENCES: AN INTRODUCTION, P1, DOI 10.1057/9780230583993; ZELEN M, 1979, NEW ENGL J MED, V300, P1242, DOI 10.1056/NEJM197905313002203; 2008, CLIN TRIALS DECIDING	22	257	260	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2010	340								c1066	10.1136/bmj.c1066	http://dx.doi.org/10.1136/bmj.c1066			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573RK	20304934				2022-12-28	WOS:000275932100008
J	Partridge, E; Fouad, M				Partridge, Edward; Fouad, Mona			Community-Driven Approaches for Reducing Health Disparities in Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRENDS; MORTALITY		[Partridge, Edward] Univ Alabama Birmingham, Dept Obstet & Gynecol, Div Gynecol Oncol, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Fouad, Mona] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Partridge, E (corresponding author), Univ Alabama Birmingham, Dept Obstet & Gynecol, Div Gynecol Oncol, Ctr Comprehens Canc, 1802 6th Ave S,NP 2555, Birmingham, AL 35294 USA.	eep3840@uab.edu			NATIONAL CANCER INSTITUTE [U54CA118638] Funding Source: NIH RePORTER; NCI NIH HHS [U54 CA118638] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		DeLancey JOL, 2008, CANCER EPIDEM BIOMAR, V17, P2908, DOI 10.1158/1055-9965.EPI-08-0131; FOUAD MN, 2006, J CANC ED S, pS91; FREMONT A, 2003, 290000012 AG HEALTHC; Glied S, 2008, DEMOGRAPHY, V45, P741; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Kinsey T, 2008, JNCI-J NATL CANCER I, V100, P1003, DOI 10.1093/jnci/djn207; Lurie N, 2007, JAMA-J AM MED ASSOC, V297, P1118, DOI 10.1001/jama.297.10.1118; Partridge EE, 2005, FAM COMMUNITY HEALTH, V28, P6, DOI 10.1097/00003727-200501000-00004; Theory at a Glance, 2005, NIH PUBL; World Health Organization, SOC DET HLTH	10	12	12	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1090	1091		10.1001/jama.2010.282	http://dx.doi.org/10.1001/jama.2010.282			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	569KC	20233830				2022-12-28	WOS:000275594100025
J	Hughes, J				Hughes, James			Gabapentin and nortriptyline combined was better than either drug alone for relief of neuropathic pain	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							GENERAL-POPULATION		Tamworth Rural Referral Hosp, Tamworth, NSW, Australia		Hughes, J (corresponding author), Tamworth Rural Referral Hosp, Tamworth, NSW, Australia.							Bouhassira D, 2008, PAIN, V136, P380, DOI 10.1016/j.pain.2007.08.013; Gilron I, 2005, NEW ENGL J MED, V352, P1324, DOI 10.1056/NEJMoa042580; Torrance N, 2006, J PAIN, V7, P281, DOI 10.1016/j.jpain.2005.11.008	3	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	2010	152	6							JC3-6	10.7326/0003-4819-152-6-201003160-02006	http://dx.doi.org/10.7326/0003-4819-152-6-201003160-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573IF	20231560				2022-12-28	WOS:000275905200023
J	Qaseem, A; Snow, V; Gosfield, A; Gregg, D; Michl, K; Wennberg, D; Weiss, KB; Schneider, EC				Qaseem, Amir; Snow, Vincenza; Gosfield, Alice; Gregg, David; Michl, Keith; Wennberg, David; Weiss, Kevin B.; Schneider, Eric C.			Pay for Performance Through the Lens of Medical Professionalism	ANNALS OF INTERNAL MEDICINE			English	Article							FOR-PERFORMANCE; QUALITY; CARE	Lagging quality of care in the U. S. health care system has been a persistent problem and challenge. In the past, medical professionalism and professional certification have served as cornerstones for improving quality in health care. Among newer efforts to improve quality, pay for performance has been proposed to propel better results, but many observers are concerned that pay for performance is at odds with medical professionalism. The authors examine the potential conflicts between pay for performance and medical professionalism and conclude that properly designed pay-for-performance models can support professional objectives.	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Alice G Gosfield & Associates, Philadelphia, PA USA; Gregg Consulting Serv, Minneapolis, MN USA; Maine Med Ctr, Portland, ME 04102 USA; Amer Board Med Specialties, Chicago, IL USA; RAND Corp, Cambridge, MA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA	American College of Physicians; Maine Medical Center; RAND Corporation; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org		Schneider, Eric/0000-0002-1132-5084	American College of Physicians Diabetes Initiative; Novo Nordisk	American College of Physicians Diabetes Initiative; Novo Nordisk(Novo Nordisk)	By the American College of Physicians Diabetes Initiative, sponsored by an unrestricted educational grant from Novo Nordisk.	American College of Physicians, 2006, ADV MED HOM PAT CENT; Brennan TA, 2004, JAMA-J AM MED ASSOC, V292, P1038, DOI 10.1001/jama.292.9.1038; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Cassel CK, 2006, JAMA-J AM MED ASSOC, V295, P939, DOI 10.1001/jama.295.8.939; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; DUDLEY RA, 2004, AHRQ PUBLICATION; EISENBERG J, 1986, DOCTORS DECISIONS CO; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; GREEN J, 1995, NEW ENGL J MED, V332, P1229, DOI 10.1056/NEJM199505043321812; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 1990, CLIN PRACTICE GUIDEL; Pearson SD, 2008, HEALTH AFFAIR, V27, P1167, DOI 10.1377/hlthaff.27.4.1167; Rosenthal MB, 2008, AM J MANAG CARE, V14, P670; Rosenthal MB, 2007, HEALTH AFFAIR, V26, P1674, DOI 10.1377/hlthaff.26.6.1674; Rosenthal MB, 2006, NEW ENGL J MED, V355, P1895, DOI 10.1056/NEJMsa063682; Schneider EC, 2004, NEW ENGL J MED, V350, P143, DOI 10.1056/NEJMsa035634; Snyder L, 2005, ANN INTERN MED, V142, P560, DOI 10.7326/0003-4819-142-7-200504050-00014; Snyder L, 2007, ANN INTERN MED, V147, P792, DOI 10.7326/0003-4819-147-11-200712040-00011; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Walter LC, 2004, JAMA-J AM MED ASSOC, V291, P2466, DOI 10.1001/jama.291.20.2466	20	28	28	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	2010	152	6					366	+		10.7326/0003-4819-152-6-201003160-00006	http://dx.doi.org/10.7326/0003-4819-152-6-201003160-00006			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573IF	20231567				2022-12-28	WOS:000275905200004
J	Stillman, M				Stillman, Michael			Concierge Medicine: A "Regular" Physician's Perspective	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							LUXURY PRIMARY-CARE	Concierge medical practices, which advertise expanded access to care and individualized attention, collect charges both from insurance companies and directly from their patients. Some bill hundreds of dollars for one-time "executive" physicals, whereas others have patients pay annual retainer fees. Yet, virtually no data are available about these "luxury" practices. It is not known how many physicians have "turned concierge," whether they have altered their testing and prescribing patterns, or whether their clinical outcomes are superior to those of their colleagues in traditional practices. Although some have voiced concern that concierge physicians create a 2-tiered system and may contribute to the difficulty that many patients have with access to care, the medical community has largely remained silent on the matter. The mere existence of concierge medicine may reflect our need as physicians to do better by our patients. Yet our responsibility as a professional community is to engage in-not run from-that monumental challenge.	[Stillman, Michael] Boston Univ, Sch Med, Brookline, MA USA	Boston University	Stillman, M (corresponding author), 209 Harvard St,Suite 407, Brookline, MA 02446 USA.	michael.stillman@bmc.org						Alexander GC, 2005, J GEN INTERN MED, V20, P1079, DOI 10.1111/j.1525-1497.2005.0233.x; Brennan TA, 2002, NEW ENGL J MED, V346, P1165, DOI 10.1056/NEJM200204113461513; Carnahan SJ, 2007, J LAW MED ETHICS, V35, P211, DOI 10.1111/j.1748-720X.2007.00125.x; Donohoe M, 2004, J GEN INTERN MED, V19, P90, DOI 10.1111/j.1525-1497.2004.20631.x; Kirkpatrick John, 2002, Physician Exec, V28, P24	5	14	13	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	2010	152	6					391	392		10.7326/0003-4819-152-6-201003160-00009	http://dx.doi.org/10.7326/0003-4819-152-6-201003160-00009			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573IF	20231570				2022-12-28	WOS:000275905200007
J	Salaita, K; Nair, PM; Petit, RS; Neve, RM; Das, D; Gray, JW; Groves, JT				Salaita, Khalid; Nair, Pradeep M.; Petit, Rebecca S.; Neve, Richard M.; Das, Debopriya; Gray, Joe W.; Groves, Jay T.			Restriction of Receptor Movement Alters Cellular Response: Physical Force Sensing by EphA2	SCIENCE			English	Article							IMMUNOLOGICAL SYNAPSE; BREAST-CANCER; LIGANDS; REORGANIZATION; RECOGNITION; MECHANISMS; MICROSCOPY; SUBSTRATE; EPHRIN-A5; MIGRATION	Activation of the EphA2 receptor tyrosine kinase by ephrin-A1 ligands presented on apposed cell surfaces plays important roles in development and exhibits poorly understood functional alterations in cancer. We reconstituted this intermembrane signaling geometry between live EphA2-expressing human breast cancer cells and supported membranes displaying laterally mobile ephrin-A1. Receptor-ligand binding, clustering, and subsequent lateral transport within this junction were observed. EphA2 transport can be blocked by physical barriers nanofabricated onto the underlying substrate. This physical reorganization of EphA2 alters the cellular response to ephrin-A1, as observed by changes in cytoskeleton morphology and recruitment of a disintegrin and metalloprotease 10. Quantitative analysis of receptor-ligand spatial organization across a library of 26 mammary epithelial cell lines reveals characteristic differences that strongly correlate with invasion potential. These observations reveal a mechanism for spatio-mechanical regulation of EphA2 signaling pathways.	[Salaita, Khalid; Nair, Pradeep M.; Petit, Rebecca S.; Groves, Jay T.] Univ Calif Berkeley, Dept Chem, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Salaita, Khalid; Nair, Pradeep M.; Petit, Rebecca S.; Groves, Jay T.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Salaita, Khalid; Nair, Pradeep M.; Petit, Rebecca S.; Groves, Jay T.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Neve, Richard M.; Das, Debopriya; Gray, Joe W.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Gray, Joe W.] Univ Calif San Francisco, Dept Lab Med & Radiat Oncol, San Francisco, CA 94143 USA; [Groves, Jay T.] Natl Univ Singapore, Res Ctr Excellence Mechanobiol, Singapore 117543, Singapore	Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco; National University of Singapore	Groves, JT (corresponding author), Univ Calif Berkeley, Dept Chem, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	jtgroves@lbl.gov	Gray, Joe/AAX-9549-2020; salaita, khalid/C-4414-2008		Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division; Materials Sciences and Engineering Division; U.S. Department of Energy (DOE) [DE-AC0205CH11231]; Office of Science, Office of Basic Energy Sciences, Scientific User Facilities Division, of the U.S. DOE [DE-AC02-05CH11231]; U.S. Army Medical Research Acquisition Activity [BC076701, W81XWH-08-1-0677]; National Cancer Institute (NCI) [U54 CA143836]; Office of Science, Office of Biological and Environmental Research, of the DOE [DE-AC02-05CH11231]; NIH [U54 CA 112970]; NCI [P50 CA 58207]; NATIONAL CANCER INSTITUTE [P50CA058207, U54CA112970, U54CA143836] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division(United States Department of Energy (DOE)); Materials Sciences and Engineering Division(United States Department of Energy (DOE)); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, Scientific User Facilities Division, of the U.S. DOE(United States Department of Energy (DOE)); U.S. Army Medical Research Acquisition Activity; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Office of Science, Office of Biological and Environmental Research, of the DOE(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank N. Bayani for assistance in performing Western blotting, A. Smoligovets and C.-H. Yu for performing transfection and imaging with EGFP-actin-expressing MDA-MB-231 cells, and A. Bershadsky for helpful discussions. This work was supported by the Director, Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division (K. S., P. M. N.; hybrid synthetic-live cell interfaces) and the Materials Sciences and Engineering Division (R. S. P.; supported membrane substrates) of the U.S. Department of Energy (DOE) under contract no. DE-AC0205CH11231. Patterned substrate fabrication was performed, in part, at the Molecular Foundry, Lawrence Berkeley National Laboratory (LBNL), and was supported by the Office of Science, Office of Basic Energy Sciences, Scientific User Facilities Division, of the U.S. DOE under contract no. DE-AC02-05CH11231. This work was also supported by the Laboratory Directed Research and Development Program of LBNL under U.S. DOE contract no. DE-AC02-05CH11231. Seed support for biomedical aspects of this work was provided by the U.S. Department of Defense Breast Cancer Research Program Concept Award BC076701 under U.S. Army Medical Research Acquisition Activity no. W81XWH-08-1-0677, with follow-on support provided by Award U54 CA143836 from the National Cancer Institute (NCI) beginning in 2009. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCI or the NIH. J. W. G. acknowledges support from the Director, Office of Science, Office of Biological and Environmental Research, of the DOE under conract no. DE-AC02-05CH11231; the NIH; NCI grant P50 CA 58207; and the NIH NCI Integrative Cancer Biology Program grant number U54 CA 112970 to J. W. G. (bioinformatics and cell lines). The Regents of the University of California have filed a related patent application through LBNL.	Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Carter N, 2002, NAT CELL BIOL, V4, P565, DOI 10.1038/ncb823; Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Day B, 2005, J BIOL CHEM, V280, P26526, DOI 10.1074/jbc.M504972200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Galush WJ, 2008, BIOPHYS J, V95, P2512, DOI 10.1529/biophysj.108.131540; Groves JT, 2006, CURR OPIN CHEM BIOL, V10, P544, DOI 10.1016/j.cbpa.2006.10.021; Groves JT, 2002, ACCOUNTS CHEM RES, V35, P149, DOI 10.1021/ar950039m; Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651; Hartman NC, 2009, P NATL ACAD SCI USA, V106, P12729, DOI 10.1073/pnas.0902621106; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hurtley S, 2009, SCIENCE, V326, P1205, DOI 10.1126/science.326.5957.1205; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lackmann M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.115re2; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Nam JM, 2006, CHEMBIOCHEM, V7, P436, DOI 10.1002/cbic.200500479; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Taddei ML, 2009, AM J PATHOL, V174, P1492, DOI 10.2353/ajpath.2009.080473; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; VERSCHUEREN H, 1985, J CELL SCI, V75, P279; Walker-Daniels J, 2002, MOL CANCER RES, V1, P79	37	252	255	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1380	1385		10.1126/science.1181729	http://dx.doi.org/10.1126/science.1181729			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223987	Green Submitted, Green Accepted			2022-12-28	WOS:000275418700042
J	Shakhova, N; Semiletov, I; Salyuk, A; Yusupov, V; Kosmach, D; Gustafsson, O				Shakhova, Natalia; Semiletov, Igor; Salyuk, Anatoly; Yusupov, Vladimir; Kosmach, Denis; Gustafsson, Orjan			Extensive Methane Venting to the Atmosphere from Sediments of the East Siberian Arctic Shelf	SCIENCE			English	Article							PERMAFROST; EXCHANGE; ECOSYSTEMS; RELEASE; FLUX; THAW	Remobilization to the atmosphere of only a small fraction of the methane held in East Siberian Arctic Shelf (ESAS) sediments could trigger abrupt climate warming, yet it is believed that sub-sea permafrost acts as a lid to keep this shallow methane reservoir in place. Here, we show that more than 5000 at-sea observations of dissolved methane demonstrates that greater than 80% of ESAS bottom waters and greater than 50% of surface waters are supersaturated with methane regarding to the atmosphere. The current atmospheric venting flux, which is composed of a diffusive component and a gradual ebullition component, is on par with previous estimates of methane venting from the entire World Ocean. Leakage of methane through shallow ESAS waters needs to be considered in interactions between the biogeosphere and a warming Arctic climate.	[Shakhova, Natalia; Semiletov, Igor] Univ Alaska, Int Arctic Res Ctr, Fairbanks, AK 99709 USA; [Shakhova, Natalia; Semiletov, Igor; Salyuk, Anatoly; Yusupov, Vladimir; Kosmach, Denis] Russian Acad Sci, Far Eastern Branch, Pacific Oceanol Inst, Vladivostok 690041, Russia; [Gustafsson, Orjan] Stockholm Univ, Bert Bolin Ctr Climate Res, S-10691 Stockholm, Sweden; [Gustafsson, Orjan] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden	University of Alaska System; University of Alaska Fairbanks; Ilichev Pacific Oceanological Institute; Russian Academy of Sciences; Stockholm University; Stockholm University	Shakhova, N (corresponding author), Univ Alaska, Int Arctic Res Ctr, Fairbanks, AK 99709 USA.	nshakhov@iarc.uaf.edu	Semiletov, Igor/CAJ-4412-2022; Salyuk, Anatoly/U-2374-2019; Yusupov, Vladimir I/B-4555-2013; Kosmach, Denis Alekseevich/AAT-5710-2020; Semiletov, Igor P/B-3616-2013; Shakhova, Natalia Evgenievna/H-6691-2016	Yusupov, Vladimir I/0000-0002-9438-6295; Kosmach, Denis Alekseevich/0000-0002-2276-324X; 	International Arctic Research Centre through a National Oceanic and Atmospheric Administration; Far Eastern Branch of the Russian Academy of Sciences; Russian Foundation for Basic Research; NSF; Swedish Research Council; Knut and Alice Wallenberg Foundation	International Arctic Research Centre through a National Oceanic and Atmospheric Administration; Far Eastern Branch of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NSF(National Science Foundation (NSF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	We thank V. Sergienko, G. Golitsyn, S. Akasofu, L. Hinzman, and V. Akulichev for their support of our work in the Siberian Arctic. This research was supported by the International Arctic Research Centre through a National Oceanic and Atmospheric Administration Cooperative Agreement, the Far Eastern Branch of the Russian Academy of Sciences, the Russian Foundation for Basic Research, NSF, the Swedish Research Council, and the Knut and Alice Wallenberg Foundation.	Baldocchi DD, 2003, GLOBAL CHANGE BIOL, V9, P479, DOI 10.1046/j.1365-2486.2003.00629.x; Edson JB, 1998, J ATMOS OCEAN TECH, V15, P547, DOI 10.1175/1520-0426(1998)015<0547:DCFEFM>2.0.CO;2; Fujitani T, 1985, PAP METEOROL GEOPHYS, V36, P157, DOI [10.2467/mripapers. 36.157, DOI 10.2467/MRIPAPERS.36.157]; GRAMBERG IS, 1983, P WORLD PET C, V11, P93; IPCC, 2007, SCI BAS; Karl DM, 2008, NAT GEOSCI, V1, P473, DOI 10.1038/ngeo234; Kattsov VM, 2015, ARCTIC CLIMATE IMPAC, P99; Leifer I, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002668; Lindsay RW, 2009, J CLIMATE, V22, P165, DOI 10.1175/2008JCLI2521.1; Mastepanov M, 2008, NATURE, V456, P628, DOI 10.1038/nature07464; Nisbet EG, 2009, SCIENCE, V324, P477, DOI 10.1126/science.1172001; OECHEL WC, 1993, NATURE, V361, P520, DOI 10.1038/361520a0; OWENS NJP, 1991, NATURE, V354, P293, DOI 10.1038/354293a0; Petrenko VV, 2009, SCIENCE, V324, P506, DOI 10.1126/science.1168909; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Rigby M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036037; Romanovskii NN, 2005, GEO-MAR LETT, V25, P167, DOI 10.1007/s00367-004-0198-6; Schuur EAG, 2009, NATURE, V459, P556, DOI 10.1038/nature08031; Semiletov IP, 1999, J ATMOS SCI, V56, P286, DOI 10.1175/1520-0469(1999)056<0286:ASASOC>2.0.CO;2; Shakhova N, 2007, J MARINE SYST, V66, P227, DOI 10.1016/j.jmarsys.2006.06.006; Shakhova N, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022751; Soloviev V.A., 1987, CRYOTHERMIA GAS HYDR; SOLOVIEV VA, 2000, 6 INT C GAS MAR SED, P123; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Walter KM, 2006, NATURE, V443, P71, DOI 10.1038/nature05040; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Westbrook GK, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039191; Zimov SA, 2006, SCIENCE, V312, P1612, DOI 10.1126/science.1128908; Zwiers FW, 2002, NATURE, V416, P690, DOI 10.1038/416690a	29	380	413	3	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2010	327	5970					1246	1250		10.1126/science.1182221	http://dx.doi.org/10.1126/science.1182221			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20203047				2022-12-28	WOS:000275162100037
J	Sipila, M; Berndt, T; Petaja, T; Brus, D; Vanhanen, J; Stratmann, F; Patokoski, J; Mauldin, RL; Hyvarinen, AP; Lihavainen, H; Kulmala, M				Sipila, Mikko; Berndt, Torsten; Petaja, Tuukka; Brus, David; Vanhanen, Joonas; Stratmann, Frank; Patokoski, Johanna; Mauldin, Roy L., III; Hyvarinen, Antti-Pekka; Lihavainen, Heikki; Kulmala, Markku			The Role of Sulfuric Acid in Atmospheric Nucleation	SCIENCE			English	Article							PARTICLE FORMATION; AEROSOL FORMATION; H2SO4; GROWTH; SIZE; NM; MECHANISMS; VAPORS; RATES; SO2	Nucleation is a fundamental step in atmospheric new-particle formation. However, laboratory experiments on nucleation have systematically failed to demonstrate sulfuric acid particle formation rates as high as those necessary to account for ambient atmospheric concentrations, and the role of sulfuric acid in atmospheric nucleation has remained a mystery. Here, we report measurements of new particles ( with diameters of approximately 1.5 nanometers) observed immediately after their formation at atmospherically relevant sulfuric acid concentrations. Furthermore, we show that correlations between measured nucleation rates and sulfuric acid concentrations suggest that freshly formed particles contain one to two sulfuric acid molecules, a number consistent with assumptions that are based on atmospheric observations. Incorporation of these findings into global models should improve the understanding of the impact of secondary particle formation on climate.	[Sipila, Mikko; Berndt, Torsten; Stratmann, Frank] Leibniz Inst Tropospharenforsch eV, D-04318 Leipzig, Germany; [Sipila, Mikko; Petaja, Tuukka; Vanhanen, Joonas; Patokoski, Johanna; Kulmala, Markku] Univ Helsinki, Dept Phys, FIN-00014 Helsinki, Finland; [Sipila, Mikko] Univ Helsinki, Helsinki Inst Phys, FIN-00014 Helsinki, Finland; [Brus, David] Acad Sci Czech Republic, Inst Chem Proc Fundamentals, Lab Aerosol Chem & Phys, Prague 18502, Czech Republic; [Brus, David; Hyvarinen, Antti-Pekka; Lihavainen, Heikki] Finnish Meteorol Inst, FIN-00101 Helsinki, Finland; [Mauldin, Roy L., III] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Kulmala, Markku] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden	Leibniz Institut fur Tropospharenforschung (TROPOS); University of Helsinki; Helsinki Institute of Physics; University of Helsinki; Czech Academy of Sciences; Institute of Chemical Process Fundamentals of the Czech Academy of Sciences; Finnish Meteorological Institute; National Center Atmospheric Research (NCAR) - USA; Stockholm University	Sipila, M (corresponding author), Leibniz Inst Tropospharenforsch eV, D-04318 Leipzig, Germany.	mikko.sipila@helsinki.fi	Kulmala, Markku T/I-7671-2016; Brus, David/A-8296-2011; Sipilä, Mikko/G-3024-2010; Hyvärinen, Antti-Pekka/A-9025-2011; Lihavainen, Heikki/N-4840-2014; Petäjä, Tuukka/A-8009-2008	Kulmala, Markku T/0000-0003-3464-7825; Brus, David/0000-0002-8766-7873; Sipilä, Mikko/0000-0002-8594-7003; Hyvärinen, Antti-Pekka/0000-0001-7938-071X; Petäjä, Tuukka/0000-0002-1881-9044	European Commision [036833-2]; Kone foundation; Vaisala foundation; Otto Malm foundation; Academy of Finland; European Research Council	European Commision; Kone foundation; Vaisala foundation; Otto Malm foundation; Academy of Finland(Academy of Finland); European Research Council(European Research Council (ERC)European Commission)	We thank K. Pielok and A. Rohmer for technical assistance and J. Heitzenberg, K. E. J. Lehtinen, V.- M. Kerminen, and M. McGrath for help preparing the manuscript. C. D. O'Dowd is acknowledged for providing the PHA-UCPC instrument. K. Lehtipalo is acknowledged for assistance with the PHA-UCPC, J. Mikkil and E. Siivola for constructing the PSM, R. Taipale for help with the PTR-MS, J. Hakala and K. Neitola for assistance with experiments, and T. Nieminen for useful discussions. This work was partially funded by European Commision 6th Framework program project European Integrated Project on Aerosol, Cloud, Climate, and Air Quality Interactions (EUCAARI), contract 036833-2. Financial support from Kone foundation, Vaisala foundation, Otto Malm foundation, the Academy of Finland and European Research Council is acknowledged.	Ball SM, 1999, J GEOPHYS RES-ATMOS, V104, P23709, DOI 10.1029/1999JD900411; Benson DR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033387; Berndt T, 2008, ATMOS CHEM PHYS, V8, P6365, DOI 10.5194/acp-8-6365-2008; Berndt T, 2005, SCIENCE, V307, P698, DOI 10.1126/science.1104054; Berndt T, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026660; Birmili W, 2000, GEOPHYS RES LETT, V27, P2205, DOI 10.1029/1999GL011334; EISELE FL, 1993, J GEOPHYS RES-ATMOS, V98, P9001, DOI 10.1029/93JD00031; FRIEND JP, 1980, J PHYS CHEM-US, V84, P2423, DOI 10.1021/j100456a018; Iida K, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009260; KASHCHIEV D, 1982, J CHEM PHYS, V76, P5098, DOI 10.1063/1.442808; Ku BK, 2009, AEROSOL SCI TECH, V43, P241, DOI 10.1080/02786820802590510; Kuang C, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009253; Kulmala M, 2006, ATMOS CHEM PHYS, V6, P787, DOI 10.5194/acp-6-787-2006; Kulmala M, 2004, J AEROSOL SCI, V35, P143, DOI 10.1016/j.jaerosci.2003.10.003; Kulmala M, 2007, SCIENCE, V318, P89, DOI 10.1126/science.1144124; Lehtinen KEJ, 2003, ATMOS CHEM PHYS, V3, P251, DOI 10.5194/acp-3-251-2003; MCMURRY PH, 1980, J COLLOID INTERF SCI, V78, P513, DOI 10.1016/0021-9797(80)90589-5; O'Dowd CD, 2002, NATURE, V416, P497, DOI 10.1038/416497a; O'Dowd CD, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000555; Riipinen I, 2007, ATMOS CHEM PHYS, V7, P1899, DOI 10.5194/acp-7-1899-2007; Sgro LA, 2004, AEROSOL SCI TECH, V38, P1, DOI 10.1080/02786820490247560; Sihto SL, 2006, ATMOS CHEM PHYS, V6, P4079, DOI 10.5194/acp-6-4079-2006; Sipila M, 2009, AEROSOL SCI TECH, V43, P126, DOI 10.1080/02786820802506227; Smith JN, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032523; Smith JN, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD005912; Viisanen Y, 1997, J CHEM PHYS, V107, P920, DOI 10.1063/1.474445; Weber RJ, 1996, CHEM ENG COMMUN, V151, P53, DOI 10.1080/00986449608936541; Weber RJ, 1999, GEOPHYS RES LETT, V26, P307, DOI 10.1029/1998GL900308; WYSLOUZIL BE, 1991, J CHEM PHYS, V94, P6842, DOI 10.1063/1.460262; Young LH, 2008, ATMOS CHEM PHYS, V8, P4997, DOI 10.5194/acp-8-4997-2008; Zhang RY, 2004, SCIENCE, V304, P1487, DOI 10.1126/science.1095139	31	522	533	11	374	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2010	327	5970					1243	1246		10.1126/science.1180315	http://dx.doi.org/10.1126/science.1180315			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20203046				2022-12-28	WOS:000275162100036
J	Auperin, A; Le Chevalier, T; Le Pechoux, C; Pignon, JP; Tribodet, H; Burdett, S; Stewart, LA; Tierney, JF; Stephens, RJ; Arriagada, R; Higgins, JP; Johnson, DH; van Meerbeeck, J; Parmar, MKB; Souhami, RL; Bergman, B; Dautzenberg, B; Douillard, JY; Dunant, A; Endo, C; Girling, DJ; Imaizumi, M; Kato, H; Keller, SM; Kimura, H; Knuuttila, A; Kodama, K; Komaki, R; Kris, MG; Lad, T; Mineo, T; Park, JH; Piantadosi, S; Pyrhonen, S; Rosell, R; Scagliotti, GV; Seymour, LW; Shepherd, FA; Spiro, SG; Strauss, GM; Sylvester, R; Tada, H; Tanaka, F; Torri, V; Wada, H; Waller, D; Xu, GC				Auperin, A.; Le Chevalier, T.; Le Pechoux, C.; Pignon, J. P.; Tribodet, H.; Burdett, S.; Stewart, L. A.; Tierney, J. F.; Stephens, R. J.; Arriagada, R.; Higgins, J. P.; Johnson, D. H.; van Meerbeeck, J.; Parmar, M. K. B.; Souhami, R. L.; Bergman, B.; Dautzenberg, B.; Douillard, J. Y.; Dunant, A.; Endo, C.; Girling, D. J.; Imaizumi, M.; Kato, H.; Keller, S. M.; Kimura, H.; Knuuttila, A.; Kodama, K.; Komaki, R.; Kris, M. G.; Lad, T.; Mineo, T.; Park, J. H.; Piantadosi, S.; Pyrhonen, S.; Rosell, R.; Scagliotti, G. V.; Seymour, L. W.; Shepherd, F. A.; Spiro, S. G.; Strauss, G. M.; Sylvester, R.; Tada, H.; Tanaka, F.; Torri, V.; Wada, H.; Waller, D.; Xu, G. C.		NSCLC Meta-Analyses Collaborative	Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data	LANCET			English	Article							RESECTED STAGE-I; VINORELBINE PLUS CISPLATIN; JAPAN STUDY-GROUP; RANDOMIZED-TRIAL; URACIL-TEGAFUR; THERAPY; SURGERY; UFT; VINDESINE; CARCINOMA	Background Many randomised controlled trials have investigated the effect of adjuvant chemotherapy in operable non-small-cell lung cancer. We undertook two comprehensive systematic reviews and meta-analyses to establish the effects of adding adjuvant chemotherapy to surgery, or to surgery plus radiotherapy. Methods We included randomised trials, not confounded by additional therapeutic differences between the two groups and that started randomisation on or after Jan 1,1965, which compared surgery plus adjuvant chemotherapy versus surgery alone, or surgery plus adjuvant radiotherapy and chemotherapy versus surgery plus adjuvant radiotherapy. Updated individual patient data were collected, checked, and included in meta-analyses stratified by trial. The primary endpoint was overall survival, defined as time from randomisation until death by any cause. All analyses were by intention to treat. Findings The first meta-analysis of surgery plus chemotherapy versus surgery alone was based on 34 trial comparisons and 8447 patients (3323 deaths). We recorded a benefit of adding chemotherapy after surgery (hazard ratio [HR] 0.86, 95% CI 0.81-0.92, p<0.0001), with an absolute increase in survival of 4% (95% CI 3-6) at 5 years (from 60% to 64%). The second meta-analysis of surgery plus radiotherapy and chemotherapy versus surgery plus radiotherapy was based on 13 trial comparisons and 2660 patients (1909 deaths). We recorded a benefit of adding chemotherapy to surgery plus radiotherapy (HR 0-88,95% CIl 0.81-0.97, p=0.009), representing an absolute improvement in survival of 4% (95% CI 1-8) at 5 years (from 29% to 33%). In both meta-analyses we noted little variation in effect according to the type of chemotherapy, other trial characteristics, or patient subgroup. Interpretation The addition of adjuvant chemotherapy after surgery for patients with operable non-small-cell lung cancer improves survival, irrespective of whether chemotherapy was adjuvant to surgery alone or adjuvant to surgery plus radiotherapy.	[Burdett, S.] MRC, Clin Trials Unit, Meta Anal Grp, London NW1 2DA, England; [Auperin, A.; Le Chevalier, T.; Le Pechoux, C.; Pignon, J. P.; Tribodet, H.; Arriagada, R.; Dunant, A.] Inst Gustave Roussy, Villejuif, France; [Arriagada, R.] Karolinska Inst, Stockholm, Sweden; [Johnson, D. H.] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [van Meerbeeck, J.] Ghent Univ Hosp, B-9000 Ghent, Belgium; [Higgins, J. P.] MRC, Biostat Unit, Cambridge CB2 2BW, England; [Souhami, R. L.] Canc Res UK, London, England; [Bergman, B.] Sahlgrens Acad, Gothenburg, Sweden; [Dautzenberg, B.] Grp Hosp Pitie Salpetriere, F-75634 Paris, France; [Endo, C.] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Imaizumi, M.] Nagoya Univ, Sch Med, Nagoya, Aichi 466, Japan; [Kato, H.] Tokyo Med Univ, Tokyo, Japan; [Keller, S. M.] Montefiore Med Ctr, Bronx, NY USA; [Kimura, H.] Chiba Canc Ctr, Chiba 2608717, Japan; [Knuuttila, A.] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Kodama, K.] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan; [Komaki, R.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Kris, M. G.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Lad, T.] Cook Cty Hosp, Chicago, IL 60612 USA; [Mineo, T.] Policlin Tor Vergata Univ, Rome, Italy; [Park, J. H.] Korea Canc Ctr Hosp, Seoul, South Korea; [Piantadosi, S.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Pyrhonen, S.] Turku Univ, Cent Hosp, Turku, Finland; [Rosell, R.] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Barcelona, Spain; [Scagliotti, G. V.] S Luigi Hosp, Turin, Italy; [Seymour, L. W.] Queens Univ, NCIC Clin Trials Grp, Kingston, ON, Canada; [Shepherd, F. A.] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; [Spiro, S. G.] Univ Coll London Hosp, London, England; [Strauss, G. M.] Tufts Med Ctr, Boston, MA USA; [Sylvester, R.] EORTC Headquarters, Brussels, Belgium; [Tada, H.] Osaka City Gen Hosp, Osaka, Japan; [Tanaka, F.] Hyogo Coll Med, Nishinomiya, Hyogo, Japan; [Torri, V.] Ist Ric Farmacol Mario Negri, Milan, Italy; [Wada, H.] Kyoto Univ, Kyoto, Japan; [Waller, D.] Glenfield Hosp, Leicester, Leics, England; [Xu, G. C.] Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	Medical Research Council Clinical Trials Unit; UNICANCER; Gustave Roussy; Karolinska Institutet; Vanderbilt University; Ghent University; Ghent University Hospital; MRC Biostatistics Unit; Cancer Research UK; University of Gothenburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Tohoku University; Nagoya University; Tokyo Medical University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Chiba Cancer Center; University of Helsinki; Helsinki University Central Hospital; Osaka Medical Center for Cancer & Cardiovascular Diseases; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; John H Stroger Junior Hospital Cook County; University of Rome Tor Vergata; Policlin Tor Vergata; National Cancer Center - Korea (NCC); Cedars Sinai Medical Center; University of Turku; Catalan Institute of Oncology; Hospital Germans Trias i Pujol; Queens University - Canada; Canadian Cancer Trials Group; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University College London Hospitals NHS Foundation Trust; University of London; University College London; Tufts Medical Center; European Organisation for Research & Treatment of Cancer; Osaka City General Hospital; Hyogo College of Medicine; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Kyoto University; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Sun Yat Sen University	Burdett, S (corresponding author), MRC, Clin Trials Unit, Meta Anal Grp, 222 Euston Rd, London NW1 2DA, England.	jean-pierre.pignon@igr.fr; sb@ctu.mrc.ac.uk	van Meerbeeck, Jan/ABA-5109-2020; Johnson, David/AHI-8369-2022; Higgins, Julian PT/H-4008-2011; Torri, Valter/H-7550-2015; DAUTZENBERG, Bertrand/F-4104-2017	Higgins, Julian PT/0000-0002-8323-2514; Torri, Valter/0000-0001-9541-9354; Tierney, Jayne/0000-0002-4734-3014; Stewart, Lesley/0000-0003-0287-4724; Kris, Mark/0000-0002-7317-5341; Arriagada, Rodrigo/0000-0002-3134-1735; DAUTZENBERG, Bertrand/0000-0001-6937-8907; PIGNON, Jean-Pierre/0000-0003-2047-1582	Programme Hospitalier de Recherche Clinique; Institut Gustave-Roussy; Programme Hospitalier de Recherche Clinique [AOM 05 209]; Ligue Nationale Contre le Cancer; Sanofi-Aventis; Cancer Research UK [11339] Funding Source: researchfish; Medical Research Council [MC_U122861323, MC_U105285807] Funding Source: researchfish; MRC [MC_U122861323, MC_U105285807] Funding Source: UKRI	Programme Hospitalier de Recherche Clinique; Institut Gustave-Roussy; Programme Hospitalier de Recherche Clinique; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Sanofi-Aventis(Sanofi-Aventis); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	UK Medical Research Council, Institut Gustave-Roussy, Programme Hospitalier de Recherche Clinique (AOM 05 209), Ligue Nationale Contre le Cancer, and Sanofi-Aventis.	ALBERTI W, 1995, BRIT MED J, V311, P899; *AM CANC SOC, 2007, CANC FACTS FIG 2007; Arriagada R, 2010, J CLIN ONCOL, V28, P35, DOI 10.1200/JCO.2009.23.2272; Ayoub J, 1991, P AN M AM SOC CLIN, V10, P247; Berghmans T, 2005, LUNG CANCER, V49, P13, DOI 10.1016/j.lungcan.2005.01.002; Bria E, 2005, J CLIN ONCOL, V23, P7140; Burdett S, 1998, LANCET, V352, P257; Butts CA, 2010, J CLIN ONCOL, V28, P29, DOI 10.1200/JCO.2009.24.0333; Clerici M, 1991, EJC SUPPL, V27, pS173; Datta D, 2003, CHEST, V123, P2096, DOI 10.1378/chest.123.6.2096; DAUTZENBERG B, 1995, CANCER, V76, P779, DOI 10.1002/1097-0142(19950901)76:5<779::AID-CNCR2820760511>3.0.CO;2-O; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; Endo C, 2003, LUNG CANCER-J IASLC, V40, P181, DOI 10.1016/S0169-5002(03)00032-1; FELD R, 1993, JNCI-J NATL CANCER I, V85, P299, DOI 10.1093/jnci/85.4.299; FIGLIN RA, 1994, CHEST, V106, pS310, DOI 10.1378/chest.106.6.310S; Hamada C, 2005, J CLIN ONCOL, V23, P4999, DOI 10.1200/JCO.2005.09.017; Hotta K, 2004, J CLIN ONCOL, V22, P3860, DOI 10.1200/JCO.2004.01.153; ICHINOSE Y, 1991, J SURG ONCOL, V46, P15, DOI 10.1002/jso.2930460105; Imaizumi M, 2005, LUNG CANCER, V49, P85, DOI 10.1016/j.lungcan.2004.11.025; International Association for the Study of Lung Cancer, 2009, STAG MAN THOR ONC; Kato H, 2004, NEW ENGL J MED, V350, P1713, DOI 10.1056/NEJMoa032792; Keller SM, 2000, NEW ENGL J MED, V343, P1217, DOI 10.1056/NEJM200010263431703; Kim S-W, 2003, LUNG CANCER S4, V41, pS152; Kimura H, 1991, LUNG CANCER S, V7, P133; LAD T, 1988, J CLIN ONCOL, V6, P9; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Lefebvre C, 2001, SYSTEMATIC REV HLTH, P69; Mineo TC, 2001, EUR J CARDIO-THORAC, V20, P378, DOI 10.1016/S1010-7940(01)00779-5; Nakagawa K, 2006, BRIT J CANCER, V95, P817, DOI 10.1038/sj.bjc.6603336; Nakagawa M, 2005, ANN ONCOL, V16, P75, DOI 10.1093/annonc/mdi008; NIIRANEN A, 1992, J CLIN ONCOL, V10, P1927, DOI 10.1200/JCO.1992.10.12.1927; OHTA M, 1993, J THORAC CARDIOV SUR, V106, P703, DOI 10.1016/S0022-5223(19)33714-6; Park JH, 2005, EUR J CARDIO-THORAC, V27, P1086, DOI 10.1016/j.ejcts.2005.01.039; Park JH, 2007, J THORACIC ONCOLO S4, V2, pS651, DOI DOI 10.1097/01.JTO.0000283860.47170.B3; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Pisters KMW, 2007, J CLIN ONCOL, V25, P5506, DOI 10.1200/JCO.2007.14.1226; PISTERS KMW, 1994, J SURG ONCOL, V56, P236, DOI 10.1002/jso.2930560407; PORT Meta-analysis Trialists Group, 2005, COCHRANE DB SYST REV, V2; Sawamura K, 1988, LUNG CANCER, V4, pA166; Scagliotti GV, 2003, JNCI-J NATL CANCER I, V95, P1453, DOI 10.1093/jnci/djg059; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Sedrakyan A, 2004, J THORAC CARDIOV SUR, V128, P414, DOI 10.1016/j.jtcvs.2004.04.027; Sekine I, 2008, BRIT J CANCER, V99, P1757, DOI 10.1038/sj.bjc.6604721; Strauss GM, 2008, J CLIN ONCOL, V26, P5043, DOI 10.1200/JCO.2008.16.4855; *STUD GROUP ADJ CH, 1995, EUR J SURG ONCOL, V21, P69; *STUD GROUP ADJ CH, 1992, HAI GAN, V32, P481; Tada H, 2004, LUNG CANCER, V43, P167, DOI 10.1016/j.lungcan.2003.08.028; Toyooka S, 2009, P AN M AM SOC CLIN, V27, pA7560; Ueda H, 2004, ANTI-CANCER DRUG, V15, P29, DOI 10.1097/00001813-200401000-00005; Wada H, 1999, EUR J CARDIO-THORAC, V15, P438, DOI 10.1016/S1010-7940(99)00031-7; Wada H, 1996, J CLIN ONCOL, V14, P1048, DOI 10.1200/JCO.1996.14.4.1048; Waller D, 2004, EUR J CARDIO-THORAC, V26, P173, DOI 10.1016/j.ejcts.2004.03.041; Wang S, 2009, P AN M AM SOC CLIN, V27, pA7563; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Wolf M, 2001, P AN M AM SOC CLIN, V20, p311a; Wu YL, 2009, J THORAC ONCOL, V4, pS583; Xu Guangchuan, 1998, Zhonghua Zhongliu Zazhi, V20, P228; Zarogoulidis K, 1996, P 2 INT C LUNG CANC, pPO35	59	427	443	0	48	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 10	2010	375	9722					1267	1277		10.1016/S0140-6736(10)60059-1	http://dx.doi.org/10.1016/S0140-6736(10)60059-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585VN	20338627	Bronze, Green Published			2022-12-28	WOS:000276858400029
J	Bass, NM; Mullen, KD; Sanyal, A; Poordad, F; Neff, G; Leevy, CB; Sigal, S; Sheikh, MY; Beavers, K; Frederick, T; Teperman, L; Hillebrand, D; Huang, S; Merchant, K; Shaw, A; Bortey, E; Forbes, WP				Bass, Nathan M.; Mullen, Kevin D.; Sanyal, Arun; Poordad, Fred; Neff, Guy; Leevy, Carroll B.; Sigal, Samuel; Sheikh, Muhammad Y.; Beavers, Kimberly; Frederick, Todd; Teperman, Lewis; Hillebrand, Donald; Huang, Shirley; Merchant, Kunal; Shaw, Audrey; Bortey, Enoch; Forbes, William P.			Rifaximin Treatment in Hepatic Encephalopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PORTAL-SYSTEMIC ENCEPHALOPATHY; DOUBLE-BLIND; NATURAL-HISTORY; LACTULOSE; CIRRHOSIS; NEOMYCIN; HOSPITALIZATIONS; MANAGEMENT; SURVIVAL; EFFICACY	BACKGROUND Hepatic encephalopathy is a chronically debilitating complication of hepatic cirrhosis. The efficacy of rifaximin, a minimally absorbed antibiotic, is well documented in the treatment of acute hepatic encephalopathy, but its efficacy for prevention of the disease has not been established. METHODS In this randomized, double-blind, placebo-controlled trial, we randomly assigned 299 patients who were in remission from recurrent hepatic encephalopathy resulting from chronic liver disease to receive either rifaximin, at a dose of 550 mg twice daily ( 140 patients), or placebo ( 159 patients) for 6 months. The primary efficacy end point was the time to the first breakthrough episode of hepatic encephalopathy. The key secondary end point was the time to the first hospitalization involving hepatic encephalopathy. RESULTS Rifaximin significantly reduced the risk of an episode of hepatic encephalopathy, as compared with placebo, over a 6-month period ( hazard ratio with rifaximin, 0.42; 95% confidence interval [CI], 0.28 to 0.64; P<0.001). A breakthrough episode of hepatic encephalopathy occurred in 22.1% of patients in the rifaximin group, as compared with 45.9% of patients in the placebo group. A total of 13.6% of the patients in the rifaximin group had a hospitalization involving hepatic encephalopathy, as compared with 22.6% of patients in the placebo group, for a hazard ratio of 0.50 (95% CI, 0.29 to 0.87; P = 0.01). More than 90% of patients received concomitant lactulose therapy. The incidence of adverse events reported during the study was similar in the two groups, as was the incidence of serious adverse events. CONCLUSIONS Over a 6-month period, treatment with rifaximin maintained remission from hepatic encephalopathy more effectively than did placebo. Rifaximin treatment also significantly reduced the risk of hospitalization involving hepatic encephalopathy. (ClinicalTrials.gov number, NCT00298038.)	[Huang, Shirley; Merchant, Kunal; Shaw, Audrey; Bortey, Enoch; Forbes, William P.] Salix Pharmaceut, 1700 Perimeter Pk Dr, Morrisville, NC 27560 USA; [Bass, Nathan M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Frederick, Todd] Calif Pacific Med Ctr, San Francisco, CA USA; [Poordad, Fred] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Sheikh, Muhammad Y.] Univ Calif San Francisco, Fresno, CA USA; [Hillebrand, Donald] Scripps Clin Res Ctr, La Jolla, CA USA; [Mullen, Kevin D.] Case Western Reserve Univ, Metrohlth Med Ctr, Cleveland, OH USA; [Neff, Guy] Univ Cincinnati, Med Ctr, Cincinnati, OH 45267 USA; [Sanyal, Arun] Virginia Commonwealth Univ, Richmond, NY USA; [Leevy, Carroll B.] Univ Med & Dent New Jersey, Newark, NY USA; [Sigal, Samuel] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Teperman, Lewis] NYU, Sch Med, New York, NY USA; [Beavers, Kimberly] Asheville Gastroenterol Associates, Asheville, NC USA	University of California System; University of California San Francisco; California Pacific Medical Center; Cedars Sinai Medical Center; University of California System; University of California San Francisco; University of California San Francisco at Fresno; Scripps Research Institute; Case Western Reserve University; MetroHealth System; University System of Ohio; University of Cincinnati; Virginia Commonwealth University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Cornell University; New York University	Forbes, WP (corresponding author), Salix Pharmaceut, 1700 Perimeter Pk Dr, Morrisville, NC 27560 USA.		Frederick, Richard Todd/AAG-1125-2020; Sigal, Samuel/AGF-2841-2022	Frederick, Todd/0000-0002-2153-3194	Salix Pharmaceuticals [RFHE3001]; Salix; Hyperion; Takeda; Sanofi-Aventis; Ikaria; Astellas; Pfizer; Gilead; Vertex; Exhalenz; Bayer-Onyx; Amylin; Norgine; Intercept; Roche; Three Rivers; Bristol-Myers Squibb; Otsuka	Salix Pharmaceuticals; Salix; Hyperion; Takeda(Takeda Pharmaceutical Company Ltd); Sanofi-Aventis(Sanofi-Aventis); Ikaria; Astellas(Astellas Pharmaceuticals); Pfizer(Pfizer); Gilead(Gilead Sciences); Vertex(Vertex Pharmaceuticals); Exhalenz; Bayer-Onyx(Bayer AG); Amylin; Norgine; Intercept; Roche(Roche Holding); Three Rivers; Bristol-Myers Squibb(Bristol-Myers Squibb); Otsuka(Otsuka Pharmaceutical)	Supported by Salix Pharmaceuticals (study RFHE3001). Dr. Bass reports receiving consulting or advisory fees from Salix and Hyperion and lecture fees from Salix; Dr. Mullen, steering committee and lecture fees from Salix; Dr. Sanyal, consulting fees or advisory fees from Salix, Takeda, Sanofi-Aventis, Ikaria, Astellas, Pfizer, Gilead, Vertex, Exhalenz, Bayer-Onyx, Amylin, and Norgine and grant support from Salix, Sanofi-Aventis, Gilead, Intercept, and Roche; Dr. Poordad, advisory fees from Salix; Dr. Neff, lecture fees from Roche, Three Rivers, and Bristol-Myers Squibb; Dr. Sigal, consulting fees or advisory fees from Salix, Otsuka, Ikaria, and Roche, lecture fees from Otsuka, and grant support from Salix and Gilead; Dr. Sheikh, grant support from Salix; Dr. Frederick, consulting fees or advisory fees from Salix and Hyperion and lecture fees from Salix; Ms. Huang, Dr. Merchant, Dr. Shaw, and Dr. Bortey report being employees of and holding stock in Salix; and Dr. Forbes reports being an officer and employee of Salix and holding stock in the company. No other potential conflict of interest relevant to this article was reported.	Als-Nielsen B, 2004, BMJ-BRIT MED J, V328, P1046, DOI 10.1136/bmj.38048.506134.EE; [Anonymous], 1983, HEPATIC COMA SYNDROM; Bass NM, 2007, ALIMENT PHARM THER, V25, P23, DOI 10.1111/j.1746-6342.2006.03218.x; Blei AT, 2001, AM J GASTROENTEROL, V96, P1968, DOI 10.1016/S0002-9270(01)02527-8; Brigidi P, 2002, J CHEMOTHERAPY, V14, P290, DOI 10.1179/joc.2002.14.3.290; Brown RS, 2002, LIVER TRANSPLANT, V8, P278, DOI 10.1053/jlts.2002.31340; BUCCI L, 1993, CURR MED RES OPIN, V13, P109, DOI 10.1185/03007999309111539; Bustamante J, 1999, J HEPATOL, V30, P890, DOI 10.1016/S0168-8278(99)80144-5; CONN HO, 1977, GASTROENTEROLOGY, V72, P573; CORDOBA J, 2007, SCHIFFS DIS LIVER, V1, P569; Cordoba J, 2008, SEMIN LIVER DIS, V28, P70, DOI 10.1055/s-2008-1040322; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; De Melo RT, 2008, AM J HEALTH-SYST PH, V65, P818, DOI 10.2146/ajhp070298; Debbia EA, 2008, J CHEMOTHERAPY, V20, P186, DOI 10.1179/joc.2008.20.2.186; DIPIAZZA S, 1991, ITAL J GASTROENTEROL, V23, P403; DuPont HL, 2004, CLIN MICROBIOL INFEC, V10, P1009, DOI 10.1111/j.1469-0691.2004.00997.x; Durante-Mangoni E, 2009, INT J ANTIMICROB AG, V33, P201, DOI 10.1016/j.ijantimicag.2008.09.001; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; FESTI D, 1993, CURR THER RES CLIN E, V54, P598, DOI 10.1016/S0011-393X(05)80681-2; Gerard Laura, 2005, Expert Rev Anti Infect Ther, V3, P201, DOI 10.1586/14787210.3.2.201; GIACOMO F, 1993, EUR J CLIN RES, V4, P57; GINES P, 1987, HEPATOLOGY, V7, P122, DOI 10.1002/hep.1840070124; Hampel H, 2001, AM J GASTROENTEROL, V96, P2206, DOI 10.1016/S0002-9270(01)02521-7; Jiang Q, 2008, EUR J GASTROEN HEPAT, V20, P1064, DOI 10.1097/MEG.0b013e328302f470; Jiang ZD, 2005, CHEMOTHERAPY, V51, P67, DOI 10.1159/000081991; Kalaitzakis E, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-46; Lawrence KR, 2008, PHARMACOTHERAPY, V28, P1019, DOI 10.1592/phco.28.8.1019; Leevy CB, 2007, DIGEST DIS SCI, V52, P737, DOI 10.1007/s10620-006-9442-4; LIETMAN PS, 1988, HEPATOLOGY, V8, P966, DOI 10.1002/hep.1840080442; Loguercio C, 2003, Minerva Gastroenterol Dietol, V49, P53; Maclayton DO, 2009, ANN PHARMACOTHER, V43, P77, DOI 10.1345/aph.1K436; Mas A, 2003, J HEPATOL, V38, P51, DOI 10.1016/S0168-8278(02)00350-1; Miglio F, 1997, CURR MED RES OPIN, V13, P593, DOI 10.1185/03007999709113333; Morgan MY, 2007, METAB BRAIN DIS, V22, P389, DOI 10.1007/s11011-007-9060-7; Munoz SJ, 2008, MED CLIN N AM, V92, P795, DOI 10.1016/j.mcna.2008.03.009; Neff GW, 2006, TRANSPL P, V38, P3552, DOI 10.1016/j.transproceed.2006.10.107; Paik YH, 2005, YONSEI MED J, V46, P399, DOI 10.3349/ymj.2005.46.3.399; PEDRETTI G, 1991, ITAL J GASTROENTEROL, V23, P175; Poordad FF, 2007, ALIMENT PHARM THERAP, V25, P3, DOI 10.1111/j.1746-6342.2006.03215.x; PUXEDDU A, 1995, CURR MED RES OPIN, V13, P274, DOI 10.1185/03007999509111552; Sharma BC, 2009, GASTROENTEROLOGY, V137, P885, DOI 10.1053/j.gastro.2009.05.056; Stewart CA, 2007, LIVER TRANSPLANT, V13, P1366, DOI 10.1002/lt.21129; Tierney Jr LM, 1999, CURRENT MED DIAGNOSI, P1453; Williams R, 2000, EUR J GASTROEN HEPAT, V12, P203, DOI 10.1097/00042737-200012020-00012; Wright G, 2007, BEST PRACT RES CL GA, V21, P95, DOI 10.1016/j.bpg.2006.07.009	45	745	778	2	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	2010	362	12					1071	1081		10.1056/NEJMoa0907893	http://dx.doi.org/10.1056/NEJMoa0907893			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573FU	20335583	Bronze			2022-12-28	WOS:000275894600004
J	Heemels, MT				Heemels, Marie-Therese			AGEING	NATURE			English	Editorial Material														Heemels, Marie Therese/0000-0002-4364-3116					0	10	10	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 25	2010	464	7288					503	503		10.1038/464503a	http://dx.doi.org/10.1038/464503a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	574FL	20336131	Bronze			2022-12-28	WOS:000275974200032
J	Ballard, JO				Ballard, J. O.			To Bed With Dad	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												jballard@psu.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2010	303	12					1125	1126		10.1001/jama.2010.318	http://dx.doi.org/10.1001/jama.2010.318			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573AC	20332391				2022-12-28	WOS:000275879600001
J	Jorgensen, KJ; Zahl, PH; Gotzsche, PC				Jorgensen, Karsten Juhl; Zahl, Per-Henrik; Gotzsche, Peter C.			Breast cancer mortality in organised mammography screening in Denmark: comparative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMPACT; DECREASE	Objective To determine whether the previously observed 25% reduction in breast cancer mortality in Copenhagen following the introduction of mammography screening was indeed due to screening, by using an additional screening region and five years additional follow-up. Design We used Poisson regression analyses adjusted for changes in age distribution to compare the annual percentage change in breast cancer mortality in areas where screening was used with the change in areas where it was not used during 10 years before screening was introduced and for 10 years after screening was in practice (starting five years after introduction of screening). Setting Copenhagen, where mammography screening started in 1991, and Funen county, where screening was introduced in 1993. The rest of Denmark (about 80% of the population) served as an unscreened control group. Participants All Danish women recorded in the Cause of Death Register and Statistics Denmark for 1971-2006. Main outcome measure Annual percentage change in breast cancer mortality in regions offering mammography screening and those not offering screening. Results In women who could benefit from screening (ages 55-74 years), we found a mortality decline of 1% per year in the screening areas (relative risk (RR) 0.99, 95% confidence interval (CI) 0.96 to 1.01) during the 10 year period when screening could have had an effect (19972006). In women of the same age in the non-screening areas, there was a decline of 2% in mortality per year (RR 0.98, 95% CI 0.97 to 0.99) in the same 10 year period. In women who were too young to benefit from screening (ages 35-55 years), breast cancer mortality during 19972006 declined 5% per year (RR 0.95, CI 0.92 to 0.98) in the screened areas and 6% per year (RR 0.94, CI 0.92 to 0.95) in the non-screened areas. For the older age groups (75-84 years), there was little change in breast cancer mortality over time in both screened and non-screened areas. Trends were less clear during the 10 year period before screening was introduced, with a possible increase in mortality in women aged less than 75 years in the non-screened regions. Conclusions We were unable to find an effect of the Danish screening programme on breast cancer mortality. The reductions in breast cancer mortality we observed in screening regions were similar or less than those in non-screened areas and in age groups too young to benefit from screening, and are more likely explained by changes in risk factors and improved treatment than by screening mammography.	[Jorgensen, Karsten Juhl; Gotzsche, Peter C.] Univ Copenhagen, Rigshosp, Nord Cochrane Ctr, DK-1168 Copenhagen, Denmark; [Zahl, Per-Henrik] Norwegian Inst Publ Hlth, Oslo, Norway	Rigshospitalet; University of Copenhagen; Norwegian Institute of Public Health (NIPH)	Jorgensen, KJ (corresponding author), Univ Copenhagen, Rigshosp, Nord Cochrane Ctr, DK-1168 Copenhagen, Denmark.	kj@cochrane.dk	Hug, Balthasar L./G-1568-2010	Jorgensen, Karsten/0000-0001-8554-0388				Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Cancer Research UK, 2010, BREAST CANC UK MORT; CANNER PL, 1980, NEW ENGL J MED, V303, P1038; *DAN NAT BOARD HLT, 1997, TIDL OPSP BEH BRYSTK; Duffy SW, 2006, CANCER EPIDEM BIOMAR, V15, P45, DOI 10.1158/1055-9965.EPI-05-0349; Duffy SW, 2002, CANCER-AM CANCER SOC, V95, P458, DOI 10.1002/cncr.10765; Forrest APM, 1987, BREAST CANC SCREEN R, V3rd, P102; Gabe R, 2005, ANN ONCOL, V16, P153, DOI 10.1093/annonc/mdi718; Gotzsche PC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub2; Gotzsche PC, 2006, NEW ENGL J MED, V354, P768; Gotzsche PC, 2005, BRIT MED J, V330, P1024, DOI 10.1136/bmj.330.7498.1024-b; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Jensen A, 2005, INT J CANCER, V113, P464, DOI 10.1002/ijc.20604; Jorgensen Karsten J, 2009, BMC Womens Health, V9, P36, DOI 10.1186/1472-6874-9-36; JORGENSEN KJ, 2009, BMJ-BRIT MED J, V338, P1288; Lawrence G, 2009, BREAST CANCER RES TR, V116, P179, DOI 10.1007/s10549-008-0100-8; Levi F, 2005, EUR J CANCER PREV, V14, P497, DOI 10.1097/00008469-200512000-00002; Lynge E, 2005, BMJ-BRIT MED J, V330, P1025, DOI 10.1136/bmj.330.7498.1025; Mayor S, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1710; Olsen AH, 2005, BMJ-BRIT MED J, V330, P220, DOI 10.1136/bmj.38313.639236.82; Olsen AH, 2007, EPIDEMIOLOGY, V18, P487, DOI 10.1097/EDE.0b013e318060cbbd; PEDERSEN FS, 2007, BERLINGSKE TIDE 0125; Raffle AE, 2007, SCREENING EVIDENCE P; Vainio H, 2002, IARC HDB CANC PREVEN, V7; von Euler-Chelpin M, 2006, EUR J EPIDEMIOL, V21, P203, DOI 10.1007/s10654-006-0002-1; Zahl PH, 2005, BMJ-BRIT MED J, V330, P1024, DOI 10.1136/bmj.330.7498.1024; 2007, JYLLAND POSTEN  0125	27	128	129	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2010	340								c1241	10.1136/bmj.c1241	http://dx.doi.org/10.1136/bmj.c1241			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	576PO	20332505	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000276157600004
J	Schulz, KF; Altman, DG; Moher, D				Schulz, Kenneth F.; Altman, Douglas G.; Moher, David		CONSORT Grp	CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EMPIRICAL-EVIDENCE; REVISED RECOMMENDATIONS; QUALITY; EXTENSION; EXPLANATION; EPIDEMIOLOGY; TREAT; BIAS		[Schulz, Kenneth F.] Family Hlth Int, Res Triangle Pk, NC 27709 USA; [Altman, Douglas G.] Univ Oxford, Wolfson Coll, Ctr Stat Med, Oxford OX1 2JD, England; [Moher, David] Univ Ottawa, Ottawa Methods Ctr, Clin Epidemiol Program,Ottawa Hosp Res Inst, Dept Epidemiol & Community Med, Ottawa, ON, Canada	University of Oxford; University of Ottawa; Ottawa Hospital Research Institute	Schulz, KF (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.	kschulz@fhi.org	Moher, David/I-3408-2019; Altman, Douglas G/A-9714-2012; Groves, Trish/A-9119-2009	Moher, David/0000-0003-2434-4206; Hopewell, Sally/0000-0002-6881-6984; Boutron, Isabelle/0000-0002-5263-6241; Groves, Trish/0000-0001-7915-6419	United Kingdom National Institute for Health Research; Medical Research Council; Canadian Institutes of Health Research; Johnson Johnson; BMJ; American Society for Clinical Oncology; Cancer Research UK; University of Ottawa; Family Health International	United Kingdom National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); BMJ; American Society for Clinical Oncology; Cancer Research UK(Cancer Research UK); University of Ottawa; Family Health International	We received financial support from United Kingdom National Institute for Health Research and the Medical Research Council; Canadian Institutes of Health Research; Presidents Fund, Canadian Institutes of Health Research; Johnson & Johnson; BMJ; and the American Society for Clinical Oncology. DGA is supported by Cancer Research UK, DM by a University of Ottawa Research Chair, and KFS by Family Health International. None of the sponsors had any involvement in the planning, execution, or writing of the CONSORT documents. Additionally, no funder played a role in drafting the manuscript.	ANDREW E, 1994, JAMA-J AM MED ASSOC, V272, P1926, DOI 10.1001/jama.1994.03520240054041; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; De Angelis C, 2004, LANCET, V364, P911, DOI 10.1016/S0140-6736(04)17034-7; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Gagnier JJ, 2006, ANN INTERN MED, V144, P364, DOI 10.7326/0003-4819-144-5-200603070-00013; Glasziou P, 2008, BMJ-BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Hopewell Sally, 2010, BMJ, V340, pc723, DOI 10.1136/bmj.c723; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Nuovo J, 2002, JAMA-J AM MED ASSOC, V287, P2813, DOI 10.1001/jama.287.21.2813; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; RENNIE D, 1995, JAMA-J AM MED ASSOC, V273, P1054, DOI 10.1001/jama.273.13.1054; Sackett DL, 2007, INT J EPIDEMIOL, V36, P664, DOI 10.1093/ije/dym088; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Schulz KF, 2002, LANCET, V359, P696, DOI 10.1016/S0140-6736(02)07816-9; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	33	3438	3484	2	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2010	340								c332	10.1136/bmj.c332	http://dx.doi.org/10.1136/bmj.c332			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	576PO	20332509	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000276157600008
J	Korner, C; Basler, D				Koerner, Christian; Basler, David			Phenology Under Global Warming	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; BUDBURST; PHOTOPERIODISM; RESPONSES		[Koerner, Christian; Basler, David] Univ Basel, Inst Bot, CH-4056 Basel, Switzerland	University of Basel	Korner, C (corresponding author), Univ Basel, Inst Bot, Hebelstr 1, CH-4056 Basel, Switzerland.	ch.koerner@unibas.ch; david.basler@unibas.ch	Körner, Christian/B-6592-2014	Körner, Christian/0000-0001-7768-7638; Basler, David/0000-0002-4068-8319				Borchert R, 2005, INT J BIOMETEOROL, V50, P57, DOI 10.1007/s00484-005-0261-7; Chuine I, 1999, NEW PHYTOL, V143, P339, DOI 10.1046/j.1469-8137.1999.00445.x; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Defila C, 2001, INT J BIOMETEOROL, V45, P203, DOI 10.1007/s004840100101; HAY RKM, 1990, NEW PHYTOL, V116, P233, DOI 10.1111/j.1469-8137.1990.tb04711.x; HEIDE OM, 1993, PHYSIOL PLANTARUM, V88, P531, DOI 10.1111/j.1399-3054.1993.tb01368.x; Jackson SD, 2009, NEW PHYTOL, V181, P517, DOI 10.1111/j.1469-8137.2008.02681.x; K/rner C., 2006, PLANT GROWTH CLIMATE, P48, DOI [10.1002/9780470988695.ch3, DOI 10.1002/9780470988695.CH3]; Keller F, 2003, ARCT ANTARCT ALP RES, V35, P361, DOI 10.1657/1523-0430(2003)035[0361:TROPIA]2.0.CO;2; Keskitalo J, 2005, PLANT PHYSIOL, V139, P1635, DOI 10.1104/pp.105.066845; Khanduri V. P., 2008, Environmentalist, V28, P143, DOI 10.1007/s10669-007-9153-1; LANGLET O, 1971, Taxon, V20, P653, DOI 10.2307/1218596; LARCHER W, 2007, SITZBER ANZEIGER MN, V212, P3; Li CY, 2003, PHYSIOL PLANTARUM, V117, P206, DOI 10.1034/j.1399-3054.2003.00002.x; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Morin X, 2009, GLOBAL CHANGE BIOL, V15, P961, DOI 10.1111/j.1365-2486.2008.01735.x; Moser L, 2010, TREE PHYSIOL, V30, P225, DOI 10.1093/treephys/tpp108; MURRAY MB, 1989, J APPL ECOL, V26, P693, DOI 10.2307/2404093; Penuelas J, 2009, SCIENCE, V324, P887, DOI 10.1126/science.1173004; WAREING PF, 1956, ANNU REV PLANT PHYS, V7, P191, DOI 10.1146/annurev.pp.07.060156.001203	20	665	719	39	603	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2010	327	5972					1461	1462		10.1126/science.1186473	http://dx.doi.org/10.1126/science.1186473			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20299580				2022-12-28	WOS:000275715200031
J	Macilwain, C				Macilwain, Colin			What can little Europe do?	NATURE			English	Editorial Material												cfmworldview@gmail.com							0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 18	2010	464	7287					349	349		10.1038/464349a	http://dx.doi.org/10.1038/464349a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	570FG	20237539	Bronze			2022-12-28	WOS:000275657100013
J	Zimmerli, W				Zimmerli, Werner			Vertebral Osteomyelitis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STAPHYLOCOCCUS-AUREUS; SPINAL OSTEOMYELITIS; FOLLOW-UP; INFECTIONS; DIAGNOSIS; SPONDYLODISCITIS; VANCOMYCIN; MANAGEMENT; DISCITIS; RIFAMPIN	A 57-year-old man presents with fever, chills, and new lumbar back pain 2 weeks after undergoing a prostate biopsy because of an increased prostate-specific antigen level. His temperature is 39.7 degrees C; he has an enlarged, tender prostate and lumbar spine tenderness. His white-cell count is 9100 per cubic millimeter, and the C-reactive protein level is 343 mg per liter. Urine and blood cultures reveal multidrug-resistant, extended-spectrum beta-lactamase-producing Escherichia coli susceptible to imipenem. How should he be evaluated and treated?	[Zimmerli, Werner] Univ Basel, Med Clin, Kantonsspital, Liestal, Switzerland	Kantonsspital Aarau AG (KSA); Kantonsspital Baselland; University of Basel	Zimmerli, W (corresponding author), Univ Basel, Med Clin, Rheinstr 26, CH-4410 Liestal, Switzerland.	werner.zimmerli@unibas.ch	Pedersen, Peter Heide/AAM-4239-2020	Pedersen, Peter Heide/0000-0001-8475-9687				An HS, 2006, CLIN ORTHOP RELAT R, P27, DOI 10.1097/01.blo.0000203452.36522.97; BATEMAN JL, 1995, ORTHOPEDICS, V18, P561; Bucher E, 2000, EUR J CLIN MICROBIOL, V19, P118, DOI 10.1007/s100960050441; Carragee E, 2008, SPINE, V33, P2089, DOI 10.1097/BRS.0b013e3181839b9c; Champsaur P, 2000, J RADIOL, V81, P516; Colmenero JD, 1997, ANN RHEUM DIS, V56, P709, DOI 10.1136/ard.56.12.709; Coskun-Ari FF, 2008, EUR J MED RES, V13, P366; Crompton JA, 2009, J CHEMOTHERAPY, V21, P414, DOI 10.1179/joc.2009.21.4.414; Fenollar F, 2008, CURR OPIN RHEUMATOL, V20, P463, DOI 10.1097/BOR.0b013e3283032030; GENTRY LO, 1991, ANTIMICROB AGENTS CH, V35, P538, DOI 10.1128/AAC.35.3.538; Gilbert DN, 2009, SANFORD GUIDE ANTIMI, P66; Grammatico L, 2008, EPIDEMIOL INFECT, V136, P653, DOI 10.1017/S0950268807008850; Hopkinson N, 2001, QJM-MON J ASSOC PHYS, V94, P465, DOI 10.1093/qjmed/94.9.465; Jensen AG, 1998, ARCH INTERN MED, V158, P509, DOI 10.1001/archinte.158.5.509; Khan Mustafa H, 2006, Spine J, V6, P311, DOI 10.1016/j.spinee.2005.07.006; Kowalski TJ, 2007, CLIN INFECT DIS, V44, P913, DOI 10.1086/512194; Kowalski TJ, 2006, CLIN INFECT DIS, V43, P172, DOI 10.1086/505118; LEE CH, 2009, INT J INFECT DI 0930; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; Livorsi DJ, 2008, J INFECTION, V57, P128, DOI 10.1016/j.jinf.2008.04.012; Love C, 2000, CLIN NUCL MED, V25, P963, DOI 10.1097/00003072-200012000-00002; Malloy KM, 2009, ORTHOPEDICS, V32, P499, DOI 10.3928/01477447-20090527-18; McHenry MC, 2002, CLIN INFECT DIS, V34, P1342, DOI 10.1086/340102; Mylona E, 2009, SEMIN ARTHRITIS RHEU, V39, P10, DOI 10.1016/j.semarthrit.2008.03.002; Nolla JM, 2002, SEMIN ARTHRITIS RHEU, V31, P271, DOI 10.1053/sarh.2002.29492; OSENBACH RK, 1990, SURG NEUROL, V33, P266, DOI 10.1016/0090-3019(90)90047-S; Palestro CJ, 2006, BEST PRACT RES CL RH, V20, P1197, DOI 10.1016/j.berh.2006.08.009; PATZAKIS MJ, 1991, CLIN ORTHOP RELAT R, P178; Perlroth J, 2008, ARCH INTERN MED, V168, P805, DOI 10.1001/archinte.168.8.805; PERRONNE C, 1994, CLIN INFECT DIS, V19, P746, DOI 10.1093/clinids/19.4.746; Pigrau C, 2005, AM J MED, V118, DOI 10.1016/j.amjmed.2005.02.027; Priest DH, 2005, SOUTH MED J, V98, P854, DOI 10.1097/01.smj.0000168666.98129.33; Rice DAK, 2009, ARCH ORTHOP TRAUM SU, V129, P1495, DOI 10.1007/s00402-008-0772-x; Robinson Y, 2009, INT ORTHOP, V33, P745, DOI 10.1007/s00264-008-0567-2; Roblot F, 2007, SEMIN ARTHRITIS RHEU, V36, P269, DOI 10.1016/j.semarthrit.2006.09.004; Scheidegger C, 1996, AIDS, V10, P1407, DOI 10.1097/00002030-199610000-00014; Schrenzel J, 2004, CLIN INFECT DIS, V39, P1285, DOI 10.1086/424506; Sendi P, 2008, QJM-INT J MED, V101, P1, DOI 10.1093/qjmed/hcm100; SOBOTTKE R, 1976, SPINE, V34, pE452; Stengel D, 2001, Lancet Infect Dis, V1, P175, DOI 10.1016/S1473-3099(01)00094-9; Stoeckle A, 2008, SWISS MED WKLY, V138, P512, DOI 2008/35/smw-12228; Strobel K, 2007, SEMIN MUSCULOSKEL R, V11, P353, DOI 10.1055/s-2008-1060337; TORDA AJ, 1995, CLIN INFECT DIS, V20, P320, DOI 10.1093/clinids/20.2.320; Weber U, 2003, CLIN RHEUMATOL, V22, P443, DOI 10.1007/s10067-003-0786-2; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181; Zimmerli W, 1998, JAMA-J AM MED ASSOC, V279, P1537, DOI 10.1001/jama.279.19.1537	46	329	338	1	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2010	362	11					1022	1029		10.1056/NEJMcp0910753	http://dx.doi.org/10.1056/NEJMcp0910753			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570CY	20237348				2022-12-28	WOS:000275650400013
J	Carlberg, B; Lindholm, LH				Carlberg, Bo; Lindholm, Lars Hjalmar			Stroke and blood-pressure variation: new permutations on an old theme	LANCET			English	Editorial Material							PROGNOSTIC VALUE; BETA-BLOCKERS; HYPERTENSION; VARIABILITY; RISK; PREVENTION; GUIDELINES; MANAGEMENT; AMLODIPINE; OUTCOMES		[Carlberg, Bo; Lindholm, Lars Hjalmar] Umea Univ Hosp, Dept Publ Hlth & Clin Med, SE-90185 Umea, Sweden	Umea University	Carlberg, B (corresponding author), Umea Univ Hosp, Dept Publ Hlth & Clin Med, SE-90185 Umea, Sweden.	bo.carlberg@medicin.umu.se						Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Ekbom T, 1992, Blood Press, V1, P168, DOI 10.3109/08037059209077513; FRATTOLA A, 1993, J HYPERTENS, V11, P1133, DOI 10.1097/00004872-199310000-00019; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; KIKUYA M, 2000, HYPERTENSION, V38, P23; Lindholm LH, 2005, LANCET, V366, P1545, DOI 10.1016/S0140-6736(05)67573-3; Mancia G, 2007, HYPERTENSION, V49, P1265, DOI 10.1161/HYPERTENSIONAHA.107.088708; Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d; MEADE TW, 1992, BMJ-BRIT MED J, V304, P405; Messerli FH, 2003, AM J HYPERTENS, V16, P870, DOI 10.1016/S0895-7061(03)01017-3; *NAT COLL CTR CHRO, 2006, HYP MAN AD PRIM CAR; Pringle E, 2003, J HYPERTENS, V21, P2251, DOI 10.1097/00004872-200312000-00012; Rosendorff C, 2007, CIRCULATION, V115, P2761, DOI 10.1161/CIRCULATIONAHA.107.183885; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; WHO Int Soc Hyperten Blood Press Lower, 1998, J HYPERTENS, V16, P127; Wiysonge CS, 2007, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD002003.PUB2; World Health Organization, 2007, PREV CARD DIS GUID A; Wright JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001841.pub2	21	6	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	2010	375	9718					867	869		10.1016/S0140-6736(10)60351-0	http://dx.doi.org/10.1016/S0140-6736(10)60351-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	574NA	20226970				2022-12-28	WOS:000275995300004
J	Basch, E				Basch, Ethan			The Missing Voice of Patients in Drug-Safety Reporting	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SYMPTOMS		Mem Sloan Kettering Canc Ctr, Hlth Outcomes Grp, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Basch, E (corresponding author), Mem Sloan Kettering Canc Ctr, Hlth Outcomes Grp, 1275 York Ave, New York, NY 10021 USA.				NATIONAL CANCER INSTITUTE [K07CA124851] Funding Source: NIH RePORTER; NCI NIH HHS [K07 CA124851, K07 CA124851-03] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Basch E, 2009, JNCI-J NATL CANCER I, V101, P1624, DOI 10.1093/jnci/djp386; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; *NAT AC SCI I MED, 2006, FUT DRUG SAF PROM PR; Pakhomov SV, 2008, AM J MANAG CARE, V14, P530; Weingart SN, 2005, ARCH INTERN MED, V165, P234, DOI 10.1001/archinte.165.2.234	5	410	416	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10					865	869		10.1056/NEJMp0911494	http://dx.doi.org/10.1056/NEJMp0911494			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	566JM	20220181	Green Accepted, Green Published			2022-12-28	WOS:000275365900001
J	Samarasekera, U; Jupp, S				Samarasekera, Udani; Jupp, Susan			Calling young researchers	LANCET			English	Editorial Material									[Samarasekera, Udani] The Lancet, London NW1 7BY, England; [Jupp, Susan] Global Forum Hlth Res, Geneva, Switzerland		Samarasekera, U (corresponding author), The Lancet, London NW1 7BY, England.								0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 6	2010	375	9717					788	789		10.1016/S0140-6736(10)60318-2	http://dx.doi.org/10.1016/S0140-6736(10)60318-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570MO	20206760				2022-12-28	WOS:000275682600009
J	Treister, E; Natarajan, P; Sanders, DB; Urry, CM; Schawinski, K; Kartaltepe, J				Treister, Ezequiel; Natarajan, Priyamvada; Sanders, David B.; Urry, C. Megan; Schawinski, Kevin; Kartaltepe, Jeyhan			Major Galaxy Mergers and the Growth of Supermassive Black Holes in Quasars	SCIENCE			English	Article							ULTRALUMINOUS INFRARED GALAXIES; ACTIVE GALACTIC NUCLEI; STAR-FORMING GALAXIES; DIGITAL-SKY-SURVEY; LUMINOSITY FUNCTION; DEPENDENT EVOLUTION; OBSCURED AGN; TO 2; SELECTION; CHANDRA	Despite observed strong correlations between central supermassive black holes (SMBHs) and star formation in galactic nuclei, uncertainties exist in our understanding of their coupling. We present observations of the ratio of heavily obscured to unobscured quasars as a function of cosmic epoch up to z congruent to 3 and show that a simple physical model describing mergers of massive, gas-rich galaxies matches these observations. In the context of this model, every obscured and unobscured quasar represents two distinct phases that result from a massive galaxy merger event. Much of the mass growth of the SMBH occurs during the heavily obscured phase. These observations provide additional evidence for a causal link between gas-rich galaxy mergers, accretion onto the nuclear SMBH, and coeval star formation.	[Treister, Ezequiel; Sanders, David B.; Kartaltepe, Jeyhan] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Natarajan, Priyamvada; Urry, C. Megan] Yale Univ, Dept Astron, New Haven, CT 06520 USA; [Natarajan, Priyamvada; Urry, C. Megan; Schawinski, Kevin] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Natarajan, Priyamvada; Urry, C. Megan; Schawinski, Kevin] Yale Ctr Astron & Astrophys, New Haven, CT 06520 USA; [Kartaltepe, Jeyhan] Natl Opt Astron Observ, Tucson, AZ 85719 USA	University of Hawaii System; Yale University; Yale University; Yale University; National Optical Astronomy Observatory	Treister, E (corresponding author), Univ Hawaii, Inst Astron, 2680 Woodlawn Dr, Honolulu, HI 96822 USA.	treister@ifa.hawaii.edu; priyamvada.natarajan@yale.edu	Natarajan, Priyamvada/AAG-2086-2021; Schawinski, Kevin/N-7057-2016; Urry, Claudia Megan/G-7381-2011; Kartaltepe, Jeyhan/ABI-1561-2020	Schawinski, Kevin/0000-0001-5464-0888; Urry, Claudia Megan/0000-0002-0745-9792; Kartaltepe, Jeyhan/0000-0001-9187-3605; Sanders, David/0000-0002-1233-9998; Treister, Ezequiel/0000-0001-7568-6412	National Aeronautics and Space Administration (NASA) [PF8-90055, PF9-00069, NAS8-03060]; NSF [AST-0407295]	National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	Support for the work of E. T. and K. S. was provided by the National Aeronautics and Space Administration (NASA) through Chandra/Einstein Postdoctoral Fellowship award numbers PF8-90055 and PF9-00069, respectively, issued by the Chandra X-ray Observatory Center, which is operated by the Smithsonian Astrophysical Observatory for and on behalf of NASA under contract NAS8-03060. P.N. acknowledges the Radcliffe Institute for Advanced Study where this work was started. C. M. U. acknowledges support from NSF grant AST-0407295.	Alexander DM, 2008, ASTROPHYS J, V687, P835, DOI 10.1086/591928; Barger AJ, 2005, ASTRON J, V129, P578, DOI 10.1086/426915; Barger AJ, 2003, ASTRON J, V126, P632, DOI 10.1086/376843; BARNES JE, 1991, ASTROPHYS J, V370, pL65, DOI 10.1086/185978; Dahlen T, 2007, ASTROPHYS J, V654, P172, DOI 10.1086/508854; Della Ceca R, 2008, ASTRON ASTROPHYS, V487, P119, DOI 10.1051/0004-6361:20079319; DIETRICH M, 1998, ASTROPHYS J, V696, P2009; Fiore F, 2009, ASTROPHYS J, V693, P447, DOI 10.1088/0004-637X/693/1/447; Genzel R, 1998, ASTROPHYS J, V498, P579, DOI 10.1086/305576; Gilli R, 2001, ASTRON ASTROPHYS, V366, P407, DOI 10.1051/0004-6361:20000105; Haehnelt MG, 1998, MON NOT R ASTRON SOC, V300, P817, DOI 10.1046/j.1365-8711.1998.01951.x; Hasinger G, 2005, ASTRON ASTROPHYS, V441, P417, DOI 10.1051/0004-6361:20042134; Hopkins PF, 2008, ASTROPHYS J SUPPL S, V175, P356, DOI 10.1086/524362; Kim DC, 1998, ASTROPHYS J SUPPL S, V119, P41, DOI 10.1086/313148; Marchesini D, 2009, ASTROPHYS J, V701, P1765, DOI 10.1088/0004-637X/701/2/1765; Marconi A, 2004, MON NOT R ASTRON SOC, V351, P169, DOI 10.1111/j.1365-2966.2004.07765.x; Martinez-Sansigre A, 2006, MON NOT R ASTRON SOC, V370, P1479, DOI 10.1111/j.1365-2966.2006.10563.x; Martinez-Sansigre A, 2009, ASTROPHYS J, V692, P964, DOI 10.1088/0004-637X/692/2/964; Richards GT, 2006, ASTRON J, V131, P2766, DOI 10.1086/503559; Richards GT, 2009, ASTROPHYS J SUPPL S, V180, P67, DOI 10.1088/0067-0049/180/1/67; SANDERS DB, 1988, ASTROPHYS J, V325, P74, DOI 10.1086/165983; Sanders DB, 1996, ANNU REV ASTRON ASTR, V34, P749, DOI 10.1146/annurev.astro.34.1.749; SCHMIDT M, 1963, NATURE, V197, P1040, DOI 10.1038/1971040a0; Teng SH, 2009, ASTROPHYS J, V691, P261, DOI 10.1088/0004-637X/691/1/261; Tozzi P, 2006, ASTRON ASTROPHYS, V451, P457, DOI 10.1051/0004-6361:20042592; Treister E, 2009, ASTROPHYS J, V706, P535, DOI 10.1088/0004-637X/706/1/535; Treister E, 2009, ASTROPHYS J, V696, P110, DOI 10.1088/0004-637X/696/1/110; Vestergaard M, 2009, ASTROPHYS J, V699, P800, DOI 10.1088/0004-637X/699/1/800; Zakamska NL, 2003, ASTRON J, V126, P2125, DOI 10.1086/378610	29	67	68	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2010	328	5978					600	602		10.1126/science.1184246	http://dx.doi.org/10.1126/science.1184246			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20339033	Green Submitted			2022-12-28	WOS:000277159800036
J	Zheng, W; Zhao, HY; Mancera, E; Steinmetz, LM; Snyder, M				Zheng, Wei; Zhao, Hongyu; Mancera, Eugenio; Steinmetz, Lars M.; Snyder, Michael			Genetic analysis of variation in transcription factor binding in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; EXPRESSION PROFILES; FILAMENTOUS GROWTH; BUDDING YEAST; OVEREXPRESSION; REGULATORS; SITES; MCM1; MAP	Variation in transcriptional regulation is thought to be a major cause of phenotypic diversity(1,2). Although widespread differences in gene expression among individuals of a species have been observed(3-8), studies to examine the variability of transcription factor binding on a global scale have not been performed, and thus the extent and underlying genetic basis of transcription factor binding diversity is unknown. By mapping differences in transcription factor binding among individuals, here we present the genetic basis of such variation on a genome-wide scale. Whole-genome Ste12-binding profiles were determined using chromatin immunoprecipitation coupled with DNA sequencing in pheromone-treated cells of 43 segregants of a cross between two highly diverged yeast strains and their parental lines. We identified extensive Ste12-binding variation among individuals, and mapped underlying cis- and trans-acting loci responsible for such variation. We showed that most transcription factor binding variation is cis- linked, and that many variations are associated with polymorphisms residing in the binding motifs of Ste12 as well as those of several proposed Ste12 cofactors. We also identified two transfactors, AMN1 and FLO8, that modulate Ste12 binding to promoters of more than ten genes under alpha-factor treatment. Neither of these two genes was previously known to regulate Ste12, and we suggest that they may be mediators of gene activity and phenotypic diversity. Ste12 binding strongly correlates with gene expression for more than 200 genes, indicating that binding variation is functional. Many of the variable-bound genes are involved in cell wall organization and biogenesis. Overall, these studies identified genetic regulators of molecular diversity among individuals and provide new insights into mechanisms of gene regulation.	[Zheng, Wei; Snyder, Michael] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Zhao, Hongyu] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Zhao, Hongyu] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; [Mancera, Eugenio; Steinmetz, Lars M.] European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany; [Snyder, Michael] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Yale University; Yale University; Yale University; European Molecular Biology Laboratory (EMBL); Stanford University	Snyder, M (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	mpsnyder@stanford.edu	Mancera, Eugenio/M-6334-2016	Mancera, Eugenio/0000-0003-0146-8732; Steinmetz, Lars/0000-0002-3962-2865; Snyder, Michael/0000-0003-0784-7987	National Institutes of Health (NIH) [RR19895]; NATIONAL CANCER INSTITUTE [R01CA077808] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068717, R01GM059507] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Gagneur for comments on data analysis, the Cornell Microarray Facility for helping with the gene expression experiments, A. Lin for preprocessing of microarray data, C. Yellman for technical help, and Yale University Biomedical High Performance Computing Center (NIH grant RR19895) for providing computation resources. Research was funded by National Institutes of Health (NIH) grants to M. S., H. Z. and L. M. S.	Aparicio Oscar, 2004, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1707s23; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Borneman AR, 2006, GENE DEV, V20, P435, DOI 10.1101/gad.1389306; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; GIMENO CJ, 1994, MOL CELL BIOL, V14, P2100, DOI 10.1128/MCB.14.3.2100; Gordon DB, 2005, BIOINFORMATICS, V21, P3164, DOI 10.1093/bioinformatics/bti481; HWANGSHUM JJ, 1991, MOL GEN GENET, V227, P197, DOI 10.1007/BF00259671; Jin R, 2008, MOL BIOL CELL, V19, P284, DOI 10.1091/mbc.E07-05-0519; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kobayashi O, 1996, MOL GEN GENET, V251, P707, DOI 10.1007/s004380050220; Lefrancois P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-37; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Liu HP, 1996, GENETICS, V144, P967; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Ni L, 2009, GENE DEV, V23, P1351, DOI 10.1101/gad.1781909; Pennisi E, 2004, SCIENCE, V306, P632, DOI 10.1126/science.306.5696.632; Pramila T, 2002, GENE DEV, V16, P3034, DOI 10.1101/gad.1034302; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Ronald J, 2005, PLOS GENET, V1, P213, DOI 10.1371/journal.pgen.0010025; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Smukalla S, 2008, CELL, V135, P726, DOI 10.1016/j.cell.2008.09.037; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	33	122	124	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1187	U106		10.1038/nature08934	http://dx.doi.org/10.1038/nature08934			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20237471	Green Accepted			2022-12-28	WOS:000276891100036
J	Akil, H; Brenner, S; Kandel, E; Kendler, KS; King, MC; Scolnick, E; Watson, JD; Zoghbi, HY				Akil, Huda; Brenner, Sydney; Kandel, Eric; Kendler, Kenneth S.; King, Mary-Claire; Scolnick, Edward; Watson, James D.; Zoghbi, Huda Y.			The Future of Psychiatric Research: Genomes and Neural Circuits	SCIENCE			English	Editorial Material							SCHIZOPHRENIA; STIMULATION; DISORDER; BRAIN; TWIN		[Akil, Huda] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Brenner, Sydney] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Kandel, Eric] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Kandel, Eric] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Kendler, Kenneth S.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23298 USA; [King, Mary-Claire] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [King, Mary-Claire] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Scolnick, Edward] Broad Inst, Cambridge, MA 02142 USA; [Watson, James D.] Cold Spring Harbor Labs, Cold Spring Harbor, NY 11724 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Columbia University; Virginia Commonwealth University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Cold Spring Harbor Laboratory; Baylor College of Medicine; Howard Hughes Medical Institute	Akil, H (corresponding author), Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA.	akil@umich.edu	Kendler, Kenneth/AAF-2876-2019	King, Mary-Claire/0000-0001-9426-1743; Zoghbi, Huda/0000-0002-0700-3349	Howard Hughes Medical Institute Funding Source: Medline; NIDA NIH HHS [P01 DA021633, P01 DA021633-01A2] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA021633] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; BAXTER LR, 1992, ARCH GEN PSYCHIAT, V49, P681; Bernard R, 2009, J NEUROSCI METH, V178, P46, DOI 10.1016/j.jneumeth.2008.11.012; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Eaton WW, 2008, EPIDEMIOL REV, V30, P1, DOI 10.1093/epirev/mxn011; Fagiolini M, 2009, CURR OPIN NEUROBIOL, V19, P207, DOI 10.1016/j.conb.2009.05.009; Gartlehner G, 2008, ANN INTERN MED, V149, P734, DOI 10.7326/0003-4819-149-10-200811180-00008; Gottesman I.I., 1991, SCHIZOPHRENIA GENESI; Jaaro-Peled H, 2009, TRENDS NEUROSCI, V32, P485, DOI 10.1016/j.tins.2009.05.007; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McClellan JM, 2007, BRIT J PSYCHIAT, V190, P194, DOI 10.1192/bjp.bp.106.025585; Messias EL, 2007, PSYCHIAT CLIN N AM, V30, P323, DOI 10.1016/j.psc.2007.04.007; Shah SG, 2009, J PSYCHIATR NEUROSCI, V34; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367	20	123	129	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2010	327	5973					1580	1581		10.1126/science.1188654	http://dx.doi.org/10.1126/science.1188654			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339051	Green Accepted			2022-12-28	WOS:000275970600019
J	Lang, RF				Lang, Rafael F.			Fishing for the Universe	SCIENCE			English	Editorial Material									Columbia Univ, Astrophys Lab, New York, NY 10027 USA	Columbia University	Lang, RF (corresponding author), Columbia Univ, Astrophys Lab, 550 W 120th St, New York, NY 10027 USA.	rafael.lang@astro.columbia.edu						Adriani O, 2009, NATURE, V458, P607, DOI 10.1038/nature07942; Ahmed Z, 2010, SCIENCE, V327, P1619, DOI 10.1126/science.1186112; Angle J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.021303; Komatsu E, 2009, ASTROPHYS J SUPPL S, V180, P330, DOI 10.1088/0067-0049/180/2/330; Vogelsberger M, 2009, MON NOT R ASTRON SOC, V395, P797, DOI 10.1111/j.1365-2966.2009.14630.x	5	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2010	327	5973					1582	1583		10.1126/science.1187972	http://dx.doi.org/10.1126/science.1187972			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339052				2022-12-28	WOS:000275970600020
J	Rogers, JA; Someya, T; Huang, YG				Rogers, John A.; Someya, Takao; Huang, Yonggang			Materials and Mechanics for Stretchable Electronics	SCIENCE			English	Review							THIN-FILMS; INTEGRATED-CIRCUITS; PRINTING TECHNIQUES; ELASTIC CONDUCTORS; CARBON NANOTUBES; SILICON; DISPLAYS; SENSORS; OPTOELECTRONICS; TRANSISTORS	Recent advances in mechanics and materials provide routes to integrated circuits that can offer the electrical properties of conventional, rigid wafer-based technologies but with the ability to be stretched, compressed, twisted, bent, and deformed into arbitrary shapes. Inorganic and organic electronic materials in microstructured and nanostructured forms, intimately integrated with elastomeric substrates, offer particularly attractive characteristics, with realistic pathways to sophisticated embodiments. Here, we review these strategies and describe applications of them in systems ranging from electronic eyeball cameras to deformable light-emitting displays. We conclude with some perspectives on routes to commercialization, new device opportunities, and remaining challenges for research.	[Rogers, John A.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Rogers, John A.] Univ Illinois, Dept Engn Sci & Mech, Urbana, IL 61801 USA; [Rogers, John A.] Univ Illinois, Dept Elect & Comp Engn & Chem, Urbana, IL 61801 USA; [Rogers, John A.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Rogers, John A.] Univ Illinois, Mat Res Lab, Urbana, IL 61801 USA; [Someya, Takao] Univ Tokyo, Dept Elect & Elect Engn & Informat Syst, Bunkyo Ku, Tokyo 1138656, Japan; [Huang, Yonggang] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL 60208 USA; [Huang, Yonggang] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Tokyo; Northwestern University; Northwestern University	Rogers, JA (corresponding author), Univ Illinois, Dept Mat Sci & Engn, 1304 W Green St, Urbana, IL 61801 USA.	jrogers@illinois.edu	Huang, Yonggang/B-6998-2009; Someya, Takao/H-3052-2015; Rogers, John/L-2798-2016; huang, yonggang/O-6236-2019	Someya, Takao/0000-0003-3051-1138; 				Ahn BY, 2009, SCIENCE, V323, P1590, DOI 10.1126/science.1168375; Bao ZN, 1997, CHEM MATER, V9, P1299, DOI 10.1021/cm9701163; Bowden N, 1998, NATURE, V393, P146, DOI 10.1038/30193; Cao Q, 2009, ADV MATER, V21, P29, DOI 10.1002/adma.200801995; Carta R, 2009, SENSOR ACTUAT A-PHYS, V156, P79, DOI 10.1016/j.sna.2009.03.012; Choi WM, 2007, NANO LETT, V7, P1655, DOI 10.1021/nl0706244; Dinyari R, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2883873; Fan ZY, 2009, ADV MATER, V21, P3730, DOI 10.1002/adma.200900860; Forrest SR, 2007, CHEM REV, V107, P923, DOI 10.1021/cr0501590; GARNIER F, 1994, SCIENCE, V265, P1684, DOI 10.1126/science.265.5179.1684; Gelinck GH, 2004, NAT MATER, V3, P106, DOI 10.1038/nmat1061; Hu LB, 2010, NANO LETT, V10, P708, DOI 10.1021/nl903949m; Hu LB, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3114463; Huang K., 2006, P SPIE, V6174, P617412; Hung PJ, 2004, APPL PHYS LETT, V85, P6051, DOI 10.1063/1.1835553; Huyghe B, 2008, IEEE T ADV PACKAGING, V31, P802, DOI 10.1109/TADVP.2008.927811; Jiang HQ, 2007, P NATL ACAD SCI USA, V104, P15607, DOI 10.1073/pnas.0702927104; Jung I, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3290244; Khang DY, 2008, NANO LETT, V8, P124, DOI 10.1021/nl072203s; Khang DY, 2006, SCIENCE, V311, P208, DOI 10.1126/science.1121401; Kim DH, 2008, SCIENCE, V320, P507, DOI 10.1126/science.1154367; Kim DH, 2008, P NATL ACAD SCI USA, V105, P18675, DOI 10.1073/pnas.0807476105; KIM DH, ADV MATER, DOI DOI 10.1002/ADMA.200902927; Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719; Ko HC, 2008, NATURE, V454, P748, DOI 10.1038/nature07113; Ko HC, 2009, SMALL, V5, P2703, DOI 10.1002/smll.200900934; Lacour SP, 2003, APPL PHYS LETT, V82, P2404, DOI 10.1063/1.1565683; Lacour SP, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2201874; Menard E, 2007, CHEM REV, V107, P1117, DOI 10.1021/cr050139y; Park SI, 2008, ADV FUNCT MATER, V18, P2673, DOI 10.1002/adfm.200800306; Park SI, 2009, SCIENCE, V325, P977, DOI 10.1126/science.1175690; Pocivavsek L, 2008, SCIENCE, V320, P912, DOI 10.1126/science.1154069; Rogers JA, 2001, P NATL ACAD SCI USA, V98, P4835, DOI 10.1073/pnas.091588098; Sekitani T, 2008, SCIENCE, V321, P1468, DOI 10.1126/science.1160309; Sekitani T, 2010, ADV MATER, V22, P2228, DOI 10.1002/adma.200904054; Sekitani T, 2009, NAT MATER, V8, P494, DOI [10.1038/NMAT2459, 10.1038/nmat2459]; Siegel AC, 2007, ADV MATER, V19, P727, DOI 10.1002/adma.200601787; Someya T, 2005, P NATL ACAD SCI USA, V102, P12321, DOI 10.1073/pnas.0502392102; Sun YG, 2007, ADV MATER, V19, P1897, DOI 10.1002/adma.200602223; Vella D, 2009, P NATL ACAD SCI USA, V106, P10901, DOI 10.1073/pnas.0902160106; Xiao L, 2008, NANO LETT, V8, P4539, DOI 10.1021/nl802750z; Yu Z, 2009, J NEUROTRAUM, V26, P1135, DOI 10.1089/neu.2008.0810	42	3510	3646	155	3570	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2010	327	5973					1603	1607		10.1126/science.1182383	http://dx.doi.org/10.1126/science.1182383			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339064				2022-12-28	WOS:000275970600032
J	Crowe, E; Lovibond, K; Gray, H; Henderson, R; Krause, T; Camm, J				Crowe, Emily; Lovibond, Kate; Gray, Huon; Henderson, Robert; Krause, Taryn; Camm, John		Guideline Dev Grp	Guidelines Early management of unstable angina and non-ST segment elevation myocardial infarction: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gray, Huon] Southampton Univ Hosp, Southampton SO16 6YD, Hants, England; [Lovibond, Kate; Krause, Taryn] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Henderson, Robert] Univ Nottingham Hosp, Nottingham NG5 1PB, England; [Camm, John] Univ London, London SW17 0RE, England	University of Southampton; Royal College of Physicians; University of Nottingham; University of London	Gray, H (corresponding author), Southampton Univ Hosp, Southampton SO16 6YD, Hants, England.	huon@cardiology.co.uk			National Clinical Guideline Centre; National Institute for Health and Clinical Excellence	National Clinical Guideline Centre; National Institute for Health and Clinical Excellence	The National Clinical Guideline Centre was commissioned and funded by the National Institute for Health and Clinical Excellence to write this summary.	Fox KAA, 2006, BMJ-BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55; *NAT I HLTH CLIN E, CLIN GUID CG NAT I H, V94; *NAT I HLTH CLIN E, 2002, TA47 NAT I HLTH CLIN; *NAT I HLTH CLIN E, 2007, CLIN GUID CG NAT I H, V48; *NAT I HLTH CLIN E, 2004, TA80 NAT I HLTH CLIN; *NAT I HLTH CLIN E, 2008, CLIN GUID CG NAT I H, V67	6	7	8	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2010	340								c1134	10.1136/bmj.c1134	http://dx.doi.org/10.1136/bmj.c1134			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	576PP	20335335				2022-12-28	WOS:000276157700008
J	Krumholz, HM				Krumholz, Harlan M.			Informed Consent to Promote Patient-Centered Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITY		[Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Yale University; Yale University; Yale University; Yale University	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, 1 Church St,Ste 200, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020					Arnold SV, 2008, CIRC-CARDIOVASC QUAL, V1, P21, DOI 10.1161/CIRCOUTCOMES.108.791863; Bottrell MM, 2000, ARCH SURG-CHICAGO, V135, P26, DOI 10.1001/archsurg.135.1.26; Chassin MR, 1996, NEW ENGL J MED, V334, P394, DOI 10.1056/NEJM199602083340611; *COMM FUND COMM HI, PATH HIGH PERF US HL; Holmboe ES, 2000, J GEN INTERN MED, V15, P632, DOI 10.1046/j.1525-1497.2000.90823.x; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSS QUAL CHASM NEW; LAVELLEJONES C, 1993, BRIT MED J, V306, P885, DOI 10.1136/bmj.306.6882.885; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Peabody FW, 1927, J AMER MED ASSOC, V88, P0877, DOI 10.1001/jama.1927.02680380001001; Towle A, 1999, BRIT MED J, V319, P766, DOI 10.1136/bmj.319.7212.766	10	88	90	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2010	303	12					1190	1191		10.1001/jama.2010.309	http://dx.doi.org/10.1001/jama.2010.309			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573AC	20332406				2022-12-28	WOS:000275879600025
J	Nissen, SE				Nissen, Steven E.			Setting the RECORD Straight	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ROSIGLITAZONE		Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland Clin, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Nissen, SE (corresponding author), Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland Clin, 9500 Euclid Ave, Cleveland, OH 44195 USA.	nissens@ccf.org						Fontanarosa PB, 2005, JAMA-J AM MED ASSOC, V294, P110, DOI 10.1001/jama.294.1.110; HARRIS GA, 2010, NY TIMES        0222; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Nathan DM, 2007, NEW ENGL J MED, V357, P64, DOI 10.1056/NEJMe078117; Nissen SE, 2007, NEW ENGL J MED, V357, P100; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Psaty BM, 2010, JAMA-J AM MED ASSOC, V303, P734, DOI 10.1001/jama.2010.97; Psaty BM, 2009, JAMA-J AM MED ASSOC, V302, P1698, DOI 10.1001/jama.2009.1497; STILES S, 2009, AVANDIA RECORD NO OV; *US SEN, STAFF REP GLAXOSMITH; *US SEN, 2007, INT J BUS DIAB DRUG	12	31	32	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2010	303	12					1194	1195		10.1001/jama.2010.333	http://dx.doi.org/10.1001/jama.2010.333			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573AC	20332408				2022-12-28	WOS:000275879600027
J	Bach, PB				Bach, Peter B.			Gardasil: from bench, to bedside, to blunder	LANCET			English	Editorial Material							UNITED-STATES; VACCINATION; HEALTH		Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA.	bachp@mskcc.org						Akers Aletha Y, 2007, Curr Probl Cancer, V31, P157, DOI 10.1016/j.currproblcancer.2007.01.001; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P997; Horner MJ, 2009, SEER CANC STAT REV 1; Kim JJ, 2008, NEW ENGL J MED, V359, P821, DOI 10.1056/NEJMsa0707052; *NAT AC SCI I MED, 2002, UN TREATM CONFR RAC; Rothman SM, 2009, JAMA-J AM MED ASSOC, V302, P781, DOI 10.1001/jama.2009.1179; *US BUR CENS, 2008, 2 YEAR AV MED HOUS I	7	38	39	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 20	2010	375	9719					963	964		10.1016/S0140-6736(09)62029-8	http://dx.doi.org/10.1016/S0140-6736(09)62029-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	575YU	20304226				2022-12-28	WOS:000276110700007
J	Hoff, K				Hoff, Karla			Fairness in Modern Society	SCIENCE			English	Editorial Material							DICTATOR GAMES; PUNISHMENT		World Bank, Washington, DC 20433 USA	The World Bank	Hoff, K (corresponding author), World Bank, 1818 H St NW,MC3-301, Washington, DC 20433 USA.	khoff@worldbank.org						Camerer C.F., 2011, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Dana J, 2006, ORGAN BEHAV HUM DEC, V100, P193, DOI 10.1016/j.obhdp.2005.10.001; Douglas M., 1986, I THINK; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Hoff Karla, 2009, 5040 WORLD BANK; List JA, 2007, J POLIT ECON, V115, P482, DOI 10.1086/519249; Mokyr J., 2010, ENLIGHTENED EC EC HI; North DC, 2005, PRINC ECON HIST W WO, P1; Posner Eric A., 2000, LAW SOCIAL NORMS; Willer R, 2009, AM SOCIOL REV, V74, P23, DOI 10.1177/000312240907400102	11	3	4	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	2010	327	5972					1467	1468		10.1126/science.1188537	http://dx.doi.org/10.1126/science.1188537			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	570YQ	20299584				2022-12-28	WOS:000275715200035
J	Littman, DR; Rudensky, AY				Littman, Dan R.; Rudensky, Alexander Y.			Th17 and Regulatory T Cells in Mediating and Restraining Inflammation	CELL			English	Review							ROR-GAMMA-T; DE-NOVO DIFFERENTIATION; GROWTH-FACTOR-BETA; TGF-BETA; FOXP3 EXPRESSION; DENDRITIC CELLS; CUTTING EDGE; HELPER-CELLS; TARGET GENES; GRANZYME-B	The vertebrate immune system is poised in a state of equilibrium that permits accurate and rapid protective responses against pathogens but curtails potential for causing harm to the host through targeting of "self'' and provoking overexuberant inflammatory processes. In this Review we discuss this balance achieved in large part by interactions of different classes of T lymphocytes that have potent pro- or anti-inflammatory activity in the context of genetic and environmental factors, particularly the commensal microbiota.	[Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Littman, Dan R.] NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA; [Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA	Howard Hughes Medical Institute; New York University; New York University; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Littman, DR (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.	dan.littman@med.nyu.edu; rudenska@mskcc.org						Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Abraham C, 2009, ANNU REV MED, V60, P97, DOI 10.1146/annurev.med.60.051407.123757; Ahern PP, 2008, IMMUNOL REV, V226, P147, DOI 10.1111/j.1600-065X.2008.00705.x; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Betti M, 2006, ANN ONCOL, V17, P235; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Feuerer M, 2009, IMMUNITY, V31, P654, DOI 10.1016/j.immuni.2009.08.023; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Guarner F, 2007, CURR OPIN GASTROEN, V23, P667, DOI 10.1097/MOG.0b013e3282eeb43b; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hauben E, 2008, BLOOD, V112, P1214, DOI 10.1182/blood-2007-08-109843; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2005, CURR TOP MICROBIOL, V293, P25, DOI 10.1007/3-540-27702-1_2; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Josefowicz SZ, 2009, J IMMUNOL, V182, P6648, DOI 10.4049/jimmunol.0803320; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kim J, 2009, J IMMUNOL, V183, P7631, DOI 10.4049/jimmunol.0804308; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liston A, 2007, J EXP MED, V204, P475, DOI 10.1084/jem.20062465; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Mason D, 1998, CURR OPIN IMMUNOL, V10, P649, DOI 10.1016/S0952-7915(98)80084-8; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Medzhitov R, 2009, IMMUNITY, V30, P766, DOI 10.1016/j.immuni.2009.06.004; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Roberts S, 2008, DEV COMP IMMUNOL, V32, P1099, DOI 10.1016/j.dci.2008.02.006; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Sakaguchi S, 2005, INT REV IMMUNOL, V24, P211, DOI 10.1080/08830180590934976; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Siegmund K, 2005, BLOOD, V106, P3097, DOI 10.1182/blood-2005-05-1864; Siewert C, 2007, EUR J IMMUNOL, V37, P978, DOI 10.1002/eji.200636575; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Sitkovsky MV, 2009, TRENDS IMMUNOL, V30, P102, DOI 10.1016/j.it.2008.12.002; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Taleb S, 2009, J EXP MED, V206, P2067, DOI 10.1084/jem.20090545; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Toivanen P, 2003, ANN RHEUM DIS, V62, P807, DOI 10.1136/ard.62.9.807; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; von Mutius E, 2009, J ALLERGY CLIN IMMUN, V123, P3, DOI 10.1016/j.jaci.2008.10.046; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Winer S, 2009, EUR J IMMUNOL, V39, P2629, DOI 10.1002/eji.200838893; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhao DM, 2006, BLOOD, V107, P3925, DOI 10.1182/blood-2005-11-4502; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	142	732	832	3	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2010	140	6					845	858		10.1016/j.cell.2010.02.021	http://dx.doi.org/10.1016/j.cell.2010.02.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	571IX	20303875	Bronze			2022-12-28	WOS:000275746600009
J	Aaron, SD				Aaron, Shawn D.			Review: Addition of inhaled corticosteroids to long-acting beta(2)-agonists does not improve outcomes in stable COPD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Ottawa Hosp, Res Inst, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute	Aaron, SD (corresponding author), Ottawa Hosp, Res Inst, Ottawa, ON, Canada.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	2010	152	6							JC3-5	10.7326/0003-4819-152-6-201003160-02005	http://dx.doi.org/10.7326/0003-4819-152-6-201003160-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573IF	20231559				2022-12-28	WOS:000275905200022
J	Riphagen, J; Modderman, P; Verrips, A				Riphagen, Joanne; Modderman, Piet; Verrips, Aad			Hiccups, nausea, and vomiting: water channels under attack!	LANCET			English	Editorial Material							NEUROMYELITIS-OPTICA		[Riphagen, Joanne; Verrips, Aad] Canisius Wilhelmina Hosp, Dept Pediat Neurol, NL-6500 GS Nijmegen, Netherlands; [Modderman, Piet] Sanquin Diagnost Serv, Dept Immunopathol Diagnost, Amsterdam, Netherlands	Canisius-Wilhelmina Hospital	Riphagen, J (corresponding author), Canisius Wilhelmina Hosp, Dept Pediat Neurol, POB 9015, NL-6500 GS Nijmegen, Netherlands.	j.riphagen@cwz.nl						Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lotze TE, 2008, PEDIATRICS, V122, pE1039, DOI 10.1542/peds.2007-2758; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P964, DOI 10.1001/archneur.63.7.964; Takahashi T, 2008, J NEUROL NEUROSUR PS, V79, P1075, DOI 10.1136/jnnp.2008.145391; Waters P, 2008, ARCH NEUROL-CHICAGO, V65, P913, DOI 10.1001/archneur.65.7.913	5	12	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	2010	375	9718					954	954		10.1016/S0140-6736(09)62066-3	http://dx.doi.org/10.1016/S0140-6736(09)62066-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	574NA	20226992				2022-12-28	WOS:000275995300035
J	Webb, AJS; Fischer, U; Mehta, Z; Rothwell, PM				Webb, Alastair J. S.; Fischer, Urs; Mehta, Ziyah; Rothwell, Peter M.			Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis	LANCET			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR EVENTS; HYPERTENSIVE PATIENTS; REGRESSION DILUTION; RANDOMIZED-TRIAL; BETA-BLOCKERS; VARIABILITY; AMLODIPINE; MORBIDITY; MORTALITY	Introduction Unexplained differences between classes of antihypertensive drugs in their effectiveness in preventing stroke might be due to Class effects on intraindividual variability in blood pressure. We did a systematic review to assess any such effects in randomised controlled trials. Methods Baseline and follow-up data for mean (SD) of systolic blood pressure (SBP) were extracted from trial reports. Effect of treatment on interindividual variance (SD2) in blood pressure (a surrogate for within-individual variability), expressed as the ratio of the variances (VR), was related to effects on clinical outcomes. Pooled estimates were derived by use of random-effects meta-analysis. Findings Mean (SD) SBP at follow-up was reported in 389 (28%) of 1372 eligible trials. There was substantial heterogeneity between trials in VR (p<1x10(-40)), 68% of which was attributable to allocated drug class. Compared with other drugs, interindividual variation in SBP was reduced by calcium-channel blockers (VR 0.81, 95% CI 0.76-0.86, p<0.0001) and non-loop diuretic drugs (0.87, 0.79-0.96, p=0.007), and increased by angiotensin-converting enzyme (ACE) inhibitors (1.08, 1.02-1.15, p=0.008), angiotensin-receptor blockers (1.16, 1.07-1.25, p=0.0002), and beta blockers (1.17, 1.07-1.28, p=0.0007). Compared with placebo only, interindividual variation in S BP was reduced the most by calcium-channel blockers (0.76, 0.67-0.85, p<0.0001). Effects were consistent in parallel group and crossover design trials, and in analyses of dose-response. Across all trials, effects of treatment on VR of SBP (r(2)=0.372, p=0.0006) and on mean SBP (r(2)=0.328, p=0.0015) accounted for effects on stroke risk (eg, odds ratio 0.79, 0.71-0.87, p<0.0001, for VR <= 0.80), and both remained significant in a combined model. Interpretation Drug-class effects on interindividual variation in blood pressure can account for differences in effects of antihypertensive drugs on risk of stroke independently of effects on mean SBP.	[Webb, Alastair J. S.; Fischer, Urs; Mehta, Ziyah; Rothwell, Peter M.] John Radcliffe Hosp, Stroke Prevent Res Unit, Univ Dept Clin Neurol, Level 6,West Wing, Oxford OX3 9DU, England	University of Oxford	Rothwell, PM (corresponding author), John Radcliffe Hosp, Stroke Prevent Res Unit, Univ Dept Clin Neurol, Level 6,West Wing, Oxford OX3 9DU, England.	peter.rothwell@clneuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211; Fischer, Urs/0000-0003-0521-4051	National Institute of Health Research (NIHR) Biomedical Research Centre, Oxford	National Institute of Health Research (NIHR) Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR))	ZM is funded by the National Institute of Health Research (NIHR) Biomedical Research Centre, Oxford; PMR is in receipt of an NIHR Senior Investigator Award.	Alderman MH, 2003, HYPERTENSION, V42, P239, DOI 10.1161/01.HYP.0000086521.95630.5A; AMERY A, 1985, LANCET, V1, P1349; [Anonymous], 1985, J Hypertens, V3, P379; [Anonymous], 1991, JAMA, V265, P3255; Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Crumley Ellen T, 2005, BMC Med Res Methodol, V5, P24, DOI 10.1186/1471-2288-5-24; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Frattola A, 2000, HYPERTENSION, V36, P622, DOI 10.1161/01.HYP.36.4.622; Hansson L, 2000, LANCET, V356, P359, DOI 10.1016/S0140-6736(00)02526-5; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Heran BS, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003823.pub2; Howard SC, 2003, J CLIN EPIDEMIOL, V56, P1084, DOI 10.1016/S0895-4356(03)00267-1; Ichihara A, 2007, J CARDIOVASC PHARM, V49, P161, DOI 10.1097/FJC.0b013e31803104e5; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Kengne AP, 2007, J HYPERTENS, V25, P1205; Kuramoto K, 1999, HYPERTENSION, V34, P1129; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lindholm LH, 2005, LANCET, V366, P1545, DOI 10.1016/S0140-6736(05)67573-3; Lithell H, 2003, J HYPERTENS, V21, P875, DOI 10.1097/00004872-200305000-00011; Liu LS, 2005, J HYPERTENS, V23, P2157, DOI 10.1097/01.hjh.0000194120.42722.ac; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Miao CY, 2006, J HYPERTENS, V24, P1125, DOI 10.1097/01.hjh.0000226203.57818.88; Musini VM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005673; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; *PATS STUD GROUP, 1995, PATS COLLABORATING G, V108, P710; Pepine CJ, 2003, JAMA-J AM MED ASSOC, V290, P2805, DOI 10.1001/jama.290.21.2805; Pitt B, 2000, CIRCULATION, V102, P1503, DOI 10.1161/01.CIR.102.13.1503; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Schrader J, 2005, STROKE, V36, P1218, DOI 10.1161/01.STR.0000166048.35740.a9; SHAFFER JP, 1992, REV EDUC RES, V62, P429, DOI 10.3102/00346543062004429; SMITH WM, 1977, CIRC RES, V40, P98; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Su DF, 2006, CURR OPIN CARDIOL, V21, P486, DOI 10.1097/01.hco.0000240587.14463.58; Suzuki H, 2005, HYPERTENS RES, V28, P307, DOI 10.1291/hypres.28.307; Teo KK, 2000, CIRCULATION, V102, P1748; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Turnbull F, 2003, LANCET, V362, P1527; Verdecchia P, 2005, HYPERTENSION, V46, P386, DOI 10.1161/01.HYP.0000174591.42889.a2; Wang JG, 2006, STROKE, V37, P1933, DOI 10.1161/01.STR.0000227223.90239.13; WILHELMSEN L, 1985, J HYPERTENS, V3, P379; Zhu ZM, 2005, HYPERTENSION, V45, P233, DOI 10.1161/01.HYP.0000152701.97426.5f	51	538	608	0	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	2010	375	9718					906	915		10.1016/S0140-6736(10)60235-8	http://dx.doi.org/10.1016/S0140-6736(10)60235-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	574NA	20226989				2022-12-28	WOS:000275995300030
J	Wiersma, DS				Wiersma, Diederik S.			Random Quantum Networks	SCIENCE			English	Editorial Material									CNR INO, European Lab Nonlinear Spect, I-50019 Florence, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR)	Wiersma, DS (corresponding author), CNR INO, European Lab Nonlinear Spect, Via Nello Carrara,1 Sesto Fiorentino, I-50019 Florence, Italy.	wiersma@lens.unifi.it	wiersma, diederik/ABG-6454-2021	wiersma, diederik/0000-0001-8150-7425				DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; ITOH T, 1993, WABI SABI SUKI ESSEN; Joannopoulos J. D., 1995, PHOTONIC CRYSTALS MO; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Koenderink AF, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.153102; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Sakoda K., 2001, OPTICAL PROPERTIES P; Sapienza L, 2010, SCIENCE, V327, P1352, DOI 10.1126/science.1185080; Wiersma DS, 2008, NAT PHYS, V4, P359, DOI 10.1038/nphys971; Wilk T, 2007, SCIENCE, V317, P488, DOI 10.1126/science.1143835	11	11	12	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	2010	327	5971					1333	1334		10.1126/science.1187084	http://dx.doi.org/10.1126/science.1187084			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223972				2022-12-28	WOS:000275418700025
J	Balibar, S				Balibar, Sebastien			The enigma of supersolidity	NATURE			English	Review							BOSE-EINSTEIN CONDENSATION; LIQUID-HELIUM; SHEAR MODULUS; HE-4 CRYSTALS; FLOW	A 'supersolid' is a quantum solid in which a fraction of the mass is superfluid. As a remarkable consequence, it is rigid, but part of its mass is able to flow owing to quantum physical processes. This paradoxical state of matter was considered as a theoretical possibility as early as 1969, but its existence was discovered only in 2004, in He-4. Since then, intense experimental and theoretical efforts have been made to explain the origins of this exotic state of matter. It now seems that its physical interpretation is more complicated than originally thought.	[Balibar, Sebastien] Ecole Normale Super, Phys Stat Lab, F-75231 Paris, France; [Balibar, Sebastien] CNRS, F-75231 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS)	Balibar, S (corresponding author), Ecole Normale Super, Phys Stat Lab, 24 Rue Lhomond, F-75231 Paris, France.	balibar@lps.ens.fr	Balibar, Sebastien/B-5546-2013; Balibar, Sebastien/P-3328-2019		Agence Nationale de la Recherche [BLAN07-1-215296]	Agence Nationale de la Recherche(French National Research Agency (ANR))	I acknowledge support from the Agence Nationale de la Recherche (grant BLAN07-1-215296).	ALEINIKAVA D, 2008, PHYS REV B UNPUB; Allen JF, 1938, NATURE, V141, P242; Allen JF, 1938, NATURE, V141, P75, DOI 10.1038/141075a0; ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Anderson PW, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.215301; Anderson PW, 2007, NAT PHYS, V3, P160, DOI 10.1038/nphys539; Anderson PW, 2009, SCIENCE, V324, P631, DOI 10.1126/science.1169456; ANDREEV AF, 1969, SOV PHYS JETP-USSR, V29, P1107; Aoki Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.015301; Balatsky AV, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.094201; Balibar S, 2005, REV MOD PHYS, V77, P317, DOI 10.1103/RevModPhys.77.317; Balibar S, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/17/173201; Balibar S, 2007, J LOW TEMP PHYS, V146, P441, DOI 10.1007/s10909-006-9276-7; Balibar S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.189601; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; BARDEEN J, 1957, PHYS REV, V106, P162, DOI 10.1103/PhysRev.106.162; Boninsegni M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.035301; Boninsegni M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.080401; Ceperley DM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.155303; Clark AC, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.135302; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; Day J, 2007, NATURE, V450, P853, DOI 10.1038/nature06383; Day J, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.214524; Galli DE, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.111010; Hunt B, 2009, SCIENCE, V324, P632, DOI 10.1126/science.1169512; IWASA I, 1980, J PHYS SOC JPN, V49, P1722, DOI 10.1143/JPSJ.49.1722; Kapitza P, 1938, NATURE, V141, P74, DOI 10.1038/141074a0; Kim E, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.065301; Kim E, 2004, SCIENCE, V305, P1941, DOI 10.1126/science.1101501; Kim E, 2004, NATURE, V427, P225, DOI 10.1038/nature02220; Kondo M, 2007, J LOW TEMP PHYS, V148, P695, DOI 10.1007/s10909-007-9471-1; LEGGETT AJ, 1970, PHYS REV LETT, V25, P1543, DOI 10.1103/PhysRevLett.25.1543; LEGGETT AJ, 2009, J CLUB CONDENS MATTE; Lin X, 2007, NATURE, V449, P1025, DOI 10.1038/nature06228; Lin X, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.125302; London F, 1938, NATURE, V141, P643, DOI 10.1038/141643a0; MEISEL MW, 1992, PHYSICA B, V178, P121, DOI 10.1016/0921-4526(92)90186-V; Mukharsky Y, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.140504; Nussinov Z, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.014530; ONNES HK, 1911, COMMUN PHYS LAB U B, V122; ONNES HK, 1911, COMMUN PHYS LAB U B, V120; ONNES HK, 1911, COMMUN PHYS LAB U C, V124; OSHEROFF DD, 1972, PHYS REV LETT, V28, P885, DOI 10.1103/PhysRevLett.28.885; OSHEROFF DD, 1972, PHYS REV LETT, V29, P920, DOI 10.1103/PhysRevLett.29.920; PAALANEN MA, 1981, PHYS REV LETT, V46, P664, DOI 10.1103/PhysRevLett.46.664; Pantalei C, 2010, J LOW TEMP PHYS, V159, P452, DOI 10.1007/s10909-010-0159-6; PENROSE O, 1951, PHILOS MAG, V42, P1373; Penzev A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.065301; Pollet L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.135301; Prokof'ev N, 2007, ADV PHYS, V56, P381, DOI 10.1080/00018730601183025; Ray MW, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.235301; REPPY JD, 2009, SUPERSOLIDS BANFF 20; Rittner ASC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.175302; Rittner ASC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.165301; Rittner ASC, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.155301; Rojas X, 2010, J LOW TEMP PHYS, V158, P478, DOI 10.1007/s10909-009-9966-z; Ruutu JP, 1996, PHYS REV LETT, V76, P4187, DOI 10.1103/PhysRevLett.76.4187; Sasaki S, 2006, SCIENCE, V313, P1098, DOI 10.1126/science.1130879; Sasaki S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.205302; Sasaki S, 2008, J LOW TEMP PHYS, V153, P43, DOI 10.1007/s10909-008-9848-9; THOULESS DJ, 1969, ANN PHYS-NEW YORK, V52, P403, DOI 10.1016/0003-4916(69)90286-3; Tisza L, 1938, NATURE, V141, P913, DOI 10.1038/141913a0; West JT, 2009, NAT PHYS, V5, P598, DOI 10.1038/NPHYS1337; Yoo CD, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.100504	64	116	116	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					176	182		10.1038/nature08913	http://dx.doi.org/10.1038/nature08913			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20220834				2022-12-28	WOS:000275366100029
J	Koff, WC				Koff, Wayne C.			Accelerating HIV vaccine development	NATURE			English	Editorial Material							PROTECTION; CHALLENGE; DESIGN; GP120; BROAD		Int AIDS Vaccine Initiat, New York, NY 10038 USA	International AIDS Vaccine Initiative	Koff, WC (corresponding author), Int AIDS Vaccine Initiat, 110 William St,27th Floor, New York, NY 10038 USA.	wkoff@iavi.org						Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; *HIV VACC MICR RES, 2009, AD REAL TRENDS HIV P; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; KOSMRLJ A, NATURE IN PRESS; Miura T, 2009, J VIROL, V83, P3407, DOI 10.1128/JVI.02459-08; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Virgin HW, 2010, NATURE, V464, P224, DOI 10.1038/nature08898; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746	15	22	25	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 11	2010	464	7286					161	162		10.1038/464161a	http://dx.doi.org/10.1038/464161a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	566JO	20220821				2022-12-28	WOS:000275366100017
J	Virgin, HW; Walker, BD				Virgin, Herbert W.; Walker, Bruce D.			Immunology and the elusive AIDS vaccine	NATURE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; T-CELL RESPONSES; HIV-1 INFECTION; NEUTRALIZING ANTIBODIES; LYMPHOCYTE ESCAPE; IMMUNE CONTROL; MACAQUE MODEL; B-CELLS; REPLICATION; PROTECTION	Developing a human immunodeficiency virus (HIV) vaccine is critical to end the global acquired immunodeficiency syndrome (AIDS) epidemic, but many question whether this goal is achievable. Natural immunity is not protective, and despite immunogenicity of HIV vaccine candidates, human trials have exclusively yielded disappointing results. Nevertheless, there is an indication that success may be possible, but this will be dependent on understanding the antiviral immune response in unprecedented depth to identify and engineer the types of immunity required. Here we outline fundamental immunological questions that need to be answered to develop a protective HIV vaccine, and the immediate need to harness a much broader scientific community to achieve this goal.	[Virgin, Herbert W.] Washington Univ, Sch Med, St Louis, MO 63110 USA; [Virgin, Herbert W.] Washington Univ, Midwest Reg Ctr Excellence Biodef & Emerging Infe, St Louis, MO 63110 USA; [Walker, Bruce D.] Massachusetts Gen Hosp, MIT, Ragon Inst, Charlestown, MA 02129 USA; [Walker, Bruce D.] Harvard Univ, Howard Hughes Med Inst, Charlestown, MA 02129 USA	Washington University (WUSTL); Washington University (WUSTL); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Howard Hughes Medical Institute	Virgin, HW (corresponding author), Washington Univ, Sch Med, Campus Box 8118,660 S Euclid Ave, St Louis, MO 63110 USA.	virgin@wustl.edu; bwalker@partners.org		Virgin, Herbert/0000-0001-8580-7628	National Institutes of Health; Bill and Melinda Gates Foundation; Mark and Lisa Schwartz Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Mark and Lisa Schwartz Foundation	We would like to acknowledge, while accepting full responsibility for the content and opinions expressed, open discussions and correspondence with: M. Altfeld, D. Brooks, D. Burton, M. Colonna, L. Corey, B. Beutler, D. Barouch, A. Chakraborty, F. Chisari, R. Desrosiers, M. Diamond, A. Garcia-Sastre, L. Glimcher, P. Goulder, H. Greenberg, A. Haase, K. Hasenkrug, B. Haynes, M. Hirsch, S. Abdool-Karim, W. Koff, B. Lamb, J. Lifson, J. Loh, R. Medzhitov, J. Moore, M. Nussenzweig, M. Oldstone, L. Picker, B. Roizman, R. Siliciano, G. Silvestri, S. Wain-Hobson, D. Watkins, R. Weiss, J. Wherry and O. Yang. This work was supported by grants from the National Institutes of Health (H. W. V. and B. D. W.), the Bill and Melinda Gates Foundation (B. D. W.), and a gift from the Mark and Lisa Schwartz Foundation (B. D. W.).	Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; Altfeld M, 2002, NATURE, V420, P434, DOI 10.1038/nature01200; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Blazkova J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000554; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brooks DG, 2008, J EXP MED, V205, P533, DOI 10.1084/jem.20071948; Brooks DG, 2008, P NATL ACAD SCI USA, V105, P20428, DOI 10.1073/pnas.0811139106; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Chachu KA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000236; Chen H, 2009, J VIROL, V83, P3138, DOI 10.1128/JVI.02073-08; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Chung C, 2007, J VIROL, V81, P1517, DOI 10.1128/JVI.01780-06; Cohen MS, 2008, J CLIN INVEST, V118, P1244, DOI 10.1172/JCI34706; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Dinoso JB, 2009, J VIROL, V83, P9247, DOI 10.1128/JVI.00840-09; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Draenert R, 2006, J EXP MED, V203, P529, DOI 10.1084/jem.20052116; Duvall MG, 2006, J IMMUNOL, V176, P6973, DOI 10.4049/jimmunol.176.11.6973; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; FIELDS BN, 1994, NATURE, V369, P95, DOI 10.1038/369095a0; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Ha SJ, 2008, J EXP MED, V205, P543, DOI 10.1084/jem.20071949; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; HASENKRUG KJ, 1995, P NATL ACAD SCI USA, V92, P10492, DOI 10.1073/pnas.92.23.10492; Hasenkrug KJ, 1998, J VIROL, V72, P6559, DOI 10.1128/JVI.72.8.6559-6564.1998; Hatziioannou T, 2009, P NATL ACAD SCI USA, V106, P4425, DOI 10.1073/pnas.0812587106; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Kaufman DR, 2008, J IMMUNOL, V181, P4188, DOI 10.4049/jimmunol.181.6.4188; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Klatt NR, 2008, J CLIN INVEST, V118, P2039, DOI 10.1172/JCI33814; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; KRONER BL, 1994, J ACQ IMMUN DEF SYND, V7, P279; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; McClellan KB, 2006, PLOS PATHOG, V2, P578, DOI 10.1371/journal.ppat.0020058; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Mehlhop E, 2005, J VIROL, V79, P7466, DOI 10.1128/JVI.79.12.7466-7477.2005; Messer RJ, 2004, P NATL ACAD SCI USA, V101, P12260, DOI 10.1073/pnas.0404769101; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Neil S, 2009, J INTERF CYTOK RES, V29, P569, DOI 10.1089/jir.2009.0077; Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060; Nix WA, 2008, J CLIN MICROBIOL, V46, P2874, DOI 10.1128/JCM.00074-08; Okoye A, 2009, J EXP MED, V206, P1575, DOI 10.1084/jem.20090356; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Pike R, 2009, J VIROL, V83, P11211, DOI 10.1128/JVI.01225-09; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Santiago ML, 2008, SCIENCE, V321, P1343, DOI 10.1126/science.1161121; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schneidewind A, 2008, J VIROL, V82, P5594, DOI 10.1128/JVI.02356-07; Schneidewind A, 2009, J VIROL, V83, P3993, DOI 10.1128/JVI.01108-08; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Tibbetts SA, 2002, J VIROL, V76, P7125, DOI 10.1128/JVI.76.14.7125-7132.2002; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; TYLER KL, 1993, J VIROL, V67, P3446, DOI 10.1128/JVI.67.6.3446-3453.1993; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wilson NA, 2009, J VIROL, V83, P6508, DOI 10.1128/JVI.00272-09; Wyand MS, 1999, J VIROL, V73, P8356, DOI 10.1128/JVI.73.10.8356-8363.1999; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Zhang JX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002035; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792	101	133	136	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					224	231		10.1038/nature08898	http://dx.doi.org/10.1038/nature08898			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20220841				2022-12-28	WOS:000275366100036
J	Mathews, CJ; Weston, VC; Jones, A; Field, M; Coakley, G				Mathews, Catherine J.; Weston, Vivienne C.; Jones, Adrian; Field, Max; Coakley, Gerald			Bacterial septic arthritis in adults	LANCET			English	Article							STAPHYLOCOCCUS-AUREUS ARTHRITIS; HOT SWOLLEN JOINT; SYNOVIAL-FLUID; METHICILLIN-RESISTANT; CLINICAL-FEATURES; LABORATORY TESTS; INFECTIONS; CULTURE; INTERLEUKIN-10; MANAGEMENT	Symptoms and signs of septic arthritis are an important medical emergency, with high morbidity and mortality. We review the changing epidemiology of septic arthritis of native joints in adults, encompassing the increasing frequency of the disorder and its evolving antibiotic resistance. We discuss various risk factors for development of septic arthritis and examine host factors (tumour necrosis factor a, interleukins 1 and 10) and bacterial proteins, toxins, and enzymes reported to be important determinants of pathogenesis in mouse models. Diagnosis of disease is largely clinical, guided by investigations and the opinion of skilled clinicians. We emphasise the need for timely medical and surgical intervention most importantly, through diagnostic aspiration of relevant joints, choice of suitable antibiotic, and appropriate supportive measures. Management is growing in complexity with the advent of novel and antibiotic-resistant causative microorganisms and within the current climate of increased immunosuppression. Findings from animal models and patients are shedding light on disease pathogenesis and the possibility of novel adjunctive treatments, including systemic corticosteroids, cytokines and anticytokines, and bisphosphonates.	[Mathews, Catherine J.; Coakley, Gerald] Queen Elizabeth Hosp, S London Healthcare Trust, London SE18 4QH, England; [Weston, Vivienne C.; Jones, Adrian] Nottingham Univ Hosp NHS Trust, Nottingham, England; [Field, Max] Royal Infirm, Ctr Rheumat Dis, Glasgow G31 2ER, Lanark, Scotland	Nottingham University Hospital NHS Trust; Royal Infirmary of Edinburgh; University of Glasgow	Coakley, G (corresponding author), Queen Elizabeth Hosp, S London Healthcare Trust, Stadium Rd, London SE18 4QH, England.	gerald.coakley@nhs.net						ABDELNOUR A, 1993, INFECT IMMUN, V61, P3879, DOI 10.1128/IAI.61.9.3879-3885.1993; Abdullah S, 2007, J CLIN PATHOL, V60, P1144, DOI 10.1136/jcp.2006.043950; Al-Nammari S S, 2008, J Orthop Surg (Hong Kong), V16, P54; Arnold SR, 2006, J PEDIATR ORTHOPED, V26, P703, DOI 10.1097/01.bpo.0000242431.91489.b4; Bean David C, 2008, Ann Clin Microbiol Antimicrob, V7, P13, DOI 10.1186/1476-0711-7-13; Belzunegui J, 1997, CLIN RHEUMATOL, V16, P450, DOI 10.1007/BF02238936; Borg MA, 2008, CLIN MICROBIOL INFEC, V14, P789, DOI 10.1111/j.1469-0691.2008.02037.x; Coakley G, 2006, RHEUMATOLOGY, V45, P1039, DOI 10.1093/rheumatology/kel163a; Coutlakis PJ, 2002, JCR-J CLIN RHEUMATOL, V8, P67, DOI 10.1097/00124743-200204000-00001; Deng GM, 2000, ARTHRITIS RHEUM-US, V43, P356, DOI 10.1002/1529-0131(200002)43:2<356::AID-ANR15>3.0.CO;2-J; Dubost JJ, 2002, ANN RHEUM DIS, V61, P267, DOI 10.1136/ard.61.3.267; Eder L, 2005, RHEUMATOLOGY, V44, P1559, DOI 10.1093/rheumatology/kei092; Edwards CJ, 2007, ARTHRIT RHEUM-ARTHR, V57, P1151, DOI 10.1002/art.23003; Falagas ME, 2007, INT J ANTIMICROB AG, V29, P233, DOI 10.1016/j.ijantimicag.2006.08.030; Falagas ME, 2007, INT J ANTIMICROB AG, V30, P202, DOI 10.1016/j.ijantimicag.2007.02.012; Fleisch F, 2001, CLIN INFECT DIS, V32, P581, DOI 10.1086/318716; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; FREED JF, 1980, JAMA-J AM MED ASSOC, V243, P2314, DOI 10.1001/jama.243.22.2314; Geirsson AJ, 2008, ANN RHEUM DIS, V67, P638, DOI 10.1136/ard.2007.077131; Gemmell CG, 2006, J ANTIMICROB CHEMOTH, V57, P589, DOI 10.1093/jac/dkl017; Gjertsson I, 2002, CLIN EXP IMMUNOL, V130, P409, DOI 10.1046/j.1365-2249.2002.01999.x; GOLDENBERG DL, 1975, ARTHRITIS RHEUM-US, V18, P83, DOI 10.1002/art.1780180116; GOLDENBERG DL, 1976, AM J MED, V60, P369, DOI 10.1016/0002-9343(76)90753-1; Gupta MN, 2001, RHEUMATOLOGY, V40, P24, DOI 10.1093/rheumatology/40.1.24; Gupta MN, 2003, ANN RHEUM DIS, V62, P327, DOI 10.1136/ard.62.4.327; Hugle T, 2008, CLIN EXP RHEUMATOL, V26, P453; Hughes JG, 2001, J CLIN MICROBIOL, V39, P4468, DOI 10.1128/JCM.39.12.4468-4471.2001; Hultgren O, 1998, J IMMUNOL, V161, P5937; Hultgren O, 1999, EUR J IMMUNOL, V29, P2400, DOI 10.1002/(SICI)1521-4141(199908)29:08<2400::AID-IMMU2400>3.0.CO;2-E; Hultgren OH, 2002, J IMMUNOL, V168, P5207, DOI 10.4049/jimmunol.168.10.5207; Josefsson E, 2001, J INFECT DIS, V184, P1572, DOI 10.1086/324430; Kaandorp CJE, 1995, ARTHRITIS RHEUM, V38, P1819, DOI 10.1002/art.1780381215; Kaandorp CJE, 1997, ANN RHEUM DIS, V56, P470, DOI 10.1136/ard.56.8.470; LeDantec L, 1996, REV RHUM, V63, P103; Li SF, 2007, EMERG MED J, V24, P75, DOI 10.1136/emj.2006.037929; Li SF, 2004, ACAD EMERG MED, V11, P276, DOI [10.1111/j.1553-2712.2004.tb02209.x, 10.1197/j.aem.2003.09.018]; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Loughrey A, 2007, INT J ANTIMICROB AG, V29, pS373, DOI 10.1016/S0924-8579(07)71188-3; Margaretten ME, 2007, JAMA-J AM MED ASSOC, V297, P1478, DOI 10.1001/jama.297.13.1478; Martinez-Aguilar G, 2004, PEDIATR INFECT DIS J, V23, P701, DOI 10.1097/01.inf.0000133044.79130.2a; Martinot M, 2005, CLIN EXP RHEUMATOL, V23, P303; Mathews CJ, 2007, ANN RHEUM DIS, V66, P440, DOI 10.1136/ard.2006.058909; MATHEWS CJ, 2008, FUTURE RHEUMATOL, V3, P43; McGillicuddy DC, 2007, AM J EMERG MED, V25, P749, DOI 10.1016/j.ajem.2006.12.001; Millar BC, 2007, J HOSP INFECT, V67, P109, DOI 10.1016/j.jhin.2007.06.003; Morgan DS, 1996, EPIDEMIOL INFECT, V117, P423, DOI 10.1017/S0950268800059070; NEWMAN JH, 1976, ANN RHEUM DIS, V35, P198, DOI 10.1136/ard.35.3.198; Nilsson IM, 1998, J CLIN INVEST, V101, P2640, DOI 10.1172/JCI1823; Odio CM, 2003, PEDIATR INFECT DIS J, V22, P883, DOI 10.1097/01.inf.0000091293.32187.7b; Palmqvist N, 2002, MICROB PATHOGENESIS, V33, P239, DOI 10.1006/mpat.2002.0533; Puliti M, 2002, ARTHRITIS RHEUM, V46, P806, DOI 10.1002/art.10170; Puliti M, 2002, INFECT IMMUN, V70, P2862, DOI 10.1128/IAI.70.6.2862-2868.2002; Sakiniene E, 1996, ARTHRITIS RHEUM, V39, P1596, DOI 10.1002/art.1780390921; Saraux A, 1997, BRIT J RHEUMATOL, V36, P333; Schelenz S, 2007, JOINT BONE SPINE, V74, P275, DOI 10.1016/j.jbspin.2006.08.007; Seaton RA, 2008, J ANTIMICROB CHEMOTH, V62, P15, DOI 10.1093/jac/dkn368; Soderquist B, 1998, SCAND J INFECT DIS, V30, P591, DOI 10.1080/00365549850161151; Stengel D, 2001, Lancet Infect Dis, V1, P175, DOI 10.1016/S1473-3099(01)00094-9; Swaminathan A, 2006, INTERN MED J, V36, P744, DOI 10.1111/j.1445-5994.2006.01220.x; Swan A, 2002, ANN RHEUM DIS, V61, P493, DOI 10.1136/ard.61.6.493; Tarkowski A, 2001, TRENDS MICROBIOL, V9, P321, DOI 10.1016/S0966-842X(01)02078-9; TISSI L, 1990, INFECT IMMUN, V58, P3093, DOI 10.1128/IAI.58.9.3093-3100.1990; Ventura G, 1997, ACTA ORTHOP SCAND, V68, P554, DOI 10.3109/17453679708999025; Verdrengh M, 2007, J ORTHOP RES, V25, P304, DOI 10.1002/jor.20317; Weston VC, 1999, ANN RHEUM DIS, V58, P214, DOI 10.1136/ard.58.4.214; Weston V, 2006, J ANTIMICROB CHEMOTH, V58, P492, DOI 10.1093/jac/dkl295; Yagupsky P, 1997, J CLIN MICROBIOL, V35, P2410, DOI 10.1128/JCM.35.9.2410-2412.1997; Yagupsky P, 2001, J CLIN MICROBIOL, V39, P738, DOI 10.1128/JCM.39.2.738-739.2001	69	326	334	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 6	2010	375	9717					846	855		10.1016/S0140-6736(09)61595-6	http://dx.doi.org/10.1016/S0140-6736(09)61595-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570MO	20206778				2022-12-28	WOS:000275682600034
J	Hawkes, N				Hawkes, Nigel			Primary Care Open all hours	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						TIMMINS N, 2009, FINANCIAL TIMES 0511	1	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 5	2010	340								c1154	10.1136/bmj.c1154	http://dx.doi.org/10.1136/bmj.c1154			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	565FL	20207686				2022-12-28	WOS:000275274600001
J	Red-Horse, K; Ueno, H; Weissman, IL; Krasnow, MA				Red-Horse, Kristy; Ueno, Hiroo; Weissman, Irving L.; Krasnow, Mark A.			Coronary arteries form by developmental reprogramming of venous cells	NATURE			English	Article							SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; SAPHENOUS-VEIN; GROWTH-FACTOR; HEART; ANGIOGENESIS; EMBRYO; MOUSE; SYSTEM; DIFFERENTIATION	Coronary artery disease is the leading cause of death worldwide. Determining the coronary artery developmental program could aid understanding of the disease and lead to new treatments, but many aspects of the process, including their developmental origin, remain obscure. Here we show, using histological and clonal analysis in mice and cardiac organ culture, that coronary vessels arise from angiogenic sprouts of the sinus venosus-the vein that returns blood to the embryonic heart. Sprouting venous endothelial cells dedifferentiate as they migrate over and invade the myocardium. Invading cells differentiate into arteries and capillaries; cells on the surface redifferentiate into veins. These results show that some differentiated venous cells retain developmental plasticity, and indicate that position-specific cardiac signals trigger their dedifferentiation and conversion into coronary arteries, capillaries and veins. Understanding this new reprogramming process and identifying the endogenous signals should suggest more natural ways of engineering coronary bypass grafts and revascularizing the heart.	[Red-Horse, Kristy; Krasnow, Mark A.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Red-Horse, Kristy; Krasnow, Mark A.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Ueno, Hiroo; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Krasnow, MA (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	krasnow@stanford.edu			National Institutes of Health [2T32HD007249]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007249] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099999, U01HL099995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank T. Quertermous, L. Iruela-Arispe and S. M. Evans for mouse strains, Krasnow laboratory members for input and comments, especially M. Kumar for guidance on clonal analysis, and C. Breitweiser and M. Petersen for help preparing figures. K. R.-H. was supported by the National Institutes of Health under Ruth L. Kirschstein National Research Service Award (2T32HD007249). M. A. K. is an investigator of the Howard Hughes Medical Institute.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Bennett HS, 1936, AM J ANAT, V60, P27, DOI 10.1002/aja.1000600103; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; Goldman S, 2004, J AM COLL CARDIOL, V44, P2149, DOI 10.1016/j.jacc.2004.08.064; GRANT R. T., 1926, HEART, V13, P261; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; HIRUMA T, 1989, AM J ANAT, V184, P129, DOI 10.1002/aja.1001840204; HUTCHINS GM, 1988, CIRCULATION, V77, P1250, DOI 10.1161/01.CIR.77.6.1250; Kattan J, 2004, DEV DYNAM, V230, P34, DOI 10.1002/dvdy.20022; Kidoya H, 2008, EMBO J, V27, P522, DOI 10.1038/sj.emboj.7601982; Kirby M. L., 2007, CARDIAC DEV; Kudo FA, 2007, ARTERIOSCL THROM VAS, V27, P1562, DOI 10.1161/ATVBAHA.107.143032; Lavine KJ, 2008, DEVELOPMENT, V135, P3161, DOI 10.1242/dev.019919; Lavine KJ, 2006, GENE DEV, V20, P1651, DOI 10.1101/gad.1411406; Lavine KJ, 2009, CIRC RES, V104, P159, DOI 10.1161/CIRCRESAHA.108.191239; le Noble F, 2004, DEVELOPMENT, V131, P361, DOI 10.1242/dev.00929; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lewis FT, 1904, ANAT ANZEIGER, V25, P261; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Majesky MW, 2004, CURR TOP DEV BIOL, V62, P225; Manner J, 1999, ANAT RECORD, V255, P212; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; Moyon D, 2001, DEVELOPMENT, V128, P3359; Othman-Hassan K, 2001, DEV BIOL, V237, P398, DOI 10.1006/dbio.2001.0383; Perez-Pomares JM, 2002, INT J DEV BIOL, V46, P1005; POELMANN RE, 1993, CIRC RES, V73, P559, DOI 10.1161/01.RES.73.3.559; Sabik JF, 2005, ANN THORAC SURG, V79, P544, DOI 10.1016/j.athoracsur.2004.07.047; Sheikh AY, 2008, AM J PHYSIOL-HEART C, V294, pH88, DOI 10.1152/ajpheart.00935.2007; Smart N, 2009, INT J EXP PATHOL, V90, P262, DOI 10.1111/j.1365-2613.2009.00646.x; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; World Health Organization, 2004, GLOB BURD DIS 2004 U; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	45	364	372	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					549	U100		10.1038/nature08873	http://dx.doi.org/10.1038/nature08873			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20336138	Green Accepted			2022-12-28	WOS:000275974200039
J	Sacanna, S; Irvine, WTM; Chaikin, PM; Pine, DJ				Sacanna, S.; Irvine, W. T. M.; Chaikin, P. M.; Pine, D. J.			Lock and key colloids	NATURE			English	Article							DNA; CRYSTALLIZATION	New functional materials can in principle be created using colloids that self-assemble into a desired structure by means of a programmable recognition and binding scheme. This idea has been explored by attaching 'programmed' DNA strands to nanometre-(1-3) and micrometre-(4,5) sized particles and then using DNA hybridization to direct the placement of the particles in the final assembly. Here we demonstrate an alternative recognition mechanism for directing the assembly of composite structures, based on particles with complementary shapes. Our system, which uses Fischer's lock-and-key principle(6), employs colloidal spheres as keys and monodisperse colloidal particles with a spherical cavity as locks that bind spontaneously and reversibly via the depletion interaction. The lock-and-key binding is specific because it is controlled by how closely the size of a spherical colloidal key particle matches the radius of the spherical cavity of the lock particle. The strength of the binding can be further tuned by adjusting the solution composition or temperature. The composite assemblies have the unique feature of having flexible bonds, allowing us to produce flexible dimeric, trimeric and tetrameric colloidal molecules as well as more complex colloidal polymers. We expect that this lock-and-key recognition mechanism will find wider use as a means of programming and directing colloidal self-assembly.	[Sacanna, S.; Irvine, W. T. M.; Chaikin, P. M.; Pine, D. J.] New York Univ, Dept Phys, New York, NY 10003 USA	New York University	Sacanna, S (corresponding author), New York Univ, Dept Phys, 4 Washington Pl, New York, NY 10003 USA.	s.sacanna@nyu.edu; pine@nyu.edu	Pine, David J/B-7740-2016; Sacanna, Stefano/D-4683-2012; Sacanna, Stefano/ABE-9434-2021	Pine, David J/0000-0002-3304-6684; Sacanna, Stefano/0000-0002-8399-3524; irvine, william/0000-0002-4925-2060	National Science Foundation [DMR 0706453]; Keck Foundation; Netherlands Organization for Scientific Research (NWO) through a Rubicon fellowship; English Speaking Union through a Lindemann Fellowship and Rhodia	National Science Foundation(National Science Foundation (NSF)); Keck Foundation(W.M. Keck Foundation); Netherlands Organization for Scientific Research (NWO) through a Rubicon fellowship(Netherlands Organization for Scientific Research (NWO)); English Speaking Union through a Lindemann Fellowship and Rhodia	This work was partially supported by National Science Foundation grants DMR 0706453 and the Keck Foundation. S. S. was supported by the Netherlands Organization for Scientific Research (NWO) through a Rubicon fellowship. W. T. M. I. acknowledges support from the English Speaking Union through a Lindemann Fellowship and Rhodia.	ASAKURA S, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740347; Fischer E., 1894, GESELLSCHAFT, V27, P2985; Konig PM, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/68006; LEKKERKERKER HNW, 1992, EUROPHYS LETT, V20, P559, DOI 10.1209/0295-5075/20/6/015; MIRKIN CA, 1996, NATURE, V382, P609; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; OBEY TM, 1994, J COLLOID INTERF SCI, V163, P454, DOI 10.1006/jcis.1994.1124; Odriozola G, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2981795; OTTEWILL RH, 1967, KOLLOID Z Z POLYM, V218, P34, DOI 10.1007/BF01517273; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; PELTON RH, 1986, COLLOID SURFACE, V20, P247, DOI 10.1016/0166-6622(86)80274-8; Rogers PH, 2005, LANGMUIR, V21, P5562, DOI 10.1021/la046790y; Saunders BR, 1999, ADV COLLOID INTERFAC, V80, P1, DOI 10.1016/S0001-8686(98)00071-2; STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Valignat MP, 2005, P NATL ACAD SCI USA, V102, P4225, DOI 10.1073/pnas.0500507102	15	596	609	4	428	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 25	2010	464	7288					575	578		10.1038/nature08906	http://dx.doi.org/10.1038/nature08906			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20336142				2022-12-28	WOS:000275974200044
J	McKeon, BJ				McKeon, Beverley J.			Controlling Turbulence	SCIENCE			English	Editorial Material							PIPE-FLOW; TRANSITION		CALTECH, Grad Aerosp Labs, Pasadena, CA 91125 USA	California Institute of Technology	McKeon, BJ (corresponding author), CALTECH, Grad Aerosp Labs, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	mckeon@caltech.edu		McKeon, Beverley/0000-0003-4220-1583				Eckhardt B, 2007, ANNU REV FLUID MECH, V39, P447, DOI 10.1146/annurev.fluid.39.050905.110308; Hof B, 2010, SCIENCE, V327, P1491, DOI 10.1126/science.1186091; McKeon BJ, 2004, J FLUID MECH, V511, P41, DOI 10.1017/S0022112004009796; WYGNANSKI IJ, 1973, J FLUID MECH, V59, P281, DOI 10.1017/S0022112073001576	5	5	5	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	2010	327	5972					1462	1463		10.1126/science.1187607	http://dx.doi.org/10.1126/science.1187607			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20299581				2022-12-28	WOS:000275715200032
J	Stark, CP; Barbour, JR; Hayakawa, YS; Hattanji, T; Hovius, N; Chen, HG; Lin, CW; Horng, MJ; Xu, KQ; Fukahata, Y				Stark, Colin P.; Barbour, Jonathan R.; Hayakawa, Yuichi S.; Hattanji, Tsuyoshi; Hovius, Niels; Chen, Hongey; Lin, Ching-Weei; Horng, Ming-Jame; Xu, Kai-Qin; Fukahata, Yukitoshi			The Climatic Signature of Incised River Meanders	SCIENCE			English	Article							SEDIMENT; BEDROCK; EROSION; UPLIFT	Climate controls landscape evolution, but quantitative signatures of climatic drivers have yet to be found in topography on a broad scale. Here we describe how a topographic signature of typhoon rainfall is recorded in the meandering of incising mountain rivers in the western North Pacific. Spatially averaged river sinuosity generated from digital elevation data peaks in the typhoon-dominated subtropics, where extreme rainfall and flood events are common, and decreases toward the equatorial tropics and mid-latitudes, where such extremes are rare. Once climatic trends are removed, the primary control on sinuosity is rock weakness. Our results indicate that the weakness of bedrock channel walls and their weakening by heavy rainfall together modulate rates of meander propagation and sinuosity development in incising rivers.	[Stark, Colin P.; Barbour, Jonathan R.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Hayakawa, Yuichi S.] Univ Tokyo, Ctr Spatial Informat Sci, Chiba 2778568, Japan; [Hattanji, Tsuyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki 3058572, Japan; [Hovius, Niels] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Chen, Hongey] Natl Taiwan Univ, Dept Geosci, Taipei 10617, Taiwan; [Lin, Ching-Weei] Natl Cheng Kung Univ, Dept Earth Sci, Tainan 70101, Taiwan; [Horng, Ming-Jame] Minist Econ Affairs, Water Resources Agcy, Taipei, Taiwan; [Xu, Kai-Qin] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Xu, Kai-Qin] Wuhan Univ, State Key Lab Water Resources & Hydropower Engn S, Wuhan 430072, Peoples R China; [Fukahata, Yukitoshi] Kyoto Univ, Disaster Prevent Res Inst, Kyoto 6110011, Japan	Columbia University; University of Tokyo; University of Tsukuba; University of Cambridge; National Taiwan University; National Cheng Kung University; National Institute for Environmental Studies - Japan; Wuhan University; Kyoto University	Stark, CP (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	cstark@ldeo.columbia.edu	hayakawa, yuichi/C-3099-2008; Hovius, Niels/F-1094-2013; Fukahata, Yukitoshi/AAL-7557-2021	hayakawa, yuichi/0000-0003-2053-8986; Hovius, Niels/0000-0002-9158-9871; CHEN, HONGEY/0000-0003-1211-3259; Xu, Kaiqin/0000-0003-0781-3031	NASA; NSF; Taiwan National Science Council	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by NASA, NSF (Earth Sciences Division, Geomorphology and Land-use Dynamics Program), and the Taiwan National Science Council. We thank W. E. Dietrich, G. Parker, and E. E. Wohl for enlightening discussions and C.-H. Jen, C. Huang, T.-C. Yi, and M. Tajikara for help in the field.	Barbour JR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035786; Bitter JGA., 1963, WEAR, V6, P169, DOI [10.1016/0043-1648(63)90073-5, DOI 10.1016/0043-1648(63)90073-5]; BLANK HR, 1970, GEOL SOC AM BULL, V81, P3135, DOI 10.1130/0016-7606(1970)81[3135:IMIMCT]2.0.CO;2; Chan JCL, 2005, ANNU REV FLUID MECH, V37, P99, DOI 10.1146/annurev.fluid.37.061903.175702; Dadson SJ, 2003, NATURE, V426, P648, DOI 10.1038/nature02150; Davis W M, 1893, Science, V21, P225; DURY GH, 1954, AM J SCI, V252, P193, DOI 10.2475/ajs.252.4.193; Galewsky J, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000428; Guzzetti F, 2007, METEOROL ATMOS PHYS, V98, P239, DOI 10.1007/s00703-007-0262-7; Hancock GS, 2002, GEOL SOC AM BULL, V114, P1131; HARDEN DR, 1990, GEOL SOC AM BULL, V102, P233, DOI 10.1130/0016-7606(1990)102<0233:CFITDA>2.3.CO;2; Hartshorn K, 2002, SCIENCE, V297, P2036, DOI 10.1126/science.1075078; Hayakawa YS, 2009, GEOMORPHOLOGY, V111, P27, DOI 10.1016/j.geomorph.2007.11.016; HIRANO M, 1981, T JPN GEOMORPHOL UNI, V1, P117; IKEDA S, 1981, J FLUID MECH, V112, P363, DOI 10.1017/S0022112081000451; Maeda Y, 2004, QUATERN INT, V115, P15, DOI 10.1016/S1040-6182(03)00093-4; MAHARD RH, 1942, J GEOMORPHOL, V5, P32; MILLIMAN JD, 1992, J GEOL, V100, P525, DOI 10.1086/629606; NAKANO A, 1999, B ENV RES CTR U TSUK, V24, P1; Ota Y, 2004, QUATERN INT, V120, P105, DOI 10.1016/j.quaint.2004.01.010; Pazzaglia FJ, 2001, AM J SCI, V301, P385, DOI 10.2475/ajs.301.4-5.385; Seminara G, 2006, J FLUID MECH, V554, P271, DOI 10.1017/S0022112006008925; Shyu JBH, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003971; Sklar LS, 2001, GEOLOGY, V29, P1087, DOI 10.1130/0091-7613(2001)029<1087:SARSCO>2.0.CO;2; Stark CP, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL023193; SUZUKI T, 1982, T JPN GEOMORPHOL UNI, P1; SUZUKI T, 1983, T JPN GEOMORPHOL UNI, P33; Turowski JM, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000697; Turowski JM, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001133; WILLETT SD, 2006, GSA SPEC PAP, V398; Winslow A, 1893, Science, V22, P31; YAGI R, 1997, B ENV RES CTR U TSUK, V22, P1	32	61	63	4	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	2010	327	5972					1497	1501		10.1126/science.1184406	http://dx.doi.org/10.1126/science.1184406			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20299592	Green Submitted			2022-12-28	WOS:000275715200044
J	Ma, LJ; van der Does, HC; Borkovich, KA; Coleman, JJ; Daboussi, MJ; Di Pietro, A; Dufresne, M; Freitag, M; Grabherr, M; Henrissat, B; Houterman, PM; Kang, S; Shim, WB; Woloshuk, C; Xie, XH; Xu, JR; Antoniw, J; Baker, SE; Bluhm, BH; Breakspear, A; Brown, DW; Butchko, RAE; Chapman, S; Coulson, R; Coutinho, PM; Danchin, EGJ; Diener, A; Gale, LR; Gardiner, DM; Goff, S; Hammond-Kosack, KE; Hilburn, K; Hua-Van, A; Jonkers, W; Kazan, K; Kodira, CD; Koehrsen, M; Kumar, L; Lee, YH; Li, LD; Manners, JM; Miranda-Saavedra, D; Mukherjee, M; Park, G; Park, J; Park, SY; Proctor, RH; Regev, A; Ruiz-Roldan, MC; Sain, D; Sakthikumar, S; Sykes, S; Schwartz, DC; Turgeon, BG; Wapinski, I; Yoder, O; Young, S; Zeng, QD; Zhou, SG; Galagan, J; Cuomo, CA; Kistler, HC; Rep, M				Ma, Li-Jun; van der Does, H. Charlotte; Borkovich, Katherine A.; Coleman, Jeffrey J.; Daboussi, Marie-Josee; Di Pietro, Antonio; Dufresne, Marie; Freitag, Michael; Grabherr, Manfred; Henrissat, Bernard; Houterman, Petra M.; Kang, Seogchan; Shim, Won-Bo; Woloshuk, Charles; Xie, Xiaohui; Xu, Jin-Rong; Antoniw, John; Baker, Scott E.; Bluhm, Burton H.; Breakspear, Andrew; Brown, Daren W.; Butchko, Robert A. E.; Chapman, Sinead; Coulson, Richard; Coutinho, Pedro M.; Danchin, Etienne G. J.; Diener, Andrew; Gale, Liane R.; Gardiner, Donald M.; Goff, Stephen; Hammond-Kosack, Kim E.; Hilburn, Karen; Hua-Van, Aurelie; Jonkers, Wilfried; Kazan, Kemal; Kodira, Chinnappa D.; Koehrsen, Michael; Kumar, Lokesh; Lee, Yong-Hwan; Li, Liande; Manners, John M.; Miranda-Saavedra, Diego; Mukherjee, Mala; Park, Gyungsoon; Park, Jongsun; Park, Sook-Young; Proctor, Robert H.; Regev, Aviv; Carmen Ruiz-Roldan, M.; Sain, Divya; Sakthikumar, Sharadha; Sykes, Sean; Schwartz, David C.; Turgeon, B. Gillian; Wapinski, Ilan; Yoder, Olen; Young, Sarah; Zeng, Qiandong; Zhou, Shiguo; Galagan, James; Cuomo, Christina A.; Kistler, H. Corby; Rep, Martijn			Comparative genomics reveals mobile pathogenicity chromosomes in Fusarium	NATURE			English	Article							MAXIMUM-LIKELIHOOD; OXYSPORUM; GENE; SEQUENCE; TOMATO; EXPRESSION; RESISTANCE; POLYMORPHISM; ANNOTATION; INFECTION	Fusarium species are among the most important phytopathogenic and toxigenic fungi. To understand the molecular underpinnings of pathogenicity in the genus Fusarium, we compared the genomes of three phenotypically diverse species: Fusarium graminearum, Fusarium verticillioides and Fusarium oxysporum f. sp. lycopersici. Our analysis revealed lineage-specific (LS) genomic regions in F. oxysporum that include four entire chromosomes and account for more than one-quarter of the genome. LS regions are rich in transposons and genes with distinct evolutionary profiles but related to pathogenicity, indicative of horizontal acquisition. Experimentally, we demonstrate the transfer of two LS chromosomes between strains of F. oxysporum, converting a non-pathogenic strain into a pathogen. Transfer of LS chromosomes between otherwise genetically isolated strains explains the polyphyletic origin of host specificity and the emergence of new pathogenic lineages in F. oxysporum. These findings put the evolution of fungal pathogenicity into a new perspective.	[Breakspear, Andrew; Gale, Liane R.; Hilburn, Karen; Kistler, H. Corby] Univ Minnesota, USDA ARS, St Paul, MN 55108 USA; [Ma, Li-Jun; Grabherr, Manfred; Chapman, Sinead; Kodira, Chinnappa D.; Koehrsen, Michael; Kumar, Lokesh; Regev, Aviv; Sakthikumar, Sharadha; Sykes, Sean; Wapinski, Ilan; Young, Sarah; Zeng, Qiandong; Galagan, James; Cuomo, Christina A.] Broad Inst, Cambridge, MA 02141 USA; [van der Does, H. Charlotte; Houterman, Petra M.; Jonkers, Wilfried; Rep, Martijn] Univ Amsterdam, NL-1098 XH Amsterdam, Netherlands; [Borkovich, Katherine A.; Li, Liande; Park, Gyungsoon; Sain, Divya] Univ Calif Riverside, Riverside, CA 92521 USA; [Coleman, Jeffrey J.] Univ Arizona, Tucson, AZ 85721 USA; [Daboussi, Marie-Josee; Hua-Van, Aurelie] Univ Paris 11, F-91405 Paris, France; [Di Pietro, Antonio; Carmen Ruiz-Roldan, M.] Univ Cordoba, E-14071 Cordoba, Spain; [Freitag, Michael] Oregon State Univ, Corvallis, OR 97331 USA; [Henrissat, Bernard; Coutinho, Pedro M.; Danchin, Etienne G. J.] Univ Aix Marseille, CNRS, F-13628 Aix En Provence, France; [Kang, Seogchan; Park, Sook-Young] Penn State Univ, University Pk, PA 16802 USA; [Shim, Won-Bo; Mukherjee, Mala] Texas A&M Univ, College Stn, TX 77843 USA; [Woloshuk, Charles; Xu, Jin-Rong; Bluhm, Burton H.] Purdue Univ, W Lafayette, IN 47907 USA; [Xie, Xiaohui] Univ Calif Irvine, Irvine, CA 92697 USA; [Antoniw, John; Hammond-Kosack, Kim E.] Ctr Sustainable Pest & Dis Management, Harpenden AL5 2JQ, Herts, England; [Baker, Scott E.] Pacific NW Natl Lab, Richland, WA 99352 USA; [Brown, Daren W.; Butchko, Robert A. E.; Proctor, Robert H.] USDA ARS NCAUR, Peoria, IL 61604 USA; [Coulson, Richard] European Bioinformat Inst, Cambridge CB10 1SD, England; [Diener, Andrew] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Gardiner, Donald M.; Kazan, Kemal; Manners, John M.] CSIRO Plant Ind, Brisbane, Qld 4067, Australia; [Goff, Stephen] Univ Arizona, Inst BIO5, Tucson, AZ 85721 USA; [Lee, Yong-Hwan; Park, Jongsun] Seoul Natl Univ, Seoul 151742, South Korea; [Miranda-Saavedra, Diego] Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Schwartz, David C.; Zhou, Shiguo] Univ Wisconsin, Madison, WI 53706 USA; [Turgeon, B. Gillian] Cornell Univ, Ithaca, NY 14853 USA	United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Amsterdam; University of California System; University of California Riverside; University of Arizona; UDICE-French Research Universities; Universite Paris Saclay; Universidad de Cordoba; Oregon State University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Texas A&M University System; Texas A&M University College Station; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California Irvine; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Agriculture (USDA); European Molecular Biology Laboratory (EMBL); University of California System; University of California Los Angeles; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Arizona; Seoul National University (SNU); University of Cambridge; University of Wisconsin System; University of Wisconsin Madison; Cornell University	Kistler, HC (corresponding author), Univ Minnesota, USDA ARS, St Paul, MN 55108 USA.	hckist@umn.edu; m.rep@uva.nl	Kazan, Kemal/B-8032-2008; Gardiner, Donald/A-1297-2010; Yoder, Olen C/D-1168-2009; Kumar, Lokesh/A-6154-2010; Zeng, Qiandong/AAF-3305-2019; Cuomo, Christina/L-2222-2019; Manners, John M/A-4922-2008; Ma, Li-Jun/AAG-2359-2020; Miranda-Saavedra, Diego/C-2707-2012; Biology, Transformational/D-5787-2011; Di Pietro, Antonio/K-9220-2014; Brown, Daren/AFR-4874-2022; Danchin, Etienne G.J./A-6648-2008; Coleman, Jeffrey J/E-2981-2015; Zhou, Shiguo/B-3832-2011; Kistler, Harold/AAC-1645-2019; Baker, Scott E/X-2065-2018; Hua-Van, Aurelie/N-3495-2013; Baker, Scott E./ABB-1635-2020; Danchin, Etienne GJ/X-6969-2019; li, liande/C-9985-2011; Henrissat, Bernard/J-2475-2012; Roldán, Carmen Ruiz/AAB-2100-2019	Kazan, Kemal/0000-0002-5169-8934; Gardiner, Donald/0000-0002-2162-8716; Yoder, Olen C/0000-0003-1177-9876; Kumar, Lokesh/0000-0002-2746-9840; Cuomo, Christina/0000-0002-5778-960X; Di Pietro, Antonio/0000-0001-5930-5763; Danchin, Etienne G.J./0000-0003-4146-5608; Zhou, Shiguo/0000-0001-7421-2506; Kistler, Harold/0000-0001-5312-6297; Baker, Scott E/0000-0001-5085-3106; Hua-Van, Aurelie/0000-0001-7859-2788; Baker, Scott E./0000-0001-5085-3106; Danchin, Etienne GJ/0000-0003-4146-5608; Henrissat, Bernard/0000-0002-3434-8588; Ma, Li-Jun/0000-0002-2733-3708; Grabherr, Manfred/0000-0001-8792-6508; Breakspear, Andrew/0000-0002-1863-3012; Xie, Xiaohui/0000-0002-5479-6345; Ruiz Roldan, M. Carmen/0000-0003-3427-2998; Galagan, James/0000-0003-0542-3291; Kang, Seogchan/0000-0003-2291-5634; Rep, Martijn/0000-0003-3608-6283; Coleman, Jeffrey/0000-0001-8579-1996; Sykes, Sean/0000-0001-8344-5176; Turgeon, Barbara/0000-0001-7979-7662; Broz, Karen/0000-0001-7928-7216; Hammond-Kosack, kim/0000-0002-9699-485X; Park, Jongsun/0000-0003-0786-4701; Park, Gyungsoon/0000-0003-1592-3847	USDA's National Institute of Food and Agriculture [2005-35600-16405]; BBSRC [BBS/E/C/00004973] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004973] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000225] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086565] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	USDA's National Institute of Food and Agriculture; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The 4 X sequence of F. verticillioides was provided by Syngenta Biotechnology Inc. Generation of the other 4 X sequence of F. verticillioides and 6.83 sequence of F. oxysporum f. sp. lycopersici was funded by the National Research Initiative of USDA's National Institute of Food and Agriculture through the Microbial Genome Sequencing Program (2005-35600-16405) and conducted by the Broad Institute Sequencing Platform. Wayne Xu and the Minnesota Supercomputing Institute for Advanced Computational Research are also acknowledged for their support. The authors thank Leslie Gaffney at the Broad Institute for graphic design and editing and Tracy E. Anderson of the University of Minnesota, College of Biological Sciences Imaging Center for spore micrographs.	Agrios G. N., 2005, PLANT PATHOL; ARMSTRONG GM, 1981, FUSARIUM DIS BIOL TA, P391; Bluthgen Nils, 2005, Genome Inform, V16, P106; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Desjardins AE, 2007, INT J FOOD MICROBIOL, V119, P47, DOI 10.1016/j.ijfoodmicro.2007.07.024; Engels R, 2006, BIOINFORMATICS, V22, P1782, DOI 10.1093/bioinformatics/btl193; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gale LR, 2003, PLANT DIS, V87, P1433, DOI 10.1094/PDIS.2003.87.12.1433; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harimoto Y, 2007, MOL PLANT MICROBE IN, V20, P1463, DOI 10.1094/MPMI-20-12-1463; Houterman PM, 2007, MOL PLANT PATHOL, V8, P215, DOI 10.1111/J.1364-3703.2007.00384.X; Houterman PM, 2009, PLANT J, V58, P970, DOI 10.1111/j.1365-313X.2009.03838.x; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Li Ming, 2004, J Bioinform Comput Biol, V2, P417, DOI 10.1142/S0219720004000661; MIAO VP, 1991, SCIENCE, V254, P1773, DOI 10.1126/science.1763326; Miranda-Saavedra D, 2007, PROTEINS, V68, P893, DOI 10.1002/prot.21444; O'Donnell K, 2004, J CLIN MICROBIOL, V42, P5109, DOI 10.1128/JCM.42.11.5109-5120.2004; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; Ortoneda M, 2004, INFECT IMMUN, V72, P1760, DOI 10.1128/IAI.72.3.1760-1766.2004; Qutob D, 2006, PLANT CELL, V18, P3721, DOI 10.1105/tpc.106.044180; Ramos B, 2007, FUNGAL GENET BIOL, V44, P864, DOI 10.1016/j.fgb.2007.03.003; Rasko DA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-2; Rep M, 2004, MOL MICROBIOL, V53, P1373, DOI 10.1111/j.1365-2958.2004.04177.x; Teunissen HAS, 2003, MOL GENET GENOMICS, V269, P215, DOI 10.1007/s00438-003-0825-3; Thatcher LF, 2009, PLANT J, V58, P927, DOI 10.1111/j.1365-313X.2009.03831.x; van der Does HC, 2008, FUNGAL GENET BIOL, V45, P1257, DOI 10.1016/j.fgb.2008.06.002; van der Does HC, 2008, ENVIRON MICROBIOL, V10, P1475, DOI 10.1111/j.1462-2920.2007.01561.x; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Xu JR, 1996, GENETICS, V143, P175; Zhou S, 2004, J BACTERIOL, V186, P7773, DOI 10.1128/JB.186.22.7773-7782.2004	37	1029	1520	10	318	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 18	2010	464	7287					367	373		10.1038/nature08850	http://dx.doi.org/10.1038/nature08850			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20237561	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000275657100037
J	Henderson, M				Henderson, Mark			Scientific Research Problems with peer review	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EMBRYONIC STEM-CELLS; SEE		The Times, London, England		Henderson, M (corresponding author), The Times, London, England.	mark.henderson@thetimes.co.uk						Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Cram DS, 2007, NATURE, V450, pE12, DOI 10.1038/nature06456; Ewen SWB, 1999, LANCET, V354, P1353, DOI 10.1016/S0140-6736(98)05860-7; Ghosh P., 2010, BBC NEWS 0202; Hwang WS, 2005, SCIENCE, V308, P1777, DOI 10.1126/science.1112286; Schiermeier Q, 2010, NATURE, V463, P596, DOI 10.1038/463596a; van Rooyen S, 1999, BRIT MED J, V318, P23; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0	8	17	17	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2010	340								c1409	10.1136/bmj.c1409	http://dx.doi.org/10.1136/bmj.c1409			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573RA	20231249				2022-12-28	WOS:000275931100004
J	Puy, H; Gouya, L; Deybach, JC				Puy, Herve; Gouya, Laurent; Deybach, Jean-Charles			Porphyrias	LANCET			English	Article							ACUTE INTERMITTENT PORPHYRIA; CONGENITAL ERYTHROPOIETIC PORPHYRIA; PORPHOBILINOGEN DEAMINASE GENE; HOMOZYGOUS VARIEGATE PORPHYRIA; DELTA-AMINOLEVULINIC-ACID; HEPATIC HEME-BIOSYNTHESIS; CHRONIC-RENAL-FAILURE; CUTANEA-TARDA; HEREDITARY COPROPORPHYRIA; UROPORPHYRINOGEN DECARBOXYLASE	Hereditary porphyrias are a group of eight metabolic disorders of the haem biosynthesis pathway that are characterised by acute neurovisceral symptoms, skin lesions, or both. Every porphyria is caused by abnormal function of a separate enzymatic step, resulting in a specific accumulation of haem precursors. Seven porphyrias are the result of a partial enzyme deficiency, and a gain of function mechanism has been characterised in a new porphyria. Acute porphyrias present with acute attacks, typically consisting of severe abdominal pain, nausea, constipation, confusion, and seizure, and can be life-threatening. Cutaneous porphyrias present with either acute painful photosensitivity or skin fragility and blisters. Rare recessive porphyrias usually manifest in early childhood with either severe cutaneous photosensitivity and chronic haemolysis or chronic neurological symptoms with or without photosensitivity. Porphyrias are still underdiagnosed, but when they are suspected, and dependent on clinical presentation, simple first-line tests can be used to establish the diagnosis in all symptomatic patients. Diagnosis is essential to enable specific treatments to be started as soon as possible. Screening of families to identify presymptomatic carriers is crucial to decrease risk of overt disease of acute porphyrias through counselling about avoidance of potential precipitants.	[Puy, Herve; Gouya, Laurent; Deybach, Jean-Charles] Hop Louis Mourier, Ctr Francais Porphyries, APHP, 178 Rue Renouillers, F-92701 Colombes, France; [Puy, Herve; Gouya, Laurent; Deybach, Jean-Charles] Univ Paris Diderot, INSERM, U773, Ctr Rech Biomed Bichat Beaujon, Paris, France; [Gouya, Laurent] Univ Versailles, St Quentin En Yvelines, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay	Deybach, JC (corresponding author), Hop Louis Mourier, Ctr Francais Porphyries, APHP, 178 Rue Renouillers, F-92701 Colombes, France.	jc.deybach@wanadoo.fr	; PUY, HERVE/O-1785-2017	Gouya, Laurent/0000-0002-1326-7025; PUY, HERVE/0000-0003-3362-2634	European Commission, Brussels, Belgium; ANR-GIS Maladies rares, Paris, France [ANR-07-MPAR-008-01]	European Commission, Brussels, Belgium(European CommissionEuropean Commission Joint Research Centre); ANR-GIS Maladies rares, Paris, France(French National Research Agency (ANR))	We thank Bernard Grandchamp, Carole Beaumont, Mike Badminton, and George Elder for informative and helpful discussions related to clinical and physiopathological details in genetic and haematology; and Jean-Pierre Laigneau for graphical support. All authors were supported by Grant Public Health and Consumer Protection Directorate Public Health Executive Agency from the European Commission, Brussels, Belgium, and grant number ANR-07-MPAR-008-01 from ANR-GIS Maladies rares, Paris, France.	Aarsand AK, 2009, CLIN CHEM, V55, P795, DOI 10.1373/clinchem.2008.117432; Aarsand AK, 2006, CLIN CHEM, V52, P650, DOI 10.1373/clinchem.2005.060772; Ajioka RS, 2008, BLOOD, V112, P4723, DOI 10.1182/blood-2008-02-138222; Allen KR, 2005, J INHERIT METAB DIS, V28, P779, DOI 10.1007/s10545-005-0092-z; Altiparmak UE, 2008, CORNEA, V27, P1093, DOI 10.1097/ICO.0b013e31817e905a; Andant C, 1998, NEW ENGL J MED, V338, P1853, DOI 10.1056/NEJM199806183382518; Andant C, 2000, J HEPATOL, V32, P933, DOI 10.1016/S0168-8278(00)80097-5; Anderson K. E., 2001, METABOLIC BASIS INHE; ANDERSON KE, 1990, NEW ENGL J MED, V322, P315, DOI 10.1056/NEJM199002013220507; Anderson KE, 2006, ANN INTERN MED, V144, P537, DOI 10.7326/0003-4819-144-7-200604040-00023; Anderson KE, 2005, ANN INTERN MED, V142, P439, DOI 10.7326/0003-4819-142-6-200503150-00010; ANDERSSON C, 1994, J INTERN MED, V236, P169, DOI 10.1111/j.1365-2796.1994.tb01279.x; Andersson C, 1996, J INTERN MED, V240, P195, DOI 10.1046/j.1365-2796.1996.21847000.x; Andersson C, 2003, J INTERN MED, V254, P176, DOI 10.1046/j.1365-2796.2003.01172.x; Anstey AV, 2007, POSTGRAD MED J, V83, P739, DOI 10.1136/gut.2006.097576; Badenas C, 2009, CLIN GENET, V75, P346, DOI 10.1111/j.1399-0004.2009.01153.x; Badminton MN, 2006, EUR J NEUROL, V13, P668, DOI 10.1111/j.1468-1331.2006.01238.x; Badminton MN, 2002, INT J CLIN PRACT, V56, P272; BISHOP DF, 1990, GENOMICS, V7, P207, DOI 10.1016/0888-7543(90)90542-3; BONKOVSKY HL, 1991, AM J GASTROENTEROL, V86, P1050; Bulaj ZJ, 2000, BLOOD, V95, P1565, DOI 10.1182/blood.V95.5.1565.005k42_1565_1571; Bylesjo I, 2009, SCAND J CLIN LAB INV, V69, P612, DOI 10.1080/00365510902935979; Cordova KB, 2009, SEMIN DIALYSIS, V22, P45, DOI 10.1111/j.1525-139X.2008.00534.x; Cox TM, 1997, J INHERIT METAB DIS, V20, P258, DOI 10.1023/A:1005317124985; Crimlisk HL, 1997, J NEUROL NEUROSUR PS, V62, P319, DOI 10.1136/jnnp.62.4.319; Cruz-Rojo J, 2002, CELL MOL BIOL, V48, P845; Dabrowska E, 2001, Med Sci Monit, V7 Suppl 1, P190; DASILVA V, 1995, CLIN CHIM ACTA, V238, P163, DOI 10.1016/0009-8981(95)06085-R; Degenhardt T, 2009, J MOL BIOL, V388, P225, DOI 10.1016/j.jmb.2009.03.024; Delaby C, 2009, J INTERN MED, V266, P277, DOI 10.1111/j.1365-2796.2009.02118.x; Delaby C, 2009, CELL MOL BIOL, V55, P45, DOI 10.1170/T837; Desnick RJ, 1998, SEMIN LIVER DIS, V18, P77, DOI 10.1055/s-2007-1007143; DEVERNEUIL H, 1978, INT J BIOCHEM, V9, P927, DOI 10.1016/0020-711X(78)90072-1; Deybach JC, 2006, PHYSIOL RES, V55, pS67, DOI 10.33549/physiolres.930000.55.S2.67; Doss MO, 2004, J INHERIT METAB DIS, V27, P529, DOI 10.1023/B:BOLI.0000037341.21975.9d; DOSS MO, 1989, CLIN BIOCHEM, V22, P223, DOI 10.1016/S0009-9120(89)80081-5; Doss MO, 2000, ALCOHOL ALCOHOLISM, V35, P109, DOI 10.1093/alcalc/35.2.109; Egger NG, 2002, DIGEST DIS SCI, V47, P419, DOI 10.1023/A:1013746828074; Egger NG, 1996, CHEM-BIOL INTERACT, V102, P69, DOI 10.1016/S0009-2797(96)03732-5; Elder GH, 1998, SEMIN LIVER DIS, V18, P67, DOI 10.1055/s-2007-1007142; ELDER GH, 1972, BIOCHEM J, V126, P877, DOI 10.1042/bj1260877; ELDER GH, 1995, J BIOENERG BIOMEMBR, V27, P207, DOI 10.1007/BF02110035; ELDER GH, 1978, NEW ENGL J MED, V299, P274, DOI 10.1056/NEJM197808102990603; Ellervik C, 2007, HEPATOLOGY, V46, P1071, DOI 10.1002/hep.21885; FARGION S, 1992, HEPATOLOGY, V16, P1322, DOI 10.1002/hep.1840160603; Floderus Y, 2002, CLIN GENET, V62, P288, DOI 10.1034/j.1399-0004.2002.620406.x; Fontanellas A, 1996, EUR J HUM GENET, V4, P274; Frank J, 1998, J INVEST DERMATOL, V110, P452, DOI 10.1046/j.1523-1747.1998.00148.x; Fraser DJ, 2002, J BIOL CHEM, V277, P34717, DOI 10.1074/jbc.M204699200; Fritsch C, 1997, J AM ACAD DERMATOL, V36, P594, DOI 10.1016/S0190-9622(97)70249-4; Fritsch C, 1998, SKIN PHARMACOL APPL, V11, P347, DOI 10.1159/000029857; Ged C, 2009, CELL MOL BIOL, V55, P53, DOI 10.1170/T838; Gisbert JP, 2004, EUR J GASTROEN HEPAT, V16, P689, DOI 10.1097/01.meg.0000108318.52416.c9; Gisbert JP, 2003, J HEPATOL, V39, P620, DOI 10.1016/S0168-8278(03)00346-5; Goodwin RG, 2006, BLOOD, V107, P60, DOI 10.1182/blood-2004-12-4939; Gouya L, 1996, AM J HUM GENET, V58, P292; Gouya L, 2002, NAT GENET, V30, P27, DOI 10.1038/ng809; Gouya L, 1999, BLOOD, V93, P2105, DOI 10.1182/blood.V93.6.2105.406k28_2105_2110; Gouya L, 2006, AM J HUM GENET, V78, P2, DOI 10.1086/498620; GRANDCHAMP B, 1989, EUR J CLIN INVEST, V19, P415, DOI 10.1111/j.1365-2362.1989.tb00252.x; Gross U, 1998, CLIN CHEM, V44, P1892; Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040; Harada FA, 2001, J AM ACAD DERMATOL, V45, P279, DOI 10.1067/mjd.2001.114730; Harms J, 2009, NEW ENGL J MED, V360, P306, DOI 10.1056/NEJMc0805682; Hessels J, 2004, J INHERIT METAB DIS, V27, P19, DOI 10.1023/B:BOLI.0000016613.75677.05; Hift RJ, 2005, MEDICINE, V84, P48, DOI 10.1097/01.md.0000152454.56435.f3; Hift RJ, 2004, CLIN CHEM, V50, P915, DOI 10.1373/clinchem.2003.025213; Hindmarsh JT, 1999, CLIN CHEM, V45, P1070; Hindmarsh JT, 1999, CLIN BIOCHEM, V32, P609, DOI 10.1016/S0009-9120(99)00067-3; Holme SA, 2007, BLOOD, V110, P4108, DOI 10.1182/blood-2007-04-088120; Holme SA, 2009, J INVEST DERMATOL, V129, P599, DOI 10.1038/jid.2008.272; IPPEN H, 1977, SEMIN HEMATOL, V14, P253; Jaffe EK, 2007, AM J HUM GENET, V80, P329, DOI 10.1086/511444; KAUPPINEN R, 1988, BRIT J CANCER, V57, P117, DOI 10.1038/bjc.1988.23; KAUPPINEN R, 1992, MEDICINE, V71, P1; Kauppinen R, 2002, CLIN CHEM, V48, P1891; Kauppinen R, 2001, J INVEST DERMATOL, V116, P610, DOI 10.1046/j.1523-1747.2001.01293.x; Kontos AP, 2003, BRIT J DERMATOL, V148, P160, DOI 10.1046/j.1365-2133.2003.05040.x; Kuhnel A, 2000, CLIN BIOCHEM, V33, P465, DOI 10.1016/S0009-9120(00)00159-4; LAIWAH AACY, 1983, Q J MED, V52, P92; Lamoril J, 1998, BLOOD, V91, P1453, DOI 10.1182/blood.V91.4.1453; Lamoril J, 2002, CELL MOL BIOL, V48, P33; Lamoril J, 2001, AM J HUM GENET, V68, P1130, DOI 10.1086/320118; Lecha M, 2003, Dermatol Ther, V16, P65, DOI 10.1046/j.1529-8019.2003.01610.x; LIM CK, 1984, CLIN CHIM ACTA, V139, P55, DOI 10.1016/0009-8981(84)90192-X; LIP GYH, 1991, BRIT MED J, V302, P507, DOI 10.1136/bmj.302.6775.507; LLEWELLYN DH, 1992, HUM GENET, V89, P97, DOI 10.1007/BF00207051; Lyoumi S, 2007, BLOOD, V109, P811, DOI 10.1182/blood-2006-04-014142; MARTASEK P, 1994, HUM MOL GENET, V3, P477, DOI 10.1093/hmg/3.3.477; MAYNARD B, 1992, J CUTAN PATHOL, V19, P40, DOI 10.1111/j.1600-0560.1992.tb01557.x; McGuire BM, 2005, LIVER TRANSPLANT, V11, P1590, DOI 10.1002/lt.20620; Meissner PN, 1996, NAT GENET, V13, P95, DOI 10.1038/ng0596-95; Meyer UA, 1998, SEMIN LIVER DIS, V18, P43, DOI 10.1055/s-2007-1007139; Minder EI, 2009, CELL MOL BIOL, V55, P84; Moore M. R., 1987, DISORDERS PORPHYRIN; Murphy Gillian M, 2003, Dermatol Ther, V16, P57, DOI 10.1046/j.1529-8019.2003.01609.x; Murphy GM, 1999, BRIT J DERMATOL, V140, P573; MUSTAJOKI P, 1993, ARCH INTERN MED, V153, P2004; MUSTAJOKI P, 1989, SEMIN HEMATOL, V26, P1; PECES R, 1994, NEPHROL DIAL TRANSPL, V9, P433; Phillips JD, 2007, P NATL ACAD SCI USA, V104, P5079, DOI 10.1073/pnas.0700547104; Phillips JD, 2007, BLOOD, V109, P2618, DOI 10.1182/blood-2006-06-022848; Pischik E, 2006, AM J MED, V119, P88, DOI 10.1016/j.amjmed.2005.08.032; Podvinec M, 2004, P NATL ACAD SCI USA, V101, P9127, DOI 10.1073/pnas.0401845101; POHFITZPATRICK MB, 1986, PHOTODERMATOLOGY, V3, P148; POHFITZPATRICK MB, 1986, ARCH DERMATOL, V122, P403, DOI 10.1001/archderm.122.4.403; Puy H, 1997, AM J HUM GENET, V60, P1373, DOI 10.1086/515455; Rand EB, 2006, PEDIATRICS, V118, pE1896, DOI 10.1542/peds.2006-0833; Robert-Richard E, 2008, AM J HUM GENET, V82, P113, DOI 10.1016/j.ajhg.2007.09.007; Roberts AG, 1997, LANCET, V349, P321, DOI 10.1016/S0140-6736(96)09436-6; Roberts AG, 1998, HUM MOL GENET, V7, P1921, DOI 10.1093/hmg/7.12.1921; Roberts AG, 1997, HEPATOLOGY, V25, P159, DOI 10.1002/hep.510250129; Rosipal R, 1999, HUM MUTAT, V13, P44, DOI 10.1002/(SICI)1098-1004(1999)13:1<44::AID-HUMU5>3.0.CO;2-Q; Rufenacht UB, 1998, AM J HUM GENET, V62, P1341, DOI 10.1086/301870; Sarkany RPE, 2006, BRIT J DERMATOL, V155, P464, DOI 10.1111/j.1365-2133.2006.07318.x; Sarkany RPE, 2001, CLIN EXP DERMATOL, V26, P225, DOI 10.1046/j.1365-2230.2001.00825.x; SASSA S, 1983, J CLIN INVEST, V71, P625, DOI 10.1172/JCI110809; Schmitt C, 2005, HUM MOL GENET, V14, P3089, DOI 10.1093/hmg/ddi342; Schneider-Yin X, 2000, EUR J PEDIATR, V159, P719, DOI 10.1007/s004310000494; Schneider-Yin XY, 2002, HUM HERED, V54, P69, DOI 10.1159/000067665; Seth AK, 2007, LIVER TRANSPLANT, V13, P1219, DOI 10.1002/lt.21261; Shaw PH, 2001, BONE MARROW TRANSPL, V27, P101, DOI 10.1038/sj.bmt.1702738; Shieh S, 2000, J AM ACAD DERMATOL, V42, P645, DOI 10.1016/S0190-9622(00)90179-8; Siegert SWK, 2008, ADV THER, V25, P842, DOI 10.1007/s12325-008-0094-y; SIERSEMA PD, 1992, LIVER, V12, P56; SIMA AAF, 1981, CAN J NEUROL SCI, V8, P105, DOI 10.1017/S0317167100042992; Smith SJ, 1997, CELL MOL BIOL, V43, P103; Soonawalla ZF, 2004, LANCET, V363, P705, DOI 10.1016/S0140-6736(04)15646-8; Thunell S, 2006, PHYSIOL RES, V55, pS43, DOI 10.33549/physiolres.930000.55.S2.43; THUNELL S, 1992, EUR J CLIN CHEM CLIN, V30, P599; Thunell S, 2007, BRIT J CLIN PHARMACO, V64, P668, DOI 10.1111/j.0306-5251.2007.02955.x; TIMONEN K, 1990, ARCH DERMATOL RES, V282, P108, DOI 10.1007/BF00493468; TIMONEN K, 1991, CLIN EXP DERMATOL, V16, P355, DOI 10.1111/j.1365-2230.1991.tb00400.x; Valls Victoria, 1994, Journal of Dermatological Science, V7, P169, DOI 10.1016/0923-1811(94)90092-2; Wahlin S, 2008, LIVER TRANSPLANT, V14, P1340, DOI 10.1002/lt.21527; Whatley SD, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016121; Whatley SD, 1999, AM J HUM GENET, V65, P984, DOI 10.1086/302586; Whatley SD, 2008, AM J HUM GENET, V83, P408, DOI 10.1016/j.ajhg.2008.08.003; Whatley SD, 2009, CLIN CHEM, V55, P1406, DOI 10.1373/clinchem.2008.122564; Zuazo E, 1994, Neurologia, V9, P296	140	464	496	4	95	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	2010	375	9718					924	937		10.1016/S0140-6736(09)61925-5	http://dx.doi.org/10.1016/S0140-6736(09)61925-5			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	574NA	20226990				2022-12-28	WOS:000275995300032
J	DeFazio, JL; Spencer, P				DeFazio, Jennifer LeeAnn; Spencer, Philip			Dermoscopy of Phthiriasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[DeFazio, Jennifer LeeAnn; Spencer, Philip] Mem Sloan Kettering Canc Ctr, Hauppauge, NY USA	Memorial Sloan Kettering Cancer Center	DeFazio, JL (corresponding author), Mem Sloan Kettering Canc Ctr, Hauppauge, NY USA.	defazioj@mskcc.org							0	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10					e33	e33		10.1056/NEJMicm0810134	http://dx.doi.org/10.1056/NEJMicm0810134			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566JM	20220180				2022-12-28	WOS:000275365900014
J	Gok, M; Heideman, DAM; van Kemenade, FJ; Berkhof, J; Rozendaal, L; Spruyt, JWM; Voorhorst, F; Belien, JAM; Babovic, M; Snijders, PJF; Meijer, CJLM				Gok, Murat; Heideman, Danielle A. M.; van Kemenade, Folkert J.; Berkhof, Johannes; Rozendaal, Lawrence; Spruyt, Johan W. M.; Voorhorst, Feja; Belien, Jeroen A. M.; Babovic, Milena; Snijders, Peter J. F.; Meijer, Chris J. L. M.			HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HUMAN-PAPILLOMAVIRUS DETECTION; RISK HUMAN-PAPILLOMAVIRUS; BASE-LINE; CANCER; CYTOLOGY; NETHERLANDS; PROGRAM; HYBRID-CAPTURE-2; IMPLEMENTATION; TRIAL	Objective To determine whether offering self sampling of cervicovaginal material for high risk human papillomavirus (HPV) testing is an effective screening method for women who do not attend regular cervical screening programmes. Design Cohort study (the PROHTECT trial). Settings Noord-Holland and Flevoland regions of the Netherlands, December 2006 to December 2007, including 13 laboratories, gynaecologists, and more than 800 general practitioners. Participants 28 073 women who had not responded to two invitations to the regular cervical screening programme: 27 792 women were assigned to the self sampling group and invited to submit a self collected cervicovaginal sample for HPV testing; 281 were assigned to the recall control group and received a second reinvitation for conventional cytology. Intervention Women with a positive result on the high risk HPV test on their self sample material were referred to their general practitioner. Women with abnormal results on cytology were referred for colposcopy. Women with normal results on cytology were re-evaluated after one year by cytology and high risk HPV testing and referred for colposcopy if either result was positive. Main outcome measures Attendance rate in both groups and yield of cervical intraepithelial neoplasia grade II/III or worse (>= CIN II/>= CIN III) in self sampling responders. Results The compliance rate in the self sampling group was significantly higher than in the control group (crude 26.6% v 16.4%, P<0.001; adjusted 27.5% v 16.6%, P<0.001). The number of detected >= CIN II and >= CIN III lesions in self sampling responders was 99 ( 1.3%) and 76 (1.0%), respectively. Self sampling responders who had not participated in the previous round of screening (43%) had increased relative risks of >= CIN II (2.04, 95% confidence interval 1.27 to 3.28) and >= CIN III (2.28, 1.31 to 3.96) compared with self sampling women who had been screened in the previous round (57%). Conclusions Offering self sampling by sending a device for collecting cervicovaginal specimens for high risk HPV testing to women who did not attend regular screening is a feasible and effective method of increasing coverage in a screening programme. The response rate and the yield of high grade lesions support implementation of this method for such women.	[Heideman, Danielle A. M.; van Kemenade, Folkert J.; Rozendaal, Lawrence; Voorhorst, Feja; Belien, Jeroen A. M.; Snijders, Peter J. F.; Meijer, Chris J. L. M.] Vrije Univ Amsterdam Med Ctr, Dept Pathol, NL-1007 MB Amsterdam, Netherlands; [Babovic, Milena] Reg Screening Org, NL-1101 BE Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Meijer, CJLM (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Pathol, POB 7057, NL-1007 MB Amsterdam, Netherlands.	cjlm.meijer@vumc.nl		Belien, Jeroen/0000-0002-7160-5942	Delphi Bioscience, Scherpenzeel, Netherlands; Zeist, Netherlands; IKA (Comprehensive Cancer Center Amsterdam)	Delphi Bioscience, Scherpenzeel, Netherlands(Netherlands Government); Zeist, Netherlands(Netherlands Government); IKA (Comprehensive Cancer Center Amsterdam)	The study was partly funded by Delphi Bioscience ( formerly Pantarhei Devices), Scherpenzeel, Netherlands, and Zeist, Netherlands, who also provided the self sampling kits, and the screening organisation Noord-Holland and Flevoland, and IKA (Comprehensive Cancer Center Amsterdam). Hybrid capture II kits and universal collection medium were provided by Qiagen, Gaithersburg, MD, USA.	Anderson MC, 1995, OBSTET GYNAECOLOGICA, P292; Bais AG, 2007, INT J CANCER, V120, P1505, DOI 10.1002/ijc.22484; Bekkers R L M, 2003, Ned Tijdschr Geneeskd, V147, P302; Brink AATP, 2006, J CLIN MICROBIOL, V44, P2518, DOI 10.1128/JCM.02440-05; Bulk S, 2004, J CLIN PATHOL, V57, P388, DOI 10.1136/jcp.2003.011841; Bulk S, 2007, INT J CANCER, V121, P361, DOI 10.1002/ijc.22677; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Bulkmans NWJ, 2004, INT J CANCER, V110, P94, DOI 10.1002/ijc.20076; Casparie M, 2007, CELL ONCOL, V29, P19; Castle PE, 2002, CANCER EPIDEM BIOMAR, V11, P1394; Castle PE, 2007, SEX TRANSM DIS, V34, P849, DOI 10.1097/OLQ.0b013e318064c8c5; Hanselaar AGJM, 2002, ACTA CYTOL, V46, P619, DOI 10.1159/000326965; Hesselink AT, 2006, J CLIN MICROBIOL, V44, P3680, DOI 10.1128/JCM.02078-05; HOPMAN EH, 1995, GYNECOL ONCOL, V58, P206, DOI 10.1006/gyno.1995.1212; Hopman EH, 2000, BRIT J OBSTET GYNAEC, V107, P600, DOI 10.1111/j.1471-0528.2000.tb13299.x; Karwalajtys T, 2006, SEX TRANSM INFECT, V82, P337, DOI 10.1136/sti.2005.019430; Khanna N, 2007, INT J GYNECOL CANCER, V17, P615, DOI 10.1111/j.1525-1438.2006.00835.x; Overmeer RM, 2008, J PATHOL, V215, P388, DOI 10.1002/path.2367; Petignat P, 2007, GYNECOL ONCOL, V105, P530, DOI 10.1016/j.ygyno.2007.01.023; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Raab SS, 2007, AM J CLIN PATHOL, V128, P817, DOI 10.1309/97JHG6GLY69BVF4Y; Rebolj M, 2007, INT J CANCER, V120, P806, DOI 10.1002/ijc.22167; Sasieni P, 2003, BRIT J CANCER, V89, P88, DOI 10.1038/sj.bjc.6600974; Sawaya GF, 1999, OBSTET GYNECOL, V94, P307, DOI 10.1016/S0029-7844(99)00289-6; Sung HY, 2000, CANCER, V88, P2283, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2283::AID-CNCR12>3.3.CO;2-4; Wikstrom I, 2007, ACTA OBSTET GYN SCAN, V86, P720, DOI 10.1080/00016340701303747; Wright TC, 2000, JAMA-J AM MED ASSOC, V283, P81, DOI 10.1001/jama.283.1.81; WRIGHT TC, 1995, PRECANCEROUS LESIONS, P248	28	170	174	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2010	340								c1040	10.1136/bmj.c1040	http://dx.doi.org/10.1136/bmj.c1040			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570FE	20223872	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000275656900001
J	Reyes, R; Mandelbaum, R; Seljak, U; Baldauf, T; Gunn, JE; Lombriser, L; Smith, RE				Reyes, Reinabelle; Mandelbaum, Rachel; Seljak, Uros; Baldauf, Tobias; Gunn, James E.; Lombriser, Lucas; Smith, Robert E.			Confirmation of general relativity on large scales from weak lensing and galaxy velocities	NATURE			English	Article							DIGITAL SKY SURVEY	Although general relativity underlies modern cosmology, its applicability on cosmological length scales has yet to be stringently tested. Such a test has recently been proposed(1), using a quantity, E-G, that combines measures of large-scale gravitational lensing, galaxy clustering and structure growth rate. The combination is insensitive to 'galaxy bias' (the difference between the clustering of visible galaxies and invisible dark matter) and is thus robust to the uncertainty in this parameter. Modified theories of gravity generally predict values of E-G different from the general relativistic prediction because, in these theories, the 'gravitational slip' (the difference between the two potentials that describe perturbations in the gravitational metric) is non-zero, which leads to changes in the growth of structure(2) and the strength of the gravitational lensing effect(3). Here we report that E-G = 0.39 +/- 0.06 on length scales of tens of megaparsecs, in agreement with the general relativistic prediction of E-G approximate to 0.4. The measured value excludes a model(1) within the tensor-vector-scalar gravity theory(4,5), which modifies both Newtonian and Einstein gravity. However, the relatively large uncertainty still permits models within f(R) theory(6), which is an extension of general relativity. A fivefold decrease in uncertainty is needed to rule out these models.	[Reyes, Reinabelle; Mandelbaum, Rachel; Gunn, James E.] Princeton Univ Observ, Princeton, NJ 08544 USA; [Seljak, Uros; Baldauf, Tobias; Lombriser, Lucas; Smith, Robert E.] Univ Zurich, Inst Theoret Phys, CH-8057 Zurich, Switzerland; [Seljak, Uros] Univ Calif Berkeley, Dept Phys & Astron, Berkeley, CA 94720 USA; [Seljak, Uros] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Seljak, Uros] Ewha Womans Univ, Inst Early Universe, Seoul 120750, South Korea	Princeton University; University of Zurich; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Ewha Womans University	Reyes, R (corresponding author), Princeton Univ Observ, Peyton Hall, Princeton, NJ 08544 USA.	rreyes@astro.princeton.edu	Mandelbaum, Rachel/N-8955-2014	Mandelbaum, Rachel/0000-0003-2271-1527; Smith, Robert E./0000-0001-9989-2149; Baldauf, Tobias/0000-0002-5081-7583	NASA; Space Telescope Science Institute; Swiss National Foundation; German National Academic Foundation	NASA(National Aeronautics & Space Administration (NASA)); Space Telescope Science Institute(Space Telescope Science Institute); Swiss National Foundation(Swiss National Science Foundation (SNSF)); German National Academic Foundation	R. M. was supported for the duration of this work by NASA through a Hubble Fellowship grant awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., for NASA. U.S. acknowledges the Swiss National Foundation. T. B. acknowledges support by a grant from the German National Academic Foundation during the initial phase of this project.	BALDAUF T, PHYS REV D UNPUB; Bartelmann M, 2001, PHYS REP, V340, P291, DOI 10.1016/S0370-1573(00)00082-X; Bekenstein JD, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.083509; Carroll SM, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.043528; Daniel SF, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.023532; Dunkley J, 2009, ASTROPHYS J SUPPL S, V180, P306, DOI 10.1088/0067-0049/180/2/306; Eisenstein DJ, 2001, ASTRON J, V122, P2267, DOI 10.1086/323717; Ferreira PG, 2009, SCIENCE, V326, P812, DOI 10.1126/science.1172245; Guzzo L, 2008, NATURE, V451, P541, DOI 10.1038/nature06555; Hamilton AJS, 1998, ASTROPHYS SPACE SC L, V231, P185; LANDY SD, 1993, ASTROPHYS J, V412, P64, DOI 10.1086/172900; Mandelbaum R, 2005, MON NOT R ASTRON SOC, V361, P1287, DOI 10.1111/j.1365-2966.2005.09282.x; MILGROM M, 1983, ASTROPHYS J, V270, P371, DOI 10.1086/161131; Seljak U, 2000, MON NOT R ASTRON SOC, V318, P203, DOI 10.1046/j.1365-8711.2000.03715.x; Smith RE, 2009, MON NOT R ASTRON SOC, V400, P851, DOI [10.1111/J.1365-2966.2009.15490.X, 10.1111/j.1365-2966.2009.15490.x]; Song YS, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.044004; Tegmark M, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.123507; Uzan JP, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.083004; Will CM, 2009, SPACE SCI REV, V148, P3, DOI 10.1007/s11214-009-9541-6; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513; Zhang PJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.141302	22	244	246	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					256	258		10.1038/nature08857	http://dx.doi.org/10.1038/nature08857			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20220843	Green Accepted			2022-12-28	WOS:000275366100041
J	Steidl, C; Lee, T; Shah, SP; Farinha, P; Han, G; Nayar, T; Delaney, A; Jones, SJ; Iqbal, J; Weisenburger, DD; Bast, MA; Rosenwald, A; Muller-Hermelink, HK; Rimsza, LM; Campo, E; Delabie, J; Braziel, RM; Cook, JR; Tubbs, RR; Jaffe, ES; Lenz, G; Connors, JM; Staudt, LM; Chan, WC; Gascoyne, RD				Steidl, Christian; Lee, Tang; Shah, Sohrab P.; Farinha, Pedro; Han, Guangming; Nayar, Tarun; Delaney, Allen; Jones, Steven J.; Iqbal, Javeed; Weisenburger, Dennis D.; Bast, Martin A.; Rosenwald, Andreas; Muller-Hermelink, Hans-Konrad; Rimsza, Lisa M.; Campo, Elias; Delabie, Jan; Braziel, Rita M.; Cook, James R.; Tubbs, Ray R.; Jaffe, Elaine S.; Lenz, Georg; Connors, Joseph M.; Staudt, Louis M.; Chan, Wing C.; Gascoyne, Randy D.			Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INDEPENDENT PROGNOSTIC-FACTOR; REGULATORY T-CELLS; GENE-EXPRESSION; FOLLICULAR LYMPHOMA; DISEASE; MICROENVIRONMENT; CHEMOTHERAPY; MICROARRAY; SIGNATURES; PREDICTOR	BACKGROUND Despite advances in treatments for Hodgkin's lymphoma, about 20% of patients still die from progressive disease. Current prognostic models predict the outcome of treatment with imperfect accuracy, and clinically relevant biomarkers have not been established to improve on the International Prognostic Score. METHODS Using gene-expression profiling, we analyzed 130 frozen samples obtained from patients with classic Hodgkin's lymphoma during diagnostic lymph-node biopsy to determine which cellular signatures were correlated with treatment outcome. We confirmed our findings in an independent cohort of 166 patients, using immunohistochemical analysis. RESULTS Gene-expression profiling identified a gene signature of tumor-associated macrophages that was significantly associated with primary treatment failure (P = 0.02). In an independent cohort of patients, we found that an increased number of CD68+ macrophages was correlated with a shortened progression-free survival (P = 0.03) and with an increased likelihood of relapse after autologous hematopoietic stem-cell transplantation (P = 0.008), resulting in shortened disease-specific survival (P = 0.003). In multivariate analysis, this adverse prognostic factor outperformed the International Prognostic Score for disease-specific survival (P = 0.003 vs. P = 0.03). The absence of an elevated number of CD68+ cells in patients with limited-stage disease defined a subgroup of patients with a long-term disease-specific survival of 100% with the use of current treatment strategies. CONCLUSIONS An increased number of tumor-associated macrophages was strongly associated with shortened survival in patients with classic Hodgkin's lymphoma and provides a new biomarker for risk stratification.	[Steidl, Christian; Lee, Tang; Shah, Sohrab P.; Farinha, Pedro; Han, Guangming; Gascoyne, Randy D.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Nayar, Tarun; Delaney, Allen; Jones, Steven J.] Univ British Columbia, Genome Sci Ctr, Vancouver, BC V5Z 1M9, Canada; [Connors, Joseph M.] Univ British Columbia, Div Med Oncol, British Columbia Canc Agcy, Vancouver, BC V5Z 1M9, Canada; [Shah, Sohrab P.] Univ British Columbia, Dept Comp Sci, Vancouver, BC V6T 1W5, Canada; [Iqbal, Javeed; Weisenburger, Dennis D.; Bast, Martin A.; Chan, Wing C.] Univ Nebraska Med Ctr, Dept Pathol, Omaha, NE USA; [Rosenwald, Andreas; Muller-Hermelink, Hans-Konrad] Univ Wurzburg, Dept Pathol, D-8700 Wurzburg, Germany; [Rimsza, Lisa M.] Univ Arizona, Dept Pathol, Tucson, AZ USA; [Campo, Elias] Univ Barcelona, Hosp Clin, Barcelona, Spain; [Delabie, Jan] Radium Hosp, Dept Pathol, Oslo, Norway; [Cook, James R.; Tubbs, Ray R.] Cleveland Clin, Dept Pathol & Lab Med, Cleveland, OH 44106 USA; [Cook, James R.; Tubbs, Ray R.] Cleveland Clin, Lerner Coll Med, Dept Mol Pathol, Cleveland, OH 44106 USA; [Jaffe, Elaine S.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Lenz, Georg; Staudt, Louis M.] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of Nebraska System; University of Nebraska Medical Center; University of Wurzburg; University of Arizona; University of Barcelona; Hospital Clinic de Barcelona; University of Oslo; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gascoyne, RD (corresponding author), British Columbia Canc Agcy, Dept Pathol & Adv Therapeut, 675 W 10th Ave,Rm 5-113, Vancouver, BC V5Z 1L3, Canada.	rgascoyn@bccancer.bc.ca	Jaffe, Elaine S/G-8984-2014; Lenz, Georg/I-6844-2012; Jones, Steven J/C-3621-2009; Staudt, Louis/AAC-5324-2019; Campo, Elias/AAC-5593-2019; Connors, Joseph/AAF-5284-2019	Jaffe, Elaine S/0000-0003-4632-0301; Jones, Steven J/0000-0003-3394-2208; Campo, Elias/0000-0001-9850-9793; Connors, Joseph/0000-0002-1361-7531; Delabie, Jan/0000-0001-5023-0689; Iqbal, Javeed/0000-0003-3668-0629; Farinha, Pedro/0000-0001-9364-9391	Deutsche Forschungsgemeinschaft; Cancer Research Society; Lymphoma Research Foundation; Michael Smith Foundation for Health Research; Roche Molecular Systems; Canadian Institutes of Health Research [178536]; National Cancer Institute [UO1-CA114778-01]; National Cancer Institute (NCI) [UO1-CA 114778]; Roche Canada; NATIONAL CANCER INSTITUTE [ZIABC011070, U01CA114778, ZIABC011006, ZIASC000550] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cancer Research Society; Lymphoma Research Foundation; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Roche Molecular Systems; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Roche Canada(Roche Holding); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from Deutsche Forschungsgemeinschaft, the Cancer Research Society, and the Lymphoma Research Foundation (to Dr. Steidl), the Michael Smith Foundation for Health Research (to Drs. Steidl and Shah), Roche Molecular Systems, the Canadian Institutes of Health Research (178536, to Dr. Gascoyne), the National Cancer Institute (UO1-CA114778-01, to Dr. Chan), and the Intramural Research Program of the National Cancer Institute (NCI) and by an NCI Strategic Partnering to Evaluate Cancer Signatures (SPECS) grant (UO1-CA 114778) to the Lymphoma/Leukemia Molecular Profiling Project consortium.; Dr. Gascoyne reports receiving consulting fees from Genentech, Roche Canada, and Eli Lilly and research support from Roche Canada. No other potential conflict of interest relevant to this article was reported.	Alvaro T, 2005, CLIN CANCER RES, V11, P1467, DOI 10.1158/1078-0432.CCR-04-1869; Alvaro-Naranjo T, 2005, LEUKEMIA LYMPHOMA, V46, P1581, DOI 10.1080/10428190500220654; [Anonymous], 1990, IARC Monogr Eval Carcinog Risks Hum, V50, P265; Bjorkholm M, 1995, ANN ONCOL, V6, P895; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; CANELLOS GP, 1992, NEW ENGL J MED, V327, P1478, DOI 10.1056/NEJM199211193272102; Chetaille B, 2009, BLOOD, V113, P2765, DOI 10.1182/blood-2008-07-168096; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Devilard E, 2002, ONCOGENE, V21, P3095, DOI 10.1038/sj.onc.1205418; Diehl Volker, 2003, Hematology Am Soc Hematol Educ Program, P225, DOI 10.1182/asheducation-2003.1.225; Diepstra A, 2007, J CLIN ONCOL, V25, P3101, DOI 10.1200/JCO.2006.10.0917; Doussis-Anagnostopoulou IA, 2008, CLIN CANCER RES, V14, P1759, DOI 10.1158/1078-0432.CCR-07-1395; Duff MD, 2007, J SURG RES, V142, P119, DOI 10.1016/j.jss.2006.12.542; Falchi L, 2007, EUR J HAEMATOL, V79, P455, DOI 10.1111/j.1600-0609.2007.00952.x; Farinha P, 2005, BLOOD, V106, P2169, DOI 10.1182/blood-2005-04-1565; Hasenclever D, 1998, NEW ENGL J MED, V339, P1506, DOI 10.1056/NEJM199811193392104; Jones RJ, 2009, BLOOD, V113, P5920, DOI 10.1182/blood-2008-11-189688; Karube K, 2006, ANN ONCOL, V17, P110, DOI 10.1093/annonc/mdj064; Kelley TW, 2007, AM J CLIN PATHOL, V128, P958, DOI 10.1309/NB3947K383DJ0LQ2; Krishnapuram B, 2005, IEEE T PATTERN ANAL, V27, P957, DOI 10.1109/TPAMI.2005.127; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Natkunam Y, 2005, BLOOD, V105, P3979, DOI 10.1182/blood-2004-08-3112; Odaka C, 2005, CELL IMMUNOL, V235, P21, DOI 10.1016/j.cellimm.2005.06.011; Perz JB, 2007, BONE MARROW TRANSPL, V39, P41, DOI 10.1038/sj.bmt.1705544; Sanchez-Aguilera A, 2006, BLOOD, V108, P662, DOI 10.1182/blood-2005-12-5125; Shaffer AL, 2006, IMMUNOL REV, V210, P67, DOI 10.1111/j.0105-2896.2006.00373.x; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sup SJ, 2005, J CLIN ONCOL, V23, P3773, DOI 10.1200/JCO.2005.04.358; Tzankov A, 2008, HAEMATOLOGICA, V93, P193, DOI 10.3324/haematol.11702; Urs S, 2004, J NUTR, V134, P762, DOI 10.1093/jn/134.4.762; Younes A, 2003, CANCER, V98, P310, DOI 10.1002/cncr.11511	34	906	952	3	82	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10					875	885		10.1056/NEJMoa0905680	http://dx.doi.org/10.1056/NEJMoa0905680			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566JM	20220182	Green Accepted			2022-12-28	WOS:000275365900008
J	Beitzinger, M; Meister, G				Beitzinger, Michaela; Meister, Gunter			MicroRNAs: From Decay to Decoy	CELL			English	Editorial Material							TRANSLATION; MECHANISMS		[Beitzinger, Michaela; Meister, Gunter] Univ Regensburg, D-93053 Regensburg, Germany; [Meister, Gunter] Max Planck Inst Biochem, Ctr Integrated Prot Sci Munich, D-82152 Martinsried, Germany	University of Regensburg; Max Planck Society	Meister, G (corresponding author), Univ Regensburg, Univ Str 31, D-93053 Regensburg, Germany.	gunter.meister@vkl.uni-regensburg.de						Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460	6	36	37	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					612	614		10.1016/j.cell.2010.02.020	http://dx.doi.org/10.1016/j.cell.2010.02.020			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211130	Bronze			2022-12-28	WOS:000275197400010
J	Bhutta, ZA				Bhutta, Zulfiqar A.			Unravelling the enigma of health statistics in China	LANCET			English	Editorial Material							DEATHS		Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan	Aga Khan University	Bhutta, ZA (corresponding author), Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu						Attane I, 2009, POP STUD-J DEMOG, V63, P87, DOI 10.1080/00324720802535023; Bredenkamp C, 2009, SOC SCI MED, V69, P1531, DOI 10.1016/j.socscimed.2009.08.017; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Chen JJ, 2007, POP STUD-J DEMOG, V61, P161, DOI 10.1080/00324720701340194; Cookson Clive, 2010, FINANCIAL TIMES 0125; Gao Y, 2009, INT J GYNECOL OBSTET, V104, P128, DOI 10.1016/j.ijgo.2008.10.004; Hesketh T, 2005, NEW ENGL J MED, V353, P1171, DOI 10.1056/NEJMhpr051833; Makris GC, 2009, MED SCI MONITOR, V15, pSR15; *MIN HLTH UNICEF, 2006, JOINT REV MAT CHILD; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; Wang Yan-ping, 2005, Zhonghua Yufang Yixue Zazhi, V39, P260; World Health Organization, 2008, GLOB BURD DIS 2004 U; Xu L, 2008, CONTEMP CLIN TRIALS, V29, P727, DOI 10.1016/j.cct.2008.05.003; Yee EL, 2009, VACCINE, V27, pF46, DOI 10.1016/j.vaccine.2009.08.065	14	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2010	375	9720					1058	1060		10.1016/S0140-6736(10)60352-2	http://dx.doi.org/10.1016/S0140-6736(10)60352-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	578ZB	20346798				2022-12-28	WOS:000276334600006
J	DeLeo, FR; Otto, M; Kreiswirth, BN; Chambers, HF				DeLeo, Frank R.; Otto, Michael; Kreiswirth, Barry N.; Chambers, Henry F.			Community-associated meticillin-resistant Staphylococcus aureus	LANCET			English	Article							PANTON-VALENTINE LEUKOCIDIN; CASSETTE CHROMOSOME MEC; SOFT-TISSUE INFECTIONS; METHICILLIN-RESISTANT; DOUBLE-BLIND; UNITED-STATES; NASAL CARRIAGE; RISK-FACTORS; ALPHA-TOXIN; TRIMETHOPRIM-SULFAMETHOXAZOLE	Meticillin-resistant Staphylococcus aureus (MRSA) is endemic in hospitals worldwide, and causes substantial morbidity and mortality. Health-care-associated MRSA infections arise in individuals with predisposing risk factors, such as surgery or presence of an indwelling medical device. By contrast, many community-associated MRSA (CA-MRSA) infections arise in otherwise healthy individuals who do not have such risk factors. Additionally, CA-MRSA infections are epidemic in some countries. These features suggest that CA-MRSA strains are more virulent and transmissible than are traditional hospital-associated MRSA strains. The restricted treatment options for CA-MRSA infections compound the effect of enhanced virulence and transmission. Although progress has been made towards understanding emergence of CA-MRSA, virulence, and treatment of infections, our knowledge remains incomplete. Here we review the most up-to-date knowledge and provide a perspective for the future prophylaxis or new treatments for CA-MRSA infections.	[DeLeo, Frank R.] NIAID, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [DeLeo, Frank R.; Otto, Michael] NIAID, Lab Human Bacterial Pathogenesis, NIH, Bethesda, MD 20892 USA; [Kreiswirth, Barry N.] Univ Med & Dent New Jersey, Publ Hlth Res Inst, TB Ctr, Int Ctr Publ Hlth, Newark, NJ 07103 USA; [Chambers, Henry F.] Univ Calif San Francisco, Div Infect Dis, Dept Med, San Francisco Gen Hosp, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Rutgers State University New Brunswick; Rutgers State University Medical Center; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	DeLeo, FR (corresponding author), NIAID, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.	fdeleo@niaid.nih.gov		Otto, Michael/0000-0002-2222-4115; DeLeo, Frank/0000-0003-3150-2516	US Public Health Service [AI070289]; National Institutes of Health, National Institutes of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070289, ZIAAI001079, ZIAAI000904] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health, National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This Seminar was supported by the US Public Health Service Grant AI070289 (HFC) and the Intramural Research Program of the National Institutes of Health, National Institutes of Allergy and Infectious Diseases (FRD and MO). We thank Scott Kobayashi for critical review of the Seminar.	Adcock PM, 1998, J INFECT DIS, V178, P577, DOI 10.1086/517478; Adem PV, 2005, NEW ENGL J MED, V353, P1245, DOI 10.1056/NEJMoa044194; Aiello AE, 2006, LANCET INFECT DIS, V6, P335, DOI 10.1016/S1473-3099(06)70491-1; Alksne LE, 2000, CURR OPIN BIOTECH, V11, P625, DOI 10.1016/S0958-1669(00)00155-5; Apodaca AA, 2003, NEW ENGL J MED, V348, P86, DOI 10.1056/NEJM200301023480123; Arnold SR, 2006, J PEDIATR ORTHOPED, V26, P703, DOI 10.1097/01.bpo.0000242431.91489.b4; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Baggett HC, 2004, J INFECT DIS, V189, P1565, DOI 10.1086/383247; Bartlett AH, 2008, J INFECT DIS, V198, P1529, DOI 10.1086/592758; Barton Michelle, 2006, Can J Infect Dis Med Microbiol, V17 Suppl C, p4C; Begier EM, 2004, CLIN INFECT DIS, V39, P1446, DOI 10.1086/425313; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Braun L, 2005, PEDIATR INFECT DIS J, V24, P622, DOI 10.1097/01.inf.0000171175.76673.64; Brown EL, 2009, CLIN MICROBIOL INFEC, V15, P156, DOI 10.1111/j.1469-0691.2008.02648.x; Buck JM, 2005, EMERG INFECT DIS, V11, P1532, DOI 10.3201/eid1110.050141; Cenizal MJ, 2007, ANTIMICROB AGENTS CH, V51, P2628, DOI 10.1128/AAC.00206-07; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chambers HF, 2005, ANTIMICROB AGENTS CH, V49, P884, DOI 10.1128/AAC.49.3.884-888.2005; Coombs GW, 2006, EMERG INFECT DIS, V12, P241; Creech CB, 2005, PEDIATR INFECT DIS J, V24, P617, DOI 10.1097/01.inf.0000168746.62226.a4; Cremieux AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007204; Crum NF, 2006, AM J MED, V119, P943, DOI 10.1016/j.amjmed.2006.01.004; Dajcs JJ, 2001, CURR EYE RES, V22, P451, DOI 10.1076/ceyr.22.6.451.5486; Daum RS, 2002, J INFECT DIS, V186, P1344, DOI 10.1086/344326; De Vriese AS, 2006, CLIN INFECT DIS, V42, P1111, DOI 10.1086/501356; Del Giudice P, 2006, BRIT J DERMATOL, V154, P118, DOI 10.1111/j.1365-2133.2005.06910.x; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Deleo FR, 2009, INFECT DIS CLIN N AM, V23, P17, DOI 10.1016/j.idc.2008.10.003; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; DIEP BA, 2009, 49 ICAAC SAN FRANC C; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Diep BA, 2008, ANN INTERN MED, V148, P249, DOI 10.7326/0003-4819-148-4-200802190-00204; Diep BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003198; Dombrowski JC, 2008, J INFECTION, V57, P110, DOI 10.1016/j.jinf.2008.04.003; Duong M, 2010, ANN EMERG MED, V55, P401, DOI 10.1016/j.annemergmed.2009.03.014; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Feil EJ, 2004, CURR OPIN MICROBIOL, V7, P308, DOI 10.1016/j.mib.2004.04.002; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; Frank AL, 2002, PEDIATR INFECT DIS J, V21, P530, DOI 10.1097/00006454-200206000-00010; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Gerson SL, 2002, ANTIMICROB AGENTS CH, V46, P2723, DOI 10.1128/AAC.46.8.2723-2726.2002; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gonzalez BE, 2005, CLIN INFECT DIS, V41, P583, DOI 10.1086/432475; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Gorwitz RJ., 2006, STRATEGIES CLIN MANA; Graham PL, 2006, ANN INTERN MED, V144, P318, DOI 10.7326/0003-4819-144-5-200603070-00006; GROJEC PL, 1981, ZBL BAKT-INT J MED M, V250, P446; Hageman JC, 2006, EMERG INFECT DIS, V12, P894, DOI 10.3201/eid1206.051141; Hawkins C, 2007, ARCH INTERN MED, V167, P1861, DOI 10.1001/archinte.167.17.1861; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Higuchi W, 2008, BIOCHEM BIOPH RES CO, V377, P752, DOI 10.1016/j.bbrc.2008.10.009; Hongo I, 2009, J INFECT DIS, V200, P715, DOI 10.1086/605332; Howden BP, 2006, CLIN INFECT DIS, V42, P394, DOI 10.1086/499365; Hulten KG, 2006, PEDIATR INFECT DIS J, V25, P349, DOI 10.1097/01.inf.0000207404.50143.1e; Hunt C, 1999, JAMA-J AM MED ASSOC, V282, P1123; Jacqueline C, 2007, ANTIMICROB AGENTS CH, V51, P3397, DOI 10.1128/AAC.01242-06; JEVONS MP, 1961, BRIT MED J, V1, P124, DOI 10.1136/bmj.1.5219.124-a; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; KHATIB R, 2008, SCAND J INFECT DIS, P1; Kim ES, 2007, J ANTIMICROB CHEMOTH, V60, P1108, DOI 10.1093/jac/dkm309; Kirby WMM, 1944, SCIENCE, V99, P452, DOI 10.1126/science.99.2579.452; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kraus D, 2008, FUTURE MICROBIOL, V3, P437, DOI 10.2217/17460913.3.4.437; Kravitz GR, 2005, CLIN INFECT DIS, V40, P941, DOI 10.1086/428573; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Larsen AR, 2009, J CLIN MICROBIOL, V47, P73, DOI 10.1128/JCM.01557-08; Laupland KB, 2008, J INFECT DIS, V198, P336, DOI 10.1086/589717; Lawton EM, 2007, MINI-REV MED CHEM, V7, P1236, DOI 10.2174/138955707782795638; Lee MC, 2004, PEDIATR INFECT DIS J, V23, P123, DOI 10.1097/01.inf.0000109288.06912.21; Lee SM, 2007, ANTIMICROB AGENTS CH, V51, P1497, DOI 10.1128/AAC.01239-06; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Liu C, 2008, CLIN INFECT DIS, V46, P1637, DOI 10.1086/587893; LLERA JL, 1985, ANN EMERG MED, V14, P15, DOI 10.1016/S0196-0644(85)80727-7; Lodise TP, 2008, ANTIMICROB AGENTS CH, V52, P1330, DOI 10.1128/AAC.01602-07; Ma XX, 2002, ANTIMICROB AGENTS CH, V46, P1147, DOI 10.1128/AAC.46.4.1147-1152.2002; MARKOWITZ N, 1992, ANN INTERN MED, V117, P390, DOI 10.7326/0003-4819-117-5-390; Martinez-Aguilar G, 2003, PEDIATR INFECT DIS J, V22, P593, DOI 10.1097/00006454-200307000-00006; Mathews WC, 2005, JAIDS-J ACQ IMM DEF, V40, P155, DOI 10.1097/01.qai.0000179464.40948.b9; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Micek ST, 2007, CLIN INFECT DIS, V45, pS184, DOI 10.1086/519471; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Miller LG, 2008, CLIN INFECT DIS, V46, P752, DOI 10.1086/526773; MINUTH JN, 1974, ANTIMICROB AGENTS CH, V6, P411, DOI 10.1128/AAC.6.4.411; Montgomery CP, 2008, J INFECT DIS, V198, P561, DOI 10.1086/590157; Montgomery CP, 2009, INFECT IMMUN, V77, P2159, DOI 10.1128/IAI.00021-09; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Nathwani D, 2008, J ANTIMICROB CHEMOTH, V61, P976, DOI 10.1093/jac/dkn096; Nguyen DM, 2005, EMERG INFECT DIS, V11, P526, DOI 10.3201/eid1104.041094; Noel GJ, 2008, ANTIMICROB AGENTS CH, V52, P37, DOI 10.1128/AAC.00551-07; O'Brien FG, 2004, J CLIN MICROBIOL, V42, P3185, DOI 10.1128/JCM.42.7.3185-3190.2004; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Oliveira DC, 2006, ANTIMICROB AGENTS CH, V50, P3457, DOI 10.1128/AAC.00629-06; Otto M, 2010, MED RES REV, V30, P1, DOI 10.1002/med.20160; Pan Angelo, 2008, Recent Pat Antiinfect Drug Discov, V3, P10, DOI 10.2174/157489108783413173; Pannaraj PS, 2006, CLIN INFECT DIS, V43, P953, DOI 10.1086/507637; Parish D, 2008, CURR OPIN INVEST DR, V9, P201; Proctor RA, 2008, CLIN INFECT DIS, V46, P584, DOI 10.1086/525536; Purcell K, 2005, ARCH PEDIAT ADOL MED, V159, P980, DOI 10.1001/archpedi.159.10.980; Rajendran PM, 2007, ANTIMICROB AGENTS CH, V51, P4044, DOI 10.1128/AAC.00377-07; Robert J, 2005, CLIN MICROBIOL INFEC, V11, P585, DOI 10.1111/j.1469-0691.2005.01173.x; ROGERS DE, 1952, J EXP MED, V95, P209, DOI 10.1084/jem.95.2.209; Rooijakkers SHM, 2007, MOL IMMUNOL, V44, P23, DOI 10.1016/j.molimm.2006.06.011; Rossney AS, 2007, J CLIN MICROBIOL, V45, P2554, DOI 10.1128/JCM.00245-07; Roundtree P. M., 1956, MED J AUSTRALIA, V42, P157; RUBE JJ, 2005, CLIN INFECT DIS, V40, P1429; Rubinstein E, 2001, CLIN INFECT DIS, V32, P402, DOI 10.1086/318486; Ruhe JJ, 2007, ANTIMICROB AGENTS CH, V51, P3298, DOI 10.1128/AAC.00262-07; SARAVOLATZ LD, 1982, ANN INTERN MED, V97, P325, DOI 10.7326/0003-4819-97-3-325; Schaffer AC, 2008, INT J ANTIMICROB AG, V32, pS71, DOI 10.1016/j.ijantimicag.2008.06.009; Shaw KJ, 2008, ANTIMICROB AGENTS CH, V52, P4442, DOI 10.1128/AAC.00859-08; Shinefield H, 2002, NEW ENGL J MED, V346, P491, DOI 10.1056/NEJMoa011297; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Shopsin B, 2000, J INFECT DIS, V182, P359, DOI 10.1086/315695; Shore AC, 2008, ANTIMICROB AGENTS CH, V52, P4407, DOI 10.1128/AAC.00447-08; Stapleton PD, 2007, MICROBIOL-SGM, V153, P2093, DOI 10.1099/mic.0.2007/007807-0; Steinkraus G, 2007, J ANTIMICROB CHEMOTH, V60, P788, DOI 10.1093/jac/dkm258; Stemper ME, 2006, EMERG INFECT DIS, V12, P1444, DOI 10.3201/eid1209.051634; Stevens DL, 2005, CLIN INFECT DIS, V41, P1373, DOI 10.1086/497143; Stevens DL, 2002, CLIN INFECT DIS, V34, P1481, DOI 10.1086/340353; Stryjewski ME, 2008, CLIN INFECT DIS, V46, pS368, DOI 10.1086/533593; Suggs AH, 1999, PEDIATR INFECT DIS J, V18, P410, DOI 10.1097/00006454-199905000-00003; Szmigielski S, 1999, ZBL BAKT-INT J MED M, V289, P185; SZMIGIELSKI S, 1966, J PATHOL BACTERIOL, V91, P599, DOI 10.1002/path.1700910237; Szumowski JD, 2007, ANTIMICROB AGENTS CH, V51, P423, DOI 10.1128/AAC.01244-06; Tristan A, 2007, EMERG INFECT DIS, V13, P594, DOI 10.3201/eid1304.061316; Tseng CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006387; UDO EE, 1993, J HOSP INFECT, V25, P97, DOI 10.1016/0195-6701(93)90100-E; Valeva A, 1997, P NATL ACAD SCI USA, V94, P11607, DOI 10.1073/pnas.94.21.11607; van Hal SJ, 2007, J CLIN MICROBIOL, V45, P2486, DOI 10.1128/JCM.00139-07; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Villaruz AE, 2009, J INFECT DIS, V200, P724, DOI 10.1086/604728; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wang GQ, 2006, J CLIN MICROBIOL, V44, P3883, DOI 10.1128/JCM.01388-06; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Weigelt J, 2005, ANTIMICROB AGENTS CH, V49, P2260, DOI 10.1128/AAC.49.6.2260-2266.2005; WOODIN AM, 1970, MICROBIAL TOXINS, V3, P327; Wunderink RG, 2003, CLIN THER, V25, P980, DOI 10.1016/S0149-2918(03)80118-2; Zhang KY, 2008, J INFECT DIS, V197, P195, DOI 10.1086/523763; Zhang KY, 2009, ANTIMICROB AGENTS CH, V53, P531, DOI 10.1128/AAC.01118-08; Zschock M, 2005, J APPL MICROBIOL, V98, P450, DOI 10.1111/j.1365-2672.2004.02470.x; 2003, MMWR MORB MORTAL WKL, V52, P793; 2004, MMWR MORB MORTAL WKL, V53, P767	155	917	956	0	158	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2010	375	9725					1557	1568		10.1016/S0140-6736(09)61999-1	http://dx.doi.org/10.1016/S0140-6736(09)61999-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596AH	20206987	Green Accepted			2022-12-28	WOS:000277655100029
J	Randel, WJ; Park, M; Emmons, L; Kinnison, D; Bernath, P; Walker, KA; Boone, C; Pumphrey, H				Randel, William J.; Park, Mijeong; Emmons, Louisa; Kinnison, Doug; Bernath, Peter; Walker, Kaley A.; Boone, Chris; Pumphrey, Hugh			Asian Monsoon Transport of Pollution to the Stratosphere	SCIENCE			English	Article							TAPE-RECORDER; WATER-VAPOR; HCN; BUDGETS; CH3CN; MODEL	Transport of air from the troposphere to the stratosphere occurs primarily in the tropics, associated with the ascending branch of the Brewer-Dobson circulation. Here, we identify the transport of air masses from the surface, through the Asian monsoon, and deep into the stratosphere, using satellite observations of hydrogen cyanide (HCN), a tropospheric pollutant produced in biomass burning. A key factor in this identification is that HCN has a strong sink from contact with the ocean; much of the air in the tropical upper troposphere is relatively depleted in HCN, and hence, broad tropical upwelling cannot be the main source for the stratosphere. The monsoon circulation provides an effective pathway for pollution from Asia, India, and Indonesia to enter the global stratosphere.	[Randel, William J.; Park, Mijeong; Emmons, Louisa; Kinnison, Doug] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Bernath, Peter] Univ York, Dept Chem, Heslington, England; [Bernath, Peter; Walker, Kaley A.; Boone, Chris] Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada; [Walker, Kaley A.] Univ Toronto, Dept Phys, Toronto, ON, Canada; [Pumphrey, Hugh] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland	National Center Atmospheric Research (NCAR) - USA; University of York - UK; University of Waterloo; University of Toronto; University of Edinburgh	Randel, WJ (corresponding author), Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA.	randel@ucar.edu	Randel, William J/K-3267-2016; Emmons, Louisa K/R-8922-2016; Bernath, Peter F/B-6567-2012; Pumphrey, Hugh/S-2969-2019	Randel, William J/0000-0002-5999-7162; Emmons, Louisa K/0000-0003-2325-6212; Bernath, Peter F/0000-0002-1255-396X; Pumphrey, Hugh/0000-0003-0747-1457	Canadian Space Agency; UK Natural Environment Research Council (NERC); National Science Foundation; U.S. National Aeronautics and Space Administration; NERC [NE/E003990/1, NE/F002041/1] Funding Source: UKRI; Natural Environment Research Council [NE/E003990/1, NE/F002041/1] Funding Source: researchfish	Canadian Space Agency(Canadian Space Agency); UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Science Foundation(National Science Foundation (NSF)); U.S. National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The ACE mission is funded primarily by the Canadian Space Agency. Some funding was also provided by the UK Natural Environment Research Council (NERC). The U.S. National Center for Atmospheric Research is sponsored by the National Science Foundation. We also acknowledge support from the U.S. National Aeronautics and Space Administration.	Bannister RN, 2004, Q J ROY METEOR SOC, V130, P1531, DOI 10.1256/qj.03.106; Bernath PF, 2005, GEOPHYS RES LETT, V32, DOI DOI 10.1029/2005; Boone CD, 2005, APPL OPTICS, V44, P7218, DOI 10.1364/AO.44.007218; Edwards DP, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004727; Fu R, 2006, P NATL ACAD SCI USA, V103, P5664, DOI 10.1073/pnas.0601584103; Fueglistaler S, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004069; Gettelman A, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004878; Hofmann D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039008; Kleinbohl A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026015; Li Q, 2009, ATMOS CHEM PHYS, V9, P8531, DOI 10.5194/acp-9-8531-2009; Li QB, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022762; Li QB, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003075; Logan JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031698; Lupu A, 2009, ATMOS CHEM PHYS, V9, P4301, DOI 10.5194/acp-9-4301-2009; Mote PW, 1996, J GEOPHYS RES-ATMOS, V101, P3989, DOI 10.1029/95JD03422; Ohara T, 2007, ATMOS CHEM PHYS, V7, P4419, DOI 10.5194/acp-7-4419-2007; Park M, 2008, ATMOS CHEM PHYS, V8, P757, DOI 10.5194/acp-8-757-2008; Park M, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008294; Park M, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010621; Plumb RA, 1996, J GEOPHYS RES-ATMOS, V101, P3957, DOI 10.1029/95JD03002; Pumphrey HC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032137; Pumphrey HC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025656; Randel WJ, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006490; Rinsland CP, 1999, J GEOPHYS RES-ATMOS, V104, P18667, DOI 10.1029/1999JD900366; Rosenlof KH, 1997, J GEOPHYS RES-ATMOS, V102, P13213, DOI 10.1029/97JD00873; Singh HB, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003006; Ueda H, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025336	27	316	328	5	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2010	328	5978					611	613		10.1126/science.1182274	http://dx.doi.org/10.1126/science.1182274			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20339030	Green Accepted			2022-12-28	WOS:000277159800040
J	Purshouse, RC; Meier, PS; Brennan, A; Taylor, KB; Rafia, R				Purshouse, Robin C.; Meier, Petra S.; Brennan, Alan; Taylor, Karl B.; Rafia, Rachid			Estimated effect of alcohol pricing policies on health and health economic outcomes in England: an epidemiological model	LANCET			English	Article							GLOBAL BURDEN; DRINKING; METAANALYSIS; CONSUMPTION; PREVENTION; BENEFITS; DISEASE	Background Although pricing policies for alcohol are known to be effective, little is known about how specific interventions affect health-care costs and health-related quality-of-life outcomes for different types of drinkers. We assessed effects of alcohol pricing and promotion policy options in various population subgroups. Methods We built an epidemiological mathematical model to appraise 18 pricing policies, with English data from the Expenditure and Food Survey and the General Household Survey for average and peak alcohol consumption. We used results from econometric analyses (256 own-price and cross-price elasticity estimates) to estimate effects of policies on alcohol consumption. We applied risk functions from systemic reviews and meta-analyses, or derived from attributable fractions, to model the effect of consumption changes on mortality and disease prevalence for 47 illnesses. Findings General price increases were effective for reduction of consumption, health-care costs, and health-related quality of life losses in all population subgroups. Minimum pricing policies can maintain this level of effectiveness for harmful drinkers while reducing effects on consumer spending for moderate drinkers. Total bans of supermarket and off-license discounting are effective but banning only large discounts has little effect. Young adult drinkers aged 18-24 years are especially affected by policies that raise prices in pubs and bars. Interpretation Minimum pricing policies and discounting restrictions might warrant further consideration because both strategies are estimated to reduce alcohol consumption, and related health harms and costs, with drinker spending increases targeting those who incur most harm.	[Purshouse, Robin C.] Univ Sheffield, Dept Automat Control & Syst Engn, Sheffield S1 3JD, S Yorkshire, England; [Meier, Petra S.; Brennan, Alan; Rafia, Rachid] Univ Sheffield, Sch Hlth & Related Res, Sheffield S1 3JD, S Yorkshire, England; [Taylor, Karl B.] Univ Sheffield, Dept Econ, Sheffield S1 3JD, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Purshouse, RC (corresponding author), Univ Sheffield, Dept Automat Control & Syst Engn, Mappin St, Sheffield S1 3JD, S Yorkshire, England.	r.purshouse@sheffield.ac.uk	Meier, Petra/P-7504-2019; Meier, Petra S/L-7387-2017; Stockwell, Tim/B-6662-2012	Meier, Petra/0000-0001-5354-1933; Meier, Petra S/0000-0001-5354-1933; Brennan, Alan/0000-0002-1025-312X; Taylor, Karl/0000-0002-6525-0815; Purshouse, Robin/0000-0001-5880-1925	Policy Research Programme, UK Department of Health	Policy Research Programme, UK Department of Health	Policy Research Programme, UK Department of Health.; We thank Yang Meng for his work on the sensitivity analyses and the three anonymous reviewers for their valuable comments and suggestions. The original data creators, depositors, or copyright holders, the finders of the Data Collections (where different), and the UK Data Archive bear no responsibility for the analysis and interpretation of the General Household Survey and Expenditure and Food Survey data. This article shows results of independent research commissioned and funded by the Policy Research Programme in the UK Department of Health. The views expressed are those of the authors and not necessarily those of the Department.	Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; [Anonymous], 2008, PURCHASING POWER PAR; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Booth A, 2008, INDEPENDENT REV EF A; Brennan A, 2008, INDEPENDENT REV EF B; *CARD RES CONS, HLTH OUTC DAT REP; Casswell S, 2009, LANCET, V373, P2247, DOI 10.1016/S0140-6736(09)60745-5; Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782; CLEMENS S, 2008, DRUG USE SMOKING DRI; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; *DEP HLTH SAF SENS, 2007, NEXT STEPS NAT ALC S; Department of Health, 2008, COST ALC HARM NHS EN; Department of Health, 2004, POL APPR HLTH; Doran C., 2008, IDENTIFYING COSTEFFE; English D.R., 1995, QUANTIFICATION DRUG; Gallet CA, 2007, AUST J AGR RESOUR EC, V51, P121, DOI 10.1111/j.1467-8489.2007.00365.x; GUNNINGSCHEPERS L, 1989, HEALTH POLICY, V12, P1; Gutjahr E, 2001, EUR ADDICT RES, V7, P117, DOI 10.1159/000050729; Hollingworth W, 2006, J STUD ALCOHOL, V67, P300, DOI 10.15288/jsa.2006.67.300; Kenkel DS, 2005, AM ECON REV, V95, P273, DOI 10.1257/000282805774670284; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Mortimer D, 2006, ALCOHOL ALCOHOLISM, V41, P92, DOI 10.1093/alcalc/agh224; *NIELS CO, ALC RET SAL DA UNPUB; Norstrom T, 2001, ADDICTION, V96, pS5, DOI 10.1080/09652140020021143; [North West Public Health Observatory Department of Health], 2008, HOSP ADM ALC REL HAR; *OFF NAT STAT, 2006, POP DAT 2006; *OFF NAT STAT DEP, 2008, EXP FOOD SURV 2006 C; *OFF NAT STAT SOC, 2006, GEN HOUS SURV 2006; Peele S, 2000, DRUG ALCOHOL DEPEN, V60, P221, DOI 10.1016/S0376-8716(00)00112-5; Rehm J, 2004, COMP QUANTIFICATION, P959; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Ridolfo B, 2001, QUANTIFICATION DRUG; Single E., 1996, COST SUBSTANCE ABUSE; Stockwell T, 2004, ADDICTION, V99, P1024, DOI 10.1111/j.1360-0443.2004.00815.x; Wagenaar AC, 2009, ADDICTION, V104, P179, DOI 10.1111/j.1360-0443.2008.02438.x; Young DJ, 2002, NATL TAX J, V55, P57, DOI 10.17310/ntj.2002.1.04	36	171	171	0	43	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2010	375	9723					1355	1364		10.1016/S0140-6736(10)60058-X	http://dx.doi.org/10.1016/S0140-6736(10)60058-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	588GW	20338629				2022-12-28	WOS:000277057800026
J	Dobrev, D; Nattel, S				Dobrev, Dobromir; Nattel, Stanley			New antiarrhythmic drugs for treatment of atrial fibrillation	LANCET			English	Article							CONGESTIVE-HEART-FAILURE; CALCIUM-HANDLING ABNORMALITIES; POLYUNSATURATED-FATTY-ACIDS; ISOLATED CARDIAC-MUSCLE; SINUS RHYTHM; IN-VIVO; MYOCARDIAL-INFARCTION; CATHETER ABLATION; RANDOMIZED-TRIAL; CHANNEL BLOCKERS	Inadequacies in current therapies for atrial fibrillation have made new drug development crucial. Conventional antiarrhythmic drugs increase the risk of ventricular proarrhythmia. In drug development, the focus has been on favourable multichannel-blocking profiles, atrial-specific ion-channels, and novel non-channel targets (upstream therapy). Molecular modification of the highly effective multichannel blocker, amiodarone, to improve safety and tolerability has produced promising analogues such as dronedarone, although this drug seems less effective than does amiodarone. Vernakalant, an atrial-selective drug with reduced proarrhythmic risk, might be useful for cardioversion in atrial fibrillation. Ranolazine, another atrial-selective agent initially developed as an antianginal, has efficacy for atrial fibrillation and is being tested in prospective clinical trials. So-called upstream therapy with angiotensin-converting enzyme and angiotensin-receptor inhibitors, statins, or omega-3 fatty acids and fish oil that target atrial remodelling could be effective, but need further clinical validation. We focus on the basic and clinical pharmacology of newly emerging antiarrhythmic drugs and non-traditional approaches such as upstream therapy for atrial fibrillation.	[Dobrev, Dobromir] Tech Univ Dresden, Dept Pharmacol & Toxicol, D-01307 Dresden, Germany; [Nattel, Stanley] Montreal Heart Inst, Dept Med, Montreal, PQ H1T 1C8, Canada; [Nattel, Stanley] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Nattel, Stanley] Univ Montreal, Montreal, PQ, Canada; [Nattel, Stanley] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada	Technische Universitat Dresden; Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University	Dobrev, D (corresponding author), Tech Univ Dresden, Dept Pharmacol & Toxicol, Fetscherstr 74, D-01307 Dresden, Germany.	dobrev@rcs.urz.tu-dresden.de	Dobrev, Dobromir/C-7388-2014; Dobrev, Prof. Dr. med. Dr. h.c. Dobromir/AAS-1666-2020	Dobrev, Dobromir/0000-0002-4612-117X; Dobrev, Prof. Dr. med. Dr. h.c. Dobromir/0000-0002-4612-117X; Nattel, Stanley/0000-0002-5565-3311	German Federal Ministry of Education and Research [01Gi0204]; Deutsche Forschungsgemeinschaft [769/1-3]; Canadian Institutes of Health Research [MOP 44365, MGP 6957]; Quebec Heart and Stroke Foundation; Fondation Leducq [07 CVD 03]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Quebec Heart and Stroke Foundation; Fondation Leducq(Leducq Foundation)	DD's studies received support from the German Federal Ministry of Education and Research (Atrial Fibrillation Competence Network grant 01Gi0204, projects C3 and C4) and the Deutsche Forschungsgemeinschaft (Do 769/1-3). SN is supported by the Canadian Institutes of Health Research (MOP 44365; MGP 6957) and the Quebec Heart and Stroke Foundation. DD and SN are co-principal investigators of a network grant supported by Fondation Leducq (07 CVD 03, "Leducq European-North American Atrial Fibrillation Research Alliance").	Adam O, 2008, CIRCULATION, V118, P1285, DOI 10.1161/CIRCULATIONAHA.107.760892; Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; ALLESSIE MA, 1977, CIRC RES, V41, P9, DOI 10.1161/01.RES.41.1.9; Amit G, 2008, J CARDIOVASC PHARM, V52, P222, DOI 10.1097/FJC.0b013e318182c8e0; Benjamin EJ, 2009, CIRCULATION, V119, P606, DOI 10.1161/CIRCULATIONAHA.108.825380; Blaauw Y, 2004, CIRCULATION, V110, P1717, DOI 10.1161/01.CIR.0000143050.22291.2E; Burashnikov A, 2003, CIRCULATION, V107, P2355, DOI 10.1161/01.CIR.0000065578.00869.7C; Burashnikov A, 2008, J CARDIOVASC PHARM, V52, P121, DOI 10.1097/FJC.0b013e31817618eb; Burstein B, 2008, J CARDIOVASC PHARM, V52, P4, DOI 10.1097/FJC.0b013e3181668057; Burstein B, 2007, CARDIOVASC RES, V76, P442, DOI 10.1016/j.cardiores.2007.07.013; Burstein B, 2009, CIRC RES, V105, P1213, DOI 10.1161/CIRCRESAHA.108.183400; *CARD PHARM CORP, CARD ANN POS PHAS 2B; Carlsson L, 2006, J CARDIOVASC PHARM, V47, P123, DOI 10.1097/01.fjc.0000196242.04384.c3; Cha TJ, 2006, CIRCULATION, V113, P1730, DOI 10.1161/CIRCULATIONAHA.105.561738; Chelu MG, 2009, J CLIN INVEST, V119, P1940, DOI 10.1172/JCI37059; Christ T, 2008, BRIT J PHARMACOL, V154, P1619, DOI 10.1038/bjp.2008.209; Christ T, 2004, CIRCULATION, V110, P2651, DOI 10.1161/01.CIR.0000145659.80212.6A; Comtois P, 2005, EUROPACE, V7, pS10, DOI 10.1016/j.eupc.2005.05.011; Comtois P, 2008, AM J PHYSIOL-HEART C, V295, pH1489, DOI 10.1152/ajpheart.01054.2007; Connolly SJ, 2009, CIRCULATION, V120, P1174, DOI 10.1161/CIRCULATIONAHA.109.875252; Crijns HJ, 2006, HEART RHYTHM, V3, P1321, DOI 10.1016/j.hrthm.2006.06.035; Dale KM, 2007, ANN PHARMACOTHER, V41, P599, DOI 10.1345/aph.1H524; DAVIDENKO JM, 1992, NATURE, V355, P349, DOI 10.1038/355349a0; Davy JM, 2008, AM HEART J, V156, DOI 10.1016/j.ahj.2008.06.010; Dernellis J, 2004, EUR HEART J, V25, P1100, DOI 10.1016/j.ehj.2004.04.025; Disertori M, 2009, NEW ENGL J MED, V360, P1606, DOI 10.1056/NEJMoa0805710; Dixen U, 2007, CARDIOLOGY, V108, P35, DOI 10.1159/000095671; Dobrev D, 2006, HERZ, V31, P108, DOI 10.1007/s00059-006-2787-9; Dobrev D, 2005, CIRCULATION, V112, P3697, DOI 10.1161/circulationaha.105.575332; Dobrev D, 2001, CIRCULATION, V104, P2551, DOI 10.1161/hc4601.099466; Dobrev D, 2008, J CARDIOVASC PHARM, V52, P293, DOI 10.1097/FJC.0b013e318171924d; Dorian P, 2008, EUR HEART J SUPPL, V10, pH11, DOI 10.1093/eurheartj/sun033; Dorian P, 2007, J CARDIOVASC PHARM, V50, P35, DOI 10.1097/FJC.0b013e3180547553; Duytschaever A, 2005, CARDIOVASC RES, V67, P69, DOI 10.1016/j.cardiores.2005.02.019; Ehrlich JR, 2008, J CARDIOVASC PHARM, V52, P129, DOI 10.1097/FJC.0b013e31816c4325; Ehrlich JR, 2006, EUR HEART J, V27, P512, DOI 10.1093/eurheartj/ehi668; *EUR SOC CARD, 2009, IRB RED HEART FAIL P; Fedida D, 2005, J CARDIOVASC ELECTR, V16, P1227, DOI 10.1111/j.1540-8167.2005.50028.x; Ford JW, 2008, J CARDIOVASC PHARM, V52, P105, DOI 10.1097/FJC.0b013e3181719b0c; Galve E, 1996, J AM COLL CARDIOL, V27, P1079, DOI 10.1016/0735-1097(95)00595-1; Gassanov N, 2006, CELL CALCIUM, V39, P175, DOI 10.1016/j.ceca.2005.10.008; Gautier P, 2005, J CARDIOVASC PHARM, V45, P125, DOI 10.1097/01.fjc.0000151899.03379.76; Goette A, 2007, CURR OPIN PHARMACOL, V7, P219, DOI 10.1016/j.coph.2006.09.006; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Grossmann M, 1998, CLIN PHARMACOL THER, V64, P302, DOI 10.1016/S0009-9236(98)90179-5; Grossmann M, 2000, CLIN PHARMACOL THER, V67, P22, DOI 10.1067/mcp.2000.103822; Guiraudou P, 2004, EUR J PHARMACOL, V496, P119, DOI 10.1016/j.ejphar.2004.05.046; Hohnloser SH, 2009, J AM COLL CARDIOL, V53, pA113; Hohnloser SH, 2009, NEW ENGL J MED, V360, P668, DOI 10.1056/NEJMoa0803778; HOLT DW, 1983, AM HEART J, V106, P840, DOI 10.1016/0002-8703(83)90006-6; Jais P, 2008, CIRCULATION, V118, P2498, DOI 10.1161/CIRCULATIONAHA.108.772582; Jerling M, 2006, CLIN PHARMACOKINET, V45, P469, DOI 10.2165/00003088-200645050-00003; Jibrini MB, 2008, AM J THER, V15, P36, DOI 10.1097/MJT.0b013e31804beb59; Kathofer S, 2005, CARDIOVASC DRUG REV, V23, P217; Kober L, 2008, NEW ENGL J MED, V358, P2678, DOI 10.1056/NEJMoa0800456; Kowey PR, 2009, CIRC-ARRHYTHMIA ELEC, V2, P652, DOI 10.1161/CIRCEP.109.870204; Laszlo R, 2008, J RENIN-ANGIO-ALDO S, V9, P125, DOI 10.1177/1470320308095262; Li DS, 2001, CIRCULATION, V104, P2608, DOI 10.1161/hc4601.099402; Lip GYH, 2007, EUR HEART J, V28, P752, DOI 10.1093/eurheartj/ehl504; Madrid Antonio H, 2003, Card Electrophysiol Rev, V7, P243, DOI 10.1023/B:CEPR.0000012391.95928.d2; Mao ZPL, 2009, J CLIN PHARMACOL, V49, P17, DOI 10.1177/0091270008325148; Milliez P, 2005, EUR HEART J, V26, P2193, DOI 10.1093/eurheartj/ehi478; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Mizuno Y, 2001, CIRCULATION, V103, P72; Morey TE, 2001, J PHARMACOL EXP THER, V297, P260; Morrow DA, 2007, JAMA-J AM MED ASSOC, V297, P1775, DOI 10.1001/jama.297.16.1775; Murdock David K, 2009, Indian Pacing Electrophysiol J, V9, P260; Murdock David K, 2008, Indian Pacing Electrophysiol J, V8, P175; Naccarelli GV, 2008, J CARDIOVASC PHARM, V52, P203, DOI 10.1097/FJC.0b013e318175dd73; Naccarelli GV, 2008, EXPERT OPIN INV DRUG, V17, P805, DOI [10.1517/13543784.17.5.805, 10.1517/13543784.17.5.805 ]; Nattel S, 2006, LANCET, V367, P262, DOI 10.1016/S0140-6736(06)68037-9; Nattel S, 2002, DRUGS, V62, P2377, DOI 10.2165/00003495-200262160-00005; Nattel S, 2002, CARDIOVASC RES, V54, P347, DOI 10.1016/S0008-6363(01)00562-4; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Nattel S, 2001, EUR HEART J, V22, P448; Nattel S, 2008, CIRC-ARRHYTHMIA ELEC, V1, P62, DOI 10.1161/CIRCEP.107.754564; Nattel S, 2006, NAT REV DRUG DISCOV, V5, P1034, DOI 10.1038/nrd2112; Nieuwlaat R, 2006, EUR HEART J, V27, P3018, DOI 10.1093/eurheartj/ehl015; Ninio DM, 2008, PROG BIOPHYS MOL BIO, V97, P401, DOI 10.1016/j.pbiomolbio.2008.02.016; Okumura Y, 2005, CIRC J, V69, P1514, DOI 10.1253/circj.69.1514; Page RL, 2008, CIRCULATION, V118, pS827; Pappone C, 2006, J AM COLL CARDIOL, V48, P2340, DOI 10.1016/j.jacc.2006.08.037; Pedersen OD, 2006, EUR HEART J, V27, P290, DOI 10.1093/eurheartj/ehi629; Pei De-an, 2007, Zhonghua Yi Xue Za Zhi, V87, P816; PERTSOV AM, 1993, CIRC RES, V72, P631, DOI 10.1161/01.RES.72.3.631; Piccini JP, 2009, J AM COLL CARDIOL, V54, P1089, DOI 10.1016/j.jacc.2009.04.085; Riley MJ, 2006, CURR PROB CARDIOLOGY, V31, P361, DOI 10.1016/j.cpcardiol.2006.01.002; Roy D, 2000, NEW ENGL J MED, V342, P913, DOI 10.1056/NEJM200003303421302; Roy D, 2004, J AM COLL CARDIOL, V44, P2355, DOI 10.1016/j.jacc.2004.09.021; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Roy D, 2008, CIRCULATION, V117, P1518, DOI 10.1161/CIRCULATIONAHA.107.723866; Sakabe M, 2007, CIRCULATION, V116, P2101, DOI 10.1161/CIRCULATIONAHA.107.704759; *SAN AV, 2008, DIONYSOS STUD RES SH; Savelieva I, 2008, NAT CLIN PRACT CARD, V5, P30, DOI 10.1038/ncpcardio1038; Schilling RJ, 2010, HEART, V96, P333, DOI 10.1136/hrt.2008.155812; Scirica BM, 2007, CIRCULATION, V116, P1647, DOI 10.1161/CIRCULATIONAHA.107.724880; Sherman DG, 2005, ARCH INTERN MED, V165, P1185, DOI 10.1001/archinte.165.10.1185; Shimano M, 2008, HEART RHYTHM, V5, P451, DOI 10.1016/j.hrthm.2007.12.010; Shinagawa K, 2003, CIRCULATION, V107, P1440, DOI 10.1161/01.CIR.0000055316.35552.74; Shiroshita-Takeshita A, 2006, CARDIOVASC RES, V69, P865, DOI 10.1016/j.cardiores.2005.11.028; Shiroshita-Takeshita A, 2004, CIRCULATION, V110, P2313, DOI 10.1161/01.CIR.0000145163.56529.D1; Shiroshita-Takeshita A, 2007, CARDIOVASC RES, V74, P75, DOI 10.1016/j.cardiores.2007.01.002; Shroff SC, 2006, J CARDIOVASC ELECTR, V17, P534, DOI 10.1111/j.1540-8167.2006.00372.x; Singh BN, 2008, J CARDIOVASC PHARM, V52, P300, DOI 10.1097/FJC.0b013e31818914b6; Singh BN, 2007, NEW ENGL J MED, V357, P987, DOI 10.1056/NEJMoa054686; Slavik RS, 2001, PROG CARDIOVASC DIS, V44, P121, DOI 10.1053/pcad.2001.26966; SOSSALLA S, 2009, EUR HEART J SUPPL, V30, P450; Stabile G, 2006, EUR HEART J, V27, P216, DOI 10.1093/eurheartj/ehi583; Sun Y, 1997, CARDIOVASC RES, V35, P138, DOI 10.1016/S0008-6363(97)00097-7; TALAJIC M, 1987, CIRCULATION, V75, P265, DOI 10.1161/01.CIR.75.1.265; Tanaka K, 2007, CIRC RES, V101, P839, DOI 10.1161/CIRCRESAHA.107.153858; Touboul P, 2003, EUR HEART J, V24, P1481, DOI 10.1016/S0195-668X(03)00321-X; Tsang TSM, 2005, PROG CARDIOVASC DIS, V48, P1, DOI 10.1016/j.pcad.2005.06.001; Tschuppert Y, 2007, BRIT J CLIN PHARMACO, V64, P785, DOI 10.1111/j.1365-2125.2007.02998.x; van Beeren HC, 2003, ENDOCRINOLOGY, V144, P552, DOI 10.1210/en.2002-220604; Van Wagoner DR, 2008, J CARDIOVASC PHARM, V52, P306, DOI 10.1097/FJC.0b013e31817f9398; Van Wagoner DR, 1999, CIRC RES, V85, P428, DOI 10.1161/01.RES.85.5.428; Vardas PE, 2000, CHEST, V117, P1538, DOI 10.1378/chest.117.6.1538; Vermes E, 2003, CIRCULATION, V107, P2926, DOI 10.1161/01.CIR.0000072793.81076.D4; Vest JA, 2005, CIRCULATION, V111, P2025, DOI 10.1161/01.CIR.0000162461.67140.4C; Voigt N, 2007, CARDIOVASC RES, V74, P426, DOI 10.1016/j.cardiores.2007.02.009; Waldo AL, 2005, J AM COLL CARDIOL, V46, P1729, DOI 10.1016/j.jacc.2005.06.077; Wang JG, 2007, HYPERTENSION, V50, P181, DOI 10.1161/HYPERTENSIONAHA.107.089763; Wazni OM, 2005, JAMA-J AM MED ASSOC, V293, P2634, DOI 10.1001/jama.293.21.2634; Wettwer E, 2004, CIRCULATION, V110, P2299, DOI 10.1161/01.CIR.0000145155.60288.71; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Wirth KJ, 2003, CARDIOVASC RES, V60, P298, DOI 10.1016/S0008-6363(03)00543-1; Wirth KJ, 2007, J CARDIOVASC PHARM, V49, P197, DOI 10.1097/FJC.0b013e318032002f; Wyse DG, 2008, J CARDIOVASC PHARM, V52, P11, DOI 10.1097/FJC.0b013e31816d5f49; Yeh YH, 2008, CIRC-ARRHYTHMIA ELEC, V1, P93, DOI 10.1161/CIRCEP.107.754788; Yue LX, 1997, CIRC RES, V81, P512, DOI 10.1161/01.RES.81.4.512; Zou RQ, 2005, AM J PHYSIOL-HEART C, V289, pH1002, DOI 10.1152/ajpheart.00252.2005	132	210	217	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 3	2010	375	9721					1212	1223		10.1016/S0140-6736(10)60096-7	http://dx.doi.org/10.1016/S0140-6736(10)60096-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585VL	20334907				2022-12-28	WOS:000276858200033
J	Oberlander, J				Oberlander, Jonathan			A Vote for Health Care Reform.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ N Carolina, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Oberlander, J (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.								0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2010	362	13								10.1056/NEJMp1002878	http://dx.doi.org/10.1056/NEJMp1002878			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	577QQ	20237340				2022-12-28	WOS:000276239500005
J	Bai, XM; Voter, AF; Hoagland, RG; Nastasi, M; Uberuaga, BP				Bai, Xian-Ming; Voter, Arthur F.; Hoagland, Richard G.; Nastasi, Michael; Uberuaga, Blas P.			Efficient Annealing of Radiation Damage Near Grain Boundaries via Interstitial Emission	SCIENCE			English	Article							IRON; IRRADIATION; COPPER; MICROSTRUCTURE; SIMULATION; CLUSTERS; DYNAMICS; DEFECTS; METALS	Although grain boundaries can serve as effective sinks for radiation-induced defects such as interstitials and vacancies, the atomistic mechanisms leading to this enhanced tolerance are still not well understood. With the use of three atomistic simulation methods, we investigated defect-grain boundary interaction mechanisms in copper from picosecond to microsecond time scales. We found that grain boundaries have a surprising "loading-unloading" effect. Upon irradiation, interstitials are loaded into the boundary, which then acts as a source, emitting interstitials to annihilate vacancies in the bulk. This unexpected recombination mechanism has a much lower energy barrier than conventional vacancy diffusion and is efficient for annihilating immobile vacancies in the nearby bulk, resulting in self-healing of the radiation-induced damage.	[Bai, Xian-Ming; Hoagland, Richard G.; Uberuaga, Blas P.] Los Alamos Natl Lab, Div Mat Sci & Technol, Los Alamos, NM 87545 USA; [Voter, Arthur F.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; [Nastasi, Michael] Los Alamos Natl Lab, MPA CINT, Mat Phys & Applicat Div, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Uberuaga, BP (corresponding author), Los Alamos Natl Lab, Div Mat Sci & Technol, MST 8, Los Alamos, NM 87545 USA.	blas@lanl.gov	Bai, Xianming/E-2376-2017; Hoagland, Richard G/G-9821-2012; Uberuaga, Blas P/I-1809-2019	Bai, Xianming/0000-0002-4609-6576; Uberuaga, Blas P/0000-0001-6934-6219; Voter, Arthur/0000-0001-9788-7194	Laboratory Directed Research and Development program at Los Alamos National Laboratory [20090061DR]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [2008LANL1026]	Laboratory Directed Research and Development program at Los Alamos National Laboratory; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	We thank K. E. Sickafus, X. Y. Liu, C. W. Pao, S. Jindal, M. J. Demkowicz, J. Wang, and S. M. Valone for helpful discussions. This work was primarily sponsored by the Laboratory Directed Research and Development program at Los Alamos National Laboratory under project number 20090061DR. The TAD simulations on the asymmetric boundary were supported as part of the Center for Materials at Irradiation and Mechanical Extremes, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under award number 2008LANL1026.	Arakawa K, 2007, SCIENCE, V318, P956, DOI 10.1126/science.1145386; Bacon DJ, 2003, J NUCL MATER, V323, P152, DOI 10.1016/j.jnucmat.2003.08.002; Chimi Y, 2001, J NUCL MATER, V297, P355, DOI 10.1016/S0022-3115(01)00629-8; de la Rubia TD, 2000, NATURE, V406, P871, DOI 10.1038/35022544; Demkowicz MJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.136102; Fu CC, 2005, NAT MATER, V4, P68, DOI 10.1038/nmat1286; Ghaly M, 1999, PHILOS MAG A, V79, P795, DOI 10.1080/01418619908210332; Henkelman G, 2000, J CHEM PHYS, V113, P9901, DOI 10.1063/1.1329672; Henkelman G, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.116101; Kavanagh K.L., 2009, PHYSICS, V2, P63; Matsukawa Y, 2007, SCIENCE, V318, P959, DOI 10.1126/science.1148336; Nita N, 2004, J NUCL MATER, V329, P953, DOI 10.1016/j.jnucmat.2004.04.058; Odette GR, 2008, ANNU REV MATER RES, V38, P471, DOI 10.1146/annurev.matsci.38.060407.130315; Osetsky YN, 2003, PHILOS MAG, V83, P61, DOI 10.1080/0141861021000016793; Perez-Perez FJ, 2000, NUCL INSTRUM METH B, V164, P487, DOI 10.1016/S0168-583X(99)01141-6; Rose M, 1997, NUCL INSTRUM METH B, V127, P119, DOI 10.1016/S0168-583X(96)00863-4; Samaras M, 2003, PHILOS MAG, V83, P3599, DOI 10.1080/14786430310001600222; Shen TD, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2753098; Sickafus KE, 2007, NAT MATER, V6, P217, DOI 10.1038/nmat1842; SINGH BN, 1974, PHILOS MAG, V29, P847, DOI 10.1080/14786437408222075; Sorensen MR, 2000, J CHEM PHYS, V112, P9599, DOI 10.1063/1.481576; Uberuaga BP, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.135501; Uberuaga B. P., 2005, HDB MAT MODELING, P1627; Victoria M, 2000, J NUCL MATER, V276, P114, DOI 10.1016/S0022-3115(99)00203-2; Voter AF, 2002, ANNU REV MATER RES, V32, P321, DOI 10.1146/annurev.matsci.32.112601.141541; WATKINS GD, 1974, PHYS REV LETT, V33, P223, DOI 10.1103/PhysRevLett.33.223; Wirth BD, 2007, SCIENCE, V318, P923, DOI 10.1126/science.1150394; ZINKLE SJ, 1989, J NUCL MATER, V168, P262, DOI 10.1016/0022-3115(89)90591-6	28	771	791	15	416	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2010	327	5973					1631	1634		10.1126/science.1183723	http://dx.doi.org/10.1126/science.1183723			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339070				2022-12-28	WOS:000275970600040
J	Moncrieff, J; Timimi, S				Moncrieff, Joanna; Timimi, Sami			Is ADHD a valid diagnosis in adults? No	BRITISH MEDICAL JOURNAL			English	Editorial Material							DEFICIT HYPERACTIVITY DISORDER; FOLLOW-UP; METHYLPHENIDATE; ABUSE		[Moncrieff, Joanna] Univ Coll London & NE London Mental Hlth Trust, Dept Mental Hlth Sci, London W1W 7EJ, England; [Timimi, Sami] Lincoln Univ, Lincolnshire Partnership NHS Fdn Trust, Sleaford NG34 8QA, England	University of London; University College London; University of Lincoln	Moncrieff, J (corresponding author), Univ Coll London & NE London Mental Hlth Trust, Dept Mental Hlth Sci, London W1W 7EJ, England.	j.moncrieff@ucl.ac.uk						Adler LA, 2008, J ATTEN DISORD, V11, P720, DOI 10.1177/1087054707308490; Barkley RA, 2004, J CHILD PSYCHOL PSYC, V45, P195, DOI 10.1111/j.1469-7610.2004.00214.x; Biederman J, 2006, AM J PSYCHIAT, V163, P1730, DOI 10.1176/appi.ajp.163.10.1730; *FOOD DRUGS ADM, 2005, 13282 MACMIS FOOD DR; HARRIS G, 2008, NY TIMES        0608; Jensen PS, 2007, J AM ACAD CHILD PSY, V46, P989, DOI 10.1097/chi.0b013e3180686d48; Koesters M, 2009, J PSYCHOPHARMACOL, V23, P733, DOI 10.1177/0269881108092338; *LEAD DIS, 2004, AD ADHD THER OPP; McGough JJ, 2005, AM J PSYCHIAT, V162, P1621, DOI 10.1176/appi.ajp.162.9.1621; National Institute for Health and Clinical Excellence, 2008, ATT DEF HYP DIS DIAG; *NHS CHOIC, 2008, ATT DEF HYP DIS ADHD; Sumnall HR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2287; Timimi S., 2009, RETHINKING ADHD BRAI; Weiss Margaret, 2002, J Psychiatr Pract, V8, P99, DOI 10.1097/00131746-200203000-00006; Westover AN, 2007, ARCH GEN PSYCHIAT, V64, P495, DOI 10.1001/archpsyc.64.4.495	15	32	33	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 26	2010	340								c547	10.1136/bmj.c547	http://dx.doi.org/10.1136/bmj.c547			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	576PR	20348183				2022-12-28	WOS:000276157900014
J	Ben-Chetrit, E; Merin, O				Ben-Chetrit, Eli; Merin, Ofer			Spontaneous Tension Pneumothorax	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ben-Chetrit, Eli; Merin, Ofer] Shaare Zedek Med Ctr, Jerusalem, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center	Ben-Chetrit, E (corresponding author), Shaare Zedek Med Ctr, Jerusalem, Israel.	elibc1@yahoo.com							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	2010	362	12					E43	E43		10.1056/NEJMicm0901473	http://dx.doi.org/10.1056/NEJMicm0901473			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573FU	20335579				2022-12-28	WOS:000275894600011
J	Kikuchi, K; Holdway, JE; Werdich, AA; Anderson, RM; Fang, Y; Egnaczyk, GF; Evans, T; MacRae, CA; Stainier, DYR; Poss, KD				Kikuchi, Kazu; Holdway, Jennifer E.; Werdich, Andreas A.; Anderson, Ryan M.; Fang, Yi; Egnaczyk, Gregory F.; Evans, Todd; MacRae, Calum A.; Stainier, Didier Y. R.; Poss, Kenneth D.			Primary contribution to zebrafish heart regeneration by gata4(+) cardiomyocytes	NATURE			English	Article							ADULT MAMMALIAN CARDIOMYOCYTES; CELL-BASED THERAPY; VENTRAL MORPHOGENESIS; TRANSCRIPTION FACTOR; TUBE FORMATION; GROWTH; DIFFERENTIATION; PROLIFERATION; INJURY; EXPRESSION	Recent studies indicate that mammals, including humans, maintain some capacity to renew cardiomyocytes throughout postnatal life(1,2). Yet, there is little or no significant cardiac muscle regeneration after an injury such as acute myocardial infarction(3). By contrast, zebrafish efficiently regenerate lost cardiac muscle, providing a model for understanding how natural heart regeneration may be blocked or enhanced(4,5). In the absence of lineage-tracing technology applicable to adult zebrafish, the cellular origins of newly regenerated cardiac muscle have remained unclear. Using new genetic fate-mapping approaches, here we identify a population of cardiomyocytes that become activated after resection of the ventricular apex and contribute prominently to cardiac muscle regeneration. Through the use of a transgenic reporter strain, we found that cardiomyocytes throughout the subepicardial ventricular layer trigger expression of the embryonic cardiogenesis gene gata4 within a week of trauma, before expression localizes to proliferating cardiomyocytes surrounding and within the injury site. Cre-recombinase-based lineage-tracing of cells expressing gata4 before evident regeneration, or of cells expressing the contractile gene cmlc2 before injury, each labelled most cardiac muscle in the ensuing regenerate. By optical voltage mapping of surface myocardium in whole ventricles, we found that electrical conduction is re-established between existing and regenerated cardiomyocytes between 2 and 4 weeks post-injury. After injury and prolonged fibroblast growth factor receptor inhibition to arrest cardiac regeneration and enable scar formation, experimental release of the signalling block led to gata4 expression and morphological improvement of the injured ventricular wall without loss of scar tissue. Our results indicate that electrically coupled cardiac muscle regenerates after resection injury, primarily through activation and expansion of cardiomyocyte populations. These findings have implications for promoting regeneration of the injured human heart.	[Kikuchi, Kazu; Holdway, Jennifer E.; Fang, Yi; Egnaczyk, Gregory F.; Poss, Kenneth D.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Kikuchi, Kazu; Holdway, Jennifer E.; Fang, Yi; Egnaczyk, Gregory F.; Poss, Kenneth D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Egnaczyk, Gregory F.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Werdich, Andreas A.; MacRae, Calum A.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Anderson, Ryan M.; Stainier, Didier Y. R.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Evans, Todd] Cornell Univ, Dept Surg, Weill Cornell Med Coll, New York, NY 10021 USA	Duke University; Duke University; Howard Hughes Medical Institute; Duke University; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco; Cornell University	Poss, KD (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	k.poss@cellbio.duke.edu	Kikuchi, Kazu/A-4097-2017	Kikuchi, Kazu/0000-0002-4681-4275; Stainier, Didier/0000-0002-0382-0026; Werdich, Andreas/0000-0002-1222-1180; Poss, Kenneth/0000-0002-6743-5709	AHA; JDRF; JSPS; NIH at Massachusetts General Hospital [HL007208]; NIH at Duke University Medical Center [HL007101]; NHLBI [HL064282, HL054737, HL081674]; NIGMS [GM075846]; March of Dimes; Pew Charitable Trusts; Whitehead Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054737, T32HL007208, R01HL109264, T32HL007101, R01HL064282, R01HL081674, K08HL068711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM075946] Funding Source: NIH RePORTER	AHA(American Heart Association); JDRF(Juvenile Diabetes Research Foundation); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH at Massachusetts General Hospital; NIH at Duke University Medical Center; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); March of Dimes(March of Dimes); Pew Charitable Trusts; Whitehead Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Burris and A. Eastes for zebrafish care, X. Meng and the Developmental Studies Hybridoma Bank for antibodies, M. Gignac for help with electron microscopy, laboratory members for comments on the manuscript, and G. Burns, P. Chambon and G. Felsenfeld for plasmids. This work was supported by postdoctoral fellowships from AHA ( K. K. and Y.F.), JDRF ( R. M. A.), and JSPS ( K. K.); NIH training grants HL007208 at Massachusetts General Hospital ( A. A. W.) and HL007101 at Duke University Medical Center ( G. F. E.); grants from NHLBI (HL064282 to T. E., HL054737 to D. Y. R. S., and HL081674 to K. D. P.), NIGMS (GM075846 to C. A. M.), and March of Dimes ( C. A. M.); and grants from AHA, Pew Charitable Trusts and Whitehead Foundation (K. D. P.).	Bayly PV, 1998, IEEE T BIO-MED ENG, V45, P563, DOI 10.1109/10.668746; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Brette F, 2008, BIOCHEM BIOPH RES CO, V374, P143, DOI 10.1016/j.bbrc.2008.06.109; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Crispino JD, 2001, GENE DEV, V15, P839, DOI 10.1101/gad.875201; de Pater E, 2009, DEVELOPMENT, V136, P1633, DOI 10.1242/dev.030924; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103; FAST VG, 1995, CARDIOVASC RES, V29, P697, DOI 10.1016/S0008-6363(96)88643-3; Heicklen-Klein A, 2004, DEV BIOL, V267, P490, DOI 10.1016/j.ydbio.2003.09.042; Holtzinger A, 2005, DEVELOPMENT, V132, P4005, DOI 10.1242/dev.01978; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Laflamme MA, 2007, ANNU REV PATHOL-MECH, V2, P307, DOI 10.1146/annurev.pathol.2.010506.092038; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Meilhac SM, 2003, DEVELOPMENT, V130, P3877, DOI 10.1242/dev.00580; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Pu WT, 2004, DEV BIOL, V275, P235, DOI 10.1016/j.ydbio.2004.08.008; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; Rottbauer W, 2002, CELL, V111, P661, DOI 10.1016/S0092-8674(02)01112-1; Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530; Sidorov VY, 2008, BASIC RES CARDIOL, V103, P537, DOI 10.1007/s00395-008-0740-1; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Waxman JS, 2008, DEV CELL, V15, P923, DOI 10.1016/j.devcel.2008.09.009; Wills AA, 2008, DEVELOPMENT, V135, P183, DOI 10.1242/dev.010363; Zeisberg EM, 2005, J CLIN INVEST, V115, P1522, DOI 10.1172/JCI23769; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	36	739	767	0	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 25	2010	464	7288					601	U162		10.1038/nature08804	http://dx.doi.org/10.1038/nature08804			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20336144	Green Accepted			2022-12-28	WOS:000275974200050
J	Krivanek, OL; Chisholm, MF; Nicolosi, V; Pennycook, TJ; Corbin, GJ; Dellby, N; Murfitt, MF; Own, CS; Szilagyi, ZS; Oxley, MP; Pantelides, ST; Pennycook, SJ				Krivanek, Ondrej L.; Chisholm, Matthew F.; Nicolosi, Valeria; Pennycook, Timothy J.; Corbin, George J.; Dellby, Niklas; Murfitt, Matthew F.; Own, Christopher S.; Szilagyi, Zoltan S.; Oxley, Mark P.; Pantelides, Sokrates T.; Pennycook, Stephen J.			Atom-by-atom structural and chemical analysis by annular dark-field electron microscopy	NATURE			English	Article							SUB-ANGSTROM RESOLUTION; SINGLE ATOMS; GRAPHITE; NITROGEN; GRAPHENE; CARBON; OXYGEN; BORON	Direct imaging and chemical identification of all the atoms in a material with unknown three-dimensional structure would constitute a very powerful general analysis tool. Transmission electron microscopy should in principle be able to fulfil this role, as many scientists including Feynman realized early on(1). It images matter with electrons that scatter strongly from individual atoms and whose wavelengths are about 50 times smaller than an atom. Recently the technique has advanced greatly owing to the introduction of aberration-corrected optics(2-8). However, neither electron microscopy nor any other experimental technique has yet been able to resolve and identify all the atoms in a non-periodic material consisting of several atomic species. Here we show that annular dark-field imaging in an aberration-corrected scanning transmission electron microscope optimized for low voltage operation can resolve and identify the chemical type of every atom in monolayer hexagonal boron nitride that contains substitutional defects. Three types of atomic substitutions were found and identified: carbon substituting for boron, carbon substituting for nitrogen, and oxygen substituting for nitrogen. The substitutions caused in-plane distortions in the boron nitride monolayer of about 0.1 angstrom magnitude, which were directly resolved, and verified by density functional theory calculations. The results demonstrate that atom-by-atom structural and chemical analysis of all radiation-damage-resistant atoms present in, and on top of, ultrathin sheets has now become possible.	[Krivanek, Ondrej L.; Corbin, George J.; Dellby, Niklas; Murfitt, Matthew F.; Own, Christopher S.; Szilagyi, Zoltan S.] Nion Co, Kirkland, WA 98033 USA; [Chisholm, Matthew F.; Pennycook, Timothy J.; Oxley, Mark P.; Pantelides, Sokrates T.; Pennycook, Stephen J.] Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37831 USA; [Nicolosi, Valeria] Univ Oxford, Dept Mat, Oxford OX1 3PH, England; [Pennycook, Timothy J.; Oxley, Mark P.; Pantelides, Sokrates T.; Pennycook, Stephen J.] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Oxford; Vanderbilt University	Krivanek, OL (corresponding author), Nion Co, 1102 8th St, Kirkland, WA 98033 USA.	krivanek@nion.com	Oxley, Mark/F-8737-2017; Nicolosi, Valeria/Y-2419-2019; Pennycook, Timothy J./B-4946-2014; Chisholm, Matthew F./F-7198-2017; Pennycook, Stephen/AAA-1112-2019; Pennycook, Timothy/AAI-2247-2021	Oxley, Mark/0000-0002-9588-6187; Pennycook, Timothy J./0000-0002-0008-6516; Chisholm, Matthew F./0000-0003-0546-5109; Pennycook, Stephen/0000-0002-3210-6323; Pennycook, Timothy/0000-0002-0008-6516; Nicolosi, Valeria/0000-0002-7637-4813	Division of Materials Sciences and Engineering of the US Department of Energy [DE-FG02-09ER46554]; McMinn Endowment	Division of Materials Sciences and Engineering of the US Department of Energy(United States Department of Energy (DOE)); McMinn Endowment	We thank L. M. Brown, J.N. Coleman, P. Rez and J. C. H. Spence for discussions. Research at Oak Ridge National Laboratory ( M. F. C., T. J. P., M. P. O., S. T. P. and S. J. P.) was sponsored by the Division of Materials Sciences and Engineering of the US Department of Energy. Research at Vanderbilt was supported in part by the US Department of Energy grant DE-FG02-09ER46554 and the McMinn Endowment. Computations were performed at the National Energy Research Scientific Computing Center at Lawrence Berkeley National Laboratory.	Alem N, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.155425; Batson PE, 2002, NATURE, V418, P617, DOI 10.1038/nature00972; CREWE AV, 1970, SCIENCE, V168, P1338, DOI 10.1126/science.168.3937.1338; Egerton R.F., 2011, ELECT ENERGY LOSS SP; Feynman R.P., 1999, FEYNMAN COMPUTATION, P63; Girit CO, 2009, SCIENCE, V323, P1705, DOI 10.1126/science.1166999; Haider M, 1998, NATURE, V392, P768, DOI 10.1038/33823; Hartel P, 1996, ULTRAMICROSCOPY, V63, P93, DOI 10.1016/0304-3991(96)00020-4; Hawkes PW, 2008, ADV IMAG ELECT PHYS, V153, P1; Hernandez Y, 2008, NAT NANOTECHNOL, V3, P563, DOI 10.1038/nnano.2008.215; ISSACSON M, 1979, ULTRAMICROSCOPY, V4, P101; Jia CL, 2003, SCIENCE, V299, P870, DOI 10.1126/science.1079121; Jin CH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.195505; Kawaguchi M, 2008, J PHYS CHEM SOLIDS, V69, P1171, DOI 10.1016/j.jpcs.2007.10.076; Kelly TF, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2709758; Kisielowski C, 2001, ULTRAMICROSCOPY, V89, P243, DOI 10.1016/S0304-3991(01)00090-0; Krivanek OL, 2008, ULTRAMICROSCOPY, V108, P179, DOI 10.1016/j.ultramic.2007.07.010; Leapman RD, 2003, J MICROSC-OXFORD, V210, P5, DOI 10.1046/j.1365-2818.2003.01173.x; Meyer JC, 2009, NANO LETT, V9, P2683, DOI 10.1021/nl9011497; Midgley PA, 2003, ULTRAMICROSCOPY, V96, P413, DOI 10.1016/S0304-3991(03)00105-0; Miller M.K., 2000, ATOM PROBE TOMOGRAPH; Muller DA, 2008, SCIENCE, V319, P1073, DOI 10.1126/science.1148820; STEPHAN O, 1994, SCIENCE, V266, P1683, DOI 10.1126/science.266.5191.1683; Suenaga K, 2000, SCIENCE, V290, P2280, DOI 10.1126/science.290.5500.2280; Suenaga K, 2009, NAT CHEM, V1, P415, DOI [10.1038/NCHEM.282, 10.1038/nchem.282]; Varela M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.095502; Voyles PM, 2002, NATURE, V416, P826, DOI 10.1038/416826a; Zobelli A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.245402	28	916	929	17	686	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 25	2010	464	7288					571	574		10.1038/nature08879	http://dx.doi.org/10.1038/nature08879			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20336141	Green Published			2022-12-28	WOS:000275974200043
J	Petersen, KF; Dufour, S; Hariri, A; Nelson-Williams, C; Foo, JN; Zhang, XM; Dziura, J; Lifton, RP; Shulman, GI				Petersen, Kitt Falk; Dufour, Sylvie; Hariri, Ali; Nelson-Williams, Carol; Foo, Jia Nee; Zhang, Xian-Man; Dziura, James; Lifton, Richard P.; Shulman, Gerald I.			Apolipoprotein C3 Gene Variants in Nonalcoholic Fatty Liver Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATIC INSULIN-RESISTANCE; DENSITY-LIPOPROTEIN RECEPTOR; CORONARY-ARTERY-DISEASE; METABOLIC SYNDROME; STEATOSIS; POLYMORPHISMS; BINDING; CIII; HYPERTRIGLYCERIDEMIA; CHYLOMICRONS	BACKGROUND Nonalcoholic fatty liver disease is associated with hepatic insulin resistance and type 2 diabetes mellitus. Whether this association has a genetic basis is unknown. METHODS In 95 healthy Asian Indian men, a group known to have a high prevalence of nonalcoholic fatty liver disease, we genotyped two single-nucleotide polymorphisms (SNPs) in the gene encoding apolipoprotein C3 (APOC3) that are known to be associated with hypertriglyceridemia (rs2854116 [T-455C] and rs2854117 [C-482T]). Plasma apolipoprotein C3 concentrations, insulin sensitivity, and hepatic triglyceride content were measured. We also measured plasma triglyceride concentrations and retinyl fatty acid ester absorption as well as plasma triglyceride clearance after oral and intravenous fat-tolerance tests. Liver triglyceride content and APOC3 genotypes were also assessed in a group of 163 healthy non-Asian Indian men. RESULTS Carriers of the APOC3 variant alleles (C-482T, T-455C, or both) had a 30% increase in the fasting plasma apolipoprotein C3 concentration, as compared with the wildtype homozygotes. They also had a 60% increase in the fasting plasma triglyceride concentration, an increase by a factor of approximately two in the plasma triglyceride and retinyl fatty acid ester concentrations after an oral fat-tolerance test, and a 46% reduction in plasma triglyceride clearance. The prevalence of nonalcoholic fatty liver disease was 38% among variant-allele carriers and 0% among wild-type homozygotes (P<0.001). The subjects with nonalcoholic fatty liver disease had marked insulin resistance. A validation study involving non-Asian Indian men confirmed the association between APOC3 variant alleles and nonalcoholic fatty liver disease. CONCLUSIONS The polymorphisms C-482T and T-455C in APOC3 are associated with nonalcoholic fatty liver disease and insulin resistance.	[Dufour, Sylvie; Lifton, Richard P.; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Petersen, Kitt Falk; Hariri, Ali; Zhang, Xian-Man; Dziura, James; Lifton, Richard P.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Nelson-Williams, Carol; Foo, Jia Nee; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University	Shulman, GI (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, TAC S-269,POB 9812, New Haven, CT 06520 USA.	gerald.shulman@yale.edu	Volti, Giovanni Li/A-2435-2008; Valenti, Luca/B-3695-2009; Nobili, Valerio/K-8670-2018; Galvano, Fabio/F-8122-2010; Foo, Jia Nee/D-6069-2014; RICHART, CRISTOBAL C/S-9158-2017; Adiels, Martin/C-9278-2011; Shulman, Gerald I./P-7176-2019	Volti, Giovanni Li/0000-0002-8678-2183; Valenti, Luca/0000-0001-8909-0345; Galvano, Fabio/0000-0003-0644-0755; Foo, Jia Nee/0000-0001-9899-2308; RICHART, CRISTOBAL C/0000-0003-0852-6739; Shulman, Gerald I./0000-0003-1529-5668	U.S. Public Health Service [R01 AG-23686, R01 DK-49230, P01 DK-068229, P30 DK-45735, UL1 RR-024139]; American Diabetes Association; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049230, P01DK068229, R01DK040936, P30DK045735, R24DK085638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023686] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); American Diabetes Association(American Diabetes Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the U.S. Public Health Service (R01 AG-23686, R01 DK-49230, P01 DK-068229, P30 DK-45735, and UL1 RR-024139) and by Distinguished Clinical Scientist Awards from the American Diabetes Association ( to Dr. Petersen and Dr. Shulman).	BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Browning JD, 2006, HEPATOLOGY, V44, P466, DOI 10.1002/hep.21248; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; COOPER AD, 1985, GASTROENTEROLOGY, V88, P192, DOI 10.1016/S0016-5085(85)80155-4; Guettier JM, 2005, J CLIN ENDOCR METAB, V90, P1705, DOI 10.1210/jc.2004-1338; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; Li WW, 1995, J CLIN INVEST, V96, P2601, DOI 10.1172/JCI118324; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Miller M, 2007, ARCH MED RES, V38, P444, DOI 10.1016/j.arcmed.2006.10.013; NAGATA Y, 1988, J BIOL CHEM, V263, P15151; Olivieri O, 2003, J LIPID RES, V44, P2374, DOI 10.1194/jlr.M300253-JLR200; Olivieri O, 2002, J LIPID RES, V43, P1450, DOI 10.1194/jlr.M200145-JLR200; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Petersen KF, 2006, P NATL ACAD SCI USA, V103, P18273, DOI 10.1073/pnas.0608537103; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; SHERRILL BC, 1978, J BIOL CHEM, V253, P1859; van Dijk KW, 2004, CURR OPIN LIPIDOL, V15, P239, DOI [10.1097/01.mol.00001300096.77252.1f, 10.1097/00041433-200406000-00002]; WEINTRAUB MS, 1987, J CLIN INVEST, V79, P1110, DOI 10.1172/JCI112926; WINDLER EET, 1988, BIOCHEM J, V252, P553, DOI 10.1042/bj2520553; Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104	27	306	324	1	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	2010	362	12					1082	1089		10.1056/NEJMoa0907295	http://dx.doi.org/10.1056/NEJMoa0907295			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573FU	20335584	Green Accepted			2022-12-28	WOS:000275894600005
J	Mayer, EK; Bottle, A; Darzi, AW; Athanasiou, T; Vale, JA				Mayer, Erik K.; Bottle, Alex; Darzi, Ara W.; Athanasiou, Thanos; Vale, Justin A.			The volume-mortality relation for radical cystectomy in England: retrospective analysis of hospital episode statistics	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SURGEON VOLUME; OPERATIVE MORTALITY; HEALTH-CARE; OUTCOMES; QUALITY; IMPACT	Objectives To investigate the relation between volume and mortality after adjustment for case mix for radical cystectomy in the English healthcare setting using improved statistical methodology, taking into account the institutional and surgeon volume effects and institutional structural and process of care factors. Design Retrospective analysis of hospital episode statistics using multilevel modelling. Setting English hospitals carrying out radical cystectomy in the seven financial years 2000/1 to 2006/7. Participants Patients with a primary diagnosis of cancer undergoing an inpatient elective cystectomy. Main outcome measure Mortality within 30 days of cystectomy. Results Compared with low volume institutions, medium volume ones had a significantly higher odds of in-hospital and total mortality: odds ratio 1.72 (95% confidence interval 1.00 to 2.98, P=0.05) and 1.82 (1.08 to 3.06, P=0.02). This was only seen in the final model, which included adjustment for structural and processes of care factors. The surgeon volume-mortality relation showed weak evidence of reduced odds of in-hospital mortality (by 35%) for the high volume surgeons, although this did not reach statistical significance at the 5% level. Conclusions The relation between case volume and mortality after radical cystectomy for bladder cancer became evident only after adjustment for structural and process of care factors, including staffing levels of nurses and junior doctors, in addition to case mix. At least for this relatively uncommon procedure, adjusting for these confounders when examining the volume-outcome relation is critical before considering centralisation of care to a few specialist institutions. Outcomes other than mortality, such as functional morbidity and disease recurrence may ultimately influence towards centralising care.	[Mayer, Erik K.; Darzi, Ara W.; Athanasiou, Thanos] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Div Surg, London W2 1NY, England; [Mayer, Erik K.; Vale, Justin A.] St Marys Hosp, Imperial Coll Healthcare NHS Trust, Dept Urol, London, England; [Bottle, Alex] Univ London Imperial Coll Sci Technol & Med, Div Epidemiol Publ Hlth & Primary Care, London W2 1NY, England	Imperial College London; Imperial College London; Imperial College London	Mayer, EK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Div Surg, St Marys Hosp Campus, London W2 1NY, England.	e.mayer@imperial.ac.uk	Mayer, Erik K/A-6207-2013	Mayer, Erik K/0000-0002-5509-4580; Bottle, Alex/0000-0001-9978-2011	National Institute for Health Research [CL-2008-21-502] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Black N, 2004, BMJ-BRIT MED J, V328, P1478, DOI 10.1136/bmj.328.7454.1478; Chopra S, 2008, BJU INT, V101, P37; *DEP HLTH, MAN CANC SERV 2004 I; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Elixhauser A, 2003, HEALTH AFFAIR, V22, P167, DOI 10.1377/hlthaff.22.2.167; Elting LS, 2005, CANCER-AM CANCER SOC, V104, P975, DOI 10.1002/cncr.21273; Gilbert SM, 2008, UROLOGY, V71, P906, DOI 10.1016/j.urology.2007.12.035; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Harmon JW, 1999, ANN SURG, V230, P404, DOI 10.1097/00000658-199909000-00013; HEWITT M, 2000, INT VOL OUTC REL CON; Hollenbeck BK, 2007, UROLOGY, V69, P871, DOI 10.1016/j.urology.2007.01.040; Hollenbeck BK, 2007, J UROLOGY, V177, P2095, DOI 10.1016/j.juro.2007.01.153; Hollenbeck BK, 2006, J UROLOGY, V176, P1363, DOI 10.1016/j.juro.2006.06.015; Killeen SD, 2005, BRIT J SURG, V92, P389, DOI 10.1002/bjs.4954; Konety BR, 2005, J UROLOGY, V173, P1695, DOI 10.1097/01.ju.0000154638.61621.03; McCabe JE, 2005, BJU INT, V96, P806, DOI 10.1111/j.1464-410X.2005.05717.x; Morris E, 2008, GUT, V57, P1690, DOI 10.1136/gut.2007.137877; *OFF NAT STAT, 2009, GRIDL; Panageas KS, 2003, ANN INTERN MED, V139, P658, DOI 10.7326/0003-4819-139-8-200310210-00009; Sheldon TA, 2004, QUAL SAF HEALTH CARE, V13, P325, DOI 10.1136/qshc.2004.012161; Sowden A J, 1998, J Health Serv Res Policy, V3, P187; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Van Poppel H, 2001, EUR J CANCER, V37, P884, DOI 10.1016/S0959-8049(01)00056-9	24	40	40	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2010	340								c1128	10.1136/bmj.c1128	http://dx.doi.org/10.1136/bmj.c1128			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573RL	20305302	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000275932200001
J	Neufeld, P; Scheck, B				Neufeld, Peter; Scheck, Barry			Making forensic science more scientific	NATURE			English	Editorial Material									[Neufeld, Peter; Scheck, Barry] Cardozo Sch Law, Innocence Project, New York, NY 10011 USA		Neufeld, P (corresponding author), Cardozo Sch Law, Innocence Project, New York, NY 10011 USA.	info@innocenceproject.org							0	13	14	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 18	2010	464	7287					351	351		10.1038/464351a	http://dx.doi.org/10.1038/464351a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	570FG	20237545	Bronze			2022-12-28	WOS:000275657100019
J	Thomson, CS; Woolnough, S; Wickenden, M; Hiom, S; Twelves, CJ				Thomson, Catherine S.; Woolnough, Sarah; Wickenden, Matthew; Hiom, Sara; Twelves, Chris J.			Sunbed use in children aged 11-17 in England: face to face quota sampling surveys in the National Prevalence Study and Six Cities Study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TANNING BED USE; ADOLESCENTS	Objectives To quantify the use of sunbeds in young people across England, identify geographical variation, and explore patterns of use, including supervision. Design Two random location sampling surveys. Setting National Prevalence Study in England; Six Cities Study in Liverpool, Stoke/Stafford, Sunderland, Bath/Gloucester, Oxford/Cambridge, and Southampton. Participants 3101 children aged 11-17 in the National Prevalence study and 6209 in the Six Cities study. Results In the National Prevalence Study 6.0% (95% confidence interval 5.1% to 6.8%) of those aged 11-17 had used a sunbed. Use was higher in girls than in boys (8.6% (7.2% to 10.0%) v 3.5% (2.6% to 4.4%), respectively), in those aged 15-17 compared with those aged 11-14 (11.2% (9.5% to 12.9%) v 1.8% (1.2% to 2.4%), respectively), and in those from lower rather than higher social grades (7.6% (5.7% to 9.5%) v 5.4% (4.5% to 6.3%), respectively). Sunbed use was higher in the "north" (11.0%, 8.9% to 13.0%) than in the "midlands" (4.2%, 2.5% to 5.8%) and the "south" (4.2%, 3.3% to 5.2%). In the Six Cities Study, sunbed use was highest in Liverpool and Sunderland (20.0% (17.5% to 22.4%) and 18.0% (15.6% to 20.3%), respectively), with rates especially high in girls, those aged 15-17, or from lower social grades. Mean age of first use was 14, and 38.4% (34.7% to 42.1%) of children used a sunbed at least once a week. Nearly a quarter (23.0%, 19.8% to 26.1%) of children had used a sunbed at home (including home of friends/relatives), and 24.7% (21.0% to 28.4%) said they had used sunbeds unsupervised in a tanning/beauty salon or gym/leisure centre. Conclusions Sunbed use by children is widespread in England, is often inadequately supervised, and is a health risk. National legislation is needed to control sunbed outlets.	[Thomson, Catherine S.; Woolnough, Sarah; Wickenden, Matthew; Hiom, Sara] Canc Res UK, London WC2A 3PX, England; [Twelves, Chris J.] St Jamess Inst Oncol, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England	Cancer Research UK; Saint James's University Hospital; University of Leeds	Thomson, CS (corresponding author), Canc Res UK, London WC2A 3PX, England.	catherine.thomson@cancer.org.uk			Department of Health; National Cancer Action Team	Department of Health; National Cancer Action Team	Cancer Research UK was commissioned by the National Cancer Action Team, supported by the Department of Health to undertake this research. The Department of Health funded the pilot studies; the National Cancer Action Team funded the full studies.	*ACORN, 2003, WELC NEW ACORN; Boldeman C, 2001, EUR J CANCER, V37, P2441, DOI 10.1016/S0959-8049(01)00310-0; *BRMB, 2010, BMRB OMN; *CANC RES UK, 2009, SKIN CANC STAT KEY F; *CANC RES UK, 2009, CANC RES UK STUD SUN; *CANC RES UK, 2006, CANCERSTATS REP MAL; *COMARE, 2009, 13 COMARE HLTH PROT; CROUCH S, 2003, MARKETING RES MANAGE; Demko CA, 2003, ARCH PEDIAT ADOL MED, V157, P854, DOI 10.1001/archpedi.157.9.854; Department of Health, 2007, CANC REF STRAT; DIFFEY BL, 1986, BRIT J DERMATOL, V115, P67, DOI 10.1111/j.1365-2133.1986.tb06221.x; Diffey BL, 2003, BRIT J DERMATOL, V149, P578, DOI 10.1046/j.1365-2133.2003.05420.x; El Ghissassi F, 2009, LANCET ONCOL, V10, P751, DOI 10.1016/S1470-2045(09)70213-X; France The International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer, 2007, International Journal of Cancer, V120, P1116, DOI 10.1002/ijc.22453; Geller AC, 2002, PEDIATRICS, V109, P1009, DOI 10.1542/peds.109.6.1009; *GOV AC DEP, 2006, POP PROJ OFF NAT STA; Hamlet N, 2004, J PUBLIC HEALTH, V26, P31, DOI 10.1093/pubmed/fdh117; Lazovich DA, 2005, EUR J CANCER, V41, P20, DOI 10.1016/j.ejca.2004.09.015; Mackay H, 2007, HEALTH EDUC J, V66, P141, DOI 10.1177/0017896907076753; O'Riordan DL, 2006, CANCER CAUSE CONTROL, V17, P679, DOI 10.1007/s10552-005-0453-9; Oliver H, 2007, BRIT J DERMATOL, V157, P350, DOI 10.1111/j.1365-2133.2007.07985.x; SHAROT T, 1986, J MARKET RES SOC, V28, P269; Suchak R, 2008, BRIT J DERMATOL, V159, P129; Thomson CS, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4643; WALSH A, 2009, SUNBED OUTLETS AREA	25	39	39	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2010	340								c877	10.1136/bmj.c877	http://dx.doi.org/10.1136/bmj.c877			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573RI	20299396	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000275931900010
J	Maruyama, T; Taguchi, O; Niederman, MS; Morser, J; Kobayashi, H; Kobayashi, T; D'Alessandro-Gabazza, C; Nakayama, S; Nishikubo, K; Noguchi, T; Takei, Y; Gabazza, EC				Maruyama, Takaya; Taguchi, Osamu; Niederman, Michael S.; Morser, John; Kobayashi, Hiroyasu; Kobayashi, Tetsu; D'Alessandro-Gabazza, Corina; Nakayama, Sei; Nishikubo, Kimiaki; Noguchi, Takashi; Takei, Yoshiyuki; Gabazza, Esteban C.			Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POLYSACCHARIDE VACCINE; ACQUIRED PNEUMONIA; OUTBREAK; ADULTS	Objective To determine the efficacy of a 23-valent pneumococcal polysaccharide vaccine in people at high risk of pneumococcal pneumonia. Design Prospective, randomised, placebo controlled double blind study. Setting Nursing homes in Japan. Participants 1006 nursing home residents. Interventions Participants were randomly allocated to either 23-valent pneumococcal polysaccharide vaccine (n=502) or placebo (n=504). Main outcome measures The primary end points were the incidence of all cause pneumonia and pneumococcal pneumonia. Secondary end points were deaths from pneumococcal pneumonia, all cause pneumonia, and other causes. Results Pneumonia occurred in 63 (12.5%) participants in the vaccine group and 104 (20.6%) in the placebo group. Pneumococcal pneumonia was diagnosed in 14 (2.8%) participants in the vaccine group and 37 (7.3%) in the placebo group (P<0.001). All cause pneumonia and pneumococcal pneumonia were significantly more frequent in the placebo group than in the vaccine group: incidence per 1000 person years 55 v 91 (P<0.0006) and 12 v 32 (P<0.001), respectively. Death from pneumococcal pneumonia was significantly higher in the placebo group than in the vaccine group (35.1% (13/37) v 0% (0/14), P<0.01). The death rate from all cause pneumonia ( vaccine group 20.6% (13/63) v placebo group 25.0% (26/104), P=0.5) and from other causes ( vaccine group 17.7% (89/502) v placebo group (80/504) 15.9%, P=0.4) did not differ between the two study groups. Conclusion The 23-valent pneumococcal polysaccharide vaccine prevented pneumococcal pneumonia and reduced mortality from pneumococcal pneumonia in nursing home residents.	[Gabazza, Esteban C.] Mie Univ, Grad Sch Med, Dept Immunol, Tsu, Mie 514, Japan; [Maruyama, Takaya; Taguchi, Osamu; Kobayashi, Hiroyasu; Kobayashi, Tetsu; D'Alessandro-Gabazza, Corina] Mie Univ, Grad Sch Med, Dept Pulm & Crit Care Med, Tsu, Mie 514, Japan; [Takei, Yoshiyuki] Mie Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Tsu, Mie 514, Japan; [Nakayama, Sei; Nishikubo, Kimiaki; Noguchi, Takashi] Kinan Gen Hosp, Minamimuro, Mie, Japan; [Morser, John] Stanford Sch Med, Div Hematol, Stanford, CA USA; [Niederman, Michael S.] Winthrop Univ Hosp, Dept Med, Mineola, NY 11501 USA	Mie University; Mie University; Mie University; Stanford University; Winthrop University Hospital	Gabazza, EC (corresponding author), Mie Univ, Grad Sch Med, Dept Immunol, Edobashi 2-174, Tsu, Mie 514, Japan.	gabazza@doc.medic.mie-u.ac.jp	Hug, Balthasar L./G-1568-2010	Gabazza, Esteban/0000-0001-5748-1499	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was funded by a grant in aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funder had no role in study design, data collection, data analysis, data interpretation, or writing of the manuscript. TM and ECG had full access to all the data and had final responsibility for the decision to publish the paper.	Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; Christenson B, 2004, EUR RESPIR J, V23, P363, DOI 10.1183/09031936.04.00063504; de Roux A, 2005, EUR RESPIR J, V26, P982, DOI 10.1183/09031936.05.00119705; Dominguez A, 2005, CLIN INFECT DIS, V40, P1250, DOI 10.1086/429236; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; GAILLAT J, 1985, REV EPIDEMIOL SANTE, V33, P437; HAGLUND LA, 1993, J INFECT DIS, V168, P1532, DOI 10.1093/infdis/168.6.1532; Jackson LA, 2003, NEW ENGL J MED, V348, P1747, DOI 10.1056/NEJMoa022678; Janssens JP, 2004, LANCET INFECT DIS, V4, P112, DOI 10.1016/S1473-3099(04)00931-4; Johnstone J, 2007, ARCH INTERN MED, V167, P1938, DOI 10.1001/archinte.167.18.1938; KAUFMAN P, 1947, ARCH INTERN MED, V79, P518, DOI 10.1001/archinte.1947.00220110058004; Lim WS, 2001, EUR RESPIR J, V18, P362, DOI 10.1183/09031936.01.00204401; Marcos MA, 2003, EUR RESPIR J, V21, P209, DOI 10.1183/09031936.03.00058802; Maruyama T, 2008, RESP MED, V102, P1287, DOI 10.1016/j.rmed.2008.03.027; Moberley SA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub2; Muder RR, 1998, AM J MED, V105, P319, DOI 10.1016/S0002-9343(98)00262-9; Musher DM, 2001, CLIN INFECT DIS, V32, P534, DOI 10.1086/318709; Nuorti JP, 1998, NEW ENGL J MED, V338, P1861, DOI 10.1056/NEJM199806253382601; Ortqvist A, 1998, LANCET, V351, P399, DOI 10.1016/S0140-6736(97)07358-3; QUICK RE, 1993, AM J MED, V94, P149, DOI 10.1016/0002-9343(93)90176-P; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; SIMS RV, 1988, ANN INTERN MED, V108, P653, DOI 10.7326/0003-4819-108-5-653; Spika J S, 1990, Infect Dis Clin North Am, V4, P11; Tan CG, 2003, INFECT CONT HOSP EP, V24, P848, DOI 10.1086/502148; 1997, MMWR MORB MORTAL WKL, V46, P60	25	165	172	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2010	340								c1004	10.1136/bmj.c1004	http://dx.doi.org/10.1136/bmj.c1004			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570FB	20211953	Green Published, hybrid			2022-12-28	WOS:000275656600001
J	Kitchener, H; Powell, M				Kitchener, Henry; Powell, Melanie			Radiotherapy for endometrial cancer: a key piece in the jigsaw	LANCET			English	Editorial Material							RANDOMIZED-TRIAL; CARCINOMA; SURGERY		[Kitchener, Henry] Univ Manchester, Acad Hlth Sci Ctr, Cent Manchester Univ Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, Manchester M13 9WL, Lancs, England; [Powell, Melanie] Barts & London NHS Trust, Dept Radiotherapy, London, England	University of Manchester; Barts Health NHS Trust	Kitchener, H (corresponding author), Univ Manchester, Acad Hlth Sci Ctr, Cent Manchester Univ Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, Manchester M13 9WL, Lancs, England.	henry.kitchener@manchester.ac.uk						AALDERS J, 1980, OBSTET GYNECOL, V56, P419; Blake P, 2009, LANCET, V373, P137, DOI 10.1016/S0140-6736(08)61767-5; *CANC RES UK, UK UT WOMB CANC INC; Creutzberg CL, 2000, LANCET, V355, P1404, DOI 10.1016/S0140-6736(00)02139-5; Creutzberg CL, 2003, GYNECOL ONCOL, V89, P201, DOI 10.1016/S0090-8258(03)00126-4; CREUTZBERG CL, 2009, RANDOMIZED PHASE 3 T; Keys HM, 2004, GYNECOL ONCOL, V92, P744, DOI 10.1016/j.ygyno.2003.11.048; Nout RA, 2010, LANCET, V375, P816, DOI 10.1016/S0140-6736(09)62163-2; Nout RA, 2009, J CLIN ONCOL, V27, P3547, DOI 10.1200/JCO.2008.20.2424	9	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 6	2010	375	9717					781	782		10.1016/S0140-6736(10)60099-2	http://dx.doi.org/10.1016/S0140-6736(10)60099-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570MO	20206759				2022-12-28	WOS:000275682600005
J	Eiring, AM; Harb, JG; Neviani, P; Garton, C; Oaks, JJ; Spizzo, R; Liu, SJ; Schwind, S; Santhanam, R; Hickey, CJ; Becker, H; Chandler, JC; Andino, R; Cortes, J; Hokland, P; Huettner, CS; Bhatia, R; Roy, DC; Liebhaber, SA; Caligiuri, MA; Marcucci, G; Garzon, R; Croce, CM; Calin, GA; Perrotti, D				Eiring, Anna M.; Harb, Jason G.; Neviani, Paolo; Garton, Christopher; Oaks, Joshua J.; Spizzo, Riccardo; Liu, Shujun; Schwind, Sebastian; Santhanam, Ramasamy; Hickey, Christopher J.; Becker, Heiko; Chandler, Jason C.; Andino, Raul; Cortes, Jorge; Hokland, Peter; Huettner, Claudia S.; Bhatia, Ravi; Roy, Denis C.; Liebhaber, Stephen A.; Caligiuri, Michael A.; Marcucci, Guido; Garzon, Ramiro; Croce, Carlo M.; Calin, George A.; Perrotti, Danilo			miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts	CELL			English	Article							CHRONIC MYELOID-LEUKEMIA; C/EBP-ALPHA; CD34(+) CELLS; BCR/ABL; BINDING; IDENTIFICATION; EXPRESSION; MICRORNAS; TARGETS; MYELOPEROXIDASE	MicroRNAs and heterogeneous ribonucleoproteins (hnRNPs) are posttranscriptional gene regulators that bind mRNA in a sequence-specific manner. Here, we report that loss of miR-328 occurs in blast crisis chronic myelogenous leukemia (CML-BC) in a BCR/ABL dose- and kinase-dependent manner through the MAPK-hnRNP E2 pathway. Restoration of miR-328 expression rescues differentiation and impairs survival of leukemic blasts by simultaneously interacting with the translational regulator poly(rC)-binding protein hnRNP E2 and with the mRNA encoding the survival factor PIM1, respectively. The interaction with hnRNP E2 is independent of the microRNA's seed sequence and it leads to release of CEBPA mRNA from hnRNP E2-mediated translational inhibition. Altogether, these data reveal the dual ability of a microRNA to control cell fate both through base pairing with mRNA targets and through a decoy activity that interferes with the function of regulatory proteins.	[Eiring, Anna M.; Harb, Jason G.; Neviani, Paolo; Garton, Christopher; Oaks, Joshua J.; Santhanam, Ramasamy; Caligiuri, Michael A.; Marcucci, Guido; Garzon, Ramiro; Croce, Carlo M.; Perrotti, Danilo] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Human Canc Genet Program, Columbus, OH 43210 USA; [Liu, Shujun; Schwind, Sebastian; Hickey, Christopher J.; Becker, Heiko; Chandler, Jason C.; Caligiuri, Michael A.; Marcucci, Guido; Garzon, Ramiro] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Schwind, Sebastian; Hickey, Christopher J.; Becker, Heiko; Caligiuri, Michael A.; Marcucci, Guido; Garzon, Ramiro; Croce, Carlo M.; Perrotti, Danilo] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Perrotti, Danilo] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Andino, Raul] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Spizzo, Riccardo; Cortes, Jorge; Calin, George A.] Univ Texas Houston, MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Dept Leukemia, Houston, TX 77030 USA; [Spizzo, Riccardo; Cortes, Jorge; Calin, George A.] Univ Texas Houston, MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Dept Expt Therapeut, Houston, TX 77030 USA; [Hokland, Peter] Aarhus Univ, Dept Hematol, DK-8000 Aarhus C, Denmark; [Huettner, Claudia S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Bhatia, Ravi] City Hope Natl Med Ctr, Dept Hematopoiet Stem Cell & Leukemia Res, Duarte, CA 91010 USA; [Roy, Denis C.] Hop Maison Neuve Rosemont, Dept Hematol Oncol, Montreal, PQ H3T 1J4, Canada; [Roy, Denis C.] Univ Montreal, Montreal, PQ H3T 1J4, Canada; [Liebhaber, Stephen A.] Univ Penn, Sch Med, Dept Genet & Med, Philadelphia, PA 19104 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of California System; University of California San Francisco; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Aarhus University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; City of Hope; Universite de Montreal; Universite de Montreal; University of Pennsylvania	Perrotti, D (corresponding author), Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Human Canc Genet Program, Columbus, OH 43210 USA.	danilo.perrotti@osumc.edu	Perrotti, Danilo/E-3852-2011; Garzon, Ramiro/E-3104-2011; Calin, George/E-9390-2011; Young, Richard A/F-6495-2012; Eiring, Anna M./ABA-8673-2020; Spizzo, Riccardo/V-1057-2019; Califano, Andrea/F-7239-2012	Young, Richard A/0000-0001-8855-8647; Eiring, Anna M./0000-0001-6533-9150; Spizzo, Riccardo/0000-0001-7772-0960; Hokland, Peter/0000-0002-1177-9756; Roy, Denis-Claude/0000-0002-5921-1692; Calin, George/0000-0001-6704-5615; Cortes, Jorge/0000-0002-8636-1071	National Cancer Institute [CA095512, CA16058]; NIH, Bethesda, MD, USA; US Army [W81XWH-07-1-0270]; American-Italian Cancer Foundation; Fonds de la Recherche en Sante du Quebec; OSU Graduate School; Leukemia and Lymphoma Society; M.D. Anderson Research Trust; University of Texas System Regents; NATIONAL CANCER INSTITUTE [R01CA095512, P30CA016058] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, Bethesda, MD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Army(United States Department of DefenseUnited States Army); American-Italian Cancer Foundation; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); OSU Graduate School; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); M.D. Anderson Research Trust; University of Texas System Regents; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Cancer Institute CA095512 (D.P.), CA16058 (OSU-CCC), NIH, Bethesda, MD, USA; the US Army, CML Research Program, W81XWH-07-1-0270 (D. P.); the American-Italian Cancer Foundation (P.N.); Fonds de la Recherche en Sante du Quebec (D.C.R.); and AGGRS from The OSU Graduate School (A.M.E.). D.P. is a Scholar of The Leukemia and Lymphoma Society. G.A.C. is a Fellow of the M.D. Anderson Research Trust and Scholar of the University of Texas System Regents. We thank J.-S. Chang, M. Odeh, and A. Martin for technical assistance and S. Lee for editorial assistance; T. Skorski (Temple University, Philadelphia, PA, USA) for providing PIM1 cDNAs; F. Racke ( OSU, Columbus OH, USA) for histopathology analysis; B. Calabretta (TJU, Philadelphia, PA, USA), R. Arlinghaus ( MDACC, Houston, TX, USA), and K. Huebner (OSU) for critical reading of the manuscript.	Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Carpenter B, 2006, BBA-REV CANCER, V1765, P85, DOI 10.1016/j.bbcan.2005.10.002; Chang IS, 2007, BLOOD, V110, P994, DOI 10.1182/blood-2007-03-078303; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Eiring AM, 2008, BLOOD, V111, P816, DOI 10.1182/blood-2007-05-090472; Evans JR, 2003, ONCOGENE, V22, P8012, DOI 10.1038/sj.onc.1206645; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Ferrari-Amorotti G, 2006, BLOOD, V108, P1353, DOI 10.1182/blood-2006-01-011833; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fujimura K, 2008, RNA, V14, P425, DOI 10.1261/rna.780708; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; George Ajish D, 2006, RNA Biol, V3, P57; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Hoover RR, 2001, ONCOGENE, V20, P5826, DOI 10.1038/sj.onc.1204549; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Keeshan K, 2003, BLOOD, V102, P1267, DOI 10.1182/blood-2003-02-0477; Khabar KSA, 2005, J INTERF CYTOK RES, V25, P1, DOI 10.1089/jir.2005.25.1; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Nieborowska-Skorska M, 2002, BLOOD, V99, P4531, DOI 10.1182/blood.V99.12.4531; Notari M, 2006, BLOOD, V107, P2507, DOI 10.1182/blood-2005-09-3732; Ostareck-Lederer A, 2004, BIOL CELL, V96, P407, DOI 10.1016/j.biolcel.2004.03.010; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Perrotti D, 2002, NAT GENET, V30, P48, DOI 10.1038/ng791; Perrotti D, 2007, CLIN CANCER RES, V13, P1638, DOI 10.1158/1078-0432.CCR-06-2320; ROSMARIN AG, 1989, BLOOD, V73, P131; Schultheis B, 2005, BLOOD, V105, P4893, DOI 10.1182/blood-2005-01-0210; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; Wagner K, 2006, P NATL ACAD SCI USA, V103, P6338, DOI 10.1073/pnas.0508143103; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Wang W, 2001, LEUKEMIA, V15, P779, DOI 10.1038/sj.leu.2402094; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5	45	380	411	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					652	665		10.1016/j.cell.2010.01.007	http://dx.doi.org/10.1016/j.cell.2010.01.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211135	Bronze, Green Accepted			2022-12-28	WOS:000275197400015
J	Yip, WCM; Hsiao, W; Meng, QY; Chen, W; Sun, XM				Yip, Winnie Chi-Man; Hsiao, William; Meng, Qingyue; Chen, Wen; Sun, Xiaoming			Realignment of incentives for health-care providers in China	LANCET			English	Review							PAY-FOR-PERFORMANCE; SYSTEM REFORM; PAYMENT; DISEASES; QUALITY; MODEL; WILL	Inappropriate incentives as part of China's fee-for-service payment system have resulted in rapid cost increase, inefficiencies, poor quality, unaffordable health care, and an erosion of medical ethics. To reverse these outcomes, a strategy of experimentation to realign incentives for providers with the social goals of improvement in quality and efficiency has been initiated in China. This Review shows how lessons that have been learned from international experiences have been improved further in China by realignment of the incentives for providers towards prevention and primary care, and incorporation of a treatment protocol for hospital services. Although many experiments are new, preliminary evidence suggests a potential to produce savings in costs. However, because these experiments have not been scientifically assessed in China, evidence of their effects on quality and health outcome is largely missing. Although a reform of the provider's payment can be an effective short-term strategy, professional ethics need to be re-established and incentives changed to alter the profit motives of Chinese hospitals and physicians alike. When hospitals are given incentives to achieve maximum profit, incentives for hospitals and physicians must be separated.	[Yip, Winnie Chi-Man] Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England; [Hsiao, William] Harvard Univ, Dept Hlth Policy & Management, Cambridge, MA 02138 USA; [Meng, Qingyue] Shandong Univ, Ctr Hlth Management & Policy, Jinan 250100, Peoples R China; [Chen, Wen] Fudan Univ, Dept Hlth Econ, Shanghai 200433, Peoples R China; [Sun, Xiaoming] Pudong Hlth Author, Shanghai, Peoples R China	University of Oxford; Harvard University; Shandong University; Fudan University	Yip, WCM (corresponding author), Univ Oxford, Dept Publ Hlth, Old Rd Campus,Rosemary Rue Bldg Room 326, Oxford OX3 7LF, England.	winnie.yip@dphpc.ox.ac.uk						ALVANZO AH, 2003, CLIN GOVERNANCE INT, V8, P69; Balabanova D, 2009, HEALTH POLICY PLANN, V24, P46, DOI 10.1093/heapol/czn041; Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Chen W, 2007, PLANT MOL BIOL REP, V25, P27, DOI 10.1007/s11105-007-0004-5; CHEN Y, 2007, CHINESE J HOSP MANAG, V8, P35; Chen Z, 2009, LANCET, V373, P1322, DOI 10.1016/S0140-6736(09)60753-4; *CHIN CDC, 2009, ANN OFF MIN HLTH REG; Donskey CJ, 2000, NEW ENGL J MED, V343, P1925, DOI 10.1056/NEJM200012283432604; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Du L., 2007, CHINESE J HOSP MANAG, V9, P23; Fleetcroft Robert, 2006, J Health Serv Res Policy, V11, P27, DOI 10.1258/135581906775094316; Frolich A, 2007, HEALTH POLICY, V80, P179, DOI 10.1016/j.healthpol.2006.03.001; FUCHS VR, 1974, HLTH EC SOCIAL CHOIC; GE YF, 2005, CHINA DEV REV, V7, P1; Guterman S, 2009, HEALTH AFFAIR, V28, pW238, DOI 10.1377/hlthaff.28.2.w238; Ham C, 2008, LANCET, V371, P98, DOI 10.1016/S0140-6736(08)60084-7; Havighurst Clark C, 1990, Jurimetrics, V30, P415; He J, 2009, LANCET, V374, P1765, DOI 10.1016/S0140-6736(09)61199-5; HSIAO WC, 2008, SOCIAL EXPT RURAL CH; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; Hughes D, 2007, HEALTH AFFAIR, V26, P999, DOI 10.1377/hlthaff.26.4.999; *JIN MED COLL HOSP, 2007, INTR IMPL CAS BAS PA; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Landon BE, 1998, JAMA-J AM MED ASSOC, V279, P1377, DOI 10.1001/jama.279.17.1377; Langenbrunner JC, 2002, HOSP CHANGING EUROPE; Langenbrunner JC, 2009, DESIGNING AND IMPLEMENTING HEALTH CARE PROVIDER PAYMENT SYSTEMS: HOW-TO MANUALS, P1; LUO K, 2007, CHIN J HOSP MANAGE, V8, P33; MARCIA A, 2000, NEW ENGL J MED, V342, P42; Maynard A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c88; Mechanic RE, 2009, HEALTH AFFAIR, V28, pW262, DOI 10.1377/hlthaff.28.2.w262; MENG Q, 2008, HLTH PROVIDER PAYMEN; MENG Q, 2007, UHPP EVALUATION REPO; *MIN HLTH CHIN, 2009, STAND C STAT COUNC C; *MOH GEN OFF, 2004, CARR OUT EXP US CAS; Olsen KR, 2009, EUR J HEALTH ECON, V10, P399, DOI 10.1007/s10198-008-0140-3; PELLEGRINO ED, 1993, JAMA-J AM MED ASSOC, V269, P1158, DOI 10.1001/jama.269.9.1158; Reynolds L, 2009, HEALTH POLICY, V90, P32, DOI 10.1016/j.healthpol.2008.09.002; Rosenthal MB, 2007, JAMA-J AM MED ASSOC, V297, P740, DOI 10.1001/jama.297.7.740; Saks M., 1995, PROFESSIONS PUBLIC I; *SHANGH BUR STAT, 2009, ANN REP SOC EC DEV S; *SHANGH BUR STAT, 2009, ANN REP SOC EC DEV C; *SHANGH BUR STAT, 2009, ANN REP SOC EC DEV Z; SHAW GB, 1913, PREFACE DOCTORS DOCT, P9; SMITH HL, 1986, PROFESSIONAL ETHICS; Smith WR, 2000, CHEST, V118, p8S, DOI 10.1378/chest.118.2_suppl.8S; Soeters R, 2006, B WORLD HEALTH ORGAN, V84, P884; WANG H, 2009, HEALTH ECON, V18, P65; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; Wenzel RP, 2000, NEW ENGL J MED, V343, P1961, DOI 10.1056/NEJM200012283432610; WU G, 2007, CHIN J HOSP MANAGE, V9, P26; WU G, 2007, CHIN J HOSP MANAGE, V9, P21; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; YAO L, 2007, STUDY DEV IMPLEMENTA; YAO L, 2007, PILOT STUDY SEPARATI; Yip W, 2008, HEALTH AFFAIR, V27, P460, DOI 10.1377/hlthaff.27.2.460; YU B, 2007, PAYMENT SYSTEMS PAYI; [No title captured]	58	254	263	7	110	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2010	375	9720					1120	1130		10.1016/S0140-6736(10)60063-3	http://dx.doi.org/10.1016/S0140-6736(10)60063-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	578ZB	20346818				2022-12-28	WOS:000276334600036
J	Zanin-Zhorov, A; Ding, Y; Kumari, S; Attur, M; Hippen, KL; Brown, M; Blazar, BR; Abramson, SB; Lafaille, JJ; Dustin, ML				Zanin-Zhorov, Alexandra; Ding, Yi; Kumari, Sudha; Attur, Mukundan; Hippen, Keli L.; Brown, Maryanne; Blazar, Bruce R.; Abramson, Steven B.; Lafaille, Juan J.; Dustin, Michael L.			Protein Kinase C-theta Mediates Negative Feedback on Regulatory T Cell Function	SCIENCE			English	Article							PKC-THETA; KAPPA-B; ACTIVATION; MECHANISMS; THERAPY; POTENT; FOXP3; BETA	T cell receptor (TCR)-dependent regulatory T cell (T-reg) activity controls effector T cell (T-eff) function and is inhibited by the inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha). Protein kinase C-theta (PKC-theta) recruitment to the immunological synapse is required for full T-eff activation. In contrast, PKC-theta was sequestered away from the T-reg immunological synapse. Furthermore, PKC-theta blockade enhanced T-reg function, demonstrating PKC-theta inhibits T-reg-mediated suppression. Inhibition of PKC-theta protected T-reg from inactivation by TNF-alpha, restored activity of defective T-reg from rheumatoid arthritis patients, and enhanced protection of mice from inflammatory colitis. T-reg freed of PKC-theta-mediated inhibition can function in the presence of inflammatory cytokines and thus have therapeutic potential in control of inflammatory diseases.	[Zanin-Zhorov, Alexandra; Ding, Yi; Kumari, Sudha; Lafaille, Juan J.; Dustin, Michael L.] NYU, Sch Med, Mol Pathogenesis Program,Dept Pathol, Helen & Martin Kimmel Ctr Biol & Med,Skirball Ins, New York, NY 10016 USA; [Attur, Mukundan; Abramson, Steven B.] NYU, Sch Med, Div Rheumatol, New York, NY 10003 USA; [Attur, Mukundan; Abramson, Steven B.] NYU, Hosp Joint Dis, New York, NY 10003 USA; [Hippen, Keli L.; Blazar, Bruce R.] Univ Minnesota, Ctr Canc, Minneapolis, MN 55455 USA; [Hippen, Keli L.; Blazar, Bruce R.] Univ Minnesota, Dept Pediat, Div Bone Blood & Marrow Transplantat, Minneapolis, MN 55455 USA; [Brown, Maryanne] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA	New York University; New York University; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Boehringer Ingelheim	Dustin, ML (corresponding author), NYU, Sch Med, Mol Pathogenesis Program,Dept Pathol, Helen & Martin Kimmel Ctr Biol & Med,Skirball Ins, New York, NY 10016 USA.	michael.dustin@med.nyu.edu	Attur, Mukundan/O-1578-2019; Dustin, Michael/AAM-4611-2020	Attur, Mukundan/0000-0001-7080-8118; Abramson, Steven/0000-0002-0668-6344; Dustin, Michael/0000-0003-4983-6389	NIH [PN2 EY016586, R01 AI43542]; Leukemia and Lymphoma Translational Research [6098-09]; Osaka University Immunology Frontier Research Center; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI043542, R01AI055037, R01AI043542, P01AI056299] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Translational Research; Osaka University Immunology Frontier Research Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH through the NIH Roadmap for Medical Research PN2 EY016586 and R01 AI43542 to M. L. D.; a Leukemia and Lymphoma Translational Research grant 6098-09 to B. B. S. K. was supported by the Osaka University Immunology Frontier Research Center. B. Blazer is an ad hoc advisor to Becton Dickinson. Becton Dickinson has purchased licensing rights for the use of T<INF>reg</INF> cells to prevent alloresponses and autoimmunity. An MTA agreement is required for use of compound 20. M. D. and A.Z.-Z. have applied for patents for the use of compound 20 and RNA interference against PKC theta in adoptive immunotherapy (patent application nos. 61173237 and 61286871).	Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; Cywin CL, 2007, BIOORG MED CHEM LETT, V17, P225, DOI 10.1016/j.bmcl.2006.09.056; Ding Y, 2008, NAT MED, V14, P162, DOI 10.1038/nm1707; Dustin ML, 2006, CURR OPIN IMMUNOL, V18, P512, DOI 10.1016/j.coi.2006.05.017; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Flores-Borja F, 2008, EUR J IMMUNOL, V38, P934, DOI 10.1002/eji.200738107; Godfrey WR, 2005, BLOOD, V105, P750, DOI 10.1182/blood-2004-06-2467; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hayashi K, 2007, PHARMACOL RES, V55, P537, DOI 10.1016/j.phrs.2007.04.009; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sarris M, 2008, IMMUNITY, V28, P402, DOI 10.1016/j.immuni.2008.01.012; Shaffer MH, 2009, J IMMUNOL, V182, P1021, DOI 10.4049/jimmunol.182.2.1021; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Srivastava KK, 2004, J BIOL CHEM, V279, P29911, DOI 10.1074/jbc.M401997200; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tran DQ, 2009, J IMMUNOL, V182, P2929, DOI 10.4049/jimmunol.0803827; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	29	219	230	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2010	328	5976					372	376		10.1126/science.1186068	http://dx.doi.org/10.1126/science.1186068			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20339032	Green Accepted			2022-12-28	WOS:000276685000042
J	Walker, AS; Ford, D; Gilks, CF; Munderi, P; Ssali, F; Reid, A; Katabira, E; Grosskurth, H; Mugyenyi, P; Hakim, J; Darbyshire, JH; Gibb, DM; Babiker, AG				Walker, A. S.; Ford, D.; Gilks, C. F.; Munderi, P.; Ssali, F.; Reid, A.; Katabira, E.; Grosskurth, H.; Mugyenyi, P.; Hakim, J.; Darbyshire, J. H.; Gibb, D. M.; Babiker, A. G.			Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort	LANCET			English	Article							TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS; PNEUMOCYSTIS-CARINII PNEUMONIA; IMMUNE ACTIVATION; EARLY MORTALITY; HIV-1-INFECTED PATIENTS; SECONDARY PROPHYLAXIS; RANDOMIZED-TRIAL; COTE-DIVOIRE; TUBERCULOSIS; DISCONTINUATION	Background Co-trimoxazole prophylaxis can reduce mortality from untreated HIV infection in Africa; whether benefits occur alongside combination antiretroviral therapy (ART) is unclear. We estimated the effect of prophylaxis after ART initiation in adults. Methods Participants in our observational analysis were from the DART randomised trial of management strategies in HIV-infected, symptomatic, previously untreated African adults starting triple-drug ART with CD4 counts lower than 200 cells per mu L. Co-trimoxazole prophylaxis was not routinely used or randomly allocated, but was variably prescribed by clinicians We estimated effects on clinical outcomes, CD4 cell count, and body-mass index (BMI) using marginal structural models to adjust for time-dependent confounding by indication. DART was registered, number ISRCTN13968779. Findings 3179 participants contributed 14 214 years of follow-up (8128 [57%] person-years on co-trimoxazole). Time-dependent predictors of co-trimoxazole use were current CD4 cell count, haemoglobin concentration, BMI, and previous WHO stage 3 or 4 events on ART. Present prophylaxis significantly reduced mortality (odds ratio 0.65, 95% CI 0.50-0.85; p=0.001). Mortality risk reduction on ART was substantial to 12 weeks (0.41, 0.27-0.65), sustained from 12-72 weeks (0.56, 0.37-0.86), but not evident subsequently (0-96, 0.63-1-45; heterogeneity p=0.02). Variation in mortality reduction was not accounted for by time on co-trimoxazole or current CD4 cell count. Prophylaxis reduced frequency of malaria (0.74, 0.63-0.88; p=0.0005), an effect that was maintained with time, but we observed no effect on new WHO stage 4 events (0.86, 0.69-1.07; p=0.17), CD4 cell count (difference vs non-users, 3 cells per mu L [-12 to 6]; p=0.50), or BMI (difference vs non-users, 0.04 kg/m(2) [-0-20 to 0.13); p=0.681. Interpretation Our results reinforce WHO guidelines and provide strong motivation for provision of co-trimoxazole prophylaxis for at least 72 weeks for all adults starting combination ART in Africa.	[Walker, A. S.; Ford, D.; Darbyshire, J. H.; Gibb, D. M.; Babiker, A. G.] MRC, Clin Trials Unit, London NW1 2DA, England; [Gilks, C. F.] Univ London Imperial Coll Sci Technol & Med, London, England; [Munderi, P.; Grosskurth, H.] MRC UVRI, Uganda Res Unit AIDS, Entebbe, Uganda; [Ssali, F.; Mugyenyi, P.] Joint Clin Res Ctr, Kampala, Uganda; [Reid, A.; Hakim, J.] Univ Zimbabwe, Harare, Zimbabwe; [Katabira, E.] Makerere Univ, Infect Dis Inst, Mulago, Uganda	Medical Research Council Clinical Trials Unit; Imperial College London; Joint Clinic Research Center - United Arab Emirates; University of Zimbabwe; Makerere University	Walker, AS (corresponding author), MRC, Clin Trials Unit, 222 Euston Rd, London NW1 2DA, England.	asw@ctu.mrc.ac.uk	Gilks, Charles/B-4184-2012; Walker, Sarah/HDM-8717-2022; Franzeck, Fabian C/B-5055-2011	Gilks, Charles/0000-0002-8953-3123; Gibb, Diana/0000-0002-9738-5490; Grosskurth, Heiner/0000-0001-9960-7280	UK Medical Research Council; UK Department for International Development; Rockefeller Foundation; GlaxoSmithKline; Gilead Sciences; Boehringer-Ingelheim; Abbott Laboratories; MRC [G0600344, MC_U950080931, MC_U122886352] Funding Source: UKRI; Medical Research Council [G0600344, MC_U950080931, MC_U122886352] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development; Rockefeller Foundation; GlaxoSmithKline(GlaxoSmithKline); Gilead Sciences(Gilead Sciences); Boehringer-Ingelheim(Boehringer Ingelheim); Abbott Laboratories(Abbott Laboratories); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	UK Medical Research Council, the UK Department for International Development, the Rockefeller Foundation, GlaxoSmithKline, Gilead Sciences, Boehringer-Ingelheim, and Abbott Laboratories.	Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Badri M, 2001, AIDS, V15, P1143, DOI 10.1097/00002030-200106150-00009; Baker CAR, 2007, AIDS RES HUM RETROV, V23, P900, DOI 10.1089/aid.2006.0309; BLOLAND PB, 1991, LANCET, V337, P518, DOI 10.1016/0140-6736(91)91299-A; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; CAMPBELL J, 2009, C RETR OPP INF 2009; CARR A, 1992, ANN INTERN MED, V117, P106, DOI 10.7326/0003-4819-117-2-106; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; de Quiros JCLB, 2001, NEW ENGL J MED, V344, P159, DOI 10.1056/NEJM200101183440301; Division of AIDS, 1992, DIV AIDS GRAD SEV AD; Forgacs P, 2009, ANTIMICROB AGENTS CH, V53, P4789, DOI 10.1128/AAC.01658-08; Glencross DK, 2008, CYTOM PART B-CLIN CY, V74B, pS131, DOI 10.1002/cyto.b.20391; Grimwade K, 2005, AIDS, V19, P163, DOI 10.1097/00002030-200501280-00008; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; HESS KR, 1994, STAT MED, V13, P1045, DOI 10.1002/sim.4780131007; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Jones J L, 1999, MMWR CDC Surveill Summ, V48, P1; Koblavi-Deme S, 2003, AIDS, V17, pS17, DOI 10.1097/00002030-200317003-00003; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Ledergerber B, 2001, NEW ENGL J MED, V344, P168, DOI 10.1056/NEJM200101183440302; Lowrance D, 2007, JAIDS-J ACQ IMM DEF, V46, P56; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Mulenga V, 2007, AIDS, V21, P77, DOI 10.1097/QAD.0b013e3280114ed7; Nunn AJ, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a257; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Walker AS, 2008, AIDS, V22, P237, DOI 10.1097/QAD.0b013e3282f2d760; *WHO, 2006, WHO CAS DEF SURV REV; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; World Health Organization, 2003, SCAL ANT THER RES LT; World Health Organization (WHO), 2006, GUID COTR PROPH HIV; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	34	85	88	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 10	2010	375	9722					1278	1286		10.1016/S0140-6736(10)60057-8	http://dx.doi.org/10.1016/S0140-6736(10)60057-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585VN	20347483	Green Published, Green Accepted			2022-12-28	WOS:000276858400030
J	Pickrell, JK; Marioni, JC; Pai, AA; Degner, JF; Engelhardt, BE; Nkadori, E; Veyrieras, JB; Stephens, M; Gilad, Y; Pritchard, JK				Pickrell, Joseph K.; Marioni, John C.; Pai, Athma A.; Degner, Jacob F.; Engelhardt, Barbara E.; Nkadori, Everlyne; Veyrieras, Jean-Baptiste; Stephens, Matthew; Gilad, Yoav; Pritchard, Jonathan K.			Understanding mechanisms underlying human gene expression variation with RNA sequencing	NATURE			English	Article							GENOME; CELLS; SEQ; CONTRIBUTE; DISCOVERY; VARIANTS	Understanding the genetic mechanisms underlying natural variation in gene expression is a central goal of both medical and evolutionary genetics, and studies of expression quantitative trait loci (eQTLs) have become an important tool for achieving this goal(1). Although all eQTL studies so far have assayed messenger RNA levels using expression microarrays, recent advances in RNA sequencing enable the analysis of transcript variation at unprecedented resolution. We sequenced RNA from 69 lymphoblastoid cell lines derived from unrelated Nigerian individuals that have been extensively genotyped by the International HapMap Project(2). By pooling data from all individuals, we generated a map of the transcriptional landscape of these cells, identifying extensive use of unannotated untranslated regions and more than 100 new putative protein-coding exons. Using the genotypes from the HapMap project, we identified more than a thousand genes at which genetic variation influences overall expression levels or splicing. We demonstrate that eQTLs near genes generally act by a mechanism involving allele-specific expression, and that variation that influences the inclusion of an exon is enriched within and near the consensus splice sites. Our results illustrate the power of high-throughput sequencing for the joint analysis of variation in transcription, splicing and allele-specific expression across individuals.	[Pickrell, Joseph K.; Marioni, John C.; Pai, Athma A.; Degner, Jacob F.; Nkadori, Everlyne; Veyrieras, Jean-Baptiste; Stephens, Matthew; Gilad, Yoav; Pritchard, Jonathan K.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Engelhardt, Barbara E.] Univ Chicago, Dept Comp Sci, Chicago, IL 60637 USA; [Nkadori, Everlyne; Pritchard, Jonathan K.] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago; University of Chicago	Pickrell, JK (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	pickrell@uchicago.edu; gilad@uchicago.edu; pritch@uchicago.edu		Edsall, Lee Elizabeth/0000-0002-0326-2829; Engelhardt, Barbara/0000-0002-6139-7334; Marioni, John/0000-0001-9092-0852; Pai, Athma/0000-0002-7995-9948	HHMI; NIH [MH084703-01, GM077959]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084703] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Gaffney, J. Bell, K. Bullaughey, Y. Guan and other members of the Pritchard, M. Przeworski and Stephens laboratory groups for helpful discussions, M. Domanus and P. Zumbo for sequencing support, and J. Zekos for computational assistance. J. F. D. and A. A. P. are supported by an NIH Training Grant to the University of Chicago. This work was supported by the HHMI and by NIH grants MH084703-01 to J. K. Pritchard and GM077959 to Y. G.	Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; Fraser HB, 2009, GENOME RES, V19, P567, DOI 10.1101/gr.083477.108; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Huang RS, 2007, P NATL ACAD SCI USA, V104, P9758, DOI 10.1073/pnas.0703736104; Kang HM, 2008, GENETICS, V180, P1909, DOI 10.1534/genetics.108.094201; Kwan T, 2007, GENOME RES, V17, P1210, DOI 10.1101/gr.6281007; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Verlaan DJ, 2009, GENOME RES, V19, P118, DOI 10.1101/gr.084798.108; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WATSON J, 2008, MOL BIOL GENE, pCH13; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	29	893	915	2	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 1	2010	464	7289					768	772		10.1038/nature08872	http://dx.doi.org/10.1038/nature08872			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20220758	Green Accepted			2022-12-28	WOS:000276205000047
J	Saumitou-Laprade, P; Vernet, P; Vassiliadis, C; Hoareau, Y; de Magny, G; Dommee, B; Lepart, J				Saumitou-Laprade, Pierre; Vernet, Philippe; Vassiliadis, Christine; Hoareau, Yves; de Magny, Guillaume; Dommee, Bertrand; Lepart, Jacques			A Self-Incompatibility System Explains High Male Frequencies in an Androdioecious Plant	SCIENCE			English	Article							PHILLYREA-ANGUSTIFOLIA OLEACEAE; SEX ALLOCATION; EVOLUTION; MAINTENANCE; GYNODIOECY; DIOECY; MODEL; HERMAPHRODITES; FEMALES; SUCCESS	Androdioecy is a sexual system in which males co-occur with hermaphrodites, which have both male and female function. Stable androdioecy is rare in nature, and theory suggests that it requires that males sire more than twice as many offspring as hermaphrodites. In several members of the olive family (Oleaceae), androdioecy occurs with higher frequencies of males than predicted by theory. In Phillyrea angustifolia L., we found that high male frequencies can be maintained in natural populations because hermaphrodites belong exclusively to one of two self-incompatibility groups, and thus, each can fertilize only half of all pollen recipients. In contrast, males can pollinate all hermaphrodites. Thus, in this species, the reproductive disadvantage that males face due to the loss of female function is offset by the fact that all males are fully compatible with all pollen recipients.	[Saumitou-Laprade, Pierre; Vernet, Philippe; Vassiliadis, Christine; Hoareau, Yves; de Magny, Guillaume] Univ Sci & Technol Lille Lille 1, Lab Genet & Evolut Populat Vegetales, CNRS, UMR 8016, F-59655 Villeneuve Dascq, France; [Dommee, Bertrand; Lepart, Jacques] CEFE, CNRS, UMR 5175, F-34293 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Saumitou-Laprade, P (corresponding author), Univ Sci & Technol Lille Lille 1, Lab Genet & Evolut Populat Vegetales, CNRS, UMR 8016, F-59655 Villeneuve Dascq, France.	pierre.saumitou@univ-lille1.fr	Constantin de Magny, Guillaume/L-6706-2017; Saumitou-Laprade, Pierre/A-2499-2009	Hoareau, Yves/0000-0002-2807-2247; Saumitou-Laprade, Pierre/0000-0001-7413-3090				ATLAN A, 1992, J EVOLUTION BIOL, V5, P189, DOI 10.1046/j.1420-9101.1992.5020189.x; BEACH JH, 1980, EVOLUTION, V34, P1138, DOI [10.2307/2408294, 10.1111/j.1558-5646.1980.tb04055.x]; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; CHARLESWORTH D, 1984, BIOL J LINN SOC, V22, P333, DOI 10.1111/j.1095-8312.1984.tb01683.x; CHARLESWORTH D, 1979, AM NAT, V114, P467, DOI 10.1086/283496; CHARLESWORTH D, 1981, HEREDITY, V46, P27, DOI 10.1038/hdy.1981.3; Delph LF, 2005, NEW PHYTOL, V166, P119, DOI 10.1111/j.1469-8137.2005.01339.x; Delph LF, 2009, CURR BIOL, V19, pR249, DOI 10.1016/j.cub.2009.01.048; Dommee B, 1999, NEW PHYTOL, V143, P419, DOI 10.1046/j.1469-8137.1999.00442.x; Hurst LD, 1996, Q REV BIOL, V71, P317, DOI 10.1086/419442; Ishida K, 1998, INT J PLANT SCI, V159, P941, DOI 10.1086/314088; Keller SR, 2006, J EVOLUTION BIOL, V19, P1128, DOI 10.1111/j.1420-9101.2006.01101.x; Kurian V, 1997, HEREDITY, V78, P383, DOI 10.1038/hdy.1997.61; LEPART J, 1992, BOT J LINN SOC, V108, P375, DOI 10.1111/j.1095-8339.1992.tb00252.x; Lewis D, 1942, BIOL REV CAMB PHILOS, V17, P46, DOI 10.1111/j.1469-185X.1942.tb00431.x; Lloyd D.G, 1992, EVOLUTION FUNCTION H, P151; LLOYD DG, 1975, GENETICA, V45, P325, DOI 10.1007/BF01508307; Pannell JR, 2006, EVOLUTION, V60, P660, DOI 10.1554/05-481.1; Pannell JR, 2000, ECOL LETT, V3, P495, DOI 10.1046/j.1461-0248.2000.00173.x; Pannell JR, 2002, ANNU REV ECOL SYST, V33, P397, DOI 10.1146/annurev.ecolsys.33.010802.150419; Pannell JR, 2002, FUNCT ECOL, V16, P862, DOI 10.1046/j.1365-2435.2002.06893.x; Poot P, 1997, AM J BOT, V84, P1256, DOI 10.2307/2446050; Sakai AK, 1997, EVOLUTION, V51, P724, DOI 10.1111/j.1558-5646.1997.tb03656.x; Saumitou-Laprade P, 2000, MOL ECOL, V9, P112, DOI 10.1046/j.1365-294x.2000.00764-4.x; SAUMITOULAPRADE P, 1994, TRENDS ECOL EVOL, V9, P431, DOI 10.1016/0169-5347(94)90126-0; Tantikanjana T, 2009, PLANT CELL, V21, P2642, DOI 10.1105/tpc.109.067801; TAYLOR HERBERT, 1945, BRITTONIA, V5, P337, DOI 10.2307/2804889; Van Etten ML, 2008, INT J PLANT SCI, V169, P271, DOI 10.1086/524109; Vassiliadis C, 2000, INT J PLANT SCI, V161, P393, DOI 10.1086/314263; Vassiliadis C, 2002, EVOLUTION, V56, P1362, DOI 10.1111/j.0014-3820.2002.tb01450.x; Vassiliadis C, 2000, HEREDITY, V85, P413, DOI 10.1046/j.1365-2540.2000.00755.x; Wallander E, 2000, AM J BOT, V87, P1827, DOI 10.2307/2656836; Weeks SC, 2006, INVERTEBR REPROD DEV, V49, P113, DOI 10.1080/07924259.2006.9652200	33	55	56	3	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	2010	327	5973					1648	1650		10.1126/science.1186687	http://dx.doi.org/10.1126/science.1186687			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339074				2022-12-28	WOS:000275970600045
J	Sahin, E; DePinho, RA				Sahin, Erguen; DePinho, Ronald A.			Linking functional decline of telomeres, mitochondria and stem cells during ageing	NATURE			English	Review							AGE-RELATED-CHANGES; DNA-DAMAGE; LIFE-SPAN; CHROMOSOMAL INSTABILITY; REVERSE-TRANSCRIPTASE; TERMINAL TRANSFERASE; TUMOR SUPPRESSION; ATM DEFICIENCY; P53; CANCER	The study of human genetic disorders and mutant mouse models has provided evidence that genome maintenance mechanisms, DNA damage signalling and metabolic regulation cooperate to drive the ageing process. In particular, age-associated telomere damage, diminution of telomere 'capping' function and associated p53 activation have emerged as prime instigators of a functional decline of tissue stem cells and of mitochondrial dysfunction that adversely affect renewal and bioenergetic support in diverse tissues. Constructing a model of how telomeres, stem cells and mitochondria interact with key molecules governing genome integrity, 'stemness' and metabolism provides a framework for how diverse factors contribute to ageing and age-related disorders.	[Sahin, Erguen; DePinho, Ronald A.] Harvard Univ, Sch Med, Belfer Inst Appl Canc Sci, Dept Med Oncol,Dana Farber Canc Inst, Boston, MA 02115 USA; [Sahin, Erguen; DePinho, Ronald A.] Harvard Univ, Sch Med, Belfer Inst Appl Canc Sci, Dept Med & Genet,Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	DePinho, RA (corresponding author), Harvard Univ, Sch Med, Belfer Inst Appl Canc Sci, Dept Med Oncol,Dana Farber Canc Inst, Boston, MA 02115 USA.	ron_depinho@dfci.harvard.edu		DePinho, Ronald/0000-0002-5625-577X	National Institutes of Health [RO1CA84628, U01 CA84313]; US Department of Defense [W81XWH-08-1-0133]; Ellison Medical Foundation; Robert A. and Renee E. Belfer Foundation Institute for Innovative Cancer Science; Deutsche Forschungsgemeinschaft; NATIONAL CANCER INSTITUTE [U01CA084313, R01CA084628] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Ellison Medical Foundation(Lawrence Ellison Foundation); Robert A. and Renee E. Belfer Foundation Institute for Innovative Cancer Science; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L. Chin, N. Sharpless, S. Artandi, F. Muller, V. Walsh, S. Colla, M. Ugolotti, M. Jaskelioff, D. Liu and A.-J. Chen for discussions and critical reading of the manuscript. A. Protopopov and E. Ivanova kindly provided the chromosomal and telomere analysis in Fig. 2. We apologize to the members of the scientific community whose work could not be cited owing to space limitations. Grant support for our work was provided by National Institutes of Health grants RO1CA84628 and U01 CA84313, US Department of Defense grant W81XWH-08-1-0133, and the Ellison Medical Foundation. R. A. D. is an American Cancer Society Research Professor and is supported by the Robert A. and Renee E. Belfer Foundation Institute for Innovative Cancer Science. E. S. was supported by the Deutsche Forschungsgemeinschaft.	Armanios M, 2009, AM J HUM GENET, V85, P823, DOI 10.1016/j.ajhg.2009.10.028; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Arrighi HM, 2010, ALZ DIS ASSOC DIS, V24, P72, DOI 10.1097/WAD.0b013e3181a1a87d; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Atzmon G, 2010, P NATL ACAD SCI USA, V107, P1710, DOI 10.1073/pnas.0906191106; Begus-Nahrmann Y, 2009, NAT GENET, V41, P1138, DOI 10.1038/ng.426; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cerletti M, 2008, COLD SH Q B, V73, P317, DOI 10.1101/sqb.2008.73.054; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; CovielloMcLaughlin GM, 1997, NUCLEIC ACIDS RES, V25, P3051, DOI 10.1093/nar/25.15.3051; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Di Iorio A, 2006, INT J IMMUNOPATH PH, V19, P703, DOI 10.1177/039463200601900401; Donehower LA, 2009, NAT REV CANCER, V9, P830, DOI 10.1038/nrc2731; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Epel ES, 2006, PSYCHONEUROENDOCRINO, V31, P277, DOI 10.1016/j.psyneuen.2005.08.011; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Farazi PA, 2006, CANCER RES, V66, P4766, DOI 10.1158/0008-5472.CAN-05-4608; Ferron S, 2004, DEVELOPMENT, V131, P4059, DOI 10.1242/dev.01215; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008; Flores I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004934; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Gopinath SD, 2008, AGING CELL, V7, P590, DOI 10.1111/j.1474-9726.2008.00399.x; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Khoo CM, 2007, P NATL ACAD SCI USA, V104, P3931, DOI 10.1073/pnas.0700093104; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kirwan M, 2009, BBA-MOL BASIS DIS, V1792, P371, DOI 10.1016/j.bbadis.2009.01.010; Kollman C, 2001, BLOOD, V98, P2043, DOI 10.1182/blood.V98.7.2043; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Leri A, 2003, EMBO J, V22, P131, DOI 10.1093/emboj/cdg013; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Martin GM, 2005, CELL, V120, P523, DOI 10.1016/j.cell.2005.01.031; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Matheu A, 2008, CANCER RES, V68, P6031, DOI 10.1158/0008-5472.CAN-07-6851; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; McClintock B, 1939, P NATL ACAD SCI USA, V25, P405, DOI 10.1073/pnas.25.8.405; Mendrysa SM, 2006, GENE DEV, V20, P16, DOI 10.1101/gad.1378506; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Morales M, 2005, GENE DEV, V19, P3043, DOI 10.1101/gad.1373705; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Njajou OT, 2009, J GERONTOL A-BIOL, V64, P860, DOI 10.1093/gerona/glp061; Oexle K, 1997, HUM MOL GENET, V6, P905, DOI 10.1093/hmg/6.6.905; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Passos JF, 2005, EXP GERONTOL, V40, P466, DOI 10.1016/j.exger.2005.04.006; Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Serrano M, 2007, NAT REV MOL CELL BIO, V8, P715, DOI 10.1038/nrm2242; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Simon NM, 2006, BIOL PSYCHIAT, V60, P432, DOI 10.1016/j.biopsych.2006.02.004; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; SZOSTAK JW, 1982, CELL, V29, P245, DOI 10.1016/0092-8674(82)90109-X; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tomas-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034; Tothova Z, 2007, CELL STEM CELL, V1, P140, DOI 10.1016/j.stem.2007.07.017; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Vianna CR, 2006, CELL METAB, V4, P453, DOI 10.1016/j.cmet.2006.11.003; Vijg J., 2007, AGING GENOME DUAL RO; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	99	491	513	3	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					520	528		10.1038/nature08982	http://dx.doi.org/10.1038/nature08982			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20336134	Green Accepted			2022-12-28	WOS:000275974200035
J	Salazar-Ciudad, I; Jernvall, J				Salazar-Ciudad, Isaac; Jernvall, Jukka			A computational model of teeth and the developmental origins of morphological variation	NATURE			English	Article							EXPRESSION PATTERNS; MAMMALIAN TEETH; EVOLUTION; SIMULATION; MORPHOGENESIS; DYNAMICS; ONTOGENY	The relationship between the genotype and the phenotype, or the genotype-phenotype map, is generally approached with the tools of multivariate quantitative genetics and morphometrics(1-4). Whereas studies of development(5-7) and mathematical models of development(4,8-12) may offer new insights into the genotype-phenotype map, the challenge is to make them useful at the level of microevolution. Here we report a computational model of mammalian tooth development that combines parameters of genetic and cellular interactions to produce a three-dimensional tooth from a simple tooth primordia. We systematically tinkered with each of the model parameters to generate phenotypic variation and used geometric morphometric analyses to identify, or developmentally ordinate, parameters best explaining population-level variation of real teeth. To model the full range of developmentally possible morphologies, we used a population sample of ringed seals (Phoca hispida ladogensis)(13). Seal dentitions show a high degree of variation, typically linked to the lack of exact occlusion(13-16). Our model suggests that despite the complexity of development and teeth, there may be a simple basis for dental variation. Changes in single parameters regulating signalling during cusp development may explain shape variation among individuals, whereas a parameter regulating epithelial growth may explain serial, tooth-to-tooth variation along the jaw. Our study provides a step towards integrating the genotype, development and the phenotype.	[Salazar-Ciudad, Isaac] Univ Autonoma Barcelona, Dept Genet & Microbiol, Fac Biociencies, E-08193 Barcelona, Spain; [Salazar-Ciudad, Isaac; Jernvall, Jukka] Univ Helsinki, Inst Biotechnol, Dev Biol Program, FIN-00014 Helsinki, Finland; [Jernvall, Jukka] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	Autonomous University of Barcelona; University of Helsinki; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Salazar-Ciudad, I (corresponding author), Univ Autonoma Barcelona, Dept Genet & Microbiol, Fac Biociencies, E-08193 Barcelona, Spain.	isaac.salazar@uab.cat; jernvall@fastmail.fm	Salazar-Ciudad, Isaac/R-2238-2018	Salazar Ciudad, Isaac/0000-0003-1607-0962	Ramon y Cajal Program [RYC-2007-00149]; Academy of Finland	Ramon y Cajal Program(Spanish Government); Academy of Finland(Academy of Finland)	We thank I. Corfe, A. R. Evans, J. Fierst, M. Fortelius, B. Julia, S. Sova, J. Hakanen, E. Harjunmaa, N. Navarro, I. Thesleff, P. C. Wright and S. Zohdy for comments, discussions, and support on this work, A. Kangas for help in data collection, and M. Hilden and I. Hanski (Finnish Museum of Natural History) for access to collections. This study was supported by the Ramon y Cajal Program (RYC-2007-00149) and the Academy of Finland.	Aberg T, 1997, DEV DYNAM, V210, P383, DOI 10.1002/(SICI)1097-0177(199712)210:4<383::AID-AJA3>3.0.CO;2-C; [Anonymous], 1861, ORIGIN SPECIES MEANS; Buchanan AV, 2009, BIOESSAYS, V31, P198, DOI 10.1002/bies.200800133; BUTLER PM, 1956, BIOL REV, V31, P30, DOI 10.1111/j.1469-185X.1956.tb01551.x; Cruwys L, 2006, POLAR REC, V42, P83, DOI 10.1017/S0032247405004869; Evans TM, 2006, EVOL DEV, V8, P273, DOI 10.1111/j.1525-142X.2006.00098.x; Forgacs G, 2005, BIOLOGICAL PHYSICS OF THE DEVELOPING EMBRYO, P1, DOI 10.1017/CBO9780511755576; Fraser GJ, 2009, PLOS BIOL, V7, P233, DOI 10.1371/journal.pbio.1000031; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Hammer O, 2005, LETHAIA, V38, P111, DOI 10.1080/00241160510013222; Harris MP, 2005, P NATL ACAD SCI USA, V102, P11734, DOI 10.1073/pnas.0500781102; Honda H, 2008, DEVELOPMENT, V135, P1407, DOI 10.1242/dev.014555; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P2641, DOI 10.1073/pnas.050586297; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P14444, DOI 10.1073/pnas.97.26.14444; Jernvall Jukka, 1995, Acta Zoologica Fennica, V198, P1; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; Kettunen P, 2000, DEV DYNAM, V219, P322, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1062>3.0.CO;2-J; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; LONNBERG E, 1923, FAUNA FLORA, V18, P116; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Miller EH, 2007, J MAMMAL, V88, P1325, DOI 10.1644/06-MAMM-A-243R.1; Nahmad M, 2008, EVOL DEV, V10, P360, DOI 10.1111/j.1525-142X.2008.00244.x; Newman TJ, 2005, MATH BIOSCI ENG, V2, P613, DOI 10.3934/mbe.2005.2.613; Osborn JW, 2008, J THEOR BIOL, V255, P338, DOI 10.1016/j.jtbi.2008.09.008; Polly PD, 2008, EVOL BIOL, V35, P83, DOI 10.1007/s11692-008-9020-0; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Roff DA, 2007, EVOLUTION, V61, P1017, DOI 10.1111/j.1558-5646.2007.00100.x; Rybczynski N, 2009, NATURE, V458, P1021, DOI 10.1038/nature07985; Salazar-Ciudad I, 2000, J THEOR BIOL, V205, P587, DOI 10.1006/jtbi.2000.2092; Salazar-Ciudad I, 2002, P NATL ACAD SCI USA, V99, P8116, DOI 10.1073/pnas.132069499; Salazar-Ciudad I, 2001, EVOL DEV, V3, P84, DOI 10.1046/j.1525-142x.2001.003002084.x; Stewart BE, 1998, MAR MAMMAL SCI, V14, P221, DOI 10.1111/j.1748-7692.1998.tb00712.x; Wagner GP, 2008, NATURE, V452, P470, DOI 10.1038/nature06756; Zeng ZB, 2005, GENETICA, V123, P25, DOI 10.1007/s10709-004-2705-0	39	221	223	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					583	U138		10.1038/nature08838	http://dx.doi.org/10.1038/nature08838			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20220757				2022-12-28	WOS:000275974200046
J	Insel, TR				Insel, Thomas R.			Psychiatrists' Relationships With Pharmaceutical Companies Part of the Problem or Part of the Solution?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONFLICT-OF-INTEREST; CLINICAL-PRACTICE GUIDELINES; INDUSTRY		NIMH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Insel, TR (corresponding author), NIMH, 6001 Execut Blvd,Room 8235, Bethesda, MD 20892 USA.	tinsel@mail.nih.gov						*ATT GEN VT OFF, 2009, PHARM MARK DISCL JUL; Blum JA, 2009, JAMA-J AM MED ASSOC, V302, P2230, DOI 10.1001/jama.2009.1669; Campbell EG, 2007, JAMA-J AM MED ASSOC, V298, P1779, DOI 10.1001/jama.298.15.1779; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; Cosgrove L, 2009, PSYCHOTHER PSYCHOSOM, V78, P228, DOI 10.1159/000214444; Freedman R, 2009, AM J PSYCHIAT, V166, P274, DOI 10.1176/appi.ajp.2009.09010093; *IMS HLTH, TOP LIN IND DAT 2008; *MERCK, DISCL PAYM US SPEAK; Perlis RH, 2005, AM J PSYCHIAT, V162, P1957, DOI 10.1176/appi.ajp.162.10.1957; SANDBURG B, 2009, BIOPHARMA TODAY 1029	10	23	23	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2010	303	12					1192	1193		10.1001/jama.2010.317	http://dx.doi.org/10.1001/jama.2010.317			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	573AC	20332407				2022-12-28	WOS:000275879600026
J	Yu, XR; Huang, YG; Qu, G; Xu, JY; Hui, SY				Yu, Xuerong; Huang, Yuguang; Qu, Ge; Xu, Jiaying; Hui, Shangyi			Safety and current status of blood transfusion in China	LANCET			English	Editorial Material									[Yu, Xuerong; Huang, Yuguang; Qu, Ge; Xu, Jiaying; Hui, Shangyi] Beijing Union Med Coll Hosp, Dept Anaesthesiol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Huang, YG (corresponding author), Beijing Union Med Coll Hosp, Dept Anaesthesiol, 1 Shuaifuyuan, Beijing 100730, Peoples R China.	pumchhyg@yahoo.com.cn	xu, jia/GSD-6347-2022					FENG Z, 2005, CHINA DAILY BEI 1201, P92502; JUAN S, 2007, CHINA DAILY BEI 0901, P92502; MINGYAN W, 2009, EVENING PAPER B 0122, P92502; MINYI C, 2007, NEWS NET CHINES 1204, P92502; QI B, BEIJING BUREAU HLTH, P92502; QI L, 1999, REGULATION BLOOD DON, P92502; The Ministry of Health of the People's Republic of China Joint United Nations Programme on HIV/AIDS and World Health Organization, 2006, 2005 UPD HIV AIDS EP; United States Department of Health and Human Services, 2007 NAT BLOOD COLL; YUGUI L, 2008, BEIJING EVENING 1006, P92502	9	25	28	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 24	2010	375	9724					1420	1421		10.1016/S0140-6736(10)60003-7	http://dx.doi.org/10.1016/S0140-6736(10)60003-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	590FL	20347128				2022-12-28	WOS:000277210000011
J	Rutishauser, U; Ross, IB; Mamelak, AN; Schuman, EM				Rutishauser, Ueli; Ross, Ian B.; Mamelak, Adam N.; Schuman, Erin M.			Human memory strength is predicted by theta-frequency phase-locking of single neurons	NATURE			English	Article							MEDIAL TEMPORAL-LOBE; HUMAN HIPPOCAMPAL; ACTION-POTENTIALS; DENTATE GYRUS; OSCILLATIONS; RHYTHM; RETRIEVAL; ELECTROENCEPHALOGRAM; INTERNEURONS; ACTIVATION	Learning from novel experiences is a major task of the central nervous system. In mammals, the medial temporal lobe is crucial for this rapid form of learning(1). The modification of synapses and neuronal circuits through plasticity is thought to underlie memory formation(2). The induction of synaptic plasticity is favoured by coordinated action-potential timing across populations of neurons(3). Such coordinated activity of neural populations can give rise to oscillations of different frequencies, recorded in local field potentials. Brain oscillations in the theta frequency range (3-8 Hz) are often associated with the favourable induction of synaptic plasticity as well as behavioural memory(4). Here we report the activity of single neurons recorded together with the local field potential in humans engaged in a learning task. We show that successful memory formation in humans is predicted by a tight coordination of spike timing with the local theta oscillation. More stereotyped spiking predicts better memory, as indicated by higher retrieval confidence reported by subjects. These findings provide a link between the known modulation of theta oscillations by many memory-modulating behaviours and circuit mechanisms of plasticity.	[Rutishauser, Ueli; Schuman, Erin M.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Schuman, Erin M.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Ross, Ian B.; Mamelak, Adam N.] Huntington Mem Hosp, Epilepsy & Brain Mapping Unit, Dept Neurosurg, Pasadena, CA 91105 USA; [Mamelak, Adam N.] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; University of Southern California; Huntington Memorial Hospital; Cedars Sinai Medical Center	Schuman, EM (corresponding author), Max Planck Inst Brain Res, Max von Laue Str 3, D-60438 Frankfurt, Germany.	schumane@brain.mpg.de	Schuman, Erin M/D-6204-2011; Mamelak, Adam/H-8347-2014; Rutishauser, Ueli/AAH-8348-2021; Rutishauser, Ueli/E-5721-2011	Mamelak, Adam/0000-0002-4245-6431; Rutishauser, Ueli/0000-0002-9207-7069; 	Gordon and Betty Moore Foundation; William T. Gimbel Discovery Fund; Howard Hughes Medical Institute	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); William T. Gimbel Discovery Fund; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank all patients for their participation; the staff of the Huntington Memorial Hospital epilepsy unit; C. Heller, L. Philpot and W. Sutherling for their support; and F. Mormann, G. Laurent and R. Adolphs for discussion. Funding was provided by the Gordon and Betty Moore Foundation, the William T. Gimbel Discovery Fund and the Howard Hughes Medical Institute.	Adolphs R, 2001, BEHAV NEUROSCI, V115, P983, DOI 10.1037//0735-7044.115.5.983; BERRY SD, 1978, SCIENCE, V200, P1298, DOI 10.1126/science.663612; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown RAM, 2005, J NEUROSCI, V25, P1985, DOI 10.1523/JNEUROSCI.4307-04.2005; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cantero JL, 2003, J NEUROSCI, V23, P10897; DUVERNOY HM, 2005, HUMAN HIPPOCAMPUS, P165; Efron B, 1993, INTRO BOOTSTRAP, P202; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; HUH K, 1990, NEUROLOGY, V40, P1177, DOI 10.1212/WNL.40.8.1177; Jacobs J, 2007, J NEUROSCI, V27, P3839, DOI 10.1523/JNEUROSCI.4636-06.2007; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; Klimesch W, 1996, NEUROREPORT, V7, P1235, DOI 10.1097/00001756-199605170-00002; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Milstein J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004338; Mitra P., 2007, OBSERVED BRAIN DYNAM; Nelson MJ, 2008, J NEUROSCI METH, V169, P141, DOI 10.1016/j.jneumeth.2007.12.010; Orzel-Gryglewska J, 2006, BRAIN RES BULL, V68, P295, DOI 10.1016/j.brainresbull.2005.08.026; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Pare D, 1996, J NEUROSCI, V16, P3334; PAVLIDES C, 1988, BRAIN RES, V439, P383, DOI 10.1016/0006-8993(88)91499-0; Rizzuto DS, 2006, NEUROIMAGE, V31, P1352, DOI 10.1016/j.neuroimage.2006.01.009; Rutishauser U, 2006, NEURON, V49, P805, DOI 10.1016/j.neuron.2006.02.015; Rutishauser U, 2008, P NATL ACAD SCI USA, V105, P329, DOI 10.1073/pnas.0706015105; Rutishauser U, 2006, J NEUROSCI METH, V154, P204, DOI 10.1016/j.jneumeth.2005.12.033; Seager MA, 2002, P NATL ACAD SCI USA, V99, P1616, DOI 10.1073/pnas.032662099; Sederberg PB, 2007, CEREB CORTEX, V17, P1190, DOI 10.1093/cercor/bhl030; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Viskontas IV, 2006, J COGNITIVE NEUROSCI, V18, P1654, DOI 10.1162/jocn.2006.18.10.1654; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646	39	405	410	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					903	U116		10.1038/nature08860	http://dx.doi.org/10.1038/nature08860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20336071				2022-12-28	WOS:000276397300040
J	Vastenhouw, NL; Zhang, Y; Woods, IG; Imam, F; Regev, A; Liu, XS; Rinn, J; Schier, AF				Vastenhouw, Nadine L.; Zhang, Yong; Woods, Ian G.; Imam, Farhad; Regev, Aviv; Liu, X. Shirley; Rinn, John; Schier, Alexander F.			Chromatin signature of embryonic pluripotency is established during genome activation	NATURE			English	Article							RNA-POLYMERASE; ZYGOTIC TRANSITION; GENES; POLYCOMB	After fertilization the embryonic genome is inactive until transcription is initiated during the maternal-zygotic transition(1-3). This transition coincides with the formation of pluripotent cells, which in mammals can be used to generate embryonic stem cells. To study the changes in chromatin structure that accompany pluripotency and genome activation, we mapped the genomic locations of histone H3 molecules bearing lysine trimethylation modifications before and after the maternal-zygotic transition in zebrafish. Histone H3 lysine 27 trimethylation (H3K27me3), which is repressive, and H3K4me3, which is activating, were not detected before the transition. After genome activation, more than 80% of genes were marked by H3K4me3, including many inactive developmental regulatory genes that were also marked by H3K27me3. Sequential chromatin immunoprecipitation demonstrated that the same promoter regions had both trimethylation marks. Such bivalent chromatin domains also exist in embryonic stem cells and are thought to poise genes for activation while keeping them repressed(4-8). Furthermore, we found many inactive genes that were uniquely marked by H3K4me3. Despite this activating modification, these monovalent genes were neither expressed nor stably bound by RNA polymerase II. Inspection of published data sets revealed similar monovalent domains in embryonic stem cells. Moreover, H3K4me3 marks could form in the absence of both sequence-specific transcriptional activators and stable association of RNA polymerase II, as indicated by the analysis of an inducible transgene. These results indicate that bivalent and monovalent domains might poise embryonic genes for activation and that the chromatin profile associated with pluripotency is established during the maternal-zygotic transition.	[Zhang, Yong; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Vastenhouw, Nadine L.; Woods, Ian G.; Imam, Farhad; Schier, Alexander F.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Zhang, Yong] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Regev, Aviv; Rinn, John; Schier, Alexander F.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Regev, Aviv; Rinn, John; Schier, Alexander F.] Harvard Univ, Cambridge, MA 02142 USA; [Rinn, John] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Schier, Alexander F.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Schier, Alexander F.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Tongji University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard University	Liu, XS (corresponding author), Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA.	xsliu@jimmy.harvard.edu; schier@fas.harvard.edu	Zhang, Yong/B-4838-2011	Zhang, Yong/0000-0001-6316-2734; Schier, Alexander Franz/0000-0001-7645-5325; Imam, Farhad/0000-0003-2854-2568; Rinn, John/0000-0002-7231-7539; Liu, Xiaole/0000-0003-4736-7339	NIH [1R01 HG004069, 5R01 GM56211]; EMBO [LT-00090/2007]; HFSP [LT-00090/2007]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056211] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); HFSP(Human Frontier Science Program); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Schier laboratory for help and advice; H. G. Shin, L. Taing and Z. J. Wufor computational analysis and discussions; N. Follmer and B. Lilley for technical advice; and J. Dubrulle, N. Francis, R. Losick, S. Mango, T. van Opijnen and W. Talbot for discussions and critical reading of the manuscript. This work was supported by NIH grants to X. S. L. (1R01 HG004069) and A. F. S. (5R01 GM56211), and by EMBO and HFSP (LT-00090/2007) fellowships to N. L. V.	Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2009, GENOME RES, V19, P1742, DOI 10.1101/gr.090951.109; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Boyer, 2009, CHROMATIN SIGNATURE, DOI [10.3824/stembook.1.45.1, DOI 10.3824/STEMBOOK.1.45.1]; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dreijerink KMA, 2006, CANCER RES, V66, P4929, DOI 10.1158/0008-5472.CAN-05-4461; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sagasti A, 2005, CURR BIOL, V15, P804, DOI 10.1016/j.cub.2005.03.048; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Song JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r178; Stockard J, 2007, JUDGM DECIS MAK, V2, P9; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wardle FC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r71; Yuzyuk T, 2009, DEV CELL, V16, P699, DOI 10.1016/j.devcel.2009.03.008; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	35	275	284	4	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					922	U143		10.1038/nature08866	http://dx.doi.org/10.1038/nature08866			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20336069	Green Submitted, Green Accepted			2022-12-28	WOS:000276397300044
J	Tripathy, P; Nair, N; Barnett, S; Mahapatra, R; Borghi, J; Rath, S; Rath, S; Gope, R; Mahto, D; Sinha, R; Lakshminarayana, R; Patel, V; Pagel, C; Prost, A; Costello, A				Tripathy, Prasanta; Nair, Nirmala; Barnett, Sarah; Mahapatra, Rajendra; Borghi, Josephine; Rath, Shibanand; Rath, Suchitra; Gope, Rajkumar; Mahto, Dipnath; Sinha, Rajesh; Lakshminarayana, Rashmi; Patel, Vikram; Pagel, Christina; Prost, Audrey; Costello, Anthony			Effect of a participatory intervention with women's groups on birth outcomes and maternal depression in Jharkhand and Orissa, India: a cluster-randomised controlled trial	LANCET			English	Article							COMMUNITY-HEALTH WORKERS; NEPAL; CARE	Background Community mobilisation through participatory women's groups might improve birth outcomes in poor rural communities. We therefore assessed this approach in a largely tribal and rural population in three districts in eastern India. Methods From 36 clusters in Jharkhand and Orissa, with an estimated population of 228186, we assigned 18 clusters to intervention or control using stratified randomisation. Women were eligible to participate if they were aged 15-49 years, residing in the project area, and had given birth during the study. In intervention clusters, a facilitator convened 13 groups every month to support participatory action and learning for women, and facilitated the development and implementation of strategies to address maternal and newborn health problems. The primary outcomes were reductions in neonatal mortality rate (NMR) and maternal depression scores. Analysis was by intention to treat. This trial is registered as an International Standard Randomised Controlled Trial, number ISRCTN21817853. Findings After baseline surveillance of 4692 births, we monitored outcomes for 19030 births during 3 years (2005-08). NMRs per 1000 were 55.6, 37.1, and 36.3 during the first, second, and third years, respectively, in intervention clusters, and 53.4, 59-6, and 64 3, respectively, in control clusters. NMR was 32% lower in intervention clusters adjusted for clustering, stratification, and baseline differences (odds ratio 0.68, 95% CI 0.59-0.78) during the 3 years, and 45% lower in years 2 and 3 (0.55, 0.46-0.66). Although we did not note a significant effect on maternal depression overall, reduction in moderate depression was 57% in year 3 (0.43, 0.23-0.80). Interpretation This intervention could be used with or as a potential alternative to health-worker-led interventions, and presents new opportunities for policy makers to improve maternal and newborn health outcomes in poor populations.	[Tripathy, Prasanta; Nair, Nirmala; Mahapatra, Rajendra; Rath, Shibanand; Rath, Suchitra; Gope, Rajkumar; Mahto, Dipnath; Sinha, Rajesh] Ekjut, Chakradharpur, Jharkhand, India; [Barnett, Sarah; Prost, Audrey; Costello, Anthony] UCL, Inst Child Hlth, Ctr Int Hlth & Dev, London, England; [Lakshminarayana, Rashmi] Univ London London Sch Econ & Polit Sci, Ctr Econ Performance, London WC2A 2AE, England; [Borghi, Josephine; Patel, Vikram] London Sch Hyg & Trop Med, London WC1, England; [Pagel, Christina] UCL, Clin Operat Res Unit, London, England	University of London; University College London; University of London; London School Economics & Political Science; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Tripathy, P (corresponding author), Ekjut, Ward 17,Plot 556B, Po Chakradharpur 833102, Jharkhand, India.	prasanta.ekjut@gmail.com		Pagel, Christina/0000-0002-2857-1628; Borghi, Josephine/0000-0002-0482-5451; Patel, Vikram/0000-0003-1066-8584	Health Foundation; UK Department for International Development; Wellcome Trust; Big Lottery Fund	Health Foundation; UK Department for International Development; Wellcome Trust(Wellcome TrustEuropean Commission); Big Lottery Fund	Health Foundation, UK Department for International Development, Wellcome Trust, and the Big Lottery Fund (UK).	3Freire P., 2005, ED CRITICAL CONSCIOU; [Anonymous], 1999, DEV FREEDOM; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Barnett S, 2008, BMC PREGNANCY CHILDB, V8, P1, DOI DOI 10.1186/1471-2393-8-6; Bell AC, 2009, CLIN PSYCHOL REV, V29, P348, DOI 10.1016/j.cpr.2009.02.003; Borghi J, 2005, LANCET, V366, P1882, DOI 10.1016/S0140-6736(05)67758-6; *CENS IND, CENS DAT 2001; Engle PL, 2009, AM J CLIN NUTR, V89, p963S, DOI 10.3945/ajcn.2008.26692G; *GOV ACC OFF, 2006, SARB OXL ACT CONS KE, P1; *GOV IND, 2007, POV EST 2004 2005; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Hayes RJ, 2009, INTERD STAT, P3; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Milgrom J, 2008, J AFFECT DISORDERS, V108, P147, DOI 10.1016/j.jad.2007.10.014; Morrison Joanna, 2005, BMC Pregnancy Childbirth, V5, P6, DOI 10.1186/1471-2393-5-6; *NAT FAM HLTH SURV, 2003, NAT FIN REP; *NAT PLANN COMM, 2001, SCH CAST SCH TRIB PO; *NAT RUR HLTH MISS, 2008, REP COMM REV MISS JH; National Rural Health Mission, ACCR SOC HLTH ACT; Patel V, 2008, PSYCHOL MED, V38, P221, DOI 10.1017/S0033291707002334; Patel V, 2008, LANCET, V372, P868, DOI 10.1016/S0140-6736(08)61374-4; Subramanian SV, 2006, PLOS MED, V3, P1794, DOI 10.1371/journal.pmed.0030421; *UNICEF, 2008, COUNTD 2015 TRACK PR; UNICEF, 2008, STAT AS PAC CHILDR; Whitney D, 2002, POWER APPRECIATIVE I; *WHO, 2006, INT CLASS DIS; *WORLD BANK, JHARKH ADDR CHALL IN; World Health Organization, 2006, NEON PER MORT COUNTR; World Health Organization, WORLD MENT HLTH SURV	32	324	326	0	36	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 3	2010	375	9721					1182	1192		10.1016/S0140-6736(09)62042-0	http://dx.doi.org/10.1016/S0140-6736(09)62042-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	585VL	20207411	Bronze			2022-12-28	WOS:000276858200030
J	Magen, D; Berger, L; Coady, MJ; Ilivitzki, A; Militianu, D; Tieder, M; Selig, S; Lapointe, JY; Zelikovic, I; Skorecki, K				Magen, Daniella; Berger, Liron; Coady, Michael J.; Ilivitzki, Anat; Militianu, Daniela; Tieder, Martin; Selig, Sara; Lapointe, Jean Yves; Zelikovic, Israel; Skorecki, Karl			BRIEF REPORT A Loss-of-Function Mutation in NaPi-IIa and Renal Fanconi's Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SODIUM-PHOSPHATE COTRANSPORTER; HEREDITARY HYPOPHOSPHATEMIC RICKETS; MICE; HYPERCALCIURIA; NEPHROLITHIASIS; HOMEOSTASIS; METABOLISM; ALBUMIN; SLC34A3; NPT2A	We describe two siblings from a consanguineous family with autosomal recessive Fanconi's syndrome and hypophosphatemic rickets. Genetic analysis revealed a homozygous in-frame duplication of 21 bp in SLC34A1, which encodes the renal sodium-inorganic phosphate cotransporter NaPi-IIa, as the causative mutation. Functional studies in Xenopus laevis oocytes and in opossum kidney cells indicated complete loss of function of the mutant NaPi-IIa, resulting from failure of the transporter to reach the plasma membrane. These findings show that disruption of the human NaPi-IIa profoundly impairs overall renal phosphate reabsorption and proximal-tubule function and provide evidence of the critical role of NaPi-IIa in human renal phosphate handling.	[Magen, Daniella; Zelikovic, Israel] Pediat Nephrol Unit, Haifa, Israel; [Magen, Daniella; Zelikovic, Israel; Skorecki, Karl] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Magen, Daniella; Zelikovic, Israel; Skorecki, Karl] Technion Israel Inst Technol, Res Inst, Haifa, Israel; [Zelikovic, Israel] Technion Israel Inst Technol, Lab Dev Nephrol, Haifa, Israel; [Tieder, Martin] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Tieder, Martin] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dana Childrens Hosp, Sect Pediat Nephrol,Dept Pediat, IL-69978 Tel Aviv, Israel; [Coady, Michael J.; Lapointe, Jean Yves] Univ Montreal, Dept Phys, Grp Etud Prot Membranaires, Montreal, PQ H3C 3J7, Canada	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Universite de Montreal	Magen, D (corresponding author), Pediat Nephrol Unit, Rambam Hlth Care Campus, Haifa, Israel.	danmag@tx.technion.ac.il			Israel Science Foundation [1735/08]; Rappaport Family Institute for Research in the Medical Sciences; Veronique Elek Fund of the Canadian Technion Society; Rosalinde and Arthur Gilbert Foundation of the American Technion Society; Canadian Institutes of Health Research [MOP-10580]; Eshaghian Estate Fund of the American Technion Society	Israel Science Foundation(Israel Science Foundation); Rappaport Family Institute for Research in the Medical Sciences; Veronique Elek Fund of the Canadian Technion Society; Rosalinde and Arthur Gilbert Foundation of the American Technion Society; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Eshaghian Estate Fund of the American Technion Society	Supported by grants from the Morasha program of the Israel Science Foundation (1735/08), the Rappaport Family Institute for Research in the Medical Sciences, the Veronique Elek Fund of the Canadian Technion Society, the Rosalinde and Arthur Gilbert Foundation of the American Technion Society, the Canadian Institutes of Health Research (MOP-10580), and the Eshaghian Estate Fund of the American Technion Society.	Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Biber J, 2009, PFLUG ARCH EUR J PHY, V458, P39, DOI 10.1007/s00424-008-0580-8; Chau H, 2003, J BONE MINER RES, V18, P644, DOI 10.1359/jbmr.2003.18.4.644; Hryciw DH, 2006, INT J BIOCHEM CELL B, V38, P1036, DOI 10.1016/j.biocel.2005.09.009; Iwaki T, 2008, J AM SOC NEPHROL, V19, P1753, DOI 10.1681/ASN.2007121360; Khan SR, 2008, AM J PHYSIOL-RENAL, V294, pF1109, DOI 10.1152/ajprenal.00620.2007; Kremke B, 2009, EXP CLIN ENDOCR DIAB, V117, P49, DOI 10.1055/s-2008-1076716; Lapointe JY, 2006, KIDNEY INT, V69, P2261, DOI 10.1038/sj.ki.5000437; Lorenz-Depiereux B, 2006, AM J HUM GENET, V78, P193, DOI 10.1086/499410; Marshansky V, 2002, CURR OPIN NEPHROL HY, V11, P527, DOI 10.1097/00041552-200209000-00009; Murer H, 2004, PFLUG ARCH EUR J PHY, V447, P763, DOI 10.1007/s00424-003-1072-5; Norden AGW, 2001, KIDNEY INT, V60, P1885, DOI 10.1046/j.1523-1755.2001.00016.x; Prie D, 2002, NEW ENGL J MED, V347, P983, DOI 10.1056/NEJMoa020028; Russo LM, 2002, AM J KIDNEY DIS, V39, P899, DOI 10.1053/ajkd.2002.32764; Segawa H, 2009, AM J PHYSIOL-RENAL, V297, pF671, DOI 10.1152/ajprenal.00156.2009; Segawa H, 2009, J AM SOC NEPHROL, V20, P104, DOI 10.1681/ASN.2008020177; TIEDER M, 1988, NEW ENGL J MED, V319, P845, DOI 10.1056/NEJM198809293191307; Virkki LV, 2003, J BONE MINER RES, V18, P2135, DOI 10.1359/jbmr.2003.18.12.2135; Wagner CA, 2008, J AM SOC NEPHROL, V19, P1625, DOI 10.1681/ASN.2008060611	20	127	130	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	2010	362	12					1102	1109		10.1056/NEJMoa0905647	http://dx.doi.org/10.1056/NEJMoa0905647			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573FU	20335586	Bronze			2022-12-28	WOS:000275894600007
J	Hemmelgarn, BR; Zhang, JG; Manns, BJ; James, MT; Quinn, RR; Ravani, P; Klarenbach, SW; Culleton, BF; Krause, R; Thorlacius, L; Jain, AK; Tonelli, M				Hemmelgarn, Brenda R.; Zhang, Jianguo; Manns, Braden J.; James, Matthew T.; Quinn, Robert R.; Ravani, Pietro; Klarenbach, Scott W.; Culleton, Bruce F.; Krause, Richard; Thorlacius, Laurel; Jain, Arsh K.; Tonelli, Marcello		Alberta Kidney Dis Network	Nephrology Visits and Health Care Resource Use Before and After Reporting Estimated Glomerular Filtration Rate	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC KIDNEY-DISEASE; CONVERTING ENZYME-INHIBITORS; SERUM CREATININE; RENAL-DISEASE; CARDIOVASCULAR OUTCOMES; ESTIMATED GFR; IMPACT; GUIDELINES; TIME; INTERVENTION	Context Laboratory reporting of estimated glomerular filtration rate (GFR) has been widely implemented, with limited evaluation. Objective To examine trends in nephrologist visits and health care resource use before and after estimated GFR reporting. Design, Setting, and Patients Community-based cohort study (N=1 135 968) with time-series analysis. Participants were identified from a laboratory registry in Alberta, Canada, and followed up from May 15, 2003, to March 14, 2007 (with estimated GFR reporting implemented October 15, 2004). Main Outcome Measure Nephrologist visits and patient management. Results Following estimated GFR reporting, the rate of first outpatient visits to a nephrologist for patients with chronic kidney disease (CKD; estimated GFR <60 mL/min/1.73 m(2)) increased by 17.5 (95% confidence interval [CI], 16.5-18.6) visits per 10 000 CKD patients per month, corresponding to a relative increase from baseline of 68.4% (95% CI, 65.7%-71.2%). There was no association between estimated GFR reporting and rate of first nephrologist visit among patients without CKD. Among patients with an estimated GFR of less than 30 mL/min/1.73 m2, the rate of first nephrologist visits increased by 134.4 (95% CI, 60.0-208.7) visits per 10 000 patients per month. This increase was predominantly seen in women, patients aged 46 to 65 years as well as those aged 86 years or older, and those with hypertension, diabetes, and comorbidity. Reporting of estimated GFR was not associated with increased rates of internal medicine or general practitioner visits or increased use of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers among patients with CKD and proteinuria or the subgroup limited to patients with diabetes. Conclusions Reporting of estimated GFR was associated with an increase in first nephrologist visits, particularly among patients with more severe kidney dysfunction, women, middle-aged and very elderly patients, and those with comorbidities. Any effect on outcomes remains to be shown. JAMA. 2010; 303(12): 1151-1158	[Hemmelgarn, Brenda R.; Zhang, Jianguo; Manns, Braden J.; James, Matthew T.; Quinn, Robert R.; Ravani, Pietro; Culleton, Bruce F.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Hemmelgarn, Brenda R.; Manns, Braden J.; James, Matthew T.; Ravani, Pietro] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Krause, Richard] Calgary Lab Serv, Calgary, AB, Canada; [Klarenbach, Scott W.; Tonelli, Marcello] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Thorlacius, Laurel] Diagnost Serv Manitoba, Winnipeg, MB, Canada; [Jain, Arsh K.] Univ Western Ontario, Dept Med, London, ON, Canada	University of Calgary; University of Calgary; University of Calgary; University of Alberta; Western University (University of Western Ontario)	Hemmelgarn, BR (corresponding author), Foothills Med Ctr, Div Nephrol, 1403 29th St NW, Calgary, AB T2N 2T9, Canada.	Brenda.Hemmelgarn@albertahealthservices.ca	Ravani, Pietro/J-3050-2015; Hug, Balthasar L./G-1568-2010; Tonelli, Marcello/B-3028-2009; Hemmelgarn, Brenda R./I-6894-2012; Manns, Braden J/I-8942-2012; Quinn, Robert R/E-7017-2011; Jain, Arsh/G-3308-2011	Ravani, Pietro/0000-0001-6973-8570; Tonelli, Marcello/0000-0002-0846-3187; MacRae, Jennifer/0000-0002-4711-1440	Alberta Heritage Foundation for Medical Research (AHFMR); Kidney Foundation of Canada; Canadian Institutes of Health Research; KRESCENT	Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Kidney Foundation of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); KRESCENT	Funding/Support: This study was funded by the Alberta Heritage Foundation for Medical Research (AHFMR) Interdisciplinary Team Grants Program and by the Kidney Foundation of Canada. Drs Hemmelgarn, Manns, and Tonelli were supported by awards from the Canadian Institutes of Health Research. Drs Hemmelgarn, Klarenbach, and Tonelli were supported by awards from the AHFMR. Dr James was supported by a KRESCENT and AHFMR Fellowship.	Aghaie-Jaladerany H, 2007, SCOT MED J, V52, P28, DOI 10.1258/rsmsmj.52.4.28; Akbari A, 2004, ARCH INTERN MED, V164, P1788, DOI 10.1001/archinte.164.16.1788; *ALB HLTH WELLN, 2008, PREM ASS PROGR PREM; Anavekar N, 2005, MED J AUSTRALIA, V183, P138, DOI 10.5694/j.1326-5377.2005.tb06958.x; Bauer C, 2008, J AM SOC NEPHROL, V19, P844, DOI 10.1681/ASN.2008010110; Bertoni AG, 2009, ARCH INTERN MED, V169, P678, DOI 10.1001/archinternmed.2009.44; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Clase CM, 2004, BMJ-BRIT MED J, V329, P912, DOI 10.1136/bmj.329.7471.912; Cook T.C., 1979, QUASIEXPERIMENTATION; *CTR CLIN EP BIOST, 2001, PHARM BEH CULT THEM; Davis D, 2009, CHEST, V135, p42S, DOI 10.1378/chest.08-2517; den Hartog JR, 2009, CLIN J AM SOC NEPHRO, V4, P419, DOI 10.2215/CJN.04080808; Drey N, 2003, AM J KIDNEY DIS, V42, P677, DOI 10.1016/S0272-6386(03)00916-8; Duncan L, 2001, NEPHROL DIAL TRANSPL, V16, P1042, DOI 10.1093/ndt/16.5.1042; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Glassock RJ, 2008, CLIN J AM SOC NEPHRO, V3, P1563, DOI 10.2215/CJN.00960208; Glassock RJ, 2009, KIDNEY INT, V75, P1001, DOI 10.1038/ki.2009.38; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hemmelgarn BR, 2007, J AM SOC NEPHROL, V18, P993, DOI 10.1681/ASN.2006080860; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Huisman RM, 2004, NEPHROL DIAL TRANSPL, V19, P2175, DOI 10.1093/ndt/gfh409; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; Jain AK, 2009, KIDNEY INT, V76, P318, DOI 10.1038/ki.2009.158; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Manns BJ, 2001, CLIN INVEST MED, V24, P164; Miller WG, 2008, AM J KIDNEY DIS, V52, P645, DOI 10.1053/j.ajkd.2008.07.032; *NAT KIDN DIS ED P, 2004, LAB PROF; Noble E, 2008, NEPHROL DIAL TRANSPL, V23, P3845, DOI 10.1093/ndt/gfn385; O'Hare AM, 2009, ANN INTERN MED, V150, P717, DOI 10.7326/0003-4819-150-10-200905190-00010; Ornstein S, 2004, ANN INTERN MED, V141, P523, DOI 10.7326/0003-4819-141-7-200410050-00008; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2009, HYPERTENSION, V54, P1423, DOI 10.1161/HYPERTENSIONAHA.109.139279; Rainey PM, 2006, CLIN CHEM, V52, P2184, DOI 10.1373/clinchem.2006.069732; Statistics Canada, ETHN PORTR CAN HIGHL; Swedko P, 2003, ARCH INTERN MED, V163, P356, DOI 10.1001/archinte.163.3.356; Tseng CL, 2008, ARCH INTERN MED, V168, P55, DOI 10.1001/archinternmed.2007.9; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Wyatt C, 2007, AM J KIDNEY DIS, V49, P634, DOI 10.1053/j.ajkd.2007.02.258	47	117	119	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2010	303	12					1151	1158		10.1001/jama.2010.303	http://dx.doi.org/10.1001/jama.2010.303			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573AC	20332400	Bronze			2022-12-28	WOS:000275879600019
J	Shelton, JD				Shelton, James D.			A tale of two-component generalised HIV epidemics	LANCET			English	Editorial Material							CONCURRENT PARTNERSHIPS; INFECTION; RISK		US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA	United States Agency for International Development (USAID)	Shelton, JD (corresponding author), US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA.	jshelton@usaid.gov						Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Bunnell R, 2008, LANCET, V371, P2148, DOI 10.1016/S0140-6736(08)60929-0; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Gray RH, 2008, LANCET, V371, P2064, DOI 10.1016/S0140-6736(08)60896-X; Hallett TB, 2009, EPIDEMICS-NETH, V1, P108, DOI 10.1016/j.epidem.2009.03.001; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Mah TL, 2010, AIDS BEHAV, V14, P25, DOI 10.1007/s10461-009-9617-z; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; *MIN HLTH KEN NAT, 2008, KEN AIDS IND SURV 20; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; PEPFAR, 2009, US PRES EM PLAN AIDS; Pinkerton SD, 2008, AIDS BEHAV, V12, P677, DOI 10.1007/s10461-007-9329-1; Sagar M, 2009, J INFECT DIS, V199, P580, DOI 10.1086/596557; Shelton JD, 2008, LANCET, V372, P273, DOI 10.1016/S0140-6736(08)61091-0; Tanser F, 2009, INT J EPIDEMIOL, V38, P1008, DOI 10.1093/ije/dyp148	16	25	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 20	2010	375	9719					964	966		10.1016/S0140-6736(10)60416-3	http://dx.doi.org/10.1016/S0140-6736(10)60416-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	575YU	20304227				2022-12-28	WOS:000276110700008
J	Farrant, M; Cull-Candy, SG				Farrant, Mark; Cull-Candy, Stuart G.			AMPA Receptors-Another Twist?	SCIENCE			English	Editorial Material							GLUTAMATE RECEPTORS; TARPS		[Farrant, Mark; Cull-Candy, Stuart G.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of London; University College London	Farrant, M (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	m.farrant@ucl.ac.uk; s.cull-candy@ucl.ac.uk		Cull-Candy, Stuart G/0000-0002-0831-8326; Farrant, Mark/0000-0002-9918-0376	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Cho CH, 2007, NEURON, V55, P890, DOI 10.1016/j.neuron.2007.08.024; Heinemann SH, 2007, CELL MOL LIFE SCI, V64, P1329, DOI 10.1007/s00018-007-6565-5; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; Kato AS, 2007, J NEUROSCI, V27, P4969, DOI 10.1523/JNEUROSCI.5561-06.2007; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Soto D, 2009, NAT NEUROSCI, V12, P277, DOI 10.1038/nn.2266; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; von Engelhardt J, 2010, SCIENCE, V327, P1518, DOI 10.1126/science.1184178; Walker CS, 2009, CURR BIOL, V19, P900, DOI 10.1016/j.cub.2009.05.017; Wang R, 2008, NEURON, V59, P997, DOI 10.1016/j.neuron.2008.07.023; Weston MC, 2006, J NEUROSCI, V26, P7650, DOI 10.1523/JNEUROSCI.1519-06.2006; Wu MN, 2010, NAT NEUROSCI, V13, P69, DOI 10.1038/nn.2454	14	11	11	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	2010	327	5972					1463	+		10.1126/science.1187920	http://dx.doi.org/10.1126/science.1187920			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20299582				2022-12-28	WOS:000275715200033
J	Iliffe, S; Pealing, L				Iliffe, Steve; Pealing, Louise			Subjective memory problems	BRITISH MEDICAL JOURNAL			English	Review							MILD COGNITIVE IMPAIRMENT; QUALITY-OF-LIFE; GENERAL-PRACTICE; FOLLOW-UP; DEMENTIA; COMPLAINTS; OLDER; FORGETFULNESS; POPULATION; DEPRESSION		[Iliffe, Steve] UCL, London WC1E 6BT, England; [Iliffe, Steve] Evidence Based Intervent Dementia Programme, London, England; [Pealing, Louise] London Sch Hyg & Trop Med, London, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Iliffe, S (corresponding author), UCL, Mortimer St, London WC1E 6BT, England.	s.iliffe@ucl.ac.uk	Iliffe, Steve/L-8379-2019	Iliffe, Stephen/0000-0003-2806-3997	Department of Health's National Institute for Health [RP-PG-0606-1005]; NIHR	Department of Health's National Institute for Health(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR))	SI is chief investigator of the EVIDEM programme (Evidence-based Interventions in Dementia) and has received financial support from the Department of Health's National Institute for Health Research Programme Grants for Applied Research funding scheme (RP-PG-0606-1005). The views and opinions expressed in this article are those of the authors and not necessarily those of the NHS, the National Institute for Health Research (NIHR), or the Department of Health. SI is also associate director of the coordinating centre for the Dementias and Neurodegenerative Diseases research network (DeNDRoN), funded by the NIHR. He has received speaker's fees from pharmaceutical companies with an interest in dementia but has no other conflicting financial academic or personal interests relevant to this paper.	Aalten P, 2005, AGING MENT HEALTH, V9, P414, DOI 10.1080/13607860500143075; Abdulrab K, 2008, EUR PSYCHIAT, V23, P321, DOI 10.1016/j.eurpsy.2008.02.004; American Psychiatric Association, 1994, DIAGN STAT MAN; Andre M, 2002, FAM PRACT, V19, P617, DOI 10.1093/fampra/19.6.617; [Anonymous], 2006, DEM SUPP PEOPL DEM T; Brodaty H, 2002, J AM GERIATR SOC, V50, P530, DOI 10.1046/j.1532-5415.2002.50122.x; Commissaris CJAM, 1998, PATIENT EDUC COUNS, V34, P25, DOI 10.1016/S0738-3991(98)00040-8; *DEP HLTH, 2009, LIV WELL DEM; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Iliffe S., 2009, AGING HLTH, V5, P51, DOI [10. 2217/1745509X. 5. 1. 51, DOI 10.2217/1745509X.5.1.51]; Jonker C, 2000, INT J GERIATR PSYCH, V15, P983, DOI 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5; KATON WJ, 2010, J GEN INTERN MED; Larrabee G J, 1994, Int Psychogeriatr, V6, P95, DOI 10.1017/S1041610294001663; Leonard BE, 2006, NEUROTOX RES, V10, P149; Mitchell AJ, 2008, INT J GERIATR PSYCH, V23, P1191, DOI 10.1002/gps.2053; Mol M, 2007, INT J GERIATR PSYCH, V22, P393, DOI 10.1002/gps.1686; Mol MEM, 2006, INT J GERIATR PSYCH, V21, P432, DOI 10.1002/gps.1487; Mol MEM, 2009, AGING MENT HEALTH, V13, P699, DOI 10.1080/13607860902845541; Palmer K, 2003, BRIT MED J, V326, P245, DOI 10.1136/bmj.326.7383.245; Panza F, 2008, INT J GERIATR PSYCH, V23, P726, DOI 10.1002/gps.1967; Panza F, 2010, AM J GERIAT PSYCHIAT, V18, P98, DOI 10.1097/JGP.0b013e3181b0fa13; Rami L, 2010, ARCH GERONTOL GERIAT, V50, P171, DOI 10.1016/j.archger.2009.03.005; Reid LM, 2006, DEMENT GERIATR COGN, V22, P471, DOI 10.1159/000096295; Schofield PW, 1997, ARCH NEUROL-CHICAGO, V54, P756, DOI 10.1001/archneur.1997.00550180064014; Wang L, 2004, J AM GERIATR SOC, V52, P2045, DOI 10.1111/j.1532-5415.2004.52568.x	25	32	32	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 19	2010	340								c1425	10.1136/bmj.c1425	http://dx.doi.org/10.1136/bmj.c1425			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	573RK	20304935	Green Accepted			2022-12-28	WOS:000275932100001
J	Goldfine, AB; Fonseca, V; Jablonski, KA; Pyle, L; Staten, MA; Shoelson, SE				Goldfine, Allison B.; Fonseca, Vivian; Jablonski, Kathleen A.; Pyle, Laura; Staten, Myrlene A.; Shoelson, Steven E.		TINSAL-T2D Targeting Inflammation	The Effects of Salsalate on Glycemic Control in Patients With Type 2 Diabetes A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							NF-KAPPA-B; GLOMERULAR-FILTRATION-RATE; INDUCED INSULIN-RESISTANCE; SODIUM-SALICYLATE; IKK-BETA; NONACETYLATED SALICYLATE; CYSTATIN-C; URIC-ACID; ASPIRIN; INFLAMMATION	Background: Salsalate, a nonacetylated prodrug of salicylate, has been shown to decrease blood glucose concentration in small studies. Objective: To compare the efficacy and safety of salsalate at different doses in patients with type 2 diabetes. Design: Parallel randomized trial with computer-generated randomization and centralized allocation. Patients and investigators, including those assessing outcomes and performing analyses, were masked to group assignment. (ClinicalTrials.gov registration number: NCT00392678) Setting: 3 private practices and 14 universities in the United States. Patients: Persons aged 18 to 75 years with fasting plasma glucose concentrations of 12.5 mmol/L or less (<= 225 mg/dL) and hemoglobin A(1c) (HbA(1c)) levels of 7.0% to 9.5% treated by diet, exercise, and oral medication at stable doses for at least 8 weeks. Intervention: After a 4-week, single-masked run-in period, patients were randomly assigned to receive placebo or salsalate in dosages of 3.0, 3.5, or 4.0 g/d for 14 weeks (27 patients each) in addition to their current therapy. Measurements: Change in HbA(1c) was the primary outcome. Adverse effects and changes in measures of coronary risk and renal function were secondary outcomes. Results: Higher proportions of patients in the 3 salsalate treatment groups experienced decreases in HbA(1c) levels of 0.5% or more from baseline (P = 0.009). Mean HbA(1c) changes were -0.36% (P = 0.02) at 3.0 g/d, -0.34% (P = 0.02) at 3.5 g/d, and -0.49% (P = 0.001) at 4.0 g/d compared with placebo. Other markers of glycemic control also improved in the 3 salsalate groups, as did circulating triglyceride and adiponectin concentrations. Mild hypoglycemia was more common with salsalate; documented events occurred only in patients taking sulfonylureas. Urine albumin concentrations increased in all salsalate groups compared with placebo. The drug was otherwise well tolerated. Limitation: The number of patients studied and the trial duration were insufficient to warrant recommending the use of salsalate for type 2 diabetes at this time. Conclusion: Salsalate lowers HbA(1c) levels and improves other markers of glycemic control in patients with type 2 diabetes and may therefore provide a new avenue for treatment. Renal and cardiac safety of the drug require further evaluation.	[Shoelson, Steven E.] Joslin Diabet Ctr, Boston, MA 02215 USA; Tulane Univ, New Orleans, LA 70118 USA; George Washington Univ, Rockville, MD USA; NIDDKD, Washington, DC USA	Harvard University; Joslin Diabetes Center, Inc.; Tulane University; George Washington University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Shoelson, SE (corresponding author), Joslin Diabet Ctr, 1 Joslin Pl, Boston, MA 02215 USA.	steven.shoelson@joslin.harvard.edu	Pyle, Laura/I-8733-2019	Pyle, Laura/0000-0001-5577-8221; Goldfine, Allison/0000-0002-0345-1048	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; National Institutes of Health [U01 DK74556, P50 HL83813]; National Institutes of Health General Clinical Research Center; Clinical and Translational Science; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008, M01RR002635, M01RR001032] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL083813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK074556] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Clinical and Translational Science; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.; By National Institutes of Health grants U01 DK74556 and P50 HL83813, National Institutes of Health General Clinical Research Center and Clinical and Translational Science Award grants at multiple sites, and the Tullis-Tulane (Dr. Fonseca) and Helen and Morton Adler (Dr. Shoelson) Chairs. Caraco Pharmaceuticals (Detroit, Michigan) supplied drug and placebo, Lifescan (Miltipas, California; a division of Johnson & Johnson) supplied home glucose-monitoring kits, and Mercodia (Uppsala, Sweden) supplied insulin assay kits.	APRIL P, 1990, SEMIN ARTHRITIS RHEU, V19, P20; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Coll E, 2000, AM J KIDNEY DIS, V36, P29, DOI 10.1053/ajkd.2000.8237; Ebstein W, 1876, BERLINER KLIN WOCHEN, V13, P337; EDMAR D, 1971, ACTA RADIOL DIAGN, V11, P57, DOI 10.1177/028418517101100107; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Fernandez-Real JM, 2008, J CLIN ENDOCR METAB, V93, P2523, DOI 10.1210/jc.2007-1212; Fleischman A, 2008, DIABETES CARE, V31, P289, DOI 10.2337/dc07-1338; FRANTZ B, 1995, SCIENCE, V270, P2017, DOI 10.1126/science.270.5244.2017; GILGORE SG, 1960, DIABETES, V9, P392, DOI 10.2337/diab.9.5.392; Goldfine AB, 2008, CTS-CLIN TRANSL SCI, V1, P36, DOI 10.1111/j.1752-8062.2008.00026.x; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; HOLM S, 1979, SCAND J STAT, V6, P65; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; JURIVICH DA, 1992, SCIENCE, V255, P1243, DOI 10.1126/science.1546322; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Koska J, 2009, DIABETOLOGIA, V52, P385, DOI 10.1007/s00125-008-1239-x; LANZA F, 1989, J RHEUMATOL, V16, P1570; LIMA MAS, 1985, ARCH INTERN MED, V145, P1139, DOI 10.1001/archinte.1985.00360060207035; LOLL PJ, 1995, NAT STRUCT BIOL, V2, P637, DOI 10.1038/nsb0895-637; MacIsaac RJ, 2006, DIABETOLOGIA, V49, P1686, DOI 10.1007/s00125-006-0275-7; MORRIS HG, 1985, THER DRUG MONIT, V7, P435, DOI 10.1097/00007691-198512000-00012; Pierce GL, 2009, CIRCULATION, V119, P1284, DOI 10.1161/CIRCULATIONAHA.108.804294; Pierce JW, 1996, J IMMUNOL, V156, P3961; REID J, 1957, BRIT MED J, V2, P1071, DOI 10.1136/bmj.2.5053.1071; Rosolowsky ET, 2008, CLIN J AM SOC NEPHRO, V3, P706, DOI 10.2215/CJN.04271007; ROTH S, 1990, SEMIN ARTHRITIS RHEU, V19, P11; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Stevens LA, 2007, J AM SOC NEPHROL, V18, P2749, DOI 10.1681/ASN.2007020199; SWEENEY JD, 1991, THROMB RES, V61, P23, DOI 10.1016/0049-3848(91)90165-S; Wagner JA, 2009, CLIN PHARMACOL THER, V86, P619, DOI 10.1038/clpt.2009.88; Williamson RT, 1901, BRIT MED J, V1901, P760, DOI 10.1136/bmj.1.2100.760; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	37	283	286	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	2010	152	6					346	+		10.7326/0003-4819-152-6-201003160-00004	http://dx.doi.org/10.7326/0003-4819-152-6-201003160-00004			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573IF	20231565	Green Accepted			2022-12-28	WOS:000275905200002
J	Carel, H; Johnson, S; Gamble, L				Carel, Havi; Johnson, Simon; Gamble, Liz			A Patient's Journey Living with lymphangioleiomyomatosis	BRITISH MEDICAL JOURNAL			English	Editorial Material							TUBEROUS SCLEROSIS COMPLEX; SIROLIMUS		[Carel, Havi] Univ W England, Fac Humanities & Social Sci, Bristol BS16 1QY, Avon, England; [Johnson, Simon] Univ Nottingham, Queens Med Ctr, Div Therapeut & Mol Med, Nottingham NG7 2RD, England; [Gamble, Liz] Bristol Royal Infirm & Gen Hosp, Dept Resp Med, Bristol, Avon, England	University of West England; University of Nottingham; Bristol Royal Infirmary	Carel, H (corresponding author), Univ W England, Fac Humanities & Social Sci, Bristol BS16 1QY, Avon, England.	havi.Carel@uwe.ac.uk; simon.johnson@nottingham.ac.uk; liz.gamble@UHBristol.nhs.uk		Johnson, Simon/0000-0002-9837-2763; Carel, Havi/0000-0002-1260-2362				Avila NA, 2000, RADIOLOGY, V216, P147, DOI 10.1148/radiology.216.1.r00jl42147; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Davies DM, 2008, NEW ENGL J MED, V358, P200, DOI 10.1056/NEJMc072500; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Henske EP, 2003, GENE CHROMOSOME CANC, V38, P376, DOI 10.1002/gcc.10252; Johnson SR, 2010, EUR RESPIR J, V35, P14, DOI 10.1183/09031936.00076209; Johnson SR, 2004, THORAX, V59, P800, DOI 10.1136/thx.2004.023283; Johnson SR, 2006, EUR RESPIR J, V27, P1056, DOI 10.1183/09031936.06.00113303	8	3	4	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 12	2010	340								c848	10.1136/bmj.c848	http://dx.doi.org/10.1136/bmj.c848			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570FF	20228149				2022-12-28	WOS:000275657000011
J	Schnorrer, F; Schonbauer, C; Langer, CCH; Dietzl, G; Novatchkova, M; Schernhuber, K; Fellner, M; Azaryan, A; Radolf, M; Stark, A; Keleman, K; Dickson, BJ				Schnorrer, Frank; Schoenbauer, Cornelia; Langer, Christoph C. H.; Dietzl, Georg; Novatchkova, Maria; Schernhuber, Katharina; Fellner, Michaela; Azaryan, Anna; Radolf, Martin; Stark, Alexander; Keleman, Krystyna; Dickson, Barry J.			Systematic genetic analysis of muscle morphogenesis and function in Drosophila	NATURE			English	Article							MELANOGASTER; ENCODES; PROTEIN; CELLS; VERTEBRATES; EXPRESSION; MUTANTS	Systematic genetic approaches have provided deep insight into the molecular and cellular mechanisms that operate in simple unicellular organisms. For multicellular organisms, however, the pleiotropy of gene function has largely restricted such approaches to the study of early embryogenesis. With the availability of genome-wide transgenic RNA interference (RNAi) libraries in Drosophila(1,2), it is now possible to perform a systematic genetic dissection of any cell or tissue type at any stage of the lifespan. Here we apply these methods to define the genetic basis for formation and function of the Drosophila muscle. We identify a role inmuscle for 2,785 genes, many of which we assign to specific functions in the organization of muscles, myofibrils or sarcomeres. Many of these genes are phylogenetically conserved, including genes implicated in mammalian sarcomere organization and human muscle diseases.	[Schnorrer, Frank; Schoenbauer, Cornelia; Langer, Christoph C. H.] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Schnorrer, Frank; Dietzl, Georg; Novatchkova, Maria; Schernhuber, Katharina; Fellner, Michaela; Azaryan, Anna; Radolf, Martin; Stark, Alexander; Keleman, Krystyna; Dickson, Barry J.] Res Inst Mol Pathol, A-1030 Vienna, Austria	Max Planck Society; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Schnorrer, F (corresponding author), Max Planck Inst Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	schnorrer@biochem.mpg.de; dickson@imp.ac.at	Dickson, Barry/AAE-7632-2019; Schnorrer, Frank/AIE-3578-2022; Stark, Alexander/D-1473-2012	Dickson, Barry/0000-0003-0715-892X; Schnorrer, Frank/0000-0002-9518-7263; Stark, Alexander/0000-0003-2611-0841; Langer, Christoph C. H./0000-0001-8751-1564	Boehringer Ingelheim GmbH; Max-Planck Society; Human Frontier Science Program; European Union; Austrian Ministry for Science and Research	Boehringer Ingelheim GmbH(Boehringer Ingelheim); Max-Planck Society(Max Planck SocietyFoundation CELLEX); Human Frontier Science Program(Human Frontier Science Program); European Union(European Commission); Austrian Ministry for Science and Research	We thank the Vienna Drosophila RNAi Center for transgenic RNAi lines, and H. Bellen, B. Bullard, J. Saide and T. Volk for their gifts of various antibodies. This work was supported by Boehringer Ingelheim GmbH, the Max-Planck Society and a postdoctoral fellowship to F. S. from the Human Frontier Science Program. Generation of a second set of RNAi lines was supported by a grant from the European Union 7th Framework Programme. A. S. and M. N. were supported by the Austrian Ministry for Science and Research (GEN-AU Bioinformatics Integration Network).	Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; AYMESOUTHGATE A, 1991, P NATL ACAD SCI USA, V88, P7973, DOI 10.1073/pnas.88.18.7973; BATE M, 1993, DEV DROSOPHILA METAN, V2, P1013; Besse F, 2007, J CELL BIOL, V177, P843, DOI 10.1083/jcb.200701111; Beuchle D, 2007, MECH DEVELOP, V124, P390, DOI 10.1016/j.mod.2007.01.006; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Butler MJ, 2003, DEVELOPMENT, V130, P659, DOI 10.1242/dev.00293; CAMPBELL HD, 1993, P NATL ACAD SCI USA, V90, P11386, DOI 10.1073/pnas.90.23.11386; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Fong KSK, 1999, GENOMICS, V58, P146, DOI 10.1006/geno.1999.5817; Hartenstein V, 2006, MOL B INT U, P8, DOI 10.1007/0-387-32963-3_2; HOMYK T, 1977, GENETICS, V87, P95; Lamb RS, 1998, MOL BIOL CELL, V9, P3505, DOI 10.1091/mbc.9.12.3505; Matsumoto A, 2007, GENE DEV, V21, P1687, DOI 10.1101/gad.1552207; Nongthomba U, 2007, GENETICS, V177, P295, DOI 10.1534/genetics.106.056812; North KN, 1997, J MED GENET, V34, P705, DOI 10.1136/jmg.34.9.705; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Quinones-Coello AT, 2007, GENETICS, V175, P1089, DOI 10.1534/genetics.106.065995; Reddy KL, 2000, DEV BIOL, V224, P401, DOI 10.1006/dbio.2000.9797; Reedy MC, 2000, J CELL BIOL, V151, P1483, DOI 10.1083/jcb.151.7.1483; Ren N, 2007, GENETICS, V176, P2223, DOI 10.1534/genetics.107.072959; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Schnorrer F, 2004, DEV CELL, V7, P9, DOI 10.1016/j.devcel.2004.06.010; Taylor MV, 2006, MOL B INT U, P169, DOI 10.1007/0-387-32963-3_14; Vigoreaux JO, 2006, MOL B INT U, P143, DOI 10.1007/0-387-32963-3_12; Vigoreaux JO, 2001, BIOESSAYS, V23, P1047, DOI 10.1002/bies.1150; Zaffran S, 1997, DEVELOPMENT, V124, P2087	27	182	184	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 11	2010	464	7286					287	291		10.1038/nature08799	http://dx.doi.org/10.1038/nature08799			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20220848				2022-12-28	WOS:000275366100049
J	Macmull, S; Skinner, JA; Bentley, G; Carrington, RWJ; Briggs, TWR				Macmull, Simon; Skinner, J. A.; Bentley, G.; Carrington, R. W. J.; Briggs, T. W. R.			Treating articular cartilage injuries of the knee in young people	BMJ-BRITISH MEDICAL JOURNAL			English	Review							AUTOLOGOUS CHONDROCYTE IMPLANTATION; FULL-THICKNESS DEFECTS; OSTEOCHONDRAL DEFECTS; CHONDRAL DEFECTS; REPAIR; TRANSPLANTATION; MOSAICPLASTY; TRIAL; JOINT		[Skinner, J. A.; Bentley, G.; Carrington, R. W. J.; Briggs, T. W. R.] Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust		simonmacmull@hotmail.com		Skinner, John/0000-0002-1901-9057				ABELOW S, OP TECH ORTHOP, V16, P257; Anders S, 2007, EUR FED NAT ASS ORTH; ASIK M, ARTHROSCOPY, V21, P1214; Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P640, DOI 10.1302/0301-620X.87B5.15905; Bentley G, 2003, J BONE JOINT SURG BR, V85B, P223, DOI 10.1302/0301-620X.85B2.13543; BENTLEY G, 1970, J BONE JOINT SURG AM, VA 52, P221, DOI 10.2106/00004623-197052020-00002; Briggs TWR, 2003, J BONE JOINT SURG BR, V85B, P1077, DOI 10.1302/0301-620X.85B7.13672; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Brown I., 2014, J GLOBAL INF TECHNOL, V6, P37, DOI [10.1080/1097198X.2003.10856358., DOI 10.1080/1097198X.2003.10856358]; Buckwalter JA, 2002, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000026073.30435.dc; Chow JCY, 2004, ARTHROSCOPY, V20, P681, DOI 10.1016/j.arthro.2004.06.005; CLAR C, 2005, HEALTH TECHNOL ASSES, V9, P47; Curl WW, 1997, ARTHROSCOPY, V13, P456, DOI 10.1016/S0749-8063(97)90124-9; Gikas PD, 2009, J BONE JOINT SURG BR, V91B, P997, DOI 10.1302/0301-620X.91B8.21824; Guettler JH, 2004, AM J SPORT MED, V32, P1451, DOI 10.1177/0363546504263234; Hangody L, 2003, J BONE JOINT SURG AM, V85A, P25, DOI 10.2106/00004623-200300002-00004; Heir S, 2010, AM J SPORT MED, V38, P231, DOI 10.1177/0363546509352157; Hubbard MJS, 1996, J BONE JOINT SURG BR, V78B, P217, DOI 10.1302/0301-620X.78B2.0780217; Hunziker EB, 2001, OSTEOARTHR CARTILAGE, V9, P22, DOI 10.1053/joca.2000.0346; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801; Jaiswal PK, 2009, J BONE JOINT SURG BR, V91B, P1575, DOI 10.1302/0301-620X.91B12.22879; Knutsen G, 2007, J BONE JOINT SURG AM, V89A, P2105, DOI 10.2106/JBJS.G.00003; Kreuz PC, 2006, OSTEOARTHR CARTILAGE, V14, P1119, DOI 10.1016/j.joca.2006.05.003; Krishnan SP, 2006, J BONE JOINT SURG BR, V88B, P203, DOI 10.1302/0301-620X.88B2.17009; Krishnan SP, 2006, J BONE JOINT SURG BR, V88B, P61, DOI 10.1302/0301-620X.88B1.16796; Lu YL, 2006, J ORTHOP RES, V24, P1261, DOI 10.1002/jor.20135; MANKIN HJ, 1982, J BONE JOINT SURG AM, V64, P460, DOI 10.2106/00004623-198264030-00022; Minas T, 1998, Am J Orthop (Belle Mead NJ), V27, P739; Minas T, 2009, AM J SPORT MED, V37, P902, DOI 10.1177/0363546508330137; Mithofer K, 2005, AM J SPORT MED, V33, P1147, DOI 10.1177/0363546504274146; MORSCHER E, 1971, RECONS SURG, V12, P2; *NAT I HLTH CLIN E, 2005, AUT CHONDR IMPL ACI; NOYES FR, 1980, J BONE JOINT SURG AM, V62, P687, DOI 10.2106/00004623-198062050-00001; OCONNOR WJ, 2003, ORTHOP CLIN AM, V31, P399; ODRISCOLL SW, 1986, J BONE JOINT SURG AM, V68A, P1017, DOI 10.2106/00004623-198668070-00008; Oeppen RS, 2004, AM J ROENTGENOL, V182, P111, DOI 10.2214/ajr.182.1.1820111; Saris DBF, 2008, AM J SPORT MED, V36, P235, DOI 10.1177/0363546507311095; Smith GD, 2005, J BONE JOINT SURG BR, V87B, P445, DOI 10.1302/0301-620X.87B4; Steadman J.R., 1997, OPER TECH ORTHOP, V7, P300, DOI [10.1016/S1048-6666(97)80033-X, DOI 10.1016/S1048-6666(97)80033-X]; Wakitani S, 2007, J TISSUE ENG REGEN M, V1, P74, DOI 10.1002/term.8	40	10	10	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2010	340								c998	10.1136/bmj.c998	http://dx.doi.org/10.1136/bmj.c998			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	565FL	20207690				2022-12-28	WOS:000275274600020
J	Garber, AM				Garber, Alan M.			Modernizing Device Regulation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Garber, Alan M.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Garber, Alan M.] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; [Garber, Alan M.] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University	Garber, AM (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA.		Garber, Alan M/F-1476-2010					*CTR DEV RAD HLTH, 2010, CDRH FY 2010 STRAT P; Dhruva SS, 2010, JAMA-J AM MED ASSOC, V303, P422, DOI 10.1001/jama.2010.59; Dhruva SS, 2009, JAMA-J AM MED ASSOC, V302, P2679, DOI 10.1001/jama.2009.1899; *FOOD DRUG ADM, 2010, OV DEV REG; MUNDY A, 2009, WALL ST J       0210, pA4	5	40	40	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2010	362	13					1161	1163		10.1056/NEJMp1000447	http://dx.doi.org/10.1056/NEJMp1000447			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	577QQ	20335575	Green Published, Green Submitted			2022-12-28	WOS:000276239500001
J	Gotzsche, PC; Berg, S				Gotzsche, Peter C.; Berg, Soren			A Patient's Journey Sleep apnoea: from person to patient, and back again	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADULTS		[Berg, Soren] ScanSleep, DK-1364 Copenhagen, Denmark			pcg@cochrane.dk						Blennerhassett M., 2008, NOTHING PERSONAL DIS; Elshaug AG, 2008, BMJ-BRIT MED J, V336, P44, DOI 10.1136/bmj.39381.509213.AE; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P887, DOI 10.1164/ajrccm/147.4.887; Sundaram S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001004.pub2; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2010	340								c360	10.1136/bmj.c360	http://dx.doi.org/10.1136/bmj.c360			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579VJ	20354019				2022-12-28	WOS:000276404100024
J	Stringhini, S; Sabia, S; Shipley, M; Brunner, E; Nabi, H; Kivimaki, M; Singh-Manoux, A				Stringhini, Silvia; Sabia, Severine; Shipley, Martin; Brunner, Eric; Nabi, Hermann; Kivimaki, Mika; Singh-Manoux, Archana			Association of Socioeconomic Position With Health Behaviors and Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; MIDDLE-AGED MEN; TIME PHYSICAL-ACTIVITY; WHITEHALL-II; FOLLOW-UP; EDUCATIONAL INEQUALITIES; SMOKING-CESSATION; EASTERN FINLAND; UNITED-STATES; RISK-FACTORS	Context Previous studies may have underestimated the contribution of health behaviors to social inequalities in mortality because health behaviors were assessed only at the baseline of the study. Objective To examine the role of health behaviors in the association between socioeconomic position and mortality and compare whether their contribution differs when assessed at only 1 point in time with that assessed longitudinally through the follow-up period. Design, Setting, and Participants Established in 1985, the British Whitehall II longitudinal cohort study includes 10 308 civil servants, aged 35 to 55 years, living in London, England. Analyses are based on 9590 men and women followed up for mortality until April 30, 2009. Socioeconomic position was derived from civil service employment grade (high, intermediate, and low) at baseline. Smoking, alcohol consumption, diet, and physical activity were assessed 4 times during the follow-up period. Main Outcome Measures All-cause and cause-specific mortality. Results A total of 654 participants died during the follow-up period. In the analyses adjusted for sex and year of birth, those with the lowest socioeconomic position had 1.60 times higher risk of death from all causes than those with the highest socioeconomic position (a rate difference of 1.94/1000 person-years). This association was attenuated by 42% (95% confidence interval [CI], 21%-94%) when health behaviors assessed at baseline were entered into the model and by 72% (95% CI, 42%-154%) when they were entered as time-dependent covariates. The corresponding attenuations were 29% (95% CI, 11%-54%) and 45% (95% CI, 24%-79%) for cardiovascular mortality and 61% (95% CI, 16%-425%) and 94% (95% CI, 35%-595%) for noncancer and noncardiovascular mortality. The difference between the baseline only and repeated assessments of health behaviors was mostly due to an increased explanatory power of diet (from 7% to 17% for all-cause mortality, respectively), physical activity (from 5% to 21% for all-cause mortality), and alcohol consumption (from 3% to 12% for all-cause mortality). The role of smoking, the strongest mediator in these analyses, did not change when using baseline or repeat assessments (from 32% to 35% for all-cause mortality). Conclusion In a civil service population in London, England, there was an association between socioeconomic position and mortality that was substantially accounted for by adjustment for health behaviors, particularly when the behaviors were assessed repeatedly. JAMA. 2010; 303(12): 1159-1166	[Stringhini, Silvia] Hop Paul Brousse, Ctr Res Epidemiol & Populat Hlth, INSERM, U1018, F-94807 Villejuif, France; [Shipley, Martin; Brunner, Eric; Kivimaki, Mika; Singh-Manoux, Archana] UCL, Dept Epidemiol & Publ Hlth, London, England; [Singh-Manoux, Archana] Hop Ste Perine, AP HP, Ctr Gerontol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Sainte-Perine - APHP	Stringhini, S (corresponding author), Hop Paul Brousse, Ctr Res Epidemiol & Populat Hlth, INSERM, U1018, Bat 15-16,16 Ave Paul Vaillant Couturier, F-94807 Villejuif, France.	silvia.stringhini@inserm.fr	Stringhini, Silvia/B-4899-2013; Kivimaki, Mika/B-3607-2012; Brunner, Eric/H-2114-2011; Sabia, Séverine/G-2966-2017; Singh-Manoux, Archana/F-6804-2013	Kivimaki, Mika/0000-0002-4699-5627; Brunner, Eric/0000-0002-0595-4474; Sabia, Séverine/0000-0003-3109-9720; Singh-Manoux, Archana/0000-0002-1244-5037; Nabi, Hermann/0000-0002-7832-0413	British Heart Foundation; European Science Foundation; British Medical Research Council; British Health and Safety Executive; British Department of Health; US National Heart, Lung, and Blood Institute [R01HL036310]; US National Institute on Aging [R01AG013196, R01AG034454]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454, R01AG013196] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); European Science Foundation(European Science Foundation (ESF)European Commission); British Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Health and Safety Executive; British Department of Health; US National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding/Support: Mr Shipley is supported by the British Heart Foundation. Dr Singh-Manoux is supported by a European Young Investigator Award from the European Science Foundation. The Whitehall II Study has been supported by grants from the British Medical Research Council, the British Heart Foundation, the British Health and Safety Executive, the British Department of Health; grant R01HL036310 from the US National Heart, Lung, and Blood Institute; and grants R01AG013196 and R01AG034454 from the US National Institute on Aging.	Andersen LB, 2004, AM J EPIDEMIOL, V160, P189, DOI 10.1093/aje/kwh195; Bartley M., 2004, HLTH INEQUALITY INTR; Berkman LF, 1983, HLTH WAYS LIVING ALA; Black D., 1982, INEQUALITIES HLTH BL; Breslow N E, 1987, IARC Sci Publ, P1; Britton A, 2004, BMJ-BRIT MED J, V329, P318, DOI 10.1136/bmj.38156.690150.AE; Britton A, 2004, AM J EPIDEMIOL, V160, P240, DOI 10.1093/aje/kwh206; Byberg L, 2009, BRIT J SPORT MED, V43, P482, DOI 10.1136/bmj.b688; Chan RHM, 2008, AM J CARDIOL, V102, P1583, DOI 10.1016/j.amjcard.2008.08.022; Demissie S, 2003, STAT MED, V22, P545, DOI 10.1002/sim.1340; Godtfredsen NS, 2008, EUR RESPIR J, V32, P844, DOI 10.1183/09031936.00160007; Gronbaek M, 2004, EPIDEMIOLOGY, V15, P222, DOI 10.1097/01.ede.0000112219.01955.56; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Hemstrom O, 2005, SOC SCI MED, V61, P637, DOI 10.1016/j.socscimed.2004.12.028; Kaplan GA, 1996, BRIT MED J, V312, P999; Kenfield SA, 2008, JAMA-J AM MED ASSOC, V299, P2037, DOI 10.1001/jama.299.17.2037; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Kivimaki M, 2008, LANCET, V372, P1648, DOI 10.1016/S0140-6736(08)61688-8; KRIEGER N, 1993, AM J PREV MED, V9, P82, DOI 10.1016/S0749-3797(18)30666-4; Krieger N, 2008, SOC SCI MED, V67, P1970, DOI 10.1016/j.socscimed.2008.09.039; Laaksonen M, 2008, EUR J PUBLIC HEALTH, V18, P38, DOI 10.1093/eurpub/ckm051; Lakka TA, 1996, INT J EPIDEMIOL, V25, P86, DOI 10.1093/ije/25.1.86; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Lynch JW, 1997, SOC SCI MED, V44, P809, DOI 10.1016/S0277-9536(96)00191-8; MACINTYRE S, 1993, J SOC POLICY, V22, P213, DOI 10.1017/S0047279400019310; MacIntyre S, 1997, SOC SCI MED, V44, P723, DOI 10.1016/S0277-9536(96)00183-9; Macintyre S, 2000, BRIT J SPORT MED, V34, P6, DOI 10.1136/bjsm.34.1.6; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; Marmot M, 2006, SOCIAL DETERMINANTS; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Martikainen P, 2003, SOC SCI MED, V56, P1397, DOI 10.1016/S0277-9536(02)00137-5; Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; *NAT HLTH SOC CAR, 2008, STAT OB PHYS ACT DIE; *NAT HLTH SOC CAR, 2008, STAT SMOK; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; PEKKANEN J, 1995, BRIT MED J, V311, P589, DOI 10.1136/bmj.311.7005.589; Purslow LR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-112; *SAS I INC, SAS ONLINEDOC JACKKN; Schrijvers CTM, 1999, AM J PUBLIC HEALTH, V89, P535, DOI 10.2105/AJPH.89.4.535; Singh GK, 2002, INT J EPIDEMIOL, V31, P600, DOI 10.1093/ije/31.3.600; Sorensen G, 2007, AM J PUBLIC HEALTH, V97, P1216, DOI 10.2105/AJPH.2006.088120; Strand BH, 2004, J EPIDEMIOL COMMUN H, V58, P705, DOI 10.1136/jech.2003.014563; Townsend P, 1992, INEQUALITIES HLTH BL; van Oort FVA, 2005, J EPIDEMIOL COMMUN H, V59, P214, DOI 10.1136/jech.2003.016493; WINKLEBY MA, 1994, AM J PUBLIC HEALTH, V84, P767, DOI 10.2105/AJPH.84.5.767; Woodward M, 2003, PREV MED, V36, P561, DOI 10.1016/S0091-7435(03)00010-0	48	658	673	1	99	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2010	303	12					1159	1166		10.1001/jama.2010.297	http://dx.doi.org/10.1001/jama.2010.297			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	573AC	20332401	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000275879600020
J	Medzhitov, R				Medzhitov, Ruslan			Inflammation 2010: New Adventures of an Old Flame	CELL			English	Editorial Material							DISEASE	Inflammation is an essential immune response that enables survival during infection or injury and maintains tissue homeostasis under a variety of noxious conditions. Inflammation comes at the cost of a transient decline in tissue function, which can in turn contribute to the pathogenesis of diseases of altered homeostasis.	[Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	ruslan.medzhitov@yale.edu						Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Besedovsky HO, 2000, Z RHEUMATOL, V59, P26, DOI 10.1007/s003930070014; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Majno G, 2004, CELLS TISSUES DIS, VSecond; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Morse D., 1976, MED HIST, V20, P461; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Pecchi E, 2009, PHYSIOL BEHAV, V97, P279, DOI 10.1016/j.physbeh.2009.02.040; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Tauber AI, 2003, NAT REV MOL CELL BIO, V4, P897, DOI 10.1038/nrm1244; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321	15	940	981	11	99	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 19	2010	140	6					771	776		10.1016/j.cell.2010.03.006	http://dx.doi.org/10.1016/j.cell.2010.03.006			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	571IX	20303867	Bronze			2022-12-28	WOS:000275746600001
J	Walther, C; Scalari, G; Amanti, MI; Beck, M; Faist, J				Walther, Christoph; Scalari, Giacomo; Amanti, Maria Ines; Beck, Mattias; Faist, Jerome			Microcavity Laser Oscillating in a Circuit-Based Resonator	SCIENCE			English	Article							QUANTUM-CASCADE LASERS; MODE; TERAHERTZ; METAMATERIALS; EMISSION; PHOTON; LIGHT	Lasers based on microcavities are extremely attractive for their compactness, low power dissipation, and potential for ultrafast modulation speed. We describe an ultrasmall laser based on a subwavelength electronic inductor-capacitor (LC) resonant circuit that allows for extreme confinement of the electric field. This electrically injected laser operates at a frequency of 1.5 terahertz, and the mode volume is strongly subwavelength. The design concept of the LC resonator can be extended from the terahertz range to higher frequencies and also applied to detectors and modulators.	[Walther, Christoph; Scalari, Giacomo; Amanti, Maria Ines; Beck, Mattias; Faist, Jerome] ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Walther, C (corresponding author), ETH, Inst Quantum Elect, Wolfgang Pauli Str 16, CH-8093 Zurich, Switzerland.	walther@phys.ethz.ch; jerome.faist@phys.ethz.ch	Faist, Jerome/A-7339-2013; Scalari, Giacomo/Q-1048-2017; Beck, Mattias/A-7959-2013	Faist, Jerome/0000-0003-4429-7988; Scalari, Giacomo/0000-0003-4028-803X; Beck, Mattias/0000-0002-0260-5797; Amanti, Maria Ines/0000-0001-5687-475X	Swiss National Science Foundation; National Center of Competence in Research "Quantum Photonics"	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research "Quantum Photonics"(Swiss National Science Foundation (SNSF))	We thank the Swiss National Science Foundation and the National Center of Competence in Research "Quantum Photonics" for support and L. Nevou for key contributions to the reflectivity measurement. This work was partly carried out in the Center for Micro- and Nanotechnology (FIRST) at ETH Zurich. J.F. would like to acknowledge fruitful discussions with E. Yablonovitch and A. Imamoglu.	Chassagneux Y, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2710754; Coccioli R, 1998, IEE P-OPTOELECTRON, V145, P391, DOI 10.1049/ip-opt:19982468; Engheta N, 2007, SCIENCE, V317, P1698, DOI 10.1126/science.1133268; FAIST J, 1994, SCIENCE, V264, P553, DOI 10.1126/science.264.5158.553; Gao JR, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1949724; Gerard JM, 1998, PHYS REV LETT, V81, P1110, DOI 10.1103/PhysRevLett.81.1110; Hill MT, 2007, NAT PHOTONICS, V1, P589, DOI 10.1038/nphoton.2007.171; Kohler R, 2002, NATURE, V417, P156, DOI 10.1038/417156a; Koyama F, 2006, J LIGHTWAVE TECHNOL, V24, P4502, DOI 10.1109/JLT.2006.886064; Kuhn S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.017402; Linden S, 2004, SCIENCE, V306, P1351, DOI 10.1126/science.1105371; Noginov MA, 2009, NATURE, V460, P1110, DOI 10.1038/nature08318; Nozaki K, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2206087; Ogawa SP, 2004, SCIENCE, V305, P227, DOI 10.1126/science.1097968; ORDAL MA, 1987, APPL OPTICS, V26, P744, DOI 10.1364/AO.26.000744; Oulton RF, 2009, NATURE, V461, P629, DOI 10.1038/nature08364; Painter O, 1999, SCIENCE, V284, P1819, DOI 10.1126/science.284.5421.1819; Park HG, 2004, SCIENCE, V305, P1444, DOI 10.1126/science.1100968; PURCELL EM, 1946, PHYS REV, V69, P681; Scalari G, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.237403; Scalari G, 2009, LASER PHOTONICS REV, V3, P45, DOI 10.1002/lpor.200810030; Scheuer J, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1947375; Sirtori C, 1998, IEEE J QUANTUM ELECT, V34, P1722, DOI 10.1109/3.709589; SLATER JC, 1946, REV MOD PHYS, V18, P441, DOI 10.1103/RevModPhys.18.441; Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Walther C, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2793177; Wegener M, 2008, OPT EXPRESS, V16, P19785, DOI 10.1364/OE.16.019785; WEISBUCH C, 1992, PHYS REV LETT, V69, P3314, DOI 10.1103/PhysRevLett.69.3314; WHEELER HA, 1947, P IRE, V35, P1479, DOI 10.1109/JRPROC.1947.226199; Williams BS, 2005, OPT EXPRESS, V13, P3331, DOI 10.1364/OPEX.13.003331; Yen TJ, 2004, SCIENCE, V303, P1494, DOI 10.1126/science.1094025	32	116	120	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	2010	327	5972					1495	1497		10.1126/science.1183167	http://dx.doi.org/10.1126/science.1183167			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20299591				2022-12-28	WOS:000275715200043
J	Davendralingam, N; Davagnanam, I; Djamshidian, A; Lees, A				Davendralingam, N.; Davagnanam, I.; Djamshidian, A.; Lees, A.			Picture Quiz Progressive dysphagia, dysarthria, dystonia, and tremor	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WILSONS-DISEASE; DIAGNOSIS		[Davagnanam, I.] Natl Hosp Neurol & Neurosurg, Lysholm Dept Neuroradiol, London WC1N 3BG, England; [Davendralingam, N.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Djamshidian, A.; Lees, A.] Natl Hosp Neurol & Neurosurg, Dept Neurol, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Imperial College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Davagnanam, I (corresponding author), Natl Hosp Neurol & Neurosurg, Lysholm Dept Neuroradiol, Queen Sq, London WC1N 3BG, England.	indran.davagnanam@uclh.nhs.uk	Lees, Andrew J/A-6605-2009	Lees, Andrew J/0000-0002-2476-4385; Djamshidian, Atbin/0000-0001-7174-6000				Brewer GJ, 2000, P SOC EXP BIOL MED, V223, P39, DOI 10.1046/j.1525-1373.2000.22305.x; Kitzberger R, 2005, METAB BRAIN DIS, V20, P295, DOI 10.1007/s11011-005-7910-8; da Costa MDL, 2009, NEURORADIOLOGY, V51, P627, DOI 10.1007/s00234-009-0536-5; Merle U, 2007, GUT, V56, P115, DOI 10.1136/gut.2005.087262; Roberts EA, 2008, HEPATOLOGY, V47, P2089, DOI 10.1002/hep.22261; Sinha S, 2006, NEURORADIOLOGY, V48, P613, DOI 10.1007/s00234-006-0101-4	6	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2010	340								c1213	10.1136/bmj.c1213	http://dx.doi.org/10.1136/bmj.c1213			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573RG	20237396				2022-12-28	WOS:000275931700001
J	Kauffman, RP				Kauffman, Robert P.			Simple models predicted 10-year fracture risk in older women as accurately as more complex FRAX models	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Texas Tech Univ, Sch Med, Amarillo, TX USA	Texas Tech University System; Texas Tech University	Kauffman, RP (corresponding author), Texas Tech Univ, Sch Med, Amarillo, TX USA.							Bischoff-Ferrari HA, 2009, J BONE MINER RES, V24, P935, DOI [10.1359/JBMR.081242, 10.1359/jbmr.081242]; Kanis JA, 2009, BONE, V44, P734, DOI 10.1016/j.bone.2009.01.373	2	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	2010	152	6							JC3-13	10.7326/0003-4819-152-6-201003160-02013	http://dx.doi.org/10.7326/0003-4819-152-6-201003160-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573IF	20231555				2022-12-28	WOS:000275905200030
J	Shinar, G; Feinberg, M				Shinar, Guy; Feinberg, Martin			Structural Sources of Robustness in Biochemical Reaction Networks	SCIENCE			English	Article							CHEMICAL-REACTION NETWORKS; BACTERIAL CHEMOTAXIS; PHOSPHATASE-ACTIVITY; PHOSPHORYLATION; DEPHOSPHORYLATION; ADAPTATION; GRADIENT; SENSOR; ENVZ	In vivo variations in the concentrations of biomolecular species are inevitable. These variations in turn propagate along networks of chemical reactions and modify the concentrations of still other species, which influence biological activity. Because excessive variations in the amounts of certain active species might hamper cell function, regulation systems have evolved that act to maintain concentrations within tight bounds. We identify simple yet subtle structural attributes that impart concentration robustness to any mass-action network possessing them. We thereby describe a large class of robustness-inducing networks that already embraces two quite different biochemical modules for which concentration robustness has been observed experimentally: the Escherichia coli osmoregulation system EnvZ-OmpR and the glyoxylate bypass control system isocitrate dehydrogenase kinase-phosphatase-isocitrate dehydrogenase. The structural attributes identified here might confer robustness far more broadly.	[Feinberg, Martin] Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Koffolt Labs 125, Columbus, OH 43210 USA; [Shinar, Guy] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Feinberg, Martin] Ohio State Univ, Dept Math, Koffolt Labs 125, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Weizmann Institute of Science; University System of Ohio; Ohio State University	Feinberg, M (corresponding author), Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Koffolt Labs 125, 140 W 19th Ave, Columbus, OH 43210 USA.	feinberg@chbmeng.ohio-state.edu			NSF [BES-0425459]; NIH [1R01GM086881-01]; Kahn Family Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086881] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kahn Family Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to U. Alon for comments, insight, and support; E. Eden for writing the software implementation of the theorem; and A. Cohen, G. Enciso, R. Kishony, D. Koster, M. Laub, A. Mayo, R. Milo, and J. Rabinowitz for their help. Supported by NSF grant BES-0425459, NIH grant 1R01GM086881-01, and the Kahn Family Foundation.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Batchelor E, 2003, P NATL ACAD SCI USA, V100, P691, DOI 10.1073/pnas.0234782100; Craciun G, 2006, P NATL ACAD SCI USA, V103, P8697, DOI 10.1073/pnas.0602767103; Csikasz-Nagy A, 2008, J R SOC INTERFACE, V5, pS41, DOI 10.1098/rsif.2008.0099.focus; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; EDEN E, 2009, REACTION NETWORK ANA; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; FEINBERG M, 1987, CHEM ENG SCI, V42, P2229, DOI 10.1016/0009-2509(87)80099-4; Feinberg M, 1995, ARCH RATION MECH AN, V132, P311, DOI 10.1007/BF00375614; FEINBERG M, 1979, LECT CHEM REACT NETW; Hsing WH, 1997, J BACTERIOL, V179, P3729, DOI 10.1128/jb.179.11.3729-3735.1997; IGO MM, 1989, GENE DEV, V3, P1725, DOI 10.1101/gad.3.11.1725; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; LAPORTE DC, 1985, J BIOL CHEM, V260, P563; Levchenko A, 2002, BIOPHYS J, V82, P50, DOI 10.1016/S0006-3495(02)75373-3; Pratt L., 1995, 2 COMPONENT SIGNAL T, P105; Sanowar S, 2005, BIOCHEM J, V390, P769, DOI 10.1042/BJ20050060; Shinar G, 2007, P NATL ACAD SCI USA, V104, P19931, DOI 10.1073/pnas.0706792104; Shinar G, 2009, SIAM J APPL MATH, V69, P977, DOI 10.1137/080719820; Shinar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000297; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649; Zhu Y, 2000, P NATL ACAD SCI USA, V97, P7808, DOI 10.1073/pnas.97.14.7808	24	236	238	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1389	1391		10.1126/science.1183372	http://dx.doi.org/10.1126/science.1183372			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223989				2022-12-28	WOS:000275418700044
J	O'Connor, AB				O'Connor, Alec B.			Building Comparative Efficacy and Tolerability Into the FDA Approval Process	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[O'Connor, Alec B.] Univ Rochester, Sch Med & Dent, Rochester, NY USA	University of Rochester	O'Connor, AB (corresponding author), Univ Rochester, Strong Mem Hosp, 601 Elmwood Ave, Rochester, NY 14642 USA.	alec_oconnor@urmc.rochester.edu		O'Connor, Alec/0000-0001-8181-5567				Alexander GC, 2009, JAMA-J AM MED ASSOC, V301, P2488, DOI 10.1001/jama.2009.851; Dhruva SS, 2009, JAMA-J AM MED ASSOC, V302, P2679, DOI 10.1001/jama.2009.1899; European Medicines Agency, EU STAND MED PROD RE; Safer DJ, 2002, J NERV MENT DIS, V190, P583, DOI 10.1097/00005053-200209000-00002; Selker HP, 2009, NEW ENGL J MED, V361, P2595, DOI 10.1056/NEJMp0910747; Stafford RS, 2009, NEW ENGL J MED, V361, P1230, DOI 10.1056/NEJMp0906490; *US FDA, FDA WHAT WE DO	7	36	36	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2010	303	10					979	980		10.1001/jama.2010.257	http://dx.doi.org/10.1001/jama.2010.257			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	565UC	20215612				2022-12-28	WOS:000275319300026
J	Ranu, H; Holden, E; Madden, B				Ranu, Harpreet; Holden, Emma; Madden, Brendan			Case report A pain in the leg and breathlessness	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							THROMBOEMBOLIC PULMONARY-HYPERTENSION; RISK STRATIFICATION; PROGNOSTIC-SIGNIFICANCE; EMBOLISM; THERAPY; ANTICOAGULATION; BIOMARKERS; SILDENAFIL; TROPONINS; BENEFIT		[Ranu, Harpreet; Holden, Emma; Madden, Brendan] St George Hosp, Dept Cardiothorac Med, London SW17 0QT, England	St Georges University London	Madden, B (corresponding author), St George Hosp, Dept Cardiothorac Med, London SW17 0QT, England.	Brendan.Madden@stgeorges.nhs.uk						Becattini C, 2007, CIRCULATION, V116, P427, DOI 10.1161/CIRCULATIONAHA.106.680421; Bresser Paul, 2006, Proc Am Thorac Soc, V3, P594, DOI 10.1513/pats.200605-115LR; Chapman TH, 2009, VASC PHARMACOL, V51, P90, DOI 10.1016/j.vph.2009.04.002; Douketis JD, 2005, J THROMB HAEMOST, V3, P508, DOI 10.1111/j.1538-7836.2005.01189.x; Elsharawy M, 2002, EUR J VASC ENDOVASC, V24, P209, DOI 10.1053/ejvs.2002.1665; Fekrazad MH, 2009, J THROMB THROMBOLYS, V28, P270, DOI 10.1007/s11239-009-0374-7; Fengler BT, 2009, AM J EMERG MED, V27, P84, DOI 10.1016/j.ajem.2007.10.021; Giannitsis E, 2005, CIRCULATION, V112, P1520, DOI 10.1161/CIRCULATIONAHA.105.566182; Gibson NS, 2008, CHEST, V134, P789, DOI 10.1378/chest.08-0344; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Hoeper MM, 2006, CIRCULATION, V113, P2011, DOI 10.1161/CIRCULATIONAHA.105.602565; Hughes RJ, 2006, EUR RESPIR J, V28, P138, DOI 10.1183/09031936.06.00135905; Jimenez D, 2009, CHEST, V136, P974, DOI 10.1378/chest.09-0608; Kahn SR, 2002, BLOOD REV, V16, P155, DOI 10.1016/S0268-960X(02)00008-5; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; KLOK FA, 2009, AM J RESP CRIT CARE; Konstantinides S, 2002, CIRCULATION, V106, P1263, DOI 10.1161/01.CIR.0000028422.51668.A2; Kucher N, 2006, CIRCULATION, V113, P577, DOI 10.1161/CIRCULATIONAHA.105.592592; Kucher N, 2003, CIRCULATION, V108, P2191, DOI 10.1161/01.CIR.0000100687.99687.CE; MOSER KM, 1993, CHEST, V103, P685, DOI 10.1378/chest.103.3.685; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Quinlan DJ, 2004, ANN INTERN MED, V140, P175, DOI 10.7326/0003-4819-140-3-200402030-00008; Scridon T, 2005, AM J CARDIOL, V96, P303, DOI 10.1016/j.amjcard.2005.03.062; Sheth A, 2005, VASC PHARMACOL, V42, P41, DOI 10.1016/j.vph.2004.11.005; Todd JL, 2009, CHEST, V135, P1321, DOI 10.1378/chest.08-2125	26	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2010	340								c925	10.1136/bmj.c925	http://dx.doi.org/10.1136/bmj.c925			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570FD	20219821				2022-12-28	WOS:000275656800034
J	Atwell, S; Huang, YS; Vilhjalmsson, BJ; Willems, G; Horton, M; Li, Y; Meng, DZ; Platt, A; Tarone, AM; Hu, TT; Jiang, R; Muliyati, NW; Zhang, X; Amer, MA; Baxter, I; Brachi, B; Chory, J; Dean, C; Debieu, M; de Meaux, J; Ecker, JR; Faure, N; Kniskern, JM; Jones, JDG; Michael, T; Nemri, A; Roux, F; Salt, DE; Tang, CL; Todesco, M; Traw, MB; Weigel, D; Marjoram, P; Borevitz, JO; Bergelson, J; Nordborg, M				Atwell, Susanna; Huang, Yu S.; Vilhjalmsson, Bjarni J.; Willems, Glenda; Horton, Matthew; Li, Yan; Meng, Dazhe; Platt, Alexander; Tarone, Aaron M.; Hu, Tina T.; Jiang, Rong; Muliyati, N. Wayan; Zhang, Xu; Amer, Muhammad Ali; Baxter, Ivan; Brachi, Benjamin; Chory, Joanne; Dean, Caroline; Debieu, Marilyne; de Meaux, Juliette; Ecker, Joseph R.; Faure, Nathalie; Kniskern, Joel M.; Jones, Jonathan D. G.; Michael, Todd; Nemri, Adnane; Roux, Fabrice; Salt, David E.; Tang, Chunlao; Todesco, Marco; Traw, M. Brian; Weigel, Detlef; Marjoram, Paul; Borevitz, Justin O.; Bergelson, Joy; Nordborg, Magnus			Genome-wide association study of 107 phenotypes in Arabidopsis thaliana inbred lines	NATURE			English	Article							FLOWERING-LOCUS-C; LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; MODEL; DISEASES; PROTEIN; FRIGIDA; TIME	Although pioneered by human geneticists as a potential solution to the challenging problem of finding the genetic basis of common human diseases(1,2), genome-wide association (GWA) studies have, owing to advances in genotyping and sequencing technology, become an obvious general approach for studying the genetics of natural variation and traits of agricultural importance. They are particularly useful when inbred lines are available, because once these lines have been genotyped they can be phenotyped multiple times, making it possible (as well as extremely cost effective) to study many different traits in many different environments, while replicating the phenotypic measurements to reduce environmental noise. Here we demonstrate the power of this approach by carrying out a GWA study of 107 phenotypes in Arabidopsis thaliana, a widely distributed, predominantly self-fertilizing model plant known to harbour considerable genetic variation for many adaptively important traits(3). Our results are dramatically different from those of human GWA studies, in that we identify many common alleles of major effect, but they are also, in many cases, harder to interpret because confounding by complex genetics and population structure make it difficult to distinguish true associations from false. However, a-priori candidates are significantly over-represented among these associations as well, making many of them excellent candidates for follow-up experiments. Our study demonstrates the feasibility of GWA studies in A. thaliana and suggests that the approach will be appropriate for many other organisms.	[Marjoram, Paul; Nordborg, Magnus] Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA; [Horton, Matthew; Li, Yan; Muliyati, N. Wayan; Zhang, Xu; Kniskern, Joel M.; Roux, Fabrice; Traw, M. Brian; Borevitz, Justin O.; Bergelson, Joy] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Baxter, Ivan] Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Salt, David E.] Purdue Univ, W Lafayette, IN 47907 USA; [Brachi, Benjamin; Faure, Nathalie; Roux, Fabrice] Univ Sci & Technol Lille 1, CNRS, UMR 8016, Lab Genet & Evolut Populat Vegetales, F-59655 Villeneuve Dascq, France; [Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Chory, Joanne; Ecker, Joseph R.; Michael, Todd] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Dean, Caroline] John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; [Debieu, Marilyne; de Meaux, Juliette] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; [Jones, Jonathan D. G.; Nemri, Adnane] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Todesco, Marco; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Nordborg, Magnus] Gregor Mendel Inst, A-1030 Vienna, Austria	University of Southern California; University of Chicago; Purdue University System; Purdue University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Howard Hughes Medical Institute; Salk Institute; Salk Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Max Planck Society; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Max Planck Society; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Nordborg, M (corresponding author), Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA.	magnus.nordborg@gmi.oeaw.ac.at	Jones, Jonathan DG/J-5129-2012; Ecker, Joseph R/B-9144-2008; Nemri, Adnane/I-3830-2012; Baxter, Ivan R/A-1052-2009; Faure, Nathalie/B-4485-2009; Weigel, Detlef/GSJ-0799-2022; Vilhjálmsson, Bjarni/ABC-1369-2020; Huang, Yu/C-2789-2011; Li, Yan/AAF-5886-2019; Traw, Milton Brian/ABD-3275-2020; Weigel, Detlef/C-1418-2008; Todesco, Marco/HCH-3494-2022; Atwell, Susanna/H-8630-2016; Vilhjalmsson, Bjarni/K-3971-2014; Roux, Fabrice/A-1718-2009; Borevitz, Justin/B-5423-2012; Tang, Chunlao/F-9203-2010; Tarone, Aaron/I-6483-2012; Weigel, Detlef/AAR-3312-2021	Jones, Jonathan DG/0000-0002-4953-261X; Ecker, Joseph R/0000-0001-5799-5895; Baxter, Ivan R/0000-0001-6680-1722; Weigel, Detlef/0000-0002-2114-7963; Vilhjálmsson, Bjarni/0000-0003-2277-9249; Li, Yan/0000-0002-1627-7763; Traw, Milton Brian/0000-0002-3148-2108; Weigel, Detlef/0000-0002-2114-7963; Atwell, Susanna/0000-0001-8680-9721; Vilhjalmsson, Bjarni/0000-0003-2277-9249; Borevitz, Justin/0000-0001-8408-3699; de Meaux, Juliette/0000-0002-2942-4750; Nordborg, Magnus/0000-0001-7178-9748; Fabrice, Roux/0000-0001-8059-5638; Horton, Matthew/0000-0002-7537-0730; Bergelson, Joy/0000-0001-7893-7387; Michael, Todd/0000-0001-6272-2875; Todesco, Marco/0000-0002-6227-4096; Platt, Alexander/0000-0003-3783-4781; Tarone, Aaron/0000-0003-0965-7634	US National Science Foundation (NSF) [DEB-0519961, DEB-0723935, MCB-0603515]; US National Institutes of Health (NIH) [GM073822, GM057994, GM078536, P42ES007373, GM62932]; Dropkin Foundation; Max Planck Society; Howard Hughes Medical Institute; Deutsche Forschungsgemeinschaft (DFG) [SFB 680]; Marie Curie [220833]; BBSRC [BBS/E/J/000CA355] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000CA355] Funding Source: researchfish; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073822, R01GM078536, R01GM057994, R01GM062932] Funding Source: NIH RePORTER	US National Science Foundation (NSF)(National Science Foundation (NSF)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dropkin Foundation; Max Planck Society(Max Planck SocietyFoundation CELLEX); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Marie Curie(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Carvalho for his advice on how to modify the OLIGO package. This work was primarily supported by US National Science Foundation (NSF) grant DEB-0519961 (J.B., M.N.), US National Institutes of Health (NIH) grant GM073822 (J.O.B.), and NSF grant DEB-0723935 (M.N.). Additional support was provided by the Dropkin Foundation, NIH grant GM057994 and NSF grant MCB-0603515 (J.B.), the Max Planck Society (D.W., M.T.), the Austrian Academy of Sciences (M.N.), the University of Lille 1 (F. R.), NIH grant GM078536 and NIH grant P42ES007373 (D. E. S.), NIH grant GM62932 (J.C., D. W.), the Howard Hughes Medical Institute (J.C.), the Deutsche Forschungsgemeinschaft (DFG) SFB 680 (J.d.M.), a Marie Curie International Outgoing Fellowship 'ANAVACO' (project number 220833; G. W.), and a Gottfried Wilhelm Leibniz Award of the DFG (D. W.). The project would not have been possible without the existence of The Arabidopsis Information Resource (http://arabidopsis.org).	Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Baxter I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000004; Bentsink L, 2006, P NATL ACAD SCI USA, V103, P17042, DOI 10.1073/pnas.0607877103; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Hischer J, 2009, CURR BIOL, V19, P1747, DOI 10.1016/j.cub.2009.08.057; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Lu H, 2003, PLANT CELL, V15, P2408, DOI 10.1105/tpc.015412; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nordborg M, 2002, NAT GENET, V30, P190, DOI 10.1038/ng813; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Rosenberg NA, 2006, GENETICS, V173, P1665, DOI 10.1534/genetics.105.055335; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Shindo C, 2005, PLANT PHYSIOL, V138, P1163, DOI 10.1104/pp.105.061309; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; Toomajian C, 2006, PLOS BIOL, V4, P732, DOI 10.1371/journal.pbio.0040137; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004	28	1171	1221	10	496	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 3	2010	465	7298					627	631		10.1038/nature08800	http://dx.doi.org/10.1038/nature08800			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20336072	Green Accepted, Green Published			2022-12-28	WOS:000278249000044
J	Xu, D; Sun, BZ; Wan, XH; Ke, Y				Xu, Dong; Sun, Baozhi; Wan, Xuehong; Ke, Yang			Reformation of medical education in China	LANCET			English	Editorial Material									[Xu, Dong] China Med Board, Beijing Off, Beijing 100025, Peoples R China; [Sun, Baozhi] China Med Univ, Shenyang, Peoples R China; [Wan, Xuehong] Sichuan Univ, W China Hosp, Chengdu 610064, Peoples R China; [Ke, Yang] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China	Nokia Corporation; Pfizer; China Medical University; Sichuan University; Peking University	Xu, D (corresponding author), China Med Board, Beijing Off, Beijing 100025, Peoples R China.	rxu@cmbfound.org	Xu, Dong/Z-1502-2019	Xu, Dong/0000-0001-7438-632X				Anand S, 2008, LANCET, V372, P1774, DOI 10.1016/S0140-6736(08)61363-X; BATES DG, 1979, CAN MED ASSOC J, V120, P1578; *CHIN MIN ED, 2009, GUID ENH WORK MED ED; *CHIN MIN HLTH, 2006, REP MERG HIGH MED I; *CHIN STAT COUNC, 2009, NOT STAT COUNC PRINT; China Green Foundation, 2008, CHIN ANN HLTH STAT, P59; Chinese Ministry of Education, 2008, ED STAT YB CHIN; DENIAN BA, 2007, NATL MED J CHINA, V87, P1; MENG Q, 2009, IMPROVE MANAGEMENT T; Zhang DQ, 2008, LANCET, V372, P1865, DOI 10.1016/S0140-6736(08)61355-0	10	49	51	1	31	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 1	2010	375	9725					1502	1504		10.1016/S0140-6736(10)60241-3	http://dx.doi.org/10.1016/S0140-6736(10)60241-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	596AH	20347127				2022-12-28	WOS:000277655100007
J	Roach, JC; Glusman, G; Smit, AFA; Huff, CD; Hubley, R; Shannon, PT; Rowen, L; Pant, KP; Goodman, N; Bamshad, M; Shendure, J; Drmanac, R; Jorde, LB; Hood, L; Galas, DJ				Roach, Jared C.; Glusman, Gustavo; Smit, Arian F. A.; Huff, Chad D.; Hubley, Robert; Shannon, Paul T.; Rowen, Lee; Pant, Krishna P.; Goodman, Nathan; Bamshad, Michael; Shendure, Jay; Drmanac, Radoje; Jorde, Lynn B.; Hood, Leroy; Galas, David J.			Analysis of Genetic Inheritance in a Family Quartet by Whole-Genome Sequencing	SCIENCE			English	Article							MIDDLE AWASH; RECOMBINATION; PLEISTOCENE; NUCLEOTIDE; ETHIOPIA; HUMANS; RATES	We analyzed the whole-genome sequences of a family of four, consisting of two siblings and their parents. Family-based sequencing allowed us to delineate recombination sites precisely, identify 70% of the sequencing errors (resulting in > 99.999% accuracy), and identify very rare single-nucleotide polymorphisms. We also directly estimated a human intergeneration mutation rate of similar to 1.1 x 10(-8) per position per haploid genome. Both offspring in this family have two recessive disorders: Miller syndrome, for which the gene was concurrently identified, and primary ciliary dyskinesia, for which causative genes have been previously identified. Family-based genome analysis enabled us to narrow the candidate genes for both of these Mendelian disorders to only four. Our results demonstrate the value of complete genome sequencing in families.	[Roach, Jared C.; Glusman, Gustavo; Smit, Arian F. A.; Huff, Chad D.; Hubley, Robert; Shannon, Paul T.; Rowen, Lee; Goodman, Nathan; Hood, Leroy; Galas, David J.] Inst Syst Biol, Seattle, WA 98103 USA; [Huff, Chad D.; Jorde, Lynn B.] Univ Utah, Eccles Inst Human Genet, Dept Human Genet, Salt Lake City, UT 84109 USA; [Pant, Krishna P.; Drmanac, Radoje] CGI, Mountain View, CA 94043 USA; [Bamshad, Michael] Univ Washington, Dept Pediat, Seattle, WA 98105 USA; [Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Institute for Systems Biology (ISB); Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hood, L (corresponding author), Inst Syst Biol, Seattle, WA 98103 USA.	lhood@systemsbiology.org; dgalas@systemsbiology.org	Shendure, Jay/AAU-3684-2021	Shendure, Jay/0000-0002-1516-1865; Glusman, Gustavo/0000-0001-8060-5955	University of Luxembourg-Institute for Systems Biology Program; NIH, Center for Systems Biology [GM076547, RO1GM081083, R01HL094976, RZ1HG004749, RC2HG005608, R01HD048895]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD048895] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094976] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004749, R01HG002939, RC2HG005608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081083, P50GM076547] Funding Source: NIH RePORTER	University of Luxembourg-Institute for Systems Biology Program; NIH, Center for Systems Biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the University of Luxembourg-Institute for Systems Biology Program and by these NIH grants: Center for Systems Biology GM076547 (L. H. and L. R.), RO1GM081083 (A. F. S. and G. G.), R01HL094976 and RZ1HG004749 (J.S.), RC2HG005608 (M. D. and J.S.), and R01HD048895 (M. B.). H. Tabor assisted with ethical review. J. Xing performed the principal components analysis. H. Mefford performed CNV analysis. A. Bigham and K. Buckingham evaluated candidate genes in unrelated individuals. D. Ballinger, A. Sparks, A. Halpern, and G. Nilsen assisted with sequencing and analysis. R. Bressler, S. Dee, and D. Mauldin assisted with bioinformatics. S. Ng and R. Qiu performed the capture array. S. Bloom obtained the resequencing data on the Illumina Genome Analyzer. M. Janer and S. Li performed Sequenom analysis. D. Cox commented on an early version of the manuscript. R. Durbin and D. Altshuler granted permission for our use of 1000 genomes SNP data. CGI employees (R. D. and K. P.) have stock options in the company. J. S. has consulted for CGI. L. H. is a scientific advisor to CGI and holds stock in the company. The dbGAP accessions can be found at www.ncbi.nlm.nih.gov/projects/gap/cgibin/study. cgi?study_id=phs000244.v1.p1 (accession phs000244. v1.p1).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; BURGESS R, 1979, MOL BIOL EVOL, V25, P2008; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; CHOI M, 2009, P NATL ACAD SCI USA, V106; Deino AL, 2002, J HUM EVOL, V42, P117, DOI 10.1006/jhev.2001.0521; DONNELLY KP, 1983, THEOR POPUL BIOL, V23, P34, DOI 10.1016/0040-5809(83)90004-7; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Haile-Selassie Y, 2004, AM J PHYS ANTHROPOL, V123, P1, DOI 10.1002/ajpa.10330; Haile-Selassie Y, 2004, SCIENCE, V303, P1503, DOI 10.1126/science.1092978; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Nachman MW, 2000, GENETICS, V156, P297; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Petkolv PM, 2007, TRENDS GENET, V23, P539, DOI 10.1016/j.tig.2007.08.015; ROACH JC, 1995, GENOMICS, V26, P345, DOI 10.1016/0888-7543(95)80219-C; TAKAHATA N, 1993, JPN J GENET, V68, P539, DOI 10.1266/jjg.68.539; Wall JD, 2003, GENETICS, V163, P395; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032; 2005, NATURE, V437, P69	23	720	758	2	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2010	328	5978					636	639		10.1126/science.1186802	http://dx.doi.org/10.1126/science.1186802			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20220176	Green Accepted, Green Submitted			2022-12-28	WOS:000277159800048
J	Martin, F; Kohler, A; Murat, C; Balestrini, R; Coutinho, PM; Jaillon, O; Montanini, B; Morin, E; Noel, B; Percudani, R; Porcel, B; Rubini, A; Amicucci, A; Amselem, J; Anthouard, V; Arcioni, S; Artiguenave, F; Aury, JM; Ballario, P; Bolchi, A; Brenna, A; Brun, A; Buee, M; Cantarel, B; Chevalier, G; Couloux, A; Da Silva, C; Denoeud, F; Duplessis, S; Ghignone, S; Hilselberger, B; Iotti, M; Marcais, B; Mello, A; Miranda, M; Pacioni, G; Quesneville, H; Riccioni, C; Ruotolo, R; Splivallo, R; Stocchi, V; Tisserant, E; Viscomi, AR; Zambonelli, A; Zampieri, E; Henrissat, B; Lebrun, MH; Paolocci, F; Bonfante, P; Ottonello, S; Wincker, P				Martin, Francis; Kohler, Annegret; Murat, Claude; Balestrini, Raffaella; Coutinho, Pedro M.; Jaillon, Olivier; Montanini, Barbara; Morin, Emmanuelle; Noel, Benjamin; Percudani, Riccardo; Porcel, Bettina; Rubini, Andrea; Amicucci, Antonella; Amselem, Joelle; Anthouard, Veronique; Arcioni, Sergio; Artiguenave, Francois; Aury, Jean-Marc; Ballario, Paola; Bolchi, Angelo; Brenna, Andrea; Brun, Annick; Buee, Marc; Cantarel, Brandi; Chevalier, Gerard; Couloux, Arnaud; Da Silva, Corinne; Denoeud, France; Duplessis, Sebastien; Ghignone, Stefano; Hilselberger, Benoit; Iotti, Mirco; Marcais, Benoit; Mello, Antonietta; Miranda, Michele; Pacioni, Giovanni; Quesneville, Hadi; Riccioni, Claudia; Ruotolo, Roberta; Splivallo, Richard; Stocchi, Vilberto; Tisserant, Emilie; Viscomi, Arturo Roberto; Zambonelli, Alessandra; Zampieri, Elisa; Henrissat, Bernard; Lebrun, Marc-Henri; Paolocci, Francesco; Bonfante, Paola; Ottonello, Simone; Wincker, Patrick			Perigord black truffle genome uncovers evolutionary origins and mechanisms of symbiosis	NATURE			English	Article							FUNGAL; INSIGHTS	The Perigord black truffle (Tuber melanosporum Vittad.) and the Piedmont white truffle dominate today's truffle market(1,2). The hypogeous fruiting body of T. melanosporum is a gastronomic delicacy produced by an ectomycorrhizal symbiont(3) endemic to calcareous soils in southern Europe. The worldwide demand for this truffle has fuelled intense efforts at cultivation. Identification of processes that condition and trigger fruit body and symbiosis formation, ultimately leading to efficient crop production, will be facilitated by a thorough analysis of truffle genomic traits. In the ectomycorrhizal Laccaria bicolor, the expansion of gene families may have acted as a 'symbiosis toolbox'(4). This feature may however reflect evolution of this particular taxon and not a general trait shared by all ectomycorrhizal species(5). To get a better understanding of the biology and evolution of the ectomycorrhizal symbiosis, we report here the sequence of the haploid genome of T. melanosporum, which at similar to 125 megabases is the largest and most complex fungal genome sequenced so far. This expansion results from a proliferation of transposable elements accounting for similar to 58% of the genome. In contrast, this genome only contains similar to 7,500 protein-coding genes with very rare multigene families. It lacks large sets of carbohydrate cleaving enzymes, but a few of them involved in degradation of plant cell walls are induced in symbiotic tissues. The latter feature and the upregulation of genes encoding for lipases and multicopper oxidases suggest that T. melanosporum degrades its host cell walls during colonization. Symbiosis induces an increased expression of carbohydrate and amino acid transporters in both L. bicolor and T. melanosporum, but the comparison of genomic traits in the two ectomycorrhizal fungi showed that genetic predispositions for symbiosis-'the symbiosis toolbox'-evolved along different ways in ascomycetes and basidiomycetes.	[Martin, Francis; Kohler, Annegret; Murat, Claude; Morin, Emmanuelle; Brun, Annick; Buee, Marc; Duplessis, Sebastien; Marcais, Benoit; Tisserant, Emilie] Nancy Univ, UMR 1136, INRA, F-54280 Champenoux, France; [Balestrini, Raffaella; Ghignone, Stefano; Mello, Antonietta; Zampieri, Elisa; Bonfante, Paola] Univ Turin, Dipartimento Biol Vegetale, I-10125 Turin, Italy; [Balestrini, Raffaella; Ghignone, Stefano; Mello, Antonietta; Zampieri, Elisa; Bonfante, Paola] Univ Turin, CNR, Ist Protez Piante, Sez Torino, I-10125 Turin, Italy; [Coutinho, Pedro M.; Cantarel, Brandi; Henrissat, Bernard] Univ Aix Marseille 1, CNRS, UMR6098, F-13288 Marseille, France; [Coutinho, Pedro M.; Cantarel, Brandi; Henrissat, Bernard] Univ Aix Marseille 2, CNRS, UMR6098, F-13288 Marseille, France; [Jaillon, Olivier; Noel, Benjamin; Porcel, Bettina; Anthouard, Veronique; Artiguenave, Francois; Aury, Jean-Marc; Couloux, Arnaud; Da Silva, Corinne; Denoeud, France; Wincker, Patrick] CEA, IG, F-91057 Evry, France; [Jaillon, Olivier; Noel, Benjamin; Porcel, Bettina; Anthouard, Veronique; Artiguenave, Francois; Aury, Jean-Marc; Couloux, Arnaud; Da Silva, Corinne; Denoeud, France; Wincker, Patrick] CNRS, UMR 8030, F-91057 Evry, France; [Jaillon, Olivier; Noel, Benjamin; Porcel, Bettina; Anthouard, Veronique; Artiguenave, Francois; Aury, Jean-Marc; Couloux, Arnaud; Da Silva, Corinne; Denoeud, France; Wincker, Patrick] Univ Evry, F-91057 Evry, France; [Montanini, Barbara; Percudani, Riccardo; Bolchi, Angelo; Ruotolo, Roberta; Viscomi, Arturo Roberto; Ottonello, Simone] Univ Parma, Dipartmento Biochim & Biol Mol, I-43100 Parma, Italy; [Rubini, Andrea; Arcioni, Sergio; Riccioni, Claudia; Paolocci, Francesco] CNR, IGV, Unita Organizzat Supporto Perugia, I-06128 Perugia, Italy; [Amicucci, Antonella] Univ Urbino, Dipartimento Sci Biomol, I-61029 Urbino, PU, Italy; [Amselem, Joelle; Hilselberger, Benoit; Quesneville, Hadi] INRA, Unite Rech Genom Info, F-78000 Versailles, France; [Ballario, Paola; Brenna, Andrea] Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; [Ballario, Paola; Brenna, Andrea] Univ Roma La Sapienza, CNR, IBPM, I-00185 Rome, Italy; [Chevalier, Gerard] Univ Blaise Pascal, INRA Clermont Theix, INRA, UMR Ameliorat & Sante Plantes, F-63122 St Genes Champanelle, France; [Iotti, Mirco; Zambonelli, Alessandra] Univ Bologna, Dipartimento Protez Valorizzaz Agroalimentare, I-40126 Bologna, Italy; [Miranda, Michele] Univ Aquila, Dipartimento Biol Base & Applicata, I-67100 Laquila, Italy; [Pacioni, Giovanni] Univ Aquila, Dipartimento Sci Ambientali, I-67100 Laquila, Italy; [Splivallo, Richard] Univ Gottingen, D-37077 Gottingen, Germany; [Lebrun, Marc-Henri] INRA Grignon, INRA, UMR BIOGER CPP, F-78850 Thiverval Grignon, France	INRAE; Universite de Lorraine; University of Turin; Consiglio Nazionale delle Ricerche (CNR); University of Turin; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Parma; Consiglio Nazionale delle Ricerche (CNR); University of Urbino; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; INRAE; Universite Clermont Auvergne (UCA); University of Bologna; University of L'Aquila; University of L'Aquila; University of Gottingen; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Martin, F (corresponding author), Nancy Univ, UMR 1136, INRA, F-54280 Champenoux, France.	fmartin@nancy.inra.fr	Bolchi, Angelo/GOJ-9730-2022; Paolocci, Francesco/AAD-9484-2019; Mello, Antonietta/B-9101-2015; Cantarel, Brandi/ABF-5756-2020; Pacioni, Giovanni/O-7646-2015; Iotti, Mirco/M-1750-2015; percudani, riccardo/B-4872-2011; Rubini, Andrea/AAB-3036-2021; Balestrini, Raffaella/Q-1106-2015; Quesneville, Hadi/AAG-1048-2020; Rubini, Andrea/AAE-2217-2022; Jaillon, Olivier/GRY-6287-2022; Kohler, Annegret/AAD-1876-2019; Murat, Claude/AAA-5226-2020; morin, emmanuelle/AAA-1246-2019; Zambonelli, Alessandra/AAF-3581-2019; Balestrini, Raffaella/D-1975-2010; Ghignone, Stefano/B-8288-2008; Zampieri, Elisa/G-6516-2011; Henrissat, Bernard/J-2475-2012; Aury, Jean-Marc/N-1621-2019; Riccioni, Claudia/AAX-1878-2020; Bonfante, Paola/ABE-6733-2020; Marcais, Benoit/O-5049-2019; , DUPLESSIS/G-4150-2011; Mello, Antonietta/AFX-6601-2022	Paolocci, Francesco/0000-0002-9394-876X; Mello, Antonietta/0000-0002-6311-377X; Cantarel, Brandi/0000-0003-4126-4478; Pacioni, Giovanni/0000-0002-0201-5789; Iotti, Mirco/0000-0003-2705-0385; percudani, riccardo/0000-0001-8452-1062; Balestrini, Raffaella/0000-0001-7958-7681; Quesneville, Hadi/0000-0003-3001-4908; Rubini, Andrea/0000-0003-3988-6294; Murat, Claude/0000-0003-0685-7307; morin, emmanuelle/0000-0002-7268-972X; Balestrini, Raffaella/0000-0001-7958-7681; Ghignone, Stefano/0000-0002-2033-2286; Henrissat, Bernard/0000-0002-3434-8588; Aury, Jean-Marc/0000-0003-1718-3010; Riccioni, Claudia/0000-0003-1069-8943; Marcais, Benoit/0000-0002-8107-644X; , DUPLESSIS/0000-0002-2072-2989; Mello, Antonietta/0000-0002-6311-377X; Splivallo, Richard/0000-0002-7567-6553; Porcel, Betina/0000-0003-0169-5302; Brenna, Andrea/0000-0002-8542-9855; Noel, Benjamin/0000-0002-5830-3253; LEBRUN, marc-henri/0000-0003-1562-1902; Denoeud, France/0000-0001-8819-7634; Brun-Jacob, Annick/0000-0002-0299-2766; ZAMPIERI, Elisa/0000-0003-4623-1747; Bonfante, Paola/0000-0003-3576-8530; Montanini, Barbara/0000-0002-5419-7975; DA SILVA, Corinne/0000-0002-7618-7831; Amselem, Joelle/0000-0001-7124-3454; Couloux, Arnaud/0000-0003-2356-0062; Buee, Marc/0000-0001-8614-3886	Genoscope, Institut de Genomique, CEA; Agence Nationale de la Recherche (ANR); European FP6 Network of Excellence EVOLTREE, Region Lorraine; Fondazione Cariparma, Compagnia di San Paolo-Torino; Italian Ministry of Education, University and Research (MIUR), Regione Umbria; Instituto Pasteur Fondazione Cenci Bolognetti	Genoscope, Institut de Genomique, CEA(French Atomic Energy Commission); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); European FP6 Network of Excellence EVOLTREE, Region Lorraine(Region Grand-Est); Fondazione Cariparma, Compagnia di San Paolo-Torino(Compagnia di San Paolo); Italian Ministry of Education, University and Research (MIUR), Regione Umbria(Ministry of Education, Universities and Research (MIUR)); Instituto Pasteur Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti)	We thank the late L. Riousset and C. Dupre for providing the Mel28 isolate, and acknowledge F. Le Tacon and J. Weissenbach for continuous support. The genome sequencing of T. melanosporum was funded by the Genoscope, Institut de Genomique, CEA, and Agence Nationale de la Recherche (ANR). Genome annotation and transcriptome analysis were supported by INRA, the European FP6 Network of Excellence EVOLTREE, Region Lorraine, the ANR FungEffector project, Fondazione Cariparma, Compagnia di San Paolo-Torino, the Italian Ministry of Education, University and Research (MIUR), Regione Umbria and Instituto Pasteur Fondazione Cenci Bolognetti. We thank D. Hibbett and J. Heitman for comments on an early draft of the manuscript, and J. Plett for a critical reading of the paper.	Bertault G, 1998, NATURE, V394, P734, DOI 10.1038/29428; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Fraser JA, 2004, MOL MICROBIOL, V51, P299, DOI 10.1046/j.1365-2958.2003.03874.x; Galagan JE, 2005, GENOME RES, V15, P1620, DOI 10.1101/gr.3767105; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; HALL IR, 2007, TAMING TRUFFLE HIST; Hibbett DS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-13; Karkehabadi S, 2008, J MOL BIOL, V383, P144, DOI 10.1016/j.jmb.2008.08.016; Liu M, 2008, APPL ENVIRON MICROB, V74, P4590, DOI 10.1128/AEM.00150-08; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martin F, 2008, NEW PHYTOL, V180, P296, DOI 10.1111/j.1469-8137.2008.02613.x; MASER C, 2008, TRUFFLES BEASTS; Mello A, 2006, FEMS MICROBIOL LETT, V260, P1, DOI 10.1111/j.1574-6968.2006.00252.x; Murat C, 2004, NEW PHYTOL, V164, P401, DOI 10.1111/j.1469-8137.2004.01189.x; Riccioni C, 2008, NEW PHYTOL, V180, P466, DOI 10.1111/j.1469-8137.2008.02560.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd; Soanes DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002300; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838	19	478	514	7	165	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1033	1038		10.1038/nature08867	http://dx.doi.org/10.1038/nature08867			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20348908	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000276635000037
J	Bzymek, M; Thayer, NH; Oh, SD; Kleckner, N; Hunter, N				Bzymek, Malgorzata; Thayer, Nathaniel H.; Oh, Steve D.; Kleckner, Nancy; Hunter, Neil			Double Holliday junctions are intermediates of DNA break repair	NATURE			English	Article							DOUBLE-STRAND-BREAK; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; MEIOTIC RECOMBINATION; GENE CONVERSION; CROSSING-OVER; CELL-CYCLE; ENDONUCLEASE; TRANSITION; HELICASE	Repair of DNA double-strand breaks (DSBs) by homologous recombination is crucial for cell proliferation and tumour suppression. However, despite its importance, the molecular intermediates of mitotic DSB repair remain undefined. The double Holliday junction (DHJ), presupposed to be the central intermediate for more than 25 years(1), has only been identified during meiotic recombination(2). Moreover, evidence has accumulated for alternative, DHJ-independent mechanisms(3-6), raising the possibility that DHJs are not formed during DSB repair in mitotically cycling cells. Here we identify intermediates of DSB repair by using a budding-yeast assay system designed to mimic physiological DSB repair. This system uses diploid cells and provides the possibility for allelic recombination either between sister chromatids or between homologues, as well as direct comparison with meiotic recombination at the same locus. In mitotically cycling cells, we detect inter-homologue joint molecule (JM) intermediates whose strand composition and size are identical to those of the canonical DHJ structures observed in meiosis(2). However, in contrast to meiosis, JMs between sister chromatids form in preference to those between homologues. Moreover, JMs seem to represent a minor pathway of DSB repair in mitotic cells, being detected at about tenfold lower levels (per DSB) than during meiotic recombination. Thus, although DHJs are identified as intermediates of DSB-promoted recombination in both mitotic and meiotic cells, their formation is distinctly regulated according to the specific dictates of the two cellular programs.	[Bzymek, Malgorzata; Hunter, Neil] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Hunter, Neil] Univ Calif Davis, Howard Hughes Med Inst, Davis, CA 95616 USA; [Hunter, Neil] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Thayer, Nathaniel H.] Univ Washington, Mol & Cellular Biol PhD Program, Seattle, WA 98195 USA; [Oh, Steve D.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Oh, Steve D.] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; [Kleckner, Nancy] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	University of California System; University of California Davis; Howard Hughes Medical Institute; University of California System; University of California Davis; University of California System; University of California Davis; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Harvard University	Hunter, N (corresponding author), Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA.	nhunter@ucdavis.edu			National Institutes of Health (NIH) National Institute of General Medical Sciences [GM025326, GM074223]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025326, R01GM074223, R01GM025326] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Schiestl for plasmid pWY203, and W. Heyer for critical reading of the manuscript. This work was supported by National Institutes of Health (NIH) National Institute of General Medical Sciences grants GM025326 to N.K. and GM074223 to N.H.	Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; BELL L, 1983, ANAL BIOCHEM, V130, P527, DOI 10.1016/0003-2697(83)90628-0; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Cromie GA, 2006, CELL, V127, P1167, DOI 10.1016/j.cell.2006.09.050; FABRE F, 1984, MOL GEN GENET, V195, P139, DOI 10.1007/BF00332736; Galli A, 1998, GENETICS, V149, P1235; Haber JE, 2002, METHOD ENZYMOL, V350, P141, DOI 10.1016/S0076-6879(02)50961-7; Heyer WD, 2003, TRENDS BIOCHEM SCI, V28, P548, DOI 10.1016/j.tibs.2003.08.011; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hunter N., 2006, MOL GENETICS RECOMBI, P381, DOI 10.1007/978-3-540-71021-9_14; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jessop L, 2005, GENETICS, V169, P1353, DOI 10.1534/genetics.104.036509; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; KADYK LC, 1992, GENETICS, V132, P387; Lee PS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000410; Liu Y, 2008, GENE DEV, V22, P2737, DOI 10.1101/gad.1732808; McMahill MS, 2007, PLOS BIOL, V5, P2589, DOI 10.1371/journal.pbio.0050299; MONTEILHET C, 1990, NUCLEIC ACIDS RES, V18, P1407, DOI 10.1093/nar/18.6.1407; Mullen JR, 2000, GENETICS, V154, P1101; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Oh SD, 2009, METHODS MOL BIOL, V557, P209, DOI 10.1007/978-1-59745-527-5_14; RESNICK MA, 1976, J THEOR BIOL, V59, P97, DOI 10.1016/S0022-5193(76)80025-2; ROMAN H, 1983, P NATL ACAD SCI-BIOL, V80, P6912, DOI 10.1073/pnas.80.22.6912; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Wu L, 2005, EMBO J, V24, P2679, DOI 10.1038/sj.emboj.7600740; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253	30	153	153	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					937	U162		10.1038/nature08868	http://dx.doi.org/10.1038/nature08868			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20348905	Green Accepted			2022-12-28	WOS:000276397300047
J	Nakagawa, T; Sharma, M; Nabeshima, Y; Braun, RE; Yoshida, S				Nakagawa, Toshinori; Sharma, Manju; Nabeshima, Yo-ichi; Braun, Robert E.; Yoshida, Shosei			Functional Hierarchy and Reversibility Within the Murine Spermatogenic Stem Cell Compartment	SCIENCE			English	Article							UNDIFFERENTIATED SPERMATOGONIA; SELF-RENEWAL; GERM-CELLS; PROLIFERATION; LESSONS; MAINTENANCE; EXPANSION; PLZF	Stem cells support tissue maintenance by balancing self-renewal and differentiation. In mice, it is believed that a homogeneous stem cell population of single spermatogonia supports spermatogenesis, and that differentiation, which is accompanied by the formation of connected cells (cysts) of increasing length, is linear and nonreversible. We evaluated this model with the use of lineage analysis and live imaging, and found that this putative stem cell population is not homogeneous. Instead, the stem cell pool that supports steady-state spermatogenesis is contained within a subpopulation of single spermatogonia. We also found that cysts are not committed to differentiation and appear to recover stem cell potential by fragmentation, and that the fate of individual spermatogonial populations was markedly altered during regeneration after damage. Thus, there are multiple and reversible paths from stem cells to differentiation, and these may also occur in other systems.	[Nakagawa, Toshinori; Nabeshima, Yo-ichi; Yoshida, Shosei] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto 6068501, Japan; [Sharma, Manju; Braun, Robert E.] Jackson Lab, Bar Harbor, ME 04609 USA; [Yoshida, Shosei] Natl Inst Nat Sci, Natl Inst Basic Biol, Div Germ Cell Biol, Okazaki, Aichi 4448787, Japan; [Yoshida, Shosei] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4448585, Japan	Kyoto University; Jackson Laboratory; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB)	Yoshida, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto 6068501, Japan.	shosei@nibb.ac.jp		Yoshida, Shosei/0000-0001-8861-1866; Nakagawa, Toshinori/0000-0001-7620-1720	NICHD/NIH Contraceptive Development Research Centers [U54 HD4254]; Uehara Memorial Foundation; Naito Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD042454] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [20116004] Funding Source: KAKEN	NICHD/NIH Contraceptive Development Research Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Miyazaki, T. Noce, and A. Imura for materials; T. Ogawa, R. Sugimoto, Y. Kitadate, K. Hara, and H. Mizuguchi-Takase for comments; T. Fujimori for discussion and technical advice; and M. Sukeno for technical assistance. Supported by a Grant-in-Aid for Scientific Research (KAKENHI) on Innovative Areas, "Regulatory Mechanism of Gamete Stem Cells" (S.Y.), NICHD/NIH Contraceptive Development Research Centers Program grant U54 HD4254 (R.E.B.), the Uehara Memorial Foundation, and the Naito Foundation.	Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Brinster RL, 2002, SCIENCE, V296, P2174, DOI 10.1126/science.1071607; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; De Rooij DG, 1998, INT J EXP PATHOL, V79, P67, DOI 10.1046/j.1365-2613.1998.00057.x; De Rooij DG, 2000, J ANDROL, V21, P776; Ehmcke J, 2005, BIOL REPROD, V72, P293, DOI 10.1095/biolreprod.104.033092; Ehmcke J, 2006, REPRODUCTION, V132, P673, DOI 10.1530/rep.1.01081; ERICKSON BH, 1981, RADIAT RES, V86, P34, DOI 10.2307/3575597; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Hofmann MC, 2005, DEV BIOL, V279, P114, DOI 10.1016/j.ydbio.2004.12.006; HUCKINS C, 1971, ANAT REC, V169, P533, DOI 10.1002/ar.1091690306; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Meistrich ML, 1993, CELL MOL BIOL TESTIS, P266; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; OAKBERG EF, 1971, ANAT REC, V169, P515, DOI 10.1002/ar.1091690305; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Suzuki H, 2009, DEV BIOL, V336, P222, DOI 10.1016/j.ydbio.2009.10.002; Tokuda M, 2007, BIOL REPROD, V76, P130, DOI 10.1095/biolreprod.106.053181; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036; Yoshida S, 2008, COLD SH Q B, V73, P25, DOI 10.1101/sqb.2008.73.046; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38	34	328	346	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2010	328	5974					62	67		10.1126/science.1182868	http://dx.doi.org/10.1126/science.1182868			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20299552	Green Accepted			2022-12-28	WOS:000276202200034
J	Brumm, A; Jensen, GM; van den Bergh, GD; Morwood, MJ; Kurniawan, I; Aziz, F; Storey, M				Brumm, Adam; Jensen, Gitte M.; van den Bergh, Gert D.; Morwood, Michael J.; Kurniawan, Iwan; Aziz, Fachroel; Storey, Michael			Hominins on Flores, Indonesia, by one million years ago	NATURE			English	Article							HOMO-FLORESIENSIS; LATE PLEISTOCENE; STONE TECHNOLOGY; SOUTHEAST-ASIA; LIANG-BUA; ARTIFACTS; MENGERUDA; EVOLUTION; ISLAND; AGES	Previous excavations at Mata Menge and Boa Lesa in the Soa Basin of Flores, Indonesia, recovered stone artefacts in association with fossilized remains of the large-bodied Stegodon florensis florensis(1-9). Zircon fission-track ages from these sites indicated that hominins had colonized the island by 0.88 +/- 0.07 million years (Myr) ago(6). Here we describe the contents, context and age of Wolo Sege, a recently discovered archaeological site in the Soa Basin that has in situ stone artefacts and that lies stratigraphically below Mata Menge and immediately above the basement breccias of the basin. We show using Ar-40/Ar-39 dating that an ignimbrite overlying the artefact layers at Wolo Sege was erupted 1.02 +/- 0.02 Myr ago, providing a new minimum age for hominins on Flores. This predates the disappearance from the Soa Basin of 'pygmy' Stegodon sondaari and Geochelone spp. (giant tortoise), as evident at the nearby site of Tangi Talo, which has been dated to 0.90 +/- 0.07 Myr ago(10). It now seems that this extirpation or possible extinction event and the associated faunal turnover were the result of natural processes rather than the arrival of hominins(9). It also appears that the volcanic and fluvio-lacustrine deposits infilling the Soa Basin may not be old enough to register the initial arrival of hominins on the island.	[Jensen, Gitte M.; Storey, Michael] Roskilde Univ, Dept Environm Social & Spatial Change, Quaternary Dating Lab, DK-4000 Roskilde, Denmark; [Brumm, Adam; van den Bergh, Gert D.; Morwood, Michael J.] Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia; [Kurniawan, Iwan; Aziz, Fachroel] Geol Survey Inst, Bandung 40122, Indonesia; [van den Bergh, Gert D.] Natl Museum Nat Hist, NL-2333 CR Leiden, Netherlands	Roskilde University; University of Wollongong	Storey, M (corresponding author), Roskilde Univ, Dept Environm Social & Spatial Change, Quaternary Dating Lab, POB 260, DK-4000 Roskilde, Denmark.	abrumm@uow.edu.au; storey@ruc.dk	van den Bergh, Gerrit D/I-7670-2016	Storey, Michael/0000-0002-3126-4637; van den Bergh, Gerrit Dirk/0000-0003-1507-3336	Australian Research Council (ARC); Australian National University; McDonald Institute for Archaeological Research, University of Cambridge; D. M. McDonald Grants and Awards Fund; Villum Kann Rasmussen Foundation; Villum Kann Rasmussen Foundation, Roskilde University; Danish Agency for Science, Technology and Innovation	Australian Research Council (ARC)(Australian Research Council); Australian National University(Australian National University); McDonald Institute for Archaeological Research, University of Cambridge(University of Cambridge); D. M. McDonald Grants and Awards Fund; Villum Kann Rasmussen Foundation(Villum Fonden); Villum Kann Rasmussen Foundation, Roskilde University; Danish Agency for Science, Technology and Innovation	The 2005 excavations in the Soa Basin were funded by a Discovery Project grant from the Australian Research Council (ARC) to M. J. M. The Soa Basin research was authorized by D. Sukarna and D. Kosasih. The Ngadha excavation team was led by K. Podhi and consisted of H. Bele, P. Carpus, J. Dadi, A. Djo, S. Gholo, M. Lalu, M. Lebe and M. Rani. Other participants included Dadang and Ngaliman. R. G. Roberts, K. Westaway and D. Phillips are acknowledged for their initial contributions to dating the site; R. G. Roberts, in particular, is thanked for his assistance and support. G. Barker and N. Ashton are also acknowledged, and M. W. Moore is thanked for preparing images of the artefacts. The 2005 fieldwork of A. B. at Wolo Sege was supported by an Australian National University PhD co-funded stipend scholarship, and follow-up research was funded by an ARC Discovery postdoctoral research fellowship based at the University of Wollongong and a postdoctoral research fellowship at the McDonald Institute for Archaeological Research, University of Cambridge. A grant from the D. M. McDonald Grants and Awards Fund is also acknowledged. The Quaternary Dating Laboratory at Roskilde University is funded by the Villum Kann Rasmussen Foundation. G. M. J. is supported by a PhD stipend co-funded by the Villum Kann Rasmussen Foundation, Roskilde University and The Danish Agency for Science, Technology and Innovation. We thank O. Stecher for technical assistance and J. Saxton and A. Deino for discussions on multi-collector noble-gas mass spectrometry.	Argue D, 2006, J HUM EVOL, V51, P360, DOI 10.1016/j.jhevol.2006.04.013; AZIZ F, 2009, SPECIAL PUBLICATION, V36, P41; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Brumm A, 2006, NATURE, V441, P624, DOI 10.1038/nature04618; Brumm A, 2010, J ARCHAEOL SCI, V37, P451, DOI 10.1016/j.jas.2009.09.012; Dennell R, 2005, NATURE, V438, P1099, DOI 10.1038/nature04259; Dennell RW, 2009, PALAEOLITHIC SETTLEM; Jungers WL, 2009, NATURE, V459, P81, DOI 10.1038/nature07989; MARINGER J, 1970, ANTHROPOS, V65, P530; MARINGER J, 1970, ANTHROPOS, V65, P229; Moore MW, 2007, J HUM EVOL, V52, P85, DOI 10.1016/j.jhevol.2006.08.002; Moore MW, 2009, VERTEBR PALEOBIOL PA, P61, DOI 10.1007/978-1-4020-9060-8_6; Morwood MJ, 2009, J HUM EVOL, V57, P640, DOI 10.1016/j.jhevol.2009.08.003; Morwood MJ, 2005, NATURE, V437, P1012, DOI 10.1038/nature04022; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; Morwood MJ, 1999, ANTIQUITY, V73, P273, DOI 10.1017/S0003598X00088244; Morwood MJ, 1998, NATURE, V392, P173, DOI 10.1038/32401; MORWOOD MJ, 2009, SPEC PUBL GEOLOGICAL, V36, P139; Muraoka H., 2002, BULL GEOL SURV JPN, V53, P109, DOI [DOI 10.9795/BULLGSJ.53.109, 10.9795 /bullgsj.53.109]; O'Sullivan PB, 2001, GEOLOGY, V29, P607, DOI 10.1130/0091-7613(2001)029<0607:AIOTGA>2.0.CO;2; Renne PR, 2005, APPL RADIAT ISOTOPES, V62, P25, DOI 10.1016/j.apradiso.2004.06.004; Renne PR, 1998, CHEM GEOL, V145, P117, DOI 10.1016/S0009-2541(97)00159-9; Shea JJ., 1999, GEOARCHAEOLOGY, V14, P191, DOI [10.1002/(SICI)1520-6548(199902)14:23.0.CO;2-K, DOI 10.1002/(SICI)1520-6548(199902)14:23.0.CO;2-K, DOI 10.1002/(SICI)1520-6548(199902)14:2]; SONDAAR PY, 1994, CR ACAD SCI II, V319, P1255; SUMINTO, 2009, SPEC PUBL GEOLOGICAL, V36, P19; Tocheri MW, 2007, SCIENCE, V317, P1743, DOI 10.1126/science.1147143; Van den Bergh GD, 2008, QUATERN INT, V182, P16, DOI 10.1016/j.quaint.2007.02.001; van den Bergh G. D., 1997, SCRIPTA GEOLOGICA, V117; van den Bergh GD, 2001, PALAEOGEOGR PALAEOCL, V171, P385, DOI 10.1016/S0031-0182(01)00255-3; VANDENBERGH GD, 2009, SPEC PUBL GEOLOGICAL, V36, P59	30	115	118	1	67	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 1	2010	464	7289					748	U123		10.1038/nature08844	http://dx.doi.org/10.1038/nature08844			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	577EO	20237472				2022-12-28	WOS:000276205000043
J	O'Hanlon, S				O'Hanlon, Shane			Personal View My year without drug reps	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Mercy Univ Hosp, Cork, Ireland	University College Cork	O'Hanlon, S (corresponding author), Mercy Univ Hosp, Cork, Ireland.	sohanlon@gmail.com	O'Hanlon, Shane/I-5990-2019	O'Hanlon, Shane/0000-0002-9270-2768					0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2010	340								c1102	10.1136/bmj.c1102	http://dx.doi.org/10.1136/bmj.c1102			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	579VI	20351076				2022-12-28	WOS:000276404000001
J	Dorn, GW				Dorn, Gerald W., II			Refugee Receptors Switch Sides	SCIENCE			English	Editorial Material							CARDIAC MYOCYTES; HEART-FAILURE; CYCLIC-AMP; CONTRACTION		Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Dorn, GW (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.	gdorn@wustl.edu			NHLBI NIH HHS [R01 HL087871] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087871] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; BRISTOW MR, 1986, CIRC RES, V59, P297, DOI 10.1161/01.RES.59.3.297; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Devic E, 2001, MOL PHARMACOL, V60, P577; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; LEVITZKI A, 1988, SCIENCE, V241, P800, DOI 10.1126/science.2841758; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Nikolaev VO, 2010, SCIENCE, V327, P1653, DOI 10.1126/science.1185988; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; Xiang Y, 2003, P NATL ACAD SCI USA, V100, P10776, DOI 10.1073/pnas.1831718100; Xiao RP, 1999, CIRC RES, V85, P1092; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982	13	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	2010	327	5973					1586	1587		10.1126/science.1188538	http://dx.doi.org/10.1126/science.1188538			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20339055				2022-12-28	WOS:000275970600023
J	Osborne, I; Lavine, M; Coontz, R				Osborne, Ian; Lavine, Marc; Coontz, Robert			Looking Beyond Silicon INTRODUCTION	SCIENCE			English	Editorial Material																			0	13	13	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	2010	327	5973					1595	1595		10.1126/science.327.5973.1595	http://dx.doi.org/10.1126/science.327.5973.1595			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	574ED	20339058				2022-12-28	WOS:000275970600026
J	Jopling, C; Sleep, E; Raya, M; Marti, M; Raya, A; Belmonte, JCI				Jopling, Chris; Sleep, Eduard; Raya, Marina; Marti, Merce; Raya, Angel; Izpisua Belmonte, Juan Carlos			Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation	NATURE			English	Article							CELL-CYCLE; INJURY; MYOCARDIUM; EXPRESSION	Although mammalian hearts show almost no ability to regenerate, there is a growing initiative to determine whether existing cardiomyocytes or progenitor cells can be coaxed into eliciting a regenerative response. In contrast to mammals, several non-mammalian vertebrate species are able to regenerate their hearts(1-3), including the zebrafish(4,5), which can fully regenerate its heart after amputation of up to 20% of the ventricle. To address directly the source of newly formed cardiomyocytes during zebrafish heart regeneration, we first established a genetic strategy to trace the lineage of cardiomyocytes in the adult fish, on the basis of the Cre/lox system widely used in the mouse(6). Here we use this system to show that regenerated heart muscle cells are derived from the proliferation of differentiated cardiomyocytes. Furthermore, we show that proliferating cardiomyocytes undergo limited dedifferentiation characterized by the disassembly of their sarcomeric structure, detachment from one another and the expression of regulators of cell-cycle progression. Specifically, we show that the gene product of polo-like kinase 1 (plk1) is an essential component of cardiomyocyte proliferation during heart regeneration. Our data provide the first direct evidence for the source of proliferating cardiomyocytes during zebrafish heart regeneration and indicate that stem or progenitor cells are not significantly involved in this process.	[Jopling, Chris; Sleep, Eduard; Raya, Marina; Marti, Merce; Raya, Angel; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Sleep, Eduard; Raya, Angel; Izpisua Belmonte, Juan Carlos] Networking Ctr Biomed Res Bioengn Biomat & Nanome, Barcelona 08003, Spain; [Raya, Angel] ICREA, Barcelona 08010, Spain; [Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; ICREA; Salk Institute	Belmonte, JCI (corresponding author), Ctr Regenerat Med Barcelona, Dr Aiguader St 88, Barcelona 08003, Spain.	belmonte@salk.edu	Raya, Angel/E-6205-2010; Jopling, Chris/D-1728-2019	Raya, Angel/0000-0003-2189-9775; jopling, chris/0000-0003-0950-0063	Ministry of Innovation, Universities and Enterprise (DIUE), Generalitat de Catalunya; Fundacion Cellex; Ipsen Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis; Ministry of Science and Innovation (MICINN); CIBER; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL088293] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Ministry of Innovation, Universities and Enterprise (DIUE), Generalitat de Catalunya(Generalitat de Catalunya); Fundacion Cellex(Foundation CELLEX); Ipsen Foundation(Ipsen); G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis(Sanofi-Aventis); Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CIBER; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ICREA(ICREA)	We thank M. C. Fabregat, C. Rodriguez Esteban and I. Dubova for technical assistance, and A. Faucherre for constructive criticism of the manuscript. E. S. was the recipient of a pre-doctoral fellowship from the Ministry of Innovation, Universities and Enterprise (DIUE), Generalitat de Catalunya. This work was supported by grants from Fundacion Cellex, the Ipsen Foundation, the G. Harold and Leila Y. Mathers Charitable Foundation, Sanofi-Aventis, the Ministry of Science and Innovation (MICINN), CIBER, and the National Institutes of Health.	Abbate A, 2007, INT J CARDIOL, V114, P118, DOI 10.1016/j.ijcard.2005.11.025; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bicknell KA, 2007, J MOL CELL CARDIOL, V42, P706, DOI 10.1016/j.yjmcc.2007.01.006; Boniface EJ, 2009, GENESIS, V47, P484, DOI 10.1002/dvg.20526; Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; Cheville NF, 1994, ULTRASTRUCTURAL PATH; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Dispersyn GD, 2001, CARDIOVASC RES, V51, P230, DOI 10.1016/S0008-6363(01)00326-1; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Flink IL, 2002, ANAT EMBRYOL, V205, P235, DOI 10.1007/s00429-002-0249-6; Glauert A.M., 1975, PRACTICAL METHODS EL, V3, P44; Hans S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004640; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Laube F, 2006, J CELL SCI, V119, P4719, DOI 10.1242/jcs.03252; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Neff AW, 1996, INT J DEV BIOL, V40, P719; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; Sleep E, 2010, J CARDIOVASC MED, V11, P369, DOI 10.2459/JCM.0b013e3283375900; Wijns W, 1998, NEW ENGL J MED, V339, P173, DOI 10.1056/NEJM199807163390307	25	889	926	2	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					606	U168		10.1038/nature08899	http://dx.doi.org/10.1038/nature08899			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20336145	Green Accepted			2022-12-28	WOS:000275974200051
J	Bassler, D; Briel, M; Montori, VM; Lane, M; Glasziou, P; Zhou, Q; Heels-Ansdell, D; Walter, SD; Guyatt, GH				Bassler, Dirk; Briel, Matthias; Montori, Victor M.; Lane, Melanie; Glasziou, Paul; Zhou, Qi; Heels-Ansdell, Diane; Walter, Stephen D.; Guyatt, Gordon H.		STOPIT-2 Study Grp	Stopping Randomized Trials Early for Benefit and Estimation of Treatment Effects Systematic Review and Meta-regression Analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CLINICAL-TRIALS; INTERIM ANALYSES; EFFICACY	Context Theory and simulation suggest that randomized controlled trials (RCTs) stopped early for benefit (truncated RCTs) systematically overestimate treatment effects for the outcome that precipitated early stopping. Objective To compare the treatment effect from truncated RCTs with that from meta-analyses of RCTs addressing the same question but not stopped early (nontruncated RCTs) and to explore factors associated with overestimates of effect. Data Sources Search of MEDLINE, EMBASE, Current Contents, and full-text journal content databases to identify truncated RCTs up to January 2007; search of MEDLINE, Cochrane Database of Systematic Reviews, and Database of Abstracts of Reviews of Effects to identify systematic reviews from which individual RCTs were extracted up to January 2008. Study Selection Selected studies were RCTs reported as having stopped early for benefit and matching nontruncated RCTs from systematic reviews. Independent reviewers with medical content expertise, working blinded to trial results, judged the eligibility of the nontruncated RCTs based on their similarity to the truncated RCTs. Data Extraction Reviewers with methodological expertise conducted data extraction independently. Results The analysis included 91 truncated RCTs asking 63 different questions and 424 matching nontruncated RCTs. The pooled ratio of relative risks in truncated RCTs vs matching nontruncated RCTs was 0.71 (95% confidence interval, 0.65-0.77). This difference was independent of the presence of a statistical stopping rule and the methodological quality of the studies as assessed by allocation concealment and blinding. Large differences in treatment effect size between truncated and nontruncated RCTs (ratio of relative risks <0.75) occurred with truncated RCTs having fewer than 500 events. In 39 of the 63 questions (62%), the pooled effects of the nontruncated RCTs failed to demonstrate significant benefit. Conclusions Truncated RCTs were associated with greater effect sizes than RCTs not stopped early. This difference was independent of the presence of statistical stopping rules and was greatest in smaller studies. JAMA. 2010; 303(12): 1180-1187	[Montori, Victor M.; Lane, Melanie] Mayo Clin, Knowledge & Encounter Res Unit, Rochester, MN 55905 USA; [Bassler, Dirk; Briel, Matthias; Zhou, Qi; Heels-Ansdell, Diane; Walter, Stephen D.; Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Bassler, Dirk] Univ Childrens Hosp Tuebingen, Dept Neonatol, Tubingen, Germany; [Briel, Matthias] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Glasziou, Paul] Univ Oxford, Dept Primary Hlth Care, Ctr Evidence Based Med, Oxford, England	Mayo Clinic; McMaster University; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Basel; University of Oxford	Montori, VM (corresponding author), Mayo Clin, Knowledge & Encounter Res Unit, Plummer 3-35,200 1st St SW, Rochester, MN 55905 USA.	montori.victor@mayo.edu	Briel, Matthias/AAT-9284-2021; Glasziou, Paul/A-7832-2008; Akl, Elie A/R-2079-2016; Zhou, Qi/GSM-9583-2022; Djulbegovic, Benjamin/I-3661-2012; Walter, Stephen/AAB-5548-2022	Glasziou, Paul/0000-0001-7564-073X; Akl, Elie A/0000-0002-3444-8618; Djulbegovic, Benjamin/0000-0003-0671-1447; Walter, Stephen/0000-0003-4157-8928; Schunemann, Holger/0000-0003-3211-8479; Briel, Matthias/0000-0002-2070-5230; Urrutia, Gerard/0000-0002-8850-0960; Alonso-Coello, Pablo/0000-0002-8001-8504; Murad, Mohammad Hassan/0000-0001-5502-5975; Montori, Victor/0000-0003-0595-2898; Perera, Rafael/0000-0003-2418-2091; Malaga, German/0000-0002-7828-300X; Ramsay, Tim/0000-0001-8478-8170; Bassler, Dirk/0000-0003-2358-4419	UK Medical Research Council [G0600561]; Swiss National Science Foundation [PASMA-112951/1]; Roche Research Foundation; Santesuisse; Gottfried and Julia Bangerter-Rhyner-Foundation; Canadian Institutes of Health Research; Medical Research Council [G0600561] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Roche Research Foundation; Santesuisse; Gottfried and Julia Bangerter-Rhyner-Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding/Support: This study was funded by the UK Medical Research Council (reference G0600561). Dr Briel is supported by a scholarship for advanced researchers from the Swiss National Science Foundation (PASMA-112951/1) and the Roche Research Foundation. Dr Kunz, Dr Bucher, Dr Nordmann, and Dr Raatz are supported by grants from Santesuisse and the Gottfried and Julia Bangerter-Rhyner-Foundation. Dr Cook holds a Research Chair from the Canadian Institutes of Health Research.	Bassler D, 2008, J CLIN EPIDEMIOL, V61, P241, DOI 10.1016/j.jclinepi.2007.07.016; Bassler D, 2007, J CLIN EPIDEMIOL, V60, P869, DOI 10.1016/j.jclinepi.2006.12.006; Briel M, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-49; Freidlin B, 2009, CLIN TRIALS, V6, P119, DOI 10.1177/1740774509102310; Goodman SN, 2007, ANN INTERN MED, V146, P882, DOI 10.7326/0003-4819-146-12-200706190-00010; Goodman SN, 2009, CLIN TRIALS, V6, P133, DOI 10.1177/1740774509103609; Grant AM, 2005, LANCET, V365, P711; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Korn EL, 2009, J CLIN ONCOL, V27, P1712, DOI 10.1200/JCO.2008.19.5339; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Mueller PS, 2007, ANN INTERN MED, V146, P878, DOI 10.7326/0003-4819-146-12-200706190-00009; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Pocock S, 1999, LANCET, V353, P943, DOI 10.1016/S0140-6736(98)00379-1; Pocock SJ, 2005, JAMA-J AM MED ASSOC, V294, P2228, DOI 10.1001/jama.294.17.2228; POCOCK SJ, 1989, CONTROL CLIN TRIALS, V10, pS209; Pocock SJ, 2006, CLIN TRIALS, V3, P513, DOI 10.1177/1740774506073467; Psaty BM, 2003, JAMA-J AM MED ASSOC, V289, P2128, DOI 10.1001/jama.289.16.2128; Sargent D, 2009, J CLIN ONCOL, V27, P1543, DOI 10.1200/JCO.2008.20.8611; Schulz KF, 2005, LANCET, V365, P1657, DOI 10.1016/S0140-6736(05)66516-6; Sydes MR, 2008, J CLIN EPIDEMIOL, V61, P203, DOI 10.1016/j.jclinepi.2007.08.002; Trotta F, 2008, ANN ONCOL, V19, P1347, DOI 10.1093/annonc/mdn042; Wheatley K, 2003, CONTROL CLIN TRIALS, V24, P66, DOI 10.1016/S0197-2456(02)00273-8	22	431	433	0	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2010	303	12					1180	1187		10.1001/jama.2010.310	http://dx.doi.org/10.1001/jama.2010.310			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573AC	20332404				2022-12-28	WOS:000275879600023
J	Lemyze, M; Baudry, JF; Collet, F; Guinard, N				Lemyze, M.; Baudry, J. F.; Collet, F.; Guinard, N.			Case Report Life threatening lactic acidosis	BRITISH MEDICAL JOURNAL			English	Editorial Material							INTENSIVE-CARE-UNIT; METFORMIN; HEMODIALYSIS; THERAPY		[Lemyze, M.] Schaffner Hosp, Dept Crit Care Med, F-62300 Lens, France; [Baudry, J. F.; Collet, F.; Guinard, N.] Hop Broussais, Dept Crit Care Med, F-35400 St Malo, France		Lemyze, M (corresponding author), Schaffner Hosp, Dept Crit Care Med, F-62300 Lens, France.	malcolmlemyze@yahoo.fr						Almirall J, 2008, NEPHROL DIAL TRANSPL, V23, P2436, DOI 10.1093/ndt/gfn152; [Anonymous], 2009, DRUG TOPICS; Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; Calabrese AT, 2002, ARCH INTERN MED, V162, P434, DOI 10.1001/archinte.162.4.434; Carvalho C, 2008, MOL CELL BIOCHEM, V308, P75, DOI 10.1007/s11010-007-9614-3; Chan KA, 2003, ARCH INTERN MED, V163, P728, DOI 10.1001/archinte.163.6.728; Cohen R.D., 1976, OXFORD; Finkle SN, 2009, CRIT CARE, V13, DOI 10.1186/cc7161; Heaney D, 1997, NEPHROL DIAL TRANSPL, V12, P1046, DOI 10.1093/ndt/12.5.1046; LeGall JR, 1996, JAMA-J AM MED ASSOC, V276, P802, DOI 10.1001/jama.276.10.802; Panzer U, 2004, NEPHROL DIAL TRANSPL, V19, P2157, DOI 10.1093/ndt/gfh337; Peters N, 2008, CRIT CARE, V12, DOI 10.1186/cc7137; Seidowsky A, 2009, CRIT CARE MED, V37, P2191, DOI 10.1097/CCM.0b013e3181a02490; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8	14	9	9	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 24	2010	340								c857	10.1136/bmj.c857	http://dx.doi.org/10.1136/bmj.c857			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	576PP	20335644				2022-12-28	WOS:000276157700015
J	Taylor, C; Munro, AJ; Glynne-Jones, R; Griffith, C; Trevatt, P; Richards, M; Ramirez, AJ				Taylor, Cath; Munro, Alastair J.; Glynne-Jones, Rob; Griffith, Clive; Trevatt, Paul; Richards, Michael; Ramirez, Amanda J.			Multidisciplinary team working in cancer: what is the evidence?	BRITISH MEDICAL JOURNAL			English	Editorial Material							BREAST-CANCER; TREATMENT PLAN; IMPACT; MANAGEMENT; OUTCOMES; SURVIVAL; DISEASE; CARE		[Munro, Alastair J.] Univ Dundee, Ninewells Hosp, Dundee DD1 9SY, Scotland; [Glynne-Jones, Rob] Mt Vernon Canc Ctr, Northwood HA6 2RN, Middx, England; [Griffith, Clive] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Trevatt, Paul] NE London Canc Network, London E1 1BB, England; [Richards, Michael] St Thomas Hosp, Natl Canc Act Team, London SE1 7EH, England; [Ramirez, Amanda J.] St Thomas Hosp, Adamson Ctr, Canc Res UK Promoting Early Presentat Grp, London SE1 7EH, England	University of Dundee; Mount Vernon Cancer Centre; Newcastle University - UK; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust		cath.taylor@kcl.ac.uk			Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Aradhana G, 2022, P 2022 IEEE INT C CO, P25; Birchall M, 2004, BRIT J CANCER, V91, P1477, DOI 10.1038/sj.bjc.6602118; Blazeby JM, 2006, ANN ONCOL, V17, P457, DOI 10.1093/annonc/mdj102; Burton S, 2006, BRIT J CANCER, V94, P351, DOI 10.1038/sj.bjc.6602947; Butow P, 2007, CANCER-AM CANCER SOC, V110, P1937, DOI 10.1002/cncr.23007; Chang JH, 2001, CANCER-AM CANCER SOC, V91, P1231, DOI 10.1002/1097-0142(20010401)91:7<1231::AID-CNCR1123>3.0.CO;2-K; Choy ET, 2007, BREAST, V16, P178, DOI 10.1016/j.breast.2006.10.002; *CLIN OUTC GROUP C, 1996, IMPR OUTC BREAST CAN; Coory M, 2008, LUNG CANCER, V60, P14, DOI 10.1016/j.lungcan.2008.01.008; Davies AR, 2006, DIS ESOPHAGUS, V19, P496, DOI 10.1111/j.1442-2050.2006.00629.x; *DEP HLTH, 2000, COR HEART DIS NAT SE; Department of Health, 2001, NAT SERV FRAM OLD PE; Department of Health, 1999, NAT SERV FRAM MENT H; Department of Health, 2001, NAT SERV FRAM DIAB S; Department of Health, 2004, MAN CANC SERV; Department of Health, 2007, CANC REF STRAT; Eaker S, 2005, CANCER EPIDEM BIOMAR, V14, P2914, DOI 10.1158/1055-9965.EPI-05-0317; Gabel M, 1997, CANCER, V79, P2380; Houssami N, 2006, EUR J CANCER, V42, P2480, DOI 10.1016/j.ejca.2006.05.023; Kagan AR, 2005, INT J RADIAT ONCOL, V61, P967, DOI 10.1016/j.ijrobp.2004.10.040; Kane B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-15; Morris E, 2006, BRIT J CANCER, V95, P979, DOI 10.1038/sj.bjc.6603372; National Cancer Action Team, 2008, NAT CANC PEER REV PR; National Institute for Health and Clinical Excellence, 2004, CHRON OBSTR PULM DIS; Picker Institute Europe, 2005, IS NHS GETT BETT WOR; Richards MA, 1994, PROVISION BREAST SER; Stephens MR, 2006, DIS ESOPHAGUS, V19, P164, DOI 10.1111/j.1442-2050.2006.00559.x; Taylor C., 2009, MULTIDISCIPLINARY TE; The Expert Advisory Group on Cancer to the Chief Medical Officers of England and Wales, 1995, POL FRAM COMM CANC S; Trevino LK, 2008, ACAD MANAGE REV, V33, P8, DOI 10.5465/AMR.2008.27744831; Wood JJ, 2008, COLORECTAL DIS, V10, P769, DOI 10.1111/j.1463-1318.2007.01464.x	31	244	254	0	32	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 23	2010	340								c951	10.1136/bmj.c951	http://dx.doi.org/10.1136/bmj.c951			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	576PO	20332315				2022-12-28	WOS:000276157600011
J	Cunningham, D; Atkin, W; Lenz, HJ; Lynch, HT; Minsky, B; Nordlinger, B; Starling, N				Cunningham, David; Atkin, Wendy; Lenz, Heinz-Josef; Lynch, Henry T.; Minsky, Bruce; Nordlinger, Bernard; Starling, Naureen			Colorectal cancer	LANCET			English	Article							III COLON-CANCER; FECAL OCCULT BLOOD; SURGICAL ADJUVANT CHEMOTHERAPY; POSITRON-EMISSION-TOMOGRAPHY; CETUXIMAB PLUS IRINOTECAN; RANDOMIZED CLINICAL-TRIAL; WEEKLY BOLUS FLUOROURACIL; INDIVIDUAL PATIENT DATA; MRC CLASICC TRIAL; QUALITY-OF-LIFE	Substantial progress has been made in colorectal cancer in the past decade. Screening, used to identify individuals at an early stage, has improved outcome. There is greater understanding of the genetic basis of inherited colorectal cancer and identification of patients at risk. Optimisation of surgery for patients with localised disease has had a major effect on survival at 5 years and 10 years. For rectal cancer, identification of patients at greatest risk of local failure is important in the selection of patients for preoperative chemoradiation, a strategy proven to improve outcomes in these patients. Stringent postoperative follow-up helps the early identification of potentially radically treatable oligometastatic disease and improves long-term survival. Treatment with adjuvant fluoropyrimidine for colon and rectal cancers further improves survival, more so in stage III than in stage II disease, and oxaliplatin-based combination chemotherapy is now routinely used for stage HI disease, although efficacy must be carefully balanced against toxicity. In stage II disease, molecular markers such as microsatellite instability might help select patients for treatment. The integration of targeted treatments with conventional cytotoxic drugs has expanded the treatment of metastatic disease resulting in incremental survival gains. However, biomarker development is essential to aid selection of patients likely to respond to therapy, thereby rationalising treatments and improving outcomes.	[Cunningham, David] Royal Marsden Hosp, Dept Med, Natl Hlth Serv Fdn Trust, Gastrointestinal Unit, Sutton SM2 5PT, Surrey, England; [Cunningham, David; Starling, Naureen] Royal Marsden Hosp, Gastrointestinal Unit, Natl Hlth Serv Fdn Trust, London SW3 6JJ, England; [Atkin, Wendy] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Lenz, Heinz-Josef] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Sharon Carpenter Lab, Los Angeles, CA 90033 USA; [Lynch, Henry T.] Creighton Univ, Sch Med, Dept Prevent Med & Publ Hlth, Omaha, NE USA; [Minsky, Bruce] Univ Chicago, Med Ctr, Chicago, IL 60637 USA; [Nordlinger, Bernard] Hop Ambroise Pare, Serv Chirurg Gen & Digest, Boulogne, France	Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Imperial College London; University of Southern California; Creighton University; University of Chicago; University of Chicago Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Cunningham, D (corresponding author), Royal Marsden Hosp, Dept Med, Natl Hlth Serv Fdn Trust, Gastrointestinal Unit, Downs Rd, Sutton SM2 5PT, Surrey, England.	David.cunningham@rmh.nhs.uk		Starling, Naureen/0000-0002-1496-6792; Cunningham, David/0000-0001-5158-1069	Sanofi-Aventis; Roche; Amgen; Pfizer; Merck; Novartis; National Institute for Health Research Biomedical Research Centre; Medical Research Council [G9615910] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10154] Funding Source: researchfish; MRC [G9615910] Funding Source: UKRI	Sanofi-Aventis(Sanofi-Aventis); Roche(Roche Holding); Amgen(Amgen); Pfizer(Pfizer); Merck(Merck & Company); Novartis(Novartis); National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	BM has been on speaker's bureau for Sanofi-Aventis, Genentech, and Roche; and has been a consultant for Sanofi-Aventis. HJL is a consultant for Response Genetics. BMS is a consultant for ImClone and Merck, and holds stock options for Response Genetics. DC has received research funding from Sanofi-Aventis, Roche, Amgen, Pfizer, Merck, Novartis. WA, BN, and NS declare that they have no conflicts of interest.; DC is part funded by the National Institute for Health Research Biomedical Research Centre.	AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Alazzouzi H, 2005, CLIN CANCER RES, V11, P2606, DOI 10.1158/1078-0432.CCR-04-1458; Alhopuro P, 2005, CLIN CANCER RES, V11, P6311, DOI 10.1158/1078-0432.CCR-05-0244; *AM CANC SOC, 2009, DET GUID COL RECT CA; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; [Anonymous], 2008, CLIN GASTROENTEROL H, V6, P206, DOI 10.1016/j.cgh.2007.10.011; ASCHELE C, 2009, P ACOS M ABSTR S, V27; Atkin WS, 2000, BRIT MED J, V320, P1504, DOI 10.1136/bmj.320.7248.1504; ATKIN WS, 1993, LANCET, V341, P736, DOI 10.1016/0140-6736(93)90499-7; Atkin WS, 2001, J MED SCREEN, V8, P137, DOI 10.1136/jms.8.3.137; Bach SP, 2009, BRIT J SURG, V96, P280, DOI 10.1002/bjs.6456; Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Barratt PL, 2002, LANCET, V360, P1381, DOI 10.1016/S0140-6736(02)11402-4; Barrow E, 2009, CLIN GENET, V75, P141, DOI 10.1111/j.1399-0004.2008.01125.x; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Benson VS, 2008, INT J CANCER, V122, P1357, DOI 10.1002/ijc.23273; Berg AO, 2009, GENET MED, V11, P35, DOI [10.1097/GIM.0b013e318181fa2ff, 10.1097/GIM.0b013e31818fa2ff]; Bertagnolli MM, 2009, J CLIN ONCOL, V27, P1814, DOI 10.1200/JCO.2008.18.2071; Bertolini F, 2007, INT J RADIAT ONCOL, V68, P1455, DOI 10.1016/j.ijrobp.2007.02.018; Bipat S, 2005, RADIOLOGY, V237, P123, DOI 10.1148/radiol.2371042060; Bipat S, 2004, RADIOLOGY, V232, P773, DOI 10.1148/radiol.2323031368; Birgisson H, 2005, J CLIN ONCOL, V23, P8697, DOI 10.1200/JCO.2005.02.9017; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; Bretagnol F, 2004, DIS COLON RECTUM, V47, P832, DOI 10.1007/s10350-004-0523-1; Bretthauer N, 2002, SCAND J GASTROENTERO, V37, P568, DOI 10.1080/00365520252903125; Brown G, 2006, BRIT MED J, V333, P779, DOI 10.1136/bmj.38937.646400.55; Brown G, 2003, BRIT J SURG, V90, P355, DOI 10.1002/bjs.4034; Bujko K, 2006, BRIT J SURG, V93, P1215, DOI 10.1002/bjs.5506; Bulow S, 1996, INT J COLORECTAL DIS, V11, P88, DOI 10.1007/s003840050027; Burton S, 2006, INT J RADIAT ONCOL, V65, P445, DOI 10.1016/j.ijrobp.2005.12.027; Bussey H.J.R., 1975, FAMILIAL POLYPOSIS C; Callister MD, 2006, INT J RADIAT ONCOL, V66, pS290, DOI 10.1016/j.ijrobp.2006.07.547; Cassidy J, 2008, J CLIN ONCOL, V26, P2006, DOI 10.1200/JCO.2007.14.9898; Castiglione G, 2002, J MED SCREEN, V9, P99, DOI 10.1136/jms.9.3.99; Ceelen W, 2007, ANN SURG ONCOL, V14, P424, DOI 10.1245/s10434-006-9102-0; Chamlou R, 2007, ANN SURG, V246, P916, DOI 10.1097/SLA.0b013e31815c29ff; Chang GJ, 2007, J NATL CANCER I, V99, P433, DOI 10.1093/jnci/djk092; Chau I, 2004, J CLIN ONCOL, V22, P1420, DOI 10.1200/JCO.2004.05.041; Collins JF, 2005, ANN INTERN MED, V142, P81, DOI 10.7326/0003-4819-142-2-200501180-00006; Copel L, 2007, RADIOLOGY, V244, P471, DOI 10.1148/radiol.2442060837; Cornish JA, 2007, ANN SURG ONCOL, V14, P2056, DOI 10.1245/s10434-007-9402-z; CRANE CH, 2008, P ASCO M ABSTR S, V26, P4091; Cunningham D, 2009, ANN ONCOL, V20, P244, DOI 10.1093/annonc/mdn638; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Cunningham D, 2007, LANCET, V370, P1980, DOI 10.1016/S0140-6736(07)61841-8; Cunningham JM, 1998, CANCER RES, V58, P3455; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Diehl F, 2008, GASTROENTEROLOGY, V135, P489, DOI 10.1053/j.gastro.2008.05.039; Dove-Edwin I, 2005, BMJ-BRIT MED J, V331, P1047, DOI 10.1136/bmj.38606.794560.EB; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Engel C, 2006, INT J CANCER, V118, P115, DOI 10.1002/ijc.21313; FERNANDEZMARTOS C, 2009, P AN M AM SOC CLIN, V27, P4103; Fields ALA, 2009, J CLIN ONCOL, V27, P1941, DOI 10.1200/JCO.2008.18.5710; Fioole B, 2008, EUR J RADIOL, V67, P169, DOI 10.1016/j.ejrad.2007.03.017; Fockens P, 2005, EUR J GASTROEN HEPAT, V17, P783, DOI 10.1097/00042737-200508000-00001; Folprecht G, 2005, ANN ONCOL, V16, P1311, DOI 10.1093/annonc/mdi246; Folprecht G, 2010, LANCET ONCOL, V11, P38, DOI 10.1016/S1470-2045(09)70330-4; Furukawa H, 2006, GUT, V55, P1007, DOI 10.1136/gut.2005.076273; Gaasenbeek M, 2006, CANCER RES, V66, P3471, DOI 10.1158/0008-5472.CAN-05-3285; GERARD J, 2009, P ASCO M ABSTR S, V27; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Glynne-Jones R, 2008, DIS COLON RECTUM, V51, P10, DOI 10.1007/s10350-007-9080-8; Gonzalez-Moreno S, 2009, CANCER J, V15, P184, DOI 10.1097/PPO.0b013e3181a58ec3; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; Grothey A, 2004, J CLIN ONCOL, V22, P1209, DOI 10.1200/JCO.2004.11.037; Grothey A, 2008, J CLIN ONCOL, V26, P5326, DOI 10.1200/JCO.2008.16.3212; Guillem JG, 2005, ANN SURG, V241, P829, DOI 10.1097/01.sla.0000161980.46459.96; Guillem JG, 2008, J CLIN ONCOL, V26, P368, DOI 10.1200/JCO.2007.13.5434; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Gunderson LL, 2010, J CLIN ONCOL, V28, P264, DOI 10.1200/JCO.2009.24.0952; Habr-Gama A, 1998, DIS COLON RECTUM, V41, P1087, DOI 10.1007/BF02239429; HALLER D, 2009, EJC SUPPL, V7, pLBA5; Halligan S, 2005, RADIOLOGY, V237, P893, DOI 10.1148/radiol.2373050176; Halling KC, 1999, JNCI-J NATL CANCER I, V91, P1295, DOI 10.1093/jnci/91.15.1295; Hampel H, 2008, J CLIN ONCOL, V26, P5783, DOI 10.1200/JCO.2008.17.5950; Hecht JR, 2009, J CLIN ONCOL, V27, P672, DOI 10.1200/JCO.2008.19.8135; Hewett PJ, 2008, ANN SURG, V248, P728, DOI 10.1097/SLA.0b013e31818b7595; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Itzkowitz SH, 2004, GASTROENTEROLOGY, V126, P1634, DOI 10.1053/j.gastro.2004.03.025; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; Aristu JJ, 2008, INT J RADIAT ONCOL, V71, P748, DOI 10.1016/j.ijrobp.2007.10.023; Jayne DG, 2007, J CLIN ONCOL, V25, P3061, DOI 10.1200/JCO.2006.09.7758; Jayne DG, 2005, BRIT J SURG, V92, P1124, DOI 10.1002/bjs.4989; Jeffery GM, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002200; JEN J, 1994, NEW ENGL J MED, V331, P213, DOI 10.1056/NEJM199407283310401; Johnston PG, 2006, J CLIN ONCOL, V24, P4049, DOI 10.1200/JCO.2006.06.6530; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Kane MF, 1997, CANCER RES, V57, P808; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; KOHNE C, 2009, P ASCO M ABSTR, V27, P4068; Kuebler JP, 2007, J CLIN ONCOL, V25, P2198, DOI 10.1200/JCO.2006.08.2974; LABIANCA R, 1995, LANCET, V345, P939; Lacy AM, 2008, ANN SURG, V248, P1, DOI 10.1097/SLA.0b013e31816a9d65; Lakoff J, 2008, CLIN GASTROENTEROL H, V6, P1117, DOI 10.1016/j.cgh.2008.05.016; Land SR, 2007, J CLIN ONCOL, V25, P2205, DOI 10.1200/JCO.2006.08.6652; Le Voyer TE, 2003, J CLIN ONCOL, V21, P2912, DOI 10.1200/JCO.2003.05.062; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Leung KL, 2004, LANCET, V363, P1187, DOI 10.1016/S0140-6736(04)15947-3; Lindor NM, 2005, JAMA-J AM MED ASSOC, V293, P1979, DOI 10.1001/jama.293.16.1979; Llor X, 2005, CLIN CANCER RES, V11, P7304, DOI 10.1158/1078-0432.CCR-05-0965; Loeve F, 2000, J NATL CANCER I, V92, P557, DOI 10.1093/jnci/92.7.557; LOTHE RA, 1993, CANCER RES, V53, P5849; Lynch HT, 2007, J CLIN ONCOL, V25, P3534, DOI 10.1200/JCO.2006.10.3119; Lynch HT, 2007, J NATL CANCER I, V99, P261, DOI 10.1093/jnci/djk077; Lynch HT, 1999, J MED GENET, V36, P801; Mainenti PP, 2005, ABDOM IMAGING, V30, P42, DOI 10.1007/s00261-004-0246-8; Marijnen CAM, 2003, INT J RADIAT ONCOL, V55, P1311, DOI 10.1016/S0360-3016(02)04291-8; Mauchley DC, 2005, AM J SURG, V189, P512, DOI 10.1016/j.amjsurg.2005.01.027; MAUGHAN T, 2009, EJC SUPPL, V7, pLBA6; Maughan TS, 2003, LANCET, V361, P457, DOI 10.1016/S0140-6736(03)12461-0; MCCLEARY NAJ, 2009, P AN M AM SOC CLIN, V27, P4010; Meyer J, 2007, CLIN COLORECTAL CANC, V6, P348, DOI 10.3816/CCC.2007.n.003; Mohiuddin M, 2006, J CLIN ONCOL, V24, P650, DOI 10.1200/JCO.2005.03.6095; Morrin MM, 1999, AM J ROENTGENOL, V172, P913, DOI 10.2214/ajr.172.4.10587120; Nascimbeni R, 2002, DIS COLON RECTUM, V45, P200, DOI 10.1007/s10350-004-6147-7; National Comprehensive Cancer Network, 2009, NCCN CLIN PRACT GUID, V1; Negri Francesca, 2004, Clin Colorectal Cancer, V4, P101, DOI 10.3816/CCC.2004.n.013; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Newcomb PA, 2003, J NATL CANCER I, V95, P622, DOI 10.1093/jnci/95.8.622; Noffsinger AE, 2009, ANNU REV PATHOL-MECH, V4, P343, DOI 10.1146/annurev.pathol.4.110807.092317; Nordlinger B, 2008, LANCET, V371, P1007, DOI 10.1016/S0140-6736(08)60455-9; Ogino S, 2009, J CLIN ONCOL, V27, P4591, DOI 10.1200/JCO.2009.22.8858; Ogunbiyi OA, 1998, J CLIN ONCOL, V16, P427, DOI 10.1200/JCO.1998.16.2.427; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peeters KCMJ, 2007, ANN SURG, V246, P693, DOI 10.1097/01.sla.0000257358.56863.ce; PEETERS M, 2010, GASTROINTESTINAL S, P282; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; PESTERS KCM, 2007, ANN SURG, V246, P693; Pickhardt PJ, 2008, RADIOLOGY, V249, P151, DOI 10.1148/radiol.2491072148; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; Pignone M, 2002, ANN INTERN MED, V137, P96, DOI 10.7326/0003-4819-137-2-200207160-00007; PIGNONE M, 2002, SCREENING COLORECTAL; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Popat S, 2005, EUR J CANCER, V41, P2060, DOI 10.1016/j.ejca.2005.04.039; Popat S, 2007, ANTICANCER RES, V27, P627; Porschen R, 2007, J CLIN ONCOL, V25, P4217, DOI 10.1200/JCO.2006.09.2684; Pox C, 2007, ENDOSCOPY, V39, P168, DOI 10.1055/s-2007-966182; Prandi M, 2002, ANN SURG, V235, P458, DOI 10.1097/00000658-200204000-00002; Quirke P, 2009, LANCET, V373, P821, DOI 10.1016/S0140-6736(09)60485-2; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Renehan AG, 2002, BMJ-BRIT MED J, V324, P813, DOI 10.1136/bmj.324.7341.813; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Rodel C, 2008, INT J RADIAT ONCOL, V70, P1081, DOI 10.1016/j.ijrobp.2007.07.2356; Ruers T, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.4012; Rullier E, 2005, ANN SURG, V241, P465, DOI 10.1097/01.sla.0000154551.06768.e1; Rutten H, 2006, J CLIN ONCOL, V24, p153S; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Saltz LB, 2007, J CLIN ONCOL, V25, P4557, DOI 10.1200/JCO.2007.12.0949; Saltz LB, 2007, J CLIN ONCOL, V25, P3456, DOI 10.1200/JCO.2007.11.2144; Sargent DJ, 2007, J CLIN ONCOL, V25, P4569, DOI 10.1200/JCO.2006.10.4323; Sargent DJ, 2005, J CLIN ONCOL, V23, P8664, DOI 10.1200/JCO.2005.01.6071; SARGENT DJ, 2008, P ASCO M ABSTR S, V26, P4008; Sauer R, 2005, NEW ENGL J MED, V352, P510; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Scappaticci FA, 2005, J SURG ONCOL, V91, P173, DOI 10.1002/jso.20301; Schmeler KM, 2006, NEW ENGL J MED, V354, P261, DOI 10.1056/NEJMoa052627; Sebag-Montefiore D, 2009, LANCET, V373, P811, DOI 10.1016/S0140-6736(09)60484-0; Segnan N, 2002, J NATL CANCER I, V94, P1763; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Senter L, 2008, GASTROENTEROLOGY, V135, P419, DOI 10.1053/j.gastro.2008.04.026; Seymour MT, 2007, LANCET, V370, P143, DOI 10.1016/S0140-6736(07)61087-3; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; SIENA S, 2010, GASTROINTESTINAL S, V283; SOBIN LH, 2010, TMN CLASSIFICATION M; Sobrero AF, 2008, J CLIN ONCOL, V26, P2311, DOI 10.1200/JCO.2007.13.1193; Steele RJC, 2001, J MED SCREEN, V8, P197, DOI 10.1136/jms.8.4.197; Tappenden P, 2007, GUT, V56, P677, DOI 10.1136/gut.2006.095109; Tejpar S, 2009, J CLIN ONCOL, V27; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Tournigand C, 2006, J CLIN ONCOL, V24, P394, DOI 10.1200/JCO.2005.03.0106; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Towler B, 1998, BRIT MED J, V317, P559, DOI 10.1136/bmj.317.7158.559; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Trautmann K, 2006, CLIN CANCER RES, V12, P6379, DOI 10.1158/1078-0432.CCR-06-1248; Triantafillidis JK, 2009, ANTICANCER RES, V29, P2727; Truant S, 2005, BRIT J SURG, V92, P362, DOI 10.1002/bjs.4843; Tsikitis VL, 2009, J CLIN ONCOL, V27, P3671, DOI 10.1200/JCO.2008.20.7050; Twelves C, 2005, NEW ENGL J MED, V352, P2696, DOI 10.1056/NEJMoa043116; Tytherleigh MG, 2008, BRIT J SURG, V95, P409, DOI 10.1002/bjs.6127; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Van Cutsem E, 2009, ANN ONCOL, V20, P49, DOI 10.1093/annonc/mdp126; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Van Cutsem E, 2009, J CLIN ONCOL, V27, P3117, DOI 10.1200/JCO.2008.21.6663; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; van Duijvendijk P, 2002, AM J GASTROENTEROL, V97, P2282, DOI 10.1016/S0002-9270(02)04138-2; VANCUTSEM E, 2010, GASTROINTESTINAL S, V281; VANCUTSEM E, 2009, EUR J CANCER, V7, P6077; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; Verdecchia A, 2007, LANCET ONCOL, V8, P784, DOI 10.1016/S1470-2045(07)70246-2; Vijan S, 2007, AM J GASTROENTEROL, V102, P380, DOI 10.1111/j.1572-0241.2006.00970.x; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; von Roon AC, 2007, DIS COLON RECTUM, V50, P839, DOI 10.1007/s10350-006-0848-z; Ward J, 2006, Cancer Imaging, V6, P33, DOI 10.1102/1470-7330.2006.0007; Watanabe T, 2001, NEW ENGL J MED, V344, P1196, DOI 10.1056/NEJM200104193441603; Watson P, 2008, INT J CANCER, V123, P444, DOI 10.1002/ijc.23508; Weissfeld JL, 2005, JNCI-J NATL CANCER I, V97, P989, DOI 10.1093/jnci/dji175; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Wilke H, 2008, J CLIN ONCOL, V26, P5335, DOI 10.1200/JCO.2008.16.3758; Willett CG, 2009, J CLIN ONCOL, V27, P3020, DOI 10.1200/JCO.2008.21.1771; WOLMARK N, 2009, P ASCO M ABSTR S, V27, pLBA4; WONG SJ, 2008, P ASCO M ABSTR S, V26, P4021; Ychou M, 2009, ANN ONCOL, V20, P674, DOI 10.1093/annonc/mdn680; Young J, 2007, GUT, V56, P1453, DOI 10.1136/gut.2007.126870; 2009, CETUXIMAB 1 LINE TRE; 2009, COLORECTAL CANC RISK; 2009, ADDITION CETUXIMAB S	213	1190	1246	2	302	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 20	2010	375	9719					1030	1047		10.1016/S0140-6736(10)60353-4	http://dx.doi.org/10.1016/S0140-6736(10)60353-4			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	575YU	20304247				2022-12-28	WOS:000276110700036
J	Huang, F; Chakraborty, P; Lundstrom, CC; Holmden, C; Glessner, JJG; Kieffer, SW; Lesher, CE				Huang, F.; Chakraborty, P.; Lundstrom, C. C.; Holmden, C.; Glessner, J. J. G.; Kieffer, S. W.; Lesher, C. E.			Isotope fractionation in silicate melts by thermal diffusion	NATURE			English	Article							TEMPERATURE-DEPENDENCE; SEPARATION; EXCHANGE; LIQUIDS; CA; ND	The phenomenon of thermal diffusion (mass diffusion driven by a temperature gradient, known as the Ludwig-Soret effect(1,2)) has been investigated for over 150 years, but an understanding of its underlying physical basis remains elusive. A significant hurdle in studying thermal diffusion has been the difficulty of characterizing it. Extensive experiments over the past century have established that the Soret coefficient, S-T (a single parameter that describes the steady-state result of thermal diffusion), is highly sensitive to many factors(3-9). This sensitivity makes it very difficult to obtain a robust characterization of thermal diffusion, even for a single material. Here we show that for thermal diffusion experiments that span a wide range in composition and temperature, the difference in ST between isotopes of diffusing elements that are network modifiers ( iron, calcium and magnesium) is independent of the composition and temperature. On the basis of this finding, we propose an additive decomposition for the functional form of ST and argue that a theoretical approach based on local thermodynamic equilibrium(3,5,10) holds promise for describing thermal diffusion in silicate melts and other complex solutions. Our results lead to a simple and robust framework for characterizing isotope fractionation by thermal diffusion in natural and synthetic systems.	[Huang, F.; Chakraborty, P.; Lundstrom, C. C.; Glessner, J. J. G.; Kieffer, S. W.] Univ Illinois, Dept Geol, Urbana, IL 61801 USA; [Holmden, C.] Univ Saskatchewan, Dept Geol Sci, Saskatoon, SK S7N 5E2, Canada; [Lesher, C. E.] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Saskatchewan; University of California System; University of California Davis	Lundstrom, CC (corresponding author), Univ Illinois, Dept Geol, Urbana, IL 61801 USA.	lundstro@illinois.edu	Lesher, Charles E/A-2468-2015	Lesher, Charles E/0000-0003-4033-4809	US National Science Foundation [NSF EAR 0609726, NSF EAR 0944169, NSF EAR 0943991, NSF EAR 0732481]; Roscoe G. Jackson II Research; S.W.K.'s Walgreen Chair funds; Division Of Earth Sciences [1019887, 0944169, 0943992] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Roscoe G. Jackson II Research; S.W.K.'s Walgreen Chair funds; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work is supported by US National Science Foundation grants NSF EAR 0609726 and NSF EAR 0944169 ( C. C. L.), and NSF EAR 0943991 (C. E. L.). The multi-collector inductively-coupled-plasma mass spectrometry laboratory at the University of Illinois at Urbana-Champaign is supported by NSF EAR 0732481. P. C. acknowledges support from a Roscoe G. Jackson II Research Fellowship. P. C. and S. W. K. acknowledge support from S.W.K.'s Walgreen Chair funds. We thank B. Fouke for use of his micro-drilling system, Z. Zhang and X. Li for analytical assistance, V. Kariwala for help with references and Y. Zhang for a review of this work.	Astumian RD, 2007, P NATL ACAD SCI USA, V104, P3, DOI 10.1073/pnas.0609754104; Braun D, 2004, PHYS BIOL, V1, pP1, DOI 10.1088/1478-3967/1/1/P01; Debuschewitz C, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.055901; Duhr S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.168301; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; Furry WH, 1939, PHYS REV, V55, P1083, DOI 10.1103/PhysRev.55.1083; GROOT SRD, 1959, THERMODYNAMICS IRREV, P111; Holmden C, 2010, GEOCHIM COSMOCHIM AC, V74, P995, DOI 10.1016/j.gca.2009.10.020; Huang F, 2009, GEOCHIM COSMOCHIM AC, V73, P729, DOI 10.1016/j.gca.2008.11.012; Huang F, 2009, CHEM GEOL, V268, P15, DOI 10.1016/j.chemgeo.2009.07.003; Kyser TK, 1998, CONTRIB MINERAL PETR, V133, P373, DOI 10.1007/s004100050459; LaTourrette T, 1996, GEOCHIM COSMOCHIM AC, V60, P1329, DOI 10.1016/0016-7037(96)00015-4; LESHER CE, 1990, NATURE, V344, P235, DOI 10.1038/344235a0; LESHER CE, 1986, GEOCHIM COSMOCHIM AC, V50, P1397, DOI 10.1016/0016-7037(86)90313-3; LESHER CE, 1994, J GEOPHYS RES-SOL EA, V99, P9585, DOI 10.1029/94JB00469; LESHER CE, 1991, ADV PHYS GE, V8, P396; Ludwig C., 1856, S B AKAD WISS VIENNA, V20, P539; Lundstrom C, 2009, GEOCHIM COSMOCHIM AC, V73, P5709, DOI 10.1016/j.gca.2009.06.020; OTT A, 1969, SCIENCE, V164, P297, DOI 10.1126/science.164.3877.297; Platten JK, 2006, J APPL MECH-T ASME, V73, P5, DOI 10.1115/1.1992517; Putnam SA, 2007, LANGMUIR, V23, P9221, DOI 10.1021/la700489e; Reith D, 2000, J CHEM PHYS, V112, P2436, DOI 10.1063/1.480809; Richter FM, 2008, GEOCHIM COSMOCHIM AC, V72, P206, DOI 10.1016/j.gca.2007.10.016; Richter FM, 2009, GEOCHIM COSMOCHIM AC, V73, P4250, DOI 10.1016/j.gca.2009.04.011; Severinghaus JP, 1998, NATURE, V391, P141, DOI 10.1038/34346; Severinghaus JP, 2001, GEOCHEM GEOPHY GEOSY, V2, DOI 10.1029/2000GC000146; Soret Ch., 1979, ARCH GENEVE, V2, P48; TYRRELL HJV, 1961, DIFFUSION HEAT FLOW; VANDERLAAN S, 1994, EARTH PLANET SC LETT, V123, P155, DOI 10.1016/0012-821X(94)90264-X; Wittko G, 2007, EPL-EUROPHYS LETT, V78, DOI 10.1209/0295-5075/78/46007; Wittko G, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1948368; ZHANG YX, 1993, J GEOPHYS RES-SOL EA, V98, P11901, DOI 10.1029/93JB00422	32	161	173	2	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					396	U89		10.1038/nature08840	http://dx.doi.org/10.1038/nature08840			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20237567				2022-12-28	WOS:000275657100043
J	Spence, D				Spence, Des			From the Frontline Men behaving madly: testosterone replacement therapy	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Martinez-Jabaloyas JM, 2007, EUR UROL, V52, P1760, DOI 10.1016/j.eururo.2007.05.021	1	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 18	2010	340								c1493	10.1136/bmj.c1493	http://dx.doi.org/10.1136/bmj.c1493			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573RI	20299394				2022-12-28	WOS:000275931900006
J	Thornton, JA; Kercher, JP; Riedel, TP; Wagner, NL; Cozic, J; Holloway, JS; Dube, WP; Wolfe, GM; Quinn, PK; Middlebrook, AM; Alexander, B; Brown, SS				Thornton, Joel A.; Kercher, James P.; Riedel, Theran P.; Wagner, Nicholas L.; Cozic, Julie; Holloway, John S.; Dube, William P.; Wolfe, Glenn M.; Quinn, Patricia K.; Middlebrook, Ann M.; Alexander, Becky; Brown, Steven S.			A large atomic chlorine source inferred from mid-continental reactive nitrogen chemistry	NATURE			English	Article							SEA-SALT AEROSOL; GASEOUS N2O5; CLNO2; CL; PHOTOCHEMISTRY; EMISSIONS; NITRATE; MODEL	Halogen atoms and oxides are highly reactive and can profoundly affect atmospheric composition. Chlorine atoms can decrease the lifetimes of gaseous elemental mercury(1) and hydrocarbons such as the greenhouse gas methane(2). Chlorine atoms also influence cycles that catalytically destroy or produce tropospheric ozone(3), a greenhouse gas potentially toxic to plant and animal life. Conversion of inorganic chloride into gaseous chlorine atom precursors within the troposphere is generally considered a coastal or marine air phenomenon(4). Here we report mid-continental observations of the chlorine atom precursor nitryl chloride at a distance of 1,400km from the nearest coastline. We observe persistent and significant nitryl chloride production relative to the consumption of its nitrogen oxide precursors. Comparison of these findings to model predictions based on aerosol and precipitation composition data from long-term monitoring networks suggests nitryl chloride production in the contiguous USA alone is at a level similar to previous global estimates for coastal and marine regions(5). We also suggest that a significant fraction of tropospheric chlorine atoms(6) may arise directly from anthropogenic pollutants.	[Thornton, Joel A.; Kercher, James P.; Riedel, Theran P.; Wolfe, Glenn M.; Alexander, Becky] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; [Riedel, Theran P.; Wolfe, Glenn M.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Wagner, Nicholas L.; Cozic, Julie; Holloway, John S.; Dube, William P.; Middlebrook, Ann M.; Brown, Steven S.] NOAA, Earth Syst Res Lab, Boulder, CO 80305 USA; [Cozic, Julie; Holloway, John S.; Dube, William P.] Cooperat Inst Res Environm Studies, Boulder, CO 80309 USA; [Quinn, Patricia K.] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Thornton, JA (corresponding author), Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA.	thornton@atmos.washington.edu	Middlebrook, Ann M/E-4831-2011; Wolfe, Glenn/D-5289-2011; Wagner, Nicholas L/E-7437-2010; Brown, Steven S/I-1762-2013; Thornton, Joel A/C-1142-2009; Holloway, John S/F-9911-2012; Dube, William/I-1658-2013; Alexander, Becky/N-7048-2013; Cozic, Julie/A-5464-2011	Middlebrook, Ann M/0000-0002-2984-6304; Wagner, Nicholas L/0000-0001-9936-1145; Thornton, Joel A/0000-0002-5098-4867; Holloway, John S/0000-0002-4585-9594; Dube, William/0000-0003-1286-4087; Alexander, Becky/0000-0001-9915-4621; 	NSF [ATM-0633897, ATM-0846183]; NOAA Atmospheric Chemistry and Climate Program; Camille and Henry Dreyfus Foundation; National Research Council; Div Atmospheric & Geospace Sciences [0846183] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NOAA Atmospheric Chemistry and Climate Program; Camille and Henry Dreyfus Foundation; National Research Council; Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding for the ClNO<INF>2</INF> observations and analysis was provided by NSF grants ATM-0633897 and ATM-0846183 to J. A. T. Boulder field measurements were supported in part by the NOAA Atmospheric Chemistry and Climate Program. J. P. K. thanks the Camille and Henry Dreyfus Foundation for a postdoctoral fellowship in environmental chemistry. N. L. W. thanks the National Research Council for a postdoctoral fellowship.	Abuduwailli J, 2008, J ARID ENVIRON, V72, P1843, DOI 10.1016/j.jaridenv.2008.05.006; Alexander B, 2009, ATMOS CHEM PHYS, V9, P5043, DOI 10.5194/acp-9-5043-2009; Allan W, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007369; Behnke W, 1997, J GEOPHYS RES-ATMOS, V102, P3795, DOI 10.1029/96JD03057; Bertram TH, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040248; Brown SS, 2006, SCIENCE, V311, P67, DOI 10.1126/science.1120120; Donohoue DL, 2005, J PHYS CHEM A, V109, P7732, DOI 10.1021/jp051354l; Erickson DJ, 1999, J GEOPHYS RES-ATMOS, V104, P8347, DOI 10.1029/98JD01384; FINLAYSONPITTS BJ, 1989, NATURE, V337, P241, DOI 10.1038/337241a0; GRAEDEL TE, 1995, GLOBAL BIOGEOCHEM CY, V9, P47, DOI 10.1029/94GB03103; Grannas AM, 2007, ATMOS CHEM PHYS, V7, P4329, DOI 10.5194/acp-7-4329-2007; Keene WC, 1998, GEOPHYS RES LETT, V25, P2181, DOI 10.1029/98GL01591; Kercher JP, 2009, ATMOS MEAS TECH, V2, P193, DOI 10.5194/amt-2-193-2009; Knipping EM, 2003, ENVIRON SCI TECHNOL, V37, P275, DOI 10.1021/es025793z; LOGAN JA, 1981, J GEOPHYS RES-OCEANS, V86, P7210, DOI 10.1029/JC086iC08p07210; MALM WC, 1994, J GEOPHYS RES-ATMOS, V99, P1347, DOI 10.1029/93JD02916; Moffet RC, 2008, ATMOS CHEM PHYS, V8, P4499, DOI 10.5194/acp-8-4499-2008; *NAT ATM DEP PROGR, 2010, NAT ATM DEP PROGR NR; NELSON HH, 1981, J PHYS CHEM-US, V85, P3891, DOI 10.1021/j150625a036; Olivier J. G. J., 2001, CLIMATE SYSTEM, P33; Osthoff HD, 2008, NAT GEOSCI, V1, P324, DOI 10.1038/ngeo177; Pechtl S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029761; Platt U, 2004, ATMOS CHEM PHYS, V4, P2393, DOI 10.5194/acp-4-2393-2004; Roberts JM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040448; Shindell DT, 2009, SCIENCE, V326, P716, DOI 10.1126/science.1174760; SINGH HB, 1981, GEOPHYS RES LETT, V8, P941, DOI 10.1029/GL008i008p00941; Thornton JA, 2003, PHYS CHEM CHEM PHYS, V5, P4593, DOI 10.1039/b307498f; Von Glasow R., 2007, TREATISE GEOCHEMISTR, P21; Wexler AS, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000451; Zhang Q, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029979	30	451	457	14	298	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					271	274		10.1038/nature08905	http://dx.doi.org/10.1038/nature08905			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20220847	Green Submitted			2022-12-28	WOS:000275366100045
J	Taylor, R; Gandhi, MM; Lloyd, G				Taylor, Robert; Gandhi, Manish M.; Lloyd, Gavin			Tachycardia due to atrial flutter with rapid 1:1 conduction following treatment of atrial fibrillation with flecainide	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Flecainide can "organise" atrial fibrillation into atrial flutter with 1:1 conduction, leading to cardiovascular compromise. The treatment of atrial fibrillation in the emergency department is often complex and depends on several factors, including time of onset of atrial fibrillation and previously known cardiac disease. Current guidelines include flecainide as a possible treatment for chemical cardioversion and maintaining sinus rhythm in paroxysmal atrial fibrillation. (1 2) An important, under-recognised complication of flecainide is the transformation of rhythm from atrial fibrillation to atrial flutter. We present four such cases.	[Taylor, Robert; Lloyd, Gavin] Royal Devon & Exeter Hosp, Emergency Dept, Exeter EX2 5DW, Devon, England; [Gandhi, Manish M.] Royal Devon & Exeter Hosp, Dept Cardiol, Exeter EX2 5DW, Devon, England	University of Exeter; University of Exeter	Lloyd, G (corresponding author), Royal Devon & Exeter Hosp, Emergency Dept, Exeter EX2 5DW, Devon, England.	gavin.lloyd@rdeft.nhs.uk						Amer Coll Cardiology Amer Heart, 2006, CIRCULATION, V114, P700, DOI 10.1161/CIRCULATIONAHA.106.177031; DeMeester A, 1996, ACTA CARDIOL, V51, P529; FALK RH, 1992, ANN INTERN MED, V117, P141, DOI 10.7326/0003-4819-117-2-141; Kawabata M, 2001, J ELECTROCARDIOL, V34, P65, DOI 10.1054/jelc.2001.22034; *NAT I HLTH CLIN E, 2006, MAN ATR FIBR	5	15	16	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2010	340								b4684	10.1136/bmj.b4684	http://dx.doi.org/10.1136/bmj.b4684			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570FD	20219811				2022-12-28	WOS:000275656800002
J	McMahon, HT; Kozlov, MM; Martens, S				McMahon, Harvey T.; Kozlov, Michael M.; Martens, Sascha			Membrane Curvature in Synaptic Vesicle Fusion and Beyond	CELL			English	Article							SYNAPTOTAGMIN-I; MECHANISM; BINDING; RELEASE; DOMAIN; CELLS		[McMahon, Harvey T.; Martens, Sascha] MRC Lab Mol Biol, Cambridge CB0 2QH, England; [Kozlov, Michael M.] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Martens, Sascha] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria	MRC Laboratory Molecular Biology; Tel Aviv University; Sackler Faculty of Medicine; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	McMahon, HT (corresponding author), MRC Lab Mol Biol, Hills Rd, Cambridge CB0 2QH, England.	hmm@mrc-lmb.cam.ac.uk; michk@post.tau.ac.il; sascha.martens@univie.ac.at	Martens, Sascha/C-3693-2011	Martens, Sascha/0000-0003-3786-8199	MRC [MC_U105178795] Funding Source: UKRI; Medical Research Council [MC_U105178795] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bright NA, 2005, CURR BIOL, V15, P360, DOI 10.1016/j.cub.2005.01.049; Brunecky R, 2005, BIOCHEMISTRY-US, V44, P16064, DOI 10.1021/bi051127+; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Groffen AJ, 2010, SCIENCE, V327, P1614, DOI 10.1126/science.1183765; Gu XJ, 1997, PLANT CELL, V9, P157, DOI 10.1105/tpc.9.2.157; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; Herrick DZ, 2006, BIOCHEMISTRY-US, V45, P9668, DOI 10.1021/bi060874j; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kweon DH, 2006, MOL CELLS, V21, P428; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lynch KL, 2008, MOL BIOL CELL, V19, P5093, DOI 10.1091/mbc.E08-03-0235; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xue MS, 2008, NAT STRUCT MOL BIOL, V15, P1160, DOI 10.1038/nsmb.1508	30	154	157	1	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					601	605		10.1016/j.cell.2010.02.017	http://dx.doi.org/10.1016/j.cell.2010.02.017			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211126	Bronze			2022-12-28	WOS:000275197400006
J	Di-Poi, N; Montoya-Burgos, JI; Miller, H; Pourquie, O; Milinkovitch, MC; Duboule, D				Di-Poi, Nicolas; Montoya-Burgos, Juan I.; Miller, Hilary; Pourquie, Olivier; Milinkovitch, Michel C.; Duboule, Denis			Changes in Hox genes' structure and function during the evolution of the squamate body plan	NATURE			English	Article							PHYLOGENETIC ANALYSIS; CLUSTERS; SNAKES; EMBRYOS; COMPLEX; GROWTH; MOUSE; CODE	Hox genes are central to the specification of structures along the anterior-posterior body axis(1,2), and modifications in their expression have paralleled the emergence of diversity in vertebrate body plans(3,4). Here we describe the genomic organization of Hox clusters in different reptiles and show that squamates have accumulated unusually large numbers of transposable elements at these loci(5), reflecting extensive genomic rearrangements of coding and non-coding regulatory regions. Comparative expression analyses between two species showing different axial skeletons, the corn snake and the whiptail lizard, revealed major alterations in Hox13 and Hox10 expression features during snake somitogenesis, in line with the expansion of both caudal and thoracic regions. Variations in both protein sequences and regulatory modalities of posterior Hox genes suggest how this genetic system has dealt with its intrinsic collinear constraint to accompany the substantial morphological radiation observed in this group.	[Di-Poi, Nicolas; Montoya-Burgos, Juan I.; Milinkovitch, Michel C.; Duboule, Denis] Univ Geneva, Dept Zool & Anim Biol, Natl Res Ctr Frontiers Genet, CH-1211 Geneva 4, Switzerland; [Miller, Hilary] Victoria Univ Wellington, Sch Biol Sci, Wellington 6140, New Zealand; [Pourquie, Olivier] Howard Hughes Med Inst, Kansas City, MO 64110 USA; [Pourquie, Olivier] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Duboule, Denis] Fed Inst Technol EPFL, Sch Life Sci, CH-1015 Lausanne, Switzerland	University of Geneva; Victoria University Wellington; Howard Hughes Medical Institute; Stowers Institute for Medical Research; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Duboule, D (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Natl Res Ctr Frontiers Genet, Sci 3, CH-1211 Geneva 4, Switzerland.	denis.duboule@unige.ch	Pourquié, Olivier/CAJ-5443-2022; Di-Poi, Nicolas/O-2378-2015; Di-Poi, Nicolas/O-6256-2019	Pourquié, Olivier/0000-0001-5189-1227; Di-Poi, Nicolas/0000-0002-3313-3016; Di-Poi, Nicolas/0000-0002-3313-3016; duboule, denis/0000-0001-9961-2960; Milinkovitch, Michel/0000-0002-2553-0724; Montoya-Burgos, Juan I./0000-0001-9080-9820	University of Geneva; Federal Institute of Technology in Lausanne; Swiss National Research Fund; National Research Center (NCCR); EU; ERC	University of Geneva; Federal Institute of Technology in Lausanne; Swiss National Research Fund(Swiss National Science Foundation (SNSF)); National Research Center (NCCR)(Swiss National Science Foundation (SNSF)); EU(European Commission); ERC(European Research Council (ERC)European Commission)	We thank A. Schmitz for sharing squamate tissues; A. Debry and F. Chabaud for technical assistance; and members of the Duboule and Milinkovitch laboratories for discussions and reagents. This work was supported by funds from the University of Geneva and the Federal Institute of Technology in Lausanne, the Swiss National Research Fund, the National Research Center (NCCR) 'Frontiers in Genetics', the EU programme 'Crescendo' and the ERC grant SystemsHox.ch (to D. D.).	[Anonymous], 2020, BIOL AMPHIBIANS, V28, P32; BURKE AC, 1995, DEVELOPMENT, V121, P333; Carapuco M, 2005, GENE DEV, V19, P2116, DOI 10.1101/gad.338705; Cohn MJ, 1999, NATURE, V399, P474, DOI 10.1038/20944; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Di-Poi N, 2009, GENOME RES, V19, P602, DOI 10.1101/gr.087932.108; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; GAUNT SJ, 1994, INT J DEV BIOL, V38, P549; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; Gomez C, 2008, NATURE, V454, P335, DOI 10.1038/nature07020; Herault Y, 1998, DEVELOPMENT, V125, P1669; Hoffstetter R., 1969, P201; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Kmita M, 2002, DEVELOPMENT, V129, P5521, DOI 10.1242/dev.00151; Kohlsdorf T, 2008, J MOL EVOL, V67, P581, DOI 10.1007/s00239-008-9156-7; Lemons D, 2006, SCIENCE, V313, P1918, DOI 10.1126/science.1132040; Lynch VJ, 2008, P NATL ACAD SCI USA, V105, P14928, DOI 10.1073/pnas.0802355105; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; Raynaud A., 1994, Bulletin de la Societe d'Histoire Naturelle de Toulouse, V130, P47; Romer A.S., 1997, OSTEOLOGY REPTILES; Scott V, 2005, J BIOCHEM, V137, P671, DOI 10.1093/jb/mvi086; Suemori H, 2000, DEV BIOL, V220, P333, DOI 10.1006/dbio.2000.9651; Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672; Wiens JJ, 2001, EVOLUTION, V55, P2303; Woltering JM, 2009, DEV BIOL, V332, P82, DOI 10.1016/j.ydbio.2009.04.031; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Young T, 2009, DEV CELL, V17, P516, DOI 10.1016/j.devcel.2009.08.010; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011	30	114	115	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2010	464	7285					99	103		10.1038/nature08789	http://dx.doi.org/10.1038/nature08789			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20203609	Green Published			2022-12-28	WOS:000275117500041
J	Gilmore, IT; Atkinson, S				Gilmore, Ian T.; Atkinson, Stephen			Evidence to drive policy on alcohol pricing	LANCET			English	Editorial Material							BRITAIN		[Gilmore, Ian T.; Atkinson, Stephen] Royal Coll Physicians, London NW1 4LE, England	Royal College of Physicians	Gilmore, IT (corresponding author), Royal Coll Physicians, London NW1 4LE, England.	Ian.Gilmore@rcplondon.ac.uk		Atkinson, Stephen/0000-0002-6910-7100				Academy of Medical Sciences (AMS), 2004, CALL TIM NAT DRINK M; BMA Board of Science, 2008, ALC MIS TACKL UK EP; *DEP HLTH, 2001, ANN REP CHIEF MED OF; Hastings G., 2010, BMJ-BRIT MED J, V340, P184; Home Office, 2010, TOUGH NEW POW TACKL; House of Commons Health Committee, 2010, ALC 1 REP SESS 2009; *KPMG LLP, 2008, REV SOC RESP STAND P, V2; Leon DA, 2006, LANCET, V367, P52, DOI 10.1016/S0140-6736(06)67924-5; McKee M, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1191; Meier Petra, 2008, INDEPENDENT REV EFFE; Purshouse RC, 2010, LANCET, V375, P1355, DOI 10.1016/S0140-6736(10)60058-X; Rabinovich L., 2009, AFFORDABILITY ALCOHO; Record C, 2009, CLIN MED, V9, P421, DOI 10.7861/clinmedicine.9-5-421; The NHS Confederation, 2010, TOO MUCH HARD STUFF	14	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 17	2010	375	9723					1322	1324		10.1016/S0140-6736(10)60276-0	http://dx.doi.org/10.1016/S0140-6736(10)60276-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	588GW	20338626				2022-12-28	WOS:000277057800005
J	Whelan, P				Whelan, Patrick			Abortion Rates and Universal Health Care.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Whelan, Patrick] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Whelan, Patrick] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Whelan, Patrick] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Whelan, P (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							DSM-V DDMNSYPICfDCP, 2009, MMWR-MORBID MORTAL W, V58, P1; *GUTTM I, 2008, STAT FACTS AB; *MASS HLTH CAR QUA, 2009, COMM FUND STAT SCOR; Wright J., 2008, REDUCING ABORTION AM; 1995, MMWR MORB MORTAL WKL, V44, P479; 1995, MMWR CDC SURVEILL SU, V44, P25	6	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2010	362	13								10.1056/NEJMp1002985	http://dx.doi.org/10.1056/NEJMp1002985			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	577QQ	20237339				2022-12-28	WOS:000276239500006
J	Hayes, M; Ostlin, G; Schaerer, D; Mas-Hesse, JM; Leitherer, C; Atek, H; Kunth, D; Verhamme, A; de Barros, S; Melinder, J				Hayes, Matthew; Ostlin, Goran; Schaerer, Daniel; Miguel Mas-Hesse, J.; Leitherer, Claus; Atek, Hakim; Kunth, Daniel; Verhamme, Anne; de Barros, Stephane; Melinder, Jens			Escape of about five per cent of Lyman-alpha photons from high-redshift star-forming galaxies	NATURE			English	Article							LY-ALPHA; EMITTING GALAXIES; EMISSION; EMITTERS; POPULATIONS; EVOLUTION; FIELD; Z=3.1	The Lyman-alpha (Ly alpha) emission line is the primary observational signature of star-forming galaxies at the highest redshifts(1), and has enabled the compilation of large samples of galaxies with which to study cosmic evolution(2-5). The resonant nature of the line, however, means that Ly alpha photons scatter in the neutral interstellar medium of their host galaxies, and their sensitivity to absorption by interstellar dust may therefore be greatly enhanced. This implies that the Ly alpha luminosity may be significantly reduced, or even completely suppressed. Hitherto, no unbiased empirical test of the escaping fraction (f(esc)) of Ly alpha photons has been performed at high redshifts. Here we report that the average f(esc) from star-forming galaxies at redshift z=2.2 is just 5 per cent by performing a blind narrowband survey in Ly alpha and H alpha. This implies that numerous conclusions based on Ly alpha-selected samples will require upwards revision by an order of magnitude and we provide a benchmark for this revision. We demonstrate that almost 90 per cent of star-forming galaxies emit insufficient Ly alpha to be detected by standard selection criteria(2-5). Both samples show an anti-correlation of f(esc) with dust content, and we show that Ly alpha- and H alpha-selection recovers populations that differ substantially in dust content and f(esc).	[Hayes, Matthew; Schaerer, Daniel; de Barros, Stephane] Univ Geneva, Astron Observ, CH-1290 Sauverny, Switzerland; [Ostlin, Goran; Melinder, Jens] Stockholm Univ, AlbaNova Univ Ctr, Dept Astron, Oskar Klein Ctr, S-10691 Stockholm, Sweden; [Schaerer, Daniel] Univ Toulouse, CNRS, Lab Astrophys Toulouse Tarbes, F-31400 Toulouse, France; [Miguel Mas-Hesse, J.] Ctr Astrobiol CSIC INTA, Madrid 28691, Spain; [Leitherer, Claus] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Atek, Hakim; Kunth, Daniel] IAP, F-75014 Paris, France; [Verhamme, Anne] Univ Oxford, Dept Phys, Oxford OX1 3RH, England	University of Geneva; Oskar Klein Centre; Stockholm University; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Space Telescope Science Institute; University of Oxford	Hayes, M (corresponding author), Univ Geneva, Astron Observ, 51 Chemin Maillettes, CH-1290 Sauverny, Switzerland.	matthew.hayes@unige.ch	Mas-Hesse, J. Miguel/K-6805-2014; Hayes, Matthew J/D-6692-2014	Mas-Hesse, J. Miguel/0000-0002-8823-9723; Hayes, Matthew J/0000-0001-8587-218X; Verhamme, Anne/0000-0002-2201-1865	Swiss National Science Foundation; Knut and Alice Wallenberg foundation; Swedish research council; Spanish MICINN [CSD2006-00070, AYA2007-67965];  [081.A-0932]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Swedish research council(Swedish Research CouncilEuropean Commission); Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); 	This work is based on observations made with ESO telescopes at the Paranal Observatory under programme ID 081.A-0932. The filter used to capture Ly alpha was financed by the Erik and Marta Holmberg foundation for astronomy and physics. M. H., D. S. and S. d. B. acknowledge the support of the Swiss National Science Foundation. G. O. is a Swedish Royal Academy of Sciences research fellow supported by the Knut and Alice Wallenberg foundation, and also acknowledges support from the Swedish research council (VR). J. M. M.-H. is funded by Spanish MICINN grants CSD2006-00070 (CONSOLIDER GTC) and AYA2007-67965. We thank D. Valls-Gabaud, M. Ouchi, and C. Scarlata for discussions.	Atek H, 2008, ASTRON ASTROPHYS, V488, P491, DOI 10.1051/0004-6361:200809527; Atek H, 2009, ASTRON ASTROPHYS, V506, pL1, DOI 10.1051/0004-6361/200912787; Bolzonella M, 2000, ASTRON ASTROPHYS, V363, P476; BROCKLEHURST M, 1971, MON NOT R ASTRON SOC, V153, P471, DOI 10.1093/mnras/153.4.471; Calzetti D, 2000, ASTROPHYS J, V533, P682, DOI 10.1086/308692; CHARLOT S, 1993, ASTROPHYS J, V415, P580, DOI 10.1086/173187; Deharveng JM, 2008, ASTROPHYS J, V680, P1072, DOI 10.1086/587953; Dijkstra M, 2007, MON NOT R ASTRON SOC, V377, P1175, DOI 10.1111/j.1365-2966.2007.11666.x; Giavalisco M, 1996, ASTROPHYS J, V466, P831, DOI 10.1086/177557; Giavalisco M, 2004, ASTROPHYS J, V600, pL93, DOI 10.1086/379232; Gronwall C, 2007, ASTROPHYS J, V667, P79, DOI 10.1086/520324; Hayes M, 2006, ASTRON ASTROPHYS, V460, P681, DOI 10.1051/0004-6361:20065493; Hayes M, 2010, ASTRON ASTROPHYS, V509, DOI 10.1051/0004-6361/200913217; Hu EM, 1998, ASTROPHYS J, V502, pL99, DOI 10.1086/311506; ISOBE T, 1986, ASTROPHYS J, V306, P490, DOI 10.1086/164359; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Kornei KA, 2010, ASTROPHYS J, V711, P693, DOI 10.1088/0004-637X/711/2/693; Le Delliou M, 2006, MON NOT R ASTRON SOC, V365, P712, DOI 10.1111/j.1365-2966.2005.09797.x; Malhotra S, 2002, ASTROPHYS J, V565, pL71, DOI 10.1086/338980; NAGAMINE K, 2008, LYMAN ALPHA EMITTERS; Nilsson KK, 2009, ASTRON ASTROPHYS, V498, P13, DOI 10.1051/0004-6361/200810881; Ostlin G, 2009, ASTRON J, V138, P923, DOI 10.1088/0004-6256/138/3/923; Ouchi M, 2008, ASTROPHYS J SUPPL S, V176, P301, DOI 10.1086/527673; PARTRIDG.RB, 1967, ASTROPHYS J, V147, P868, DOI 10.1086/149079; Santos MR, 2004, MON NOT R ASTRON SOC, V349, P1137, DOI 10.1111/j.1365-2966.2004.07594.x; Scarlata C, 2009, ASTROPHYS J LETT, V704, pL98, DOI 10.1088/0004-637X/704/2/L98; Schaerer D, 2003, ASTRON ASTROPHYS, V397, P527, DOI 10.1051/0004-6361:20021525; Verhamme A, 2008, ASTRON ASTROPHYS, V491, P89, DOI 10.1051/0004-6361:200809648; Verhamme A, 2006, ASTRON ASTROPHYS, V460, P397, DOI 10.1051/0004-6361:20065554	30	138	138	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					562	565		10.1038/nature08881	http://dx.doi.org/10.1038/nature08881			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20336139	Green Submitted			2022-12-28	WOS:000275974200041
J	Kenyon, CJ				Kenyon, Cynthia J.			The genetics of ageing	NATURE			English	Review							LIFE-SPAN EXTENSION; RESTRICTION-INDUCED LONGEVITY; DIETARY RESTRICTION; CAENORHABDITIS-ELEGANS; C. ELEGANS; CALORIE RESTRICTION; MEDIATES LONGEVITY; SIGNALING PATHWAY; AUTOPHAGY GENES; INSULIN	The nematode Caenorhabditis elegans ages and dies in a few weeks, but humans can live for 100 years or more. Assuming that the ancestor we share with nematodes aged rapidly, this means that over evolutionary time mutations have increased lifespan more than 2,000-fold. Which genes can extend lifespan? Can we augment their activities and live even longer? After centuries of wistful poetry and wild imagination, we are now getting answers, often unexpected ones, to these fundamental questions.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Kenyon, CJ (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	cynthia.kenyon@ucsf.edu		Kenyon, Cynthia/0000-0003-3446-2636				ALCEDO J, 2010, PROTEIN METABOLISM H; Anisimov VN, 2008, CELL CYCLE, V7, P2769, DOI 10.4161/cc.7.17.6625; Anselmi CV, 2009, REJUV RES, V12, P95, DOI 10.1089/rej.2008.0827; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Arum O, 2009, AGING CELL, V8, P756, DOI 10.1111/j.1474-9726.2009.00520.x; Ayyadevara S, 2009, AGING CELL, V8, P706, DOI 10.1111/j.1474-9726.2009.00524.x; Bartke A, 2008, CELL CYCLE, V7, P3338, DOI 10.4161/cc.7.21.7012; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Budovskaya YV, 2008, CELL, V134, P291, DOI 10.1016/j.cell.2008.05.044; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016; Cristina D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000450; Curran SP, 2009, NATURE, V459, P1079, DOI 10.1038/nature08106; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Davies BSJ, 2009, ANNU REV GENOM HUM G, V10, P153, DOI 10.1146/annurev-genom-082908-150150; Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Flatt T, 2008, P NATL ACAD SCI USA, V105, P6368, DOI 10.1073/pnas.0709128105; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Garigan D, 2002, GENETICS, V161, P1101; Gems D, 2009, CELL CYCLE, V8, P1681, DOI 10.4161/cc.8.11.8595; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Griswoldt AJ, 2008, P NATL ACAD SCI USA, V105, P8673, DOI 10.1073/pnas.0803837105; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Heidler T, 2010, BIOGERONTOLOGY, V11, P183, DOI 10.1007/s10522-009-9239-x; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hernebring M, 2006, P NATL ACAD SCI USA, V103, P7700, DOI 10.1073/pnas.0510944103; Honjoh S, 2009, NATURE, V457, P726, DOI 10.1038/nature07583; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hsu AL, 2009, NEUROBIOL AGING, V30, P1498, DOI 10.1016/j.neurobiolaging.2007.12.007; Hull-Thompson J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000460; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2007, AGEING RES REV, V6, P128, DOI 10.1016/j.arr.2007.04.001; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kappeler L, 2008, PLOS BIOL, V6, P2144, DOI 10.1371/journal.pbio.0060254; Kayser EB, 2004, J BIOL CHEM, V279, P54479, DOI 10.1074/jbc.M403066200; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KENYON CA, ANN NY ACAD IN PRESS; Kirchman PA, 1999, GENETICS, V152, P179; Kojima T, 2004, EXP GERONTOL, V39, P1595, DOI 10.1016/j.exger.2004.05.007; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lapointe J, 2008, J BIOL CHEM, V283, P26217, DOI 10.1074/jbc.M803287200; Lee SJ, 2009, CELL METAB, V10, P379, DOI 10.1016/j.cmet.2009.10.003; Lee SJ, 2009, CURR BIOL, V19, P715, DOI 10.1016/j.cub.2009.03.041; Li Y, 2009, HUM MOL GENET, V18, P4897, DOI 10.1093/hmg/ddp459; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Lunetta KL, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S13; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Parker WH, 2009, OBSTET GYNECOL, V113, P1027, DOI 10.1097/AOG.0b013e3181a11c64; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Pinkston JM, 2006, SCIENCE, V313, P971, DOI 10.1126/science.1121908; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Riesen M, 2009, AGING CELL, V8, P624, DOI 10.1111/j.1474-9726.2009.00514.x; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Shama S, 1998, EXP CELL RES, V245, P379, DOI 10.1006/excr.1998.4279; Sheaffer KL, 2008, CURR BIOL, V18, P1355, DOI 10.1016/j.cub.2008.07.097; Smith DL, 2009, AGING CELL, V8, P633, DOI 10.1111/j.1474-9726.2009.00516.x; Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Tomas-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034; Toth ML, 2008, AUTOPHAGY, V4, P330, DOI 10.4161/auto.5618; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Walker RF, 2009, MECH AGEING DEV, V130, P350, DOI 10.1016/j.mad.2009.02.003; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Wang YM, 2006, MECH AGEING DEV, V127, P48, DOI 10.1016/j.mad.2005.09.005; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	103	1819	1890	21	611	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					504	512		10.1038/nature08980	http://dx.doi.org/10.1038/nature08980			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20336132				2022-12-28	WOS:000275974200033
J	Hof, B; de Lozar, A; Avila, M; Tu, XY; Schneider, TM				Hof, Bjoern; de Lozar, Alberto; Avila, Marc; Tu, Xiaoyun; Schneider, Tobias M.			Eliminating Turbulence in Spatially Intermittent Flows	SCIENCE			English	Article							PIPE-FLOW; WALL TURBULENCE; TRANSITION; PRESSURE	Flows through pipes and channels are the most common means to transport fluids in practical applications and equally occur in numerous natural systems. In general, the transfer of fluids is energetically far more efficient if the motion is smooth and laminar because the friction losses are lower. However, even at moderate velocities pipe and channel flows are sensitive to minute disturbances, and in practice most flows are turbulent. Investigating the motion and spatial distribution of vortices, we uncovered an amplification mechanism that constantly feeds energy from the mean shear into turbulent eddies. At intermediate flow rates, a simple control mechanism suffices to intercept this energy transfer by reducing inflection points in the velocity profile. When activated, an immediate collapse of turbulence is observed, and the flow relaminarizes.	[Hof, Bjoern; de Lozar, Alberto; Avila, Marc; Tu, Xiaoyun] Max Planck Inst Dynam & Self Org, D-37073 Gottingen, Germany; [Schneider, Tobias M.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Max Planck Society; Harvard University	Hof, B (corresponding author), Max Planck Inst Dynam & Self Org, Bunsenstr 10, D-37073 Gottingen, Germany.	bhof@gwdg.de	Schneider, Tobias/C-5797-2015; de Lozar, Alberto/A-4987-2010; Avila, Marc/A-1263-2009	Schneider, Tobias/0000-0002-8617-8998; Avila, Marc/0000-0001-5988-1090	Max Planck Society; Deutsche Forschungsgemeinschaft [Schn 1167/1-1]; Kavli Institut for Bionano Science and Technology at Harvard; Harvard Materials Research and Engineering Center	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Kavli Institut for Bionano Science and Technology at Harvard; Harvard Materials Research and Engineering Center	We thank F. Mellibovsky and A. Meseguer for sharing their spectral code. This research was supported by the Max Planck Society (B. H., A.dL., M. A., and X. T.), The Deutsche Forschungsgemeinschaft under grant Schn 1167/1-1, Kavli Institut for Bionano Science and Technology at Harvard, and Harvard Materials Research and Engineering Center (T. M. S.).	Avila M, 2010, J FLUID MECH, V646, P127, DOI 10.1017/S0022112009993296; BANDYOPADHYAY PR, 1986, J FLUID MECH, V163, P439, DOI 10.1017/S0022112086002379; DARBYSHIRE AG, 1995, J FLUID MECH, V289, P83, DOI 10.1017/S0022112095001248; Draad AA, 1998, J FLUID MECH, V377, P267, DOI 10.1017/S0022112098003139; Drazin P.G., 1982, HYDRODYNAMIC STABILI; Du YQ, 2000, SCIENCE, V288, P1230, DOI 10.1126/science.288.5469.1230; Eckhardt B, 2007, ANNU REV FLUID MECH, V39, P447, DOI 10.1146/annurev.fluid.39.050905.110308; Fransson JHM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.064501; Gavarini MI, 2004, J FLUID MECH, V517, P131, DOI 10.1017/S0022112004000825; Grossmann S, 2000, REV MOD PHYS, V72, P603, DOI 10.1103/RevModPhys.72.603; HAMILTON JM, 1995, J FLUID MECH, V287, P317, DOI 10.1017/S0022112095000978; Hof B, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.214502; Hof B, 2004, SCIENCE, V305, P1594, DOI 10.1126/science.1100393; Hof B, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.244502; Hof B, 2006, NATURE, V443, P59, DOI 10.1038/nature05089; Hof B, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.214501; Hogberg M, 2003, J FLUID MECH, V481, P149, DOI 10.1017/S0022112003003823; Jimenez J, 1999, J FLUID MECH, V389, P335, DOI 10.1017/S0022112099005066; Khanafer KM, 2007, ANN VASC SURG, V21, P67, DOI 10.1016/j.avsg.2006.10.009; Kim J, 2007, ANNU REV FLUID MECH, V39, P383, DOI 10.1146/annurev.fluid.39.050905.110153; Mellibovsky F, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2222376; Meseguer A, 2007, APPL NUMER MATH, V57, P920, DOI 10.1016/j.apnum.2006.09.002; Park S, 2009, J SOUND VIB, V319, P1067, DOI 10.1016/j.jsv.2008.06.030; Rathnasingham R, 2003, J FLUID MECH, V495, P209, DOI 10.1017/S0022112003006177; Rayleigh L., 1880, P LOND MATH SOC, V11, P57, DOI DOI 10.1112/PLMS/S1-11.1.57; Reynolds O., 1883, PHIL T R SOC LONDON, V935, P174, DOI [10.1098/rstl.1883.0029, DOI 10.1098/RSTL.1883.0029, DOI 10.1098/RSPL.1883.0018, 10.1098/rspl.1883.0018]; Schoppa W, 2002, J FLUID MECH, V453, P57, DOI 10.1017/S002211200100667X; Shimizu M, 2009, FLUID DYN RES, V41, DOI 10.1088/0169-5983/41/4/045501; Sirovich L, 1997, NATURE, V388, P753, DOI 10.1038/41966; Tan FPP, 2009, COMPUT STRUCT, V87, P680, DOI 10.1016/j.compstruc.2008.09.007; van Doorne CWH, 2009, PHILOS T R SOC A, V367, P489, DOI 10.1098/rsta.2008.0227; WYGNANSKI IJ, 1973, J FLUID MECH, V59, P281, DOI 10.1017/S0022112073001576	32	84	89	4	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2010	327	5972					1491	1494		10.1126/science.1186091	http://dx.doi.org/10.1126/science.1186091			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20299590				2022-12-28	WOS:000275715200042
J	Nathan, C; Ding, AH				Nathan, Carl; Ding, Aihao			SnapShot: Reactive Oxygen Intermediates (ROI)	CELL			English	Editorial Material									[Nathan, Carl; Ding, Aihao] Weill Cornell Med Coll, New York, NY 10065 USA	Cornell University	Nathan, C (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.							Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Liu HJ, 2005, CIRC RES, V97, P967, DOI 10.1161/01.RES.0000188210.72062.10; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nathan C, 2003, J CLIN INVEST, V111, P769, DOI 10.1172/JCI200318174; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016	6	158	169	3	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2010	140	6							952.e1	10.1016/j.cell.2010.03.008	http://dx.doi.org/10.1016/j.cell.2010.03.008			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	571IX	20303882	Bronze			2022-12-28	WOS:000275746600016
J	Larsson, SC; Orsini, N; Wolk, A				Larsson, Susanna C.; Orsini, Nicola; Wolk, Alicja			Vitamin B-6 and Risk of Colorectal Cancer A Meta-analysis of Prospective Studies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							DOSE-RESPONSE DATA; COLON TUMORIGENESIS; MULTIETHNIC COHORT; CELL-PROLIFERATION; PLASMA VITAMIN-B-6; TREND ESTIMATION; DIETARY-FOLATE; FOLIC-ACID; WOMEN; METHIONINE	Context Mounting evidence indicates that vitamin B-6, a coenzyme involved in nearly 100 enzymatic reactions, may reduce the risk of colorectal cancer. Objective To conduct a systematic review with meta-analysis of prospective studies assessing the association of vitamin B-6 intake or blood levels of pyridoxal 5'-phosphate (PLP; the active form of vitamin B-6) with risk of colorectal cancer. Data Sources Relevant studies were identified by a search of MEDLINE and EMBASE databases to February 2010, with no restrictions. We also reviewed reference lists from retrieved articles. Study Selection We included prospective studies that reported relative risk (RR) estimates with 95% confidence intervals (CIs) for the association between vitamin B-6 intake or blood PLP levels and the risk of colorectal, colon, or rectal cancer. Data Extraction Two authors independently extracted data and assessed study quality. Study-specific RRs were pooled using a random-effects model. Data Synthesis Nine studies on vitamin B-6 intake and 4 studies on blood PLP levels were included in the meta-analysis. The pooled RRs of colorectal cancer for the highest vs lowest category of vitamin B-6 intake and blood PLP levels were 0.90 (95% CI, 0.75-1.07) and 0.52 (95% CI, 0.38-0.71), respectively. There was heterogeneity among studies of vitamin B-6 intake (P=.01) but not among studies of blood PLP levels (P=.95). Omitting 1 study that contributed substantially to the heterogeneity among studies of vitamin B-6 intake yielded a pooled RR of 0.80 (95% CI, 0.69-0.92). The risk of colorectal cancer decreased by 49% for every 100-pmol/mL increase (approximately 2 SDs) in blood PLP levels (RR, 0.51; 95% CI, 0.38-0.69). Conclusion Vitamin B-6 intake and blood PLP levels were inversely associated with the risk of colorectal cancer in this meta-analysis. JAMA. 2010; 303(11): 1077-1083	[Larsson, Susanna C.; Orsini, Nicola; Wolk, Alicja] Karolinska Inst, Natl Inst Environm Med, Div Nutr Epidemiol, SE-17177 Stockholm, Sweden	Karolinska Institutet	Larsson, SC (corresponding author), Karolinska Inst, Natl Inst Environm Med, Div Nutr Epidemiol, POB 210, SE-17177 Stockholm, Sweden.	susanna.larsson@ki.se	Larsson, Susanna C./F-6065-2015; Orsini, Nicola/A-3602-2012	Larsson, Susanna C./0000-0003-0118-0341; Orsini, Nicola/0000-0002-2210-5634	Swedish Cancer Foundation; Swedish Research Council for Infrastructure	Swedish Cancer Foundation; Swedish Research Council for Infrastructure	Funding/Support: This work was supported by research grants from the Swedish Cancer Foundation and the Swedish Research Council for Infrastructure.	de Vogel S, 2008, J NUTR, V138, P2372, DOI 10.3945/jn.108.091157; de Vogel S, 2008, CARCINOGENESIS, V29, P1765, DOI 10.1093/carcin/bgn074; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ebbing M, 2009, JAMA-J AM MED ASSOC, V302, P2119, DOI 10.1001/jama.2009.1622; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Figueiredo JC, 2008, CANCER EPIDEM BIOMAR, V17, P2136, DOI 10.1158/1055-9965.EPI-07-2895; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Harnack L, 2002, NUTR CANCER, V43, P152, DOI 10.1207/S15327914NC432_5; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ishihara J, 2007, J NUTR, V137, P1808, DOI 10.1093/jn/137.7.1808; Komatsu S, 2001, J NUTR, V131, P2204, DOI 10.1093/jn/131.8.2204; Larsson SC, 2005, GASTROENTEROLOGY, V128, P1830, DOI 10.1053/j.gastro.2005.03.005; Le Marchand L, 2005, CANCER EPIDEM BIOMAR, V14, P1198, DOI 10.1158/1055-9965.EPI-04-0840; Le Marchand L, 2009, CANCER EPIDEM BIOMAR, V18, P2195, DOI 10.1158/1055-9965.EPI-09-0141; Lee JE, 2009, CANCER EPIDEM BIOMAR, V18, P1197, DOI 10.1158/1055-9965.EPI-08-1001; Martinez M, 2000, J NUTR, V130, P1115, DOI 10.1093/jn/130.5.1115; Matsubara K, 2003, J NUTR BIOCHEM, V14, P246, DOI 10.1016/S0955-2863(03)00009-3; Moshfegh A., 2005, WHAT WE EAT AM NHANE; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Ross AC., 2006, MODERN NUTR HLTH DIS, P452; Schemhammer ES, 2008, CANCER EPIDEM BIOMAR, V17, P2895, DOI 10.1158/1055-9965.EPI-08-0638; Schernhammer ES, 2008, GASTROENTEROLOGY, V135, P770, DOI 10.1053/j.gastro.2008.06.033; Schernhammer ES, 2010, GUT, V59, P794, DOI 10.1136/gut.2009.183707; Selhub J, 2002, J Nutr Health Aging, V6, P39; Shen J, 2010, AM J CLIN NUTR, V91, P337, DOI 10.3945/ajcn.2009.28571; Shrubsole MJ, 2009, CANCER EPIDEM BIOMAR, V18, P1003, DOI 10.1158/1055-9965.EPI-08-1200; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Theodoratou E, 2008, CANCER EPIDEM BIOMAR, V17, P171, DOI 10.1158/1055-9965.EPI-07-0621; Wei EK, 2005, J NATL CANCER I, V97, P684, DOI 10.1093/jnci/dji116; Weinstein SJ, 2008, CANCER EPIDEM BIOMAR, V17, P3233, DOI 10.1158/1055-9965.EPI-08-0459; Wells G., NEWCASTLE OTTAWA SCA; Zhang SM, 2006, AM J EPIDEMIOL, V163, P108, DOI 10.1093/aje/kwj016	33	184	187	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1077	1083		10.1001/jama.2010.263	http://dx.doi.org/10.1001/jama.2010.263			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569KC	20233826				2022-12-28	WOS:000275594100021
J	Kaw, R; Cai, O				Kaw, Roop; Cai, Olivia			Review: Preoperative brain natriuretic peptide level is an independent predictor of adverse cardiovascular events after noncardiac surgery	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARDIAC EVENTS		[Kaw, Roop; Cai, Olivia] Cleveland Clin, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Kaw, R (corresponding author), Cleveland Clin, Cleveland, OH 44106 USA.		Kaw, Roop/A-7877-2009	Kaw, Roop/0000-0001-7712-7729				Dernellis J, 2006, HEART, V92, P1645, DOI 10.1136/hrt.2005.085530; Feringa HHH, 2006, AM J CARDIOL, V98, P111, DOI 10.1016/j.amjcard.2006.01.058; Rajagopalan S, 2008, J VASC SURG, V48, P912, DOI 10.1016/j.jvs.2008.05.015; Rodseth RN, 2008, ANAESTHESIA, V63, P1226, DOI 10.1111/j.1365-2044.2008.05574.x	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	2010	152	6							JC3-12	10.7326/0003-4819-152-6-201003160-02012	http://dx.doi.org/10.7326/0003-4819-152-6-201003160-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573IF	20231554				2022-12-28	WOS:000275905200029
J	Weijer, C				Weijer, Charles			Commentary: Ethics in conduct of trials in developing countries	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Weijer, Charles] Univ Western Ontario, Dept Philosophy, Joseph L Rotman Inst Sci & Values, London, ON N6A 3T2, Canada; [Weijer, Charles] Univ Western Ontario, Dept Med, London, ON N6A 3T2, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Weijer, C (corresponding author), Univ Western Ontario, Dept Philosophy, Joseph L Rotman Inst Sci & Values, London, ON N6A 3T2, Canada.	cweijer@uwo.ca	Weijer, Charles/ABC-5433-2020	Weijer, Charles/0000-0002-5510-1074				ELLENBERG SS, 2002, DATA MONITORING COMM, P14; ROTA AE, 2010, BRIT MED J, pC671; *UNICEF, GLANC GUINEABISSAU; Weijer C, 2010, NEW GENERATION VACCI, P59	4	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 15	2010	340								c1373	10.1136/bmj.c1373	http://dx.doi.org/10.1136/bmj.c1373			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	573RA	20231248	Green Published, hybrid			2022-12-28	WOS:000275931100003
J	Levesque, LE; Hanley, JA; Kezouh, A; Suissa, S				Levesque, Linda E.; Hanley, James A.; Kezouh, Abbas; Suissa, Samy			Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes	BRITISH MEDICAL JOURNAL			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MYOCARDIAL-INFARCTION; ELDERLY PATIENTS; INHALED CORTICOSTEROIDS; RISK; MORTALITY; INHIBITORS; ADHERENCE; SURVIVAL; USERS		[Levesque, Linda E.; Hanley, James A.; Suissa, Samy] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Levesque, Linda E.] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON, Canada; [Levesque, Linda E.] Kingston Frontenac Lennox & Addington Publ Hlth, Kingston, ON, Canada; [Hanley, James A.; Kezouh, Abbas; Suissa, Samy] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, Montreal, PQ H3T 1E2, Canada	McGill University; Queens University - Canada; McGill University	Levesque, LE (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	linda.levesque@queensu.ca	brophy, james/H-6673-2019	brophy, james/0000-0001-8049-6875	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Breslow NL, 1987, STAT METHODS CANC RE, VII, P178; COX DR, 1972, J R STAT SOC B, V187, P220; Downey W, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P295; Ellis JJ, 2004, J GEN INTERN MED, V19, P638, DOI 10.1111/j.1525-1497.2004.30516.x; GUYATT GH, 1995, JAMA-J AM MED ASSOC, V274, P1800, DOI 10.1001/jama.274.22.1800; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V330, P1366, DOI 10.1136/bmj.330.7504.1366; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Jackevicius CA, 2008, CIRCULATION, V117, P1028, DOI 10.1161/CIRCULATIONAHA.107.706820; KLEINBAUM DG, 1998, APPL REGRESSION ANAL, P687; Levesque LE, 2005, ANN INTERN MED, V142, P481, DOI 10.7326/0003-4819-142-7-200504050-00113; Levesque LE, 2006, CAN MED ASSOC J, V174, P1563, DOI 10.1503/cmaj.051679; LIDDELL FDK, 1977, J R STAT SOC A STAT, V140, P469, DOI 10.2307/2345280; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Rothman K., 1998, MODERN EPIDEMIOLOGY, P79; Schade R, 2007, NEW ENGL J MED, V356, P29, DOI 10.1056/NEJMoa062222; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Sheehy O, 2008, CAN MED ASSOC J, V178, P413, DOI 10.1503/cmaj.070586; Sin DD, 2002, AM J MED, V113, P650, DOI 10.1016/S0002-9343(02)01346-3; Sin DD, 2001, AM J RESP CRIT CARE, V164, P580, DOI 10.1164/ajrccm.164.4.2009033; Soriano JB, 2002, EUR RESPIR J, V20, P819, DOI 10.1183/09031936.02.00301302; Strom BL, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P17; Suissa S, 2004, EUR RESPIR J, V23, P391, DOI 10.1183/09031936.04.00062504; Suissa S, 2003, AM J RESP CRIT CARE, V168, P49, DOI 10.1164/rccm.200210-1231OC; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Suissa S, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P811; Suissa S, 2007, PHARMACOEPIDEM DR S, V16, P241, DOI 10.1002/pds.1357; Trojano M, 2007, ANN NEUROL, V61, P300, DOI 10.1002/ana.21102; VONKORFF M, 1992, J CLIN EPIDEMIOL, V45, P197, DOI 10.1016/0895-4356(92)90016-G; Yee A, 2004, DIABETIC MED, V21, P962, DOI 10.1111/j.1464-5491.2004.01263.x; Zhou Z, 2005, AM J EPIDEMIOL, V162, P1016, DOI 10.1093/aje/kwi307; 2004, DIABETES CARE S1, V27, pS15	31	580	580	1	32	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 12	2010	340								b5087	10.1136/bmj.b5087	http://dx.doi.org/10.1136/bmj.b5087			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570FF	20228141				2022-12-28	WOS:000275657000001
J	Sohl, F				Sohl, Frank			Revealing Titan's Interior	SCIENCE			English	Editorial Material							ORIGIN; SHAPE		German Aerosp Ctr DLR, Inst Planetary Res, D-12489 Berlin, Germany	Helmholtz Association; German Aerospace Centre (DLR)	Sohl, F (corresponding author), German Aerosp Ctr DLR, Inst Planetary Res, Rutherfordstr 2, D-12489 Berlin, Germany.	frank.sohl@dlr.de						Barr AC, 2010, NAT GEOSCI, V3, P164, DOI 10.1038/NGEO746; Fortes AD, 2007, ICARUS, V188, P139, DOI 10.1016/j.icarus.2006.11.002; Grasset O, 2000, PLANET SPACE SCI, V48, P617, DOI 10.1016/S0032-0633(00)00039-8; Iess L, 2010, SCIENCE, V327, P1367, DOI 10.1126/science.1182583; Jaumann R, 2009, TITAN FROM CASSINI-HUYGENS, P75, DOI 10.1007/978-1-4020-9215-2_5; Lopes RMC, 2007, ICARUS, V186, P395, DOI 10.1016/j.icarus.2006.09.006; Lunine J, 2009, TITAN FROM CASSINI-HUYGENS, P35, DOI 10.1007/978-1-4020-9215-2_3; Schubert G, 2004, CAMB PLANET, P281; Sohl F, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002044; SOHL F, 1995, ICARUS, V115, P278, DOI 10.1006/icar.1995.1097; Tobie G, 2006, NATURE, V440, P61, DOI 10.1038/nature04497; Zebker HA, 2009, SCIENCE, V324, P921, DOI 10.1126/science.1168905	12	8	8	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1338	1339		10.1126/science.1186255	http://dx.doi.org/10.1126/science.1186255			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223976				2022-12-28	WOS:000275418700029
J	Rowland, LP				Rowland, Lewis P.			Ameliorating Amyotrophic Lateral Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MICRORNAS; TARGETS		Columbia Univ, Med Ctr, Neurol Inst, New York, NY 10027 USA	Columbia University	Rowland, LP (corresponding author), Columbia Univ, Med Ctr, Neurol Inst, New York, NY 10027 USA.							Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ferrer I, 2008, CELL TISSUE BANK, V9, P181, DOI 10.1007/s10561-008-9077-0; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046	6	4	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10					953	954		10.1056/NEJMcibr0912229	http://dx.doi.org/10.1056/NEJMcibr0912229			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566JM	20220193				2022-12-28	WOS:000275365900020
J	Gubb, J				Gubb, James			Will a market deliver quality and efficiency in health care better than central planning ever could? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material									Civitas Hlth Unit, London SW1P 2EZ, England		Gubb, J (corresponding author), Civitas Hlth Unit, London SW1P 2EZ, England.	james.gubb@civitas.org.uk						Bloom N, MANAGEMENT PRACTICES; COOPER ZN, BMJ, V339, pB3264; FERRIER D, 2005, PEER EFFECTS EFFICIE; Gaynor M., 2006, WHAT WE KNOW COMPETI; Gubb J, 2009, MARKETS HLTH CARE TH; Kay J., 2004, TRUTH MARKETS; MAHER M, 2005, PRODUCT MARKET COMPE; Nolte E, 2008, HEALTH AFFAIR, V27, P58, DOI 10.1377/hlthaff.27.1.58; Office of Fair Trading, 2007, PROD COMP OFT PERSP; Phelps M., 2009, TOTAL PUBLIC SERVICE; SEDDON N, 2007, QUITE HEAVEN OPTIONS, P72	11	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2010	340								c1297	10.1136/bmj.c1297	http://dx.doi.org/10.1136/bmj.c1297			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570FD	20219812				2022-12-28	WOS:000275656800004
J	Goldberg, AD; Banaszynski, LA; Noh, KM; Lewis, PW; Elsaesser, SJ; Stadler, S; Dewell, S; Law, M; Guo, XY; Li, X; Wen, DC; Chapgier, A; DeKelver, RC; Miller, JC; Lee, YL; Boydston, EA; Holmes, MC; Gregory, PD; Greally, JM; Rafii, S; Yang, CW; Scambler, PJ; Garrick, D; Gibbons, RJ; Higgs, DR; Cristea, IM; Urnov, FD; Zheng, DY; Allis, CD				Goldberg, Aaron D.; Banaszynski, Laura A.; Noh, Kyung-Min; Lewis, Peter W.; Elsaesser, Simon J.; Stadler, Sonja; Dewell, Scott; Law, Martin; Guo, Xingyi; Li, Xuan; Wen, Duancheng; Chapgier, Ariane; DeKelver, Russell C.; Miller, Jeffrey C.; Lee, Ya-Li; Boydston, Elizabeth A.; Holmes, Michael C.; Gregory, Philip D.; Greally, John M.; Rafii, Shahin; Yang, Chingwen; Scambler, Peter J.; Garrick, David; Gibbons, Richard J.; Higgs, Douglas R.; Cristea, Ileana M.; Urnov, Fyodor D.; Zheng, Deyou; Allis, C. David			Distinct Factors Control Histone Variant H3.3 Localization at Specific Genomic Regions	CELL			English	Article							ZINC-FINGER NUCLEASES; EMBRYONIC STEM-CELLS; REPEAT-CONTAINING RNA; ATR-X SYNDROME; MAMMALIAN TELOMERES; SYNDROME PROTEIN; GENE-EXPRESSION; POLYMERASE-II; DNA-SYNTHESIS; ES CELLS	The incorporation of histone H3 variants has been implicated in the epigenetic memory of cellular state. Using genome editing with zinc-finger nucleases to tag endogenous H3.3, we report genome-wide profiles of H3 variants in mammalian embryonic stem cells and neuronal precursor cells. Genome-wide patterns of H3.3 are dependent on amino acid sequence and change with cellular differentiation at developmentally regulated loci. The H3.3 chaperone Hira is required for H3.3 enrichment at active and repressed genes. Strikingly, Hira is not essential for localization of H3.3 at telomeres and many transcription factor binding sites. Immunoaffinity purification and mass spectrometry reveal that the proteins Atrx and Daxx associate with H3.3 in a Hira-independent manner. Atrx is required for Hira-independent localization of H3.3 at telomeres and for the repression of telomeric RNA. Our data demonstrate that multiple and distinct factors are responsible for H3.3 localization at specific genomic locations in mammalian cells.	[Guo, Xingyi; Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Greally, John M.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Greally, John M.; Zheng, Deyou] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Goldberg, Aaron D.; Banaszynski, Laura A.; Noh, Kyung-Min; Lewis, Peter W.; Elsaesser, Simon J.; Stadler, Sonja; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Dewell, Scott] Rockefeller Univ, Genom Resource Ctr, New York, NY 10065 USA; [Li, Xuan; Yang, Chingwen] Rockefeller Univ, Gene Targeting Resource Ctr, New York, NY 10065 USA; [Law, Martin; Garrick, David; Gibbons, Richard J.; Higgs, Douglas R.] John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford OX3 9DS, England; [Wen, Duancheng; Rafii, Shahin] Weill Cornell Med Coll, Howard Hughes Med Inst, New York, NY 10065 USA; [Wen, Duancheng; Rafii, Shahin] Weill Cornell Med Coll, Ansary Stem Cell Inst, New York, NY 10065 USA; [Wen, Duancheng; Rafii, Shahin] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA; [Chapgier, Ariane; Scambler, Peter J.] Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; [DeKelver, Russell C.; Miller, Jeffrey C.; Lee, Ya-Li; Boydston, Elizabeth A.; Holmes, Michael C.; Gregory, Philip D.; Urnov, Fyodor D.] Sangamo BioSci, Point Richmond Tech Ctr, Richmond, CA 94804 USA; [Cristea, Ileana M.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Rockefeller University; Rockefeller University; Rockefeller University; University of Oxford; Cornell University; Howard Hughes Medical Institute; Cornell University; Cornell University; University of London; University College London; Sangamo Therapeutics, Inc.; Princeton University	Zheng, DY (corresponding author), Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA.	deyou.zheng@einstein.yu.edu; alliscd@rockefeller.edu	Elsässer, Simon/AAM-3986-2020; Lewis, Peter/C-4348-2008; GARRICK, David/O-5734-2019; Goldberg, Aaron/C-6565-2009; Garrick, David/F-1728-2017; Scambler, Peter/AAZ-6026-2020; Greally, John/AAF-9540-2019; Elsässer, Simon/B-8911-2014; Gibbons, Richard/E-6937-2011	Elsässer, Simon/0000-0001-8724-4849; GARRICK, David/0000-0001-7422-7986; Garrick, David/0000-0001-7422-7986; Scambler, Peter/0000-0002-1487-4628; Greally, John/0000-0001-6069-7960; Elsässer, Simon/0000-0001-8724-4849; Noh, Kyung-Min/0000-0002-0708-787X; Lewis, Peter/0000-0002-9816-7823; Gregory, Philip/0000-0001-9249-2468; Higgs, Douglas/0000-0003-3579-8705; Gibbons, Richard/0000-0002-7680-9311; Wen, Duancheng/0000-0002-3160-6289; Chapgier, Ariane/0000-0002-1734-0744; Zheng, Deyou/0000-0003-4354-5337; Goldberg, Aaron/0000-0002-2892-2643; Costa, Elizabeth/0000-0001-8365-0436	National Institutes of Health (NIH) [GM07739, RR00862, RR022220, DP1DA026192, GM53122, GM53512]; Damon Runyon Cancer Research Foundation; Rockefeller University; Starr Foundation; New York State Department of Health [C023046]; Howard Hughes Medical Institute; Biotechnology and Biological Sciences Research Council UK; British Heart Foundation; Albert Einstein College of Medicine of Yeshiva University; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862, U54RR022220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053512, R37GM053512, T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026192] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/E009603/1] Funding Source: researchfish; Medical Research Council [G1000801b, MC_U137961147, G1000801j] Funding Source: researchfish; BBSRC [BB/E009603/1] Funding Source: UKRI; MRC [MC_U137961147] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; Rockefeller University; Starr Foundation; New York State Department of Health; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Albert Einstein College of Medicine of Yeshiva University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank L. Baker, E.M. Duncan, G.G. Wang for critical reading of the manuscript, P. Wu, A. Sfeir, and T. de Lange for telomere reagents and helpful discussion, P.D. Adams for Hira antibodies, R. Jaenisch for F1 hybrid male 129SVJae x M. m. castaneus ESCs, G. Almouzni for H3.1 and H3.3-FLAG-HA HeLa cells, K. Zhao for sharing his native ChIP-seq protocol, E. Moehle for drawing the gene editing schemes, N. Jina of the University College London Genomics Core, K.R. Molloy for assistance with mass spectrometric analysis, and S. Mazel and A. North of the Rockefeller University Flow Cytometry and Bio-Imaging Resource Centers. A. D. G. is supported by National Institutes of Health (NIH) Medical Scientist Training Program grant GM07739. L. A. B. is a Damon Runyon Cancer Research Foundation fellow. This work was funded by institutional support from The Rockefeller University and grants from the Tri-Institutional Stem Cell Initiative (funded by the Starr Foundation), Empire State Stem Cell fund through New York State Department of Health contract #C023046, the Howard Hughes Medical Institute (S.R.), Biotechnology and Biological Sciences Research Council UK and the British Heart Foundation (P.J.S.), startup funds from the Albert Einstein College of Medicine of Yeshiva University (D.Z.), and NIH grants RR00862, RR022220, DP1DA026192 (I.M.C.), GM53122, and GM53512 (C.D.A.). J.C.M., M.C.H., Y.L.L., P.D.G., and F.D.U. are full-time employees of Sangamo BioSciences, Inc.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bonnefoy E, 2007, PLOS GENET, V3, P1991, DOI 10.1371/journal.pgen.0030182; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Carroll D, 2008, GENE THER, V15, P1463, DOI 10.1038/gt.2008.145; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Cristea IM, 2005, MOL CELL PROTEOMICS, V4, P1933, DOI 10.1074/mcp.M500227-MCP200; Daury L, 2006, EMBO REP, V7, P66, DOI 10.1038/sj.embor.7400561; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Gibbons RJ, 2008, HUM MUTAT, V29, P796, DOI 10.1002/humu.20734; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Hake SB, 2006, J BIOL CHEM, V281, P559, DOI 10.1074/jbc.M509266200; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Hodl M, 2009, CURR BIOL, V19, P1221, DOI 10.1016/j.cub.2009.05.048; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jin C, 2006, P NATL ACAD SCI USA, V103, P574, DOI 10.1073/pnas.0509974103; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Loppin B, 2005, NATURE, V437, P1386, DOI 10.1038/nature04059; Loyola A, 2007, TRENDS BIOCHEM SCI, V32, P425, DOI 10.1016/j.tibs.2007.08.004; Luke B, 2009, EMBO J, V28, P2503, DOI 10.1038/emboj.2009.166; Luo Y, 2010, J AM SOC MASS SPECTR, V21, P34, DOI 10.1016/j.jasms.2009.08.026; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Nakayama T, 2007, GENE DEV, V21, P552, DOI 10.1101/gad.1503407; Picketts DJ, 1996, HUM MOL GENET, V5, P1899, DOI 10.1093/hmg/5.12.1899; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; Roberts C, 2002, MOL CELL BIOL, V22, P2318, DOI 10.1128/MCB.22.7.2318-2328.2002; Sakai A, 2009, CURR BIOL, V19, P1816, DOI 10.1016/j.cub.2009.09.021; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schneiderman JI, 2009, P NATL ACAD SCI USA, V106, P14472, DOI 10.1073/pnas.0905816106; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Siegel TN, 2009, GENE DEV, V23, P1063, DOI 10.1101/gad.1790409; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Sutcliffe EL, 2009, MOL CELL BIOL, V29, P1972, DOI 10.1128/MCB.01590-08; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Talbert PB, 2009, GENE DEV, V23, P1037, DOI 10.1101/gad.1806409; Tamura T, 2009, J BIOL CHEM, V284, P12217, DOI 10.1074/jbc.M805651200; Tang J, 2004, J BIOL CHEM, V279, P20369, DOI 10.1074/jbc.M401321200; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wong LH, 2009, GENOME RES, V19, P404, DOI 10.1101/gr.084947.108; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100	69	849	870	3	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					678	691		10.1016/j.cell.2010.01.003	http://dx.doi.org/10.1016/j.cell.2010.01.003			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211137	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000275197400017
J	Johnston, RJ; Desplan, C				Johnston, Robert J., Jr.; Desplan, Claude			A Penetrating Look at Stochasticity in Development	CELL			English	Editorial Material							NOISE; TRANSCRIPTION		[Johnston, Robert J., Jr.; Desplan, Claude] NYU, Dept Biol, New York, NY 10003 USA	New York University	Desplan, C (corresponding author), NYU, Dept Biol, 1009 Silver Ctr,100 Washington Sq E, New York, NY 10003 USA.	cd38@nyu.edu		Desplan, Claude/0000-0002-6914-1413	NEI NIH HHS [R01 EY013010, R01 EY013010-11] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013010] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Calvo D, 2001, EMBO J, V20, P7197, DOI 10.1093/emboj/20.24.7197; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Masel J, 2009, TRENDS GENET, V25, P395, DOI 10.1016/j.tig.2009.07.005; McGhee James D, 2007, WormBook, P1; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588	10	7	7	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					610	612		10.1016/j.cell.2010.02.018	http://dx.doi.org/10.1016/j.cell.2010.02.018			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211129	Bronze, Green Accepted			2022-12-28	WOS:000275197400009
J	Koonin, EV				Koonin, Eugene V.			The Incredible Expanding Ancestor of Eukaryotes	CELL			English	Editorial Material							EVOLUTION; GENOMES; COMPLEX; GENES		NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA	National Institutes of Health (NIH) - USA	Koonin, EV (corresponding author), NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA.	koonin@ncbi.nlm.nih.gov			Intramural NIH HHS [ZIA LM000073-16] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [ZIALM000061, ZIALM000073] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Collins L, 2005, MOL BIOL EVOL, V22, P1053, DOI 10.1093/molbev/msi091; Csuros M, 2009, MOL BIOL EVOL, V26, P2087, DOI 10.1093/molbev/msp123; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Keeling PJ, 2007, SCIENCE, V317, P1875, DOI 10.1126/science.1149593; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Mans BJ, 2004, CELL CYCLE, V3, P1612; Yutin N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-223	9	55	55	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 5	2010	140	5					606	608		10.1016/j.cell.2010.02.022	http://dx.doi.org/10.1016/j.cell.2010.02.022			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211127	Green Accepted, Bronze			2022-12-28	WOS:000275197400007
J	Qin, JJ; Li, RQ; Raes, J; Arumugam, M; Burgdorf, KS; Manichanh, C; Nielsen, T; Pons, N; Levenez, F; Yamada, T; Mende, DR; Li, JH; Xu, JM; Li, SC; Li, DF; Cao, JJ; Wang, B; Liang, HQ; Zheng, HS; Xie, YL; Tap, J; Lepage, P; Bertalan, M; Batto, JM; Hansen, T; Le Paslier, D; Linneberg, A; Nielsen, HB; Pelletier, E; Renault, P; Sicheritz-Ponten, T; Turner, K; Zhu, HM; Yu, C; Li, ST; Jian, M; Zhou, Y; Li, YR; Zhang, XQ; Li, SG; Qin, N; Yang, HM; Wang, J; Brunak, S; Dore, J; Guarner, F; Kristiansen, K; Pedersen, O; Parkhill, J; Weissenbach, J; Bork, P; Ehrlich, SD; Wang, J				Qin, Junjie; Li, Ruiqiang; Raes, Jeroen; Arumugam, Manimozhiyan; Burgdorf, Kristoffer Solvsten; Manichanh, Chaysavanh; Nielsen, Trine; Pons, Nicolas; Levenez, Florence; Yamada, Takuji; Mende, Daniel R.; Li, Junhua; Xu, Junming; Li, Shaochuan; Li, Dongfang; Cao, Jianjun; Wang, Bo; Liang, Huiqing; Zheng, Huisong; Xie, Yinlong; Tap, Julien; Lepage, Patricia; Bertalan, Marcelo; Batto, Jean-Michel; Hansen, Torben; Le Paslier, Denis; Linneberg, Allan; Nielsen, H. Bjorn; Pelletier, Eric; Renault, Pierre; Sicheritz-Ponten, Thomas; Turner, Keith; Zhu, Hongmei; Yu, Chang; Li, Shengting; Jian, Min; Zhou, Yan; Li, Yingrui; Zhang, Xiuqing; Li, Songgang; Qin, Nan; Yang, Huanming; Wang, Jian; Brunak, Soren; Dore, Joel; Guarner, Francisco; Kristiansen, Karsten; Pedersen, Oluf; Parkhill, Julian; Weissenbach, Jean; Bork, Peer; Ehrlich, S. Dusko; Wang, Jun		MetaHIT Consortium	A human gut microbial gene catalogue established by metagenomic sequencing	NATURE			English	Article							16S RIBOSOMAL-RNA; INTESTINAL MICROBIOTA; COMMUNITIES; HOST; DIVERSITY; OBESITY; FERMENTATION; ENVIRONMENT; ALIGNMENT; NETWORKS	To understand the impact of gut microbes on human health and well-being it is crucial to assess their genetic potential. Here we describe the Illumina-based metagenomic sequencing, assembly and characterization of 3.3 million non-redundant microbial genes, derived from 576.7 gigabases of sequence, from faecal samples of 124 European individuals. The gene set, similar to 150 times larger than the human gene complement, contains an overwhelming majority of the prevalent (more frequent) microbial genes of the cohort and probably includes a large proportion of the prevalent human intestinal microbial genes. The genes are largely shared among individuals of the cohort. Over 99% of the genes are bacterial, indicating that the entire cohort harbours between 1,000 and 1,150 prevalent bacterial species and each individual at least 160 such species, which are also largely shared. We define and describe the minimal gut metagenome and the minimal gut bacterial genome in terms of functions present in all individuals and most bacteria, respectively.	[Qin, Junjie; Li, Ruiqiang; Li, Junhua; Xu, Junming; Li, Shaochuan; Li, Dongfang; Cao, Jianjun; Wang, Bo; Liang, Huiqing; Zheng, Huisong; Xie, Yinlong; Zhu, Hongmei; Yu, Chang; Li, Shengting; Jian, Min; Zhou, Yan; Li, Yingrui; Zhang, Xiuqing; Li, Songgang; Qin, Nan; Yang, Huanming; Wang, Jian; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Raes, Jeroen; Arumugam, Manimozhiyan; Yamada, Takuji; Mende, Daniel R.; Bork, Peer] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Raes, Jeroen] Vrije Univ Brussel VIB, B-1050 Brussels, Belgium; [Burgdorf, Kristoffer Solvsten; Nielsen, Trine; Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, DK-2820 Copenhagen, Denmark; [Manichanh, Chaysavanh; Guarner, Francisco] Hosp Univ Val dHebron, Barcelona 08035, Spain; [Pons, Nicolas; Levenez, Florence; Tap, Julien; Lepage, Patricia; Batto, Jean-Michel; Renault, Pierre; Dore, Joel; Ehrlich, S. Dusko] INRA, F-78350 Jouy En Josas, France; [Li, Junhua; Xie, Yinlong] S China Univ Technol, Sch Software Engn, Guangzhou 510641, Peoples R China; [Li, Dongfang] Shenzhen Univ, Sch Med, Genome Res Inst, Shenzhen 518000, Peoples R China; [Bertalan, Marcelo; Nielsen, H. Bjorn; Sicheritz-Ponten, Thomas; Brunak, Soren] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Le Paslier, Denis; Pelletier, Eric; Weissenbach, Jean] CEA, F-91000 Evry, France; [Linneberg, Allan] Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Turner, Keith; Parkhill, Julian] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, DK-8000 Aarhus, Denmark; [Pedersen, Oluf] Univ Copenhagen, Inst Biomed Sci, DK-8000 Aarhus, Denmark	Beijing Genomics Institute (BGI); European Molecular Biology Laboratory (EMBL); Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Novo Nordisk; Hagedorn Research Institute; INRAE; UDICE-French Research Universities; Universite Paris Saclay; South China University of Technology; Shenzhen University; Technical University of Denmark; CEA; Wellcome Trust Sanger Institute; University of Copenhagen; Aarhus University; University of Copenhagen	Wang, J (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	dusko.ehrlich@jouy.inra.fr; wangj@genomics.org.cn	Lepage, Patricia/D-4362-2014; Guarner, Francisco/ABF-1192-2020; InWeb, Inct/J-9839-2013; Chervaux, Christian/N-1972-2014; Knol, Jan/AAL-6487-2020; Parkhill, Julian/G-4703-2011; Ehrlich, S./Y-2423-2019; Arumugam, Manimozhiyan/E-1211-2011; Borruel, Natalia/AFO-6891-2022; de Melo-Minardi, Raquel C./AAG-6540-2021; Bork, Peer/F-1813-2013; Dore, Joel/ABA-8921-2020; Knol, Jan/A-2178-2010; Yu, Chang/AAE-8538-2019; Ganesh, Dunna Sai/AGX-5170-2022; Leclerc, Marion/AAZ-3950-2021; Li, Yingrui/K-1064-2015; Li, Shengxu/D-8915-2012; raes, jeroen/D-7835-2018; Rescigno, Maria/J-9704-2012; Pedersen, Oluf/Z-1731-2019; Li, Junhua/AAG-3919-2019; BLOTTIERE, Hervé M/C-6120-2011; Arumugam, Manimozhiyan/AAJ-2394-2020; Guédon, Eric/AAP-4143-2021; Pedersen, Oluf/AAG-8015-2020; Guedon, Eric/S-5635-2016; GUEDON, Eric/N-8624-2019; Nielsen, Henrik/B-8961-2019; Mende, Daniel R/I-3662-2019; Tap, Julien/E-5760-2010; Brunak, Soren/O-6621-2016; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016; Sicheritz-Ponten, Thomas/A-4325-2017	Lepage, Patricia/0000-0002-9501-6771; Guarner, Francisco/0000-0002-4051-0836; Chervaux, Christian/0000-0001-6812-0912; Knol, Jan/0000-0002-2103-5961; Parkhill, Julian/0000-0002-7069-5958; Ehrlich, S./0000-0002-7563-4046; Arumugam, Manimozhiyan/0000-0002-0886-9101; Borruel, Natalia/0000-0002-4449-2292; Bork, Peer/0000-0002-2627-833X; Knol, Jan/0000-0002-2103-5961; Leclerc, Marion/0000-0001-8684-2847; raes, jeroen/0000-0002-1337-041X; Rescigno, Maria/0000-0002-6464-509X; Pedersen, Oluf/0000-0002-3321-3972; Li, Junhua/0000-0001-6784-1873; BLOTTIERE, Hervé M/0000-0002-8390-0607; Arumugam, Manimozhiyan/0000-0002-0886-9101; Guedon, Eric/0000-0002-0901-4447; GUEDON, Eric/0000-0002-0901-4447; Nielsen, Henrik/0000-0003-2281-5713; Mende, Daniel R/0000-0001-6831-4557; Tap, Julien/0000-0001-8998-5413; Le Paslier, Denis/0000-0003-4335-9956; TORREJON, ANTONIO/0000-0002-3126-1532; Brunak, Soren/0000-0003-0316-5866; Delorme, Christine/0000-0002-5208-7238; Nielsen, Trine/0000-0002-2066-7895; Burgdorf, Kristoffer/0000-0001-5814-6844; Wang, Jun/0000-0002-8540-8931; Varela Castro, Encarna/0000-0001-6334-9320; Pelletier, Eric/0000-0003-4228-1712; Wang, Jun/0000-0002-2113-5874; Chaysavanh, Manichanh/0000-0002-2287-4003; Kleerebezem, Michiel/0000-0001-8552-2235; Li, Dongfang/0000-0002-6587-2892; Linneberg, Allan/0000-0002-0994-0184; C. de Melo-Minardi, Raquel/0000-0001-5190-100X; Sicheritz-Ponten, Thomas/0000-0001-6615-1141	European Community [HEALTH-F4-2007-201052]; Danish Natural Science Research Council; Solexa project [272-07-0196]; Shenzhen Municipal Government of China; National Natural Science Foundation of China [30725008]; International Science and Technology Cooperation, China [CXB200903110066A, ZYC200903240076A]; Danish Strategic Research Council [2106-07-0021]; Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention and Care; Instituto de Salud Carlos III (Spain)	European Community(European Commission); Danish Natural Science Research Council(Danish Natural Science Research Council); Solexa project; Shenzhen Municipal Government of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation, China; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention and Care; Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III)	We are indebted to the faculty and staff of Beijing Genomics Institute at Shenzhen, whose names were not included in the author list, but who contributed to large-scale sequencing of this team work. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013): MetaHIT, grant agreement HEALTH-F4-2007-201052, the Ole Romer grant from the Danish Natural Science Research Council, the Solexa project (272-07-0196), the Shenzhen Municipal Government of China, the National Natural Science Foundation of China (30725008), the International Science and Technology Cooperation Project (0806), China (CXB200903110066A; ZYC200903240076A), the Danish Strategic Research Council grant no 2106-07-0021 (Seqnet), and the Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention and Care. Ciberehd is funded by Instituto de Salud Carlos III (Spain). We also thank X. Wang from the School of Biosciences and Bioengineering, South China University of Technology, for his coordination on the Innovative Program for Undergraduate Students in which J.L. and Y.X. joined.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Colwell R.K, 1997, ESTIMATES STAT ESTIM; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; Dongowski G, 2000, APPL ENVIRON MICROB, V66, P1321, DOI 10.1128/AEM.66.4.1321-1327.2000; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Elango R, 2009, AMINO ACIDS, V37, P19, DOI 10.1007/s00726-009-0234-y; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Green Tringe Susannah, 2005, Nature Reviews Genetics, V6, P805, DOI 10.1038/nrg1709; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001; LEY R, 2006, NATURE, V444, P1023; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Metges CC, 2000, J NUTR, V130, p1857S, DOI 10.1093/jn/130.7.1857S; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Toft U, 2008, PREV MED, V47, P378, DOI 10.1016/j.ypmed.2008.05.013; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Van Dongen S, 2000, THESIS U UTRECHT NET; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wang X, 2003, J APPL MICROBIOL, V95, P508, DOI 10.1046/j.1365-2672.2003.02005.x; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	44	6569	7278	84	1991	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 4	2010	464	7285					59	U70		10.1038/nature08821	http://dx.doi.org/10.1038/nature08821			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20203603	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000275117500033
J	Zhang, JF; Mauzerall, DL; Zhu, T; Liang, S; Ezzati, M; Remais, JV				Zhang, Junfeng; Mauzerall, Denise L.; Zhu, Tong; Liang, Song; Ezzati, Majid; Remais, Justin V.			Environmental health in China: progress towards clean air and safe water	LANCET			English	Review							BIOMASS FUELS; POLLUTION; MORTALITY; CANCER; SCHISTOSOMIASIS; IMPACTS; DISEASE; OZONE	Environmental risk factors, especially air and water pollution, are a major source of morbidity and mortality in China. Biomass fuel and coal are burned for cooking and heating in almost all rural and many urban households, resulting in severe indoor air pollution that contributes greatly to the burden of disease. Many communities lack access to safe drinking water and sanitation, and thus the risk of waterborne disease in many regions is high. At the same time, China is rapidly industrialising with associated increases in energy use and industrial waste. Although economic growth from industrialisation has improved health and quality of life indicators, it has also increased the release of chemical toxins into the environment and the rate of environmental disasters, with severe effects on health. Air quality in China's cities is among the worst in the world, and industrial water pollution has become a widespread health hazard. Moreover, emissions of climate-warming greenhouse gases from energy use are rapidly increasing. Global climate change will inevitably intensify China's environmental health troubles, with potentially catastrophic outcomes from major shifts in temperature and precipitation. Facing the overlap of traditional, modern, and emerging environmental dilemmas, China has committed substantial resources to environmental improvement. The country has the opportunity to address its national environmental health challenges and to assume a central role in the international effort to improve the global environment.	[Remais, Justin V.] Emory Univ, Rollins Sch Publ Hlth, Dept Environm & Occupat Hlth, Atlanta, GA 30322 USA; [Zhang, Junfeng] Univ Med & Dent New Jersey, Sch Publ Hlth, Piscataway, NJ 08854 USA; [Mauzerall, Denise L.] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Mauzerall, Denise L.] Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA; [Zhu, Tong] Peking Univ, State Key Lab Environm Simulat & Pollut Control, Coll Environm Sci & Engn, Beijing 100871, Peoples R China; [Zhu, Tong] Peking Univ, Ctr Environm & Hlth, Beijing 100871, Peoples R China; [Liang, Song] Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA; [Ezzati, Majid] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Emory University; Rollins School Public Health; Rutgers State University New Brunswick; Rutgers State University Medical Center; Princeton University; Princeton University; Peking University; Peking University; University System of Ohio; Ohio State University; Harvard University; Harvard T.H. Chan School of Public Health	Remais, JV (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Environm & Occupat Hlth, Atlanta, GA 30322 USA.	justin.remais@emory.edu	ZHU, TONG/H-6501-2011; Zhang, Junfeng/AAJ-9183-2020; Mauzerall, Denise L/I-5977-2013; Remais, Justin/V-3207-2019	ZHU, TONG/0000-0002-2752-7924; Zhang, Junfeng/0000-0003-3759-6672; Mauzerall, Denise L/0000-0003-3479-1798; Remais, Justin/0000-0002-0223-4615	National Institute of Environmental Health Sciences Center [P30ES 05022]; Princeton University; Chinese Natural Science Foundation [20637020]; National Institutes of Health/National Institute of Allergy and Infectious Diseases [R01 AI068854]; National Institutes of Health/National Science Foundation [0622743]; Emory University's Global Health Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050038, K01AI091864, R01AI068854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Princeton University(Princeton University); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health/National Science Foundation(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University's Global Health Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank The China Medical Board for facilitating development of the manuscript, and five anonymous referees whose comments greatly improved the article. JZ is in part supported by a National Institute of Environmental Health Sciences Center Grant (#P30ES 05022) awarded to the University of Medicine and Dentistry, New Jersey and Rutgers University. DLM is supported by Princeton University. TZ is in part supported by a grant from the Chinese Natural Science Foundation (20637020). SL is in part supported by a National Institutes of Health/National Institute of Allergy and Infectious Diseases grant (R01 AI068854) to University of California, Berkeley. JVR is supported by the National Institutes of Health/National Science Foundation Ecology of Infectious Disease Program (grant 0622743) and Emory University's Global Health Institute.	Bao QS, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-217; Boden T. A., 2009, GLOBAL REGIONAL NATL; Bond TC, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003697; Campbell-Lendrum D, 2007, J URBAN HEALTH, V84, pI109, DOI 10.1007/s11524-007-9170-x; *CHIN MIN HLTH, 2007, NAT ENV HLTH ACT PLA; *CHIN MIN HLTH, 2007, 2007 HLTH YB CHIN MI; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Ezzati M, 2001, WORLD DEV, V29, P1421, DOI 10.1016/S0305-750X(01)00044-4; Gakidou E, 2007, JAMA-J AM MED ASSOC, V298, P1876, DOI 10.1001/jama.298.16.1876; Gleick P, 2008, CHINA WATER WORLDS W, P402; Health Effect Institute (HEI), 2004, 15 HEI; Hedley AJ, 2002, LANCET, V360, P1646, DOI 10.1016/S0140-6736(02)11612-6; Hu XUJ, 2008, LANCET, V372, P1717, DOI 10.1016/S0140-6736(08)61360-4; IPCC, 2008, CLIM CHANG 2007 SYNT; Jia ZW, 2008, EMERG INFECT DIS, V14, P1413, DOI [10.3201/1409.071543, 10.3201/eid1409.071543]; Liang S, 2006, B WORLD HEALTH ORGAN, V84, P139, DOI 10.2471/BLT.05.025031; Liu JF, 2009, ATMOS ENVIRON, V43, P4339, DOI 10.1016/j.atmosenv.2009.05.032; Liu SM, 2007, THORAX, V62, P889, DOI 10.1136/thx.2006.061457; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; *MEP, 2009, B CHIN ENV COND MEP; NAS/ NRC (National Academy of Sciences National Research Council), 2000, TOX EFF METH; *NBSC, 1986, CHIN STAT YB NBSC; *NBSC, 1998, CHIN ENV STAT YB NBS; OECD (Organization for Economic Cooperation and Development), 2007, ENV PERF REV CHIN; Pacyna EG, 2006, ATMOS ENVIRON, V40, P4048, DOI 10.1016/j.atmosenv.2006.03.041; Parrish DD, 2009, SCIENCE, V326, P674, DOI 10.1126/science.1176064; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Pruss-Ustun A., 2006, WORLD HEALTH; Saikawa E, 2009, ATMOS ENVIRON, V43, P2814, DOI 10.1016/j.atmosenv.2009.02.017; SEPA, 2006, STAT ENV REP; Shao M, 2006, FRONT ECOL ENVIRON, V4, P353, DOI 10.1890/1540-9295(2006)004[0353:CCICAA]2.0.CO;2; Smith AH, 2008, EPIDEMIOLOGY, V19, P24, DOI 10.1097/EDE.0b013e31815c40dc; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; *UNEP, 2005, SONGH RIV SPILL CHIN; Wang M, 2009, ATMOS CHEM PHYS, V9, P8247, DOI 10.5194/acp-9-8247-2009; Wang XP, 2006, ATMOS ENVIRON, V40, P1706, DOI 10.1016/j.atmosenv.2005.10.066; Wang XP, 2004, ATMOS ENVIRON, V38, P4383, DOI 10.1016/j.atmosenv.2004.03.067; Wang XY, 2006, B WORLD HEALTH ORGAN, V84, P561, DOI 10.2471/BLT.05.023853; West JJ, 2006, P NATL ACAD SCI USA, V103, P3988, DOI 10.1073/pnas.0600201103; WHO, 2009, QUANT DIS BURD ATTR; *WHO UNDP, 2001, ENV PEOPL HLTH CHIN; World Bank, 2007, COST POLLUTION CHINA; World Bank, 2009, POOR AR POOR PEOPL C; Wu KS, 2008, SCI TOTAL ENVIRON, V393, P219, DOI 10.1016/j.scitotenv.2007.12.029; Xie J, 2009, ADDRESSING CHINA'S WATER SCARCITY: RECOMMENDATIONS FOR SELECTED WATER RESOURCE MANAGEMENT ISSUES, P1, DOI 10.1596/978-0-8213-7645-4; Zhang GY, 2006, J RARE EARTH, V24, P97, DOI 10.1016/S1002-0721(06)60073-2; Zhang JJ, 2007, ENVIRON HEALTH PERSP, V115, P848, DOI 10.1289/ehp.9479; Zhang Rong, 2009, Journal of Environment and Health, V26, P3; Zhou XN, 2008, AM J TROP MED HYG, V78, P188, DOI 10.4269/ajtmh.2008.78.188; Zhuang P, 2009, ENVIRON GEOCHEM HLTH, V31, P707, DOI 10.1007/s10653-009-9248-3	51	303	326	21	388	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2010	375	9720					1110	1119		10.1016/S0140-6736(10)60062-1	http://dx.doi.org/10.1016/S0140-6736(10)60062-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578ZB	20346817	Green Accepted			2022-12-28	WOS:000276334600035
J	Metzger, E; Imhof, A; Patel, D; Kahl, P; Hoffmeyer, K; Friedrichs, N; Muller, JM; Greschik, H; Kirfel, J; Ji, S; Kunowska, N; Beisenherz-Huss, C; Gunther, T; Buettner, R; Schule, R				Metzger, Eric; Imhof, Axel; Patel, Dharmeshkumar; Kahl, Philip; Hoffmeyer, Katrin; Friedrichs, Nicolaus; Mueller, Judith M.; Greschik, Holger; Kirfel, Jutta; Ji, Sujuan; Kunowska, Natalia; Beisenherz-Huss, Christian; Guenther, Thomas; Buettner, Reinhard; Schuele, Roland			Phosphorylation of histone H3T6 by PKC beta(I) controls demethylation at histone H3K4	NATURE			English	Article							DOMAIN-CONTAINING PROTEINS; ANDROGEN-RECEPTOR; PROSTATE-CANCER; TRANSCRIPTIONAL REGULATION; STRUCTURAL BASIS; LSD1; COMPLEX; GENE	Demethylation at distinct lysine residues in histone H3 by lysine-specific demethylase 1 (LSD1) causes either gene repression or activation(1,2). As a component of co-repressor complexes, LSD1 contributes to target gene repression by removing mono-and dimethyl marks from lysine 4 of histone H3 (H3K4)(1,3). In contrast, during androgen receptor (AR)-activated gene expression, LSD1 removes mono-and dimethyl marks from lysine 9 of histone H3 (H3K9)(2). Yet, the mechanisms that control this dual specificity of demethylation are unknown. Here we show that phosphorylation of histone H3 at threonine 6 (H3T6) by protein kinase C beta I (PKC beta(I), also known as PRKCb beta) is the key event that prevents LSD1 from demethylating H3K4 during AR-dependent gene activation. In vitro, histone H3 peptides methylated at lysine 4 and phosphorylated at threonine 6 are no longer LSD1 substrates. In vivo, PKC beta(I) co-localizes with AR and LSD1 on target gene promoters and phosphorylates H3T6 after androgen-induced gene expression. RNA interference (RNAi)-mediated knockdown of PKC beta(I) abrogates H3T6 phosphorylation, enhances demethylation at H3K4, and inhibits AR-dependent transcription. Activation of PKC beta(I) requires androgen-dependent recruitment of the gatekeeper kinase protein kinase C (PKC)-related kinase 1 (PRK1)(4). Notably, increased levels of PKC beta(I) and phosphorylated H3T6 (H3T6ph) positively correlate with high Gleason scores of prostate carcinomas, and inhibition of PKC beta(I) blocks AR-induced tumour cell proliferation in vitro and cancer progression of tumour xeno-grafts in vivo. Together, our data establish that androgen-dependent kinase signalling leads to the writing of the new chromatin mark H3T6ph, which in consequence prevents removal of active methyl marks from H3K4 during AR-stimulated gene expression.	[Metzger, Eric; Patel, Dharmeshkumar; Hoffmeyer, Katrin; Friedrichs, Nicolaus; Mueller, Judith M.; Greschik, Holger; Ji, Sujuan; Kunowska, Natalia; Guenther, Thomas; Schuele, Roland] Univ Freiburg Klinikum, Urol Klin, Frauenklin, D-79106 Freiburg, Germany; [Metzger, Eric; Patel, Dharmeshkumar; Hoffmeyer, Katrin; Friedrichs, Nicolaus; Mueller, Judith M.; Greschik, Holger; Ji, Sujuan; Kunowska, Natalia; Guenther, Thomas; Schuele, Roland] Univ Freiburg Klinikum, Zent Klin Forsch, D-79106 Freiburg, Germany; [Beisenherz-Huss, Christian] ProQinase, D-79106 Freiburg, Germany; [Imhof, Axel] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Imhof, Axel] Univ Munich, Munich CIPS, D-80336 Munich, Germany; [Kahl, Philip; Kirfel, Jutta; Buettner, Reinhard] Univ Klinikum Bonn, Inst Pathol, D-53127 Bonn, Germany	University of Freiburg; University of Freiburg; University of Munich; University of Munich; University of Bonn	Schule, R (corresponding author), Univ Freiburg Klinikum, Urol Klin, Frauenklin, Breisacherstr 66, D-79106 Freiburg, Germany.	roland.schuele@uniklinik-freiburg.de	Imhof, Axel/AAU-5313-2021	Imhof, Axel/0000-0003-2993-8249; Gunther, Thomas/0000-0003-3903-9490	Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft [SFB 746/P2, Schu 688/9-1, SFB 832/Z1]	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank U. Elsasser-Beile, K. Alt, U. Wetterauer, W. Schulze-Seelmann, R. Schneider, T. Waldmann, L. Heukamp, J. M. G. Higgins and N. Potier for providing reagents. We are obliged to A. Rieder, F. Pfefferle, L. Walz, L. Spady and J. Lauterwasser for technical assistance. This work was supported by grants of the Deutsche Krebshilfe and the Deutsche Forschungsgemeinschaft (Reinhart Koselleck-Projekt, SFB 746/P2, Schu 688/9-1, Dr. Hans Messner Stiftung, Dr. Oetker-Stiftung and SFB 832/Z1) to R. S. and R. B.	Forneris F, 2007, J BIOL CHEM, V282, P20070, DOI 10.1074/jbc.C700100200; Hsing AW, 2000, INT J CANCER, V85, P60, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;60::AID-IJC11&gt;3.0.CO;2-B; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; Kang ZG, 2004, MOL ENDOCRINOL, V18, P2633, DOI 10.1210/me.2004-0245; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Magee JA, 2006, ENDOCRINOLOGY, V147, P590, DOI 10.1210/en.2005-1001; Makkonen H, 2008, ONCOGENE, V27, P4865, DOI 10.1038/onc.2008.125; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668; Metzger E, 2007, NAT STRUCT MOL BIOL, V14, P252, DOI 10.1038/nsmb0407-252; ONEILL TE, 1992, J MOL BIOL, V223, P67, DOI 10.1016/0022-2836(92)90716-W; SCHRODER FH, 1992, PROSTATE, P129; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yang MJ, 2007, NAT STRUCT MOL BIOL, V14, P535, DOI 10.1038/nsmb1255	23	208	222	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 1	2010	464	7289					792	U175		10.1038/nature08839	http://dx.doi.org/10.1038/nature08839			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20228790				2022-12-28	WOS:000276205000052
J	Douma, RA; le Gal, G; Sohne, M; Righini, M; Kamphuisen, PW; Perrier, A; Kruip, MJHA; Bounameaux, H; Buller, HR; Roy, PM				Douma, Renee A.; le Gal, Gregoire; Soehne, Maaike; Righini, Marc; Kamphuisen, Pieter W.; Perrier, Arnaud; Kruip, Marieke J. H. A.; Bounameaux, Henri; Bueller, Harry R.; Roy, Pierre-Marie			Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts	BRITISH MEDICAL JOURNAL			English	Article							COMPUTED-TOMOGRAPHY; CLINICAL PROBABILITY; ELDERLY-PATIENTS; OUTPATIENTS; PREDICTION; SCORE	Objectives In older patients, the the D-dimer test for pulmonary embolism has reduced specificity and is therefore less useful. In this study a new, age dependent cut-off value for the test was devised and its usefulness with older patients assessed. Design Retrospective multicentre cohort study. Setting General and teaching hospitals in Belgium, France, the Netherlands, and Switzerland. Patients 5132 consecutive patients with clinically suspected pulmonary embolism. Intervention Development of a new D-dimer cut-off point in patients aged >50 years in a derivation set (data from two multicentre cohort studies), based on receiver operating characteristics (ROC) curves. This cut-off value was then validated with two independent validation datasets. Main outcome measures The proportion of patients in the validation cohorts with a negative D-dimer test, the proportion in whom pulmonary embolism could be excluded, and the false negative rates. Results The new D-dimer cut-off value was defined as (patient's age x 10) mu g/l in patients aged >50. In 1331 patients in the derivation set with an "unlikely" score from clinical probability assessment, pulmonary embolism could be excluded in 42% with the new cut-off value versus 36% with the old cut-off value (<500 mu g/l). In the two validation sets, the increase in the proportion of patients with a D-dimer below the new cut-off value compared with the old value was 5% and 6%. This absolute increase was largest among patients aged >70 years, ranging from 13% to 16% in the three datasets. The failure rates (all ages) were 0.2% (95% CI 0% to 1.0%) in the derivation set and 0.6% (0.3% to 1.3%) and 0.3% (0.1% to 1.1%) in the two validation sets. Conclusions The age adjusted D-dimer cut-off point, combined with clinical probability, greatly increased the proportion of older patients in whom pulmonary embolism could be safely excluded.	[Douma, Renee A.; Soehne, Maaike; Kamphuisen, Pieter W.; Bueller, Harry R.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [le Gal, Gregoire] Brest Univ Hosp, Dept Internal Med & Chest Dis, CHU Cavale Blanche, Equipe Accueil GETBO 3878, F-29609 Brest, France; [Righini, Marc; Bounameaux, Henri] Univ Geneva, Div Angiol & Haemostasis, Dept Internal Med, Geneva Fac Med, CH-1211 Geneva, Switzerland; [Perrier, Arnaud] Univ Geneva, Div Gen Internal Med, Geneva Fac Med, CH-1211 Geneva, Switzerland; [Kruip, Marieke J. H. A.] Erasmus MC, Dept Haematol, NL-3015 CE Rotterdam, Netherlands; [Roy, Pierre-Marie] Univ Angers, Dept Emergency Med, F-49933 Angers 9, France	University of Amsterdam; Academic Medical Center Amsterdam; CHU Brest; University of Geneva; University of Geneva; Erasmus University Rotterdam; Erasmus MC; Universite d'Angers	Douma, RA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	R.A.Douma@amc.uva.nl	LE GAL, Gregoire/K-1077-2012; Perrier, Arnaud/M-2263-2014; Righini, Marc/AAX-8731-2020; Roy, Pierre-Marie/AAA-7737-2022	Kamphuisen, Pieter/0000-0002-6263-0177; LE GAL, Gregoire/0000-0002-9253-248X				Chagnon I, 2002, AM J MED, V113, P269, DOI 10.1016/S0002-9343(02)01212-3; HAGER K, 1995, GERONTOLOGY, V41, P159; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Masotti L, 2000, THROMB RES, V98, P577, DOI 10.1016/S0049-3848(00)00193-6; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Perrier A, 2004, AM J MED, V116, P291, DOI 10.1016/j.amjmed.2003.09.041; Perrier A, 1997, AM J RESP CRIT CARE, V156, P492, DOI 10.1164/ajrccm.156.2.9702032; Righini M, 2000, AM J MED, V109, P357, DOI 10.1016/S0002-9343(00)00493-9; Righini M, 2007, J THROMB HAEMOST, V5, P1869, DOI 10.1111/j.1538-7836.2007.02667.x; Righini M, 2004, ARCH INTERN MED, V164, P2483, DOI 10.1001/archinte.164.22.2483; Righini M, 2001, THROMB HAEMOSTASIS, V85, P744, DOI 10.1055/s-0037-1615663; Righini M, 2008, LANCET, V371, P1343, DOI 10.1016/S0140-6736(08)60594-2; Sohne M, 2006, J THROMB HAEMOST, V4, P1042, DOI 10.1111/j.1538-7836.2006.01918.x; Tardy B, 1998, THROMB HAEMOSTASIS, V79, P38, DOI 10.1055/s-0037-1614215; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; Wicki J, 2001, ARCH INTERN MED, V161, P92, DOI 10.1001/archinte.161.1.92	17	205	218	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 30	2010	340								c1475	10.1136/bmj.c1475	http://dx.doi.org/10.1136/bmj.c1475			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579VJ	20354012	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000276404100005
J	Kumar, S; Molina-Cruz, A; Gupta, L; Rodrigues, J; Barillas-Mury, C				Kumar, Sanjeev; Molina-Cruz, Alvaro; Gupta, Lalita; Rodrigues, Janneth; Barillas-Mury, Carolina			A Peroxidase/Dual Oxidase System Modulates Midgut Epithelial Immunity in Anopheles gambiae	SCIENCE			English	Article							PERITROPHIC MATRIX PROTEIN; DROSOPHILA GUT IMMUNITY; DUAL OXIDASE; PLASMODIUM; INFECTION; PATHWAY; DUOX	Extracellular matrices in diverse biological systems are cross-linked by dityrosine covalent bonds catalyzed by the peroxidase/oxidase system. We show that a peroxidase, secreted by the Anopheles gambiae midgut, and dual oxidase form a dityrosine network that decreases gut permeability to immune elicitors. This network protects the microbiota by preventing activation of epithelial immunity. It also provides a suitable environment for malaria parasites to develop within the midgut lumen without inducing nitric oxide synthase expression. Disruption of this barrier results in strong and effective pathogen-specific immune responses.	[Kumar, Sanjeev; Molina-Cruz, Alvaro; Gupta, Lalita; Rodrigues, Janneth; Barillas-Mury, Carolina] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Barillas-Mury, C (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.	cbarillas@niaid.nih.gov	Gupta, Lalita/R-1111-2019	Kumar, Sanjeev/0000-0003-3866-4593; GUPTA, LALITA/0000-0002-0712-8512; Rodrigues, Janneth/0000-0001-9693-1958	Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000947] Funding Source: NIH RePORTER	Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH. We thank A. Laughinghouse, K. Lee, T. Lehman, and R. Gwadz for insectary support; J. Kabat for assistance with confocal imaging; J. Ribeiro and J. Valenzuela for their comments and insight; and B. Marshall for editorial assistance. The complete data set for this microarray experiment has been submitted to the National Center for Biotechnology Information Gene Expression Omnibus database with accession number GSE20204.	Devenport M, 2004, INSECT MOL BIOL, V13, P349, DOI 10.1111/j.0962-1075.2004.00488.x; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Gupta L, 2009, CELL HOST MICROBE, V5, P498, DOI 10.1016/j.chom.2009.04.003; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200; Lim JH, 2005, INFECT IMMUN, V73, P2778, DOI 10.1128/IAI.73.5.2778-2789.2005; Meitzler JL, 2009, J BIOL CHEM, V284, P18634, DOI 10.1074/jbc.M109.013581; Shen ZC, 1999, P NATL ACAD SCI USA, V96, P5610, DOI 10.1073/pnas.96.10.5610; Shen ZC, 1998, J BIOL CHEM, V273, P17665, DOI 10.1074/jbc.273.28.17665; Wong JL, 2004, DEV CELL, V7, P801, DOI 10.1016/j.devcel.2004.10.014; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012	15	223	233	3	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2010	327	5973					1644	1648		10.1126/science.1184008	http://dx.doi.org/10.1126/science.1184008			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20223948	Green Accepted			2022-12-28	WOS:000275970600044
J	Yamey, G				Yamey, Gavin			Medicine in Developing Countries Do schools hold the key to controlling parasitic disease?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MALARIA; SCHOOLCHILDREN; EDUCATION; HEALTH		Univ Calif San Francisco, Global Hlth Grp, Evidence Policy Initiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Yamey, G (corresponding author), Univ Calif San Francisco, Global Hlth Grp, Evidence Policy Initiat, San Francisco, CA 94143 USA.	YameyG@globalhealth.ucsf.edu						Brooker S, 2008, T ROY SOC TROP MED H, V102, P304, DOI 10.1016/j.trstmh.2008.01.010; Bundy DAP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000362; Clarke SE, 2008, LANCET, V372, P127, DOI 10.1016/S0140-6736(08)61034-X; *CLIN TRIALS SERV, DEVTA; *DEP INT DEV, FACTS KEN; Gulani A, 2007, BMJ-BRIT MED J, V334, P1095, DOI 10.1136/bmj.39150.510475.AE; Lalloo DG, 2006, LANCET INFECT DIS, V6, P780, DOI 10.1016/S1473-3099(06)70655-7; Lengeler C, 2004, COCHRANE DATABASE SY; Miguel E, 2004, ECONOMETRICA, V72, P159, DOI 10.1111/j.1468-0262.2004.00481.x; Mwandawiro Charles S, 2004, Afr J Health Sci, V11, pi; NOKES C, 1994, PARASITOL TODAY, V10, P14, DOI 10.1016/0169-4758(94)90348-4; Taylor-Robinson DC, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000371.pub3	12	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2010	340								c1565	10.1136/bmj.c1565	http://dx.doi.org/10.1136/bmj.c1565			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	576PR	20348176				2022-12-28	WOS:000276157900005
J	Smale, ST				Smale, Stephen T.			Selective Transcription in Response to an Inflammatory Stimulus	CELL			English	Review							NF-KAPPA-B; INDUCIBLE NUCLEAR-PROTEIN; GENE-SPECIFIC CONTROL; BINDING PROTEIN; INNATE IMMUNITY; C-FOS; REMODELING COMPLEXES; CELL-DIFFERENTIATION; CHROMATIN STRUCTURE; CRYSTAL-STRUCTURE	An inflammatory response is initiated by the temporally controlled activation of genes encoding a broad range of regulatory and effector proteins. A central goal is to devise strategies for the selective modulation of proinflammatory gene transcription, to allow the suppression of genes responsible for inflammation-associated pathologies while maintaining a robust host response to microbial infection. Toward this goal, recent studies have revealed an unexpected level of diversity in the mechanisms by which chromatin structure and individual transcription factors contribute to the selective regulation of inflammatory genes.	Univ Calif Los Angeles, Inst Mol Biol, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Smale, ST (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.	smale@mednet.ucla.edu			National Institutes of Health [5R01AI073868, 5R01GM086372, 5R01CA127279]; NATIONAL CANCER INSTITUTE [R01CA127279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073868, R21AI076921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086372] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I would like to thank Sankar Ghosh, Alexander Hoffmann, Ruslan Medzhitov, Gioacchino Natoli, Simona Saccani, Ranjan Sen, and Peter Tontonoz for helpful discussions and critical comments on this article. Work in our laboratory on gene regulation in response to inflammatory stimuli is funded by National Institutes of Health grants 5R01AI073868, 5R01GM086372, and 5R01CA127279.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amir-Zilberstein L, 2007, MOL CELL BIOL, V27, P5246, DOI 10.1128/MCB.00586-07; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Arnosti DN, 2005, J CELL BIOCHEM, V94, P890, DOI 10.1002/jcb.20352; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Carey M., 2009, TRANSCRIPTIONAL REGU; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; COLLART MA, 1986, J EXP MED, V164, P2112; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; DALTON S, 1992, CELL, V68, P597, DOI 10.1016/0092-8674(92)90194-H; de Laat W, 2008, CURR TOP DEV BIOL, V82, P117, DOI 10.1016/S0070-2153(07)00005-1; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Dong J, 2008, GENE DEV, V22, P1159, DOI 10.1101/gad.1657408; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; ENGELKE DR, 1980, CELL, V19, P717, DOI 10.1016/S0092-8674(80)80048-1; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Foster SL, 2009, CLIN IMMUNOL, V130, P7, DOI 10.1016/j.clim.2008.08.015; GEORGIEV GP, 1969, J THEOR BIOL, V25, P473, DOI 10.1016/S0022-5193(69)80034-2; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GIERER A, 1973, COLD SPRING HARB SYM, V38, P951, DOI 10.1101/SQB.1974.038.01.097; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GRUNSTEIN M, 1990, ANNU REV CELL BIOL, V6, P643, DOI 10.1146/annurev.cellbio.6.1.643; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Jepsen K, 2002, J CELL SCI, V115, P689; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200; KOVESDI I, 1986, CELL, V45, P219, DOI 10.1016/0092-8674(86)90386-7; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Lai DZ, 2009, P NATL ACAD SCI USA, V106, P1169, DOI 10.1073/pnas.0811274106; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; LEE W, 1987, NATURE, V325, P368, DOI 10.1038/325368a0; Lefevre P, 2008, MOL CELL, V32, P129, DOI 10.1016/j.molcel.2008.07.023; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Lomvardas S, 2002, CELL, V110, P261, DOI 10.1016/S0092-8674(02)00822-X; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; MILANESI G, 1970, P NATL ACAD SCI USA, V66, P181, DOI 10.1073/pnas.66.1.181; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Munshi N, 2001, SCIENCE, V293, P1133, DOI 10.1126/science.293.5532.1133; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Natoli G, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.11pe1; NEIGEBORN L, 1984, GENETICS, V108, P845; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; Saccani S, 2002, GENE DEV, V16, P2219, DOI 10.1101/gad.232502; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; SARIBAN E, 1988, J CLIN INVEST, V81, P1506, DOI 10.1172/JCI113482; Savinova OV, 2009, MOL CELL, V34, P591, DOI 10.1016/j.molcel.2009.04.033; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Sen R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000257; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SIEBENLIST U, 1986, MOL CELL BIOL, V6, P3042, DOI 10.1128/MCB.6.9.3042; STERN M, 1984, J MOL BIOL, V178, P853, DOI 10.1016/0022-2836(84)90315-2; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van Essen D, 2009, PLOS BIOL, V7, P549, DOI 10.1371/journal.pbio.1000073; Wang JM, 2007, J IMMUNOL, V178, P6777, DOI 10.4049/jimmunol.178.11.6777; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7; WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749; WU C, 1979, CELL, V16, P797, DOI 10.1016/0092-8674(79)90095-3; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; YAMAMOTO KR, 1976, ANNU REV BIOCHEM, V45, P721, DOI 10.1146/annurev.bi.45.070176.003445; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamamoto Masahiro, 2008, Journal of Infection and Chemotherapy, V14, P265, DOI 10.1007/s10156-008-0619-y; Zaret KS, 2008, COLD SH Q B, V73, P119, DOI 10.1101/sqb.2008.73.040; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; ZINN K, 1983, CELL, V34, P865, DOI 10.1016/0092-8674(83)90544-5	100	233	242	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 19	2010	140	6					833	844		10.1016/j.cell.2010.01.037	http://dx.doi.org/10.1016/j.cell.2010.01.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	571IX	20303874	Bronze, Green Accepted			2022-12-28	WOS:000275746600008
J	Wang, AT; Mccoy, CP; Murad, MH; Montori, VM				Wang, Amy T.; McCoy, Christopher P.; Murad, Mohammad Hassan; Montori, Victor M.			Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CONFLICTS-OF-INTEREST; PHARMACEUTICAL-INDUSTRY; COULD DISCLOSURE; INTERESTS WORK; PUBLIC-HEALTH; EVENTS; EPIDEMIOLOGY; MEDICINE; LAWS	Objective To explore a possible link between authors' financial conflicts of interest and their position on the association of rosiglitazone with increased risk of myocardial infarction in patients with diabetes. Data sources On 10 April 2009, we searched Web of Science and Scopus for articles citing and commenting on either of two index publications that contributed key data to the controversy (a meta-analysis of small trials and a subsequent large trial). Data selection Articles had to comment on rosiglitazone and the risk of myocardial infarction. Guidelines, meta-analyses, reviews, clinical trials, letters, commentaries, and editorials were included. Data extraction For each article, we sought information about the authors' financial conflicts of interest in the report itself and elsewhere (that is, in all publications within two years of the original publication and online). Two reviewers blinded to the authors' financial relationships independently classified each article as presenting a favourable (that is, rosiglitazone does not increase the risk of myocardial infarction), neutral, or unfavourable view on the risk of myocardial infarction with rosiglitazone and on recommendations on the use of the drug. Results Of the 202 included articles, 108 (53%) had a conflict of interest statement. Ninety authors (45%) had financial conflicts of interest. Authors who had a favourable view of the risk of myocardial infarction with rosiglitazone were more likely to have financial conflicts of interest with manufacturers of antihyperglycaemic agents in general, and with rosiglitazone manufacturers in particular, than authors who had an unfavourable view (rate ratio 3.38, 95% CI 2.26 to 5.06 and 4.29, 2.63 to 7.02, respectively). There was likewise a strong association between favourable recommendations on the use of rosiglitazone and financial conflicts of interest (3.36, 1.94 to 5.83). These links persisted when articles rather than authors were used as the unit of analysis (4.69, 2.84 to 7.72), when the analysis was restricted to opinion articles (6.29, 2.15 to 18.38) or to articles in which the rosiglitazone controversy was the main focus (6.50, 2.56 to 16.53), and both in articles published before and after the Food and Drug Administration issued a safety warning for rosiglitazone (3.43, 0.99 to 11.82 and 4.95, 2.87 to 8.53, respectively). Conclusions Disclosure rates for financial conflicts of interest were unexpectedly low, and there was a clear and strong link between the orientation of authors' expressed views on the rosiglitazone controversy and their financial conflicts of interest with pharmaceutical companies. Although these findings do not necessarily indicate a causal link between the position taken on the cardiac risk of rosiglitazone in patients with diabetes and the authors' financial conflicts of interest, they underscore the need for further changes in disclosure procedures in order for the scientific record to be trusted.	[Wang, Amy T.; McCoy, Christopher P.; Murad, Mohammad Hassan; Montori, Victor M.] Mayo Clin, Dept Internal Med, Rochester, MN 55905 USA; [Wang, Amy T.; Murad, Mohammad Hassan; Montori, Victor M.] Mayo Clin, Knowledge & Encounter Res Unit, Rochester, MN USA; [Murad, Mohammad Hassan] Mayo Clin, Div Prevent Occupat & Aerosp Med, Rochester, MN USA; [Montori, Victor M.] Mayo Clin, Div Endocrinol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Murad, MH (corresponding author), Mayo Clin, Dept Internal Med, Rochester, MN 55905 USA.	murad.mohammad@mayo.edu	amy.tu.wang, amy.tu.wang/F-8331-2014; Murad, M. Hassan/AAW-4367-2020	amy.tu.wang, amy.tu.wang/0000-0002-0929-1399; Murad, Mohammad Hassan/0000-0001-5502-5975; Montori, Victor/0000-0003-0595-2898				Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bhandari M, 2004, CAN MED ASSOC J, V170, P477; Brennan TA, 2007, JAMA-J AM MED ASSOC, V297, P1255, DOI 10.1001/jama.297.11.1255; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; *FOOD DRUG ADM, 2007, FDA ADDS BOX WAM HEA; Greenland S, 2009, J EPIDEMIOL COMMUN H, V63, P593, DOI 10.1136/jech.2008.084913; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; *ICGME, 2008, BIOMEDICAL J UNPUB; Jorgensen AW, 2006, BMJ-BRIT MED J, V333, P782, DOI 10.1136/bmj.38973.444699.0B; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Ross JS, 2008, JAMA-J AM MED ASSOC, V299, P1800, DOI 10.1001/jama.299.15.1800; Ross JS, 2007, JAMA-J AM MED ASSOC, V297, P1216, DOI 10.1001/jama.297.11.1216; Spelsberg A, 2009, J EPIDEMIOL COMMUN H, V63, P603, DOI 10.1136/jech.2008.084939; Starner CI, 2008, J MANAGE CARE PHARM, V14, P523, DOI 10.18553/jmcp.2008.14.6.523; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206	17	104	107	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2010	340								c1344	10.1136/bmj.c1344	http://dx.doi.org/10.1136/bmj.c1344			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573RI	20299696	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000275931900004
J	Barrett-Connor, E; Nielson, CM; Orwoll, E; Bauer, DC; Cauley, JA				Barrett-Connor, Elizabeth; Nielson, Carrie M.; Orwoll, Eric; Bauer, Douglas C.; Cauley, Jane A.		Osteoporotic Fractures Men MrOS St	Epidemiology of rib fractures in older men: Osteoporotic Fractures in Men (MrOS) prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							HIGH-TRAUMA FRACTURES; BONE-MINERAL DENSITY; WOMEN	Objective To study the causes and consequences of radiologically confirmed rib fractures (seldom considered in the context of osteoporosis) in community dwelling older men. Design Prospective cohort study (Osteoporotic Fractures in Men (MrOS) Study). Setting and participants 5995 men aged 65 or over recruited in 2000-2 from six US sites; 99% answered mailed questionnaires about falls and fractures every four months for a mean 6.2 (SD 1.3) year follow-up. Main outcome measures New fractures validated by radiology reports; multivariate Cox proportional hazard ratios were used to evaluate factors independently associated with time to incident rib fracture; associations between baseline rib fracture and incident hip and wrist fracture were also evaluated. Results The incidence of rib fracture was 3.5/1000 person years, and 24% (126/522) of all incident non-spine fractures were rib fractures. Nearly half of new rib fractures (48%; n=61) followed falling from standing height or lower. Independent risk factors for an incident rib fracture were age 80 or above, low bone density, difficulty with instrumental activities of daily living, and a baseline history of rib/chest fracture. Men with a history of rib/chest fracture had at least a twofold increased risk of an incident rib fracture (adjusted hazard ratio 2.71, 95% confidence interval 1.86 to 3.95), hip fracture (2.05, 1.33 to 3.15), and wrist fracture (2.06, 1.14 to 3.70). Only 14/82 of men reported being treated with bone specific drugs after their incident rib fracture. Conclusions Rib fracture, the most common incident clinical fracture in men, was associated with classic risk markers for osteoporosis, including old age, low hip bone mineral density, and history of fracture. A history of rib fracture predicted a more than twofold increased risk of future fracture of the rib, hip, or wrist, independent of bone density and other covariates. Rib fractures should be considered to be osteoporotic fractures in the evaluation of older men for treatment to prevent future fracture.	[Barrett-Connor, Elizabeth] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA; [Nielson, Carrie M.; Orwoll, Eric] Oregon Hlth & Sci Univ, Bone & Mineral Unit, Portland, OR 97201 USA; [Bauer, Douglas C.] Univ Calif San Francisco, San Francisco, CA 94107 USA; [Cauley, Jane A.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15241 USA	University of California System; University of California San Diego; Oregon Health & Science University; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Barrett-Connor, E (corresponding author), Univ Calif San Diego, Dept Family & Prevent Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ebarrettconnor@ucsd.edu		Orwoll, Eric/0000-0002-8520-7355; Cauley, Jane A/0000-0003-0752-4408	National Institutes of Health [U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01-AG027810, UL1 RR024140]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Institute on Aging (NIA); National Center for Research Resources (NCRR)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The Osteoporotic Fractures in Men (MrOS) Study is supported by National Institutes of Health funding. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institute on Aging (NIA), the National Center for Research Resources (NCRR), and NIH Roadmap for Medical Research provide support under the following grant numbers: U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01-AG027810, and UL1 RR024140.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Barnea Y, 2002, CAN J SURG, V45, P43; Blank JB, 2005, CONTEMP CLIN TRIALS, V26, P557, DOI 10.1016/j.cct.2005.05.005; Block G, 1990, Epidemiology, V1, P58, DOI 10.1097/00001648-199001000-00013; COOPER C, 1992, TRENDS ENDOCRIN MET, V3, P224, DOI 10.1016/1043-2760(92)90032-V; Davie MWJ, 1996, J ORTHOP RHEUMATOL, V9, P41; HONKANEN R, 1995, J CLIN EPIDEMIOL, V48, P881, DOI 10.1016/0895-4356(94)00220-K; Ismail AA, 2006, OSTEOPOROSIS INT, V17, P41, DOI 10.1007/s00198-005-1887-3; JONES G, 1994, OSTEOPOROSIS INT, V4, P277, DOI 10.1007/BF01623352; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Mackey DC, 2007, JAMA-J AM MED ASSOC, V298, P2381, DOI 10.1001/jama.298.20.2381; Marcus R, 2008, OSTEOPOROSIS, VOLS I AND II, 3RD EDITION, P1; NEVITT M, 1992, P INT S FALLS ELD MA; NEVITT MC, 1992, AM J EPIDEMIOL, V135, P490, DOI 10.1093/oxfordjournals.aje.a116315; NEVITT MC, 1991, P INT S FALLS ELD MA; Orwoll E, 2005, CONTEMP CLIN TRIALS, V26, P569, DOI 10.1016/j.cct.2005.05.006; PAHOR M, 1994, EUR J EPIDEMIOL, V10, P405, DOI 10.1007/BF01719664; Palvanen M, 2004, OSTEOPOROSIS INT, V15, P649, DOI 10.1007/s00198-003-1585-y; Sanders KM, 1998, J BONE MINER RES, V13, P1337, DOI 10.1359/jbmr.1998.13.8.1337; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4	20	47	47	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAR 15	2010	340								c1069	10.1136/bmj.c1069	http://dx.doi.org/10.1136/bmj.c1069			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573RA	20231246	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000275931100001
J	Roch, S				Roch, Sebastien			Toward Extracting All Phylogenetic Information from Matrices of Evolutionary Distances	SCIENCE			English	Article							GENERALIZED LEAST-SQUARES; SEQUENCE DATA; TREES; RECONSTRUCTION; MODEL; PERFORMANCE	The matrix of evolutionary distances is a model-based statistic, derived from molecular sequences, summarizing the pairwise phylogenetic relations between a collection of species. Phylogenetic tree reconstruction methods relying on this matrix are relatively fast and thus widely used in molecular systematics. However, because of their intrinsic reliance on summary statistics, distance-matrix methods are assumed to be less accurate than likelihood-based approaches. In this paper, pairwise sequence comparisons are shown to be more powerful than previously hypothesized. A statistical analysis of certain distance-based techniques indicates that their data requirement for large evolutionary trees essentially matches the conjectured performance of maximum likelihood methods-challenging the idea that summary statistics lead to suboptimal analyses. On the basis of a connection between ancestral state reconstruction and distance averaging, the critical role played by the covariances of the distance matrix is identified.	Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Roch, S (corresponding author), Univ Calif Los Angeles, Dept Math, 520 Portola Plaza, Los Angeles, CA 90095 USA.	roch@math.ucla.edu						Atteson K, 1999, ALGORITHMICA, V25, P251, DOI 10.1007/PL00008277; Bruno WJ, 2000, MOL BIOL EVOL, V17, P189, DOI 10.1093/oxfordjournals.molbev.a026231; BULMER M, 1991, MOL BIOL EVOL, V8, P868; Chor B, 2006, J ACM, V53, P722, DOI 10.1145/1183907.1183909; Daskalakis C., 2006, STOC'06. Proceedings of the 38th Annual ACM Symposium on Theory of Computing, P159, DOI 10.1145/1132516.1132540; Daskalakis C, 2011, PROBAB THEORY REL, V149, P149, DOI 10.1007/s00440-009-0246-2; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Erdos PL, 1999, RANDOM STRUCT ALGOR, V14, P153, DOI 10.1002/(SICI)1098-2418(199903)14:2<153::AID-RSA3>3.0.CO;2-R; Evans W, 2000, ANN APPL PROBAB, V10, P410; Felsenstein J., 2004, INFERRING PHYLOGENIE; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; GRAHAM RL, 1982, MATH BIOSCI, V60, P133, DOI 10.1016/0025-5564(82)90125-0; HUSON DH, 1999, WAE 99, P271; Kim J, 1998, SYST BIOL, V47, P43, DOI 10.1080/106351598261021; Lacey MR, 2006, MATH BIOSCI, V199, P188, DOI 10.1016/j.mbs.2005.11.003; MIHAESCU R, 2008, THESIS U CALIFORNIA; Mihaescu R, 2008, P NATL ACAD SCI USA, V105, P13206, DOI 10.1073/pnas.0802089105; Mossel E, 2004, T AM MATH SOC, V356, P2379, DOI 10.1090/S0002-9947-03-03382-8; Mossel E, 2001, ANN APPL PROBAB, V11, P285, DOI 10.1214/aoap/998926994; MOSSEL E, COMMUNICATION; Roch S., 2008, FOCS, P729; Rzhetsky A, 1996, MOL BIOL EVOL, V13, P1255, DOI 10.1093/oxfordjournals.molbev.a025691; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schervish M J., 1995, THEORY STAT; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Sokal RR, 1963, PRINCIPLES NUMERICAL; Steel MA, 2002, SIAM J DISCRETE MATH, V15, P562, DOI 10.1137/S089548010138790X; STEEL MA, 1988, NATURE, V336, P118, DOI 10.1038/336118a0; Steel M, 2009, J THEOR BIOL, V256, P467, DOI 10.1016/j.jtbi.2008.10.010; Susko E, 2003, MOL BIOL EVOL, V20, P862, DOI 10.1093/molbev/msg093; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023	34	35	36	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	2010	327	5971					1376	1379		10.1126/science.1182300	http://dx.doi.org/10.1126/science.1182300			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223986				2022-12-28	WOS:000275418700041
J	West, SA; Gardner, A				West, Stuart A.; Gardner, Andy			Altruism, Spite, and Greenbeards	SCIENCE			English	Review							KIN SELECTION; STRONG RECIPROCITY; EVOLUTION; EUSOCIALITY; BACTERIOCINS; COOPERATION; COMPETITION; BEHAVIOUR; VIRULENCE; MONOGAMY	Hamilton's theory of inclusive fitness showed how natural selection could lead to behaviors that decrease the relative fitness of the actor and also either benefit (altruism) or harm (spite) other individuals. However, several fundamental issues in the evolution of altruism and spite have remained contentious. Here, we show how recent work has resolved three key debates, helping clarify how Hamilton's theoretical overview links to real-world examples, in organisms ranging from bacteria to humans: Is the evolution of extreme altruism, represented by the sterile workers of social insects, driven by genetics or ecology? Does spite really exist in nature? And, can altruism be favored between individuals who are not close kin but share a "greenbeard" gene for altruism?	[West, Stuart A.; Gardner, Andy] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	West, SA (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	stuart.west@zoo.ox.ac.uk; andy.gardner@zoo.ox.ac.uk	Gardner, Andy/K-5353-2013; West, Stuart A/M-3608-2014	Gardner, Andy/0000-0002-1304-3734; West, Stuart A/0000-0003-2152-3153	Royal Society; European Research Council; Leverhulme Trust	Royal Society(Royal Society of London); European Research Council(European Research Council (ERC)European Commission); Leverhulme Trust(Leverhulme Trust)	We thank J. Alpedrinha, K. Boomsma, A. Griffin, M. Hauser, K. Jensen, L. Keller and P. Taylor for comments and the Royal Society, European Research Council, and Leverhulme Trust for funding.	[Anonymous], 1861, ORIGIN SPECIES MEANS; Boomsma JJ, 2007, CURR BIOL, V17, pR673, DOI 10.1016/j.cub.2007.06.033; Boomsma JJ, 2009, PHILOS T R SOC B, V364, P3191, DOI 10.1098/rstb.2009.0101; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; CRAIG R, 1979, EVOLUTION, V33, P319, DOI 10.1111/j.1558-5646.1979.tb04685.x; Dawkins Richard, 1976, SELFISH GENE; Duffy JE, 2010, P ROY SOC B-BIOL SCI, V277, P575, DOI 10.1098/rspb.2009.1483; Fisher R.A., 1930, GENETICAL THEORY NAT; Foster KR, 2001, ANN ZOOL FENN, V38, P229; FRANK RH, 1987, AM ECON REV, V77, P593; Gardner A, 2004, J EVOLUTION BIOL, V17, P1195, DOI 10.1111/j.1420-9101.2004.00775.x; Gardner A, 2004, P ROY SOC B-BIOL SCI, V271, P1529, DOI 10.1098/rspb.2004.2756; Gardner A, 2007, AM NAT, V169, P519, DOI 10.1086/512107; Gardner A, 2010, EVOLUTION, V64, P25, DOI 10.1111/j.1558-5646.2009.00842.x; Gardner A, 2009, BIOL LETTERS, V5, P861, DOI 10.1098/rsbl.2009.0674; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Giron D, 2004, NATURE, V430, P676, DOI 10.1038/nature02721; Grafen A, 2007, J EVOLUTION BIOL, V20, P1243, DOI 10.1111/j.1420-9101.2007.01321.x; Hamilton W. D., 1975, BIOSOCIAL ANTHR, P133; HAMILTON WD, 1970, NATURE, V228, P1218, DOI 10.1038/2281218a0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hauser M, 2009, PHILOS T R SOC B, V364, P3255, DOI 10.1098/rstb.2009.0116; Hughes WOH, 2008, SCIENCE, V320, P1213, DOI 10.1126/science.1156108; Inglis RF, 2009, P NATL ACAD SCI USA, V106, P5703, DOI 10.1073/pnas.0810850106; Jensen K, 2007, P NATL ACAD SCI USA, V104, P13046, DOI 10.1073/pnas.0705555104; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1507, DOI 10.1111/j.1420-9101.2006.01128.x; Owren MJ, 2001, EMO SOC BEH, P152; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Strassmann JE, 2007, P NATL ACAD SCI USA, V104, P8619, DOI 10.1073/pnas.0701285104; TRIVERS RL, 1976, SCIENCE, V191, P249, DOI 10.1126/science.1108197; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102	35	168	172	1	267	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	2010	327	5971					1341	1344		10.1126/science.1178332	http://dx.doi.org/10.1126/science.1178332			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223978	Green Submitted			2022-12-28	WOS:000275418700031
J	Sellar, RS; Corbett, EL; D'Sa, S; Linch, DC; Ardeshna, KM				Sellar, Rob S.; Corbett, E. L.; D'Sa, Shirley; Linch, David C.; Ardeshna, Kirit M.			Lesson of the Week Treatment for lymph node tuberculosis	BRITISH MEDICAL JOURNAL			English	Article							ASPIRATION CYTOLOGY		[Sellar, Rob S.; D'Sa, Shirley; Linch, David C.; Ardeshna, Kirit M.] Univ Coll London Hosp, London NW1 2PG, England; [Corbett, E. L.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [D'Sa, Shirley; Ardeshna, Kirit M.] Mt Vernon Canc Ctr, Northwood HA6 2RN, Middx, England; [Linch, David C.] UCL, London WC1E 6BT, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Mount Vernon Cancer Centre; University of London; University College London	Ardeshna, KM (corresponding author), Univ Coll London Hosp, London NW1 2PG, England.	kirit.ardeshna@uclh.nhs.uk		Corbett, Elizabeth/0000-0002-3552-3181	Wellcome Trust Funding Source: Medline; National Institute for Health Research [NF-SI-0507-10370] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Khurana KK, 1998, CANCER CYTOPATHOL, V84, P84, DOI 10.1002/(SICI)1097-0142(19980425)84:2<84::AID-CNCR3>3.0.CO;2-D; *NAT COLL CTR CHRO, 2006, TUB CLIN DIAGN MAN T; PATIL PS, 1993, J CLIN PATHOL, V46, P806, DOI 10.1136/jcp.46.9.806; *ROYAL COLL PATH B, 2010, BEST PRACT LYMPH DIA; WHO, 2007, IMPR DIAGN TREATM SM	5	7	9	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2010	340								c63	10.1136/bmj.c63	http://dx.doi.org/10.1136/bmj.c63			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570FD	20219818	Green Accepted			2022-12-28	WOS:000275656800033
J	Lassen, MR; Raskob, GE; Gallus, A; Pineo, G; Chen, DL; Hornick, P				Lassen, Michael Rud; Raskob, Gary E.; Gallus, Alexander; Pineo, Graham; Chen, Dalei; Hornick, Philip		ADVANCE 2 Investigators	Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial	LANCET			English	Article							FACTOR XA INHIBITOR; VENOUS THROMBOEMBOLISM; DABIGATRAN ETEXILATE; TOTAL HIP; PREVENTION; RIVAROXABAN; ARTHROPLASTY; THROMBOSIS; SAFETY	Background Low-molecular-weight heparins such as enoxaparin are preferred for prevention of venous thromboembolism after major joint replacement. Apixaban, an orally active factor Xa inhibitor, might be as effective, have lower bleeding risk, and be easier to use than is enoxaparin. We assessed efficacy and safety of these drugs after elective total knee replacement. Methods In ADVANCE-2, a multicentre, randomised, double-blind phase 3 study, patients undergoing elective unilateral or bilateral total knee replacement were randomly allocated through an interactive central telephone system to receive oral apixaban 2.5 mg twice daily (n=1528) or subcutaneous enoxaparin 40 mg once daily (1529). The randomisation schedule was generated by the Bristol-Myers Squibb randomisation centre and stratified by study site and by unilateral or bilateral surgery with a block size of four. Investigators, patients, statisticians, adjudicators, and steering committee were masked to allocation. Apixaban was started 12-24 h after wound closure and enoxaparin 12 h before surgery; both drugs were continued for 10-14 days, when bilateral ascending venography was scheduled. Primary outcome was the composite of asymptomatic and symptomatic deep vein thrombosis, non-fatal pulmonary embolism, and all-cause death during treatment. The statistical plan required non-inferiority of apixaban before testing for superiority; analysis was by intention to treat for non-inferiority testing. The study is registered at ClinicalTrials.gov, number NCT00452530. Findings 1973 of 3057 patients allocated to treatment (1528 apixaban, 1529 enoxaparin) were eligible for primary efficacy analysis. The primary outcome was reported in 147 (15%) of 976 apixaban patients and 243 (24%) of 997 enoxaparin patients (relative risk 0.62 [95% CI 0.51-0.74]; p<0.0001; absolute risk reduction 9.3% [5.8-12.7]). Major or clinically relevant non-major bleeding occurred in 53 (4%) of 1501 patients receiving apixaban and 72 (5%) of 1508 treated with enoxaparin (p=0.09). Interpretation Apixaban 2.5 mg twice daily, starting on the morning after total knee replacement, offers a convenient and more effective orally administered alternative to 40 mg per day enoxaparin, without increased bleeding.	[Lassen, Michael Rud] Univ Copenhagen, Horsholm Hosp, Dept Orthopaed, Spine Clin,Clin Trial Unit, DK-2970 Horsholm, Denmark; [Raskob, Gary E.] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Oklahoma City, OK USA; [Gallus, Alexander] Flinders Med Ctr, SA Pathol, Adelaide, SA, Australia; [Gallus, Alexander] Flinders Univ S Australia, Adelaide, SA, Australia; [Pineo, Graham] Univ Calgary, Dept Med & Oncol, Calgary, AB, Canada; [Chen, Dalei; Hornick, Philip] Bristol Myers Squibb Co, Res & Dev, Princeton, NJ USA	University of Copenhagen; University of Oklahoma System; University of Oklahoma Health Sciences Center; Flinders Medical Centre; SA Pathology; Flinders University South Australia; University of Calgary; Bristol-Myers Squibb	Lassen, MR (corresponding author), Univ Copenhagen, Horsholm Hosp, Dept Orthopaed, Spine Clin,Clin Trial Unit, Usserod Kongevej 102, DK-2970 Horsholm, Denmark.	mirula@noh.regionh.dk	Schulman, Sam/I-7559-2019	Schulman, Sam/0000-0002-8512-9043; Borris, Lars/0000-0002-0527-1518; Gallus, Alexander/0000-0001-7347-9989	Bristol-Myers Squibb; Pfizer	Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer)	Editorial assistance with formatting the report for submission was provided by J Bellhouse and L Prisco at PPSI and funded by Bristol-Myers Squibb and Pfizer.	Agnelli G, 2009, THROMB RES, V123, P488, DOI 10.1016/j.thromres.2008.02.017; Colwell CW, 2005, J BONE JOINT SURG AM, V87A, P2169, DOI 10.2106/JBJS.D.02184; Eriksson BI, 2007, J THROMB HAEMOST, V5, P2178, DOI 10.1111/j.1538-7836.2007.02748.x; Eriksson BI, 2009, J BONE JOINT SURG BR, V91B, P636, DOI 10.1302/0301-620X.91B5.21691; Eriksson BI, 2008, NEW ENGL J MED, V358, P2765, DOI 10.1056/NEJMoa0800374; Eriksson BI, 2007, LANCET, V370, P949, DOI 10.1016/S0140-6736(07)61445-7; Friedman RJ, 2008, CURR MED RES OPIN, V24, P87, DOI 10.1185/030079907X242746; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Ginsberg JS, 2009, J ARTHROPLASTY, V24, P1, DOI 10.1016/j.arth.2008.01.132; Kakkar AK, 2008, LANCET, V372, P31, DOI 10.1016/S0140-6736(08)60880-6; Lassen MR, 2007, J THROMB HAEMOST, V5, P2368, DOI 10.1111/j.1538-7836.2007.02764.x; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; Lassen MR, 2009, NEW ENGL J MED, V361, P594, DOI 10.1056/NEJMoa0810773; RABINOV K, 1972, ARCH SURG-CHICAGO, V104, P134; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Turpie AGG, 2002, ARCH INTERN MED, V162, P1833, DOI 10.1001/archinte.162.16.1833; Turpie AGG, 2009, LANCET, V373, P1673, DOI 10.1016/S0140-6736(09)60734-0; Wong PC, 2008, J THROMB HAEMOST, V6, P820, DOI 10.1111/j.1538-7836.2008.02939.x; YANAGAWA T, 1994, BIOMETRICS, V50, P859, DOI 10.2307/2532800; YANAGAWA T, 1995, BIOMETRICS, V51, P392	20	591	628	2	56	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 6	2010	375	9717					807	815		10.1016/S0140-6736(09)62125-5	http://dx.doi.org/10.1016/S0140-6736(09)62125-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570MO	20206776				2022-12-28	WOS:000275682600030
J	Behr, M; Schurr, E; Gros, P				Behr, Marcel; Schurr, Erwin; Gros, Philippe			TB: Screening for Responses to a Vile Visitor	CELL			English	Review							MYCOBACTERIUM-TUBERCULOSIS; INFECTED MACROPHAGES; AUTOPHAGY; BCG; SUSCEPTIBILITY; IMMUNITY; DISEASES; LEPROSY; ROLES		[Gros, Philippe] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Behr, Marcel; Schurr, Erwin] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H3G 0B1, Canada	McGill University; McGill University	Gros, P (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada.	philippe.gros@mcgill.ca						Al-Muhsen S, 2008, J ALLERGY CLIN IMMUN, V122, P1043, DOI 10.1016/j.jaci.2008.10.037; Bafica A, 2005, J CLIN INVEST, V115, P1601, DOI 10.1172/JCI23949; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Deretic V, 2009, CURR TOP MICROBIOL, V335, P169, DOI 10.1007/978-3-642-00302-8_8; DESOUZA JB, 2009, PARASITOLOGY, DOI DOI 10.1017/S00311182009991715; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Fortin A, 2007, ANNU REV GENOM HUM G, V8, P163, DOI 10.1146/annurev.genom.8.080706.092315; Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Herb F, 2008, HUM MOL GENET, V17, P1052, DOI 10.1093/hmg/ddm378; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Korenromp EL, 2009, INT J TUBERC LUNG D, V13, P283; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Schurr E, 2009, NEW ENGL J MED, V361, P2666, DOI 10.1056/NEJMe0910690; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	17	22	23	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					615	618		10.1016/j.cell.2010.02.030	http://dx.doi.org/10.1016/j.cell.2010.02.030			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211131	Bronze			2022-12-28	WOS:000275197400011
J	Geva-Zatorsky, N; Dekel, E; Cohen, AA; Danon, T; Cohen, L; Alon, U				Geva-Zatorsky, Naama; Dekel, Erez; Cohen, Ariel A.; Danon, Tamar; Cohen, Lydia; Alon, Uri			Protein Dynamics in Drug Combinations: a Linear Superposition of Individual-Drug Responses	CELL			English	Article							GENE NETWORKS; HUMAN-CELLS; SYSTEMS; PROTEOMICS; THERAPY; SYNERGY	Drugs and drug combinations have complex biological effects on cells and organisms. Little is known about how drugs affect protein dynamics that determine these effects. Here, we use a dynamic proteomics approach to accurately follow 15 protein levels in human cells in response to 13 different drugs. We find that protein dynamics in response to combinations of drugs are described accurately by a linear superposition ( weighted sum) of their response to individual drugs. The weights in this superposition describe the relative impact of each drug on each protein. Using these weights, we show that one can predict the dynamics in a three-drug or four-drug combination on the basis of the dynamics in drug pairs. Our approach might eliminate the need to increase the number of experiments exponentially with the number of drugs and suggests that it might be possible to rationally control protein dynamics with specific drug combinations.	[Geva-Zatorsky, Naama; Dekel, Erez; Cohen, Ariel A.; Danon, Tamar; Cohen, Lydia; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Geva-Zatorsky, Naama; Dekel, Erez; Cohen, Ariel A.; Danon, Tamar; Cohen, Lydia; Alon, Uri] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	urialon@weizmann.ac.il	Geva-Zatorsky, Naama/AAP-9176-2021	Geva-Zatorsky, Naama/0000-0002-7303-854X	Kahn Family Foundation; Keren Isra-Pa'amei Tikva	Kahn Family Foundation; Keren Isra-Pa'amei Tikva	This work was supported by the Kahn Family Foundation and by Keren Isra-Pa'amei Tikva. We thank Pierre Choukroun for assistance with the computer cluster. We thank J. Lehar, W. Koestler, J. Bar, I. Glinert, Y. Aylon, and all members of the Alon laboratory for fruitful discussions, comments, and technical help.	Alon U., 2006, INTRO SYSTEMS BIOL D; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Garman KS, 2007, HUM MOL GENET, V16, pR226, DOI 10.1093/hmg/ddm184; GRECO WR, 1995, PHARMACOL REV, V47, P331; Jolliffe I. T, 2002, PRINCIPLE COMPONENT; Jonker DM, 2005, PHARMACOL THERAPEUT, V106, P1, DOI 10.1016/j.pharmthera.2004.10.014; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; LOEWE S, 1953, ARZNEIMITTEL-FORSCH, V3, P285; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; Sigal A, 2007, NAT PROTOC, V2, P1515, DOI 10.1038/nprot.2007.197; Sigal A, 2006, NAT METHODS, V3, P525, DOI 10.1038/NMETH892; Strogatz S. H., 2001, NONLINEAR DYNAMICS C; Tegner J, 2003, P NATL ACAD SCI USA, V100, P5944, DOI 10.1073/pnas.0933416100; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; ZHANG SZ, 1990, CELL BIOL TOXICOL, V6, P219	24	80	80	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					643	651		10.1016/j.cell.2010.02.011	http://dx.doi.org/10.1016/j.cell.2010.02.011			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211134	Bronze			2022-12-28	WOS:000275197400014
J	Low, K; Harding, T; Jardine, P				Low, Karen; Harding, Teresa; Jardine, Philip			A Patient's Journey Dopa responsive dystonia	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Low, Karen] Bristol Royal Hosp Children, Bristol BS2 8BJ, Avon, England; [Jardine, Philip] Frenchay Hosp, Bristol BS16 1LE, Avon, England	Bristol Royal Hospital For Children	Harding, T (corresponding author), 42 Braikenridge Close, Clevedon, England.	harding@blueyonder.co.uk							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 4	2010	340								c668	10.1136/bmj.c668	http://dx.doi.org/10.1136/bmj.c668			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	565FK	20203076				2022-12-28	WOS:000275274500005
J	Rasmussen, K; Maeng, M; Kaltoft, A; Thayssen, P; Kelbaek, H; Tilsted, HH; Abildgaard, U; Christiansen, EH; Engstrom, T; Krusell, LR; Ravkilde, J; Hansen, PR; Hansen, KN; Abildstrom, SZ; Aaroe, J; Jensen, JS; Kristensen, SD; Botker, HE; Madsen, M; Johnsen, SP; Jensen, LO; Sorensen, HT; Thuesen, L; Lassen, JF				Rasmussen, Klaus; Maeng, Michael; Kaltoft, Anne; Thayssen, Per; Kelbaek, Henning; Tilsted, Hans Henrik; Abildgaard, Ulrik; Christiansen, Evald Hoj; Engstrom, Thomas; Krusell, Lars Romer; Ravkilde, Jan; Hansen, Peter Riis; Hansen, Knud Norregaard; Abildstrom, Steen Zabell; Aaroe, Jens; Jensen, Jan Skov; Kristensen, Steen Dalby; Botker, Hans Erik; Madsen, Morten; Johnsen, Soren Paaske; Jensen, Lisette Okkels; Sorensen, Henrik Toft; Thuesen, Leif; Lassen, Jens Flensted		SORT OUT III Study Grp	Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; ARTERY-DISEASE; FOLLOW-UP; DRUG; ENDEAVOR; THROMBOSIS; LESIONS; OUTCOMES; IMPLANTATION	Background In low-risk patients, the zotarolimus-eluting stent has been shown to reduce rates of restenosis without increasing the risk of stent thrombosis. We compared the efficacy and safety of the zotarolimus-eluting stent versus the sirolimus-eluting stent in patients with coronary artery disease who were receiving routine clinical care with no direct follow-up. Methods We did a single-blind, all-corner superiority trial in adult patients with chronic stable coronary artery disease or acute coronary syndromes, and at least one target lesion. Patients were treated at one of five percutaneous coronary intervention centres between January, 2006, and August, 2007. Computer-generated block randomisation and a telephone allocation service were used to randomly assign patients to receive the zotarolimus-eluting or the sirolimus-eluting stent. Data for follow-up were obtained from national Danish administrative and health-care registries. The primary endpoint was a composite of major adverse cardiac events within 9 months: cardiac death, myocardial infarction, and target vessel revascularisation. Intention-to-treat analyses were done at 9-month and 18-month follow-up. This trial is registered with ClinicalTrials.gov, number NCT00660478. Findings 1162 patients (1619 lesions) were assigned to receive the zotarolimus-eluting stent, and 1170 patients (1611 lesions) to receive the sirolimus-eluting stent. 67 patients (72 lesions) had stent failure, and six patients were lost to follow-up. All randomly assigned patients were induded in analyses at 9-month follow-up; 2200 patients (94%) had completed 18-month follow-up by the time of our assessment. At 9 months, the primary endpoint had occurred in a higher proportion of patients treated with the zotarolimus-eluting stent than in those treated with the sirolimus-eluting stent (72 [6%] vs 34 [3%]; HR 2.15, 95% CI 1.43-3.23; p=0.0002). At 18-month follow-up, this difference was sustained (113 [10%] vs 53 [5%]; 2.19, 1.58-3.04; p<0.0001). For patients receiving the zotarolimus-eluting stent and those receiving the sirolimus-eluting stent, all cause-mortality was similar at 9-month follow-up (25 [2%] vs 18 [2%]; 1.40, 0.76-2.56; p=0.28), but was significantly different at 18-month follow-up (51 [4%] vs 32 [3%]; 1.61, 1.03-2.50; p=0.035). Interpretation The sirolimus-eluting stent is superior to the zotarolimus-eluting stent for patients receiving routine clinical care.	[Maeng, Michael; Kaltoft, Anne; Christiansen, Evald Hoj; Krusell, Lars Romer; Kristensen, Steen Dalby; Botker, Hans Erik; Jensen, Lisette Okkels; Thuesen, Leif; Lassen, Jens Flensted] Aarhus Univ Hosp, Dept Cardiol, DK-8200 Aarhus N, Denmark; [Rasmussen, Klaus; Tilsted, Hans Henrik; Ravkilde, Jan; Aaroe, Jens] Aalborg Hosp, Aarhus Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Madsen, Morten; Johnsen, Soren Paaske; Sorensen, Henrik Toft] Aalborg Hosp, Aarhus Univ Hosp, Dept Clin Epidemiol, Aalborg, Denmark; [Johnsen, Soren Paaske] Aalborg Hosp, Aarhus Univ Hosp, Cardiovasc Res Ctr, Aalborg, Denmark; [Thayssen, Per; Hansen, Knud Norregaard; Jensen, Lisette Okkels] Odense Univ Hosp, Dept Cardiol, DK-5000 Odense, Denmark; [Kelbaek, Henning; Engstrom, Thomas] Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, Copenhagen, Denmark; [Abildgaard, Ulrik; Hansen, Peter Riis; Jensen, Jan Skov] Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark; [Abildstrom, Steen Zabell] Univ So Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark	Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Southern Denmark	Lassen, JF (corresponding author), Aarhus Univ Hosp, Dept Cardiol, Brendstrupgaardsvej 100, DK-8200 Aarhus N, Denmark.	jens.lassen@ki.au.dk	Lassen, Jens Flensted/AAY-2127-2021; Maeng, Michael/AAY-2135-2021; Johnsen, Søren P/K-1724-2013; Hansen, Peter Riis/AAR-7659-2020; Sorensen, Henrik Toft/Z-6181-2019	Lassen, Jens Flensted/0000-0001-7972-9192; Maeng, Michael/0000-0002-4310-6433; Sorensen, Henrik Toft/0000-0003-4299-7040; Jensen, Lisette Okkels/0000-0002-4838-2429; Engstrom, Thomas/0000-0001-5436-9194; terkelsen, christian juhl/0000-0003-0205-9551; Hansen, Peter Riis/0000-0002-9056-535X; Botker, Hans Erik/0000-0001-6358-8962; Madsen, Morten/0000-0002-6036-8240; Christiansen, Evald/0000-0002-8740-4862	Cordis; Medtronic; Boston Scientific; Abbott Cardiovascular; Terumo	Cordis; Medtronic(Medtronic); Boston Scientific(Boston Scientific); Abbott Cardiovascular; Terumo	MMae has received speaking honoraria from Cordis, consulting fees from Medtronic, and travel grants from both companies. LOJ and AK have received speaking honoraria from Cordis. HHT has received honoraria from Medtronic (CEC member), and travel grants from Cordis and Medtronic; and his wife is a Cordis employee. EHC has received speaking honoraria and a travel grant from Cordis. HEB has received a travel grant from Medtronic. JR has received travel grants from Cordis and Medtronic. LT has received unrestricted research grants to his institution from Cordis, Medtronic, Boston Scientific, Abbott Cardiovascular, and Terumo; and travel grants from Cordis, Medtronic. and Terumo. JFL has received speaking honoraria from Cordis, Medtronic, AstraZeneca, and Abbott; and travel grants from Cordis, Medtronic, and Abbott. All other authors declare that they have no conflicts of interest.; The SORT OUT III trial was supported by unrestricted grants from Cordis and Medtronic.	Andersen TF, 1999, DAN MED BULL, V46, P263; Byrne RA, 2009, EUR HEART J, V30, P923, DOI 10.1093/eurheartj/ehp044; Camenzind E, 2009, AM HEART J, V158, P902, DOI 10.1016/j.ahj.2009.10.002; Cook S, 2007, CIRCULATION, V115, P2426, DOI 10.1161/CIRCULATIONAHA.106.658237; Cook S, 2009, CIRCULATION, V120, P391, DOI 10.1161/CIRCULATIONAHA.109.854398; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; *DAN SOC CARD, 2007, GUID THROMB; Fajadet J, 2006, CIRCULATION, V114, P798, DOI 10.1161/CIRCULATIONAHA.105.591206; Finn AV, 2007, ARTERIOSCL THROM VAS, V27, P1500, DOI 10.1161/ATVBAHA.107.144220; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Galloe AM, 2008, JAMA-J AM MED ASSOC, V299, P409, DOI 10.1001/jama.299.4.409; Juel K, 1999, DAN MED BULL, V46, P354; Kaltoft A, 2009, J AM COLL CARDIOL, V53, P658, DOI 10.1016/j.jacc.2008.09.058; Kandzari DE, 2006, J AM COLL CARDIOL, V48, P2440, DOI 10.1016/j.jacc.2006.08.035; Kelbaek H, 2008, CIRCULATION, V118, P1155, DOI 10.1161/CIRCULATIONAHA.107.758698; Kelbaek H, 2008, J AM COLL CARDIOL, V51, P2011, DOI 10.1016/j.jacc.2008.01.056; Leon MB, 2009, JACC-CARDIOVASC INTE, V2, P1208, DOI 10.1016/j.jcin.2009.10.008; Lewis AL, 2002, BIOMATERIALS, V23, P1697, DOI 10.1016/S0142-9612(01)00297-6; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Mauri L, 2008, CIRCULATION, V118, P1817, DOI 10.1161/CIRCULATIONAHA.108.781377; Meredith IT, 2007, AM J CARDIOL, V100, p56M; Miyazawa A, 2008, AM HEART J, V155, P108, DOI 10.1016/j.ahj.2007.08.008; Moher D, 2005, EXPLORE-NY, V1, P40, DOI 10.1016/j.explore.2004.11.001; Morice MC, 2006, JAMA-J AM MED ASSOC, V295, P895, DOI 10.1001/jama.295.8.895; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; PARK SJ, 2009, C AM COLL CARD ORL F; Ruygrok PN, 1999, J AM COLL CARDIOL, V34, P1507, DOI 10.1016/S0735-1097(99)00380-0; Sakurai R, 2007, AM J CARDIOL, V100, P818, DOI 10.1016/j.amjcard.2007.04.016; Sorensen H T, 1997, Int J Risk Saf Med, V10, P1, DOI 10.3233/JRS-1997-10101; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Thygesen K, 2007, EUR HEART J, V28, P2525; Tu JV, 2007, NEW ENGL J MED, V357, P1393, DOI 10.1056/NEJMoa071076; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; *US FDA, 2007, UPD FDA STAT COR DRU; Wenaweser P, 2008, J AM COLL CARDIOL, V52, P1134, DOI 10.1016/j.jacc.2008.07.006	36	152	161	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2010	375	9720					1090	1099		10.1016/S0140-6736(10)60208-5	http://dx.doi.org/10.1016/S0140-6736(10)60208-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578ZB	20231034				2022-12-28	WOS:000276334600032
J	Say, RF; Fuchs, G				Say, Rafael F.; Fuchs, Georg			Fructose 1,6-bisphosphate aldolase/phosphatase may be an ancestral gluconeogenic enzyme	NATURE			English	Article							CARBON-DIOXIDE ASSIMILATION; THERMOCOCCUS-KODAKARAENSIS; PURIFICATION; EVOLUTION; ALDOLASE; METABOLISM; EXPRESSION; CLONING; GENOME; REDUCTASE	Most archaeal groups and deeply branching bacterial lineages harbour thermophilic organisms with a chemolithoautotrophic metabolism. They live at high temperatures in volcanic habitats at the expense of inorganic substances, often under anoxic conditions(1). These autotrophic organisms use diverse carbon dioxide fixation mechanisms generating acetyl-coenzyme A, from which gluconeogenesis must start(2-4). Here we show that virtually all archaeal groups as well as the deeply branching bacterial lineages contain a bifunctional fructose 1,6-bisphosphate (FBP) aldolase/phosphatase with both FBP aldolase and FBP phosphatase activity. This enzyme is missing inmost other Bacteria and in Eukaryota, and is heat-stabile even in mesophilic marine Crenarchaeota. Its bifunctionality ensures that heat-labile triosephosphates are quickly removed and trapped in stabile fructose 6-phosphate, rendering gluconeogenesis unidirectional. We propose that this highly conserved, heat-stabile and bifunctional FBP aldolase/phosphatase represents the pacemaking ancestral gluconeogenic enzyme, and that in evolution gluconeogenesis preceded glycolysis(5).	[Say, Rafael F.; Fuchs, Georg] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany	University of Freiburg	Fuchs, G (corresponding author), Univ Freiburg, Fak Biol, Schanzlestr 1, D-79104 Freiburg, Germany.	georg.fuchs@biologie.uni-freiburg.de			Deutsche Forschungsgemeinschaft; Evonik-Degussa	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Evonik-Degussa	We thank R. Thauer, S. Ragsdale, H. Atomi and H. Huber for the supply of strains; F. Drepper for help with bioinformatic approaches; W. Haehnel and B. Knapp for MS analysis; N. Gad'on and C. Ebenau-Jehle for growing cells and maintaining the laboratory running; the DOE Joint Genome Institute for early release of archaeal genomic sequence data; and the Deutsche Forschungsgemeinschaft and Evonik-Degussa for financial support. We also thank M. Ziemski and I. Berg for help with data base analysis as the basis of Fig. 1a, and H. Teeling and F. O. Glockner for providing Fig. 1b.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; BABUL J, 1983, ARCH BIOCHEM BIOPHYS, V225, P944, DOI 10.1016/0003-9861(83)90109-1; BERG IA, NATURE REV IN PRESS; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Chong PK, 2007, J PROTEOME RES, V6, P1430, DOI 10.1021/pr060575g; Dagan T, 2008, P NATL ACAD SCI USA, V105, P10039, DOI 10.1073/pnas.0800679105; Dawson Rex M.C., 1986, DATA BIOCH RES; DeMontigny C, 1996, EUR J BIOCHEM, V241, P243; Donahue JL, 2000, J BACTERIOL, V182, P5624, DOI 10.1128/JB.182.19.5624-5627.2000; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Erb TJ, 2008, J BIOL CHEM, V283, P32283, DOI 10.1074/jbc.M805527200; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Ferry JG, 2006, MOL BIOL EVOL, V23, P1286, DOI 10.1093/molbev/msk014; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; FUCHS G, 1983, ARCH MICROBIOL, V136, P160, DOI 10.1007/BF00404793; FUJITA Y, 1979, J BIOL CHEM, V254, P5340; Gascuel O, 2006, MOL BIOL EVOL, V23, P1997, DOI 10.1093/molbev/msl072; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Grochowski LL, 2008, ANN NY ACAD SCI, V1125, P190, DOI 10.1196/annals.1419.001; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Huber H, 2000, INT J SYST EVOL MICR, V50, P2093, DOI 10.1099/00207713-50-6-2093; Huber H, 2008, P NATL ACAD SCI USA, V105, P7851, DOI 10.1073/pnas.0801043105; Imanaka H, 2002, J BIOSCI BIOENG, V94, P237, DOI 10.1263/jbb.94.237; Jahn U, 2007, J BACTERIOL, V189, P4108, DOI 10.1128/JB.00047-07; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lorentzen E, 2004, BIOCHEM SOC T, V32, P259, DOI 10.1042/BST0320259; Ludwig W, 2005, BERGEYS MANUAL SYSTE, V2, P49, DOI DOI 10.1007/978-0-387-21609-6_8; Makarova KS, 2003, TRENDS GENET, V19, P172, DOI 10.1016/S0168-9525(03)00047-7; Martin W, 2008, NAT REV MICROBIOL, V6, P805, DOI 10.1038/nrmicro1991; Nishimasu H, 2004, STRUCTURE, V12, P949, DOI 10.1016/j.str.2004.03.026; Pierce E, 2008, ENVIRON MICROBIOL, V10, P2550, DOI 10.1111/j.1462-2920.2008.01679.x; Poele EMT, 2008, ANTON LEEUW INT J G, V94, P127, DOI 10.1007/s10482-008-9255-x; Ramos-Vera WH, 2009, J BACTERIOL, V191, P4286, DOI 10.1128/JB.00145-09; Rashid N, 2002, J BIOL CHEM, V277, P30649, DOI 10.1074/jbc.M202868200; Ronimus Ron S., 2003, Archaea, V1, P199, DOI 10.1155/2003/162593; Sato T, 2004, J BACTERIOL, V186, P5799, DOI 10.1128/JB.186.17.5799-5807.2004; Sauve V, 2001, PROTEIN EXPRES PURIF, V21, P293, DOI 10.1006/prep.2000.1380; Sauve V, 2001, ACTA CRYSTALLOGR D, V57, P310, DOI 10.1107/S0907444900019727; SCAMUFFA MD, 1980, BIOCHIM BIOPHYS ACTA, V614, P583, DOI 10.1016/0005-2744(80)90247-8; SCHAFER S, 1986, ARCH MICROBIOL, V146, P301, DOI 10.1007/BF00403234; Schofield LR, 2004, PROTEIN EXPRES PURIF, V34, P17, DOI 10.1016/j.pep.2003.11.008; Schopfer P, 2008, PLANT PHYSIOL, V147, P864, DOI 10.1104/pp.108.118745; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; Stec B, 2000, NAT STRUCT BIOL, V7, P1046, DOI 10.1038/80968; Stetter KO, 2006, PHILOS T R SOC B, V361, P1837, DOI 10.1098/rstb.2006.1907; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teeling H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-66; Teufel R, 2009, J BACTERIOL, V191, P4572, DOI 10.1128/JB.00068-09; Wachtershauser G, 2007, CHEM BIODIVERS, V4, P584, DOI 10.1002/cbdv.200790052; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; White RH, 2004, BIOCHEMISTRY-US, V43, P7618, DOI 10.1021/bi0495127; WITKE C, 1993, J BACTERIOL, V175, P7495, DOI 10.1128/JB.175.22.7495-7499.1993; Zhaxybayeva O, 2009, P NATL ACAD SCI USA, V106, P5865, DOI 10.1073/pnas.0901260106	58	133	151	1	50	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1077	U156		10.1038/nature08884	http://dx.doi.org/10.1038/nature08884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20348906				2022-12-28	WOS:000276635000046
J	Zhang, L; Ren, XY; Alt, E; Bai, XW; Huang, SY; Xu, ZM; Lynch, PM; Moyer, MP; Wen, XF; Wu, XW				Zhang, Ling; Ren, Xiaoyang; Alt, Eckhard; Bai, Xiaowen; Huang, Shaoyi; Xu, Zhengming; Lynch, Patrick M.; Moyer, Mary P.; Wen, Xian-Feng; Wu, Xiangwei			Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis	NATURE			English	Article							MULTIPLE INTESTINAL NEOPLASIA; STEM-CELLS; C-MYC; TRAIL; GENE; MUTATION; LIGAND; MOUSE; IDENTIFICATION; SENSITIVITY	Cancer chemoprevention uses natural, synthetic, or biological substances to reverse, suppress, or prevent either the initial phase of carcinogenesis or the progression of neoplastic cells to cancer(1). It holds promise for overcoming problems associated with the treatment of late-stage cancers. However, the broad application of chemoprevention is compromised at present by limited effectiveness and potential toxicity. To overcome these challenges, here we developed a new chemoprevention approach that specifically targets premalignant tumour cells for apoptosis. We show that a deficiency in the adenomatous polyposis coli (APC) gene and subsequent activation of beta-catenin lead to the repression of cellular caspase-8 inhibitor c-FLIP (also known as CFLAR) expression through activation of c-Myc, and that all-trans-retinyl acetate (RAc) independently upregulates tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptors and suppresses decoy receptors. Thus, the combination of TRAIL and RAc induces apoptosis in APC-deficient premalignant cells without affecting normal cells in vitro. In addition, we show that short-term and non-continuous TRAIL and RAc treatment induce apoptosis specifically in intestinal polyps, strongly inhibit tumour growth, and prolong survival in multiple intestinal neoplasms C57BL/6J-Apc(Min)/J (Apc(Min)) mice. With our approach, we further demonstrate that TRAIL and RAc induce significant cell death in human colon polyps, providing a potentially selective approach for colorectal cancer chemoprevention by targeting APC-deficient cells for apoptosis.	[Zhang, Ling; Ren, Xiaoyang; Huang, Shaoyi; Xu, Zhengming; Wen, Xian-Feng; Wu, Xiangwei] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Alt, Eckhard; Bai, Xiaowen] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; [Lynch, Patrick M.] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Wu, Xiangwei] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Moyer, Mary P.] INCELL Corp, San Antonio, TX 78249 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wu, XW (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, 1515 Holcombe Blvd, Houston, TX 77030 USA.	xwwu@mdanderson.org	ren, xianyan/J-3165-2018		NIH [AI063063]; M. D. Anderson Cancer Center; Alliance of Cardiovascular Researchers [543102]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063063] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. D. Anderson Cancer Center; Alliance of Cardiovascular Researchers; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank H. Yang for technical support, R. Lotan for the BW1799 cells, and W. El-Deiry for DR5 expression plasmid; and M. Chambers, J. Yate, L. Ingram, D. Chow and G. Reyes for their involvement in IRB approval and human tissue acquisition. We also thank J. Vykoukal, A. E. Kadala and D. Malone for their help in editing the manuscript. This work was supported by NIH grant AI063063 and Institutional Funds from M. D. Anderson Cancer Center (to X. W.), and in part by Alliance of Cardiovascular Researchers grant 543102 (to E. A.).	Altucci L, 2001, NAT MED, V7, P680, DOI 10.1038/89050; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Bai XW, 2007, AM J PHYSIOL-CELL PH, V293, pC1539, DOI 10.1152/ajpcell.00089.2007; Bai XW, 2007, FEBS LETT, V581, P4681, DOI 10.1016/j.febslet.2007.08.063; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Chen DH, 2003, CANCER RES, V63, P6626; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; EVANS GS, 1992, J CELL SCI, V101, P219; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Hasson E, 2005, J GENE MED, V7, P926, DOI 10.1002/jgm.740; Jin FS, 2005, CANCER RES, V65, P6354, DOI 10.1158/0008-5472.CAN-04-4061; Koschny R, 2007, J MOL MED, V85, P923, DOI 10.1007/s00109-007-0194-1; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Nieminen AI, 2007, EMBO J, V26, P1055, DOI 10.1038/sj.emboj.7601551; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Ren XY, 2007, CANCER BIOL THER, V6, P1031, DOI 10.4161/cbt.6.7.4206; Ricci MS, 2004, MOL CELL BIOL, V24, P8541, DOI 10.1128/MCB.24.19.8541-8555.2004; SPORN MB, 1976, FED PROC, V35, P1332; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Sun SY, 2000, CANCER RES, V60, P7149; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; WILLSON JKV, 1987, CANCER RES, V47, P2704; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Yang K, 1997, J EXP ZOOL, V277, P245, DOI 10.1002/(SICI)1097-010X(19970215)277:3<245::AID-JEZ5>3.3.CO;2-N	27	110	112	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1058	U128		10.1038/nature08871	http://dx.doi.org/10.1038/nature08871			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20348907	Green Accepted			2022-12-28	WOS:000276635000042
J	Azad, K; Barnett, S; Banerjee, B; Shaha, S; Khan, K; Rego, AR; Barua, S; Flatman, D; Pagel, C; Prost, A; Ellis, M; Costello, A				Azad, Kishwar; Barnett, Sarah; Banerjee, Biplob; Shaha, Sanjit; Khan, Kasmin; Rego, Arati Roselyn; Barua, Shampa; Flatman, Dorothy; Pagel, Christina; Prost, Audrey; Ellis, Matthew; Costello, Anthony			Effect of scaling up women's groups on birth outcomes in three rural districts in Bangladesh: a cluster-randomised controlled trial	LANCET			English	Article							NEONATAL-MORTALITY; INTERVENTION	Background Two recent trials have shown that women's groups can reduce neonatal mortality in poor communities. We assessed the effectiveness of a scaled-up development programme with women's groups to address maternal and neonatal care in three rural districts of Bangladesh. Methods 18 clusters (with a mean population of 27 953 [SD 5953]) in three districts were randomly assigned to either intervention or control (nine clusters each) by use of stratified randomisation. For each district, cluster names were written on pieces of paper, which were folded and placed in a bottle. The first three cluster names drawn from the bottle were allocated to the intervention group and the remaining three to control. All clusters received health services strengthening and basic training of traditional birth attendants. In intervention clusters, a facilitator convened 18 groups every month to support participatory action and learning for women, and to develop and implement strategies to address maternal and neonatal health problems. Women were eligible to participate if they were aged 15-49 years, residing in the project area, and had given birth during the study period (Feb 1, 2005, to Dec 31, 2007). Neither study investigators nor participants were masked to treatment assignment. In a population of 229 195 people (intervention clusters only), 162 women's groups provided coverage of one group per 1414 population. The primary outcome was neonatal mortality rate (NMR). Analysis was by intention to treat. This trial is registered as an International Standard Randomised Controlled Trial, number ISRCTN54792066. Findings We monitored outcomes for 36 113 births (intervention clusters, n=17 514; control clusters, n=18 599) in a population of 503 163 over 3 years. From 2005 to 2007, there were 570 neonatal deaths in the intervention clusters and 656 in the control clusters. Cluster-level mean NMR (adjusted for stratification and clustering) was 33.9 deaths per 1000 livebirths in the intervention clusters compared with 36.5 per 1000 in the control clusters (risk ratio 0.93, 95% CI 0.80-1.09). Interpretation For participatory women's groups to have a significant effect on neonatal mortality in rural Bangladesh, detailed attention to programme design and contextual factors, enhanced population coverage, and increased enrolment of newly pregnant women might be needed.	[Azad, Kishwar] Diabet Assoc Bangladesh, Perinatal Care Project, BADAS, Dhaka 1000, Bangladesh; [Barnett, Sarah; Prost, Audrey; Costello, Anthony] UCL, Ctr Int Hlth & Dev, Inst Child Hlth, London, England; [Pagel, Christina] UCL, Clin Operat Res Unit, London, England; [Flatman, Dorothy] Women & Children First, London, England; [Flatman, Dorothy] Hlth Fdn, London, England; [Ellis, Matthew] Univ Bristol, Ctr Child & Adolescent Hlth, Bristol, Avon, England	University of London; University College London; University of London; University College London; University of Bristol	Azad, K (corresponding author), Diabet Assoc Bangladesh, Perinatal Care Project, BADAS, BIRDEM 122 Kazi Nazrul Islam Ave, Dhaka 1000, Bangladesh.	pcp@dab-bd.org		Pagel, Christina/0000-0002-2857-1628	Women and Children First; UK Big Lottery Fund; Saving Newborn Lives; UK Department for International Development	Women and Children First; UK Big Lottery Fund; Saving Newborn Lives; UK Department for International Development	Women and Children First, the UK Big Lottery Fund, Saving Newborn Lives, and the UK Department for International Development.	Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Barnett S, 2006, J HEALTH POPUL NUTR, V24, P394; Barnett S, 2008, BMC PREGNANCY CHILDB, V8, P1, DOI DOI 10.1186/1471-2393-8-6; Chowdhury ME, 2007, LANCET, V370, P1320, DOI 10.1016/S0140-6736(07)61573-6; Donner A, 1996, J CLIN EPIDEMIOL, V49, P435, DOI 10.1016/0895-4356(95)00511-0; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Hayes RJ, 2009, INTERD STAT, P3; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Mercer A, 2006, HEALTH POLICY PLANN, V21, P432, DOI 10.1093/heapol/czl024; National Institute of Population Research and Training, 2007, BANGL DEM HLTH SURV; Ronsmans C, 2008, PAEDIATR PERINAT EP, V22, P269, DOI 10.1111/j.1365-3016.2008.00939.x; Tripathy P, 2010, LANCET, V375, P1182, DOI 10.1016/S0140-6736(09)62042-0; *UN DEV PROGR, MILL DEV GOALS MID T; *US DEP COMM, POP TRENDS BANGL; *WHO, COUNTR COOP STRAT BA; *WHO, 2003, COUNTR PROF REPR HLT; World Health Organization, 1977, INT CLASS DIS; World Health Organization, NEON PER MORT COUNTR	19	159	161	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 3	2010	375	9721					1193	1202		10.1016/S0140-6736(10)60142-0	http://dx.doi.org/10.1016/S0140-6736(10)60142-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585VL	20207412	Bronze			2022-12-28	WOS:000276858200031
J	Watts, G				Watts, Geoff			Patient safety Wise before the event	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						*AVMA, 2010, ADD INS INJ NHS FAIL; BOADEN R, 2009, HLTH CARE ERRORS PAT; Degeling P, 2003, BRIT MED J, V326, P649, DOI 10.1136/bmj.326.7390.649; Duckers M, 2009, MED CARE RES REV, V66, p90S, DOI 10.1177/1077558709345870; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Hoff T, 2004, MED CARE RES REV, V61, P3, DOI 10.1177/1077558703257171; LAMONT T, 2009, BMJ-BRIT MED J, V339, P1196; National Institute for Health and Care Excellence (NICE), 2010, VEN THROMB RED RISK	8	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2010	340								c1378	10.1136/bmj.c1378	http://dx.doi.org/10.1136/bmj.c1378			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	579VI	20351077				2022-12-28	WOS:000276404000002
J	Moreno, NP; Erdmann, DB				Moreno, Nancy P.; Erdmann, Deanne B.			Addressing Science Teacher Needs	SCIENCE			English	Editorial Material									[Moreno, Nancy P.; Erdmann, Deanne B.] Baylor Coll Med, Ctr Educ Outreach, Houston, TX 77030 USA	Baylor College of Medicine	Moreno, NP (corresponding author), Baylor Coll Med, Ctr Educ Outreach, 1 Baylor Plaza, Houston, TX 77030 USA.	nmoreno@bcm.edu	Moreno, Nancy P./AAG-4104-2021		NATIONAL CENTER FOR RESEARCH RESOURCES [R25RR013454, R25RR018605] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL075747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R25AI084826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R25ES010698] Funding Source: NIH RePORTER; Howard Hughes Medical Institute [51006084, 51004102] Funding Source: Medline; NCRR NIH HHS [R25 RR13454, R25 RR18605, R25 RR013454, R25 RR018605] Funding Source: Medline; NHLBI NIH HHS [R25 HL75747, R25 HL075747] Funding Source: Medline; NIAID NIH HHS [R25 AI084826] Funding Source: Medline; NIEHS NIH HHS [R25 ES10698, R25 ES010698] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		MORENO N, 2004, CBE-LIFE SCI EDUC, V4, P122; MORENO NP, 2006, TEACHING SCI 21 CENT, P292; National Research Council, 2007, RIS GATH STORM; National Science Board, 2010, SCI ENG IND 2010; U.S. Department of Labor, 2009, OCC OUTL HDB 2008 20	5	2	2	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	2010	327	5973					1589	1590		10.1126/science.1182432	http://dx.doi.org/10.1126/science.1182432			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	574ED	20339057	Green Accepted			2022-12-28	WOS:000275970600025
J	Bloom, P				Bloom, Paul			How do morals change?	NATURE			English	Editorial Material									Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Yale University	Bloom, P (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	paul.bloom@yale.edu							0	62	63	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 25	2010	464	7288					490	490		10.1038/464490a	http://dx.doi.org/10.1038/464490a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	574FL	20336117	Bronze, Green Published			2022-12-28	WOS:000275974200021
J	Ettwig, KF; Butler, MK; Le Paslier, D; Pelletier, E; Mangenot, S; Kuypers, MMM; Schreiber, F; Dutilh, BE; Zedelius, J; de Beer, D; Gloerich, J; Wessels, HJCT; van Alen, T; Luesken, F; Wu, ML; van de Pas-Schoonen, KT; den Camp, HJMO; Janssen-Megens, EM; Francoijs, KJ; Stunnenberg, H; Weissenbach, J; Jetten, MSM; Strous, M				Ettwig, Katharina F.; Butler, Margaret K.; Le Paslier, Denis; Pelletier, Eric; Mangenot, Sophie; Kuypers, Marcel M. M.; Schreiber, Frank; Dutilh, Bas E.; Zedelius, Johannes; de Beer, Dirk; Gloerich, Jolein; Wessels, Hans J. C. T.; van Alen, Theo; Luesken, Francisca; Wu, Ming L.; van de Pas-Schoonen, Katinka T.; den Camp, Huub J. M. Op; Janssen-Megens, Eva M.; Francoijs, Kees-Jan; Stunnenberg, Henk; Weissenbach, Jean; Jetten, Mike S. M.; Strous, Marc			Nitrite-driven anaerobic methane oxidation by oxygenic bacteria	NATURE			English	Article							CHLORITE DISMUTASE; NITROUS-OXIDE; GENOME; MICROSENSOR; TRANSFORMATION; MONOOXYGENASE; ENRICHMENT; ATMOSPHERE; SOILS; N2O	Only three biological pathways are known to produce oxygen: photosynthesis, chlorate respiration and the detoxification of reactive oxygen species. Here we present evidence for a fourth pathway, possibly of considerable geochemical and evolutionary importance. The pathway was discovered after metagenomic sequencing of an enrichment culture that couples anaerobic oxidation of methane with the reduction of nitrite to dinitrogen. The complete genome of the dominant bacterium, named 'Candidatus Methylomirabilis oxyfera', was assembled. This apparently anaerobic, denitrifying bacterium encoded, transcribed and expressed the well-established aerobic pathway for methane oxidation, whereas it lacked known genes for dinitrogen production. Subsequent isotopic labelling indicated that 'M. oxyfera' bypassed the denitrification intermediate nitrous oxide by the conversion of two nitric oxidemolecules to dinitrogen and oxygen, which was used to oxidize methane. These results extend our understanding of hydrocarbon degradation under anoxic conditions and explain the biochemical mechanism of a poorly understood freshwater methane sink. Because nitrogen oxides were already present on early Earth, our finding opens up the possibility that oxygen was available to microbial metabolism before the evolution of oxygenic photosynthesis.	[Ettwig, Katharina F.; Butler, Margaret K.; van Alen, Theo; Luesken, Francisca; Wu, Ming L.; van de Pas-Schoonen, Katinka T.; den Camp, Huub J. M. Op; Jetten, Mike S. M.; Strous, Marc] Radboud Univ Nijmegen, IWWR, Dept Microbiol, NL-6525 AJ Nijmegen, Netherlands; [Le Paslier, Denis; Pelletier, Eric; Mangenot, Sophie; Weissenbach, Jean] CEA Genoscope, F-91057 Evry, France; [Le Paslier, Denis; Pelletier, Eric; Weissenbach, Jean] CNRS, UMR 8030, F-91057 Evry, France; [Le Paslier, Denis; Pelletier, Eric; Weissenbach, Jean] Univ Evry Val Essonne, F-91057 Evry, France; [Kuypers, Marcel M. M.; Schreiber, Frank; Zedelius, Johannes; de Beer, Dirk; Strous, Marc] Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; [Dutilh, Bas E.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Gloerich, Jolein; Wessels, Hans J. C. T.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Prote Facil, Dept Lab Med,Lab Genet Endocrine & Metab Dis, NL-6525 GA Nijmegen, Netherlands; [Janssen-Megens, Eva M.; Francoijs, Kees-Jan; Stunnenberg, Henk] Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Strous, Marc] Univ Bielefeld, Ctr Biotechnol, D-33501 Bielefeld, Germany	Radboud University Nijmegen; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Max Planck Society; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Bielefeld	Ettwig, KF (corresponding author), Radboud Univ Nijmegen, IWWR, Dept Microbiol, Heyendaalseweg 135, NL-6525 AJ Nijmegen, Netherlands.	k.ettwig@science.ru.nl; mstrous@mpi-bremen.de	Wessels, Hans J/P-6248-2015; Camp, Huub J.M. Op den/F-5114-2011; Stunnenberg, Hendrik G./D-6875-2012; de Beer, Dirk/L-4840-2013; Strous, Marc/B-4064-2017; Jetten, Mike/B-8834-2011; Dutilh, Bas E./B-9719-2011; Ettwig, Katharina F/B-9395-2011; Gloerich, Jolein/L-4327-2015; Schreiber, Frank/I-9182-2012	Wessels, Hans J/0000-0001-5957-3127; Camp, Huub J.M. Op den/0000-0003-1990-9030; Stunnenberg, Hendrik G./0000-0002-0066-1576; de Beer, Dirk/0000-0001-5274-1781; Strous, Marc/0000-0001-9600-3828; Jetten, Mike/0000-0002-4691-7039; Dutilh, Bas E./0000-0003-2329-7890; Gloerich, Jolein/0000-0001-5976-8426; Schreiber, Frank/0000-0003-1957-6328; Pelletier, Eric/0000-0003-4228-1712; Le Paslier, Denis/0000-0003-4335-9956	Max Planck Society; European Research Council [232937]; Netherlands Organisation for Scientific Research (NWO) [050-71-058]	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council(European Research Council (ERC)European Commission); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	We thank F. Stams and N. Tan for sharing their ideas on NO decomposition; D. Speth and L. Russ for pilot experiments; N. Kip for providing M. acidophilus cultures; A. Pierik for electron paramagnetic resonance analysis; G. Klockgether and G. Lavik for technical assistance; and B. Kartal, J. Keltjens, A. Pol, J. van de Vossenberg and F. Widdel for helpful discussions. M. M. M. K., F. S., J. Z. and D. d. B. were supported by the Max Planck Society, M. S. M. J. by European Research Council grant 232937, M. S., K. F. E. and M. K. B. by a Vidi grant to M. S. from the Netherlands Organisation for Scientific Research (NWO), and M. L. W. and B. D. by a Horizon grant (050-71-058) from NWO.	ALLEN MB, 1952, J BACTERIOL, V64, P397, DOI 10.1128/JB.64.3.397-412.1952; Andersen K, 2001, SENSOR ACTUAT B-CHEM, V81, P42, DOI 10.1016/S0925-4005(01)00924-8; Bab-Dinitz E, 2006, BIOINFORMATICS, V22, P671, DOI 10.1093/bioinformatics/btk043; Bodelier PLE, 2004, FEMS MICROBIOL ECOL, V47, P265, DOI 10.1016/S0168-6496(03)00304-0; BRODA E, 1975, J MOL EVOL, V7, P87, DOI 10.1007/BF01732182; Castresana J, 2004, ADV PHOTO RESPIRAT, V15, P1; CHAPMAN DJ, 1983, BIOL BIOCH EFFECTS D; Chistoserdova L, 2005, ASM NEWS, V71, P521; Daniels F., 1958, J PHYS CHEM, V62, P360, DOI [10.1021/j150561a030, DOI 10.1021/J150561A030]; Demicheli V, 2007, FREE RADICAL BIO MED, V42, P1359, DOI 10.1016/j.freeradbiomed.2007.01.034; Ducluzeau AL, 2009, TRENDS BIOCHEM SCI, V34, P9, DOI 10.1016/j.tibs.2008.10.005; Dutilh BE, 2009, BIOINFORMATICS, V25, P2878, DOI 10.1093/bioinformatics/btp377; Ettwig KF, 2008, ENVIRON MICROBIOL, V10, P3164, DOI 10.1111/j.1462-2920.2008.01724.x; Ettwig KF, 2009, APPL ENVIRON MICROB, V75, P3656, DOI 10.1128/AEM.00067-09; Farrer RA, 2009, FEMS MICROBIOL LETT, V291, P103, DOI 10.1111/j.1574-6968.2008.01441.x; Fenchel T., 2002, ORIGIN EARLY EVOLUTI; FRIEDMAN SH, 1986, J BIOL CHEM, V261, P538; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hakemian AS, 2007, ANNU REV BIOCHEM, V76, P223, DOI 10.1146/annurev.biochem.76.061505.175355; Hayes JM., 1983, EARTHS EARLIEST BIOS, P291; Heider J, 2007, CURR OPIN CHEM BIOL, V11, P188, DOI 10.1016/j.cbpa.2007.02.027; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Hu SH, 2009, ENV MICROBIOL REP, V1, P377, DOI 10.1111/j.1758-2229.2009.00083.x; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kool DM, 2007, RAPID COMMUN MASS SP, V21, P3569, DOI 10.1002/rcm.3249; Kruger M, 2003, NATURE, V426, P878, DOI 10.1038/nature02207; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McIlvin MR, 2005, ANAL CHEM, V77, P5589, DOI 10.1021/ac050528s; Parvulescu VI, 1998, CATAL TODAY, V46, P233, DOI 10.1016/S0920-5861(98)00399-X; Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134; PRIOR SD, 1985, FEMS MICROBIOL LETT, V29, P105; Raghoebarsing AA, 2006, NATURE, V440, P918, DOI 10.1038/nature04617; RAGHOEBARSING AA, 2006, THESIS RADBOUD U NIJ; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Schreiber F, 2008, ANAL CHEM, V80, P1152, DOI 10.1021/ac071563x; Stoecker K, 2006, P NATL ACAD SCI USA, V103, P2363, DOI 10.1073/pnas.0506361103; Thauer RK, 2008, ANN NY ACAD SCI, V1125, P158, DOI 10.1196/annals.1419.000; Trotsenko YA, 2008, ADV APPL MICROBIOL, V63, P183, DOI 10.1016/S0065-2164(07)00005-6; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; vanGlinkel CG, 1996, ARCH MICROBIOL, V166, P321, DOI 10.1007/s002030050390; Weatherly DB, 2005, MOL CELL PROTEOMICS, V4, P762, DOI 10.1074/mcp.M400215-MCP200; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wilmes P, 2009, FEMS MICROBIOL REV, V33, P109, DOI 10.1111/j.1574-6976.2008.00144.x; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996; Zumft WG, 2007, ADV MICROB PHYSIOL, V52, P107, DOI 10.1016/S0065-2911(06)52003-X; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997; Zumft WG, 2005, J INORG BIOCHEM, V99, P194, DOI 10.1016/j.jinorgbio.2004.09.024	51	1113	1216	49	1178	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					543	+		10.1038/nature08883	http://dx.doi.org/10.1038/nature08883			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20336137	Green Published			2022-12-28	WOS:000275974200038
J	Haque, SA; Nelson, J				Haque, Saif A.; Nelson, Jenny			Toward Organic All-Optical Switching	SCIENCE			English	Editorial Material							SOLAR-CELLS		[Haque, Saif A.] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England; [Nelson, Jenny] Univ London Imperial Coll Sci Technol & Med, Dept Phys, Ctr Plast Elect, London SW7 2AZ, England	Imperial College London; Imperial College London	Haque, SA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England.	s.a.haque@imperial.ac.uk; jenny.nelson@imperial.ac.uk	Nelson, Jenny/CAF-2009-2022	Nelson, Jenny/0000-0003-1048-1330	Engineering and Physical Sciences Research Council [EP/E036341/1] Funding Source: researchfish; EPSRC [EP/E036341/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		BREDAS JL, 1994, CHEM REV, V94, P243, DOI 10.1021/cr00025a008; CLARKE TM, 2010, CHEM REV; Forrest SR, 2004, NATURE, V428, P911, DOI 10.1038/nature02498; Friend RH, 1999, NATURE, V397, P121, DOI 10.1038/16393; Gunes S, 2007, CHEM REV, V107, P1324, DOI 10.1021/cr050149z; Hales JM, 2010, SCIENCE, V327, P1485, DOI 10.1126/science.1185117; Liang YY, 2010, ADV MATER, V22, pE135, DOI 10.1002/adma.200903528; Yap BK, 2008, NAT MATER, V7, P376, DOI 10.1038/nmat2165	8	49	50	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	2010	327	5972					1466	1467		10.1126/science.1188291	http://dx.doi.org/10.1126/science.1188291			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20299583				2022-12-28	WOS:000275715200034
J	Andersen, CBF; Madsen, M; Storm, T; Moestrup, SK; Andersen, GR				Andersen, Christian Brix Folsted; Madsen, Mette; Storm, Tina; Moestrup, Soren K.; Andersen, Gregers R.			Structural basis for receptor recognition of vitamin-B-12-intrinsic factor complexes	NATURE			English	Article							FACTOR-VITAMIN B-12; HUMAN INTRINSIC-FACTOR; ELECTRON-DENSITY MAPS; MANNAN-BINDING LECTIN; X-RAY-STRUCTURE; LIGAND RECOGNITION; CRYSTAL-STRUCTURE; CUBILIN; PROTEIN; IDENTIFICATION	Cobalamin (Cbl, vitamin B-12) is a bacterial organic compound and an essential coenzyme in mammals, which take it up from the diet. This occurs by the combined action of the gastric intrinsic factor (IF) and the ileal endocytic cubam receptor formed by the 460-kilodalton (kDa) protein cubilin and the 45-kDa transmembrane protein amnionless(1,2). Loss of function of any of these proteins ultimately leads to Cbl deficiency in man(3,4). Here we present the crystal structure of the complex between IF-Cbl and the cubilin IF-Cbl-binding-region (CUB5-8)(5) determined at 3.3 angstrom resolution. The structure provides insight into how several CUB (for 'complement C1r/C1s, Uegf, Bmp1') domains collectively function as modular ligand-binding regions, and how two distant CUB domains embrace the Cbl molecule by binding the two IF domains in a Ca2+-dependent manner. This dual-point model provides a probable explanation of how Cbl indirectly induces ligand-receptor coupling. Finally, the comparison of Ca2+-binding CUB domains and the low-density lipoprotein (LDL) receptor-type A modules suggests that the electrostatic pairing of a basic ligand arginine/lysine residue with Ca2+-coordinating acidic aspartates/glutamates is a common theme of Ca2+-dependent ligand-receptor interactions.	[Andersen, Christian Brix Folsted; Madsen, Mette; Storm, Tina; Moestrup, Soren K.] Aarhus Univ, Dept Med Biochem, DK-8000 Aarhus C, Denmark; [Andersen, Christian Brix Folsted; Andersen, Gregers R.] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University	Moestrup, SK (corresponding author), Aarhus Univ, Dept Med Biochem, DK-8000 Aarhus C, Denmark.	skm@biokemi.au.dk	Moestrup, Søren Kragh/AAD-1735-2019; Moestrup, Søren Kragh/A-1403-2014; Andersen, Christian/G-9954-2011	Moestrup, Søren Kragh/0000-0003-3862-2107; Storm, Tina/0000-0001-6550-4072; Andersen, Gregers Rom/0000-0001-6292-3319; Madsen, Mette/0000-0001-7241-6505	Lundbeck foundation; Danish Science Research Council; Novo Nordisk Foundation; Lundbeck Foundation [R7-2006-752] Funding Source: researchfish	Lundbeck foundation(Lundbeckfonden); Danish Science Research Council(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden)	We are grateful to G. Biller, G. Ratz and G. Hartvigsen for technical assistance, the staff at MAX-lab and SLS beamlines for help with data collection, and S. Fedosov for advice on expression. The study was essentially supported by a grant to S. K. M. from the Lundbeck foundation. G. R. A. was supported by the Danish Science Research Council and a Hallas-Moller stipend from the Novo-Nordisk foundation. M. M. was supported by the Novo Nordisk Foundation.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aminoff M, 1999, NAT GENET, V21, P309, DOI 10.1038/6831; Appleton BA, 2007, EMBO J, V26, P4902, DOI 10.1038/sj.emboj.7601906; Bally I, 2009, J BIOL CHEM, V284, P19340, DOI 10.1074/jbc.M109.004473; Bates PA, 2001, PROTEINS, P39; Birn H, 1997, J BIOL CHEM, V272, P26497, DOI 10.1074/jbc.272.42.26497; Blacklow SC, 2007, CURR OPIN STRUC BIOL, V17, P419, DOI 10.1016/j.sbi.2007.08.017; Blanc G, 2007, J BIOL CHEM, V282, P16924, DOI 10.1074/jbc.M701610200; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Christensen EI, 2009, PFLUG ARCH EUR J PHY, V458, P1039, DOI 10.1007/s00424-009-0685-8; DeLano W.L, PYMOL MOL GRAPHICS S; Fedosov SN, 2004, BIOCHEMISTRY-US, V43, P15095, DOI 10.1021/bi048924c; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Fyfe JC, 2004, BLOOD, V103, P1573, DOI 10.1182/blood-2003-08-2852; GORDON MM, 1991, AM J PHYSIOL, V260, pG736, DOI 10.1152/ajpgi.1991.260.5.G736; Gregory LA, 2004, J BIOL CHEM, V279, P29391, DOI 10.1074/jbc.M402687200; Gregory LA, 2003, J BIOL CHEM, V278, P32157, DOI 10.1074/jbc.M305175200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; KLEYWEGT GJ, HALLOWEEN MASKS BONE; Kozyraki R, 1998, BLOOD, V91, P3593; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kristiansen M, 2000, BLOOD, V96, P405; Kristiansen M, 1999, J BIOL CHEM, V274, P20540, DOI 10.1074/jbc.274.29.20540; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lindblom A, 1999, J BIOL CHEM, V274, P6374, DOI 10.1074/jbc.274.10.6374; Mathews FS, 2007, P NATL ACAD SCI USA, V104, P17311, DOI 10.1073/pnas.0703228104; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; Tanner SM, 2005, P NATL ACAD SCI USA, V102, P4130, DOI 10.1073/pnas.0500517102; Tanner SM, 2004, HUM MUTAT, V23, P327, DOI 10.1002/humu.20014; Teillet F, 2008, J BIOL CHEM, V283, P25715, DOI 10.1074/jbc.M803551200	34	82	88	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					445	U147		10.1038/nature08874	http://dx.doi.org/10.1038/nature08874			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20237569				2022-12-28	WOS:000275657100054
J	Paczolt, KA; Jones, AG				Paczolt, Kimberly A.; Jones, Adam G.			Post-copulatory sexual selection and sexual conflict in the evolution of male pregnancy	NATURE			English	Article							PIPEFISH SPECIES SYNGNATHIDAE; ROLE-REVERSED PIPEFISH; MATE CHOICE; DIFFERENTIAL-ALLOCATION; GULF PIPEFISH; BROOD POUCH; SEAHORSES; COMPETITION; INVESTMENT; HYPOTHESIS	Male pregnancy in seahorses, pipefishes and sea dragons ( family Syngnathidae) represents a striking reproductive adaptation that has shaped the evolution of behaviour and morphology in this group of fishes(1-4). In many syngnathid species, males brood their offspring in a specialized pouch, which presumably evolved to facilitate male parental care(5,6). However, an unexplored possibility is that brood pouch evolution was partly shaped by parent-offspring or sexual conflict, processes that would result in trade-offs between current and future pregnancies. Here we report a controlled breeding experiment using the sexually dimorphic Gulf pipefish, Syngnathus scovelli, to test for post-copulatory sexual selection within broods and for trade-offs between successive male pregnancies as functions of female attractiveness. Offspring survivorship within a pregnancy was affected by the size of a male's mate, the number of eggs transferred and the male's sexual responsiveness. Significantly, we also found that embryo survivorship in a current pregnancy was negatively related to survivorship in the prior pregnancy, clearly demonstrating fitness trade-offs between broods. Overall, our data indicate that post-copulatory sexual selection and sexual conflict occur in Gulf pipefishes. The conflict seems to be mediated by a strategy of cryptic choice in which males increase rates of offspring abortion in pregnancies from unattractive mothers to retain resources for future reproductive opportunities. Hence, the male brood pouch of syngnathid fishes, which nurtures offspring(7-9), also seems to have an important role as an arbiter of conflict between the sexes.	[Paczolt, Kimberly A.; Jones, Adam G.] Texas A&M Univ, Dept Biol, College Stn, TX 77845 USA	Texas A&M University System; Texas A&M University College Station	Paczolt, KA (corresponding author), Texas A&M Univ, Dept Biol, 3258 TAMU, College Stn, TX 77845 USA.	kpaczolt@mail.bio.tamu.edu		Jones, Adam/0000-0003-0228-7124	US National Science Foundation [IOS-0455927]	US National Science Foundation(National Science Foundation (NSF))	This work was supported by grant IOS-0455927 from the US National Science Foundation. We thank S. Scobell and R. Carter for help with animal husbandry. We are also grateful to S. Arnold, A. Berglund, M. Giresi, N. Ratterman, E. Rose, G. Rosenthal, C. Small and D. Zeh for comments on the manuscript.	Ahnesjo I, 1996, BEHAV ECOL SOCIOBIOL, V38, P167, DOI 10.1007/s002650050229; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Arnqvist Goran, 2005, pUnpaginated; Berglund A, 2003, ADV STUD BEHAV, V32, P131, DOI 10.1016/S0065-3454(03)01003-9; BERGLUND A, 1986, MAR ECOL PROG SER, V29, P209, DOI 10.3354/meps029209; BERGLUND A, 1986, BEHAV ECOL SOCIOBIOL, V19, P301, DOI 10.1007/BF00300646; Brown JD, 1972, THESIS U FLORIDA; BURLEY N, 1988, AM NAT, V132, P611, DOI 10.1086/284877; Dawson C.E., 1985, INDOPACIFIC PIPEFISH; Harlin-Cognato A, 2006, P NATL ACAD SCI USA, V103, P19407, DOI 10.1073/pnas.0603000103; HERALD EARL S., 1959, PROC CALIFORNIA ACAD SCI, V29, P465; Hunt J, 2009, J EVOLUTION BIOL, V22, P13, DOI 10.1111/j.1420-9101.2008.01633.x; Jones AG, 2000, P ROY SOC B-BIOL SCI, V267, P677, DOI 10.1098/rspb.2000.1055; Jones AG, 1997, MOL ECOL, V6, P203, DOI 10.1046/j.1365-294X.1997.00173.x; Jones AG, 2001, P ROY SOC B-BIOL SCI, V268, P2531, DOI 10.1098/rspb.2001.1841; Parker GA, 2002, PHILOS T R SOC B, V357, P295, DOI 10.1098/rstb.2001.0950; Partridge C, 2007, COMP BIOCHEM PHYS A, V147, P556, DOI 10.1016/j.cbpa.2007.02.007; Partridge C, 2009, BEHAV ECOL SOCIOBIOL, V63, P345, DOI 10.1007/s00265-008-0668-3; Ripley JL, 2009, COMP BIOCHEM PHYS A, V154, P98, DOI 10.1016/j.cbpa.2009.05.003; Ripley JL, 2009, J COMP PHYSIOL B, V179, P325, DOI 10.1007/s00360-008-0316-2; Ripley JL, 2006, J EXP BIOL, V209, P1112, DOI 10.1242/jeb.02119; Sagebakken G, 2010, P ROY SOC B-BIOL SCI, V277, P971, DOI 10.1098/rspb.2009.1767; Scobell SK, 2009, ANIM BEHAV, V78, P747, DOI 10.1016/j.anbehav.2009.05.036; Sheldon BC, 2000, TRENDS ECOL EVOL, V15, P397, DOI 10.1016/S0169-5347(00)01953-4; Steiger J. H., 1980, P ANN SPRING M PSYCH; Stolting KN, 2007, BIOESSAYS, V29, P884, DOI 10.1002/bies.zm.uzh.ch; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; VINCENT A, 1992, TRENDS ECOL EVOL, V7, P237, DOI 10.1016/0169-5347(92)90052-D; Wilson AB, 2003, EVOLUTION, V57, P1374; Wolfner MF, 2002, HEREDITY, V88, P85, DOI 10.1038/sj.hdy.6800017; Zeh DW, 2000, BIOESSAYS, V22, P938, DOI 10.1002/1521-1878(200010)22:10<938::AID-BIES9>3.0.CO;2-9	31	62	62	3	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 18	2010	464	7287					401	U94		10.1038/nature08861	http://dx.doi.org/10.1038/nature08861			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20237568				2022-12-28	WOS:000275657100044
J	Wacholder, S; Hartge, P; Prentice, R; Garcia-Closas, M; Feigelson, HS; Diver, WR; Thun, MJ; Cox, DG; Hankinson, SE; Kraft, P; Rosner, B; Berg, CD; Brinton, LA; Lissowska, J; Sherman, ME; Chlebowski, R; Kooperberg, C; Jackson, RD; Buckman, DW; Hui, P; Pfeiffer, R; Jacobs, KB; Thomas, GD; Hoover, RN; Gail, MH; Chanock, SJ; Hunter, DJ				Wacholder, Sholom; Hartge, Patricia; Prentice, Ross; Garcia-Closas, Montserrat; Feigelson, Heather Spencer; Diver, W. Ryan; Thun, Michael J.; Cox, David G.; Hankinson, Susan E.; Kraft, Peter; Rosner, Bernard; Berg, Christine D.; Brinton, Louise A.; Lissowska, Jolanta; Sherman, Mark E.; Chlebowski, Rowan; Kooperberg, Charles; Jackson, Rebecca D.; Buckman, Dennis W.; Hui, Peter; Pfeiffer, Ruth; Jacobs, Kevin B.; Thomas, Gilles D.; Hoover, Robert N.; Gail, Mitchell H.; Chanock, Stephen J.; Hunter, David J.			Performance of Common Genetic Variants in Breast-Cancer Risk Models.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; POLYMORPHISMS; PREVENTION; ALLELES; MARKER	Background: Genomewide association studies have identified multiple genetic variants associated with breast cancer. The extent to which these variants add to existing risk-assessment models is unknown. Methods: We used information on traditional risk factors and 10 common genetic variants associated with breast cancer in 5590 case subjects and 5998 control subjects, 50 to 79 years of age, from four U.S. cohort studies and one case-control study from Poland to fit models of the absolute risk of breast cancer. With the use of receiver-operating-characteristic curve analysis, we calculated the area under the curve (AUC) as a measure of discrimination. By definition, random classification of case and control subjects provides an AUC of 50%; perfect classification provides an AUC of 100%. We calculated the fraction of case subjects in quintiles of estimated absolute risk after the addition of genetic variants to the traditional risk model. Results: The AUC for a risk model with age, study and entry year, and four traditional risk factors was 58.0%; with the addition of 10 genetic variants, the AUC was 61.8%. About half the case subjects (47.2%) were in the same quintile of risk as in a model without genetic variants; 32.5% were in a higher quintile, and 20.4% were in a lower quintile. Conclusions: The inclusion of newly discovered genetic factors modestly improved the performance of risk models for breast cancer. The level of predicted breast-cancer risk among most women changed little after the addition of currently available genetic information. N Engl J Med 2010;362:986-93.	[Wacholder, Sholom; Hartge, Patricia; Garcia-Closas, Montserrat; Brinton, Louise A.; Sherman, Mark E.; Pfeiffer, Ruth; Jacobs, Kevin B.; Thomas, Gilles D.; Hoover, Robert N.; Gail, Mitchell H.; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Berg, Christine D.] NCI, Early Detect Res Grp, Canc Prevent Div, Bethesda, MD 20892 USA; [Prentice, Ross; Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Feigelson, Heather Spencer; Diver, W. Ryan; Thun, Michael J.] Amer Canc Soc, Dept Epidemiol, Atlanta, GA 30329 USA; [Feigelson, Heather Spencer] Kaiser Permanente, Inst Hlth Res, Denver, CO USA; [Cox, David G.] INSERM, F-69008 Lyon, France; [Cox, David G.; Hankinson, Susan E.; Kraft, Peter; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Rosner, Bernard] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Hankinson, Susan E.; Rosner, Bernard; Hunter, David J.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Hankinson, Susan E.; Rosner, Bernard; Hunter, David J.] Harvard Univ, Sch Med, Boston, MA USA; [Lissowska, Jolanta] Maria Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Chlebowski, Rowan] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Div Hematol & Med Oncol, Torrance, CA 90509 USA; [Jackson, Rebecca D.] Ohio State Univ, Columbus, OH 43210 USA; [Buckman, Dennis W.; Hui, Peter] Informat Management Serv Inc, Silver Spring, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fred Hutchinson Cancer Center; American Cancer Society; Kaiser Permanente; Institut National de la Sante et de la Recherche Medicale (Inserm); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University System of Ohio; Ohio State University; Information Management Services, Inc.	Wacholder, S (corresponding author), NCI, Div Canc Epidemiol & Genet, 6120 Execut Blvd,EPS 5050,MSC 7244, Bethesda, MD 20892 USA.	wacholds@mail.nih.gov	Diver, Ryan/AAG-3469-2019; Garcia-Closas, Montserrat/AAZ-6930-2021; Lissowska, Jolanta/AAH-3252-2020; Cox, David/ABA-7454-2020; Garcia-Closas, Montserrat/F-3871-2015; Pfeiffer, Ruth M/F-4748-2011; Brinton, Louise A/G-7486-2015; Cox, David G/A-2023-2009	Diver, Ryan/0000-0002-5418-9000; Garcia-Closas, Montserrat/0000-0003-1033-2650; Lissowska, Jolanta/0000-0003-2695-5799; Garcia-Closas, Montserrat/0000-0003-1033-2650; Brinton, Louise A/0000-0003-3853-8562; Cox, David G/0000-0002-2152-9259; Cox, David/0000-0003-2047-4687; Jacobs, Kevin/0000-0002-4657-6473	Division of Cancer Epidemiology and Genetics of the National Cancer Institute; National Institutes of Health [N01WH22110, P01 CA87969, P01 CA53996, R01 CA49449, U01CA098233, U01CA098710]; NATIONAL CANCER INSTITUTE [P01CA053996, ZIACP010181, P01CA087969, U01CA098710, R01CA049449, U01CA098233] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005007] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH022110] Funding Source: NIH RePORTER	Division of Cancer Epidemiology and Genetics of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported in part by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute and by grants from the National Institutes of Health (N01WH22110, P01 CA87969, P01 CA53996, R01 CA49449, U01CA098233, and U01CA098710).	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; American College of Obstetricians and Gynecologists, 2009, OBSTET GYNECOL, V113, P957, DOI DOI 10.1097/AOG.0B013E3181A106D4; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P2490, DOI 10.1002/cncr.101970; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Chatterjee N, 2006, AM J HUM GENET, V79, P1002, DOI 10.1086/509704; Chen JB, 2006, J NATL CANCER I, V98, P1215, DOI 10.1093/jnci/djj332; Costantino JP, 1999, J NATL CANCER I, V91, P1541, DOI 10.1093/jnci/91.18.1541; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 1999, J NATL CANCER I, V91, P1829, DOI 10.1093/jnci/91.21.1829; Gail MH, 2000, J NATL CANCER I, V92, P758, DOI 10.1093/jnci/92.9.758; GAIL MH, 1994, J NATL CANCER I, V86, P573, DOI 10.1093/jnci/86.8.573; Gail MH, 2008, J NATL CANCER I, V100, P1037, DOI 10.1093/jnci/djn180; Gail MH, 2009, J NATL CANCER I, V101, P959, DOI 10.1093/jnci/djp130; Garcia-Closas M, 2006, HUM GENET, V119, P376, DOI 10.1007/s00439-006-0135-z; Hayes RB, 2000, CONTROL CLIN TRIALS, V21, p349S, DOI 10.1016/S0197-2456(00)00101-X; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Katki HA, 2009, LANCET ONCOL, V10, P1022, DOI 10.1016/S1470-2045(09)70253-0; Kraft P, 2009, NAT REV GENET, V10, P264, DOI 10.1038/nrg2516; Langer RD, 2003, ANN EPIDEMIOL, V13, pS107, DOI 10.1016/S1047-2797(03)00047-4; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; *M SKLOD MEM CANC, NUMB NEW CANC CAS SI; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; *SEER PROGR, 2007, SEER 17 INC MORT 200; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; TUKEY JW, 1949, BIOMETRICS, V5, P232, DOI 10.2307/3001938; WILLETT WC, 1987, NEW ENGL J MED, V316, P1174, DOI 10.1056/NEJM198705073161902	31	331	344	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2010	362	11					986	993		10.1056/NEJMoa0907727	http://dx.doi.org/10.1056/NEJMoa0907727			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570CY	20237344	Green Accepted, Bronze			2022-12-28	WOS:000275650400009
J	Halpern, SD; Raz, A; Kohn, R; Rey, M; Asch, DA; Reese, P				Halpern, Scott D.; Raz, Amelie; Kohn, Rachel; Rey, Michael; Asch, David A.; Reese, Peter			Regulated Payments for Living Kidney Donation: An Empirical Assessment of the Ethical Concerns	ANNALS OF INTERNAL MEDICINE			English	Article							ORGAN DONATION; CONJOINT-ANALYSIS; HEALTH-CARE; CONFIDENCE-INTERVALS; COST-EFFECTIVENESS; CLINICAL-TRIALS; DONORS; INCENTIVES; TRANSPLANTATION; CONSEQUENCES	Background: Although regulated payments to encourage living kidney donation could reduce morbidity and mortality among patients waiting for a kidney transplant, doing so raises several ethical concerns. Objective: To determine the extent to which the 3 main concerns with paying kidney donors might manifest if a regulated market were created. Design: Cross-sectional study of participants' willingness to donate a kidney in 12 scenarios. Setting: Regional rail and urban trolley lines in Philadelphia County, Philadelphia, Pennsylvania. Participants: Of 550 potential participants, 409 completed the questionnaire (response rate, 74.4%); 342 of these participants were medically eligible to donate. Intervention: Across scenarios, researchers experimentally manipulated the amount of money that participants would receive, the participants' risk for subsequently developing kidney failure themselves, and who would receive the donated kidney. Measurements: The researchers determined whether payment represents an undue inducement by evaluating participants' sensitivity to risk in relation to the payment offered or an unjust inducement by evaluating participants' sensitivity to payment as a function of their annual income. The researchers also evaluated whether introducing payment would hinder altruistic donations by comparing participants' willingness to donate altruistically before versus after the introduction of payments. Results: Generalized estimating equation models revealed that participants' willingness to donate increased significantly as their risk for kidney failure decreased, as the payment offered increased, and when the kidney recipient was a family member rather than a patient on a public waiting list (P < 0.001 for each). No statistical interactions were identified between payment and risk (odds ratio, 1.00 [95% CI, 0.96 to 1.03]) or between payment and income (odds ratio, 1.01 [CI, 0.99 to 1.03]). The proximity of these estimates to 1.0 and narrowness of the CIs suggest that payment is neither an undue nor an unjust inducement, respectively. Alerting participants to the possibility of payment did not alter their willingness to donate for altruistic reasons (P = 0.40). Limitation: Choices revealed in hypothetical scenarios may not reflect real-world behaviors. Conclusion: Theoretical concerns about paying persons for living kidney donation are not corroborated by empirical evidence. A real-world test of regulated payments for kidney donation is needed to definitively show whether payment provides a viable and ethical method to increase the supply of kidneys available for transplantation.	[Halpern, Scott D.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Halpern, SD (corresponding author), Univ Penn, Sch Med, 724 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	scott.halpern@uphs.upenn.edu	Kohn, Rachel/M-6742-2019	Kohn, Rachel/0000-0002-9373-5035; Asch, David/0000-0002-7970-286X	Greenwall Foundation Faculty Scholar Award in Bioethics; National Institutes of Health [K23-078688-01]; University of Pennsylvania Center for Bioethics; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK078688] Funding Source: NIH RePORTER	Greenwall Foundation Faculty Scholar Award in Bioethics; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Center for Bioethics; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By a Greenwall Foundation Faculty Scholar Award in Bioethics (Dr. Halpern), the National Institutes of Health (Dr. Reese; grant K23-078688-01), and internships from the University of Pennsylvania Center for Bioethics (Ms. Raz, Ms. Kohn, and Mr. Rey).	Becker GS, 2007, J ECON PERSPECT, V21, P3, DOI 10.1257/jep.21.3.3; Boulware LE, 2006, AM J TRANSPLANT, V6, P2774, DOI 10.1111/j.1600-6143.2006.01532.x; BYAR DP, 1985, CANCER TREAT REP, V69, P1055; Chkhotua AB, 2003, UROLOGY, V62, P1002, DOI 10.1016/S0090-4295(03)00760-X; Delmonico FL, 2002, NEW ENGL J MED, V346, P2002, DOI 10.1056/NEJMsb013216; Fehrman-Ekholm I, 2001, TRANSPLANTATION, V72, P444, DOI 10.1097/00007890-200108150-00015; Friedman AL, 2006, BMJ-BRIT MED J, V333, P746, DOI 10.1136/bmj.38961.475718.68; Ghods AJ, 2006, CLIN J AM SOC NEPHRO, V1, P1136, DOI 10.2215/CJN.00700206; GOODMAN SN, 1994, ANN INTERN MED, V121, P200, DOI 10.7326/0003-4819-121-3-199408010-00008; Goyal M, 2002, JAMA-J AM MED ASSOC, V288, P1589, DOI 10.1001/jama.288.13.1589; Guadagnoli E, 2003, HEALTH CARE FINANC R, V24, P101; Halpern SD, 2008, NEW ENGL J MED, V358, P2832, DOI 10.1056/NEJMsb0800674; Halpern SD, 2004, ARCH INTERN MED, V164, P801, DOI 10.1001/archinte.164.7.801; Halpern SD, 2004, AM J MED, V116, P606, DOI 10.1016/j.amjmed.2003.12.025; Harmon W, 2006, CLIN J AM SOC NEPHRO, V1, P1146, DOI 10.2215/CJN.03050906; Heyman J, 2004, PSYCHOL SCI, V15, P787, DOI 10.1111/j.0956-7976.2004.00757.x; Hippen BE, 2005, J MED PHILOS, V30, P593, DOI 10.1080/03605310500421397; Ibrahim HN, 2009, NEW ENGL J MED, V360, P459, DOI 10.1056/NEJMoa0804883; Israni AK, 2005, AM J TRANSPLANT, V5, P15, DOI 10.1111/j.1600-6143.2004.00656.x; Jasper JD, 1999, TRANSPL P, V31, P2181, DOI 10.1016/S0041-1345(99)00301-2; Kerry SM, 1998, BRIT MED J, V316, P1455, DOI 10.1136/bmj.316.7142.1455; Localio AR, 2007, J CLIN EPIDEMIOL, V60, P874, DOI 10.1016/j.jclinepi.2006.12.001; Mange KC, 2001, NEW ENGL J MED, V344, P726, DOI 10.1056/NEJM200103083441004; Matas AJ, 2004, AM J TRANSPLANT, V4, P2007, DOI 10.1111/j.1600-6143.2004.00664.x; Matas AJ, 2004, AM J TRANSPLANT, V4, P216, DOI 10.1046/j.1600-6143.2003.00290.x; Matas AJ, 2008, CLIN TRANSPLANT, V22, P378, DOI 10.1111/j.1399-0012.2008.00798.x; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Phillips KA, 2002, HEALTH SERV RES, V37, P1681, DOI 10.1111/1475-6773.01115; Port FK, 2002, TRANSPLANTATION, V74, P1281, DOI 10.1097/00007890-200211150-00014; Radcliffe-Richards J, 1998, LANCET, V351, P1950, DOI 10.1016/S0140-6736(97)08211-1; Rothman SM, 2006, AM J TRANSPLANT, V6, P1524, DOI 10.1111/j.1600-6143.2006.01325.x; Ryan M, 2000, BMJ-BRIT MED J, V320, P1530, DOI 10.1136/bmj.320.7248.1530; Ryan M, 1998, HEALTH ECON, V7, P373, DOI 10.1002/(SICI)1099-1050(199806)7:4<373::AID-HEC348>3.0.CO;2-J; Scheper-Hughes N, 2003, LANCET, V361, P1645, DOI 10.1016/S0140-6736(03)13305-3; Schnitzler MA, 2005, TRANSPLANTATION, V80, P1636, DOI 10.1097/01.tp.0000179637.37276.5a; Schnitzler MA, 2005, AM J TRANSPLANT, V5, P2289, DOI 10.1111/j.1600-6143.2005.01021.x; Sheehy E, 2003, NEW ENGL J MED, V349, P667, DOI 10.1056/NEJMsa021271; Soneji ND, 2008, EXP CLIN TRANSPLANT, V6, P215; U.S. Census Bureau, STAT COUNT QUICK FAC; Veatch RM, 2003, KENNEDY INST ETHIC J, V13, P19, DOI 10.1353/ken.2003.0007; Weber M, 2002, NEW ENGL J MED, V347, P248, DOI 10.1056/NEJMoa020274; Young A, 2008, KIDNEY INT, V73, P1159, DOI 10.1038/ki.2008.65; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	43	46	46	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	2010	152	6					358	+		10.7326/0003-4819-152-6-201003160-00005	http://dx.doi.org/10.7326/0003-4819-152-6-201003160-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	573IF	20231566	Green Accepted			2022-12-28	WOS:000275905200003
J	Stiell, IG				Stiell, Ian G.			Withholding intravenous drugs did not improve survival to hospital discharge in out-of-hospital cardiac arrest	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Ottawa, Ottawa, ON, Canada	University of Ottawa	Stiell, IG (corresponding author), Univ Ottawa, Ottawa, ON, Canada.			Stiell, Ian/0000-0002-2583-6408				[Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	2010	152	6							JC3-8	10.7326/0003-4819-152-6-201003160-02008	http://dx.doi.org/10.7326/0003-4819-152-6-201003160-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573IF	20231562				2022-12-28	WOS:000275905200025
J	McLean, S; Sheikh, A				McLean, Susannah; Sheikh, Aziz			Uncertainties Page Does avoidance of peanuts in early life reduce the risk of peanut allergy?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHILDREN; INFANCY; PREVALENCE; DISORDERS; FORMULAS		[Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, Allergy & Resp Res Grp, Edinburgh EH8 9AG, Midlothian, Scotland	University of Edinburgh	Sheikh, A (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Allergy & Resp Res Grp, Edinburgh EH8 9AG, Midlothian, Scotland.	Aziz.sheikh@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056; Mclean, Susannah/0000-0001-8238-5167				Anandan C, 2006, BMJ-BRIT MED J, V333, P485, DOI 10.1136/bmj.333.7566.485; [Anonymous], RANDOMISED CONTROLLE; ARSHAD SH, 1992, LANCET, V339, P1493, DOI 10.1016/0140-6736(92)91260-F; Baker SS, 2000, PEDIATRICS, V106, P346; Committee on Toxicity of Chemicals in Food, 1998, PEAN ALL; *DEP HLTH, REV GOV ADV CONS PEA; Du Toit G, 2008, J ALLERGY CLIN IMMUN, V122, P984, DOI 10.1016/j.jaci.2008.08.039; Greer FR, 2008, PEDIATRICS, V121, P183, DOI 10.1542/peds.2007-3022; Hourihane JO, 1996, BRIT MED J, V313, P518, DOI 10.1136/bmj.313.7056.518; Hourihane JO, 2007, J ALLERGY CLIN IMMUN, V119, P1197, DOI 10.1016/j.jaci.2006.12.670; Kramer MS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000133.pub2; *MIN HLTH, 2006, FOOD NUTR GUID HLTH; Prescott SL, 2008, PEDIAT ALLERG IMM-UK, V19, P375, DOI 10.1111/j.1399-3038.2008.00718.x; Turke J, 2005, PEDIAT ALLERG IMM-UK, V16, P512, DOI 10.1111/j.1399-3038.2005.00305.x; Wennergren G, 2009, ACTA PAEDIATR, V98, P1085, DOI 10.1111/j.1651-2227.2009.01342.x; INDUCTION TOLERANCE	17	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2010	340								c424	10.1136/bmj.c424	http://dx.doi.org/10.1136/bmj.c424			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570FE	20223870				2022-12-28	WOS:000275656900013
J	Ladd, TD; Jelezko, F; Laflamme, R; Nakamura, Y; Monroe, C; O'Brien, JL				Ladd, T. D.; Jelezko, F.; Laflamme, R.; Nakamura, Y.; Monroe, C.; O'Brien, J. L.			Quantum computers	NATURE			English	Review							SINGLE-PHOTON; FACTORING ALGORITHM; RYDBERG BLOCKADE; SPIN QUBITS; DYNAMICS; ENTANGLEMENT; MANIPULATION; INFORMATION; COMPUTATION; INTERFACE	Over the past several decades, quantum information science has emerged to seek answers to the question: can we gain some advantage by storing, transmitting and processing information encoded in systems that exhibit unique quantum properties? Today it is understood that the answer is yes, and many research groups around the world are working towards the highly ambitious technological goal of building a quantum computer, which would dramatically improve computational power for particular tasks. A number of physical systems, spanning much of modern physics, are being developed for quantum computation. However, it remains unclear which technology, if any, will ultimately prove successful. Here we describe the latest developments for each of the leading approaches and explain the major challenges for the future.	[O'Brien, J. L.] Univ Bristol, Ctr Quantum Photon, HH Wills Phys Lab, Bristol BS8 1UB, Avon, England; [O'Brien, J. L.] Univ Bristol, Dept Elect & Elect Engn, Bristol BS8 1UB, Avon, England; [Ladd, T. D.] Stanford Univ, Edward L Ginzton Lab, Stanford, CA 94305 USA; [Jelezko, F.] Univ Stuttgart, Inst Phys 3, D-70550 Stuttgart, Germany; [Laflamme, R.] Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada; [Laflamme, R.] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada; [Laflamme, R.] Perimeter Inst, Waterloo, ON N2L 2Y5, Canada; [Nakamura, Y.] NEC Corp Ltd, Nano Elect Res Labs, Tsukuba, Ibaraki 3058501, Japan; [Nakamura, Y.] RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan; [Monroe, C.] Univ Maryland, Dept Phys, Joint Quantum Inst, College Pk, MD 20742 USA; [Monroe, C.] NIST, College Pk, MD 20742 USA	University of Bristol; University of Bristol; Stanford University; University of Stuttgart; University of Waterloo; University of Waterloo; Perimeter Institute for Theoretical Physics; NEC Corporation; RIKEN; University System of Maryland; University of Maryland College Park; National Institute of Standards & Technology (NIST) - USA	O'Brien, JL (corresponding author), Univ Bristol, Ctr Quantum Photon, HH Wills Phys Lab, Merchant Venturers Bldg,Woodland Rd, Bristol BS8 1UB, Avon, England.	jeremy.obrien@bristol.ac.uk	Nakamura, Yasunobu/H-1300-2012	Nakamura, Yasunobu/0000-0003-0424-630X; O'Brien, Jeremy/0000-0002-3576-8285	NSF; EPSRC; QIP IRC; IARPA; ERC; Leverhulme Trust; CREST-JST; DFG; BMBF; Landesstiftung BW; Royal Society; Engineering and Physical Sciences Research Council [EP/F008023/1, EP/F010524/1] Funding Source: researchfish; EPSRC [EP/F008023/1, EP/F010524/1] Funding Source: UKRI	NSF(National Science Foundation (NSF)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); QIP IRC; IARPA; ERC(European Research Council (ERC)European Commission); Leverhulme Trust(Leverhulme Trust); CREST-JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Landesstiftung BW; Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank R. Hanson, M. D. Lukin, and W. D. Oliver for comments. We acknowledge support from NSF, EPSRC, QIP IRC, IARPA, ERC, the Leverhulme Trust, CREST-JST, DFG, BMBF and Landesstiftung BW. J.L.O'B. acknowledges a Royal Society Wolfson Merit Award.	Anderlini M, 2007, NATURE, V448, P452, DOI 10.1038/nature06011; Andre A, 2006, NAT PHYS, V2, P636, DOI 10.1038/nphys386; Ansmann M, 2009, NATURE, V461, P504, DOI 10.1038/nature08363; Atature M, 2006, SCIENCE, V312, P551, DOI 10.1126/science.1126074; Balasubramanian G, 2009, NAT MATER, V8, P383, DOI [10.1038/nmat2420, 10.1038/NMAT2420]; Barnes CHW, 2000, PHYS REV B, V62, P8410, DOI 10.1103/PhysRevB.62.8410; Batra A, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2805634; Benhelm J, 2008, NAT PHYS, V4, P463, DOI 10.1038/nphys961; Berezovsky J, 2006, SCIENCE, V314, P1916, DOI 10.1126/science.1133862; Bertet P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.257002; Blatt R, 2008, NATURE, V453, P1008, DOI 10.1038/nature07125; Braunstein SL, 2005, REV MOD PHYS, V77, P513, DOI 10.1103/RevModPhys.77.513; Braunstein SL, 1999, PHYS REV LETT, V83, P1054, DOI 10.1103/PhysRevLett.83.1054; Chang DE, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.053002; Chiorescu I, 2003, SCIENCE, V299, P1869, DOI 10.1126/science.1081045; CHOW JM, 2009, ENTANGLEMENT METROLO; Cory DG, 1997, P NATL ACAD SCI USA, V94, P1634, DOI 10.1073/pnas.94.5.1634; de Riedmatten H, 2008, NATURE, V456, P773, DOI 10.1038/nature07607; Devitt SJ, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.052312; DiCarlo L, 2009, NATURE, V460, P240, DOI 10.1038/nature08121; DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; Duan LM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.080503; Duan LM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.127902; Dur W, 1999, PHYS REV A, V59, P169, DOI 10.1103/PhysRevA.59.169; Emerson J, 2007, SCIENCE, V317, P1893, DOI 10.1126/science.1145699; Fushman I, 2008, SCIENCE, V320, P769, DOI 10.1126/science.1154643; Gaetan A, 2009, NAT PHYS, V5, P115, DOI 10.1038/NPHYS1183; Garcia-Ripoll JJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.157901; Gerardot BD, 2008, NATURE, V451, P441, DOI 10.1038/nature06472; Gershenfeld NA, 1997, SCIENCE, V275, P350, DOI 10.1126/science.275.5298.350; Grangier P., 2004, NEW J PHYS, V6; Gruber A, 1997, SCIENCE, V276, P2012, DOI 10.1126/science.276.5321.2012; Dutt MVG, 2007, SCIENCE, V316, P1312, DOI 10.1126/science.1139831; Hanson R, 2008, SCIENCE, V320, P352, DOI 10.1126/science.1155400; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Hanson R, 2008, NATURE, V453, P1043, DOI 10.1038/nature07129; HARRIS R, 2009, EXPT DEMONSTRATION R; Harrison J, 2006, DIAM RELAT MATER, V15, P586, DOI 10.1016/j.diamond.2005.12.027; Jiang L, 2009, SCIENCE, V326, P267, DOI 10.1126/science.1176496; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Khitun A, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.062304; Kistner C, 2008, OPT EXPRESS, V16, P15006, DOI 10.1364/OE.16.015006; Knill E, 2005, NATURE, V434, P39, DOI 10.1038/nature03350; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Ladd TD, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.014401; Langer C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060502; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Leuenberger MN, 2001, NATURE, V410, P789, DOI 10.1038/35071024; Liu HW, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2938693; Lupascu A, 2007, NAT PHYS, V3, P119, DOI 10.1038/nphys509; Mason N, 2004, SCIENCE, V303, P655, DOI 10.1126/science.1093605; Matthews JCF, 2009, NAT PHOTONICS, V3, P346, DOI 10.1038/NPHOTON.2009.93; Mehring M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.153001; Micheli A, 2006, NAT PHYS, V2, P341, DOI 10.1038/nphys287; MIGDAL A, 2004, J MOD OPT, V51; Mizel A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.070502; MORSCH O, 2006, REV MOD PHYS, V179, P215; Morton JJL, 2006, NAT PHYS, V2, P40, DOI 10.1038/nphys192; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Negrevergne C, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.170501; Neumann P, 2008, SCIENCE, V320, P1326, DOI 10.1126/science.1157233; Neumann P, 2010, NAT PHYS, V6, P249, DOI 10.1038/NPHYS1536; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Niskanen AO, 2007, SCIENCE, V316, P723, DOI 10.1126/science.1141324; O'Brien JL, 2007, SCIENCE, V318, P1567, DOI 10.1126/science.1142892; O'Brien JL, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.161401; Olmschenk S, 2009, SCIENCE, V323, P486, DOI 10.1126/science.1167209; Piermarocchi C, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.167402; Platzman PM, 1999, SCIENCE, V284, P1967, DOI 10.1126/science.284.5422.1967; Politi A, 2009, SCIENCE, V325, P1221, DOI 10.1126/science.1173731; Press D, 2008, NATURE, V456, P218, DOI 10.1038/nature07530; Privman V, 1998, PHYS LETT A, V239, P141, DOI 10.1016/S0375-9601(97)00974-2; Quinteiro GF, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.097401; Raussendorf R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.190504; Recher P, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.165314; Rippe L, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.022307; Ryan CA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.140501; Ryan CA, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/1/013034; Sanaka K, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.053601; Schmidt H, 1996, OPT LETT, V21, P1936, DOI 10.1364/OL.21.001936; Schneider C, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2920189; Schreier JA, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.180502; Shor PW, 2008, QUANTUM INF COMPUT, V8, P681; Simmons CB, 2009, NANO LETT, V9, P3234, DOI 10.1021/nl9014974; Smelyanskiy VN, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.081304; Takahashi S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.047601; Tian L, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.266403; Tian L, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.247902; Treutlein P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.203005; TYRYSHKIN AM, 2009, SIL QUB WORKSH 24 25; Uhrig GS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.100504; Urban E, 2009, NAT PHYS, V5, P110, DOI 10.1038/NPHYS1178; Vandersypen LMK, 2001, NATURE, V414, P883, DOI 10.1038/414883a; Vion D, 2002, SCIENCE, V296, P886, DOI 10.1126/science.1069372; Vrijen R, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.012306; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Wang CF, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2813023; Wang CL, 2006, J PHYS B-AT MOL OPT, V39, P37, DOI 10.1088/0953-4075/39/1/005; Wu E, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/12/434; Yang A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.257401	111	2107	2146	29	1085	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2010	464	7285					45	53		10.1038/nature08812	http://dx.doi.org/10.1038/nature08812			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20203602	Green Submitted			2022-12-28	WOS:000275117500031
J	Mitsuhashi, R; Suzuki, Y; Yamanari, Y; Mitamura, H; Kambe, T; Ikeda, N; Okamoto, H; Fujiwara, A; Yamaji, M; Kawasaki, N; Maniwa, Y; Kubozono, Y				Mitsuhashi, Ryoji; Suzuki, Yuta; Yamanari, Yusuke; Mitamura, Hiroki; Kambe, Takashi; Ikeda, Naoshi; Okamoto, Hideki; Fujiwara, Akihiko; Yamaji, Minoru; Kawasaki, Naoko; Maniwa, Yutaka; Kubozono, Yoshihiro			Superconductivity in alkali-metal-doped picene	NATURE			English	Article							THIN-FILMS	Efforts to identify and develop new superconducting materials continue apace, motivated by both fundamental science and the prospects for application. For example, several new superconducting material systems have been developed in the recent past, including calcium-intercalated graphite compounds(1), boron-doped diamond(2) and-most prominently-iron arsenides such as LaO1-xFxFeAs (ref. 3). In the case of organic superconductors, however, no new material system with a high superconducting transition temperature (T-c) has been discovered in the past decade. Here we report that intercalating an alkali metal into picene, a wide-bandgap semiconducting solid hydrocarbon, produces metallic behaviour and superconductivity. Solid potassium-intercalated picene (K(x)picene) shows T-c values of 7K and 18 K, depending on the metal content. The drop of magnetization in Kxpicene solids at the transition temperature is sharp (<2 K), similar to the behaviour of Ca-intercalated graphite(1). The Tc of 18K is comparable to that of K-intercalated C-60 (ref. 4). This discovery of superconductivity in K(x)picene shows that organic hydrocarbons are promising candidates for improved T-c values.	[Mitsuhashi, Ryoji; Mitamura, Hiroki; Kawasaki, Naoko; Kubozono, Yoshihiro] Okayama Univ, Surface Sci Res Lab, Okayama 7008530, Japan; [Suzuki, Yuta; Yamanari, Yusuke; Kambe, Takashi; Ikeda, Naoshi] Okayama Univ, Dept Phys, Okayama 7008530, Japan; [Okamoto, Hideki] Okayama Univ, Dept Chem, Okayama 7008530, Japan; [Okamoto, Hideki] Kyushu Univ, Inst Mat Chem & Engn, Fukuoka 8128581, Japan; [Fujiwara, Akihiko] Japan Adv Inst Sci & Technol, Kanazawa, Ishikawa 9231292, Japan; [Yamaji, Minoru] Gunma Univ, Dept Chem & Chem Biol, Kiryu, Gunma 3768515, Japan; [Maniwa, Yutaka] Tokyo Metropolitan Univ, Dept Phys, Hachioji, Tokyo 1920397, Japan	Okayama University; Okayama University; Okayama University; Kyushu University; Japan Advanced Institute of Science & Technology (JAIST); Gunma University; Tokyo Metropolitan University	Kubozono, Y (corresponding author), Okayama Univ, Surface Sci Res Lab, Okayama 7008530, Japan.	kubozono@cc.okayama-u.ac.jp	Mitsuhashi, Ryoji/F-1263-2015; KUBOZONO, Yoshihiro/B-2091-2011; Okamoto, Hideki/C-3276-2015; KAMBE, Takashi/B-2117-2011; Fujiwara, Akihiko/F-3031-2015; IKEDA, Naoshi/B-2587-2011; Mitsuhashi, Ryoji/J-6647-2019	Mitsuhashi, Ryoji/0000-0002-0603-7301; Okamoto, Hideki/0000-0002-8742-4089; Fujiwara, Akihiko/0000-0002-1319-388X; Mitsuhashi, Ryoji/0000-0002-0603-7301; Yamaji, Minoru/0000-0001-9963-2136; Kubozono, Yoshihiro/0000-0002-7910-0308	MEXT, Japan [20045012, 18340104]	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The X-ray diffraction patterns were measured with synchrotron radiation at KEK-PF (proposal no. 2007G612), Tsukuba, Japan. This work was supported in part by Grants-in-Aid 20045012 and 18340104 from MEXT, Japan.	DE A, 1985, ACTA CRYSTALLOGR C, V41, P907, DOI 10.1107/S0108270185005959; Ekimov EA, 2004, NATURE, V428, P542, DOI 10.1038/nature02449; Emery N, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.087003; FLEMING RM, 1991, NATURE, V352, P787, DOI 10.1038/352787a0; Ganin AY, 2008, NAT MATER, V7, P367, DOI 10.1038/nmat2179; HANNAY NB, 1965, PHYS REV LETT, V14, P225, DOI 10.1103/PhysRevLett.14.225; Hansson A, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.184114; HEBARD AF, 1991, NATURE, V350, P600, DOI 10.1038/350600a0; Kaji Y, 2009, ORG ELECTRON, V10, P432, DOI 10.1016/j.orgel.2009.01.006; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Kaneko Y, 2005, SYNTHETIC MET, V154, P177, DOI 10.1016/j.synthmet.2005.07.045; Kawasaki N, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3076124; Matsuo Y, 2004, PHYS LETT A, V321, P62, DOI 10.1016/j.physleta.2003.12.004; MINAKATA T, 1993, J APPL PHYS, V74, P1079, DOI 10.1063/1.354955; Okamoto H, 2008, J AM CHEM SOC, V130, P10470, DOI 10.1021/ja803291a; PALSTRA TTM, 1995, SOLID STATE COMMUN, V93, P327, DOI 10.1016/0038-1098(94)00786-1; SCHIRBER JE, 1991, PHYS REV B, V44, P4666, DOI 10.1103/PhysRevB.44.4666; Takabayashi Y, 2009, SCIENCE, V323, P1585, DOI 10.1126/science.1169163; TANIGAKI K, 1991, NATURE, V352, P222, DOI 10.1038/352222a0; Weller TE, 2005, NAT PHYS, V1, P39, DOI 10.1038/nphys0010	20	399	401	7	302	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 4	2010	464	7285					76	79		10.1038/nature08859	http://dx.doi.org/10.1038/nature08859			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20203605				2022-12-28	WOS:000275117500036
